"","name","strength","authdate","licensenum","licenseholder","ACTIVE_COMP"
"1","0.18 % w/v Sodium Chloride and 4 % w/v Glucose Intravenous Infusion BP, Solution for Infusion","0.18 and 4 percent weight/volume Solution for infusion",1983-04-01,"PA0179/003/006","B. Braun Medical Limited","Glucose|Sodiumchloride"
"2","0.9 % w/v Sodium Chloride Injection BP","0.9 percent weight/volume Solution for injection",1987-04-08,"PA0179/002/013","B. Braun Medical Limited","Sodiumchloride"
"3","1% w/v Lidocaine Hydrochloride Injection BP","1 percent weight/volume Solution for injection",1992-04-22,"PA0179/037/001","B. Braun Medical Limited","LIDOCAINEHYDROCHLORIDE"
"4","2% w/v Lidocaine Hydrochloride Injection BP","2 percent weight/volume Solution for injection",1992-04-22,"PA0179/037/004","B. Braun Medical Limited","LIDOCAINEHYDROCHLORIDE"
"5","8.4% w/v Sodium Bicarbonate Intravenous Infusion BP","8.4 percent weight/volume Solution for infusion",1983-04-01,"PA0179/006/001","B. Braun Medical Limited","Sodiumhydrogencarbonate"
"6","ABACAVIR/LAMIVUDINE","600mg/300 Milligram                                                                                            Film Coated Tablet",2017-11-10,"PA0405/107/001","Generics (UK) Limited","ABACAVIRSULFATE|LAMIVUDINE"
"7","ABACAVIR/LAMIVUDINE","600/300 Milligram                                                                                            Film Coated Tablet",2017-10-27,"PA1390/152/001","Accord Healthcare Limited","LAMIVUDINE"
"8","ABACAVIR/LAMIVUDINE CLONMEL","600/300 Milligram                                                                                            Film Coated Tablet",2016-05-06,"PA0126/284/001","Clonmel Healthcare Ltd","LAMIVUDINE"
"9","Abacavir/Lamivudine Mylan 600 mg/300 mg film-coated tablets","600/300 milligram(s) Film-coated tablet",2016-10-07,"PA0405/088/001","Generics (UK) Limited","Abacavir|Lamivudine"
"10","Abacavir/Lamivudine Rowex 600 mg/300 mg film-coated tablets","600/300 milligram(s) Film-coated tablet",2016-09-02,"PA0711/251/001","Rowex Ltd","Abacavir|Lamivudine"
"11","Abacavir/Lamivudine Teva 600 mg/300 mg Film-coated Tablets","600/300 milligram(s) Tablet",2016-10-07,"PA1986/014/001","Teva B.V.","Abacavir|Lamivudine"
"12","Abasaglar","100 unit(s)/millilitre Solution for injection",2014-09-09,"EU/1/14/944/001-004","Eli Lilly Nederland B.V.","Insulinglargine"
"13","ABASAGLAR","100 Units/ml                                                                                             Solution for injection in pre-filled pen",2014-09-09,"EU/1/14/944/005-008","Eli Lilly Nederland B.V.","INSULINGLARGINE"
"14","ABIDEC MULTIVITAMIN","25 Millilitre                                                                                           Oral Drops Solution",2000-09-01,"PA1186/001/001","Chefaro Ireland DAC","RETINOLPALMITATE|ERGOCALCIFEROL|THIAMINEHYDROCHLORIDE|RIBOFLAVINSODIUMPHOSPHATE|PYRIDOXINEHYDROCHLORIDE|NICOTINAMIDE|ASCORBICACID"
"15","Abilify","5 milligram(s) Tablet",NA,"EU/1/04/276/001-005","Otsuka Pharmaceutical Netherlands B.V.","Aripiprazole"
"16","ABILIFY","10 Milligram                                                                                            Tablets",0001-01-01,"EU/1/04/276/006-010","Otsuka Pharmaceutical Europe Ltd","ARIPIPRAZOLE"
"17","ABILIFY","15 Milligram                                                                                            Tablets",0001-01-01,"EU/1/04/276/011-015","Otsuka Pharmaceutical Europe Ltd","ARIPIPRAZOLE"
"18","ABILIFY","30 Milligram                                                                                            Tablets",0001-01-01,"EU/1/04/276/016-020","Otsuka Pharmaceutical Europe Ltd","ARIPIPRAZOLE"
"19","Abilify","10 milligram(s) Orodispersible tablet",2005-06-20,"EU/1/04/276/024-026","Otsuka Pharmaceutical Netherlands B.V.","Aripiprazole"
"20","ABILIFY","15 Milligram                                                                                            Orodispersible Tablet",0001-01-01,"EU/1/04/276/027-029","Otsuka Pharmaceutical Europe Ltd","ARIPIPRAZOLE"
"21","ABILIFY","30 Milligram                                                                                            Orodispersible Tablet",0001-01-01,"EU/1/04/276/030-032","Otsuka Pharmaceutical Europe Ltd","ARIPIPRAZOLE"
"22","Abilify","1 milligram(s)/millilitre Oral solution",NA,"EU/1/04/276/033-035","Otsuka Pharmaceutical Netherlands B.V.","Aripiprazole"
"23","Abilify","7.5 milligram(s)/millilitre Solution for injection",NA,"EU/1/04/276/036","Otsuka Pharmaceutical Netherlands B.V.","Aripiprazole"
"24","Abilify Maintena","300 milligram(s) Powder and solvent for suspension for injection",NA,"EU/1/13/882/001,003","Otsuka Pharmaceutical Netherlands B.V.","Aripiprazole"
"25","Abilify Maintena","400 milligram(s) Powder and solvent for suspension for injection",2014-01-30,"EU/1/13/882/002,004","Otsuka Pharmaceutical Netherlands B.V.","Aripiprazole"
"26","ABRAXANE","5 Mg/Ml Powder for suspension for infusion",2008-01-11,"EU/1/07/428/001","Celgene Europe B.V.","PACLITAXEL(FORMULATEDASALBUMINBOUNDNANOPARTICLES)"
"27","ABSEAMED","20000/0.5 IU/ML                                                                                                Solution for Injection",2009-11-26,"EU/1/07/412/021-22","Medice Arzneimittel Putter GmbH","EPOETINALFA"
"28","ABSEAMED","30000/0.75 IU/ML                                                                                                Solution for Injection",2009-11-26,"EU/1/07/412/023-24","Medice Arzneimittel Putter GmbH","EPOETINALFA"
"29","ABSEAMED","40000/1 IU/ML                                                                                                Solution for Injection",2009-11-26,"EU/1/07/412/025-26","Medice Arzneimittel Putter GmbH","EPOETINALFA"
"30","ABSEAMED","6000 International Unit                                                                                   Solution for Injection",2007-08-28,"EU/1/07/412/11-12","Medice Arzneimittel Putter GmbH","RECOMBINANTHUMANERYTHROPOIETINALFA"
"31","ABSEAMED","1000 International Unit                                                                                   Solution for Injection",2007-08-28,"EU/1/07/412/1-2","Medice Arzneimittel Putter GmbH","RECOMBINANTHUMANERYTHROPOIETINALFA"
"32","ABSEAMED","8000 International Unit                                                                                   Solution for Injection",2007-08-28,"EU/1/07/412/13-14","Medice Arzneimittel Putter GmbH","RECOMBINANTHUMANERYTHROPOIETINALFA"
"33","ABSEAMED","10,000 International Unit                                                                                   Solution for Injection",2007-08-28,"EU/1/07/412/15-16","Medice Arzneimittel Putter GmbH","RECOMBINANTHUMANERYTHROPOIETINALFA"
"34","ABSEAMED","2000 International Unit                                                                                   Solution for Injection",2007-08-28,"EU/1/07/412/3-4","Medice Arzneimittel Putter GmbH","RECOMBINANTHUMANERYTHROPOIETINALFA"
"35","ABSEAMED","3000 International Unit                                                                                   Solution for Injection",2007-08-28,"EU/1/07/412/5-6","Medice Arzneimittel Putter GmbH","RECOMBINANTHUMANERYTHROPOIETINALFA"
"36","ABSEAMED","4000 International Unit                                                                                   Solution for Injection",2007-08-28,"EU/1/07/412/7-8","Medice Arzneimittel Putter GmbH","RECOMBINANTHUMANERYTHROPOIETINALFA"
"37","ABSEAMED","5000 International Unit                                                                                   Solution for Injection",2007-08-28,"EU/1/07/412/9-10","Medice Arzneimittel Putter GmbH","RECOMBINANTHUMANERYTHROPOIETINALFA"
"38","ABSTRAL","100 Microgram                                                                                            Tablet Sublingual",2009-05-22,"PA1049/006/002","Kyowa Kirin Ltd","FENTANYL,ASCITRATESALT"
"39","ABSTRAL","200 Microgram                                                                                            Tablet Sublingual",2009-05-22,"PA1049/006/003","Kyowa Kirin Ltd","FENTANYL,ASCITRATESALT"
"40","ABSTRAL","300 Microgram                                                                                            Tablet Sublingual",2009-05-22,"PA1049/006/004","Kyowa Kirin Ltd","FENTANYL,ASCITRATESALT"
"41","ABSTRAL","400 Microgram                                                                                            Tablet Sublingual",2009-05-22,"PA1049/006/005","Kyowa Kirin Ltd","FENTANYL,ASCITRATESALT"
"42","ABSTRAL","600 Microgram                                                                                            Tablet Sublingual",2009-05-22,"PA1049/006/006","Kyowa Kirin Ltd","FENTANYL,ASCITRATESALT"
"43","ABSTRAL","800 Microgram                                                                                            Tablet Sublingual",2009-05-22,"PA1049/006/007","Kyowa Kirin Ltd","FENTANYL,ASCITRATESALT"
"44","ACCOFIL","30/0.5 Microgram/ML                                                                                         Solution for injection in pre-filled syringe",2014-09-18,"EU/1/14/946/001-002","Accord Healthcare Limited","FILGRASTIM"
"45","ACCOFIL","48/0.5 Microgram/ML                                                                                         Solution for injection in pre-filled syringe",2014-09-18,"EU/1/14/943/003-004","Accord Healthcare Limited","FILGRASTIM"
"46","ACCOLATE","20 Milligram                                                                                            Tablets",1996-01-03,"PA0970/001/001","AstraZeneca UK Limited","ZAFIRLUKAST"
"47","ACCUPRO","5 Milligram                                                                                            Film Coated Tablet",1989-08-09,"PA0822/007/001","Pfizer Healthcare Ireland","QUINAPRILHYDROCHLORIDE"
"48","ACCUPRO","10 Milligram                                                                                            Film Coated Tablet",1989-08-09,"PA0822/007/002","Pfizer Healthcare Ireland","QUINAPRILHYDROCHLORIDE"
"49","ACCUPRO","20 Milligram                                                                                            Film Coated Tablet",1989-08-09,"PA0822/007/003","Pfizer Healthcare Ireland","QUINAPRILHYDROCHLORIDE"
"50","ACCUPRO","40 Milligram                                                                                            Film Coated Tablet",1994-12-16,"PA0822/007/004","Pfizer Healthcare Ireland","QUINAPRILHYDROCHLORIDE"
"51","ACCUPRO 10 MG FILM-COATED TABLETS","10 Milligram                                                                                            Film Coated Tablet",2004-11-12,"PPA0465/135/002","PCO Manufacturing","QUINAPRILHYDROCHLORIDE"
"52","ACCUPRO 20 MG FILM-COATED TABLETS","20 Milligram                                                                                            Film Coated Tablet",2004-11-12,"PPA0465/135/003","PCO Manufacturing","QUINAPRILHYDROCHLORIDE"
"53","ACCUPRO 5 MG FILM-COATED TABLETS","5 Milligram                                                                                            Film Coated Tablet",2004-11-12,"PPA0465/135/001","PCO Manufacturing","QUINAPRILHYDROCHLORIDE"
"54","Accuretic 20 mg/12.5 mg film-coated tablets","20/12.5 milligram(s) Film-coated tablet",1992-04-16,"PA0822/008/002","Pfizer Healthcare Ireland","Quinaprilhydrochloride|Hydrochlorothiazide"
"55","Accusol 35 Potassium 2 mmol/lSolution for haemofiltration, haemodialysis and haemodiafiltration","2 ZZZ mmol/L Solution for haemodialysis/haemofiltration",2006-04-28,"PA2021/002/001","Nikkiso Belgium bvba","Sodiumchloride|Calciumchloride|Magnesiumchloride|Sodiumbicarbonate|Potassiumchloride|Glucoseanhydrous"
"56","Accusol 35 Potassium 4 mmol/lSolution for haemofiltration, haemodialysis and haemodiafiltration","4 ZZZ mmol/L Solution for haemodialysis/haemofiltration",2006-04-28,"PA2021/002/002","Nikkiso Belgium bvba","Sodiumchloride|Calciumchloride|Magnesiumchloride|Sodiumbicarbonate|Potassiumchloride|Glucoseanhydrous"
"57","Accusol 35 Solution for haemofiltration, haemodialysis and haemodiafiltration","0  Solution for haemofiltration",2006-04-28,"PA2021/001/001","Nikkiso Belgium bvba","Sodiumchloride|Calciumchloride|Magnesiumchloride|Sodiumbicarbonate"
"58","ACERYCAL","5/5 mg/mg Tablets",2012-04-20,"PPA0465/283/001","PCO Manufacturing","PERINDOPRILARGININE|AMLODIPINEBESYLATE"
"59","ACERYCAL","10/10 mg/mg Tablets",2012-04-20,"PPA0465/283/002","PCO Manufacturing","PERINDOPRILARGININE|AMLODIPINEBESYLATE"
"60","ACERYCAL","5/10 mg/mg Tablets",2012-04-27,"PPA0465/283/003","PCO Manufacturing","PERINDOPRILARGININE|AMLODIPINEBESILATE"
"61","ACERYCAL","10/5 mg/mg Tablets",2012-04-27,"PPA0465/283/004","PCO Manufacturing","PERINDOPRILARGININE|AMLODIPINEBESILATE"
"62","ACERYCAL","5/5 mg/mg Tablets",2011-11-11,"PPA1562/071/001","LTT Pharma Limited","PERINDOPRILARGININE|AMLODIPINEBESYLATE"
"63","ACERYCAL","5/10 mg/mg Tablets",2011-11-11,"PPA1562/071/002","LTT Pharma Limited","PERINDOPRILARGININE|AMLODIPINEBESYLATE"
"64","ACERYCAL","10/5 mg/mg Tablets",2011-11-11,"PPA1562/071/003","LTT Pharma Limited","PERINDOPRILARGININE|AMLODIPINEBESYLATE"
"65","ACERYCAL","10/10 mg/mg Tablets",2011-11-11,"PPA1562/071/004","LTT Pharma Limited","PERINDOPRILARGININE|AMLODIPINEBESYLATE"
"66","Acerycal  10mg/10mg tablets","10/10 ZZZ mg/mg Tablet",2008-06-13,"PA0568/018/004","Les Laboratoires Servier","Perindoprilarginine|Amlodipinebesylate"
"67","Acerycal  5mg/10mg tablets","5/10 ZZZ mg/mg Tablet",2008-06-13,"PA0568/018/002","Les Laboratoires Servier","Perindoprilarginine|Amlodipinebesylate"
"68","ACERYCAL 10mg/10mg tablets","10/10 milligram(s) Tablet",2015-01-30,"PPA1633/035/004","Primecrown 2010 Limited","Perindoprilarginine|Amlodipinebesylate"
"69","ACERYCAL 10mg/5mg tablets","10/5 milligram(s) Tablet",2015-01-30,"PPA1633/035/003","Primecrown 2010 Limited","Perindoprilarginine|Amlodipinebesylate"
"70","Acerycal 10mg/5mg tablets","10/5 ZZZ mg/mg Tablet",2008-06-13,"PA0568/018/003","Les Laboratoires Servier","Perindoprilarginine|Amlodipinebesylate"
"71","ACERYCAL 5mg/10mg tablets","5/10 milligram(s) Tablet",2015-01-30,"PPA1633/035/002","Primecrown 2010 Limited","Perindoprilarginine|Amlodipinebesylate"
"72","ACERYCAL 5mg/5mg tablets","5/5 milligram(s) Tablet",2015-01-30,"PPA1633/035/001","Primecrown 2010 Limited","Perindoprilarginine|Amlodipinebesylate"
"73","Acerycal 5mg/5mg tablets","5/5 ZZZ mg/mg Tablet",2008-06-13,"PA0568/018/001","Les Laboratoires Servier","Perindoprilarginine|Amlodipinebesylate"
"74","ACETYLCYSTEINE ESSENTIAL-HEALTHCARE","600 Milligram                                                                                            Tablets Effervescent",2018-03-29,"PA2130/002/001","Essential-Healthcare Ltd.","ACETYLCYSTEINE"
"75","ACIC","5 Per Cent                                                                                             Cream",2003-05-02,"PA0711/017/001","Rowex Ltd","ACICLOVIR"
"76","ACIC COLD SORE","5 %w/w                                                                                                 Cream",2012-11-23,"PA0711/017/006","Rowex Ltd","ACICLOVIR"
"77","ACICLOVIR","200/5 Mg/Ml Oral Suspension",2016-05-26,"PA1861/014/001","SYRI Limited, t/a Thame Laboratories","ACICLOVIR"
"78","ACICLOVIR","400/5 Mg/Ml Oral Suspension",2016-05-26,"PA1861/014/002","SYRI Limited, t/a Thame Laboratories","ACICLOVIR"
"79","Aciclovir 25mg/ml Concentrate for solution for infusion","25 milligram(s)/millilitre Concentrate for solution for infusion",2013-03-27,"PA2299/041/001","Baxter Holding B.V.","ACICLOVIR"
"80","Aciclovir 25mg/ml Concentrate for Solution for Infusion","25 milligram(s)/millilitre Concentrate for solution for infusion",1999-01-22,"PA0822/215/001","Pfizer Healthcare Ireland","Aciclovirsodium"
"81","Aciclovir 25mg/ml Concentrate for Solution for Infusion","25 milligram(s)/millilitre Concentrate for solution for infusion",1999-01-22,"PA000822/215/001","Pfizer Healthcare Ireland","Aciclovirsodium|Aciclovirsodium"
"82","ACICLOVIR AZEVEDOS","250 Milligram                                                                                            Pdr for Soln for Infusion",2017-10-06,"PA1852/003/001","Laboratórios Azevedos - Indústria Farmacêutica S.A","ACICLOVIRSODIUM"
"83","ACIDEX","Milligram                                                                                            Oral Suspension",1998-06-26,"PA0281/075/001","Pinewood Laboratories Ltd,","SODIUMBICARBONATE|SODIUMALGINATE|CALCIUMCARBONATE"
"84","Aclasta","5/100 micromole(s) Solution for infusion",NA,"EU/1/05/308/001","Novartis Europharm Limited","Zoledronicacid"
"85","ACNECIDE 5% W/W GEL","5 %w/w                                                                                                 Gel",1984-04-17,"PA0590/007/001","Galderma (UK) Ltd","BENZOYLPEROXIDE"
"86","ACNECIDE WASH 5 % W/W GEL","5 %w/w                                                                                                 Gel",1997-10-31,"PA0590/007/003","Galderma (UK) Ltd","BENZOYLPEROXIDEHYDROUS"
"87","ACONITE","6C & 30C  Tablets",2010-09-10,"HOR0407/013/001","Weleda (UK) Limited","ACONITUMNAPELLUS"
"88","ACONITE","6C-MM N/A",2011-03-11,"HOR1149/001/001","A. Nelson & Company Limited","ACONITUMNAPELLUS"
"89","ACTELSAR HCT","40/12.5 mg/mg Tablets",2013-03-13,"EU/1/13/817/001-013","Actavis Group PTC ehf","TELMISARTAN|HYDROCHLOROTHIAZIDE"
"90","ACTELSAR HCT","80/12.5 mg/mg Tablets",2013-03-13,"EU/1/13/817/014-028","Actavis Group PTC ehf","TELMISARTAN|HYDROCHLOROTHIAZIDE"
"91","ACTELSAR HCT","80/25 mg/mg Tablets",2013-03-13,"EU/1/13/817/029-041","Actavis Group PTC ehf","TELMISARTAN|HYDROCHLOROTHIAZIDE"
"92","ACTIFED 30mg/1.25mg per 5ml Syrup","30/1.25 mg/5ml Syrup",NA,"PA0330/049/001","Johnson & Johnson (Ireland) Limited","PSEUDOEPHEDRINEHYDROCHLORIDE|TRIPROLIDINEHYDROCHLORIDE"
"93","Actifed 60mg/2.5mg Tablets","60/2.5 milligram(s) Tablet",NA,"PA0330/049/002","Johnson & Johnson (Ireland) Limited","PSEUDOEPHEDRINEHYDROCHLORIDE|TRIPROLIDINEHYDROCHLORIDE"
"94","Actifed 60mg/2.5mg tablets","60/2.5 milligram(s) Tablet",2014-02-07,"PPA1151/210/001","Imbat Limited","TRIPROLIDINEHYDROCHLORIDE|PSEUDOEPHEDRINEHYDROCHLORIDE"
"95","Actilyse 10 mg powder and solvent for solution for injection and infusion","10 milligram(s) Powder and solvent for solution for injection/infusion",1994-09-08,"PA0007/043/003","Boehringer Ingelheim Limited","Alteplase"
"96","Actilyse 20 mg powder and solvent for solution for injection and infusion","20 milligram(s) Powder and solvent for solution for injection/infusion",1989-06-19,"PA0007/043/001","Boehringer Ingelheim Limited","Alteplase"
"97","Actilyse 50 mg powder and solvent for solution for injection and infusion","50 milligram(s) Powder and solvent for solution for injection/infusion",1989-06-19,"PA0007/043/002","Boehringer Ingelheim Limited","Alteplase"
"98","ACTILYSE CATHFLO","2 Milligram                                                                                            Pdr+Solv for soln for inf/inj",2010-04-09,"PA0007/043/005","Boehringer Ingelheim Limited","ALTEPLASE"
"99","ACTIPROFEN","200 Milligram                                                                                            Film Coated Tablet",1992-03-24,"PA0678/061/002","GlaxoSmithKline Consumer Healthcare (Ireland) Limited","IBUPROFEN"
"100","ACTIQ","200 Microgram                                                                                            Lozenges",2002-01-23,"PA0749/195/001","Teva Pharma B.V.","FENTANYLCITRATE"
"101","ACTIQ","400 Microgram                                                                                            Lozenges",2002-01-23,"PA0749/195/002","Teva Pharma B.V.","FENTANYLCITRATE"
"102","ACTIQ","600 Microgram                                                                                            Lozenges",2002-01-23,"PA0749/195/003","Teva Pharma B.V.","FENTANYLCITRATE"
"103","ACTIQ","800 Microgram                                                                                            Lozenges",2002-01-23,"PA0749/195/004","Teva Pharma B.V.","FENTANYLCITRATE"
"104","ACTIQ","1200 Microgram                                                                                            Lozenges",2002-01-23,"PA0749/195/005","Teva Pharma B.V.","FENTANYLCITRATE"
"105","ACTIQ","1600 Microgram                                                                                            Lozenges",2002-01-23,"PA0749/195/006","Teva Pharma B.V.","FENTANYLCITRATE"
"106","ACTIQ","200 Microgram                                                                                            Lozenges",2015-05-15,"PPA0465/407/001","PCO Manufacturing","FENTANYL"
"107","ACTIQ","400 Microgram                                                                                            Lozenges",2015-05-15,"PPA0465/407/002","PCO Manufacturing","FENTANYL"
"108","ACTIVELLE","1 / 0.5 Milligram                                                                                            Film Coated Tablet",1998-08-28,"PA0218/052/001","Novo Nordisk A/S","ESTRADIOLHEMIHYDRATE|NORETHISTERONEACETATE"
"109","Activelle 1 mg/0.5 mg Film-coated Tablets","1/0.5 milligram(s) Film-coated tablet",2007-10-19,"PPA0465/199/001","PCO Manufacturing","Norethisteroneacetate|Estradiol"
"110","ACTONEL","5 Milligram                                                                                            Film Coated Tablet",2000-03-20,"PA1390/193/001","Accord Healthcare Limited","RISEDRONATESODIUM"
"111","ACTONEL","30 Milligram                                                                                            Film Coated Tablet",2000-03-20,"PA1390/193/002","Accord Healthcare Limited","RISEDRONATESODIUM"
"112","ACTONEL","75 Milligram                                                                                            Film Coated Tablet",2008-10-24,"PA1390/193/004","Accord Healthcare Limited","RISEDRONATESODIUM"
"113","Actonel Combi 35mg + 500mg film-coated tablets","35/500 milligram(s) Film-coated tablet",2005-03-18,"PA1635/002/001","Teva NI Limited","Risedronatesodium|Calciumcarbonate"
"114","ACTONEL ONCE A WEEK","35 Milligram                                                                                            Tablets Gastro-Resistant",2016-12-16,"PA1390/193/005","Accord Healthcare Limited","RISEDRONATESODIUM"
"115","ACTONEL ONCE A WEEK","35 Milligram                                                                                            Film Coated Tablet",2003-01-24,"PA1390/193/003","Accord Healthcare Limited","RISEDRONATESODIUM"
"116","ACTONEL ONCE A WEEK","35 Milligram                                                                                            Film Coated Tablet",2005-11-04,"PPA0465/165/001","PCO Manufacturing","RISEDRONATESODIUM"
"117","ACTONEL ONCE A WEEK","35 Milligram                                                                                            Film Coated Tablet",2010-04-09,"PPA1633/002/001","Primecrown 2010 Ltd","RISEDRONATESODIUM"
"118","ACTONEL ONCE A WEEK 35MG FILM-COATED TABLETS","35 Milligram                                                                                            Film Coated Tablet",2009-07-03,"PPA1463/023/001","IMED Healthcare Ltd.",""
"119","ACTONEL PLUS CA & D","35mg/1000m  Unknown",2013-03-08,"PPA0465/305/001","PCO Manufacturing","RISEDRONATESODIUM|CALCIUMCARBONATE|COLECALCIFEROL"
"120","ACTONEL PLUS CA & D","35 + 1000/880 IU Milligram                                                                                            Granules Effervescent",2007-10-12,"PA1635/003/001","Warner Chilcott UK Limited","RISEDRONATESODIUM|CALCIUMCARBONATE|COLECALCIFEROL"
"121","Actos","15 milligram(s) Tablet",2000-10-13,"EU/1/00/150/001","Takeda Pharma A/S","Pioglitazone"
"122","Actos","15 milligram(s) Tablet",2000-10-13,"EU/1/00/150/002","Takeda Pharma A/S","Pioglitazone"
"123","Actos","15 milligram(s) Tablet",2000-10-13,"EU/1/00/150/003","Takeda Pharma A/S","Pioglitazone"
"124","Actos","30 milligram(s) Tablet",2000-10-13,"EU/1/00/150/004","Takeda Pharma A/S","Pioglitazone"
"125","Actos","30 milligram(s) Tablet",2000-10-13,"EU/1/00/150/005","Takeda Pharma A/S","Pioglitazone"
"126","Actos","30 milligram(s) Tablet",2000-10-13,"EU/1/00/150/006","Takeda Pharma A/S","Pioglitazone"
"127","Actos","45 milligram(s) Tablet",2003-09-16,"EU/1/00/150/011","Takeda Pharma A/S","Pioglitazone"
"128","Actraphane","percent volume/volume Solution for injection",2002-10-07,"EU/1/02/229/001-035","Novo Nordisk A/S","Insulinhuman"
"129","ACTRAPHANE 30","40 IU/ML                                                                                                Suspension for Injection",2003-08-13,"EU/1/02/229/036-037","Novo Nordisk A/S","INSULINHUMAN|INSULINHUMAN"
"130","Actrapid","international unit(s)/millilitre Solution for injection",2002-10-07,"EU/1/02/230/001-015","Novo Nordisk A/S","Insulinhuman"
"131","ACTRAPID","40/100 IU/ML                                                                                                Solution for Injection",2003-08-13,"EU/1/02/230/016-017","Novo Nordisk A/S","INSULINHUMAN"
"132","ACULAR","0.5 %w/v                                                                                                 Eye Drops Solution",2010-12-03,"PPA1151/142/001","Imbat Limited","KETOROLACTROMETAMOL"
"133","Acular 0.5% w/v Eye Drops, solution","0.5 percent weight/volume Eye drops, solution",1995-06-14,"PA0148/057/001","Allergan Pharmaceuticals Ireland","Ketorolactrometamol"
"134","ACULAR 0.5% w/v Eye drops, solution","0.5 percent weight/volume Eye drops, solution",2012-07-20,"PPA0465/287/001","PCO Manufacturing","Ketorolactrometamol"
"135","Acupan 30mg Film-Coated Tablets","30 milligram(s) Tablet",1981-02-19,"PA0057/061/002","3M Health Care Limited","NEFOPAMHYDROCHLORIDE"
"136","ADALAT","30 Milligram                                                                                            Tablet Prolonged Release",2009-06-19,"PPA1151/047/002","Imbat Limited","NIFEDIPINE"
"137","ADALAT 10 MG SOFT CAPSULES","10 Milligram                                                                                            Capsules, Soft",1977-05-25,"PA1410/025/002","Bayer Limited","NIFEDIPINE"
"138","ADALAT 5 MG SOFT CAPSULES","5 Milligram                                                                                            Capsules, Soft",1982-02-26,"PA1410/025/001","Bayer Limited","NIFEDIPINE"
"139","ADALAT LA","60 Milligram                                                                                            Tablets",2001-12-14,"PPA0465/012/006","PCO Manufacturing","NIFEDIPINE"
"140","ADALAT LA","20 Milligram                                                                                            Tablet Prolonged Release",2005-12-22,"PPA0465/012/007","PCO Manufacturing","NIFEDIPINE"
"141","ADALAT LA","20 Milligram                                                                                            Tablet Prolonged Release",2012-04-05,"PPA1463/058/001","IMED Healthcare Ltd.","NIFEDIPINE"
"142","ADALAT LA","30 Milligram                                                                                            Tablet Prolonged Release",2012-04-05,"PPA1463/058/002","IMED Healthcare Ltd.","NIFEDIPINE"
"143","ADALAT LA","60 Milligram                                                                                            Tablet Prolonged Release",2012-04-05,"PPA1463/058/003","IMED Healthcare Ltd.","NIFEDIPINE"
"144","ADALAT LA","30 Milligram                                                                                            Tablet Prolonged Release",2010-11-26,"PPA1562/036/002","LTT Pharma Limited","NIFEDIPINE"
"145","ADALAT LA","60 Milligram                                                                                            Tablet Prolonged Release",2010-11-26,"PPA1562/036/003","LTT Pharma Limited","NIFEDIPINE"
"146","ADALAT LA 20 MG PROLONGED-RELEASE TABLET","20mg Milligram                                                                                            Tablet Prolonged Release",1999-03-04,"PA1410/025/005","Bayer Limited","NIFEDIPINE"
"147","ADALAT LA 30 MG PROLONGED-RELEASE TABLET","30 Milligram                                                                                            Tablet Prolonged Release",1994-04-11,"PA1410/025/006","Bayer Limited","NIFEDIPINE"
"148","ADALAT LA 30 MG PROLONGED-RELEASE TABLETS","30 Milligram                                                                                            Tablets",2001-12-14,"PPA0465/012/005","PCO Manufacturing","NIFEDIPINE"
"149","ADALAT LA 60 MG PROLONGED-RELEASE TABLET","60 Milligram                                                                                            Tablet Prolonged Release",1994-04-11,"PA1410/025/007","Bayer Limited","NIFEDIPINE"
"150","ADALAT RETARD","20 Milligram                                                                                            Tablet Prolonged Release",1987-08-12,"PPA0465/012/003","PCO Manufacturing","NIFEDIPINE"
"151","Adalat Retard","20 mg milligram(s) Prolonged-release tablet",1981-04-15,"PA0021/003/002","Bayer PLC","Nifedipine"
"152","Adalat Retard","10 mg milligram(s) Prolonged-release tablet",1987-11-06,"PA0021/003/005","Bayer PLC","Nifedipine"
"153","ADALAT RETARD","20 Milligram                                                                                            Tablet Prolonged Release",2010-11-12,"PPA1562/036/005","LTT Pharma Limited","NIFEDIPINE"
"154","ADALAT RETARD","20 Milligram                                                                                            Tablet Prolonged Release",2008-03-07,"PPA1151/047/001","Imbat Limited","NIFEDIPINE"
"155","ADALAT RETARD 10 MG PROLONGED-RELEASE TABLETS.","10 mg Milligram                                                                                            Tablet Prolonged Release",1987-11-06,"PA1410/025/003","Bayer Limited","NIFEDIPINE"
"156","ADALAT RETARD 20MG PROLONGED-RELEASE TABLETS","20 mg Milligram                                                                                            Tablet Prolonged Release",1981-04-15,"PA1410/025/004","Bayer Limited","NIFEDIPINE"
"157","ADALUZIS","500 Milligram                                                                                            Pdr/Conc/Soln for Infus",2017-09-29,"PA2319/001/001","Correvio","CEFTOBIPROLEMEDOCARILSODIUM"
"158","ADASUVE","4.5 Milligram                                                                                            Powder for Inhalation",2013-03-14,"EU/1/13/823/001","Ferrer Internacional, S.A","LOXAPINE"
"159","ADASUVE","9.1 Milligram                                                                                            Powder for Inhalation",2013-03-14,"EU/1/13/823/002","Ferrer Internacional, S.A","LOXAPINE"
"160","Adcetris","50 *** AWAITING VALUE *** ZZZ Pdr/Conc/Soln for Infus",2012-10-25,"EU/1/12/794/001","Takeda Global R&D Centre Europe Limited","Brentuximabvedotin"
"161","ADCIRCA (PREVIOUSLY TADALAFIL LILLY)","20 Milligram                                                                                            Film Coated Tablet",2008-10-01,"EU/1/08/476/001-004","Eli Lilly Nederland B.V.","TADALAFIL"
"162","Adcortyl Intra-articular/Intradermal Injection 10 mg/ml, Suspension for Injection, 5ml","10 milligram(s)/millilitre Suspension for injection",1978-04-01,"PA0002/018/003","Bristol-Myers Squibb Pharmaceuticals uc","Triamcinoloneacetonide"
"163","Adcortyl Intra-articular/Intra-Dermal Injection 10mg/ml suspension for injection, 1 ml","10 milligram(s)/millilitre Suspension for injection",1978-04-01,"PA0002/018/002","Bristol-Myers Squibb Pharmaceuticals uc","Triamcinoloneacetonide"
"164","ADCUS","3 Mg/Ml Solution for Infusion",2013-01-11,"PA1338/007/001","Focus Pharmaceuticals Ltd","ADENOSINE"
"165","ADDIPHOS","170. 133.5 14.0 g/20ml                                                                                               Concentrate for Soln for Inf",1983-04-01,"PA0566/005/001","Fresenius Kabi Limited","POTASSIUMPHOSPHATEMONOBASIC|SODIUMPHOSPHATEDIBASICDIHYDRATE|POTASSIUMHYDROXIDE"
"166","ADDITRACE N","N/A Concentrate for Soln for Inf",2015-03-27,"PA0566/015/002","Fresenius Kabi Limited","CHROMICCHLORIDEHEXAHYDRATE|CUPRICCHLORIDEDIHYDRATE|FERRICCHLORIDEHEXAHYDRATE|MANGANESECHLORIDETETRAHYDRATE|POTASSIUMIODIDE|SODIUMFLUORIDE|SODIUMMOLYBDATEDIHYDRATE|SODIUMSELENITEANHYDROUS|ZINCCHLORIDE"
"167","ADDITRACE, CONCENTRATE FOR SOLUTION FOR INFUSION","10 Millilitre                                                                                           Concentrate for Soln for Inf",1988-05-16,"PA0566/015/001","Fresenius Kabi Limited","FERRICCHLORIDEHEXAHYDRATE|ZINCCHLORIDE|MANGANESECHLORIDETETRAHYDRATE|CUPRICCHLORIDEDIHYDRATE|POTASSIUMIODIDE|CHROMIUMTRICHLORIDEHEXAHYDRATE|SODIUMSELENITE|SODIUMMOLYBDATEDIHYDRATE|SODIUMFLUORIDE"
"168","Adempas","0.5 milligram(s) Film-coated tablet",NA,"EU/1/13/907/001-003","Bayer AG","Riociguat"
"169","ADEMPAS","1 Milligram                                                                                            Film Coated Tablet",2014-03-27,"EU/1/13/907/004-006","Bayer AG","RIOCIGUAT"
"170","ADEMPAS","1.5 Milligram                                                                                            Film Coated Tablet",2014-03-27,"EU/1/13/907/007-009","Bayer AG","RIOCIGUAT"
"171","ADEMPAS","2 Milligram                                                                                            Film Coated Tablet",2014-03-27,"EU/1/13/907/010-012","Bayer AG","RIOCIGUAT"
"172","ADEMPAS","2.5 Milligram                                                                                            Film Coated Tablet",2014-03-27,"EU/1/13/907/013-015","Bayer AG","RIOCIGUAT"
"173","Adenocor 3mg/ml Solution for Injection","3 milligram(s)/millilitre Solution for injection",1994-06-16,"PA0540/139/001","Sanofi-Aventis Ireland Limited T/A SANOFI","ADENOSINE"
"174","ADENOSINE","3 Mg/Ml Solution for Injection",2013-10-04,"PA1339/034/001","Wockhardt UK Limited","ADENOSINE"
"175","ADENOSINE","30 Mg/Ml Solution for Infusion",2013-10-04,"PA1339/035/001","Wockhardt UK Limited","ADENOSINE"
"176","ADENOSINE","3 Mg/Ml Solution for Injection",2015-08-28,"PA2059/004/001","Fresenius Kabi Deutschland GmbH","ADENOSINE"
"177","Adenosine 3mg/ml Solution for Injection","3 milligram(s)/millilitre Solution for injection",2013-01-11,"PA1338/008/001","Focus Pharmaceuticals Ltd","ADENOSINE"
"178","Adenuric","80 milligram(s) Film-coated tablet",2008-04-21,"EU/1/08/447/001-002","Menarini International Operations Luxembourg S.A.","Febuxostat"
"179","ADENURIC","120 Milligram                                                                                            Film Coated Tablet",2008-04-21,"EU/1/08/447/003-004","Menarini International Operations Luxembourg S.A.","FEBUXOSTAT"
"180","ADIZEM - XL","180 Milligram                                                                                            Prolonged Release Capsules",1994-12-16,"PA1688/001/005","Mundipharma Pharmaceuticals Limited","DILTIAZEMHYDROCHLORIDE"
"181","ADIZEM-SR","90 Milligram                                                                                            Prolonged Release Capsules",1995-04-20,"PA1688/001/001","Mundipharma Pharmaceuticals Limited","DILTIAZEMHYDROCHLORIDE"
"182","ADIZEM-SR","120 Milligram                                                                                            Prolonged Release Capsules",1995-04-20,"PA1688/001/002","Mundipharma Pharmaceuticals Limited","DILTIAZEMHYDROCHLORIDE"
"183","ADIZEM-SR","180 Milligram                                                                                            Prolonged Release Capsules",1995-04-20,"PA1688/001/003","Mundipharma Pharmaceuticals Limited","DILTIAZEMHYDROCHLORIDE"
"184","ADIZEM-XL","240 Milligram                                                                                            Prolonged Release Capsules",1994-12-16,"PA1688/001/006","Mundipharma Pharmaceuticals Limited","DILTIAZEMHYDROCHLORIDE"
"185","ADIZEM-XL","300 Milligram                                                                                            Prolonged Release Capsules",1994-12-16,"PA1688/001/007","Mundipharma Pharmaceuticals Limited","DILTIAZEMHYDROCHLORIDE"
"186","ADIZEM–XL","120 Milligram                                                                                            Prolonged Release Capsules",1994-12-16,"PA1688/001/004","Mundipharma Pharmaceuticals Limited","DILTIAZEMHYDROCHLORIDE"
"187","ADJUPANRIX","3.75/0.5 Microgram/ML                                                                                         Suspension and Emulsion for emulsion for injection",2009-11-05,"EU/1/09/578/001","GlaxoSmithKline Biologicals S.A.","PURIFIEDANTIGENFRACTIONSOFINACTIVATEDSPLITVIRIONSA/VIETNAM/1194/2004NIBRG-14(H5N1)"
"188","ADRENALINE (1:10,000)","1 mg/10ml Solution for injection in pre-filled syringe",2016-03-11,"PA1968/002/001","Laboratoire AGUETTANT","EPINEPHRINEBITARTRATE"
"189","ADRENALINE (EPINEPHRINE) 1:1,000 MINIJET","1 Mg/Ml Solution for Injection",1978-01-25,"PA0255/002/002","International Medication Systems (UK) Ltd","EPINEPHRINE"
"190","Adrenaline (Epinephrine) 1:1,000 Solution for Injection","1:1000 micromole(s) Solution for injection",1979-04-01,"PA0073/035/001","Mercury Pharmaceuticals (Ireland) Ltd","Adrenaline(epinephrine)"
"191","ADRENALINE (EPINEPHRINE) MINIJET","Mg/Ml Sterile Solution",1978-01-25,"PA0255/002/003","International Medication Systems (UK) Ltd","EPINEPHRINE"
"192","ADROVANCE","70/2800 mg/IU Tablets",2007-01-04,"EU/1/06/364/001-004","Merck Sharp and Dohme Limited","ALENDRONICACID|COLECALCIFEROL"
"193","ADVAGRAF","3 Milligram                                                                                            Prolonged Release Capsules",2009-04-27,"EU/1/07/387/11-13","Astellas Pharma Europe BV","TACROLIMUS"
"194","ADVAGRAF","0.5 Milligram                                                                                            Prolonged Release Capsules",2007-04-23,"EU/1/07/387/1-2","Astellas Pharma Europe BV","TACROLIMUS"
"195","ADVAGRAF","1 Milligram                                                                                            Prolonged Release Capsules",2007-04-23,"EU/1/07/387/3-6","Astellas Pharma Europe BV","TACROLIMUS"
"196","ADVAGRAF","5 Milligram                                                                                            Prolonged Release Capsules",2007-04-23,"EU/1/07/387/7-8","Astellas Pharma Europe BV","TACROLIMUS"
"197","ADVANTAN","0.1%w/w percent weight/weight Cream",NA,"PA0012/082/001","HE Clissmann","Methylprednisoloneaceponate"
"198","Advantan","0.1%w/w percent weight/weight Ointment",1998-04-03,"PA0012/082/002","HE Clissmann","Methylprednisoloneaceponate"
"199","ADVANTAN 0.1%W/W FATTY OINTMENT","0.1%w/w %w/w                                                                                                 Ointment",1998-04-03,"PA1410/070/003","Bayer Limited","METHYLPREDNISOLONEACEPONATE"
"200","ADVANTAN 0.1%W/W OINTMENT","0.1%w/w %w/w                                                                                                 Ointment",1998-04-03,"PA1410/070/002","Bayer Limited","METHYLPREDNISOLONEACEPONATE"
"201","ADVANTAN CREAM","0.1%w/w %w/w                                                                                                 Cream",1998-04-03,"PA1410/070/001","Bayer Limited","METHYLPREDNISOLONEACEPONATE"
"202","Advantan Fatty","0.1%w/w percent weight/weight Ointment",NA,"PA0012/082/003","HE Clissmann","Methylprednisoloneaceponate"
"203","ADVATE","2000 International Unit                                                                                   Pdr+Solv for Soln for Inj",2008-05-22,"EU/1/03/271/005","Baxter","RECOMBINANTCOAGULATIONFVIII(OCTOCOGALFA)"
"204","ADVATE","3000 International Unit                                                                                   Pdr+Solv for Soln for Inj",2008-05-22,"EU/1/03/271/006","Baxter","RECOMBINANTCOAGULATIONFVIII(OCTOCOGALFA)"
"205","ADVATE","250 International Unit                                                                                   Pdr+Solv for Soln for Inj",2011-12-19,"EU/1/03/271/007","Baxter","RECOMBINANTCOAGULATIONFVIII(OCTOCOGALFA)"
"206","ADVATE","500 International Unit                                                                                   Pdr+Solv for Soln for Inj",2011-12-19,"EU/1/03/271/008","Baxter","RECOMBINANTCOAGULATIONFVIII(OCTOCOGALFA)"
"207","ADVATE","1000 International Unit                                                                                   Pdr+Solv for Soln for Inj",2011-12-19,"EU/1/03/271/009","Baxter","RECOMBINANTCOAGULATIONFVIII(OCTOCOGALFA)"
"208","ADVATE","1500 International Unit                                                                                   Pdr+Solv for Soln for Inj",2011-12-19,"EU/1/03/271/010","Baxter","RECOMBINANTCOAGULATIONFVIII(OCTOCOGALFA)"
"209","ADVATE","250 international unit(s) Powder and solvent for solution for injection",2004-03-31,"EU/1/03/271/1-4","Baxter Innovations GmbH","Recombinantcoagulationfviii(octocogalfa)"
"210","ADVIL","200 Milligram                                                                                            Coated Tablets",1997-07-09,"PA0822/163/002","Pfizer Healthcare Ireland","IBUPROFEN"
"211","Advil Cold & Flu Coated TabletsIbuprofen 200mgPseudoephedrine Hydrochloride 30mg","200/30 milligram(s) Coated tablet",1994-09-08,"PA0822/164/001","Pfizer Healthcare Ireland","Ibuprofen|PSEUDOEPHEDRINEHYDROCHLORIDE"
"212","ADVIL COLD & FLU RELIEF","200/30 Milligram                                                                                            Capsules, Soft",2016-03-16,"PA0822/164/002","Pfizer Healthcare Ireland","IBUPROFEN|PSEUDOEPHEDRINEHYDROCHLORIDE"
"213","ADYNOVI","250 IU/5 Millilitre                                                                                           Pdr+Solv for Soln for Inj",2018-01-08,"EU/1/17/1247/001-004","Baxalta Innovations GmbH","RURIOCTOCOGALFAPEGOL"
"214","ADYNOVI","500 IU/5 Millilitre                                                                                           Pdr+Solv for Soln for Inj",2018-01-08,"EU/1/17/1247/005-008","Baxalta Innovations GmbH","RURIOCTOCOGALFAPEGOL"
"215","ADYNOVI","1000 IU/5 Millilitre                                                                                           Pdr+Solv for Soln for Inj",2018-01-08,"EU/1/17/1247/010-012","Baxalta Innovations GmbH","RURIOCTOCOGALFAPEGOL"
"216","ADYNOVI","2000 IU/5 Millilitre                                                                                           Pdr+Solv for Soln for Inj",2018-01-08,"EU/1/17/1247/013-014","Baxalta Innovations GmbH","RURIOCTOCOGALFAPEGOL"
"217","AERINAZE","2.5/120 Milligram                                                                                            Tablets",2007-07-30,"EU/1/07/399/001-006","Merck Sharp & Dohme Ltd","DESLORATIDINE|PSEUDOEPHEDRINESULFATE"
"218","AERIUS","5mg Milligram                                                                                            Tablets",2001-01-15,"EU/1/00/160/001","SP Europe","DESLORATIDINE"
"219","AERIUS","5 Milligram                                                                                            Tablets",2001-01-15,"EU/1/00/160/002","SP Europe","DESLORATIDINE"
"220","AERIUS","5 Milligram                                                                                            Tablets",2001-01-15,"EU/1/00/160/003","SP Europe","DESLORATIDINE"
"221","AERIUS","5 Milligram                                                                                            Tablets",2001-01-15,"EU/1/00/160/004","SP Europe","DESLORATIDINE"
"222","AERIUS","5 Milligram                                                                                            Tablets",2001-01-15,"EU/1/00/160/005","SP Europe","DESLORATIDINE"
"223","AERIUS","5 Milligram                                                                                            Tablets",2001-01-15,"EU/1/00/160/006","SP Europe","DESLORATIDINE"
"224","AERIUS","5 Milligram                                                                                            Tablets",2001-01-15,"EU/1/00/160/007","SP Europe","DESLORATIDINE"
"225","AERIUS","5 Milligram                                                                                            Tablets",2001-01-15,"EU/1/00/160/008","SP Europe","DESLORATIDINE"
"226","AERIUS","5 Milligram                                                                                            Tablets",2001-01-15,"EU/1/00/160/009","SP Europe","DESLORATIDINE"
"227","AERIUS","5 Milligram                                                                                            Tablets",2001-01-15,"EU/1/00/160/010","SP Europe","DESLORATIDINE"
"228","AERIUS","5 Milligram                                                                                            Tablets",2001-01-15,"EU/1/00/160/011","SP Europe","DESLORATIDINE"
"229","AERIUS","5 Milligram                                                                                            Tablets",2001-01-15,"EU/1/00/160/012","SP Europe","DESLORATIDINE"
"230","AERIUS","5 Milligram                                                                                            Tablets",2001-01-15,"EU/1/00/160/013","SP Europe","DESLORATIDINE"
"231","AERIUS","0.5mg/ml Mg/Ml Syrup",2002-04-16,"EU/1/00/160/014","Merck Sharp & Dohme BV","DESLORATIDINE"
"232","AERIUS","0.5 Mg/Ml Syrup",2002-04-16,"EU/1/00/160/015","Merck Sharp & Dohme BV","DESLORATIDINE"
"233","AERIUS","0.5 Mg/Ml Syrup",2002-04-16,"EU/1/00/160/016","Merck Sharp & Dohme BV","DESLORATIDINE"
"234","AERIUS","0.5 Mg/Ml Syrup",2002-04-16,"EU/1/00/160/017","Merck Sharp & Dohme BV","DESLORATIDINE"
"235","AERIUS","0.5 Mg/Ml Syrup",2002-04-16,"EU/1/00/160/018","Merck Sharp & Dohme BV","DESLORATIDINE"
"236","AERIUS","0.5 Mg/Ml Syrup",2002-04-16,"EU/1/00/160/019","Merck Sharp & Dohme BV","DESLORATIDINE"
"237","AERIUS","0.5 Mg/Ml Syrup",2002-04-16,"EU/1/00/160/020","Merck Sharp & Dohme BV","DESLORATIDINE"
"238","AERIUS","0.5 Mg/Ml Syrup",2002-04-16,"EU/1/00/160/021","Merck Sharp & Dohme BV","DESLORATIDINE"
"239","AERIUS","5 Milligram                                                                                            Oral Lyophilisate",2002-04-16,"EU/1/00/160/022","SP Europe","DESLORATIDINE"
"240","AERIUS","5 Milligram                                                                                            Oral Lyophilisate",2002-04-16,"EU/1/00/160/023","SP Europe","DESLORATIDINE"
"241","AERIUS","5 Milligram                                                                                            Oral Lyophilisate",2002-04-16,"EU/1/00/160/024","SP Europe","DESLORATIDINE"
"242","AERIUS","5 Milligram                                                                                            Oral Lyophilisate",2002-04-16,"EU/1/00/160/025","SP Europe","DESLORATIDINE"
"243","AERIUS","5 Milligram                                                                                            Oral Lyophilisate",2002-04-16,"EU/1/00/160/026","SP Europe","DESLORATIDINE"
"244","AERIUS","5 Milligram                                                                                            Oral Lyophilisate",2002-04-16,"EU/1/00/160/027","SP Europe","DESLORATIDINE"
"245","AERIUS","5 Milligram                                                                                            Oral Lyophilisate",2002-04-16,"EU/1/00/160/028","SP Europe","DESLORATIDINE"
"246","AERIUS","5 Milligram                                                                                            Oral Lyophilisate",2002-04-16,"EU/1/00/160/029","SP Europe","DESLORATIDINE"
"247","AERIUS","5 Milligram                                                                                            Oral Lyophilisate",2002-04-16,"EU/1/00/160/030","SP Europe","DESLORATIDINE"
"248","AERIUS","5 Milligram                                                                                            Oral Lyophilisate",2002-04-16,"EU/1/00/160/031","SP Europe","DESLORATIDINE"
"249","AERIUS","5 Milligram                                                                                            Oral Lyophilisate",2002-04-16,"EU/1/00/160/032","SP Europe","DESLORATIDINE"
"250","AERIUS","5 Milligram                                                                                            Oral Lyophilisate",2002-04-16,"EU/1/00/160/033","SP Europe","DESLORATIDINE"
"251","AERIUS","5 Milligram                                                                                            Oral Lyophilisate",2002-04-16,"EU/1/00/160/034","SP Europe","DESLORATIDINE"
"252","AERIUS","2.5 Milligram                                                                                            Orodispersible Tablet",2007-04-23,"EU/1/00/160/37-48","SP Europe","DESLORATIDINE"
"253","AERIUS","5 Milligram                                                                                            Orodispersible Tablet",2007-04-23,"EU/1/00/160/49-60","SP Europe","DESLORATIDINE"
"254","AERIUS","0.5 Mg/Ml Oral Solution",2007-04-23,"EU/1/00/160/61-69","SP Europe","DESLORATADINE,MICRONIZED"
"255","Aerivio Spiromax","500mcg/500 microgram(s) Inhalation powder",2016-08-18,"EU/1/16/1122/001-002","Teva B.V.","FLUTICASONEPROPIONATE|SALMETEROLXINAFOATE"
"256","AFINITOR","5 Milligram                                                                                            Tablets",2009-09-08,"EU/1/09/538/001","Novartis Europharm Limited",""
"257","AFINITOR","10 Milligram                                                                                            Tablets",2009-08-03,"EU/1/09/538/004","Novartis Europharm Limited","EVEROLIMUS"
"258","AFINITOR","2.5 Milligram                                                                                            Tablets",2013-03-14,"EU/1/09/538/009-010","Novartis Europharm Limited","RADNBHT"
"259","AFLUNOV","75 Mcg/Dose                                                                                             Suspension for Injection",2010-11-29,"EU/1/10/658/001-002","Seqirus S.r.l.","H5N1(A/VIETNAM/1194/2004)"
"260","AFSTYLA","250 International Unit                                                                                   Pdr+Solv for soln for inf/inj",2017-01-04,"EU/1/16/1158/001","CSL Behring GmbH","LONOCTOCOGALFA"
"261","AFSTYLA","500 International Unit                                                                                   Pdr+Solv for soln for inf/inj",2017-01-04,"EU/1/16/1158/002","CSL Behring GmbH","LONOCTOCOGALFA"
"262","AFSTYLA","1000 International Unit                                                                                   Pdr+Solv for soln for inf/inj",2017-01-04,"EU/1/16/1158/003","CSL Behring GmbH","LONOCTOCOGALFA"
"263","AFSTYLA","1500 International Unit                                                                                   Pdr+Solv for soln for inf/inj",2017-01-04,"EU/1/16/1158/004","CSL Behring GmbH","LONOCTOCOGALFA"
"264","AFSTYLA","2000 International Unit                                                                                   Pdr+Solv for soln for inf/inj",2017-01-04,"EU/1/16/1158/005","CSL Behring GmbH","LONOCTOCOGALFA"
"265","AFSTYLA","2500 International Unit                                                                                   Pdr+Solv for soln for inf/inj",2017-01-04,"EU/1/16/1158/006","CSL Behring GmbH","LONOCTOCOGALFA"
"266","AFSTYLA","3000 International Unit                                                                                   Pdr+Solv for soln for inf/inj",2017-01-04,"EU/1/16/1158/007","CSL Behring GmbH","LONOCTOCOGALFA"
"267","AFTER BITE 3.5% W/V CUTANEOUS EMULSION","3.5 %w/v                                                                                                 Cutaneous Emulsion",1991-06-10,"PA1039/001/001","Tender Limited","AMMONIA"
"268","AGERDEX","1 Milligram                                                                                            Film Coated Tablet",2007-11-09,"PA0577/088/001","McDermott Laboratories Ltd t/a Gerard Laboratories","ANASTROZOLE"
"269","AGIOLAX","52,2.2 and 6.74-13.2 %w/w                                                                                                 Granules",1996-01-03,"PA1288/002/001","Madaus GmbH","ISPAGHULA|ISPAGHULAHUSKS|CASSIASENNA"
"270","Agnus castus oral drops",".  Oral drops, solution",2014-12-12,"TR2309/017/001","A. Vogel Ireland Limited","Tincturefromagnuscastusfruits"
"271","Agomelatine Mylan 25 mg film-coated tablets","25 milligram(s) Film-coated tablet",2018-10-26,"PA0577/189/001","McDermott Laboratories Ltd t/a Gerard Laboratories","Agomelatine"
"272","AGOMELATINE ROWEX","25 Milligram                                                                                            Film Coated Tablet",2018-06-14,"PA0711/281/001","Rowex Ltd","AGOMELATINE"
"273","AGOMELATINE TEVA","25 Milligram                                                                                            Film Coated Tablet",2018-06-01,"PA1986/047/001","Teva B.V.","AGOMELATINEUREA"
"274","Agrippal, Suspension for injection in pre-filled syringeInfluenza Vaccine Surface Antigen, Inactivated(2017/2018 season)","Suspension for injection",1999-02-19,"PA2032/001/001","Seqirus S.r.l.","A/california/7/2009(h1n1)pdm09-likestrain(a/california/7/2009,x-181)|A/hongkong/4801/2014(h3n2)-likestrain(a/hongkong/4801/2014,nymcx-263b)|B/brisbane/60/2008-likestrain(b/brisbane/60/2008)"
"275","AIMOVIG","70 Milligram                                                                                            Solution for Injection",2018-07-26,"EU/1/18/1293/001-003","Novartis Europharm Limited","ERENUMAB"
"276","AIRBUFO FORSPIRO","160/4.5 Mcg/Dose                                                                                             Powder for Inhalation",2018-05-18,"PA0711/284/001","Rowex Ltd","BUDESONIDE|FORMOTEROLFUMARATEDIHYDRATE"
"277","Airexar Spiromax","500/50 *** AWAITING VALUE *** Powder for Inhalation",2016-08-18,"EU/1/16/1123/001-002","Teva B.V.","FLUTICASONEPROPIONATE|SALMETEROLXINAFOATE"
"278","AIRFLUSAL FORSPIRO","50/250 Microgram                                                                                            Powder for Inhalation",2014-11-14,"PA0711/237/001","Rowex Ltd","SALMETEROLXINAFOATE|FLUTICASONEPROPIONATE"
"279","AIRFLUSAL FORSPIRO","50/500 Microgram                                                                                            Powder for Inhalation",2014-11-14,"PA0711/237/002","Rowex Ltd","SALMETEROLXINAFOATE|FLUTICASONEPROPIONATE"
"280","AIRFLUSAL FORSPIRO","50/250 Microgram                                                                                            Powder for Inhalation",2017-05-19,"PPA1097/009/001","Lexon (UK) Ltd","SALMETEROLXINAFOATE|FLUTICASONEPROPIONATE"
"281","AIRFLUSAL FORSPIRO","50/500 Microgram                                                                                            Powder for Inhalation",2017-05-19,"PPA1097/009/002","Lexon (UK) Ltd","SALMETEROLXINAFOATE|FLUTICASONEPROPIONATE"
"282","AIRFLUSAL MDI","25 microgram/125 Microgram                                                                                            Pressurised Inhalation Suspension",2017-05-12,"PA0711/270/001","Rowex Ltd","SALMETEROLXINAFOATE|FLUTICASONEPROPIONATE"
"283","AIRFLUSAL MDI","25 microgram/250 Microgram                                                                                            Pressurised Inhalation Suspension",2017-05-12,"PA0711/270/002","Rowex Ltd","SALMETEROLXINAFOATE|FLUTICASONEPROPIONATE"
"284","AKINETON","2 Milligram                                                                                            Tablets",2017-07-28,"PPA1097/021/001","Lexon (UK) Ltd","BIPERIDENHYDROCHLORIDE"
"285","Akineton Retard Prolonged release Tablets 4 mg","4 milligram(s) Prolonged-release tablet",1979-04-01,"PA1253/002/001","Laboratorio Farmaceutico S.I.T.","BIPERIDENHYDROCHLORIDE"
"286","Akineton Tablets 2 mg","2 milligram(s) Tablet",1979-04-01,"PA1253/001/001","Laboratorio Farmaceutico S.I.T.","BIPERIDENHYDROCHLORIDE"
"287","Akynzeo","300mg/0.50 milligram(s) Capsule, hard",2015-05-27,"EU/1/15/1001/001","Helsinn Birex Pharmaceuticals Limited","Netupitant|Palonosetron(ashydrochloride)"
"288","ALACARE","8 Milligram                                                                                            Medicated Plaster",2009-08-28,"PA2071/001/001","Photonamic GmbH & Co. KG","5-AMINOLEVULINICACIDHYDROCHLORIDE"
"289","ALBUNORM 20%","200 g/l                                                                                                  Solution for Infusion",2009-06-25,"PA2219/007/002","Octapharma (IP) SPRL","HUMANPLASMAPROTEINNOTCONTAININGLESSTHAN96%HUMANALBUMIN"
"290","ALBUNORM 5%","50 g/l                                                                                                  Solution for Infusion",2009-06-25,"PA2219/007/001","Octapharma (IP) SPRL","HUMANPLASMAPROTEINNOTCONTAININGLESSTHAN96%HUMANALBUMIN"
"291","Alburex 20, 200 g/l, solution for infusion","200 gram(s)/litre Solution for infusion",2014-06-13,"PA0800/008/002","CSL Behring GmbH","Humanalbumin"
"292","Alburex 5, 50 g/l, solution for infusion","50 gram(s)/litre Solution for infusion",2014-06-13,"PA0800/008/001","CSL Behring GmbH","Humanalbumin"
"293","ALCARTIS","5 Milligram                                                                                            Tablets",2016-02-26,"PA1470/005/001","EGIS Pharmaceuticals PLC","ARIPIPRAZOLE"
"294","ALCARTIS","10 Milligram                                                                                            Tablets",2016-02-26,"PA1470/005/002","EGIS Pharmaceuticals PLC","ARIPIPRAZOLE"
"295","ALCARTIS","15 Milligram                                                                                            Tablets",2016-02-26,"PA1470/005/003","EGIS Pharmaceuticals PLC","ARIPIPRAZOLE"
"296","ALCARTIS","30 Milligram                                                                                            Tablets",2016-02-26,"PA1470/005/004","EGIS Pharmaceuticals PLC","ARIPIPRAZOLE"
"297","ALCARTIS","5 Milligram                                                                                            Orodispersible Tablet",2016-02-26,"PA1470/005/005","EGIS Pharmaceuticals PLC","ARIPIPRAZOLE"
"298","ALCARTIS","10 Milligram                                                                                            Orodispersible Tablet",2016-02-26,"PA1470/005/006","EGIS Pharmaceuticals PLC","ARIPIPRAZOLE"
"299","ALCARTIS","15 Milligram                                                                                            Orodispersible Tablet",2016-02-26,"PA1470/005/007","EGIS Pharmaceuticals PLC","ARIPIPRAZOLE"
"300","ALCARTIS","30 Milligram                                                                                            Orodispersible Tablet",2016-02-26,"PA1470/005/008","EGIS Pharmaceuticals PLC","ARIPIPRAZOLE"
"301","ALDACTONE","25 Milligram                                                                                            Film Coated Tablet",2016-06-17,"PPA0465/418/001","PCO Manufacturing","SPIRONOLACTONE"
"302","ALDACTONE","25 Milligram                                                                                            Film Coated Tablet",2014-08-01,"PPA1151/197/001","Imbat Limited","SPIRONOLACTONE"
"303","ALDACTONE","25 Milligram                                                                                            Film Coated Tablet",2013-09-13,"PPA1633/030/001","Primecrown 2010 Ltd","SPIRONOLACTONE"
"304","Aldactone 100 mg Film-coated tablets","100 milligram(s) Film-coated tablet",1975-03-13,"PA0822/110/003","Pfizer Healthcare Ireland","Spironolactone"
"305","Aldactone 25 mg Film-coated Tablets","25 milligram(s) Film-coated tablet",1978-04-01,"PA0822/110/001","Pfizer Healthcare Ireland","Spironolactone"
"306","Aldactone 25mg Film-coated Tablets","25 milligram(s) Film-coated tablet",2014-10-24,"PPA1562/133/001","LTT Pharma Limited","Spironolactone"
"307","Aldactone 50 mg Film-coated tablets","50 milligram(s) Film-coated tablet",1984-12-12,"PA0822/110/002","Pfizer Healthcare Ireland","Spironolactone"
"308","ALDARA","5% w/w %w/w                                                                                                 Cream",1998-09-18,"EU/1/98/080/001","Meda AB","IMIQUIMOD"
"309","ALDOMET","250 mg Milligram                                                                                            Coated Tablets",1979-04-01,"PA1691/012/001","Aspen Pharma Trading Limited","METHYLDOPA"
"310","ALDOMET","500 mg Milligram                                                                                            Coated Tablets",1979-04-01,"PA1691/012/002","Aspen Pharma Trading Limited","METHYLDOPA"
"311","ALDURAZYME","500 U Units/ml                                                                                             Solution for Infusion",2003-06-10,"EU/1/03/253/01-3","Genzyme Europe B.V.","LARONIDASE"
"312","ALECENSA","150 Milligram                                                                                            Capsules Hard",2017-02-16,"EU/1/16/1169/001","Roche Registration GmbH","ALECTINIBHYDROCHLORIDE"
"313","ALENDRONATE/COLECALCIFEROL ROWEX","70/5600 mg/IU Tablets",2016-09-16,"PA0711/259/001","Rowex Ltd","COLECALCIFEROL|ALENDRONATESODIUMTRIHYDRATE"
"314","ALENDRONATE/COLECALCIFEROL TEVA","70/2800 mg/IU Tablets",2014-04-16,"PA0749/196/001","Teva Pharma B.V.","ALENDRONATESODIUMMONOHYDRATE|COLECALCIFEROL"
"315","ALENDRONATE/COLECALCIFEROL TEVA","70/5600 mg/IU Tablets",2014-04-16,"PA0749/196/002","Teva Pharma B.V.","ALENDRONATESODIUMMONOHYDRATE|COLECALCIFEROL"
"316","Alendronic Acid 70 mg Tablets Once Weekly","70 milligram(s) Tablet",2015-05-29,"PPA0565/058/001","WPR Healthcare Limited","Alendronicacid"
"317","Alendronic Acid Bluefish Once weekly 70 mg tablets","70 milligram(s) Tablet",2009-04-24,"PA1436/004/001","Bluefish Pharmaceuticals AB","Sodiumalendronate"
"318","ALENDRONIC ACID ONCE WEEKLY","70 Milligram                                                                                            Tablets",2011-02-18,"PA1390/035/002","Accord Healthcare Limited","ALENDRONICACID"
"319","ALENDRONIC ACID ONCE WEEKLY","70 Milligram                                                                                            Tablets",2006-07-24,"PA0711/102/001","Rowex Ltd","ALENDRONATESODIUMTRIHYDRATE"
"320","ALEXETTE","0.02/3 Milligram                                                                                            Film Coated Tablet",2012-05-25,"PA1330/009/001","Gedeon Richter Plc","DROSPIRENONE|ETHINYLESTRADIOL"
"321","ALFU","10 Milligram                                                                                            Tablet Prolonged Release",2014-08-08,"PA1445/018/001","Aurobindo Pharma (Malta) Limited","ALFUZOSINHYDROCHLORIDE"
"322","Alfuzosin hydrochloride Rowex 10 mg prolonged-release tablets","10 milligram(s) Prolonged-release tablet",2006-04-28,"PA0711/083/002","Rowex Ltd","ALFUZOSINHYDROCHLORIDE"
"323","ALIMEMAZINE TARTRATE","10 Milligram                                                                                            Film Coated Tablet",2015-01-23,"PA0073/153/001","Mercury Pharmaceuticals (Ireland) Ltd","ALIMEMAZINETARTRATE"
"324","ALIMEMAZINE TARTRATE","30 MG/5ml                                                                                               Syrup",2015-01-30,"PA0073/153/002","Mercury Pharmaceuticals (Ireland) Ltd","TRIMEPRAZINE(ALIMEMAZINE)TARTRATE"
"325","ALIMEMAZINE TARTRATE","7.5 MG/5ml                                                                                               Syrup",2015-01-30,"PA0073/153/003","Mercury Pharmaceuticals (Ireland) Ltd","TRIMEPRAZINE(ALIMEMAZINE)TARTRATE"
"326","ALIMTA","500mg milligram(s) ZZZ Pdr/Conc/Soln for Infus",2004-10-14,"EU/1/04/290/001","Eli Lilly Nederland B.V.","Pemetrexed"
"327","ALIMTA","100 Milligram                                                                                            Pdr for Soln for Infusion",2004-10-14,"EU/1/04/290/002","Eli Lilly Nederland B.V.","PEMETREXED"
"328","ALKA-SELTZER","324/1744/965 Milligram                                                                                            Tablets Effervescent",1978-04-01,"PA1410/032/001","Bayer Limited","ACETYLSALICYLICACID|SODIUMBICARBONATE|CITRICACID"
"329","ALKERAN","2 Milligram                                                                                            Film Coated Tablet",1979-04-01,"PA1691/004/002","Aspen Pharma Trading Limited","MELPHALAN"
"330","Alkeran 50mg, Powder and Solvent for Solution for Infusion","50 milligram(s) Powder and solvent for solution for infusion",2002-10-25,"PA1691/004/001","Aspen Pharma Trading Limited","Melphalan"
"331","Alkindi","0.5 milligram(s) Granules",2018-02-09,"EU/1/17/1260/001","Diurnal Europe B.V.","Hydrocortisone"
"332","Alkindi","1 milligram(s) Granules",2018-02-09,"EU/1/17/1260/002","Diurnal Europe B.V.","Hydrocortisone"
"333","Alkindi","2 milligram(s) Granules",2018-02-09,"EU/1/17/1260/003","Diurnal Europe B.V.","Hydrocortisone"
"334","Alkindi","5 milligram(s) Granules",2018-02-09,"EU/1/17/1260/004","Diurnal Europe B.V.","Hydrocortisone"
"335","ALLI","27 Milligram                                                                                            Tablets Chewable",2010-11-29,"EU/1/07/401/12-15","Glaxo Group Limited","ORLISTAT"
"336","ALLI","60 Milligram                                                                                            Tablets Chewable",2009-01-20,"EU/1/07/401/7-11","Glaxo Group Limited","ORLISTAT"
"337","Allopurinol 100mg Tablets","100 milligram(s) Tablet",1985-03-06,"PA2315/056/001","Accord Healthcare Ireland Ltd.","Allopurinol"
"338","Allopurinol 300mg Tablets","300 milligram(s) Tablet",1985-03-06,"PA2315/056/002","Accord Healthcare Ireland Ltd.","Allopurinol"
"339","ALLOPURINOL TEVA","100 Milligram                                                                                            Tablets",2010-09-10,"PA0749/099/001","Teva Pharma B.V.","ALLOPURINOL"
"340","ALLOPURINOL TEVA","300 Milligram                                                                                            Tablets",2010-09-10,"PA0749/099/003","Teva Pharma B.V.","ALLOPURINOL"
"341","Almogran 12.5 mg film-coated tablet","12.5 milligram(s) Film-coated tablet",2000-10-27,"PA0968/001/001","Almirall, S.A.","Almotriptan"
"342","ALMOTRIPTAN","12.5 Milligram                                                                                            Film Coated Tablet",2013-11-15,"PA0688/028/001","Chanelle Medical","ALMOTRIPTANMALATE"
"343","ALOFISEL","5,000,000 20 Milligram Suspension for Injection",2018-03-23,"EU/1/17/1261/001","Takeda Pharma A/S","EXPANDEDHUMANALLOGENEICMESENCHYMALADULTSTEM"
"344","ALOMIDE 0.1 % W/V EYE DROPS, SOLUTION","0.1 %w/v                                                                                                 Eye Drops Solution",1991-12-16,"PA0896/001/001","Novartis Ireland Limited","LODOXAMIDETROMETHAMINE"
"345","Alopur 100 mg Tablets","100 milligram(s) Tablet",2009-04-03,"PA0711/154/001","Rowex Ltd","Allopurinol"
"346","Alopur 300 mg Tablets","300 milligram(s) Tablet",2009-04-03,"PA0711/154/002","Rowex Ltd","Allopurinol"
"347","ALOXI","250 microgram(s) Solution for injection",2005-03-22,"EU/1/04/306/001","Helsinn Birex Pharmaceuticals Limited","Palonosetron(ashydrochloride)"
"348","Aloxi","500 microgram(s) Capsule, soft",2010-05-05,"EU/1/04/306/002-003","Helsinn Birex Pharmaceuticals Limited","Palonosetron(ashydrochloride)"
"349","ALOXI","500 Microgram                                                                                            Capsules, Soft",2010-05-05,"EU/1/04/306/2-3","Helsinn Birex Pharmaceuticals Limited","PALONOSETRON(ASHYDROCHLORIDE)"
"350","ALPHADERM 1% & 10% W/W CREAM","1/10 %w/w                                                                                                 Cream",1978-04-01,"PA0943/004/001","Alliance Pharmaceuticals Ltd.","HYDROCORTISONE|UREA"
"351","ALPHAGAN","0.2 %w/v                                                                                                 Eye Drops Solution",2015-07-01,"PPA0465/413/001","PCO Manufacturing","BRIMONIDINETARTRATE"
"352","ALPHAGAN","0.2 Per Cent                                                                                             Eye Drops Solution",2007-02-08,"DPR0465/002/001","PCO Manufacturing","BRIMONIDINETARTRATE"
"353","ALPHAGAN","0.2 %w/v                                                                                                 Eye Drops Solution",2017-03-31,"PPA1097/015/001","Lexon (UK) Ltd","BRIMONIDINETARTRATE"
"354","Alphagan 0.2% w/v (2 mg/ml) eye drops, solution","0.2 percent weight/volume Eye drops, solution",1997-11-14,"PA0148/006/001","Allergan Pharmaceuticals Ireland","Brimonidinetartrate"
"355","ALPHAGAN EYE DROPS SOLUTION","0.2 %w/v                                                                                                 Eye Drops Solution",2009-09-10,"DPR1392/044/001","Eurodrug Ltd","BRIMONIDINETARTRATE"
"356","Alpivab","200 milligram(s) Concentrate for solution for infusion",2018-04-13,"EU/1/18/1269/001","Biocryst UK Ltd c/o Morgan Lewis & Bockius","Peramivir"
"357","ALPRAZOLAM","0.25 Milligram                                                                                            Tablets",2008-10-17,"PA0711/140/001","Rowex Ltd","ALPRAZOLAM"
"358","ALPRAZOLAM","0.50 Milligram                                                                                            Tablets",2008-10-17,"PA0711/140/002","Rowex Ltd","ALPRAZOLAM"
"359","ALPRAZOLAM","1 Milligram                                                                                            Tablets",2008-10-17,"PA0711/140/003","Rowex Ltd","ALPRAZOLAM"
"360","Alprolix","250 international unit(s) Powder and solvent for solution for injection",2016-05-12,"EU/1/16/1098/001","Swedish Orphan Biovitrum AB","Eftrenonacogalfa"
"361","ALPROLIX","500 International Unit                                                                                   Pdr+Solv for Soln for Inj",2016-05-12,"EU/1/16/1098/002","Swedish Orphan Biovitrum International AB","EFTRENONACOGALFA"
"362","ALPROLIX","1000 International Unit                                                                                   Pdr+Solv for Soln for Inj",2016-05-12,"EU/1/16/1098/003","Swedish Orphan Biovitrum International AB","EFTRENONACOGALFA"
"363","ALPROLIX","2000 International Unit                                                                                   Pdr+Solv for Soln for Inj",2016-05-12,"EU/1/16/1098/004","Swedish Orphan Biovitrum International AB","EFTRENONACOGALFA"
"364","ALPROLIX","3000 International Unit                                                                                   Pdr+Solv for Soln for Inj",2016-05-12,"EU/1/16/1098/005","Swedish Orphan Biovitrum International AB","EFTRENONACOGALFA"
"365","ALTARGO","1 %w/w                                                                                                 Ointment",2007-05-24,"EU/1/07/390/1-4","Glaxo Group Limited","RETAPAMULIN"
"366","ALTAVITA D3","50,000 International Unit                                                                                   Oral Solution",2015-07-10,"PA1876/002/001","Consilient Health Limited","COLECALCIFEROL"
"367","ALTAVITAD3","25,000 International Unit                                                                                   Oral Solution",2015-09-03,"PA1876/002/002","Consilient Health Limited","COLECALCIFEROL|COLECALCIFEROL"
"368","ALTAVITAD3","400 International Unit                                                                                   Unknown",2016-09-02,"PA1876/004/001","Consilient Health Limited","COLECALCIFEROL"
"369","ALTAVITAD3","25,000 International Unit                                                                                   Capsules, Soft",2016-09-02,"PA1876/004/003","Consilient Health Limited","COLECALCIFEROLCONCENTRATE(OILYFORM)"
"370","ALTAVITAD3","50,000 International Unit                                                                                   Capsules, Soft",2016-09-02,"PA1876/004/004","Consilient Health Limited","COLECALCIFEROLCONCENTRATE(OILYFORM)"
"371","ALTAVITAD3","1000 International Unit                                                                                   Capsules, Soft",2016-09-02,"PA1876/005/001","Consilient Health Limited","COLECALCIFEROL"
"372","ALTAVITAD3","7000 International Unit                                                                                   Capsules, Soft",2016-09-02,"PA1876/005/002","Consilient Health Limited","COLECALCIFEROL"
"373","ALTAVITAD3","5,600 International Unit                                                                                   Capsules, Soft",2016-10-07,"PA1876/007/001","Consilient Health Limited","COLECALCIFEROLCONCENTRATE(OILYFORM)"
"374","AltavitaD3 800IU soft capsules","800 international unit(s) Capsule, soft",2016-03-16,"PA1876/004/002","Consilient Health Limited","Cholecalciferol(02)"
"375","ALVERINE CITRATE","60 Milligram                                                                                            Capsules Hard",2016-03-11,"PA2013/001/001","Blackrock Pharmaceuticals Limited","ALVERINECITRATE"
"376","ALVERINE CITRATE","120 Milligram                                                                                            Capsules Hard",2016-03-11,"PA2013/001/002","Blackrock Pharmaceuticals Limited","ALVERINECITRATE"
"377","ALVERINE MAYOLY SPINDLER","60 Milligram                                                                                            Capsules Hard",2014-06-05,"PA1993/001/001","Laboratoires Mayoly Spindler","ALVERINECITRATE"
"378","ALVESCO","80 Microgram                                                                                            Pressurised Inhalation Soln",2005-02-18,"PA0970/064/001","AstraZeneca UK Limited","CICLESONIDE"
"379","ALVESCO","160 Microgram                                                                                            Pressurised Inhalation Soln",2005-02-18,"PA0970/064/002","AstraZeneca UK Limited","CICLESONIDE"
"380","AMARYL","1 Milligram                                                                                            Tablets",2008-02-01,"PPA1151/063/001","Imbat Limited","GLIMEPIRIDE"
"381","AMARYL","2 Milligram                                                                                            Tablets",2008-04-11,"PPA1151/063/002","Imbat Limited","GLIMEPIRIDE"
"382","AMARYL","4 Milligram                                                                                            Tablets",2008-04-11,"PPA1151/063/003","Imbat Limited","GLIMEPIRIDE"
"383","AMARYL 1 MG TABLET","1.0 mg Milligram                                                                                            Tablets",1996-11-29,"PA0540/028/001","Sanofi-Aventis Ireland Limited T/A SANOFI","GLIMEPIRIDE"
"384","Amaryl 3 mg tablet","3.0mg milligram(s) Tablet",1996-11-29,"PA0540/028/003","Sanofi-Aventis Ireland Limited T/A SANOFI","Glimepiride"
"385","AMBIRIX","%v/v                                                                                                 Suspension for Injection",2002-08-30,"EU/1/02/224/001","GlaxoSmithKline Biologicals S.A.","HEPATITAVIRUSANTIGEN|HEPATITISBSURFACEANTIGEN(HBSAG)"
"386","AMBIRIX","Per Cent                                                                                             Suspension for Injection",2002-08-30,"EU/1/02/224/002","GlaxoSmithKline Biologicals S.A.","HEPATITAVIRUSANTIGEN|HEPATITISBSURFACEANTIGEN(HBSAG)"
"387","AMBIRIX","Per Cent                                                                                             Suspension for Injection",2002-08-30,"EU/1/02/224/003","GlaxoSmithKline Biologicals S.A.","HEPATITAVIRUSANTIGEN|HEPATITISBSURFACEANTIGEN(HBSAG)"
"388","AMBIRIX","Per Cent                                                                                             Suspension for Injection",2002-08-30,"EU/1/02/224/004","GlaxoSmithKline Biologicals S.A.","HEPATITAVIRUSANTIGEN|HEPATITISBSURFACEANTIGEN(HBSAG)"
"389","AMBIRIX","Per Cent                                                                                             Suspension for Injection",2002-08-30,"EU/1/02/224/005","GlaxoSmithKline Biologicals S.A.","HEPATITAVIRUSANTIGEN|HEPATITISBSURFACEANTIGEN(HBSAG)"
"390","AmBisome Liposomal Amphotericin B 50mg Powder for Concentrate for Dispersion for Infusion","50 milligram(s) Concentrate for solution for infusion",1990-12-13,"PA2322/001/001","Gilead Sciences Ireland UC","Amphotericinb"
"391","AMBROBENE","3 Mg/Ml Oral Solution",2013-05-03,"PA0749/158/001","Teva Pharma B.V.","AMBROXOLHYDROCHLORIDE"
"392","AMBROBENE EXTRA STRENGTH","6 Mg/Ml Oral Solution",2013-05-03,"PA0749/158/002","Teva Pharma B.V.","AMBROXOLHYDROCHLORIDE"
"393","AMELUZ","78 mg/g Gel",2012-12-14,"EU/1/11/740/001","Biofrontera Bioscience GmbH","5-AMINOLEVULINICACIDHYDROCHLORIDE"
"394","AMETOP 40 MG/G GEL","40 mg/g Gel",1996-05-21,"PA0943/028/001","Alliance Pharmaceuticals Ltd.","TETRACAINEHYDROCHLORIDE"
"395","Amgevita","20 milligram(s) Solution for injection",NA,"EU/1/16/1164/001","Amgen Europe B.V.","Adalimumab"
"396","Amgevita","40 milligram(s) Solution for injection",NA,"EU/1/16/1164/002-009","Amgen Europe B.V.","Adalimumab"
"397","AMGLIDIA","0.6 Mg/Ml Oral Suspension",2018-05-24,"EU/1/18/1279/001-002","Pharma Services","GLIBENCLAMIDE"
"398","AMGLIDIA","6 Mg/Ml Oral Suspension",2018-05-24,"EU/1/18/1279/003-004","Pharma Services","GLIBENCLAMIDE"
"399","Amidex 1 mg film-coated tablets","1 milligram(s) Film-coated tablet",2009-07-24,"PA0126/189/001","Clonmel Healthcare Ltd","Anastrozole"
"400","AMIKIN","100 mg/2ml Solution for Injection",1976-07-15,"PA2255/001/001","Bristol-Myers Squibb Pharmaceuticals uc","AMIKACINSULFATE"
"401","AMINOPHYLLINE HYDRATE","25 Mg/Ml Solution for Injection",1988-09-01,"PA0073/099/001","Mercury Pharmaceuticals (Ireland) Ltd","AMINOPHYLLINEHYDRATE"
"402","Aminoven 16, solution for infusion, bottle","10 % gram(s)/litre Solution for infusion",1999-09-07,"PA0566/002/002","Fresenius Kabi Limited","Isoleucine|Leucine|Lysineacetate|Methionine|Phenylalanine|Threonine|Tryptophan|Valine|Arginine|Histidine|Alanine|Glycine|Proline|Serine|Tyrosine|Taurine"
"403","Aminoven 25, solution for infusion, bottle","15 percent Solution for infusion",1999-09-07,"PA0566/002/003","Fresenius Kabi Limited","Isoleucine|Leucine|Lysineacetate|Methionine|Phenylalanine|Threonine|Tryptophan|Valine|Arginine|Histidine|Alanine|Glycine|Proline|Serine|Tyrosine|Taurine"
"404","Aminoven 8, solution for infusion, bottle","5 gram(s)/litre Solution for infusion",1999-09-07,"PA0566/002/001","Fresenius Kabi Limited","Isoleucine|Leucine|Lysineacetate|Methionine|Phenylalanine|Threonine|Tryptophan|Valine|Arginine|Histidine|Alanine|Glycine|Proline|Serine|Tyrosine|Taurine"
"405","AMIODARONE","50 Mg/Ml Concentrate for Soln for Inj",2007-12-19,"PA1294/005/001","Stragen UK Limited","AMIODARONEHYDROCHLORIDE"
"406","AMISULPRIDE","100 Mg/Ml Oral Solution",2011-06-03,"PA1338/006/001","Focus Pharmaceuticals Ltd","AMISULPRIDE"
"407","AMISULPRIDE","50 Milligram                                                                                            Tablets",2014-09-19,"PA0577/182/001","McDermott Laboratories Ltd t/a Gerard Laboratories","AMISULPRIDE"
"408","AMISULPRIDE","200 Milligram                                                                                            Tablets",2014-09-19,"PA0577/182/002","McDermott Laboratories Ltd t/a Gerard Laboratories","AMISULPRIDE"
"409","AMISULPRIDE MYLAN","50 Milligram                                                                                            Tablets",2009-08-28,"PA0577/125/001","McDermott Laboratories Ltd t/a Gerard Laboratories","AMISULPRIDE"
"410","AMISULPRIDE MYLAN","200 Milligram                                                                                            Tablets",2009-08-28,"PA0577/125/003","McDermott Laboratories Ltd t/a Gerard Laboratories","AMISULPRIDE"
"411","AMITRIPTYLINE 25 MG FILM-COATED TABLETS","25 Milligram                                                                                            Film Coated Tablet",1985-03-15,"PA0126/041/001","Clonmel Healthcare Ltd","AMITRIPTYLINEHYDROCHLORIDE"
"412","AMITRIPTYLINE HYDROCHLORIDE","50/5 Milligram                                                                                            Oral Solution",2010-11-26,"PA1339/024/002","Wockhardt UK Limited","AMITRIPTYLINEHYDROCHLORIDE"
"413","AMITRIPTYLINE HYDROCHLORIDE","10 MG/5ml                                                                                               Oral Solution",2015-04-24,"PA1861/004/001","SYRI Limited, t/a Thame Laboratories","AMITRIPTYLINEHYDROCHLORIDE"
"414","AMITRIPTYLINE HYDROCHLORIDE","25 MG/5ml                                                                                               Oral Solution",2015-04-24,"PA1861/004/002","SYRI Limited, t/a Thame Laboratories","AMITRIPTYLINEHYDROCHLORIDE"
"415","AMITRIPTYLINE HYDROCHLORIDE","50 MG/5ml                                                                                               Oral Solution",2015-04-24,"PA1861/004/003","SYRI Limited, t/a Thame Laboratories","AMITRIPTYLINEHYDROCHLORIDE"
"416","Amitriptyline Hydrochloride 25 mg/ 5 ml Oral Solution","25/5 milligram(s) Oral solution",NA,"PA1339/024/001","Wockhardt UK Limited","AMITRIPTYLINEHYDROCHLORIDE"
"417","AMLODE","5 Milligram                                                                                            Tablets",2007-06-01,"PA0711/138/001","Rowex Ltd","AMLODIPINEBESYLATE"
"418","AMLODE","10 Milligram                                                                                            Tablets",2007-06-01,"PA0711/138/002","Rowex Ltd","AMLODIPINEBESYLATE"
"419","AMLODIPINE","5 Milligram                                                                                            Capsules Hard",2008-11-13,"PA0688/009/001","Chanelle Medical","AMLODIPINEBESILATE"
"420","AMLODIPINE","10 Milligram                                                                                            Capsules Hard",2008-11-13,"PA0688/009/002","Chanelle Medical","AMLODIPINEBESILATE"
"421","AMLODIPINE","5 Milligram                                                                                            Tablets",2017-08-04,"PA1390/133/001","Accord Healthcare Limited","AMLODIPINEBESILATE"
"422","AMLODIPINE","10 Milligram                                                                                            Tablets",2017-08-04,"PA1390/133/002","Accord Healthcare Limited","AMLODIPINEBESILATE"
"423","AMLODIPINE","1 Mg/Ml Oral Solution",2015-02-27,"PA0312/035/001","Rosemont Pharmaceuticals Ltd","AMLODIPINEBESILATE"
"424","AMLODIPINE","2 Mg/Ml Oral Solution",2015-02-27,"PA0312/035/002","Rosemont Pharmaceuticals Ltd","AMLODIPINEBESILATE"
"425","AMLODIPINE","5 Milligram                                                                                            Tablets",2015-07-31,"PPA0565/059/001","WPR Healthcare Limited","AMLODIPINEASAMLODIPINEBESILATE"
"426","AMLODIPINE","10 Milligram                                                                                            Tablets",2015-07-31,"PPA0565/059/002","WPR Healthcare Limited","AMLODIPINEASAMLODIPINEBESILATE"
"427","AMLODIPINE","5 Milligram                                                                                            Tablets",2018-03-16,"PPA0465/439/001","PCO Manufacturing","AMLODIPINEBESILATE"
"428","Amlodipine 10 mg tablets","10 milligram(s) Tablet",2013-02-22,"PA1063/051/002","Niche Generics Limited","Amlodipinebesylate"
"429","Amlodipine 5 mg Tablets","5 milligram(s) Tablet",2013-02-22,"PA1063/051/001","Niche Generics Limited","Amlodipinebesilate"
"430","AMLODIPINE BLUEFISH","5 Milligram                                                                                            Tablets",2010-05-07,"PA1436/016/001","Bluefish Pharmaceuticals AB","AMLODIPINEBESILATE"
"431","AMLODIPINE BLUEFISH","10 Milligram                                                                                            Tablets",2010-05-07,"PA1436/016/002","Bluefish Pharmaceuticals AB","AMLODIPINEBESILATE"
"432","AMLODIPINE CLONMEL","5 Milligram                                                                                            Tablets",2014-12-05,"PA0126/258/001","Clonmel Healthcare Ltd","AMLODIPINEBESILATE|AMLODIPINE"
"433","AMLODIPINE CLONMEL","10 Milligram                                                                                            Tablets",2014-12-05,"PA0126/258/002","Clonmel Healthcare Ltd","AMLODIPINEBESILATE|AMLODIPINE"
"434","AMLODIPINE FAIR-MED","5 Milligram                                                                                            Tablets",2014-02-28,"PA1789/006/001","Fair-Med Healthcare GmbH","AMLODIPINEBESILATE"
"435","AMLODIPINE FAIR-MED","10 Milligram                                                                                            Tablets",2014-02-28,"PA1789/006/002","Fair-Med Healthcare GmbH","AMLODIPINEBESILATE"
"436","AMLODIPINE KRKA","5 Milligram                                                                                            Tablets",2013-03-01,"PA1347/034/001","Krka d.d., Novo mesto","AMLODIPINEBESYLATE"
"437","AMLODIPINE KRKA","10 Milligram                                                                                            Tablets",2013-03-01,"PA1347/034/002","Krka d.d., Novo mesto","AMLODIPINEBESYLATE"
"438","AMLODIPINE MYLAN","5 Milligram                                                                                            Tablets",2010-09-10,"PA0577/133/001","McDermott Laboratories Ltd t/a Gerard Laboratories","AMLODIPINEBESILATE"
"439","AMLODIPINE MYLAN","10 Milligram                                                                                            Tablets",2010-09-10,"PA0577/133/002","McDermott Laboratories Ltd t/a Gerard Laboratories","AMLODIPINEBESILATE"
"440","AMLODIPINE PFIZER","5 Milligram                                                                                            Tablets",2011-12-09,"PA0822/210/001","Pfizer Healthcare Ireland","AMLODIPINEBESILATE"
"441","AMLODIPINE PFIZER","10 Milligram                                                                                            Tablets",2011-12-09,"PA0822/210/002","Pfizer Healthcare Ireland","AMLODIPINEBESILATE"
"442","AMLODIPINE TEVA","5 Milligram                                                                                            Tablets",2008-08-01,"PA0749/067/001","Teva Pharma B.V.","AMLODIPINEASAMLODIPINEBESILATE"
"443","AMLODIPINE TEVA","10 Milligram                                                                                            Tablets",2008-08-01,"PA0749/067/002","Teva Pharma B.V.","AMLODIPINEASAMLODIPINEBESILATE"
"444","AMLODIPINE THAME","5 MG/5ml                                                                                               Oral Solution",2015-08-21,"PA1861/007/001","SYRI Limited, t/a Thame Laboratories","AMLODIPINEBESILATE"
"445","AMLODIPINE THAME","10 MG/5ml                                                                                               Oral Solution",2015-08-21,"PA1861/007/002","SYRI Limited, t/a Thame Laboratories","AMLODIPINEBESILATE"
"446","Amlodipine/Valsartan Clonmel 10 mg/160 mg film-coated tablets","10/160 milligram(s) Film-coated tablet",2016-09-09,"PA0126/274/003","Clonmel Healthcare Ltd","Amlodipine|Valsartan"
"447","Amlodipine/Valsartan Clonmel 5 mg/160 mg film-coated tablets","5/160 milligram(s) Film-coated tablet",2016-09-09,"PA0126/274/002","Clonmel Healthcare Ltd","Amlodipine|Valsartan"
"448","Amlodipine/Valsartan Clonmel 5 mg/80 mg film-coated tablets","5/80 milligram(s) Film-coated tablet",2016-09-09,"PA0126/274/001","Clonmel Healthcare Ltd","Amlodipine|Valsartan"
"449","AMLODIPINE/VALSARTAN KRKA","5/80 Milligram                                                                                            Film Coated Tablet",2016-02-05,"PA1347/055/001","Krka d.d., Novo mesto","VALSARTAN|AMLODIPINEASAMLODIPINEBESILATE"
"450","AMLODIPINE/VALSARTAN KRKA","5/160 Milligram                                                                                            Film Coated Tablet",2016-02-05,"PA1347/055/002","Krka d.d., Novo mesto","VALSARTAN|AMLODIPINEASAMLODIPINEBESILATE"
"451","AMLODIPINE/VALSARTAN KRKA","10/160 Milligram                                                                                            Film Coated Tablet",2016-02-05,"PA1347/055/003","Krka d.d., Novo mesto","VALSARTAN|AMLODIPINEASAMLODIPINEBESILATE"
"452","AMLODIPINE/VALSARTAN KRKA","5/320 Milligram                                                                                            Film Coated Tablet",2016-02-05,"PA1347/055/004","Krka d.d., Novo mesto","VALSARTAN|AMLODIPINEASAMLODIPINEBESILATE"
"453","AMLODIPINE/VALSARTAN KRKA","10/320 Milligram                                                                                            Film Coated Tablet",2016-02-05,"PA1347/055/005","Krka d.d., Novo mesto","VALSARTAN|AMLODIPINEASAMLODIPINEBESILATE"
"454","AMLODIPINE/VALSARTAN MYLAN","5 mg/80 Milligram                                                                                            Film Coated Tablet",2016-03-22,"EU/1/16/1092/001-013","Mylan S.A.S.","VALSARTAN|AMLODIPINEBESILATE"
"455","AMLODIPINE/VALSARTAN MYLAN","5 mg/160 Milligram                                                                                            Film Coated Tablet",2016-03-22,"EU/1/16/1092/014-026","Mylan S.A.S.","VALSARTAN|AMLODIPINEBESILATE"
"456","AMLODIPINE/VALSARTAN MYLAN","10 mg/160 Milligram                                                                                            Film Coated Tablet",2016-03-22,"EU/1/16/1092/027-039","Mylan S.A.S.","VALSARTAN|AMLODIPINEBESILATE"
"457","AMLODIPINE/VALSARTAN ROWEX","5/80 Milligram                                                                                            Film Coated Tablet",2016-09-02,"PA0711/253/001","Rowex Ltd","AMLODIPINEBESILATE|VALSARTAN"
"458","AMLODIPINE/VALSARTAN ROWEX","5/160 Milligram                                                                                            Film Coated Tablet",2016-09-02,"PA0711/253/002","Rowex Ltd","AMLODPINEBESILATE|VALSARTAN"
"459","AMLODIPINE/VALSARTAN ROWEX","10/160 Milligram                                                                                            Film Coated Tablet",2016-09-02,"PA0711/253/003","Rowex Ltd","AMLODPINEBESILATE|VALSARTAN"
"460","AMLOTAN","5 Milligram                                                                                            Tablets",2006-08-18,"PA0298/015/001","Athlone Laboratories Ltd","AMLODIPINEMESILATEMONOHYDRATE"
"461","AMLOTAN","10 Milligram                                                                                            Tablets",2006-08-18,"PA0298/015/002","Athlone Laboratories Ltd","AMLODIPINEMESILATEMONOHYDRATE"
"462","AMMONAPS","500mg milligram(s) Tablet",1999-12-08,"EU/1/99/120/001","Swedish Orphan International AB","Sodiumphenylbutyrate"
"463","AMMONAPS","500mg milligram(s) Tablet",1999-12-08,"EU/1/99/120/002","Swedish Orphan International AB","Sodiumphenylbutyrate"
"464","AMMONAPS","940 mg/g percent volume/volume Granules",1999-12-08,"EU/1/99/120/003","Swedish Orphan International AB","Sodiumphenylbutyrate"
"465","AMMONAPS","940 mg/g percent volume/volume Granules",1999-12-08,"EU/1/99/120/004","Swedish Orphan International AB","Sodiumphenylbutyrate"
"466","AMOCLAV","125/31.25 MG/5ml                                                                                               Powder for Oral Suspension",2003-03-21,"PA0711/162/001","Rowex Ltd","AMOXICILLIN|CLAVULANICACID"
"467","AMOCLAV","250/125 Milligram                                                                                            Film Coated Tablet",2003-03-21,"PA0711/162/002","Rowex Ltd","AMOXICILLINTRIHYDRATE|CLAVULANICACID"
"468","AMOCLAV","500125 Milligram                                                                                            Film Coated Tablet",2014-04-11,"PA0711/162/003","Rowex Ltd","CLAVULANICACID(INTHEFORMOFPOTASSIUMCLAVULANATE)|AMOXICILLINTRIHYDRATE"
"469","Amorolfine 5% w/v medicated nail lacquer","5 percent Medicated nail lacquer",2013-06-21,"PA0688/031/001","Chanelle Medical","Amorolfine"
"470","AMOXICILIN/CLAVULANIC ACID KRKA","500 / 125 Milligram                                                                                            Film Coated Tablet",2015-09-18,"PA1347/044/001","Krka d.d., Novo mesto","AMOXICILLINTRIHYDRATE|CLAVULANICACID(ASPOTASSIUMCLAVULANATE,DILUTEDWITHMICROCRYSTALLINECELLULOSE(1:1))"
"471","AMOXICILLIN","250 Milligram                                                                                            Capsules Hard",2016-08-26,"PA0126/282/001","Clonmel Healthcare Ltd","AMOXICILLIN"
"472","AMOXICILLIN","500 Milligram                                                                                            Capsules Hard",2016-08-26,"PA0126/282/002","Clonmel Healthcare Ltd","AMOXICILLIN"
"473","AMOXICILLIN","125mg/5ml Mg/Ml Powder for Oral Suspension",2016-08-26,"PA0126/282/003","Clonmel Healthcare Ltd","AMOXICILLIN"
"474","AMOXICILLIN","250mg/5ml Mg/Ml Powder for Oral Suspension",2016-08-26,"PA0126/282/004","Clonmel Healthcare Ltd","AMOXICILLIN"
"475","Amoxicillin DSM Sinochem Pharmaceuticals 250 mg hard capsules","250 milligram(s) Capsule, hard",2013-07-26,"PA1832/001/001","DSM Sinochem Pharmaceuticals Netherlands B.V.","Amoxicillin(astrihydrate)"
"476","Amoxicillin DSM Sinochem Pharmaceuticals 500 mg hard capsules","500 milligram(s) Capsule, hard",2013-07-26,"PA1832/001/002","DSM Sinochem Pharmaceuticals Netherlands B.V.","Amoxicillin(astrihydrate)"
"477","AMOXICILLIN/CLAVULANIC ACID DSM-SINOCHEM","500/125 Milligram                                                                                            Film Coated Tablet",2015-09-03,"PA1832/002/001","DSM Sinochem Pharmaceuticals Netherlands B.V.","AMOXICILLINTRIHYDRATE|CLAVULANICACID(ASPOTASSIUMCLAVULANATE,DILUTEDWITHMICROCRYSTALLINECELLULOSE(1:1))"
"478","AMOXICILLIN/CLAVULANIC ACID DSM-SINOCHEM","875/125 Milligram                                                                                            Film Coated Tablet",2015-09-03,"PA1832/002/002","DSM Sinochem Pharmaceuticals Netherlands B.V.","AMOXICILLINTRIHYDRATE|CLAVULANICACID(ASPOTASSIUMCLAVULANATE,DILUTEDWITHMICROCRYSTALLINECELLULOSE(1:1))"
"479","AMOXICILLIN/CLAVULANIC ACID SINOCHEM DSM","500/125 Milligram                                                                                            Film Coated Tablet",2015-09-03,"PA1832/003/001","DSM Sinochem Pharmaceuticals Netherlands B.V.","AMOXICILLINTRIHYDRATE|CLAVULANICACID(ASPOTASSIUMCLAVULANATE,DILUTED:CELLULOSE,MICROCRYSTALLINE(1:1))"
"480","AMOXIL PAEDIATRIC","125/1.25 Millilitre                                                                                           Powder for Oral Suspension",1983-08-08,"PA1077/033/005","GlaxoSmithKline (Ireland) Limited","AMOXICILLINTRIHYDRATE"
"481","Amoxil Vials 500 mg, powder for solution for injection or infusion","500 milligram(s) Powder for solution for injection/infusion",1977-04-01,"PA1077/033/004","GlaxoSmithKline (Ireland) Limited","Amoxicillinsodium"
"482","Ampres 10mg/ml solution for injection","10 milligram(s)/millilitre Solution for injection",2012-07-13,"PA2154/001/001","Sintetica UK Limited","Chloroprocainehydrochloride"
"483","AMSIDINE","50 Mg/Ml Concentrate and solvent for solution for infusion",2018-06-08,"PA1591/002/001","Eurocept International BV","AMSACRINE"
"484","AMYViD","800 ZZZ MBq/ml Solution for injection",2013-01-14,"EU/1/12/805/001-002","Eli Lilly Nederland B.V.","Florbetapir(18f)"
"485","AMYVID","1900 MBq/ml                                                                                               Solution for Injection",2013-01-14,"EU/1/12/805/003-004","Eli Lilly Nederland B.V.","FLORBETAPIR(18F)"
"486","Anadin Analgesic Film-coated TabletsAspirin 325mgCaffeine 15mg","325/15 milligram(s) Film-coated tablet",1983-01-10,"PA0822/165/001","Pfizer Healthcare Ireland","Aspirin|Caffeine"
"487","Anadin Extra Film-coated TabletsAspirin 300mgParacetamol 200mgCaffeine 45mg","300/200/45 milligram(s) Film-coated tablet",1984-02-28,"PA0822/166/001","Pfizer Healthcare Ireland","Acetylsalicylicacid|Caffeine|Paracetamol"
"488","ANADIN MAXIMUM STRENGTH","500/32 Milligram                                                                                            Capsules Hard",1984-01-27,"PA0822/165/002","Pfizer Healthcare Ireland","ACETYLSALICYLICACID|CAFFEINE"
"489","ANAFRANIL","50 Milligram                                                                                            Capsule",1975-04-25,"PA0013/084/001","Novartis Pharmaceuticals UK Ltd","CLOMIPRAMINEHYDROCHLORIDE"
"490","ANAFRANIL","10 Milligram                                                                                            Capsule",1978-04-01,"PA0013/084/002","Novartis Pharmaceuticals UK Ltd","CLOMIPRAMINEHYDROCHLORIDE"
"491","ANAFRANIL","25 Milligram                                                                                            Capsule",1978-04-01,"PA0013/084/003","Novartis Pharmaceuticals UK Ltd","CLOMIPRAMINEHYDROCHLORIDE"
"492","ANAFRANIL SR","75 Milligram                                                                                            Tablets",1988-09-19,"PA0896/002/001","Novartis Ireland Limited","CLOMIPRAMINEHYDROCHLORIDE"
"493","ANAGRELIDE","0.5 Milligram                                                                                            Capsules Hard",2018-04-20,"PA2169/001/001","Kent Pharmaceuticals Limited","ANAGRELIDE"
"494","ANAGRELIDE MYLAN","1 Milligram                                                                                            Capsules Hard",2018-02-15,"EU/1/17/1253/002","Mylan S.A.S.","ANAGRELIDEHYDROCHLORIDEMONOHYDRATE"
"495","ANAGRELIDE MYLAN","0.5 Milligram                                                                                            Capsules Hard",2018-02-15,"EU/1/17/1256/001","Mylan S.A.S.","ANAGRELIDEHYDROCHLORIDEMONOHYDRATE"
"496","Anapen 300 micrograms in 0.3ml solution for injection in a pre-filled syringe","0.3 milligram(s) Solution for injection",2003-02-21,"PA22580/001/002","Bioprojet Pharma","Epinephrine"
"497","Anapen 500 micrograms / 0.3ml solution for injection in a pre-filled syringe","500mcg / 0.3ml ZZZ Mcg/Dose Solution for injection in pre-filled syringe",2018-08-10,"PA22580/001/003","Bioprojet Pharma","Epinephrine"
"498","Anapen Junior 150 micrograms in 0.3ml solution for injection in a pre- filled syringe","0.15 milligram(s) Solution for injection",2003-02-21,"PA22580/001/001","Bioprojet Pharma","Epinephrine"
"499","ANASTROZOLE","1 Milligram                                                                                            Film Coated Tablet",2009-10-23,"PA2315/011/001","Accord Healthcare Ireland Ltd.","ANASTROZOLE"
"500","ANASTROZOLE","1 Milligram                                                                                            Film Coated Tablet",2011-10-21,"PA1422/010/001","Fresenius Kabi Oncology Plc","ANASTRAZOLE"
"501","ANASTROZOLE","1 Milligram                                                                                            Film Coated Tablet",2010-07-02,"PA1390/028/001","Accord Healthcare Limited","ANASTROZOLE"
"502","ANASTROZOLE","1 Milligram                                                                                            Film Coated Tablet",2009-11-27,"PA0074/068/001","Rowa Pharmaceuticals Limited","ANASTROZOLE"
"503","ANASTROZOLE","1 Milligram                                                                                            Film Coated Tablet",2015-05-01,"PPA0565/060/001","WPR Healthcare Limited","ANASTROZOLE"
"504","ANASTROZOLE BLUEFISH","1 Milligram                                                                                            Film Coated Tablet",2011-03-25,"PA1436/010/001","Bluefish Pharmaceuticals AB","ANASTROZOLE"
"505","ANASTROZOLE SYNTHON","1 Milligram                                                                                            Film Coated Tablet",2007-09-28,"PA0840/004/001","Synthon BV","ANASTROZOLE"
"506","ANASTROZOLE TEVA","1 Milligram                                                                                            Film Coated Tablet",2007-11-23,"PA0749/028/001","Teva Pharma B.V.","ANASTROZOLE"
"507","Anastrozole Zaphyr Pharmaceuticals 1 mg film-coated tablets","1 milligram(s) Film-coated tablet",2009-11-27,"PA1914/001/001","Zaphyr Pharmaceuticals Ireland Limited","Anastrozole"
"508","ANBESOL ANAESTHETIC ANTISEPTIC","0.9/0.1/0. Unknown Oromucosal Solution",1983-04-01,"PA0943/020/001","Alliance Pharmaceuticals Ltd.","LIDOCAINEHYDROCHLORIDE|CHLOROCRESOL|CETYLPYRIDINIUMCHLORIDE|ETHANOL"
"509","Ancotil 2.5g/250ml Solution for Infusion","2.5/250 *** AWAITING VALUE *** Solution for infusion",1976-06-08,"PA2010/048/001","Mylan IRE Healthcare Limited","Flucytosine"
"510","ANDREWS LIVER SALTS","22.6  17.4  19.5 %w/w                                                                                                 Powder Effervescent",1992-02-25,"PA0678/043/001","GlaxoSmithKline Consumer Healthcare (Ireland) Limited","SODIUMBICARBONATE|CITRICACID|MAGNESIUMSULPHATEDIHYDRATE"
"511","ANDROCUR 100 MG TABLETS","100 Milligram                                                                                            Tablets",1997-01-24,"PA1410/001/001","Bayer Limited","CYPROTERONEACETATE"
"512","ANDROGEL","25 Milligram                                                                                            Gel",2003-06-03,"PA1054/001/001","Laboratoires Besins International","TESTOSTERONE"
"513","ANDROGEL","50 Milligram                                                                                            Gel",2003-06-03,"PA1054/001/002","Laboratoires Besins International","TESTOSTERONE"
"514","ANECTINE","50 Mg/Ml Solution for Inj/Inf",1979-04-01,"PA1691/033/001","Aspen Pharma Trading Limited","SUXAMETHONIUMCHLORIDE"
"515","ANEXATE","500 Micrograms/5ml Solution for Inj/Inf",1988-02-18,"PA1868/002/001","Cheplapharm Arzneimittel GmbH","FLUMAZENIL"
"516","ANGELIQ","1, 2 Milligram                                                                                            Film Coated Tablet",2004-03-05,"PA1410/013/001","Bayer Limited","ESTRADIOL|DROSPIRENONE"
"517","Anhydrol Forte 20% w/v Cutaneous Solution","20 percent weight/volume Cutaneous solution",1982-03-15,"PA0278/007/001","Dermal Laboratories Ltd","Aluminiumchloridehexahydrate"
"518","ANIDULAFUNGIN TEVA","100 Milligram                                                                                            Pdr/Conc/Soln for Infus",2018-02-16,"PA1986/045/001","Teva B.V.","ANIDULAFUNGIN"
"519","Anoro Ellipta","55mcg/22 microgram(s) Powder for Inhalation",2014-05-08,"EU/1/14/898/001-003","Glaxo Group Limited","Umeclidiniumbromide|Vilanteroltrifenatate"
"520","ANTABUSE 400 MG EFFERVESCENT TABLETS","400 Milligram                                                                                            Tablets Effervescent",1985-02-06,"PA1380/008/001","Actavis Group PTC ehf","DISULFIRAM"
"521","ANTEPSIN","1 g/5ml                                                                                                Oral Suspension",2000-03-31,"PA0950/001/001","Chugai Pharma UK Ltd","SUCRALFATE"
"522","ANTEPSIN","1 Grams                                                                                                Tablets",2000-03-31,"PA0950/001/003","Chugai Pharma UK Ltd","SUCRALFATE"
"523","ANTHISAN CREAM 2% W/W","2 %w/w                                                                                                 Cream",1979-04-01,"PA0540/092/001","Sanofi-Aventis Ireland Limited T/A SANOFI","MEPYRAMINEMALEATE"
"524","ANTI-HIST ALLERGY","10 Milligram                                                                                            Film Coated Tablet",2006-06-23,"PA0126/267/001","Clonmel Healthcare Ltd","CETIRIZINEDIHYDROCHLORIDE"
"525","ANTI-HIST ALLERGY","1 Mg/Ml Oral Solution",2015-05-29,"PA0126/267/002","Clonmel Healthcare Ltd","CETRIZINEDIHYDROCHLORIDE"
"526","ANTISEPTIC THROAT LOZENGES ORANGE & MENTHOL","0.6 Milligram                                                                                            Lozenges",2001-05-17,"PA0004/055/001","The Boots Company Plc","AMYLMETACRESOL"
"527","ANUSOL","2.14/1.8/1 Grams                                                                                                Cream",1990-04-03,"PA2190/001/001","Church & Dwight UK Limited","BISMUTHOXIDE|BALSAMPERU|ZINCOXIDE"
"528","ANUSOL","Suppositories",1990-04-03,"PA2190/001/003","Church & Dwight UK Limited","BISMUTHOXIDE|ZINCOXIDE|BALSAMPERU|BISMUTHSUBGALLATE"
"529","ANUSOL HC","N/A Ointment",1990-03-30,"PA2190/002/001","Church & Dwight UK Limited","HYDROCORTISONEACETATE|BENZYLBENZOATE|BISMUTHSUBGALLATE|BISMUTHOXIDE|BALSAMPERU|ZINCOXIDE"
"530","ANUSOL HC","%w/w                                                                                                 Suppositories",1990-03-30,"PA2190/002/002","Church & Dwight UK Limited","HYDROCORTISONEACETATE|BENZYLBENZOATE|BISMUTHOXIDE|BALSAMPERU|ZINCOXIDE|BISMUTHSUBGALLATE"
"531","Anusol Ointment","*** AWAITING VALUE *** Ointment",NA,"PA2190/001/002","Church & Dwight UK Limited","Zincoxide|Bismuthoxide|Bismuthsubgallate|Balsamperu"
"532","ANXICALM","2 mg Milligram                                                                                            Tablets",1979-04-25,"PA0126/011/001","Clonmel Healthcare Ltd","DIAZEPAM"
"533","ANXICALM","5 mg Milligram                                                                                            Tablets",1979-04-25,"PA0126/011/002","Clonmel Healthcare Ltd","DIAZEPAM"
"534","ANXICALM","10 mg Milligram                                                                                            Tablets",1979-04-25,"PA0126/011/003","Clonmel Healthcare Ltd","DIAZEPAM"
"535","APHTHEAL","5 %w/w                                                                                                 Oromucosal Paste",2006-06-02,"PA1332/037/001","Meda Health Sales Ireland Limited","AMLEXANOX"
"536","Apidra","100 unit(s)/millilitre Solution for injection",2010-01-12,"EU/1/04/285/021-036","Sanofi-Aventis Deutschland GmbH","Insulinglulisine"
"537","APIDRA","100 IU/ml IU/ML                                                                                                Solution for Injection",2004-09-27,"EU/1/04/285/1-20","Aventis Pharma Deutschland GmbH","INSULINGLULISINE"
"538","APIS MEL","6C-200C &  Tablets",2012-01-16,"HOR0407/047/001","Weleda (UK) Limited","APISMELLIFICA"
"539","APO-go AMPOULES 10 mg/ml Solution for Injection or Infusion *Abbreviated to APO-go in the text","10 milligram(s)/millilitre Solution for injection/infusion",2003-03-07,"PA0356/010/002","Britannia Pharmaceuticals Ltd","Apomorphinehydrochloride"
"540","APO-go® PEN 10 mg/ml Solution for Injection** Abbreviated to APO-go in the text","10 milligram(s)/millilitre Solution for injection",2003-03-07,"PA0356/010/001","Britannia Pharmaceuticals Ltd","Apomorphinehydrochloride"
"541","APO-go® PFS 5mg/ml Solution for Infusion in Pre-filled Syringe*Abbreviated to APO-go in the text","5 milligram(s)/millilitre Solution for infusion in pre-filled syringe",2008-02-29,"PA0356/010/003","Britannia Pharmaceuticals Ltd","Apomorphinehydrochloride"
"542","Apomorphine hydrochloride 5mg/ml solution for infusion","5 milligram(s)/millilitre Solution for infusion",2012-10-26,"PA1807/001/001","Pharmaceuticals Sales & Development Sweden AB (PharmSwed)","Apomorphinehydrochloridehemihydrate"
"543","APRESOLINE","20 Milligram                                                                                            Pdr/Conc/Soln/Inj/Inf",1979-04-01,"PA1142/015/001","Amdipharm Limited","HYDRALAZINEHYDROCHLORIDE"
"544","APROK","50 Base Milligrams                                                                                      Pdr for Soln for Injection",2012-09-07,"PA1107/006/001","Laboratoires Thea","CEFUROXIMESODIUM"
"545","APROVEL","75 Milligram                                                                                            Tablets",1997-08-27,"EU/1/97/046/001","Sanofi Pharma Bristol-Myers Squibb SNC","IRBESARTAN"
"546","APROVEL","75 Milligram                                                                                            Tablets",1997-08-27,"EU/1/97/046/002","Sanofi Pharma Bristol-Myers Squibb SNC","IRBESARTAN"
"547","APROVEL","75 Milligram                                                                                            Tablets",1997-08-27,"EU/1/97/046/003","Sanofi Pharma Bristol-Myers Squibb SNC","IRBESARTAN"
"548","APROVEL","150 Milligram                                                                                            Tablets",1997-08-27,"EU/1/97/046/004","Sanofi Pharma Bristol-Myers Squibb SNC","IRBESARTAN"
"549","APROVEL","150 Milligram                                                                                            Tablets",1997-08-27,"EU/1/97/046/005","Sanofi Pharma Bristol-Myers Squibb SNC","IRBESARTAN"
"550","APROVEL","150 Milligram                                                                                            Tablets",1997-08-27,"EU/1/97/046/006","Sanofi Pharma Bristol-Myers Squibb SNC","IRBESARTAN"
"551","APROVEL","300 Milligram                                                                                            Tablets",1997-08-27,"EU/1/97/046/007","Sanofi Pharma Bristol-Myers Squibb SNC","IRBESARTAN"
"552","APROVEL","300 Milligram                                                                                            Tablets",1997-08-27,"EU/1/97/046/008","Sanofi Pharma Bristol-Myers Squibb SNC","IRBESARTAN"
"553","APROVEL","300 Milligram                                                                                            Tablets",1997-08-27,"EU/1/97/046/009","Sanofi Pharma Bristol-Myers Squibb SNC","IRBESARTAN"
"554","APTIVUS","250 Milligram                                                                                            Capsules, Soft",2005-10-25,"EU/1/05/315/001","Boehringer Ingelheim International GmbH","TIPRANAVIR"
"555","APTIVUS","100 Mg/Ml Oral Solution",2009-06-23,"EU/1/05/315/002","Boehringer Ingelheim International GmbH","TIPRANAVIR"
"556","AQUASEPT SKIN CLEANSER","2 %w/v                                                                                                 Cutaneous Solution",1992-04-22,"PA0501/007/001","Ayrton Saunders Ltd","TRICLOSAN"
"557","AQUEOUS","30 %w/w                                                                                                 Cream",1988-11-18,"PA0206/021/001","Ovelle Limited","EMULSIFYINGWAX|WHITESOFTPARAFFIN|PARAFFIN,LIQUID"
"558","ARANESP","10 Microgram                                                                                            Solution for Injection",2001-06-08,"EU/1/01/185/001-002","Amgen Europe B.V.","DARBEPOETINALFA"
"559","Aranesp","15 microgram(s) Solution for injection",NA,"EU/1/01/185/003-004","Amgen Europe B.V.","Darbepoetinalfa"
"560","Aranesp","20 microgram(s) Solution for injection",NA,"EU/1/01/185/005-006","Amgen Europe B.V.","Darbepoetinalfa"
"561","Aranesp","30 microgram(s) Solution for injection",NA,"EU/1/01/185/007-008","Amgen Europe B.V.","Darbepoetinalfa"
"562","Aranesp","40 microgram(s) Solution for injection",2001-06-08,"EU/1/01/185/009-010","Amgen Europe B.V.","Darbepoetinalfa"
"563","Aranesp","50 microgram(s) Solution for injection",NA,"EU/1/01/185/011-012","Amgen Europe B.V.","Darbepoetinalfa"
"564","Aranesp","60 microgram(s) Solution for injection",NA,"EU/1/01/185/013-014","Amgen Europe B.V.","Darbepoetinalfa"
"565","Aranesp","80 microgram(s) Solution for injection",NA,"EU/1/01/185/015-016","Amgen Europe B.V.","Darbepoetinalfa"
"566","Aranesp","100 microgram(s) Solution for injection",NA,"EU/1/01/185/017-018","Amgen Europe B.V.","Darbepoetinalfa"
"567","Aranesp","150 microgram(s) Solution for injection",NA,"EU/1/01/185/019-020","Amgen Europe B.V.","Darbepoetinalfa"
"568","Aranesp","300 microgram(s) Solution for injection",NA,"EU/1/01/185/021-022","Amgen Europe B.V.","Darbepoetinalfa"
"569","Aranesp","500 microgram(s) Solution for injection",NA,"EU/1/01/185/031-032","Amgen Europe B.V.","Darbepoetinalfa"
"570","ARAVA","10 mg Milligram                                                                                            Tablets",1999-09-02,"EU/1/99/118/001","Sanofi-Aventis Deutschland GmbH","LEFLUNOMIDE"
"571","ARAVA","10 Milligram                                                                                            Tablets",1999-09-02,"EU/1/99/118/002","Sanofi-Aventis Deutschland GmbH","LEFLUNOMIDE"
"572","ARAVA","10 Milligram                                                                                            Tablets",1999-09-02,"EU/1/99/118/003","Sanofi-Aventis Deutschland GmbH","LEFLUNOMIDE"
"573","ARAVA","10 Milligram                                                                                            Tablets",1999-09-02,"EU/1/99/118/004","Sanofi-Aventis Deutschland GmbH","LEFLUNOMIDE"
"574","ARAVA","20 Milligram                                                                                            Tablets",1999-09-02,"EU/1/99/118/005","Sanofi-Aventis Deutschland GmbH","LEFLUNOMIDE"
"575","ARAVA","20 Milligram                                                                                            Tablets",1999-09-02,"EU/1/99/118/006","Sanofi-Aventis Deutschland GmbH","LEFLUNOMIDE"
"576","ARAVA","20 Milligram                                                                                            Tablets",1999-09-02,"EU/1/99/118/007","Sanofi-Aventis Deutschland GmbH","LEFLUNOMIDE"
"577","ARAVA","20 Milligram                                                                                            Tablets",1999-09-02,"EU/1/99/118/008","Sanofi-Aventis Deutschland GmbH","LEFLUNOMIDE"
"578","ARAVA","100 Milligram                                                                                            Tablets",1999-09-02,"EU/1/99/118/009","Sanofi-Aventis Deutschland GmbH","LEFLUNOMIDE"
"579","ARCOXIA","60 Milligram                                                                                            Film Coated Tablet",2011-05-05,"DPR1633/009/001","Primecrown 2010 Ltd","ETORICOXIB"
"580","ARCOXIA","90 Milligram                                                                                            Film Coated Tablet",2011-05-05,"DPR1633/009/002","Primecrown 2010 Ltd","ETORICOXIB"
"581","ARCOXIA","120 Milligram                                                                                            Film Coated Tablet",2011-05-05,"DPR1633/009/003","Primecrown 2010 Ltd","ETORICOXIB"
"582","ARCOXIA","30 Milligram                                                                                            Film Coated Tablet",2007-11-09,"PA1997/001/001","Merck Sharp & Dohme BV,","ETORICOXIB"
"583","ARCOXIA","60 Milligram                                                                                            Film Coated Tablet",2002-10-11,"PA1997/001/002","Merck Sharp & Dohme BV,","ETORICOXIB"
"584","ARCOXIA","90 Milligram                                                                                            Film Coated Tablet",2002-10-11,"PA1997/001/003","Merck Sharp & Dohme BV,","ETORICOXIB"
"585","ARCOXIA","120 Milligram                                                                                            Film Coated Tablet",2002-10-11,"PA1997/001/004","Merck Sharp & Dohme BV,","ETORICOXIB"
"586","ARCOXIA","60 Milligram                                                                                            Film Coated Tablet",2006-04-07,"PPA0465/176/001","PCO Manufacturing","ETORICOXIB"
"587","ARCOXIA","90 Milligram                                                                                            Film Coated Tablet",2006-04-07,"PPA0465/176/002","PCO Manufacturing","ETORICOXIB"
"588","ARCOXIA","120 Milligram                                                                                            Film Coated Tablet",2006-04-07,"PPA0465/176/003","PCO Manufacturing","ETORICOXIB"
"589","ARCOXIA","30 Milligram                                                                                            Film Coated Tablet",2010-08-06,"PPA1151/137/001","Imbat Limited","ETORICOXIB"
"590","ARCOXIA","60 Milligram                                                                                            Film Coated Tablet",2010-08-06,"PPA1151/137/002","Imbat Limited","ETORICOXIB"
"591","ARCOXIA","90 Milligram                                                                                            Film Coated Tablet",2012-06-28,"PPA1151/137/003","Imbat Limited","ETORICOXIB"
"592","ARCOXIA","120 Milligram                                                                                            Film Coated Tablet",2016-04-08,"PPA1151/137/004","Imbat Limited","ETORICOXIB"
"593","ARCOXIA","60 Milligram                                                                                            Film Coated Tablet",2012-06-01,"PPA1562/080/001","LTT Pharma Limited","ETORICOXIB"
"594","ARCOXIA","90 Milligram                                                                                            Film Coated Tablet",2012-06-01,"PPA1562/080/002","LTT Pharma Limited","ETORICOXIB"
"595","ARCOXIA","30 Milligram                                                                                            Film Coated Tablet",2012-09-24,"PPA1562/080/003","LTT Pharma Limited","ETORICOXIB"
"596","ARCOXIA","120 Milligram                                                                                            Film Coated Tablet",2014-11-03,"PPA1562/080/004","LTT Pharma Limited","ETORICOXIB"
"597","ARCOXIA","60 Milligram                                                                                            Film Coated Tablet",2010-08-06,"PPA1463/041/001","IMED Healthcare Ltd.","ETORICOXIB"
"598","ARCOXIA","90 Milligram                                                                                            Film Coated Tablet",2010-08-06,"PPA1463/041/002","IMED Healthcare Ltd.","ETORICOXIB"
"599","Arcoxia 120 mg film-coated tablets","120 milligram(s) Film-coated tablet",2012-02-03,"PPA1633/045/004","Primecrown 2010 Limited","Etoricoxib"
"600","Arcoxia 30 mg film-coated tablets","30 milligram(s) Film-coated tablet",2011-07-22,"PPA1633/045/001","Primecrown 2010 Limited","Etoricoxib"
"601","ARCOXIA 30MG FILM COATED TABLETS","30 Milligram                                                                                            Film Coated Tablet",2010-10-08,"PPA0465/176/004","PCO Manufacturing","ETORICOXIB"
"602","Arcoxia 60 mg film-coated tablets","60 milligram(s) Film-coated tablet",2012-05-04,"PPA1633/045/002","Primecrown 2010 Limited","Etoricoxib"
"603","Arcoxia 90 mg film-coated tablets","90 milligram(s) Film-coated tablet",2012-05-04,"PPA1633/045/003","Primecrown 2010 Limited","Etoricoxib"
"604","ARCOXIA FILM COATED TABLETS","60 Milligram                                                                                            Film Coated Tablet",2009-11-11,"DPR1392/056/001","Eurodrug Ltd","ETORICOXIB"
"605","ARCOXIA FILM COATED TABLETS","90 Milligram                                                                                            Film Coated Tablet",2009-11-11,"DPR1392/056/002","Eurodrug Ltd","ETORICOXIB"
"606","ARCOXIA FILM COATED TABLETS","120 Milligram                                                                                            Film Coated Tablet",2009-11-11,"DPR1392/056/003","Eurodrug Ltd","ETORICOXIB"
"607","ARELIX","6 Milligram                                                                                            Tablets",1983-05-12,"PA0540/030/003","Sanofi-Aventis Ireland Limited T/A SANOFI","PIRETANIDE"
"608","ARELOGER","7.5 Milligram                                                                                            Tablets",2004-09-17,"PA0577/057/001","McDermott Laboratories Ltd t/a Gerard Laboratories","MELOXICAM"
"609","ARELOGER","15 Milligram                                                                                            Tablets",2004-09-17,"PA0577/057/002","McDermott Laboratories Ltd t/a Gerard Laboratories","MELOXICAM"
"610","ARGENTUM NITRICUM (ARGENT. NIT.)","6C & 30C  Tablets",2009-11-20,"HOR0407/001/001","Weleda (UK) Limited","ARGENTUMNITRICUM"
"611","ARICEPT","5 Milligram                                                                                            Film Coated Tablet",2017-01-20,"PPA0465/426/001","PCO Manufacturing","DONEPEZILHYDROCHLORIDE"
"612","ARICEPT","10 Milligram                                                                                            Film Coated Tablet",2017-01-20,"PPA0465/426/002","PCO Manufacturing","DONEPEZILHYDROCHLORIDE"
"613","ARICEPT","5 Milligram                                                                                            Film Coated Tablet",1997-02-25,"PA0822/002/001","Pfizer Healthcare Ireland","DONEPEZILHYDROCHLORIDE"
"614","ARICEPT","10 Milligram                                                                                            Film Coated Tablet",1997-02-25,"PA0822/002/002","Pfizer Healthcare Ireland","DONEPEZILHYDROCHLORIDE"
"615","ARICEPT","5 Milligram                                                                                            Orodispersible Tablet",2006-06-02,"PA0822/002/003","Pfizer Healthcare Ireland","DONEPEZILHYDROCHLORIDE"
"616","ARICEPT","10 Milligram                                                                                            Orodispersible Tablet",2006-06-02,"PA0822/002/004","Pfizer Healthcare Ireland","DONEPEZILHYDROCHLORIDE"
"617","Ariclaim (RETHERA)","40mg milligram(s) Gastro-resistant capsule",2015-07-17,"EU/1/04/283/1-6","Eli Lilly Nederland B.V.","Evolocumab"
"618","ARIMIDEX","1 Milligram                                                                                            Film Coated Tablet",2012-09-28,"PPA1463/070/001","IMED Healthcare Ltd.","ANASTROZOLE"
"619","ARIMIDEX","1 Milligram                                                                                            Film Coated Tablet",2011-10-21,"PPA1151/161/001","Imbat Limited","ANASTRAZOLE"
"620","Arimidex 1 mg Film-coated Tablets","1 milligram(s) Film-coated tablet",2009-05-28,"PPA0465/218/001","PCO Manufacturing","Anastrozole"
"621","Arimidex 1mg Film-coated Tablets","1 milligram(s) Film-coated tablet",1996-01-17,"PA0970/003/001","AstraZeneca UK Limited","Anastrozole"
"622","ARIPIL","5 Milligram                                                                                            Film Coated Tablet",2008-10-03,"PA0577/099/001","McDermott Laboratories Ltd t/a Gerard Laboratories","DONEPEZILHYDROCHLORIDE"
"623","ARIPIL","10 Milligram                                                                                            Film Coated Tablet",2008-10-03,"PA0577/099/002","McDermott Laboratories Ltd t/a Gerard Laboratories","DONEPEZILHYDROCHLORIDE"
"624","ARIPIPRAZOLE","5 Milligram                                                                                            Tablets",2015-08-20,"EU/1/15/1029/001-014","Sandoz GmbH","ARIPIPRAZOLE"
"625","ARIPIPRAZOLE","10 Milligram                                                                                            Tablets",2015-08-20,"EU/1/15/1029/015-028","Sandoz GmbH","ARIPIPRAZOLE"
"626","ARIPIPRAZOLE","15 Milligram                                                                                            Tablets",2015-08-20,"EU/1/15/1029/029-042","Sandoz GmbH","ARIPIPRAZOLE"
"627","ARIPIPRAZOLE","20 Milligram                                                                                            Tablets",2015-08-20,"EU/1/15/1029/043-047","Sandoz GmbH","ARIPIPRAZOLE"
"628","ARIPIPRAZOLE","30 Milligram                                                                                            Tablets",2015-08-20,"EU/1/15/1029/048-061","Sandoz GmbH","ARIPIPRAZOLE"
"629","ARIPIPRAZOLE","5 Milligram                                                                                            Tablets",2017-10-06,"PA1240/024/001","Bristol Laboratories Limited","ARIPIPRAZOLE"
"630","ARIPIPRAZOLE","10 Milligram                                                                                            Tablets",2017-10-06,"PA1240/024/002","Bristol Laboratories Limited","ARIPIPRAZOLE"
"631","ARIPIPRAZOLE","15 Milligram                                                                                            Tablets",2017-10-06,"PA1240/024/003","Bristol Laboratories Limited","ARIPIPRAZOLE"
"632","ARIPIPRAZOLE","20 Milligram                                                                                            Tablets",2017-10-06,"PA1240/024/004","Bristol Laboratories Limited","ARIPIPRAZOLE"
"633","ARIPIPRAZOLE","30 Milligram                                                                                            Tablets",2017-10-06,"PA1240/024/005","Bristol Laboratories Limited","ARIPIPRAZOLE"
"634","ARIPIPRAZOLE","1 Mg/Ml Oral Solution",2015-09-18,"PA1339/058/001","Wockhardt UK Limited","ARIPIPRAZOLE"
"635","ARIPIPRAZOLE ACCORD","5 Milligram                                                                                            Tablets",2015-11-16,"EU/1/15/1045/001-006","Accord Healthcare Limited","ARIPIPRAZOLE"
"636","ARIPIPRAZOLE ACCORD","10 Milligram                                                                                            Tablets",2015-11-16,"EU/1/15/1045/007-012","Accord Healthcare Limited","ARIPIPRAZOLE"
"637","ARIPIPRAZOLE ACCORD","15 Milligram                                                                                            Tablets",2015-11-16,"EU/1/15/1045/013-018","Accord Healthcare Limited","ARIPIPRAZOLE"
"638","ARIPIPRAZOLE ACCORD","30 Milligram                                                                                            Tablets",2015-11-16,"EU/1/15/1045/019-022","Accord Healthcare Limited","ARIPIPRAZOLE"
"639","ARIPIPRAZOLE CLONMEL","5 Milligram                                                                                            Tablets",2015-07-17,"PA0126/266/001","Clonmel Healthcare Ltd","ARIPIPRAZOLE"
"640","ARIPIPRAZOLE CLONMEL","10 Milligram                                                                                            Tablets",2015-07-17,"PA0126/266/002","Clonmel Healthcare Ltd","ARIPIPRAZOLE"
"641","ARIPIPRAZOLE CLONMEL","15 Milligram                                                                                            Tablets",2015-07-17,"PA0126/266/003","Clonmel Healthcare Ltd","ARIPIPRAZOLE"
"642","ARIPIPRAZOLE CLONMEL","30 Milligram                                                                                            Tablets",2015-07-17,"PA0126/266/004","Clonmel Healthcare Ltd","ARIPIPRAZOLE"
"643","Aripiprazole Krka 10mg Tablets","10 milligram(s) Tablet",2015-02-13,"PA1347/089/002","Krka d.d., Novo mesto","Aripiprazole"
"644","Aripiprazole Krka 15mg Tablets","15 milligram(s) Tablet",2015-02-13,"PA1347/089/003","Krka d.d., Novo mesto","Aripiprazole"
"645","Aripiprazole Krka 30mg Tablets","30 milligram(s) Tablet",2015-02-13,"PA1347/089/004","Krka d.d., Novo mesto","Aripiprazole"
"646","Aripiprazole Krka 5mg Tablets","5 milligram(s) Tablet",2015-02-13,"PA1347/089/001","Krka d.d., Novo mesto","Aripiprazole"
"647","ARIPIPRAZOLE MYLAN PHARMA","5 Milligram                                                                                            Tablets",2015-06-30,"EU/1/15/1005/001-003","Mylan S.A.S.","ARIPIPRAZOLE"
"648","ARIPIPRAZOLE MYLAN PHARMA","10 Milligram                                                                                            Tablets",2015-06-30,"EU/1/15/1005/004-006","Mylan S.A.S.","ARIPIPRAZOLE"
"649","ARIPIPRAZOLE MYLAN PHARMA","15 Milligram                                                                                            Tablets",2015-06-30,"EU/1/15/1005/007-009","Mylan S.A.S.","ARIPIPRAZOLE"
"650","ARIPIPRAZOLE MYLAN PHARMA","30 Milligram                                                                                            Tablets",2015-06-30,"EU/1/15/1005/010-012","Mylan S.A.S.","ARIPIPRAZOLE"
"651","Aripiprazole Teva 10 mg tablets","10 milligram(s) Tablet",2015-06-05,"PA1986/019/002","Teva B.V.","Aripiprazole"
"652","Aripiprazole Teva 15 mg tablets","15 milligram(s) Tablet",2015-06-05,"PA1986/019/003","Teva B.V.","Aripiprazole"
"653","Aripiprazole Teva 30 mg tablets","30 milligram(s) Tablet",2015-06-05,"PA1986/019/004","Teva B.V.","Aripiprazole"
"654","Aripiprazole Teva 5 mg tablets","5 milligram(s) Tablet",2015-06-05,"PA1986/019/001","Teva B.V.","Aripiprazole"
"655","ARIPIPRAZOLE UNIVERSAL FARMA","5 Milligram                                                                                            Tablets",2015-08-28,"PA1066/002/001","Universal Farma S.L.","ARIPIPRAZOLE"
"656","ARIPIPRAZOLE UNIVERSAL FARMA","10 Milligram                                                                                            Tablets",2015-08-28,"PA1066/002/002","Universal Farma S.L.","ARIPIPRAZOLE"
"657","ARIPIPRAZOLE UNIVERSAL FARMA","15 Milligram                                                                                            Tablets",2015-08-28,"PA1066/002/003","Universal Farma S.L.","ARIPIPRAZOLE"
"658","ARIPIPRAZOLE UNIVERSAL FARMA","30 Milligram                                                                                            Tablets",2015-08-28,"PA1066/002/004","Universal Farma S.L.","ARIPIPRAZOLE"
"659","ARIPIPRAZOLE WOCKHARDT","5 Milligram                                                                                            Tablets",2015-10-09,"PA1339/058/002","Wockhardt UK Limited","ARIPIPRAZOLE"
"660","ARIPIPRAZOLE WOCKHARDT","10 Milligram                                                                                            Tablets",2015-10-09,"PA1339/058/003","Wockhardt UK Limited","ARIPIPRAZOLE"
"661","ARIPIPRAZOLE WOCKHARDT","15 Milligram                                                                                            Tablets",2015-10-09,"PA1339/058/004","Wockhardt UK Limited","ARIPIPRAZOLE"
"662","ARIPIPRAZOLE WOCKHARDT","30 Milligram                                                                                            Tablets",2015-10-09,"PA1339/058/005","Wockhardt UK Limited","ARIPIPRAZOLE"
"663","ARIPIPRAZOLE ZENTIVA","5 Milligram                                                                                            Tablets",2015-06-25,"EU/1/15/1009/001-005","Zentiva k.s.","ARIPIPRAZOLE"
"664","ARIPIPRAZOLE ZENTIVA","10 Milligram                                                                                            Tablets",2015-06-25,"EU/1/15/1009/006-010","Zentiva k.s.","ARIPIPRAZOLE"
"665","ARIPIPRAZOLE ZENTIVA","15 Milligram                                                                                            Tablets",2015-06-25,"EU/1/15/1009/011-015","Zentiva k.s.","ARIPIPRAZOLE"
"666","ARIPIPRAZOLE ZENTIVA","30 Milligram                                                                                            Tablets",2015-06-25,"EU/1/15/1009/016-020","Zentiva k.s.","ARIPIPRAZOLE"
"667","ARIPIPRAZOLE ZENTIVA","10 Milligram                                                                                            Orodispersible Tablet",2015-06-25,"EU/1/15/1009/021-023","Zentiva k.s.","ARIPIPRAZOLE"
"668","ARIPIPRAZOLE ZENTIVA","15 Milligram                                                                                            Orodispersible Tablet",2015-06-25,"EU/1/15/1009/024-026","Zentiva k.s.","ARIPIPRAZOLE"
"669","ARIPIPRAZOLE ZENTIVA","30 Milligram                                                                                            Orodispersible Tablet",2015-06-25,"EU/1/15/1009/027-029","Zentiva k.s.","ARIPIPRAZOLE"
"670","ARISTIGA","5 / 2.5 Milligram                                                                                            Tablet Prolonged Release",2017-03-10,"PA0549/017/001","Ethypharm","OXYCODONEHYDROCHLORIDE|NALOXONEHYDROCHLORIDEDIHYDRATE"
"671","ARISTIGA","10 / 5 Milligram                                                                                            Tablet Prolonged Release",2017-03-10,"PA0549/017/002","Ethypharm","OXYCODONEHYDROCHLORIDE|NALOXONEHYDROCHLORIDEDIHYDRATE"
"672","ARISTIGA","20 / 10 Milligram                                                                                            Tablet Prolonged Release",2017-03-10,"PA0549/017/003","Ethypharm","OXYCODONEHYDROCHLORIDE|NALOXONEHYDROCHLORIDEDIHYDRATE"
"673","ARISTIGA","40 / 20 Milligram                                                                                            Tablet Prolonged Release",2017-03-10,"PA0549/017/004","Ethypharm","OXYCODONEHYDROCHLORIDE|NALOXONEHYDROCHLORIDEDIHYDRATE"
"674","ARIXTRA","Solution for Injection",2002-03-21,"EU/1/02/206/12-14,19-20","Aspen Pharma Trading Limited","FONDAPARINUXSODIUM"
"675","ARIXTRA","2.5mg/0.5m %v/v                                                                                                 Solution for Injection",2002-03-21,"EU/1/02/206/1-4,22,23","Aspen Pharma Trading Limited","FONDAPARINUXSODIUM"
"676","ARIXTRA","Solution for Injection",2003-10-24,"EU/1/02/206/15-17,21","Aspen Pharma Trading Limited","FONDAPARINUXSODIUM"
"677","ARIXTRA","Solution for Injection",2004-11-12,"EU/1/02/206/29,30,34","Aspen Pharma Trading Limited","FONDAPARINUXSODIUM"
"678","ARIXTRA","Mg/Ml Solution for Injection",2007-08-29,"EU/1/02/206/31,32,35","Aspen Pharma Trading Limited","FONDAPARINUXSODIUM"
"679","ARIXTRA","%v/v                                                                                                 Solution for Injection",2002-03-21,"EU/1/02/206/5-8,18,24-26","Aspen Pharma Trading Limited","FONDAPARINUXSODIUM"
"680","ARIXTRA","Solution for Injection",2002-03-21,"EU/1/02/206/9-11,27,28,33","Aspen Pharma Trading Limited","FONDAPARINUXSODIUM"
"681","ARLEVERT","20/40 Milligram                                                                                            Tablets",2007-07-13,"PA1238/001/001","Hennig Arzneimittel GmbH & Co KG","CINNARIZINE|DIMENHYDRINATE"
"682","Armisarte (Previosuly Pemetrexed Actavis)","25 milligram(s)/millilitre Concentrate for solution for infusion",2016-01-18,"EU/1/15/1063/001-003","Actavis Group PTC ehf","Pemetrexeddiacid"
"683","ARMONEVE","2.5 / 1.25 Milligram                                                                                            Tablet Prolonged Release",2018-03-05,"PA1688/017/001","Mundipharma Pharmaceuticals Limited","OXYCODONEHYDROCHLORIDE|NALOXONEHYDROCHLORIDEDIHYDRATE"
"684","ARMONEVE","5 / 2.5 Milligram                                                                                            Tablet Prolonged Release",2018-03-05,"PA1688/017/002","Mundipharma Pharmaceuticals Limited","OXYCODONEHYDROCHLORIDE|NALOXONEHYDROCHLORIDEDIHYDRATE"
"685","ARMONEVE","10 / 5 Milligram                                                                                            Tablet Prolonged Release",2018-03-05,"PA1688/017/003","Mundipharma Pharmaceuticals Limited","OXYCODONEHYDROCHLORIDE|NALOXONEHYDROCHLORIDEDIHYDRATE"
"686","ARMONEVE","15 / 7.5 Milligram                                                                                            Tablet Prolonged Release",2018-03-05,"PA1688/017/004","Mundipharma Pharmaceuticals Limited","OXYCODONEHYDROCHLORIDE|NALOXONEHYDROCHLORIDEDIHYDRATE"
"687","ARMONEVE","20 / 10 Milligram                                                                                            Tablet Prolonged Release",2018-03-05,"PA1688/017/005","Mundipharma Pharmaceuticals Limited","OXYCODONEHYDROCHLORIDE|NALOXONEHYDROCHLORIDEDIHYDRATE"
"688","ARMONEVE","30 / 15 Milligram                                                                                            Tablet Prolonged Release",2018-03-05,"PA1688/017/006","Mundipharma Pharmaceuticals Limited","OXYCODONEHYDROCHLORIDE|NALOXONEHYDROCHLORIDEDIHYDRATE"
"689","ARMONEVE","40 / 20 Milligram                                                                                            Tablet Prolonged Release",2018-03-05,"PA1688/017/007","Mundipharma Pharmaceuticals Limited","OXYCODONEHYDROCHLORIDE|NALOXONEHYDROCHLORIDEDIHYDRATE"
"690","ARNICA","%v/w                                                                                                 Ointment",1992-11-04,"PA0407/001/001","Weleda (UK) Limited","ARNICAMONTANA"
"691","ARNICA","6X-MM                                                                                                      Tablets",2017-03-31,"HOR1149/031/001","A. Nelson & Company Limited","ARNICAMONTANA(GHP)"
"692","ARNICA","6X-MM %v/v",2010-10-29,"HOR1149/004/001","A. Nelson & Company Limited","ARNICAMONTANA"
"693","ARNICA - TABLETS","6C & 30C  Tablets",2010-06-11,"HOR0407/014/001","Weleda (UK) Limited","ARNICAMONTANA"
"694","AROMASIN","25 Milligram                                                                                            Coated Tablets",2009-08-14,"PPA0465/236/001","PCO Manufacturing","EXEMESTANE"
"695","AROMASIN","25mg Milligram                                                                                            Tablets",1999-11-12,"PA0822/111/001","Pfizer Healthcare Ireland","EXEMESTANE"
"696","AROMASIN","25 Milligram                                                                                            Coated Tablets",2012-05-25,"PPA1151/178/001","Imbat Limited","EXEMESTANE"
"697","AROMASIN","25 Milligram                                                                                            Coated Tablets",2015-04-17,"PPA1562/155/001","LTT Pharma Limited","EXEMESTANE"
"698","Aromasin 25 mg coated tablets","25 milligram(s) Coated tablet",2012-08-31,"PPA1463/069/001","IMED Healthcare Ltd.","Exemestane"
"699","AROVI","100 Milligram                                                                                            Solution for injection in pre-filled syringe",2018-07-27,"PA1995/001/001","Laboratorios Farmacéuticos ROVI, S.A.","ENOXAPARINSODIUM"
"700","AROVI","20 Milligram                                                                                            Solution for injection in pre-filled syringe",2018-07-27,"PA1995/001/002","Laboratorios Farmacéuticos ROVI, S.A.","ENOXAPARINSODIUM"
"701","AROVI","40 Milligram                                                                                            Solution for injection in pre-filled syringe",2018-07-27,"PA1995/001/003","Laboratorios Farmacéuticos ROVI, S.A.","ENOXAPARINSODIUM"
"702","AROVI","60 Milligram                                                                                            Solution for injection in pre-filled syringe",2018-07-27,"PA1995/001/004","Laboratorios Farmacéuticos ROVI, S.A.","ENOXAPARINSODIUM"
"703","AROVI","80 Milligram                                                                                            Solution for injection in pre-filled syringe",2018-07-27,"PA1995/001/005","Laboratorios Farmacéuticos ROVI, S.A.","ENOXAPARINSODIUM"
"704","ARQUIST","125 Mcg/Acutuation                                                                                       Pressurised Inhalation Suspension",2015-10-02,"PA1809/025/001","Cipla (EU) Limited","FLUTICASONEPROPIONATE"
"705","ARQUIST","250 Mcg/Acutuation                                                                                       Pressurised Inhalation Suspension",2015-10-02,"PA1809/025/002","Cipla (EU) Limited","FLUTICASONEPROPIONATE"
"706","ARRET","2 Milligram                                                                                            Capsules Hard",2005-11-28,"PPA0465/155/001","PCO Manufacturing","LOPERAMIDEHYDROCHLORIDE"
"707","ARRET 2 MG HARD CAPSULES.","2mg Milligram                                                                                            Capsule",1989-05-03,"PA0330/042/001","Johnson & Johnson (Ireland) Limited","LOPERAMIDEHYDROCHLORIDE"
"708","ARSENICUM ALBUM","6c-200c",2009-12-22,"HOR1154/004/001","Helios Homeopathy Ltd","ARSENICUMALBUM"
"709","ARSENICUM ALBUM (ARSEN. ALB.)","6C & 30C  Tablets",2009-11-20,"HOR0407/002/001","Weleda (UK) Limited","ARSENICUMALBUM"
"710","ARTELAC","3.2 Mg/Ml Eye Drops Solution",1996-07-09,"PA0555/007/001","Bausch & Lomb UK Limited","HYPROMELLOSE"
"711","ARTELAC PRESERVATIVE FREE SDU","3.2 Mg/Ml Eye Drops Solution",2014-10-17,"PPA1463/099/001","IMED Healthcare Ltd.","HYPROMELLOSE"
"712","Artelac Preservative Free Single Dose Unit","3.2 milligram(s)/millilitre Eye drops, solution",2014-01-31,"PPA1097/060/001","Lexon (UK) Ltd","Hypromellose"
"713","ARTELAC PRESERVATIVE FREE SINGLE DOSE UNIT","3.2 Mg/Ml Eye Drops Solution",1996-07-09,"PA0555/007/002","Bausch & Lomb UK Limited","HYPROMELLOSE"
"714","ARTHRIMEL","500 Milligram                                                                                            Film Coated Tablet",2005-07-22,"PA1113/011/001","Phoenix Labs","GLUCOSAMINESULFATESODIUMCHLORIDE"
"715","ARTHRIMEL","750 Milligram                                                                                            Film Coated Tablet",2011-07-15,"PA1113/011/002","Phoenix Labs","GLUCOSAMINESULPHATESODIUMCHLORIDE"
"716","ARTHRIMEL","1500 Milligram                                                                                            Film Coated Tablet",2011-07-15,"PA1113/011/003","Phoenix Labs","GLUCOSAMINESULPHATESODIUMCHLORIDE"
"717","ARTHROTEC","50/0.2 Milligram                                                                                            Modified-release Tablets",1993-06-16,"PA0822/112/001","Pfizer Healthcare Ireland","DICLOFENAC|MISOPROSTOL"
"718","ARTHROTEC","75/0.2 Milligram                                                                                            Modified-release Tablets",1997-02-07,"PA0822/112/002","Pfizer Healthcare Ireland","DICLOFENACSODIUM|MISOPROSTOL"
"719","ARTHROTEC","50/0.2 Milligram                                                                                            Modified-release Tablets",2004-03-31,"PPA0465/114/001","PCO Manufacturing","DICLOFENACSODIUM|MISOPROSTOL"
"720","ARTHROTEC","75/0.2 Milligram                                                                                            Modified-release Tablets",2004-03-31,"PPA0465/114/002","PCO Manufacturing","DICLOFENACSODIUM|MISOPROSTOL"
"721","ARTHROTEC","50/0.2 Milligram                                                                                            Modified-release Tablets",2015-05-29,"PPA1151/199/001","Imbat Limited","DICLOFENACSODIUM|MISOPROSTOL"
"722","ARTHROTEC","75/0.2 Milligram                                                                                            Modified-release Tablets",2015-05-29,"PPA1151/199/002","Imbat Limited","DICLOFENACSODIUM|MISOPROSTOL"
"723","ARTHROTEC","75/0.2 Milligram                                                                                            Modified-release Tablets",2017-03-01,"PPA1562/179/001","LTT Pharma Limited","DICLOFENACSODIUM|MISOPROSTOL"
"724","Artichoke-Milk Thistle Complex Tablets","*** AWAITING VALUE *** Tablet",2014-07-25,"TR2309/015/001","A. Vogel Ireland Limited","Dryextractfrompeumusboldusmolina(1:10-11)extractionsolvent:ethanol70%v/v|Dryextractfromsilybummarianuml.gaertnfruits(1:2.0-2.1)extrationsolventethanol58%v/v|Dryextractfromfreshdandelionroot&amp;herb(taraxacumofficinalisweb)(1:17-18)extractionsolvent:ethanol51%|Dryextractfromfreshcynarascolymusl.leaves(1:30-31)extractionsolvent:ethanol65%v/v"
"725","ARTISS Solutions for Sealant, deep frozen","4 ml *** AWAITING VALUE *** Solution for sealant",2009-07-03,"PA0167/131/001","Baxter Healthcare Limited","Aprotinin|Humanfibrinogen|Calciumchloride|Humanthrombin"
"726","ARZERRA","100 Milligram                                                                                            Concentrate for Soln for Inf",2010-04-19,"EU/1/10/625/1-2","Novartis Europharm Limited","OFATUMUMAB"
"727","ASACARD","162.5 Milligram                                                                                            Capsule",1999-10-01,"PA1966/001/001","New Haven Pharma (UK) Limited","ACETYLSALICYLICACID"
"728","ASACOLON","500 Milligram                                                                                            Suppositories",1995-06-26,"PA2018/001/003","Tillotts Pharma GmbH","MESALAZINE"
"729","ASACOLON","800 Milligram                                                                                            Tablets Gastro-Resistant",2018-04-06,"PPA1463/117/001","IMED Healthcare Ltd.","MESALAZINE"
"730","ASACOLON","400 Milligram                                                                                            Tablets Gastro-Resistant",2017-05-19,"PPA1097/008/001","Lexon (UK) Ltd","MESALAZINE"
"731","ASACOLON","800 Milligram                                                                                            Tablets Gastro-Resistant",2017-05-19,"PPA1097/008/002","Lexon (UK) Ltd","MESALAZINE"
"732","ASACOLON","800 Milligram                                                                                            Tablets Gastro-Resistant",2016-07-01,"PPA1151/107/003","Imbat Limited","MESALAZINE"
"733","Asacolon 1600 mg modified-release tablets","1600 milligram(s) Modified-release tablet",2018-02-23,"PA2018/004/001","Tillotts Pharma GmbH","Mesalazine"
"734","Asacolon 400mg Gastro-Resistant Tablets","400 milligram(s) Gastro-resistant tablet",1990-12-11,"PA2018/001/001","Tillotts Pharma GmbH","Mesalazine"
"735","Asacolon 800mg Gastro-resistant Tablets","800 milligram(s) Gastro-resistant tablet",2003-02-07,"PA2018/001/002","Tillotts Pharma GmbH","Mesalazine"
"736","ASACOLON GASTRO-RESISTANT TABLETS","400 Milligram                                                                                            Tablets Gastro-Resistant",2009-06-19,"PPA1151/107/001","Imbat Limited","MESALAZINE"
"737","ASASANTIN RETARD","200/25 mg/mg Capsules Modified Release",2009-11-27,"PPA1151/128/001","Imbat Limited","DIPYRIDAMOLE|ACETYLSALICYLICACID"
"738","ASMANEX TWISTHALER","200 Microgram                                                                                            Inhalation Powder, Capsule",2002-04-05,"PA1286/039/002","Merck Sharp & Dohme Ireland (Human Health) Limited","MOMETASONEFUROATE"
"739","ASMANEX TWISTHALER","400 Microgram                                                                                            Inhalation Powder, Capsule",2002-04-05,"PA1286/039/003","Merck Sharp & Dohme Ireland (Human Health) Limited","MOMETASONEFUROATE"
"740","ASMOKEN","1.5 Milligram                                                                                            Tablets",2018-03-05,"PA2079/001/001","Pharmacia Poloncia Sp.z.o.o","CYTISINE"
"741","ASPIRIN","300 Milligram                                                                                            Tablets Effervescent",1976-06-08,"PA1410/037/001","Bayer Limited","ACETYLSALICYLICACID"
"742","Aspirin 75mg gastro-resistant tablets","75 milligram(s) Gastro-resistant tablet",2014-02-14,"PA0126/246/001","Clonmel Healthcare Ltd","Acetylsalicylicacid"
"743","ASPIRIN EC","300 Milligram                                                                                            Tablets Gastro-Resistant",2002-07-17,"PA0465/057/001","PCO Manufacturing","ACETYLSALICYLICACID"
"744","ASPIRIN KRKA 75 MG GASTRO-RESISTANT TABLETS","75 Milligram                                                                                            Gastro-resistant, prolonged release granules",2017-03-10,"PA1347/070/001","Krka d.d., Novo mesto","ACETYLSALICYLICACID"
"745","Aspirin Rowex 75mg gastro-resistant tablets","75 milligram(s) Gastro-resistant tablet",2015-05-08,"PA0711/247/001","Rowex Ltd","Acetylsalicylicacid"
"746","ASTEPRO","1 Mg/Ml Nasal Spray Solution",2012-10-05,"PA1332/039/001","Meda Health Sales Ireland Limited","AZELASTINEHYDROCHLORIDE"
"747","Astepro 1.5 mg/ml Nasal Spray, Solution","1.5 milligram(s)/millilitre Nasal spray, solution",2013-09-13,"PA1332/039/002","Meda Health Sales Ireland Limited","Azelastinehydrochloride"
"748","AT 10","250 Microgram/ML                                                                                         Oral Drops Solution",1986-03-26,"PA0997/001/001","Intrapharm Laboratories Limited","DIHYDROTACHYSTEROL"
"749","ATACAND","4 Milligram                                                                                            Tablets",1998-01-23,"PA0970/030/002","AstraZeneca UK Limited","CANDESARTANCILEXETIL"
"750","ATACAND","8 Milligram                                                                                            Tablets",1998-01-23,"PA0970/030/003","AstraZeneca UK Limited","CANDESARTANCILEXETIL"
"751","ATACAND","16 Milligram                                                                                            Tablets",1998-01-23,"PA0970/030/004","AstraZeneca UK Limited","CANDESARTANCILEXETIL"
"752","ATACAND","16 Milligram                                                                                            Tablets",2009-06-19,"PPA1151/109/001","Imbat Limited","CANDESARTANCILEXETIL"
"753","ATACAND","4 Milligram                                                                                            Tablets",2012-10-12,"PPA1151/109/002","Imbat Limited","CANDESARTANCILEXETIL"
"754","ATACAND","8 Milligram                                                                                            Tablets",2012-10-12,"PPA1151/109/003","Imbat Limited","CANDESARTANCILEXETIL"
"755","ATACAND","8 Milligram                                                                                            Tablets",2010-02-05,"PPA1463/031/001","IMED Healthcare Ltd.","CANDESARTANCILEXETIL"
"756","ATACAND","16 Milligram                                                                                            Tablets",2010-02-05,"PPA1463/031/002","IMED Healthcare Ltd.","CANDESARTANCILEXETIL"
"757","ATACAND","4 Milligram                                                                                            Tablets",2009-10-09,"PPA1463/031/003","IMED Healthcare Ltd.","CANDESARTANCILEXETIL"
"758","Atacand 16 mg Tablets","16 milligram(s) Tablet",2004-02-06,"PPA0465/116/002","PCO Manufacturing","Candesartancilexetil"
"759","Atacand 4mg Tablets","4 milligram(s) Tablet",2005-11-04,"PPA0465/116/003","PCO Manufacturing","Candesartancilexetil"
"760","Atacand 8 mg Tablets","8 milligram(s) Tablet",2004-02-06,"PPA0465/116/001","PCO Manufacturing","Candesartancilexetil"
"761","ATACAND PLUS","8/12.5 Milligram                                                                                            Tablets",1998-11-27,"PA0970/031/001","AstraZeneca UK Limited","CANDESARTANCILEXETIL|HYDROCHLOROTHIAZIDE"
"762","ATACAND PLUS","16/12.5 Milligram                                                                                            Tablets",2009-06-19,"PPA1151/110/001","Imbat Limited","CANDESARTANCILEXETIL|HYDROCHLOROTHIAZIDE"
"763","Atacand Plus 16 mg/12.5 mg tablets","16/12.5 milligram(s) Tablet",2000-06-23,"PA0970/031/002","AstraZeneca UK Limited","Candesartancilexetil|Hydrochlorothiazide"
"764","Atacand Plus 16 mg/12.5 mg tablets","16/12.5 milligram(s) Tablet",2004-01-26,"PPA0465/117/001","PCO Manufacturing","Candesartancilexetil|Hydrochlorothiazide"
"765","Atacand Plus 16mg/12.5mg Tablets","16/12.5 milligram(s) Tablet",2011-10-07,"PPA1463/053/001","IMED Healthcare Ltd.","Candesartancilexetil|Hydrochlorothiazide"
"766","ATAZANAVIR MYLAN","150 Milligram                                                                                            Capsules Hard",2016-08-22,"EU/1/16/1091/001-003","Mylan S.A.S.","ATAZANAVIRSULFATE"
"767","ATAZANAVIR MYLAN","200 Milligram                                                                                            Capsules Hard",2016-08-22,"EU/1/16/1091/004-006","Mylan S.A.S.","ATAZANAVIRSULFATE"
"768","ATAZANAVIR MYLAN","300 Milligram                                                                                            Capsules Hard",2016-08-22,"EU/1/16/1091/007-010","Mylan S.A.S.","ATAZANAVIRSULFATE"
"769","Atazanavir Teva 150 mg Capsules, hard","150 milligram(s) Capsule, hard",2015-10-30,"PA1986/028/001","Teva B.V.","Atazanavirsulfate"
"770","Atazanavir Teva 200 mg Capsules, hard","200 milligram(s) Capsule, hard",2015-10-30,"PA1986/028/002","Teva B.V.","Atazanavirsulfate"
"771","Atazanavir Teva 300 mg Capsules, hard","300 milligram(s) Capsule, hard",2015-10-30,"PA1986/028/003","Teva B.V.","Atazanavirsulfate"
"772","ATECOR","25 Milligram                                                                                            Film Coated Tablet",1989-11-29,"PA0711/003/001","Rowex Ltd","ATENOLOL"
"773","ATECOR","50 Milligram                                                                                            Film Coated Tablet",1989-11-29,"PA0711/003/002","Rowex Ltd","ATENOLOL"
"774","ATECOR","100 Milligram                                                                                            Film Coated Tablet",1991-02-27,"PA0711/003/003","Rowex Ltd","ATENOLOL"
"775","ATECOR CT","50/12.5 Milligram                                                                                            Film Coated Tablet",1999-11-26,"PA0711/020/001","Rowex Ltd","ATENOLOL|CHLORTALIDONE"
"776","ATECOR CT","100/25 Milligram                                                                                            Film Coated Tablet",1999-11-26,"PA0711/020/002","Rowex Ltd","ATENOLOL|CHLORTALIDONE"
"777","ATENETIC","50/12.5 Milligram                                                                                            Coated Tablets",1991-05-21,"PA0405/031/001","Generics (UK) Limited","ATENOLOL|CHLORTALIDONE"
"778","ATENETIC","100/25 Milligram                                                                                            Coated Tablets",1991-05-21,"PA0405/031/002","Generics (UK) Limited","ATENOLOL|CHLORTALIDONE"
"779","Ateni 100mg Film-coated Tablets","100 milligram(s) Film-coated tablet",1987-04-09,"PA0405/019/002","Generics (UK) Limited","Atenolol"
"780","Ateni 50mg Film-coated Tablets","50 milligram(s) Film-coated tablet",1987-04-09,"PA0405/019/001","Generics (UK) Limited","Atenolol"
"781","ATENOLOL","5 Mg/Ml Oral Solution",2015-10-09,"PA1861/016/001","SYRI Limited, t/a Thame Laboratories","ATENOLOL"
"782","ATENOMEL","50 mg Milligram                                                                                            Tablets",1988-07-25,"PA0126/069/001","Clonmel Healthcare Ltd","ATENOLOL"
"783","ATENOMEL","100 mg Milligram                                                                                            Tablets",1988-07-25,"PA0126/069/002","Clonmel Healthcare Ltd","ATENOLOL"
"784","ATENOMEL","25mg Milligram                                                                                            Tablets",1988-07-25,"PA0126/069/003","Clonmel Healthcare Ltd","ATENOLOL"
"785","Ativan 1 mg Tablets","1 milligram(s) Tablet",NA,"PA0822/090/001","Pfizer Healthcare Ireland","Lorazepam"
"786","Ativan 4 mg/ml Solution for injection","4 milligram(s)/millilitre Solution for injection",NA,"PA0822/090/002","Pfizer Healthcare Ireland","Lorazepam"
"787","ATOMOXETINE","10 Milligram                                                                                            Capsules Hard",2017-11-24,"PA0405/103/001","Generics (UK) Limited","ATOMOXETINEHYDROCHLORIDE"
"788","ATOMOXETINE","18 Milligram                                                                                            Capsules Hard",2017-11-24,"PA0405/103/002","Generics (UK) Limited","ATOMOXETINEHYDROCHLORIDE"
"789","ATOMOXETINE","25 Milligram                                                                                            Capsules Hard",2017-11-24,"PA0405/103/003","Generics (UK) Limited","ATOMOXETINEHYDROCHLORIDE"
"790","ATOMOXETINE","40 Milligram                                                                                            Capsules Hard",2017-11-24,"PA0405/103/004","Generics (UK) Limited","ATOMOXETINEHYDROCHLORIDE"
"791","ATOMOXETINE","60 Milligram                                                                                            Capsules Hard",2017-11-24,"PA0405/103/005","Generics (UK) Limited","ATOMOXETINEHYDROCHLORIDE"
"792","ATOMOXETINE","80 Milligram                                                                                            Capsules Hard",2017-11-24,"PA0405/103/006","Generics (UK) Limited","ATOMOXETINEHYDROCHLORIDE"
"793","ATOMOXETINE","100 Milligram                                                                                            Capsules Hard",2017-11-24,"PA0405/103/007","Generics (UK) Limited","ATOMOXETINEHYDROCHLORIDE"
"794","Atorvas 10 mg Film-Coated Tablets","10 milligram(s) Film-coated tablet",2010-09-03,"PA0711/180/001","Rowex Ltd","Atorvastatin"
"795","Atorvas 20 mg Film-Coated Tablets","20 milligram(s) Film-coated tablet",2010-09-03,"PA0711/180/002","Rowex Ltd","Atorvastatin"
"796","Atorvas 40 mg Film-Coated Tablets","40 milligram(s) Film-coated tablet",2010-09-03,"PA0711/180/003","Rowex Ltd","Atorvastatin"
"797","Atorvas 80 mg Film-Coated Tablets","80 milligram(s) Film-coated tablet",2010-09-03,"PA0711/180/004","Rowex Ltd","Atorvastatin"
"798","ATORVASTATIN","10 Milligram                                                                                            Film Coated Tablet",2012-09-07,"PA2050/003/001","Sun Pharmaceutical Industries Europe B.V.",""
"799","ATORVASTATIN","20 Milligram                                                                                            Film Coated Tablet",2012-09-07,"PA2050/003/002","Sun Pharmaceutical Industries Europe B.V.",""
"800","ATORVASTATIN","40 Milligram                                                                                            Film Coated Tablet",2012-09-07,"PA2050/003/003","Sun Pharmaceutical Industries Europe B.V.",""
"801","ATORVASTATIN","80 Milligram                                                                                            Film Coated Tablet",2012-09-07,"PA2050/003/004","Sun Pharmaceutical Industries Europe B.V.",""
"802","ATORVASTATIN","10 Milligram                                                                                            Film Coated Tablet",2009-09-18,"PA1380/017/001","Actavis Group PTC ehf","ATORVASTATIN-CALCIUM"
"803","ATORVASTATIN","20 Milligram                                                                                            Film Coated Tablet",2009-09-18,"PA1380/017/002","Actavis Group PTC ehf","ATORVASTATIN-CALCIUM"
"804","ATORVASTATIN","40 Milligram                                                                                            Film Coated Tablet",2009-09-18,"PA1380/017/003","Actavis Group PTC ehf","ATORVASTATIN-CALCIUM"
"805","ATORVASTATIN","80 Milligram                                                                                            Film Coated Tablet",2012-09-07,"PA1380/017/006","Actavis Group PTC ehf","ATORVASTATINCALCIUMTRIHYDRATE"
"806","ATORVASTATIN","10 Milligram                                                                                            Film Coated Tablet",2017-07-28,"PA1390/123/001","Accord Healthcare Limited","ATORVASTATIN"
"807","ATORVASTATIN","20 Milligram                                                                                            Film Coated Tablet",2017-07-28,"PA1390/123/002","Accord Healthcare Limited","ATORVASTATIN"
"808","ATORVASTATIN","40 Milligram                                                                                            Film Coated Tablet",2017-07-28,"PA1390/123/003","Accord Healthcare Limited","ATORVASTATIN"
"809","ATORVASTATIN","80 Milligram                                                                                            Film Coated Tablet",2017-07-28,"PA1390/123/004","Accord Healthcare Limited","ATORVASTATIN"
"810","ATORVASTATIN","10 Milligram                                                                                            Film Coated Tablet",2015-06-12,"PPA0565/061/001","WPR Healthcare Limited","ATORVASTATINCALCIUM"
"811","ATORVASTATIN","20 Milligram                                                                                            Film Coated Tablet",2015-06-12,"PPA0565/061/002","WPR Healthcare Limited","ATORVASTATINCALCIUM"
"812","ATORVASTATIN","40 Milligram                                                                                            Film Coated Tablet",2015-06-12,"PPA0565/061/003","WPR Healthcare Limited","ATORVASTATINCALCIUM"
"813","ATORVASTATIN","80 Milligram                                                                                            Film Coated Tablet",2015-06-12,"PPA0565/061/004","WPR Healthcare Limited","ATORVASTATINCALCIUM"
"814","Atorvastatin 10 mg film-coated tablets","10 milligram(s) Film-coated tablet",2011-12-05,"PA0895/010/001","Dexcel-Pharma Limited","Atorvastatinca,hemi-hydratesalt"
"815","Atorvastatin 10 mg Film-Coated Tablets","10 milligram(s) Film-coated tablet",2012-06-22,"PA1339/031/001","Wockhardt UK Limited","Atorvastatincalciumtrihydrate"
"816","Atorvastatin 20 mg Film-Coated Tablets","20 milligram(s) Film-coated tablet",2012-06-22,"PA1339/031/002","Wockhardt UK Limited","Atorvastatincalciumtrihydrate"
"817","Atorvastatin 20 mg film-coated tablets","20 milligram(s) Film-coated tablet",2011-12-05,"PA0895/010/002","Dexcel-Pharma Limited","Atorvastatinca,hemi-hydratesalt"
"818","Atorvastatin 40 mg film-coated tablets","40 milligram(s) Film-coated tablet",2011-12-05,"PA0895/010/003","Dexcel-Pharma Limited","Atorvastatinca,hemi-hydratesalt"
"819","Atorvastatin 40 mg Film-Coated Tablets","40 milligram(s) Film-coated tablet",2012-06-22,"PA1339/031/003","Wockhardt UK Limited","Atorvastatincalciumtrihydrate"
"820","Atorvastatin 80 mg Film-Coated Tablets","80 milligram(s) Film-coated tablet",2012-06-22,"PA1339/031/004","Wockhardt UK Limited","Atorvastatincalciumtrihydrate"
"821","Atorvastatin Clonmel 10 mg film-coated tablets","10 milligram(s) Film-coated tablet",2016-03-11,"PA0126/271/001","Clonmel Healthcare Ltd","Atorvastatincalciumtrihydrate"
"822","Atorvastatin Clonmel 20 mg film-coated tablets","20 milligram(s) Film-coated tablet",2016-03-11,"PA0126/271/002","Clonmel Healthcare Ltd","Atorvastatincalciumtrihydrate"
"823","Atorvastatin Clonmel 40 mg film-coated tablets","40 milligram(s) Film-coated tablet",2016-03-11,"PA0126/271/003","Clonmel Healthcare Ltd","Atorvastatincalciumtrihydrate"
"824","Atorvastatin Clonmel 80 mg film-coated tablets","80 milligram(s) Film-coated tablet",2016-03-11,"PA0126/271/004","Clonmel Healthcare Ltd","Atorvastatincalciumtrihydrate"
"825","ATORVASTATIN DSM SINOCHEM","10 Milligram                                                                                            Film Coated Tablet",2017-10-20,"PA1832/005/001","DSM Sinochem Pharmaceuticals Netherlands B.V.","ATORVASTATINCALCIUMTRIHYDRATE"
"826","ATORVASTATIN DSM SINOCHEM","20 Milligram                                                                                            Film Coated Tablet",2017-10-20,"PA1832/005/002","DSM Sinochem Pharmaceuticals Netherlands B.V.","ATORVASTATINCALCIUMTRIHYDRATE"
"827","ATORVASTATIN DSM SINOCHEM","30 Milligram                                                                                            Film Coated Tablet",2017-10-20,"PA1832/005/003","DSM Sinochem Pharmaceuticals Netherlands B.V.","ATORVASTATINCALCIUMTRIHYDRATE"
"828","ATORVASTATIN DSM SINOCHEM","40 Milligram                                                                                            Film Coated Tablet",2017-10-20,"PA1832/005/004","DSM Sinochem Pharmaceuticals Netherlands B.V.","ATORVASTATINCALCIUMTRIHYDRATE"
"829","ATORVASTATIN DSM SINOCHEM","60 Milligram                                                                                            Film Coated Tablet",2017-10-20,"PA1832/005/005","DSM Sinochem Pharmaceuticals Netherlands B.V.","ATORVASTATINCALCIUMTRIHYDRATE"
"830","ATORVASTATIN DSM SINOCHEM","80 Milligram                                                                                            Film Coated Tablet",2017-10-20,"PA1832/005/006","DSM Sinochem Pharmaceuticals Netherlands B.V.","ATORVASTATINCALCIUMTRIHYDRATE"
"831","ATORVASTATIN KRKA","80 Milligram                                                                                            Film Coated Tablet",2011-09-23,"PA1347/009/004","Krka d.d., Novo mesto","ATORVASTATINCALCIUM"
"832","Atorvastatin Krka 10mg film-coated tablets","10 milligram(s) Film-coated tablet",2010-07-21,"PA1347/023/001","Krka d.d., Novo mesto","Atorvastatincalcium"
"833","Atorvastatin Krka 20mg film-coated tablets","20 milligram(s) Film-coated tablet",2010-07-21,"PA1347/023/002","Krka d.d., Novo mesto","Atorvastatincalcium"
"834","Atorvastatin Krka 40mg film-coated tablets","40 milligram(s) Film-coated tablet",2010-07-21,"PA1347/023/003","Krka d.d., Novo mesto","Atorvastatincalcium"
"835","ATORVASTATIN MYLAN","10 Milligram                                                                                            Film Coated Tablet",2011-02-04,"PA0577/118/001","McDermott Laboratories Ltd t/a Gerard Laboratories","ATORVASTATINCALCIUMTRIHYDRATE"
"836","ATORVASTATIN MYLAN","20 Milligram                                                                                            Film Coated Tablet",2011-02-04,"PA0577/118/002","McDermott Laboratories Ltd t/a Gerard Laboratories","ATORVASTATINCALCIUMTRIHYDRATE"
"837","ATORVASTATIN MYLAN","40 Milligram                                                                                            Film Coated Tablet",2011-02-04,"PA0577/118/003","McDermott Laboratories Ltd t/a Gerard Laboratories","ATORVASTATINCALCIUMTRIHYDRATE"
"838","ATORVASTATIN MYLAN","80 Milligram                                                                                            Film Coated Tablet",2011-02-04,"PA0577/118/004","McDermott Laboratories Ltd t/a Gerard Laboratories","ATORVASTATINCALCIUMTRIHYDRATE"
"839","Atorvastatin Pfizer 10 mg film coated tablets","10 milligram(s) Film-coated tablet",2011-10-28,"PA1740/002/001","Pfizer Ireland Pharmaceuticals","Atorvastatincalcium"
"840","Atorvastatin Pfizer 20 mg film coated tablets","20 milligram(s) Film-coated tablet",2011-10-28,"PA1740/002/002","Pfizer Ireland Pharmaceuticals","Atorvastatincalcium"
"841","Atorvastatin Pfizer 40 mg film coated tablets","40 milligram(s) Film-coated tablet",2011-10-28,"PA1740/002/003","Pfizer Ireland Pharmaceuticals","Atorvastatincalcium"
"842","Atorvastatin Pfizer 80 mg film coated tablets","80 milligram(s) Film-coated tablet",2011-10-28,"PA1740/002/004","Pfizer Ireland Pharmaceuticals","Atorvastatincalcium"
"843","ATORVASTATIN TEVA","10 Milligram                                                                                            Film Coated Tablet",2010-10-08,"PA0749/110/001","Teva Pharma B.V.","ATORVASTATINCALCIUM"
"844","ATORVASTATIN TEVA","20 Milligram                                                                                            Film Coated Tablet",2010-10-08,"PA0749/110/002","Teva Pharma B.V.","ATORVASTATINCALCIUM"
"845","ATORVASTATIN TEVA","40 Milligram                                                                                            Film Coated Tablet",2010-10-08,"PA0749/110/003","Teva Pharma B.V.","ATORVASTATINCALCIUM"
"846","ATORVASTATIN TEVA","80 Milligram                                                                                            Film Coated Tablet",2010-10-08,"PA0749/110/004","Teva Pharma B.V.","ATORVASTATINCALCIUM"
"847","ATOSIBAN","37.5 MG/5ml                                                                                               Concentrate for Soln for Inf",2015-09-11,"PA1390/100/001","Accord Healthcare Limited","ATOSIBAN"
"848","ATOSIBAN ACCORD","6.75 Milligram                                                                                            Solution for injection in pre-filled syringe",2018-07-27,"PA1390/100/002","Accord Healthcare Limited","ATOSIBAN"
"849","ATOSIBAN SUN","6.75/0.9 Mg/Ml Solution for Injection",2013-07-31,"EU/1/13/852/001","Sun Phamaceutical Industries Europe B.V.","ATOSIBAN"
"850","ATOSIBAN SUN","37.5/5 Mg/Ml Concentrate for Soln for Inf",2013-07-31,"EU/1/13/852/002","Sun Phamaceutical Industries Europe B.V.","ATOSIBAN"
"851","ATOVAQUONE/PROGUANIL","250/100 Milligram                                                                                            Film Coated Tablet",2016-09-02,"PPA1562/177/001","LTT Pharma Limited","ATOVAQUONE|PROGUANILHYDROCHLORIDE"
"852","ATOVAQUONE/PROGUANIL HYDROCHLORIDE","250/100 Milligram                                                                                            Film Coated Tablet",2013-05-31,"PA0405/062/001","Generics (UK) Limited","ATOVAQUONE|PROGUANILHYDROCHLORIDE"
"853","ATOVAQUONE/PROGUANIL HYDROCHLORIDE","250/100 Milligram                                                                                            Film Coated Tablet",2017-07-07,"PA1462/016/001","Glenmark Pharmaceuticals Europe Limited","ATOVAQUONE|PROGUANILHYDROCHLORIDE"
"854","Atozet 10mg/10mg Film-coated tablets","10 /10 milligram(s) Film-coated tablet",2014-11-07,"PA1286/060/001","Merck Sharp & Dohme Ireland (Human Health) Limited","Ezetimibe,micronized|Atorvastatin|Atorvastatincalciumtrihydrate"
"855","Atozet 10mg/20mg Film-coated tablets","10 / 20 milligram(s) Film-coated tablet",2014-11-07,"PA1286/060/002","Merck Sharp & Dohme Ireland (Human Health) Limited","Ezetimibe,micronized|Atorvastatincalciumtrihydrate"
"856","Atozet 10mg/40mg Film-coated tablets","10 / 40 milligram(s) Film-coated tablet",2014-11-07,"PA1286/060/003","Merck Sharp & Dohme Ireland (Human Health) Limited","Ezetimibe,micronized|Ezetimibe,micronized|Atorvastatin|Atorvastatincalciumtrihydrate"
"857","Atozet 10mg/80mg Film-coated tablets","10 / 80 milligram(s) Film-coated tablet",2014-11-07,"PA1286/060/004","Merck Sharp & Dohme Ireland (Human Health) Limited","Ezetimibe,micronized|Ezetimibe,micronized|Atorvastatin|Atorvastatincalciumtrihydrate"
"858","ATRACURIUM","10 Mg/Ml Solution for Injection",2014-07-04,"PA1217/011/001","Hikma Farmaceutica (Portugal) SA","ATRACURIUMBESILATE"
"859","ATRACURIUM BESILATE","10 Mg/Ml Solution for Inj/Inf",2017-11-24,"PA2165/001/001","AS KALCEKS","ATRACURIUMBESILATE"
"860","ATRIANCE 5mg/ml Solution for Infusion","5 milligram(s)/millilitre Solution for infusion",2007-08-22,"EU/1/07/403/001","Novartis Europharm Limited","Nelarabine"
"861","ATRIPLA","600/200/245 Milligram                                                                                            Film Coated Tablet",2007-12-13,"EU/1/07/430/001","Bristol-Myers Squibb Pharmaceuticals uc","EFAVIRENZ|EMTRICITABINE|TENOFOVIRDISOPROXILFUMARATE"
"862","Atrogel Arnica Gel","*** AWAITING VALUE *** Gel",2011-01-14,"TR2309/001/001","A. Vogel Ireland Limited","Arnicamontanal.flowers(der1:20)"
"863","Atropine Injection BP Minijet 100 microgram/ml Solution for Injection","100 microgram(s)/millilitre Solution for injection",1977-09-08,"PA0255/006/002","International Medication Systems (UK) Ltd","ATROPINESULFATE"
"864","Atropine Sulfate Aguettant 0.1mg/ml Solution for Injection in Pre-Filled Syringe","0.1 milligram(s)/millilitre Solution for injection in pre-filled syringe",2015-10-02,"PA1968/003/001","Laboratoire AGUETTANT","ATROPINESULFATE"
"865","Atropine Sulfate Aguettant 0.2mg/ml Solution for Injection in Pre-Filled Syringe","0.2 milligram(s)/millilitre Solution for injection in pre-filled syringe",2015-07-24,"PA1968/003/002","Laboratoire AGUETTANT","ATROPINESULFATE"
"866","ATROPINE SULPHATE","600 Microgram/ML                                                                                         Solution for Injection",1979-04-01,"PA0073/036/001","Mercury Pharmaceuticals (Ireland) Ltd","ATROPINESULFATE"
"867","Atrosan Devil's Claw film-coated tablets","480 milligram(s) Film-coated tablet",2011-12-09,"TR2309/003/001","A. Vogel Ireland Limited","Devil'sclawextract(asdryroot)"
"868","ATROVENT 250 UDVS","250 Microgram/ML                                                                                         Solution for Inhalation",1996-06-10,"PA0007/002/007","Boehringer Ingelheim Limited","IPRATROPIUMBROMIDE"
"869","Atrovent 500 UDVs, 500 micrograms/ 2ml Nebuliser Solution","500mcg/2ml microgram(s) Nebuliser solution",1985-09-27,"PA0007/002/004","Boehringer Ingelheim Limited","Ipratropiumbromide"
"870","ATROVENT INHALER CFC-FREE","20 Mcg/Dose                                                                                             Pressurised Inhalation Soln",2004-05-14,"PA0007/002/010","Boehringer Ingelheim Limited","IPRATROPIUMBROMIDE"
"871","ATRYN","1750 International Unit                                                                                   Pdr for Soln for Infusion",2006-07-28,"EU/1/06/355/1-3","Laboratoire francais du Fractionnement et des Biotechnolgies","ANTITHROMBINALFA"
"872","Aubagio","14 milligram(s) Film-coated tablet",NA,"EU/1/13/838/001-005","sanofi-aventis groupe","Teriflunomide"
"873","AUDAVAL","0.1 %w/w                                                                                                 Ointment",2012-10-05,"PA1352/020/002","Auden Mckenzie (Pharma Division) Ltd","BETAMETHASONEVALERATE"
"874","AUDAVAL RD","0.025 %w/w                                                                                                 Ointment",2012-10-05,"PA1352/020/004","Auden Mckenzie (Pharma Division) Ltd","BETAMETHASONEVALERATE(ASBETAMETHASONE)"
"875","AUDAX","20/12.6 %w/v                                                                                                 Ear Drops Solution",1983-04-01,"PA0257/058/001","GR Lane Health Products Ltd","CHOLINESALICYLATE|GLYCEROL"
"876","AUGMENTIN","875/125 Milligram                                                                                            Film Coated Tablet",2004-11-12,"PA1077/019/005","GlaxoSmithKline (Ireland) Limited","AMOXICILLINTRIHYDRATE|CLAVULANICACID(INTHEFORMOFPOTASSIUMCLAVULANATE)"
"877","AUGMENTIN","250/125 Milligram                                                                                            Film Coated Tablet",2008-01-11,"PPA1151/050/001","Imbat Limited","AMOXICILLIN|CLAVULANICACID"
"878","AUGMENTIN","500/125 Milligram                                                                                            Film Coated Tablet",2010-08-06,"PPA1151/050/003","Imbat Limited","AMOXICILLINTRIHYDRATE|CLAVULANATEPOTASSIUM"
"879","Augmentin  250mg/125 mg film-coated tablets","250/125 milligram(s) Tablet",1982-09-06,"PA1077/093/007","GlaxoSmithKline (Ireland) Limited","Amoxicillintrihydrate|Potassiumclavulanate"
"880","Augmentin  500 mg/125 mg film-coated tablets","500/125 milligram(s) Film-coated tablet",1999-02-19,"PA1077/019/003","GlaxoSmithKline (Ireland) Limited","Amoxycillintrihydrate|Potassiumclavulanate"
"881","Augmentin 875 mg/125 mg film-coated tablets","875/125 milligram(s) Film-coated tablet",2018-03-16,"PPA1097/043/001","Lexon (UK) Ltd","Clavulanicacid(intheformofpotassiumclavulanate)|Amoxicillintrihydrate"
"882","AUGMENTIN DUO","400/57 MG/5ml                                                                                               Powder for Oral Suspension",2008-10-17,"PPA1151/050/002","Imbat Limited","AMOXICILLINTRIHYDRATE|CLAVULANATEPOTASSIUM"
"883","AUGMENTIN DUO","400/57 MG/5ml                                                                                               Powder for Oral Suspension",1999-02-19,"PA1077/019/002","GlaxoSmithKline (Ireland) Limited","AMOXICILLINTRIHYDRATE|CLAVULANATEPOTASSIUM"
"884","Augmentin Duo Mixed Fruit 400 mg/57 mg/5 ml Powder for Oral Suspension","400mg/57 mg/5ml Powder for oral suspension",2017-07-14,"PA1077/019/006","GlaxoSmithKline (Ireland) Limited","Amoxicillin(asamoxicillintrihydrate)|Clavulanicacid(aspotassiumclavulanateph.eur.)"
"885","AUGMENTIN INTRAVENOUS","500/100 Milligram                                                                                            Pdr for Soln Inj/Inf",1985-07-01,"PA1077/093/001","GlaxoSmithKline (Ireland) Limited","AMOXICILLINSODIUM|CLAVULANICACID(INTHEFORMOFPOTASSIUMCLAVULANATE)"
"886","AUGMENTIN INTRAVENOUS","1000/200 Milligram                                                                                            Pdr for Soln Inj/Inf",1985-07-01,"PA1077/093/002","GlaxoSmithKline (Ireland) Limited","AMOXICILLINSODIUM|CLAVULANICACID(INTHEFORMOFPOTASSIUMCLAVULANATE)"
"887","Augmentin Paediatric 125mg/31.25mg per 5ml Powder for Oral Suspension","125/31.25 mg/5ml Powder for oral suspension",1983-07-28,"PA1077/093/004","GlaxoSmithKline (Ireland) Limited","Potassiumclavulanate|Amoxicillintrihydrate"
"888","AVAMYS","27.5 Microgram                                                                                            Nasal Spray Suspension",2008-01-11,"EU/1/07/434/001-3","Glaxo Group Limited","FLUTICASONEFUROATE"
"889","AVASTIN","25mg/ml milligram(s)/millilitre Concentrate for solution for infusion",2005-01-12,"EU/1/04/300/001-002","Roche Registration GmbH","Bevacizumab"
"890","AVAXIM, suspension for injection in a pre-filled syringeHepatitis A vaccine (inactivated, adsorbed)","160 D-ant. percent volume/volume Suspension for injection in pre-filled syringe",1997-02-21,"PA2131/002/001","Sanofi Pasteur","Hepatitisavirus"
"891","AVELOX","400 Milligram                                                                                            Film Coated Tablet",2009-07-24,"PPA0465/230/001","PCO Manufacturing","MOXIFLOXACINHYDROCHLORIDE"
"892","AVELOX","400 Milligram                                                                                            Film Coated Tablet",2017-07-21,"PPA1097/025/001","Lexon (UK) Ltd","MOXIFLOXACINHYDROCHLORIDE"
"893","AVELOX","400 Milligram                                                                                            Film Coated Tablet",2018-03-16,"PPA1463/118/001","IMED Healthcare Ltd.","MOXIFLOXACINHYDROCHLORIDE"
"894","Avelox 400 mg film-coated tablets","400 milligram(s) Film-coated tablet",1999-12-10,"PA1410/027/001","Bayer Limited","Moxifloxacinhydrochloride"
"895","Avelox 400 mg/250 ml solution for infusion","400/250 milligram(s)/millilitre Solution for infusion",2003-04-04,"PA1410/027/003","Bayer Limited","Moxifloxacinhydrochloride"
"896","AvenaCalm Avena sativa oral drops","*** AWAITING VALUE *** ZZZ Infus/Pdr/Oral Soln",2016-07-01,"TR2309/012/001","A. Vogel Ireland Limited","Tincturefrompressedjuicefromavenasatival,herbarec(freshoatherb),(1:1.2)"
"897","AVODART","0.5 Milligram                                                                                            Capsules, Soft",2010-06-25,"PPA1463/038/001","IMED Healthcare Ltd.","DUTASTERIDE"
"898","AVODART","0.5 Milligram                                                                                            Capsules, Soft",2009-09-18,"PPA1151/124/001","Imbat Limited","DUTASTERIDE"
"899","AVODART","0.5 Milligram                                                                                            Capsules, Soft",2004-12-17,"PA1077/104/001","GlaxoSmithKline (Ireland) Limited","DUTASTERIDE"
"900","Avodart 0.5 mg soft capsules","0.5 milligram(s) Capsule, soft",2014-10-17,"PPA1562/131/001","LTT Pharma Limited","Dutasteride"
"901","Avodart 0.5mg soft capsules","0.5 milligram(s) Capsule, soft",2008-06-20,"PPA0465/211/001","PCO Manufacturing","Dutasteride"
"902","AVONEX","30 Microgram                                                                                            Pdr+Solv for soln for Inf",2001-01-22,"EU/1/97/033/002","Biogen Netherlands B.V.","INTERFERONBETA-1A"
"903","AVONEX","30/0.5 Microgram/ML                                                                                         Solution for Injection",2003-06-24,"EU/1/97/033/003","Biogen Netherlands B.V.","INTERFERONBETA-1A"
"904","AXSAIN","0.075 %w/w                                                                                                 Cream",1994-06-14,"PA0827/004/001","Cephalon UK Limited","CAPSAICIN"
"905","AXUMIN","1600 MBq/ml                                                                                               Solution for Injection",2017-05-22,"EU/1/17/1186/001","Blue Earth Diagnostics Ltd.","FLUCICLOVINE(18F)"
"906","AXUMIN","3200 MBq/ml                                                                                               Solution for Injection",2017-05-22,"EU/1/17/1186/002","Blue Earth Diagnostics Ltd.","FLUCICLOVINE(18F)"
"907","AXURA","10 Milligram                                                                                            Film Coated Tablet",2002-05-17,"EU/1/02/218/1-3","Merz Pharmaceuticals GmbH","MEMANTINEHYDROCHLORIDE"
"908","AXURA","5+10+15+20 Milligram                                                                                            Film Coated Tablet",2008-05-08,"EU/1/02/218/16","Merz Pharmaceuticals GmbH","MEMANTINE"
"909","AXURA","20 Milligram                                                                                            Film Coated Tablet",2008-05-08,"EU/1/02/218/17-22","Merz Pharmaceuticals GmbH","MEMANTINE"
"910","AXURA","5 Milligram                                                                                            Infus/Pdr/Oral Soln",2002-05-17,"EU/1/02/218/5-6","Merz Pharmaceuticals GmbH","MEMANTINEHYDROCHLORIDE"
"911","AXYMPA","180 Milligram                                                                                            Tablets Gastro-Resistant",2013-09-13,"PA0749/213/001","Teva Pharma B.V.","MYCOPHENOLATESODIUM"
"912","AXYMPA","360 Milligram                                                                                            Tablets Gastro-Resistant",2013-09-13,"PA0749/213/002","Teva Pharma B.V.","MYCOPHENOLATESODIUM"
"913","AZACTAM","1 Grams                                                                                                Pdr for Soln Inj/Inf",1985-03-05,"PA0002/052/002","Bristol-Myers Squibb Pharmaceuticals uc","AZTREONAM"
"914","AZACTAM","2 Grams                                                                                                Pdr for Soln Inj/Inf",1985-03-05,"PA0002/052/003","Bristol-Myers Squibb Pharmaceuticals uc","AZTREONAM"
"915","AZALIA","75 Microgram                                                                                            Film Coated Tablet",2010-10-08,"PA1330/010/001","Gedeon Richter Plc","DESOGESTREL"
"916","AZARGA 10 MG/ML + 5 MG/ML EYE DROPS, SUSPENSION","10/5 Micromol Eye Drops Suspension",2008-11-25,"EU/1/08/482/1-2","Novartis Europharm Limited","BRINZOLAMIDE|TIMOLOLMALEATE"
"917","Azathioprine 50mg film-coated Tablets","50 milligram(s) Film-coated tablet",2007-11-23,"PA1128/004/001","Relon Chem Limited","Azathioprine"
"918","Azecort 137 micrograms / 50 micrograms per actuation, Nasal Spray Suspension","137/50 microgram(s) Nasal spray, suspension",2013-02-22,"PA1332/046/001","Meda Health Sales Ireland Limited","Azelastinehydrochloride|FLUTICASONEPROPIONATE"
"919","Azelastine Eye Drops, 0.5 mg/ml, Eye Drops, solution","0.5 milligram(s)/millilitre Eye drops, solution",1998-08-28,"PA2010/046/001","Mylan IRE Healthcare Limited","Azelastinehydrochloride"
"920","AZILECT","1 Milligram                                                                                            Tablets",2005-02-21,"EU/1/04/304/1-7","Teva B.V.","RASAGILINEMESILATE"
"921","AZILSARTAN MEDOXOMIL/CHLORTALIDONE","40/12.5 Milligram                                                                                            Film Coated Tablet",2017-08-04,"PA2167/001/001","Takeda Pharma A/S","AZILSARTANMEDOXOMILPOTASSIUM|CHLORTALIDONE"
"922","AZILSARTAN MEDOXOMIL/CHLORTALIDONE","40/25 Milligram                                                                                            Film Coated Tablet",2017-08-04,"PA2167/001/002","Takeda Pharma A/S","AZILSARTANMEDOXOMILPOTASSIUM|CHLORTALIDONE"
"923","AZITHROMYCIN","250 Milligram                                                                                            Film Coated Tablet",2017-10-20,"PA1339/038/002","Wockhardt UK Limited","AZITHROMYCINANHYDROUS"
"924","AZITHROMYCIN","500 Milligram                                                                                            Film Coated Tablet",2017-10-20,"PA1339/038/003","Wockhardt UK Limited","AZITHROMYCINANHYDROUS"
"925","AZITHROMYCIN ACTAVIS","250 Milligram                                                                                            Film Coated Tablet",2012-11-16,"PA1380/138/001","Actavis Group PTC ehf","AZITHROMYCIN"
"926","AZITHROMYCIN CLONMEL","250 Milligram                                                                                            Film Coated Tablet",2005-11-18,"PA0126/150/001","Clonmel Healthcare Ltd","AZITHROMYCINMONOHYDRATE"
"927","Azithromycin Krka 250mg Film-coated Tablet","250 milligram(s) Film-coated tablet",2014-05-09,"PA1347/047/001","Krka d.d., Novo mesto","Azithromycindihydrate"
"928","AZITHROMYCIN TEVA","250 Milligram                                                                                            Film Coated Tablet",2013-02-15,"PA0749/039/002","Teva Pharma B.V.","AZITHROMYCINDIHYDRATE"
"929","AZOMYR","5 Milligram                                                                                            Tablets",2001-01-15,"EU/1/00/157/001","Schering Plough Europe","DESLORATIDINE"
"930","AZOMYR","5 Milligram                                                                                            Tablets",2001-01-15,"EU/1/00/157/002","Schering Plough Europe","DESLORATIDINE"
"931","AZOMYR","5 Milligram                                                                                            Tablets",2001-01-15,"EU/1/00/157/003","Schering Plough Europe","DESLORATIDINE"
"932","AZOMYR","5 Milligram                                                                                            Tablets",2001-01-15,"EU/1/00/157/004","Schering Plough Europe","DESLORATIDINE"
"933","AZOMYR","5 Milligram                                                                                            Tablets",2001-01-15,"EU/1/00/157/005","Schering Plough Europe","DESLORATIDINE"
"934","AZOMYR","5 Milligram                                                                                            Tablets",2001-01-15,"EU/1/00/157/006","Schering Plough Europe","DESLORATIDINE"
"935","AZOMYR","5 Milligram                                                                                            Tablets",2001-01-15,"EU/1/00/157/007","Schering Plough Europe","DESLORATIDINE"
"936","AZOMYR","5 Milligram                                                                                            Tablets",2001-01-15,"EU/1/00/157/008","Schering Plough Europe","DESLORATIDINE"
"937","AZOMYR","5 Milligram                                                                                            Tablets",2001-01-15,"EU/1/00/157/009","Schering Plough Europe","DESLORATIDINE"
"938","AZOMYR","5 Milligram                                                                                            Tablets",2001-01-15,"EU/1/00/157/010","Schering Plough Europe","DESLORATIDINE"
"939","AZOMYR","5 Milligram                                                                                            Tablets",2001-01-15,"EU/1/00/157/011","Schering Plough Europe","DESLORATIDINE"
"940","AZOMYR","5 Milligram                                                                                            Tablets",2001-01-15,"EU/1/00/157/012","Schering Plough Europe","DESLORATIDINE"
"941","AZOMYR","5 Milligram                                                                                            Tablets",2001-01-15,"EU/1/00/157/013","Schering Plough Europe","DESLORATIDINE"
"942","AZOMYR","0.5mg/ml Mg/Ml Syrup",2002-04-16,"EU/1/00/157/014","Merck Sharp & Dohme BV","DESLORATIDINE"
"943","AZOMYR","0.5 Mg/Ml Syrup",2002-04-16,"EU/1/00/157/015","Merck Sharp & Dohme BV","DESLORATIDINE"
"944","AZOMYR","0.5 Mg/Ml Syrup",2002-04-16,"EU/1/00/157/016","Merck Sharp & Dohme BV","DESLORATIDINE"
"945","AZOMYR","0.5 Mg/Ml Syrup",2002-04-16,"EU/1/00/157/017","Merck Sharp & Dohme BV","DESLORATIDINE"
"946","AZOMYR","0.5 Mg/Ml Syrup",2002-04-16,"EU/1/00/157/018","Merck Sharp & Dohme BV","DESLORATIDINE"
"947","AZOMYR","0.5 Mg/Ml Syrup",2002-04-16,"EU/1/00/157/019","Merck Sharp & Dohme BV","DESLORATIDINE"
"948","AZOMYR","0.5 Mg/Ml Syrup",2002-04-16,"EU/1/00/157/020","Merck Sharp & Dohme BV","DESLORATIDINE"
"949","AZOMYR","0.5 Mg/Ml Syrup",2002-04-16,"EU/1/00/157/021","Merck Sharp & Dohme BV","DESLORATIDINE"
"950","AZOMYR","5 Milligram                                                                                            Oral Lyophilisate",2002-04-16,"EU/1/00/157/022","Schering Plough Europe","DESLORATIDINE"
"951","AZOMYR","5 Milligram                                                                                            Oral Lyophilisate",2002-04-16,"EU/1/00/157/023","Schering Plough Europe","DESLORATIDINE"
"952","AZOMYR","5 Milligram                                                                                            Oral Lyophilisate",2002-04-16,"EU/1/00/157/024","Schering Plough Europe","DESLORATIDINE"
"953","AZOMYR","5 Milligram                                                                                            Oral Lyophilisate",2002-04-16,"EU/1/00/157/025","Schering Plough Europe","DESLORATIDINE"
"954","AZOMYR","5 Milligram                                                                                            Oral Lyophilisate",2002-04-16,"EU/1/00/157/026","Schering Plough Europe","DESLORATIDINE"
"955","AZOMYR","5 Milligram                                                                                            Oral Lyophilisate",2002-04-16,"EU/1/00/157/027","Schering Plough Europe","DESLORATIDINE"
"956","AZOMYR","5 Milligram                                                                                            Oral Lyophilisate",2002-04-16,"EU/1/00/157/028","Schering Plough Europe","DESLORATIDINE"
"957","AZOMYR","5 Milligram                                                                                            Oral Lyophilisate",2002-04-16,"EU/1/00/157/029","Schering Plough Europe","DESLORATIDINE"
"958","AZOMYR","5 Milligram                                                                                            Oral Lyophilisate",2002-04-16,"EU/1/00/157/030","Schering Plough Europe","DESLORATIDINE"
"959","AZOMYR","5 Milligram                                                                                            Oral Lyophilisate",2002-04-16,"EU/1/00/157/031","Schering Plough Europe","DESLORATIDINE"
"960","AZOMYR","5 Milligram                                                                                            Oral Lyophilisate",2002-04-16,"EU/1/00/157/032","Schering Plough Europe","DESLORATIDINE"
"961","AZOMYR","5 Milligram                                                                                            Oral Lyophilisate",2002-04-16,"EU/1/00/157/033","Schering Plough Europe","DESLORATIDINE"
"962","AZOMYR","5 Milligram                                                                                            Oral Lyophilisate",2002-04-16,"EU/1/00/157/034","Schering Plough Europe","DESLORATIDINE"
"963","AZOMYR","2.5 Milligram                                                                                            Orodispersible Tablet",2007-04-23,"EU/1/00/157/35-46","Schering Plough Europe","DESLORATIDINE"
"964","AZOMYR","5 Milligram                                                                                            Orodispersible Tablet",2007-04-23,"EU/1/00/157/47-58","Schering Plough Europe","DESLORATIDINE"
"965","AZOMYR","0.5 Mg/Ml Infus/Pdr/Oral Soln",2007-04-23,"EU/1/00/157/59-67","Merck Sharp & Dohme BV","DESLORATADINE,MICRONIZED"
"966","AZOPT","10 Mg/Ml Eye Drops Suspension",2000-03-09,"EU/1/00/129/002","Novartis Europharm Limited","BRINZOLAMIDE"
"967","AZOPT EYE DROPS","10 Mg/Ml Eye Drops Suspension",2000-03-09,"EU/1/00/129/001","Novartis Europharm Limited","BRINZOLAMIDE"
"968","AZROMAX","250 Milligram                                                                                            Film Coated Tablet",2010-06-04,"PA0577/122/001","McDermott Laboratories Ltd t/a Gerard Laboratories","AZITHROMYCINMONOHYDRATE"
"969","AZYTER","15 mg/g Eye Drops Solution",2011-05-20,"PA1107/004/001","Laboratoires Thea","AZITHROMYCINDIHYDRATE"
"970","Azzalure, 125 Speywood units, powder for solution for injection","125 Speywood Powder for solution for injection",2010-03-26,"PA1613/001/001","Ipsen Pharma","Clostridiumbotulinumtoxintypeahaemagglutinincomplex|Clostridiumbotulinumtoxintypeahaemagglutinincomplex"
"971","BACLOFEN","5 MG/5ml                                                                                               Oral Solution",2016-02-12,"PA1861/019/001","SYRI Limited, t/a Thame Laboratories","BACLOFEN"
"972","BACLOPAR","10 Milligram                                                                                            Tablets",1989-11-21,"PA0405/029/001","Generics (UK) Limited","BACLOFEN"
"973","BACTROBAN","2 %w/w                                                                                                 Ointment",1986-04-29,"PA1077/094/001","GlaxoSmithKline (Ireland) Limited","MUPIROCIN"
"974","BACTROBAN","2.0 %w/w                                                                                                 Nasal Ointment",1989-07-17,"PA1077/094/002","GlaxoSmithKline (Ireland) Limited","MUPIROCINCALCIUM"
"975","BACTROBAN","2 Base %w/w                                                                                            Nasal Ointment",2012-02-17,"PPA1151/169/001","Imbat Limited","MUPIROCINCALCIUM"
"976","Bactroban Nasal Ointment 2% w/w","2.0 percent weight/weight Nasal ointment",2013-07-26,"PPA0465/312/001","PCO Manufacturing","Mupirocin"
"977","BANDIDA","150 Milligram                                                                                            Capsules Hard",2017-01-13,"PA1380/183/001","Actavis Group PTC ehf","FLUCONAZOLE"
"978","BARACLUDE","0.5 Milligram                                                                                            Tablets",2006-06-26,"EU/1//06/343/01","Bristol Myers Squibb Pharma EEIG","ENTECAVIR"
"979","BARACLUDE","1.0 Milligram                                                                                            Tablets",2006-06-26,"EU/1/06/343/02,04,07","Bristol Myers Squibb Pharma EEIG","ENTECAVIR"
"980","BARACLUDE","0.05 Mg/Ml Oral Solution",2006-06-26,"EU/1/06/343/05","Bristol Myers Squibb Pharma EEIG","ENTECAVIR"
"981","Bavencio","20 milligram(s)/millilitre Concentrate for solution for infusion",2017-09-18,"EU/1/17/1214/001","Merck Serono Europe Limited","Avelumab"
"982","BCG VACCINE SSI Powder and solvent for suspension for injection","percent volume/volume Powder and solvent for suspension for injection",2001-12-14,"PA2160/003/001","AJ Vaccines A/S","Mycobacteriumbovis(bcg)stam1331"
"983","BCG-medac, powder and solvent for suspension for intravesical use","*** AWAITING VALUE *** ZZZ Powder + Solvent/Suspension/Intravesical Use",2002-04-05,"PA0623/004/001","Medac Gesellschaft fur Klinische Spezialpraparate mbH","Bcgbacteriaattenuatedstrainrivm"
"984","BECLAZONE CFC-FREE INHALER","250 Mcg/Acutuation                                                                                       Pressurised Inhalation Soln",1997-11-14,"PA0436/021/012","Norton Waterford","BECLOMETASONEDIPROPIONATE"
"985","BECLAZONE CFC-FREE INHALER","50 Mcg/Acutuation                                                                                       Pressurised Inhalation Soln",1997-11-14,"PA0436/021/009","Norton Waterford","BECLOMETASONEDIPROPIONATE"
"986","BECLAZONE CFC-FREE INHALER","100 Mcg/Acutuation                                                                                       Pressurised Inhalation Soln",1997-11-14,"PA0436/021/010","Norton Waterford","BECLOMETASONEDIPROPIONATE"
"987","BECLAZONE EASI BREATHE CFC-FREE INHALER","250 Mcg/Acutuation                                                                                       Pressurised Inhalation Soln",1997-11-14,"PA0436/021/016","Norton Waterford","BECLOMETASONEDIPROPIONATE"
"988","BECLAZONE EASI BREATHE CFC-FREE INHALER","50 Mcg/Acutuation                                                                                       Pressurised Inhalation Soln",1997-11-14,"PA0436/021/013","Norton Waterford","BECLOMETASONEDIPROPIONATE"
"989","BECLAZONE EASI BREATHE CFC-FREE INHALER","100 Mcg/Acutuation                                                                                       Pressurised Inhalation Soln",1997-11-14,"PA0436/021/014","Norton Waterford","BECLOMETASONEDIPROPIONATE"
"990","BECLAZONE INHALER CFC FREE","200 %v/v                                                                                                 Pressurised Inhalation Suspension",1997-11-14,"PA0436/021/011","Norton Waterford","BECLOMETASONEDIPROPIONATEANHYDROUS"
"991","BECLAZONE INHALER EASI BREATHE CFC-FREE","200 Microgram                                                                                            Pressurised Inhalation Soln",1997-11-14,"PA0436/021/015","Norton Waterford","BECLOMETASONEDIPROPIONATEANHYDROUS"
"992","BECLONEB","400mcg/1ml Microgram/ML                                                                                         Nebuliser Solution",2005-03-18,"PA0584/003/001","Chiesi Farmaceutici S.p.A.","BECLOMETASONEDIPROPIONATE"
"993","BECLONEB","800mcg/2ml Microgram/ML                                                                                         Nebuliser Solution",2005-03-18,"PA0584/003/002","Chiesi Farmaceutici S.p.A.","BECLOMETASONEDIPROPIONATE"
"994","BECLOSPIN","400mcg/1ml Microgram/ML                                                                                         Nebuliser Solution",2005-03-18,"PA0584/004/001","Chiesi Farmaceutici S.p.A.","BECLOMETASONEDIPROPIONATEANHYDROUS"
"995","BECLOSPIN","800mcg/2ml Microgram/ML                                                                                         Nebuliser Solution",2005-03-18,"PA0584/004/002","Chiesi Farmaceutici S.p.A.","BECLOMETASONEDIPROPIONATE"
"996","Beconase Hayfever nasal spray 50 micrograms per spray","50 ZZZ Mcg/Dose Nasal spray, suspension",1999-09-17,"PA1186/008/001","Chefaro Ireland DAC","Beclometasonedipropionate"
"997","BECOTIDE EVOHALER","50 Mcg/Acutuation                                                                                       Pressurised Inhalation Soln",2007-04-27,"PPA0465/041/005","PCO Manufacturing","BECLOMETASONEDIPROPIONATE"
"998","BECOTIDE EVOHALER","250 Microgram                                                                                            Pressurised Inhalation Soln",2013-10-25,"PPA1151/204/001","Imbat Limited","BECLOMETASONEDIPROPIONATE"
"999","BECOTIDE EVOHALER","50 Microgram                                                                                            Pressurised Inhalation Soln",2014-01-24,"PPA1151/204/002","Imbat Limited","BECLOMETASONEDIPROPIONATE"
"1000","Becotide Evohaler 100 micrograms, Pressurised Inhalation Solution","100 microgram(s) Pressurised inhalation, solution",2005-01-07,"PA1077/042/007","GlaxoSmithKline (Ireland) Limited","Beclometasonedipropionate"
"1001","Becotide Evohaler 250 micrograms, Pressurised Inhalation Solution","250 microgram(s) Pressurised inhalation, solution",2007-01-07,"PA1077/042/009","GlaxoSmithKline (Ireland) Limited","Beclometasonedipropionate"
"1002","Becotide Evohaler 250 micrograms, Pressurised Inhalation Solution","250 microgram(s) Pressurised inhalation, solution",2007-10-19,"PPA0465/041/006","PCO Manufacturing","BECLOMETASONEDIPROPIONATE"
"1003","Becotide Evohaler 50 micrograms, Pressurised Inhalation Solution","50 microgram(s) Pressurised inhalation, solution",2005-01-07,"PA1077/042/006","GlaxoSmithKline (Ireland) Limited","Beclometasonedipropionate"
"1004","BELKYRA","10 Mg/Ml Solution for Injection",2017-06-02,"PA2103/003/001","Allergan Pharmaceuticals International Limited","DEOXYCHOLICACID"
"1005","BELLADONNA","0.25% %w/w                                                                                                 Medicated Plaster",1983-04-01,"PA0229/004/001","Cuxson Gerrard & Company Ltd","BELLADONNAALKALOIDS|ATROPINE|ATROPABELLADONNA"
"1006","BELLADONNA","6C-MM %v/v",2011-03-11,"HOR1149/006/001","A. Nelson & Company Limited","ATROPABELLADONNA"
"1007","BELLADONNA POROUS PLASTER ON WHITE CLOTH","0.25%w/w percent weight/weight Impregnated dressing",NA,"PA0206/011/002","Ovelle Limited","Belladonnaalkaloids"
"1008","BELLADONNA TABLETS","6C & 30C Milligram                                                                                            Tablets",2010-06-11,"HOR0407/019/001","Weleda (UK) Limited","ATROPABELLADONNA"
"1009","BEMFOLA","600IU/44 Microgram                                                                                            Solution for Injection",2014-03-27,"EU/1/13/909/001-005","Finox Biotech AG","FOLLITROPINALFA"
"1010","BENDAMUSTINE","25 Milligram                                                                                            Pdr/Conc/Soln for Infus",2015-08-21,"PA0405/072/001","Generics (UK) Limited","BENDAMUSTINEHYDROCHLORIDE"
"1011","BENDAMUSTINE","100 Milligram                                                                                            Pdr/Conc/Soln for Infus",2015-08-21,"PA0405/072/002","Generics (UK) Limited","BENDAMUSTINEHYDROCHLORIDE"
"1012","BENDAMUSTINE","25 Milligram                                                                                            Pdr/Conc/Soln for Infus",2015-05-15,"PA1380/163/001","Actavis Group PTC ehf","BENDAMUSTINEHYDROCHLORIDE"
"1013","BENDAMUSTINE","100 Milligram                                                                                            Pdr/Conc/Soln for Infus",2015-05-15,"PA1380/163/002","Actavis Group PTC ehf","BENDAMUSTINEHYDROCHLORIDE"
"1014","BENDAMUSTINE","25 Milligram                                                                                            Pdr/Conc/Soln for Infus",2014-10-17,"PA1390/095/001","Accord Healthcare Limited","BENDAMUSTINEHYDROCHLORIDE"
"1015","BENDAMUSTINE","100 Milligram                                                                                            Pdr/Conc/Soln for Infus",2014-10-17,"PA1390/095/002","Accord Healthcare Limited","BENDAMUSTINEHYDROCHLORIDE"
"1016","BENDAMUSTINE HCL","25 Milligram                                                                                            Pdr/Conc/Soln for Infus",2016-10-28,"PA1422/018/001","Fresenius Kabi Oncology Plc","BENDAMUSTINEHYDROCHLORIDE"
"1017","BENDAMUSTINE HCL","100 Milligram                                                                                            Pdr/Conc/Soln for Infus",2016-10-28,"PA1422/018/002","Fresenius Kabi Oncology Plc","BENDAMUSTINEHYDROCHLORIDE"
"1018","Bendroflumethiazide 2.5mg Tablets","2.5 milligram(s) Tablet",2018-11-23,"PA1240/028/001","Bristol Laboratories Limited","Bendroflumethiazide|Bendroflumethiazide"
"1019","Bendroflumethiazide 5 mg Tablets","5 milligram(s) Tablet",2018-11-23,"PA1240/028/002","Bristol Laboratories Limited","Bendroflumethiazide|Bendroflumethiazide"
"1020","BENEFIX","250 IU international unit(s) Powder and solvent for solution for injection",1997-08-27,"EU/1/97/047/001","Wyeth Europa Limited","Factorix,humanrecombinant"
"1021","BeneFIX","500 international unit(s) Powder and solvent for solution for injection",1997-08-27,"EU/1/97/047/002","Pfizer Europe MA EEIG","Factorix,humanrecombinant"
"1022","BeneFIX","1000 international unit(s) Powder and solvent for solution for injection",1997-08-27,"EU/1/97/047/003","Pfizer Europe MA EEIG","Factorix,humanrecombinant"
"1023","Benefix","250 international unit(s) Powder and solvent for solution for injection",2007-07-30,"EU/1/97/047/004","Pfizer Europe MA EEIG","Nonacogalfa"
"1024","Benefix","500 international unit(s) Powder and solvent for solution for injection",NA,"EU/1/97/047/005","Pfizer Europe MA EEIG","Nonacogalfa"
"1025","Benefix","1000 international unit(s) Powder and solvent for solution for injection",NA,"EU/1/97/047/006","Pfizer Europe MA EEIG","Nonacogalfa"
"1026","Benefix","2000 international unit(s) Powder and solvent for solution for injection",NA,"EU/1/97/047/007","Pfizer Europe MA EEIG","Nonacogalfa"
"1027","BeneFIX","3000 international unit(s) Powder and solvent for solution for injection",NA,"EU/1/97/047/008","Pfizer Europe MA EEIG","Nonacogalfa"
"1028","BeneFIX","1500 international unit(s) Powder and solvent for solution for injection",2017-03-22,"EU/1/97/047/009","Pfizer Europe MA EEIG","Nonacogalfa"
"1029","Benepali","50 milligram(s) Solution for injection in pre-filled syringe",2016-01-14,"EU/1/15/1074/001","Samsung Bioepis UK Limited","Etanercept"
"1030","BENEPALI","50 Milligram                                                                                            Solution for injection in pre-filled pen",2016-01-14,"EU/1/15/1074/002","Samsung Bioepis UK Limited","ETANERCEPT"
"1031","BENEPALI","25 Milligram                                                                                            Solution for injection in pre-filled syringe",2017-05-31,"EU/1/15/1074/005-007","Samsung Bioepis UK Limited","ETANERCEPT"
"1032","BENETOR","10 Milligram                                                                                            Film Coated Tablet",2003-09-19,"PA1595/001/001","Daiichi Sankyo Ireland Ltd","OLMESARTANMEDOXOMIL"
"1033","BENETOR","20 Milligram                                                                                            Film Coated Tablet",2003-09-19,"PA1595/001/002","Daiichi Sankyo Ireland Ltd","OLMESARTANMEDOXOMIL"
"1034","BENETOR","40 Milligram                                                                                            Film Coated Tablet",2003-09-19,"PA1595/001/003","Daiichi Sankyo Ireland Ltd","OLMESARTANMEDOXOMIL"
"1035","BENETOR PLUS","20/25 Milligram                                                                                            Film Coated Tablet",2005-05-12,"PA1595/002/002","Daiichi Sankyo Ireland Ltd","OLMESARTANMEDOXOMIL|HYDROCHLOROTHIAZIDE"
"1036","BENETOR PLUS","40/12.5 Milligram                                                                                            Film Coated Tablet",2010-08-06,"PA1595/002/003","Daiichi Sankyo Ireland Ltd","OLMESARTANMEDOXOMIL|HYDROCHLOROTHIAZIDE"
"1037","BENETOR PLUS","40/25 Milligram                                                                                            Film Coated Tablet",2010-08-06,"PA1595/002/004","Daiichi Sankyo Ireland Ltd","OLMESARTANMEDOXOMIL|HYDROCHLOROTHIAZIDE"
"1038","Benetor Plus 20 mg /12.5 mg film-coated tablets","20/12.5 milligram(s) Film-coated tablet",2005-05-12,"PA1595/002/001","Daiichi Sankyo Ireland Ltd","Hydrochlorothiazide|Olmesartanmedoxomil"
"1039","Benlysta","120 milligram(s) Powder for solution for infusion",2011-07-13,"EU/1/11/700/001-002","GlaxoSmithKline (Ireland) Limited","Belimumab"
"1040","BENLYSTA","200 Milligram                                                                                            Solution for injection in pre-filled pen",2017-11-10,"EU/1/11/700/003-005","Glaxo Group Limited","BELIMUMAB"
"1041","BENLYSTA","200 Milligram                                                                                            Solution for injection in pre-filled syringe",2017-11-10,"EU/1/11/700/006-007","Glaxo Group Limited","BELIMUMAB"
"1042","BENYLIN CHILDREN’S CHESTY COUGH","50mg / 5ml N/A Syrup",1998-07-27,"PA0330/026/001","Johnson & Johnson (Ireland) Limited","GUAIFENESIN"
"1043","BENYLIN CHILDRENS COUGHS AND COLDS","5/0.625mg/ MG/5ml                                                                                               Syrup",1998-03-20,"PA0823/001/001","McNeil Healthcare (Ireland) Ltd","DEXTROMETHORPHANHYDROBROMIDE|TRIPROLIDINEHYDROCHLORIDE"
"1044","BENYLIN CHILDREN'S DRY COUGHS SYRUP DIPHENHYDRAMI","7.0/0.55 MG/5ml                                                                                               Syrup",1992-08-24,"PA0330/022/001","Johnson & Johnson (Ireland) Limited","DIPHENHYDRAMINEHYDROCHLORIDE|LEVOMENTHOL"
"1045","BENYLIN COUGH MEDICINE","14 / 1.1 MG/5ml                                                                                               Syrup",1979-04-01,"PA0330/019/001","Johnson & Johnson (Ireland) Limited","DIPHENHYDRAMINEHYDROCHLORIDE|LEVOMENTHOL"
"1046","BENYLIN DAY & NIGHT","500/60 & 25 Milligram                                                                                            Tablets",2018-01-12,"PPA1151/264/001","Imbat Limited","PARACETAMOL|DIPHENHYDRAMINEHYDROCHLORIDE|PARACETAMOL|PSEUDOEPHEDRINEHYDROCHLORIDE"
"1047","Benylin Day & Night Tablets","500/60 & 25 milligram(s) Tablet",1988-11-10,"PA0330/020/001","Johnson & Johnson (Ireland) Limited","Diphenhydraminehydrochloride|Paracetamol|PSEUDOEPHEDRINEHYDROCHLORIDE"
"1048","BENYLIN Dry Coughs SyrupDiphenydramine Hydrochloride 14mg/5mlDextromethorphan hydrobromide 6.5mg/5mlLevomenthol 2mg/5ml","14/6.5/2 per 5ml percent volume/volume Syrup",1987-09-29,"PA0330/018/001","Johnson & Johnson (Ireland) Limited","Diphenhydraminehydrochloride|Dextromethorphanhydrobromide|Levomenthol"
"1049","BENYLIN DUAL ACTION DRY - PSEUDOEPHEDRINE/DEXTROMETHORPHAN/TRIPROLIDINE","30/10/1.25 Milligram                                                                                            Syrup",1984-03-15,"PA0823/001/002","Johnson & Johnson (Ireland) Limited","PSEUDOEPHEDRINEHYDROCHLORIDE|DEXTROMETHORPHANHYDROBROMIDE|TRIPROLIDINEHYDROCHLORIDE"
"1050","BENYLIN FOUR FLU","500 12.5 22.5 Milligram                                                                                            Film Coated Tablet",2009-09-25,"PPA1151/130/001","Imbat Limited","DIPHENHYDRAMINE|PARACETAMOL|PSEUDOEPHEDRINE"
"1051","Benylin Four Flu Film-Coated Tablets.Paracetamol 500mgDiphenhydramine hydrochloride 12.5mgPseudoephedrine hydrochloride 22.5mg","500/12.5/22.5 milligram(s) Film-coated tablet",1998-06-02,"PA0330/028/001","Johnson & Johnson (Ireland) Limited","Diphenhydraminehydrochloride|Paracetamol|PSEUDOEPHEDRINEHYDROCHLORIDE"
"1052","BENYLIN MUCUS RELIEF 250 MG/5 ML SYRUP","250mg/5ml Millilitre                                                                                           Syrup",2001-07-27,"PA0823/035/001","McNeil Healthcare (Ireland) Ltd","CARBOCISTEINE"
"1053","Benylin Non-Drowsy Dry Coughs, Syrup Dextromethorphan hydrobromide 7.5mg/5ml","7.5 mg/5ml Syrup",1994-11-10,"PA0330/025/001","Johnson & Johnson (Ireland) Limited","Dextromethorphanhydrobromide"
"1054","BENYLIN NON-DROWSY FOR CHESTY COUGHS","100/1.1mg/ MG/5ml                                                                                               Syrup",1992-10-20,"PA0330/021/001","Johnson & Johnson (Ireland) Limited","GUAIFENESIN|LEVOMENTHOL"
"1055","BENYLIN PHLEGM COUGH","100 / 1.1 MG/5ml                                                                                               Syrup",2011-09-09,"PA0330/052/001","Johnson & Johnson (Ireland) Limited","GUAIFENESIN|LEVOMENTHOL"
"1056","Benylin Phlegm Cough Menthol 100 mg/5 ml Oral Solution","100 mg/5ml Oral solution",2011-10-07,"PA0823/066/001","McNeil Healthcare (Ireland) Ltd","Guaifenesin|Guaifenesin"
"1057","BENYLIN PHLEGM COUGH PLUS DECONGESTANT","100mg/5ml 30mg/5ml %v/v                                                                                                 Syrup",1997-04-07,"PA0330/032/001","Johnson & Johnson (Ireland) Limited","PSEUDOEPHEDRINEHYDROCHLORIDE|GUAIFENESIN"
"1058","Benzalkonium Chloride Reckitt Benckiser 0.20%w/w Cutaneous Spray solution","0.20 percent weight/weight Cutaneous spray, solution",2009-11-20,"PA0979/049/001","Reckitt Benckiser Ireland Ltd","BENZALKONIUMCHLORIDE"
"1059","BENZYDAMINE HYDROCHLORIDE","0.15 %w/v                                                                                                 Oromucosal Spray, Soln",2018-02-09,"PA2158/001/001","ABDI FARMA Unipessoal Lda.","BENZYDAMINEHYDROCHLORIDE"
"1060","BENZYL BENZOATE APPLICATION","25 %w/v                                                                                                 Cutaneous Emulsion",1988-09-01,"PA0206/023/001","Ovelle Limited","BENZYLBENZOATE"
"1061","BEPANTISEPTIC FIRST AID","1.2/0.25 %w/w                                                                                                 Cream",1987-01-02,"PA1410/047/001","Bayer Limited","PHENOL|CHLORHEXIDINEDIGLUCONATE(ASCHLORHEXIDINEDIGLUCONATESOLUTION(20%W/V)PH.EUR."
"1062","BERIPLEX P/N","250 International Unit                                                                                   Pdr+Solv for Soln for Inj",2016-05-06,"PA0800/010/001","CSL Behring GmbH","FACTORIIACTIVITY|FACTORVIIACTIVITY|FACTORXACTIVITY|FACTORIXACTIVITY|PROTEINCACTIVITY|PROTEINSANTIGEN"
"1063","BERIPLEX P/N","500 International Unit                                                                                   Pdr+Solv for Soln for Inj",2016-05-06,"PA0800/010/002","CSL Behring GmbH","FACTORIIACTIVITY|FACTORVIIACTIVITY|FACTORXACTIVITY|FACTORIXACTIVITY|PROTEINCACTIVITY|PROTEINSANTIGEN"
"1064","BERIPLEX P/N","1000 International Unit                                                                                   Pdr+Solv for Soln for Inj",2016-05-06,"PA0800/010/003","CSL Behring GmbH","FACTORIIACTIVITY|FACTORVIIACTIVITY|FACTORXACTIVITY|FACTORIXACTIVITY|PROTEINCACTIVITY|PROTEINSANTIGEN"
"1065","BEROMUN","1 mg milligram(s) Powder for solution for infusion",1999-04-13,"EU/1/99/097/001","Belpharma S.A.","Tumournecrosisfactoralfa1a"
"1066","BESPONSA 1 mg powder for concentrate for solution for infusion","1 milligram(s) Powder for concentrate for solution for infusion",2017-06-29,"EU/1/17/1200/001","Pfizer Limited","Inotuzumabozogamicin"
"1067","BETACAP SCALP APPLICATION","0.1 %w/w                                                                                                 Cutaneous Solution",2009-09-10,"DPR1392/042/001","Eurodrug Ltd","BETAMETHASONEVALERATE"
"1068","Betacap Scalp Application 0.1 % w/w cutaneous solution","0.1 percent weight/weight Cutaneous solution",1993-10-11,"PA0278/019/001","Dermal Laboratories Ltd","Betamethasonevalerate"
"1069","BETADINE","10 %w/w                                                                                                 Ointment",1983-04-01,"PA0501/006/006","Ayrton Saunders Ltd","IODINATEDPOVIDONEPH.EUR."
"1070","BETADINE","4 %w/v                                                                                                 Shampoo",1975-11-25,"PA0501/006/007","Ayrton Saunders Ltd","POVIDONE-IODINE"
"1071","Betadine","4 percent weight/volume Shampoo",NA,"PA0696/002/014","Seton Healthcare Group PLC","Povidone-iodine"
"1072","Betadine 10% w/v Alcoholic Solution","10.0 percent weight/volume Cutaneous solution",1993-04-01,"PA0696/002/001","Seton Healthcare Group PLC","Povidone-iodine"
"1073","Betadine 10% w/v Antiseptic Paint","10 percent weight/volume Cutaneous solution",1993-03-15,"PA0696/002/002","Seton Healthcare Group PLC","Povidone-iodine"
"1074","BETADINE ALCOHOLIC 100MG/ML CUTANEOUS SOLUTION","10.0 %w/v                                                                                                 Cutaneous Solution",1983-04-01,"PA0501/006/001","Ayrton Saunders Ltd","POVIDONE-IODINE"
"1075","BETADINE ANTISEPTIC PAINT","10 %w/v                                                                                                 Cutaneous Solution",1978-03-15,"PA0501/006/002","Ayrton Saunders Ltd","POVIDONE-IODINE"
"1076","Betadine Antiseptic Tulle 250 mg Impregnated Dressing","10 percent weight/weight Impregnated dressing",1992-02-16,"PA0696/002/005","Seton Healthcare Group PLC","Povidone-iodine"
"1077","Betadine Dry Powder","2.5 percent weight/weight Cutaneous spray, powder",NA,"PA0696/002/008","Seton Healthcare Group PLC","Povidone-iodine"
"1078","Betadine Dry Powder 25 mg/g cutaneous spray","25 milligram(s)/gram Cutaneous spray, powder",1986-01-17,"PA0501/006/004","Ayrton Saunders Ltd","Povidone-iodine"
"1079","BETADINE GARGLE & MOUTHWASH","1 %w/v                                                                                                 Mouth Wash",1983-04-01,"PA0501/006/005","Ayrton Saunders Ltd","POVIDONE-IODINE"
"1080","Betadine Skin Ceanser","4 percent weight/volume Cutaneous solution",NA,"PA0696/002/015","Seton Healthcare Group PLC","Povidone-iodine"
"1081","BETADINE SKIN CLEANSER","4 %w/v                                                                                                 Cutaneous Solution",1975-11-25,"PA0501/006/008","Ayrton Saunders Ltd","POVIDONE-IODINE"
"1082","BETADINE SURGICAL SCRUB","7.5 %w/v                                                                                                 Cutaneous Solution",1983-04-01,"PA0501/006/009","Ayrton Saunders Ltd","POVIDONE-IODINE"
"1083","BETAFERON","0.25 Mg/Ml Pdr+Solv for Soln for Inj",1995-11-30,"EU/1/95/003/001","Bayer AG","INTERFERONBETA-1B"
"1084","BETAFERON","0.25 Mg/Ml Pdr+Solv for Soln for Inj",1996-11-21,"EU/1/95/003/002","Bayer AG","INTERFERONBETA-1B"
"1085","BETAFERON","mg/ml Mg/Ml Pdr+Solv for Soln for Inj",2000-02-03,"EU/1/95/003/003","Bayer AG","INTERFERONBETA-1B"
"1086","BETAFERON","mg/ml Mg/Ml Pdr+Solv for Soln for Inj",2000-02-03,"EU/1/95/003/004","Bayer AG","INTERFERONBETA-1B"
"1087","BETAGAN","0.5 %w/v                                                                                                 Eye Drops Solution",1985-03-05,"PA0148/040/001","Allergan Pharmaceuticals Ireland","LEVOBUNOLOLHYDROCHLORIDE"
"1088","Betagan 0.5% w/v Unit Dose Eye Drops, Solution","0.5 percent weight/volume Eye drops, solution",1993-10-11,"PA0148/040/004","Allergan Pharmaceuticals Ireland","Levobunololhydrochloride"
"1089","BETAHISTINE DIHYDROCHLORIDE","8 Milligram                                                                                            Tablets",2011-10-07,"PA1390/038/001","Accord Healthcare Limited","BETAHISTINEDIHYDROCHLORIDE"
"1090","BETAHISTINE DIHYDROCHLORIDE","16 Milligram                                                                                            Tablets",2011-10-07,"PA1390/038/002","Accord Healthcare Limited","BETAHISTINEDIHYDROCHLORIDE"
"1091","Betaloc 1 mg/ml Solution for Injection","1 milligram(s)/millilitre Solution for injection",1983-05-02,"PA0970/032/001","AstraZeneca UK Limited","METOPROLOLTARTRATE|Metoprololtartrate"
"1092","BETA-PROGRANE","160 Milligram                                                                                            Prolonged Release Capsules",1994-09-09,"PA0644/001/001","Tillomed Laboratories Limited","PROPRANOLOLHYDROCHLORIDE"
"1093","BETA-PROGRANE","160 Milligram                                                                                            Prolonged Release Capsules",2016-09-02,"PPA1562/182/001","LTT Pharma Limited","PROPRANOLOLHYDROCHLORIDE"
"1094","Betmiga","25 milligram(s) Prolonged-release tablet",NA,"EU/1/12/809/001-007","Astellas Pharma Europe BV","Mirabegron(ym178)"
"1095","BETMIGA","50 Milligram                                                                                            Tablet Prolonged Release",2013-01-15,"EU/1/12/809/008-014","Astellas Pharma Europe BV","MIRABEGRON(YM178)"
"1096","BETNESOL","500 Microgram                                                                                            Soluble tablet",1993-08-13,"PA1638/001/003","RPH Pharmaceuticals AB","BETAMETHASONESODIUMPHOSPHATE"
"1097","Betnesol 0.1% w/v Eye, Ear and Nasal Drops, solution","0.1 percent weight/volume Ear/eye drops, solution",1978-04-01,"PA1638/001/001","RPH Pharmaceuticals AB","BETAMETHASONESODIUMPHOSPHATE"
"1098","Betnesol-N 0.1% w/v, 3500 IU/ml Eye, Ear and Nasal Drops, solution","0.1% w/v 3500 IU/ml percent weight/volume Ear/eye drops, solution",1993-08-13,"PA1638/002/001","RPH Pharmaceuticals AB","Neomycinsulfate|BETAMETHASONESODIUMPHOSPHATE"
"1099","BETNOVATE","0.1 %w/w                                                                                                 Ointment",1983-12-13,"PA1077/001/002","GlaxoSmithKline (Ireland) Limited","BETAMETHASONEVALERATE"
"1100","Betnovate Cream 0.1% w/w","0.1 percent weight/weight Cream",1983-12-13,"PA1077/001/001","GlaxoSmithKline (Ireland) Limited","Betamethasonevalerate"
"1101","BETNOVATE RD (READY DILUTED)","0.025 %w/w                                                                                                 Cream",1984-08-24,"PA1077/001/004","GlaxoSmithKline (Ireland) Limited","BETAMETHASONEVALERATE"
"1102","BETNOVATE RD (READY DILUTED)","0.025 %w/w                                                                                                 Ointment",1984-08-24,"PA1077/001/005","GlaxoSmithKline (Ireland) Limited","BETAMETHASONEVALERATE"
"1103","BETNOVATE SCALP APPLICATION","0.1 Base %w/v                                                                                            Cutaneous Solution",1984-03-05,"PA1077/001/003","GlaxoSmithKline (Ireland) Limited","BETAMETHASONE"
"1104","BETNOVATE-C","0.1 / 3.0 %w/w                                                                                                 Cream",1983-10-27,"PA1077/002/001","GlaxoSmithKline (Ireland) Limited","BETAMETHASONE|CLIOQUINOL"
"1105","BETOPTIC","0.5 %w/v                                                                                                 Eye Drops Solution",1986-08-27,"PA0896/003/001","Novartis Ireland Limited","BETAXOLOLHYDROCHLORIDE"
"1106","BETOPTIC","0.5% %w/v                                                                                                 Eye Drops Solution",2005-06-10,"PPA0465/143/001","PCO Manufacturing","BETAXOLOLHYDROCHLORIDE"
"1107","BETOPTIC","0.5 Base %w/v                                                                                            Eye Drops Solution",2011-11-04,"PPA1151/170/001","Imbat Limited","BETAXOLOLHYDROCHLORIDE"
"1108","BETOPTIC SUSPENSION SINGLE DOSE","0.25 %w/v                                                                                                 Eye Drops Suspension",1995-07-13,"PA0896/003/002","Novartis Ireland Limited","BETAXOLOLHYDROCHLORIDE"
"1109","BETTAMOUSSE","1 (0.1%) mg/g Cutaneous Foam",2008-02-22,"PPA0465/209/001","PCO Manufacturing","BETAMETHASONE"
"1110","BETTAMOUSSE","0.1 %w/w                                                                                                 Cutaneous Foam",1998-11-13,"PA1638/009/001","RPH Pharmaceuticals AB","BETAMETHASONEVALERATE"
"1111","Bexsero","0.5 millilitre(s) Suspension for injection",2013-01-14,"EU/1/12/812/001-004","GSK Vaccines S.r.l.","Recombinantneisseriameningitidisserogroupbnhbafusionprotein|Recombinantneisseriameningitidisserogroupbnadafusionprotein|Recombinantneisseriameningitidisserogroupbfhbpfusionprotein|Outerrmembranevesicles(omv)"
"1112","BICALUTAMIDE","150 Milligram                                                                                            Film Coated Tablet",2011-11-25,"PA1422/006/002","Fresenius Kabi Oncology Plc","BICALUTAMIDE"
"1113","BICALUTAMIDE","50 Milligram                                                                                            Film Coated Tablet",2008-12-08,"PA1390/009/001","Accord Healthcare Limited","BICALUTAMIDE"
"1114","Bicalutamide 50mg Film-coated tablets","50 milligram(s) Film-coated tablet",2011-01-28,"PA1422/006/001","Fresenius Kabi Oncology Plc","Bicalutamide"
"1115","BICALUTAMIDE FAIR-MED","50 Milligram                                                                                            Film Coated Tablet",2012-09-14,"PA1789/001/001","Fair-Med Healthcare GmbH","BICALUTAMIDE"
"1116","BICALUTAMIDE FAIR-MED","150 Milligram                                                                                            Film Coated Tablet",2012-09-14,"PA1789/001/002","Fair-Med Healthcare GmbH","BICALUTAMIDE"
"1117","BICALUTAMIDE TEVA","50 Milligram                                                                                            Film Coated Tablet",2007-05-18,"PA0749/032/001","Teva Pharma B.V.","BICALUTAMIDE"
"1118","BIFRIL 15 MG FILM-COATED TABLETS","15mg Milligram                                                                                            Film Coated Tablet",1999-03-04,"PA0865/004/002","Menarini International Operations Luxembourg S.A.","ZOFENOPRILCALCIUM"
"1119","BIFRIL 30MG FILM-COATED TABLETS","30mg Milligram                                                                                            Film Coated Tablet",1999-03-04,"PA0865/004/003","Menarini International Operations Luxembourg S.A.","ZOFENOPRILCALCIUM"
"1120","BIFRIL 60 MG FILM-COATED TABLETS.","60mg Milligram                                                                                            Film Coated Tablet",1999-03-04,"PA0865/004/004","Menarini International Operations Luxembourg S.A.","ZOFENOPRILCALCIUM"
"1121","BIFRIL 7.5 MG FILM-COATED TABLETS","7.5mg Milligram                                                                                            Film Coated Tablet",1999-03-04,"PA0865/004/001","Menarini International Operations Luxembourg S.A.","ZOFENOPRILCALCIUM"
"1122","BIFRIL PLUS","30/12.5 Milligram                                                                                            Tablets",2005-05-13,"PA0865/013/001","Menarini International Operations Luxembourg S.A.","ZOFENOPRILCALCIUM|HYDROCHLOROTHIAZIDE"
"1123","Biktarvy","50/200/25 milligram(s) Film-coated tablet",2018-06-21,"EU/1/18/1289/001-002","Gilead Sciences Ireland UC","BICTEGRAVIR|Emtricitabine|Tenofoviralafenamide"
"1124","Biluta 50 mg Film-coated tablets","50 milligram(s) Film-coated tablet",2007-04-27,"PA0711/100/001","Rowex Ltd","Bicalutamide"
"1125","BINOCRIT","6000 International Unit                                                                                   Solution for Injection",2007-08-28,"EU/1/07/410/11-12","Sandoz GmbH","RECOMBINANTHUMANERYTHROPOIETINALFA"
"1126","BINOCRIT","1000 International Unit                                                                                   Solution for Injection",2007-08-28,"EU/1/07/410/1-2","Sandoz GmbH","RECOMBINANTHUMANERYTHROPOIETINALFA"
"1127","BINOCRIT","8000 International Unit                                                                                   Solution for Injection",2007-08-28,"EU/1/07/410/13-014","Sandoz GmbH","RECOMBINANTHUMANERYTHROPOIETINALFA"
"1128","BINOCRIT","10000 International Unit                                                                                   Solution for Injection",2007-08-28,"EU/1/07/410/15-16","Sandoz GmbH","RECOMBINANTHUMANERYTHROPOIETINALFA"
"1129","BINOCRIT","20000/0.5 IU/ML                                                                                                Solution for injection in pre-filled syringe",2009-10-01,"EU/1/07/410/21-22","Sandoz GmbH","EPOETINALFA"
"1130","BINOCRIT","30000/0.75 IU/ML                                                                                                Solution for injection in pre-filled syringe",2009-10-01,"EU/1/07/410/23-24","Sandoz GmbH","EPOETINALFA"
"1131","BINOCRIT","40000/1 IU/ML                                                                                                Solution for injection in pre-filled syringe",2009-10-01,"EU/1/07/410/25-26","Sandoz GmbH","EPOETINALFA"
"1132","BINOCRIT","2000 International Unit                                                                                   Solution for Injection",2007-08-28,"EU/1/07/410/3-4","Sandoz GmbH","RECOMBINANTHUMANERYTHROPOIETINALFA"
"1133","BINOCRIT","3000 International Unit                                                                                   Solution for Injection",2007-08-28,"EU/1/07/410/5-6","Sandoz GmbH","RECOMBINANTHUMANERYTHROPOIETINALFA"
"1134","BINOCRIT","4000 International Unit                                                                                   Solution for Injection",2007-08-28,"EU/1/07/410/7-8","Sandoz GmbH","RECOMBINANTHUMANERYTHROPOIETINALFA"
"1135","BINOCRIT","5000 International Unit                                                                                   Solution for Injection",2007-08-28,"EU/1/07/410/9-10","Sandoz GmbH","RECOMBINANTHUMANERYTHROPOIETINALFA"
"1136","BINOSTO ONCE WEEKLY","70 Milligram                                                                                            Tablets Effervescent",2012-03-02,"PA0126/280/001","Clonmel Healthcare Ltd","ALENDRONICACID"
"1137","BINOSTO ONCE WEEKLY","70 Base Milligrams                                                                                      Tablets Effervescent",2018-04-27,"PPA1097/045/001","Lexon (UK) Ltd","SODIUMALENDRONATETRIHYDRATE(MICRONISED)"
"1138","BIOPOIN","10000/1.0 IU/ML                                                                                                Solution for Injection",2009-10-23,"EU/1/09/565/11-16","Teva GmbH","XM01DRUGSUBSTANCEEPOETINTHETA"
"1139","BIOPOIN","1000/0.5 IU/ML                                                                                                Solution for Injection",2009-10-23,"EU/1/09/565/1-2","Teva GmbH","XM01DRUGSUBSTANCEEPOETINTHETA"
"1140","BIOPOIN","20000/1.0 IU/ML                                                                                                Solution for Injection",2009-10-23,"EU/1/09/565/17-22","Teva GmbH","XM01DRUGSUBSTANCEEPOETINTHETA"
"1141","BIOPOIN","30000/1.0 IU/ML                                                                                                Solution for Injection",2009-10-23,"EU/1/09/565/23-28","Teva GmbH","XM01DRUGSUBSTANCEEPOETINTHETA"
"1142","BIOPOIN","2000/0.5 IU/ML                                                                                                Solution for Injection",2009-10-23,"EU/1/09/565/3-4","Teva GmbH","XM01DRUGSUBSTANCEEPOETINTHETA"
"1143","BIOPOIN","3000/0.5 IU/ML                                                                                                Solution for Injection",2009-10-23,"EU/1/09/565/5-6","Teva GmbH","XM01DRUGSUBSTANCEEPOETINTHETA"
"1144","BIOPOIN","4000/0.5 IU/ML                                                                                                Solution for Injection",2009-10-23,"EU/1/09/565/7-8","Teva GmbH","XM01DRUGSUBSTANCEEPOETINTHETA"
"1145","BIOPOIN","5000/0.5 IU/ML                                                                                                Solution for Injection",2009-10-23,"EU/1/09/565/9-10","Teva GmbH","XM01DRUGSUBSTANCEEPOETINTHETA"
"1146","Biphozyl Solution for haemodialysis / haemofiltration","22  Solution for haemodialysis/haemofiltration",2014-11-28,"PA0785/009/001","Gambro Lundia AB","Magnesiumchloridehexahydrate|Sodiumchloride|Sodiumhydrogencarbonate|Potassiumchloride|Disodiumphosphatedihydrate"
"1147","Bisocor 10 mg Tablets","10 milligram(s) Tablet",2001-06-29,"PA1063/013/002","Niche Generics Limited","BISOPROLOLFUMARATE"
"1148","Bisocor 5 mg Tablets","5 milligram(s) Tablet",2001-06-29,"PA1063/013/001","Niche Generics Limited","BISOPROLOLFUMARATE"
"1149","BISODOL ANTACID","522/68/64 Milligram                                                                                            Tablets Chewable",1983-04-01,"PA1986/071/001","Teva B.V.","SODIUMBICARBONATE|CALCIUMCARBONATE|LIGHTMAGNESIUMCARBONATE"
"1150","BISODOL EXTRA STRONG MINT","522/68/64 Milligram                                                                                            Tablets Chewable",1999-08-23,"PA1986/070/001","Teva B.V.","CALCIUMCARBONATE|MAGNESIUMCARBONATELIGHT|SODIUMBICARBONATE"
"1151","Bisolvon 4mg/5ml Oral Solution","4 mg/5ml Oral solution",1984-11-14,"PA0540/180/001","Sanofi-Aventis Ireland Limited T/A SANOFI","Bromhexinehydrochloride"
"1152","BISOP","1.25 Milligram                                                                                            Film Coated Tablet",2008-12-08,"PA0711/159/001","Rowex Ltd","BISOPROLOLFUMARATE"
"1153","BISOP","2.5 Milligram                                                                                            Film Coated Tablet",2008-12-08,"PA0711/159/002","Rowex Ltd","BISOPROLOLFUMARATE"
"1154","BISOP","3.75 Milligram                                                                                            Film Coated Tablet",2008-12-08,"PA0711/159/003","Rowex Ltd","BISOPROLOLFUMARATE"
"1155","BISOP","5 Milligram                                                                                            Film Coated Tablet",2008-12-08,"PA0711/159/004","Rowex Ltd","BISOPROLOLFUMARATE"
"1156","BISOP","7.5 Milligram                                                                                            Film Coated Tablet",2008-12-08,"PA0711/159/005","Rowex Ltd","BISOPROLOLFUMARATE"
"1157","BISOP","10 Milligram                                                                                            Film Coated Tablet",2008-12-08,"PA0711/159/006","Rowex Ltd","BISOPROLOLFUMARATE"
"1158","BISOPINE","5 Milligram                                                                                            Tablets",2000-12-08,"PA1063/009/001","Niche Generics Limited","BISOPROLOLFUMARATE"
"1159","BISOPINE","10 Milligram                                                                                            Tablets",2000-12-08,"PA1063/009/002","Niche Generics Limited","BISOPROLOLFUMARATE"
"1160","Bisoprolol 10 mg film-coated tablets","10 milligram(s) Film-coated tablet",2015-10-30,"PA1390/114/003","Accord Healthcare Limited","BISOPROLOLFUMARATE"
"1161","Bisoprolol 2.5 mg film-coated tablets","2.5 milligram(s) Film-coated tablet",2015-10-30,"PA1390/114/001","Accord Healthcare Limited","BISOPROLOLFUMARATE"
"1162","Bisoprolol 5 mg film-coated tablets","5 milligram(s) Film-coated tablet",2015-10-30,"PA1390/114/002","Accord Healthcare Limited","BISOPROLOLFUMARATE"
"1163","BISOPROLOL FUMARATE","5 Milligram                                                                                            Tablets",2010-10-01,"PA1390/158/001","Accord Healthcare Limited","BISOPROLOLFUMARATE"
"1164","BISOPROLOL FUMARATE","10 Milligram                                                                                            Tablets",2010-10-01,"PA1390/158/002","Accord Healthcare Limited","BISOPROLOLFUMARATE"
"1165","BISOPROLOL FUMARATE","1.25 Milligram                                                                                            Tablets",2008-02-01,"PA0688/014/001","Chanelle Medical","BISOPROLOLFUMARATE"
"1166","BISOPROLOL FUMARATE","2.5 Milligram                                                                                            Tablets",2008-02-01,"PA0688/014/002","Chanelle Medical","BISOPROLOLFUMARATE"
"1167","BISOPROLOL FUMARATE","3.75 Milligram                                                                                            Tablets",2008-02-01,"PA0688/014/003","Chanelle Medical","BISOPROLOLFUMARATE"
"1168","BISOPROLOL FUMARATE","5 Milligram                                                                                            Tablets",2008-02-01,"PA0688/014/004","Chanelle Medical","BISOPROLOLFUMARATE"
"1169","BISOPROLOL FUMARATE","10 Milligram                                                                                            Tablets",2008-02-01,"PA0688/014/005","Chanelle Medical","BISOPROLOLFUMARATE"
"1170","Bisoprolol Fumarate 2.5 mg Tablets","2.5 milligram(s) Tablet",2010-04-16,"PA1063/044/001","Niche Generics Limited","BISOPROLOLFUMARATE"
"1171","BISOPROLOL HEMIFUMARATE","10 Milligram                                                                                            Film Coated Tablet",2002-11-22,"PA0740/007/002","Genthon BV","BISOPROLOLHEMIFUMARATE"
"1172","BISOPROLOL HEMIFUMARATE GENTHON","5 Milligram                                                                                            Film Coated Tablet",2002-11-22,"PA0740/007/001","Genthon BV","BISOPROLOLHEMIFUMARATE"
"1173","Bisoprolol Krka 10mg Film-coated Tablets","10 milligram(s) Film-coated tablet",2013-12-13,"PA1347/031/003","Krka d.d., Novo mesto","BISOPROLOLFUMARATE"
"1174","Bisoprolol Krka 2.5mg Film-coated Tablets","2.5 milligram(s) Film-coated tablet",2013-12-13,"PA1347/031/001","Krka d.d., Novo mesto","BISOPROLOLFUMARATE"
"1175","Bisoprolol Krka 5mg Film-coated Tablets","5 milligram(s) Film-coated tablet",2013-12-13,"PA1347/031/002","Krka d.d., Novo mesto","BISOPROLOLFUMARATE"
"1176","Bisoprolol Mylan 1.25 mg film-coated tablets","1.25 milligram(s) Film-coated tablet",2011-08-19,"PA0577/153/001","McDermott Laboratories Ltd t/a Gerard Laboratories","BISOPROLOLFUMARATE"
"1177","Bisoprolol Mylan 10 mg film-coated tablets","10 milligram(s) Film-coated tablet",2011-08-19,"PA0577/153/006","McDermott Laboratories Ltd t/a Gerard Laboratories","BISOPROLOLFUMARATE"
"1178","Bisoprolol Mylan 2.5 mg film-coated tablets","2.5 milligram(s) Film-coated tablet",2011-08-19,"PA0577/153/002","McDermott Laboratories Ltd t/a Gerard Laboratories","BISOPROLOLFUMARATE"
"1179","Bisoprolol Mylan 3.75 mg film-coated tablets","3.75 milligram(s) Film-coated tablet",2011-08-19,"PA0577/153/003","McDermott Laboratories Ltd t/a Gerard Laboratories","BISOPROLOLFUMARATE"
"1180","Bisoprolol Mylan 5 mg film-coated tablets","5 milligram(s) Film-coated tablet",2011-08-19,"PA0577/153/004","McDermott Laboratories Ltd t/a Gerard Laboratories","BISOPROLOLFUMARATE"
"1181","Bisoprolol Mylan 7.5 mg film-coated tablets","7.5 milligram(s) Film-coated tablet",2011-08-19,"PA0577/153/005","McDermott Laboratories Ltd t/a Gerard Laboratories","BISOPROLOLFUMARATE"
"1182","Blincyto","12.5 microgram(s)/millilitre ZZZ Pdr/Conc/Soln for Infus",2015-11-23,"EU/1/15/1047/001","Amgen Europe B.V.","Blinatumomab"
"1183","BLISSEL","50 Micrograms/g                                                                                         Vaginal Gel",2016-09-09,"PA2102/001/001","Italfarmaco S.A.","ESTRIOL"
"1184","BLISTEX COLD SORE CREAM","100 mg/g Cream",2007-06-22,"PA0302/012/001","D.D.D. Limited","DOCOSANOL"
"1185","BLISTEX RELIEF","0.270  6.040   0.494 %w/w                                                                                                 Cream",1994-01-18,"PA0302/004/001","D.D.D. Limited","STRONGAMMONIASOLUTION|AMMONIASOLUTION,ARAMATIC|PHENOL,LIQUEFIED"
"1186","BLITZIMA","500 Milligram                                                                                            Concentrate for Soln for Inf",2017-07-13,"EU/1/17/1205/001-002","Celltrion Healthcare Hungary Kft.","RITUXIMAB"
"1187","BLOPRESS","2 Milligram                                                                                            Tablets",1997-11-14,"PA2229/001/001","Takeda Products Ireland Ltd","CANDESARTANCILEXETIL"
"1188","BLOPRESS","4 Milligram                                                                                            Tablets",1997-11-14,"PA2229/001/002","Takeda Products Ireland Ltd","CANDESARTANCILEXETIL"
"1189","BLOPRESS","8 Milligram                                                                                            Tablets",1997-11-14,"PA2229/001/003","Takeda Products Ireland Ltd","CANDESARTANCILEXETIL"
"1190","BLOPRESS","16 Milligram                                                                                            Tablets",1997-11-14,"PA2229/001/004","Takeda Products Ireland Ltd","CANDESARTANCILEXETIL"
"1191","BLOPRESS","32 Milligram                                                                                            Tablets",2005-08-12,"PA2229/001/005","Takeda Products Ireland Ltd","CANDESARTANCILEXETIL"
"1192","BLOPRESS PLUS","16/12.5 Milligram                                                                                            Tablets",2000-03-31,"PA2229/002/002","Takeda Products Ireland Ltd","CANDESARTANCILEXETIL|HYDROCHLOROTHIAZIDE"
"1193","BLOPRESS PLUS","32/12.5 Milligram                                                                                            Tablets",2009-06-19,"PA2229/002/003","Takeda Products Ireland Ltd","CANDESARTANCILEXETIL|HYDROCHLOROTHIAZIDE"
"1194","BLOPRESS PLUS","32/25 Milligram                                                                                            Tablets",2009-06-19,"PA2229/002/004","Takeda Products Ireland Ltd","CANDESARTANCILEXETIL|HYDROCHLOROTHIAZIDE"
"1195","Blopress Plus 8 mg/12.5 mg tablets","8/12.5 milligram(s) Tablet",1998-12-10,"PA2229/002/001","Takeda Products Ireland Ltd","Hydrochlorothiazide|Candesartancilexetil"
"1196","BLUGRAL","25 Milligram                                                                                            Film Coated Tablet",2013-01-11,"PA1063/048/001","Niche Generics Limited","SILDENAFILCITRATE"
"1197","Blugral 100 mg film coated tablets","100 milligram(s) Film-coated tablet",2013-01-11,"PA1063/048/003","Niche Generics Limited","Sildenafilcitrate"
"1198","Blugral 50 mg film coated tablets","50 milligram(s) Film-coated tablet",2013-01-11,"PA1063/048/002","Niche Generics Limited","Sildenafilcitrate"
"1199","BONAPENYA","30 Milligram                                                                                            Film Coated Tablet",2010-11-26,"PA0281/158/002","Pinewood Laboratories Ltd,","RISEDRONATESODIUM"
"1200","BONASOL ONCE WEEKLY","70 Milligram                                                                                            Oral Solution",2011-02-25,"PA1572/001/001","Xeolas Pharmaceuticals Limited","ALENDRONICACID"
"1201","BONDRONAT","1 Micromol Concentrate for Soln for Inf",1996-06-25,"EU/1/96/012/001","Roche Registration GmbH","IBANDRONICACIDMONOSODIUMMONOHYDRATE"
"1202","BONDRONAT","2 Mg/Ml Concentrate for Soln for Inf",1997-08-27,"EU/1/96/012/004","Roche Registration GmbH","IBANDRONICACIDMONOSODIUMMONOHYDRATE"
"1203","BONDRONAT","mg mg/tablet Film Coated Tablet",1996-06-25,"EU/1/96/012/010","Roche Registration GmbH","IBANDRONICACID"
"1204","BONDRONAT","6 Mg/Ml Concentrate for Soln for Inf",1996-06-25,"EU/1/96/012/011-13","Roche Registration GmbH","IBANDRONICACID"
"1205","BONDRONAT FILM-COATED","50 Milligram                                                                                            Tablets",2003-10-24,"EU/1/96/012/009","Roche Registration GmbH","IBANDRONICACID"
"1206","BONEFURBIT","150 Base Milligrams                                                                                      Film Coated Tablet",2010-11-12,"PA0074/064/001","Rowa Pharmaceuticals Limited","IBANDRONATESODIUMMONOHYDRATE"
"1207","BONJELA","0 %w/w                                                                                                 Oromucosal Gel",1983-04-01,"PA0979/001/001","Reckitt Benckiser Ireland Ltd","CHOLINESALICYLATE|CETALKONIUMCHLORIDE"
"1208","BONJELA TEETHING GEL OROMUCOSAL GEL","8.714 / 0.010 %w/w                                                                                                 Oromucosal Gel",2010-03-12,"PA0979/001/003","Reckitt Benckiser Ireland Ltd","CHOLINESALICYLATE|CETALKONIUMCHLORIDE"
"1209","BONVIVA","150 Milligram                                                                                            Coated Tablets",2005-09-15,"EU/1/03/265/3-4","Atnahs Pharma UK Limited","IBANDRONICACID"
"1210","BONVIVA","3 Mg/Ml Solution for Injection",2006-03-29,"EU/1/03/265/5-6","Atnahs Pharma UK Limited","IBANDRONICACID"
"1211","BONVIVA 2.5MG FILM-COATED TABLETS","2.5 mg Milligram                                                                                            Tablets",2004-03-31,"EU/1/03/265/01-2","Atnahs Pharma UK Limited","IBANDRONICACID"
"1212","Boostrix suspension for injection in pre-filled syringe Diphtheria, tetanus and pertussis (acellular, component) vaccine (adsorbed, reduced antigen(s) content)","1 dose(s) Suspension for injection in pre-filled syringe",2001-04-20,"PA1077/020/001","GlaxoSmithKline (Ireland) Limited","Diphtheriatoxoidadsorbed|Tetanustoxoid|Pertussistoxoid|Filamentoushaemagglutinin(fha)|Pertactin"
"1213","BOOTS BITE AND STING ANTIHISTAMINE","2 %w/w                                                                                                 Cream",2005-12-09,"PA0004/065/001","The Boots Company Plc","MEPYRAMINEMALEATE"
"1214","Boots Day Cold & Flu Relief Oral SolutionParacetamol 1000mg/30mg Pholcodine 10mg/30ml Pseudoephedrine Hydrochloride 60mg/30ml","1000 ZZZ mg/30ml Oral solution",2003-12-18,"PA0004/061/002","The Boots Company Plc","Paracetamol|Pseudoephedrinehydrochloride|Pholcodine"
"1215","BOOTS PHARMACEUTICAL DECONGESTANT","60 Milligram                                                                                            Tablets",2003-11-04,"PA0004/064/001","The Boots Company Plc","PSEUDOEPHEDRINEHYDROCHLORIDE"
"1216","Boots Pharmaceuticals Chesty Cough & Congestion Relief Oral Solution Guaifenesin 100 mg/5 mlPseudoephedrine Hydrochloride 30 mg/5 ml","100mg/30mg mg/5ml Oral solution",2000-05-12,"PA0004/054/001","The Boots Company Plc","PSEUDOEPHEDRINEHYDROCHLORIDE|Guaiphenesin"
"1217","Boots Pharmaceuticals Day Cold & Flu Relief Hard Capsules Paracetamol 500 mg Pholcodine 5 mg Pseudoephedrine Hydrochloride 30 mg","500/5/30 milligram(s) Capsule, hard",2003-11-04,"PA0004/061/001","The Boots Company Plc","Pholcodine|Paracetamol|Pseudoephedrinehydrochloride"
"1218","BOOTS PHARMACEUTICALS DIARRHOEA RELIEF","2 Milligram                                                                                            Capsules Hard",2002-12-06,"PA0004/059/001","The Boots Company Plc","LOPERAMIDEHYDROCHLORIDE"
"1219","BOOTS PHARMACEUTICALS DRY COUGH & CONGESTION RELIEF","10 / 30 MG/5ml                                                                                               Oral Solution",1999-11-26,"PA0004/053/001","The Boots Company Plc","PSEUDOEPHEDRINEHYDROCHLORIDE|DEXTROMETHORPHANHYDROBROMIDE"
"1220","Boots Pharmaceuticals Ibuprofen and Codeine 200mg / 12.8 mg film-coated tablets","200/12.8 milligram(s) Film-coated tablet",2010-12-17,"PA0004/066/001","The Boots Company Plc","Ibuprofen|Codeinephosphatehemihydrate"
"1221","BOOTS PHARMACEUTICALS SORE THROAT RELIEF LEMON FLAVOUR","Milligram                                                                                            Lozenges",2001-05-17,"PA0004/057/001","The Boots Company Plc","AMYLMETACRESOL"
"1222","BORTEZOMIB","1 Milligram                                                                                            Pdr for Soln for Injection",2017-06-02,"PA1619/006/001","Aspire Pharma Limited",""
"1223","BORTEZOMIB","3.5 Milligram                                                                                            Pdr for Soln for Injection",2017-06-02,"PA1619/006/002","Aspire Pharma Limited","BORTEZOMIB"
"1224","BORTEZOMIB ACCORD","3.5 Milligram                                                                                            Pdr for Soln for Injection",2015-07-20,"EU/1/15/1019/001","Accord Healthcare Limited",""
"1225","BORTEZOMIB ACCORD","1 Milligram                                                                                            Pdr for Soln for Injection",2018-05-28,"EU/1/15/1019/002","Accord Healthcare Limited","BORTEZOMIB"
"1226","BORTEZOMIB CLONMEL","2.5 Mg/Ml Solution for Injection",2018-04-20,"PA0126/297/001","Clonmel Healthcare Ltd",""
"1227","BORTEZOMIB HOSPIRA","3.5 Milligram                                                                                            Pdr for Soln for Injection",2016-07-22,"EU/1/16/1114/001","Pfizer Europe MA EEIG",""
"1228","BORTEZOMIB KOANAA","3.5 Milligram                                                                                            Infus/Pdr/Oral Soln",2017-02-16,"PA2041/003/001","Koanaa Healthcare Limited",""
"1229","BORTEZOMIB MEDAC","3.5 Milligram                                                                                            Pdr for Soln for Injection",2018-05-18,"PA0623/018/001","Medac Gesellschaft fur Klinische Spezialpraparate mbH",""
"1230","BORTEZOMIB ROWEX","3.5 Milligram                                                                                            Pdr for Soln for Injection",2018-04-13,"PA0711/288/001","Rowex Ltd","BORTEZOMIB(ASMANNITOLBORONICESTER)"
"1231","BORTEZOMIB SUN","3.5 Milligram                                                                                            Pdr for Soln for Injection",2016-07-22,"EU/1/16/1102/001","Sun Phamaceutical Industries Europe B.V.",""
"1232","BORTEZOMIB TEVA","3.5 Unknown Pdr for Soln for Injection",2016-07-08,"PA1986/032/001","Teva B.V.","BORTEZOMIB(ASMANNITOLBORONICESTER)"
"1233","Bortezomib Teva 2.5mg powder for solution for injection","2.5 milligram(s) Powder for solution for injection",2018-11-02,"PA1986/032/002","Teva B.V.","Bortezomib"
"1234","Bosulif","100 milligram(s) Film-coated tablet",NA,"EU/1/13/818/001-002","Pfizer Limited","Bosutinibmonohydrate"
"1235","BOSULIF","500 Milligram                                                                                            Film Coated Tablet",2013-03-27,"EU/1/13/818/003-004","Pfizer Europe MA EEIG","BOSUTINIBMONOHYDRATE"
"1236","BOSULIF","400 Milligram                                                                                            Film Coated Tablet",2018-05-22,"EU/1/13/818/006-007","Pfizer Europe MA EEIG","BOSUTINIBMONOHYDRATE"
"1237","BOTOX","50 Allergan Units Pdr for Soln for Injection",2008-01-18,"PA0148/060/002","Allergan Pharmaceuticals Ireland","BOTULINUMTOXINTYPEA"
"1238","BOTOX","200 Allergan Units Pdr for Soln for Injection",2008-01-18,"PA0148/060/003","Allergan Pharmaceuticals Ireland","BOTULINUMTOXINTYPEA"
"1239","BOTOX100 Allergan UnitsPowder for solution for injection","100 Allergan Units Powder and solvent for solution for injection",NA,"PA0148/060/001","Allergan Pharmaceuticals Ireland","Botulinumtoxintypea"
"1240","BRABIO","40 Mg/Ml Solution for injection in pre-filled syringe",2017-11-24,"PA0405/101/001","Generics (UK) Limited","GLATIRAMERACETATE"
"1241","Brabio 20 mg/ml solution for injection, pre-filled syringe","20 milligram(s)/millilitre Solution for injection in pre-filled syringe",2016-11-04,"PA0405/099/001","Generics (UK) Limited","Glatirameracetate"
"1242","Braftovi","50 milligram(s) Capsule, hard",2018-09-20,"EU/1/18/1314/001","Pierre Fabre Medicament","ENCORAFENIB"
"1243","Braftovi","75 milligram(s) Capsule, hard",2018-09-20,"EU/1/18/1314/002","Pierre Fabre Medicament","ENCORAFENIB"
"1244","Braltus 10 microgram per delivered dose inhalation powder, hard capsule","10 microgram(s) ZZZ Inhalation Powder, Capsule",2016-07-08,"PA1986/006/001","Teva B.V.","Tiotropiumbromide"
"1245","Bramitob 300mg/4ml Nebuliser Solution","300/4 milligram(s)/millilitre Nebuliser solution",2007-06-01,"PA0743/017/001","Chiesi Limited","Tobramycin"
"1246","BRAVELLE","75 International Unit                                                                                   Pdr+Solv for Soln for Inj",2006-01-09,"PA1009/019/001","Ferring Ireland Ltd","UROFOLLITROPIN"
"1247","BREAKYL","200 Microgram                                                                                            Buccal Film",2011-05-03,"PA2010/027/001","Mylan IRE Healthcare Limited","FENTANYLCITRATE"
"1248","BREAKYL","400 Microgram                                                                                            Buccal Film",2011-05-03,"PA2010/027/002","Mylan IRE Healthcare Limited","FENTANYLCITRATE"
"1249","BREAKYL","600 Microgram                                                                                            Buccal Film",2011-05-03,"PA2010/027/003","Mylan IRE Healthcare Limited","FENTANYLCITRATE"
"1250","BREAKYL","800 Microgram                                                                                            Buccal Film",2011-05-03,"PA2010/027/004","Mylan IRE Healthcare Limited","FENTANYLCITRATE"
"1251","BREAKYL","1200 Microgram                                                                                            Buccal Film",2011-05-03,"PA2010/027/005","Mylan IRE Healthcare Limited","FENTANYLCITRATE"
"1252","BREAKYL START","Microgram                                                                                            Buccal Film",2011-05-03,"PA2010/027/006","Mylan IRE Healthcare Limited","FENTANYLCITRATE"
"1253","BRETARIS GENUAIR","322 Microgram                                                                                            Powder for Inhalation",2012-09-26,"EU/1/12/781/001-003","Almirall, S.A.","MICRONIZEDACLIDINIUMBROMIDE"
"1254","Brevibloc Premixed 10 mg/ml Solution for Infusion","10 milligram(s)/millilitre Solution for infusion",2010-12-10,"PA0167/099/004","Baxter Healthcare Limited","ESMOLOLHYDROCHLORIDE"
"1255","Brevibloc Premixed 10 mg/ml Solution for Injection","10 milligram(s)/millilitre Solution for injection",2010-12-10,"PA0167/099/003","Baxter Healthcare Limited","ESMOLOLHYDROCHLORIDE"
"1256","BREVOXYL","40 mg/g Cream",1995-11-13,"PA0678/111/001","GlaxoSmithKline Consumer Healthcare (Ireland) Limited","BENZOYLPEROXIDE"
"1257","BRICANYL 500 MICROGRAMS/ML SOLUTION FOR INJECTION","500 Microgram/ML                                                                                         Solution for Injection",1979-04-01,"PA0970/036/002","AstraZeneca UK Limited","TERBUTALINESULFATE"
"1258","BRICANYL TURBOHALER","500 Mcg/Acutuation                                                                                       Powder for Inhalation",1989-02-07,"PA0970/036/008","AstraZeneca UK Limited","TERBUTALINESULFATE"
"1259","BRICANYL TURBOHALER","500 Mcg/Acutuation                                                                                       Powder for Inhalation",2012-08-03,"PPA1151/175/001","Imbat Limited","TERBUTALINESULFATE"
"1260","BRIDION 100 MG/ML SOLUTION FOR INJECTION","100 Micromol Solution for Injection",2008-07-25,"EU/1/08/466/1-2","Merck Sharp & Dohme BV","SUGAMMADEX"
"1261","Brieka 100 mg Hard Capsules","100 milligram(s) Capsule, hard",2015-08-07,"PA1380/175/004","Actavis Group PTC ehf","Pregabalin"
"1262","Brieka 150 mg Hard Capsules","150 milligram(s) Capsule, hard",2015-08-07,"PA1380/175/005","Actavis Group PTC ehf","Pregabalin"
"1263","Brieka 200 mg Hard Capsules","200 milligram(s) Capsule, hard",2015-08-07,"PA1380/175/006","Actavis Group PTC ehf","Pregabalin"
"1264","Brieka 225 mg Hard Capsules","225 milligram(s) Capsule, hard",2015-08-07,"PA1380/175/007","Actavis Group PTC ehf","Pregabalin"
"1265","Brieka 25 mg Hard Capsules","25 milligram(s) Capsule, hard",2015-08-07,"PA1380/175/001","Actavis Group PTC ehf","Pregabalin"
"1266","Brieka 300 mg Hard Capsules","300 milligram(s) Capsule, hard",2015-08-07,"PA1380/175/008","Actavis Group PTC ehf","Pregabalin"
"1267","Brieka 50 mg Hard Capsules","50 milligram(s) Capsule, hard",2015-08-07,"PA1380/175/002","Actavis Group PTC ehf","Pregabalin"
"1268","Brieka 75 mg Hard Capsules","75 milligram(s) Capsule, hard",2015-08-07,"PA1380/175/003","Actavis Group PTC ehf","Pregabalin"
"1269","Brilique","90 milligram(s) Film-coated tablet",2010-12-03,"EU/1/10/655/001-006","AstraZeneca AB","Ticagrelor"
"1270","Brilique","60 milligram(s) Film-coated tablet",2016-02-18,"EU/1/10/655/007-011","AstraZeneca AB","Ticagrelor"
"1271","Brilique","90 milligram(s) Orodispersible tablet",2017-05-18,"EU/1/10/655/012-014","AstraZeneca AB","Ticagrelor"
"1272","BRIMICA GENUAIR","340/12 Microgram                                                                                            Powder for Inhalation",2014-11-19,"EU/1/14/963/001-002","AstraZeneca AB","MICRONIZEDFORMOTEROLFUMARATEDIHYDRATE|MICRONIZEDACLIDINIUMBROMIDE"
"1273","BRINAVESS","20 Mg/Ml Concentrate for Soln for Inf",2010-09-01,"EU/1/10/645/001-002","Correvio","VERNAKALANTHYDROCHLORIDE"
"1274","Brineura","150 mg/5ml Solution for infusion",2017-05-30,"EU/1/17/1192/001","BioMarin International Limited","Cerliponase"
"1275","Brintellix","5 milligram(s) Film-coated tablet",2013-12-18,"EU/1/13/891/001-007","H. Lundbeck A/S","Vortioxetinehydrobromide"
"1276","BRINTELLIX","10 Milligram                                                                                            Film Coated Tablet",2014-01-30,"EU/1/13/891/008-017","H. Lundbeck A/S","VORTIOXETINEHYDROBROMIDE"
"1277","BRINTELLIX","15 Milligram                                                                                            Film Coated Tablet",2014-01-30,"EU/1/13/891/018-026","H. Lundbeck A/S","VORTIOXETINEHYDROBROMIDE"
"1278","BRINTELLIX","20 Milligram                                                                                            Film Coated Tablet",2014-01-30,"EU/1/13/891/027-035","H. Lundbeck A/S","VORTIOXETINEHYDROBROMIDE"
"1279","BRINTELLIX","20 Mg/Ml Oral Drops Solution",2014-01-30,"EU/1/13/891/036","H. Lundbeck A/S","VORTIOXETINE-DL-LACTATE"
"1280","BRINZOLAMIDE","10 Mg/Ml Eye Drops Suspension",2015-10-02,"PA1380/150/001","Actavis Group PTC ehf","BRINZOLAMIDE"
"1281","BRINZOLAMIDE SANDOZ","10 Mg/Ml Eye Drops Suspension",2014-07-04,"PA0711/226/001","Rowex Ltd","BRINZOLAMIDE"
"1282","Briviact","10 milligram(s) Film-coated tablet",2016-01-14,"EU/1/15/1073/001-004","UCB Pharma S.A.","Brivaracetam"
"1283","BRIVIACT","25 Milligram                                                                                            Film Coated Tablet",2016-01-14,"EU/1/15/1073/005-008","UCB Pharma S.A.","BRIVARACETAM"
"1284","BRIVIACT","50 Milligram                                                                                            Film Coated Tablet",2016-01-14,"EU/1/15/1073/009-012","UCB Pharma S.A.","BRIVARACETAM"
"1285","BRIVIACT","75 Milligram                                                                                            Film Coated Tablet",2016-01-14,"EU/1/15/1073/013-016","UCB Pharma S.A.","BRIVARACETAM"
"1286","BRIVIACT","100 Milligram                                                                                            Film Coated Tablet",2016-01-14,"EU/1/15/1073/017-020","UCB Pharma S.A.","BRIVARACETAM"
"1287","BRIVIACT","10 Mg/Ml Oral Solution",2016-01-14,"EU/1/15/1073/021","UCB Pharma S.A.","BRIVARACETAM"
"1288","BRIVIACT","10 Mg/Ml Solution for Injection",2016-01-14,"EU/1/15/1073/022","UCB Pharma S.A.","BRIVARACETAM"
"1289","BROLENE","0.1 %w/v                                                                                                 Eye Drops Solution",1983-04-01,"PA0540/094/001","Sanofi-Aventis Ireland Limited T/A SANOFI","PROPAMIDINEISETIONATE"
"1290","BROLENE","0.15 %w/w                                                                                                 Eye Ointment",1983-04-01,"PA0540/094/002","Sanofi-Aventis Ireland Limited T/A SANOFI","DIBROMPROPAMIDINEISETIONATE"
"1291","BROLENE","0.1 %w/v                                                                                                 Eye Drops Solution",2012-06-08,"PPA1151/176/001","Imbat Limited","PROPAMIDINEISETIONATE"
"1292","BROLENE","0.1 %w/v                                                                                                 Eye Drops Solution",2018-05-04,"PPA1097/046/001","Lexon (UK) Ltd","PROPAMIDINEISETIONATE"
"1293","Bronchitol","40 milligram(s) ZZZ Infus/Pdr/Oral Soln",2012-09-26,"EU/1/12/760/001-002","Pharmaxis Pharmaceuticals Ltd","Mannitol"
"1294","Bronchoforce chesty cough oral drops","*** AWAITING VALUE *** Oral drops, solution",2015-02-27,"TR2309/010/001","A. Vogel Ireland Limited","Tincturefromfreshaerialpartsofthyme(thymusvulgarisl.)(1:8.0-8.2)extractionsolvent:ethanol51%v/v|Tincturefromfreshivyherb(hederahelixl.)(1:5.7-6.0)extractionsolvent:ethanol51%v/v.|Tincturefromliquoriceroot(glycyrrhizaglabral.)(1:10-11)extractionsolvent:ethanol51%v/v."
"1295","BRONCHOSAN DRY, TICKLY COUGH SYRUP","Syrup",2014-03-07,"TR0725/008/001","Bioforce (UK) Ltd","EXTRACT(ASSOFTEXTRACT)FROMPICEAABIES(L.)KARSTEN(SPRUCE)SHOOTS(0.9-1.2:1).EXTRACTIONSOLVENT:WATER"
"1296","BRUFEN","400 Milligram                                                                                            Film Coated Tablet",1975-04-14,"PA2010/002/001","Mylan IRE Healthcare Limited","IBUPROFEN"
"1297","BRUFEN","600 Milligram                                                                                            Film Coated Tablet",1982-06-01,"PA2010/002/002","Mylan IRE Healthcare Limited","IBUPROFEN"
"1298","BRUFEN","200 Milligram                                                                                            Granules Effervescent",2013-05-17,"PA2010/002/003","Mylan IRE Healthcare Limited","IBUPROFEN"
"1299","BRUFEN","400 Milligram                                                                                            Granules Effervescent",2013-01-18,"PA2010/002/004","Mylan IRE Healthcare Limited","IBUPROFEN"
"1300","BRUFEN","600 Milligram                                                                                            Granules Effervescent",2013-06-21,"PA2010/002/005","Mylan IRE Healthcare Limited","IBUPROFEN"
"1301","BRUFEN PAEDIATRIC","100 MG/5ml                                                                                               Oral Suspension",1981-03-02,"PA2010/002/006","Mylan IRE Healthcare Limited","IBUPROFEN"
"1302","BRUFEN RETARD","800 Milligram                                                                                            Tablet Prolonged Release",1990-01-03,"PA2010/002/007","Mylan IRE Healthcare Limited","IBUPROFEN"
"1303","BRUPRO","200 Milligram                                                                                            Capsules, Soft",2015-06-12,"PA0711/225/002","Rowex Ltd","IBUPROFEN"
"1304","BRUPRO","200 Milligram                                                                                            Film Coated Tablet",2015-03-13,"PA0074/067/001","Rowa Pharmaceuticals Limited","IBUPROFEN"
"1305","BRUPRO MAX","400 Milligram                                                                                            Film Coated Tablet",2015-03-13,"PA0074/067/002","Rowa Pharmaceuticals Limited","IBUPROFEN"
"1306","BRUPRO MAX","400 Milligram                                                                                            Capsules, Soft",2015-06-12,"PA0711/225/003","Rowex Ltd","IBUPROFEN"
"1307","BRUPRO RX","600 Milligram                                                                                            Film Coated Tablet",2015-03-13,"PA0074/067/003","Rowa Pharmaceuticals Limited","IBUPROFEN"
"1308","BRYONIA","6C & 30C Milligram                                                                                            Tablets",2010-09-10,"HOR0407/026/001","Weleda (UK) Limited","BRYONIA"
"1309","BRYONIA","6C-MM",2010-10-29,"HOR1149/007/001","A. Nelson & Company Limited","BRYONIACRETICA"
"1310","BUCCOLAM","2.5 Milligram                                                                                            Oromucosal Solution",2011-09-05,"EU/1/11/709/001","ViroPharma SPRL","MIDAZOLAM"
"1311","BUCCOLAM","5 Mg/Ml Oromucosal Solution",2011-10-26,"EU/1/11/709/002","ViroPharma SPRL","MIDAZOLAM"
"1312","BUCCOLAM","7.5 Milligram                                                                                            Oromucosal Solution",2011-09-05,"EU/1/11/709/003","ViroPharma SPRL","MIDAZOLAM"
"1313","BUCCOLAM","10 Milligram                                                                                            Oromucosal Solution",2011-09-05,"EU/1/11/709/004","ViroPharma SPRL","MIDAZOLAM"
"1314","BUDENOFALK","3mg Milligram                                                                                            Capsules Gastro-Resistant",2001-04-06,"PA0573/002/001","Dr. Falk Pharma GmbH","BUDESONIDE"
"1315","BUDENOFALK","2 Mg/Dose                                                                                              Rectal Foam",2009-06-05,"PA0573/002/002","Dr. Falk Pharma GmbH","BUDESONIDE"
"1316","BUDENOFALK","9 Milligram                                                                                            Granules Gastro-Resistant",2011-02-25,"PA0573/002/003","Dr. Falk Pharma GmbH","BUDESONIDE"
"1317","BUDESONIDE TEVA PHARMA","0.5 mg/2ml Nebuliser Suspension",2014-03-07,"PA0749/207/002","Teva Pharma B.V.","BUDESONIDE"
"1318","BUDESONIDE TEVA PHARMA","1 mg/2ml Nebuliser Suspension",2014-03-07,"PA0749/207/003","Teva Pharma B.V.","BUDESONIDE"
"1319","Bufomix Easyhaler, 160 micrograms/4.5 micrograms/inhalation, inhalation powder","160/4.5 microgram(s) Powder for Inhalation",2014-04-11,"PA1327/015/002","Orion Corporation","Budesonide|Formoterolfumaratedihydrate"
"1320","Bufomix Easyhaler, 320 micrograms/9 micrograms/inhalation, inhalation powder","320/9 microgram(s) Powder for Inhalation",2014-04-11,"PA1327/015/003","Orion Corporation","Formoterolfumaratedihydrate|Budesonide"
"1321","Bufomix Easyhaler, 80 micrograms/4.5 micrograms/inhalation, inhalation powder","80/4.5 microgram(s) Powder for Inhalation",2016-04-29,"PA1327/015/004","Orion Corporation","Budesonide|Formoterolfumaratedihydrate"
"1322","BUPIVACAINE","2.5 Mg/Ml Solution for Injection",2017-05-19,"PA1390/132/001","Accord Healthcare Limited","BUPIVACAINEHYDROCHLORIDE"
"1323","BUPIVACAINE","5 Mg/Ml Solution for Injection",2017-05-19,"PA1390/132/002","Accord Healthcare Limited","BUPIVACAINEHYDROCHLORIDE"
"1324","Bupivacaine 2.5 mg/ml  Solution for Injection","2.5 milligram(s)/millilitre Solution for injection",2010-09-03,"PA1389/007/001","Claris Lifesciences (UK) Limited","BUPIVACAINEHYDROCHLORIDE"
"1325","Bupivacaine 5 mg/ml Solution for Injection","5 milligram(s)/millilitre Solution for injection",2010-09-03,"PA1389/007/002","Claris Lifesciences (UK) Limited","BUPIVACAINEHYDROCHLORIDE"
"1326","Bupivacaine Hydrochloride 0.25% w/v Solution for Injection","0.25 percent weight/volume Solution for injection",1988-01-21,"PA0073/091/001","Mercury Pharmaceuticals (Ireland) Ltd","BUPIVACAINEHYDROCHLORIDE"
"1327","Bupivacaine Hydrochloride 0.5% w/v Solution for Injection","0.005 percent weight/volume Solution for injection",1988-01-21,"PA0073/091/002","Mercury Pharmaceuticals (Ireland) Ltd","BUPIVACAINEHYDROCHLORIDE"
"1328","BUPLEX","200 Milligram                                                                                            Film Coated Tablet",2009-07-03,"PA1380/087/001","Actavis Group PTC ehf","IBUPROFEN"
"1329","BUPLEX","400 Milligram                                                                                            Film Coated Tablet",2009-07-03,"PA1380/087/002","Actavis Group PTC ehf","IBUPROFEN"
"1330","BUPLEX RX","200 Milligram                                                                                            Film Coated Tablet",2009-07-03,"PA1380/088/001","Actavis Group PTC ehf","IBUPROFEN"
"1331","BUPLEX RX","400 Milligram                                                                                            Film Coated Tablet",2009-07-03,"PA1380/088/002","Actavis Group PTC ehf","IBUPROFEN"
"1332","BUPLEX RX","600 Milligram                                                                                            Film Coated Tablet",2009-07-03,"PA1380/088/003","Actavis Group PTC ehf","IBUPROFEN"
"1333","BUPRENORPHINE","0.4 Milligram                                                                                            Tablet Sublingual",2010-12-10,"PA1567/001/001","Activase Pharmaceuticals Ltd","BUPRENORPHINEHYDROCHLORIDE"
"1334","BUPRENORPHINE","2 Milligram                                                                                            Tablet Sublingual",2010-12-10,"PA1567/001/002","Activase Pharmaceuticals Ltd","BUPRENORPHINEHYDROCHLORIDE"
"1335","BUPRENORPHINE","8 Milligram                                                                                            Tablet Sublingual",2010-12-10,"PA1567/001/003","Activase Pharmaceuticals Ltd","BUPRENORPHINEHYDROCHLORIDE"
"1336","BUPRENORPHINE","2 Milligram                                                                                            Tablet Sublingual",2010-09-10,"PA1333/003/002","Morningside Healthcare Limited","BUPRENORPHINEHYDROCHLORIDE"
"1337","BUPRENORPHINE","8 Milligram                                                                                            Tablet Sublingual",2010-09-10,"PA1333/003/003","Morningside Healthcare Limited","BUPRENORPHINEHYDROCHLORIDE"
"1338","BURINEX","1 Milligram                                                                                            Tablets",1978-04-01,"PA0046/016/002","Leo Laboratories Limited","BUMETANIDE"
"1339","BURINEX","5.0 Milligram                                                                                            Tablets",1978-04-01,"PA0046/016/003","Leo Laboratories Limited","BUMETANIDE"
"1340","BURNEZE SPRAY","1 %w/w                                                                                                 Cutaneous Spray Solution",1996-07-09,"PA0257/070/001","GR Lane Health Products Ltd","BENZOCAINE"
"1341","BUSCOPAN","10 Milligram                                                                                            Coated Tablets",1979-04-01,"PA0540/181/002","Sanofi-Aventis Ireland Limited T/A SANOFI","HYOSCINEBUTYLBROMIDE"
"1342","Buscopan Ampoules 20 mg/ml Solution for Injection","20 milligram(s)/millilitre Solution for injection",1979-04-01,"PA0540/181/001","Sanofi-Aventis Ireland Limited T/A SANOFI","Hyoscinebutylbromide"
"1343","Buscopan Rx 10mg Coated Tablets","10 milligram(s) Coated tablet",2016-12-02,"PA0540/190/001","Sanofi-Aventis Ireland Limited T/A SANOFI","Hyoscinebutylbromide"
"1344","BUSIETE","5 Microgram per hour Transdermal Patch",2016-11-25,"PA1986/026/001","Teva B.V.","BUPRENORPHINE"
"1345","BUSIETE","10 Microgram per hour Transdermal Patch",2016-11-25,"PA1986/026/002","Teva B.V.","BUPRENORPHINE"
"1346","BUSIETE","20 Microgram per hour Transdermal Patch",2016-11-25,"PA1986/026/003","Teva B.V.","BUPRENORPHINE"
"1347","BUSILVEX","6 Mg/Ml Concentrate for Soln for Inf",2003-07-09,"EU/1/03/254/002","Pierre Fabre Medicament","BUSULFAN"
"1348","BUSULFAN FRESENIUS KABI","6 Mg/Ml Concentrate for Soln for Inf",2014-09-22,"EU/1/14/951/001","Fresenius Kabi Deutschland GmbH","BUSULFAN"
"1349","BUTRANS","15 Microgram per hour Transdermal Patch",2015-08-13,"PA1688/002/004","Mundipharma Pharmaceuticals Limited","BUPRENORPHINE"
"1350","BUTRANS","5 Microgram per hour Transdermal Patch",2013-03-15,"PPA1151/194/001","Imbat Limited","BUPRENORPHINE"
"1351","BUTRANS","10 Microgram per hour Transdermal Patch",2013-03-15,"PPA1151/194/002","Imbat Limited","BUPRENORPHINE"
"1352","BUTRANS","20 Microgram per hour Transdermal Patch",2013-03-15,"PPA1151/194/003","Imbat Limited","BUPRENORPHINE"
"1353","BUTRANS 10 MICROGRAMS/HOUR TRANSDERMAL PATCH.","10 Milligram                                                                                            Transdermal Patch",2005-06-24,"PA1688/002/002","Mundipharma Pharmaceuticals Limited","BUPRENORPHINE"
"1354","BUTRANS 20 MICROGRAMS/HOUR TRANSDERMAL PATCH.","20 Milligram                                                                                            Transdermal Patch",2005-06-24,"PA1688/002/003","Mundipharma Pharmaceuticals Limited","BUPRENORPHINE"
"1355","BUTRANS 5 MICROGRAMS/HOUR TRANSDERMAL PATCH.","5 Milligram                                                                                            Transdermal Patch",2005-06-24,"PA1688/002/001","Mundipharma Pharmaceuticals Limited","BUPRENORPHINE"
"1356","BUTTERCUP BRONCHOSTOP COUGH","59.5 N/A Syrup",2015-03-13,"TR2006/001/001","Kwizda Pharma GmbH","THYMEHERBEXTRACTDER7-13:1,EXTRACTIONMEDIUM:WATER,NATIVE|MARSHMALLOWLIQUIDEXTRACTDER1:12-14,EXTRACTIONMEDIUM:WATER,NATIVE"
"1357","BUTTERCUP BRONCHOSTOP COUGH","59.5 Milligram                                                                                            Pastilles",2015-03-13,"TR2006/001/002","Kwizda Pharma GmbH","THYMEHERBDRYEXTRACT7-13:1,NATIVEEXTRACTIONSOLVENT:WATER"
"1358","Bydureon","2 milligram(s) Powder and solvent for suspension for injection",NA,"EU/1/11/696/001-004","AstraZeneca AB","Exenatide"
"1359","Bydureon","2 milligram(s) Prolonged-release suspension for injection in pre-filled syringe",2018-08-27,"EU/1/11/696/005","AstraZeneca AB","Exenatide"
"1360","Byetta","5 microgram(s) Solution for injection",2006-11-20,"EU/1/06/362/1-2","AstraZeneca AB","Exenatide"
"1361","BYETTA","10 Microgram                                                                                            Solution for Injection",2006-11-20,"EU/1/06/362/3-4","AstraZeneca AB","EXENATIDE"
"1362","BY-MADOL SR","50 Milligram                                                                                            Prolonged Release Capsules",2006-10-27,"PA0549/016/001","Ethypharm","TRAMADOLHYDROCHLORIDE"
"1363","BY-MADOL SR","100 Milligram                                                                                            Prolonged Release Capsules",2006-10-27,"PA0549/016/002","Ethypharm","TRAMADOLHYDROCHLORIDE"
"1364","BY-MADOL SR","150 Milligram                                                                                            Prolonged Release Capsules",2006-10-27,"PA0549/016/003","Ethypharm","TRAMADOLHYDROCHLORIDE"
"1365","BY-MADOL SR","200 Milligram                                                                                            Prolonged Release Capsules",2006-10-27,"PA0549/016/004","Ethypharm","TRAMADOLHYDROCHLORIDE"
"1366","BY-MYCIN","50 Milligram                                                                                            Capsules Hard",1994-09-08,"PA1457/010/001","Fannin Limited","DOXYCYCLINEHYCLATE"
"1367","BY-MYCIN","100 Milligram                                                                                            Capsules Hard",1994-09-08,"PA1457/010/002","Fannin Limited","DOXYCYCLINEHYCLATE"
"1368","BY-VERTIN","8 Milligram                                                                                            Tablets",2001-01-26,"PA1457/011/001","Fannin Limited","BETAHISTINEDIHYDROCHLORIDE"
"1369","BY-VERTIN","16 Milligram                                                                                            Tablets",2001-01-26,"PA1457/011/002","Fannin Limited","BETAHISTINEDIHYDROCHLORIDE"
"1370","Cabaser 1 mg Tablet","1 milligram(s) Tablet",1999-10-29,"PA0822/114/001","Pfizer Healthcare Ireland","Cabergoline"
"1371","Cabaser 2 mg Tablet","2 milligram(s) Tablet",1999-10-29,"PA0822/114/002","Pfizer Healthcare Ireland","Cabergoline"
"1372","Cablivi","10 milligram(s) Powder and solvent for solution for injection",NA,"EU/1/18/1305/001","Ablynx NV","caplacizumab"
"1373","CABOMETYX","20 Milligram                                                                                            Film Coated Tablet",2016-09-09,"EU/1/16/1136/001-002","Ipsen Pharma","CABOZANTINIB"
"1374","CABOMETYX","40 Milligram                                                                                            Film Coated Tablet",2016-09-09,"EU/1/16/1136/003-004","Ipsen Pharma","CABOZANTINIB"
"1375","CABOMETYX","60 Milligram                                                                                            Film Coated Tablet",2016-09-09,"EU/1/16/1136/005-006","Ipsen Pharma","CABOZANTINIB"
"1376","CADELIUS","600mg/1000 Base Milligrams                                                                                      Orodispersible Tablet",2017-04-13,"PA2102/002/001","Italfarmaco S.A.","CALCIUMCARBONATE|COLECALCIFEROL"
"1377","CAELYX","2 Mg/Ml Concentrate for Susp for Inf",1996-06-21,"EU/1/96/011/001","Janssen-Cilag International NV","DOXORUBICINHYDROCHLORIDE"
"1378","CAELYX","2.0 Mg/Ml Concentrate for Susp for Inf",1996-06-21,"EU/1/96/011/002","Janssen-Cilag International NV","DOXORUBICINHYDROCHLORIDE"
"1379","CALAMINE","5, 15 %w/v                                                                                                 Cutaneous Suspension",1999-04-16,"PA0281/051/001","Pinewood Laboratories Ltd,","ZINCOXIDE|CALAMINE"
"1380","CALAMINE LOTION","15/5 %w/v                                                                                                 Cutaneous Suspension",1992-10-14,"PA0206/016/002","Ovelle Limited","CALAMINE|ZINCOXIDE"
"1381","Calcichew 500 mg chewable tablets","500 milligram(s) Chewable tablet",2005-12-02,"PPA0465/156/001","PCO Manufacturing","Calcium"
"1382","CALCICHEW 500MG","500 Milligram                                                                                            Tablets Chewable",1993-12-20,"PA2229/005/001","Takeda Products Ireland Ltd","CALCIUMCARBONATE"
"1383","CALCICHEW D3 FORTE","500mg/400IU mg/IU Tablets Chewable",2013-06-28,"PPA1562/100/001","LTT Pharma Limited","CALCIUM|COLECALCIFEROL"
"1384","CALCICHEW D3 FORTE 500 MG/400 IU CHEWABLE/DISPERSIBLE TABLETS","500mg/400IU mg/IU Chewable/Dispersible tablet",2015-05-29,"DPR1633/017/001","Primecrown 2010 Ltd","CALCIUMCARBONATE|COLECALCIFEROL"
"1385","CALCICHEW D3 FORTE CHEWABLE TABLETS","500mg/400IU  Tablets Chewable",2014-10-29,"DPR1463/044/001","IMED Healthcare Ltd.","CALCIUMCARBONATE|COLECALCIFEROL"
"1386","CALCICHEW D3 FORTE CHEWABLE TABLETS","500mg/400IU mg/IU Tablets Chewable",2007-02-07,"DPR0465/001/001","PCO Manufacturing","CALCIUMCARBONATE|CHOLECALCIFEROL(02)400INTERNATIONUNIT"
"1387","CALCICHEW-D3 FORTE","500mg/400IU mg/IU Tablets Chewable",2015-06-18,"DPR1392/074/001","Eurodrug Ltd","CALCIUMCARBONATE|COLECALCIFEROL"
"1388","CALCICHEW-D3 FORTE","500mg/400IU %v/v                                                                                                 Tablets Chewable",1996-10-10,"PA2229/005/002","Takeda Products Ireland Ltd","CALCIUMCARBONATE|COLECALCIFEROL"
"1389","CALCICHEW-D3 FORTE","500mg/400IU mg/IU Tablets Chewable",2012-09-28,"PPA1151/155/001","Imbat Limited","CALCIUMCARBONATE|COLECALCIFEROL"
"1390","CALCICHEW-D3 FORTE CHEWABLE TABLETS","500mg/400IU mg/IU Tablets Chewable",2007-09-28,"PPA0465/156/002","PCO Manufacturing","CALCIUMCARBONATE|COLECALCIFEROL"
"1391","CALCICHEW-D3 FORTE CHEWABLE TABLETS","500mg/400IU mg/IU Tablets Chewable",2013-10-10,"DPR0465/046/001","PCO Manufacturing","CALCIUMCARBONATE|CHOLECALCIFEROL(02)"
"1392","CALCICHEW-D3 FORTE DOUBLE STRENGTH","1000/80 International Unit                                                                                   Tablets Chewable",2009-12-11,"PA2229/005/003","Takeda Products Ireland Ltd","CALCIUMCARBONATE|CHOLECALCIFEROLCONCENTRATE(POWDERFORM)"
"1393","CALCIPOTRIOL/BETAMETHASONE ROWEX","50 + 0.5 Unknown Ointment",2016-01-29,"PA0711/254/001","Rowex Ltd","CALCIPOTRIOL|BETAMETHASONE"
"1394","CALCIUM ACETATE","500 Milligram                                                                                            Tablets",1998-01-23,"PA0281/063/001","Pinewood Laboratories Ltd,","CALCIUMACETATE"
"1395","CALCIUM CARBONICUM HAHNEMANII (CALC CARB)","6C & 30C  Tablets",2009-11-20,"HOR0407/012/001","Weleda (UK) Limited","CALCIUMCARBONICUMHAHNEMANNI(CONCHAE)"
"1396","CALCIUM CHLORIDE INJECTION MINIJET","10 %w/v                                                                                                 Solution for Injection",1977-09-08,"PA0255/007/001","International Medication Systems (UK) Ltd","CALCIUMCHLORIDEDIHYDRATE"
"1397","CALCIUM FLUORATUM (CALC. FLUOR.)","6C & 30C  Tablets",2009-11-20,"HOR0407/046/001","Weleda (UK) Limited","CALCIUMFLUORATUM"
"1398","CALCIUM RESONIUM","99.934 %w/w                                                                                                 Powder for Oral Suspension",1983-04-01,"PA0540/141/001","Sanofi-Aventis Ireland Limited T/A SANOFI","CALCIUMPOLYSTYRENESULFONATE"
"1399","CALCIUP","500mg/440I Milligram                                                                                            Tablets Chewable",2014-08-01,"PA0711/217/002","Rowex Ltd","CALCIUMCARBONATE|CHOLECALCIFEROLCONCENTRATE"
"1400","Calciup D3 Forte 1000mg/880 IU Chewable Tablets","1000/880 international unit(s) Chewable tablet",2012-02-17,"PA0711/217/001","Rowex Ltd","Cholecalciferolconcentrate(powderform100,000iu/g)|CALCIUMCARBONATE"
"1401","Caldease 15% w/w Medicated Ointment","15 percent weight/weight Ointment",1985-01-08,"PA0126/153/001","Clonmel Healthcare Ltd","Zincoxide"
"1402","CALDESENE 10 % W/W MEDICATED POWDER","10 %w/w                                                                                                 Cutaneous Powder",1977-04-03,"PA0126/152/001","Clonmel Healthcare Ltd","CALCIUMUNDECYLEN"
"1403","CALDESENE ADULT","10 %w/w                                                                                                 Unknown",2014-03-14,"PA0126/247/001","Clonmel Healthcare Ltd","CALCIUMUNDECYLENATE"
"1404","CALENDULA LOTION","13.3 %w/v                                                                                                 Cutaneous Solution Concentrate",1991-10-11,"PA0407/025/001","Weleda (UK) Limited","CALENDULAOFFICINALIS"
"1405","CALFOVIT D3","%v/v                                                                                                 Powder for Oral Suspension",2002-06-28,"PA0865/006/001","Menarini International Operations Luxembourg S.A.","CALCIUMPHOSPHATE|COLECALCIFEROL"
"1406","CALMURID","%w/w                                                                                                 Cream",1978-07-28,"PA0590/008/001","Galderma (UK) Ltd","UREA|LACTICACID"
"1407","CALMURID HC 10%/5%/1%","10/1/5 %w/w                                                                                                 Cream",1978-04-01,"PA0590/009/001","Galderma (UK) Ltd","UREA|HYDROCORTISONE|LACTICACID"
"1408","Calpol 120 mg/ 5 ml Sugar Free Infant Oral Suspension","120 mg/5ml Oral suspension",1988-03-22,"PA0823/010/005","McNeil Healthcare (Ireland) Ltd","PARACETAMOL"
"1409","Calpol 120 mg/5 ml Infant Oral Suspension","120 mg/5ml Oral suspension",1978-04-01,"PA0823/010/002","McNeil Healthcare (Ireland) Ltd","PARACETAMOL"
"1410","CALPOL SIX PLUS","250 MG/5ml                                                                                               Oral Suspension",1985-01-25,"PA0823/010/003","McNeil Healthcare (Ireland) Ltd","PARACETAMOL"
"1411","Calpol Six Plus 250mg/5ml Sugar/Colour Free Oral Suspension","250 mg/5ml Oral suspension",1994-10-14,"PA0823/010/004","McNeil Healthcare (Ireland) Ltd","Paracetamol"
"1412","Calpol Six Plus Fastmelts 250 mg Paracetamol Orodispersible Tablets","250 milligram(s) Orodispersible tablet",2001-02-23,"PA0823/010/008","McNeil Healthcare (Ireland) Ltd","Paracetamol|Paracetamol"
"1413","CALTRATE","600/400                                                                                                      Film Coated Tablet",2009-04-24,"PA0822/173/001","Pfizer Healthcare Ireland","CALCIUMCARBONATE|CHOLECALCIFEROLCONCENTRATE"
"1414","CALTRATE","500mg/1000IU Milligram                                                                                            Tablets Chewable",2018-06-22,"PA0822/187/001","Pfizer Healthcare Ireland","CALCIUM|CHOLECALCIFEROL(02)"
"1415","CALVEPEN","333 Milligram                                                                                            Film Coated Tablet",1977-04-01,"PA0126/137/001","Clonmel Healthcare Ltd","PHENOXYMETHYLPENICILLINCALCIUM"
"1416","CALVEPEN","666 Milligram                                                                                            Film Coated Tablet",1977-04-01,"PA0126/137/002","Clonmel Healthcare Ltd","PHENOXYMETHYLPENICILLINCALCIUM"
"1417","CALVEPEN 250 MG/5 ML POWDER FOR ORAL SUSPENSION","250 Milligram                                                                                            Powder for Oral Suspension",1986-01-20,"PA0126/137/003","Clonmel Healthcare Ltd","PHENOXYMETHYLPENICILLINCALCIUM"
"1418","CALVIDIN","600/400IU Base Milligrams                                                                                      Tablets Chewable",2000-11-10,"PA2010/038/001","Mylan IRE Healthcare Limited","CALCIUMCARBONATE|COLECALCIFEROL"
"1419","CAMCOLIT","250 mg Milligram                                                                                            Film Coated Tablet",1978-04-01,"PA1994/001/001","Essential Pharma Ltd","LITHIUMCARBONATE"
"1420","CAMCOLIT","400 mg Milligram                                                                                            Film Coated Tablet",1978-04-01,"PA1994/001/002","Essential Pharma Ltd","LITHIUMCARBONATE"
"1421","Campral EC 333mg Gastro-resistant tablets","333.0 milligram(s) Gastro-resistant tablet",1996-02-16,"PA2286/007/001","Merck Serono (Ireland) Limited","Acamprosatecalcium"
"1422","Campral EC 333mg Gastro-resistant tablets","333 milligram(s) Gastro-resistant tablet",2016-08-19,"PPA1562/178/001","LTT Pharma Limited","Acamprosatecalcium"
"1423","CAMPTO 20 mg/ml concentrate for solution for infusion","20 milligram(s)/millilitre Concentrate for solution for infusion",2008-02-15,"PA0822/212/001","Pfizer Healthcare Ireland","Irinotecanhydrochloridetrihydrate"
"1424","CANCIDAS","50mg Milligram                                                                                            Pdr/Conc/Soln for Infus",2001-10-24,"EU/1/01/196/001","Merck Sharp & Dohme BV","CASPOFUNGIN"
"1425","CANCIDAS","70 Milligram                                                                                            Pdr/Conc/Soln for Infus",2001-10-24,"EU/1/01/196/003","Merck Sharp & Dohme BV","CASPOFUNGIN"
"1426","CANDESARTAN / HYDROCHLOROTHIAZIDE CLONMEL","16/12.5 Milligram                                                                                            Tablets",2013-04-05,"PA0126/251/001","Clonmel Healthcare Ltd","CANDESARTANCILEXETIL|HYDROCHLOROTHIAZIDE"
"1427","CANDESARTAN ACTAVIS","4 Milligram                                                                                            Tablets",2011-04-15,"PA1380/092/001","Actavis Group PTC ehf","CANDESARTANCILEXETIL"
"1428","CANDESARTAN ACTAVIS","8 Milligram                                                                                            Tablets",2011-04-15,"PA1380/092/002","Actavis Group PTC ehf","CANDESARTANCILEXETIL"
"1429","CANDESARTAN ACTAVIS","16 Milligram                                                                                            Tablets",2011-04-15,"PA1380/092/003","Actavis Group PTC ehf","CANDESARTANCILEXETIL"
"1430","Candesartan Hydrochlorothiazide 16 mg/12.5 mg Tablets","16/12.5 milligram(s) Tablet",2012-04-20,"PA1380/126/002","Actavis Group PTC ehf","Hydrochlorothiazide|Candesartancilexetil"
"1431","Candesartan Hydrochlorothiazide Krka 16mg/12.5mg tablets","16/12.5 milligram(s) Tablet",2011-08-12,"PA1347/011/002","Krka d.d., Novo mesto","Candesartancilexetil|Hydrochlorothiazide"
"1432","Candesartan Hydrochlorothiazide Krka 32mg/12.5mg tablets","32/12.5 milligram(s) Tablet",2011-08-12,"PA1347/011/003","Krka d.d., Novo mesto","Candesartancilexetil|Hydrochlorothiazide"
"1433","Candesartan Hydrochlorothiazide Krka 32mg/25mg Tablets","32/25 milligram(s) Tablet",2011-08-12,"PA1347/011/004","Krka d.d., Novo mesto","Candesartancilexetil|Hydrochlorothiazide"
"1434","Candesartan Hydrochlorothiazide Krka 8mg/12.5mg tablets","8/12.5 milligram(s) Tablet",2011-08-12,"PA1347/011/001","Krka d.d., Novo mesto","Candesartancilexetil|Hydrochlorothiazide"
"1435","CANDESARTAN KRKA","4 Milligram                                                                                            Tablets",2012-03-09,"PA1347/026/001","Krka d.d., Novo mesto","CANDESARTANCILEXETIL"
"1436","CANDESARTAN KRKA","8 Milligram                                                                                            Tablets",2012-03-09,"PA1347/026/002","Krka d.d., Novo mesto","CANDESARTANCILEXETIL"
"1437","CANDESARTAN KRKA","16 Milligram                                                                                            Tablets",2012-03-09,"PA1347/026/003","Krka d.d., Novo mesto","CANDESARTANCILEXETIL"
"1438","CANDESARTAN KRKA","32 Milligram                                                                                            Tablets",2012-03-09,"PA1347/026/004","Krka d.d., Novo mesto","CANDESARTANCILEXETIL"
"1439","CANDESARTAN MYLAN","4 Milligram                                                                                            Tablets",2011-08-26,"PA0577/120/001","McDermott Laboratories Ltd t/a Gerard Laboratories","CANDESARTANCILEXETIL"
"1440","CANDESARTAN MYLAN","8 Milligram                                                                                            Tablets",2011-08-26,"PA0577/120/002","McDermott Laboratories Ltd t/a Gerard Laboratories","CANDESARTANCILEXETIL"
"1441","CANDESARTAN MYLAN","16 Milligram                                                                                            Tablets",2011-08-26,"PA0577/120/003","McDermott Laboratories Ltd t/a Gerard Laboratories","CANDESARTANCILEXETIL"
"1442","CANDIST","4 Milligram                                                                                            Tablets",2011-09-23,"PA0126/206/001","Clonmel Healthcare Ltd","CANDESARTANCILEXETIL"
"1443","CANDIST","8 Milligram                                                                                            Tablets",2011-09-23,"PA0126/206/002","Clonmel Healthcare Ltd","CANDESARTANCILEXETIL"
"1444","CANDIST","16 Milligram                                                                                            Tablets",2011-09-23,"PA0126/206/003","Clonmel Healthcare Ltd","CANDESARTANCILEXETIL"
"1445","Candist Plus 16 mg/12.5 mg Tablets","16/12.5 milligram(s) Tablet",2011-10-21,"PA0126/207/002","Clonmel Healthcare Ltd","Candesartancilexetil|Hydrochlorothiazide"
"1446","CANECLEAR","150 Milligram                                                                                            Capsule",2012-12-18,"PA1113/013/001","Phoenix Labs","FLUCONAZOLE"
"1447","Canespor 10 mg/g Cream","10 milligram(s)/gram Cream",2018-03-09,"PA1410/083/001","Bayer Limited","Bifonazole"
"1448","CANESTEN","1 %w/w                                                                                                 Cream",1977-04-01,"PA1410/039/002","Bayer Limited","CLOTRIMAZOLE"
"1449","CANESTEN","100 Milligram                                                                                            Pessary",1977-04-01,"PA1410/039/007","Bayer Limited","CLOTRIMAZOLE"
"1450","CANESTEN","200 Milligram                                                                                            Pessary",1979-10-10,"PA1410/039/008","Bayer Limited","CLOTRIMAZOLE"
"1451","CANESTEN","500 Milligram                                                                                            Pessary",1983-03-14,"PA1410/039/009","Bayer Limited","CLOTRIMAZOLE"
"1452","CANESTEN","500 Milligram                                                                                            Vaginal Capsule",2014-12-12,"PA1410/039/010","Bayer Limited","CLOTRIMAZOLE"
"1453","CANESTEN","10 mg/g Cream",2000-04-14,"PPA0465/048/001","PCO Manufacturing","CLOTRIMAZOLE"
"1454","CANESTEN","500 Milligram                                                                                            Pessary",2006-03-03,"PPA0465/048/002","PCO Manufacturing","CLOTRIMAZOLE"
"1455","CANESTEN","1 Per Cent                                                                                             Cream",2016-11-11,"PPA1562/191/001","LTT Pharma Limited","CLOTRIMAZOLE"
"1456","Canesten Athlete’s Foot Cream","1 percent weight/weight Cream",2015-02-20,"PA1410/039/013","Bayer Limited","Clotrimazole"
"1457","CANESTEN COMBI","500mg/2 %w/w                                                                                                 Pessaries and Cream",2001-08-24,"PA1410/039/001","Bayer Limited","CLOTRIMAZOLE|CLOTRIMAZOLE"
"1458","CANESTEN COMBI PESSARY & CREAM","500/20 Milligram                                                                                            Pessaries and Cream",2009-06-25,"PPA0465/048/003","PCO Manufacturing","CLOTRIMAZOLE"
"1459","CANESTEN CREAM COMBI","2 Unknown Vaginal Cream",2006-07-28,"PA1410/039/003","Bayer Limited","CLOTRIMAZOLE|CLOTRIMAZOLE"
"1460","CANESTEN DUOPACK","100mg/1 %w/w                                                                                                 Pessaries and Cream",1977-04-01,"PA1410/039/005","Bayer Limited","CLOTRIMAZOLE|CLOTRIMAZOLE"
"1461","CANESTEN HC","1/1 %w/w                                                                                                 Cream",1984-08-15,"PA1410/040/001","Bayer Limited","CLOTRIMAZOLE|HYDROCORTISONE"
"1462","CANESTEN HC","1.0 %w/w                                                                                                 Cream",2018-06-29,"PA1410/040/002","Bayer Limited","CLOTRIMAZOLE|HYDROCORTISONE"
"1463","CANESTEN HC","1.0 / 1.0 %w/w                                                                                                 Cream",2011-09-02,"PPA1463/049/001","IMED Healthcare Ltd.","CLOTRIMAZOLE|HYDROCORTISONE"
"1464","CANESTEN INTERNAL CREAM","10 %w/w                                                                                                 Vaginal Cream",1986-05-19,"PA1410/039/006","Bayer Limited","CLOTRIMAZOLE"
"1465","CANESTEN SOFT VAGINAL CAPSULE COMBI","500mg/2%w/w Milligram                                                                                            Capsules, Soft",2016-03-24,"PA1410/039/014","Bayer Limited","CLOTRIMAZOLE|CLOTRIMAZOLE"
"1466","CANESTEN THRUSH","2 %w/w                                                                                                 Vaginal Cream",1981-03-02,"PA1410/039/012","Bayer Limited","CLOTRIMAZOLE"
"1467","CANESTEN THRUSH","20 mg/g Vaginal Cream",2010-05-07,"PPA0465/048/004","PCO Manufacturing","CLOTRIMAZOLE"
"1468","CANESTEN THRUSH VAGINAL CREAM","2 %w/w                                                                                                 Vaginal Cream",2016-10-07,"PPA1151/201/004","Imbat Limited","CLOTRIMAZOLE"
"1469","CANORAL","150 Milligram                                                                                            Capsules Hard",2005-04-15,"PA1410/041/001","Bayer Limited","FLUCONAZOLE"
"1470","CANTHARIS","6C-200C  Tablets",2012-06-28,"HOR0407/048/001","Weleda (UK) Limited","LYTTAVESICATORIA"
"1471","CAPASAL THERAPEUTIC SHAMPOO","0.5/1/1 %w/w                                                                                                 Shampoo",1991-01-10,"PA0278/016/001","Dermal Laboratories Ltd","SALICYLICACID|COCONUTOIL|COALTAR"
"1472","CAPECITABINE","150 Milligram                                                                                            Film Coated Tablet",2012-04-20,"EU/1/12/762/001-006","Accord Healthcare Limited","CAPECITABINE"
"1473","CAPECITABINE","300 Milligram                                                                                            Film Coated Tablet",2012-04-20,"EU/1/12/762/007-012","Accord Healthcare Limited","CAPECITABINE"
"1474","CAPECITABINE","500 Milligram                                                                                            Film Coated Tablet",2012-04-20,"EU/1/12/762/013-018","Accord Healthcare Limited","CAPECITABINE"
"1475","CAPECITABINE","150 Milligram                                                                                            Film Coated Tablet",2012-11-09,"PA1422/011/001","Fresenius Kabi Oncology Plc","CAPECITABIINE"
"1476","CAPECITABINE","500 Milligram                                                                                            Film Coated Tablet",2012-11-09,"PA1422/011/002","Fresenius Kabi Oncology Plc","CAPECITABINE"
"1477","CAPECITABINE MEDAC","150 Milligram                                                                                            Film Coated Tablet",2012-11-19,"EU/1/12/802/001-014","Medac Gesellschaft fur Klinische Spezialpraparate mbH","CAPECITABINE"
"1478","CAPECITABINE MEDAC","300 Milligram                                                                                            Film Coated Tablet",2012-11-19,"EU/1/12/802/015-028","Medac Gesellschaft fur Klinische Spezialpraparate mbH","CAPECITABINE"
"1479","CAPECITABINE MEDAC","500 Milligram                                                                                            Film Coated Tablet",2012-11-19,"EU/1/12/802/029-042","Medac Gesellschaft fur Klinische Spezialpraparate mbH","CAPECITABINE"
"1480","CAPECITABINE SANDOZ","150 Milligram                                                                                            Film Coated Tablet",2013-05-17,"PA0711/206/001","Rowex Ltd","CAPECITABINE"
"1481","CAPECITABINE SANDOZ","500 Milligram                                                                                            Film Coated Tablet",2013-05-17,"PA0711/206/002","Rowex Ltd","CAPECITABINE"
"1482","CAPECITABINE TEVA","150 Milligram                                                                                            Film Coated Tablet",2012-04-20,"EU/1/12/761/001","Teva B.V.","CAPECITABIINE"
"1483","CAPECITABINE TEVA","500 Milligram                                                                                            Film Coated Tablet",2012-04-20,"EU/1/12/761/002","Teva B.V.","CAPECITABIINE"
"1484","Caprelsa","100 milligram(s) Film-coated tablet",2012-02-17,"EU/1/11/749/001","Genzyme Europe B.V.","Vandetanib"
"1485","CAPRELSA","300 Milligram                                                                                            Film Coated Tablet",2012-02-17,"EU/1/11/749/002","Genzyme Europe B.V.","VANDETANIB"
"1486","CAPRIN","75 Milligram                                                                                            Tablets Gastro-Resistant",2000-06-23,"PA0281/130/001","Pinewood Laboratories Ltd,","ACETYLSALICYLICACID"
"1487","Captopril 25mg/5ml Oral Solution","25/5 milligram(s)/millilitre Oral solution",2018-07-06,"PA2282/001/002","JensonR+ (Ireland) Limited","Captopril"
"1488","Captopril 5mg/5ml Oral Solution","5/5 milligram(s)/millilitre Oral solution",2018-07-06,"PA2282/001/001","JensonR+ (Ireland) Limited","Captopril"
"1489","CAPTOR","12.5 Milligram                                                                                            Tablets",1996-02-16,"PA0711/002/001","Rowex Ltd","CAPTOPRIL"
"1490","CAPTOR","25 Milligram                                                                                            Tablets",1996-02-16,"PA0711/002/002","Rowex Ltd","CAPTOPRIL"
"1491","CAPTOR","50 Milligram                                                                                            Tablets",1996-02-16,"PA0711/002/003","Rowex Ltd","CAPTOPRIL"
"1492","CAPTOR-HCT 25 MG/12.5 MG TABLETS","25/12.5 mg Milligram                                                                                            Tablets",1998-10-16,"PA0711/025/001","Rowex Ltd","CAPTOPRIL|HYDROCHLOROTHIAZIDE"
"1493","CAPTOR-HCT 50 MG/25 MG TABLETS","50/25mg Milligram                                                                                            Tablets",1998-10-16,"PA0711/025/003","Rowex Ltd","CAPTOPRIL|HYDROCHLOROTHIAZIDE"
"1494","CARBAGLU DISPERSIBLE","200 Milligram                                                                                            Tablets",2003-01-24,"EU/1/02/246/1-2","Orphan Europe","CARGLUMICACID"
"1495","CARBAMAZEPINE ESSENTIAL PHARMA","125 Milligram                                                                                            Suppositories",1994-04-19,"PA1994/003/001","Essential Pharma Ltd","CARBAMAZEPINE"
"1496","CARBAMAZEPINE ESSENTIAL PHARMA","250 Milligram                                                                                            Suppositories",1994-04-19,"PA1994/003/002","Essential Pharma Ltd","CARBAMAZEPINE"
"1497","CARBIDOPA/LEVODOPA FAIR-MED","12.5/50 Milligram                                                                                            Tablets",2016-03-04,"PA1789/007/001","Fair-Med Healthcare GmbH","CARBIDOPA|LEVODOPA"
"1498","CARBIDOPA/LEVODOPA FAIR-MED","10/100 Milligram                                                                                            Tablets",2016-03-04,"PA1789/007/002","Fair-Med Healthcare GmbH","CARBIDOPA|LEVODOPA"
"1499","CARBIDOPA/LEVODOPA FAIR-MED","25/100 Milligram                                                                                            Tablets",2016-03-04,"PA1789/007/003","Fair-Med Healthcare GmbH","CARBIDOPA|LEVODOPA"
"1500","CARBIDOPA/LEVODOPA FAIR-MED","25/250 Milligram                                                                                            Tablets",2016-03-04,"PA1789/007/004","Fair-Med Healthcare GmbH","CARBIDOPA|LEVODOPA"
"1501","CARBIMAZOLE","5 Milligram                                                                                            Tablets",2018-06-14,"PA2130/001/001","Essential-Healthcare Ltd.","CARBIMAZOLE"
"1502","CARBIMAZOLE","20 Milligram                                                                                            Tablets",2018-06-14,"PA2130/001/002","Essential-Healthcare Ltd.","CARBIMAZOLE"
"1503","CARBO VEGETABILIS (CARBO. VEG.)","6C & 30C  Tablets",2009-11-20,"HOR0407/003/001","Weleda (UK) Limited","CARBOVEGETABILIS"
"1504","CARBOCISTEINE","375 Milligram                                                                                            Capsules Hard",2016-12-09,"PA0688/045/001","Chanelle Medical","CARBOCISTEINE"
"1505","CARBOMIX","81.3%w/w percent weight/weight Granules",NA,"PA1074/001/001","Meadow Laboratories Limited","Charcoal,activated"
"1506","Carbomix 50 g Granules for Oral Suspension","81.3 percent weight/weight Granules for oral suspension",1992-12-03,"PA0298/022/001","Athlone Laboratories Ltd","Charcoal,activated"
"1507","CARBOPLATIN","10 Mg/Ml Concentrate for Soln for Inf",1990-07-20,"PA0437/017/002A","Hospira  UK Limited","CARBOPLATIN"
"1508","CARBOPLATIN","10 Mg/Ml Concentrate for Soln for Inf",2009-01-09,"PA1390/006/001","Accord Healthcare Limited","CARBOPLATIN"
"1509","Carboplatin 10 mg/ml concentrate for solution for infusion","10 milligram(s)/millilitre Concentrate for solution for infusion",2012-02-17,"PA1422/008/001","Fresenius Kabi Oncology Plc","Carboplatin"
"1510","Carboplatin-Teva 10 mg/ml Concentrate for Solution for Infusion","10 milligram(s)/millilitre Concentrate for solution for infusion",2001-03-09,"PA0749/004/001","Teva Pharma B.V.","Carboplatin"
"1511","CARBOSAN","2 %w/w                                                                                                 Gel",1987-03-13,"PA0074/011/001","Rowa Pharmaceuticals Limited","CARBENOXOLONESODIUM"
"1512","CARBOSYLANE","140 Milligram                                                                                            Capsule",1987-05-21,"PA0345/001/001","Laboratoires Grimberg","CHARCOAL,ACTIVATED|DIMETICONE,ACTIVATED|DIMETICONE,ACTIVATED|CHARCOAL,ACTIVATED"
"1513","CARDICOR","1.25 Milligram                                                                                            Film Coated Tablet",2015-01-23,"PPA1562/142/001","LTT Pharma Limited","BISOPROLOLHEMIFUMARATE"
"1514","CARDICOR","2.5 Milligram                                                                                            Film Coated Tablet",2015-01-23,"PPA1562/142/002","LTT Pharma Limited","BISOPROLOLHEMIFUMARATE"
"1515","CARDICOR","7.5 Milligram                                                                                            Film Coated Tablet",2015-01-23,"PPA1562/142/003","LTT Pharma Limited","BISOPROLOLHEMIFUMARATE"
"1516","CARDICOR","1.25 Milligram                                                                                            Film Coated Tablet",2013-10-25,"PPA1463/085/001","IMED Healthcare Ltd.","BISOPROLOLFUMARATE"
"1517","CARDICOR","2.5 Milligram                                                                                            Film Coated Tablet",2013-10-25,"PPA1463/085/002","IMED Healthcare Ltd.","BISOPROLOLFUMARATE"
"1518","CARDICOR","1.25 Milligram                                                                                            Film Coated Tablet",2008-05-02,"PPA1151/048/001","Imbat Limited","BISOPROLOLFUMARATE"
"1519","CARDICOR","2.5 Milligram                                                                                            Film Coated Tablet",2008-05-02,"PPA1151/048/002","Imbat Limited","BISOPROLOLHEMIFUMARATE"
"1520","CARDICOR","3.75 Milligram                                                                                            Film Coated Tablet",2008-05-02,"PPA1151/048/003","Imbat Limited","BISOPROLOLHEMIFUMARATE"
"1521","CARDICOR","5 Milligram                                                                                            Film Coated Tablet",2008-05-02,"PPA1151/048/004","Imbat Limited","BISOPROLOLHEMIFUMARATE"
"1522","CARDICOR","7.5 Milligram                                                                                            Film Coated Tablet",2008-05-02,"PPA1151/048/005","Imbat Limited","BISOPROLOLHEMIFUMARATE"
"1523","CARDICOR","10 Milligram                                                                                            Film Coated Tablet",2008-05-02,"PPA1151/048/006","Imbat Limited","BISOPROLOLHEMIFUMARATE"
"1524","Cardicor 1.25 mg film-coated tablets","1.25 milligram(s) Film-coated tablet",2000-03-20,"PA2286/004/001","Merck Serono (Ireland) Limited","Bisoprololhemifumarate"
"1525","Cardicor 10 mg film-coated tablets","10 milligram(s) Film-coated tablet",2000-03-20,"PA2286/004/006","Merck Serono (Ireland) Limited","Bisoprololhemifumarate"
"1526","Cardicor 2.5 mg film-coated tablets","2.5 milligram(s) Film-coated tablet",2000-03-20,"PA2286/004/002","Merck Serono (Ireland) Limited","Bisoprololhemifumarate"
"1527","Cardicor 3.75 mg film-coated tablets","3.75 milligram(s) Film-coated tablet",2000-03-20,"PA2286/004/003","Merck Serono (Ireland) Limited","Bisoprololhemifumarate"
"1528","Cardicor 5 mg film-coated tablets","5 milligram(s) Film-coated tablet",2000-03-20,"PA2286/004/004","Merck Serono (Ireland) Limited","Bisoprololhemifumarate"
"1529","Cardicor 7.5 mg, film-coated tablets","7.5 milligram(s) Film-coated tablet",2000-03-20,"PA2286/004/005","Merck Serono (Ireland) Limited","Bisoprololhemifumarate"
"1530","CARDIOPLAST","0.2                                                                                                      Transdermal Patch",2013-07-19,"PA0577/174/001","McDermott Laboratories Ltd t/a Gerard Laboratories","NITROGLYCERIN(GLYCERYLTRINITRATE)"
"1531","CARDIOPLAST","0.4  Transdermal Patch",2013-07-19,"PA0577/174/002","McDermott Laboratories Ltd t/a Gerard Laboratories","NITROGLYCERIN(GLYCERYLTRINITRATE)"
"1532","CARDIOPLAST","0.6  Transdermal Patch",2013-07-19,"PA0577/174/003","McDermott Laboratories Ltd t/a Gerard Laboratories","NITROGLYCERIN(GLYCERYLTRINITRATE)"
"1533","CARDURA","1 Milligram                                                                                            Tablets",1987-12-21,"PA0822/192/001","Pfizer Healthcare Ireland","DOXAZOSINMESILATE"
"1534","CARDURA","2 Milligram                                                                                            Tablets",1987-12-21,"PA0822/192/002","Pfizer Healthcare Ireland","DOXAZOSIN"
"1535","CARDURA XL","8 Milligram                                                                                            Tablet Prolonged Release",2007-05-11,"PPA1151/022/002","Imbat Limited","DOXAZOSINMESILATE"
"1536","Cardura XL 4 mg Prolonged-release tablets","4 milligram(s) Prolonged-release tablet",1999-10-29,"PA0822/004/001","Pfizer Healthcare Ireland","DOXAZOSINMESILATE"
"1537","Cardura XL 8 mg Prolonged-release tablets","8 milligram(s) Prolonged-release tablet",1999-10-29,"PA0822/004/002","Pfizer Healthcare Ireland","DOXAZOSINMESILATE"
"1538","CARISTENOL","2 Milligram                                                                                            Prolonged Release Capsules",2016-06-10,"PA1390/109/001","Accord Healthcare Limited","TOLTERODINETARTRATE"
"1539","CARISTENOL","4 Milligram                                                                                            Prolonged Release Capsules",2016-06-10,"PA1390/109/002","Accord Healthcare Limited","TOLTERODINETARTRATE"
"1540","Carmustine Obvius","100 milligram(s) Powder and solvent for solution for infusion",NA,"EU/1/18/1278/001","Obvius Investment B.V.","Carmustine"
"1541","Carnation Callous Caps 40% w/w Medicated plasters","40 percent weight/weight Medicated plaster",1983-04-01,"PA0229/003/002","Cuxson Gerrard & Company Ltd","Salicylicacid"
"1542","Carnation Corn Caps 40% w/w Medicated plasters","40 percent weight/weight Medicated plaster",1983-04-01,"PA0229/003/001","Cuxson Gerrard & Company Ltd","Salicylicacid"
"1543","Carnation Vericap Verruca Treatment 10% w/w medicated plaster","10 percent weight/weight Medicated plaster",1990-01-08,"PA0229/003/003","Cuxson Gerrard & Company Ltd","Salicylicacid"
"1544","Carteolol hydrochloride Thea 20 mg/ml eye drops, solution","20 milligram(s)/millilitre Eye drops, solution",2018-11-30,"PA1107/016/001","Laboratoires Thea","CarteololHydrochloride"
"1545","CARVEDILOL KRKA","3.125 Milligram                                                                                            Tablets",2003-08-22,"PA1347/037/001","Krka d.d., Novo mesto","CARVEDILOL"
"1546","CARVEDILOL KRKA","6.25 Milligram                                                                                            Tablets",2003-08-22,"PA1347/037/002","Krka d.d., Novo mesto","CARVEDILOL"
"1547","CARVEDILOL KRKA","12.5 Milligram                                                                                            Tablets",2003-08-22,"PA1347/037/003","Krka d.d., Novo mesto","CARVEDILOL"
"1548","CARVEDILOL KRKA","25 Milligram                                                                                            Tablets",2003-08-22,"PA1347/037/004","Krka d.d., Novo mesto","CARVEDILOL"
"1549","CASACOL EXPECTORANT SYRUP","20/100/200 MG/5ml                                                                                               Infus/Pdr/Oral Soln",1979-05-23,"PA1113/007/001","Phoenix Labs","METHOXYPHENAMINEHYDROCHLORIDE|GUAIFENESIN|SODIUMCITRATE"
"1550","CASODEX","50 Milligram                                                                                            Film Coated Tablet",2016-04-15,"PPA1463/107/001","IMED Healthcare Ltd.","BICALUTAMIDE"
"1551","CASODEX","50 Milligram                                                                                            Tablets",2018-03-09,"PPA1633/068/001","Primecrown 2010 Ltd","BICALUTAMIDE"
"1552","CASODEX 50 MG FILM-COATED TABLETS","50 Milligram                                                                                            Film Coated Tablet",2009-04-24,"PPA1151/104/001","Imbat Limited","BICALUTAMIDE"
"1553","Casodex 50 mg Film-coated Tablets","50mg milligram(s) Tablet",2000-04-21,"PA0970/004/001","AstraZeneca UK Limited","Bicalutamide"
"1554","Casodex 50 mg Film-Coated Tablets","50 milligram(s) Film-coated tablet",2004-07-02,"PPA0465/144/001","PCO Manufacturing","Bicalutamide"
"1555","CASPOFUNGIN","50 Milligram                                                                                            Pdr/Conc/Soln for Infus",2016-09-16,"PA1989/001/001","Demo S.A.","CASPOFUNGIN"
"1556","CASPOFUNGIN","70 Milligram                                                                                            Pdr/Conc/Soln for Infus",2016-09-16,"PA1989/001/002","Demo S.A.","CASPOFUNGIN"
"1557","Caspofungin 50 mg powder for concentrate for solution for infusion","50.00 milligram(s) ZZZ Pdr/Conc/Soln for Infus",2017-05-12,"PA0274/002/001","Macarthys Laboratories Limited","Caspofungin"
"1558","Caspofungin 50mg powder for concentrate for solution for infusion","50 milligram(s) ZZZ Pdr/Conc/Soln for Infus",2017-02-03,"PA1339/070/001","Wockhardt UK Limited","Caspofungin"
"1559","Caspofungin 50mg powder for concentrate for solution for infusion","50 milligram(s) ZZZ Pdr/Conc/Soln for Infus",2017-01-13,"PA1226/013/001","Flynn Pharma Ltd","Caspofungin"
"1560","Caspofungin 70 mg powder for concentrate for solution for infusion","70.00 milligram(s) ZZZ Pdr/Conc/Soln for Infus",2017-05-12,"PA0274/002/002","Macarthys Laboratories Limited","Caspofungin"
"1561","Caspofungin 70mg powder for concentrate for solution for infusion","70 milligram(s) ZZZ Pdr/Conc/Soln for Infus",2017-01-13,"PA1226/013/002","Flynn Pharma Ltd","Caspofungin"
"1562","Caspofungin 70mg powder for concentrate for solution for infusion","70 milligram(s) ZZZ Pdr/Conc/Soln for Infus",2017-02-03,"PA1339/070/002","Wockhardt UK Limited","Caspofungin"
"1563","CASPOFUNGIN ACCORD","50 Milligram                                                                                            Pdr/Conc/Soln for Infus",2016-02-11,"EU/1/15/1081/001","Accord Healthcare Limited","CASPOFUNGINACETATE"
"1564","CASPOFUNGIN ACCORD","70 Milligram                                                                                            Pdr/Conc/Soln for Infus",2016-02-11,"EU/1/15/1081/002","Accord Healthcare Limited","CASPOFUNGINACETATE"
"1565","CASPOFUNGIN ACTAVIS","50 Milligram                                                                                            Pdr/Conc/Soln for Infus",2016-10-14,"PA1380/193/001","Actavis Group PTC ehf","CASPOFUNGIN"
"1566","CASPOFUNGIN ACTAVIS","70 Milligram                                                                                            Pdr/Conc/Soln for Infus",2016-10-14,"PA1380/193/002","Actavis Group PTC ehf","CASPOFUNGIN"
"1567","CASPOFUNGIN CLONMEL","50 Milligram                                                                                            Concentrate for Soln for Inf",2016-11-25,"PA0126/287/001","Clonmel Healthcare Ltd","CASPOFUNGINACETATE"
"1568","CASPOFUNGIN CLONMEL","70 Milligram                                                                                            Concentrate for Soln for Inf",2016-11-25,"PA0126/287/002","Clonmel Healthcare Ltd","CASPOFUNGINACETATE"
"1569","CASPOFUNGIN FRESENIUS KABI","50 Milligram                                                                                            Pdr/Conc/Soln for Infus",2016-12-02,"PA2059/005/001","Fresenius Kabi Deutschland GmbH","CASPOFUNGIN"
"1570","CASPOFUNGIN FRESENIUS KABI","70 Milligram                                                                                            Pdr/Conc/Soln for Infus",2016-12-02,"PA2059/005/002","Fresenius Kabi Deutschland GmbH","CASPOFUNGIN"
"1571","CASPOFUNGIN MYLAN","50 Milligram                                                                                            Pdr/Conc/Soln for Infus",2017-07-28,"PA0577/184/001","McDermott Laboratories Ltd t/a Gerard Laboratories","CASPOFUNGIN"
"1572","CASPOFUNGIN MYLAN","70 Milligram                                                                                            Pdr/Conc/Soln for Infus",2017-07-28,"PA0577/184/002","McDermott Laboratories Ltd t/a Gerard Laboratories","CASPOFUNGIN"
"1573","CASPOFUNGIN TEVA","50 Milligram                                                                                            Pdr/Conc/Soln for Infus",2016-08-12,"PA1986/009/001","Teva B.V.","CASPOFUNGINACETATE"
"1574","CASPOFUNGIN TEVA","70 Milligram                                                                                            Pdr/Conc/Soln for Infus",2016-08-12,"PA1986/009/002","Teva B.V.","CASPOFUNGINACETATE"
"1575","CATACROM","2 %w/v                                                                                                 Eye Drops Solution",2009-11-27,"PA2161/001/001","Rayner Pharmaceuticals Limited",""
"1576","Cataflam 50mg Coated Tablets","50 milligram(s) Coated tablet",1995-03-13,"PA0896/004/001","Novartis Ireland Limited","Diclofenacpotassium"
"1577","Catapres Ampoules 150 micrograms in 1 ml Solution for Injection","0.15 micromole(s) Solution for injection",1979-04-01,"PA0007/014/003","Boehringer Ingelheim Limited","CLONIDINEHYDROCHLORIDE"
"1578","Catapres Tablets 100 micrograms","0.1 milligram(s) Tablet",1979-04-01,"PA0007/014/001","Boehringer Ingelheim Limited","CLONIDINEHYDROCHLORIDE"
"1579","Catasart 16 mg Tablets","16 milligram(s) Tablet",2009-09-04,"PA0711/134/003","Rowex Ltd","Candesartancilexetil"
"1580","Catasart 4 mg Tablets","4 milligram(s) Tablet",2009-09-04,"PA0711/134/001","Rowex Ltd","Candesartancilexetil"
"1581","Catasart 8 mg Tablets","8 milligram(s) Tablet",2009-09-04,"PA0711/134/002","Rowex Ltd","Candesartancilexetil"
"1582","Catasart Plus 16mg/12.5mg tablets","16/12.5 milligram(s) Tablet",2010-07-02,"PA0711/164/001","Rowex Ltd","Candesartancilexetil|Hydrochlorothiazide"
"1583","Catephen 10 % ointment","10 percent Ointment",2015-04-17,"PA1748/003/001","Kora Corporation Ltd t/a Kora Healthcare","Greenteadryextract"
"1584","Caverject 10 micrograms Powder and Solvent for Solution for Injection","10 microgram(s) Powder and solvent for solution for injection",1997-04-04,"PA0822/115/002","Pfizer Healthcare Ireland","Alprostadil"
"1585","Caverject 20 micrograms Powder and Solvent for Solution for Injection","20 microgram(s) Powder and solvent for solution for injection",1995-03-13,"PA0822/115/003","Pfizer Healthcare Ireland","Alprostadil"
"1586","Cayston","75 milligram(s) Powder and solvent for nebuliser solution",2009-09-21,"EU/1/09/543/001","Gilead Sciences International","Aztreonam(aslysinesalt)"
"1587","CECLOVA","75/20 Milligram                                                                                            Capsules Modified Release",2018-07-20,"PA2222/001/001","Temmler Pharma GmbH","DICLOFENACSODIUM|OMEPRAZOLE"
"1588","CEFACLOR","250 Milligram                                                                                            Capsules Hard",2007-04-13,"PA0688/013/001","Chanelle Medical","CEFACLOR"
"1589","CEFACLOR","500 Milligram                                                                                            Capsules Hard",2007-04-13,"PA0688/013/002","Chanelle Medical","CEFACLOR"
"1590","Cefixime 200 mg film-coated tablets","200 milligram(s) Film-coated tablet",2010-10-15,"PA1335/002/001","Orchid Europe Limited","Cefixime"
"1591","Cefixime Nectar Lifesciences 100 mg/5 ml Powder for Oral Suspension","100/5 milligram(s)/millilitre Powder for oral suspension",2018-11-16,"PA2151/001/001","Nectar Lifesciences UK Limited","Cefixime"
"1592","CEFOTAXIME","500 Milligram                                                                                            Pdr for Soln Inj/Inf",2003-09-19,"PA1339/002/001","Wockhardt UK Limited","CEFOTAXIMESODIUM"
"1593","CEFOTAXIME","1 Grams                                                                                                Pdr for Soln Inj/Inf",2003-09-19,"PA1339/002/002","Wockhardt UK Limited","CEFOTAXIMESODIUM"
"1594","CEFOTAXIME","2 Grams                                                                                                Pdr for Soln Inj/Inf",2003-09-19,"PA1339/002/003","Wockhardt UK Limited","CEFOTAXIMESODIUM"
"1595","CEFTAL","250 Milligram                                                                                            Coated Tablets",2006-10-13,"PA0711/101/002","Rowex Ltd","CEFUROXIMEAXETIL"
"1596","CEFTAL","500 Milligram                                                                                            Coated Tablets",2006-10-13,"PA0711/101/003","Rowex Ltd","CEFUROXIMEAXETIL"
"1597","CEFTAZIDIME","1 Grams                                                                                                Pdr for Soln Inj/Inf",2004-12-17,"PA1339/003/001","Wockhardt UK Limited","CEFTAZIDIMEPENTAHYDRATE"
"1598","CEFTAZIDIME","2 Grams                                                                                                Pdr for Soln Inj/Inf",2004-12-17,"PA1339/003/002","Wockhardt UK Limited","CEFTAZIDIMEPENTAHYDRATE"
"1599","CEFTAZIDIME","500 Milligram                                                                                            Pdr for Soln for Injection",2014-09-12,"PA1217/012/001","Hikma Farmaceutica (Portugal) SA","CEFTAZIDIMEPENTAHYDRATE"
"1600","CEFTAZIDIME","1 Grams                                                                                                Pdr for Soln Inj/Inf",2014-09-12,"PA1217/012/002","Hikma Farmaceutica (Portugal) SA","CEFTAZIDIMEPENTAHYDRATE"
"1601","CEFTAZIDIME","2 Grams                                                                                                Pdr for Soln Inj/Inf",2014-09-12,"PA1217/012/003","Hikma Farmaceutica (Portugal) SA","CEFTAZIDIMEPENTAHYDRATE"
"1602","CEFTRIAXONE","1 Grams                                                                                                Pdr for Soln for Injection",2003-09-19,"PA1339/004/001","Wockhardt UK Limited","CEFTRIAXONESODIUM"
"1603","CEFTRIAXONE","2 Grams                                                                                                Pdr for Soln Inj/Inf",2003-03-19,"PA1339/004/002","Wockhardt UK Limited","CEFTRIAXONESODIUM"
"1604","CEFUROXIME","750 Milligram                                                                                            Powder for suspension for injection",2000-06-23,"PA1226/009/001","Flynn Pharma Ltd","CEFUROXIMESODIUM"
"1605","CEFUROXIME","1.5 Grams                                                                                                Pdr for Soln for Injection",2000-06-23,"PA1226/009/002","Flynn Pharma Ltd","CEFUROXIMESODIUM"
"1606","CEFUROXIME","250 Milligram                                                                                            Pdr for Soln for Injection",2015-08-13,"PA1947/002/001","Stravencon Ltd","CEFUROXIMESODIUM"
"1607","CEFUROXIME","750 Milligram                                                                                            Pdr for Soln for Injection",2015-08-13,"PA1947/002/002","Stravencon Ltd","CEFUROXIMESODIUM"
"1608","CEFUROXIME","1500 Milligram                                                                                            Pdr for Soln for Injection",2015-08-13,"PA1947/002/003","Stravencon Ltd","CEFUROXIMESODIUM"
"1609","CEFUROXIME","750 Milligram                                                                                            Pdr for Soln Inj/Inf",2009-08-21,"PA2059/006/001","Fresenius Kabi Deutschland GmbH","CEFUROXIMESODIUM"
"1610","CEFUROXIME","1.5 Grams                                                                                                Pdr for Soln Inj/Inf",2009-08-21,"PA2059/006/002","Fresenius Kabi Deutschland GmbH","CEFUROXIMESODIUM"
"1611","Cefuroxime Milpharm 250mg Film-coated tablets","250 milligram(s) Film-coated tablet",2015-10-23,"PA1445/022/001","Aurobindo Pharma (Malta) Limited","Cefuroximeaxetil(amorphous)"
"1612","Cefuroxime Milpharm 500mg Film-coated tablets","500 milligram(s) Film-coated tablet",2015-10-23,"PA1445/022/002","Aurobindo Pharma (Malta) Limited","Cefuroximeaxetil(amorphous)"
"1613","CELEBREX","100 Milligram                                                                                            Capsules Hard",2004-03-19,"PPA0465/118/001","PCO Manufacturing","CELECOXIB"
"1614","CELEBREX","200 Milligram                                                                                            Capsules Hard",2004-03-19,"PPA0465/118/002","PCO Manufacturing","CELECOXIB"
"1615","CELEBREX","200 Milligram                                                                                            Capsule",2008-08-01,"PPA1151/070/001","Imbat Limited","CELECOXIB"
"1616","Celebrex 100 mg capsules, hard","100 milligram(s) Capsule, hard",2000-05-12,"PA0822/116/001","Pfizer Healthcare Ireland","Celecoxib"
"1617","Celebrex 200 mg capsules, hard","200 milligram(s) Capsule, hard",2000-05-12,"PA0822/116/002","Pfizer Healthcare Ireland","Celecoxib"
"1618","Celecoxib 100 mg hard capsules","100 milligram(s) Capsule, hard",2017-06-30,"PA0343/002/001","Key Pharmaceuticals Ltd","Celecoxib"
"1619","Celecoxib 200 mg hard capsules","200 milligram(s) Capsule, hard",2017-06-30,"PA0343/002/002","Key Pharmaceuticals Ltd","Celecoxib"
"1620","Celecoxib Actavis 100mg hard capsules","100 milligram(s) Capsule, hard",2014-02-14,"PA1380/139/001","Actavis Group PTC ehf","Celecoxib"
"1621","Celecoxib Actavis 200mg hard capsules","200 milligram(s) Capsule, hard",2014-02-14,"PA1380/139/002","Actavis Group PTC ehf","Celecoxib"
"1622","Celecoxib Krka 100mg capsules, hard","100 milligram(s) Capsule, hard",2013-11-29,"PA1347/033/001","Krka d.d., Novo mesto","Celecoxib"
"1623","Celecoxib Krka 200mg capsules, hard","200 milligram(s) Capsule, hard",2013-11-29,"PA1347/033/002","Krka d.d., Novo mesto","Celecoxib"
"1624","CELECOXIB PFIZER","100 Milligram                                                                                            Capsules Hard",2012-03-16,"PA0822/083/001","Pfizer Healthcare Ireland","CELECOXIB"
"1625","CELECOXIB PFIZER","200 Milligram                                                                                            Capsules Hard",2012-03-16,"PA0822/083/002","Pfizer Healthcare Ireland","CELECOXIB"
"1626","Celecoxib Rowex 100 mg capsules, hard","100 milligram(s) Capsule, hard",2014-10-03,"PA0711/241/001","Rowex Ltd","Celecoxib"
"1627","Celecoxib Rowex 200 mg capsules, hard","200 milligram(s) Capsule, hard",2014-10-03,"PA0711/241/002","Rowex Ltd","Celecoxib"
"1628","CELEVAC 500MG TABLETS","500 Milligram                                                                                            Tablets",1988-01-07,"PA1142/010/001","Amdipharm Limited","METHYLCELLULOSE"
"1629","CELLCEPT","250 mg Milligram                                                                                            Capsule",1996-02-14,"EU/1/96/005/001","Roche Registration GmbH","MYCOPHENOLATEMOFETIL"
"1630","CELLCEPT","500 Milligram                                                                                            Tablets",1996-02-14,"EU/1/96/005/002","Roche Registration GmbH","MYCOPHENOLATEMOFETIL"
"1631","CELLCEPT","250 Milligram                                                                                            Capsule",1997-05-13,"EU/1/96/005/003","Roche Registration Limited","MYCOPHENOLATEMOFETIL"
"1632","CELLCEPT","500 Milligram                                                                                            Tablets",1997-05-13,"EU/1/96/005/004","Roche Registration Limited","MYCOPHENOLATEMOFETIL"
"1633","CELLCEPT","1g/5ml                                                                                                      Powder for Oral Suspension",1999-02-26,"EU/1/96/005/006","Roche Registration GmbH","MYCOPHENOLATEMOFETIL"
"1634","CELLCEPT IV","500 mg Mg/Ml Pdr for Soln for Infusion",1998-10-20,"EU/1/96/005/005","Roche Registration Limited","MYCOPHENOLATEMOFETIL"
"1635","CELLUVISC","0.5 %w/v                                                                                                 Eye Drops Solution",2006-11-10,"PA0148/059/002","Allergan Pharmaceuticals Ireland","CARMELLOSESODIUM"
"1636","CELLUVISC","1 %w/v                                                                                                 Ear Drops Solution",2011-09-15,"DPR1633/014/001","Primecrown 2010 Ltd","CARMELLOSESODIUM"
"1637","CELLUVISC","1 %w/v                                                                                                 Eye Drops Solution",2011-04-15,"PPA0465/259/001","PCO Manufacturing","CARMELLOSESODIUM"
"1638","CELLUVISC","1 %w/v                                                                                                 Eye Drops Solution",2009-08-28,"PPA1151/102/001","Imbat Limited","CARMELLOSESODIUM"
"1639","Celluvisc 1% w/v Eye drops, solution, unit dose","1 percent weight/volume Eye drops, solution",2011-06-17,"PPA1097/039/001","Lexon (UK) Ltd","Carmellosesodium"
"1640","Celluvisc 1% w/v Eye drops, solution, unit dose","1 percent weight/volume Eye drops, solution",1997-04-23,"PA0148/059/001","Allergan Pharmaceuticals Ireland","Carmellosesodium"
"1641","Celsentri","20 milligram(s)/millilitre Oral solution",2017-07-06,"EU/01/07/418/013","ViiV Healthcare BV","Maraviroc"
"1642","Celsentri","25 milligram(s) Film-coated tablet",2017-07-06,"EU/1/07/418/011","ViiV Healthcare BV","Maraviroc"
"1643","Celsentri","75 milligram(s) Film-coated tablet",2017-07-06,"EU/1/07/418/012","ViiV Healthcare BV","Maraviroc"
"1644","Celsentri","150 milligram(s) Film-coated tablet",2007-09-18,"EU/1/07/418/1-5","ViiV Healthcare BV","Maraviroc"
"1645","Celsentri","300 milligram(s) Film-coated tablet",NA,"EU/1/07/418/6-10","ViiV Healthcare BV","Maraviroc"
"1646","Celsior solution for organ preservation","1L bag *** AWAITING VALUE *** Solution for organ preservation",2011-04-01,"PA1996/001/001","Institut Georges Lopez - IGL","Glutathione|Mannitol|Lactobionicacid|Glutamicacid|Sodiumhydroxide|Calciumchloride2h2o|Potassiumchloride|Magnesiumchloride6h2o|Histidine"
"1647","CENTRAX","10 Milligram                                                                                            Tablets",1975-07-07,"PA0822/010/001","Pfizer Healthcare Ireland","PRAZEPAM"
"1648","Centyl K 2.5 mg/573 mg modified-release tablets","2.5/573 milligram(s) Modified-release tablet",NA,"PA0046/019/001","Leo Laboratories Limited","Bendroflumethiazide|Potassiumchloride"
"1649","CEPLENE 0.5 MG/0.5 ML SOLUTION FOR INJECTION","0.5/0.5 Mg/Ml Solution for Injection",2008-10-07,"EU/1/08/477/1","Noventia Pharma Srl","HISTAMINEDIHYDROCHLORIDE"
"1650","CEPROTIN","500 International Unit                                                                                   Pdr+Solv for Soln for Inj",2001-07-16,"EU/1/01/190/001","Baxter AG","PROTEINC"
"1651","CEPROTIN","1000 International Unit                                                                                   Pdr+Solv for Soln for Inj",2001-07-16,"EU/1/01/190/002","Baxter AG","PROTEINC"
"1652","CERAZETTE","75 Microgram                                                                                            Film Coated Tablet",1998-08-14,"PA1286/048/001","Merck Sharp & Dohme Ireland (Human Health) Limited","DESOGESTREL"
"1653","CERAZETTE","75 Microgram                                                                                            Film Coated Tablet",2014-06-13,"PPA1151/222/001","Imbat Limited","DESOGESTREL"
"1654","CERAZETTE","75 Microgram                                                                                            Film Coated Tablet",2013-02-08,"PPA1463/071/001","IMED Healthcare Ltd.","DESOGESTREL"
"1655","Cerdelga","84 milligram(s) Capsule, hard",2015-01-19,"EU/1/14/974/001-002","Genzyme Europe B.V.","Eliglustat(astartrate)"
"1656","CERETEC FREEZE DRIED","500 Microgram                                                                                            Kit for radiopharmaceutical preparation",1988-04-19,"PA0240/004/001","GE Healthcare Limited","EXAMETAZIME"
"1657","Cerezyme","percent volume/volume Powder for solution for infusion",1997-11-17,"EU/1/97/053/001","Genzyme Europe B.V.","Imiglucerase"
"1658","Cerezyme","200 percent volume/volume Powder for solution for infusion",1997-11-17,"EU/1/97/053/002","Genzyme Europe B.V.","Imiglucerase"
"1659","Cerezyme","percent volume/volume Powder for solution for infusion",2000-01-28,"EU/1/97/053/003","Genzyme Europe B.V.","Imiglucerase"
"1660","Cerezyme","percent volume/volume Powder for solution for infusion",2000-01-28,"EU/1/97/053/004","Genzyme Europe B.V.","Imiglucerase"
"1661","Cerezyme","percent volume/volume Powder for solution for infusion",2000-01-28,"EU/1/97/053/005","Genzyme Europe B.V.","Imiglucerase"
"1662","Cernevit, Powder for Solution for Injection or Infusion","Powder for solution for injection/infusion",1993-01-04,"PA0167/097/001","Baxter Healthcare Limited","Retinolpalmitate|Colecalciferol|Dl-alfatocoferol|Ascorbicacid|Pyridoxinehydrochloride|Cyanocobalamin|Folicacid|Dexpanthenol|Biotin|Nicotinamide|Cocarboxylasetetrahydrate|Cocarboxylasetetrahydrate|Riboflavinsodiumphosphate"
"1663","Certican 0.1mg Dispersible Tablets","0.1 milligram(s) Dispersible tablet",2014-12-12,"PA0896/005/005","Novartis Ireland Limited","Everolimus(stabilisedwithbht)"
"1664","Certican 0.25mg Dispersible Tablets","0.25 milligram(s) Dispersible tablet",2014-12-12,"PA0896/005/006","Novartis Ireland Limited","Everolimus(stabilisedwithbht)"
"1665","Certican 0.25mg Tablets","0.25 milligram(s) Tablet",2014-12-12,"PA0896/005/001","Novartis Ireland Limited","Everolimus(stabilisedwithbht)"
"1666","Certican 0.5mg Tablets","0.5 milligram(s) Tablet",2014-12-12,"PA0896/005/002","Novartis Ireland Limited","Everolimus(stabilisedwithbht)"
"1667","Certican 0.75mg Tablets","0.75 milligram(s) Tablet",2014-12-12,"PA0896/005/003","Novartis Ireland Limited","Everolimus(stabilisedwithbht)"
"1668","Certican 1 mg Tablets","1 milligram(s) Tablet",2014-12-12,"PA0896/005/004","Novartis Ireland Limited","Everolimus(stabilisedwithbht)"
"1669","Cerubidin 20 mg Powder for Concentrate for Solution for Infusion","20 milligram(s) ZZZ Pdr/Conc/Soln for Infus",1995-04-20,"PA0540/096/001","Sanofi-Aventis Ireland Limited T/A SANOFI","Daunorubicin"
"1670","CERUMOL","%w/v                                                                                                 Ear Drops Solution",1991-08-26,"PA0610/018/001","Thornton & Ross Limited","CHLOROBUTANOL|ARACHISOIL"
"1671","CERVARIX","20 Microgram                                                                                            Suspension for Injection",2007-09-20,"EU/1/07/419/1-12","GlaxoSmithKline Biologicals S.A.","HPV16L1PROTEIN|HPV18L1PROTEIN"
"1672","CETIRELIEF ALLERGY 10 MG FILM-COATED TABLETS","10 Milligram                                                                                            Film Coated Tablet",2006-06-30,"PA1113/014/001","Phoenix Labs","CETIRIZINEHYDROCHLORIDE"
"1673","Cetirizine dihydrochloride 10mg Film-coated Tablets","10 milligram(s) Film-coated tablet",2006-05-26,"PA1186/015/001","Chefaro Ireland DAC","Cetirizinedihydrochloride"
"1674","Cetrine 10 mg Film-coated Tablets","10 milligram(s) Film-coated tablet",2004-08-06,"PA0711/075/001","Rowex Ltd","Cetirizinehydrochloride"
"1675","Cetrine Allergy 10mg Film-coated Tablets","10 milligram(s) Film-coated tablet",2004-08-06,"PA0711/075/002","Rowex Ltd","Cetirizinehydrochloride"
"1676","CETRIZ","10 Milligram                                                                                            Film Coated Tablet",2006-07-07,"PA1380/054/001","Actavis Group PTC ehf","CETIRIZINEHYDROCHLORIDE"
"1677","CETROTIDE","0.25 Milligram                                                                                            Pdr+Solv for Soln for Inj",1999-04-13,"EU/1/99/100/001","Merck Europe B.V.","CETRORELIXACETATE"
"1678","CETROTIDE","0.25 Milligram                                                                                            Pdr+Solv for Soln for Inj",1999-04-13,"EU/1/99/100/002","Merck Europe B.V.","CETRORELIXACETATE"
"1679","CETROTIDE","3 Milligram                                                                                            Pdr+Solv for Soln for Inj",1999-04-13,"EU/1/99/100/003","Merck Europe B.V.","CETRORELIXACETATE"
"1680","CHAMOMILLA - TABLETS","6C & 30C Milligram                                                                                            Tablets",2010-06-11,"HOR0407/018/001","Weleda (UK) Limited","MATRICARIARECUTITA"
"1681","CHAMPIX","0.5 Milligram                                                                                            Tablets",2006-09-26,"EU/1/06/360/01","Pfizer Europe MA EEIG","VARENICLINETARTRATE"
"1682","CHAMPIX","1.0 Milligram                                                                                            Tablets",2006-09-26,"EU/1/06/360/02","Pfizer Europe MA EEIG","VARENICLINETARTRATE"
"1683","Chenodeoxycholic acid","250 milligram(s) Capsule, hard",2017-04-10,"EU/1/16/1110/001","Leadiant Gmbh","Chenodeoxycholicacid"
"1684","Chirocaine 0.625 mg/ml solution for infusion","0.625 milligram(s)/millilitre Solution for infusion",NA,"PA1824/003/004","AbbVie Limited","Levobupivacainehydrochloride"
"1685","Chirocaine 1.25 mg/ml solution for infusion","1.25 milligram(s)/millilitre Solution for infusion",NA,"PA1824/003/005","AbbVie Limited","Levobupivacainehydrochloride"
"1686","Chirocaine 2.5 mg/ml solution for injection/concentrate for solution for infusion","2.5 milligram(s)/millilitre ZZZ Solution injection or concentrate for solution infusion",NA,"PA1824/003/001","AbbVie Limited","Levobupivacainehydrochloride"
"1687","Chirocaine 5 mg/ml solution for injection/concentrate for solution for infusion","5.0 micromole(s) ZZZ Solution injection or concentrate for solution infusion",NA,"PA1824/003/002","AbbVie Limited","Levobupivacainehydrochloride"
"1688","Chirocaine 7.5 mg/ml solution for injection/concentrate for solution for infusion","7.5 micromole(s) ZZZ Solution injection or concentrate for solution infusion",NA,"PA1824/003/003","AbbVie Limited","Levobupivacainehydrochloride"
"1689","CHLORAMPHENICOL EYE DROPS BP","0.5 %w/v                                                                                                 Eye Drops Solution",2001-01-26,"PA0361/013/001","Martindale Pharmaceuticals Ltd","CHLORAMPHENICOL"
"1690","CHLORAMPHENICOL EYE OINTMENT BP","1 %w/v                                                                                                 Ointment",2001-01-26,"PA0361/013/002","Martindale Pharmaceuticals Ltd","CHLORAMPHENICOL"
"1691","ChloraPrep 2% w/v/ 70% v/v Cutaneous Solution","2.0/70 percent Cutaneous solution",2012-12-14,"PA1435/001/002","Carefusion U.K. 244 Limited","Chlorhexidinegluconate|ISOPROPYLALCOHOL"
"1692","ChloraPrep with Tint 2% w/v / 70% v/v cutaneous solution","2/70 percent Cutaneous solution",2010-07-02,"PA1435/001/001","Carefusion U.K. 244 Limited","Chlorhexidinegluconate|ISOPROPYLALCOHOL"
"1693","Chlorhexidine acetate 0.015% w/v and Cetrimide 0.15% w/v Irrigation solution",".015/.15 percent weight/volume ZZZ Infus/Pdr/Oral Soln",1983-04-01,"PA0167/032/025","Baxter Healthcare Limited","Chlorhexidineacetate|Cetrimide"
"1694","Chlorhexidine Acetate BP 0.05% w/v Irrigation solution","0.05 percent weight/volume ZZZ Solution for Irrigation",1983-04-01,"PA0167/010/012","Baxter Healthcare Limited","Chlorhexidineacetate"
"1695","CHLORHEXIDINE GLUCONATE ANTISEPTIC MOUTHWASH ORIGINAL FLAVOUR","0.2 %w/v                                                                                                 Oromucosal Solution",2000-02-18,"PA1110/011/001","Ecolab Limited","CHLORHEXIDINEGLUCONATE"
"1696","CHLORHEXIDINE GLUCONATE ANTISEPTIC MOUTHWASH PEPPERMINT FLAVOUR","0.2 %w/v                                                                                                 Oromucosal Solution",2000-02-18,"PA1110/011/002","Ecolab Limited","CHLORHEXIDINEGLUCONATE"
"1697","CHLORHEXIDINE ORIGINAL 0.2% MOUTHWASH","0.2 %w/v                                                                                                 Oromucosal Solution",2016-08-04,"DPR1392/075/001","Eurodrug Ltd","CHLORHEXIDINEGLUCONATE"
"1698","CHLORHEXIDINE PEPPERMINT 0.2% MOUTHWASH","0.2 %w/v                                                                                                 Oromucosal Solution",2016-08-04,"DPR1392/075/002","Eurodrug Ltd","CHLORHEXIDINEGLUCONATE"
"1699","CHLOROMYCETIN 0.5% W/V REDIDROPS EYE DROPS, SOLUTION","0.5 %w/v                                                                                                 Eye Drops Solution",1974-12-20,"PA0899/028/002","Mercury Pharmaceuticals Ltd","CHLORAMPHENICOL"
"1700","Chlorphenamine 10 mg/ml Solution for Injection","10 milligram(s)/millilitre Solution for injection",1995-06-10,"PA2288/001/002","Kyowa Kirin Holdings B.V.","Chlorphenaminemaleate"
"1701","Chlorpromazine Elixir BP 25 mg/5 ml Oral Solution","25 mg/5ml Oral solution",1983-06-23,"PA0281/124/001","Pinewood Laboratories Ltd,","CHLORPROMAZINEHYDROCHLORIDE"
"1702","CHOLEDIAM KIT FOR RADIOPHARMACEUTICAL PREPARATION","N/A Pdr for Soln for Injection",2001-07-13,"PA1229/001/001","MEDiAM","MEBROFENIN"
"1703","CHOLESTAGEL 625 mg  FILM-COATED tablets","625 mg milligram(s) Tablet",2004-03-31,"EU/1/03/268/1-3","Genzyme Europe B.V.",""
"1704","Cholib","145/20 milligram(s) Film-coated tablet",2013-08-26,"EU/1/13/866/001-002","Mylan IRE Healthcare Limited","Micronizedfenofibrate|Simvastatinwith0.2%butylatedhydroxyanisole(bha),(E320)"
"1705","Cholib","145/40 milligram(s) Film-coated tablet",2013-08-26,"EU/1/13/866/003-004","Mylan IRE Healthcare Limited","Micronizedfenofibrate|Simvastatinwith0.2%butylatedhydroxyanisole(bha),(E320)"
"1706","CHOLURSO","250 Milligram                                                                                            Film Coated Tablet",2017-10-13,"PA1913/002/001","Laboratoires Mayoly Spindler","URSODEOXYCHOLICACID"
"1707","CHOLURSO","500 Milligram                                                                                            Film Coated Tablet",2017-10-13,"PA1913/002/002","Laboratoires Mayoly Spindler","URSODEOXYCHOLICACID"
"1708","CHONDROMEL","400 Milligram                                                                                            Capsule",2005-12-22,"PA1104/003/001","IBSA Farmaceutici Italia S.r.l","CHONDROITINSULFATE"
"1709","CIALIS","2.5 Milligram                                                                                            Film Coated Tablet",2007-06-20,"EU/1/02/237/006","Eli Lilly Nederland B.V.","TADALAFIL"
"1710","CIALIS","10, 20mg Milligram                                                                                            Film Coated Tablet",2002-11-12,"EU/1/02/237/1-5","Eli Lilly Nederland B.V.","TADALAFIL"
"1711","CIALIS","5 Milligram                                                                                            Film Coated Tablet",2007-06-20,"EU/1/02/237/7-8","Eli Lilly Nederland B.V.","TADALAFIL"
"1712","CIAMBRA","100 Milligram                                                                                            Pdr+Solv for conc/solv for inf",2015-12-02,"EU/1/15/1055/001","Menarini International Operations Luxembourg S.A.","PEMETREXEDDISODIUM"
"1713","CIAMBRA","500 Milligram                                                                                            Pdr+Solv for conc/solv for inf",2015-12-02,"EU/1/15/1055/002","Menarini International Operations Luxembourg S.A.","PEMETREXEDDISODIUM"
"1714","CIBACEN 10 MG FILM COATED TABLET","10 Milligram                                                                                            Film Coated Tablet",1999-06-16,"PA2010/029/002","Mylan IRE Healthcare Limited","BENAZEPRILHYDROCHLORIDE"
"1715","Cibacen 5 mg Film Coated Tablet","5 milligram(s) Film-coated tablet",1999-06-16,"PA2010/029/001","Mylan IRE Healthcare Limited","Benazeprilhydrochloride"
"1716","Cicatrin","percent volume/volume Cream",NA,"PA0017/019/002","GlaxoSmithKline (Ireland) Limited","Neomycinsulfate|BACITRACINZINC|Cysteine|Threonine|Glycine"
"1717","CIDOMYCIN PAEDIATRIC","20 mg/2ml Solution for Injection",1977-03-09,"PA0540/036/004","Sanofi-Aventis Ireland Limited T/A SANOFI","GENTAMICINSULFATE"
"1718","CIFLOXAGER","500 Milligram                                                                                            Film Coated Tablet",2005-02-04,"PA0577/069/002","McDermott Laboratories Ltd t/a Gerard Laboratories","CIPROFLOXACINHYDROCHLORIDE"
"1719","Cifloxager 250 mg Film-coated Tablets","250 milligram(s) Film-coated tablet",2005-02-04,"PA0577/069/001","McDermott Laboratories Ltd t/a Gerard Laboratories","CIPROFLOXACINHYDROCHLORIDE"
"1720","CIFOX","500 Milligram                                                                                            Film Coated Tablet",2006-09-22,"PA0711/122/002","Rowex Ltd","CIPROFLOXACINHYDROCHLORIDE"
"1721","CIFOX","750 Milligram                                                                                            Film Coated Tablet",2006-09-22,"PA0711/122/003","Rowex Ltd","CIPROFLOXACINHYDROCHLORIDE"
"1722","Cifox 250 mg Film-coated Tablets","250 milligram(s) Film-coated tablet",2006-09-22,"PA0711/122/001","Rowex Ltd","CIPROFLOXACINHYDROCHLORIDE"
"1723","CILEST","250/35 Microgram                                                                                            Tablets",1990-08-23,"PA0748/029/001","Janssen-Cilag Ltd","NORGESTIMATE|ETHINYLESTRADIOL"
"1724","Cilique 250/35 micrograms tablets","250 / 35 microgram(s) Tablet",2015-12-11,"PA1876/003/001","Consilient Health Limited","Norgestimate|Ethinylestradiol"
"1725","Cilostazol 100mg Tablets","100 milligram(s) Tablet",NA,"PA1338/014/001","Focus Pharmaceuticals Ltd","Cilostazol"
"1726","Ciloxan 3 mg/ml ear drops, solution","3 milligram(s)/millilitre Ear drops, solution",2006-02-03,"PA0896/006/001","Novartis Ireland Limited","CIPROFLOXACINHYDROCHLORIDE"
"1727","Cimeldine 400 mg Film-coated tablets","400 milligram(s) Tablet",1989-11-06,"PA0126/077/002","Clonmel Healthcare Ltd","Cimetidine"
"1728","Cimzia","200 milligram(s) Solution for injection",2009-10-01,"EU/1/09/544/1-2","UCB Pharma S.A.","Certolizumabpegol"
"1729","CINACALCET ACCORD","30 Milligram                                                                                            Film Coated Tablet",2016-12-02,"PA1390/129/001","Accord Healthcare Limited","CINACALCET"
"1730","CINACALCET ACCORD","60 Milligram                                                                                            Film Coated Tablet",2016-12-02,"PA1390/129/002","Accord Healthcare Limited","CINACALCET"
"1731","CINACALCET ACCORD","90 Milligram                                                                                            Film Coated Tablet",2016-12-02,"PA1390/129/003","Accord Healthcare Limited","CINACALCET"
"1732","CINACALCET APOTEX","30 Milligram                                                                                            Film Coated Tablet",2017-06-02,"PA1513/009/001","Apotex Europe B.V.","CINACALCETHYDROCHLORIDE"
"1733","CINACALCET APOTEX","60 Milligram                                                                                            Film Coated Tablet",2017-06-02,"PA1513/009/002","Apotex Europe B.V.","CINACALCETHYDROCHLORIDE"
"1734","CINACALCET APOTEX","90 Milligram                                                                                            Film Coated Tablet",2017-06-02,"PA1513/009/003","Apotex Europe B.V.","CINACALCETHYDROCHLORIDE"
"1735","CINACALCET MYLAN","30 Milligram                                                                                            Film Coated Tablet",2015-11-19,"EU/1/15/1054/001-004","Mylan S.A.S.","CINACALCETHYDROCHLORIDE"
"1736","CINACALCET MYLAN","60 Milligram                                                                                            Film Coated Tablet",2015-11-19,"EU/1/15/1054/005-007","Mylan S.A.S.","CINACALCETHYDROCHLORIDE"
"1737","CINACALCET MYLAN","90 Milligram                                                                                            Film Coated Tablet",2015-11-19,"EU/1/15/1054/008-010","Mylan S.A.S.","CINACALCETHYDROCHLORIDE"
"1738","CINACALCET ROWEX","30 Milligram                                                                                            Film Coated Tablet",2018-01-26,"PA0711/285/001","Rowex Ltd","CINACALCETHYDROCHLORIDE"
"1739","CINACALCET ROWEX","60 Milligram                                                                                            Film Coated Tablet",2018-01-26,"PA0711/285/002","Rowex Ltd","CINACALCETHYDROCHLORIDE"
"1740","CINACALCET ROWEX","90 Milligram                                                                                            Film Coated Tablet",2018-01-26,"PA0711/285/003","Rowex Ltd","CINACALCETHYDROCHLORIDE"
"1741","CINACALCET TEVA","30 Milligram                                                                                            Film Coated Tablet",2016-02-05,"PA1986/007/001","Teva B.V.","CINACALCETHYDROCHLORIDE"
"1742","CINACALCET TEVA","60 Milligram                                                                                            Film Coated Tablet",2016-02-05,"PA1986/007/002","Teva B.V.","CINACALCETHYDROCHLORIDE"
"1743","CINACALCET TEVA","90 Milligram                                                                                            Film Coated Tablet",2016-02-05,"PA1986/007/003","Teva B.V.","CINACALCETHYDROCHLORIDE"
"1744","Cinqaero","10 milligram(s)/millilitre Concentrate for solution for infusion",NA,"EU/1/16/1125/001","Teva B.V.","Reslizumab"
"1745","CINRYZE","500 N/A Pdr+Solv for Soln for Inj",2011-06-15,"EU/1/11/688/001","ViroPharma SPRL","C1INHIBITOR"
"1746","Ciplox 250 mg Film-coated Tablets","250 milligram(s) Film-coated tablet",2004-07-02,"PA1390/135/001","Accord Healthcare Limited","CIPROFLOXACINHYDROCHLORIDE"
"1747","Ciplox 500 mg Film-coated Tablets","500 milligram(s) Film-coated tablet",2004-07-02,"PA1390/135/002","Accord Healthcare Limited","CIPROFLOXACINHYDROCHLORIDE"
"1748","Ciplox 750 mg Film-coated Tablets","750 milligram(s) Film-coated tablet",2004-07-02,"PA1390/135/003","Accord Healthcare Limited","CIPROFLOXACINHYDROCHLORIDE"
"1749","Ciprager 10 mg Film-coated tablets","10 milligram(s) Film-coated tablet",2003-06-03,"PA0577/047/001","McDermott Laboratories Ltd t/a Gerard Laboratories","Citalopramhydrobromide"
"1750","Ciprager 20 mg Film-coated tablets","20 milligram(s) Film-coated tablet",2003-06-03,"PA0577/047/002","McDermott Laboratories Ltd t/a Gerard Laboratories","Citalopramhydrobromide"
"1751","Ciprager 40 mg Film-coated tablets","40 milligram(s) Film-coated tablet",2004-07-30,"PA0577/047/003","McDermott Laboratories Ltd t/a Gerard Laboratories","Citalopramhydrobromide"
"1752","CIPRAMIL","10 Milligram                                                                                            Film Coated Tablet",1995-09-22,"PA0776/001/001","Lundbeck ( Ireland ) Limited","CITALOPRAMHYDROBROMIDE"
"1753","CIPRAMIL","20 Milligram                                                                                            Film Coated Tablet",1995-09-22,"PA0776/001/002","Lundbeck ( Ireland ) Limited","CITALOPRAMHYDROBROMIDE"
"1754","CIPRAMIL","40 Mg/Ml Oral Drops Solution",1999-04-16,"PA0776/001/004","Lundbeck ( Ireland ) Limited","CITALOPRAMHYDROCHLORIDE"
"1755","CIPRAMIL","20 Milligram                                                                                            Film Coated Tablet",2008-01-25,"PPA1151/049/001","Imbat Limited","CITALOPRAMHYDROBROMIDE"
"1756","CIPRAMIL","10 Milligram                                                                                            Film Coated Tablet",2009-04-24,"PPA1151/049/002","Imbat Limited","CITALOPRAMHYDROBROMIDE"
"1757","Cipramil 20 mg film-coated tablets","20 milligram(s) Film-coated tablet",2001-08-24,"PPA0465/068/002","PCO Manufacturing","Citalopram"
"1758","CIPROFLOXACIN","2 Mg/Ml Solution for Infusion",2007-06-01,"PA0437/057/002","Hospira  UK Limited","CIPROFLOXACINLACTATE"
"1759","Ciprofloxacin 2 mg/ml solution for infusion","2 milligram(s)/millilitre Solution for infusion",2007-06-01,"PA0437/057/001","Hospira  UK Limited","Ciprofloxacinlactate"
"1760","Ciprofloxacin 2 mg/ml Solution for Infusion","2 milligram(s)/millilitre Solution for infusion",2008-06-13,"PA1122/005/001","Noridem Enterprises Ltd","Ciprofloxacin"
"1761","Ciprofloxacin 2mg/ml, Solution for Infusion","2 milligram(s)/millilitre Solution for infusion",2008-06-20,"PA1389/002/001","Claris Lifesciences (UK) Limited","Ciprofloxacinlactate"
"1762","CIPROFLOXACIN KRKA","500 Milligram                                                                                            Film Coated Tablet",2005-10-07,"PA1347/035/002","Krka d.d., Novo mesto","CIPROFLOXACINHYDROCHLORIDE"
"1763","CIPROFLOXACIN KRKA","750 Milligram                                                                                            Film Coated Tablet",2005-10-07,"PA1347/035/003","Krka d.d., Novo mesto","CIPROFLOXACINHYDROCHLORIDE"
"1764","Ciprofloxacin Krka 250 mg film-coated tablets","250 milligram(s) Film-coated tablet",2005-10-07,"PA1347/035/001","Krka d.d., Novo mesto","CIPROFLOXACINHYDROCHLORIDE"
"1765","Ciprofloxacin Mylan 2mg/1ml solution for infusion","2 milligram(s)/millilitre Solution for injection",2010-07-02,"PA0405/058/001","Generics (UK) Limited","Ciprofloxacin"
"1766","CIPROFLOXACIN OLINKA","100mg milligram(s) Tablet",NA,"PA0476/017/001","Olinka (UK) Limited","CIPROFLOXACINHYDROCHLORIDE"
"1767","CIPROFLOXACIN OLINKA","250mg milligram(s) Tablet",NA,"PA0476/017/002","Olinka (UK) Limited","CIPROFLOXACINHYDROCHLORIDE"
"1768","CIPROFLOXACIN OLINKA","500mg milligram(s) Tablet",NA,"PA0476/017/003","Olinka (UK) Limited","CIPROFLOXACINHYDROCHLORIDE"
"1769","CIPROFLOXACIN OLINKA","750mg milligram(s) Tablet",NA,"PA0476/017/004","Olinka (UK) Limited","CIPROFLOXACINHYDROCHLORIDE"
"1770","Ciprofloxacin Teva 250 mg Film-coated Tablets","250 milligram(s) Film-coated tablet",2007-04-20,"PA0749/031/002","Teva Pharma B.V.","Ciprofloxacin"
"1771","Ciprofloxacin Teva 500 mg Film-coated Tablets","500 milligram(s) Film-coated tablet",2007-04-20,"PA0749/031/003","Teva Pharma B.V.","Ciprofloxacin"
"1772","Ciprotan 10mg film-coated tablets","10 milligram(s) Film-coated tablet",2004-11-17,"PA0126/131/001","Clonmel Healthcare Ltd","Citalopramhydrobromide’"
"1773","Ciprotan 20mg film-coated tablets","20 milligram(s) Film-coated tablet",2004-11-17,"PA0126/131/002","Clonmel Healthcare Ltd","Citalopramhydrobromide’"
"1774","Ciproxin 250mg Film-coated Tablets","250 milligram(s) Film-coated tablet",NA,"PA1410/028/002","Bayer Limited","CIPROFLOXACINHYDROCHLORIDE"
"1775","Ciproxin 500mg Film-coated Tablets","500 milligram(s) Film-coated tablet",NA,"PA1410/028/003","Bayer Limited","CIPROFLOXACINHYDROCHLORIDE"
"1776","Ciproxin 750mg Film-coated Tablets","750 milligram(s) Film-coated tablet",NA,"PA1410/028/004","Bayer Limited","CIPROFLOXACINHYDROCHLORIDE"
"1777","Ciproxin Solution for Infusion 2mg/ml, 100ml","2 milligram(s)/millilitre Solution for infusion",NA,"PA1410/028/006","Bayer Limited","Ciprofloxacinlactate"
"1778","Ciproxin Solution for Infusion 2mg/ml, 200ml","2 milligram(s)/millilitre Solution for infusion",NA,"PA1410/028/007","Bayer Limited","Ciprofloxacinlactate"
"1779","CIRCADIN","2 Milligram                                                                                            Tablet Prolonged Release",2007-06-29,"EU/1/07/392/001","Neurim Pharmaceuticals EEC Ltd","MELATONIN"
"1780","CISATRACURIUM","2 Mg/Ml Solution for Inj/Inf",2013-07-12,"PA1122/017/001","Noridem Enterprises Ltd","CISATRACURIUM"
"1781","CISPLATIN","1 Mg/Ml Concentrate for Soln for Inf",2011-10-07,"PA1390/025/001","Accord Healthcare Limited","CISPLATIN"
"1782","Cisplatin 1 mg/ml concentrate for solution for infusion","1 milligram(s)/millilitre Concentrate for solution for infusion",2014-05-02,"PA1422/015/001","Fresenius Kabi Oncology Plc","Cisplatin"
"1783","Cisplatin 1 mg/ml Concentrate for Solution for Infusion","1 milligram(s)/millilitre Concentrate for solution for infusion",NA,"PA0822/199/001","Pfizer Healthcare Ireland","Cisplatin"
"1784","CITALOPRAM","10 Milligram                                                                                            Film Coated Tablet",2006-07-07,"PA0688/008/001","Chanelle Medical","CITALOPRAMHYDROBROMIDE"
"1785","CITALOPRAM","20 Milligram                                                                                            Film Coated Tablet",2006-07-07,"PA0688/008/002","Chanelle Medical","CITALOPRAMHYDROBROMIDE"
"1786","CITALOPRAM","40 Milligram                                                                                            Film Coated Tablet",2006-07-07,"PA0688/008/003","Chanelle Medical","CITALOPRAMHYDROBROMIDE"
"1787","CITALOPRAM","40 Mg/Ml Oral Drops Solution",2009-04-03,"PA1338/003/001","Focus Pharmaceuticals Ltd","CITALOPRAMHYDROCHLORIDE"
"1788","CITALOPRAM","20 Milligram                                                                                            Film Coated Tablet",2017-01-20,"PPA0565/062/001","WPR Healthcare Limited","CITALOPRAMHYDROBROMIDE"
"1789","Citalopram 10 mg Film-coated tablet","10 milligram(s) Film-coated tablet",NA,"PA2315/042/001","Accord Healthcare Ireland Ltd.","Citalopramhydrobromide"
"1790","Citalopram 20 mg Film-coated tablet","20 milligram(s) Film-coated tablet",NA,"PA2315/042/002","Accord Healthcare Ireland Ltd.","Citalopramhydrobromide"
"1791","CITALOPRAM BLUEFISH","10 Milligram                                                                                            Film Coated Tablet",2010-04-09,"PA1436/018/001","Bluefish Pharmaceuticals AB","CITALOPRAMHYDROBROMIDE"
"1792","CITALOPRAM BLUEFISH","20 Milligram                                                                                            Film Coated Tablet",2010-04-09,"PA1436/018/002","Bluefish Pharmaceuticals AB","CITALOPRAMHYDROBROMIDE"
"1793","CITALOPRAM BLUEFISH","40 Milligram                                                                                            Film Coated Tablet",2010-04-09,"PA1436/018/003","Bluefish Pharmaceuticals AB","CITALOPRAMHYDROBROMIDE"
"1794","CITALOPRAM TEVA","10 Milligram                                                                                            Film Coated Tablet",2007-01-19,"PA0749/019/001","Teva Pharma B.V.","CITALOPRAMHYDROBROMIDE"
"1795","CITALOPRAM TEVA","20 Milligram                                                                                            Film Coated Tablet",2007-01-19,"PA0749/019/002","Teva Pharma B.V.","CITALOPRAMHYDROBROMIDE"
"1796","CITALOPRAM TEVA","40 Milligram                                                                                            Film Coated Tablet",2007-01-19,"PA0749/019/003","Teva Pharma B.V.","CITALOPRAMHYDROBROMIDE"
"1797","CITANEST WITH OCTAPRESSIN DENTAL","3% w/v, 0.54 Microgr N/A Solution for Injection",1980-04-01,"PA1045/001/001","Dentsply Limited","PRILOCAINEHYDROCHLORIDE|FELYPRESSIN"
"1798","CITRAFLEET","0.01,3.5,10.97/15.08 Grams                                                                                                Powder for Oral Solution",2008-04-18,"PA2028/002/001","Casen-Recordati S.L.","SODIUMPICOSULFATE|MAGNESIUMOXIDUMLEVE|CITRICACID"
"1799","Citrol 10 mg Film-Coated Tablets","10 milligram(s) Film-coated tablet",2004-11-12,"PA0711/064/001","Rowex Ltd","Citalopramhydrobromide"
"1800","CITROL 20 mg Film-Coated Tablets","20 milligram(s) Film-coated tablet",2004-11-12,"PA0711/064/002","Rowex Ltd","Citalopramhydrobromide"
"1801","Citrol 30 mg Film-Coated Tablets","30 milligram(s) Film-coated tablet",2004-11-12,"PA0711/064/003","Rowex Ltd","Citalopramhydrobromide"
"1802","Claforan","500 milligram(s) Powder for solution for injection",NA,"PA0006/024/002","Roussel Laboratories Limited","Cefotaximesodium"
"1803","Claforan","1 gram(s) Powder for solution for injection",NA,"PA0006/024/003","Roussel Laboratories Limited","Cefotaximesodium"
"1804","CLAFORAN","500 Milligram                                                                                            Pdr for Soln for Injection",1981-05-13,"PA0540/037/002","Sanofi-Aventis Ireland Limited T/A SANOFI","CEFOTAXIMESODIUM"
"1805","CLAFORAN","1 Grams                                                                                                Pdr for Soln for Injection",1981-05-13,"PA0540/037/003","Sanofi-Aventis Ireland Limited T/A SANOFI","CEFOTAXIMESODIUM"
"1806","CLAREEZE ALLERGY 10 MG TABLETS","10 Milligram                                                                                            Tablets",2001-08-24,"PA1113/015/001","Phoenix Labs","LORATADINE"
"1807","CLARIPSINE","250mg milligram(s) Coated tablet",2006-07-07,"PA1111/001/001","Jubilant Pharmaceuticals nv","Clarithromycin"
"1808","CLARISCAN","279.3 Mg/Ml Solution for Injection",2017-12-22,"PA0735/011/001","GE Healthcare AS","GADOTERICACID"
"1809","CLARISCAN","279.3 Mg/Ml Solution for injection in pre-filled syringe",2017-12-22,"PA0735/011/002","GE Healthcare AS","GADOTERICACID"
"1810","CLARITHROMYCIN","250 Milligram                                                                                            Film Coated Tablet",2006-10-20,"PA2050/002/001","Sun Pharmaceutical Industries Europe B.V.","CLARITHROMYCIN"
"1811","CLARITHROMYCIN","500 Milligram                                                                                            Film Coated Tablet",2006-10-20,"PA2050/002/002","Sun Pharmaceutical Industries Europe B.V.","CLARITHROMYCIN"
"1812","CLARITHROMYCIN","250 Milligram                                                                                            Film Coated Tablet",2017-04-21,"PA1390/124/001","Accord Healthcare Limited","CLARITHROMYCIN"
"1813","CLARITHROMYCIN","500 Milligram                                                                                            Film Coated Tablet",2017-04-21,"PA1390/124/002","Accord Healthcare Limited","CLARITHROMYCIN"
"1814","Clarithromycin 500 mg Powder for Concentrate for Solution for Infusion","500 milligram(s) Powder for concentrate for solution for infusion",2010-08-13,"PA0899/035/001","Mercury Pharmaceuticals Ltd","Clarithromycin|Clarithromycin"
"1815","CLARITHROMYCIN ACTAVIS","250 Milligram                                                                                            Film Coated Tablet",2006-07-07,"PA1390/124/003","Accord Healthcare Limited","CLARITHROMYCIN"
"1816","CLARITHROMYCIN ACTAVIS","500 Milligram                                                                                            Film Coated Tablet",2006-07-07,"PA1390/124/004","Accord Healthcare Limited","CLARITHROMYCIN"
"1817","CLARITHROMYCIN KRKA","250 Milligram                                                                                            Film Coated Tablet",2017-01-13,"PA1347/068/001","Krka d.d., Novo mesto","CLARITHROMYCIN"
"1818","CLARITHROMYCIN KRKA","500 Milligram                                                                                            Film Coated Tablet",2017-01-13,"PA1347/068/002","Krka d.d., Novo mesto","CLARITHROMYCIN"
"1819","Clarithromycin Martindale Pharma 500 mg Powder for Concentrate for Solution for Infusion","500 milligram(s) ZZZ Pdr/Conc/Soln for Infus",2009-10-16,"PA0361/025/001","Martindale Pharmaceuticals Ltd","Clarithromycin"
"1820","Clarithromycin Teva 250 mg Film-coated Tablets","250 milligram(s) Film-coated tablet",2012-05-04,"PA0749/148/001","Teva Pharma B.V.","Clarithromycin"
"1821","Clarithromycin Teva 500 mg Film-coated Tablets","500 milligram(s) Film-coated tablet",2012-05-04,"PA0749/148/002","Teva Pharma B.V.","Clarithromycin"
"1822","CLARITYN","10 Milligram                                                                                            Tablets",2014-08-08,"PPA0465/336/001","PCO Manufacturing","LORATADINE"
"1823","Clarityn 10 mg Tablets","10 milligram(s) Tablet",1988-11-18,"PA1410/075/001","Bayer Limited","Loratadine"
"1824","Clarityn 1mg/1ml Syrup","5 mg/5ml Syrup",1994-01-18,"PA1410/075/002","Bayer Limited","Loratadine"
"1825","CLARITYN RAPIDE ALLERGY","10 Milligram                                                                                            Oral Lyophilisate",1999-11-26,"PA1410/075/003","Bayer Limited","LORATADINE"
"1826","Clavamel Forte 500mg/125mg film-coated tablet","500 /125 milligram(s) Film-coated tablet",2014-03-21,"PA0126/243/001","Clonmel Healthcare Ltd","CLAVULANATEPOTASSIUM|Amoxicillintrihydrate"
"1827","Cleenema Ready-to-Use 21.4g / 9.4g Enema","21.4/9.4 gram(s) Rectal solution",1995-02-16,"PA2028/001/001","Casen-Recordati S.L.","Sodiumdihydrogenphosphatedihydrate|Disodiumphosphatedodecahydrate"
"1828","Clenil Modulite 100 micrograms per metered dose Pressurised Inhalation Solution","100 microgram(s) Pressurised inhalation, solution",2005-09-30,"PA0743/014/002","Chiesi Limited","BECLOMETASONEDIPROPIONATE"
"1829","Clenil Modulite 200 micrograms per metered dose Pressurised Inhalation Solution","200 microgram(s) Pressurised inhalation, solution",2005-09-30,"PA0743/014/003","Chiesi Limited","BECLOMETASONEDIPROPIONATE"
"1830","Clenil Modulite 250 micrograms per metered dose Pressurised Inhalation Solution","250 microgram(s) Pressurised inhalation, solution",2005-09-30,"PA0743/014/004","Chiesi Limited","BECLOMETASONEDIPROPIONATE"
"1831","Clenil Modulite 50 micrograms per metered dose Pressurised Inhalation Solution","50 microgram(s) Pressurised inhalation, solution",2005-09-30,"PA0743/014/001","Chiesi Limited","BECLOMETASONEDIPROPIONATE"
"1832","Clexane 10,000 IU (100mg)/1ml Solution for Injection in pre-filled syringes","100 milligram(s)/millilitre Solution for injection",1989-08-22,"PA0540/097/001","Sanofi-Aventis Ireland Limited T/A SANOFI","Enoxaparinsodium"
"1833","Clexane 2,000 IU (20mg) /0.2 mL Solution for Injection in pre-filled syringes","20 milligram(s) Solution for injection in pre-filled syringe",2017-07-14,"PA0540/097/004","Sanofi-Aventis Ireland Limited T/A SANOFI","Enoxaparinsodium"
"1834","Clexane 4,000 IU (40mg) /0.4 mL Solution for Injection in pre-filled syringes","40 milligram(s) Solution for injection in pre-filled syringe",2017-07-14,"PA0540/097/005","Sanofi-Aventis Ireland Limited T/A SANOFI","Enoxaparinsodium"
"1835","Clexane 6,000 IU (60mg) /0.6 mL Solution for Injection in pre-filled syringes","60 milligram(s) Solution for injection in pre-filled syringe",2017-07-14,"PA0540/097/006","Sanofi-Aventis Ireland Limited T/A SANOFI","Enoxaparinsodium"
"1836","Clexane 8,000 IU (80mg) /0.8 mL Solution for Injection in pre-filled syringes","80 milligram(s) Solution for injection in pre-filled syringe",2017-07-14,"PA0540/097/007","Sanofi-Aventis Ireland Limited T/A SANOFI","Enoxaparinsodium"
"1837","Clexane Forte 12,000 IU (120mg) / 0.8 mL Solution for Injection in pre-filled syringes","120 milligram(s) Solution for injection in pre-filled syringe",2017-07-14,"PA0540/097/008","Sanofi-Aventis Ireland Limited T/A SANOFI","Enoxaparinsodium"
"1838","Clexane Forte 15,000 IU (150mg)/1ml Solution for Injection in pre-filled syringes","150 milligram(s)/millilitre Solution for injection",2001-06-15,"PA0540/097/002","Sanofi-Aventis Ireland Limited T/A SANOFI","Enoxaparinsodium"
"1839","CLIMARA","50 Milligram                                                                                            Transdermal Patch",1996-07-25,"PA1410/015/001","Bayer Limited","ESTRADIOL"
"1840","CLIMARA FORTE","100 Milligram                                                                                            Transdermal Patch",1996-07-25,"PA1410/015/002","Bayer Limited","ESTRADIOL"
"1841","CLINDAMYCIN","150 Base mg/ml                                                                                           Solution for Inj/Inf",2012-02-03,"PPA1151/156/001","Imbat Limited","CLINDAMYCINPHOSPHATE"
"1842","Clindamycin 150 mg Capsule","150 milligram(s) Capsule, hard",2008-07-04,"PA0688/044/001","Chanelle Medical","Clindamycinhydrochloride"
"1843","Clindamycin 150 mg/ml solution for injection","150 milligram(s)/millilitre Solution for injection",2008-05-30,"PA2059/007/001","Fresenius Kabi Deutschland GmbH","CLINDAMYCINPHOSPHATE"
"1844","Clindamycin 150mg/ml Solution for Injection or Infusion","150 milligram(s)/millilitre Solution for injection/infusion",2010-11-12,"PA1338/004/001","Focus Pharmaceuticals Ltd","Clindamycin"
"1845","Clindamycin 300 mg Capsules","300 milligram(s) Capsule",2009-05-15,"PA0688/044/002","Chanelle Medical","Clindamycinhydrochloride"
"1846","CLINIMIX N14G30E","8.5/30 %v/v                                                                                                 Solution for Infusion",1996-04-30,"PA0167/098/004","Baxter Healthcare Limited","LEUCINE|PHENYLALANINE|L-METHIONINE|L-LYSINE|ISOLEUCINE|VALINE|HISTIDINE|THREONINE|TRYPTOPHAN,L-|ALANINE|ARGININE|AMINOACETICACID|PROLINE|SERINE|TYROSINE|SODIUMACETATETRIHYDRATE|POTASSIUMPHOSPHATEDIBASIC|SODIUMCHLORIDE|MAGNESIUMCHLORIDEHEXAHYDRATE|GLUCOSE|CALCIUMCHLORIDEDIHYDRATE"
"1847","CLOBADERM","0.5 mg/g Cream",2012-07-20,"PA1986/057/001","Teva B.V.","CLOBETASOLPROPIONATE"
"1848","CLOBADERM","0.5 mg/g Ointment",2012-07-20,"PA1986/057/002","Teva B.V.","CLOBETASOLPROPIONATE"
"1849","CLOBAZAM THAME","5 MG/5ml                                                                                               Oral Suspension",2016-02-19,"PA1861/012/001","SYRI Limited, t/a Thame Laboratories","CLOBAZAM"
"1850","CLOBAZAM THAME","10 MG/5ml                                                                                               Oral Suspension",2016-02-19,"PA1861/012/002","SYRI Limited, t/a Thame Laboratories","CLOBAZAM"
"1851","Clodel 75 mg film-coated tablets","75 milligram(s) Film-coated tablet",2009-08-14,"PA0711/166/001","Rowex Ltd","Clopidogrelhydrochloride"
"1852","CLOMID","50 Milligram                                                                                            Tablets",1982-12-01,"PA0540/020/001","Sanofi-Aventis Ireland Limited T/A SANOFI","CLOMIFENECITRATE"
"1853","CLONACTIL","50 Milligram                                                                                            Film Coated Tablet",1977-04-01,"PA0126/026/001","Clonmel Healthcare Ltd","CHLORPROMAZINEHYDROCHLORIDE"
"1854","CLONACTIL","100 Milligram                                                                                            Film Coated Tablet",1977-04-01,"PA0126/026/002","Clonmel Healthcare Ltd","CHLORPROMAZINEHYDROCHLORIDE"
"1855","CLONACTIL","25 Milligram                                                                                            Film Coated Tablet",1987-04-08,"PA0126/026/003","Clonmel Healthcare Ltd","CHLORPROMAZINEHYDROCHLORIDE"
"1856","CLONAZEPAM","0.5 MG/5ml                                                                                               Oral Solution",2012-02-24,"PA0312/022/001","Rosemont Pharmaceuticals Ltd","CLONAZEPAM"
"1857","CLONAZEPAM","2 MG/5ml                                                                                               Oral Solution",2012-02-24,"PA0312/022/002","Rosemont Pharmaceuticals Ltd","CLONAZEPAM"
"1858","Clonfolic 0.4 mg Tablets","0.4 milligram(s) Tablet",1995-02-15,"PA0126/095/001","Clonmel Healthcare Ltd","Folicacid"
"1859","CLONIDINE HYDROCHLORIDE","25 Microgram                                                                                            Tablets",2008-12-12,"PA1986/058/001","Teva B.V.","CLONIDINEHYDROCHLORIDE"
"1860","Clonocid 250 mg film-coated Tablets","250 milligram(s) Film-coated tablet",2005-04-15,"PA0126/136/001","Clonmel Healthcare Ltd","Clarithromycin"
"1861","Clonocid 500 mg film-coated Tablets","500 milligram(s) Film-coated tablet",2005-04-15,"PA0126/136/002","Clonmel Healthcare Ltd","Clarithromycin"
"1862","CLOPIDOGREL  ZENTIVA","75 Milligram                                                                                            Film Coated Tablet",2008-07-16,"EU/1/08/465/1-14,18-19","Zentiva k.s.","CLOPIDOGRELHYDROGENSULFATE"
"1863","Clopidogrel 75 mg film-coated tablets","75 milligram(s) Film-coated tablet",2009-11-27,"PA1380/057/001","Actavis Group PTC ehf","Clopidogrelbesilate"
"1864","Clopidogrel 75mg Film-coated Tablets","75 milligram(s) Film-coated tablet",2013-05-17,"PA1390/092/001","Accord Healthcare Limited","Clopidogrelhydrogensulphate"
"1865","CLOPIDOGREL APOTEX","75 Milligram                                                                                            Film Coated Tablet",2009-10-16,"EU/1/09/568/1-18","Apotex Europe B.V.","CLOPIDOGRELBESYLATE"
"1866","CLOPIDOGREL BGR","75 Milligram                                                                                            Film Coated Tablet",2009-09-21,"EU/1/09/558/1-10","Laboratoires BIOGARAN","CLOPIDOGRELHYDROGENSULPHATE"
"1867","CLOPIDOGREL CLONMEL","75 Unknown Film Coated Tablet",2016-11-25,"PA0126/279/001","Clonmel Healthcare Ltd","CLOPIDOGREL(HYDROGENSULFATE)"
"1868","CLOPIDOGREL HCS","75 Milligram                                                                                            Film Coated Tablet",2010-10-28,"EU/1/10/651/001-015","HCS bvba","CLOPIDOGRELHYDROCHLORIDE"
"1869","CLOPIDOGREL KRKA","75 Milligram                                                                                            Film Coated Tablet",2009-09-23,"EU/1/09/556/1-9","Krka d.d., Novo mesto","CLOPIDOGRELHYDROCHLORIDE"
"1870","CLOPIDOGREL KRKA D.D.","75 Milligram                                                                                            Film Coated Tablet",2009-10-02,"EU/1/09/562/001-9","Krka, d.d., Novo mesto","CLOPIDOGRELHYDROCHLORIDE"
"1871","CLOPIDOGREL MYLAN","75 Milligram                                                                                            Film Coated Tablet",2009-09-21,"EU/1/09/559/1-9","Mylan S.A.S.","CLOPIDOGRELHYDROCHLORIDE"
"1872","CLOPIDOGREL RATIOPHARM","75 Milligram                                                                                            Film Coated Tablet",2015-02-19,"EU/1/14/975/001-017","Teva B.V.","CLOPIDOGRELHYDROGENSULPHATE"
"1873","CLOPIDOGREL RATIOPHARM GMBH","75 Milligram                                                                                            Film Coated Tablet",2009-07-28,"EU/1/09/541/1-8","Archie Samuel s.r.o.","CLOPIDOGRELBESILATE|MACROGOL6000|CARBONDIOXIDE"
"1874","CLOPIDOGREL TAD","75 Milligram                                                                                            Film Coated Tablet",2009-09-23,"EU/1/09/555/1-9","TAD Pharma GmbH","CLOPIDOGRELHYDROCHLORIDE"
"1875","CLOPIDOGREL TEVA","75 Milligram                                                                                            Film Coated Tablet",2009-07-28,"EU/1/09/540/1-16","Teva B.V.","CLOPIDOGRELHYDROGENSULPHATE"
"1876","CLOPIDOGREL ZENTIVA","300 Milligram                                                                                            Film Coated Tablet",2008-07-16,"EU/1/08/465/15-17","Zentiva k.s.","CLOPIDOGREL"
"1877","Clopidogrel-Splendris 75mg Film-coated Tablets","75 milligram(s) Film-coated tablet",2009-09-18,"PA1772/001/001","Splendris Pharmaceuticals GmbH","Clopidogrelhydrogensulphate"
"1878","CLOPIDROGEL IWA","75 Milligram                                                                                            Film Coated Tablet",2010-04-09,"PA1367/003/001","IWA Consulting ApS","CLOPIDOGRELBESILATE"
"1879","CLOPIXOL","200 Mg/Ml Solution for Injection",1977-06-13,"PA0115/005/001","Lundbeck Limited","ZUCLOPENTHIXOLDECANOATE"
"1880","CLOPIXOL","10 Milligram                                                                                            Film Coated Tablet",1982-11-01,"PA0115/005/003","Lundbeck Limited","ZUCLOPENTHIXOLDIHYDROCHLORIDE"
"1881","CLOPIXOL CONC.","500 Mg/Ml Solution for Injection",1983-10-12,"PA0115/005/007","Lundbeck Limited","ZUCLOPENTHIXOLDECANOATE"
"1882","CLOROM","250 Milligram                                                                                            Film Coated Tablet",2004-10-08,"PA0711/061/001","Rowex Ltd","CLARITHROMYCIN"
"1883","CLOROM","500 Milligram                                                                                            Film Coated Tablet",2004-10-08,"PA0711/061/002","Rowex Ltd","CLARITHROMYCIN"
"1884","CLOROM XL","500 Milligram                                                                                            Tablet Prolonged Release",2011-04-15,"PA1333/010/001","Morningside Healthcare Limited","CLARITHROMYCIN"
"1885","Clozalux 100 mg tablets","100 milligram(s) Tablet",2007-09-14,"PA0711/125/003","Rowex Ltd","Clozapine"
"1886","Clozalux 25 mg tablets","25 milligram(s) Tablet",2007-09-14,"PA0711/125/001","Rowex Ltd","Clozapine"
"1887","Clozalux 50 mg tablets","50 milligram(s) Tablet",2007-09-14,"PA0711/125/002","Rowex Ltd","Clozapine"
"1888","Clozaril 100 mg tablets","100 milligram(s) Tablet",1992-05-14,"PA2010/020/002","Mylan IRE Healthcare Limited","Clozapine"
"1889","Clozaril 25 mg Tablets","25 milligram(s) Tablet",1992-05-14,"PA2010/020/001","Mylan IRE Healthcare Limited","Clozapine"
"1890","Coagadex","250 IU *** AWAITING VALUE *** Powder and solvent for solution for injection",2016-03-16,"EU/1/16/1087/001","Bio Products Laboratory Limited","Humancoagulationfactorx"
"1891","COAGADEX","500 IU  Pdr+Solv for Soln for Inj",2016-03-16,"EU/1/16/1087/002","Bio Products Laboratory Limited","HUMANCOAGULATIONFACTORX"
"1892","CO-AMOXICLAV","500/100 Milligram                                                                                            Pdr for Soln Inj/Inf",2011-08-19,"PA1457/001/001","Fannin Limited","AMOXICILLINSODIUM|CLAVULANICACID(INTHEFORMOFPOTASSIUMCLAVULANATE)"
"1893","CO-AMOXICLAV","1000/200 Milligram                                                                                            Pdr for Soln Inj/Inf",2011-08-19,"PA1457/001/002","Fannin Limited","AMOXICILLINSODIUM|CLAVULANICACID(INTHEFORMOFPOTASSIUMCLAVULANATE)"
"1894","CO-AMOXICLAV","250/125 Milligram                                                                                            Film Coated Tablet",2012-03-09,"PA1648/004/001","Brown & Burk UK Ltd","AMOXICILLIN(INTHEFORMOFAMOXICILLINTRIHYDRATE)|CLAVULANICACID(ASPOTASSIUMCLAVULANATE,DILUTEDWITHMICROCRYSTALLINECELLULOSE(1:1))"
"1895","CO-AMOXICLAV","500/125 Milligram                                                                                            Film Coated Tablet",2012-03-09,"PA1648/004/002","Brown & Burk UK Ltd","AMOXICILLIN(INTHEFORMOFAMOXICILLINTRIHYDRATE)|CLAVULANICACID(ASPOTASSIUMCLAVULANATE,DILUTEDWITHMICROCRYSTALLINECELLULOSE(1:1))"
"1896","CO-AMOXICLAV","875/125 Milligram                                                                                            Film Coated Tablet",2012-03-09,"PA1648/004/003","Brown & Burk UK Ltd","AMOXICILLIN(ASAMOXICILLINTRIHYDRATE)|CLAVULANICACID(ASPOTASSIUMCLAVULANATE,DILUTEDWITHMICROCRYSTALLINECELLULOSE(1:1))"
"1897","CO-AMOXICLAV","500/100 Milligram                                                                                            Pdr for Soln Inj/Inf",2004-12-03,"PA1339/005/001","Wockhardt UK Limited","AMOXICILLINSODIUM|CLAVULANATEPOTASSIUM"
"1898","CO-AMOXICLAV","1000/200 Milligram                                                                                            Pdr for Soln Inj/Inf",2004-12-03,"PA1339/005/002","Wockhardt UK Limited","AMOXICILLINSODIUM|CLAVULANATEPOTASSIUM"
"1899","CO-AMOXICLAV","250/125 Milligram                                                                                            Film Coated Tablet",2005-09-23,"PA1217/007/001","Hikma Farmaceutica (Portugal) SA","AMOXICILLINTRIHYDRATE|CLAVULANICACID(INTHEFORMOFPOTASSIUMCLAVULANATE)"
"1900","Co-amoxiclav 1000mg/200mg powder for solution for injection/infusion","1000/200 milligram(s) Powder for solution for injection/infusion",2014-02-28,"PA0566/064/001","Fresenius Kabi Limited","Amoxicillinsodium|Clavulanicacid(intheformofpotassiumclavulanate)"
"1901","Co-amoxiclav 500 mg/125 mg, film-coated tablets","500/125 milligram(s) Film-coated tablet",2013-09-27,"PA2315/001/001","Accord Healthcare Ireland Ltd.","Amoxicillinetrihydrate|Potassiumclavulanate&amp;avicel(1:1)ph.eur.equivalenttoclavulanicacid"
"1902","Co-amoxiclav 875 mg/125 mg, film-coated tablets","875/125 milligram(s) Film-coated tablet",2013-09-27,"PA2315/001/002","Accord Healthcare Ireland Ltd.","Amoxicillinetrihydrate|Potassiumclavulanate&amp;avicel(1:1)ph.eur.equivalenttoclavulanicacid"
"1903","CO-AMOXICLAV BLUEFISH","500/125 Milligram                                                                                            Film Coated Tablet",2009-11-06,"PA1436/002/002","Bluefish Pharmaceuticals AB","AMOXICILLIN|CLAVULANICACID"
"1904","CO-AMOXICLAV BLUEFISH","875/125 Milligram                                                                                            Film Coated Tablet",2009-11-06,"PA1436/002/003","Bluefish Pharmaceuticals AB","AMOXICILLIN|CLAVULANICACID"
"1905","CO-AMOXICLAV SUGAR FREE","200/28.5 MG/5ml                                                                                               Powder for Oral Suspension",2012-11-09,"PA1648/005/003","Brown & Burk UK Ltd","AMOXICILLIN|CLAVULANICACID"
"1906","CO-AMOXICLAV SUGAR FREE","400/57 MG/5ml                                                                                               Powder for Oral Suspension",2012-11-09,"PA1648/005/004","Brown & Burk UK Ltd","AMOXICILLIN|CLAVULANICACID"
"1907","CO-AMOXICLAV TEVA","500/100 Milligram                                                                                            Pdr for Soln Inj/Inf",2006-08-04,"PA0749/011/001","Teva Pharma B.V.","AMOXICILLINSODIUM|CLAVULANATEPOTASSIUM"
"1908","CO-AMOXICLAV TEVA","1000/200 Milligram                                                                                            Pdr for Soln for Injection",2006-08-04,"PA0749/011/002","Teva Pharma B.V.","AMOXICILLINSODIUM|CLAVULANATEPOTASSIUM"
"1909","COAPROVEL","300/25 Milligram                                                                                            Tablets",2006-08-28,"EU/1/98/86/23-28","Sanofi Pharma Bristol-Myers Squibb SNC","IRBESARTAN|HYDROCHLOROTHIAZIDE"
"1910","COAPROVEL","150/12.5 Milligram                                                                                            Tablets",1998-10-15,"EU/1/98/086/001","Sanofi Pharma Bristol-Myers Squibb SNC","IRBESARTAN|HYDROCHLOROTHIAZIDE"
"1911","CoAprovel","150 milligram(s) Tablet",1998-10-15,"EU/1/98/086/002","Sanofi Pharma Bristol-Myers Squibb SNC","Irbesartan|Hydrochlorothiazide"
"1912","COAPROVEL","150 Milligram                                                                                            Tablets",1998-10-15,"EU/1/98/086/003","Sanofi Pharma Bristol-Myers Squibb SNC","IRBESARTAN|HYDROCHLOROTHIAZIDE"
"1913","COAPROVEL","300/12.5 Milligram                                                                                            Tablets",1998-10-15,"EU/1/98/086/004","Sanofi Pharma Bristol-Myers Squibb SNC","IRBESARTAN|HYDROCHLOROTHIAZIDE"
"1914","COAPROVEL","300 Milligram                                                                                            Tablets",1998-10-15,"EU/1/98/086/005","Sanofi Pharma Bristol-Myers Squibb SNC","IRBESARTAN|HYDROCHLOROTHIAZIDE"
"1915","COAPROVEL","300 Milligram                                                                                            Tablets",1998-10-15,"EU/1/98/086/007","Sanofi Pharma Bristol-Myers Squibb SNC","IRBESARTAN|HYDROCHLOROTHIAZIDE"
"1916","COCCULUS","6C - 200C  Tablets",2012-09-28,"HOR0407/050/001","Weleda (UK) Limited","ANAMIRTACOCCULUSFRUCT.SIC."
"1917","CO-CODAMOL","30/500 Milligram                                                                                            Tablets Effervescent",2010-10-08,"PA0899/034/001","Mercury Pharmaceuticals Ltd","PARACETAMOL|CODEINEPHOSPHATEHEMIHYDRATE"
"1918","COCOIS","%v/v                                                                                                 Ointment",1996-05-01,"PA1638/005/001","RPH Pharmaceuticals AB","COALTARSOLUTION|SULFUR|SALICYLICACID"
"1919","CODANT","30 Milligram                                                                                            Tablets",1978-04-01,"PA0073/029/001","Mercury Pharmaceuticals (Ireland) Ltd","CODEINEPHOSPHATEHEMIHYDRATE"
"1920","Co-Danthramer 25mg/200mg per 5ml Oral Suspension","25/200 ZZZ mg/mg per 5ml Oral suspension",2000-12-08,"PA0281/080/001","Pinewood Laboratories Ltd,","Dantron|POLOXAMER188PH.EUR."
"1921","Co-Danthramer 75mg/1000mg per 5ml Oral Suspension","75/1000 ZZZ mg/mg per 5ml Oral suspension",2000-12-08,"PA0281/080/002","Pinewood Laboratories Ltd,","Dantron|POLOXAMER188PH.EUR."
"1922","Codinex Codeine Phosphate 15mg/5ml Oral Solution","3 micromole(s) Oral solution",1981-08-25,"PA0281/005/001","Pinewood Laboratories Ltd,","Codeinephosphate"
"1923","CO-DIOVAN","160/12.5                                                                                                      Film Coated Tablet",2003-11-04,"PA0896/007/002","Novartis Ireland Limited","VALSARTAN|HYDROCHLOROTHIAZIDE"
"1924","CO-DIOVAN","160/25                                                                                                      Film Coated Tablet",2004-12-03,"PA0896/007/003","Novartis Ireland Limited","VALSARTAN|HYDROCHLOROTHIAZIDE"
"1925","CO-DIOVAN","320/12.5                                                                                                      Film Coated Tablet",2008-02-01,"PA0896/007/004","Novartis Ireland Limited","VALSARTAN|HYDROCHLOROTHIAZIDE,MICRONIZED"
"1926","CO-DIOVAN","320/25                                                                                                      Film Coated Tablet",2008-02-01,"PA0896/007/005","Novartis Ireland Limited","VALSARTAN|HYDROCHLOROTHIAZIDE,MICRONIZED"
"1927","CO-DIOVAN","80/12.5 mg/mg Film Coated Tablet",2011-01-21,"PPA1463/043/001","IMED Healthcare Ltd.","VALSARTAN|HYDROCHLOROTHIAZIDE"
"1928","Co-Diovan 160 mg/12.5 mg film-coated tablets","160/12.5 milligram(s) Film-coated tablet",2011-01-21,"PPA1463/043/002","IMED Healthcare Ltd.","Valsartan|Hydrochlorothiazide"
"1929","Co-Diovan 160 mg/12.5 mg film-coated tablets","160/12.5 milligram(s) Film-coated tablet",2009-07-31,"PPA0465/226/002","PCO Manufacturing","Hydrochlorothiazide|Valsartan"
"1930","Co-Diovan 160 mg/25 mg film-coated tablets","160/25 ZZZ mg/mg Film-coated tablet",2009-07-31,"PPA0465/226/003","PCO Manufacturing","Hydrochlorothiazide|Valsartan"
"1931","Co-Diovan 160mg/25mg Film-coated Tablets","160/25 milligram(s) Film-coated tablet",2011-09-16,"PPA1463/043/003","IMED Healthcare Ltd.","Hydrochlorothiazide|Valsartan"
"1932","Co-Diovan 320 mg/12.5 mg film-coated tablets","320/12.5 ZZZ mg/mg Film-coated tablet",2013-04-12,"PPA0465/226/005","PCO Manufacturing","Valsartan|Hydrochlorothiazide"
"1933","Co-Diovan 320 mg/25 mg film-coated tablets","320/25 ZZZ mg/mg Film-coated tablet",2012-11-30,"PPA0465/226/004","PCO Manufacturing","Valsartan|Hydrochlorothiazide"
"1934","Co-Diovan 80 mg/12.5 mg film-coated tablets","80/12.5 milligram(s) Film-coated tablet",2009-07-31,"PPA0465/226/001","PCO Manufacturing","Valsartan|Hydrochlorothiazide"
"1935","Co-Diovan 80 mg/12.5 mg film-coated tablets","80/12.5 ZZZ mg/mg Film-coated tablet",1998-12-10,"PA0896/007/001","Novartis Ireland Limited","Hydrochlorothiazide|Valsartan"
"1936","Codipar 15 mg/ 500 mg Capsules","15/500 milligram(s) Capsule, hard",2012-07-13,"PA0899/033/002","Mercury Pharmaceuticals Ltd","Codeinephosphatehemihydrate|Paracetamol"
"1937","Codipar 15mg/500mg Effervescent Tablets","15/500 milligram(s) Effervescent tablet",2010-10-08,"PA0899/033/001","Mercury Pharmaceuticals Ltd","Paracetamol|Codeinephosphatehemihydrate"
"1938","Colchicine 500 microgram Tablets","500 microgram(s) Tablet",2017-12-15,"PA2091/002/001","Renata (UK) Limited","Colchicine"
"1939","COLCHICINE TIOFARMA","500 Microgram                                                                                            Tablets",2017-09-29,"PA2200/001/001","Tiofarma B.V.","COLCHICINEPH.EUR."
"1940","COLCHICINE TIOFARMA","1000 Microgram                                                                                            Tablets",2017-09-29,"PA2200/001/002","Tiofarma B.V.","COLCHICINEPH.EUR."
"1941","COLDENZA","6C  Tablets",2016-12-23,"HOA1149/005/001","A. Nelson & Company Limited","GELSEMIUMSEMPERVIRENS(GHP)"
"1942","COLECALCIFEROL","3000 IU/ML                                                                                                Oral Solution",2015-01-30,"PA1861/005/001","SYRI Limited, t/a Thame Laboratories","COLECALCIFEROL"
"1943","Colecalciferol  30000 IU film-coated tablets","30000 international unit(s) Film-coated tablet",2015-01-30,"PA1876/008/004","Consilient Health Limited","Cholecalciferol|Cholecalciferolconcentrate(powderform)"
"1944","Colecalciferol  Aristo 20,000 IU Capsules, soft","20,000 international unit(s) Capsule, soft",2018-02-23,"PA1983/002/001","Aristo Pharma GmbH","Colecalciferol"
"1945","Colecalciferol 1000 IU film-coated tablets","1000 international unit(s) Film-coated tablet",2015-01-30,"PA1876/008/002","Consilient Health Limited","Cholecalciferol|Cholecalciferolconcentrate(powderform)"
"1946","Colecalciferol 7000 IU film-coated tablets","7000 international unit(s) Film-coated tablet",2015-01-30,"PA1876/008/003","Consilient Health Limited","Cholecalciferol|Cholecalciferolconcentrate(powderform)"
"1947","Colecalciferol 800 IU film-coated tablets","800 international unit(s) Film-coated tablet",2015-01-30,"PA1876/008/001","Consilient Health Limited","Cholecalciferol|Cholecalciferolconcentrate(powderform)"
"1948","COLGATE TOTAL PRO GUM HEALTH TARTAR CONTROL TOOTHP","0.30 . 0.32 %w/w                                                                                                 Toothpaste",2004-04-02,"PA0320/005/003","Colgate-Palmolive (U.K.) Ltd","SODIUMFLUORIDE|TRICLOSAN"
"1949","Colgate TOTAL Pro Gum Health Toothpaste","0.30 . 0.32 percent weight/weight Toothpaste",1999-04-01,"PA0320/005/001","Colgate-Palmolive (U.K.) Ltd","Sodiumfluoride|Triclosan"
"1950","COLIFOAM","10 %w/w                                                                                                 Rectal Foam",1978-04-01,"PA2010/021/001","Mylan IRE Healthcare Limited","HYDROCORTISONEACETATE"
"1951","Colobreathe","125 milligram(s) ZZZ Inhalation Powder, Capsule",2012-02-13,"EU/1/11/747/001","Teva B.V.","Colistimethatesodium(rinn)"
"1952","COLOFAC","50 mg/5 ml mg/5ml Oral suspension",1983-01-07,"PA0108/014/002","Abbott Healthcare Products Ltd","Mebeverinepamoate"
"1953","COLOFAC","135 Milligram                                                                                            Coated Tablets",2009-08-14,"PPA1151/122/001","Imbat Limited","MEBEVERINEHYDROCHLORIDE"
"1954","Colofac 135 mg Tablets","135 milligram(s) Tablet",1983-02-07,"PA2010/007/001","Mylan IRE Healthcare Limited","MEBEVERINEHYDROCHLORIDE"
"1955","COLOMYCIN","1 000 000 International Unit                                                                                   Pdr for Soln Inj/Inf",2005-06-07,"PA1986/046/001","Teva B.V.","COLISTINMESILATESODIUM"
"1956","COLOMYCIN","2 000 000 International Unit                                                                                   Pdr for Soln Inj/Inf",2005-06-07,"PA1986/046/002","Teva B.V.","COLISTINMESILATESODIUM"
"1957","COLOMYCIN","2000 000 International Unit                                                                                   Pdr for Soln Inj/Inf",NA,"DPR0465/041/002","PCO Manufacturing","COLISTINMESILATESODIUM"
"1958","COLOMYCIN INJECTION","1 000 000 International Unit                                                                                   Pdr for Soln Inj/Inf",2011-05-24,"DPR0465/041/001","PCO Manufacturing","COLISTINMESILATESODIUM"
"1959","COLPERMIN","0.2 Millilitre                                                                                           Capsules Gastro-Resistant",2009-03-06,"PPA1151/087/001","Imbat Limited","PEPPERMINTOIL"
"1960","Colpermin Gastro-resistant CapsulesPeppermint oil 0.2ml","0.2 millilitre(s) Gastro-resistant capsule, hard",1985-03-08,"PA0823/045/001","McNeil Healthcare (Ireland) Ltd","Peppermintoil"
"1961","COMBIGAN","2/5 Mg/Ml Eye Drops Solution",2009-12-16,"DPR1392/059/001","Eurodrug Ltd","BRIMONIDINETARTRATE|TIMOLOL"
"1962","COMBIGAN","2/5 Mg/Ml Eye Drops Solution",2005-12-22,"PA0148/064/001","Allergan Pharmaceuticals Ireland","BRIMONIDINETARTRATE|TIMOLOLMALEATE"
"1963","Combiprasal 0.5 mg / 2.5 mg per 2.5 ml nebuliser solution","0.5/2.5 ZZZ mg/mg Nebuliser solution",2014-01-10,"PA1815/001/001","Pharma Stulln GmbH","Ipratropiumbromide|SALBUTAMOLSULFATE"
"1964","COMBIVIR","150/300 Milligram                                                                                            Tablets",1998-03-18,"EU/1/98/058/001","ViiV Healthcare UK Ltd","ZIDOVUDINE|LAMIVUDINE"
"1965","COMBIVIR","150/300 Milligram                                                                                            Tablets",1998-03-18,"EU/1/98/058/002","ViiV Healthcare UK Ltd","ZIDOVUDINE|LAMIVUDINE"
"1966","COMBODART","0.5/0.4 Milligram                                                                                            Capsules Hard",2014-02-28,"PPA0465/334/001","PCO Manufacturing","DUTASTERIDE|TAMSULOSINHYDROCHLORIDE"
"1967","COMBODART","0.5/0.4 Milligram                                                                                            Capsules Hard",2012-10-19,"PPA1463/068/001","IMED Healthcare Ltd.","DUTASTERIDE|TAMSULOSINHYDROCHLORIDE"
"1968","COMBODART","0.5/0.4 mg/mg Capsules Hard",2012-02-10,"PPA1151/171/001","Imbat Limited","DUTASTERIDE|TAMSULOSINHYDROCHLORIDE"
"1969","Combodart 0.5 mg/ 0.4 mg hard capsules","0.5/0.4 milligram(s) Capsule, hard",NA,"PA1077/118/001","GlaxoSmithKline (Ireland) Limited","Tamsulosinhydrochloride|Dutasteride"
"1970","COMETRIQ","20 Milligram                                                                                            Capsules Hard",2014-03-21,"EU/1/13/890/001","Ipsen Pharma","CABOZANTINIB(S)-MALATE"
"1971","COMETRIQ","20 + 80 Milligram                                                                                            Capsules Hard",2014-03-21,"EU/1/13/890/002-003","Ipsen Pharma","CABOZANTINIB(S)-MALATE"
"1972","Competact","15/500 milligram(s) Tablet",2006-07-28,"EU/1/06/354/001-009","Takeda Pharma A/S","METFORMINHYDROCHLORIDE|Pioglitazone"
"1973","Competact","15mg/850 milligram(s) Film-coated tablet",2006-07-28,"EU/1/06/354/001-012","Takeda Pharma A/S","METFORMINHYDROCHLORIDE|Pioglitazone"
"1974","COMPOUND SODIUM LACTATE INTRAVENOUS INFUSION","Per Cent                                                                                             Solution for Infusion",2007-03-30,"PA0179/004/008","B. Braun Medical Limited","SODIUMCHLORIDE|POTASSIUMCHLORIDE|SODIUMLACTATESOLUTION50%|CALCIUMCHLORIDEDIHYDRATE"
"1975","COMPOUND SODIUM LACTATE INTRAVENOUS INFUSION BP","6/6.24/0.40/0.27 %v/v                                                                                                 Solution for Infusion",1983-04-01,"PA0179/004/003","B. Braun Medical Limited","SODIUMCHLORIDE|POTASSIUMCHLORIDE|SODIUMLACTATESOLUTION|CALCIUMCHLORIDEDIHYDRATE"
"1976","Compound Sodium Lactate Solution for Infusion BP","0 percent volume/volume Solution for infusion",2003-04-17,"PA0167/055/007","Baxter Healthcare Limited","Sodiumchloride|Potassiumchloride|Calciumchloridedihydrate|Sodiumlactate"
"1977","COMTAN","200 Milligram                                                                                            Tablets",1998-09-22,"EU/1/98/081/001","Novartis Europharm Limited","ENTACAPONE"
"1978","COMTAN","200 Milligram                                                                                            Tablets",1998-09-22,"EU/1/98/081/002","Novartis Europharm Limited","ENTACAPONE"
"1979","COMTAN","200 Milligram                                                                                            Tablets",1998-09-22,"EU/1/98/081/003","Novartis Europharm Limited","ENTACAPONE"
"1980","COMTAN","200 Milligram                                                                                            Tablets",1998-09-22,"EU/1/98/081/004","Novartis Europharm Limited","ENTACAPONE"
"1981","COMTESS","200 Milligram                                                                                            Tablets",1998-09-16,"EU/1/98/082/001","Orion Corporation","ENTACAPONE"
"1982","COMTESS","200 Milligram                                                                                            Tablets",1998-09-16,"EU/1/98/082/002","Orion Corporation","ENTACAPONE"
"1983","COMTESS","200 Milligram                                                                                            Tablets",1998-09-16,"EU/1/98/082/003","Orion Corporation","ENTACAPONE"
"1984","COMTESS","200 Milligram                                                                                            Tablets",1998-09-16,"EU/1/98/082/004","Orion Corporation","ENTACAPONE"
"1985","CONBRIZA","20 Milligram                                                                                            Film Coated Tablet",2009-04-17,"EU/1/09/511/1-4","Pfizer Europe MA EEIG","BAZEDOXIFENE"
"1986","CONCERTA XL","18 Milligram                                                                                            Tablet Prolonged Release",2002-11-22,"PA0748/049/001","Janssen-Cilag Ltd","METHYLPHENIDATEHYDROCHLORIDE"
"1987","CONCERTA XL","36 Milligram                                                                                            Tablet Prolonged Release",2002-11-22,"PA0748/049/002","Janssen-Cilag Ltd","METHYLPHENIDATEHYDROCHLORIDE"
"1988","CONCERTA XL","54 Milligram                                                                                            Tablet Prolonged Release",2002-11-22,"PA0748/049/003","Janssen-Cilag Ltd","METHYLPHENIDATEHYDROCHLORIDE"
"1989","CONCERTA XL","27 Milligram                                                                                            Tablet Prolonged Release",2008-08-01,"PA0748/049/004","Janssen-Cilag Ltd","METHYLPHENIDATEHYDROCHLORIDE|METHYLPHENIDATEHYDROCHLORIDE"
"1990","CONCERTA XL","18 Milligram                                                                                            Tablet Prolonged Release",2015-04-02,"PPA1151/243/001","Imbat Limited","METHYLPHENIDATEHYDROCHLORIDE"
"1991","CONCERTA XL","27 Milligram                                                                                            Tablet Prolonged Release",2015-04-02,"PPA1151/243/002","Imbat Limited","METHYLPHENIDATEHYDROCHLORIDE"
"1992","CONCERTA XL","36 Milligram                                                                                            Tablet Prolonged Release",2015-04-02,"PPA1151/243/003","Imbat Limited","METHYLPHENIDATEHYDROCHLORIDE"
"1993","Condyline 0.5 % w/v Cutaneous Solution","0.5% percent weight/volume Cutaneous solution",1988-04-11,"PA2229/006/001","Takeda Products Ireland Ltd","Podophyllotoxin"
"1994","CONSTELLA","290 Microgram                                                                                            Capsules Hard",2012-11-26,"EU/1/12/801/001-004","Allergan Pharmaceuticals International Limited","LINACLOTIDE"
"1995","CONTROLOC CONTROL","20 Milligram                                                                                            Tablets Gastro-Resistant",2009-06-12,"EU/1/09/515/001","Takeda GmbH","PANTOPRAZOLESODIUMSESQUIHYDRATE"
"1996","CONTROLOC CONTROL","20 Milligram                                                                                            Tablets Gastro-Resistant",2009-06-12,"EU/1/09/515/002","Takeda GmbH","PANTOPRAZOLESODIUMSESQUIHYDRATE"
"1997","CONTROLOC CONTROL","20 Milligram                                                                                            Tablets Gastro-Resistant",2009-06-12,"EU/1/09/515/003","Takeda GmbH","PANTOPRAZOLESODIUMSESQUIHYDRATE"
"1998","CONTROLOC CONTROL","20 Milligram                                                                                            Tablets Gastro-Resistant",2009-06-12,"EU/1/09/515/004","Takeda GmbH","PANTOPRAZOLESODIUMSESQUIHYDRATE"
"1999","COPALIA","5/80 Unknown Film Coated Tablet",2007-01-16,"EU/1/06/372/001-008","Novartis Europharm Limited","AMLODIPINEBESYLATE|VALSARTAN"
"2000","COPALIA","5/160                                                                                                      Film Coated Tablet",2007-01-16,"EU/1/06/372/009-016","Novartis Europharm Limited","AMLODIPINEBESYLATE|VALSARTAN"
"2001","COPALIA","10/160 Unknown Film Coated Tablet",2007-01-16,"EU/1/06/372/017-024","Novartis Europharm Limited","AMLODIPINEBESYLATE|VALSARTAN"
"2002","COPALIA HCT","5/160/12.5 Unknown Film Coated Tablet",2009-11-04,"EU/1/09/575/1-12","Novartis Europharm Limited","AMLODIPINEBESYLATE|VALSARTAN|HYDROCHLOROTHIAZIDE"
"2003","COPALIA HCT","10/160/12.5 Unknown Film Coated Tablet",2009-11-04,"EU/1/09/575/13-24","Novartis Europharm Limited","AMLODIPINEBESYLATE|VALSARTAN|HYDROCHLOROTHIAZIDE"
"2004","COPALIA HCT","5/160/25 Unknown Film Coated Tablet",2009-11-04,"EU/1/09/575/25-36","Novartis Europharm Limited","AMLODIPINEBESYLATE|VALSARTAN|HYDROCHLOROTHIAZIDE"
"2005","COPALIA HCT","10/160/25 Unknown Film Coated Tablet",2009-11-04,"EU/1/09/575/37-48","Novartis Europharm Limited","AMLODIPINEBESYLATE|VALSARTAN|HYDROCHLOROTHIAZIDE"
"2006","COPALIA HCT","10/320/25 Unknown Film Coated Tablet",2009-11-04,"EU/1/09/575/49-60","Novartis Europharm Limited","AMLODIPINEBESYLATE|VALSARTAN|HYDROCHLOROTHIAZIDE"
"2007","Copaxone 20 mg/ml solution for injection in pre-filled syringe","20 milligram(s)/millilitre Solution for injection",2004-02-10,"PA22579/001/001","TEVA GmbH","Glatirameracetate"
"2008","Copaxone 40mg/ml solution for injection in pre-filled syringe","40 milligram(s)/millilitre Solution for injection",2015-01-09,"PA22579/001/002","TEVA GmbH","Glatirameracetate"
"2009","COPAXONE PRE-FILLED SYRINGE","20 Mg/Ml Solution for Injection",2017-11-03,"PPA0465/432/001","PCO Manufacturing","GLATIRAMERACETATE"
"2010","CORDARONE X","200 Milligram                                                                                            Tablets",2004-03-05,"PPA0465/119/001","PCO Manufacturing","AMIODARONEHYDROCHLORIDE"
"2011","CORDARONE X","100 Milligram                                                                                            Tablets",2014-10-24,"PPA0465/119/002","PCO Manufacturing","AMIODARONEHYDROCHLORIDE"
"2012","CORDARONE X","100 Milligram                                                                                            Tablets",2014-01-17,"PPA1463/094/001","IMED Healthcare Ltd.","AMIODARONEHYDROCHLORIDE"
"2013","CORDARONE X","200 Milligram                                                                                            Tablets",2014-01-17,"PPA1463/094/002","IMED Healthcare Ltd.","AMIODARONEHYDROCHLORIDE"
"2014","CORDARONE X","100 Milligram                                                                                            Tablets",2008-10-03,"PPA1151/084/001","Imbat Limited","AMIODARONEHYDROCHLORIDE"
"2015","CORDARONE X","200 Milligram                                                                                            Tablets",2008-10-03,"PPA1151/084/002","Imbat Limited","AMIODARONEHYDROCHLORIDE"
"2016","CORDARONE X","100 Milligram                                                                                            Tablets",2018-08-03,"PPA1097/051/001","Lexon (UK) Ltd","AMIODARONEHYDROCHLORIDE"
"2017","Cordarone X 100mg Tablets","100 milligram(s) Tablet",NA,"PA0540/142/001","Sanofi-Aventis Ireland Limited T/A SANOFI","AMIODARONEHYDROCHLORIDE"
"2018","Cordarone X 200mg Tablets","200 milligram(s) Tablet",NA,"PA0540/142/002","Sanofi-Aventis Ireland Limited T/A SANOFI","AMIODARONEHYDROCHLORIDE"
"2019","Cordarone X 200mg Tablets","200 milligram(s) Tablet",2016-09-02,"PPA1562/176/001","LTT Pharma Limited","AMIODARONEHYDROCHLORIDE"
"2020","Cordarone X Intravenous, 150mg/3ml, Concentrate for solution for infusion or slow injection","150mg/3ml  Solution for infusion",NA,"PA0540/142/003","Sanofi-Aventis Ireland Limited T/A SANOFI","AMIODARONEHYDROCHLORIDE"
"2021","CORLENTOR","5 Milligram                                                                                            Tablets",2005-10-25,"EU/1/05/317/1-7","Les Laboratoires Servier","IVABRADINE"
"2022","CORLENTOR","7.5 Milligram                                                                                            Tablets",2005-10-25,"EU/1/05/317/8-14","Les Laboratoires Servier","IVABRADINE"
"2023","CORSODYL","1 %w/w                                                                                                 Dental Gel",1975-04-29,"PA0678/002/001","GlaxoSmithKline Consumer Healthcare (Ireland) Limited","CHLORHEXIDINEDIGLUCONATE(ASCHLORHEXIDINEDIGLUCONATESOLUTION(20%W/V)PH.EUR."
"2024","CORSODYL ANISEED","0.2 %w/v                                                                                                 Mouth Wash",1995-01-10,"PA0678/002/004","GlaxoSmithKline Consumer Healthcare (Ireland) Limited","CHLORHEXIDINEGLUCONATE"
"2025","CORSODYL FRESHMINT","0.2 %w/v                                                                                                 Mouth Wash",2012-02-03,"PA0678/002/005","GlaxoSmithKline Consumer Healthcare (Ireland) Limited","CHLORHEXIDINEDIGLUCONATE(ASCHLORHEXIDINEDIGLUCONATESOLUTION(20%W/V)PH.EUR."
"2026","Corsodyl Mint 0.2% w/v Mouthwash","0.2 percent weight/volume Mouthwash",1976-09-30,"PA0678/002/002","GlaxoSmithKline Consumer Healthcare (Ireland) Limited","Chlorhexidinegluconate"
"2027","CORTIMENT","9 Milligram                                                                                            Tablet Prolonged Release",2014-12-05,"PA1009/026/001","Ferring Ireland Ltd","BUDESONIDE"
"2028","CORTOPIN","1 %w/w                                                                                                 Cream",1989-07-17,"PA0281/071/002","Pinewood Laboratories Ltd,","HYDROCORTISONE"
"2029","Cosartal 100 mg Film-coated tablets","100 milligram(s) Film-coated tablet",2006-06-02,"PA2315/047/002","Accord Healthcare Ireland Ltd.","Losartanpotassium"
"2030","Cosartal 50 mg Film-coated tablets","50 milligram(s) Film-coated tablet",2006-06-02,"PA2315/047/001","Accord Healthcare Ireland Ltd.","Losartanpotassium"
"2031","Cosartal Plus 100 mg/12.5 mg Film-coated tablets","100/12.5 milligram(s) Film-coated tablet",2012-03-02,"PA1380/098/003","Actavis Group PTC ehf","Hydrochlorothiazide|Losartanpotassium"
"2032","Cosartal Plus 100 mg/25 mg Film-coated tablets","100/25 milligram(s) Film-coated tablet",2010-06-04,"PA1380/098/002","Actavis Group PTC ehf","Losartanpotassium|Hydrochlorothiazide"
"2033","Cosartal Plus 50 mg/12.5 mg Film-coated tablets","50/12.5 milligram(s) Film-coated tablet",2010-06-04,"PA1380/098/001","Actavis Group PTC ehf","Losartanpotassium|Hydrochlorothiazide"
"2034","COSENTYX","150 Milligram                                                                                            Pdr for Soln for Injection",2015-01-15,"EU/1/14/980/001","Novartis Europharm Limited","SECUKINUMAB"
"2035","COSENTYX","150 Milligram                                                                                            Solution for injection in pre-filled syringe",2015-01-15,"EU/1/14/980/002-003","Novartis Europharm Limited","SECUKINUMAB"
"2036","COSENTYX","150 Milligram                                                                                            Solution for injection in pre-filled pen",2015-01-15,"EU/1/14/980/004-005","Novartis Europharm Limited","SECUKINUMAB"
"2037","COSIMPREL","5/10 Milligram                                                                                            Film Coated Tablet",2016-03-04,"PA0568/029/002","Les Laboratoires Servier","BISOPROLOLFUMARATE|PERINDOPRILARGININE"
"2038","COSIMPREL","10/5 Milligram                                                                                            Film Coated Tablet",2016-03-04,"PA0568/029/003","Les Laboratoires Servier","BISOPROLOLFUMARATE|PERINDOPRILARGININE"
"2039","COSIMPREL","10/10 Milligram                                                                                            Film Coated Tablet",2016-03-04,"PA0568/029/004","Les Laboratoires Servier","BISOPROLOLFUMARATE|PERINDOPRILARGININE"
"2040","Cosimprel 5mg/5mg Film-Coated Tablets","5/5 milligram(s) Film-coated tablet",2016-03-04,"PA0568/029/001","Les Laboratoires Servier","BISOPROLOLFUMARATE|Perindoprilarginine"
"2041","COSMOFER","50 Milligram                                                                                            Solution for Inj/Inf",2018-02-09,"PPA1097/034/001","Lexon (UK) Ltd","IRON"
"2042","CosmoFer 50mg/ml solution for infusion and injection","50 milligram(s)/millilitre Solution for injection/infusion",2001-06-29,"PA0982/001/001","Pharmacosmos A/S","Iron|Iron(III)hydroxidedextrancomplex"
"2043","COSOPT","20/5 Mg/Ml Eye Drops Solution",2016-08-04,"DPR1392/072/001","Eurodrug Ltd","DORZOLAMIDE|TIMOLOL"
"2044","COSOPT","20/5 Milligram                                                                                            Eye Drops Solution",2017-03-15,"DPR1463/046/001","IMED Healthcare Ltd.","DORZOLAMIDE|TIMOLOL"
"2045","COSOPT","20  + 5 Base mg/ml                                                                                           Ear Drops Solution",2011-09-23,"PPA1151/159/001","Imbat Limited","DORZOLAMIDEHYDROCHLORIDE|TIMOLOLMALEATE"
"2046","COSOPT","20 + 5 Mg/Ml Eye Drops Solution",2014-06-20,"PPA1562/043/003","LTT Pharma Limited","DORZOLAMIDEHYDROCHLORIDE|TIMOLOLMALEATE"
"2047","COSOPT","20/5 Milligram                                                                                            Eye Drops Solution",2012-04-20,"PPA1463/060/001","IMED Healthcare Ltd.","DORZOLAMIDE|TIMOLOL"
"2048","COSOPT 20mg/ml + 5mg/ml eye drops, solution","20+5 milligram(s)/millilitre Eye drops, solution",1998-08-14,"PA0879/005/001","Santen OY","Dorzolamide|Dorzolamide|Timolol|Timolol"
"2049","COSOPT 20mg/ml + 5mg/ml eye drops, solution","20/5 milligram(s)/millilitre Eye drops, solution",2012-10-05,"PPA0465/296/001","PCO Manufacturing","Dorzolamide|TIMOLOLMALEATE"
"2050","Cosopt Multi preservative-free 20mg/ml+5mg/ml eye drops, solution","20/5 milligram(s)/millilitre Eye drops, solution",2018-06-01,"PA0879/005/003","Santen OY","Dorzolamidehydrochloride|Dorzolamidehydrochloride|TIMOLOLMALEATE|TIMOLOLMALEATE"
"2051","COSOPT Preservative-Free 20 mg/ml + 5 mg/ml, eye drops, solution in single-dose container","20/5 milligram(s)/millilitre Eye drops, solution",2006-09-01,"PA0879/005/002","Santen OY","Dorzolamide|Timolol"
"2052","Cotellic","20 milligram(s) Film-coated tablet",2015-11-20,"EU/1/15/1048/001","Roche Registration GmbH","Cobimetinibhemifumarate"
"2053","CO-TIPOL","500/30 Milligram                                                                                            Capsules Hard",2013-11-29,"PA1684/003/001","Carysfort Healthcare Limited","PARACETAMOL|CODEINEPHOSPHATEHEMIHYDRATE"
"2054","CO-TIPOL","500/30 Milligram                                                                                            Suppositories",2013-11-29,"PA1684/003/002","Carysfort Healthcare Limited","PARACETAMOL|CODEINEPHOSPHATEHEMIHYDRATE"
"2055","CO-TIPOL MAX","1000/60 Milligram                                                                                            Suppositories",2013-11-29,"PA1684/003/003","Carysfort Healthcare Limited","PARACETAMOL|CODEINEPHOSPHATEHEMIHYDRATE"
"2056","Co-Vatan 160 mg/12.5 mg Film-coated Tablets","160/12.5 mg/tablet Film-coated tablet",2010-10-01,"PA0711/182/002","Rowex Ltd","Hydrochlorothiazide|Valsartan"
"2057","Co-Vatan 160 mg/25 mg Film-coated Tablets","160/25 mg/tablet Film-coated tablet",2010-10-01,"PA0711/182/003","Rowex Ltd","Hydrocholothiazide|Valsartan"
"2058","Co-Vatan 80 mg/12.5 mg Film-coated Tablets","80/12.5 mg/tablet Film-coated tablet",2010-10-01,"PA0711/182/001","Rowex Ltd","Hydrochlorothiazide|Valsartan"
"2059","COVERDINE","5/1.25/5 Milligram                                                                                            Film Coated Tablet",2014-04-16,"PA0568/024/002","Les Laboratoires Servier","PERINDOPRILARGININE|INDAPAMIDE|AMLODIPINEBESILATE"
"2060","COVERDINE","5/1.25/10 Milligram                                                                                            Film Coated Tablet",2014-04-16,"PA0568/024/003","Les Laboratoires Servier","PERINDOPRILARGININE|INDAPAMIDE|AMLODIPINEBESILATE"
"2061","COVERDINE","10/2.5/5 Milligram                                                                                            Film Coated Tablet",2014-04-16,"PA0568/024/004","Les Laboratoires Servier","PERINDOPRILARGININE|INDAPAMIDE|AMLODIPINEBESILATE"
"2062","COVERDINE","10/2.5/10 Milligram                                                                                            Film Coated Tablet",2014-04-16,"PA0568/024/005","Les Laboratoires Servier","PERINDOPRILARGININE|INDAPAMIDE|AMLODIPINEBESILATE"
"2063","Coverdine 10 mg/2.5 mg/10 mg film-coated tablets","10/2.5/10 milligram(s) Film-coated tablet",2018-08-31,"PPA1097/053/003","Lexon (UK) Ltd","Perindoprilarginine|Indapamide|Amlodipine"
"2064","Coverdine 10mg/2.5mg/5mg film-coated tablets","10/2.5/5 milligram(s) Film-coated tablet",2018-08-31,"PPA1097/053/002","Lexon (UK) Ltd","Perindoprilarginine|Indapamide|Amlodipine"
"2065","Coverdine 5mg/1.25mg/5mg film-coated tablets","5/1.25/5 milligram(s) Film-coated tablet",2018-08-31,"PPA1097/053/001","Lexon (UK) Ltd","Perindoprilarginine|Indapamide|Amlodipine"
"2066","COVERSYL ARGININE","2.5 Milligram                                                                                            Film Coated Tablet",2005-10-28,"PA0568/002/004","Les Laboratoires Servier","PERINDOPRILARGININE"
"2067","COVERSYL ARGININE","5 Milligram                                                                                            Film Coated Tablet",2005-10-28,"PA0568/002/005","Les Laboratoires Servier","PERINDOPRILARGININE"
"2068","COVERSYL ARGININE","10 Milligram                                                                                            Film Coated Tablet",2005-10-28,"PA0568/002/006","Les Laboratoires Servier","PERINDOPRILARGININE"
"2069","COVERSYL ARGININE","5 Milligram                                                                                            Film Coated Tablet",2007-08-31,"PPA0465/067/004","PCO Manufacturing","PERINDOPRILARGININE"
"2070","COVERSYL ARGININE","10 Milligram                                                                                            Film Coated Tablet",2007-08-31,"PPA0465/067/005","PCO Manufacturing","PERINDOPRILARGININE"
"2071","Coversyl Arginine 10 mg orodispersible tablets","10 milligram(s) Orodispersible tablet",2010-07-09,"PA0568/002/009","Les Laboratoires Servier","Perindoprilarginine"
"2072","Coversyl Arginine 5 mg orodispersible tablets","5 milligram(s) Orodispersible tablet",2010-07-09,"PA0568/002/008","Les Laboratoires Servier","Perindoprilarginine"
"2073","COVERSYL ARGININE PLUS","10/2.5 Milligram                                                                                            Film Coated Tablet",2017-03-01,"PPA1562/063/002","LTT Pharma Limited","PERINDOPRILARGININE|INDAPAMIDE"
"2074","Coversyl Arginine Plus 10mg/2.5mg film-coated tablets","10/2.5 ZZZ mg/mg Film-coated tablet",2009-08-14,"PA0568/022/002","Les Laboratoires Servier","Perindoprilarginine|Indapamide"
"2075","Coversyl Arginine Plus 2.5mg/0.625mg film-coated tablets","2.5/0.625 *** AWAITING VALUE *** Film-coated tablet",2007-05-11,"PA0568/008/003","Les Laboratoires Servier","Perindoprilarginine|Indapamide"
"2076","Coversyl Arginine Plus 5mg/1.25mg film-coated tablets","5/1.25 *** AWAITING VALUE *** Film-coated tablet",2007-05-11,"PA0568/016/002","Les Laboratoires Servier","Perindoprilarginine|Indapamide"
"2077","COZAAR","100 milligram(s) Film-coated tablet",2001-11-16,"PA0035/082/003","Merck Sharp and Dohme Limited","Losartanpotassium"
"2078","COZAAR","50 Milligram                                                                                            Film Coated Tablet",2004-02-06,"PPA0465/106/001","PCO Manufacturing","LOSARTANPOTASSIUM"
"2079","COZAAR","100 Milligram                                                                                            Film Coated Tablet",2008-02-08,"PPA0465/106/002","PCO Manufacturing","LOSARTANPOTASSIUM"
"2080","COZAAR","12.5 Milligram                                                                                            Film Coated Tablet",2009-03-06,"PA1286/004/001","Merck Sharp & Dohme Ireland (Human Health) Limited","LOSARTANPOTASSIUM"
"2081","COZAAR","50 Milligram                                                                                            Film Coated Tablet",1995-06-06,"PA1286/004/002","Merck Sharp & Dohme Ireland (Human Health) Limited","LOSARTANPOTASSIUM"
"2082","COZAAR","100 Milligram                                                                                            Film Coated Tablet",2001-11-16,"PA1286/004/003","Merck Sharp & Dohme Ireland (Human Health) Limited","LOSARTANPOTASSIUM"
"2083","COZAAR","50 Milligram                                                                                            Film Coated Tablet",2004-07-30,"PPA1151/005/001","Imbat Limited","LOSARTANPOTASSIUM"
"2084","COZAAR","100 Milligram                                                                                            Film Coated Tablet",2008-02-22,"PPA1151/005/002","Imbat Limited","LOSARTANPOTASSIUM"
"2085","Cozaar 100mg Film-Coated Tablets","100 milligram(s) Film-coated tablet",2010-02-12,"PPA1463/029/002","IMED Healthcare Ltd.","Losartanpotassium"
"2086","Cozaar 2.5mg/ml Powder and Solvent for Oral Suspension","2.5 milligram(s)/millilitre Powder for oral suspension",2009-02-27,"PA1286/004/004","Merck Sharp & Dohme Ireland (Human Health) Limited","Losartanpotassium"
"2087","Cozaar 50mg Film-Coated Tablets","50 milligram(s) Film-coated tablet",2010-02-12,"PPA1463/029/001","IMED Healthcare Ltd.","Losartanpotassium"
"2088","COZAAR COMP","50/12.5 Milligram                                                                                            Film Coated Tablet",2004-01-09,"PPA0465/109/001","PCO Manufacturing","LOSARTANPOTASSIUM|HYDROCHLOROTHIAZIDE"
"2089","COZAAR COMP","100/25 Milligram                                                                                            Film Coated Tablet",2008-02-08,"PPA0465/109/002","PCO Manufacturing","LOSARTANPOTASSIUM|HYDROCHLOROTHIAZIDE"
"2090","Cozaar Comp 100 mg/12.5 mg film-coated tablets","100/12.5 milligram(s) Film-coated tablet",NA,"PA1286/001/001","Merck Sharp & Dohme Ireland (Human Health) Limited","Losartanpotassium|Hydrochlorothiazide"
"2091","Cozaar Comp 100mg/25mg film-coated tablets","100/25 milligram(s) Film-coated tablet",NA,"PA1286/001/003","Merck Sharp & Dohme Ireland (Human Health) Limited","Losartanpotassium|Hydrochlorothiazide"
"2092","Cozaar Comp 50 mg/12.5 mg film-coated tablets","50/12.5 milligram(s) Film-coated tablet",NA,"PA1286/001/002","Merck Sharp & Dohme Ireland (Human Health) Limited","Losartanpotassium|Hydrochlorothiazide"
"2093","Cozatan 100 mg Film-coated Tablets","100 milligram(s) Film-coated tablet",2007-09-14,"PA0126/167/002","Clonmel Healthcare Ltd","Losartanpotassium"
"2094","Cozatan 50 mg Film-coated Tablets","50 milligram(s) Film-coated tablet",2007-09-14,"PA0126/167/001","Clonmel Healthcare Ltd","Losartanpotassium"
"2095","Cozatan Comp 100 mg/25 mg film-coated tablets","100/25 milligram(s) Film-coated tablet",2009-01-23,"PA0126/184/002","Clonmel Healthcare Ltd","Losartanpotassium|Hydrochlorothiazide"
"2096","Cozatan Comp 50 mg/12.5 mg film-coated tablets","50/12.5 milligram(s) Film-coated tablet",2009-01-23,"PA0126/184/001","Clonmel Healthcare Ltd","Losartanpotassium|Hydrochlorothiazide"
"2097","CRAMPEX TABLETS","%v/v                                                                                                 Tablets",1993-04-23,"PA0610/006/001","Thornton & Ross Limited","COLECALCIFEROL|CALCIUMCARBONATE|NICOTINICACID"
"2098","CREON","25000 Unknown Capsules Gastro-Resistant",2004-06-25,"PPA0465/125/002","PCO Manufacturing","PANCREATIN"
"2099","CREON","25000 Unknown Capsules Gastro-Resistant",2015-02-13,"PPA1562/143/001","LTT Pharma Limited","PANCREATIN"
"2100","CREON","150 Milligram                                                                                            Capsules Gastro-Resistant",2008-02-22,"PPA1151/065/001","Imbat Limited","PANCREASPOWDER"
"2101","CREON","25000  Capsules Gastro-Resistant",2014-06-20,"PPA1151/065/002","Imbat Limited","PANCREATIN"
"2102","CREON 10000","150 Milligram                                                                                            Capsules Gastro-Resistant",2010-02-12,"PPA1463/033/001","IMED Healthcare Ltd.","PANCREATIN"
"2103","CREON 10000","150 Milligram                                                                                            Capsules Gastro-Resistant",2018-02-16,"PPA1633/071/001","Primecrown 2010 Ltd","PANCREASPOWDER"
"2104","Creon 10000 Gastro-resistant Capsules","10000 units/dose Gastro-resistant capsule",2015-02-13,"PPA1562/143/002","LTT Pharma Limited","Pancreatin"
"2105","Creon 10000 Gastro-resistant Capsules","10000 *** AWAITING VALUE *** Gastro-resistant capsule",2004-06-25,"PPA0465/125/001","PCO Manufacturing","Pancreatin"
"2106","Creon 10000 Gastro-resistant Capsules","150 milligram(s) Gastro-resistant capsule",1997-03-21,"PA2010/008/001","Mylan IRE Healthcare Limited","Pancreaspowder"
"2107","CREON 25000","300 Milligram                                                                                            Capsules Gastro-Resistant",2013-01-10,"PPA1463/033/002","IMED Healthcare Ltd.","PANCREASPOWDER"
"2108","Creon 25000 Gastro-resistant Capsules","300 milligram(s) Gastro-resistant capsule",1997-04-24,"PA2010/008/002","Mylan IRE Healthcare Limited","Pancreaspowder"
"2109","Creon 40000 Gastro-resistant Capsules","400 milligram(s) Gastro-resistant capsule",2006-09-08,"PA2010/008/003","Mylan IRE Healthcare Limited","Pancreaspowder"
"2110","Creon for Children 5000 Gastro-resistant Granules","60.12 milligram(s) Gastro-resistant granules",2006-06-23,"PA2010/008/004","Mylan IRE Healthcare Limited","Pancreaspowder"
"2111","Cresemba","200 milligram(s) ZZZ Pdr/Conc/Soln for Infus",2015-10-15,"EU/1/15/1036/001","Basilea Medical Ltd (c/o Cox Costello & Horne Limited)","Isavuconazoniumsulfate"
"2112","CRESEMBA","100 Milligram                                                                                            Capsules Hard",2015-10-15,"EU/1/15/1036/002","Basilea Medical Ltd (c/o Cox Costello & Horne Limited)","ISAVUCONAZONIUMSULFATE"
"2113","CRESTOR","40 Milligram                                                                                            Film Coated Tablet",2013-03-27,"PPA1151/044/004","Imbat Limited","ROSUVASTATIN(ASCALCIUM)"
"2114","Crestor 10 mg film-coated tablets","10 milligram(s) Film-coated tablet",2018-04-27,"PPA1463/119/002","IMED Healthcare Ltd.","Rosuvastatin"
"2115","Crestor 10 mg film-coated tablets","10 milligram(s) Film-coated tablet",2003-04-17,"PA0970/057/001","AstraZeneca UK Limited","Rosuvastatincalcium"
"2116","Crestor 10mg Film-coated Tablets","10 milligram(s) Film-coated tablet",2011-09-02,"PPA1151/044/002","Imbat Limited","Rosuvastatin(ascalcium)"
"2117","Crestor 10mg film-coated tablets","10 milligram(s) Film-coated tablet",2018-10-12,"PPA0465/441/002","PCO Manufacturing","Rosuvastatincalcium|Rosuvastatin(ascalcium)"
"2118","Crestor 20 mg film-coated tablets","20 milligram(s) Film-coated tablet",2018-04-27,"PPA1463/119/003","IMED Healthcare Ltd.","Rosuvastatin"
"2119","Crestor 20 mg film-coated tablets","20 milligram(s) Film-coated tablet",2003-04-17,"PA0970/057/002","AstraZeneca UK Limited","Rosuvastatincalcium"
"2120","Crestor 20mg film-coated tablets","20 milligram(s) Film-coated tablet",2018-10-12,"PPA0465/441/003","PCO Manufacturing","Rosuvastatincalcium|Rosuvastatin(ascalcium)"
"2121","Crestor 20mg Film-coated tablets","20 milligram(s) Film-coated tablet",2007-11-09,"PPA1151/044/001","Imbat Limited","Rosuvastatin"
"2122","Crestor 40 mg film-coated tablets","40 milligram(s) Film-coated tablet",2003-04-17,"PA0970/057/003","AstraZeneca UK Limited","Rosuvastatincalcium|Rosuvastatincalcium"
"2123","Crestor 40mg film-coated tablets","40 milligram(s) Film-coated tablet",2018-10-12,"PPA0465/441/004","PCO Manufacturing","Rosuvastatincalcium|Rosuvastatin(ascalcium)"
"2124","Crestor 5 mg film-coated tablets","5 milligram(s) Film-coated tablet",2013-03-27,"PPA1151/044/003","Imbat Limited","Rosuvastatin(ascalcium)"
"2125","Crestor 5 mg film-coated tablets","5 milligram(s) Film-coated tablet",2018-04-27,"PPA1463/119/001","IMED Healthcare Ltd.","Rosuvastatin"
"2126","Crestor 5 mg film-coated tablets","5 milligram(s) Film-coated tablet",2005-09-23,"PA0970/057/004","AstraZeneca UK Limited","Rosuvastatincalcium"
"2127","Crestor 5mg film-coated tablets","5 milligram(s) Film-coated tablet",2018-10-12,"PPA0465/441/001","PCO Manufacturing","Rosuvastatincalcium|Rosuvastatin(ascalcium)"
"2128","CRINONE","8 %w/w                                                                                                 Vaginal Gel",2017-03-31,"PPA1463/112/001","IMED Healthcare Ltd.","PROGESTERONE"
"2129","CRINONE","8 Per Cent                                                                                             Vaginal Gel",2014-08-15,"PPA1151/235/001","Imbat Limited","PROGESTERONE"
"2130","CRINONE","8 %w/w                                                                                                 Vaginal Gel",2013-02-22,"PPA0465/301/001","PCO Manufacturing","PROGESTERONE"
"2131","Crinone 8% w/w progesterone vaginal gel","8 percent weight/weight Vaginal gel",1997-07-25,"PA2286/001/001","Merck Serono (Ireland) Limited","Progesterone"
"2132","Crinone 8% w/w progesterone vaginal gel","8 percent weight/weight Vaginal gel",2015-03-06,"PPA1562/146/001","LTT Pharma Limited","Progesterone"
"2133","CRIXIVAN","200 Milligram                                                                                            Capsule",1996-10-04,"EU/1/96/024/001","Merck Sharp & Dohme BV","INDINAVIRSULFATE"
"2134","CRIXIVAN","200 Milligram                                                                                            Capsule",1996-10-04,"EU/1/96/024/002","Merck Sharp & Dohme BV","INDINAVIRSULFATE"
"2135","CRIXIVAN","200 Milligram                                                                                            Capsule",1996-10-04,"EU/1/96/024/003","Merck Sharp & Dohme BV","INDINAVIRSULFATE"
"2136","CRIXIVAN","400 Milligram                                                                                            Capsule",1996-10-04,"EU/1/96/024/004","Merck Sharp & Dohme BV","INDINAVIRSULFATE"
"2137","CRIXIVAN","400 Milligram                                                                                            Capsule",1996-10-04,"EU/1/96/024/005","Merck Sharp & Dohme BV","INDINAVIRSULFATE"
"2138","CRIXIVAN","333 Milligram                                                                                            Capsule",1999-04-13,"EU/1/96/024/007","Merck Sharp & Dohme BV","INDINAVIRSULFATE"
"2139","CRIXIVAN","400 Milligram                                                                                            Capsule",1999-04-13,"EU/1/96/024/008","Merck Sharp & Dohme BV","INDINAVIRSULFATE"
"2140","CRIXIVAN","100 Base Milligrams                                                                                      Capsule",2000-11-16,"EU/1/96/024/010","Merck Sharp & Dohme BV","INDINAVIR"
"2141","CRYSTAPEN 600MG POWDER FOR SOLUTION FOR INJECTION","600 Milligram                                                                                            Pdr for Soln Inj/Inf",2001-04-20,"PA1496/001/001","Genus Pharmaceuticals Limited","BENZYLPENICILLINSODIUM"
"2142","CRYSVITA","10 milligram(s)/millilitre Solution for injection",2018-02-19,"EU/1/17/1262/001","Kyowa Kirin Holdings B.V.","Recombinanthumanigg1monoclonalantibodytofibroblastgrowthfactor23"
"2143","CRYSVITA","20 milligram(s)/millilitre Solution for injection",2018-02-19,"EU/1/17/1262/002","Kyowa Kirin Holdings B.V.","Recombinanthumanigg1monoclonalantibodytofibroblastgrowthfactor23"
"2144","CRYSVITA","30 milligram(s)/millilitre Solution for injection",2018-02-19,"EU/1/17/1262/003","Kyowa Kirin Holdings B.V.","Recombinanthumanigg1monoclonalantibodytofibroblastgrowthfactor23"
"2145","CUBICIN","350 Milligram                                                                                            Pdr for Soln Inj/Inf",2006-01-19,"EU/1/05/328/001","Merck Sharp & Dohme BV","DAPTOMYCIN"
"2146","CUBICIN","500 Milligram                                                                                            Pdr for Soln Inj/Inf",2006-01-19,"EU/1/05/328/002","Merck Sharp & Dohme BV","DAPTOMYCIN"
"2147","Cuprior","150 milligram(s) Tablet",2017-09-05,"EU/1/17/1199/001","gmp-orphan SA","Trientinetetrahydrochloride"
"2148","CUPRYMINA","Radio-Pharm Precursor",2012-08-23,"EU/1/12/784/001","Sparkle S.r.l.","COPPER(64CU)CHLORIDE"
"2149","CURANAIL","5 %w/v                                                                                                 Medicated Nail Lacquer",2012-03-16,"PA0590/027/001","Galderma (UK) Ltd","AMOROLFINEHYDROCHLORIDE"
"2150","CUROSURF","120 Milligram                                                                                            Endotrachpulm Inst, Susp",1994-09-08,"PA0743/013/001","Chiesi Limited","PORCINELUNGSURFACTANT"
"2151","CUROSURF","Milligram                                                                                            Endotrachpulm Inst, Susp",1994-09-08,"PA0743/013/002","Chiesi Limited","PORCINELUNGSURFACTANT"
"2152","Cuvitru 200 mg/ml solution for subcutaneous injection","200 milligram(s)/millilitre Solution for injection",2016-07-08,"PA2004/008/001","Baxalta Innovations GmbH","Humannormalimmunoglobulin"
"2153","CYANOKIT","2.5 Grams                                                                                                Unknown",2007-11-23,"EU/1/07/420/001","SERB S.A.,","HYDROXOCOBALAMIN"
"2154","CYANOKIT","5 Grams                                                                                                Pdr for Soln for Infusion",2010-10-07,"EU/1/07/420/002","SERB S.A.,","HYDROXOCOBALAMIN"
"2155","CYCLIMORPH 10","10/50mg/ml Milligram                                                                                            Solution for Injection",1978-04-01,"PA1142/003/001","Amdipharm Limited","MORPHINETARTRATE|CYCLIZINE"
"2156","CYCLIMORPH 15","15/50mg/ml Milligram                                                                                            Solution for Injection",1978-04-01,"PA1142/003/002","Amdipharm Limited","MORPHINETARTRATE|CYCLIZINE"
"2157","CYKLOKAPRON","500 Milligram                                                                                            Film Coated Tablet",1983-04-01,"PA1332/003/001","Meda Health Sales Ireland Limited","TRANEXAMICACID"
"2158","Cyklokapron 500mg/5ml, Solution for injection or infusion","500mg/5ml mg/5ml Solution for injection",1983-04-01,"PA0822/117/001","Pfizer Healthcare Ireland","Tranexamicacid"
"2159","CYLTEZO","40 Milligram                                                                                            Solution for injection in pre-filled syringe",2017-11-10,"EU/1/17/1240/001-004","Boehringer Ingelheim International GmbH","ADALIMUMAB"
"2160","CYLTEZO","40 Milligram                                                                                            Solution for injection in pre-filled pen",2017-11-10,"EU/1/17/1240/005-008","Boehringer Ingelheim International GmbH","ADALIMUMAB"
"2161","CYMALON","N/A Granules for oral solution",1989-02-08,"PA1380/051/001","Actavis Group PTC ehf","CITRICACID|SODIUMBICARBONATE|SODIUMCITRATEDIHYDRATE|SODIUMCARBONATEANHYDROUS"
"2162","Cymbalta","60 milligram(s) Gastro-resistant capsule",2004-12-17,"EU/1/04/296/002-005","Eli Lilly Nederland B.V.","Duloxetine"
"2163","Cymbalta","30 milligram(s) Gastro-resistant capsule",2004-12-17,"EU/1/04/296/1-4","Eli Lilly Nederland B.V.","Duloxetinehydrochloride"
"2164","CYMEVENE","500 mg Milligram                                                                                            Pdr/Conc/Soln for Infus",1990-01-09,"PA2307/001/001","Roche Products (Ireland) Ltd","GANCICLOVIRSODIUM"
"2165","CYMEX","Cream",1997-04-23,"PA1380/012/001","Actavis Group PTC ehf","UREA|CETRIMONIUMBROMIDE|CHLOROCRESOL|DIMETICONE"
"2166","Cyramza","10 milligram(s)/millilitre Concentrate for solution for infusion",2014-12-19,"EU/1/14/957/001-003","Eli Lilly Nederland B.V.","Ramucirumab"
"2167","CYSTADANE","1 Grams                                                                                                Oral Powder",2007-02-15,"EU/1/06/379/001","Orphan Europe","BETAINEANHYDROUS"
"2168","Cystadrops","3.8 milligram(s)/millilitre Eye drops, solution",2017-01-19,"EU/1/15/1049/001","Orphan Europe","Mercaptaminehydrochloride"
"2169","CYSTAGON","50 Milligram                                                                                            Capsule",1997-06-23,"EU/1/97/039/001","Orphan Europe Sarl","MERCAPTAMINEBITARTRATE"
"2170","CYSTAGON","50 Milligram                                                                                            Capsule",1997-06-23,"EU/1/97/039/002","Orphan Europe Sarl","MERCAPTAMINEBITARTRATE"
"2171","CYSTAGON","150 Milligram                                                                                            Capsule",1997-06-23,"EU/1/97/039/003","Orphan Europe Sarl","MERCAPTAMINEBITARTRATE"
"2172","CYSTAGON","150 Milligram                                                                                            Capsule",1997-06-23,"EU/1/97/039/004","Orphan Europe Sarl","MERCAPTAMINEBITARTRATE"
"2173","CYSTOPURIN","3 Grams                                                                                                Granules for oral solution",2011-04-08,"PPA1151/144/001","Imbat Limited","POTASSIUMCITRATE"
"2174","Cystopurin 3g Granules for oral solution","3 gram(s) Granules for oral solution",1995-09-19,"PA1410/042/001","Bayer Limited","Potassiumcitrate"
"2175","Cystrin 3 mg Tablets","3 milligram(s) Tablet",1998-03-26,"PA0077/156/001","Sanofi-aventis Ireland Ltd","OXYBUTYNINHYDROCHLORIDE"
"2176","Cystrin 3mg Tablets","3 milligram(s) Tablet",1993-03-26,"PA0540/143/001","Sanofi-Aventis Ireland Limited T/A SANOFI","OXYBUTYNINHYDROCHLORIDE"
"2177","Cystrin 5mg Tablets","5 milligram(s) Tablet",1991-10-11,"PA0540/143/002","Sanofi-Aventis Ireland Limited T/A SANOFI","OXYBUTYNINHYDROCHLORIDE"
"2178","CYTARABINE","100 Mg/Ml Solution for Inj/Inf",2013-02-15,"PA1390/091/001","Accord Healthcare Limited","CYTARABINE"
"2179","Cytarabine 100 mg/ml Solution for Injection","100 milligram(s)/millilitre Solution for injection",1990-05-21,"PA0822/200/002","Pfizer Healthcare Ireland","Cytarabine"
"2180","Cytarabine 100 mg/ml Solution for Injection or Infusion","100 milligram(s)/millilitre Solution for injection/infusion",2012-11-23,"PA1422/009/001","Fresenius Kabi Oncology Plc","Cytarabine"
"2181","Cytarabine 20 mg/ml Solution for Injection or Infusion","20 milligram(s)/millilitre Solution for injection/infusion",1989-11-20,"PA0822/200/001","Pfizer Healthcare Ireland","Cytarabine"
"2182","Cytarabine 20 mg/ml Solution for Injection/Infusion","20 milligram(s)/millilitre Solution for injection/infusion",2018-06-22,"PA1390/091/002","Accord Healthcare Limited","Cytarabine"
"2183","Cytotec 200 microgram Tablets","200 microgram(s) Tablet",1989-04-11,"PA0822/118/001","Pfizer Healthcare Ireland","Misoprostol"
"2184","DACARBAZIN LIPOMED","500 Milligram                                                                                            Pdr for Soln for Infusion",2017-08-18,"PA1760/001/002","Lipomed GmbH","DACARBAZINE"
"2185","DACARBAZIN LIPOMED","1000 Milligram                                                                                            Pdr for Soln for Infusion",2017-08-18,"PA1760/001/003","Lipomed GmbH","DACARBAZINE"
"2186","Dacarbazine Lipomed 200 mg powder for solution for injection or infusion","200 milligram(s) Powder for solution for injection/infusion",2012-07-06,"PA1760/001/001","Lipomed GmbH","Dacarbazine"
"2187","DACARBAZINE MEDAC","200 Milligram                                                                                            Pdr for Soln Inj/Inf",1997-11-14,"PA0623/003/002","Medac Gesellschaft fur Klinische Spezialpraparate mbH","DACARBAZINECITRATE"
"2188","DACARBAZINE MEDAC","500 Milligram                                                                                            Pdr for Soln for Infusion",1997-11-14,"PA0623/003/003","Medac Gesellschaft fur Klinische Spezialpraparate mbH","DACARBAZINECITRATE"
"2189","DACARBAZINE MEDAC","1000 Milligram                                                                                            Pdr for Soln for Infusion",1997-11-14,"PA0623/003/004","Medac Gesellschaft fur Klinische Spezialpraparate mbH","DACARBAZINECITRATE"
"2190","DACEPTON","5 Mg/Ml Solution for Infusion",2014-05-09,"PA1774/001/002","EVER Valinject GmbH","APOMORPHINEHYDROCHLORIDEHEMIHYDRATE"
"2191","DACEPTON","10 Mg/Ml Infus/Pdr/Oral Soln",2017-06-16,"PA1774/001/003","EVER Valinject GmbH","APOMORPHINEHYDROCHLORIDE"
"2192","Dacogen","50 *** AWAITING VALUE *** ZZZ Pdr/Conc/Soln for Infus",NA,"EU/1/12/792/001","Janssen-Cilag International NV","Decitabine"
"2193","DAFIRO","5/80 Unknown Film Coated Tablet",2007-01-16,"EU/1/06/371/001-008","Novartis Europharm Limited","AMLODIPINEBESYLATE|VALSARTAN"
"2194","DAFIRO","5/160 Unknown Film Coated Tablet",2007-01-16,"EU/1/06/371/009-016","Novartis Europharm Limited","AMLODIPINEBESYLATE|VALSARTAN"
"2195","DAFIRO","10/160 Unknown Film Coated Tablet",2007-01-16,"EU/1/06/371/017-024","Novartis Europharm Limited","AMLODIPINEBESYLATE|VALSARTAN"
"2196","DAFIRO HCT","5/160/12.5 Milligram                                                                                            Film Coated Tablet",2009-11-04,"EU/1/09/574/1-12","Novartis Europharm Limited","AMLODIPINEBESYLATE|VALSARTAN|HYDROCHLOROTHIAZIDE"
"2197","DAFIRO HCT","10/160/12. Milligram                                                                                            Film Coated Tablet",2009-11-04,"EU/1/09/574/13-24","Novartis Europharm Limited","AMLODIPINEBESYLATE|VALSARTAN|HYDROCHLOROTHIAZIDE"
"2198","DAFIRO HCT","5/160/25 Milligram                                                                                            Film Coated Tablet",2009-11-04,"EU/1/09/574/25-36","Novartis Europharm Limited","AMLODIPINEBESYLATE|VALSARTAN|HYDROCHLOROTHIAZIDE"
"2199","DAFIRO HCT","10/160/25 Milligram                                                                                            Film Coated Tablet",2009-11-04,"EU/1/09/574/37-48","Novartis Europharm Limited","AMLODIPINEBESYLATE|VALSARTAN|HYDROCHLOROTHIAZIDE"
"2200","DAFIRO HCT","10/320/25 Milligram                                                                                            Film Coated Tablet",2009-11-04,"EU/1/09/574/49-60","Novartis Europharm Limited","AMLODIPINEBESYLATE|VALSARTAN|HYDROCHLOROTHIAZIDE"
"2201","Daklinza","30 milligram(s) Film-coated tablet",2014-08-22,"EU/1/14/939/001-002","Bristol-Myers Squibb Pharma EEIG","Daclatasvirdihydrochloride"
"2202","DAKLINZA","60 Milligram                                                                                            Film Coated Tablet",2014-08-22,"EU/1/14/939/003-004","Bristol-Myers Squibb Pharma EEIG","DACLATASVIRDIHYDROCHLORIDE"
"2203","DAKLINZA","90 Milligram                                                                                            Film Coated Tablet",2016-06-24,"EU/1/14/939/005-006","Bristol-Myers Squibb Pharma EEIG","DECLATASVIRDIHYDROCHLORIDE(BMS-790052-05)"
"2204","DAKTACORT 2% / 1% W/W CREAM","2% / 1% %w/w                                                                                                 Cream",1996-12-16,"PA0748/026/001","Janssen-Cilag Ltd","MICONAZOLENITRATE|HYDROCORTISONE"
"2205","DAKTARIN","2.0 %w/w                                                                                                 Cream",1988-03-31,"PA0330/048/001","Johnson & Johnson (Ireland) Limited","MICONAZOLENITRATE"
"2206","DAKTARIN","2.0 %w/w                                                                                                 Cutaneous Powder",1977-04-01,"PA0330/048/002","Johnson & Johnson (Ireland) Limited","MICONAZOLENITRATE"
"2207","Daktarin 20mg/g Oral Gel","20mg/g mg/5ml Oral gel",1979-07-10,"PA0330/048/003","Johnson & Johnson (Ireland) Limited","Miconazole"
"2208","DALACIN","2 Per Cent                                                                                             Vaginal Cream",2015-12-11,"PPA0465/416/001","PCO Manufacturing","CLINDAMYCINPHOSPHATE"
"2209","Dalacin 100 mg Vaginal Ovule","100 milligram(s) Pessary",1998-12-21,"PA0822/119/001","Pfizer Healthcare Ireland","CLINDAMYCINPHOSPHATE"
"2210","Dalacin 2% Vaginal Cream","2 percent weight/weight Vaginal cream",1993-10-15,"PA0822/119/002","Pfizer Healthcare Ireland","CLINDAMYCINPHOSPHATE"
"2211","Dalacin 2% Vaginal Cream","2 percent Vaginal cream",2015-06-19,"PPA1562/162/001","LTT Pharma Limited","Clindamycin"
"2212","DALACIN C","150 Milligram                                                                                            Capsules Hard",2014-08-29,"PPA1151/223/001","Imbat Limited","CLINDAMYCINHYDROCHLORIDE"
"2213","DALACIN C","150 Milligram                                                                                            Capsules Hard",2013-06-28,"PPA1633/028/001","Primecrown 2010 Ltd","CLINDAMYCINHYDROCHLORIDE"
"2214","Dalacin C 150 mg Hard Capsules","150 ZZZ Base Milligrams Capsule, hard",1977-05-10,"PA0822/120/001","Pfizer Healthcare Ireland","Clindamycinhydrochloride"
"2215","Dalacin C 150 mg Hard Capsules","150 milligram(s) Capsule, hard",2007-10-05,"PPA0465/205/001","PCO Manufacturing","Clindamycin"
"2216","DALACIN C PHOSPHATE 2ML","150 Mg/Ml Concentrate for Soln for Inf",1976-09-09,"PA0822/120/002","Pfizer Healthcare Ireland","CLINDAMYCINPHOSPHATE"
"2217","DALACIN C PHOSPHATE 4ML","150 Mg/Ml Concentrate for Soln for Inf",1976-09-09,"PA0822/120/003","Pfizer Healthcare Ireland","CLINDAMYCINPHOSPHATE"
"2218","Dalacin T Topical 10 mg/ml Cutaneous Solution","10 milligram(s)/millilitre Cutaneous solution",1989-04-12,"PA0822/121/002","Pfizer Healthcare Ireland","CLINDAMYCINPHOSPHATE"
"2219","Dalacin T Topical Lotion 10 mg/ml Cutaneous Emulsion","10 milligram(s)/millilitre Cutaneous emulsion",1991-01-03,"PA0822/121/001","Pfizer Healthcare Ireland","Clindamycin"
"2220","Dalmane 15 mg Hard Capsules","15 *** AWAITING VALUE *** Capsule, hard",1977-04-01,"PA2010/039/001","Mylan IRE Healthcare Limited","FLURAZEPAMHYDROCHLORIDE"
"2221","Dalmane 30 mg Hard Capsules","30 *** AWAITING VALUE *** Capsule, hard",1977-04-01,"PA2010/039/002","Mylan IRE Healthcare Limited","FLURAZEPAMHYDROCHLORIDE"
"2222","DALMAPAM","15                                                                                                      Capsules Hard",1993-04-14,"PA0281/073/001","Pinewood Laboratories Ltd,","FLURAZEPAMHYDROCHLORIDE"
"2223","DALMAPAM","30                                                                                                      Capsules Hard",1993-04-14,"PA0281/073/002","Pinewood Laboratories Ltd,","FLURAZEPAMHYDROCHLORIDE"
"2224","DANCEX SR","5 Milligram                                                                                            Tablet Prolonged Release",2008-08-01,"PA0711/143/001","Rowex Ltd","OXYCODONEHYDROCHLORIDE"
"2225","DANCEX SR","10 Milligram                                                                                            Tablet Prolonged Release",2008-08-01,"PA0711/143/002","Rowex Ltd","OXYCODONEHYDROCHLORIDE"
"2226","DANCEX SR","20 Milligram                                                                                            Tablet Prolonged Release",2008-08-01,"PA0711/143/003","Rowex Ltd","OXYCODONEHYDROCHLORIDE"
"2227","DANCEX SR","40 Milligram                                                                                            Tablet Prolonged Release",2012-09-24,"PA0711/143/004","Rowex Ltd","OXYCODONEHYDROCHLORIDE"
"2228","DANCEX SR","80 Milligram                                                                                            Tablet Prolonged Release",2012-09-24,"PA0711/143/006","Rowex Ltd","OXYCODONEHYDROCHLORIDE"
"2229","DANCEX SR PLUS","5 / 2.5 Milligram                                                                                            Tablet Prolonged Release",2016-04-15,"PA0711/250/001","Rowex Ltd","OXYCODONEHYDROCHLORIDE|NALOXONEHYDROCHLORIDE"
"2230","DANCEX SR PLUS","10 / 5 Milligram                                                                                            Tablet Prolonged Release",2016-04-15,"PA0711/250/002","Rowex Ltd","OXYCODONEHYDROCHLORIDE|NALOXONEHYDROCHLORIDE"
"2231","DANCEX SR PLUS","20 / 10 Milligram                                                                                            Tablet Prolonged Release",2016-04-15,"PA0711/250/003","Rowex Ltd","OXYCODONEHYDROCHLORIDE|NALOXONEHYDROCHLORIDE"
"2232","DANCEX SR PLUS","40 / 20 Milligram                                                                                            Tablet Prolonged Release",2016-04-15,"PA0711/250/004","Rowex Ltd","OXYCODONEHYDROCHLORIDE|NALOXONEHYDROCHLORIDE"
"2233","Dantrium 100mg Capsules","100 milligram(s) Capsule, hard",1975-03-19,"PA1336/004/002","Norgine B.V.","DANTROLENESODIUM"
"2234","Dantrium 25 mg Capsules","25 milligram(s) Capsule, hard",1975-03-19,"PA1336/004/001","Norgine B.V.","DANTROLENESODIUM"
"2235","Dantrium Intravenous 20mg Powder for Solution for injection","20 milligram(s) Powder for solution for injection",1980-12-02,"PA1336/004/003","Norgine B.V.","DANTROLENESODIUM"
"2236","DAPTOMYCIN CLONMEL","350 Milligram                                                                                            Pdr for Soln Inj/Inf",2017-07-14,"PA0126/286/001","Clonmel Healthcare Ltd","DAPTOMYCIN"
"2237","DAPTOMYCIN CLONMEL","500 Milligram                                                                                            Pdr for Soln Inj/Inf",2017-07-14,"PA0126/286/002","Clonmel Healthcare Ltd","DAPTOMYCIN"
"2238","DAPTOMYCIN HOSPIRA","350 Milligram                                                                                            Pdr for Soln Inj/Inf",2017-03-22,"EU/1/17/1175/001-002","Hospira  UK Limited","DAPTOMYCIN"
"2239","DAPTOMYCIN HOSPIRA","500 Milligram                                                                                            Pdr for Soln Inj/Inf",2017-03-22,"EU/1/17/1175/003-004","Hospira  UK Limited","DAPTOMYCIN"
"2240","DAPTOMYCIN XELLIA","350 Milligram                                                                                            Pdr for Soln Inj/Inf",2017-09-15,"PA1982/003/001","Xellia Pharmaceuticals ApS","DAPTOMYCIN"
"2241","DAPTOMYCIN XELLIA","500 Milligram                                                                                            Pdr for Soln Inj/Inf",2017-09-15,"PA1982/003/002","Xellia Pharmaceuticals ApS","DAPTOMYCIN"
"2242","DARUNAVIR","600 Milligram                                                                                            Film Coated Tablet",2017-06-02,"PA1986/015/002","Teva B.V.","DARUNAVIR"
"2243","DARUNAVIR CLONMEL","600 Milligram                                                                                            Film Coated Tablet",2017-06-02,"PA0126/299/002","Clonmel Healthcare Ltd","DARUNAVIR"
"2244","DARUNAVIR CLONMEL","800 Milligram                                                                                            Film Coated Tablet",2017-06-02,"PA0126/299/003","Clonmel Healthcare Ltd","DARUNAVIR"
"2245","DARUNAVIR KRKA","400 Milligram                                                                                            Film Coated Tablet",2018-01-26,"EU/1/17/1249/001-004","Krka d.d., Novo mesto","DARUNAVIR"
"2246","DARUNAVIR KRKA","600 Milligram                                                                                            Film Coated Tablet",2018-01-26,"EU/1/17/1249/005-008","Krka d.d., Novo mesto","DARUNAVIR"
"2247","DARUNAVIR KRKA","800 Milligram                                                                                            Film Coated Tablet",2018-01-26,"EU/1/17/1249/009-010","Krka d.d., Novo mesto","DARUNAVIR"
"2248","DARUNAVIR KRKA D.D.","400 Milligram                                                                                            Film Coated Tablet",2018-01-18,"EU/1/17/1248/001-004","Krka d.d., Novo mesto","DARUNAVIR"
"2249","DARUNAVIR KRKA D.D.","600 Milligram                                                                                            Film Coated Tablet",2018-01-18,"EU/1/17/1248/005-008","Krka d.d., Novo mesto","DARUNAVIR"
"2250","DARUNAVIR KRKA D.D.","800 Milligram                                                                                            Film Coated Tablet",2018-01-18,"EU/1/17/1248/009-010","Krka d.d., Novo mesto","DARUNAVIR"
"2251","DARUNAVIR MYLAN","75 Milligram                                                                                            Film Coated Tablet",2017-01-04,"EU/1/16/1140/001-005","Generics (UK) Limited","DARUNAVIR"
"2252","DARUNAVIR MYLAN","150 Milligram                                                                                            Film Coated Tablet",2017-01-04,"EU/1/16/1140/006-011","Generics (UK) Limited","DARUNAVIR"
"2253","DARUNAVIR MYLAN","300 Milligram                                                                                            Film Coated Tablet",2017-01-04,"EU/1/16/1140/012-021","Generics (UK) Limited","DARUNAVIR"
"2254","DARUNAVIR MYLAN","400 Milligram                                                                                            Film Coated Tablet",2017-01-04,"EU/1/16/1140/022-029","Generics (UK) Limited","DARUNAVIR"
"2255","DARUNAVIR MYLAN","600 Milligram                                                                                            Film Coated Tablet",2017-01-04,"EU/1/16/1140/030-038","Generics (UK) Limited","DARUNAVIR"
"2256","DARUNAVIR MYLAN","800 Milligram                                                                                            Film Coated Tablet",2017-01-04,"EU/1/16/1140/039-045","Generics (UK) Limited","DARUNAVIR"
"2257","DARUNAVIR ROWEX","75 Milligram                                                                                            Film Coated Tablet",2017-06-02,"PA0711/269/001","Rowex Ltd","DARUNAVIR"
"2258","DARUNAVIR ROWEX","400 Milligram                                                                                            Film Coated Tablet",2017-06-02,"PA0711/269/002","Rowex Ltd","DARUNAVIR"
"2259","DARUNAVIR ROWEX","600 Milligram                                                                                            Film Coated Tablet",2017-06-02,"PA0711/269/003","Rowex Ltd","DARUNAVIR"
"2260","DARUNAVIR ROWEX","800 Milligram                                                                                            Film Coated Tablet",2017-06-02,"PA0711/269/004","Rowex Ltd","DARUNAVIR"
"2261","Darzalex","20 milligram(s)/millilitre Concentrate for solution for infusion",2016-05-20,"EU/1/16/1101/001-002","Janssen-Cilag International NV","Daratumumab"
"2262","DASERGIN","5 Milligram                                                                                            Film Coated Tablet",2018-07-06,"PA2096/006/001","HCS bvba","DESLORATADINE"
"2263","DASSAN","700 Milligram                                                                                            Medicated Plaster",2017-12-22,"PA2242/002/001","Grunenthal Pharma Ltd","LIDOCAINE"
"2264","DASSELTA","5 Milligram                                                                                            Film Coated Tablet",2011-11-28,"EU/1/11/739/001-008","Krka d.d., Novo mesto","DESLORATIDINE"
"2265","DATSCAN","2.5 Millilitre                                                                                           Solution for Injection",2000-07-27,"EU/1/00/135/001","GE Healthcare Limited","IOFLUPANE"
"2266","Daxas","500 microgram(s) Film-coated tablet",NA,"EU/1/10/636/001-3","AstraZeneca AB","Roflumilast"
"2267","Daxas","250 ZZZ Micrograms/g Tablet",NA,"EU/1/10/636/008","AstraZeneca AB","Roflumilast"
"2268","Day Nurse CapsulesParacetamol 500mgPseudoephedrine Hydrochloride 30mgPholcodine 5mg","500/30/5 milligram(s) Capsule, hard",2003-11-04,"PA0678/100/001","GlaxoSmithKline Consumer Healthcare (Ireland) Limited","Pholcodine|Paracetamol|PSEUDOEPHEDRINEHYDROCHLORIDE"
"2269","Dazonay 100mg/25mg/200mg Film-coated Tablets","100/25/200 milligram(s) Film-coated tablet",2016-01-29,"PA0711/252/003","Rowex Ltd","Levodopa|Carbidopa|Entacapone"
"2270","Dazonay 125mg/31.25mg/200mg Film-coated Tablets","125/31.25/200 milligram(s) Film-coated tablet",2016-01-29,"PA0711/252/004","Rowex Ltd","Levodopa|Carbidopa|Entacapone"
"2271","Dazonay 150mg/37.5mg/200mg Film-coated Tablets","150/37.5/200 milligram(s) Film-coated tablet",2016-01-29,"PA0711/252/005","Rowex Ltd","Levodopa|Carbidopa|Entacapone"
"2272","Dazonay 175mg/43.75mg/200mg Film-coated Tablets","175/43.75/200 milligram(s) Film-coated tablet",2016-01-29,"PA0711/252/006","Rowex Ltd","Levodopa|Carbidopa|Entacapone"
"2273","Dazonay 200mg/50mg/200mg Film-coated Tablets","200/50/200 milligram(s) Film-coated tablet",2016-01-29,"PA0711/252/007","Rowex Ltd","Levodopa|Carbidopa|Entacapone"
"2274","Dazonay 50mg/12.5mg/200mg Film-coated Tablets","50/12.5/200 milligram(s) Film-coated tablet",2016-01-29,"PA0711/252/001","Rowex Ltd","Levodopa|Carbidopa|Entacapone"
"2275","Dazonay 75mg/18.75mg/200mg Film-coated Tablets","75/18.75/200 milligram(s) Film-coated tablet",2016-01-29,"PA0711/252/002","Rowex Ltd","Levodopa|Carbidopa|Entacapone"
"2276","DDAVP Desmopressin 100 micrograms/ml Nasal drops, solution","100 microgram(s)/millilitre Nasal drops, solution",NA,"PA1009/001/001","Ferring Ireland Ltd","DESMOPRESSINACETATE"
"2277","DDAVP/Desmopressin 0.1mg Tablets","0.1 milligram(s) Tablet",NA,"PA1009/001/003","Ferring Ireland Ltd","DESMOPRESSINACETATE"
"2278","DDAVP/Desmopressin 4 micrograms/ml Solution for Injection","4 microgram(s)/millilitre Solution for injection",NA,"PA1009/001/002","Ferring Ireland Ltd","DESMOPRESSINACETATE"
"2279","DECAPEPTYL 3-MONTH, 11.25 MG","11.25 Milligram                                                                                            Pdr+Solv for Susp for Inj",1998-10-02,"PA0869/003/002","Ipsen Pharmaceuticals Limited","TRIPTORELINPAMOATE"
"2280","Decapeptyl 3-month, 11.25 mg Powder and solvent for suspension for injection","11.25 milligram(s) Powder and solvent for suspension for injection",2011-05-20,"PPA0465/261/001","PCO Manufacturing","Triptorelin"
"2281","DECAPEPTYL 6-MONTH","22.5 Milligram                                                                                            Pdr+Solv for Susp for Inj",2011-04-08,"PA0869/003/003","Ipsen Pharmaceuticals Limited","TRIPTORELINPAMOATE"
"2282","DECAPEPTYL SR","3 Milligram                                                                                            Pdr+Solv for Susp for Inj",1989-12-05,"PA0869/003/001","Ipsen Pharmaceuticals Limited","TRIPTORELINACETATE"
"2283","Deep Freeze Cold Gel 2.0 % w/w","2 percent weight/weight Gel",1999-03-19,"PA0076/005/001","The Mentholatum Company Ltd.","Racementhol"
"2284","Deferiprone Lipomed","500 milligram(s) Film-coated tablet",2018-09-20,"EU/1/18/1310/001","Lipomed GmbH","Deferiprone"
"2285","Defitelio","200 milligram(s) Solution for infusion",2013-10-18,"EU/01/13/878/001","Gentium S.p.A.","Defibrotide"
"2286","DELMOSART PR","18 Milligram                                                                                            Tablet Prolonged Release",2016-09-16,"PA1380/195/001","Actavis Group PTC ehf","METHYLPHENIDATEHYDROCHLORIDE"
"2287","DELMOSART PR","27 Milligram                                                                                            Tablet Prolonged Release",2016-09-16,"PA1380/195/002","Actavis Group PTC ehf","METHYLPHENIDATEHYDROCHLORIDE"
"2288","DELMOSART PR","36 Milligram                                                                                            Tablet Prolonged Release",2016-09-16,"PA1380/195/003","Actavis Group PTC ehf","METHYLPHENIDATEHYDROCHLORIDE"
"2289","DELMOSART PR","54 Milligram                                                                                            Tablet Prolonged Release",2016-09-16,"PA1380/195/004","Actavis Group PTC ehf","METHYLPHENIDATEHYDROCHLORIDE"
"2290","DELTACORTRIL ENTERIC","5 Milligram                                                                                            Tablets Gastro-Resistant",1977-03-01,"PA1113/003/001","Phoenix Labs","PREDNISOLONE"
"2291","DELTACORTRIL ENTERIC","2.5 Milligram                                                                                            Tablets Gastro-Resistant",1977-03-01,"PA1113/003/002","Phoenix Labs","PREDNISOLONE"
"2292","DELTACORTRIL ENTERIC","5 Milligram                                                                                            Tablets Gastro-Resistant",2015-01-23,"PPA1151/213/001","Imbat Limited","PREDNISOLONE"
"2293","Deltyba","50 milligram(s) Film-coated tablet",2014-04-28,"EU/1/13/875/001-003","Otsuka Novel Products GmbH","Delamanid"
"2294","DENTINOX CRADLE CAP SHAMPOO","6 / 2.7 %w/w                                                                                                 Shampoo",1995-01-09,"PA0302/011/001","D.D.D. Limited","SODIUMLAURYLSULFATE|SODIUMLAURYLETHERSULFOSUCCINATE"
"2295","DENTINOX INFANT COLIC DROPS","42 MG/5ml                                                                                               Oral Suspension",1983-10-05,"PA0302/003/001","D.D.D. Limited","DIMETICONE,ACTIVATED"
"2296","DENTOMYCIN 2% w/w Periodontal Gel","2 percent weight/weight Gel",1998-12-10,"PA1321/001/001","Henry Schein UK Holdings Limited","Minocyclinehydrochloridedihydrate"
"2297","Denzapine ®100 mg Tablets","100 milligram(s) Tablet",2008-09-05,"PA0126/235/002","Clonmel Healthcare Ltd","Clozapine"
"2298","Denzapine ®25 mg Tablets","25 milligram(s) Tablet",2008-09-05,"PA0126/235/001","Clonmel Healthcare Ltd","Clozapine"
"2299","Denzapine 200 mg Tablets","200 milligram(s) Tablet",2009-04-03,"PA0126/235/004","Clonmel Healthcare Ltd","Clozapine"
"2300","Denzapine 50 mg/ml Oral Suspension","50 milligram(s)/millilitre Oral suspension",2009-03-06,"PA0126/235/005","Clonmel Healthcare Ltd","Clozapine"
"2301","Denzapine 50mg Tablets","50 milligram(s) Tablet",2009-04-03,"PA0126/235/003","Clonmel Healthcare Ltd","Clozapine"
"2302","DEPIXOL 20MG/ML SOLUTION FOR INJECTION","20 Micromol Solution for Injection",1976-06-21,"PA0115/001/001","Lundbeck Limited","FLUPENTIXOLDECANOATE"
"2303","DEPIXOL CONC. 100MG/ML SOLUTION FOR INJECTION","100 Micromol Solution for Injection",1988-01-25,"PA0115/001/009","Lundbeck Limited","FLUPENTIXOLDECANOATE"
"2304","DEPO-MEDRONE","40 Mg/Ml Suspension for Injection",1978-04-01,"PA0822/122/001","Pfizer Healthcare Ireland","METHYLPREDNISOLONEACETATE"
"2305","DEPO-MEDRONE","40 Mg/Ml Suspension for Injection",1978-04-01,"PA0822/122/002","Pfizer Healthcare Ireland","METHYLPREDNISOLONEACETATE"
"2306","DEPO-MEDRONE","40 Mg/Ml Suspension for Injection",1991-04-19,"PA0822/122/003","Pfizer Healthcare Ireland","METHYLPREDNISOLONEACETATE"
"2307","DEPO-MEDRONE 40MG/ML WITH LIDOCAINE","40/10 Mg/Ml Suspension for Injection",1981-03-02,"PA0822/123/002","Pfizer Healthcare Ireland","METHYLPREDNISOLONEACETATE|LIDOCAINEHYDROCHLORIDE"
"2308","DEPO-MEDRONE 40MG/ML WITH LIDOCAINE 10MG/ML","40 + 10 Mg/Ml Suspension for Injection",1983-07-05,"PA0822/123/001","Pfizer Healthcare Ireland","METHYLPREDNISOLONEACETATE|LIDOCAINEHYDROCHLORIDE"
"2309","DEPO-PROVERA","150 Mg/Ml Suspension for Injection",1996-01-19,"PA0822/124/001","Pfizer Healthcare Ireland","MEDROXYPROGESTERONEACETATE"
"2310","DEPREGER","100 Milligram                                                                                            Film Coated Tablet",2005-08-05,"PA0577/067/002","McDermott Laboratories Ltd t/a Gerard Laboratories","SERTRALINEHYDROCHLORIDE"
"2311","Depreger 50 mg film-coated tablet","50 milligram(s) Film-coated tablet",2005-08-05,"PA0577/067/001","McDermott Laboratories Ltd t/a Gerard Laboratories","Sertralinehydrochloride"
"2312","DERBAC-M LIQUID","0.5%w/w %w/w                                                                                                 Cutaneous Emulsion",1993-07-13,"PA0257/059/001","GR Lane Health Products Ltd","MALATHION"
"2313","DERMATRANS 10 mg/24 h transdermal patch","10 milligram(s)/24 hours Transdermal patch",2000-04-14,"PA0868/006/002","Rottapharm Ltd","Glyceryltrinitrate"
"2314","DERMATRANS 15 mg/24 h transdermal patch","15 milligram(s)/24 hours Transdermal patch",2000-04-14,"PA0868/006/003","Rottapharm Ltd","Glyceryltrinitrate"
"2315","DERMATRANS 5 mg/24 h transdermal patch","5 milligram(s)/24 hours Transdermal patch",2000-04-14,"PA0868/006/001","Rottapharm Ltd","Glyceryltrinitrate"
"2316","DERMESTRIL -SEPTEM","50 mcg/24 Microgram/day                                                                                        Transdermal Patch",1999-08-23,"PA0868/002/005","Rottapharm Ltd","ESTRADIOLHEMIHYDRATE"
"2317","DERMESTRIL-SEPTEM","75 mcg/24 Microgram/day                                                                                        Transdermal Patch",1999-08-23,"PA0868/002/006","Rottapharm Ltd","ESTRADIOLHEMIHYDRATE"
"2318","DERMESTRIL-SEPTEM","25 mcg/24 Microgram/day                                                                                        Transdermal Patch",1999-08-23,"PA0868/002/004","Rottapharm Ltd","ESTRADIOLHEMIHYDRATE"
"2319","DERMOVATE","0.05 %w/w                                                                                                 Cream",1983-10-27,"PA1077/005/001","GlaxoSmithKline (Ireland) Limited","CLOBETASOLPROPIONATE"
"2320","DERMOVATE","0.05 %w/w                                                                                                 Ointment",1983-10-27,"PA1077/005/002","GlaxoSmithKline (Ireland) Limited","CLOBETASOLPROPIONATE"
"2321","Dermovate 0.05 % w/w Ointment","0.05 percent weight/weight Ointment",2017-04-13,"PPA1097/011/001","Lexon (UK) Ltd","CLOBETASOLPROPIONATE"
"2322","DERMOVATE SCALP APPLICATION","0.05 %w/v                                                                                                 Cutaneous Solution",1983-10-27,"PA1077/005/003","GlaxoSmithKline (Ireland) Limited","CLOBETASOLPROPIONATE"
"2323","Dermovate Scalp Application 0.05% w/v Cutaneous Solution","0.05 percent weight/volume Cutaneous solution",2017-07-21,"PPA1097/011/002","Lexon (UK) Ltd","CLOBETASOLPROPIONATE"
"2324","Descovy","200mg/10mg milligram(s) Film-coated tablet",2016-04-21,"EU/1/16/1099/001-002","Gilead Sciences Ltd","Emtricitabine|Tenofoviralafenamide"
"2325","DESCOVY","200mg/25mg Unknown Film Coated Tablet",2016-04-21,"EU/1/16/1099/003-004","Gilead Sciences Ireland UC","EMTRICITABINE|TENOFOVIRALAFENAMIDE"
"2326","DESENEX OINTMENT","20 5 %w/w                                                                                                 Ointment",1998-03-20,"PA0126/154/001","Clonmel Healthcare Ltd","ZINCUNDECYLENATE|UNDECYLENICACID"
"2327","DESENEX POWDER","20/2 %w/w                                                                                                 Cutaneous Powder",1998-03-20,"PA0126/154/002","Clonmel Healthcare Ltd","ZINCUNDECYLENATE|UNDECYLENICACID"
"2328","DESFERAL","500 Milligram                                                                                            Pdr/Conc/Soln/Inj/Inf",1980-02-07,"PA0896/008/001","Novartis Ireland Limited","DEFEROXAMINEMESILATE"
"2329","Deslor 0.5 mg/ml Oral Solution","0.5 milligram(s)/millilitre Oral solution",2012-06-22,"PA0711/202/002","Rowex Ltd","Desloratidine"
"2330","Deslor 5 mg film-coated tablets","5 milligram(s) Film-coated tablet",2012-06-22,"PA0711/202/001","Rowex Ltd","Desloratidine"
"2331","DESLORATADINE","5 Milligram                                                                                            Film Coated Tablet",2012-01-13,"EU/1/11/745/001-009","Actavis Group PTC ehf","DESLORATIDINE"
"2332","DESLORATADINE","5 Milligram                                                                                            Film Coated Tablet",2012-01-13,"EU/1/11/746/001-012","Ratiopharm GmbH","DESLORATIDINE"
"2333","DESLORATADINE GLENMARK","5 Milligram                                                                                            Tablets",2012-04-20,"PA1462/007/001","Glenmark Pharmaceuticals Europe Limited","DESLORATIDINE"
"2334","DESLORATADINE TEVA","5 Milligram                                                                                            Film Coated Tablet",2011-11-24,"EU/1/11/732/001-013","Teva B.V.","DESLORATIDINE"
"2335","Desmospray, Desmopressin Nasal Spray","10 microgram(s) Nasal spray, solution",NA,"PA1009/005/001","Ferring Ireland Ltd","DESMOPRESSINACETATE"
"2336","Desmotabs 0.2mg Tablets","0.2 milligram(s) Tablet",NA,"PA1009/007/001","Ferring Ireland Ltd","DESMOPRESSINACETATE"
"2337","DESMOTABS MELT","120 Microgram                                                                                            Oral Lyophilisate",2011-07-08,"PPA0465/260/001","PCO Manufacturing","DESMOPRESSIN"
"2338","Desmotabs Melt 120 micrograms oral lyophilisate","120 microgram(s) Oral lyophilisate",NA,"PA1009/007/003","Ferring Ireland Ltd","DESMOPRESSINACETATE"
"2339","Desmotabs Melt 240 micrograms oral lyophilisate","240 microgram(s) Oral lyophilisate",NA,"PA1009/007/004","Ferring Ireland Ltd","DESMOPRESSINACETATE"
"2340","Desmotabs Melt 60 micrograms oral lyophilisate","60 microgram(s) Oral lyophilisate",NA,"PA1009/007/002","Ferring Ireland Ltd","DESMOPRESSINACETATE"
"2341","DESOGESTREL ROWEX","75 Microgram                                                                                            Film Coated Tablet",2015-10-02,"PA0711/243/001","Rowex Ltd","DESOGESTRELMICRONIZED"
"2342","DESUNIN","800 International Unit                                                                                   Tablets",2012-06-08,"PA1332/044/001","Meda Health Sales Ireland Limited","COLECALCIFEROL"
"2343","DESUNIN","1000 International Unit                                                                                   Tablets",2015-12-11,"PA1332/044/002","Meda Health Sales Ireland Limited","COLECALCIFEROL"
"2344","DESUNIN","2000 International Unit                                                                                   Tablets",2015-12-11,"PA1332/044/003","Meda Health Sales Ireland Limited","COLECALCIFEROL"
"2345","DESUNIN","4000 International Unit                                                                                   Tablets",2015-12-11,"PA1332/044/004","Meda Health Sales Ireland Limited","COLECALCIFEROLCONCENTRATE"
"2346","DESUNIN TABLETS","800 International Unit                                                                                   Tablets",2018-04-06,"PPA1463/116/001","IMED Healthcare Ltd.","COLECALCIFEROL"
"2347","DETRUNORM","15 Milligram                                                                                            Coated Tablets",2008-12-12,"PA0803/004/001","Apogepha Arzneimittel GmbH","PROPIVERINEHYDROCHLORIDE"
"2348","DETRUNORM XL","45 Milligram                                                                                            Capsules Modified Release",2011-09-30,"PA1142/004/003","Amdipharm Limited","PROPIVERINEHYDROCHLORIDE"
"2349","Detrunorm XL 30 mg Modified-Release Capsules","30 milligram(s) Capsules Modified Release",2007-09-28,"PA1142/004/002","Amdipharm Limited","Propiverinehydrochloride|Gelatin"
"2350","DETRUSITOL","1 Milligram                                                                                            Film Coated Tablet",2014-12-12,"PPA1562/060/002","LTT Pharma Limited","TOLTERODINEL-TARTRATE"
"2351","DETRUSITOL","2 Milligram                                                                                            Film Coated Tablet",2014-12-12,"PPA1562/060/003","LTT Pharma Limited","TOLTERODINEL-TARTRATE"
"2352","DETRUSITOL","1 Milligram                                                                                            Film Coated Tablet",2011-09-16,"PPA1151/158/001","Imbat Limited","TOLTERODINETARTRATE"
"2353","DETRUSITOL","2 Milligram                                                                                            Film Coated Tablet",2011-12-21,"PPA1151/158/002","Imbat Limited","TOLTERODINETARTARE"
"2354","Detrusitol 1 mg film-coated tablets","1 milligram(s) Film-coated tablet",1998-02-06,"PA0822/213/001","Pfizer Healthcare Ireland","Tolterodinel-tartrate"
"2355","Detrusitol 2 mg film-coated tablets","2 milligram(s) Film-coated tablet",1998-02-06,"PA0822/213/002","Pfizer Healthcare Ireland","Tolterodinel-tartrate"
"2356","DETRUSITOL SR","2 Milligram                                                                                            Prolonged Release Capsules",2001-07-27,"PA0822/125/001","Pfizer Healthcare Ireland","TOLTERODINEL-TARTRATE"
"2357","DETRUSITOL SR","4 Milligram                                                                                            Prolonged Release Capsules",2001-07-27,"PA0822/125/002","Pfizer Healthcare Ireland","TOLTERODINEL-TARTRATE"
"2358","DETRUSITOL SR","4 Milligram                                                                                            Prolonged Release Capsules",2012-02-03,"PPA1151/164/001","Imbat Limited","TOLTERODINETARTRATE"
"2359","DETTOL ANTISEPTIC DISINFECTANT","4.8% %w/v                                                                                                 Cutaneous Solution Concentrate",1983-04-01,"PA0979/004/002","Reckitt Benckiser Ireland Ltd","CHLOROXYLENOL"
"2360","DEXAFREE","1 Mg/Ml Eye Drops Solution",2012-08-24,"PA1107/005/001","Laboratoires Thea","DEXAMETHASONEPHOSPHATE"
"2361","Dexamethasone 10mg/5ml Oral Solution","10 mg/5ml Oral solution",2013-12-20,"PA0312/030/001","Rosemont Pharmaceuticals Ltd","Dexamethasonesodiumphosphate"
"2362","Dexamethasone 2mg Tablets","2 milligram(s) Tablet",1978-04-01,"PA1691/014/001","Aspen Pharma Trading Limited","Dexamethasone"
"2363","DEXAMETHASONE PHOSPHATE","4 Mg/Ml Solution for Inj/Inf",2015-01-09,"PA1339/052/002","Wockhardt UK Limited","DEXAMETHASONESODIUMPHOSPHATE"
"2364","DEXAMETHASONE PHOSPHATE","1.0 Mg/Ml Eye Drops Solution",2015-03-13,"PA1887/001/001","Alissa Healthcare Research Limited","DEXAMETHASONESODIUMPHOSPHATE"
"2365","Dexamethasone Phosphate 4 mg/ml Solution for Injection","4 milligram(s)/millilitre Solution for injection",1986-07-28,"PA0822/201/001","Pfizer Healthcare Ireland","Dexamethasonesodiumphosphate"
"2366","DEXAMETHASONE SODIUM PHOSPHATE","0.1 %w/v                                                                                                 Eye Drops Solution",2014-12-12,"PA1339/052/001","Wockhardt UK Limited","DEXAMETHASONESODIUMPHOSPHATE|DEXAMETHASONEPHOSPHATE"
"2367","Dexdor","100 microgram(s)/millilitre Concentrate for solution for infusion",2011-09-16,"EU/1/11/718/001-006","Orion Corporation","Dexmedetomidinehydrochloride"
"2368","DEXIMUNE","25 Milligram                                                                                            Capsules, Soft",2007-03-02,"PA2261/001/001","Dexcel Pharma GmbH","CICLOSPORIN"
"2369","DEXIMUNE","50 Milligram                                                                                            Capsules, Soft",2007-03-02,"PA2261/001/002","Dexcel Pharma GmbH","CICLOSPORIN"
"2370","DEXIMUNE","100 Milligram                                                                                            Capsules, Soft",2007-03-02,"PA2261/001/003","Dexcel Pharma GmbH","CICLOSPORIN"
"2371","DEXKETOPROFEN ROWEX","25 Milligram                                                                                            Film Coated Tablet",2013-10-11,"PA0711/216/002","Rowex Ltd","DEXKETOPROFENTROMETAMOL"
"2372","DEXLIQ","4 Mg/Ml Oral Solution",2017-06-30,"PA2137/001/001","Laboratoires CTRS","DEXAMETHASONESODIUMPHOSPHATE"
"2373","DEXMEDETOMIDINE EVER PHARMA","100 Microgram/ML                                                                                         Concentrate for Soln for Inf",2018-07-06,"PA1774/002/001","EVER Valinject GmbH","DEXMEDETOMIDINEHYDROCHLORIDE"
"2374","DEXSOL","2 MG/5ml                                                                                               Oral Solution",2006-02-03,"PA0312/009/001","Rosemont Pharmaceuticals Ltd","DEXAMETHASONESODIUMPHOSPHATE"
"2375","Diabact UBT","50 milligram(s) Tablet",NA,"PA1057/001/001","Orexo AB","13c-urea"
"2376","Diabact UBT 50 mg tablets","50 milligram(s) Tablet",2002-10-11,"PA1273/001/001","Kibion AB","13c-urea"
"2377","DIABREZIDE","80 Milligram                                                                                            Tablets",1999-04-30,"PA0925/001/001","L. Molteni & C. dei F.lli Alitti","GLICLAZIDE"
"2378","DIACLIDE MR","30 Milligram                                                                                            Modified-release Tablets",2009-07-24,"PA0577/030/002","McDermott Laboratories Ltd t/a Gerard Laboratories","GLICLAZIDE"
"2379","DIACLIDE MR","60 Milligram                                                                                            Modified-release Tablets",2015-02-13,"PA0577/030/003","McDermott Laboratories Ltd t/a Gerard Laboratories","GLICLAZIDE"
"2380","DIACOMIT","250 Milligram                                                                                            Capsule",2007-01-04,"EU/1/06/367/001-3","Biocodex","STIRIPENTOL"
"2381","DIACOMIT","500 Milligram                                                                                            Powder for Oral Suspension",2007-01-04,"EU/1/06/367/10-12","Biocodex","STIRIPENTOL"
"2382","DIACOMIT","500 Milligram                                                                                            Capsule",2007-01-04,"EU/1/06/367/4-6","Biocodex","STIRIPENTOL"
"2383","DIACOMIT","250 Milligram                                                                                            Powder for Oral Suspension",2007-01-04,"EU/1/06/367/7-9","Biocodex","STIRIPENTOL"
"2384","Diacronal MR 30 mg modified-release tablets","30 milligram(s) Modified-release tablet",2008-07-04,"PA1347/024/002","Krka d.d., Novo mesto","Gliclazide"
"2385","Diacronal MR 60 mg modified-release tablets","60 milligram(s) Modified-release tablet",2013-02-22,"PA1347/024/001","Krka d.d., Novo mesto","Gliclazide"
"2386","Diafer 50 mg/ml solution for injection","50 milligram(s)/millilitre Solution for injection",2014-05-09,"PA0982/004/001","Pharmacosmos A/S","Iron(iii)isomaltoside1000|Iron"
"2387","DIAGLYC","30 Milligram                                                                                            Modified-release Tablets",2008-08-01,"PA0749/076/001","Teva Pharma B.V.","GLICLAZIDE"
"2388","DIAMICRON","80 Milligram                                                                                            Tablets",2007-12-19,"PPA1151/026/002","Imbat Limited","GLICLAZIDE"
"2389","DIAMICRON MR","30 Milligram                                                                                            Modified-release Tablets",2008-01-18,"PPA1151/026/001","Imbat Limited","GLICLAZIDE"
"2390","DIAMICRON MR","30 Milligram                                                                                            Modified-release Tablets",2000-11-24,"PA0568/013/001","Les Laboratoires Servier","GLICLAZIDE"
"2391","DIAMICRON MR","60 Milligram                                                                                            Modified-release Tablets",2009-12-18,"PA0568/013/002","Les Laboratoires Servier","GLICLAZIDE"
"2392","DIAMOX","500 Milligram                                                                                            Pdr for Soln for Injection",1978-04-01,"PA0899/021/002","Mercury Pharmaceuticals Ltd","ACETAZOLAMIDESODIUM"
"2393","DIAMOX","250 Milligram                                                                                            Tablets",1978-04-01,"PA0899/021/003","Mercury Pharmaceuticals Ltd","ACETAZOLAMIDE"
"2394","DIAMOX SR","250 Milligram                                                                                            Capsules Modified Release",1992-03-20,"PA0899/021/001","Mercury Pharmaceuticals Ltd","ACETAZOLAMIDE"
"2395","Dianeal PD4 Glucose 1.36 % w/v (13.6 mg/ml), Solution for peritoneal dialysis","13.6 milligram(s)/millilitre Solution for Dialysis",1993-06-03,"PA0167/084/001","Baxter Healthcare Limited","Glucose,anhydrous|Sodiumchloride|Sodiumlactate|Calciumchloride|Magnesiumchloride"
"2396","Dianeal PD4 Glucose 2.27 % w/v (22.7 mg/ml), Solution for peritoneal dialysis","2.27 percent weight/volume Solution for Dialysis",1993-06-03,"PA0167/084/011","Baxter Healthcare Limited","Glucose,anhydrous|Calciumchloridedihydrate|Magnesiumchloridehexahydrate|Sodiumlactate|Sodiumchloride"
"2397","Dianeal PD4 Glucose 3.86 % w/v (38.6 mg/ml), Solution for peritoneal dialysis","3.86 percent weight/volume Solution for Dialysis",1993-06-03,"PA0167/084/021","Baxter Healthcare Limited","Glucose,anhydrous|Magnesiumchloridehexahydrate|Sodiumlactate|Sodiumchloride|Calciumchloridedihydrate"
"2398","DIANETTE","2 / 0.035 Milligram                                                                                            Coated Tablets",1998-10-16,"PPA0465/050/001","PCO Manufacturing","CYPROTERONEACETATE|ETHINYLESTRADIOL"
"2399","DIANETTE","2/35 mg/mcg Coated Tablets",2015-03-27,"PPA1562/154/001","LTT Pharma Limited","CYPROTERONEACETATE|ETHINYLESTRADIOL"
"2400","DIANETTE","2/35 Milligram                                                                                            Film Coated Tablet",2012-07-13,"PPA1151/181/001","Imbat Limited","CYPROTERONEACETATE|ETHINYLESTRADIOL"
"2401","Dianette 2mg/35 microgram coated tablets","2/35 milligram(s) Tablet",1988-11-18,"PA1410/003/001","Bayer Limited","CYPROTERONEACETATE|Ethinylestradiol|Ethinylestradiolph.eur."
"2402","DIAZEMULS","5 Mg/Ml Emulsion for Injection",1989-08-31,"PA1390/138/001","Accord Healthcare Limited","DIAZEPAM"
"2403","DIAZEPAM","5 Milligram                                                                                            Tablets",2018-03-29,"PA1390/186/001","Accord Healthcare Limited","DIAZEPAM"
"2404","DIAZEPAM","10 Milligram                                                                                            Tablets",2018-03-29,"PA1390/186/002","Accord Healthcare Limited","DIAZEPAM"
"2405","Diazepam 10 mg Tablets","10 milligram(s) Tablet",2012-02-24,"PA1380/108/003","Actavis Group PTC ehf","Diazepam"
"2406","Diazepam 2 mg Tablets","2 milligram(s) Tablet",2012-02-24,"PA1380/108/001","Actavis Group PTC ehf","Diazepam"
"2407","Diazepam 5 mg Tablets","5 milligram(s) Tablet",2012-02-24,"PA1380/108/002","Actavis Group PTC ehf","Diazepam"
"2408","DICLAC","1 %w/w                                                                                                 Gel",1999-08-23,"PA0711/009/002","Rowex Ltd","DICLOFENACSODIUM"
"2409","DICLAC","75 Milligram                                                                                            Tablet Prolonged Release",1999-05-27,"PA0711/009/003","Rowex Ltd","DICLOFENACSODIUM"
"2410","DICLAC","50 Milligram                                                                                            Tablets Gastro-Resistant",1992-03-05,"PA0711/009/008","Rowex Ltd","DICLOFENACSODIUM"
"2411","DICLAC","100 Milligram                                                                                            Suppositories",1992-03-05,"PA0711/009/009","Rowex Ltd","DICLOFENACSODIUM"
"2412","DICLAC","25 Micromol Solution for Injection",1992-08-26,"PA0711/009/010","Rowex Ltd","DICLOFENACSODIUM"
"2413","DICLAC RELIEF","1 %w/w                                                                                                 Gel",2004-07-30,"PA0711/009/005","Rowex Ltd","DICLOFENACSODIUM"
"2414","DICLAC RETARD","100 Milligram                                                                                            Tablet Prolonged Release",1992-03-05,"PA0711/009/006","Rowex Ltd","DICLOFENACSODIUM"
"2415","DICLO","75 Milligram                                                                                            Tablet Prolonged Release",1999-05-27,"PA0281/106/001","Pinewood Laboratories Ltd,","DICLOFENACSODIUM"
"2416","Diclofenac Potassium 50 mg Film-coated Tablets","50 milligram(s) Film-coated tablet",2009-08-28,"PA1390/139/001","Accord Healthcare Limited","Diclofenacpotassium"
"2417","DICLOFENAC POTASSIUM NCH","12.5 Milligram                                                                                            Film Coated Tablet",2009-12-22,"PA0678/129/001","GlaxoSmithKline Consumer Healthcare (Ireland) Limited","DICLOFENACPOTASSIUM"
"2418","DICLOFENAC/MISOPROSTOL","50/0.2 Milligram                                                                                            Modified-release Tablets",2013-01-18,"PA1333/014/001","Morningside Healthcare Limited","DICLOFENACSODIUM|3MISOPROSTOL1%HPMCDISPERSION|MISOPROSTOL"
"2419","DICLOFENAC/MISOPROSTOL","75/0.2 Milligram                                                                                            Modified-release Tablets",2013-01-18,"PA1333/014/002","Morningside Healthcare Limited","DICLOFENACSODIUM|MISOPROSTOL"
"2420","DICYCLOVERINE HYDROCHLORIDE","10 MG/5ml                                                                                               Oral Solution",2015-01-30,"PA1861/008/001","SYRI Limited, t/a Thame Laboratories","DICYCLOVERINEHYDROCHLORIDE"
"2421","DIFENE","25 Milligram                                                                                            Capsules Gastro-Resistant",1990-08-28,"PA2256/001/001","Glenwood GmbH","DICLOFENACSODIUM"
"2422","DIFENE","50 Milligram                                                                                            Capsules Gastro-Resistant",1990-08-28,"PA2256/001/002","Glenwood GmbH","DICLOFENACSODIUM"
"2423","DIFENE","100 Milligram                                                                                            Suppositories",1990-08-28,"PA2256/001/006","Glenwood GmbH","DICLOFENACSODIUM"
"2424","Difene 1% w/w Gel","1 percent weight/weight Gel",1995-07-06,"PA2256/001/005","Glenwood GmbH","DICLOFENACSODIUM"
"2425","DIFENE 100 MG DUAL RELEASE","100 Milligram                                                                                            Capsules Modified Release",1997-05-30,"PA2256/001/004","Glenwood GmbH","DICLOFENACSODIUM"
"2426","DIFENE DUAL RELEASE","75 Milligram                                                                                            Capsules Modified Release",1994-06-16,"PA2256/001/003","Glenwood GmbH","DICLOFENACSODIUM"
"2427","Difene Spray Gel 4% w/w Cutaneous Spray, Solution","4 percent weight/weight Cutaneous spray, solution",2003-05-02,"PA2256/001/007","Glenwood GmbH","DICLOFENACSODIUM"
"2428","DIFFERIN","0.1 %w/w                                                                                                 Cream",2000-02-18,"PA0590/006/003","Galderma (UK) Ltd","ADAPALENE"
"2429","DIFFERIN","0.1 %w/w                                                                                                 Gel",2015-05-15,"PPA1151/198/002","Imbat Limited","ADAPALENE"
"2430","DIFFERIN","0.1 %w/w                                                                                                 Gel",2015-01-09,"PPA1562/136/001","LTT Pharma Limited","ADAPALENE"
"2431","DIFFERIN","0.1 %w/w                                                                                                 Cream",2015-01-09,"PPA1562/136/002","LTT Pharma Limited","ADAPALENE"
"2432","DIFFERIN","0.1 %w/w                                                                                                 Gel",2017-12-15,"PPA0465/437/001","PCO Manufacturing","ADAPALENE"
"2433","DIFFERIN","0.1 %w/w                                                                                                 Cream",2017-12-15,"PPA0465/437/002","PCO Manufacturing","ADAPALENE"
"2434","Differin 0.1% w/w Gel","0.1 percent weight/weight Gel",1994-11-14,"PA0590/006/002","Galderma (UK) Ltd","Adapalene"
"2435","DIFFLAM","3 %w/w                                                                                                 Cream",1981-04-15,"PA1332/017/001","Meda Health Sales Ireland Limited","BENZYDAMINEHYDROCHLORIDE"
"2436","Difflam 3 % Cream","3 percent weight/weight Cream",1989-02-03,"PA0057/059/001","3M Health Care Limited","BENZYDAMINEHYDROCHLORIDE"
"2437","Difflam Oral Rinse 0.15% w/v, gargle","0.15 percent weight/volume Gargle",1983-01-31,"PA1332/017/002","Meda Health Sales Ireland Limited","BENZYDAMINEHYDROCHLORIDE"
"2438","DIFFLAM SPRAY","0.15 %w/v                                                                                                 Oromucosal Spray",1987-11-20,"PA1332/017/003","Meda Health Sales Ireland Limited","BENZYDAMINEHYDROCHLORIDE"
"2439","DIFFLAM SPRAY","0.15 %w/v                                                                                                 Oromucosal Spray",2017-03-01,"PPA0465/425/001","PCO Manufacturing","BENZYDAMINEHYDROCHLORIDE"
"2440","Difflam Spray, 0.15% w/v, Oromucosal Spray","0.15 percent weight/volume Oromucosal spray",1992-11-20,"PA0057/059/003","3M Health Care Limited","BENZYDAMINEHYDROCHLORIDE"
"2441","Dificlir","200 milligram(s) Film-coated tablet",2011-12-05,"EU/1/11/733/001-004","Astellas Pharma Europe BV","Fidaxomicin"
"2442","Diflucan 10 mg/ml powder for oral suspension","10 milligram(s)/millilitre Powder for oral suspension",1991-11-12,"PA0822/211/006","Pfizer Healthcare Ireland","Fluconazole"
"2443","Diflucan 150 mg hard capsules","150 mg milligram(s) Capsule, hard",1988-08-05,"PA0822/211/002","Pfizer Healthcare Ireland","Fluconazole"
"2444","Diflucan 2 mg/ml solution for infusion","2 milligram(s)/millilitre Solution for infusion",1989-08-22,"PA0822/211/004","Pfizer Healthcare Ireland","Fluconazole"
"2445","Diflucan 2 mg/ml solution for infusion","2 milligram(s)/millilitre Solution for infusion",2012-09-24,"PA0822/211/005","Pfizer Healthcare Ireland","Fluconazole"
"2446","Diflucan 200 mg hard capsules","200 milligram(s) Capsule, hard",1989-08-22,"PA0822/211/003","Pfizer Healthcare Ireland","Fluconazole"
"2447","Diflucan 40 mg/ml powder for oral suspension","40 milligram(s)/millilitre Powder for oral suspension",1991-11-12,"PA0822/211/007","Pfizer Healthcare Ireland","Fluconazole"
"2448","Diflucan 50 mg hard capsules","50 mg milligram(s) Capsule, hard",1988-08-05,"PA0822/211/001","Pfizer Healthcare Ireland","Fluconazole"
"2449","Digestisan oral drops","*** AWAITING VALUE *** Oral drops, solution",2014-02-07,"TR0725/007/001","Bioforce (UK) Ltd","Tincturefrompeumusboldusmolina.,foliumsicc.(boldoleaves)(1:10-11)|Tincturefromcynarascolymusl.,foliumrec.(freshartichokeleaves)(1:30-31)|Tincturefromtaraxacumofficinalisweb.,radixcumherbarec.(freshdandelionrootandherb)(1:17-18)|Tincturefrommenthaxpiperital.,herbarec.(freshpeppermintherb)(1:18-19)"
"2450","DILACORT","2.5 Milligram                                                                                            Tablets Gastro-Resistant",2013-01-04,"PA2025/001/001","Crescent Pharma Limited","PREDNISOLONE"
"2451","DILACORT","5 Milligram                                                                                            Tablets Gastro-Resistant",2013-01-04,"PA2025/001/002","Crescent Pharma Limited","PREDNISOLONE"
"2452","Diltam 90 mg Prolonged release tablets","90 milligram(s) Prolonged-release tablet",1995-12-12,"PA0711/004/002","Rowex Ltd","Diltiazemhydrochloride"
"2453","DILZEM XL","120 Milligram                                                                                            Prolonged Release Capsules",1990-07-04,"PA0827/006/004","Cephalon UK Limited","DILTIAZEMHYDROCHLORIDE"
"2454","DILZEM XL","180 Milligram                                                                                            Prolonged Release Capsules",1990-07-04,"PA0827/006/005","Cephalon UK Limited","DILTIAZEMHYDROCHLORIDE"
"2455","DILZEM XL","240 Milligram                                                                                            Prolonged Release Capsules",1990-07-04,"PA0827/006/006","Cephalon UK Limited","DILTIAZEMHYDROCHLORIDE"
"2456","DINUTUXIMAB BETA APEIRON","4.5 Mg/l                                                                                                 Concentrate for Soln for Inf",2017-05-08,"EU/1/17/1191/001","EUSA Pharma (UK) Limited","DINUTUXIMABBETA"
"2457","Dioderm 0.1% w/w Cream","0.1 percent weight/weight Cream",1980-12-01,"PA0278/003/001","Dermal Laboratories Ltd","Hydrocortisone"
"2458","DIORALYTE BLACKCURRANT POWDER FOR ORAL SOLUTION","%v/v                                                                                                 Powder for Oral Solution",1992-06-03,"PA0540/098/001","Sanofi-Aventis Ireland Limited T/A SANOFI","SODIUMCHLORIDE|POTASSIUMCHLORIDE|GLUCOSE|SODIUMCITRATEACID"
"2459","DIORALYTE CITRUS POWDER FOR ORAL SOLUTION","%v/v                                                                                                 Powder for Oral Solution",1992-06-03,"PA0540/098/002","Sanofi-Aventis Ireland Limited T/A SANOFI","GLUCOSE|SODIUMCHLORIDE|POTASSIUMCHLORIDE|SODIUMCITRATEACID"
"2460","DIORALYTE NATURAL, POWDER FOR ORAL SOLUTION","%v/v                                                                                                 Powder for Oral Solution",1989-07-13,"PA0540/099/001","Sanofi-Aventis Ireland Limited T/A SANOFI","GLUCOSE|SODIUMCHLORIDE|POTASSIUMCHLORIDE|SODIUMCITRATEACID"
"2461","DIOVAN","80 Milligram                                                                                            Film Coated Tablet",2001-12-14,"PA0896/009/001","Novartis Ireland Limited","VALSARTAN"
"2462","DIOVAN","160 Milligram                                                                                            Film Coated Tablet",2001-12-14,"PA0896/009/002","Novartis Ireland Limited","VALSARTAN"
"2463","DIOVAN","40 Milligram                                                                                            Film Coated Tablet",2005-07-29,"PA0896/009/003","Novartis Ireland Limited","VALSARTAN"
"2464","DIOVAN","320 Milligram                                                                                            Film Coated Tablet",2007-06-01,"PA0896/009/004","Novartis Ireland Limited","VALSARTAN"
"2465","DIOVAN","3 Mg/Ml Oral Solution",2010-05-28,"PA0896/009/005","Novartis Ireland Limited","VALSARTAN"
"2466","DIOVAN","80 Milligram                                                                                            Film Coated Tablet",2006-09-01,"PPA0465/180/001","PCO Manufacturing","VALSARTAN"
"2467","DIOVAN","160 Milligram                                                                                            Film Coated Tablet",2012-08-31,"PPA0465/180/002","PCO Manufacturing","VALSARTAN"
"2468","DIOVAN","80 Milligram                                                                                            Film Coated Tablet",2008-10-03,"PPA1151/067/001","Imbat Limited","VALSARTAN"
"2469","DIOVAN","160 Milligram                                                                                            Film Coated Tablet",2008-10-03,"PPA1151/067/002","Imbat Limited","VALSARTAN"
"2470","DIOVAN","40 Milligram                                                                                            Film Coated Tablet",2012-05-11,"PPA1151/067/003","Imbat Limited","VALSARTAN"
"2471","DIOVAN","80 Milligram                                                                                            Film Coated Tablet",2013-01-25,"PPA1463/077/001","IMED Healthcare Ltd.","VALSARTAN"
"2472","DIOVAN","160 Milligram                                                                                            Film Coated Tablet",2013-03-15,"PPA1463/077/002","IMED Healthcare Ltd.","VALSARTAN"
"2473","Dipentum 250mg hard Capsules","250 milligram(s) Capsule",NA,"PA1967/001/001","Atnahs Pharma UK Limited","OLSALAZINESODIUM"
"2474","Dipentum 500mg Tablets","500 milligram(s) Tablet",NA,"PA1967/001/002","Atnahs Pharma UK Limited","OLSALAZINESODIUM"
"2475","DIPEPTIVEN, CONCENTRATE FOR SOLUTION FOR INFUSION","200 Mg/Ml Concentrate for Soln for Inf",1996-05-20,"PA0697/002/001","Fresenius AG","L-ALANYL-LGLUTAMINE"
"2476","DIPRIVAN","1 %w/v                                                                                                 Emulsion for Inj/Inf",1995-10-19,"PA1691/022/001","Aspen Pharma Trading Limited","PROPOFOL"
"2477","DIPROBASE","Cream",1983-10-05,"PA1410/076/002","Bayer Limited",""
"2478","DIPROBASE","Cream",2009-09-08,"DPR1463/032/001","IMED Healthcare Ltd.",""
"2479","DIPROBASE","Infus/Pdr/Oral Soln",2013-08-07,"DPR0465/044/001","PCO Manufacturing",""
"2480","DIPROBASE OINTMENT","5/95 %w/w                                                                                                 Ointment",1983-10-05,"PA1410/076/001","Bayer Limited","PARAFFIN,LIQUID|WHITESOFTPARAFFIN"
"2481","DIPROSALIC","0.05 + 2 %w/w                                                                                                 Cutaneous Solution",2015-03-06,"PPA1562/151/001","LTT Pharma Limited","BETAMETHASONEDIPROPIONATE|SALICYLICACID"
"2482","DIPROSALIC 0.05% W/W +","2 %w/w                                                                                                 Cutaneous Solution",1983-10-27,"PA1286/029/001","Merck Sharp & Dohme Ireland (Human Health) Limited","BETAMETHASONEDIPROPIONATE|SALICYLICACID"
"2483","DIPYRIDAMOLE","200 Milligram                                                                                            Prolonged Release Capsules",2018-07-06,"PA2091/003/001","Renata (UK) Limited","DIPYRIADMOLE"
"2484","DIPYRIDAMOLE","50 MG/5ml                                                                                               Oral Suspension",2014-05-02,"PA0281/149/001","Pinewood Laboratories Ltd,","DIPYRIDAMOLE"
"2485","DIPYRIDAMOLE 200MG/5ML ORAL","200/5 Mg/Ml Oral Suspension",2016-01-15,"PA1861/018/001","SYRI Limited, t/a Thame Laboratories","DIPYRIDAMOLE"
"2486","DISODIUM PAMIDRONATE","15 Mg/Ml Concentrate for Soln for Inf",2005-08-26,"PA1339/007/001","Wockhardt UK Limited","PAMIDRONICACID"
"2487","DISODIUM PAMIDRONATE","15 Mg/Ml Concentrate for Soln for Inf",2005-08-26,"PA1339/007/002","Wockhardt UK Limited","PAMIDRONICACID"
"2488","DISODIUM PAMIDRONATE","15 Mg/Ml Concentrate for Soln for Inf",2005-08-26,"PA1339/007/003","Wockhardt UK Limited","PAMIDRONICACID"
"2489","DISODIUM PAMIDRONATE","15 Mg/Ml Concentrate for Soln for Inf",2005-08-26,"PA1339/007/004","Wockhardt UK Limited","PAMIDRONICACID"
"2490","DISPRIN DIRECT","300 Milligram                                                                                            Tablets Chewable",1983-07-26,"PA0979/007/001","Reckitt Benckiser Ireland Ltd","ACETYLSALICYLICACID"
"2491","DISPRIN EXTRA STRENGTH","500mg Milligram                                                                                            Tablets Effervescent",1998-09-18,"PA0979/006/002","Reckitt Benckiser Ireland Ltd","ACETYLSALICYLICACID"
"2492","DISPRIN ORIGINAL","300mg Milligram                                                                                            Dispersable Tablet",1978-04-01,"PA0979/006/001","Reckitt Benckiser Ireland Ltd","ACETYLSALICYLICACID"
"2493","DISTACLOR","500 Milligram                                                                                            Capsules Hard",1978-11-16,"PA1226/001/001","Flynn Pharma Ltd","CEFACLOR"
"2494","DISTACLOR","125 MG/5ml                                                                                               Granules for Oral Suspension",1998-11-16,"PA1226/001/002","Flynn Pharma Ltd","CEFACLOR"
"2495","DISTACLOR","250 MG/5ml                                                                                               Granules for Oral Suspension",1998-11-16,"PA1226/001/003","Flynn Pharma Ltd","CEFACLOR"
"2496","DISTACLOR LA","375 Milligram                                                                                            Tablet Prolonged Release",1994-06-16,"PA1226/001/004","Flynn Pharma Ltd","CEFACLORMONOHYDRATE"
"2497","DISTACLOR LA FORTE","500 Milligram                                                                                            Tablet Prolonged Release",1994-06-16,"PA1226/001/005","Flynn Pharma Ltd","CEFACLORMONOHYDRATE"
"2498","DITEBOOSTER","Per Cent                                                                                             Suspension for Injection",2007-02-02,"PA2160/001/001","AJ Vaccines A/S","DIPHTHERIATOXOID|TETANUSTOXOID"
"2499","DITHROCREAM","0.1 %w/w                                                                                                 Cream",1980-12-01,"PA0278/001/001","Dermal Laboratories Ltd","DITHRANOL"
"2500","DITHROCREAM","0.25 %w/w                                                                                                 Cream",1980-12-01,"PA0278/001/002","Dermal Laboratories Ltd","DITHRANOL"
"2501","DITHROCREAM","0.5 %w/w                                                                                                 Cream",1980-12-01,"PA0278/001/003","Dermal Laboratories Ltd","DITHRANOL"
"2502","DITHROCREAM","1.0 %w/w                                                                                                 Cream",1985-04-17,"PA0278/001/004","Dermal Laboratories Ltd","DITHRANOL"
"2503","DITHROCREAM","2 %w/w                                                                                                 Cream",1987-07-03,"PA0278/001/005","Dermal Laboratories Ltd","DITHRANOL"
"2504","DITROPAN","5 Milligram                                                                                            Tablets",2010-08-27,"PPA0465/252/001","PCO Manufacturing","OXYBUTYNINHYDROCHLORIDE"
"2505","DITROPAN","5 Milligram                                                                                            Tablets",2016-10-07,"PPA1562/180/001","LTT Pharma Limited","OXYBUTYNINHYDROCHLORIDE"
"2506","Ditropan 2.5mg Tablets","2.5 milligram(s) Tablet",1995-08-24,"PA0540/146/002","Sanofi-Aventis Ireland Limited T/A SANOFI","OXYBUTYNINHYDROCHLORIDE"
"2507","Ditropan 2.5mg/5ml Oral Solution","2.5 mg/5ml Oral solution",1999-01-04,"PA0077/143/001","Sanofi-aventis Ireland Ltd","OXYBUTYNINHYDROCHLORIDE"
"2508","Ditropan 5mg Tablets","5 milligram(s) Tablet",1995-08-24,"PA0540/146/003","Sanofi-Aventis Ireland Limited T/A SANOFI","OXYBUTYNINHYDROCHLORIDE"
"2509","DIVIGEL","1 Mg/Dose                                                                                              Gel",1996-12-03,"PA1327/002/001","Orion Corporation","ESTRADIOL"
"2510","Dobutamine 12.5mg/ml Concentrate for solution for infusion","12.5 milligram(s)/millilitre Concentrate for solution for infusion",2011-07-22,"PA2299/039/001","Baxter Holding B.V.","DOBUTAMINEHYDROCHLORIDE"
"2511","Dobutamine 12.5mg/ml Concentrate for Solution for Infusion","12.5 milligram(s)/millilitre Concentrate for solution for infusion",1996-01-03,"PA0073/137/001","Mercury Pharmaceuticals (Ireland) Ltd","DOBUTAMINEHYDROCHLORIDE"
"2512","DOCETAXEL","40 Mg/Ml Concentrate and solvent for solution for infusion",2010-01-26,"EU/1/09/611/1-2","Teva B.V.","DOCETAXEL"
"2513","DOCETAXEL","20 Mg/Ml Concentrate for Soln for Inf",2011-08-26,"PA1840/003/001","Seacross Pharmaceuticals Limited","DOCETAXELANHYDROUS"
"2514","DOCETAXEL ACCORD","20mg/1 Millilitre                                                                                           Concentrate for Soln for Inf",2012-05-22,"EU/1/12/769/001","Accord Healthcare Limited","DOCETAXEL"
"2515","DOCETAXEL ACCORD","80mg/4 Millilitre                                                                                           Concentrate for Soln for Inf",2012-06-27,"EU/1/12/769/002","Accord Healthcare Limited","DOCETAXEL"
"2516","DOCETAXEL ACCORD","160mg/8 Millilitre                                                                                           Concentrate for Soln for Inf",2012-06-27,"EU/1/12/769/003","Accord Healthcare Limited","DOCETAXEL"
"2517","Docetaxel Actavis 20mg/ml concentrate for solution for infusion","20 milligram(s)/millilitre Concentrate for solution for infusion",2010-09-24,"PA1380/084/001","Actavis Group PTC ehf","Docetaxel"
"2518","DOCETAXEL HOSPIRA","20 Mg/Ml Concentrate for Soln for Inf",2015-08-28,"EU/1/15/1017/001","Hospira  UK Limited","DOCETAXELTRIHYDRATE"
"2519","DOCETAXEL HOSPIRA","10 Micromol Concentrate for Soln for Inf",2009-12-22,"PA0437/067/001","Hospira  UK Limited","DOCETAXEL"
"2520","DOCETAXEL KABI","80/4 Mg/Ml Concentrate for Soln for Inf",2012-05-22,"EU/1/12/770/001","Fresenius Kabi Deutschland GmbH","DOCETAXEL"
"2521","DOCETAXEL KABI","120/6 Mg/Ml Concentrate for Soln for Inf",2012-05-22,"EU/1/12/770/002","Fresenius Kabi Deutschland GmbH","DOCETAXEL"
"2522","DOCETAXEL KABI","160/8 Mg/Ml Concentrate for Soln for Inf",2012-05-22,"EU/1/12/770/003","Fresenius Kabi Deutschland GmbH","DOCETAXEL"
"2523","DOCETAXEL KABI","180/9 Mg/Ml Concentrate for Soln for Inf",2012-05-22,"EU/1/12/770/004","Fresenius Kabi Deutschland GmbH","DOCETAXEL"
"2524","DOCETAXEL MYLAN","20 Mg/Ml Concentrate for Soln for Inf",2012-01-31,"EU/1/11/748/001-006","Mylan S.A.S.","ANHYDROUSDOCETAXEL"
"2525","DOCETAXEL PFIZER","10 Mg/Ml Concentrate for Soln for Inf",2012-11-16,"PA0822/146/001","Pfizer Healthcare Ireland","DOCETAXEL"
"2526","DOCETAXEL WINTHROP","20 Milligram                                                                                            Concentrate for Soln for Inf",2007-04-20,"EU/1/07/384/001","Aventis Pharma S.A.","DOCETAXELTRIHYDRATE"
"2527","DOCETAXEL WINTHROP","80 Milligram                                                                                            Concentrate for Soln for Inj",2007-04-20,"EU/1/07/384/002","Aventis Pharma S.A.","DOCETAXELTRIHYDRATE"
"2528","DOCETAXEL WINTHROP","20 Mg/Ml Concentrate for Soln for Inf",2009-11-30,"EU/1/07/384/003","Aventis Pharma S.A.","DOCETAXELTRIHYDRATE"
"2529","DOCETAXEL WINTHROP","80/4 Mg/Ml Concentrate for Soln for Inf",2009-11-30,"EU/1/07/384/004","Aventis Pharma S.A.","DOCETAXELTRIHYDRATE"
"2530","DOLENIO","1500 Milligram                                                                                            Film Coated Tablet",2009-03-20,"PA1516/001/001","Blue Bio Pharmaceuticals Ltd","GLUCOSAMINESULFATE|GLUCOSAMINESULPHATESODIUMCHLORIDE"
"2531","DOLMATIL","200 Milligram                                                                                            Tablets",1987-04-08,"PA0540/147/001","Sanofi-Aventis Ireland Limited T/A SANOFI","SULPIRIDE"
"2532","DOLMATIL","400 Milligram                                                                                            Film Coated Tablet",1990-03-23,"PA0540/147/002","Sanofi-Aventis Ireland Limited T/A SANOFI","SULPIRIDE"
"2533","DOLMATIL","200 Milligram                                                                                            Tablets",2014-07-18,"PPA1151/183/001","Imbat Limited","SULPIRIDE"
"2534","Dolocopin 40mg/g Cream","40 milligram(s)/gram Cream",2015-11-27,"PA1155/008/001","Ferndale Pharmaceuticals Ltd","Lidocaine"
"2535","Domerid 10mg tablets","10 milligram(s) Tablet",2003-04-04,"PA0711/046/001","Rowex Ltd","DOMPERIDONEMALEATE"
"2536","Domerid Relief 10mg tablets","10 milligram(s) Tablet",2003-04-04,"PA0711/046/002","Rowex Ltd","DOMPERIDONEMALEATE"
"2537","DOMPERIDONE","1 Mg/Ml Oral Suspension",2014-12-05,"PA1339/050/001","Wockhardt UK Limited","DOMPERIDONE"
"2538","DONA","500 Milligram                                                                                            Capsules Hard",2006-07-14,"PA2010/022/001","Mylan IRE Healthcare Limited","GLUCOSAMINESULFATESODIUMCHLORIDE"
"2539","DONA","1500 Milligram                                                                                            Powder for Oral Solution",2007-11-30,"PPA1151/056/001","Imbat Limited","GLUCOSAMINESULFATEASCRYSTALLINEGLUCOSAMINESULFATE"
"2540","DONA 1500 MG POWDER FOR ORAL SOLUTION","1500 Milligram                                                                                            Powder for Oral Solution",1998-04-03,"PA2010/022/002","Mylan IRE Healthcare Limited","GLUCOSAMINESULFATE|SODIUMCHLORIDE"
"2541","Dona 1500 mg Powder for Oral Solution","1500 milligram(s) Powder for oral solution",2014-09-12,"PPA0465/401/001","PCO Manufacturing","Glucosamine"
"2542","DONECEPT","5 Milligram                                                                                            Film Coated Tablet",2008-11-21,"PA1380/060/001","Actavis Group PTC ehf","DONEPEZILHYDROCHLORIDE"
"2543","DONECEPT","10 Milligram                                                                                            Film Coated Tablet",2008-11-21,"PA1380/060/002","Actavis Group PTC ehf","DONEPEZILHYDROCHLORIDE"
"2544","DONEPEZIL","5 Milligram                                                                                            Film Coated Tablet",2011-08-19,"PA1390/039/001","Accord Healthcare Limited","DONEPEZILHYDROCHLORIDE"
"2545","DONEPEZIL","10 Milligram                                                                                            Film Coated Tablet",2011-08-19,"PA1390/039/002","Accord Healthcare Limited","DONEPEZILHYDROCHLORIDE"
"2546","DONEPEZIL HYDROCHLORIDE","5 Milligram                                                                                            Film Coated Tablet",2013-03-22,"PA1240/006/001","Bristol Laboratories Limited","DONEPEZILHYDROCHLORIDE"
"2547","DONEPEZIL HYDROCHLORIDE","10 Milligram                                                                                            Film Coated Tablet",2013-03-22,"PA1240/006/002","Bristol Laboratories Limited","DONEPEZILHYDROCHLORIDE"
"2548","Donepezil Hydrochloride 10mg Film-Coated Tablets","10 milligram(s) Film-coated tablet",2013-05-17,"PA1339/039/002","Wockhardt UK Limited","Donepezilhydrochloride"
"2549","Donepezil Hydrochloride 5mg Film-Coated Tablets","5 milligram(s) Film-coated tablet",2013-05-17,"PA1339/039/001","Wockhardt UK Limited","Donepezilhydrochloride"
"2550","DONEPEZIL HYDROCHLORIDE BLUEFISH","5 Milligram                                                                                            Film Coated Tablet",2010-07-09,"PA1436/015/001","Bluefish Pharmaceuticals AB","DONEPEZILHYDROCHLORIDE"
"2551","DONEPEZIL HYDROCHLORIDE BLUEFISH","10 Milligram                                                                                            Film Coated Tablet",2010-07-09,"PA1436/015/002","Bluefish Pharmaceuticals AB","DONEPEZILHYDROCHLORIDE"
"2552","DONEPEZIL KRKA","5 Milligram                                                                                            Film Coated Tablet",2011-10-28,"PA1347/014/003","Krka d.d., Novo mesto","DONEPEZILHYDROCHLORIDE"
"2553","DONEPEZIL KRKA","10 Milligram                                                                                            Film Coated Tablet",2011-10-28,"PA1347/014/004","Krka d.d., Novo mesto","DONEPEZILHYDROCHLORIDE"
"2554","DONEPEZIL TEVA","5 Milligram                                                                                            Film Coated Tablet",2009-11-27,"PA0749/194/001","Teva Pharma B.V.","DONEPEZILHYDROCHLORIDE"
"2555","DONEPEZIL TEVA","10 Milligram                                                                                            Film Coated Tablet",2009-11-27,"PA0749/194/002","Teva Pharma B.V.","DONEPEZILHYDROCHLORIDE"
"2556","DONESYN","5 Milligram                                                                                            Film Coated Tablet",2008-05-16,"PA0126/183/001","Clonmel Healthcare Ltd","DONEPEZILHYDROCHLORIDE"
"2557","DONESYN","10 Milligram                                                                                            Film Coated Tablet",2008-05-16,"PA0126/183/002","Clonmel Healthcare Ltd","DONEPEZILHYDROCHLORIDE"
"2558","DONOPA","50%/50 %v/v                                                                                                 Medicinal gas, compressed",2016-07-15,"PA1848/003/001","SOL S.p.A.","NITROUSOXIDE|OXYGEN"
"2559","Dopamine Hydrochloride 40 mg/ml Sterile Concentrate","40 milligram(s)/millilitre Concentrate for solution for infusion",1986-05-21,"PA0822/202/001","Pfizer Healthcare Ireland","DOPAMINEHYDROCHLORIDE"
"2560","Dormeasan Sleep Valerian-Hops oral drops","*** AWAITING VALUE *** Oral drops, solution",2014-05-02,"TR0725/005/001","Bioforce (UK) Ltd","Tinctureofhopstrobile(humuluslupulusl.)(1:12-13)extractionsolvent:ethanol65%v/v|Tinctureofvalerianroot(valerianaofficinalisl.)(1:10-11)extractionsolvent:ethanol58%v/v"
"2561","DORZOLAMIDE","20 Mg/Ml Eye Drops Solution",2011-01-14,"PA1380/082/001","Actavis Group PTC ehf","DORZOLAMIDEHYDROCHLORIDE"
"2562","Dorzolamide + Timolol PharmaSwiss 20 mg/ml + 5 mg/ml, eye drops solution","20+5 milligram(s)/millilitre Eye drops, solution",2016-10-14,"PA1696/008/001","PharmaSwiss Ceska republika s.r.o.","Dorzolamidehydrochloride|TIMOLOLMALEATE"
"2563","Dorzolamide PharmaSwiss 20 mg/ml eye drops solution","20 milligram(s)/millilitre Ear/eye drops, solution",2016-11-25,"PA1696/007/001","PharmaSwiss Ceska republika s.r.o.","Dorzolamide"
"2564","DORZOLAMIDE/TIMOLOL","20+5 Mg/Ml Eye Drops Solution",2011-08-12,"PA1380/081/001","Actavis Group PTC ehf","DORZOLAMIDE|TIMOLOL"
"2565","DOSTINEX","500 Microgram                                                                                            Tablets",2014-10-10,"PPA0465/338/001","PCO Manufacturing","CABERGOLINE"
"2566","DOSTINEX","0.5 Milligram                                                                                            Tablets",2017-09-29,"PPA1097/029/001","Lexon (UK) Ltd","CABERGOLINE"
"2567","DOSTINEX","500 Microgram                                                                                            Tablets",2014-02-28,"PPA1562/108/001","LTT Pharma Limited","CABERGOLINE"
"2568","Dostinex 500 microgram Tablets","0.5 milligram(s) Tablet",1995-04-20,"PA0822/126/001","Pfizer Healthcare Ireland","Cabergoline"
"2569","DOTAGRAF","279.32 Mg/Ml Solution for Injection",2016-12-16,"PA1410/082/001","Bayer Limited","GADOTERICACID"
"2570","DOTAGRAF","279.32 Mg/Ml Solution for Injection",2016-12-16,"PA1410/082/002","Bayer Limited","GADOTERICACID"
"2571","DOTAREM","279.32 Mg/Ml Solution for Injection",1996-06-10,"PA0686/003/005","GUERBET","GADOTERICACID"
"2572","Dotarem 279.32mg/ml solution for injection, glass vials","279.32 milligram(s)/millilitre Solution for injection",1996-06-10,"PA0686/003/002","Guerbet","Gadotericacid"
"2573","DOTEVATROL","50 + 0.5 Unknown Ointment",2013-12-09,"PA0749/189/001","Teva Pharma B.V.","BETAMETHASONE|CALCIPOTRIOL,ANHYDROUS"
"2574","DOVOBET","50/0.5 Unknown Ointment",2002-02-08,"PA1025/001/001","LEO Pharma A/S","CALCIPOTRIOLHYDRATE|BETAMETHASONEDIPROPIONATE"
"2575","DOVOBET","50mcg/g + 0.5mg/g Unknown Gel",2008-09-12,"PA1025/001/002","LEO Pharma A/S","CALCIPOTRIOL|BETAMETHASONE"
"2576","DOVOBET","50 mcg/g +  Gel",2012-07-06,"PPA0465/213/002","PCO Manufacturing","CALCIPOTRIOL|BETAMETHASONE"
"2577","DOVOBET","50 Micrograms/g                                                                                         Ointment",2008-01-18,"PPA1151/053/001","Imbat Limited","CALCIPOTRIOL|BETAMETHASONEDIPROPIONATE"
"2578","DOVONEX","50 Micrograms/g                                                                                         Ointment",1991-02-25,"PA0046/061/001","Leo Laboratories Limited","CALCIPOTRIOL"
"2579","DOVONEX","50 Micrograms/g                                                                                         Cream",1994-03-14,"PA0046/061/002","Leo Laboratories Limited","CALCIPOTRIOL"
"2580","DOVONEX PSORIASIS","50 Micrograms/g                                                                                         Ointment",2016-04-08,"PA0046/064/001","Leo Laboratories Limited","CALCIPOTRIOL,ANHYDROUS"
"2581","DOXACAR","4 Milligram                                                                                            Tablet Prolonged Release",2006-06-02,"PA0577/076/001","McDermott Laboratories Ltd t/a Gerard Laboratories","DOXAZOSINMESILATE"
"2582","DOXANE XL","4 Milligram                                                                                            Tablet Prolonged Release",2007-01-12,"PA0711/103/001","Rowex Ltd","DOXAZOSINMESILATE"
"2583","DOXAPRAM HYDROCHLORIDE","2/1 Mg/Ml Solution for Infusion",1980-04-01,"PA0857/003/001","MercuryPharm Ltd","DOXAPRAMHYDROCHLORIDE"
"2584","DOXAPRAM HYDROCHLORIDE","20 Mg/Ml Solution for Injection",1980-04-01,"PA0857/003/002","MercuryPharm Ltd","DOXAPRAMHYDROCHLORIDE"
"2585","DOXATAN","1 Milligram                                                                                            Tablets",2000-01-21,"PA0126/202/001","Clonmel Healthcare Ltd","DOXAZOSIN"
"2586","DOXATAN","2 Milligram                                                                                            Tablets",2000-01-21,"PA0126/202/002","Clonmel Healthcare Ltd","DOXAZOSIN"
"2587","DOXATAN","4 Milligram                                                                                            Tablets",2000-01-21,"PA0126/202/003","Clonmel Healthcare Ltd","DOXAZOSIN"
"2588","Doxatan XL 4 mg Prolonged-release Tablets","4 milligram(s) Prolonged-release tablet",2005-07-29,"PA0126/202/004","Clonmel Healthcare Ltd","Doxazosin"
"2589","DOXORUBICIN","2 Mg/Ml Solution for Injection",2004-03-19,"PA1070/003/001","STADApharm GmbH","DOXORUBICINHYDROCHLORIDE"
"2590","DOXORUBICIN","2 Mg/Ml Concentrate for Soln for Inf",2011-12-09,"PA1380/111/001","Actavis Group PTC ehf","DOXORUBICINHYDROCHLORIDE"
"2591","DOXORUBICIN","2 Mg/Ml Concentrate for Soln for Inf",2010-07-09,"PA1390/022/001","Accord Healthcare Limited","DOXORUBICINHYDROCHLORIDE"
"2592","Doxorubicin 2mg/ml Concentrate for Solution for Infusion","2 milligram(s)/millilitre Concentrate for solution for infusion",2009-11-13,"PA1658/001/001","Genepharm (Europe) Trading Ltd","DOXORUBICINHYDROCHLORIDE"
"2593","Doxorubicin 2mg/ml Concentrate for Solution for Infusion","2 milligram(s)/millilitre Concentrate for solution for infusion",2010-01-29,"PA1840/002/001","Seacross Pharmaceuticals Limited","DOXORUBICINHYDROCHLORIDE"
"2594","DOXORUBICIN TEVA","2 Micromol Concentrate for Soln for Inf",2009-11-20,"PA0749/083/001","Teva Pharma B.V.","DOXORUBICINHYDROCHLORIDE"
"2595","DOXYCYCLINE","100 Milligram                                                                                            Capsule",2010-07-22,"PA0688/042/001","Chanelle Medical","DOXYCYCLINE"
"2596","DOXYCYCLINE PINEWOOD","100 Milligram                                                                                            Capsule",2010-07-22,"PA0281/161/001","Pinewood Laboratories Ltd,","DOXYCYCLINE"
"2597","DOXYCYCLINE TEVA 100MG HARD CAPSULES","100 Milligram                                                                                            Capsule",1985-05-07,"PA0282/033/001","Norton Healthcare Limited T/A IVAX Pharmaceuticals UK","DOXYCYCLINEHYDROCHLORIDE"
"2598","DOZEPT","5 Milligram                                                                                            Film Coated Tablet",2008-10-10,"PA0711/141/001","Rowex Ltd","DONEPEZILHYDROCHLORIDE"
"2599","DOZEPT","10 Milligram                                                                                            Film Coated Tablet",2008-10-10,"PA0711/141/002","Rowex Ltd","DONEPEZILHYDROCHLORIDE"
"2600","Dozol Oral SolutionParacetamol 120mg/5mlDiphenhydramine Hydrochloride 12.5mg/5ml","120 mg/5ml Oral solution",1978-04-01,"PA0095/004/001","Ricesteele Manufacturing Ltd","Diphenhydraminehydrochloride|Paracetamol"
"2601","DRAPOLENE","0.01/0.2 %w/w                                                                                                 Cream",1983-04-01,"PA2034/001/001","Ravira Ltd","BENZALKONIUMCHLORIDE|CETRIMONIUMBROMIDE"
"2602","DRETINE","0.03 / 3 Milligram                                                                                            Film Coated Tablet",2009-10-09,"PA0749/159/001","Teva Pharma B.V.","DROSPIRENONE|ETHINYLESTRADIOL"
"2603","DRETINELLE","0.02 / 3 Milligram                                                                                            Film Coated Tablet",2009-10-09,"PA0749/118/001","Teva Pharma B.V.","DROSPIRENONE|ETHINYLESTRADIOL"
"2604","DROPIZOL","10 Mg/Ml Oral Drops Solution",2018-06-22,"PA2245/001/001","Pharmanovia A/S","OPIUMTINCTURE"
"2605","Dropodex 0.1% w/v Eye Drops, solution","0.1 percent weight/volume Eye drops, solution",2013-05-03,"PA2161/003/001","Rayner Pharmaceuticals Limited","DEXAMETHASONEPHOSPHATE"
"2606","DRYNOL","20 Milligram                                                                                            Tablets",2017-03-01,"PPA0465/424/001","PCO Manufacturing","BILASTINE"
"2607","Drynol 10 mg orodispersible tablet","10 milligram(s) Orodispersible tablet",2017-07-14,"PA0865/018/002","Menarini International Operations Luxembourg S.A.","Bilastine"
"2608","Drynol 2.5 mg/ml oral solution","2.5 milligram(s)/millilitre Oral solution",2017-07-14,"PA0865/018/003","Menarini International Operations Luxembourg S.A.","Bilastine"
"2609","Drynol 20 mg Tablets","20 milligram(s) Tablet",NA,"PA0865/018/001","Menarini International Operations Luxembourg S.A.","Bilastine"
"2610","DRYTEC","2.5-100 Gig.bequerel                                                                                         Radionuclide Generator",1999-08-23,"PA0240/021/001","GE Healthcare Limited","MOLYBDENUM-99"
"2611","DUAC ONCE DAILY 10MG/G + 50MG/G GEL","10/50 mg/g Gel",2005-07-22,"PA1077/120/001","GlaxoSmithKline (Ireland) Limited","CLINDAMYCINPHOSPHATE|BENZOYLPEROXIDEHYDROUS"
"2612","DUAKLIR GENUAIR","340/12 Microgram                                                                                            Powder for Inhalation",2014-11-19,"EU/1/14/964/001-002","AstraZeneca AB","MICRONIZEDACLIDINIUMBROMIDE|MICRONIZEDFORMOTEROLFUMARATEDIHYDRATE"
"2613","Duavive","20mg/0.45 milligram(s) Modified-release tablet",2014-12-16,"EU/1/14/960/001","Pfizer Limited","Conjugatedestrogens(ce)|Bazedoxifeneacetate"
"2614","DUBINE","10 mg/g Cream",2017-06-16,"PA1744/003/001","Ferrer Internacional, S.A","OZENOXACIN"
"2615","DUKORAL","%v/v                                                                                                 Infus/Pdr/Oral Soln",2004-05-20,"EU/1/03/263/1-3","Crucell Sweden AB","CHOLERAVACCINE"
"2616","DULCOLAX","5 Milligram                                                                                            Tablets Gastro-Resistant",2011-04-11,"DPR1392/066/001","Eurodrug Ltd","BISACODYL"
"2617","DULCOLAX","10 Milligram                                                                                            Suppositories",1986-06-05,"PA0540/184/002","Sanofi-Aventis Ireland Limited T/A SANOFI","BISACODYL"
"2618","DULCOLAX","5 Milligram                                                                                            Tablets Gastro-Resistant",1986-06-05,"PA0540/184/003","Sanofi-Aventis Ireland Limited T/A SANOFI","BISACODYL"
"2619","DULCOLAX","5 Milligram                                                                                            Tablets Gastro-Resistant",2007-10-26,"PPA1151/045/001","Imbat Limited","BISACODYL"
"2620","DULCOLAX FOR CHILDREN","5 Milligram                                                                                            Suppositories",1986-06-05,"PA0540/184/001","Sanofi-Aventis Ireland Limited T/A SANOFI","BISACODYL"
"2621","DULCOLAX PICO LIQUID","5 MG/5ml                                                                                               Oral Solution",1975-08-31,"PA0540/182/001","Sanofi-Aventis Ireland Limited T/A SANOFI","SODIUMPICOSULPHATEMONOHYDRATE"
"2622","DULCOLAX PICO PERLES","2.5 Milligram                                                                                            Capsules, Soft",1999-04-01,"PA0540/183/001","Sanofi-Aventis Ireland Limited T/A SANOFI","SODIUMPICOSULPHATEMONOHYDRATE"
"2623","Duloxetine","*** AWAITING VALUE *** Not Currently Available",NA,"IC0091","IC Company",""
"2624","DULOXETINE","20 Milligram                                                                                            Capsules Gastro-Resistant",2015-10-02,"PA1339/061/001","Wockhardt UK Limited","DULOXETINEHYDROCHLORIDE"
"2625","DULOXETINE","30 Milligram                                                                                            Capsules Gastro-Resistant",2015-10-02,"PA1339/061/002","Wockhardt UK Limited","DULOXETINEHYDROCHLORIDE"
"2626","DULOXETINE","40 Milligram                                                                                            Capsules Gastro-Resistant",2015-10-02,"PA1339/061/003","Wockhardt UK Limited","DULOXETINEHYDROCHLORIDE"
"2627","DULOXETINE","60 Milligram                                                                                            Capsules Gastro-Resistant",2015-10-02,"PA1339/061/004","Wockhardt UK Limited","DULOXETINEHYDROCHLORIDE"
"2628","Duloxetine 30 mg gastro-resistant capsules","30 milligram(s) Gastro-resistant capsule",2015-06-19,"PA2315/006/001","Accord Healthcare Ireland Ltd.","Duloxetinehydrochloride"
"2629","Duloxetine 60 mg gastro-resistant capsules","60 milligram(s) Gastro-resistant capsule",2015-06-19,"PA2315/006/002","Accord Healthcare Ireland Ltd.","Duloxetinehydrochloride"
"2630","Duloxetine Clonmel 30 mg gastro resistant capsules, hard","30 milligram(s) Gastro-resistant capsule",2015-09-25,"PA0126/269/002","Clonmel Healthcare Ltd","Duloxetinehydrochloride"
"2631","Duloxetine Clonmel 60 mg gastro resistant capsules, hard","60 milligram(s) Gastro-resistant capsule",2015-09-25,"PA0126/269/004","Clonmel Healthcare Ltd","Duloxetinehydrochloride"
"2632","DULOXETINE KRKA","30 Milligram                                                                                            Capsules Gastro-Resistant",2015-03-13,"PA1347/051/002","Krka d.d., Novo mesto","DULOXETINEHYDROCHLORIDE"
"2633","DULOXETINE KRKA","60 Milligram                                                                                            Capsules Gastro-Resistant",2015-03-13,"PA1347/051/004","Krka d.d., Novo mesto","DULOXETINEHYDROCHLORIDE"
"2634","Duloxetine Lilly","30 milligram(s) Gastro-resistant capsule",2014-12-08,"EU/1/14/972/001-003","Eli Lilly Nederland B.V.","Duloxetinehydrochloride"
"2635","DULOXETINE LILLY","60 Milligram                                                                                            Capsules Gastro-Resistant",2014-12-08,"EU/1/14/972/005-009","Eli Lilly Nederland B.V.","DULOXETINEHYDROCHLORIDE"
"2636","DULOXETINE MYLAN","30 Milligram                                                                                            Capsules Gastro-Resistant",2015-06-19,"EU/1/15/1010/01-010","Mylan S.A.S.","DULOXETINEHYDROCHLORIDE"
"2637","DULOXETINE MYLAN","60 Milligram                                                                                            Capsules Gastro-Resistant",2015-06-19,"EU/1/15/1010/011-020","Mylan S.A.S.","DULOXETINEHYDROCHLORIDE"
"2638","DULOXETINE ROWA","30 Milligram                                                                                            Capsules Gastro-Resistant",2017-09-01,"PA0074/077/001","Rowa Pharmaceuticals Limited","DULOXETINEHYDROCHLORIDE"
"2639","DULOXETINE ROWA","60 Milligram                                                                                            Capsules Gastro-Resistant",2017-09-01,"PA0074/077/002","Rowa Pharmaceuticals Limited","DULOXETINEHYDROCHLORIDE"
"2640","DULOXETINE ROWEX","30 Milligram                                                                                            Capsules Gastro-Resistant",2016-03-24,"PA0711/263/001","Rowex Ltd","DULOXETINEHYDROCHLORIDE"
"2641","DULOXETINE ROWEX","60 Milligram                                                                                            Capsules Gastro-Resistant",2016-03-24,"PA0711/263/002","Rowex Ltd","DULOXETINEHYDROCHLORIDE"
"2642","DULOXETINE TEVA","30 Milligram                                                                                            Capsules Gastro-Resistant",2015-07-10,"PA1986/004/001","Teva B.V.","DULOXETINEHYDROCHLORIDE"
"2643","DULOXETINE TEVA","60 Milligram                                                                                            Capsules Gastro-Resistant",2015-07-10,"PA1986/004/002","Teva B.V.","DULOXETINEHYDROCHLORIDE"
"2644","DULOXETINE ZENTIVA","30 Milligram                                                                                            Capsules Gastro-Resistant",2015-08-20,"EU/1/15/1028/001-003","Zentiva k.s.","DULOXETINE"
"2645","DULOXETINE ZENTIVA","60 Milligram                                                                                            Capsules Gastro-Resistant",2015-08-20,"EU/1/15/1028/004-007","Zentiva k.s.","DULOXETINE"
"2646","DUOCOVER","75/75 mg/mg Film Coated Tablet",2010-03-15,"EU/1/10/619/1-7","sanofi-aventis groupe","CLOPIDOGRELHYDROGENSULPHATE|ACETYLSALICYLICACID"
"2647","DUOCOVER","75/75  Film Coated Tablet",2010-03-15,"EU/1/10/623/1-7","sanofi-aventis groupe","CLOPIDOGRELHYDROGENSULPHATE|ACETYLSALICYLICACID"
"2648","DUOCOVER","75/100  Film Coated Tablet",2010-03-15,"EU/1/10/623/8-14","sanofi-aventis groupe","CLOPIDOGRELHYDROGENSULPHATE|ACETYLSALICYLICACID"
"2649","DUODOPA","20/5 Mg/Ml Gel",2005-11-18,"PA1824/002/001","AbbVie Limited","LEVODOPA|CARBIDOPA"
"2650","DUOFILM","16.7/15.0 %w/w                                                                                                 Cutaneous Solution",1977-01-21,"PA0678/114/001","GlaxoSmithKline Consumer Healthcare (Ireland) Limited","SALICYLICACID|S)-LACTICACID"
"2651","DUOPLAVIN","75/100 mg/mg Film Coated Tablet",2010-03-15,"EU/1/10/619/8-14","Sanofi Pharma Bristol-Myers Squibb SNC","CLOPIDOGRELHYDROGENSULPHATE|ACETYLSALICYLICACID"
"2652","DUOPLAVIN","75/75 mg/mg Film Coated Tablet",2010-03-15,"EU/1/10/619/001","Sanofi Pharma Bristol-Myers Squibb SNC","CLOPIDOGRELHYDROGENSULPHATE|ACETYLSALICYLICACID"
"2653","DuoResp Spiromax","160/4.5 microgram(s) Powder for Inhalation",2014-04-28,"EU/1/14/920/001-003","Teva Pharma B.V.",NA
"2654","DuoResp Spiromax","320/9 microgram(s) Powder for Inhalation",2014-04-28,"EU/1/14/920/004-006","Teva Pharma B.V.",NA
"2655","DuoResp Spiromax Teva","160/4.5 microgram(s) Powder for Inhalation",2014-04-28,"EU/1/14/921/001-003","Teva Pharma B.V.","Formoterolfumaratedihydrate|Budesonide"
"2656","DuoResp Spiromax Teva","320/9 microgram(s) Powder for Inhalation",2014-04-28,"EU/1/14/921/004-006","Teva Pharma B.V.","Budesonide|Formoterolfumaratedihydrate"
"2657","DUOTRAV (EXTRAVAN)","40/5 Microgram/ML                                                                                         Eye Drops Solution",2006-04-24,"EU/1/06/338/001-003","Novartis Europharm Limited","TRAVOPOST|TIMOLOL|TIMOLOLMALEATE"
"2658","DUPHALAC","3.335 g/5ml                                                                                                Oral Solution",1983-04-01,"PA2010/009/001","Mylan IRE Healthcare Limited","LACTULOSE"
"2659","Duphaston 10 mg film-coated tablets","10 milligram(s) Film-coated tablet",1985-01-28,"PA2010/010/001","Mylan IRE Healthcare Limited","Dydrogesterone"
"2660","Dupixent","300 milligram(s) Solution for injection in pre-filled syringe",2017-09-27,"EU/1/17/1229/001-008","Sanofi-Aventis Groupe","Dupilumab"
"2661","Duraphat 5000 ppm Fluoride Toothpaste","5000 ZZZ ppm Toothpaste",2003-07-25,"PA22581/001/001","Colgate-Palmolive A/S","Sodiumfluoride"
"2662","DUROGESIC DTRANS","25 Microgram per hour Transdermal Patch",1995-10-31,"PA0748/002/001","Janssen-Cilag Ltd","FENTANYL"
"2663","DUROGESIC DTRANS","50 Microgram per hour Transdermal Patch",1995-10-31,"PA0748/002/002","Janssen-Cilag Ltd","FENTANYL"
"2664","DUROGESIC DTRANS","75 Microgram per hour Transdermal Patch",1995-10-31,"PA0748/002/003","Janssen-Cilag Ltd","FENTANYL"
"2665","DUROGESIC DTRANS","100 Microgram per hour Transdermal Patch",1995-10-31,"PA0748/002/004","Janssen-Cilag Ltd","FENTANYL"
"2666","DUROGESIC DTRANS","12 Microgram per hour Transdermal Patch",2006-07-07,"PA0748/002/005","Janssen-Cilag Ltd","FENTANYL"
"2667","DUROGESIC DTRANS","50 Microgram per hour Transdermal Patch",2015-11-13,"PPA1151/252/001","Imbat Limited","FENTANYL"
"2668","DUROGESIC DTRANS","75 Microgram per hour Transdermal Patch",2015-11-13,"PPA1151/252/002","Imbat Limited","FENTANYL"
"2669","DUROGESIC DTRANS","25 Microgram per hour Transdermal Patch",2015-10-23,"PPA1151/252/003","Imbat Limited","FENTANYL"
"2670","DUROGESIC DTRANS","100 Microgram per hour Transdermal Patch",2015-10-23,"PPA1151/252/004","Imbat Limited","FENTANYL"
"2671","Durogesic DTrans 100 micrograms/hour Transdermal Patch","100 micrograms/hour Transdermal patch",2014-07-25,"PPA0465/314/004","PCO Manufacturing","Fentanyl|Fentanyl"
"2672","Durogesic DTrans 12 micrograms/hour Transdermal Patch","12 micrograms/hour Transdermal patch",2015-04-17,"PPA0465/314/005","PCO Manufacturing","Fentanyl"
"2673","Durogesic DTrans 25 micrograms/hour Transdermal Patch","25 micrograms/hour Transdermal patch",2014-07-25,"PPA0465/314/001","PCO Manufacturing","Fentanyl"
"2674","Durogesic DTrans 50 micrograms/hour Transdermal Patch","50 micrograms/hour Transdermal patch",2014-07-25,"PPA0465/314/002","PCO Manufacturing","Fentanyl"
"2675","Durogesic DTrans 75 micrograms/hour Transdermal Patch","75 micrograms/hour Transdermal patch",2014-07-25,"PPA0465/314/003","PCO Manufacturing","Fentanyl"
"2676","DUTASTERIDE","0.5 Milligram                                                                                            Capsules, Soft",2016-10-14,"PA1986/027/001","Teva B.V.","DUTASTERIDE"
"2677","DUTASTERIDE","0.5 Milligram                                                                                            Capsules, Soft",2014-12-05,"PA1963/005/001","Cipla Europe NV","DUTASTERIDE(DMF)"
"2678","Dutasteride 0.5mg Soft Capsules","0.5 milligram(s) Capsule, soft",2015-06-26,"PA1380/165/001","Actavis Group PTC ehf","Dutasteride"
"2679","DUTASTERIDE KRKA","0.5 Milligram                                                                                            Capsules, Soft",2017-03-01,"PA1347/069/001","Krka d.d., Novo mesto","DUTASTERIDE"
"2680","DUTASTERIDE TEVA","0.5 Milligram                                                                                            Capsules, Soft",2013-02-01,"PA0749/167/001","Teva Pharma B.V.","DUTASTERIDE"
"2681","Duzallo","200/200 milligram(s) Film-coated tablet",NA,"EU/1/18/1300/001-002","Grunenthal GmbH","Lesinurad|Allopurinol"
"2682","DYMISTA","137/50 Microgram                                                                                            Nasal Spray Suspension",2017-10-27,"PPA1151/260/001","Imbat Limited","AZELASTINEHYDROCHLORIDE|FLUTICASONEPROPIONATE"
"2683","DYMISTA","137/50 Microgram                                                                                            Nasal Spray Suspension",2017-04-21,"PPA1463/114/001","IMED Healthcare Ltd.","AZELASTINEHYDROCHLORIDE|FLUTICASONEPROPIONATE|WATER,PURIFIED"
"2684","DYMISTA","137/50 Microgram                                                                                            Nasal Spray Suspension",2018-02-09,"PPA1633/067/001","Primecrown 2010 Ltd","AZELASTINEHYDROCHLORIDE|FLUTICASONEPROPIONATE"
"2685","Dymista 137 micrograms / 50 micrograms per actuation, Nasal Spray Suspension","137/50 microgram(s) Nasal spray, suspension",2018-10-19,"PPA1097/065/001","Lexon (UK) Ltd","Azelastinehydrochloride|FLUTICASONEPROPIONATE"
"2686","Dymista 137 micrograms / 50 micrograms per actuation, Nasal Spray Suspension","137/50 microgram(s) Nasal spray, suspension",2013-02-22,"PA1332/045/001","Meda Health Sales Ireland Limited","Azelastinehydrochloride|FLUTICASONEPROPIONATE"
"2687","Dymista 137 micrograms / 50 micrograms per actuation, Nasal Spray Suspension","137/50 microgram(s) Nasal spray, suspension",2016-12-23,"PPA0465/422/001","PCO Manufacturing","Azelastinehydrochloride|FLUTICASONEPROPIONATE"
"2688","Dynastat","20 milligram(s) Powder for solution for injection",2002-03-22,"EU/1/02/209/001","Pfizer Europe MA EEIG","Parecoxibsodium"
"2689","Dynastat","20 milligram(s) Powder and solvent for solution for injection",NA,"EU/1/02/209/002","Pfizer Europe MA EEIG","Parecoxibsodium"
"2690","Dynastat","20 milligram(s) Powder and solvent for solution for injection",NA,"EU/1/02/209/003","Pfizer Europe MA EEIG","Parecoxibsodium"
"2691","Dynastat","20 milligram(s) Powder and solvent for solution for injection",NA,"EU/1/02/209/004","Pfizer Europe MA EEIG","Parecoxibsodium"
"2692","Dynastat","40 milligram(s) Powder for solution for injection",2002-03-22,"EU/1/02/209/005","Pfizer Europe MA EEIG","Parecoxibsodium"
"2693","Dynastat","40 milligram(s) Powder and solvent for solution for injection",2002-03-22,"EU/1/02/209/006","Pfizer Europe MA EEIG","Parecoxibsodium"
"2694","Dynastat","40 milligram(s) Powder and solvent for solution for injection",2002-03-22,"EU/1/02/209/007","Pfizer Europe MA EEIG","Parecoxibsodium"
"2695","Dynastat","40 milligram(s) Powder and solvent for solution for injection",2002-03-22,"EU/1/02/209/008","Pfizer Europe MA EEIG","Parecoxibsodium"
"2696","Dysport 500 units Powder for solution for injection","500 unit(s) Powder for solution for injection",1994-04-20,"PA1613/002/001","Ipsen Pharma","Clostridiumbotulinumtoxintypeahaemagglutinincomplex"
"2697","DZUVEO","30 Microgram                                                                                            Tablet Sublingual",2018-06-25,"EU/1/18/1284/001-002","FGK Representative Service GmbH","SUFENTANILCITRATE"
"2698","E45 CreamWhite Soft Paraffin           14.5%      w/wLight Liquid Paraffin        12.6%      w/wAnhydrous Lanolin           1.0%        w/w","14.5%/12.6%/1.0% percent weight/weight Cream",1977-04-01,"PA0979/043/001","Reckitt Benckiser Ireland Ltd","Paraffinsoft|Paraffin,liquid|Lanolinanhydrous"
"2699","Easofen 200mg Film-Coated Tablets","200 milligram(s) Film-coated tablet",1986-07-02,"PA0126/060/001","Clonmel Healthcare Ltd","Ibuprofen"
"2700","EASOFEN FOR CHILDREN SIX PLUS STRAWBERRY","200 MG/5ml                                                                                               Oral Suspension",2014-07-11,"PA0126/060/004","Clonmel Healthcare Ltd","IBUPROFEN"
"2701","EASOFEN FOR CHILDREN STRAWBERRY","100 MG/5ml                                                                                               Oral Suspension",2014-07-11,"PA0126/060/003","Clonmel Healthcare Ltd","IBUPROFEN"
"2702","Easofen Max Strength 400 mg Film-coated Tablets","400 milligram(s) Film-coated tablet",2011-09-09,"PA0126/060/002","Clonmel Healthcare Ltd","Ibuprofen"
"2703","Easolief Duo 500mg/150mg Film-coated Tablets","500/150 milligram(s) Film-coated tablet",2017-12-22,"PA0126/294/001","Clonmel Healthcare Ltd","Paracetamol|Ibuprofen"
"2704","EBILFUMIN","30 Milligram                                                                                            Capsules Hard",2014-05-22,"EU/1/14/915/001-002","Actavis Group PTC ehf","OSELTAMIVIRPHOSPHATE"
"2705","EBILFUMIN","45 Milligram                                                                                            Capsules Hard",2014-05-22,"EU/1/14/915/003-004","Actavis Group PTC ehf","OSELTAMIVIRPHOSPHATE"
"2706","EBILFUMIN","75 Milligram                                                                                            Capsules Hard",2014-05-22,"EU/1/14/915/005-006","Actavis Group PTC ehf","OSELTAMIVIRPHOSPHATE"
"2707","EBIXA","10 Milligram                                                                                            Film Coated Tablet",2001-12-04,"EU/1/02/219/001-003","H. Lundbeck A/S","MEMANTINE"
"2708","Ebixa","5 ZZZ mg/pump actuation Oral solution",2001-12-04,"EU/1/02/219/005-006","H. Lundbeck A/S","MEMANTINEHYDROCHLORIDE"
"2709","Ebixa","5+10+15+20 milligram(s) Film-coated tablet",2008-05-08,"EU/1/02/219/022","H. Lundbeck A/S","MEMANTINEHYDROCHLORIDE"
"2710","Ebixa","20 milligram(s) Film-coated tablet",2008-05-08,"EU/1/02/219/023-035","H. Lundbeck A/S","MEMANTINEHYDROCHLORIDE"
"2711","Ebymect","5mg/850 milligram(s) Film-coated tablet",NA,"EU/1/15/1051/001-006","AstraZeneca AB","METFORMINHYDROCHLORIDE|Dapagliflozinpropanediolmonohydrate"
"2712","Ebymect","5mg/1000 milligram(s) Film-coated tablet",2015-11-16,"EU/1/15/1051/007-012","AstraZeneca AB","METFORMINHYDROCHLORIDE|Dapagliflozinpropanediolmonohydrate"
"2713","Ecalta","100 milligram(s) Powder and solvent for solution for infusion",NA,"EU/1/07/416/001","Pfizer Europe MA EEIG","Anidulafungin"
"2714","Ecalta","100 milligram(s) ZZZ Pdr/Conc/Soln for Infus",2009-07-23,"EU/1/07/416/002","Pfizer Europe MA EEIG","Anidulafungin"
"2715","ECANSYA","150 Milligram                                                                                            Film Coated Tablet",2012-04-20,"EU/1/12/763/001-006","Krka d.d., Novo mesto","CAPECITABINE"
"2716","ECANSYA","300 Milligram                                                                                            Film Coated Tablet",2012-04-20,"EU/1/12/763/007-012","Krka d.d., Novo mesto","CAPECITABINE"
"2717","ECANSYA","500 Milligram                                                                                            Film Coated Tablet",2012-04-20,"EU/1/12/763/013-018","Krka d.d., Novo mesto","CAPECITABINE"
"2718","ECHINACE","Film Coated Tablet",2014-07-04,"TR1725/001/001","Sona Nutrition Ltd","ECHINACEAPURPUREAPOWDEREXTRACT6-7:1(EQUIVALENTTO762MG-889MGOFECHINACEAPURPUREAROOT)"
"2719","Echinaforce Cold & Flu tablets","*** AWAITING VALUE *** Tablet",2012-11-05,"TR2309/009/004","A. Vogel Ireland Limited","Extract(asdryextract)fromfreshechinaceapurpurea(l.)moenchherb|Extract(asdryextract)fromfreshechinaceapurpurea(l.)moenchroot"
"2720","Echinaforce Cold and Flu chewable tablets","0  Chewable tablet",2012-11-05,"TR2309/009/003","A. Vogel Ireland Limited",""
"2721","Echinaforce Cold and Flu Oral Drops",".  Oral drops, solution",2013-07-19,"TR2309/009/002","A. Vogel Ireland Limited","Tincturefromfreshechinaceapurpurea(l.)moenchherb(1:12-13)extractionsolvent:ethanol57.3%m/m|Tincturefromfreshechinaceapurpurea(l.)moenchroot(1:11-12).extractionsolvent:ethanol57.3%m/m"
"2722","Echinaforce Forte Cold and Flu tablets","*** AWAITING VALUE *** Tablet",2012-11-05,"TR2309/009/001","A. Vogel Ireland Limited","Extract(asdryextract)fromfreshechinaceapurpurea(l.)moenchherb|Extract(asdryextract)fromfreshechinaceapurpurea(l.)moenchroot"
"2723","Echinaforce Hot Drink Cold and Flu Echinacea concentrate for oral solution","5 millilitre(s) Concentrate for oral solution",2016-10-07,"TR2309/009/005","A. Vogel Ireland Limited","Tincturefromfreshechinaceapurpurea(l.)moenchroot(1:11).extractionsolvent:65%v/v|Tincturefromfreshechinaceapurpurea(l.)moenchherb(1:12).extractionsolvent:ethanol65%v/v"
"2724","Echinaforce Sore Throat Spray","Oromucosal spray",2015-04-24,"TR2309/013/001","A. Vogel Ireland Limited","Tincturefromfreshechinaceapurpurea(l)moenchherb(1:12-13)extractionsolvent:ethanol65v/v"
"2725","ECZIBET","20 + 1 mg/g Cream",2015-06-19,"PA0405/089/001","Generics (UK) Limited","FUSIDICACID|BETAMETHASONEVALERATE"
"2726","EDARBI","20 Milligram                                                                                            Tablets",2011-12-07,"EU/1/11/734/001-004","Takeda Pharma A/S","AZILSARTANMEDOXOMIL"
"2727","EDARBI","40 Milligram                                                                                            Tablets",2011-12-07,"EU/1/11/734/005-008","Takeda Pharma A/S","AZILSARTANMEDOXOMIL"
"2728","EDARBI","80 Milligram                                                                                            Tablets",2011-12-07,"EU/1/11/734/009-011","Takeda Pharma A/S","AZILSARTANMEDOXOMIL"
"2729","EDICIS","2 Milligram                                                                                            Kit for radiopharmaceutical preparation",2013-11-15,"PA0677/021/001","CIS bio International","N'N'-ETHYLENE-(L,L)-DICYSTEINE"
"2730","Edistride","5 milligram(s) Film-coated tablet",NA,"EU/1/15/1052/001-005","AstraZeneca AB","Dapagliflozinpropanediolmonohydrate"
"2731","Edistride","10 milligram(s) Film-coated tablet",2015-11-09,"EU/1/15/1052/006-010","AstraZeneca AB","Dapagliflozinpropanediolmonohydrate"
"2732","EDLUAR","5 Milligram                                                                                            Tablet Sublingual",2012-09-24,"PA1332/040/001","Meda Health Sales Ireland Limited","ZOLPIDEMTARTRATE"
"2733","EDLUAR","10 Milligram                                                                                            Tablet Sublingual",2012-09-24,"PA1332/040/002","Meda Health Sales Ireland Limited","ZOLPIDEMTARTRATE"
"2734","EDRONAX 4 MG TABLETS","4 Milligram                                                                                            Tablets",1997-11-28,"PA0822/127/001","Pfizer Healthcare Ireland","REBOXETINEMESYLATE"
"2735","EDURANT","25 Milligram                                                                                            Film Coated Tablet",2011-11-28,"EU/1/11/736/001","Janssen-Cilag International NV","RILPIVIRINE(ASHYDROCHLORIDE)"
"2736","Efavirenz Mylan 600 mg Film-coated Tablets","600 milligram(s) Film-coated tablet",2012-10-12,"PA0577/156/001","McDermott Laboratories Ltd t/a Gerard Laboratories","Efavirenz"
"2737","Efavirenz Rowex 600mg Film-coated Tablets","600 milligram(s) Film-coated tablet",2013-10-25,"PA0711/207/001","Rowex Ltd","Efavirenz"
"2738","EFAVIRENZ TEVA","600 Milligram                                                                                            Film Coated Tablet",2012-01-09,"EU/1/11/742/001-010","Teva B.V.","EFAVIRENZ"
"2739","EFAVIRENZ/EMTRICITABINE/TENOFOVIR DISOPROXIL CLONMEL","600 mg/200 mg/245 Milligram                                                                                            Film Coated Tablet",2017-12-22,"PA0126/301/001","Clonmel Healthcare Ltd","EFAVIRENZ|EMTRICITABINE|TENOFOVIRDISOPROXILSUCCINATE"
"2740","EFAVIRENZ/EMTRICITABINE/TENOFOVIR DISOPROXIL KRKA","600/200/245 Milligram                                                                                            Film Coated Tablet",2018-02-08,"EU/1/17/1263/001-002","Krka, d.d., Novo mesto","EFAVIRENZ|EMTRICITABINE|TENOFOVIRDISOPROXILSUCCINATE"
"2741","EFAVIRENZ/EMTRICITABINE/TENOFOVIR DISOPROXIL MYLAN","600/200/245 Milligram                                                                                            Film Coated Tablet",2017-09-05,"EU/1/17/1222/001-002","Mylan S.A.S.","EFAVIRENZ|EMTRICITABINE|TENOFOVIRDISOPROXILMALEATE"
"2742","Efavirenz/Emtricitabine/Tenofovir disoproxil Teva 600 mg/200 mg/245 mg Film-coated Tablets","600mg/200mg/245 milligram(s) Film-coated tablet",2017-03-24,"PA1986/033/001","Teva B.V.","Efavirenz|Emtricitabine|Tenofovirdisoproxilphosphate"
"2743","EFAVIRENZ/EMTRICITABINE/TENOFOVIR DISOPROXIL ZENTIVA","600/200/245 Milligram                                                                                            Film Coated Tablet",2017-07-17,"EU/1/17/1210/001","Zentiva k.s.","EFAVIRENZ|EMTRICITABINE|TENOFOVIRDISOPROXILPHOSPHATE"
"2744","EFESTAD","5 Milligram                                                                                            Film Coated Tablet",2012-05-25,"PA0126/223/001","Clonmel Healthcare Ltd","DESLORATIDINE"
"2745","EFEXOR XL","75 Milligram                                                                                            Prolonged Release Capsules",2009-07-31,"PPA1151/076/004","Imbat Limited","VENLAFAXINEHYDROCHLORIDE"
"2746","EFEXOR XL","150 Milligram                                                                                            Prolonged Release Capsules",2009-07-31,"PPA1151/076/005","Imbat Limited","VENLAFAXINEHYDROCHLORIDE"
"2747","EFEXOR XL","150 Milligram                                                                                            Prolonged Release Capsules",2010-05-14,"PPA1500/058/002","Profind Wholesale Ltd","VENLAFAXINEHYDROCHLORIDE"
"2748","EFEXOR XL","150 Milligram                                                                                            Prolonged Release Capsules",2013-02-01,"PPA1463/075/001","IMED Healthcare Ltd.","VENLAFAXINEHYDROCHLORIDE"
"2749","EFEXOR XL","75 Milligram                                                                                            Prolonged Release Capsules",2010-05-14,"PPA1463/075/002","IMED Healthcare Ltd.","VENLAFAXINE"
"2750","Efexor XL 150 mg prolonged-release capsules, hard","150 milligram(s) Prolonged-release capsule",1999-07-26,"PA0822/072/003","Pfizer Healthcare Ireland","Venlafaxinehydrochloride"
"2751","Efexor XL 150mg prolonged-release capsules, hard","150 milligram(s) Prolonged-release capsule",2003-06-03,"PPA0465/085/004","PCO Manufacturing","Venlafaxinehydrochloride"
"2752","Efexor XL 37.5 mg prolonged-release capsules, hard","37.5 milligram(s) Prolonged-release capsule",1999-07-26,"PA0822/072/001","Pfizer Healthcare Ireland","Venlafaxinehydrochloride"
"2753","Efexor XL 75mg prolonged-release capsules, hard","75 milligram(s) Prolonged-release capsule",1999-07-26,"PA0822/072/002","Pfizer Healthcare Ireland","Venlafaxinehydrochloride"
"2754","Efexor XL 75mg prolonged-release capsules, hard","75 milligram(s) Prolonged-release capsule",2003-06-03,"PPA0465/085/003","PCO Manufacturing","Venlafaxinehydrochloride"
"2755","EFFENTORA","100 Microgram                                                                                            Buccal Tablet",2008-04-04,"EU/1/08/441/1-2","Teva B.V.","FENTANYLCITRATE"
"2756","EFFENTORA","200 Microgram                                                                                            Buccal Tablet",2008-04-04,"EU/1/08/441/3-4","Teva B.V.","FENTANYLCITRATE"
"2757","EFFENTORA","400 Microgram                                                                                            Buccal Tablet",2008-04-04,"EU/1/08/441/5-6","Teva B.V.","FENTANYLCITRATE"
"2758","EFFENTORA","600 Microgram                                                                                            Buccal Tablet",2008-04-04,"EU/1/08/441/7-8","Teva B.V.","FENTANYLCITRATE"
"2759","EFFENTORA","800 Microgram                                                                                            Buccal Tablet",2008-04-04,"EU/1/08/441/9-10","Teva B.V.","FENTANYLCITRATE"
"2760","Efficib","50/850 milligram(s) Film-coated tablet",2008-07-16,"EU/1/08/457/1-7","Merck Sharp and Dohme Limited","Sitagliptinphosphate|METFORMINHYDROCHLORIDE"
"2761","EFFICIB","50/1000 Milligram                                                                                            Film Coated Tablet",2008-07-16,"EU/1/08/457/8-14","Merck Sharp & Dohme BV","SITAGLIPTINPHOSPHATE|METFORMINHYDROCHLORIDE"
"2762","EFFICO TONIC","0.18/20.20/2.10/0.31 Milligram                                                                                            Oral Solution",1992-11-27,"PA0100/045/001","Forest Laboratories UK Ltd","THIAMINEHYDROCHLORIDE|CAFFEINE|NICOTINAMIDE|GENTIANCOMPOUNDINFUSION"
"2763","Efient","5 milligram(s) Film-coated tablet",2009-02-25,"EU/1/08/503/1-7","Daiichi Sankyo Europe GmbH","Prasugrelhydrochloride"
"2764","EFIENT","10 Milligram                                                                                            Film Coated Tablet",2009-02-25,"EU/1/08/503/8-14","Daiichi Sankyo Europe GmbH","PRASUGRELHYDROCHLORIDE"
"2765","EFRACEA","40 Milligram                                                                                            Capsules Modified Release",2009-01-30,"PA0590/025/001","Galderma (UK) Ltd","DOXYCYCLINE"
"2766","EFUDIX","5 %w/w                                                                                                 Cream",2014-08-08,"PPA1562/119/001","LTT Pharma Limited","FLUOROURACIL"
"2767","Efudix 5 % w/w Cream","5 percent weight/weight Cream",1979-04-01,"PA2010/049/001","Mylan IRE Healthcare Limited","Fluorouracil"
"2768","EIRFEM","2.5 Milligram                                                                                            Film Coated Tablet",2009-08-28,"PA0074/066/001","Rowa Pharmaceuticals Limited","LETROZOLE"
"2769","EKLIRA GENUAIR","322 Microgram                                                                                            Powder for Inhalation",2012-07-20,"EU/1/12/778/001-003","Almirall, S.A.","MICRONIZEDACLIDINIUMBROMIDE"
"2770","Ekstoniv 400 mg Prolonged-Release Tablets","400 milligram(s) Prolonged-release capsule",2017-09-01,"PA1339/071/001","Wockhardt UK Limited","Nevirapineanhydrous"
"2771","ELANTAN","10 Milligram                                                                                            Tablets",1991-10-11,"PA2118/002/001","Merus Labs Luxco II S.à.R.L.","ISOSORBIDEMONONITRATE"
"2772","ELANTAN","40 Milligram                                                                                            Tablets",1983-08-02,"PA2118/002/002","Merus Labs Luxco II S.à.R.L.","ISOSORBIDEMONONITRATE"
"2773","ELANTAN","20 Milligram                                                                                            Tablets",1983-04-21,"PA2118/002/003","Merus Labs Luxco II S.à.R.L.","ISOSORBIDEMONONITRATE"
"2774","ELANTAN LA","25 Milligram                                                                                            Prolonged Release Capsules",1995-05-18,"PA2118/002/005","Merus Labs Luxco II S.à.R.L.","ISOSORBIDEMONONITRATE"
"2775","ELANTAN LA 25","25 Unknown Prolonged Release Capsules",2009-03-13,"PPA1151/078/002","Imbat Limited","ISOSORBIDEMONONITRATE"
"2776","Elantan LA 50mg Prolonged-Release Capsules, hard","50 milligram(s) Prolonged-release capsule",2008-09-26,"PPA1151/078/001","Imbat Limited","ISOSORBIDEMONONITRATE"
"2777","ELANTAN LA HARD","50 Milligram                                                                                            Prolonged Release Capsules",1987-07-24,"PA2118/002/004","Merus Labs Luxco II S.à.R.L.","ISOSORBIDEMONONITRATE"
"2778","ELAPRASE","2 Mg/Ml Concentrate for Soln for Inf",2008-01-08,"EU/1/06/365/1-3","TKT Europe AB","IDURSULFASE"
"2779","ELASTOPLAST","4.8mg Milligram                                                                                            Transdermal Patch",2004-05-24,"PA1106/001/001","Beiersdorf AG","CAYENNEPEPPERSOFTEXTRACT4-7:1"
"2780","ELAXIGOL","13.7 Grams                                                                                                Powder for Oral Solution",2013-02-01,"PA0688/029/001","Chanelle Medical","MACROGOL3350|POTASSIUMCHLORIDE|SODIUMCHLORIDE|SODIUMHYDROGENCARBONATE"
"2781","ELDEPRYL","5 Milligram                                                                                            Tablets",1996-01-03,"PA1327/003/001","Orion Corporation","SELEGILINEHYDROCHLORIDE"
"2782","Eldepryl 5 mg Tablets","5 milligram(s) Tablet",2013-02-22,"PPA0465/304/001","PCO Manufacturing","Selegilinehydrochloride"
"2783","Elebrato Ellipta","92/55/22 ZZZ Micrograms/g Inhalation powder",2017-11-15,"EU/1/17/1237/001-003","GlaxoSmithKline Trading Services Limited","Fluticasonefuroate|Umeclidiniumbromide"
"2784","ELETRIPTAN","20 Milligram                                                                                            Film Coated Tablet",2017-07-28,"PA0688/048/001","Chanelle Medical","ELETRIPTAN"
"2785","ELETRIPTAN","40 Milligram                                                                                            Film Coated Tablet",2017-07-28,"PA0688/048/002","Chanelle Medical","ELETRIPTAN"
"2786","ELIGARD 22.5 mg, powder and solvent for solution for injection","22.5 milligram(s) Powder and solvent for solution for injection",2005-10-13,"PA1241/003/002","Astellas Pharma Co. Ltd","LEUPRORELINACETATE"
"2787","ELIGARD 45 mg powder and solvent for solution for injection","45 milligram(s) Powder and solvent for solution for injection",2007-10-26,"PA1241/003/003","Astellas Pharma Co. Ltd","Leuprorelinacetate(syringeb)"
"2788","ELIGARD 7.5 mg powder and solvent for solution for injection","7.5 milligram(s) Powder and solvent for solution for injection",2005-10-13,"PA1241/003/001","Astellas Pharma Co. Ltd","LEUPRORELINACETATE"
"2789","Eliquis","2.5 milligram(s) Film-coated tablet",NA,"EU/1/11/691/001-005,013","Bristol-Myers Squibb Pharma/Pfizer EEIG",NA
"2790","ELIQUIS","5 Milligram                                                                                            Film Coated Tablet",2013-12-20,"EU/1/11/691/006-012","Bristol-Myers Squibb Pharma/Pfizer EEIG","APIXABAN(BMS-562247-01)"
"2791","ELLAONE","30 Milligram                                                                                            Tablets",2009-05-15,"EU/1/09/522/001","Laboratoire HRA Pharma","ULIPRISTAL(INN)"
"2792","ELLAONE","30 Milligram                                                                                            Film Coated Tablet",2017-11-10,"EU/1/09/552/003","Laboratoire HRA Pharma","ULIPRISTALACETATE"
"2793","ELMIRON (PREVIOUSLY CALLED PENTOSAN)","100 Milligram                                                                                            Capsules Hard",2017-06-02,"EU/1/17/1189/001-002","bene-Arzneimittel GmbH","PENTOSANPOLYSULFATESODIUM"
"2794","ELOCON","0.1 %w/w                                                                                                 Cream",1993-12-20,"PA1286/035/001","Merck Sharp & Dohme Ireland (Human Health) Limited","MOMETASONEFUROATE"
"2795","ELOCON","0.1 %w/v                                                                                                 Cutaneous Solution",1993-12-20,"PA1286/035/003","Merck Sharp & Dohme Ireland (Human Health) Limited","MOMETASONEFUROATE"
"2796","ELOCON","0.1 %w/w                                                                                                 Cream",2011-05-06,"PPA0465/268/001","PCO Manufacturing","MOMETASONEFUROATE"
"2797","ELOCON","0.1 %w/w                                                                                                 Cream",2015-12-04,"PPA1562/145/001","LTT Pharma Limited","MOMETASONEFUROATE"
"2798","ELOCON","0.1 %w/w                                                                                                 Ointment",2015-12-04,"PPA1562/145/002","LTT Pharma Limited","MOMETASONEFUROATE"
"2799","ELOCON 0.1% W/W OINTMENT","0.1 %w/w                                                                                                 Ointment",1993-12-20,"PA1286/035/002","Merck Sharp & Dohme Ireland (Human Health) Limited","MOMETASONEFUROATE"
"2800","ELOCTA","250 International Unit                                                                                   Pdr+Solv for Soln for Inj",2015-11-19,"EU/1/15/1046/001","Swedish Orphan Biovitrum International AB","EFMOROCTOCOGALFA"
"2801","ELOCTA","500 International Unit                                                                                   Pdr+Solv for Soln for Inj",2015-11-19,"EU/1/15/1046/002","Swedish Orphan Biovitrum International AB","EFMOROCTOCOGALFA"
"2802","ELOCTA","750 International Unit                                                                                   Pdr+Solv for Soln for Inj",2015-11-19,"EU/1/15/1046/003","Swedish Orphan Biovitrum International AB","EFMOROCTOCOGALFA"
"2803","ELOCTA","1000 International Unit                                                                                   Pdr+Solv for Soln for Inj",2015-11-19,"EU/1/15/1046/004","Swedish Orphan Biovitrum International AB","EFMOROCTOCOGALFA"
"2804","ELOCTA","1500 International Unit                                                                                   Pdr+Solv for Soln for Inj",2015-11-19,"EU/1/15/1046/005","Swedish Orphan Biovitrum International AB","EFMOROCTOCOGALFA"
"2805","ELOCTA","2000 International Unit                                                                                   Pdr+Solv for Soln for Inj",2015-11-19,"EU/1/15/1046/006","Swedish Orphan Biovitrum International AB","EFMOROCTOCOGALFA"
"2806","ELOCTA","3000 International Unit                                                                                   Pdr+Solv for Soln for Inj",2015-11-19,"EU/1/15/1046/007","Swedish Orphan Biovitrum International AB","EFMOROCTOCOGALFA"
"2807","ELONVA","100/0.5 Microgram/ML                                                                                         Solution for Injection",2010-01-25,"EU/1/09/609/001","Merck Sharp & Dohme BV,","CORIFOLLITROPINALFA"
"2808","ELONVA","150/0.5 Microgram/ML                                                                                         Solution for Injection",2010-02-25,"EU/1/09/609/002","Merck Sharp & Dohme BV,","CORIFOLLITROPINALFA"
"2809","Eloxatin 5 mg/ml Concentrate for Solution for Infusion","5 micromole(s) Concentrate for solution for infusion",2006-05-05,"PA0077/159/001","Sanofi-aventis Ireland Ltd","Oxaliplatin"
"2810","Eloxatin 5 mg/ml Concentrate for Solution for Infusion","5 milligram(s)/millilitre Concentrate for solution for infusion",2006-05-05,"PA0540/148/001","Sanofi-Aventis Ireland Limited T/A SANOFI","Oxaliplatin"
"2811","ELTROXIN","25 Microgram                                                                                            Tablets",2004-07-02,"PA0899/020/001","Mercury Pharmaceuticals Ltd","LEVOTHYROXINESODIUM"
"2812","ELTROXIN","50 Microgram                                                                                            Tablets",1995-09-18,"PA0701/001/001","Mercury Pharma Group Limited","LEVOTHYROXINESODIUM"
"2813","ELTROXIN","100 Microgram                                                                                            Tablets",1995-09-18,"PA0701/001/002","Mercury Pharma Group Limited","LEVOTHYROXINESODIUM"
"2814","ELVINA","0.03/3 Milligram                                                                                            Film Coated Tablet",2010-08-20,"PA1330/007/001","Gedeon Richter Plc","DROSPIRENONE|ETHINYLESTRADIOL"
"2815","ELVINETTE","0.02/3 Milligram                                                                                            Film Coated Tablet",2011-06-03,"PA1330/008/001","Gedeon Richter Plc","DROSPIRENONE|ETHINYLESTRADIOL"
"2816","EMADINE","0.05 %w/v                                                                                                 Eye Drops Solution",2002-05-30,"EU/1/98/095/003","Novartis Europharm Limited","EMEDASTINEDIFUMARATE"
"2817","EMADINE","0.05 %w/v                                                                                                 Eye Drops Solution",2002-05-30,"EU/1/98/095/004","Novartis Europharm Limited","EMEDASTINEDIFUMARATE"
"2818","EMADINE EYE DROPS","0.05 Per Cent                                                                                             Eye Drops Solution",1999-01-27,"EU/1/98/095/001","Novartis Europharm Limited","EMEDASTINEDIFUMARATE"
"2819","EMADINE EYE DROPS","0.05 Per Cent                                                                                             Eye Drops Solution",1999-01-27,"EU/1/98/095/002","Novartis Europharm Limited","EMEDASTINEDIFUMARATE"
"2820","EMAZOLE","40 Milligram                                                                                            Tablets Gastro-Resistant",2009-04-08,"PA0711/158/002","Rowex Ltd","ESOMEPRAZOLEMAGNESIUMDIHYDRATE"
"2821","Emazole 20 mg Gastro-Resistant Tablets","20 milligram(s) Gastro-resistant tablet",2009-04-08,"PA0711/158/001","Rowex Ltd","Esomeprazolemagnesiumdihydrate"
"2822","EMBESIN","40IU/2 Millilitre                                                                                           Concentrate for Soln for Inf",2018-03-23,"PA1353/005/001","Orpha-Devel Handels und Vertriebs GmbH","ARGIPRESSIN"
"2823","Emcor 10 mg Film-coated tablets","10 milligram(s) Film-coated tablet",1988-06-30,"PA2286/002/002","Merck Serono (Ireland) Limited","BISOPROLOLFUMARATE"
"2824","Emcor 5 mg Film-coated tablets","5 milligram(s) Film-coated tablet",1988-06-30,"PA2286/002/001","Merck Serono (Ireland) Limited","Bisoprololhemifumarate"
"2825","EMEND","165 Milligram                                                                                            Capsules Hard",2011-11-28,"EU/1/03/262/009-010","Merck Sharp & Dohme BV,","APREPITANT"
"2826","EMEND","125 Milligram                                                                                            Powder for Oral Solution",2015-12-16,"EU/1/03/262/011","Merck Sharp & Dohme BV,","APREPITANT"
"2827","EMEND","80 &125 mg Milligram                                                                                            Capsules Hard",2003-11-11,"EU/1/03/262/1-6","Merck Sharp and Dohme Limited","APREPITANT"
"2828","EMEND","40 Milligram                                                                                            Capsules Hard",2006-08-29,"EU/1/03/262/7-8","Merck Sharp and Dohme Limited","APREPITANT"
"2829","Emerade 150 micrograms solution for injection in pre-filled pen","150 microgram(s) Solution for injection in pre-filled pen",2015-09-11,"PA1696/009/001","PharmaSwiss Ceska republika s.r.o.","Adrenalinetartrate"
"2830","Emerade 300 micrograms solution for injection in pre-filled pen","300 microgram(s) Solution for injection in pre-filled pen",2015-09-11,"PA1696/009/002","PharmaSwiss Ceska republika s.r.o.","Adrenalinetartrate"
"2831","Emerade 500 micrograms solution for injection in pre-filled pen","500 microgram(s) Solution for injection in pre-filled pen",2015-09-11,"PA1696/009/003","PharmaSwiss Ceska republika s.r.o.","Adrenalinetartrate"
"2832","EMERPAND","4.6 mg/24 hours Transdermal Patch",2015-01-09,"PA1390/192/001","Accord Healthcare Limited","RIVASTIGMINE"
"2833","EMERPAND","9.5 mg/24 hours Transdermal Patch",2015-01-09,"PA1390/192/002","Accord Healthcare Limited","RIVASTIGMINE"
"2834","EMERPAND","13.3 mg/24 hours Transdermal Patch",2015-01-09,"PA1390/192/003","Accord Healthcare Limited","RIVASTIGMINE"
"2835","EMIZOF","8 Milligram                                                                                            Film Coated Tablet",2006-09-29,"PA0577/083/002","McDermott Laboratories Ltd t/a Gerard Laboratories","ONDANSETRON"
"2836","EMIZOF","4 Milligram                                                                                            Film Coated Tablet",2006-09-29,"PA0577/083/003","McDermott Laboratories Ltd t/a Gerard Laboratories","ONDANSETRON"
"2837","EMLA 5% w/w Cream","5 percent weight/weight Cream",2017-09-08,"PA1691/023/001","Aspen Pharma Trading Limited","Lidocaine|Prilocaine"
"2838","EMPLICITI","300 Milligram                                                                                            Pdr/Conc/Soln for Infus",2016-05-11,"EU/1/16/1088/001","Bristol-Myers Squibb Pharma EEIG","ELOTUZUMAB"
"2839","EMPLICITI","400 Milligram                                                                                            Pdr/Conc/Soln for Infus",2016-05-11,"EU/1/16/1088/002","Bristol-Myers Squibb Pharma EEIG","ELOTUZUMAB"
"2840","EMSELEX","7.5 Milligram                                                                                            Tablet Prolonged Release",2004-10-22,"EU/1/04/294/1-12","Merus Labs Luxco II S.à.R.L.","DARIFENACINHYDROBROMIDE"
"2841","EMTRICITABINE - TENOFOVIR DISOPROXIL ZENTIVA","200/245 Milligram                                                                                            Film Coated Tablet",2016-11-09,"EU/1/16/1148/001-002","Zentiva k.s.","TENOFOVIRDISOPROXILPHOSPHATE|EMTRICITABINE"
"2842","EMTRICITABINE/TENOFOVIR DISOPROXIL","200mg/245 Milligram                                                                                            Film Coated Tablet",2017-05-05,"PA1390/125/001","Accord Healthcare Limited","EMTRICITABINE|TENOFOVIRDISOPROXIL"
"2843","EMTRICITABINE/TENOFOVIR DISOPROXIL CLONMEL","200/245 mg/mg Film Coated Tablet",2016-08-26,"PA0126/289/001","Clonmel Healthcare Ltd","TENOFOVIRDISOPROXIL|EMTRICITABINE"
"2844","EMTRICITABINE/TENOFOVIR DISOPROXIL KRKA D.D","200/245 Milligram                                                                                            Film Coated Tablet",2017-04-28,"EU/1/17/1182/001-004","Krka d.d., Novo mesto","EMTRICITABINE|TENOFOVIRDISOPROXILSUCCINATE"
"2845","EMTRICITABINE/TENOFOVIR DISOPROXIL MYLAN","200/245 Milligram                                                                                            Film Coated Tablet",2016-12-16,"EU/1/16/1133/001-006","Mylan S.A.S.","EMTRICITABINE|TENOFOVIRDISOPROXIL"
"2846","EMTRICITABINE/TENOFOVIR DISOPROXIL ROWEX","200mg/245 Milligram                                                                                            Film Coated Tablet",2017-05-12,"PA0711/271/001","Rowex Ltd","EMTRICITABINE|TENOFOVIRDISOPROXIL"
"2847","EMTRICITABINE/TENOFOVIR KRKA","200/245 Milligram                                                                                            Film Coated Tablet",2016-12-08,"EU/1/16/1151/001-004","Krka d.d., Novo mesto","EMTRICITABINE|TENOFOVIRDISOPROXILSUCCINATE"
"2848","EMTRICITABINE/TENOFOVIR TEVA","200/245 Milligram                                                                                            Film Coated Tablet",2016-05-06,"PA1986/016/001","Teva B.V.","EMTRICITABINE|TENOFOVIRDISOPROXILPHOSPHATE"
"2849","Emtriva","200mg milligram(s) Capsule, hard",2003-10-24,"EU/1/03/261/1-3","Gilead Sciences International","Emtricitabine"
"2850","EMULSIDERM EMOLLIENT","0.5/25/25 %w/w                                                                                                 Cutaneous Emulsion",1982-09-01,"PA0278/008/001","Dermal Laboratories Ltd","BENZALKONIUMCHLORIDE|ISOPROPYLMYRISTATE|PARAFFIN,LIQUID"
"2851","EMULSIFYING OINTMENT","30 50  20 %w/w                                                                                                 Ointment",1988-11-18,"PA0206/019/001","Ovelle Limited","EMULSIFYINGWAX|WHITESOFTPARAFFIN|PARAFFIN,LIQUID"
"2852","ENADOR&PLACEBO","0.02/3 Milligram                                                                                            Film Coated Tablet",2011-06-03,"PA1330/008/002","Gedeon Richter Plc","DROSPIRENONE|ETHINYLESTRADIOL"
"2853","Enalapril/Lercanidipine Krka 10mg/10mg film-coated tablets","10/10 milligram(s) Film-coated tablet",2013-08-09,"PA1347/029/001","Krka d.d., Novo mesto","Lercanidipinehydrochloride|Lercanidipine|Enalaprilmaleate"
"2854","Enalapril/Lercanidipine Krka 20mg/10mg film-coated tablets","20/10 milligram(s) Film-coated tablet",2013-08-09,"PA1347/029/002","Krka d.d., Novo mesto","Lercanidipinehydrochloride|Lercanidipine|Enalaprilmaleate"
"2855","ENANTYUM","12.5 Milligram                                                                                            Film Coated Tablet",1998-04-03,"PA0901/001/001","Laboratorios Menarini S.A.","DEXKETOPROFENTROMETAMOL"
"2856","ENANTYUM","25 Milligram                                                                                            Tablets",1998-04-03,"PA0901/001/002","Laboratorios Menarini S.A.","DEXKETOPROFENTROMETAMOL"
"2857","ENANTYUM","50 Mg/Ml Solution for Injection",2004-03-19,"PA0901/001/003","Laboratorios Menarini S.A.","DEXKETOPROFEN"
"2858","ENANTYUM","12.5 Milligram                                                                                            Granules for oral solution",2011-07-08,"PA0901/001/004","Laboratorios Menarini S.A.","DEXKETOPROFENTROMETAMOL"
"2859","Enantyum 25 mg granules for oral solution","25 milligram(s) Granules for oral solution",2011-07-08,"PA0901/001/005","Laboratorios Menarini S.A.","Dexketoprofentrometamol"
"2860","ENANTYUM 25 MG ORAL SOLUTION","25 Milligram                                                                                            Oral Solution",2017-05-12,"PA0901/001/006","Laboratorios Menarini S.A.","DEXKETOPROFEN"
"2861","ENAP 10mg Tablets","10 milligram(s) Tablet",1999-11-26,"PA0711/028/002","Rowex Ltd","Enalaprilmaleate"
"2862","ENAP 20mg Tablets","20 milligram(s) Tablet",1999-11-26,"PA0711/028/003","Rowex Ltd","Enalaprilmaleate"
"2863","ENAP 5mg Tablets","5 milligram(s) Tablet",1999-11-26,"PA0711/028/001","Rowex Ltd","Enalaprilmaleate"
"2864","ENBREL","25mg milligram(s) Powder and solvent for solution for injection",2000-02-03,"EU/1/99/126/001-003","Pfizer Limited","Etanercept"
"2865","ENBREL","25 Milligram                                                                                            Pdr for Soln for Injection",2006-08-04,"EU/1/99/126/002","Pfizer Europe MA EEIG","ETANERCEPT"
"2866","ENBREL","25 Milligram                                                                                            Solution for injection in pre-filled syringe",2006-09-26,"EU/1/99/126/013-015","Pfizer Europe MA EEIG","ETANERCEPT"
"2867","ENBREL","50 Milligram                                                                                            Solution for injection in pre-filled syringe",2006-09-26,"EU/1/99/126/016-021","Pfizer Europe MA EEIG","ETANERCEPT"
"2868","ENBREL","10 Milligram                                                                                            Pdr+Solv for Soln for Inj",2011-06-29,"EU/1/99/126/022","Pfizer Limited","ETANERCEPT"
"2869","ENBREL","25 Milligram                                                                                            Solution for injection in pre-filled pen",2005-04-28,"EU/1/99/126/023-025","Pfizer Europe MA EEIG","ETANERCEPT"
"2870","ENDOFALK","AP Grams                                                                                                Powder for Oral Solution",2004-03-25,"PA0573/006/001","Dr. Falk Pharma GmbH","MACROGOL3350|POTASSIUMCHLORIDE|SODIUMCHLORIDE|SODIUMBICARBONATE"
"2871","ENDOLUCINBETA","40 GBq/ml                                                                                               Radio-Pharm Precursor",2016-07-07,"EU/1/16/1105/001-002","ITG Isotope Technologies Garching GmbH","LUTETIUM(177LU)CHLORIDE"
"2872","ENDOXANA","50 Milligram                                                                                            Coated Tablets",1990-08-10,"PA0167/134/005","Baxter Healthcare Limited","CYCLOPHOSPHAMIDEMONOHYDRATE"
"2873","ENDOXANA INJECTION","500 Milligram                                                                                            Pdr for Soln for Injection",1990-08-10,"PA0167/134/003","Baxter Healthcare Limited","CYCLOPHOSPHAMIDE"
"2874","ENDOXANA INJECTION","1000 Milligram                                                                                            Pdr for Soln for Injection",1990-08-10,"PA0167/134/004","Baxter Healthcare Limited","CYCLOPHOSPHAMIDE"
"2875","Engerix B 10 micrograms/0.5 mlSuspension for injection in pre-filled syringeHepatitis B (rDNA) vaccine (adsorbed) (HBV)","10 microgram(s) Suspension for injection",NA,"PA1077/023/001","GlaxoSmithKline (Ireland) Limited","Hepatitisbsurfaceantigen,recominant"
"2876","Engerix B 20 micrograms/1 ml Suspension for injection in pre-filled syringeHepatitis B (rDNA) vaccine (adsorbed) (HBV)","20 microgram(s)/millilitre Suspension for injection",NA,"PA1077/023/002","GlaxoSmithKline (Ireland) Limited","Hepatitisbsurfaceantigen,recominant"
"2877","ENSTILAR","50 micrograms/g + 0. Unknown Cutaneous Foam",2016-04-29,"PA1025/005/001","LEO Pharma A/S","CALCIPOTRIOL|BETAMETHASONEDIPROPIONATE"
"2878","ENTACAPONE","200 Milligram                                                                                            Film Coated Tablet",2011-08-18,"EU/1/11/708/001-004","Orion Corporation","ENTACAPONE"
"2879","ENTACAPONE TEVA","200 Milligram                                                                                            Film Coated Tablet",2011-02-18,"EU/1/10/665/001-004","Teva B.V.","ENTACAPONE"
"2880","Entecavir 0.5 mg Film-coated Tablet","0.5 milligram(s) Film-coated tablet",2017-10-20,"PA2315/057/001","Accord Healthcare Ireland Ltd.","ENTECAVIRMONOHYDRATE"
"2881","Entecavir 1 mg Film-coated Tablet","1 milligram(s) Film-coated tablet",2017-10-20,"PA2315/057/002","Accord Healthcare Ireland Ltd.","ENTECAVIRMONOHYDRATE"
"2882","ENTECAVIR ACCORD","0.5 Milligram                                                                                            Film Coated Tablet",2017-09-26,"EU/1/17/1211/001-003","Accord Healthcare Limited","ENTECAVIR"
"2883","ENTECAVIR ACCORD","1 Milligram                                                                                            Film Coated Tablet",2017-09-26,"EU/1/17/1211/004-006","Accord Healthcare Limited","ENTECAVIR"
"2884","ENTECAVIR MYLAN","0.5 Milligram                                                                                            Film Coated Tablet",2017-09-18,"EU/1/17/1227/001-005","Mylan S.A.S.","ENTECAVIR"
"2885","ENTECAVIR MYLAN","1 Milligram                                                                                            Film Coated Tablet",2017-09-18,"EU/1/17/1227/006-010","Mylan S.A.S.","ENTECAVIR"
"2886","ENTECAVIR ROWEX","0.5 Milligram                                                                                            Film Coated Tablet",2017-06-16,"PA0711/274/001","Rowex Ltd","ENTECAVIRMONOHYDRATE"
"2887","ENTECAVIR ROWEX","1 Milligram                                                                                            Film Coated Tablet",2017-06-16,"PA0711/274/002","Rowex Ltd","ENTECAVIRMONOHYDRATE"
"2888","ENTECAVIR TEVA","0.5 Milligram                                                                                            Tablets",2017-06-23,"PA1986/036/001","Teva B.V.","ENTECAVIR"
"2889","ENTOCORT CR","3 Milligram                                                                                            Capsules Gastro-Resistant",1996-09-24,"PA2018/003/001","Tillotts Pharma GmbH","BUDESONIDE"
"2890","ENTONOX","50/50 %v/v                                                                                                 Medicinal gas, compressed",1980-04-01,"PA0208/005/001","BOC Gases Ireland Ltd","OXYGEN|NITROUSOXIDE"
"2891","Entresto","24/26 milligram(s) Film-coated tablet",2015-11-19,"EU/1/15/1058/001","Novartis Europharm Limited","Sacubitril/valsartan(lcz696-aba)"
"2892","ENTRESTO","49/51 Milligram                                                                                            Film Coated Tablet",2015-11-19,"EU/1/15/1058/002-004","Novartis Europharm Limited","SACUBITRIL/VALSARTAN(LCZ696-ABA)"
"2893","ENTRESTO","97/103 Milligram                                                                                            Film Coated Tablet",2015-11-19,"EU/1/15/1058/005-007","Novartis Europharm Limited","SACUBITRIL/VALSARTAN(LCZ696-ABA)"
"2894","ENTYVIO","300 milligram(s) ZZZ Pdr/Conc/Soln for Infus",NA,"EU/1/14/923/001","Takeda Pharma A/S","Vedolizumab"
"2895","ENUREV BREEZHALER","44 Microgram                                                                                            Inhalation Powder, Capsule",2012-09-28,"EU/1/12/789/001-006","Novartis Europharm Ltd","GLYCOPYRRONIUMBROMIDE"
"2896","ENVARSUS","0.75 Milligram                                                                                            Tablet Prolonged Release",2014-07-18,"EU/1/14/35/001-003","Chiesi Farmaceutici S.p.A.","TACROLIMUSMONOHYDRATE"
"2897","ENVARSUS","1 Milligram                                                                                            Tablet Prolonged Release",2014-07-18,"EU/1/14/35/004-006","Chiesi Farmaceutici S.p.A.","TACROLIMUSMONOHYDRATE"
"2898","ENVARSUS","4 Milligram                                                                                            Tablet Prolonged Release",2014-07-18,"EU/1/14/35/007-009","Chiesi Farmaceutici S.p.A.","TACROLIMUSMONOHYDRATE"
"2899","ENYGLID","2 Milligram                                                                                            Tablets",2009-10-14,"EU/1/09/580/13-18","Krka d.d., Novo mesto","REPAGLINIDE"
"2900","ENYGLID","0.5 Milligram                                                                                            Tablets",2009-10-14,"EU/1/09/580/1-6","Krka d.d., Novo mesto","REPAGLINIDE"
"2901","ENYGLID","1 Milligram                                                                                            Tablets",2009-10-14,"EU/1/09/580/7-12","Krka d.d., Novo mesto","REPAGLINIDE"
"2902","Enzira Suspension for injection, pre-filled syringeInfluenza vaccine (split virion, inactivated)","0 percent Suspension for injection",2007-06-22,"PA1373/001/001","Seqirus GmbH","A/MICHIGAN/45/2015(H1N1)PDM09-LIKESTRAIN(A/SINGAPORE/GP1908/2015,IVR-180A)|A/SINGAPORE/IMFIMH-16-0019/2016(H3N2)-LIKESTRAIN(A/SINGAPORE/INFIMH-16-0019/2016,NIB-104)|B/COLORADO/06/2017-LIKESTRAIN(B/VICTORIA/2/87LINEAGE)(B/MARYLAND/15/2016,NYMCBX-69A)|B/COLORADO/06/2017-LIKESTRAIN(B/MARYLAND/15/2016,WILDTYPE)"
"2903","EPACLOB","1mg/ml Millilitre                                                                                           Oral Suspension",2016-11-25,"PA0361/035/001","Martindale Pharmaceuticals Ltd","CLOBAZAM"
"2904","EPACLOB","2 Mg/Ml Oral Suspension",2016-11-25,"PA0361/035/002","Martindale Pharmaceuticals Ltd","CLOBAZAM"
"2905","EPANUTIN","100 Milligram                                                                                            Capsules Hard",2011-04-08,"PPA0465/244/001","PCO Manufacturing","PHENYTOINSODIUM"
"2906","EPANUTIN","250 MG/5ml                                                                                               Solution for Inj/Inf",1975-05-09,"PA0822/011/006","Pfizer Healthcare Ireland","PHENYTOINSODIUM"
"2907","EPANUTIN","50 Milligram                                                                                            Capsules Hard",1979-04-01,"PA0822/011/002","Pfizer Healthcare Ireland","PHENYTOINSODIUM"
"2908","EPANUTIN","100 Milligram                                                                                            Capsules Hard",1979-04-01,"PA0822/011/003","Pfizer Healthcare Ireland","PHENYTOINSODIUM"
"2909","EPANUTIN","300 Milligram                                                                                            Capsules Hard",1990-03-26,"PA0822/011/004","Pfizer Healthcare Ireland","PHENYTOINSODIUM"
"2910","EPANUTIN","100 Milligram                                                                                            Capsules Hard",2011-12-21,"PPA1151/165/001","Imbat Limited","PHENYTOINSODIUM"
"2911","Epanutin 25 mg Hard Capsules","25 milligram(s) Capsule, hard",1976-10-29,"PA0822/011/001","Pfizer Healthcare Ireland","PHENYTOINSODIUM"
"2912","Epanutin 30 mg/5ml Oral Suspension","30 mg/5ml Oral suspension",1979-04-01,"PA0822/011/007","Pfizer Healthcare Ireland","Phenytoin"
"2913","EPANUTIN INFATABS","50 Milligram                                                                                            Tablets Chewable",1975-05-09,"PA0822/011/005","Pfizer Healthcare Ireland","PHENYTOIN"
"2914","Epclusa (previously- Sofosbuvir Velpatasvir Gilead)","400mg/100mg milligram(s) Film-coated tablet",2016-07-06,"EU/1/16/1116/001","Gilead Sciences International","Sofosbuvir|Velpatasvir"
"2915","Eperzan","30 milligram(s) Powder and solvent for solution for injection",2014-03-21,"EU/1/13/908/001","GlaxoSmithKline Trading Services Limited","Albiglutide"
"2916","EPERZAN","50 Milligram                                                                                            Pdr+Solv for Soln for Inj",2014-03-21,"EU/1/13/908/002","GlaxoSmithKline Trading Services Limited","ALBIGLUTIDE"
"2917","Epethinan 10 mg/5 mg prolonged release tablet","10 / 5 milligram(s) Prolonged-release tablet",2016-05-20,"PA2168/001/002","Acino AG","OXYCODONEHYDROCHLORIDE|NALOXONEHYDROCHLORIDE"
"2918","Epethinan 20 mg/10 mg prolonged release tablet","20 / 10 milligram(s) Prolonged-release tablet",2016-05-20,"PA2168/001/003","Acino AG","OXYCODONEHYDROCHLORIDE|NALOXONEHYDROCHLORIDE"
"2919","Epethinan 40 mg/20 mg prolonged release tablet","40 / 20 milligram(s) Prolonged-release tablet",2016-05-20,"PA2168/001/004","Acino AG","OXYCODONEHYDROCHLORIDE|NALOXONEHYDROCHLORIDE"
"2920","Epethinan 5 mg/2.5 mg prolonged release tablet","5 / 2.5 milligram(s) Prolonged-release tablet",2016-05-20,"PA2168/001/001","Acino AG","OXYCODONEHYDROCHLORIDE|NALOXONEHYDROCHLORIDE"
"2921","EPHEDRINE HYDROCHLORIDE","30 Mg/Ml Solution for Injection",2004-11-26,"PA0361/015/001","Martindale Pharmaceuticals Ltd","EPHEDRINEHYDROCHLORIDE"
"2922","EPIDUO","0.1 Per Cent                                                                                             Gel",2017-05-05,"PA0590/030/001","Galderma (UK) Ltd","ADAPALENE|BENZOYLPEROXIDE"
"2923","Epilim 100 mg Crushable Tablets","100 milligram(s) Tablet",1984-06-25,"PA0540/150/001","Sanofi-Aventis Ireland Limited T/A SANOFI","SODIUMVALPROATE"
"2924","Epilim Chrono 200mg Prolonged Release Tablets","200 milligram(s) Prolonged-release tablet",1992-08-24,"PA0540/150/010","Sanofi-Aventis Ireland Limited T/A SANOFI","SODIUMVALPROATE|Valproicacid"
"2925","Epilim Chrono 300mg Prolonged Release Tablets","300 milligram(s) Prolonged-release tablet",1992-08-24,"PA0540/150/011","Sanofi-Aventis Ireland Limited T/A SANOFI","SODIUMVALPROATE|Valproicacid"
"2926","Epilim Chrono 500mg Prolonged Release Tablets","500 milligram(s) Prolonged-release tablet",1992-08-24,"PA0540/150/012","Sanofi-Aventis Ireland Limited T/A SANOFI","SODIUMVALPROATE|Valproicacid"
"2927","Epilim Chronosphere 100mg prolonged-release granules","100 milligram(s) Prolonged-release granules",2007-03-02,"PA0540/150/005","Sanofi-Aventis Ireland Limited T/A SANOFI","SODIUMVALPROATE|Valproicacid"
"2928","Epilim Chronosphere 250mg prolonged-release granules","250 milligram(s) Prolonged-release granules",2007-03-02,"PA0540/150/006","Sanofi-Aventis Ireland Limited T/A SANOFI","SODIUMVALPROATE|Valproicacid"
"2929","Epilim Chronosphere 500mg prolonged-release granules","500 milligram(s) Prolonged-release granules",2007-03-02,"PA0540/150/007","Sanofi-Aventis Ireland Limited T/A SANOFI","SODIUMVALPROATE|Valproicacid"
"2930","Epilim Enteric 200 mg gastro-resistant coated tablets","200 milligram(s) Gastro-resistant tablet",1983-08-30,"PA0540/150/002","Sanofi-Aventis Ireland Limited T/A SANOFI","SODIUMVALPROATE"
"2931","Epilim Enteric 500mg Gastro-resistant Coated Tablets","500 milligram(s) Gastro-resistant tablet",1983-08-24,"PA0540/150/003","Sanofi-Aventis Ireland Limited T/A SANOFI","SODIUMVALPROATE"
"2932","Epilim Intravenous 400mg powder and solvent for solution for injection or infusion","400 milligram(s) Powder and solvent for solution for injection/infusion",1998-12-15,"PA0540/150/013","Sanofi-Aventis Ireland Limited T/A SANOFI","SODIUMVALPROATE"
"2933","Epilim Liquid 200 mg/5ml Oral Solution","200 mg/5ml Oral solution",1984-03-30,"PA0540/150/014","Sanofi-Aventis Ireland Limited T/A SANOFI","SODIUMVALPROATE"
"2934","Epilim Syrup 200mg/5ml Oral Solution","200 mg/5ml Oral solution",1983-11-01,"PA0540/150/015","Sanofi-Aventis Ireland Limited T/A SANOFI","SODIUMVALPROATE"
"2935","EPINITRIL 10 mg/24 h transdermal patch","10 milligram(s)/24 hours Transdermal patch",2000-04-14,"PA0868/003/002","Rottapharm Ltd","Glyceryltrinitrate"
"2936","EPINITRIL 15 mg/24 h transdermal patch","15 milligram(s)/24 hours Transdermal patch",2000-04-14,"PA0868/003/003","Rottapharm Ltd","Glyceryltrinitrate"
"2937","EPINITRIL 5 mg/24 h transdermal patch","5 milligram(s)/24 hours Transdermal patch",2000-04-14,"PA0868/003/001","Rottapharm Ltd","Glyceryltrinitrate"
"2938","Epipen 300 micrograms solution for injection in pre-filled pen","0.30 milligram(s)/dose Solution for injection in pre-filled pen",2013-08-29,"PA1332/050/002","Meda Health Sales Ireland Limited","Adrenaline"
"2939","Epipen Junior 150 micrograms solution for injection in pre-filled pen","0.15 milligram(s)/dose Solution for injection in pre-filled pen",2013-08-29,"PA1332/050/001","Meda Health Sales Ireland Limited","Adrenaline"
"2940","EPIRUBICIN","2 Mg/Ml Solution for Injection",2009-04-03,"PA1840/001/001","Seacross Pharmaceuticals Limited","EPIRUBICINHYDROCHLORIDE"
"2941","EPIRUBICIN","2 Mg/Ml Solution for Injection",2008-04-18,"PA1366/003/001","Actavis Group hf","EPIRUBICINHYDROCHLORIDE"
"2942","Epirubicin Hydrochloride 2 mg/ml solution for injection or infusion","2 milligram(s)/millilitre Solution for injection",2009-03-13,"PA1390/004/001","Accord Healthcare Limited","Epirubicinhydrochloride"
"2943","EPISALVAN ((PREVIOUSLY OLEOGEL-S10))","10 Per Cent                                                                                             Ointment",2016-01-14,"EU/1/15/1069/001","Birken AG","DRYEXTRACTFROMBETULAECORTEX(BIRCHBARK)(5-10:1)"
"2944","EPIVIR","150 Milligram                                                                                            Coated Tablets",1996-08-08,"EU/1/96/015/001","ViiV Healthcare UK Ltd","LAMIVUDINE"
"2945","EPIVIR","10 Mg/Ml Infus/Pdr/Oral Soln",1996-08-08,"EU/1/96/015/002","ViiV Healthcare UK Ltd","LAMIVUDINE"
"2946","EPIVIR 300MG","300 Milligram                                                                                            Coated Tablets",2001-11-15,"EU/1/96/015/003","ViiV Healthcare UK Ltd","LAMIVUDINE"
"2947","EPLERENONE","25 Milligram                                                                                            Film Coated Tablet",2015-10-23,"PA1390/102/001","Accord Healthcare Limited","EPLERENONE"
"2948","EPLERENONE","50 Milligram                                                                                            Film Coated Tablet",2015-10-23,"PA1390/102/002","Accord Healthcare Limited","EPLERENONE"
"2949","EPLERENONE","25 Milligram                                                                                            Film Coated Tablet",2013-04-05,"PA1333/015/001","Morningside Healthcare Limited","EPLERENONE"
"2950","EPLERENONE","50 Milligram                                                                                            Film Coated Tablet",2013-04-05,"PA1333/015/002","Morningside Healthcare Limited","EPLERENONE"
"2951","Eplerenone Actavis 25 mg, film-coated tablets","25 milligram(s) Film-coated tablet",2013-08-09,"PA2315/010/001","Accord Healthcare Ireland Ltd.","Eplerenone"
"2952","Eplerenone Actavis 50 mg, film-coated tablets","50 milligram(s) Film-coated tablet",2013-08-09,"PA2315/010/002","Accord Healthcare Ireland Ltd.","Eplerenone"
"2953","EPLERENONE BLUEFISH","25 Milligram                                                                                            Film Coated Tablet",2013-11-29,"PA1436/022/001","Bluefish Pharmaceuticals AB","EPLERENONE"
"2954","EPLERENONE BLUEFISH","50 Milligram                                                                                            Film Coated Tablet",2013-11-29,"PA1436/022/002","Bluefish Pharmaceuticals AB","EPLERENONE"
"2955","Eplerenone Krka 25 mg Film-Coated Tablet","25 milligram(s) Film-coated tablet",2018-08-24,"PA1347/078/001","Krka d.d., Novo mesto","Eplerenone"
"2956","Eplerenone Krka 50 mg Film-Coated Tablet","50 milligram(s) Film-coated tablet",2018-08-24,"PA1347/078/002","Krka d.d., Novo mesto","Eplerenone"
"2957","Eplerenone Mylan 25 mg film-coated tablets","25 milligram(s) Film-coated tablet",2013-11-08,"PA0577/168/001","McDermott Laboratories Ltd t/a Gerard Laboratories","Eplerenone"
"2958","Eplerenone Mylan 50 mg film-coated tablets","50 milligram(s) Film-coated tablet",2013-11-08,"PA0577/168/002","McDermott Laboratories Ltd t/a Gerard Laboratories","Eplerenone"
"2959","EPLERENONE ROWEX","25 Milligram                                                                                            Film Coated Tablet",2011-11-25,"PA0711/235/001","Rowex Ltd","EPLERENONE"
"2960","EPLERENONE ROWEX","50 Milligram                                                                                            Film Coated Tablet",2011-11-25,"PA0711/235/002","Rowex Ltd","EPLERENONE"
"2961","EPOETIN ALFA HEXAL","6000 International Unit                                                                                   Solution for Injection",2007-08-28,"EU/1/07/411/11-12","Hexal AG","RECOMBINANTHUMANERYTHROPOIETINALFA"
"2962","EPOETIN ALFA HEXAL","1000 International Unit                                                                                   Solution for Injection",2007-08-28,"EU/1/07/411/1-2","Hexal AG","RECOMBINANTHUMANERYTHROPOIETINALFA"
"2963","EPOETIN ALFA HEXAL","8000 International Unit                                                                                   Solution for Injection",2007-08-28,"EU/1/07/411/13-14","Hexal AG","RECOMBINANTHUMANERYTHROPOIETINALFA"
"2964","EPOETIN ALFA HEXAL","10,000 International Unit                                                                                   Solution for Injection",2007-08-28,"EU/1/07/411/15-16","Hexal AG","RECOMBINANTHUMANERYTHROPOIETINALFA"
"2965","EPOETIN ALFA HEXAL","20000/0.5 IU/ML                                                                                                Solution for injection in pre-filled syringe",2009-10-01,"EU/1/07/411/21-22","Hexal AG","EPOETINALFA"
"2966","EPOETIN ALFA HEXAL","30000/0.75 IU/ML                                                                                                Solution for injection in pre-filled syringe",2009-10-01,"EU/1/07/411/23-24","Hexal AG","EPOETINALFA"
"2967","EPOETIN ALFA HEXAL","40000/1 IU/ML                                                                                                Solution for injection in pre-filled syringe",2009-10-01,"EU/1/07/411/25-26","Hexal AG","EPOETINALFA"
"2968","EPOETIN ALFA HEXAL","2000 International Unit                                                                                   Solution for Injection",2007-08-28,"EU/1/07/411/3-4","Hexal AG","RECOMBINANTHUMANERYTHROPOIETINALFA"
"2969","EPOETIN ALFA HEXAL","3000 International Unit                                                                                   Solution for Injection",2007-08-28,"EU/1/07/411/5-6","Hexal AG","RECOMBINANTHUMANERYTHROPOIETINALFA"
"2970","EPOETIN ALFA HEXAL","4000 International Unit                                                                                   Solution for Injection",2007-08-28,"EU/1/07/411/7-8","Hexal AG","RECOMBINANTHUMANERYTHROPOIETINALFA"
"2971","EPOETIN ALFA HEXAL","5000 International Unit                                                                                   Solution for Injection",2007-08-28,"EU/1/07/411/9-10","Hexal AG","RECOMBINANTHUMANERYTHROPOIETINALFA"
"2972","EPORATIO","10000 IU/ML                                                                                                Solution for Injection",2009-10-29,"EU/1/09/573/11-16","Ratiopharm GmbH","XM01DRUGSUBSTANCEEPOETINTHETA"
"2973","EPORATIO","1000/0.5 IU/ML                                                                                                Solution for Injection",2009-10-29,"EU/1/09/573/1-2","Ratiopharm GmbH","XM01DRUGSUBSTANCEEPOETINTHETA"
"2974","EPORATIO","20000 IU/ML                                                                                                Solution for Injection",2009-10-29,"EU/1/09/573/17-22","Ratiopharm GmbH","XM01DRUGSUBSTANCEEPOETINTHETA"
"2975","EPORATIO","30000 IU/ML                                                                                                Solution for Injection",2009-10-29,"EU/1/09/573/23-28","Ratiopharm GmbH","XM01DRUGSUBSTANCEEPOETINTHETA"
"2976","EPORATIO","2000/0.5 IU/ML                                                                                                Solution for Injection",2009-10-29,"EU/1/09/573/3-4","Ratiopharm GmbH","XM01DRUGSUBSTANCEEPOETINTHETA"
"2977","EPORATIO","3000/0.5 IU/ML                                                                                                Solution for Injection",2009-10-29,"EU/1/09/573/5-6","Ratiopharm GmbH","XM01DRUGSUBSTANCEEPOETINTHETA"
"2978","EPORATIO","4000/0.5 IU/ML                                                                                                Solution for Injection",2009-10-29,"EU/1/09/573/7-8","Ratiopharm GmbH","XM01DRUGSUBSTANCEEPOETINTHETA"
"2979","EPORATIO","5000/0.5 IU/ML                                                                                                Solution for Injection",2009-10-29,"EU/1/09/573/9-10","Ratiopharm GmbH","XM01DRUGSUBSTANCEEPOETINTHETA"
"2980","EPREX 10,000 IU/mL solution for injection in pre-filled syringe","10000 international unit(s)/millilitre Solution for injection",1995-03-06,"PA0748/025/009","Janssen-Cilag Ltd","Epoetinalfa"
"2981","EPREX 2,000 IU/mL solution for injection in pre-filled syringe","2000 unit(s)/millilitre Solution for injection",1995-03-06,"PA0748/025/005","Janssen-Cilag Ltd","Epoetinalfa"
"2982","EPREX 4,000 IU/mL solution for injection in pre-filled syringe","4000 unit(s)/millilitre Solution for injection",1995-03-06,"PA0748/025/006","Janssen-Cilag Ltd","Epoetinalfa"
"2983","EPREX 40,000 IU/mL solution for injection in pre-filled syringe","40, 000 international unit(s)/millilitre Solution for injection",1989-11-02,"PA0748/025/012","Janssen-Cilag Ltd","Epoetinumalfa"
"2984","EPROSARTAN NICHE","300 Milligram                                                                                            Film Coated Tablet",2015-05-29,"PA1063/052/001","Niche Generics Limited","EPROSARTANMESYLATE"
"2985","EPROSARTAN NICHE","400 Milligram                                                                                            Film Coated Tablet",2015-05-29,"PA1063/052/002","Niche Generics Limited","EPROSARTANMESYLATE"
"2986","EPROSARTAN NICHE","600 Milligram                                                                                            Film Coated Tablet",2015-05-29,"PA1063/052/003","Niche Generics Limited","EPROSARTANMESYLATE"
"2987","EPROSARTAN TEVA","300 Milligram                                                                                            Film Coated Tablet",2015-05-29,"PA1986/018/001","Teva B.V.","EPROSARTANMESYLATE"
"2988","EPROSARTAN TEVA","400 Milligram                                                                                            Film Coated Tablet",2015-05-29,"PA1986/018/002","Teva B.V.","EPROSARTANMESYLATE"
"2989","EPROSARTAN TEVA","600 Milligram                                                                                            Film Coated Tablet",2015-05-29,"PA1986/018/003","Teva B.V.","EPROSARTANMESYLATE"
"2990","EPTIFIBATIDE ACCORD","0.75 Mg/Ml Solution for Infusion",2016-01-11,"EU/1/15/1065/001","Accord Healthcare Limited","EPTIFIBATIDE"
"2991","EPTIFIBATIDE ACCORD","2.0 Mg/Ml Solution for Injection",2016-01-11,"EU/1/15/1065/002","Accord Healthcare Limited","EPTIFIBATIDE"
"2992","EQUASYM","5 Milligram                                                                                            Tablets",2004-01-26,"PA1575/001/004","Shire Pharmaceuticals Ireland Limited","METHYLPHENIDATEHYDROCHLORIDE"
"2993","EQUASYM","10 Milligram                                                                                            Tablets",2004-01-26,"PA1575/001/005","Shire Pharmaceuticals Ireland Limited","METHYLPHENIDATEHYDROCHLORIDE"
"2994","EQUASYM","20 Milligram                                                                                            Tablets",2004-01-26,"PA1575/001/006","Shire Pharmaceuticals Ireland Limited","METHYLPHENIDATEHYDROCHLORIDE"
"2995","EQUASYM XL","40 Milligram                                                                                            Capsules Modified Release",2013-02-08,"PA1575/001/007","Shire Pharmaceuticals Ireland Limited","METHYLPHENIDATEHYDROCHLORIDE"
"2996","EQUASYM XL","50 Milligram                                                                                            Capsules Modified Release",2013-02-08,"PA1575/001/008","Shire Pharmaceuticals Ireland Limited","METHYLPHENIDATEHYDROCHLORIDE"
"2997","EQUASYM XL","60 Milligram                                                                                            Capsules Modified Release",2013-02-08,"PA1575/001/009","Shire Pharmaceuticals Ireland Limited","METHYLPHENIDATEHYDROCHLORIDE"
"2998","EQUASYM XL","10 Milligram                                                                                            Capsules Modified Release",2006-07-28,"PA1575/001/001","Shire Pharmaceuticals Ireland Limited","METHYLPHENIDATEHYDROCHLORIDE"
"2999","EQUASYM XL","20 Milligram                                                                                            Capsules Modified Release",2006-07-28,"PA1575/001/002","Shire Pharmaceuticals Ireland Limited","METHYLPHENIDATEHYDROCHLORIDE"
"3000","EQUASYM XL","30 Milligram                                                                                            Capsules Modified Release",2006-07-28,"PA1575/001/003","Shire Pharmaceuticals Ireland Limited","METHYLPHENIDATEHYDROCHLORIDE"
"3001","Erbitux","2 mg/ml micromole(s) Solution for infusion",2004-06-29,"EU/1/04/281/001","Merck KGaA","Cetuximab"
"3002","ERBITUX","5 Micromol Solution for Infusion",2007-02-20,"EU/1/04/281/2-5","Merck KGaA","CETUXIMAB,CHIMERICANTIBODY"
"3003","ERDOTIN","300 Milligram                                                                                            Capsule",2006-10-13,"PA1325/001/001","Edmond Pharma S.r.l.","ERDOSTEINE"
"3004","Erelzi (Formely known: Etanercept Sandoz)","25 milligram(s) Solution for injection in pre-filled syringe",2017-06-23,"EU/1/17/1195/001-004","Sandoz GmbH","Etanercept"
"3005","ERELZI (FORMELY KNOWN: ETANERCEPT SANDOZ)","50 Milligram                                                                                            Solution for Injection",2017-06-23,"EU/1/17/1195/005-012","Sandoz GmbH","ETANERCEPT"
"3006","Erivedge","150 milligram(s) Capsule, hard",2013-07-12,"EU/1/13/848/001","Roche Registration Limited","Vismodegib"
"3007","ERTRACER SOLUTION FOR INJECTION","10-130GBq Unknown Solution for Injection",2015-02-27,"PA1125/002/001","M2i Limited","FLUDEOXYGLUCOSE(18F)INJECTION"
"3008","Erwinase 10,000 Units. Powder for solution for injection","10000 percent volume/volume Powder for solution for injection",1998-09-18,"PA1020/002/001","Jazz Pharmaceuticals France SAS","Cristanspase"
"3009","ERYTHROCIN","500 Milligram                                                                                            Film Coated Tablet",1977-04-01,"PA1142/008/003","Amdipharm Limited","ERYTHROMYCINSTEARATE"
"3010","Erythrocin 250 mg Tablets","250 milligram(s) Film-coated tablet",1977-04-01,"PA1142/008/002","Amdipharm Limited","ERYTHROMYCINSTEARATE"
"3011","ERYTHROCIN IV LACTOBIONATE","1 Grams                                                                                                Pdr/Conc/Soln for Infus",1980-01-28,"PA1142/008/001","Amdipharm Limited","ERYTHROMYCINLACTOBIONATE"
"3012","ERYTHROPED ADULT","500 Milligram                                                                                            Tablets",1986-01-27,"PA1142/006/004","Amdipharm Limited","ERYTHROMYCINETHYLSUCCINATE"
"3013","ERYTHROPED FORTE SF","500 MG/5ml                                                                                               Granules for Oral Suspension",1999-02-19,"PA1142/006/003","Amdipharm Limited","ERYTHROMYCIN"
"3014","ERYTHROPED PI SF","125 MG/5ml                                                                                               Granules for Oral Suspension",1999-02-19,"PA1142/006/002","Amdipharm Limited","ERYTHROMYCIN"
"3015","ERYTHROPED SF","250 MG/5ml                                                                                               Granules for Oral Suspension",1999-02-19,"PA1142/006/001","Amdipharm Limited","ERYTHROMYCIN"
"3016","Esbriet","267 milligram(s) Capsule, hard",2011-02-28,"EU/1/11/667/001-003","Roche Registration GmbH","Pirfenidone"
"3017","ESBRIET","267 Milligram                                                                                            Film Coated Tablet",2017-04-24,"EU/1/11/667/005-008","Roche Registration GmbH","PIRFENIDONE"
"3018","ESBRIET","534 Milligram                                                                                            Film Coated Tablet",2017-04-24,"EU/1/11/667/009-010","Roche Registration GmbH","PIRFENIDONE"
"3019","Esbriet","801 milligram(s) Film-coated tablet",NA,"EU/1/11/667/011","Roche Registration GmbH","Pirfenidone"
"3020","Esciprex 10 mg Film-Coated Tablets","10 milligram(s) Film-coated tablet",2011-08-12,"PA0711/194/002","Rowex Ltd","Escitalopramoxalate"
"3021","Esciprex 15 mg Film-Coated Tablets","15 milligram(s) Film-coated tablet",2011-08-12,"PA0711/194/003","Rowex Ltd","Escitalopramoxalate"
"3022","Esciprex 20 mg Film-Coated Tablets","20 milligram(s) Film-coated tablet",2011-08-12,"PA0711/194/004","Rowex Ltd","Escitalopramoxalate"
"3023","Esciprex 5 mg Film-Coated Tablets","5 milligram(s) Film-coated tablet",2011-08-12,"PA0711/194/001","Rowex Ltd","Escitalopramoxalate"
"3024","ESCITALOPRAM","20 Mg/Ml Oral Drops Solution",2012-03-23,"PA0688/041/001","Chanelle Medical","ESCITALOPRAMOXALATE"
"3025","ESCITALOPRAM","5 Milligram                                                                                            Film Coated Tablet",2014-12-05,"PA1240/012/001","Bristol Laboratories Limited","ESCITALOPRAMOXALATE|ESCITALOPRAM"
"3026","ESCITALOPRAM","10 Milligram                                                                                            Film Coated Tablet",2014-12-05,"PA1240/012/002","Bristol Laboratories Limited","ESCITALOPRAMOXALATE|ESCITALOPRAM"
"3027","ESCITALOPRAM","15 Milligram                                                                                            Film Coated Tablet",2014-12-05,"PA1240/012/003","Bristol Laboratories Limited","ESCITALOPRAMOXALATE|ESCITALOPRAM"
"3028","ESCITALOPRAM","20 Milligram                                                                                            Film Coated Tablet",2014-12-05,"PA1240/012/004","Bristol Laboratories Limited","ESCITALOPRAMOXALATE|ESCITALOPRAM"
"3029","ESCITALOPRAM","5 Milligram                                                                                            Film Coated Tablet",2012-01-13,"PA1390/037/001","Accord Healthcare Limited","ESCITALOPRAMOXALATE"
"3030","ESCITALOPRAM","10 Milligram                                                                                            Film Coated Tablet",2012-01-13,"PA1390/037/002","Accord Healthcare Limited","ESCITALOPRAMOXALATE"
"3031","ESCITALOPRAM","20 Milligram                                                                                            Film Coated Tablet",2012-01-13,"PA1390/037/003","Accord Healthcare Limited","ESCITALOPRAMOXALATE"
"3032","ESCITALOPRAM ACTAVIS","5 Milligram                                                                                            Film Coated Tablet",2010-03-19,"PA1380/091/001","Actavis Group PTC ehf","ESCITALOPRAM"
"3033","ESCITALOPRAM ACTAVIS","10 Milligram                                                                                            Film Coated Tablet",2010-03-19,"PA1380/091/002","Actavis Group PTC ehf","ESCITALOPRAM"
"3034","ESCITALOPRAM ACTAVIS","15 Milligram                                                                                            Film Coated Tablet",2010-03-19,"PA1380/091/003","Actavis Group PTC ehf","ESCITALOPRAM"
"3035","ESCITALOPRAM ACTAVIS","20 Milligram                                                                                            Film Coated Tablet",2010-03-19,"PA1380/091/004","Actavis Group PTC ehf","ESCITALOPRAM"
"3036","ESCITALOPRAM BIOORGANICS","10 Milligram                                                                                            Film Coated Tablet",2010-10-15,"PA1082/002/001","BioOrganics BV","ESCITALOPRAMOXALATE"
"3037","ESCITALOPRAM BIOORGANICS","15 Milligram                                                                                            Film Coated Tablet",2010-10-15,"PA1082/002/002","BioOrganics BV","ESCITALOPRAMOXALATE"
"3038","ESCITALOPRAM BIOORGANICS","20 Milligram                                                                                            Film Coated Tablet",2010-10-15,"PA1082/002/003","BioOrganics BV","ESCITALOPRAMOXALATE"
"3039","Escitalopram Bluefish 10mg Film-coated Tablets","10 milligram(s) Film-coated tablet",2014-03-28,"PA1436/023/002","Bluefish Pharmaceuticals AB","Escitalopramoxalate"
"3040","Escitalopram Bluefish 15mg Film-coated Tablets","15 milligram(s) Film-coated tablet",2014-03-28,"PA1436/023/003","Bluefish Pharmaceuticals AB","Escitalopramoxalate"
"3041","Escitalopram Bluefish 20mg Film-coated Tablets","20 milligram(s) Film-coated tablet",2014-03-28,"PA1436/023/004","Bluefish Pharmaceuticals AB","Escitalopramoxalate"
"3042","Escitalopram Bluefish 5mg Film-Coated Tablets","5 milligram(s) Film-coated tablet",2014-03-28,"PA1436/023/001","Bluefish Pharmaceuticals AB","Escitalopramoxalate"
"3043","ESCITALOPRAM GLENMARK","10 Milligram                                                                                            Film Coated Tablet",2010-11-05,"PA1543/001/001","Glenmark Pharmaceuticals s.r.o.","ESCITALOPRAMOXALATE"
"3044","ESCITALOPRAM GLENMARK","15 Milligram                                                                                            Film Coated Tablet",2010-11-05,"PA1543/001/002","Glenmark Pharmaceuticals s.r.o.","ESCITALOPRAMOXALATE"
"3045","ESCITALOPRAM GLENMARK","20 Milligram                                                                                            Film Coated Tablet",2010-11-05,"PA1543/001/003","Glenmark Pharmaceuticals s.r.o.","ESCITALOPRAMOXALATE"
"3046","Escitalopram Glenmark 10mg Film-coated Tablets","10 milligram(s) Film-coated tablet",2012-02-24,"PA1462/010/002","Glenmark Pharmaceuticals Europe Limited","Escitalopram"
"3047","Escitalopram Glenmark 15mg Film-coated Tablets","15 milligram(s) Film-coated tablet",2012-02-24,"PA1462/010/003","Glenmark Pharmaceuticals Europe Limited","Escitalopram"
"3048","Escitalopram Glenmark 20mg Film-coated Tablets","20 milligram(s) Film-coated tablet",2012-02-24,"PA1462/010/004","Glenmark Pharmaceuticals Europe Limited","Escitalopram"
"3049","Escitalopram Glenmark 5mg Film-coated Tablets","5 milligram(s) Film-coated tablet",2012-02-24,"PA1462/010/001","Glenmark Pharmaceuticals Europe Limited","Escitalopram"
"3050","ESCITALOPRAM KRKA","5 Milligram                                                                                            Film Coated Tablet",2014-02-28,"PA1347/046/001","Krka d.d., Novo mesto","ESCITALOPRAMOXALATE"
"3051","ESCITALOPRAM KRKA","10 Milligram                                                                                            Film Coated Tablet",2014-02-28,"PA1347/046/002","Krka d.d., Novo mesto","ESCITALOPRAMOXALATE"
"3052","ESCITALOPRAM KRKA","15 Milligram                                                                                            Film Coated Tablet",2014-02-28,"PA1347/046/003","Krka d.d., Novo mesto","ESCITALOPRAMOXALATE"
"3053","ESCITALOPRAM KRKA","20 Milligram                                                                                            Film Coated Tablet",2014-02-28,"PA1347/046/004","Krka d.d., Novo mesto","ESCITALOPRAMOXALATE"
"3054","ESCITALOPRAM TEVA","5 Milligram                                                                                            Film Coated Tablet",2009-03-06,"PA0749/111/001","Teva Pharma B.V.","ESCITALOPRAMOXALATE"
"3055","ESCITALOPRAM TEVA","10 Milligram                                                                                            Film Coated Tablet",2009-03-06,"PA0749/111/002","Teva Pharma B.V.","ESCITALOPRAMOXALATE"
"3056","ESCITALOPRAM TEVA","15 Milligram                                                                                            Film Coated Tablet",2009-03-06,"PA0749/111/003","Teva Pharma B.V.","ESCITALOPRAMOXALATE"
"3057","ESCITALOPRAM TEVA","20 Milligram                                                                                            Film Coated Tablet",2009-03-06,"PA0749/111/004","Teva Pharma B.V.","ESCITALOPRAMOXALATE"
"3058","ESCITALPRO","5 Milligram                                                                                            Film Coated Tablet",2009-12-22,"PA0577/108/001","McDermott Laboratories Ltd t/a Gerard Laboratories","ESCITALOPRAMOXALATE"
"3059","ESCITALPRO","10 Milligram                                                                                            Film Coated Tablet",2009-12-22,"PA0577/108/002","McDermott Laboratories Ltd t/a Gerard Laboratories","ESCITALOPRAMOXALATE"
"3060","ESCITALPRO","15 Milligram                                                                                            Film Coated Tablet",2009-12-22,"PA0577/108/003","McDermott Laboratories Ltd t/a Gerard Laboratories","ESCITALOPRAMOXALATE"
"3061","ESCITALPRO","20 Milligram                                                                                            Film Coated Tablet",2009-12-22,"PA0577/108/004","McDermott Laboratories Ltd t/a Gerard Laboratories","ESCITALOPRAMOXALATE"
"3062","ESCITOTAB","15 Milligram                                                                                            Film Coated Tablet",2010-10-15,"PA0740/011/002","Genthon BV","ESCITALOPRAMOXALATE"
"3063","Escitotab 10 mg film-coated tablets","10 milligram(s) Film-coated tablet",2010-10-15,"PA0740/011/001","Genthon B.V.","Escitalopramoxalate"
"3064","Escitotab 20 mg film-coated tablets","20 milligram(s) Film-coated tablet",2010-10-15,"PA0740/011/003","Genthon B.V.","Escitalopramoxalate"
"3065","ESCIVRIENS","10 Milligram                                                                                            Film Coated Tablet",2010-10-15,"PA0740/012/001","Genthon BV","ESCITALOPRAMOXALATE"
"3066","ESCIVRIENS","15 Milligram                                                                                            Film Coated Tablet",2010-10-15,"PA0740/012/002","Genthon BV","ESCITALOPRAMOXALATE"
"3067","ESCIVRIENS","20 Milligram                                                                                            Film Coated Tablet",2010-10-15,"PA0740/012/003","Genthon BV","ESCITALOPRAMOXALATE"
"3068","Esmeron 10 mg/ml Solution for Injection/Infusion","10 milligram(s)/millilitre Solution for injection/infusion",1996-08-07,"PA1286/058/001","Merck Sharp & Dohme Ireland (Human Health) Limited","Rocuroniumbromide"
"3069","ESMOCARD 100 mg/10 ml solution for injection","100 milligram(s) Solution for injection",2008-03-07,"PA1353/001/001","Orpha-Devel Handels und Vertriebs GmbH","ESMOLOLHYDROCHLORIDE"
"3070","ESMOCARD LYO 2500 mg powder for concentrate for solution for infusion","2500 milligram(s) ZZZ Pdr/Conc/Soln for Infus",2011-02-25,"PA1353/001/003","Orpha-Devel Handels und Vertriebs GmbH","ESMOLOLHYDROCHLORIDE"
"3071","Esmya","5 milligram(s) Tablet",NA,"EU/1/12/750/001","Gedeon Richter Plc","Ulipristalacetate"
"3072","ESOMEPRAZOLE","40 Milligram                                                                                            Pdr for Soln Inj/Inf",2016-08-08,"PA1380/127/005","Actavis Group PTC ehf","ESOMEPRAZOLE|ESOMEPRAZOLESODIUM"
"3073","ESOMEPRAZOLE","40 Milligram                                                                                            Pdr for Soln Inj/Inf",2014-11-24,"PA1390/097/001","Accord Healthcare Limited","ESOMEPRAZOLESODIUM"
"3074","ESOMEPRAZOLE","40 Milligram                                                                                            Tablets Gastro-Resistant",2014-12-12,"PA1240/011/002","Bristol Laboratories Limited","ESOMEPRAZOLEMAGNESIUMDIHYDRATE"
"3075","Esomeprazole 20mg Gastro-resistant Tablets","20 milligram(s) Gastro-resistant tablet",2014-12-12,"PA1240/011/001","Bristol Laboratories Limited","Esomeprazolemagnesiumdihydrate"
"3076","Esomeprazole 20mg Gastro-resistant Tablets","20 milligram(s) Gastro-resistant tablet",2018-03-29,"PA2061/001/001","Brillpharma Limited","Esomeprazole"
"3077","ESOMEPRAZOLE ACTAVIS","40 Milligram                                                                                            Capsules Gastro-Resistant",2012-08-17,"PA1380/127/002","Actavis Group PTC ehf","ESOMEPRAZOLEMAGNESIUMDIHYDRATE"
"3078","ESOMEPRAZOLE ACTAVIS","40 Milligram                                                                                            Tablets Gastro-Resistant",2013-03-01,"PA1380/127/004","Actavis Group PTC ehf","ESOMEPRAZOLEMAGNESIUMDIHYDRATE"
"3079","Esomeprazole Actavis 20 mg gastro-resistant capsules, hard","20 milligram(s) Gastro-resistant capsule, hard",2012-08-17,"PA1380/127/001","Actavis Group PTC ehf","Esomeprazolemagnesiumdihydrate"
"3080","Esomeprazole Actavis 20mg Gastro-resistant tablets","20 milligram(s) Gastro-resistant tablet",2013-03-01,"PA1380/127/003","Actavis Group PTC ehf","Esomeprazolemagnesiumdihydrate"
"3081","Esomeprazole Aristo 20 mg gastro-resistant capsules, hard","20 milligram(s) Gastro-resistant capsule, hard",2012-09-07,"PA1983/001/001","Aristo Pharma GmbH","Esomeprazolemagnesiumdihydrate"
"3082","Esomeprazole Aristo 40 mg gastro-resistant capsules, hard","40 milligram(s) Gastro-resistant capsule",2012-09-07,"PA1983/001/002","Aristo Pharma GmbH","Esomeprazolemagnesiumdihydrate"
"3083","Esomeprazole Krka 20 mg gastro-resistant capsules, hard","20 milligram(s) Gastro-resistant capsule, hard",2010-10-01,"PA1347/017/001","Krka d.d., Novo mesto","Esomeprazolemagnesiumdihydrate"
"3084","Esomeprazole Krka 40 mg gastro-resistant capsules, hard","40 milligram(s) Gastro-resistant capsule",2010-10-01,"PA1347/017/002","Krka d.d., Novo mesto","Esomeprazolemagnesiumdihydrate"
"3085","ESOMEPRAZOLE MYLAN","40 Milligram                                                                                            Gastro-resistance capsule, hard",2011-04-01,"PA0577/123/002","McDermott Laboratories Ltd t/a Gerard Laboratories","ESOMEPRAZOLE"
"3086","Esomeprazole Mylan 20 mg Gastro-resistant Hard Capsules","20 milligram(s) Gastro-resistant capsule, hard",2011-04-01,"PA0577/123/001","McDermott Laboratories Ltd t/a Gerard Laboratories","Esomeprazole"
"3087","Esomeprazole Ticerin 40mg Powder for Solution for Injection or Infusion","40 milligram(s) Powder for solution for injection/infusion",2014-04-11,"PA1852/002/001","Laboratórios Azevedos - Indústria Farmacêutica S.A","Esomeprazolesodium"
"3088","Esomeprazole/Acetylsalicylic Acid","*** AWAITING VALUE *** Not Currently Available",NA,"IC0030A","IC Company",""
"3089","ESPESTESIN","40/0.010 Mg/Ml Solution for Injection",2003-02-21,"PA1762/001/001","3M Deutschland GmbH","ARTICAINEHYDROCHLORIDE|EPINEPHRINEHYDROCHLORIDE"
"3090","ESPESTESIN","40/0.005 Mg/Ml Solution for Injection",2003-02-21,"PA1762/001/002","3M Deutschland GmbH","ARTICAINEHYDROCHLORIDE|EPINEPHRINEHYDROCHLORIDE"
"3091","ESPRANOR","2 Milligram                                                                                            Oral Lyophilisate",2017-07-14,"PA0361/036/001","Martindale Pharmaceuticals Ltd","BUPRENORPHINEHYDROCHLORIDE"
"3092","ESPRANOR","8 Milligram                                                                                            Oral Lyophilisate",2017-07-14,"PA0361/036/002","Martindale Pharmaceuticals Ltd","BUPRENORPHINEHYDROCHLORIDE"
"3093","ESTRADOT","37.5 Microgram/day                                                                                        Transdermal Patch",2002-02-08,"PA0896/010/001","Novartis Ireland Limited","ESTRADIOLHEMIHYDRATE"
"3094","ESTRADOT","50 Microgram/day                                                                                        Transdermal Patch",2002-02-08,"PA0896/010/002","Novartis Ireland Limited","ESTRADIOLHEMIHYDRATE"
"3095","ESTRADOT","75 Microgram/day                                                                                        Transdermal Patch",2002-02-08,"PA0896/010/003","Novartis Ireland Limited","ESTRADIOLHEMIHYDRATE"
"3096","ESTRADOT","100 Microgram/day                                                                                        Transdermal Patch",2002-02-08,"PA0896/010/004","Novartis Ireland Limited","ESTRADIOLHEMIHYDRATE"
"3097","ESTRADOT","25 Microgram/day                                                                                        Transdermal Patch",2005-05-24,"PA0896/010/005","Novartis Ireland Limited","ESTRADIOLHEMIHYDRATE"
"3098","ESTRIOL","0.03 Milligram                                                                                            Pessary",2018-03-16,"PA2268/001/001","Besins Healthcare (UK) Ltd","ESTRIOL"
"3099","ESTROFEM","2 Milligram                                                                                            Tablets",1996-05-01,"PA0218/050/001","Novo Nordisk A/S","ESTRADIOL"
"3100","ETALOPRO","5 Milligram                                                                                            Film Coated Tablet",2009-12-04,"PA0126/212/001","Clonmel Healthcare Ltd","ESCITALOPRAMOXALATE"
"3101","ETALOPRO","10 Milligram                                                                                            Film Coated Tablet",2009-12-04,"PA0126/212/002","Clonmel Healthcare Ltd","ESCITALOPRAMOXALATE"
"3102","ETALOPRO","15 Milligram                                                                                            Film Coated Tablet",2009-12-04,"PA0126/212/003","Clonmel Healthcare Ltd","ESCITALOPRAMOXALATE"
"3103","ETALOPRO","20 Milligram                                                                                            Film Coated Tablet",2009-12-04,"PA0126/212/004","Clonmel Healthcare Ltd","ESCITALOPRAMOXALATE"
"3104","ETHAMBUTOL","100 Milligram                                                                                            Film Coated Tablet",2010-10-01,"PA1333/007/001","Morningside Healthcare Limited","ETHAMBUTOLDIHYDROCHLORIDE"
"3105","ETHAMBUTOL","400 Milligram                                                                                            Film Coated Tablet",2010-10-01,"PA1333/007/002","Morningside Healthcare Limited","ETHAMBUTOLDIHYDROCHLORIDE"
"3106","ETHAMBUTOL","100 Milligram                                                                                            Film Coated Tablet",1977-04-01,"PA0822/180/001","Pfizer Healthcare Ireland","ETHAMBUTOLDIHYDROCHLORIDE"
"3107","ETHAMBUTOL","400 Milligram                                                                                            Film Coated Tablet",1977-04-01,"PA0822/180/002","Pfizer Healthcare Ireland","ETHAMBUTOLDIHYDROCHLORIDE"
"3108","Ethinylestradiol / Drospirenone Leon Farma & Placebo Film-coated Tablets","0.02 / 3 milligram(s) Film-coated tablet",2009-10-09,"PA1474/008/001","Laboratorios Leon Farma, S.A.","Drospirenone|Ethinylestradiol"
"3109","Ethinylestradiol / Drospirenone Leon Farma & Placebo Film-coated Tablets","0.03 / 3 milligram(s) Film-coated tablet",2009-10-09,"PA1474/008/002","Laboratorios Leon Farma, S.A.","Drospirenone|Ethinylestradiol"
"3110","Ethinylestradiol / Drospirenone Leon Farma 0.02mg/3 mg Film-coated Tablets","0.02 / 3 milligram(s) Film-coated tablet",2009-10-09,"PA1474/004/001","Laboratorios Leon Farma, S.A.","Drospirenone|Ethinylestradiol"
"3111","Ethinylestradiol / Drospirenone Leon Farma 0.03 mg/3 mg Film-coated Tablets","0.03 / 3 milligram(s) Film-coated tablet",NA,"PA0711/208/002","Rowex Ltd","Drospirenone|Ethinylestradiol"
"3112","Ethinylestradiol / Drospirenone Leon Farma 0.03mg/3 mg Film-coated Tablets","0.03 / 3 milligram(s) Film-coated tablet",2009-10-09,"PA1474/004/002","Laboratorios Leon Farma, S.A.","Drospirenone|Ethinylestradiol"
"3113","Ethinylestradiol/Drospirenone Leon Farma & Placebo 0.02 mg/3 mg film-coated tablets","0.02/3 milligram(s) Film-coated tablet",2009-10-09,"PA1474/006/001","Laboratorios Leon Farma, S.A.","Ethinylestradiol|Drospirenone"
"3114","Ethinylestradiol/Drospirenone Leon Farma & Placebo 0.03 mg/3 mg film-coated tablets","0.03/3 milligram(s) Film-coated tablet",2009-10-09,"PA1474/006/002","Laboratorios Leon Farma, S.A.","Ethinylestradiol|Drospirenone"
"3115","Ethylex 50 mg film-coated tablets","50 milligram(s) Film-coated tablet",2004-04-20,"PA0934/002/001","AOP Orphan Pharmaceuticals AG","Naltrexonehydrochloride"
"3116","ETOFLAM 5% W/W GEL","5 %w/w                                                                                                 Gel",1990-04-04,"PA1113/002/001","Phoenix Labs","ETOFENAMATE"
"3117","Etonogestrel/Ethinylestradiol 0.120 mg/0.015 mg per 24 hours vaginal delivery system","0.120/0.015 milligram(s) Vaginal Device",2017-06-23,"PA1474/014/001","Laboratorios Leon Farma, S.A.","Etonogestrel|Ethinylestradiolph.eur."
"3118","ETOPOSIDE","20 Mg/Ml Concentrate for Soln for Inf",2014-05-16,"PA1422/012/001","Fresenius Kabi Oncology Plc","ETOPOSIDE"
"3119","ETOPOSIDE","20 Mg/Ml Concentrate for Soln for Inf",2014-07-18,"PA1380/168/001","Actavis Group PTC ehf","ETOPOSIDE"
"3120","ETOPOSIDE","20 Mg/Ml Concentrate for Soln for Inf",2014-07-25,"PA1390/094/001","Accord Healthcare Limited","ETOPOSIDE"
"3121","Etoposide-Teva 20 mg/ml Concentrate for Solution for Infusion","20 micromole(s) Concentrate for solution for infusion",1998-07-27,"PA0749/002/001","Teva Pharma B.V.","Etoposide"
"3122","ETORICOXIB","30 Milligram                                                                                            Film Coated Tablet",2015-06-26,"PA0711/232/001","Rowex Ltd","ETORICOXIB"
"3123","ETORICOXIB","60 Milligram                                                                                            Film Coated Tablet",2015-06-26,"PA0711/232/002","Rowex Ltd","ETORICOXIB"
"3124","ETORICOXIB","90 Milligram                                                                                            Film Coated Tablet",2015-06-26,"PA0711/232/003","Rowex Ltd","ETORICOXIB"
"3125","ETORICOXIB","120 Milligram                                                                                            Film Coated Tablet",2015-06-26,"PA0711/232/004","Rowex Ltd","ETORICOXIB"
"3126","ETORICOXIB","30 Milligram                                                                                            Film Coated Tablet",2015-09-11,"PA0405/104/001","Generics (UK) Limited","ETORICOXIB"
"3127","ETORICOXIB","60 Milligram                                                                                            Film Coated Tablet",2015-09-11,"PA0405/104/002","Generics (UK) Limited","ETORICOXIB"
"3128","ETORICOXIB","90 Milligram                                                                                            Film Coated Tablet",2015-09-11,"PA0405/104/003","Generics (UK) Limited","ETORICOXIB"
"3129","ETORICOXIB","120 Milligram                                                                                            Film Coated Tablet",2015-09-11,"PA0405/104/004","Generics (UK) Limited","ETORICOXIB"
"3130","Etoricoxib 120 mg Film-Coated Tablets","120 milligram(s) Film-coated tablet",2017-06-16,"PA1240/026/004","Bristol Laboratories Limited","Etoricoxib"
"3131","Etoricoxib 120 milligram Film Coated Tablet","120 milligram(s) Film-coated tablet",NA,"PA2315/043/004","Accord Healthcare Ireland Ltd.","Etoricoxib"
"3132","Etoricoxib 120mg Film-coated Tablets","120 milligram(s) Film-coated tablet",2014-11-28,"PA0688/032/004","Chanelle Medical","Etoricoxib"
"3133","Etoricoxib 30 mg Film-Coated Tablets","30 milligram(s) Film-coated tablet",2017-06-16,"PA1240/026/001","Bristol Laboratories Limited","Etoricoxib"
"3134","Etoricoxib 30 milligram Film Coated Tablet","30 milligram(s) Film-coated tablet",NA,"PA2315/043/001","Accord Healthcare Ireland Ltd.","Etoricoxib"
"3135","Etoricoxib 30mg Film-coated Tablets","30 milligram(s) Film-coated tablet",2014-11-28,"PA0688/032/001","Chanelle Medical","Etoricoxib"
"3136","Etoricoxib 60 mg Film-Coated Tablets","60 milligram(s) Film-coated tablet",2017-06-16,"PA1240/026/002","Bristol Laboratories Limited","Etoricoxib"
"3137","Etoricoxib 60 milligram Film Coated Tablet","60 milligram(s) Film-coated tablet",NA,"PA2315/043/002","Accord Healthcare Ireland Ltd.","Etoricoxib"
"3138","Etoricoxib 60mg Film-coated Tablets","60 milligram(s) Film-coated tablet",2014-11-28,"PA0688/032/002","Chanelle Medical","Etoricoxib"
"3139","Etoricoxib 90 mg Film-Coated Tablets","90 milligram(s) Film-coated tablet",2017-06-16,"PA1240/026/003","Bristol Laboratories Limited","Etoricoxib"
"3140","Etoricoxib 90 milligram Film Coated Tablet","90 milligram(s) Film-coated tablet",NA,"PA2315/043/003","Accord Healthcare Ireland Ltd.","Etoricoxib"
"3141","Etoricoxib 90mg Film-coated Tablets","90 milligram(s) Film-coated tablet",2014-11-28,"PA0688/032/003","Chanelle Medical","Etoricoxib"
"3142","ETORICOXIB KRKA","30 Milligram                                                                                            Film Coated Tablet",2016-11-25,"PA1347/064/001","Krka d.d., Novo mesto","ETORICOXIB"
"3143","ETORICOXIB KRKA","60 Milligram                                                                                            Film Coated Tablet",2016-11-25,"PA1347/064/002","Krka d.d., Novo mesto","ETORICOXIB"
"3144","ETORICOXIB KRKA","90 Milligram                                                                                            Film Coated Tablet",2016-11-25,"PA1347/064/003","Krka d.d., Novo mesto","ETORICOXIB"
"3145","ETORICOXIB KRKA","120 Milligram                                                                                            Film Coated Tablet",2016-11-25,"PA1347/064/004","Krka d.d., Novo mesto","ETORICOXIB"
"3146","ETORICOXIB TEVA","30 Milligram                                                                                            Film Coated Tablet",2016-02-19,"PA1986/002/001","Teva B.V.","ETORICOXIB"
"3147","ETORICOXIB TEVA","60 Milligram                                                                                            Film Coated Tablet",2016-02-19,"PA1986/002/002","Teva B.V.","ETORICOXIB"
"3148","ETORICOXIB TEVA","90 Milligram                                                                                            Film Coated Tablet",2016-02-19,"PA1986/002/003","Teva B.V.","ETORICOXIB"
"3149","ETORICOXIB TEVA","120 Milligram                                                                                            Film Coated Tablet",2016-02-19,"PA1986/002/004","Teva B.V.","ETORICOXIB"
"3150","ETRIVEX","500 Micrograms/g                                                                                         Shampoo",2007-04-20,"PA0590/023/001","Galderma (UK) Ltd","CLOBETASOLPROPIONATE"
"3151","EUCARBON HERBAL","Tablets",2015-05-29,"TR1743/001/001","F. Trenka chem. Pharm. Fabrik Gesmbh","SENNAFOLIUMPOWDER|RHUBARBDRYEXTRACT|VEGETABLECHARCOAL(CARBOLIGNI)"
"3152","EUCARDIC 12.5MG TABLETS","12.5mg Milligram                                                                                            Tablets",1995-01-19,"PA2239/001/002","Cheplapharm Arzneimittel GmbH","CARVEDILOL"
"3153","EUCARDIC 25MG TABLETS","25mg Milligram                                                                                            Tablets",1995-01-19,"PA2239/001/003","Cheplapharm Arzneimittel GmbH","CARVEDILOL"
"3154","EUCARDIC 3.125MG TABLETS","3.125mg Milligram                                                                                            Tablets",2000-06-14,"PA2239/001/004","Cheplapharm Arzneimittel GmbH","CARVEDILOL"
"3155","EUCARDIC 6.25 MG TABLETS","6.25mg Milligram                                                                                            Tablets",1998-04-03,"PA2239/001/001","Cheplapharm Arzneimittel GmbH","CARVEDILOL"
"3156","EUCERIN INTENSIVE 10% W/W UREA TREATMENT CREAM","10 %w/w                                                                                                 Cream",2004-09-24,"PA1159/001/001","Beiersdorf UK Limited","UREA"
"3157","EUCERIN INTENSIVE 10% W/W UREA TREATMENT LOTION","10 %w/w                                                                                                 Cutaneous Emulsion",2005-04-15,"PA1159/001/002","Beiersdorf UK Limited","UREA"
"3158","EUCREAS","50/850 Milligram                                                                                            Film Coated Tablet",2007-11-14,"EU/1/07/425/13-15","Novartis Europharm Limited","VILDAGLIPTIN|METFORMINHCI"
"3159","Eucreas","50/850 milligram(s) Film-coated tablet",NA,"EU/1/07/425/1-6","Novartis Europharm Limited","Vildagliptin|Metforminhci"
"3160","EUCREAS","50/1000 Milligram                                                                                            Film Coated Tablet",2007-11-14,"EU/1/07/425/16-18","Novartis Europharm Limited","VILDAGLIPTIN|METFORMINHCI"
"3161","EUCREAS","50/1000 Milligram                                                                                            Film Coated Tablet",2007-11-14,"EU/1/07/425/7-12","Novartis Europharm Limited","VILDAGLIPTIN|METFORMINHCI"
"3162","EUMOVATE","0.05% %w/w                                                                                                 Cream",1976-06-03,"PA1077/006/001","GlaxoSmithKline (Ireland) Limited","CLOBETASONEBUTYRATE"
"3163","EUMOVATE","0.05 %w/w                                                                                                 Ointment",1976-06-03,"PA1077/006/002","GlaxoSmithKline (Ireland) Limited","CLOBETASONEBUTYRATE"
"3164","EUPHRASIA","6C-MM N/A",2010-10-29,"HOR1149/011/001","A. Nelson & Company Limited","EUPHRASIAOFFICINALIS"
"3165","EUPHRASIA","6C & 30C  Tablets",2010-12-17,"HOR0407/027/001","Weleda (UK) Limited","EUPHRASIAOFFICINALIS"
"3166","EURARTESIM","40/320 Milligram                                                                                            Film Coated Tablet",2011-10-27,"EU/1/11/716/001-004","Alfasigma S.p.A","PIPERAQUINEPHOSPHATE|DIHYDROARTEMISININ"
"3167","EURARTESIM","20/160 Milligram                                                                                            Film Coated Tablet",2011-10-27,"EU/1/11/716/005","Alfasigma S.p.A","PIPERAQUINEPHOSPHATE|DIHYDROARTEMISININ"
"3168","EURAX","10 %w/w                                                                                                 Cream",1978-04-01,"PA0678/119/001","GlaxoSmithKline Consumer Healthcare (Ireland) Limited","CROTAMITON"
"3169","EURAX","10 %w/w                                                                                                 Cutaneous Emulsion",1978-04-01,"PA0678/119/002","GlaxoSmithKline Consumer Healthcare (Ireland) Limited","CROTAMITON"
"3170","EVEROLIMUS TEVA","2.5 Milligram                                                                                            Tablets",2017-06-30,"PA1986/034/001","Teva B.V.","EVEROLIMUS"
"3171","EVEROLIMUS TEVA","5 Milligram                                                                                            Tablets",2017-06-30,"PA1986/034/002","Teva B.V.","EVEROLIMUS"
"3172","EVEROLIMUS TEVA","10 Milligram                                                                                            Tablets",2017-06-30,"PA1986/034/003","Teva B.V.","EVEROLIMUS"
"3173","EVICEL","N/A Solution for Sealant",2008-10-06,"EU/1/08/473/1-3","Omrix Biopharmaceuticals S.A.","HUMANFIBRINOGEN|HUMANTHROMBIN"
"3174","EVIPLERA","200/25/300 Milligram                                                                                            Film Coated Tablet",2011-11-28,"EU/1/11/737/001-002","Gilead Sciences International","EMTRICITABINE(FTC)|RILPIVIRINEHC1(RPV)|TENOFOVIRDISOPROXILFUMARATE(TDF)"
"3175","EVISTA","60 Milligram                                                                                            Tablets",1998-08-05,"EU/1/98/073/001","Daiichi Sankyo Europe GmbH","RALOXIFENE"
"3176","EVISTA","60 Milligram                                                                                            Tablets",1998-08-05,"EU/1/98/073/002","Daiichi Sankyo Europe GmbH","RALOXIFENE"
"3177","EVISTA","60 Milligram                                                                                            Tablets",1998-08-05,"EU/1/98/073/003","Daiichi Sankyo Europe GmbH","RALOXIFENE"
"3178","EVISTA","60 Milligram                                                                                            Tablets",1998-08-05,"EU/1/98/073/004","Daiichi Sankyo Europe GmbH","RALOXIFENE"
"3179","Evoltra","1 milligram(s)/millilitre ZZZ Conc For haemodialysis Soln",2006-11-07,"EU/1/06/334/01","Bioenvision Limited","Clofarabine"
"3180","EVOREL","50 Microgram/day                                                                                        Transdermal Patch",1994-06-10,"PA0748/004/004","Janssen-Cilag Ltd","ESTRADIOLHEMIHYDRATE"
"3181","EVOREL CONTI","50/170 Microgram                                                                                            Transdermal Patch",1998-04-03,"PA0748/008/001","Janssen-Cilag Ltd","NORETHISTERONEACETATE|ESTRADIOLHEMIHYDRATE"
"3182","Evotaz","300/150 milligram(s) Film-coated tablet",2015-07-13,"EU/1/15/1025/001-002","Bristol-Myers Squibb Pharma EEIG","Atazanavir|Cobicistat"
"3183","EVRA","%v/v                                                                                                 Transdermal Patch",2002-08-22,"EU/1/02/223/001","Janssen-Cilag International NV","NORELGESTROMIN|ETHINYLESTRADIOL"
"3184","EVRA","%v/v                                                                                                 Transdermal Patch",2002-08-22,"EU/1/02/223/002","Janssen-Cilag International NV","NORELGESTROMIN|ETHINYLESTRADIOL"
"3185","EVRA","%v/v                                                                                                 Transdermal Patch",2002-08-22,"EU/1/02/223/003","Janssen-Cilag International NV","NORELGESTROMIN|ETHINYLESTRADIOL"
"3186","EXALIEF","400 Milligram                                                                                            Tablets",2009-04-21,"EU/1/09/520/1-6","BIAL - Portela & Cª, S.A.","ESLICARBAZEPINEACETATE"
"3187","Excedrin 250 mg/ 250 mg/ 65 mg film coated tablets","250/250/65 milligram(s) Film-coated tablet",2010-06-04,"PA0678/122/001","GlaxoSmithKline Consumer Healthcare (Ireland) Limited","Acetylsalicylicacid|Paracetamol|Caffeine"
"3188","EXELON","1.5 mg Milligram                                                                                            Capsule",1998-05-12,"EU/1/98/066/001","Novartis Europharm Limited","RIVASTIGMINEHYDROGENTARTRATE"
"3189","EXELON","1.5 Milligram                                                                                            Capsule",1998-05-12,"EU/1/98/066/002","Novartis Europharm Limited","RIVASTIGMINEHYDROGENTARTRATE"
"3190","EXELON","1.5 Milligram                                                                                            Capsule",1998-05-12,"EU/1/98/066/003","Novartis Europharm Limited","RIVASTIGMINEHYDROGENTARTRATE"
"3191","EXELON","3.0 Milligram                                                                                            Capsule",1998-05-12,"EU/1/98/066/004","Novartis Europharm Limited","RIVASTIGMINEHYDROGENTARTRATE"
"3192","EXELON","3 Milligram                                                                                            Capsule",1998-05-12,"EU/1/98/066/005","Novartis Europharm Limited","RIVASTIGMINEHYDROGENTARTRATE"
"3193","EXELON","3 Milligram                                                                                            Capsule",1998-05-12,"EU/1/98/066/006","Novartis Europharm Limited","RIVASTIGMINEHYDROGENTARTRATE"
"3194","EXELON","4.5 Milligram                                                                                            Capsule",1998-05-12,"EU/1/98/066/007","Novartis Europharm Limited","RIVASTIGMINEHYDROGENTARTRATE"
"3195","EXELON","4.5 Milligram                                                                                            Capsule",1998-05-12,"EU/1/98/066/008","Novartis Europharm Limited","RIVASTIGMINEHYDROGENTARTRATE"
"3196","EXELON","4.5 Milligram                                                                                            Capsule",1998-05-12,"EU/1/98/066/009","Novartis Europharm Limited","RIVASTIGMINEHYDROGENTARTRATE"
"3197","EXELON","6.0 Milligram                                                                                            Capsule",1998-05-12,"EU/1/98/066/010","Novartis Europharm Limited","RIVASTIGMINEHYDROGENTARTRATE"
"3198","EXELON","6 Milligram                                                                                            Capsule",1998-05-12,"EU/1/98/066/011","Novartis Europharm Limited","RIVASTIGMINEHYDROGENTARTRATE"
"3199","EXELON","6 Milligram                                                                                            Capsule",1998-05-12,"EU/1/98/066/012","Novartis Europharm Limited","RIVASTIGMINEHYDROGENTARTRATE"
"3200","EXELON","2 Mg/Ml",1999-06-02,"EU/1/98/066/013","Novartis Europharm Limited","RIVASTIGMINEHYDROGENTARTRATE"
"3201","EXELON","13.3 mg/24 hours Transdermal Patch",2013-03-14,"EU/1/98/066/027-030","Novartis Europharm Limited","RIVASTIGMINE"
"3202","EXELON","4.6 Mg/day                                                                                               Transdermal Patch",2007-09-17,"EU/1/98/066/19-22","Novartis Europharm Limited","RIVASTIGMINEBASE"
"3203","EXELON","9.5 Mg/day                                                                                               Transdermal Patch",2007-09-17,"EU/1/98/066/23-26","Novartis Europharm Limited","RIVASTIGMINEBASE"
"3204","EXEMESTANE","25 Milligram                                                                                            Film Coated Tablet",2010-06-25,"PA1390/026/001","Accord Healthcare Limited","EXEMESTANE"
"3205","EXEMESTANE","25 Milligram                                                                                            Film Coated Tablet",2016-10-07,"PPA1562/184/001","LTT Pharma Limited","EXEMESTANE"
"3206","Exemestane Actavis 25 mg film-coated tablets","25 milligram(s) Film-coated tablet",2010-10-08,"PA1380/083/001","Actavis Group PTC ehf","Exemestane"
"3207","EXFORGE","5/80 Unknown Tablets",2007-01-17,"EU/1/06/370/001-008","Novartis Europharm Limited","AMLODIPINEBESYLATE|VALSARTAN"
"3208","EXFORGE","5/160 Unknown Tablets",2007-01-17,"EU/1/06/370/009-016","Novartis Europharm Limited","AMLODIPINEBESYLATE|VALSARTAN"
"3209","EXFORGE","10/160 Unknown Film Coated Tablet",2007-01-17,"EU/1/06/370/017-024","Novartis Europharm Limited","AMLODIPINEBESYLATE|VALSARTAN"
"3210","Exforge HCT","5/160/12.5 milligram(s) Film-coated tablet",2009-10-16,"EU/1/09/569/1-12","Novartis Europharm Limited","Amlodipinebesylate|Hydrochlorothiazide|Valsartan"
"3211","EXFORGE HCT","10/160/12.5 Milligram                                                                                            Film Coated Tablet",2009-10-16,"EU/1/09/569/13-24","Novartis Europharm Limited","AMLODIPINEBESYLATE|VALSARTAN|HYDROCHLOROTHIAZIDE"
"3212","EXFORGE HCT","5/160/25 Milligram                                                                                            Film Coated Tablet",2009-10-16,"EU/1/09/569/25-36","Novartis Europharm Limited","AMLODIPINEBESYLATE|VALSARTAN|HYDROCHLOROTHIAZIDE"
"3213","EXFORGE HCT","10/160/25 Milligram                                                                                            Film Coated Tablet",2009-10-16,"EU/1/09/569/37-48","Novartis Europharm Limited","AMLODIPINEBESYLATE|VALSARTAN|HYDROCHLOROTHIAZIDE"
"3214","EXFORGE HCT","10/320/25 Milligram                                                                                            Film Coated Tablet",2009-10-16,"EU/1/09/569/49-60","Novartis Europharm Limited","AMLODIPINEBESYLATE|VALSARTAN|HYDROCHLOROTHIAZIDE"
"3215","EXJADE","90 Milligram                                                                                            Film Coated Tablet",2016-03-22,"EU/1/06/356/011-013","Novartis Europharm Limited","DEFERASIROX"
"3216","EXJADE","180 Milligram                                                                                            Film Coated Tablet",2016-03-22,"EU/1/06/356/014-016","Novartis Europharm Ltd","DEFERASIROX"
"3217","EXJADE","360 Milligram                                                                                            Film Coated Tablet",2016-03-22,"EU/1/06/356/017-019","Novartis Europharm Ltd","DEFERASIROX"
"3218","EXJADE","90 Milligram                                                                                            Granules",2017-11-10,"EU/1/06/356/020","Novartis Europharm Limited","DEFERASIROX"
"3219","EXJADE","180 Milligram                                                                                            Granules",2017-11-10,"EU/1/06/356/021","Novartis Europharm Limited","DEFERASIROX"
"3220","EXJADE","360 Milligram                                                                                            Granules",2017-11-10,"EU/1/06/356/022","Novartis Europharm Limited","DEFERASIROX"
"3221","EXJADE DISPERSIBLE","125/250/50 Milligram                                                                                            Tablets",2006-08-28,"EU/1/06/356/001-009","Novartis Europharm Limited","DEFERASIROX"
"3222","EXOCIN (Ofloxacin) 0.3% w/v Eye Drops Solution","0.3 percent weight/volume Eye drops, solution",1991-06-10,"PA0148/049/001","Allergan Pharmaceuticals Ireland","Ofloxacin|Benzalkoniumchloride"
"3223","EXOREX LOTION","5 %v/w                                                                                                 Cutaneous Emulsion",2003-10-16,"PA1986/078/001","Teva B.V.","COALTARSOLUTION"
"3224","Exputex 250mg / 5ml Oral Solution","250 mg/5ml Oral solution",1985-12-20,"PA1113/010/001","Phoenix Labs","Carbocisteine"
"3225","EXTAVIA","250 Microgram/ML                                                                                         Pdr+Solv for Soln for Inj",2008-05-20,"EU/1/08/454/1,2,5","Novartis Europharm Limited","INTERFERONBETA-1B"
"3226","EXTEROL","5 %w/w                                                                                                 Ear Drops Solution",2009-06-10,"DPR1392/041/001","Eurodrug Ltd","UREAHYDROGENPEROXIDE"
"3227","EXTEROL","5 %w/w                                                                                                 Ear Drops Solution",1982-02-26,"PA0278/009/001","Dermal Laboratories Ltd","UREAHYDROGENPEROXIDE"
"3228","EXTEROL","5 %w/w                                                                                                 Ear Drops Solution",2018-02-09,"PPA1097/044/001","Lexon (UK) Ltd","UREAHYDROGENPEROXIDE"
"3229","EXTRANEAL","N/A Solution for Dialysis",1997-07-25,"PA0167/088/001","Baxter Healthcare Limited","ICODEXTRIN|SODIUMCHLORIDE|SODIUMLACTATE|CALCIUMCHLORIDEDIHYDRATE|MAGNESIUMCHLORIDEANHYDROUS"
"3230","Exviera","250 milligram(s) Film-coated tablet",2015-01-15,"EU/1/14/983/001","AbbVie Ltd","Dasabuvirsodium"
"3231","EYLEA","40 Mg/Ml Solution for Injection",2012-11-22,"EU/1/12/797/001-002","Bayer AG","AFLIBERCEPT"
"3232","EZETIMIBE","10 Milligram                                                                                            Tablets",2014-07-25,"PA0405/063/001","Generics (UK) Limited","EZETIMIBE"
"3233","EZETIMIBE","10 Milligram                                                                                            Tablets",2018-02-09,"PA0343/001/001","Key Pharmaceuticals Ltd","EZETIMIBE"
"3234","Ezetimibe 10 mg Tablets","10 milligram(s) Tablet",2017-03-10,"PA2315/044/001","Accord Healthcare Ireland Ltd.","Ezetimibe"
"3235","Ezetimibe 10 mg Tablets","10 milligram(s) Tablet",2016-04-15,"PA1390/112/001","Accord Healthcare Limited","Ezetimibe"
"3236","Ezetimibe 10 mg Tablets","10 milligram(s) Tablet",2015-07-10,"PA1462/014/001","Glenmark Pharmaceuticals Europe Limited","Ezetimibe"
"3237","EZETIMIBE APOTEX","10 Milligram                                                                                            Tablets",2017-12-15,"PA1513/012/001","Apotex Europe B.V.","EZETIMIBE"
"3238","EZETIMIBE KRKA","10 Milligram                                                                                            Tablets",2016-12-02,"PA1347/066/001","Krka d.d., Novo mesto","EZETIMIBE"
"3239","EZETIMIBE ROWA","10 Milligram                                                                                            Tablets",2017-07-28,"PA0074/074/001","Rowa Pharmaceuticals Limited","EZETIMIBE"
"3240","EZETIMIBE TEVA","10 Milligram                                                                                            Tablets",2016-06-03,"PA1986/012/001","Teva B.V.","EZETIMIBE"
"3241","EZETIMIBE/SIMVASTATIN","10/20 Milligram                                                                                            Tablets",2016-12-16,"PA1986/067/001","Teva B.V.","EZETIMIBE|SIMVASTATIN"
"3242","EZETIMIBE/SIMVASTATIN","10/40 Milligram                                                                                            Tablets",2016-12-16,"PA1986/067/002","Teva B.V.","EZETIMIBE|SIMVASTATIN"
"3243","EZETIMIBE/SIMVASTATIN","10/80 Milligram                                                                                            Tablets",2016-12-16,"PA1986/067/003","Teva B.V.","EZETIMIBE|SIMVASTATIN"
"3244","Ezetimibe/Simvastatin 10mg/20mg Tablets","10/20 milligram(s) Tablet",2015-05-22,"PA0577/180/001","McDermott Laboratories Ltd t/a Gerard Laboratories","Ezetimibe|Simvastatin"
"3245","Ezetimibe/Simvastatin 10mg/40mg Tablets","10/40 milligram(s) Tablet",2015-05-22,"PA0577/180/002","McDermott Laboratories Ltd t/a Gerard Laboratories","Ezetimibe|Simvastatin"
"3246","Ezetimibe/Simvastatin 10mg/80mg Tablets","10/80 milligram(s) Tablet",2015-05-22,"PA0577/180/003","McDermott Laboratories Ltd t/a Gerard Laboratories","Ezetimibe|Simvastatin"
"3247","EZETIMIBE/SIMVASTATIN CLONMEL","10mg/10 Milligram                                                                                            Tablets",2017-04-07,"PA0126/281/001","Clonmel Healthcare Ltd","EZETIMIBE|SIMVASTATINCONTAINSBUTYLHYDROXYANISOLE(BHA)0.01%"
"3248","EZETIMIBE/SIMVASTATIN CLONMEL","10mg/20 Milligram                                                                                            Tablets",2017-04-07,"PA0126/281/002","Clonmel Healthcare Ltd","EZETIMIBE|SIMVASTATINCONTAINSBUTYLHYDROXYANISOLE(BHA)0.01%"
"3249","EZETIMIBE/SIMVASTATIN CLONMEL","10mg/40 Milligram                                                                                            Tablets",2017-04-07,"PA0126/281/003","Clonmel Healthcare Ltd","EZETIMIBE|SIMVASTATINCONTAINSBUTYLHYDROXYANISOLE(BHA)0.01%"
"3250","EZETIMIBE/SIMVASTATIN CLONMEL","10mg/80 Milligram                                                                                            Tablets",2017-04-07,"PA0126/281/004","Clonmel Healthcare Ltd","EZETIMIBE|SIMVASTATINCONTAINSBUTYLHYDROXYANISOLE(BHA)0.01%"
"3251","Ezetimibe/Simvastatin Krka 10 mg/10 mg tablets","10mg/10 milligram(s) Tablet",2017-03-01,"PA1347/067/001","Krka d.d., Novo mesto","Ezetimibe|Simvastatin"
"3252","Ezetimibe/Simvastatin Krka 10 mg/20 mg tablets","10mg/20 milligram(s) Tablet",2017-03-01,"PA1347/067/002","Krka d.d., Novo mesto","Ezetimibe|Simvastatin"
"3253","Ezetimibe/Simvastatin Krka 10 mg/40 mg tablets","10mg/40 milligram(s) Tablet",2017-03-01,"PA1347/067/003","Krka d.d., Novo mesto","Ezetimibe|Simvastatin"
"3254","EZETIMIBE/SIMVASTATIN ROWEX","10mg/20 Milligram                                                                                            Tablets",2017-04-07,"PA0711/262/001","Rowex Ltd","EZETIMIBE|SIMVASTATINCONTAINSBUTYLHYDROXYANISOLE(BHA)0.01%"
"3255","EZETIMIBE/SIMVASTATIN ROWEX","10mg/40 Milligram                                                                                            Tablets",2017-04-07,"PA0711/262/002","Rowex Ltd","EZETIMIBE|SIMVASTATINCONTAINSBUTYLHYDROXYANISOLE(BHA)0.01%"
"3256","EZETIMIBE/SIMVASTATIN ROWEX","10mg/80 Milligram                                                                                            Tablets",2017-04-07,"PA0711/262/003","Rowex Ltd","EZETIMIBE|SIMVASTATINCONTAINSBUTYLHYDROXYANISOLE(BHA)0.01%"
"3257","EZETIMIBE/SIMVASTATIN TEVA","10/20 Unknown Tablets",2017-05-05,"PA1986/030/001","Teva B.V.","EZETIMIBE|SIMVASTATIN"
"3258","EZETIMIBE/SIMVASTATIN TEVA","10/40 Unknown Tablets",2017-05-05,"PA1986/030/002","Teva B.V.","EZETIMIBE|SIMVASTATIN"
"3259","EZETIMIBE/SIMVASTATIN TEVA","10/80 Unknown Tablets",2017-05-05,"PA1986/030/003","Teva B.V.","EZETIMIBE|SIMVASTATIN"
"3260","EZETROL","10 Milligram                                                                                            Tablets",2009-07-31,"PPA0465/227/001","PCO Manufacturing","EZETIMIBE"
"3261","EZETROL","10 Milligram                                                                                            Tablets",2009-03-30,"DPR1392/031/001","Eurodrug Ltd","EZETIMIBE"
"3262","EZETROL","10 Milligram                                                                                            Tablets",2008-09-03,"DPR0465/022/001","PCO Manufacturing","EZETIMIBE"
"3263","EZETROL","10 Milligram                                                                                            Tablets",NA,"DPR1633/019/001","Primecrown 2010 Ltd","EZETIMIBE"
"3264","EZETROL","10 Milligram                                                                                            Tablets",2013-08-08,"DPR1463/042/001","IMED Healthcare Ltd.","EZETIMIBE"
"3265","EZETROL","10 Milligram                                                                                            Tablets",2016-10-21,"PPA1151/256/001","Imbat Limited","EZETIMIBE"
"3266","Ezetrol 10 mg Tablets","10mg milligram(s) Tablet",2003-07-25,"PA1286/061/001","Merck Sharp & Dohme Ireland (Human Health) Limited","Ezetimibe"
"3267","Fabrazyme","35 milligram(s) ZZZ Pdr/Conc/Soln for Infus",NA,"EU/1/01/188/001-002","Genzyme Europe B.V.","Proteincagalsidasebeta(recombinanthuman-a-galactosidea)"
"3268","FABRAZYME","35 Milligram                                                                                            Pdr/Conc/Soln for Infus",2001-08-03,"EU/1/01/188/003","Genzyme Europe B.V.","PROTEINCAGALSIDASEBETA(RECOMBINANTHUMAN-A-GALACTOSIDEA)"
"3269","FABRAZYME","05 Milligram                                                                                            Pdr/Conc/Soln for Infus",2001-08-03,"EU/1/01/188/004-006","Genzyme Europe B.V.","PROTEINCAGALSIDASEBETA(RECOMBINANTHUMAN-A-GALACTOSIDEA)"
"3270","FAMCICLOVIR","250 Milligram                                                                                            Film Coated Tablet",2008-02-15,"PA0749/025/002","Teva Pharma B.V.","FAMCICLOVIR"
"3271","FAMCICLOVIR","500 Milligram                                                                                            Film Coated Tablet",2011-09-09,"PA2030/001/001","Medinutrix Ltd","FAMCICLOVIR"
"3272","FAMPYRA","10 Milligram                                                                                            Tablet Prolonged Release",2011-07-20,"EU/1/11/699/001-002","Biogen Netherlands B.V.","FAMPRIDINE(4-AMINOPYRIDINE)"
"3273","FAMVIR","500 Milligram                                                                                            Film Coated Tablet",2017-10-20,"PPA1097/028/001","Lexon (UK) Ltd","FAMCICLOVIR"
"3274","Famvir 125 mg Film-Coated Tablets","125 milligram(s) Coated tablet",NA,"PA0896/011/001","Novartis Ireland Limited","Famciclovir"
"3275","Famvir 250 mg Film-Coated Tablets","250 milligram(s) Coated tablet",NA,"PA0896/011/002","Novartis Ireland Limited","Famciclovir"
"3276","Famvir 250mg Film-Coated Tablets","250 milligram(s) Film-coated tablet",2008-09-26,"PPA0465/212/001","PCO Manufacturing","Famciclovir"
"3277","Famvir 500mg film-coated tablets","500 milligram(s) Film-coated tablet",2014-07-18,"PPA0465/212/002","PCO Manufacturing","Famciclovir"
"3278","Famvir 500mg film-coated tablets","500 milligram(s) Film-coated tablet",NA,"PA0896/011/003","Novartis Ireland Limited","Famciclovir"
"3279","Fanhdi 1000 IU powder and solvent for solution for injection","1000 international unit(s) Powder and solvent for solution for injection",2000-07-07,"PA0849/001/003","Instituto Grifols S.A.","Factorviii(antihaemophilicfactor)"
"3280","Fanhdi 250 IU powder and solvent for solution for injection","250 international unit(s) Powder and solvent for solution for injection",2000-07-07,"PA0849/001/001","Instituto Grifols S.A.","Factorviii(antihaemophilicfactor)"
"3281","Fanhdi 500 IU powder and solvent for solution for injection","500 international unit(s) Powder and solvent for solution for injection",2000-07-07,"PA0849/001/002","Instituto Grifols S.A.","Factorviii(antihaemophilicfactor)"
"3282","FARESTON","60 Milligram                                                                                            Tablets",1996-02-14,"EU/1/96/004/001","Orion Corporation","TOREMIFENECITRATE"
"3283","FARESTON","60 Milligram                                                                                            Tablets",1996-02-14,"EU/1/96/004/002","Orion Corporation","TOREMIFENE"
"3284","FARYDAK","10 Milligram                                                                                            Capsules Hard",2015-08-28,"EU/1/15/1023/001-003","Novartis Europharm Limited","PANOBINOSTAT"
"3285","FARYDAK","15 Milligram                                                                                            Capsules Hard",2015-08-28,"EU/1/15/1023/004-006","Novartis Europharm Limited","PANOBINOSTAT"
"3286","FARYDAK","20 Milligram                                                                                            Capsules Hard",2015-08-28,"EU/1/15/1023/007-009","Novartis Europharm Limited","PANOBINOSTAT"
"3287","FASENRA","30 Milligram",2018-01-08,"EU/1/17/1252/001","AstraZeneca AB","BENRALIZUMAB"
"3288","FASLODEX 250 MG/5 ML-SOLUTION FOR INJECTION","250mg/5ml Milligram                                                                                            Solution for Injection",2004-03-31,"EU/1/03/269/001","AstraZeneca AB","FULVESTRANT"
"3289","FASTUM","2.5 %w/w                                                                                                 Gel",1992-08-19,"PA0512/001/001","A. Menarini Industrie Farmaceutische Riunite S.r.l.","KETOPROFEN"
"3290","Fastum 2.5% w/w Gel","2.5 percent weight/weight Gel",2015-02-06,"PPA1562/150/001","LTT Pharma Limited","Ketoprofen"
"3291","FASTUM GEL","2.5 %w/w                                                                                                 Gel",2016-07-01,"PPA0465/419/001","PCO Manufacturing","KETOPROFEN"
"3292","FASTURTEC","1.5 Mg/Ml Pdr/Conc/Soln for Infus",2001-02-23,"EU/1/00/170/001-002","Sanofi aventis","RASBURICASE"
"3293","Faverin 100 mg film-coated tablets","100 milligram(s) Film-coated tablet",1989-10-11,"PA2010/031/002","Mylan IRE Healthcare Limited","Fluvoxaminemaleate"
"3294","Faverin 50 mg film-coated tablets","50 milligram(s) Film-coated tablet",1989-10-11,"PA2010/031/001","Mylan IRE Healthcare Limited","Fluvoxaminemaleate"
"3295","FEBUXOSTAT CLONMEL","80 Milligram                                                                                            Film Coated Tablet",2018-04-27,"PA0126/295/001","Clonmel Healthcare Ltd","FEBUXOSTAT"
"3296","FEBUXOSTAT CLONMEL","120 Milligram                                                                                            Film Coated Tablet",2018-04-27,"PA0126/295/002","Clonmel Healthcare Ltd","FEBUXOSTAT"
"3297","FEBUXOSTAT MYLAN","80 Milligram                                                                                            Film Coated Tablet",2017-06-15,"EU/1/17/1194/001-008","Mylan S.A.S.","FEBUXOSTAT"
"3298","FEBUXOSTAT MYLAN","120 Milligram                                                                                            Film Coated Tablet",2017-06-15,"EU/1/17/1194/009-016","Mylan S.A.S.","FEBUXOSTAT"
"3299","Febuxostat Pinewood 120 mg Film-coated Tablets","120 milligram(s) Film-coated tablet",2018-11-30,"PA0281/160/002","Pinewood Laboratories Ltd,","Febuxostat"
"3300","Febuxostat Pinewood 80 mg Film-coated Tablets","80 milligram(s) Film-coated tablet",2018-11-30,"PA0281/160/001","Pinewood Laboratories Ltd,","Febuxostat"
"3301","Febuxostat Rowex 120 mg Film-coated Tablets","120 milligram(s) Film-coated tablet",2017-07-14,"PA0711/273/002","Rowex Ltd","Febuxostat"
"3302","Febuxostat Rowex 80 mg Film-coated Tablets","80 milligram(s) Film-coated tablet",2017-07-14,"PA0711/273/001","Rowex Ltd","Febuxostat"
"3303","FEFOL SPANSULE","150/0.5 Milligram                                                                                            Capsules Modified Release",1980-04-01,"PA2240/001/001","Intapharm Laboratories Limited","FERROUSSULFATEEXSICCATED|FOLICACID"
"3304","FEIBA 25 U/ml powder and solvent for solution for infusion","25 unit(s)/millilitre Powder and solvent for solution for infusion",NA,"PA2004/001/001","Baxalta Innovations GmbH","Feiba"
"3305","FEIBA 50 U/ml powder and solvent for solution for infusion","50 unit(s)/millilitre Powder and solvent for solution for infusion",NA,"PA2004/001/002","Baxalta Innovations GmbH","Feiba"
"3306","FELDENE","5.0 mg/g Gel",1988-07-07,"PA0822/194/003","Pfizer Healthcare Ireland","PIROXICAM"
"3307","FELDENE 10 MG CAPSULES, HARD","10 mg Milligram                                                                                            Capsule",1979-04-03,"PA0019/024/002","Pfizer Limited","PIROXICAM"
"3308","FELDENE 20 MG CAPSULES, HARD","20 mg Milligram                                                                                            Capsule",1979-04-03,"PA0019/024/003","Pfizer Limited","PIROXICAM"
"3309","FEMARA","2.5 Milligram                                                                                            Film Coated Tablet",1997-01-10,"PA0896/012/001","Novartis Ireland Limited","LETROZOLE"
"3310","Femara 2.5 mg film-coated tablets","2.5 milligram(s) Film-coated tablet",2013-01-25,"PPA0465/303/001","PCO Manufacturing","Letrozole"
"3311","Femara 2.5 mg film-coated tablets","2.5 milligram(s) Film-coated tablet",2018-09-14,"PPA2306/001/001","Originalis B.V.","Letrozole"
"3312","FEMATAB","1 Milligram                                                                                            Film Coated Tablet",1999-04-16,"PA2010/011/001","Mylan IRE Healthcare Limited","ESTRADIOLHEMIHYDRATE"
"3313","FEMATAB","2 Milligram                                                                                            Film Coated Tablet",1994-12-12,"PA2010/011/002","Mylan IRE Healthcare Limited","ESTRADIOL"
"3314","Femoston 1/10mg film-coated tablets","1/10 milligram(s) Film-coated tablet",1998-01-23,"PA2010/012/001","Mylan IRE Healthcare Limited","Estradiolhemihydrate|Dydrogesterone"
"3315","Femoston 2/10mg film-coated tablets","2/10 milligram(s) Film-coated tablet",1997-10-31,"PA2010/012/002","Mylan IRE Healthcare Limited","Estradiolhemihydrate|Dydrogesterone"
"3316","FEMOSTON-CONTI","0.5/2.5 Milligram                                                                                            Film Coated Tablet",2010-10-01,"PA2010/012/003","Mylan IRE Healthcare Limited","ESTRADIOL|DYDROGESTERONE"
"3317","FEMOSTON-CONTI","1mg/5mg Milligram                                                                                            Film Coated Tablet",2000-12-08,"PA2010/012/004","Mylan IRE Healthcare Limited","ESTRADIOL|DYDROGESTERONE"
"3318","FENDRIX","20mg/0.5ml milligram(s)/millilitre Suspension for injection",2005-02-02,"EU/1/04/0299/001-003","GlaxoSmithKline Biologicals S.A.","Hepatitisbvaccine"
"3319","FENOPINE","200 Milligram                                                                                            Film Coated Tablet",1980-12-22,"PA0281/088/001","Pinewood Laboratories Ltd,","IBUPROFEN"
"3320","FENOPINE","400 Milligram                                                                                            Film Coated Tablet",1981-03-10,"PA0281/088/002","Pinewood Laboratories Ltd,","IBUPROFEN"
"3321","FENOPINE","600 Milligram                                                                                            Film Coated Tablet",1986-06-04,"PA0281/088/003","Pinewood Laboratories Ltd,","IBUPROFEN"
"3322","FENOPINE","100/5 Mg/Ml Oral Suspension",2010-09-03,"PA0281/088/004","Pinewood Laboratories Ltd,","IBUPROFEN"
"3323","FENTADUR","25 Microgram per hour Transdermal Patch",2012-01-06,"PA1676/002/001","Lavipharm S.A.","FENTANYL"
"3324","FENTADUR","50 Microgram per hour Transdermal Patch",2012-01-06,"PA1676/002/002","Lavipharm S.A.","FENTANYL"
"3325","FENTADUR","75 Microgram per hour Transdermal Patch",2012-01-06,"PA1676/002/003","Lavipharm S.A.","FENTANYL"
"3326","FENTADUR","100 Microgram per hour Transdermal Patch",2012-01-06,"PA1676/002/004","Lavipharm S.A.","FENTANYL"
"3327","FENTADUR","12 Microgram per hour Transdermal Patch",2012-05-18,"PA1676/002/005","Lavipharm S.A.","FENTANYL"
"3328","FENTAL MATRIX","25 Microgram per hour Transdermal Patch",2007-04-27,"PA0711/146/001","Rowex Ltd","FENTANYL"
"3329","FENTAL MATRIX","50 Microgram per hour Transdermal Patch",2007-04-27,"PA0711/146/002","Rowex Ltd","FENTANYL"
"3330","FENTAL MATRIX","75 Microgram per hour Transdermal Patch",2007-04-27,"PA0711/146/003","Rowex Ltd","FENTANYL"
"3331","FENTAL MATRIX","100 Microgram per hour Transdermal Patch",2007-04-27,"PA0711/146/004","Rowex Ltd","FENTANYL"
"3332","FENTANYL 100 MICROGRAMS IN 2ML","50 Microgram/ML                                                                                         Solution for Injection",1990-07-04,"PA0073/122/001","Mercury Pharmaceuticals (Ireland) Ltd","FENTANYLCITRATE"
"3333","FENTANYL 500 MICROGRAMS IN 10ML","50 Microgram/ML                                                                                         Solution for Injection",1990-07-04,"PA0073/122/002","Mercury Pharmaceuticals (Ireland) Ltd","FENTANYLCITRATE"
"3334","FEOSPAN SPANSULE","150 Milligram                                                                                            Capsules Modified Release",1980-04-01,"PA0997/007/001","Intrapharm Laboratories Limited","FERROUSSULFATEEXSICCATED"
"3335","Feraccru","30 milligram(s) Capsule, hard",2016-02-18,"EU/1/15/1075/001","Iron Therapeutics (UK) Ltd","Ferricmaltol"
"3336","FERINJECT","50 Mg/Ml Solution for Inj/Inf",2008-04-11,"PA0949/004/001","Vifor France","FERRICCARBOXYMALTOSE"
"3337","FERRIPROX","100 Mg/Ml Unknown",2007-11-19,"EU/1/99/108/002-003","Apotex Europe Limited","DEFERIPRONE"
"3338","FERRIPROX","1000 Milligram                                                                                            Film Coated Tablet",2010-07-28,"EU/1/99/108/004-006","Apotex Nederland B.V.","DEFERIPRONE"
"3339","FERRIPROX FILM-COATED","500 mg Milligram                                                                                            Tablets",1999-08-25,"EU/1/99/108/001","Apotex Europe Limited","DEFERIPRONE"
"3340","FERROGRAD","325 Milligram                                                                                            Tablets",1980-04-01,"PA1235/001/001","Teofarma S.R.L.","FERROUSSULFATE"
"3341","FERROGRAD C","%v/v                                                                                                 Tablets",1980-04-01,"PA1235/002/001","Teofarma S.R.L.","FERROUSSULFATE|SODIUMASCORBATE"
"3342","FERROGRAD C","325/500 Milligram                                                                                            Tablet Prolonged Release",2010-12-17,"PPA1151/141/001","Imbat Limited","FERROUSSULFATEEXSICCATED|ASCORBICACID"
"3343","FERROGRAD FOLIC","%v/v                                                                                                 Tablets",1980-04-01,"PA1235/003/001","Teofarma S.R.L.","FERROUSSULFATE|FOLICACID"
"3344","FERTAVID","150/0.5 IU/ML                                                                                                Solution for Injection",2009-03-19,"EU/1/09/510/10-11","Merck Sharp and Dohme Limited","FOLLITROPINBETA"
"3345","FERTAVID","150/0.5 IU/ML                                                                                                Solution for Injection",2009-03-19,"EU/1/09/510/12","Merck Sharp and Dohme Limited","FOLLITROPINBETA"
"3346","FERTAVID","50/0.5 IU/ML                                                                                                Solution for Injection",2009-03-19,"EU/1/09/510/1-2","Merck Sharp and Dohme Limited","FOLLITROPINBETA"
"3347","FERTAVID","200/0.5 IU/ML                                                                                                Solution for Injection",2009-03-19,"EU/1/09/510/13","Merck Sharp and Dohme Limited","FOLLITROPINBETA"
"3348","FERTAVID","200/0.5 IU/ML                                                                                                Solution for Injection",2009-03-19,"EU/1/09/510/14","Merck Sharp and Dohme Limited","FOLLITROPINBETA"
"3349","FERTAVID","200/0.5 IU/ML                                                                                                Solution for Injection",2009-03-19,"EU/1/09/510/15","Merck Sharp and Dohme Limited","FOLLITROPINBETA"
"3350","FERTAVID","150/0.18 IU/ML                                                                                                Solution for Injection",2009-03-19,"EU/1/09/510/16","Merck Sharp and Dohme Limited","FOLLITROPINBETA"
"3351","FERTAVID","300/0.36 IU/ML                                                                                                Solution for Injection",2009-03-19,"EU/1/09/510/17","Merck Sharp and Dohme Limited","FOLLITROPINBETA"
"3352","FERTAVID","600/0.72 IU/ML                                                                                                Solution for Injection",2009-03-19,"EU/1/09/510/18","Merck Sharp and Dohme Limited","FOLLITROPINBETA"
"3353","FERTAVID","900/1.08 IU/ML                                                                                                Solution for Injection",2009-03-19,"EU/1/09/510/19","Merck Sharp and Dohme Limited","FOLLITROPINBETA"
"3354","FERTAVID","50/0.5 IU/ML                                                                                                Solution for Injection",2009-03-19,"EU/1/09/510/3","Schering Plough Europe","FOLLITROPINBETA"
"3355","FERTAVID","75/0.5 IU/ML                                                                                                Solution for Injection",2009-03-19,"EU/1/09/510/4-5","Merck Sharp and Dohme Limited","FOLLITROPINBETA"
"3356","FERTAVID","75/0.5 IU/ML                                                                                                Solution for Injection",2009-03-19,"EU/1/09/510/6","Merck Sharp and Dohme Limited","FOLLITROPINBETA"
"3357","FERTAVID","100/0.5 IU/ML                                                                                                Solution for Injection",2009-03-19,"EU/1/09/510/7-8","Merck Sharp and Dohme Limited","FOLLITROPINBETA"
"3358","FERTAVID","100/0.5 IU/ML                                                                                                Solution for Injection",2009-03-19,"EU/1/09/510/9","Merck Sharp and Dohme Limited","FOLLITROPINBETA"
"3359","FETANEX","12.5 Microgram per hour Transdermal Patch",2008-11-14,"PA0711/137/001","Rowex Ltd","FENTANYL"
"3360","FETANEX","37.5 Microgram per hour Transdermal Patch",2008-11-14,"PA0711/137/003","Rowex Ltd","FENTANYL"
"3361","Fexeric","1 gram(s) Film-coated tablet",2015-09-23,"EU/1/15/1039/001","Keryx Biopharma UK Ltd","Ferriccitratecoordinationcomplex"
"3362","FEXOFAST","120 Milligram                                                                                            Film Coated Tablet",2005-10-21,"PA1585/002/001","Fannin (UK) Ltd","FEXOFENADINEHYDROCHLORIDE"
"3363","FEXOFAST","180 Milligram                                                                                            Film Coated Tablet",2005-10-21,"PA1585/002/002","Fannin (UK) Ltd","FEXOFENADINEHYDROCHLORIDE"
"3364","FEXOFENADINE HYDROCHLORIDE","120 Milligram                                                                                            Film Coated Tablet",2007-09-14,"PA0688/017/001","Chanelle Medical","FEXOFENADINEHYDROCHLORIDE"
"3365","FEXOFENADINE HYDROCHLORIDE","180 Milligram                                                                                            Film Coated Tablet",2007-09-14,"PA0688/017/002","Chanelle Medical","FEXOFENADINEHYDROCHLORIDE"
"3366","FEXOFENADINE HYDROCHLORIDE","120 Milligram                                                                                            Film Coated Tablet",2013-03-01,"PA0540/170/001","Sanofi-Aventis Ireland Limited T/A SANOFI","FEXOFENADINEHYDROCHLORIDE"
"3367","Fiasp","100 unit(s)/millilitre Solution for injection",2017-01-09,"EU/1/16/1160/001-011","Novo Nordisk A/S","Insulinaspart"
"3368","FIBRO-VEIN","1 %w/v                                                                                                 Solution for Injection",2001-05-04,"PA0246/001/004","STD Pharmaceutical Products Ltd","SODIUMTETRADECYLSULFATE"
"3369","FIBRO-VEIN","3 %w/v                                                                                                 Solution for Injection",2001-05-04,"PA0246/001/005","STD Pharmaceutical Products Ltd","SODIUMTETRADECYLSULFATE"
"3370","FIBRO-VEIN","3 %w/v                                                                                                 Solution for Injection",2001-05-04,"PA0246/001/006","STD Pharmaceutical Products Ltd","SODIUMTETRADECYLSULFATE"
"3371","FIBRO-VEIN","0.2 %w/v                                                                                                 Solution for Injection",2001-05-04,"PA0246/001/007","STD Pharmaceutical Products Ltd","SODIUMTETRADECYLSULFATE"
"3372","Fibro-Vein 0.5% w/v Solution for Injection","0.5 percent weight/volume Solution for injection",NA,"PA0246/001/003","STD Pharmaceutical Products Ltd","Sodiumtetradecylsulfate"
"3373","Filgrastim HEXAL","30MU/0.5 millilitre(s) Solution for injection in pre-filled syringe",NA,"EU/1/08/496/1-4","Hexal AG","Ep2006(recombinanthumangranulocyte-colonystimulatingfactor)"
"3374","FILGRASTIM HEXAL","48MU/0.5 Millilitre                                                                                           Solution for injection in pre-filled syringe",2009-02-06,"EU/1/08/496/5-8","Hexal AG","EP2006(RECOMBINANTHUMANGRANULOCYTE-COLONYSTIMULATINGFACTOR)"
"3375","FINASTERIDE","5 Milligram                                                                                            Film Coated Tablet",2008-11-13,"PA1390/013/002","Accord Healthcare Limited","FINASTERIDE"
"3376","FINASTERIDE","5 Milligram                                                                                            Film Coated Tablet",2016-09-16,"PPA1562/185/001","LTT Pharma Limited","FINASTERIDE"
"3377","FINASTERIDE ROWEX","5 Milligram                                                                                            Film Coated Tablet",2005-06-07,"PA0711/073/001","Rowex Ltd","FINASTERIDE"
"3378","FINTRID","5 Milligram                                                                                            Film Coated Tablet",2008-06-20,"PA1445/019/001","Aurobindo Pharma (Malta) Limited","FINASTERIDE"
"3379","Firazyr","30 milligram(s) Solution for injection",2008-07-11,"EU/1/08/461/1","Shire Pharmaceuticals Ireland Limited","Icatibant"
"3380","FIRDAPSE","10 Milligram                                                                                            Tablets",2009-12-23,"EU/1/09/601/001","BioMarin Europe Limited","3,4-DIAMINOPYRIDINEPHOSPHATE"
"3381","FIRMAGON","80 Milligram                                                                                            Pdr+Solv for Soln for Inj",2009-02-17,"EU/1/08/504/001","Ferring Pharmaceuticals A/S","DEGARELIX(ASACETATE)"
"3382","FIRMAGON","120 Milligram                                                                                            Pdr+Solv for Soln for Inj",2009-02-17,"EU/1/08/504/002","Ferring Pharmaceuticals A/S","DEGARELIX(ASACETATE)"
"3383","FIXAPOST","50micrograms/ml +5 Mg/Ml Eye Drops Solution",2018-06-22,"PA1107/014/001","Laboratoires Thea","LATANOPROST|TIMOLOL"
"3384","FLAGYL","0.5 %w/v                                                                                                 Solution for Infusion",1982-04-19,"PA0540/100/003","Sanofi-Aventis Ireland Limited T/A SANOFI","METRONIDAZOLE"
"3385","FLAGYL","200 Milligram                                                                                            Tablets",1977-04-01,"PA0540/100/007","Sanofi-Aventis Ireland Limited T/A SANOFI","METRONIDAZOLE"
"3386","FLAGYL","400 Milligram                                                                                            Film Coated Tablet",1977-04-01,"PA0540/100/008","Sanofi-Aventis Ireland Limited T/A SANOFI","METRONIDAZOLE"
"3387","FLAGYL","500 mg milligram(s) Suppository",NA,"PA0040/003/004","May & Baker Limited","Metronidazole"
"3388","FLAGYL-S 200MG/5ML ORAL SUSPENSION","200 Base mg/5ml                                                                                          Oral Suspension",1977-04-01,"PA0540/100/001","Sanofi-Aventis Ireland Limited T/A SANOFI","METRONIDAZOLEBENZOATE"
"3389","FLAMAZINE","1.0 %w/w                                                                                                 Cream",1977-04-01,"PA0710/003/001","Smith & Nephew Pharmaceuticals","SULFADIAZINESILVER"
"3390","FLAMERIO","50/250 Microgram                                                                                            Inhalation Powder",2013-05-03,"PA1879/001/001","Elpen Pharmaceutical Co. Inc.","SALMETEROL|FLUTICASONEPROPIONATE"
"3391","FLAMERIO","50/500 Microgram                                                                                            Inhalation Powder",2013-05-03,"PA1879/001/002","Elpen Pharmaceutical Co. Inc.","SALMETEROL|FLUTICASONEPROPIONATE"
"3392","FLAVUSTENOL XL","80 Milligram                                                                                            Tablet Prolonged Release",2012-09-14,"PA1390/043/001","Accord Healthcare Limited","FLUVASTATINSODIUM"
"3393","FLEBOGAMMA","50  Solution for Infusion",2007-08-23,"EU/1/07/404/1-5","Instituto Grifols S.A.","HUMANNORMALIMMUNOGLOBULIN"
"3394","FLEBOGAMMA DIF","100 Mg/Ml Solution for Infusion",2010-12-13,"EU/1/07/404/006-008","Instituto Grifols S.A.","HUMANNORMALIMMUNOGLOBULIN"
"3395","FLECAINIDE","50 Milligram                                                                                            Tablets",2006-06-13,"PA1986/050/001","Teva B.V.","FLECAINIDEACETATE"
"3396","FLECAINIDE","100 Milligram                                                                                            Tablets",2006-06-13,"PA1986/050/002","Teva B.V.","FLECAINIDEACETATE"
"3397","Flector Tissugel 140 mg medicated plaster","1.293 g gram(s) Medicated plaster",2003-11-04,"PA1104/004/001","IBSA Farmaceutici Italia S.r.l","Diclofenacepolamine"
"3398","Fleet Phospho-soda","percent weight/weight Oral solution",1998-02-06,"PA0299/015/001","E.C. De Witt & Company Limited","Sodiumphosphatedibasicdodecahydrate|Sodiumphosphatedibasicdihydrate"
"3399","FLERIN","700 Milligram                                                                                            Medicated Plaster",2017-03-24,"PA2242/010/001","Grunenthal Pharma Ltd","LIDOCAINE"
"3400","Flexbumin 200 g/l solution for infusion","200 gram(s)/litre Solution for infusion",2007-08-24,"PA2004/002/001","Baxalta Innovations GmbH","Humanplasmaprotein"
"3401","FLEXOVE","625 Milligram                                                                                            Tablets",2007-10-05,"PA1616/001/001","Laboratoires Expanscience","GLUCOSAMINE"
"3402","Flixabi ((SB2))","100 milligram(s) ZZZ Pdr/Conc/Soln for Infus",2016-05-26,"EU/1/16/1106/001","Samsung Bioepis UK Limited","Infliximab"
"3403","Flixonase Allergy Relief 50 micrograms per dose Nasal Spray","50 microgram(s) Nasal spray, suspension",2003-05-02,"PA0678/095/001","GlaxoSmithKline Consumer Healthcare (Ireland) Limited","FLUTICASONEPROPIONATE"
"3404","FLIXOTIDE DISKUS","50 Mcg/Acutuation                                                                                       Powder for Inhalation",1996-12-02,"PA1077/044/009","GlaxoSmithKline (Ireland) Limited","FLUTICASONEPROPIONATE"
"3405","FLIXOTIDE DISKUS","100 Mcg/Acutuation                                                                                       Powder for Inhalation",1996-12-02,"PA1077/044/010","GlaxoSmithKline (Ireland) Limited","FLUTICASONEPROPIONATE"
"3406","FLIXOTIDE DISKUS","250 Mcg/Acutuation                                                                                       Powder for Inhalation",1996-12-02,"PA1077/044/011","GlaxoSmithKline (Ireland) Limited","FLUTICASONEPROPIONATE"
"3407","FLIXOTIDE DISKUS","500 Mcg/Acutuation                                                                                       Powder for Inhalation",1996-12-02,"PA1077/044/012","GlaxoSmithKline (Ireland) Limited","FLUTICASONEPROPIONATE"
"3408","FLIXOTIDE EVOHALER","50 Microgram                                                                                            Pressurised Inhalation Suspension",2000-12-20,"PA1077/044/013","GlaxoSmithKline (Ireland) Limited","FLUTICASONEPROPIONATE"
"3409","FLIXOTIDE EVOHALER","125 Microgram                                                                                            Pressurised Inhalation Suspension",1999-01-08,"PA1077/044/014","GlaxoSmithKline (Ireland) Limited","FLUTICASONEPROPIONATE"
"3410","FLIXOTIDE EVOHALER","250 Microgram                                                                                            Pressurised Inhalation Suspension",1999-01-08,"PA1077/044/015","GlaxoSmithKline (Ireland) Limited","FLUTICASONEPROPIONATE"
"3411","FLIXOTIDE EVOHALER","125 Mcg/Dose                                                                                             Pressurised Inhalation Suspension",2015-02-20,"PPA1562/144/001","LTT Pharma Limited","FLUTICASONEPROPIONATE"
"3412","FLIXOTIDE EVOHALER","250 Mcg/Dose                                                                                             Pressurised Inhalation Suspension",2015-02-20,"PPA1562/144/002","LTT Pharma Limited","FLUTICASONEPROPIONATE"
"3413","Flixotide Evohaler 125 micrograms per metered dose, Pressurised Inhalation, Suspension","125 microgram(s) Pressurised inhalation, suspension",2001-07-07,"PPA0465/073/001","PCO Manufacturing","FLUTICASONEPROPIONATE"
"3414","Flixotide Evohaler 250 micrograms per metered dose, Pressurised Inhalation, Suspension","250 microgram(s) Pressurised inhalation, suspension",2001-09-07,"PPA0465/073/002","PCO Manufacturing","FLUTICASONEPROPIONATE"
"3415","Flixotide Evohaler 50 micrograms per metered dose, Pressurised Inhalation Suspension","50 microgram(s) Pressurised inhalation, suspension",2018-06-01,"PPA1097/050/001","Lexon (UK) Ltd","FLUTICASONEPROPIONATE"
"3416","FLIXOTIDE NEBULES","0.5 mg/2ml Nebuliser Suspension",2015-02-06,"PPA1562/144/003","LTT Pharma Limited","FLUTICASONEPROPIONATE"
"3417","FLIXOTIDE NEBULES","2 mg/2ml Nebuliser Suspension",2015-02-06,"PPA1562/144/004","LTT Pharma Limited","FLUTICASONEPROPIONATE"
"3418","FLIXOTIDE NEBULES","0.5mg/2ml Milligram                                                                                            Nebuliser Suspension",1999-02-05,"PA1077/044/016","GlaxoSmithKline (Ireland) Limited","FLUTICASONEPROPIONATE"
"3419","FLIXOTIDE NEBULES","2mg/2ml Unknown Nebuliser Suspension",1999-02-05,"PA1077/044/017","GlaxoSmithKline (Ireland) Limited","FLUTICASONEPROPIONATE"
"3420","FLOLAN","0.5 Milligram                                                                                            Pdr+Solv for soln for Inf",1992-12-17,"PA1077/058/002","GlaxoSmithKline (Ireland) Limited","EPOPROSTENOLSODIUM"
"3421","Flolan 1.5 mg powder and solvent for solution for infusion","1.5 milligram(s) Powder and solvent for solution for infusion",2000-12-20,"PA1077/058/001","GlaxoSmithKline (Ireland) Limited","EPOPROSTENOLSODIUM"
"3422","Florinef 0.1 mg Tablets","0.1 milligram(s) Tablet",1978-04-01,"PA0002/019/001","Bristol-Myers Squibb Pharmaceuticals uc","FLUDROCORTISONEACETATE"
"3423","FLOTROS","20 Milligram                                                                                            Film Coated Tablet",2010-09-09,"DPR1392/064/001","Eurodrug Ltd","TROSPIUMCHLORIDE"
"3424","FLOTROS","20 Milligram                                                                                            Film Coated Tablet",2009-05-01,"PA1329/008/001","Galen Limited","TROSPIUMCHLORIDE"
"3425","FLOXAPEN","250 Milligram                                                                                            Capsules Hard",1979-01-18,"PA1380/011/001","Actavis Group PTC ehf","FLUCLOXACILLINSODIUM"
"3426","FLOXAPEN","500 Milligram                                                                                            Capsules Hard",1979-01-18,"PA1380/011/002","Actavis Group PTC ehf","FLUCLOXACILLINSODIUM"
"3427","FLOXAPEN","250mg Milligram                                                                                            Pdr for Soln for Injection",1979-01-18,"PA1380/011/003","Actavis Group PTC ehf","FLUCLOXACILLINSODIUM(STERILE)"
"3428","FLOXAPEN","500mg Milligram                                                                                            Pdr for Soln for Injection",1979-01-18,"PA1380/011/004","Actavis Group PTC ehf","FLUCLOXACILLINSODIUM(STERILE)"
"3429","FLOXAPEN","1000 Milligram                                                                                            Pdr for Soln Inj/Inf",2012-08-03,"PA1380/011/007","Actavis Group PTC ehf","FLUCLOXACILLINSODIUM|FLUCLOXACILLIN"
"3430","FLOXAPEN","2000 Milligram                                                                                            Pdr for Soln Inj/Inf",2012-08-03,"PA1380/011/008","Actavis Group PTC ehf","FLUCLOXACILLINSODIUM|FLUCLOXACILLIN"
"3431","Fluad, suspension for injection in pre-filled syringeInfluenza Vaccine, Surface Antigen, Inactivated, Adjuvanted with MF59C.1(2018/2019 SEASON)","0.5 millilitre(s) Suspension for injection",NA,"PA2032/002/001","Seqirus S.r.l.","A/MICHIGAN/45/2015(H1N1)PDM09-LIKESTRAIN(A/SINGAPORE/GP1908/2015,IVR-180A)|A/SINGAPORE/IMFIMH-16-0019/2016(H3N2)-LIKESTRAIN(A/SINGAPORE/INFIMH-16-0019/2016,NIB-104)|B/COLORADO/06/2017-LIKESTRAIN(B/VICTORIA/2/87LINEAGE)(B/MARYLAND/15/2016,NYMCBX-69A)"
"3432","Fluarix Tetra suspension for injection in pre-filled syringe Influenza vaccine (split virion, inactivated)","15 international unit(s) Suspension for injection",2018-06-01,"PA1077/134/001","GlaxoSmithKline (Ireland) Limited","A/MICHIGAN/45/2015(H1N1)PDM09-LIKESTRAIN(A/SINGAPORE/GP1908/2015,IVR-180A)|A/SINGAPORE/IMFIMH-16-0019/2016(H3N2)-LIKESTRAIN(A/SINGAPORE/INFIMH-16-0019/2016,NIB-104)|B/COLORADO/06/2017-LIKESTRAIN(B/VICTORIA/2/87LINEAGE)(B/MARYLAND/15/2016,NYMCBX-69A)|B/PHUKET/3073/2013-LIKESTRAIN(B/PHUKET/3073/2013,WILDTYPE)"
"3433","FLUCILLIN – FLUCLOXACILLIN","250 Milligram                                                                                            Capsules Hard",1995-05-03,"PA0281/031/004","Pinewood Laboratories Ltd,","FLUCLOXACILLINSODIUM"
"3434","FLUCILLIN – FLUCLOXACILLIN","500 Milligram                                                                                            Capsules Hard",1995-05-03,"PA0281/031/005","Pinewood Laboratories Ltd,","FLUCLOXACILLINSODIUM"
"3435","FLUCLOXACILLIN","250 MG/5ml                                                                                               Powder for Oral Solution",2010-10-08,"PA0298/017/004","Athlone Laboratories Ltd","FLUCLOXACILLIN"
"3436","FLUCLOXACILLIN","250 Milligram                                                                                            Pdr for Soln Inj/Inf",2008-09-19,"PA1339/008/001","Wockhardt UK Limited","FLUCLOXACILLINSODIUMMONOHYDRATE"
"3437","FLUCLOXACILLIN","500 Milligram                                                                                            Pdr for Soln Inj/Inf",2003-09-19,"PA1339/008/002","Wockhardt UK Limited","FLUCLOXACILLINSODIUMMONOHYDRATE"
"3438","FLUCLOXACILLIN","1 Grams                                                                                                Pdr for Soln Inj/Inf",2003-09-19,"PA1339/008/003","Wockhardt UK Limited","FLUCLOXACILLINSODIUMMONOHYDRATE"
"3439","FLUCLOXACILLIN","250 Milligram                                                                                            Pdr for Soln Inj/Inf",2016-08-26,"PA1862/003/001","Ibigen Srl","FLUCLOXACILLINSODIUM"
"3440","FLUCLOXACILLIN","500 Milligram                                                                                            Pdr for Soln Inj/Inf",2016-08-26,"PA1862/003/002","Ibigen Srl","FLUCLOXACILLINSODIUM"
"3441","FLUCLOXACILLIN","1000 Milligram                                                                                            Pdr for Soln Inj/Inf",2016-08-26,"PA1862/003/003","Ibigen Srl","FLUCLOXACILLINSODIUM"
"3442","FLUCLOXACILLIN","2000 Milligram                                                                                            Pdr for Soln Inj/Inf",2016-08-26,"PA1862/003/004","Ibigen Srl","FLUCLOXACILLINSODIUM"
"3443","Flucloxacillin 125mg/5ml Oral Solution","125 mg/5ml Powder for oral solution",2011-10-14,"PA0298/017/003","Athlone Laboratories Ltd","FLUCLOXACILLINSODIUM"
"3444","Flucloxacillin 125mg/5ml Oral Solution BP","125 mg/5ml Powder for oral solution",2011-10-14,"PA0298/016/003","Athlone Laboratories Ltd","FLUCLOXACILLINSODIUM"
"3445","Flucloxacillin 250 mg Capsules","250 milligram(s) Capsule",2011-10-14,"PA0298/017/001","Athlone Laboratories Ltd","Flucloxacillin"
"3446","Flucloxacillin 250 mg Capsules","250 milligram(s) Capsule",2011-10-14,"PA0298/016/001","Athlone Laboratories Ltd","Flucloxacillin"
"3447","Flucloxacillin 500 mg Capsules","500 milligram(s) Capsule, hard",2011-10-14,"PA0298/016/002","Athlone Laboratories Ltd","FLUCLOXACILLINSODIUM"
"3448","Flucloxacillin 500 mg Capsules","500 milligram(s) Capsule",2011-10-14,"PA0298/017/002","Athlone Laboratories Ltd","Flucloxacillin"
"3449","FLUCOL 150 MG CAPSULES","150mg Milligram                                                                                            Capsules Hard",2004-07-30,"PA0711/057/003","Rowex Ltd","FLUCONAZOLE"
"3450","FLUCOL 2 MG/ML SOLUTION FOR INFUSION","2 Mg/Ml Solution for Infusion",2003-02-26,"PA0711/057/006","Rowex Ltd","FLUCONAZOLE"
"3451","FLUCOL 200 MG CAPSULES","200mg Milligram                                                                                            Capsules Hard",2004-07-30,"PA0711/057/004","Rowex Ltd","FLUCONAZOLE"
"3452","FLUCOL 50 MG CAPSULES","50mg Milligram                                                                                            Capsules Hard",2004-07-30,"PA0711/057/001","Rowex Ltd","FLUCONAZOLE"
"3453","FLUCONAZOLE","2 Mg/Ml Solution for Infusion",2008-11-28,"PA0736/030/001","B. Braun Melsungen AG","FLUCONAZOLE"
"3454","FLUCONAZOLE","50 Milligram                                                                                            Capsules Hard",2012-03-30,"PA1390/060/001","Accord Healthcare Limited","FLUCONAZOLE"
"3455","FLUCONAZOLE","150 Milligram                                                                                            Capsules Hard",2012-03-30,"PA1390/060/002","Accord Healthcare Limited","FLUCONAZOLE"
"3456","FLUCONAZOLE","200 Milligram                                                                                            Capsules Hard",2012-03-30,"PA1390/060/003","Accord Healthcare Limited","FLUCONAZOLE"
"3457","FLUCONAZOLE","2 Micromol Solution for Infusion",NA,"PA1389/001/001","Claris Lifesciences (UK) Limited","FLUCONAZOLE"
"3458","FLUCONAZOLE","2 Mg/Ml Solution for Infusion",NA,"PA1389/001/002","Claris Lifesciences (UK) Limited","FLUCONAZOLE"
"3459","FLUCONAZOLE 150 MG CAPSULES","150 Milligram                                                                                            Capsules Hard",2003-03-07,"PA1330/014/002","Gedeon Richter Plc","FLUCONAZOLE"
"3460","Fluconazole 2mg/ml Solution for Infusion","2 milligram(s)/millilitre Solution for infusion",2010-02-05,"PA1122/006/001","Noridem Enterprises Ltd","Fluconazole"
"3461","FLUCONAZOLE ACTAVIS","50 Milligram                                                                                            Capsules Hard",2011-04-15,"PA1380/100/001","Actavis Group PTC ehf","FLUCONAZOLE"
"3462","FLUCONAZOLE ACTAVIS","150 Milligram                                                                                            Capsules Hard",2011-04-15,"PA1380/100/003","Actavis Group PTC ehf","FLUCONAZOLE"
"3463","FLUCONAZOLE ACTAVIS","200 Milligram                                                                                            Capsules Hard",2011-04-15,"PA1380/100/004","Actavis Group PTC ehf","FLUCONAZOLE"
"3464","FLUDARA","50 Milligram                                                                                            Pdr for Soln Inj/Inf",1994-12-12,"PA0611/004/001","Genzyme Europe B.V.","FLUDARABINEPHOSPHATE"
"3465","FLUDARA ORAL","10 Milligram                                                                                            Film Coated Tablet",2002-03-08,"PA0611/004/002","Genzyme Europe B.V.","FLUDARABINEPHOSPHATE"
"3466","FLUDARABINE","25 Mg/Ml Concentrate for Soln for Inf",2014-09-19,"PA1390/096/001","Accord Healthcare Limited","FLUDARABINEPHOSPHATE"
"3467","FLUDARABINE PHOSPHATE","50 Milligram                                                                                            Solution for Inj/Inf",2013-05-03,"PA1422/013/001","Fresenius Kabi Oncology Plc","FLUDARABINEPHOSPHATE"
"3468","Fludarabine Phosphate 25mg/ml Concentrate for Solution for Injection or Infusion","25 milligram(s)/millilitre Concentrate for solution for injection",2013-07-04,"PA1380/134/001","Actavis Group PTC ehf","Fludarabinephosphate"
"3469","FLUDROCORTISONE ACETATE","0.1 Milligram                                                                                            Tablets",1978-04-01,"PA1691/018/001","Aspen Pharma Trading Limited","FLUDROCORTISONEACETATE"
"3470","Fluenz Tetra","*** AWAITING VALUE *** Nasal spray, suspension",2013-12-04,"EU/1/13/887/001","MedImmune, LLC","Influenzavirus,typea,h1n1|Influenzavirus,typea,h3n2|Influenzavirus,typeb(yamagatalineage)|Influenzavirus,typeb(victorialineage)"
"3471","FLUIMUCIL 200 MG GRANULES FOR ORAL SOLUTION","200 Milligram                                                                                            Granules for oral solution",1983-07-20,"PA1441/001/001","Zambon S.p.A.","ACETYLCYSTEINE"
"3472","FLUMAZENIL","0.1 Mg/Ml Solution for Injection and Concentrate for Infusion",2007-07-06,"PA0566/040/001","Fresenius Kabi Limited","FLUMAZENIL"
"3473","Fluorouracil 25 mg/ml Solution for Injection or Infusion","25 milligram(s)/millilitre Solution for injection/infusion",1986-05-22,"PA0822/223/001","Pfizer Healthcare Ireland","Fluorouracilsodium"
"3474","Fluorouracil 50 mg/ml Solution for Injection or Infusion","50 milligram(s)/millilitre Solution for injection/infusion",2010-02-26,"PA1390/015/001","Accord Healthcare Limited","Fluorouracil"
"3475","FLUOXETINE","20 MG/5ml                                                                                               Infus/Pdr/Oral Soln",2016-05-20,"PA1861/020/001","SYRI Limited, t/a Thame Laboratories","FLUOXETINEHYDROCHLORIDE"
"3476","Fluoxetine 20mg Hard Capsules","20 milligram(s) Capsule, hard",2012-07-13,"PA1240/002/001","Bristol Laboratories Limited","FLUOXETINEHYDROCHLORIDE"
"3477","Fluoxetine 60 mg Hard Capsules","60 milligram(s) Capsule, hard",2012-07-13,"PA1240/002/002","Bristol Laboratories Limited","FLUOXETINEHYDROCHLORIDE"
"3478","FLURSIL RELIEF SUGAR FREE","8.75 Milligram                                                                                            Lozenges",2016-10-28,"PA0711/257/001","Rowex Ltd","FLURBIPROFEN"
"3479","Fluticasone propionate 50 micrograms/actuation, nasal spray, suspension","50 ZZZ Mcg/Acutuation Nasal spray, suspension",2015-06-12,"PA0678/118/001","GlaxoSmithKline Consumer Healthcare (Ireland) Limited","Fluticasonepropionate(micronised)"
"3480","Flutiform 125 microgram/5 microgram per metered dose pressurised inhalation, suspension","125/5 microgram(s) Pressurised inhalation, suspension",2012-10-19,"PA1688/013/002","Mundipharma Pharmaceuticals Limited","FLUTICASONEPROPIONATE|Formoterolfumarate"
"3481","Flutiform 250 microgram/10 microgram per metered dose pressurised inhalation, suspension","250/10 microgram(s) Pressurised inhalation, suspension",2012-10-19,"PA1688/013/003","Mundipharma Pharmaceuticals Limited","Formoterolfumarate|FLUTICASONEPROPIONATE"
"3482","Flutiform 50 microgram/5 microgram per metered dose pressurised inhalation, suspension","50/5 microgram(s) Pressurised inhalation, suspension",2012-10-19,"PA1688/013/001","Mundipharma Pharmaceuticals Limited","FLUTICASONEPROPIONATE|Formoterolfumarate"
"3483","Flutiform K-haler 125 microgram/5 microgram per actuation pressurised inhalation, suspension","*** AWAITING VALUE *** Pressurised inhalation, suspension",2018-01-26,"PA1688/013/005","Mundipharma Pharmaceuticals Limited","Formoterolfumaratedihydrate(micronised)|Fluticasonepropionate(micronised)"
"3484","Flutiform K-haler 50 microgram/5 microgram per actuation pressurised inhalation, suspension","*** AWAITING VALUE *** Pressurised inhalation, suspension",2018-01-26,"PA1688/013/004","Mundipharma Pharmaceuticals Limited","Fluticasonepropionate(micronised)|Formoterolfumaratedihydrate(micronised)"
"3485","FLUZAC","20 Milligram                                                                                            Capsules Hard",2006-03-10,"PA0711/110/001","Rowex Ltd","FLUOXETINEHYDROCHLORIDE"
"3486","FML Liquifilm 0.1% w/v Sterile Eye Drops Suspension","0.1 percent weight/volume Eye drops, suspension",1978-04-01,"PA0148/007/001","Allergan Pharmaceuticals Ireland","Fluorometholone"
"3487","FOCETRIA","7.5 Microgram                                                                                            Suspension for Injection",2007-05-02,"EU/1/07/385/1-4","GSK Vaccines S.r.l.","A/CALIFORNIA/7/2009(H1N1)VLIKESTRAIN(X-179A)"
"3488","FOCLIVIA","15 Microgram/ML                                                                                         Suspension for Injection",2009-10-19,"EU/1/09/577/1-4","Seqirus S.r.l.","A/VIETNAM/1194/2004(H5N1)VIRUSSURFACEINACTIVATEDANTIGEN"
"3489","FOLIC ACID","5 mg Milligram                                                                                            Tablets",1988-05-11,"PA0126/057/001","Clonmel Healthcare Ltd","FOLICACID"
"3490","FOLIC ACID","400 Microgram                                                                                            Tablets",1997-05-30,"PA0126/057/002","Clonmel Healthcare Ltd","FOLICACID"
"3491","FOLIC ACID","2.5 MG/5ml                                                                                               Oral Solution",2010-05-28,"PA1339/022/001","Wockhardt UK Limited","FOLICACID"
"3492","FOLIC ACID","400 Microgram                                                                                            Tablets",2018-06-14,"PA1887/010/001","Alissa Healthcare Research Limited","FOLICACID"
"3493","Folinic Acid (as Calcium Folinate) 10mg/ml Solution for Injection","10 milligram(s)/millilitre Solution for injection",1992-08-18,"PA0822/198/003","Pfizer Healthcare Ireland","Calciumfolinate"
"3494","Folinic acid (as calcium folinate) 10mg/ml solution for injection or infusion","10 milligram(s)/millilitre Solution for injection/infusion",2016-01-22,"PA2059/001/001","Fresenius Kabi Deutschland GmbH","Folinicacid"
"3495","Folinic Acid (as Calcium Folinate) 15mg Tablets","15 milligram(s) Tablet",1986-07-28,"PA0822/198/001","Pfizer Healthcare Ireland","Calciumfolinate"
"3496","Folinic Acid (as Calcium Folinate) 7.5mg/ml Solution for Injection","7.5 milligram(s)/millilitre Solution for injection",1986-05-22,"PA0822/198/002","Pfizer Healthcare Ireland","Calciumfolinate"
"3497","FOMEPIZOLE EUSA PHARMA","5 Mg/Ml Concentrate for Soln for Inf",2002-10-11,"PA2073/001/001","EUSA Pharma (UK) Limited","FOMEPIZOLESULPHATE"
"3498","FOMICYT","40 Mg/Ml Pdr for Soln for Infusion",2015-07-31,"PA1972/001/001","InfectoPharm Arzneimittel und Consilium GmbH","FOSFOMYCINSODIUM"
"3499","Foradil Aerolizer 12 microgram inhalation powder, hard capsules","12 microgram(s) Capsule",1996-01-26,"PA0896/013/001","Novartis Ireland Limited","Formoterolfumarate"
"3500","FORANE","99.9w/w %w/w                                                                                                 Inhalation Gas",1983-06-23,"PA1824/001/001","AbbVie Limited","ISOFLURANE"
"3501","FORMOTEROL","12 Microgram                                                                                            Inhalation Powder, Capsule",2008-03-14,"PA1239/001/001","Laboratorios LICONSA, S.A.","FORMOTEROL"
"3502","FORSTEO","20/80 Microgram/ML                                                                                         Solution for Injection",2003-06-10,"EU/1/03/247/01-2","Eli Lilly Nederland B.V.","TERIPARATIDE"
"3503","FORTACIN","150/50 Mg/Ml Cutaneous Spray Solution",2013-11-15,"EU/1/13/381/001","Recordati Ireland Limited","LIDOCAINE|PRILOCAINE"
"3504","FORTUM","1 Grams                                                                                                Pdr for Soln Inj/Inf",1984-09-24,"PA1077/007/002","GlaxoSmithKline (Ireland) Limited","CEFTAZIDIMEPENTAHYDRATE"
"3505","FORTUM","2 Grams                                                                                                Pdr for Soln Inj/Inf",1984-09-24,"PA1077/007/003","GlaxoSmithKline (Ireland) Limited","CEFTAZIDIMEPENTAHYDRATE"
"3506","Fortum 500 mg powder for solution for injection","500 milligram(s) Powder for solution for injection",1984-09-24,"PA1077/007/001","GlaxoSmithKline (Ireland) Limited","CEFTAZIDIMEPENTAHYDRATE"
"3507","Forxiga","5 milligram(s) Film-coated tablet",NA,"EU/1/12/795/001-005","Bristol-Myers Squibb/AstraZeneca EEIG","Dapagliflozinpropanediolmonohydrateequivalentto5mgdapagliflozin"
"3508","Forxiga","10 milligram(s) Film-coated tablet",2012-05-09,"EU/1/12/795/006-010","AstraZeneca AB","Dapagliflozinpropanediolmonohydrateequivalentto10mgdapagliflozin"
"3509","FOSAMAX ONCE WEEKLY","70 Milligram                                                                                            Tablets",2010-08-03,"DPR1633/001/001","Primecrown 2010 Ltd","ALENDRONATESODIUM"
"3510","FOSAMAX ONCE WEEKLY","70 Milligram                                                                                            Tablets",2001-05-17,"PA1286/008/001","Merck Sharp & Dohme Ireland (Human Health) Limited","ALENDRONATESODIUM"
"3511","FOSAVANCE","70/2800 mg/IU Tablets",2005-08-24,"EU/1/05/310/1-4","Merck Sharp & Dohme BV","ALENDRONICACID|COLECALCIFEROL"
"3512","FOSAVANCE","70/5600 mg/IU Tablets",2007-10-04,"EU/1/05/310/6-8","Merck Sharp & Dohme BV","ALENDRONICACID|COLECALCIFEROL"
"3513","FOSCAN","4 Mg/Ml Solution for Injection",2001-10-24,"EU/1/01/197/001","QuantaNova Limited","TEMOPORFIN"
"3514","FOSCAN","4 Mg/Ml Solution for Injection",2001-10-24,"EU/1/01/197/002","QuantaNova Limited","TEMOPORFIN"
"3515","Fostair 100 microgram/6 microgram per actuation pressurised inhalation solution","100/6 microgram(s) Pressurised inhalation, solution",2017-09-01,"PA0743/018/001","Chiesi Limited","Beclometasonedipropionateanhydrous|Formoterolfumaratedihydrate"
"3516","Fostair 200 microgram/6 microgram per actuation pressurised inhalation solution","200/6 ZZZ Mcg/Acutuation Pressurised inhalation, solution",2018-04-13,"PA0743/018/003","Chiesi Limited","Beclometasonedipropionateanhydrous|Formoterolfumaratedihydrate"
"3517","FOSTAIR NEXTHALER","100/6 Mcg/Dose                                                                                             Inhalation Powder",2018-01-19,"PA0743/018/002","Chiesi Limited","BECLOMETASONEDIPROPIONATEANHYDROUS|FORMOTEROLFUMARATEDIHYDRATE"
"3518","Fostair Nexthaler 200 micrograms/6 micrograms per metered dose inhalation powder","200/6 ZZZ Mcg/Acutuation Powder for Inhalation",2018-04-13,"PA0743/018/004","Chiesi Limited","Beclometasonedipropionateanhydrous|Formoterolfumaratedihydrate"
"3519","FOSTEPOR ONCE WEEKLY","70 Milligram                                                                                            Tablets",2006-10-13,"PA0577/086/002","McDermott Laboratories Ltd t/a Gerard Laboratories","ALENDRONICACID"
"3520","FOSTIMON","75 IU/ML                                                                                                Pdr+Solv for Soln for Inj",2007-11-23,"PA1104/002/001","IBSA Farmaceutici Italia S.r.l","UROFOLLITROPIN"
"3521","FOSTIMON","150 IU/ML                                                                                                Pdr+Solv for Soln for Inj",2007-11-23,"PA1104/002/002","IBSA Farmaceutici Italia S.r.l","UROFOLLITROPIN"
"3522","FOSTIMON  PFS","150 IU/ML                                                                                                Pdr+Solv for Soln for Inj",2007-11-23,"PA1104/002/004","IBSA Farmaceutici Italia S.r.l","UROFOLLITROPIN"
"3523","FOSTIMON PFS","225 International Unit                                                                                   Pdr+Solv for Soln for Inj",2013-02-22,"PA1104/002/005","IBSA Farmaceutici Italia S.r.l","UROFOLLITROPIN"
"3524","FOSTIMON PFS","300 International Unit                                                                                   Pdr+Solv for Soln for Inj",2013-02-22,"PA1104/002/006","IBSA Farmaceutici Italia S.r.l","UROFOLLITROPIN"
"3525","FOSTIMON PFS","75 IU/ML                                                                                                Pdr+Solv for Soln for Inj",2007-11-23,"PA1104/002/003","IBSA Farmaceutici Italia S.r.l","UROFOLLITROPIN"
"3526","Fostolin Once Weekly 70mg tablets","70 milligram(s) Tablet",2009-01-23,"PA1390/156/001","Accord Healthcare Limited","Alendronicacid"
"3527","Fotivda","890 microgram(s) Capsule, hard",2017-08-24,"EU/1/17/1215/001","EUSA Pharma (UK) Limited","Tivozanib"
"3528","FOTIVDA","1340 Microgram                                                                                            Capsules Hard",2017-08-24,"EU/1/17/1215/002","EUSA Pharma (UK) Limited","TIVOZANIB"
"3529","Foznol 1000 mg Chewable Tablets","1000 milligram(s) Chewable tablet",2005-06-17,"PA1575/002/004","Shire Pharmaceuticals Ireland Limited","Lanthanumcarbonatehydrate"
"3530","Foznol 1000 mg Oral Powder","1000 milligram(s) Oral powder",2012-05-11,"PA1575/002/006","Shire Pharmaceuticals Ireland Limited","Lanthanumcarbonatehydrate"
"3531","Foznol 250 mg Chewable Tablets","250 milligram(s) Chewable tablet",2005-06-17,"PA1575/002/001","Shire Pharmaceuticals Ireland Limited","Lanthanumcarbonatehydrate"
"3532","Foznol 500 mg Chewable Tablets","500 milligram(s) Chewable tablet",2005-06-17,"PA1575/002/002","Shire Pharmaceuticals Ireland Limited","Lanthanumcarbonatehydrate"
"3533","Foznol 750 mg Chewable Tablets","750 milligram(s) Chewable tablet",2005-06-17,"PA1575/002/003","Shire Pharmaceuticals Ireland Limited","Lanthanumcarbonatehydrate"
"3534","Foznol 750 mg Oral Powder","750 milligram(s) Oral powder",2012-05-11,"PA1575/002/005","Shire Pharmaceuticals Ireland Limited","Lanthanumcarbonatehydrate"
"3535","FREEDO","0.03 / 3 Milligram                                                                                            Film Coated Tablet",2009-10-09,"PA0711/218/001","Rowex Ltd","DROSPIRENONE|ETHINYLESTRADIOL"
"3536","FREEDONEL","0.02 / 3 Milligram                                                                                            Film Coated Tablet",2009-10-09,"PA0711/208/001","Rowex Ltd","DROSPIRENONE|ETHINYLESTRADIOL"
"3537","Fresenius Propoven 1%, emulsion for injection or infusion, ampoule","1 percent weight/volume Emulsion for injection/infusion",2005-04-22,"PA2059/017/001","Fresenius Kabi Deutschland GmbH","Propofol"
"3538","Fresenius Propoven 1%, emulsion for injection or infusion, vial","1 percent weight/volume Emulsion for injection/infusion",2005-04-22,"PA2059/017/002","Fresenius Kabi Deutschland GmbH","Propofol"
"3539","Fresenius Propoven 2%, emulsion for injection or infusion, vial","2 percent weight/volume Emulsion for injection/infusion",2005-04-22,"PA2059/017/003","Fresenius Kabi Deutschland GmbH","Propofol"
"3540","FRISIUM","10 Milligram                                                                                            Tablets",1980-08-25,"PA0540/043/001","Sanofi-Aventis Ireland Limited T/A SANOFI","CLOBAZAM"
"3541","Frovatriptan 2.5mg Film-coated Tablets","2.5 milligram(s) Film-coated tablet",2013-07-19,"PA0688/027/001","Chanelle Medical","Frovatriptansuccinatemonohydrate"
"3542","FROVEX","2.5 Milligram                                                                                            Film Coated Tablet",2002-05-17,"PA0865/009/001","Menarini International Operations Luxembourg S.A.","FROVATRIPTANSUCCINATEMONOHYDRATE"
"3543","FROVEX","2.5 Milligram                                                                                            Film Coated Tablet",2018-05-04,"PPA1463/121/001","IMED Healthcare Ltd.","FROVATRIPTAN"
"3544","FROVEX 2.5 mg film-coated tablets","2.5 milligram(s) Film-coated tablet",2015-04-17,"PPA1562/153/001","LTT Pharma Limited","FROVATRIPTAN"
"3545","Frovex 2.5 mg film-coated tablets","2.5 milligram(s) Film-coated tablet",2013-08-23,"PPA0465/321/001","PCO Manufacturing","Frovatriptansuccinatemonohydrate"
"3546","FRUMIL","40/5 Milligram                                                                                            Tablets",1991-01-29,"PA0540/101/002","Sanofi-Aventis Ireland Limited T/A SANOFI","FUROSEMIDE|AMILORIDEHYDROCHLORIDE"
"3547","FRUMIL LOW STRENGTH","20/2.5 Milligram                                                                                            Tablets",1990-05-14,"PA0540/101/001","Sanofi-Aventis Ireland Limited T/A SANOFI","FUROSEMIDE|AMILORIDEHYDROCHLORIDE"
"3548","FRUSIDE 40MG","40mg Milligram                                                                                            Tablets",1993-08-16,"PA0281/087/001","Pinewood Laboratories Ltd,","FUROSEMIDE"
"3549","FUCIBET","20/1 mg/g Cream",1984-05-23,"PA0046/040/001","Leo Laboratories Limited","FUSIDICACIDANHYDROUS|BETAMETHASONE"
"3550","FUCIBET","20 + 1 mg/g Cream",2013-10-18,"PPA1463/082/001","IMED Healthcare Ltd.","FUSIDICACID|BETAMETHASONEVALERATE"
"3551","FUCIBET","20 + 1 mg/g Cream",2014-12-12,"PPA1633/040/001","Primecrown 2010 Ltd","FUSIDICACID|BETAMETHASONE"
"3552","FUCIBET CREAM","20 / 1 mg/g Cream",2009-08-14,"PPA0465/231/001","PCO Manufacturing","FUSIDICACID|BETAMETHASONE(ASBETAMETHASONEVALERATE)"
"3553","FUCIBET LIPID","20/1 mg/g Cream",2006-05-12,"PA0046/040/002","Leo Laboratories Limited","FUSIDICACID|BETAMETHASONEVALERATE"
"3554","FUCIBET LIPID CREAM","20 and 1 mg/g Cream",2012-07-27,"PPA0465/231/002","PCO Manufacturing","FUSIDICACID|BETAMETHASONE"
"3555","FUCIDIN","20 mg/g Cream",2007-04-13,"PPA0465/197/001","PCO Manufacturing","FUSIDICACID"
"3556","FUCIDIN","30 Milligram                                                                                            Impregnated Dressing",2015-09-11,"PA1025/004/001","LEO Pharma A/S","FUSIDATESODIUM"
"3557","FUCIDIN","20 mg/g Ointment",1977-04-01,"PA0046/004/008","Leo Laboratories Limited","FUSIDATESODIUM"
"3558","FUCIDIN","250mg/5ml Mg/Ml Oral Suspension",1977-04-01,"PA0046/004/010","Leo Laboratories Limited","FUSIDICACID"
"3559","FUCIDIN","20 mg/g Cream",1980-10-13,"PA0046/004/012","Leo Laboratories Limited","FUSIDICACID"
"3560","FUCIDIN","250 Milligram                                                                                            Tablets",1990-03-13,"PA0046/004/014","Leo Laboratories Limited","FUSIDATESODIUM"
"3561","FUCIDIN","20 mg/g Cream",2013-10-18,"PPA1463/083/001","IMED Healthcare Ltd.","FUSIDICACID"
"3562","FUCIDIN","20 mg/g Cream",2009-03-27,"PPA1151/086/001","Imbat Limited","FUSIDICACID"
"3563","FUCIDIN H","20 + 10 mg/g Cream",1985-03-29,"PA0046/005/005","Leo Laboratories Limited","FUSIDICACIDANHYDROUS|HYDROCORTISONEACETATE"
"3564","Fucithalmic 10mg/g Viscous Eye Drops, suspension","10 milligram(s)/gram Eye drops, suspension",1988-04-06,"PA1142/016/001","Amdipharm Limited","Fusidicacidanhydrous"
"3565","FULTIUM-D3","800 International Unit                                                                                   Capsule",2017-11-24,"PA2191/001/001","Internis Pharmaceuticals Limited","COLECALCIFEROL"
"3566","FULTIUM-D3","3200 International Unit                                                                                   Capsule",2017-11-24,"PA2191/001/002","Internis Pharmaceuticals Limited","COLECALCIFEROL"
"3567","FULTIUM-D3","20000 International Unit                                                                                   Capsule",2017-11-24,"PA2191/001/003","Internis Pharmaceuticals Limited","COLECALCIFEROL"
"3568","FULTIUM-D3","67  Oral Drops Solution",2017-11-24,"PA2191/001/004","Internis Pharmaceuticals Limited","COLECALCIFEROL"
"3569","FULTIUM-D3","250  Oral Drops Solution",2017-11-24,"PA2191/001/005","Internis Pharmaceuticals Limited","COLECALCIFEROL"
"3570","FULTIUM-D3","25000 International Unit                                                                                   Oral Solution",2017-11-24,"PA2191/001/006","Internis Pharmaceuticals Limited","COLECALCIFEROL"
"3571","Fulvestrant 250 mg Solution for injection in pre-filled syringe","250mg millilitre(s) Solution for injection in pre-filled syringe",2017-10-20,"PA2315/046/001","Accord Healthcare Ireland Ltd.","Fulvestrant"
"3572","FULVESTRANT MYLAN","250 Mg/Ml Solution for injection in pre-filled syringe",2018-01-08,"EU/1/17/1253/001-002","Mylan S.A.S.","FULVESTRANT"
"3573","FULVESTRANT ROWEX","250 MG/5ml                                                                                               Solution for injection in pre-filled syringe",2015-08-28,"PA0711/245/001","Rowex Ltd","FULVESTRANT"
"3574","FULVESTRANT TEVA","250 Milligram                                                                                            Solution for Injection",2016-03-04,"PA1986/011/001","Teva B.V.","FULVESTRANT"
"3575","FUNGASIL","10 mg/g Cream",2007-01-26,"PA0126/166/001","Clonmel Healthcare Ltd","TERBINAFINEHYDROCHLORIDE"
"3576","Fungasil 250mg Tablets","250 milligram(s) Tablet",2009-08-12,"PA0126/141/001","Clonmel Healthcare Ltd","Terbinafine"
"3577","Fungizone 50 mg Powder for sterile concentrate","50 milligram(s) Powder for solution for infusion",1977-04-01,"PA0002/006/001","Bristol-Myers Squibb Pharmaceuticals uc","Amphotericin"
"3578","FURADANTIN","50 Milligram                                                                                            Tablets",1977-04-01,"PA0899/013/001","Mercury Pharmaceuticals Ltd","NITROFURANTOIN"
"3579","FURADANTIN","100 Milligram                                                                                            Tablets",1997-04-01,"PA0899/013/002","Mercury Pharmaceuticals Ltd","NITROFURANTOIN"
"3580","FUROSEMIDE","4 Mg/Ml Oral Solution",2015-10-23,"PA1861/017/001","SYRI Limited, t/a Thame Laboratories","FUROSEMIDE"
"3581","FUROSEMIDE","8 Mg/Ml Oral Solution",2015-10-23,"PA1861/017/002","SYRI Limited, t/a Thame Laboratories","FUROSEMIDE"
"3582","FUROSEMIDE","10 Mg/Ml Oral Solution",2015-10-23,"PA1861/017/003","SYRI Limited, t/a Thame Laboratories","FUROSEMIDE"
"3583","FUROSEMIDE","20 Mg/Ml Unknown",1982-03-15,"PA0073/059/004","Mercury Pharmaceuticals (Ireland) Ltd","FUROSEMIDE"
"3584","FUROSEMIDE","20 mg Milligram                                                                                            Tablets",1978-11-03,"PA0126/008/001","Clonmel Healthcare Ltd","FUROSEMIDE"
"3585","FUROSEMIDE","40 mg Milligram                                                                                            Tablets",1978-11-03,"PA0126/008/002","Clonmel Healthcare Ltd","FUROSEMIDE"
"3586","FUROSEMIDE","20 mg/2ml Solution for Injection",2008-02-01,"PA0566/041/001","Fresenius Kabi Limited","FUROSEMIDE"
"3587","Furosemide 10 mg/ml Solution for Injection","10 milligram(s)/millilitre Solution for injection",2009-04-03,"PA2299/036/001","Baxter Holding B.V.","Furosemide"
"3588","Furosemide 10 mg/ml Solution for Injection or Infusion","10 milligram(s)/millilitre Solution for injection/infusion",2005-07-22,"PA1390/049/001","Accord Healthcare Limited","Furosemide"
"3589","Furosemide 250mg in 25ml Solution for Injection/Infusion","250/25 milligram(s)/millilitre Solution for injection/infusion",NA,"PA0073/059/006","Mercury Pharmaceuticals (Ireland) Ltd","Furosemide"
"3590","Furosemide 50mg in 5ml Solution for Injection","50 mg/5ml Solution for injection",NA,"PA0073/059/005","Mercury Pharmaceuticals (Ireland) Ltd","Furosemide"
"3591","FUROSEMIDE BRISTOL","20 Milligram                                                                                            Tablets",2006-05-26,"PA1240/001/001","Bristol Laboratories Limited","FUROSEMIDE"
"3592","FUROSEMIDE BRISTOL","40 Milligram                                                                                            Tablets",2006-05-26,"PA1240/001/002","Bristol Laboratories Limited","FUROSEMIDE"
"3593","FUROSEMIDE INJECTION","10 Mg/Ml Solution for Injection",NA,"PA1390/049/002","Accord Healthcare Limited",""
"3594","FUROSEMIDE INJECTION BP MINIJET","10 Mg/Ml Solution for Injection",1990-01-11,"PA0255/010/004","International Medication Systems (UK) Ltd","FUROSEMIDE"
"3595","FUZEON","90 Per Cent                                                                                             Pdr+Solv for Soln for Inj",2003-05-27,"EU/1/03/252/1-3","Roche Registration Limited","ENFUVIRTIDE"
"3596","FYBOGEL CITRUS","3.5 Grams                                                                                                Granules for Oral Suspension",1975-01-27,"PA0979/009/001","Reckitt Benckiser Ireland Ltd","ISPAGHULAHUSKS"
"3597","FYBOGEL MEBEVERINE","0.135/3.5 Grams                                                                                                Granules Effervescent",1986-03-14,"PA0979/010/001","Reckitt Benckiser Ireland Ltd","MEBEVERINEHYDROCHLORIDE|ISPAGHULAHUSKS"
"3598","FYBOGEL ORANGE","3.5 Grams                                                                                                Granules",1993-04-08,"PA0979/009/002","Reckitt Benckiser Ireland Ltd","ISPAGHULAHUSKS"
"3599","Fycompa","2 milligram(s) Film-coated tablet",NA,"EU/1/12/776/001","Eisai GmbH","Perampanel"
"3600","Fycompa","4 milligram(s) Film-coated tablet",NA,"EU/1/12/776/002-004","Eisai GmbH","Perampanel"
"3601","Fycompa","6 milligram(s) Film-coated tablet",NA,"EU/1/12/776/005-007","Eisai GmbH","Perampanel"
"3602","Fycompa","8 milligram(s) Film-coated tablet",NA,"EU/1/12/776/008-010","Eisai GmbH","Perampanel"
"3603","Fycompa","10 milligram(s) Film-coated tablet",NA,"EU/1/12/776/011-013","Eisai GmbH","Perampanel"
"3604","Fycompa","12 milligram(s) Film-coated tablet",NA,"EU/1/12/776/014-016","Eisai GmbH","Perampanel"
"3605","Fycompa","0.5 milligram(s)/millilitre Oral suspension",2016-06-19,"EU/1/12/776/024","Eisai GmbH","Perampanel"
"3606","Fydrane 0.2 mg/ml + 3.1 mg/ml + 10 mg/ml, solution for injection","0.2 + 3.1 + 10 milligram(s)/millilitre Solution for injection",2015-08-28,"PA1107/012/001","Laboratoires Thea","LIDOCAINEHYDROCHLORIDE|Phenylephrinehydrochloride|Tropicamide"
"3607","GABAPENTIN","100 Milligram                                                                                            Capsule",2007-03-30,"PA0711/132/001","Rowex Ltd","GABAPENTIN"
"3608","GABAPENTIN","300 Milligram                                                                                            Capsule",2007-03-30,"PA0711/132/002","Rowex Ltd","GABAPENTIN"
"3609","GABAPENTIN","400 Milligram                                                                                            Capsule",2007-03-30,"PA0711/132/003","Rowex Ltd","GABAPENTIN"
"3610","GABAPENTIN","600 Milligram                                                                                            Film Coated Tablet",2011-12-05,"PA1390/057/001","Accord Healthcare Limited","GABAPENTIN"
"3611","GABAPENTIN","800 Milligram                                                                                            Film Coated Tablet",2011-12-05,"PA1390/057/002","Accord Healthcare Limited","GABAPENTIN"
"3612","GABAPENTIN","100 Milligram                                                                                            Capsules Hard",2016-10-14,"PA1390/057/003","Accord Healthcare Limited","GABAPENTIN"
"3613","GABAPENTIN","300 Milligram                                                                                            Capsules Hard",2016-10-14,"PA1390/057/004","Accord Healthcare Limited","GABAPENTIN"
"3614","GABAPENTIN","400 Milligram                                                                                            Capsules Hard",2016-10-14,"PA1390/057/005","Accord Healthcare Limited","GABAPENTIN"
"3615","GABAPENTIN","100mg Milligram                                                                                            Capsule",2005-11-18,"PA0577/097/001","McDermott Laboratories Ltd t/a Gerard Laboratories","GABAPENTIN"
"3616","GABAPENTIN","300mg Milligram                                                                                            Capsule",2005-11-18,"PA0577/097/002","McDermott Laboratories Ltd t/a Gerard Laboratories","GABAPENTIN"
"3617","GABAPENTIN","400mg Milligram                                                                                            Capsule",2005-11-18,"PA0577/097/003","McDermott Laboratories Ltd t/a Gerard Laboratories","GABAPENTIN"
"3618","Gabapentin Rosemont 50mg/ml Oral Solution","50 milligram(s)/millilitre Oral solution",2012-10-26,"PA0312/025/001","Rosemont Pharmaceuticals Ltd","Gabapentin"
"3619","GABIN","100 Milligram                                                                                            Capsules Hard",2011-06-03,"PA1445/020/001","Aurobindo Pharma (Malta) Limited","GABAPENTIN"
"3620","GABIN","300 Milligram                                                                                            Capsules Hard",2011-06-03,"PA1445/020/002","Aurobindo Pharma (Malta) Limited","GABAPENTIN"
"3621","GABIN","400 Milligram                                                                                            Capsules Hard",2011-06-03,"PA1445/020/003","Aurobindo Pharma (Malta) Limited","GABAPENTIN"
"3622","GABITRIL","5 Milligram                                                                                            Film Coated Tablet",1997-03-07,"PA0749/199/001","Teva Pharma B.V.","TIAGABINE"
"3623","GABITRIL","10 Milligram                                                                                            Film Coated Tablet",1997-03-07,"PA0749/199/002","Teva Pharma B.V.","TIAGABINE"
"3624","GABITRIL","15 Milligram                                                                                            Film Coated Tablet",1997-03-07,"PA0749/199/003","Teva Pharma B.V.","TIAGABINE"
"3625","GADOVIST","1.0 mMol/ml                                                                                              Solution for Injection",2001-04-20,"PA1410/018/002","Bayer Limited","GADOBUTROL"
"3626","GADOVIST","1.0 mMol/ml                                                                                              Solution for Injection",2000-12-08,"PA1410/018/003","Bayer Limited","GADOBUTROL"
"3627","GADOVIST","1.0 mMol/ml                                                                                              Solution for Injection",2009-04-08,"PA1410/018/004","Bayer Limited","GADOBUTROL"
"3628","Gadovist 1.0 mmol/ml solution for injection","1.0 millimole(s)/millilitre Solution for injection",2000-12-08,"PA1410/018/001","Bayer Limited","Gadobutrol"
"3629","GALAFOLD","123 Milligram                                                                                            Capsules Hard",2016-05-26,"EU/1/15/1082/001","Amicus Therapeutics UK Ltd","MIGALASTATHYDROCHLORIDE"
"3630","GALFER","305 Milligram                                                                                            Capsules Hard",1976-06-04,"PA0610/012/001","Thornton & Ross Limited","FERROUSFUMARATE"
"3631","GALFER","140 MG/5ml                                                                                               Oral Suspension",1988-07-25,"PA0610/012/002","Thornton & Ross Limited","FERROUSFUMARATE"
"3632","GALFER FA 305 MG / 0.35 MG HARD CAPSULES","305/0.35 Milligram                                                                                            Capsules Hard",1976-06-04,"PA0610/013/001","Thornton & Ross Limited","FERROUSFUMARATE|FOLICACID"
"3633","GALLIAPHARM","0.74-1.85  Radionuclide Generator",2017-09-01,"PA2192/001/001","Eckert & Ziegler Radiopharma GmbH","GERMANIUM(68GE)CHLORIDE|GALLIUM(68G)CHLORIDE"
"3634","Gallium (Ga67) Citrate Injection","37 ZZZ MBq/ml Solution for injection",2000-03-31,"PA0690/003/001","Mallinckrodt Medical B.V.","Gallium(67ga)citrate"
"3635","Galsya SR 16 mg prolonged-release capsules, hard","16 milligram(s) Prolonged-release capsule, hard",2011-06-03,"PA1347/015/002","Krka d.d., Novo mesto","GALANTAMINEHYDROBROMIDE|Galantamine"
"3636","Galsya SR 24 mg prolonged-release capsules, hard","24 milligram(s) Prolonged-release capsule, hard",2011-06-03,"PA1347/015/003","Krka d.d., Novo mesto","Galantamine"
"3637","Galsya SR 8 mg prolonged-release capsules, hard","8 milligram(s) Prolonged-release capsule, hard",2011-06-03,"PA1347/015/001","Krka d.d., Novo mesto","Galantamine"
"3638","Galvus","50 milligram(s) Tablet",NA,"EU/1/07/414/1-10","Novartis Europharm Limited","Vildagliptin"
"3639","GALVUS","100 Milligram                                                                                            Tablets",2007-09-26,"EU/1/07/414/11-17","Novartis Europharm Limited","VILDAGLIPTIN"
"3640","Gamanil 70mg film-coated tablets","70 milligram(s) Film-coated tablet",1984-05-14,"PA1884/001/001","Creo Pharma Limited","Lofepraminehydrochloride"
"3641","GAMMAGARD S/D","0.5 g/30 m Micromol Pdr+Solv for soln for Inf",1998-05-01,"PA2004/003/001","Baxalta Innovations GmbH","HUMANPLASMAPROTEIN&gt;90%GAMMAGLOBULIN"
"3642","GAMMANORM, 165 mg/mL, solution for injection","165 milligram(s)/millilitre Solution for injection",2007-06-01,"PA2219/006/001","Octapharma (IP) SPRL","Humannormalimmunoglobulin"
"3643","GAMMAPLEX 10%","100 Mg/Ml Solution for Infusion",2018-07-06,"PA0763/003/001","Bio Products Laboratory Limited","HUMANNORMALIMMUNOGLOBULIN"
"3644","Gamunex® 10%,100 mg/ml, solution for infusion","100 milligram(s)/millilitre Solution for infusion",2006-08-11,"PA1405/001/001","Grifols Deutschland GmbH","Immunoglobulinhumannormal"
"3645","GANFORT","0.3/5 Mg/Ml Eye Drops Solution",2006-05-19,"EU/1/06/340/001-002","Allergan Pharmaceuticals Ireland","BIMATOPROST|TIMOLOL"
"3646","GARDASIL","Per Cent                                                                                             Suspension for Injection",2006-09-20,"EU/1/06/357/01-21","MSD Vaccins","QUADRIVALENTHUMANPAPILLOMAVIRUSTYPE11RECOMBINANTVACCINE(IN)|QUADRIVALENTHUMANPAPILLOMAVIRUSTYPE16RECOMBINANTVACCINE(IN)|QUADRIVALENTHUMANPAPILLOMAVIRUSTYPE18RECOMBINANTVACCINE(IN)|QUADRIVALENTHUMANPAPILLOMAVIRUSTYPE6RECOMBINANTVACCINE"
"3647","GARDASIL 9","0.5 Millilitre                                                                                           Suspension for Injection",2015-06-10,"EU/1/15/1007/001-003","MSD Vaccins","HPVTYPE6L1PROTEIN|HPVTYPE11L1PROTEIN|HPV16L1PROTEIN|HPV18L1PROTEIN|HPVTYPE31L1PROTEIN|HPVTYPE33L1PROTEIN|HPVTYPE45L1PROTEIN|HPVTYPE52L1PROTEIN|HPVTYPE58L1PROTEIN"
"3648","GASTROGRAFIN, 660MG/ML + 100MG/ML ORAL AND RECTAL","%v/v                                                                                                 Oral Solution",1983-04-01,"PA1410/004/001","Bayer Limited","SODIUMAMIDOTRIZOATE|AMIDOTRIZOATEMEGLUMINE"
"3649","GASTROLIEF","20 Milligram                                                                                            Tablets Gastro-Resistant",2011-04-01,"PA0126/220/001","Clonmel Healthcare Ltd","PANTOPRAZOLESODIUMSESQUIHYDRATE"
"3650","GASTROMIRO 612.4MG/ML ORAL OR RECTAL SOLUTION","612.4 Mg/Ml Unknown",1990-04-10,"PA1826/005/001","Bracco Imaging spa","IOPAMIDOL"
"3651","GAVISCON ADVANCE","500mg/100m MG/5ml                                                                                               Oral Suspension",1998-08-14,"PA0979/011/001","Reckitt Benckiser Ireland Ltd","SODIUMALGINATE|POTASSIUMHYDROGENCARBONATE"
"3652","GAVISCON ADVANCE","1000/200 Milligram                                                                                            Oral Suspension",2004-03-05,"PA0979/011/006","Reckitt Benckiser Ireland Ltd","SODIUMALGINATE|POTASSIUMHYDROGENCARBONATE"
"3653","GAVISCON ADVANCE","500/100 Milligram                                                                                            Tablets Chewable",2006-02-10,"PA0979/011/008","Reckitt Benckiser Ireland Ltd","SODIUMALGINATE|POTASSIUMBICARBONATE"
"3654","GAVISCON ADVANCE - PEPPERMINT FLAVOUR","1000/200 Milligram                                                                                            Unknown",2004-03-05,"PA0979/011/007","Reckitt Benckiser Ireland Ltd","SODIUMALGINATE|POTASSIUMBICARBONATE"
"3655","GAVISCON EXTRA","500/213/325 Milligram                                                                                            Oral Suspension",2010-10-01,"PA0979/015/011","Reckitt Benckiser Ireland Ltd","SODIUMALGINATE|SODIUMBICARBONATE|CALCIUMCARBONATE"
"3656","GAVISCON EXTRA","250/106.5/187.50 Milligram                                                                                            Tablets Chewable",2010-10-01,"PA0979/015/012","Reckitt Benckiser Ireland Ltd","SODIUMALGINATE|SODIUMBICARBONATE|CALCIUMCARBONATE"
"3657","Gaviscon Extra Liquid Sachets Peppermint Flavour Oral SuspensionSodium Alginate 500 mg/10 ml Sodium Bicarbonate 213 mg/10 ml Calcium Carbonate 325 mg/10 ml","500/213/325 milligram/10 millilitres Oral suspension",2012-12-14,"PA0979/015/013","Reckitt Benckiser Ireland Ltd","CALCIUMCARBONATE|Sodiumalginate|Sodiumbicarbonate"
"3658","GAVISCON INFANT","%v/v                                                                                                 Powder for Oral Solution",1991-07-12,"PA0979/012/001","Reckitt Benckiser Ireland Ltd","SODIUMALGINATE|MAGNESIUMALGINATE"
"3659","GAVISCON LIQUID - PEPPERMINT FLAVOUR","10 Micromol Oral Suspension",1996-01-03,"PA0979/015/002","Reckitt Benckiser Ireland Ltd","SODIUMALGINATE|SODIUMBICARBONATE|CALCIUMCARBONATE"
"3660","GAVISCON LIQUID SACHETS","500/267/16 Milligram                                                                                            Oral Suspension",2010-10-01,"PA0979/015/010","Reckitt Benckiser Ireland Ltd","SODIUMALGINATE|SODIUMBICARBONATE|CALCIUMCARBONATE"
"3661","GAVISCON LIQUID-ANISEED FLAVOUR, ORAL SUSPENSION","%v/v                                                                                                 Oral Suspension",2001-06-29,"PA0979/015/003","Reckitt Benckiser Ireland Ltd","SODIUMALGINATE|SODIUMBICARBONATE|CALCIUMCARBONATE"
"3662","GAVISCON ORAL SUSPENSION","500/267/160 Milligram                                                                                            Oral Suspension",1978-05-03,"PA0979/015/001","Reckitt Benckiser Ireland Ltd","SODIUMALGINATE|SODIUMBICARBONATE|CALCIUMCARBONATE"
"3663","GAVISCON PEPPERMINT","250 Milligram                                                                                            Tablets Chewable",2004-12-22,"PA0979/015/004","Reckitt Benckiser Ireland Ltd","SODIUMALGINATE|CALCIUMCARBONATE|SODIUMBICARBONATE"
"3664","GAVISCON STRAWBERRY","250/133.5/ Milligram                                                                                            Tablets Chewable",2004-12-22,"PA0979/015/005","Reckitt Benckiser Ireland Ltd","SODIUMALGINATE|SODIUMBICARBONATE|CALCIUMCARBONATE"
"3665","GAZYVARO","1000 Milligram                                                                                            Concentrate for Soln for Inf",2014-07-23,"EU/1/14/937/001","Roche Registration GmbH","OBINUTUZUMAB"
"3666","GEDAREL","20/150 Microgram                                                                                            Film Coated Tablet",2009-01-23,"PA1330/006/001","Gedeon Richter Plc","ETHINYLESTRADIOL|DESOGESTREL"
"3667","GEDAREL EXTRA","30/150 Microgram                                                                                            Film Coated Tablet",2009-01-23,"PA1330/005/001","Gedeon Richter Plc","ETHINYLESTRADIOL|DESOGESTREL"
"3668","Gefitinib Mylan","250 milligram(s) Film-coated tablet",2018-09-27,"EU/1/18/1321/001-002","Mylan S.A.S.","Gefitinib"
"3669","GELASPAN","4 Per Cent                                                                                             Solution for Infusion",2011-09-09,"PA0736/034/001","B. Braun Melsungen AG","SUCCINYLATEDGELATINE(=MODIFIEDFLUIDGELATINE)|SODIUMCHLORIDE|SODIUMACETATETRIHYDRATE|POTASSIUMCHLORIDE|CALCIUMCHLORIDEDIHYDRATE|MAGNESIUMCHLORIDEHEXAHYDRATE"
"3670","GELOFUSINE","40 Mg/Ml Solution for Infusion",2000-03-03,"PA0736/011/001","B. Braun Melsungen AG","SUCCINYLATEDGELATINE(=MODIFIEDFLUIDGELATINE)|SODIUMCHLORIDE|SODIUMHYDROXIDE"
"3671","GELOPLASMA","3 Grams                                                                                                Solution for Infusion",2007-04-20,"PA2059/008/001","Fresenius Kabi Deutschland GmbH","MODIFIEDLIQUIDGELATINE|SODIUMCHLORIDE|MAGNESIUMCHLORIDEHEXAHYDRATE|POTASSIUMCHLORIDE|SODIUMLACTATESOLUTION"
"3672","GELOPLASMA","3 Grams                                                                                                Solution for Infusion",2010-09-10,"PA2059/008/002","Fresenius Kabi Deutschland GmbH","MODIFIEDLIQUIDGELATINE|SODIUMCHLORIDE|MAGNESIUMCHLORIDEHEXAHYDRATE|POTASSIUMCHLORIDE|SODIUMLACTATESOLUTION"
"3673","GELSEMIUM","6C & 30C  Tablets",2010-09-10,"HOR0407/024/001","Weleda (UK) Limited","GELSEMIUMSEMPERVIRENS"
"3674","GELSEMIUM","6C-MM N/A",2011-03-11,"HOR1149/012/001","A. Nelson & Company Limited","GELSEMIUMSEMPERVIRENS"
"3675","GELTEARS","0.2 %w/w                                                                                                 Eyegel",1997-02-07,"PA0555/011/001","Bausch & Lomb UK Limited","CARBOMER"
"3676","Gemcitabine 1 g powder for solution for infusion","1 gram(s) Powder for solution for infusion",2010-04-23,"PA1422/003/002","Fresenius Kabi Oncology Plc","Gemcitabine"
"3677","Gemcitabine 1 g powder for solution for infusion","1 gram(s) Powder for solution for infusion",2008-12-12,"PA1380/015/002","Actavis Group PTC ehf","GEMCITABINEHYDROCHLORIDE"
"3678","Gemcitabine 1 g Powder for Solution for Infusion","1 gram(s) Powder for solution for injection",2009-07-24,"PA1390/007/002","Accord Healthcare Limited","Gemcitabine"
"3679","Gemcitabine 100 mg/ml Concentrate for Solution for Infusion","100 ZZZ Base mg/ml Concentrate for solution for infusion",NA,"PA1390/007/004","Accord Healthcare Limited","Gemcitabine"
"3680","Gemcitabine 2 g powder for solution for infusion","2 gram(s) Powder for solution for infusion",2010-06-04,"PA1380/015/004","Actavis Group PTC ehf","GEMCITABINEHYDROCHLORIDE"
"3681","Gemcitabine 2 g powder for solution for infusion","2 gram(s) Powder for solution for infusion",2010-04-23,"PA1422/003/003","Fresenius Kabi Oncology Plc","Gemcitabine"
"3682","Gemcitabine 200 mg powder for solution for infusion","200 milligram(s) Powder for solution for infusion",2010-04-23,"PA1422/003/001","Fresenius Kabi Oncology Plc","Gemcitabine"
"3683","Gemcitabine 200 mg powder for solution for infusion","200 milligram(s) Powder for solution for infusion",2008-12-12,"PA1380/015/001","Actavis Group PTC ehf","GEMCITABINEHYDROCHLORIDE"
"3684","Gemcitabine 200 mg Powder for Solution for Infusion","200 milligram(s) Powder for solution for injection",2009-07-24,"PA1390/007/001","Accord Healthcare Limited","Gemcitabine"
"3685","Gemcitabine 2g Powder for Solution for Infusion","2 gram(s) Powder for solution for infusion",NA,"PA1390/007/003","Accord Healthcare Limited","GEMCITABINEHYDROCHLORIDE"
"3686","Gemcitabine 38 mg/ml Concentrate for Solution for Infusion","38 ZZZ Base mg/ml Concentrate for solution for infusion",2011-06-10,"PA0437/063/001","Hospira  UK Limited","GEMCITABINEHYDROCHLORIDE"
"3687","Gemcitabine 38mg/ml Concentrate for Solution for Infusion","38 milligram(s)/millilitre Concentrate for solution for infusion",NA,"PA1422/003/005","Fresenius Kabi Oncology Plc","GEMCITABINEHYDROCHLORIDE"
"3688","Gemcitabine 40mg/ml concentrate for solution for Infusion","40 milligram(s)/millilitre Concentrate for solution for infusion",NA,"PA1422/003/004","Fresenius Kabi Oncology Plc","GEMCITABINEHYDROCHLORIDE"
"3689","Gemcitabine Actavis 40mg/ml Concentrate for Solution for Infusion","40 milligram(s)/millilitre Concentrate for solution for infusion",NA,"PA1380/182/001","Actavis Group PTC ehf","GEMCITABINEHYDROCHLORIDE|Gemcitabine"
"3690","GENOTROPIN","5.3 milligram(s)/millilitre Powder and solvent for solution for injection",1991-02-20,"PA0822/128/001","Pfizer Healthcare Ireland","Somatropin"
"3691","GENOTROPIN","12 milligram(s)/millilitre Powder and solvent for solution for injection",1992-09-01,"PA0822/128/002","Pfizer Healthcare Ireland","Somatropin"
"3692","GENOTROPIN MINIQUICK","0.2 milligram(s)/millilitre Powder and solvent for solution for injection",1998-12-10,"PA0822/128/003","Pfizer Healthcare Ireland","Somatropin"
"3693","GENOTROPIN MINIQUICK","0.4 milligram(s)/millilitre Powder and solvent for solution for injection",1998-12-10,"PA0822/128/004","Pfizer Healthcare Ireland","Somatropin"
"3694","GENOTROPIN MINIQUICK","0.6 milligram(s)/millilitre Powder and solvent for solution for injection",1998-12-10,"PA0822/128/005","Pfizer Healthcare Ireland","Somatropin"
"3695","GENOTROPIN MINIQUICK","0.8 milligram(s)/millilitre Powder and solvent for solution for injection",1998-12-10,"PA0822/128/006","Pfizer Healthcare Ireland","Somatropin"
"3696","GENOTROPIN MINIQUICK","1 milligram(s)/millilitre Powder and solvent for solution for injection",1998-12-10,"PA0822/128/007","Pfizer Healthcare Ireland","Somatropin"
"3697","GENOTROPIN MINIQUICK","1.2 milligram(s)/millilitre Powder and solvent for solution for injection",1998-12-10,"PA0822/128/008","Pfizer Healthcare Ireland","Somatropin"
"3698","GENOTROPIN MINIQUICK","1.4 milligram(s)/millilitre Powder and solvent for solution for injection",1998-12-10,"PA0822/128/009","Pfizer Healthcare Ireland","Somatropin"
"3699","GENOTROPIN MINIQUICK","1.6 milligram(s)/millilitre Powder and solvent for solution for injection",1998-12-10,"PA0822/128/010","Pfizer Healthcare Ireland","Somatropin"
"3700","GENOTROPIN MINIQUICK","1.8 milligram(s)/millilitre Powder and solvent for solution for injection",1998-12-10,"PA0822/128/011","Pfizer Healthcare Ireland","Somatropin"
"3701","GENOTROPIN MINIQUICK","2.0 milligram(s)/millilitre Powder and solvent for solution for injection",1998-12-10,"PA0822/128/012","Pfizer Healthcare Ireland","Somatropin"
"3702","GENTAMICIN","1 Mg/Ml Solution for Infusion",2009-03-06,"PA0736/031/001","B. Braun Melsungen AG","GENTAMICIN(ASGENTAMICINSULPHATE)"
"3703","GENTAMICIN","3 Mg/Ml Solution for Infusion",2009-03-06,"PA0736/031/002","B. Braun Melsungen AG","GENTAMICIN(ASGENTAMICINSULPHATE)"
"3704","Gentamicin 10mg/ml Solution for Injection or Infusion","10 milligram(s)/millilitre Solution for injection/infusion",2015-03-13,"PA1339/065/001","Wockhardt UK Limited","Gentamicin(asgentamicinsulphate)"
"3705","Gentamicin 40 mg/ml Injection, vials","40 milligram(s)/millilitre Solution for injection",1986-08-06,"PA0822/203/001","Pfizer Healthcare Ireland","Gentamicinsulfate"
"3706","Gentamicin 40mg/ml Solution for Injection or Infusion","40 milligram(s)/millilitre Solution for injection/infusion",2015-03-13,"PA1339/065/002","Wockhardt UK Limited","Gentamicin(asgentamicinsulphate)"
"3707","GENTICIN","80 mg/2ml Solution for Injection",1995-04-20,"PA1142/013/001","Amdipharm Limited","GENTAMICINSULFATE"
"3708","GENTICIN","0.3 %w/v                                                                                                 Ear/Eye Drops, solution",1995-04-20,"PA1142/013/002","Amdipharm Limited","GENTAMICINSULFATE"
"3709","GENTISONE HC","0.3 & 1.0 %w/v                                                                                                 Ear Drops Suspension",1995-05-18,"PA1142/014/001","Amdipharm Limited","GENTAMICINSULFATE|HYDROCORTISONEACETATE"
"3710","Genvoya","150/150/200/10 milligram(s) Film-coated tablet",2015-11-19,"EU/1/15/1061/001-002","Gilead Sciences Ireland UC","Emtricitabine|Cobicistat|Elvitegravir|Tenofoviralafenamidefumarate"
"3711","Geodon 20mg capsules, hard","20 milligram(s) Capsule, hard",2002-03-08,"PA0822/214/001","Pfizer Healthcare Ireland","Ziprasidonehydrochloridemonohydrate"
"3712","Geodon 40mg capsules, hard","40 milligram(s) Capsule, hard",2002-03-08,"PA0822/214/002","Pfizer Healthcare Ireland","Ziprasidonehydrochloridemonohydrate"
"3713","Geodon 60mg capsules, hard","60 milligram(s) Capsule, hard",2002-03-08,"PA0822/214/003","Pfizer Healthcare Ireland","Ziprasidonehydrochloridemonohydrate"
"3714","Geodon 80mg capsules, hard","80 milligram(s) Capsule, hard",2002-03-08,"PA0822/214/004","Pfizer Healthcare Ireland","Ziprasidonehydrochloridemonohydrate"
"3715","GERAMOX","250 Milligram                                                                                            Capsules Hard",1984-11-28,"PA0405/005/001","Generics (UK) Limited","AMOXICILLINTRIHYDRATE"
"3716","GERAMOX","500 Milligram                                                                                            Capsules Hard",1984-11-28,"PA0405/005/002","Generics (UK) Limited","AMOXICILLINTRIHYDRATE"
"3717","GERAX","250 Microgram                                                                                            Tablets",1996-01-08,"PA0577/010/001","McDermott Laboratories Ltd t/a Gerard Laboratories","ALPRAZOLAM"
"3718","GERAX","500 Microgram                                                                                            Tablets",1996-01-08,"PA0577/010/002","McDermott Laboratories Ltd t/a Gerard Laboratories","ALPRAZOLAM"
"3719","GERAX","1 Milligram                                                                                            Tablets",1996-01-08,"PA0577/010/003","McDermott Laboratories Ltd t/a Gerard Laboratories","ALPRAZOLAM"
"3720","GERIFLOX","500 Milligram                                                                                            Capsule",1988-07-25,"PA0405/010/002","Generics (UK) Limited","FLUCLOXACILLINSODIUM"
"3721","GERMENTIN","250/125 Milligram                                                                                            Film Coated Tablet",2004-03-05,"PA0577/034/003","McDermott Laboratories Ltd t/a Gerard Laboratories","AMOXICILLINTRIHYDRATE|CLAVULANICACID"
"3722","GERMENTIN","500/125 Milligram                                                                                            Film Coated Tablet",2000-08-18,"PA0577/034/001","McDermott Laboratories Ltd t/a Gerard Laboratories","AMOXICILLINTRIHYDRATE|CLAVULANATEPOTASSIUM"
"3723","Germentin 125 mg/31.25 mg per 5 ml Powder for Oral Suspension","125/31.25 mg/5ml Powder for oral suspension",2004-03-05,"PA0577/034/002","McDermott Laboratories Ltd t/a Gerard Laboratories","Amoxycillintrihydrate|Clavulanicacid"
"3724","Geroquel 100 mg film-coated tablets","100 milligram(s) Film-coated tablet",2007-10-19,"PA0577/090/002","McDermott Laboratories Ltd t/a Gerard Laboratories","Quetiapinefumarate"
"3725","Geroquel 200 mg film-coated tablets","200 milligram(s) Film-coated tablet",2007-10-19,"PA0577/090/003","McDermott Laboratories Ltd t/a Gerard Laboratories","Quetiapinefumarate"
"3726","Geroquel 25 mg film-coated tablets","25 milligram(s) Film-coated tablet",2007-10-19,"PA0577/090/001","McDermott Laboratories Ltd t/a Gerard Laboratories","Quetiapinefumarate"
"3727","Geroquel 300 mg film-coated tablets","300 milligram(s) Film-coated tablet",2007-10-19,"PA0577/090/004","McDermott Laboratories Ltd t/a Gerard Laboratories","Quetiapinefumarate"
"3728","GEROZAC","60 Milligram                                                                                            Capsules Hard",2006-03-03,"PA0577/071/001","McDermott Laboratories Ltd t/a Gerard Laboratories","FLUOXETINEHYDROCHLORIDE|FLUOXETINEHYDROCHLORIDE"
"3729","GEROZAC","20 Milligram                                                                                            Capsules Hard",1999-02-19,"PA0405/036/001","Generics (UK) Limited","FLUOXETINEHYDROCHLORIDE"
"3730","GERTAC","150 Milligram                                                                                            Film Coated Tablet",1997-02-21,"PA0577/023/001","McDermott Laboratories Ltd t/a Gerard Laboratories","RANITIDINEHYDROCHLORIDE"
"3731","Gertac 300 mg Film-coated Tablets","300 milligram(s) Film-coated tablet",1997-02-21,"PA0577/023/002","McDermott Laboratories Ltd t/a Gerard Laboratories","RANITIDINEHYDROCHLORIDE"
"3732","GILENYA","0.5 milligram(s) Capsule, hard",NA,"EU/1/11/677/001-004","Novartis Europharm Limited","Fingolimod"
"3733","GINKGO-BILOBA PHARMA NORD","Unknown Film Coated Tablet",2018-03-16,"TR1242/001/001","Pharma Nord ApS","GINKGOBILOBAEXTRACT"
"3734","GIOTRIF","20 Milligram                                                                                            Film Coated Tablet",2013-09-25,"EU/1/13/879/001-003","Boehringer Ingelheim International GmbH","AFATINIB-DIMALEATE"
"3735","GIOTRIF","30 Milligram                                                                                            Film Coated Tablet",2013-09-25,"EU/1/13/879/004-006","Boehringer Ingelheim International GmbH","AFATINIB-DIMALEATE"
"3736","GIOTRIF","40 Milligram                                                                                            Film Coated Tablet",2013-09-25,"EU/1/13/879/007-009","Boehringer Ingelheim International GmbH","AFATINIB-DIMALEATE"
"3737","GIOTRIF","50 Milligram                                                                                            Film Coated Tablet",2013-09-25,"EU/1/13/879/010-012","Boehringer Ingelheim International GmbH","AFATINIB-DIMALEATE"
"3738","GLIADEL","7.7 Milligram                                                                                            Implant",1999-07-07,"PA1018/001/001","MGI Pharma Limited","CARMUSTINE"
"3739","GLIBENCLAMIDE","2.5 Milligram                                                                                            Tablets",2008-12-12,"PA0688/040/001","Chanelle Medical","GLIBENCLAMIDE"
"3740","GLIBENCLAMIDE","5 Milligram                                                                                            Tablets",2008-12-12,"PA0688/040/002","Chanelle Medical","GLIBENCLAMIDE"
"3741","GLICLAZIDE MR","30 Milligram                                                                                            Tablet Prolonged Release",2014-09-12,"PA1240/010/001","Bristol Laboratories Limited","GLICLAZIDE"
"3742","GLIDIPION","15 Milligram                                                                                            Tablets",2012-03-15,"EU/1/12/756/001-009","Actavis Group PTC ehf","PIOGLITAZONEHYDROCHLORIDE"
"3743","GLIDIPION","30 Milligram                                                                                            Tablets",2012-03-15,"EU/1/12/756/010-018","Actavis Group PTC ehf","PIOGLITAZONEHYDROCHLORIDE"
"3744","GLIDIPION","45 Milligram                                                                                            Tablets",2012-03-15,"EU/1/12/756/019-027","Actavis Group PTC ehf","PIOGLITAZONEHYDROCHLORIDE"
"3745","GLIMEPIRIDE","1mg milligram(s) Tablet",NA,"PA0476/026/001","Olinka (UK) Limited","Glimepiride"
"3746","GLIMEPIRIDE","2mg milligram(s) Tablet",NA,"PA0476/026/002","Olinka (UK) Limited","Glimepiride"
"3747","GLIMEPIRIDE","3mg milligram(s) Tablet",NA,"PA0476/026/003","Olinka (UK) Limited","Glimepiride"
"3748","GLIMEPIRIDE","4mg milligram(s) Tablet",NA,"PA0476/026/004","Olinka (UK) Limited","Glimepiride"
"3749","GLIMEPIRIDE","1 Milligram                                                                                            Tablets",2008-10-10,"PA1390/018/001","Accord Healthcare Limited","GLIMEPIRIDE"
"3750","GLIMEPIRIDE","2 Milligram                                                                                            Tablets",2008-10-10,"PA1390/018/002","Accord Healthcare Limited","GLIMEPIRIDE"
"3751","GLIMEPIRIDE","3 Milligram                                                                                            Tablets",2008-10-10,"PA1390/018/003","Accord Healthcare Limited","GLIMEPIRIDE"
"3752","GLIMEPIRIDE","4 Milligram                                                                                            Tablets",2008-10-10,"PA1390/018/004","Accord Healthcare Limited","GLIMEPIRIDE"
"3753","Gliolan","30 milligram(s)/millilitre Powder for oral solution",2007-09-07,"EU/1/07/413/1-3","Medac Gesellschaft fur Klinische Spezialpraparate mbH","5-aminolevulinicacidhydrochloride"
"3754","GLIVEC","50 Milligram                                                                                            Capsules Hard",2001-11-07,"EU/1/01/198/001","Novartis Europharm Limited","IMATINIBMESILATE"
"3755","GLIVEC","100 Milligram                                                                                            Capsules Hard",2001-11-07,"EU/1/01/198/002","Novartis Europharm Limited","IMATINIBMESILATE"
"3756","GLIVEC","100 Milligram                                                                                            Capsules Hard",2001-11-07,"EU/1/01/198/003","Novartis Europharm Limited","IMATINIBMESILATE"
"3757","GLIVEC","100 Milligram                                                                                            Capsules Hard",2001-11-07,"EU/1/01/198/004","Novartis Europharm Limited","IMATINIBMESILATE"
"3758","GLIVEC","100 Milligram                                                                                            Capsules Hard",2001-11-07,"EU/1/01/198/005","Novartis Europharm Limited","IMATINIBMESILATE"
"3759","GLIVEC","100 Milligram                                                                                            Capsules Hard",2001-11-07,"EU/1/01/198/006","Novartis Europharm Limited","IMATINIBMESILATE"
"3760","GLIVEC","100 Milligram                                                                                            Coated Tablets",2003-11-11,"EU/1/01/198/007","Novartis Europharm Limited","IMATINIBMESILATE"
"3761","GLIVEC","100 Milligram                                                                                            Coated Tablets",2003-11-11,"EU/1/01/198/008","Novartis Europharm Limited","IMATINIBMESILATE"
"3762","GLIVEC","400 Milligram                                                                                            Coated Tablets",2003-11-11,"EU/1/01/198/009","Novartis Europharm Limited","IMATINIBMESILATE"
"3763","GLIVEC","400 Milligram                                                                                            Coated Tablets",2003-11-11,"EU/1/01/198/010","Novartis Europharm Limited","IMATINIBMESILATE"
"3764","GLOSAN","700 Milligram                                                                                            Medicated Plaster",2017-12-22,"PA2242/003/001","Grunenthal Pharma Ltd","LIDOCAINE"
"3765","GLUBRAVA","15/850 Base Milligrams                                                                                      Film Coated Tablet",2007-12-11,"EU/1/07/421/001-009","Takeda Pharma A/S","PIOGLITAZONEHYDROCHLORIDE|METFORMINHYDROCHLORIDE"
"3766","GLUCAGEN HYPOKIT","1 Milligram                                                                                            Pdr+Solv for Soln for Inj",2014-10-10,"PPA0465/331/001","PCO Manufacturing","GLUCAGON"
"3767","GlucaGen HypoKit 1 mg powder and solvent for solution for injection","1 milligram(s) Powder and solvent for solution for injection",1991-12-17,"PA0218/031/002","Novo Nordisk A/S","Glucagonhydr0chloride"
"3768","GLUCOBAY 100 MG TABLETS","100 Milligram                                                                                            Tablets",1992-06-04,"PA1410/029/002","Bayer Limited","ACARBOSE"
"3769","GLUCOBAY 50 MG TABLETS","50 Milligram                                                                                            Tablets",1992-06-04,"PA1410/029/001","Bayer Limited","ACARBOSE"
"3770","GLUCOPHAGE","500 Milligram                                                                                            Film Coated Tablet",1983-05-16,"PA2286/005/001","Merck Serono (Ireland) Limited","METFORMINHYDROCHLORIDE"
"3771","GLUCOPHAGE","850 Milligram                                                                                            Film Coated Tablet",1983-05-16,"PA2286/005/002","Merck Serono (Ireland) Limited","METFORMINHYDROCHLORIDE"
"3772","GLUCOPHAGE","1000 Milligram                                                                                            Film Coated Tablet",2001-11-16,"PA2286/005/003","Merck Serono (Ireland) Limited","METFORMINHYDROCHLORIDE"
"3773","GLUCOSAMINE PHARMA NORD","400 Base Milligrams                                                                                      Capsules Hard",2005-10-28,"PA1242/001/001","Pharma Nord ApS","GLUCOSAMINEHEMISULPHATE:POTASSIUMCHLORIDECOMPLEX(1:1)"
"3774","GLUCOSAMINE SULFATE","750 Milligram                                                                                            Film Coated Tablet",2011-08-26,"PA1521/003/002","FMC Pharma Ltd","GLUCOSAMINESULFATE2NACI"
"3775","GLUCOSAMINE SULFATE","1500 Milligram                                                                                            Film Coated Tablet",2011-08-26,"PA1521/003/003","FMC Pharma Ltd","GLUCOSAMINESULPHATE2NACI"
"3776","GLUCOSE","5 %w/v                                                                                                 Solution for Infusion",1999-05-31,"PA0931/002/001","Maco Pharma (UK) Ltd","GLUCOSEMONOHYDRATE"
"3777","GLUCOSE","10 %w/v                                                                                                 Solution for Infusion",2010-06-11,"PA0167/009/031","Baxter Healthcare Limited","GLUCOSEMONOHYDRATE"
"3778","GLUCOSE","50 %w/v                                                                                                 Concentrate for Soln for Inf",1992-08-17,"PA0179/001/039","B. Braun Medical Limited","GLUCOSEMONOHYDRATE"
"3779","GLUCOSE","5 %w/v                                                                                                 Solution for Infusion",2004-01-09,"PA0566/031/001","Fresenius Kabi Limited","GLUCOSEANHYDROUS"
"3780","GLUCOSE","5 %w/v                                                                                                 Solution for Infusion",2004-01-09,"PA0566/031/002","Fresenius Kabi Limited","GLUCOSEANHYDROUS"
"3781","GLUCOSE","5 %w/v                                                                                                 Solution for Infusion",2004-01-09,"PA0566/031/003","Fresenius Kabi Limited","GLUCOSEANHYDROUS"
"3782","GLUCOSE","5 %w/v                                                                                                 Solution for Infusion",2004-01-09,"PA0566/031/004","Fresenius Kabi Limited","GLUCOSEANHYDROUS"
"3783","GLUCOSE","10 %w/v                                                                                                 Solution for Infusion",2004-01-09,"PA0566/031/005","Fresenius Kabi Limited","GLUCOSEANHYDROUS"
"3784","GLUCOSE","10 %w/v                                                                                                 Solution for Infusion",2004-01-09,"PA0566/031/006","Fresenius Kabi Limited","GLUCOSEANHYDROUS"
"3785","GLUCOSE","10 %w/v                                                                                                 Solution for Infusion",2004-01-09,"PA0566/031/007","Fresenius Kabi Limited","GLUCOSEANHYDROUS"
"3786","GLUCOSE","10 %w/v                                                                                                 Solution for Infusion",2004-01-09,"PA0566/031/008","Fresenius Kabi Limited","GLUCOSEANHYDROUS"
"3787","GLUCOSE","5 %w/w                                                                                                 Solution for Infusion",2009-07-31,"PA0566/031/009","Fresenius Kabi Limited","GLUCOSEANHYDROUS"
"3788","GLUCOSE","10 %w/w                                                                                                 Solution for Infusion",2009-07-31,"PA0566/031/010","Fresenius Kabi Limited","GLUCOSEANHYDROUS"
"3789","GLUCOSE 5% W/V INTRAVENOUS INFUSION","5.0 Anhyd %w/v                                                                                           Solution for Infusion",2003-05-16,"PA0167/009/030","Baxter Healthcare Limited","GLUCOSEMONOHYDRATE"
"3790","GLUCOSE INJECTION BP MINIJET","50 %w/v                                                                                                 Solution for Injection",1977-09-08,"PA0255/008/003","International Medication Systems (UK) Ltd","GLUCOSE"
"3791","GLUCOSE INTRAVENOUS INFUSION BP","5 %w/v                                                                                                 Solution for Infusion",1983-04-01,"PA0179/001/003","B. Braun Medical Limited","GLUCOSE"
"3792","GLUCOSE INTRAVENOUS INFUSION BP","5 %w/v                                                                                                 Solution for Infusion",1998-02-06,"PA0736/004/001","B. Braun Melsungen AG","GLUCOSEMONOHYDRATE"
"3793","Glucose Intravenous Infusion BP 10% w/v, solution for infusion","10 percent weight/volume Solution for infusion",1992-08-17,"PA0179/001/028","B. Braun Medical Limited","Glucoseanhydrous"
"3794","Glustin","15 milligram(s) Tablet",2000-10-11,"EU/1/00/151/001-003","Takeda Pharma A/S","Pioglitazone"
"3795","Glustin","30 milligram(s) Tablet",2000-10-11,"EU/1/00/151/004","Takeda Pharma A/S","Pioglitazone"
"3796","Glustin","15 mg milligram(s) Tablet",2000-10-11,"EU/1/00/151/007","Takeda Pharma A/S","Pioglitazone"
"3797","Glustin","45 milligram(s) Tablet",2003-09-16,"EU/1/00/151/009","Takeda Pharma A/S","Pioglitazonehydrochloride"
"3798","Glustin","30 milligram(s) Tablet",2000-10-11,"EU/1/00/151/17-19,24","Takeda Pharma A/S","Pioglitazone"
"3799","Glustin","45 milligram(s) Tablet",2000-10-11,"EU/1/00/151/20-22","Takeda Pharma A/S","Pioglitazone"
"3800","GLUTAROL","10 %w/v                                                                                                 Cutaneous Solution",1980-12-15,"PA0278/005/001","Dermal Laboratories Ltd","GLUTARAL"
"3801","GLYBERA","3x10  Solution for Injection",2012-10-31,"EU/1/12/791/001","Amsterdam Molecular Therapeutics","ALIPOGENETIPRAVOVEC"
"3802","GLYCEROL 1G SUPPOSITORIES","70 %w/w                                                                                                 Suppositories",1993-02-25,"PA0361/011/001","Martindale Pharmaceuticals Ltd","GLYCEROL"
"3803","GLYCEROL 2G SUPPOSITORIES","70 %w/w                                                                                                 Suppositories",1993-02-25,"PA0361/011/002","Martindale Pharmaceuticals Ltd","GLYCEROL"
"3804","GLYCEROL SUPPOSITORIES BP FOR ADULTS","70 %w/v                                                                                                 Unknown",1991-10-18,"PA0361/011/003","Martindale Pharmaceuticals Ltd","GLYCEROL"
"3805","Glyceryl Trinitrate 5 mg/ml Sterile Concentrate","5 milligram(s)/millilitre Concentrate for solution for infusion",1987-10-01,"PA0822/204/001","Pfizer Healthcare Ireland","Glyceryltrinitrate"
"3806","GLYCOPYRRONIUM BROMIDE","200 Microgram/ML                                                                                         Solution for Injection",1981-03-09,"PA0857/001/001","MercuryPharm Ltd","GLYCOPYRRONIUMBROMIDE"
"3807","Glycopyrronium bromide 200 micrograms/ml Solution for injection","200 microgram(s)/millilitre Solution for injection",2018-05-18,"PA0361/038/001","Martindale Pharmaceuticals Ltd","Glycopyrroniumbromide"
"3808","GLYCOPYRRONIUM BROMIDE AND NEOSTIGMINE METILSULFATE","0.5/2.5 Mg/Ml Solution for Injection",1986-11-07,"PA0857/002/001","MercuryPharm Ltd","GLYCOPYRRONIUMBROMIDE|NEOSTIGMINEMETILSULFATE"
"3809","GLYPRESSIN","0.12 N/A Solution for Injection",2009-09-25,"PA1009/004/002","Ferring Ireland Ltd","TERLIPRESSINACETATE"
"3810","GLYPRESSIN 1 mg Powder and Solvent for Solution for Injection","1 milligram(s) Powder and solvent for solution for injection",1987-04-09,"PA1009/004/001","Ferring Ireland Ltd","TERLIPRESSINACETATE"
"3811","Glytrin 400 micrograms per metered dose Sublingual Spray","0.7%w/w percent weight/weight Sublingual spray",1990-11-29,"PA0501/004/001","Ayrton Saunders Ltd","Glyceryltrinitrate"
"3812","Glyxambi","10/5 milligram(s) Film-coated tablet",2016-11-11,"EU/1/16/1146/001-009","Boehringer Ingelheim International GmbH","Linagliptin|Empagliflozin"
"3813","GLYXAMBI","25/5 Milligram                                                                                            Film Coated Tablet",2016-11-11,"EU/1/16/1146/010-018","Boehringer Ingelheim International GmbH","EMPAGLIFLOZIN|LINAGLIPTIN"
"3814","GOLDEN EYE","0.1% %w/v                                                                                                 Eye Drops Solution",1993-03-02,"PA0980/004/001","Cambridge Healthcare Supplies Limited","PROPAMIDINEISETIONATE"
"3815","GOLDEN EYE","0.15 Unknown Eye Ointment",1993-03-02,"PA0980/004/002","Cambridge Healthcare Supplies Limited","DIBROMPROPAMIDINEISETIONATE"
"3816","GONAL-F","75 International Unit                                                                                   Pdr+Solv for Soln for Inj",1995-10-20,"EU/1/95/001/005","Merck Europe B.V.","FOLLITROPINALFA"
"3817","GONAL-F","1050/1.75 IU/ML                                                                                                Pdr+Solv for Soln for Inj",2001-01-29,"EU/1/95/001/021","Merck Europe B.V.","FOLLITROPINALFA"
"3818","GONAL-F","75 International Unit                                                                                   Pdr+Solv for Soln for Inj",2002-06-07,"EU/1/95/001/025","Merck Europe B.V.","FOLLITROPINALFA"
"3819","GONAL-F","75 International Unit                                                                                   Pdr+Solv for Soln for Inj",2002-06-07,"EU/1/95/001/026","Merck Europe B.V.","FOLLITROPINALFA"
"3820","GONAL-F","75 International Unit                                                                                   Pdr+Solv for Soln for Inj",2002-06-07,"EU/1/95/001/027","Merck Europe B.V.","FOLLITROPINALFA"
"3821","GONAL-F","450/IU/0.75 Millilitre                                                                                           Pdr+Solv for Soln for Inj",2002-06-07,"EU/1/95/001/031","Merck Europe B.V.","FOLLITROPINALFA"
"3822","GONAL-F","300 IU / 0.5 Millilitre                                                                                           Pdr+Solv for Soln for Inj",1995-10-20,"EU/1/95/001/032","Merck Europe B.V.","FOLLITROPINALFA"
"3823","GONAL-F","600/0.5 IU/ML                                                                                                Solution for Injection",2004-03-31,"EU/1/95/001/033","Merck Europe B.V.","FOLLITROPINALFA"
"3824","GONAL-F","450/0.5 IU/ML                                                                                                Pdr+Solv for Soln for Inj",1995-10-20,"EU/1/95/001/034","Merck Europe B.V.","FOLLITROPINALFA"
"3825","Gonapeptyl Depot 3.75mg Powder and solvent for Suspension for Injection","3.75 milligram(s) Powder and solvent for suspension for injection",2001-12-14,"PA1009/018/001","Ferring Ireland Ltd","Triptorelin"
"3826","Grafalon 20 mg/ml concentrate for solution for infusion","20 milligram(s)/millilitre Concentrate for solution for infusion",2001-06-05,"PA1015/001/001","Neovii Biotech GmbH","Anti-humant-lymphocyteimmunoglobulinfromrabbits"
"3827","GRANISETRON MARTINDALE PHARMA","1                                                                                                      Concentrate for Soln for Inj",2008-09-05,"PA0361/029/001","Martindale Pharmaceuticals Ltd","GRANISETRONHYDROCHLORIDE"
"3828","GRANISETRON MARTINDALE PHARMA","3/3                                                                                                      Concentrate for Soln for Inj",2008-09-05,"PA0361/029/002","Martindale Pharmaceuticals Ltd","GRANISETRONHYDROCHLORIDE"
"3829","GRANOCYTE 13 million IU/mL, powder and solvent for solution for injection/infusion, in a pre-filled syringe","105mcg microgram(s) Powder and solvent for solution for injection/infusion",1996-07-25,"PA0950/002/002","Chugai Pharma UK Ltd","Lenograstim"
"3830","GRANOCYTE 34 million IU/mL, powder and solvent for solution for injection/infusion, in a pre-filled syringe","263mcg microgram(s) Powder and solvent for solution for injection/infusion",1993-08-16,"PA0950/002/001","Chugai Pharma UK Ltd","Lenograstim"
"3831","GRANPIDAM","20 Milligram                                                                                            Film Coated Tablet",2016-11-14,"EU/1/16/1137/001-005","Accord Healthcare Limited","SILDENAFILBASE(ASCITRATE)"
"3832","GRANUPAS","4 gram(s) Gastro-resistant granules",2014-04-07,"EU/1/13/896/001","Eurocept International BV","Para-aminosalicylicacid"
"3833","GRAPHITES","8X-MM",2011-04-21,"HOR1149/013/001","A. Nelson & Company Limited","GRAPHITES"
"3834","GRAPHITES (GRAPH.)","6C & 30C  Tablets",2009-11-20,"HOR0407/004/001","Weleda (UK) Limited","GRAPHITES"
"3835","GRASTOFIL","30MU/0.5 Millilitre                                                                                           Solution for Injection",2013-10-18,"EU/1/13/877/001-002","Apotex Europe B.V.","FILGRASTIM"
"3836","GRASTOFIL","48MU/0.5 Millilitre                                                                                           Solution for Injection",2013-10-18,"EU/1/13/877/003-004","Apotex Europe B.V.","FILGRASTIM"
"3837","GRAZAX 75,000 SQ-T","75, 000 Per Cent                                                                                             Oral Lyophilisate",2006-11-27,"PA1255/004/001","ALK-Abello A/S","GRASSPOLLENEXTRACT(PHLEUMPRATENSE)"
"3838","GREPID","75 Milligram                                                                                            Film Coated Tablet",2009-07-28,"EU/1/09/535/1-16","Pharmathen S.A.","CLOPIDOGRELBESYLATE"
"3839","Griseofulvin 500 mg film-coated tablets","500 milligram(s) Film-coated tablet",2011-03-25,"PA1648/006/001","Brown & Burk UK LTD","Griseofulvin"
"3840","GRISOL","1 %w/w                                                                                                 Cutaneous Spray Solution",1992-07-27,"PA0991/001/001","Transdermal Limited","GRISEOFULVIN"
"3841","Gyno-Daktarin 1200 mg vaginal capsule","1200 milligram(s) Vaginal capsule",1989-06-09,"PA0748/020/002","Janssen-Cilag Ltd","Miconazolenitrate"
"3842","Gyno-Daktarin 20mg/g vaginal cream","20 milligram(s)/gram Vaginal cream",1987-11-06,"PA0748/020/001","Janssen-Cilag Ltd","Miconazolenitrate"
"3843","GYNO-PEVARYL ONCE","150 Milligram                                                                                            Pessary",1983-03-29,"PA0748/017/002","Janssen-Cilag Ltd","ECONAZOLENITRATE"
"3844","GYNOXIN","200 Milligram                                                                                            Vaginal Capsule",1992-02-24,"PA0812/004/001","Recordati Industria Chimica e Farmaceutica SpA","FENTICONAZOLENITRATE"
"3845","GYNOXIN","600 Milligram                                                                                            Vaginal Capsule",1992-02-24,"PA0812/004/002","Recordati Industria Chimica e Farmaceutica SpA","FENTICONAZOLENITRATE"
"3846","HAEMOPRESSIN","1 Milligram                                                                                            Pdr+Solv for Soln for Inj",2009-05-01,"PA0943/026/001","Alliance Pharmaceuticals Ltd.","TERLIPRESSINACETATE"
"3847","Halaven","0.5 milligram(s)/millilitre Solution for injection",2011-03-17,"EU/1/11/678/001-002","Eisai GmbH","Eribulinmesylate"
"3848","HALCION","250 Microgram                                                                                            Tablets",1977-09-30,"PA0822/129/001","Pfizer Healthcare Ireland","TRIAZOLAM"
"3849","HALCION","125 Microgram                                                                                            Tablets",1984-11-13,"PA0822/129/002","Pfizer Healthcare Ireland","TRIAZOLAM"
"3850","HALDOL DECANOATE","100 Mg/Ml Solution for Injection",1989-08-03,"PA0748/021/002","Janssen-Cilag Ltd","HALOPERIDOLDECANOATE"
"3851","Haldol Decanoate 50mg/ml Solution for Injection","50 milligram(s)/millilitre Solution for injection",1983-10-10,"PA0748/021/001","Janssen-Cilag Ltd","HALOPERIDOLDECANOATE"
"3852","HALF BETA PROGRANE","80 Milligram                                                                                            Prolonged Release Capsules",1999-06-25,"PA0644/001/002","Tillomed Laboratories Limited","PROPRANOLOLHYDROCHLORIDE"
"3853","HALF BETA-PROGRANE","80 Milligram                                                                                            Prolonged Release Capsules",2017-09-26,"PPA1097/018/001","Lexon (UK) Ltd","PROPRANOLOLHYDROCHLORIDE"
"3854","HALF SINEMET CR","25/100 Milligram                                                                                            Tablet Prolonged Release",1993-02-22,"PA1286/009/001","Merck Sharp & Dohme Ireland (Human Health) Limited","LEVODOPA|CARBIDOPA"
"3855","HALIMATOZ","40 Milligram",2018-07-26,"EU/1/18/1288/001-003","Sandoz GmbH","ADALIMUMAB"
"3856","HALIMATOZ","40 Milligram                                                                                            Solution for injection in pre-filled pen",2018-07-26,"EU/1/18/1288/004-006","Sandoz GmbH","ADALIMUMAB"
"3857","HALOPERIDOL 5MG/ML SOLUTION FOR INJECTION","5 Mg/Ml Solution for Injection",1988-10-12,"PA0073/101/001","Mercury Pharmaceuticals (Ireland) Ltd","HALOPERIDOL"
"3858","HARPADOL","Capsule",2012-03-23,"TR1450/001/001","Laboratoires ARKOPHARMA","DEVILSCLAWSECONDARYROOTS"
"3859","HARTMANN'S","%v/v                                                                                                 Solution for Infusion",2005-05-20,"PA0566/030/001","Fresenius Kabi Limited","SODIUMCHLORIDE|POTASSIUMCHLORIDE|CALCIUMCHLORIDEANHYDROUS|SODIUMLACTATE"
"3860","HARTMANN'S","%v/v                                                                                                 Solution for Infusion",2005-05-20,"PA0566/030/002","Fresenius Kabi Limited","SODIUMCHLORIDE|POTASSIUMCHLORIDE|CALCIUMCHLORIDEANHYDROUS|SODIUMLACTATE"
"3861","HARTMANN'S","%v/v                                                                                                 Solution for Infusion",2005-05-20,"PA0566/030/003","Fresenius Kabi Limited","SODIUMCHLORIDE|POTASSIUMCHLORIDE|CALCIUMCHLORIDEANHYDROUS|SODIUMLACTATE"
"3862","HARTMANN'S","%v/v                                                                                                 Solution for Infusion",2005-05-20,"PA0566/030/004","Fresenius Kabi Limited","SODIUMCHLORIDE|POTASSIUMCHLORIDE|CALCIUMCHLORIDEANHYDROUS|SODIUMLACTATE"
"3863","HARTMANN'S","%v/v                                                                                                 Solution for Infusion",2009-07-24,"PA0566/030/005","Fresenius Kabi Limited","SODIUMCHLORIDE|POTASSIUMCHLORIDE|CALCIUMCHLORIDEDIHYDRATE|SODIUMLACTATESOLUTION50%"
"3864","HARTMANN'S SOLUTION COMPOUND SODIUM LACTATE INTRAVENOUS INFUSION BP","6/0.27/0.4 Grams                                                                                                Solution for Infusion",2007-05-18,"PA0931/009/001","Maco Pharma (UK) Ltd","SODIUMCHLORIDE|CALCIUMCHLORIDEDIHYDRATE|POTASSIUMCHLORIDE|SODIUMLACTATESOLUTION60%"
"3865","HARTMANN'S SOLUTION COMPOUND SODIUM LACTATE INTRAVENOUS INFUSION BP","Grams                                                                                                Solution for Infusion",2007-05-18,"PA0931/009/003","Maco Pharma (UK) Ltd","SODIUMCHLORIDE|CALCIUMCHLORIDEDIHYDRATE|POTASSIUMCHLORIDE|SODIUMLACTATESOLUTION60%"
"3866","Harvoni","90\400 milligram(s) Film-coated tablet",2014-11-17,"EU/1/14/958/001-002","Gilead Sciences International","Ledipasvir|Sofosbuvir"
"3867","HAVRIX JUNIOR MONDOSE VACCINE HEPATITIS A VACCINE","720 Elisa Units                                                                                          Suspension for Injection",1998-10-02,"PA1077/026/001","GlaxoSmithKline (Ireland) Limited","HEPATITAVIRUSANTIGEN"
"3868","HAVRIX MONODOSE VACCINE","Elisa Units                                                                                          Suspension for Injection",1994-12-13,"PA1077/026/002","GlaxoSmithKline (Ireland) Limited","HEPATITAVIRUSANTIGEN|ALUMINIUMHYDROXIDE"
"3869","HAY-CROM","2 %w/v                                                                                                 Eye Drops Solution",2010-03-05,"PPA1151/120/001","Imbat Limited","SODIUMCROMOGLICATE"
"3870","HBVAXPRO","0.5 microgram(s) Suspension for injection",2001-04-27,"EU/1/01/183/001","Sanofi Pasteur MSD Ltd","Hepatitisbvaccine"
"3871","HBVAXPRO","5 Microgram                                                                                            Suspension for Injection",2001-04-27,"EU/1/01/183/004","Sanofi Pasteur MSD Ltd","HEPATITISBVACCINE"
"3872","HBVAXPRO","5 Microgram                                                                                            Suspension for Injection",2001-04-27,"EU/1/01/183/005","Sanofi Pasteur MSD Ltd","HEPATITISBVACCINE"
"3873","HBVAXPRO","10 Microgram/ML                                                                                         Suspension for Injection",2001-04-27,"EU/1/01/183/007","Sanofi Pasteur MSD Ltd","HEPATITISBVACCINE"
"3874","HBVAXPRO","10 Microgram/ML                                                                                         Suspension for Injection",2001-04-27,"EU/1/01/183/008","Sanofi Pasteur MSD Ltd","HEPATITISBVACCINE"
"3875","HBVAXPRO","10 Microgram/ML                                                                                         Suspension for Injection",2001-04-27,"EU/1/01/183/011","Sanofi Pasteur MSD Ltd","HEPATITISBVACCINE"
"3876","HBVAXPRO","10 Microgram/ML                                                                                         Suspension for Injection",2001-04-27,"EU/1/01/183/013","Sanofi Pasteur MSD Ltd","HEPATITISBVACCINE"
"3877","HBVAXPRO","40 Microgram/ML                                                                                         Suspension for Injection",2001-04-27,"EU/1/01/183/015","Sanofi Pasteur MSD Ltd","HEPATITISBVACCINE"
"3878","HBVAXPRO","0.5ml Microgram/ML                                                                                         Suspension for Injection",2001-04-27,"EU/1/01/183/018-025,30-31","Sanofi Pasteur MSD Ltd","HEPATITISBVACCINE"
"3879","HBVAXPRO","1 ml Microgram/ML                                                                                         Suspension for Injection",2001-04-27,"EU/1/01/183/026-029,32","Sanofi Pasteur MSD Ltd","HEPATITISBVACCINE"
"3880","HC45 HYDROCORTISONE ACETATE CREAM","1 %w/v                                                                                                 Cream",1996-09-24,"PA0979/045/001","Reckitt Benckiser Ireland Ltd","HYDROCORTISONEACETATE"
"3881","HEFIYA","40 Milligram",2018-07-26,"EU/1/18/1287/001-003","Sandoz GmbH","ADALIMUMAB"
"3882","HEFIYA","40 Milligram                                                                                            Solution for injection in pre-filled pen",2018-07-26,"EU/1/18/1287/004-006","Sandoz GmbH","ADALIMUMAB"
"3883","HELIOBACTER  Test INFAI","75 milligram(s) Powder for oral solution",1997-08-14,"EU/1/97/045/001","INFAI Institut fur biomedizinish","13c-urea"
"3884","HELIOBACTER TEST INFAI","Powder for Oral Solution",2002-10-10,"EU/1/97/045/003","INFAI Institut fur biomedizinish","13C-UREA"
"3885","HELIXATE NEXGEN","250IU International Unit                                                                                   Pdr+Solv for Soln for Inj",2000-08-04,"EU/1/00/144/001","Bayer AG","FACTORVIII,RECOMBINANT"
"3886","HELIXATE NEXGEN","500 International Unit                                                                                   Pdr+Solv for Soln for Inj",2000-08-04,"EU/1/00/144/002","Bayer AG","FACTORVIII,RECOMBINANT"
"3887","HELIXATE NEXGEN","1000 International Unit                                                                                   Pdr+Solv for Soln for Inj",2000-08-04,"EU/1/00/144/003","Bayer AG","FACTORVIII,RECOMBINANT"
"3888","HELIXATE NEXGEN","2000 International Unit                                                                                   Pdr+Solv for Soln for Inj",2007-12-18,"EU/1/00/144/004","Bayer AG","OCTOCOGALFA"
"3889","HELIXATE NEXGEN","3000 International Unit                                                                                   Pdr+Solv for Soln for Inj",2010-08-06,"EU/1/00/144/005","Bayer AG","OCTOCOGALFA"
"3890","Hemangiol","3.75 milligram(s)/millilitre Oral solution",2014-04-23,"EU/1/14/919/001","Pierre Fabre Dermatologie","PROPRANOLOLHYDROCHLORIDE"
"3891","Hemlibra","30/1 milligram(s)/millilitre Solution for injection",2018-02-23,"EU/1/18/1271/001","Roche Registration GmbH","Emicizumab"
"3892","Hemlibra","150 milligram(s)/millilitre Solution for injection",2018-02-23,"EU/1/18/1271/002-004","Roche Registration GmbH","Emicizumab"
"3893","HEMOSOL B0","solution for haemodialysis/haemofiltration",1999-06-11,"PA0785/005/001","Gambro Lundia AB","MAGNESIUMCHLORIDEHEXAHYDRATE|CALCIUMCHLORIDEDIHYDRATE|LACTICACID|SODIUMHYDROGENCARBONATE|SODIUMCHLORIDE"
"3894","HEMOSOL B0","solution for haemodialysis/haemofiltration",1999-06-11,"PA0785/005/002","Gambro Lundia AB","MAGNESIUMCHLORIDEHEXAHYDRATE|CALCIUMCHLORIDEDIHYDRATE|LACTICACID|SODIUMBICARBONATE|SODIUMCHLORIDE"
"3895","HEPAR SULFURIS CALCAREUM (HEPAR. SULF.)","6C & 30C  Tablets",2009-11-20,"HOR0407/011/001","Weleda (UK) Limited","HEPARSULFURISCALCAREUMGHP"
"3896","Heparin sodium 1,000 I.U./ml Solution for injection or concentrate for solution for infusion, 10ml ampoules","1000 international unit(s)/millilitre ZZZ Solution injection or concentrate for solution infusion",1999-04-30,"PA1339/009/004","Wockhardt UK Limited","Heparinsodium"
"3897","Heparin sodium 1,000 I.U./ml Solution for injection or concentrate for solution for infusion, 5ml ampoules","1000 international unit(s)/millilitre ZZZ Solution injection or concentrate for solution infusion",1985-11-14,"PA1339/009/003","Wockhardt UK Limited","Heparinsodium"
"3898","Heparin sodium 1,000 I.U./ml Solution for injection or concentrate for solution for infusion, 5ml vials","1000 international unit(s)/millilitre ZZZ Solution injection or concentrate for solution infusion",1985-11-14,"PA1339/009/006","Wockhardt UK Limited","Heparinsodium"
"3899","Heparin Sodium 10 I.U./ml Flushing Solution 10 I.U./mlFlushing solution for maintenance of patency of intravenous devices","10 international unit(s)/millilitre ZZZ Flushing solution maintenance patency intravenous devices",1985-11-14,"PA1339/010/001","Wockhardt UK Limited","Heparinsodium"
"3900","Heparin sodium 25,000 I.U./ml Solution for injection or concentrate for solution for infusion, 0.2ml ampoules","25,000 international unit(s)/millilitre ZZZ Solution injection or concentrate for solution infusion",1985-11-14,"PA1339/009/005","Wockhardt UK Limited","Heparinsodium"
"3901","Heparin sodium 25,000 I.U./ml Solution for injection or concentrate for solution for infusion, 5 ml vials","25000 international unit(s)/millilitre ZZZ Solution injection or concentrate for solution infusion",1985-11-14,"PA1339/009/008","Wockhardt UK Limited","Heparinsodium"
"3902","Heparin sodium 5,000 I.U./ml Solution for injection or concentrate for solution for infusion, 5 ml vials","5000 international unit(s)/millilitre ZZZ Solution injection or concentrate for solution infusion",1985-11-14,"PA1339/009/007","Wockhardt UK Limited","Heparinsodium"
"3903","Heparin Sodium BP 1000 IU/l in 0.9% w/v Sodium Chloride IV Infusion","1 international unit(s)/millilitre Solution for infusion",1984-06-06,"PA0167/067/001","Baxter Healthcare Limited","Heparinsodium|Sodiumchloride|Sodiumphosphate|Citricacidmonohydrate"
"3904","Heparin Sodium BP 2000 IU/l in 0.9 % w/v Sodium Chloride IV infusion","2 international unit(s)/millilitre Solution for infusion",1984-06-06,"PA0167/067/003","Baxter Healthcare Limited","Heparinsodium|Sodiumchloride|Sodiumphosphate"
"3905","HEPATECT CP","50 IU/ML                                                                                                Solution for Infusion",2008-08-22,"PA0592/005/004","Biotest Pharma GmbH","HUMANPLASMAPROTEIN&gt;96%IMMUNOGLOBULINS"
"3906","HEPSERA","10mg Milligram                                                                                            Tablets",2003-03-06,"EU/1/03/251/001","Gilead Sciences Ireland UC","ADEFOVIRDIPIVOXIL"
"3907","HERCEPTIN","600 MG/5ml                                                                                               Solution for Injection",2013-08-26,"EU/1/00/145/002","Roche Registration Limited","TRASTUZUMAB"
"3908","HERCEPTIN 150MG","milligram(s) Powder for solution for infusion",2000-08-28,"EU/1/00/145/001","Roche Registration GmbH","Trastuzumab"
"3909","Herzuma","150 milligram(s) ZZZ Pdr/Conc/Soln for Infus",2018-02-09,"EU/1/17/1257/001","Celltrion Healthcare Hungary Kft.","Trastuzumab"
"3910","HETLIOZ","20 Milligram                                                                                            Capsules Hard",2015-07-22,"EU/1/15/1008/001","Vanda Pharmaceuticals Limited","TASIMELTEON"
"3911","Hexabrix 320 Solution for Injection","320 ZZZ Base mg/ml Solution for injection",1996-05-09,"PA0686/006/001","Guerbet","Iodine|SODIUMIOXAGLATE|Meglumineioxaglate"
"3912","Hexacima","0.5 millilitre(s) Suspension for injection",2013-04-17,"EU/1/13/828/001-007","Sanofi Pasteur SA","Diphtheriatoxoid|Tetanustoxoid|Pertussistoxoid|Filamentoushaemagglutinin|Type1(mahoney)|Type2(mef-1)|Type3(saukett)|Haemophilusinfluenzaetypebcapsularpolysaccharide|(polyribosylribitolphosphate)conjugatedtotetanousprotein|Hepatitisbsurfaceantigen"
"3913","HEXVIX","85 Milligram                                                                                            Pdr+Solv/Soln/Intravesical Use",2007-02-23,"PA0869/007/001","Ipsen Pharmaceuticals Limited","HEXAMINOLEVULINATEHYDROCHLORIDE"
"3914","Hexyon","0.5 millilitre(s) Suspension for injection",2013-04-17,"EU/1/13/829/001-007","Sanofi Pasteur","Diphtheriatoxoid|Tetanustoxoid|Pertussistoxoid|Filamentoushaemagglutinin|Type1(mahoney)|Type2(mef-1)|Type3(saukett)|Hepatitisbsurfaceantigen|Haemophilusinfluenzaetypebpolysaccharide|(polyribosylribitolphosphate)conjugatedtotetanousprotein"
"3915","Hiberix. Haemophilus Type b (Hib) vaccine.Powder and Solvent for Solution for Injection","0.5 millilitre(s) Powder and solvent for solution for injection",1999-06-11,"PA1077/027/001","GlaxoSmithKline (Ireland) Limited","Haemophilusinfluenzaetypebpolysaccharide|Tetanustoxoid"
"3916","Hibiscrub 4.0% w/v Cutaneous Solution","4.0 percent weight/volume Cutaneous solution",1980-05-30,"PA2317/001/001","Molnlycke Health Care AB","Chlorhexidinegluconate"
"3917","HIDRASEC","100 Milligram                                                                                            Capsules Hard",2012-05-11,"PA1714/001/001","Bioproject Europe Ltd","RACECADOTRIL"
"3918","HIDRASEC CHILDREN","30 Milligram                                                                                            Granules for Oral Suspension",2012-05-11,"PA1714/001/003","Bioproject Europe Ltd","RACECADOTRIL"
"3919","HIDRASEC INFANTS","10 Milligram                                                                                            Granules for Oral Suspension",2012-05-11,"PA1714/001/002","Bioproject Europe Ltd","RACECADOTRIL"
"3920","HIROBRIZ BREEZHALER","150 Microgram                                                                                            Inhalation Powder, Capsule",2009-11-30,"EU/1/09/594/1-5","Novartis Europharm Limited","INDACATEROLMALEATE"
"3921","HIROBRIZ BREEZHALER","300 Microgram                                                                                            Inhalation Powder, Capsule",2009-11-30,"EU/1/09/594/6-10","Novartis Europharm Limited","INDACATEROLMALEATE"
"3922","Histaclar 10mg Film-coated Tablets","10 milligram(s) Coated tablet",2003-01-24,"PA0577/046/001","McDermott Laboratories Ltd t/a Gerard Laboratories","Loratadine"
"3923","Hizentra","200 milligram(s)/millilitre Solution for injection",2011-04-14,"EU/1/11/687/001-12","CSL Behring GmbH","Humannormalimmunoglobulin"
"3924","HOLLAND & BARRETT AGNUS CASTUS PMS RELIEF","Tablets",2014-06-13,"TR1563/007/001","Holland & Barrett International Limited","AGNUSCASTUSEXTRACT(ASDRYROOT)FROMAGNUSCASTUSFRUIT(VITEXAGNUS-CASTUSL)"
"3925","HOLLAND & BARRETT HYPERICUM","Capsules Hard",2016-11-11,"TR1563/002/002","Holland & Barrett International Limited","ST.JOHN'SWORTDRYEXTRACT(ASDRYEXTRACT)FROMST.JOHN'SWORTAERIALPART(HYPERICUMPERFORATUML)"
"3926","HOLLAND & BARRETT MILK THISTLE","Unknown Capsules Hard",2014-09-26,"TR1563/027/001","Holland & Barrett International Limited","MILKTHISTLEEXTRACT(ASDRYROOT)"
"3927","HOLLAND AND BARRETT DEVIL'S CLAW","Unknown Capsules Hard",2013-05-03,"TR1563/006/001","Holland & Barrett International Limited","DEVIL'SCLAWEXTRACT(ASDRYROOT)"
"3928","HOLLAND AND BARRETT ECHINACEA COLD AND FLU","Unknown Capsules Hard",2014-01-17,"TR1563/005/001","Holland & Barrett International Limited","ECHINACEAROOTEXTRACT(ASDRYROOT)FROMECHINACEAROOT(ECHINACEAPURPUREAL)"
"3929","HOLLAND AND BARRETT LEMON BALM","Capsules Hard",2014-09-05,"TR1563/004/001","Holland & Barrett International Limited","DRYEXTRACTFROMMELISSAOFFICINALISL.FOLIUM(LEMONBALMLEAF)"
"3930","HOLLAND AND BARRETT VALERIAN","Unknown Unknown",2012-09-07,"TR1563/001/001","Holland & Barrett International Limited","VALERIANDRYROOTEXTRACT"
"3931","Holoclar","79,000-316,000 *** AWAITING VALUE *** Not Currently Available",NA,"EU/1/14/987/001","Chiesi Farmaceutici S.p.A.","Exvivoexpandedautologouscornealepithelialcellscontainingstemcells"
"3932","HRF 100 micrograms powder and solvent for solution for Injection","100 microgram(s) Powder and solvent for solution for injection",1978-09-29,"PA0997/005/001","Intrapharm Laboratories Limited","Gonadorelin"
"3933","Hulio","40/0.8 milligram(s)/millilitre Solution for injection",2018-09-17,"EU/1/18/1319/001-007","Mylan S.A.S.","Adalimumab"
"3934","HUMALOG","100 Units/ml                                                                                             Solution for Injection",2001-12-05,"EU/1/96/007/019","Eli Lilly and Company Limited","INSULINLISPRO"
"3935","HUMALOG","200 Units/ml                                                                                             Solution for Injection",2014-09-30,"EU/1/96/007/039-042","Eli Lilly and Company Limited",""
"3936","HUMALOG 3ML","100 Units/ml                                                                                             Solution for Injection",1997-06-26,"EU/1/96/007/004","Eli Lilly and Company Limited","INSULINLISPRO"
"3937","HUMALOG MIX25","100 Units/ml                                                                                             Suspension for Injection",1998-11-19,"EU/1/96/007/005","Eli Lilly and Company Limited","INSULINLISPRO"
"3938","HUMALOG MIX25","100 Units/ml                                                                                             Suspension for Injection",1998-11-19,"EU/1/96/007/008","Eli Lilly Nederland B.V.","INSULINLISPRO"
"3939","HUMALOG MIX50","100 Units/ml                                                                                             Suspension for Injection",1998-11-19,"EU/1/96/007/006","Eli Lilly Nederland B.V.","INSULINLISPRO"
"3940","HUMALOG NPL","100 Units/ml                                                                                             Suspension for Injection",1998-11-19,"EU/1/96/007/010","Eli Lilly Nederland B.V.","INSULINLISPRO"
"3941","Humalog Vials","100 international unit(s) Solution for injection",1996-04-30,"EU/1/96/007/002","Eli Lilly and Company Limited","Insulinlispro"
"3942","Human Albumin Baxalta 200 g/l Solution for Infusion","200 gram(s)/litre Solution for infusion",2006-12-21,"PA2004/004/002","Baxalta Innovations GmbH","Plasmaproteincontainingatleast95%humanalbumin"
"3943","Human Albumin Baxalta 50 g/l  Solution for Infusion","50 gram(s)/litre Solution for infusion",2006-12-21,"PA2004/004/001","Baxalta Innovations GmbH","Plasmaproteincontainingatleast95%humanalbumin"
"3944","Human Albumin Grifols 200g/l Solution for Infusion","200 gram(s)/litre Solution for infusion",2001-10-19,"PA0849/002/001","Instituto Grifols S.A.","Humanalbumin"
"3945","Human Albumin Grifols 50 g/l solution for infusion","50 gram(s)/litre Solution for infusion",2007-01-26,"PA0849/002/002","Instituto Grifols S.A.","Humanalbumin"
"3946","Humira","80 milligram(s) Solution for injection",NA,"EU/1/03/256/020","AbbVie Deutschland GmbH & Co. KG","Adalimumab"
"3947","Humira","20 milligram(s) Solution for injection in pre-filled syringe",NA,"EU/1/03/256/022","AbbVie Deutschland GmbH & Co. KG","Adalimumab"
"3948","HUMIRA","40 mg milligram(s) Solution for injection",NA,"EU/1/03/256/1-10","AbbVie Deutschland GmbH & Co. KG","Adalimumab"
"3949","HUMULIN I (ISOPHANE)","100 IU/ML                                                                                                Suspension for Injection",1983-06-22,"PA2276/002/001","Eli Lilly Nederland B.V.","INSULINHUMAN"
"3950","HUMULIN I (ISOPHANE)","100 IU/ML                                                                                                Suspension for Injection",1996-04-30,"PA2276/002/002","Eli Lilly Nederland B.V.","INSULINHUMAN"
"3951","Humulin I (Isophane) 100 IU/ml Suspension for Injection in vial","100 international unit(s)/millilitre Suspension for injection",2015-03-13,"PA2276/002/003","Eli Lilly Nederland B.V.","Humaninsulin(recombinantdnaorigin)"
"3952","HUMULIN I (ISOPHANE) CARTRIDGE","100 IU/ML                                                                                                Suspension for Injection",2015-03-13,"PA2276/002/004","Eli Lilly Nederland B.V.","HUMANINSULIN(RECOMBINANTDNAORIGIN)"
"3953","Humulin I KwikPen (Isophane) 100 IU/ml suspension for injection","100 international unit(s)/millilitre Suspension for injection",1998-09-18,"PA2276/005/001","Eli Lilly Nederland B.V.","Insulinhuman"
"3954","Humulin I KwikPen (Isophane) 100 IU/ml Suspension for Injection","100 international unit(s)/millilitre Suspension for injection",2015-03-13,"PA2276/005/002","Eli Lilly Nederland B.V.","Humaninsulin(recombinantdnaorigin)"
"3955","Humulin M3 (Mixture 3) 100 IU/ ml Suspension for Injection in vial","100 international unit(s)/millilitre Suspension for injection",1993-02-23,"PA2276/003/001","Eli Lilly Nederland B.V.","Insulinhuman"
"3956","Humulin M3 (Mixture 3) 100 IU/ml Suspension for Injection in cartridge","100 international unit(s)/millilitre Suspension for injection",1996-04-30,"PA2276/003/002","Eli Lilly Nederland B.V.","Insulinhuman"
"3957","Humulin M3 (Mixture 3) 100 IU/ml Suspension for Injection in cartridge","100 international unit(s)/millilitre Suspension for injection",2015-03-13,"PA2276/003/004","Eli Lilly Nederland B.V.","Humaninsulin(recombinantdnaorigin)"
"3958","Humulin M3 (Mixture 3) 100 IU/ml Suspension for Injection in vial","100 international unit(s)/millilitre Suspension for injection",2015-03-13,"PA2276/003/003","Eli Lilly Nederland B.V.","Humaninsulin(recombinantdnaorigin)"
"3959","Humulin M3 KwikPen (Mixture 3) 100 IU/ml suspension for injection","100 international unit(s)/millilitre Suspension for injection",1998-09-18,"PA2276/006/001","Eli Lilly Nederland B.V.","Insulinhuman"
"3960","Humulin M3 KwikPen (mixture 3) 100 IU/ml Suspension for Injection","100 international unit(s)/millilitre Suspension for injection",2015-03-13,"PA2276/006/002","Eli Lilly Nederland B.V.","Humaninsulin(recombinantdnaorigin)"
"3961","HUMULIN S (SOLUBLE)","100 IU/ML                                                                                                Solution for Injection",1983-06-22,"PA2276/001/001","Eli Lilly Nederland B.V.","INSULINHUMAN"
"3962","HUMULIN S (SOLUBLE)","100 IU/ML                                                                                                Solution for Injection",1996-04-30,"PA2276/001/002","Eli Lilly Nederland B.V.","INSULINHUMAN"
"3963","Humulin S (Soluble) 100 IU/ml Solution for Injection in vial","100 international unit(s)/millilitre Solution for injection",2015-03-13,"PA2276/001/003","Eli Lilly Nederland B.V.","Humaninsulin(recombinantdnaorigin)"
"3964","HUMULIN S (SOLUBLE) CARTRIDGE","100 IU/ML                                                                                                Solution for Injection",2015-03-13,"PA2276/001/004","Eli Lilly Nederland B.V.","HUMANINSULIN(RECOMBINANTDNAORIGIN)"
"3965","HYALGAN PREFILLED SYRINGE","20mg/2ml Mg/Ml Solution for Injection",1999-04-01,"PA0814/001/001","Fidia Farmaceutici S.p.A.","HYALURONATESODIUM"
"3966","HYALURONIDASE","1500 International Unit                                                                                   Pdr for Soln Inj/Inf",1984-03-22,"PA1339/011/001","Wockhardt UK Limited","HYALURONIDASE"
"3967","HYCAMTIN","4 Milligram                                                                                            Pdr for Soln for Infusion",1996-11-12,"EU/1/96/027/001","Novartis Europharm Limited","TOPOTECANHYDROCHLORIDE"
"3968","HYCAMTIN","4 Milligram                                                                                            Pdr for Soln for Infusion",1997-04-15,"EU/1/96/027/003","Novartis Europharm Limited","TOPOTECANHYDROCHLORIDE"
"3969","HYCAMTIN","1mg/1ml International Unit                                                                                   Pdr for Soln for Infusion",2000-03-16,"EU/1/96/027/004","Novartis Europharm Limited","TOPOTECAN(ASHYDROCHLORIDE)"
"3970","HYCAMTIN","1mg/1ml International Unit                                                                                   Pdr for Soln for Infusion",2000-03-16,"EU/1/96/027/005","Novartis Europharm Limited","TOPOTECAN(ASHYDROCHLORIDE)"
"3971","HYCAMTIN","0.25 Milligram                                                                                            Capsules Hard",2008-03-18,"EU/1/96/027/006","Novartis Europharm Limited","TOPOTECANHYDROCHLORIDE"
"3972","HYCAMTIN","1 Milligram                                                                                            Capsules Hard",2008-03-18,"EU/1/96/027/007","Novartis Europharm Limited","TOPOTECANHYDROCHLORIDE"
"3973","HYDREA","500 Milligram                                                                                            Capsules Hard",1979-04-01,"PA0002/027/001","Bristol-Myers Squibb Pharmaceuticals uc","HYDROXYCARBAMIDE"
"3974","HYDREX SURGICAL SCRUB 4.0% W/V CUTANEOUS SOLUTION","4 %w/v                                                                                                 Cutaneous Solution",1995-10-16,"PA1110/004/001","Ecolab Limited","CHLORHEXIDINEGLUCONATE"
"3975","HYDROBATH EMOLLIENT","%w/w                                                                                                 Unknown",1991-06-17,"PA0943/014/001","Alliance Pharmaceuticals Ltd.","NOACTIVELISTED"
"3976","HYDROCORTISONE","10 Milligram                                                                                            Tablets",2016-10-28,"PA1142/019/001","Amdipharm Limited","HYDROCORTISONE"
"3977","HYDROCORTISONE","20 Milligram                                                                                            Tablets",2016-10-28,"PA1142/019/002","Amdipharm Limited","HYDROCORTISONE"
"3978","HYDROCORTISONE","10 Milligram                                                                                            Tablets",2017-10-20,"PA2091/001/001","Renata (UK) Limited","HYDROCORTISONE"
"3979","HYDROCORTISONE","20 Milligram                                                                                            Tablets",2017-10-20,"PA2091/001/002","Renata (UK) Limited","HYDROCORTISONE"
"3980","HYDROCORTISONE 1 % W/W CREAM","1 %w/w                                                                                                 Cream",1998-03-20,"PA0206/030/001","Ovelle Limited","HYDROCORTISONE"
"3981","Hydrocortisyl Skin Cream 1%","1.0 percent weight/weight Cream",1978-04-01,"PA0540/046/001","Sanofi-Aventis Ireland Limited T/A SANOFI","Hydrocortisone"
"3982","HYDROCORTONE","10 Milligram                                                                                            Tablets",1978-04-01,"PA1986/054/001","Teva B.V.","HYDROCORTISONE"
"3983","HYDROMORPHONE HYDROCHLORIDE","20 Mg/Ml Solution for Injection and Concentrate for Infusion",2005-10-28,"PA0361/018/001","Martindale Pharmaceuticals Ltd","HYDROMORPHONEHYDROCHLORIDE"
"3984","HYDROMORPHONE HYDROCHLORIDE","50 Mg/Ml Solution for Injection and Concentrate for Infusion",2005-10-28,"PA0361/018/002","Martindale Pharmaceuticals Ltd","HYDROMORPHONEHYDROCHLORIDE"
"3985","HYDROXOCOBALAMIN","1 Mg/Ml Solution for Injection",2018-08-03,"PA1770/002/001","G.L. Pharma GmbH","HYDROXOCOBALAMIN"
"3986","HYOSCINE","400 Microgram/ML                                                                                         Solution for Injection",2005-08-26,"PA0361/017/001","Martindale Pharmaceuticals Ltd","HYOSCINEHYDROBROMIDE"
"3987","HYOSCINE","600 Microgram/ML                                                                                         Solution for Injection",2005-08-26,"PA0361/017/002","Martindale Pharmaceuticals Ltd","HYOSCINEHYDROBROMIDE"
"3988","HYPERICUM","6C & 30C  Tablets",2011-01-28,"HOR0407/030/001","Weleda (UK) Limited","HYPERICUMPERFORATUM"
"3989","HYPERICUM","6C-MM N/A",2010-10-29,"HOR1149/015/001","A. Nelson & Company Limited","HYPERICUMPERFORATUM"
"3990","Hypnovel","10 mg/2ml Solution for injection",1983-04-18,"PA2307/002/001","Roche Products (Ireland) Ltd","MIDAZOLAMHYDROCHLORIDE"
"3991","Hypnovel","10 mg/5ml Solution for injection",1985-03-27,"PA2307/002/002","Roche Products (Ireland) Ltd","MIDAZOLAMHYDROCHLORIDE"
"3992","Hypoloc 5 mg tablets","5 milligram(s) Tablet",2003-04-04,"PA0865/010/001","Menarini International Operations Luxembourg S.A.","Nebivolol"
"3993","HYPOLOC PLUS","5/12.5 Milligram                                                                                            Film Coated Tablet",2009-03-06,"PA0865/016/001","Menarini International Operations Luxembourg S.A.","NEBIVOLOL|HYDROCHLOROTHIAZIDE"
"3994","HYPOLOC PLUS","5/25 Milligram                                                                                            Film Coated Tablet",2009-03-06,"PA0865/016/002","Menarini International Operations Luxembourg S.A.","NEBIVOLOL|HYDROCHLOROTHIAZIDE"
"3995","HYPOVASE","0.5 mg Milligram                                                                                            Tablets",1979-04-01,"PA0822/195/001","Pfizer Healthcare Ireland","PRAZOSINHYDROCHLORIDE"
"3996","HYPOVASE","1 mg Milligram                                                                                            Tablets",1979-04-01,"PA0822/195/002","Pfizer Healthcare Ireland","PRAZOSINHYDROCHLORIDE"
"3997","HYQVIA","100 Mg/Ml Solution for Infusion",2013-06-28,"EU/1/13/840/001","Baxter","HUMANNORMALIMMUNOGLOBULIN|RECOMBINANTHUMANHYALURONIDASE"
"3998","HYRIMOZ","40 Milligram                                                                                            Solution for injection in pre-filled syringe",2018-07-26,"EU/1/18/1286/001-003","Sandoz GmbH","ADALIMUMAB"
"3999","HYRIMOZ","40 Milligram                                                                                            Solution for injection in pre-filled pen",2018-07-26,"EU/1/18/1286/004-006","Sandoz GmbH","ADALIMUMAB"
"4000","HYTRIN","2 Milligram                                                                                            Tablets",2005-09-30,"PPA0465/161/001","PCO Manufacturing","TERAZOSIN"
"4001","HYTRIN","5 Milligram                                                                                            Tablets",2005-09-30,"PPA0465/161/002","PCO Manufacturing","TERAZOSIN"
"4002","HYTRIN","10 Milligram                                                                                            Tablets",2005-09-30,"PPA0465/161/003","PCO Manufacturing","TERAZOSIN"
"4003","Hytrin 10mg Tablets","10 milligram(s) Tablet",1989-05-25,"PA1142/005/004","Amdipharm Limited","Terazosinhydrochloridedihydrate"
"4004","Hytrin 1mg and 2mg Tablets (Starter Pack)","1 and 2 milligram(s) Tablet",1989-05-25,"PA1142/005/001","Amdipharm Limited","Terazosinhydrochloridedihydrate|Terazosinhydrochloridedihydrate"
"4005","Hytrin 2mg Tablets","2 milligram(s) Tablet",1989-05-25,"PA1142/005/002","Amdipharm Limited","Terazosinhydrochloridedihydrate"
"4006","Hytrin 5mg Tablets","5 milligram(s) Tablet",1989-05-25,"PA1142/005/003","Amdipharm Limited","Terazosinhydrochloridedihydrate"
"4007","IASIBON","50 Milligram                                                                                            Film Coated Tablet",2011-01-21,"EU/1/10/659/001-002&8-10","Pharmathen S.A.",NA
"4008","IASIBON","1 Milligram                                                                                            Concentrate for Soln for Inf",2011-01-21,"EU/1/10/659/003","Pharmathen S.A.","IBANDRONICACID"
"4009","IASIBON","2 Milligram                                                                                            Concentrate for Soln for Inf",2011-01-21,"EU/1/10/659/004","Pharmathen S.A.","IBANDRONICACID"
"4010","IASIBON","6 Milligram                                                                                            Concentrate for Soln for Inf",2011-01-21,"EU/1/10/659/005-007","Pharmathen S.A.","IBANDRONICACID"
"4011","IBANDRONIC ACID","6 Milligram                                                                                            Concentrate for Soln for Inf",2013-05-03,"PA1122/018/001","Noridem Enterprises Ltd","IBANDRONATESODIUMMONOHYDRATE"
"4012","IBANDRONIC ACID ACCORD","2 Milligram                                                                                            Concentrate for Soln for Inf",2012-11-19,"EU/1/12/798/001","Accord Healthcare Limited","IBANDRONATESODIUMMONOHYDRATE"
"4013","IBANDRONIC ACID ACCORD","6 Milligram                                                                                            Concentrate for Soln for Inf",2012-11-19,"EU/1/12/798/002-004","Accord Healthcare Limited","IBANDRONATESODIUMMONOHYDRATE"
"4014","IBANDRONIC ACID ACCORD","3 Milligram                                                                                            Solution for Injection",2015-03-23,"EU/1/12/798/005-006","Accord Healthcare Limited","IBANDRONATESODIUMMONOHYDRATE|IBANDRONATESODIUM|IBANDRONICACID"
"4015","IBANDRONIC ACID CLONMEL","150 Milligram                                                                                            Film Coated Tablet",2011-01-28,"PA0126/240/001","Clonmel Healthcare Ltd","IBANDRONATESODIUMMONOHYDRATE"
"4016","Ibandronic Acid Liconsa 150 mg Film-Coated Tablets","150 milligram(s) Film-coated tablet",2010-11-12,"PA1239/013/001","Laboratorios  LICONSA, S.A.","Ibandronicacid"
"4017","IBANDRONIC ACID MYLAN","150 Milligram                                                                                            Film Coated Tablet",2010-07-02,"PA0577/111/001","McDermott Laboratories Ltd t/a Gerard Laboratories","IBANDRONICSODIUMMONOHYDRATE"
"4018","IBANDRONIC ACID ROCHE 2.5MG FILM-COATED TABLETS","2.5 mg Milligram                                                                                            Tablets",2004-03-31,"EU/1/03/266/01-2","Roche Registration Limited","IBANDRONICACID"
"4019","IBANDRONIC ACID SANDOZ","50 Milligram                                                                                            Film Coated Tablet",2011-07-26,"EU/1/11/685/001-005","Sandoz GmbH","IBANDRONICACID"
"4020","IBANDRONIC ACID TEVA","50 Milligram                                                                                            Film Coated Tablet",2010-09-17,"EU/1/10/642/001-002","Teva B.V.","IBANDRONICACID"
"4021","IBANDRONIC ACID TEVA","150 Milligram                                                                                            Film Coated Tablet",2010-09-17,"EU/1/10/642/003-004","Teva B.V.","IBANDRONICACID"
"4022","IBLIAS","250 International Unit                                                                                   Pdr+Solv for Soln for Inj",2016-02-18,"EU/1/15/1077/001","Bayer AG","OCTOCOGALFA"
"4023","IBLIAS","500 International Unit                                                                                   Pdr+Solv for Soln for Inj",2016-02-18,"EU/1/15/1077/002","Bayer AG","OCTOCOGALFA"
"4024","IBLIAS","1000 International Unit                                                                                   Pdr+Solv for Soln for Inj",2016-02-18,"EU/1/15/1077/003","Bayer AG","OCTOCOGALFA"
"4025","IBLIAS","2000 International Unit                                                                                   Pdr+Solv for Soln for Inj",2016-02-18,"EU/1/15/1077/004","Bayer AG","OCTOCOGALFA"
"4026","IBLIAS","3000 International Unit                                                                                   Pdr+Solv for Soln for Inj",2016-02-18,"EU/1/15/1077/005","Bayer AG","OCTOCOGALFA"
"4027","Ibrance","75 milligram(s) Capsule, hard",2016-11-09,"EU/1/16/1147/001-002","Pfizer Limited","Palbociclib"
"4028","IBRANCE","100 Milligram                                                                                            Capsules Hard",2016-11-09,"EU/1/16/1147/003-004","Pfizer Europe MA EEIG","PALBOCICLIB"
"4029","IBRANCE","125 Milligram                                                                                            Capsules Hard",2016-11-09,"EU/1/16/1147/005-006","Pfizer Europe MA EEIG","PALBOCICLIB"
"4030","Ibugel 5% w/w Gel","5 percent weight/weight Gel",1995-09-19,"PA0278/020/001","Dermal Laboratories Ltd","Ibuprofen"
"4031","IBUPROFEN","200 Milligram                                                                                            Film Coated Tablet",2016-10-07,"PA1390/104/001","Accord Healthcare Limited","IBUPROFEN"
"4032","IBUPROFEN","400 Milligram                                                                                            Film Coated Tablet",2016-10-07,"PA1390/104/002","Accord Healthcare Limited","IBUPROFEN"
"4033","IBUPROFEN","600 Milligram                                                                                            Film Coated Tablet",2016-10-07,"PA1390/104/003","Accord Healthcare Limited","IBUPROFEN"
"4034","Ibuprofen 200 mg film-coated tablets","200 milligram(s) Film-coated tablet",NA,"PA1240/007/001","Bristol Laboratories Limited","Ibuprofen"
"4035","Ibuprofen 200mg Coated Tablets","200 milligram(s) Coated tablet",2013-11-29,"PA1754/001/001","Galpharm Healthcare Limited","Ibuprofen"
"4036","Ibuprofen 200mg Soft capsules","200 milligram(s) Capsule, soft",2002-03-08,"PA0822/163/001","Pfizer Healthcare Ireland","Ibuprofen"
"4037","Ibuprofen 400 mg film-coated tablet","400 milligram(s) Film-coated tablet",NA,"PA1240/007/002","Bristol Laboratories Limited","Ibuprofen"
"4038","Ibuprofen 600 mg film-coated tablets","600 milligram(s) Film-coated tablet",NA,"PA1240/007/003","Bristol Laboratories Limited","Ibuprofen"
"4039","IBUPROFEN B. BRAUN","400mg Mg/Ml Solution for Injection",2017-10-06,"PA0736/041/001","B. Braun Melsungen AG","IBUPROFEN"
"4040","IBUPROFEN B. BRAUN","600mg Mg/Ml Solution for Injection",2017-10-06,"PA0736/041/002","B. Braun Melsungen AG","IBUPROFEN"
"4041","IBUPROFEN FARMALIDER","200 Milligram                                                                                            Film Coated Tablet",2018-01-05,"PA2090/002/001","Farmalider, S.A.","IBUPROFENPH.EUR."
"4042","Ibuprofen Galpharm Max 400mg Film-coated Tablets","400 milligram(s) Film-coated tablet",2013-11-29,"PA1754/001/002","Galpharm Healthcare Limited","Ibuprofen"
"4043","Ibuprofen/Phenylephrine Clonmel 400 mg/10 mg film-coated tablets","400/10 milligram(s) Film-coated tablet",NA,"PA0126/296/001","Clonmel Healthcare Ltd","Ibuprofen|Phenylephrinehydrochloride"
"4044","IBUPROFEN/PSEUDOEPHEDRINE HYDROCHLORIDE","200/30 Milligram                                                                                            Film Coated Tablet",2016-01-29,"PA1958/005/001","Diapharm GmbH & Co. KG","IBUPROFEN|PSEUDOEPHEDRINEHYDROCHLORIDE"
"4045","ICANDRA","50/850 Milligram                                                                                            Film Coated Tablet",2008-12-01,"EU/1/08/484/1-6,13-15","Novartis Europharm Limited",NA
"4046","ICANDRA","50/1000 Milligram                                                                                            Film Coated Tablet",2008-12-01,"EU/1/08/484/7-12,16-18","Novartis Europharm Limited",NA
"4047","Iclusig","15 milligram(s) Film-coated tablet",2013-07-01,"EU/1/13/839/001-002","Incyte Bioscience UK Ltd","Ponatinibhci"
"4048","Iclusig","45 milligram(s) Film-coated tablet",2013-07-01,"EU/1/13/839/003-004","Incyte Bioscience UK Ltd","Ponatinibhci"
"4049","Iclusig","30 milligram(s) Film-coated tablet",2015-11-21,"EU/1/13/839/006","Incyte Bioscience UK Ltd","Ponatinibhci"
"4050","Icorvida SR 1.5mg Prolonged-release Tablets","1.5 milligram(s) Prolonged-release tablet",2012-02-03,"PA1347/022/001","Krka d.d., Novo mesto","Indapamide"
"4051","Ictastan 200 mg/245 mg film-coated tablets","200/245 milligram(s) Film-coated tablet",2016-05-06,"PA1380/191/001","Actavis Group PTC ehf","Emtricitabine|Tenofovirdisoproxil"
"4052","IDELVION","250 international unit(s) Powder and solvent for solution for injection",2016-05-11,"EU/1/16/1095/001","CSL Behring GmbH","Rix-fp"
"4053","IDELVION","500 International Unit                                                                                   Pdr+Solv for Soln for Inj",2016-05-11,"EU/1/16/1095/002","CSL Behring GmbH","RIX-FP"
"4054","IDELVION","1000 International Unit                                                                                   Pdr+Solv for Soln for Inj",2016-05-11,"EU/1/16/1095/003","CSL Behring GmbH","RIX-FP"
"4055","IDELVION","2000 International Unit                                                                                   Pdr+Solv for Soln for Inj",2016-05-11,"EU/1/16/1095/004","CSL Behring GmbH","RIX-FP"
"4056","IDEOS","500/400IU Milligram                                                                                            Tablets Chewable",1996-01-08,"PA1033/001/001","Laboratoire Innotech International","CALCIUMCARBONATE|COLECALCIFEROL"
"4057","IDEOS","500/400IU Milligram                                                                                            Tablets Chewable",2013-10-11,"PPA1633/033/001","Primecrown 2010 Ltd","CALCIUMCARBONATE|COLECALCIFEROL"
"4058","IDEOS","500mg/400 IU Milligram                                                                                            Tablets Chewable",2013-12-20,"PPA1151/202/001","Imbat Limited","CALCIUMCARBONATE|COLECALCIFEROL"
"4059","IDEOS","500/400IU Milligram                                                                                            Tablets Chewable",2012-07-06,"PPA1562/078/001","LTT Pharma Limited","CALCIUMCARBONATE|COLECALCIFEROL"
"4060","IDEOS 500 MG/400 IU CHEWABLE TABLETS","500 mg/400 IU Base Milligrams                                                                                      Tablets Chewable",2004-06-11,"PPA0465/128/001","PCO Manufacturing","CALCIUMCARBONATE|COLECALCIFEROL"
"4061","IDROLAX","10 Grams                                                                                                Powder for Oral Solution",2002-02-22,"PA1613/003/001","Ipsen Pharma","MACROGOL4000"
"4062","Idrolax ® 4g Junior, powder for oral solution","4g gram(s) Powder for oral solution",2004-10-29,"PA0271/011/002","SCHWARZ PHARMA Limited","Macrogol4000"
"4063","Idrolax 10g, powder for oral solution","10g gram(s) Powder for oral solution",2002-02-22,"PA0271/011/001","SCHWARZ PHARMA Limited","Macrogol4000"
"4064","IELMAG3","0.2 Milligram                                                                                            Kit for radiopharmaceutical preparation",2013-08-09,"PA2226/001/001","ROTOP Pharmaka GmbH","MERTIATIDE"
"4065","IFIRMACOMBI","150/12.5 Milligram                                                                                            Film Coated Tablet",2011-03-04,"EU/1/11/673/001-008","Krka d.d., Novo mesto","IRBESARTANHYDROCHLORIDE|HYDROCHLOROTHIAZIDE"
"4066","IFIRMACOMBI","300mg/12.5mg Milligram                                                                                            Film Coated Tablet",2011-03-04,"EU/1/11/673/009-016","Krka d.d., Novo mesto","IRBESARTANHYDROCHLORIDE|HYDROCHLOROTHIAZIDE"
"4067","IFIRMACOMBI","300/25 Milligram                                                                                            Film Coated Tablet",2011-03-04,"EU/1/11/673/017-024","Krka d.d., Novo mesto","IRBESARTANHYDROCHLORIDE|HYDROCHLOROTHIAZIDE"
"4068","IFIRMASTA","300 Milligram                                                                                            Film Coated Tablet",2008-12-03,"EU/1/08/480/13-18","Krka d.d., Novo mesto","IRBESARTANHYDROCHLORIDE"
"4069","IFIRMASTA","75 Milligram                                                                                            Film Coated Tablet",2008-12-03,"EU/1/08/480/1-6","Krka d.d., Novo mesto","IRBESARTANHYDROCHLORIDE"
"4070","IFIRMASTA","150 Milligram                                                                                            Film Coated Tablet",2008-12-03,"EU/1/08/480/7-12","Krka d.d., Novo mesto","IRBESARTANHYDROCHLORIDE"
"4071","IGNATIA","6C & 30C Unknown Tablets",2011-01-28,"HOR0407/029/001","Weleda (UK) Limited","STRYCHNOSIGNATII"
"4072","Ikervis","1 milligram(s)/millilitre Eye drops, emulsion",2015-05-28,"EU/1/15/990/001-002","Santen OY","Ciclosporin"
"4073","IKOREL","10 Milligram                                                                                            Tablets",1997-10-17,"PA0540/102/001","Sanofi-Aventis Ireland Limited T/A SANOFI","NICORANDIL"
"4074","IKOREL","20 Milligram                                                                                            Tablets",1997-10-17,"PA0540/102/002","Sanofi-Aventis Ireland Limited T/A SANOFI","NICORANDIL"
"4075","IKOREL","10 Milligram                                                                                            Tablets",2011-12-09,"PPA1151/160/001","Imbat Limited","NICORANDIL"
"4076","IKOREL","20 Milligram                                                                                            Tablets",2011-12-09,"PPA1151/160/002","Imbat Limited","NICORANDIL"
"4077","Ikorel 10 mg Tablets","10 milligram(s) Tablet",2003-11-18,"PPA0465/103/001","PCO Manufacturing","Nicorandil"
"4078","Ikorel 20 mg Tablets","20 milligram(s) Tablet",2003-11-18,"PPA0465/103/002","PCO Manufacturing","Nicorandil"
"4079","ILARIS","150 Milligram                                                                                            Pdr+Solv for Soln for Inj",2011-09-16,"EU/1/09/564/003","Novartis Europharm Limited","CANAKINUMAB"
"4080","ILARIS","150 Mg/Ml Solution for Injection",2017-02-23,"EU/1/09/564/004","Novartis Europharm Limited","CANAKINUMAB"
"4081","ILARIS","150 Micromol Pdr for Soln for Injection",2009-10-23,"EU/1/09/564/1-2","Novartis Europharm Limited","CANAKINUMAB"
"4082","ILUBE","5 %w/v                                                                                                 Eye Drops Solution",1992-12-17,"PA2161/002/001","Rayner Pharmaceuticals Limited","ACETYLCYSTEINE"
"4083","Ilumetri","100 milligram(s) Solution for injection",2018-09-17,"EU/1/18/1323/001","Almirall, S.A.","Tildrakizumab"
"4084","ILUVIEN","190 Microgram",2014-11-07,"PA1953/001/001","Alimera Sciences Limited","FLUOCINOLONEACETONIDE"
"4085","Ilvico Cold and Flu film-coated tabletsParacetamol 325 mgCaffeine 30 mgBrompheniramine maleate 3 mg","325 / 30 / 3 milligram(s) Film-coated tablet",2010-11-05,"PA0417/018/001","Seven Seas Ltd","Paracetamol|BROMPHENIRAMINEMALEATE|Caffeine"
"4086","IMATINIB","100 Milligram                                                                                            Film Coated Tablet",2016-07-22,"PA0405/095/001","Generics (UK) Limited","IMATINIBMESILATE"
"4087","IMATINIB","400 Milligram                                                                                            Film Coated Tablet",2016-07-22,"PA0405/095/002","Generics (UK) Limited","IMATINIBMESILATE"
"4088","IMATINIB","100 Milligram                                                                                            Film Coated Tablet",2013-07-01,"EU/1/13/845/001-008","Accord Healthcare Limited","IMATINIBMESYLATE"
"4089","IMATINIB","400 Milligram                                                                                            Film Coated Tablet",2013-07-01,"EU/1/13/845/009-014","Accord Healthcare Limited","IMATINIBMESYLATE"
"4090","IMATINIB","100 Milligram                                                                                            Film Coated Tablet",2016-04-08,"PA2059/002/001","Fresenius Kabi Deutschland GmbH","IMATINIBMESILATE"
"4091","IMATINIB","400 Milligram                                                                                            Film Coated Tablet",2016-04-08,"PA2059/002/002","Fresenius Kabi Deutschland GmbH","IMATINIBMESILATE"
"4092","IMATINIB","100 Milligram                                                                                            Film Coated Tablet",2015-09-25,"PA1339/060/001","Wockhardt UK Limited","IMATINIB"
"4093","IMATINIB","400 Milligram                                                                                            Film Coated Tablet",2015-09-25,"PA1339/060/002","Wockhardt UK Limited","IMATINIB"
"4094","IMATINIB ACTAVIS","50 Milligram                                                                                            Capsules Hard",2013-05-27,"EU/1/13/825/001-002","Actavis Group PTC ehf","IMATINIBMESYLATE"
"4095","IMATINIB ACTAVIS","100 Milligram                                                                                            Capsules Hard",2013-05-27,"EU/1/13/825/003-007","Actavis Group PTC ehf","IMATINIBMESYLATE"
"4096","IMATINIB ACTAVIS","100 Milligram                                                                                            Film Coated Tablet",2013-05-27,"EU/1/13/825/008-014","Actavis Group PTC ehf","IMATINIBMESYLATE"
"4097","IMATINIB ACTAVIS","400 Milligram                                                                                            Film Coated Tablet",2013-05-27,"EU/1/13/825/015-018","Actavis Group PTC ehf","IMATINIBMESYLATE"
"4098","IMATINIB ACTAVIS","400 Milligram                                                                                            Capsules Hard",2014-06-12,"EU/1/13/825/019-023","Actavis Group PTC ehf","IMATINIBMESYLATE"
"4099","IMATINIB ACTAVIS GROUP","100 Milligram                                                                                            Film Coated Tablet",2015-10-23,"PA1380/164/001","Actavis Group PTC ehf","IMATINIBMESILATE"
"4100","IMATINIB ACTAVIS GROUP","400 Milligram                                                                                            Film Coated Tablet",2015-10-23,"PA1380/164/002","Actavis Group PTC ehf","IMATINIBMESYLATE"
"4101","IMATINIB CLONMEL","400 Milligram                                                                                            Film Coated Tablet",2015-10-02,"PA0126/256/002","Clonmel Healthcare Ltd","IMATINIBMESYLATE"
"4102","Imatinib Clonmel 100 mg Film-coated Tablets","100 milligram(s) Film-coated tablet",2015-10-02,"PA0126/256/001","Clonmel Healthcare Ltd","Imatinibmesylate"
"4103","IMATINIB KOANAA","100 Milligram                                                                                            Film Coated Tablet",2017-08-04,"PA2041/001/001","Koanaa Healthcare Limited","IMATINIBMESYLATE"
"4104","IMATINIB KOANAA","400 Milligram                                                                                            Film Coated Tablet",2017-08-04,"PA2041/001/002","Koanaa Healthcare Limited","IMATINIBMESYLATE"
"4105","Imatinib Krka d.d 100 mg film-coated tablets","100 milligram(s) Film-coated tablet",2016-01-15,"PA1347/054/001","Krka d.d., Novo mesto","Imatinibmesilate"
"4106","IMATINIB KRKA D.D.","100 Milligram                                                                                            Dispersable Tablet",2017-09-26,"PA1347/054/003","Krka d.d., Novo mesto","IMATINIB"
"4107","IMATINIB KRKA D.D.","400 Milligram                                                                                            Dispersable Tablet",2017-09-26,"PA1347/054/004","Krka d.d., Novo mesto","IMATINIB"
"4108","Imatinib Krka d.d. 400 mg film-coated tablets","400 milligram(s) Film-coated tablet",2016-01-15,"PA1347/054/002","Krka d.d., Novo mesto","Imatinibmesilate"
"4109","IMATINIB MEDAC","100 Milligram                                                                                            Capsules Hard",2013-09-25,"EU/1/13/876/001","Medac Gesellschaft fur Klinische Spezialpraparate mbH","IMATINIBMESILATE"
"4110","IMATINIB MEDAC","400 Milligram                                                                                            Capsules Hard",2013-09-25,"EU/1/13/876/002","Medac Gesellschaft fur Klinische Spezialpraparate mbH","IMATINIBMESILATE"
"4111","IMATINIB ROWEX","100 Milligram                                                                                            Film Coated Tablet",2015-12-04,"PA0711/248/001","Rowex Ltd","IMATINIBMESILATE"
"4112","IMATINIB ROWEX","400 Milligram                                                                                            Film Coated Tablet",2015-12-04,"PA0711/248/002","Rowex Ltd","IMATINIBMESILATE"
"4113","IMATINIB TEVA","100 Milligram                                                                                            Film Coated Tablet",2013-01-17,"EU/1/12/808/001-012","Teva B.V.","IMATINIBMESILATE"
"4114","IMATINIB TEVA","400 Milligram                                                                                            Film Coated Tablet",2013-01-17,"EU/1/12/808/013-020","Teva B.V.","IMATINIBMESILATE"
"4115","IMATINIB TEVA","100 Milligram                                                                                            Capsules Hard",2013-01-17,"EU/1/12/808/021-032","Teva B.V.","IMATINIBMESILATE"
"4116","IMATINIB TEVA","400 Milligram                                                                                            Capsules Hard",2013-01-17,"EU/1/12/808/033-040","Teva B.V.","IMATINIBMESILATE"
"4117","Imbruvica","140 milligram(s) Capsule, hard",2014-10-21,"EU/1/14/945/001-002","Janssen-Cilag International NV","Ibrutinib"
"4118","IMBRUVICA","140 milligram(s) Film-coated tablet",NA,"EU/1/14/945/003","Janssen-Cilag International NV","Ibrutinib"
"4119","IMBRUVICA","280 milligram(s) Film-coated tablet",NA,"EU/1/14/945/004","Janssen-Cilag International NV","Ibrutinib"
"4120","IMBRUVICA","420 milligram(s) Film-coated tablet",NA,"EU/1/14/945/005","Janssen-Cilag International NV","Ibrutinib"
"4121","IMBRUVICA","560 milligram(s) Film-coated tablet",NA,"EU/1/14/945/006","Janssen-Cilag International NV","Ibrutinib"
"4122","IMDUR","60 Milligram                                                                                            Tablet Prolonged Release",2007-03-16,"PPA1151/027/001","Imbat Limited","ISOSORBIDEMONONITRATE"
"4123","IMDUR PROLONGED-RELEASE","60 Milligram                                                                                            Film Coated Tablet",1987-04-02,"PA2129/001/001","Topridge Pharma (Ireland) Limited","ISOSORBIDEMONONITRATE"
"4124","IMETOXIM","1 Grams                                                                                                Pdr+Solv for soln for inf/inj",2018-04-06,"PA1952/002/001","Novocat Farma S.A.","CEFOTAXIME"
"4125","IMIGRAN","10 Milligram                                                                                            Nasal Spray Solution",1999-07-07,"PA1077/008/003","GlaxoSmithKline (Ireland) Limited","SUMATRIPTAN"
"4126","IMIGRAN","20 Milligram                                                                                            Nasal Spray Solution",1999-07-07,"PA1077/008/004","GlaxoSmithKline (Ireland) Limited","SUMATRIPTAN"
"4127","IMIGRAN","50 Milligram                                                                                            Film Coated Tablet",2017-03-01,"PPA1562/188/001","LTT Pharma Limited","SUMATRIPTANSUCCINATE"
"4128","IMIGRAN","100 Milligram                                                                                            Film Coated Tablet",2017-03-01,"PPA1562/188/002","LTT Pharma Limited","SUMATRIPTANSUCCINATE"
"4129","IMIGRAN FTAB","100 Milligram                                                                                            Film Coated Tablet",2015-07-24,"PPA1151/248/001","Imbat Limited","SUMATRIPTANSUCCINATE"
"4130","IMIGRAN FTAB","50 Milligram                                                                                            Film Coated Tablet",2004-12-10,"PA1077/008/006","GlaxoSmithKline (Ireland) Limited","SUMATRIPTANSUCCINATE"
"4131","IMIGRAN FTAB","100 Milligram                                                                                            Film Coated Tablet",2004-12-10,"PA1077/008/007","GlaxoSmithKline (Ireland) Limited","SUMATRIPTANSUCCINATE"
"4132","IMIGRAN FTAB","50 Milligram                                                                                            Film Coated Tablet",2009-04-17,"PPA0465/070/003","PCO Manufacturing","SUMATRIPTAN"
"4133","IMIGRAN FTAB","100 Milligram                                                                                            Film Coated Tablet",2009-05-08,"PPA0465/070/004","PCO Manufacturing","SUMATRIPTANSUCCINATE"
"4134","IMIPENEM/CILASTATIN","500/500 Milligram                                                                                            Pdr for Soln for Infusion",2010-12-03,"PA1217/005/001","Hikma Farmaceutica (Portugal) SA","IMIPENEM|CILASTATIN"
"4135","IMLYGIC","1 x 10e6 PFU Millilitre                                                                                           Solution for Injection",2015-12-16,"EU/1/15/1064/001","Amgen Europe B.V.","TALIMOGENELAHERPAREPVEC"
"4136","IMLYGIC","1 x 10e8 PFU Millilitre                                                                                           Solution for Injection",2015-12-16,"EU/1/15/1064/002","Amgen Europe B.V.","TALIMOGENELAHERPAREPVEC"
"4137","Imnovid","1 milligram(s) Capsule, hard",2013-08-05,"EU/1/13/850/001","Celgene Europe B.V.","Pomalidomide"
"4138","Imnovid","2 milligram(s) Capsule, hard",NA,"EU/1/13/850/002","Celgene Europe B.V.","Pomalidomide"
"4139","Imnovid","3 milligram(s) Capsule, hard",NA,"EU/1/13/850/003","Celgene Europe B.V.","Pomalidomide"
"4140","Imnovid","4 milligram(s) Capsule, hard",NA,"EU/1/13/850/004","Celgene Europe B.V.","Pomalidomide"
"4141","IMODIUM","2mg Milligram                                                                                            Capsule",1977-04-14,"PA0330/045/002","Johnson & Johnson (Ireland) Limited","LOPERAMIDEHYDROCHLORIDE"
"4142","IMODIUM","2 Milligram                                                                                            Capsules Hard",2008-02-01,"PPA1151/060/001","Imbat Limited","LOPERAMIDEHYDROCHLORIDE"
"4143","IMODIUM INSTANTS","2 Milligram                                                                                            Orodispersible Tablet",2014-08-01,"PPA1151/060/002","Imbat Limited","LOPERAMIDEHYDROCHLORIDE"
"4144","IMODIUM INSTANTS","2 Milligram                                                                                            Orodispersible Tablet",2012-08-31,"PPA0465/001/002","PCO Manufacturing","LOPERAMIDEHYDROCHLORIDE"
"4145","Imodium Instants 2 mg Orodispersible Tablets","2mg milligram(s) Tablet",2003-10-03,"PA0330/045/001","Johnson & Johnson (Ireland) Limited","LOPERAMIDEHYDROCHLORIDE"
"4146","Imodium LiquiRelief 2mg Soft Capsules","2 milligram(s) Capsule, soft",2011-04-01,"PA0330/045/003","Johnson & Johnson (Ireland) Limited","LOPERAMIDEHYDROCHLORIDE"
"4147","IMODIUM PLUS","2/125 Milligram                                                                                            Tablets",2009-07-24,"PPA1151/112/001","Imbat Limited","LOPERAMIDEHYDROCHLORIDE|DIMETICONE,ACTIVATED"
"4148","Imodium Plus 2mg/125mg Tablets","2/125 milligram(s) Tablet",2007-04-20,"PA0330/050/001","Johnson & Johnson (Ireland) Limited","LOPERAMIDEHYDROCHLORIDE|Simeticone"
"4149","IMPLANON NXT","68 Milligram                                                                                            Implant",2012-05-04,"PPA0465/250/001","PCO Manufacturing","ETONOGESTREL"
"4150","IMPLANON NXT","68 Milligram                                                                                            Implant",2009-05-22,"PPA1151/094/001","Imbat Limited","ETONOGESTREL"
"4151","IMPLANON NXT","68 Milligram                                                                                            Implant",2014-09-12,"PPA1562/125/001","LTT Pharma Limited","ETONOGESTREL"
"4152","IMPLANON NXT IMPLANT FOR SUBDERMAL USE","68 Milligram                                                                                            Implant",2016-05-06,"PPA1463/108/001","IMED Healthcare Ltd.","ETONOGESTREL"
"4153","Implanon NXT, 68 mg implant for subdermal use","68 milligram(s) Implant",2017-03-01,"PPA1097/005/001","Lexon (UK) Ltd","Etonogestrel"
"4154","Implanon NXT, 68 mg implant for subdermal use","68 milligram(s) Implant",1999-03-19,"PA1286/050/001","Merck Sharp & Dohme Ireland (Human Health) Limited","Etonogestrel"
"4155","Imraldi","40 milligram(s) Solution for infusion in pre-filled syringe",2017-08-24,"EU/1/17/1216/001-004","Samsung Bioepis UK Limited","Adalimumab"
"4156","Imraldi","40 milligram(s) Solution for injection in pre-filled pen",NA,"EU/1/17/1216/005-008","Samsung Bioepis UK Limited","Adalimumab"
"4157","IMUGER","25 Milligram                                                                                            Film Coated Tablet",2000-05-26,"PA0577/032/001","McDermott Laboratories Ltd t/a Gerard Laboratories","AZATHIOPRINE"
"4158","IMUGER","50 Milligram                                                                                            Film Coated Tablet",2000-05-26,"PA0577/032/002","McDermott Laboratories Ltd t/a Gerard Laboratories","AZATHIOPRINE"
"4159","IMUNOVIR","500 Milligram                                                                                            Tablets",1983-11-03,"PA1748/001/001","Kora Corporation Ltd t/a Kora Healthcare","INOSINEACEDOBENDIMEPRANOL"
"4160","IMURAN","50 Milligram                                                                                            Pdr for Soln Inj/Inf",1979-04-01,"PA1691/003/001","Aspen Pharma Trading Limited","AZATHIOPRINESODIUM"
"4161","IMURAN","50 Milligram                                                                                            Film Coated Tablet",2007-06-15,"PPA1151/039/001","Imbat Limited","AZATHIOPRINE"
"4162","IMURAN","50 Milligram                                                                                            Film Coated Tablet",2009-01-09,"PPA1463/014/001","IMED Healthcare Ltd.","AZATHIOPRINE"
"4163","IMURAN 25 MILLIGRAM FILM-COATED TABLETS","25 Milligram                                                                                            Tablets",2001-09-07,"PPA0465/077/001","PCO Manufacturing","AZATHIOPRINE"
"4164","Imuran 50 mg Film-coated Tablets","50 milligram(s) Film-coated tablet",2001-09-07,"PPA0465/077/002","PCO Manufacturing","Azathioprine"
"4165","Imuran Film-coated Tablets 25 mg","25 milligram(s) Film-coated tablet",1987-07-09,"PA1691/003/002","Aspen Pharma Trading Limited","Azathioprine"
"4166","Imuran Film-coated Tablets 50 mg","50 milligram(s) Film-coated tablet",1979-04-01,"PA1691/003/003","Aspen Pharma Trading Limited","Azathioprine"
"4167","Imvanex","*** AWAITING VALUE *** Suspension for injection",2013-07-31,"EU/1/13/855/001","Bavarian Nordic A/S","Mva-bnvirus"
"4168","INACTIVATED INFLUENZA VACCINE (SPLIT VIRION) BP, suspension for injection in prefilled syringe.Influenza vaccine (split virion, inactivated)","15/15/15mc percent volume/volume Suspension for injection",NA,"PA2131/012/001","Sanofi Pasteur","A/Michigan/45/2015(H1N1)pdm09-likestrain(A/Michigan/45/2015,NYMCX-275)|A/hongkong/4801/2014(h3n2)-likestrain(a/hongkong/4801/2014,nymcx-263b)|B/brisbane/60/2008-likestrain(b/brisbane/60/2008)"
"4169","INCRELEX","10 Mg/Ml Solution for Injection",2007-08-03,"EU/1/07/402/001","Ipsen Pharma","MECASERMIN"
"4170","INCRESYNC","12.5mg/45 Milligram                                                                                            Film Coated Tablet",2013-09-19,"EU/1/13/842/010-018","Takeda Global R&D Centre Europe Limited","ALOGLIPTIN(ASBENZOATE)|PIOGLITAZONE(ASHYDROCHLORIDE)"
"4171","Incresync","12.5mg/30 milligram(s) Film-coated tablet",2013-09-19,"EU/1/13/842/01-09","Takeda Global R&D Centre Europe Limited","Alogliptin(asbenzoate)|Pioglitazone(ashydrochloride)"
"4172","INCRESYNC","25mg/30 Milligram                                                                                            Film Coated Tablet",2013-09-19,"EU/1/13/842/019-027","Takeda Global R&D Centre Europe Limited","ALOGLIPTIN(ASBENZOATE)|PIOGLITAZONE(ASHYDROCHLORIDE)"
"4173","INCRESYNC","25mg/45 Milligram                                                                                            Film Coated Tablet",2013-09-19,"EU/1/13/842/028-036","Takeda Global R&D Centre Europe Limited","ALOGLIPTIN(ASBENZOATE)|PIOGLITAZONE(ASHYDROCHLORIDE)"
"4174","Incruse","55 microgram(s) Powder for Inhalation",2014-04-28,"EU/1/14/922/001-003","Glaxo Group Limited","Umeclidiniumbromide"
"4175","INDERAL","10 Milligram                                                                                            Film Coated Tablet",1979-04-01,"PA0970/010/002","AstraZeneca UK Limited","PROPRANOLOLHYDROCHLORIDE"
"4176","Indium (111In) DTPA 37MBq/ml Solution for Injection","37 ZZZ MBq/ml Solution for injection",2004-03-31,"PA0690/009/001","Mallinckrodt Medical B.V.","Indium(111in)|PENTETICACID"
"4177","Indium (In111) Chloride 370MBq/ml radiopharmaceutical precursor","370 ZZZ MBq/ml Radiopharmaceutical precursor",2000-02-18,"PA0690/008/001","Mallinckrodt Medical B.V.","Indium(111in)"
"4178","INDIVINA","1mg/2.5mg milligram(s) Tablet",NA,"PA0795/002/001","Orion Corporation","Estradiolvalerate|Medroxyprogesteroneacetate"
"4179","INDIVINA","1mg/5mg milligram(s) Tablet",NA,"PA0795/002/002","Orion Corporation","Estradiolvalerate|Medroxyprogesteroneacetate"
"4180","INDIVINA","2mg/5mg milligram(s) Tablet",NA,"PA0795/002/003","Orion Corporation","Estradiolvalerate|Medroxyprogesteroneacetate"
"4181","Indivina 1 mg/2.5 mg tablets","1/2.5 milligram(s) Tablet",NA,"PA1327/005/001","Orion Corporation","Estradiolvalerate|Medroxyprogesteroneacetate"
"4182","Indivina 1 mg/5 mg tablets","1/5 milligram(s) Tablet",NA,"PA1327/005/002","Orion Corporation","Estradiolvalerate|Medroxyprogesteroneacetate"
"4183","Indivina 2 mg/5 mg tablets","2/5 milligram(s) Tablet",NA,"PA1327/005/003","Orion Corporation","Estradiolvalerate|Medroxyprogesteroneacetate"
"4184","Indoramin 20 mg Film-coated Tablets","20 milligram(s) Tablet",NA,"PA1161/004/001","Chemidex Pharma Limited","INDORAMINHYDROCHLORIDE"
"4185","INDUCTOS","%v/v                                                                                                 Implant",2002-09-09,"EU/1/02/226/001","Medtronic BioPharma B.V.","DIBOTERMINALFA"
"4186","INEGY","10/80 Milligram                                                                                            Tablets",2009-04-17,"DPR0465/025/003","PCO Manufacturing","EZETIMIBE|SIMVASTATIN"
"4187","INEGY","10/20 Milligram                                                                                            Tablets",2009-06-19,"PPA0465/223/001","PCO Manufacturing","EZETIMIBE|SIMVASTATIN"
"4188","Inegy 10 mg / 20 mg Tablets","10/20 milligram(s) Tablet",2004-12-03,"PA1286/062/002","Merck Sharp & Dohme Ireland (Human Health) Limited","Ezetimibe|Simvastatin"
"4189","Inegy 10 mg / 40 mg Tablets","10/40 milligram(s) Tablet",2004-12-03,"PA1286/062/003","Merck Sharp & Dohme Ireland (Human Health) Limited","Ezetimibe|Simvastatin"
"4190","Inegy 10 mg / 80 mg Tablets","10/80 milligram(s) Tablet",2004-12-03,"PA1286/062/004","Merck Sharp & Dohme Ireland (Human Health) Limited","Ezetimibe|Simvastatin"
"4191","Inegy 10mg / 10mg Tablets","10/10 milligram(s) Tablet",2004-12-03,"PA1286/062/001","Merck Sharp & Dohme Ireland (Human Health) Limited","Ezetimibe|Simvastatin"
"4192","INFACOL","40 Milligram                                                                                            Oral Drops Suspension",1991-02-27,"PA0100/041/001","Forest Laboratories UK Ltd","DIMETICONE,ACTIVATED"
"4193","INFANRIX HE","5 Millilitre                                                                                           Suspension for Injection",2000-10-20,"EU/1/00/152/015","GlaxoSmithKline Biologicals S.A.","DIPHTHERIATOXOID|TETANUSTOXOID|PERTUSSISTOXOID|FILAMENTOUSHAEMAGGLUTININ(FHA)|PERTACTIN|HEPATITISBSURFACEANTIGEN(HBSAG)|HAEMOPHILUSINFLUENZAE|POLYSACCHARIDE-K|TETANUSTOXOID"
"4194","INFANRIX HEXA","5 Millilitre                                                                                           Solution for Injection",2000-10-20,"EU/1/00/152/016","GlaxoSmithKline Biologicals S.A.","DIPHTHERIATOXOID|TETANUSTOXOID|PERTUSSISTOXOID|FILAMENTOUSHAEMAGGLUTININ(FHA)|PERTACTIN|HEPATITISBSURFACEANTIGEN(HBSAG)|HAEMOPHILUSINFLUENZAE|POLYSACCHARIDE-K|TETANUSTOXOID"
"4195","INFANRIX HEXA","Infus/Pdr/Oral Soln",2010-05-10,"EU/1/00/152/19-20","GlaxoSmithKline Biologicals S.A.","PERTUSSISTOXOID(PT)|FILAMENTOUSHAEMAGGLUTININ(FHA)|PERTACTIN(69KDAOUTERMEMBRANEPROTEIN-PRN)|DIPHTHERIATOXOID(D)|TETANUSTOXOID(T)|R-DNAHEPATITISBSURFACEANTIGEN(HBSAG)|INACTIVATEDPOLIOVIRUSTYPE1|INACTIVATEDPOLIOVIRUSTYPE2|INACTIVATEDPOLIOVIRUSTYPE3|CONJUGATEOFHAEMOPHILUSINFLUENZAETYPEBCAPSULARPOLYSACCHARIDE(PRP)ANDTETANUSTOXOID"
"4196","INFANRIX HEXA","5 ml Millilitre                                                                                           Suspension for Injection",2000-10-23,"EU/1/00/152/001","GlaxoSmithKline Biologicals S.A.","DIPHTHERIATOXOID|TETANUSTOXOID|PERTUSSISTOXOID|FILAMENTOUSHAEMAGGLUTININ(FHA)|PERTACTIN|HEPATITISBSURFACEANTIGEN(HBSAG)|HAEMOPHILUSINFLUENZAE|POLYSACCHARIDE-K|TETANUSTOXOID"
"4197","INFANRIX HEXA","5 Millilitre                                                                                           Suspension for Injection",2000-10-23,"EU/1/00/152/002","GlaxoSmithKline Biologicals S.A.","DIPHTHERIATOXOID|TETANUSTOXOID|PERTUSSISTOXOID|FILAMENTOUSHAEMAGGLUTININ(FHA)|PERTACTIN|HEPATITISBSURFACEANTIGEN(HBSAG)|HAEMOPHILUSINFLUENZAE|POLYSACCHARIDE-K|TETANUSTOXOID"
"4198","INFANRIX HEXA","5 Millilitre                                                                                           Suspension for Injection",2000-10-23,"EU/1/00/152/003","GlaxoSmithKline Biologicals S.A.","DIPHTHERIATOXOID|TETANUSTOXOID|PERTUSSISTOXOID|FILAMENTOUSHAEMAGGLUTININ(FHA)|PERTACTIN|HEPATITISBSURFACEANTIGEN(HBSAG)|HAEMOPHILUSINFLUENZAE|POLYSACCHARIDE-K|TETANUSTOXOID"
"4199","INFANRIX HEXA","5 Millilitre                                                                                           Suspension for Injection",2000-10-23,"EU/1/00/152/004","GlaxoSmithKline Biologicals S.A.","DIPHTHERIATOXOID|TETANUSTOXOID|PERTUSSISTOXOID|FILAMENTOUSHAEMAGGLUTININ(FHA)|PERTACTIN|HEPATITISBSURFACEANTIGEN(HBSAG)|HAEMOPHILUSINFLUENZAE|POLYSACCHARIDE-K|TETANUSTOXOID"
"4200","INFANRIX HEXA","5 Millilitre                                                                                           Suspension for Injection",2000-10-23,"EU/1/00/152/005","GlaxoSmithKline Biologicals S.A.","DIPHTHERIATOXOID|TETANUSTOXOID|PERTUSSISTOXOID|FILAMENTOUSHAEMAGGLUTININ(FHA)|PERTACTIN|HEPATITISBSURFACEANTIGEN(HBSAG)|HAEMOPHILUSINFLUENZAE|POLYSACCHARIDE-K|TETANUSTOXOID"
"4201","INFANRIX HEXA","5 Millilitre                                                                                           Suspension for Injection",2000-10-23,"EU/1/00/152/006","GlaxoSmithKline Biologicals S.A.","DIPHTHERIATOXOID|TETANUSTOXOID|PERTUSSISTOXOID|FILAMENTOUSHAEMAGGLUTININ(FHA)|PERTACTIN|HEPATITISBSURFACEANTIGEN(HBSAG)|HAEMOPHILUSINFLUENZAE|POLYSACCHARIDE-K|TETANUSTOXOID"
"4202","INFANRIX HEXA","5 Millilitre                                                                                           Suspension for Injection",2000-10-23,"EU/1/00/152/007","GlaxoSmithKline Biologicals S.A.","DIPHTHERIATOXOID|TETANUSTOXOID|PERTUSSISTOXOID|FILAMENTOUSHAEMAGGLUTININ(FHA)|PERTACTIN|HEPATITISBSURFACEANTIGEN(HBSAG)|HAEMOPHILUSINFLUENZAE|POLYSACCHARIDE-K|TETANUSTOXOID"
"4203","INFANRIX HEXA","5 Millilitre                                                                                           Suspension for Injection",2000-10-23,"EU/1/00/152/008","GlaxoSmithKline Biologicals S.A.","DIPHTHERIATOXOID|TETANUSTOXOID|PERTUSSISTOXOID|FILAMENTOUSHAEMAGGLUTININ(FHA)|PERTACTIN|HEPATITISBSURFACEANTIGEN(HBSAG)|HAEMOPHILUSINFLUENZAE|POLYSACCHARIDE-K|TETANUSTOXOID"
"4204","INFANRIX HEXA","5 Millilitre                                                                                           Suspension for Injection",2000-10-20,"EU/1/00/152/009","GlaxoSmithKline Biologicals S.A.","DIPHTHERIATOXOID|TETANUSTOXOID|PERTUSSISTOXOID|FILAMENTOUSHAEMAGGLUTININ(FHA)|PERTACTIN|HEPATITISBSURFACEANTIGEN(HBSAG)|HAEMOPHILUSINFLUENZAE|POLYSACCHARIDE-K|TETANUSTOXOID"
"4205","INFANRIX HEXA","5 Millilitre                                                                                           Suspension for Injection",2000-10-20,"EU/1/00/152/010","GlaxoSmithKline Biologicals S.A.","DIPHTHERIATOXOID|TETANUSTOXOID|PERTUSSISTOXOID|FILAMENTOUSHAEMAGGLUTININ(FHA)|PERTACTIN|HEPATITISBSURFACEANTIGEN(HBSAG)|HAEMOPHILUSINFLUENZAE|POLYSACCHARIDE-K|TETANUSTOXOID"
"4206","INFANRIX HEXA","ml Millilitre                                                                                           Suspension for Injection",2000-10-20,"EU/1/00/152/011","GlaxoSmithKline Biologicals S.A.","DIPHTHERIATOXOID|TETANUSTOXOID|PERTUSSISTOXOID|FILAMENTOUSHAEMAGGLUTININ(FHA)|PERTACTIN|HEPATITISBSURFACEANTIGEN(HBSAG)|HAEMOPHILUSINFLUENZAE|POLYSACCHARIDE-K|TETANUSTOXOID"
"4207","INFANRIX HEXA","5 Millilitre                                                                                           Suspension for Injection",2000-10-20,"EU/1/00/152/012","GlaxoSmithKline Biologicals S.A.","DIPHTHERIATOXOID|TETANUSTOXOID|PERTUSSISTOXOID|FILAMENTOUSHAEMAGGLUTININ(FHA)|PERTACTIN|HEPATITISBSURFACEANTIGEN(HBSAG)|HAEMOPHILUSINFLUENZAE|POLYSACCHARIDE-K|TETANUSTOXOID"
"4208","INFANRIX HEXA","5 Millilitre                                                                                           Suspension for Injection",2000-10-20,"EU/1/00/152/013","GlaxoSmithKline Biologicals S.A.","DIPHTHERIATOXOID|TETANUSTOXOID|PERTUSSISTOXOID|FILAMENTOUSHAEMAGGLUTININ(FHA)|PERTACTIN|HEPATITISBSURFACEANTIGEN(HBSAG)|HAEMOPHILUSINFLUENZAE|POLYSACCHARIDE-K|TETANUSTOXOID"
"4209","INFANRIX HEXA","5 Millilitre                                                                                           Solution for Injection",2000-10-20,"EU/1/00/152/014","GlaxoSmithKline Biologicals S.A.","DIPHTHERIATOXOID|TETANUSTOXOID|PERTUSSISTOXOID|FILAMENTOUSHAEMAGGLUTININ(FHA)|PERTACTIN|HEPATITISBSURFACEANTIGEN(HBSAG)|HAEMOPHILUSINFLUENZAE|POLYSACCHARIDE-K|TETANUSTOXOID"
"4210","Inflectra","100 milligram(s) ZZZ Pdr/Conc/Soln for Infus",2013-09-10,"EU/1/13/854/001-005","Hospira  UK Limited","Ct-p13(infliximab)"
"4211","Influvac Sub-unit, suspension for injection (influenza vaccine, surface antigen, inactivated)","0.5 microgram(s) Suspension for injection",1998-05-01,"PA2010/053/001","Mylan IRE Healthcare Limited","B/COLORADO/06/2017-LIKESTRAIN(B/VICTORIA/2/87LINEAGE)(B/MARYLAND/15/2016,NYMCBX-69A)|A/SINGAPORE/IMFIMH-16-0019/2016(H3N2)-LIKESTRAIN(A/SINGAPORE/INFIMH-16-0019/2016,NIB-104)|A/MICHIGAN/45/2015(H1N1)PDM09-LIKESTRAIN(A/SINGAPORE/GP1908/2015,IVR-180A)"
"4212","Influvac Tetra, suspension for injection in pre-filled syringe (influenza vaccine, surface antigen, inactivated)","15 microgram(s) Solution for injection in pre-filled syringe",2017-08-25,"PA2010/053/002","Mylan IRE Healthcare Limited","A/SINGAPORE/IMFIMH-16-0019/2016(H3N2)-LIKESTRAIN(A/SINGAPORE/INFIMH-16-0019/2016,NIB-104)|B/COLORADO/06/2017-LIKESTRAIN(B/VICTORIA/2/87LINEAGE)(B/MARYLAND/15/2016,NYMCBX-69A)|A/MICHIGAN/45/2015(H1N1)PDM09-LIKESTRAIN(A/SINGAPORE/GP1908/2015,IVR-180A)|B/PHUKET/3073/2013-LIKESTRAIN(B/PHUKET/3073/2013,WILDTYPE)"
"4213","INHIXA","20 mg/0.5ml Solution for injection in pre-filled syringe",2016-09-15,"EU/1/16/1132/001-002","Techdow Europe AB","ENOXAPARINSODIUM"
"4214","INHIXA","40 Milligram                                                                                            Solution for injection in pre-filled syringe",2016-09-15,"EU/1/16/1132/003-004","Techdow Europe AB","ENOXAPARINSODIUM"
"4215","INHIXA","60 Milligram                                                                                            Solution for injection in pre-filled syringe",2016-09-15,"EU/1/16/1132/005-006","Techdow Europe AB","ENOXAPARINSODIUM"
"4216","INHIXA","80 Milligram                                                                                            Solution for injection in pre-filled syringe",2016-09-15,"EU/1/16/1132/007-008","Techdow Europe AB","ENOXAPARINSODIUM"
"4217","INHIXA","100 Milligram                                                                                            Solution for injection in pre-filled syringe",2016-09-15,"EU/1/16/1132/009-010","Techdow Europe AB","ENOXAPARINSODIUM"
"4218","Inlyta","1 milligram(s) Film-coated tablet",2012-09-03,"EU/1/12/777/001-003","Pfizer Limited","Axitinib"
"4219","INLYTA","5 Milligram                                                                                            Film Coated Tablet",2012-09-03,"EU/1/12/777/004-006","Pfizer Europe MA EEIG","AXITINIB"
"4220","INLYTA","3 Milligram                                                                                            Film Coated Tablet",2013-08-26,"EU/1/12/777/007-009","Pfizer Europe MA EEIG","AXITINIB"
"4221","INLYTA","7 Milligram                                                                                            Film Coated Tablet",2013-08-26,"EU/1/12/777/010-012","Pfizer Europe MA EEIG","AXITINIB"
"4222","INNOHEP","4,500 International Unit                                                                                   Solution for Injection",2015-03-13,"PPA0465/322/002","PCO Manufacturing","TINZAPARINSODIUM"
"4223","INNOHEP","4,500 IU/ML                                                                                                Solution for Injection",2018-01-19,"PPA1151/265/001","Imbat Limited","TINZAPARINSODIUM"
"4224","INNOHEP 10,000 IU IN 0.5 ML","20000 IU/ML                                                                                                Solution for Injection",2018-01-12,"PPA1151/265/002","Imbat Limited","TINZAPARINSODIUM"
"4225","INNOHEP 10,000 IU IN 0.5 ML","20000 IU/ML                                                                                                Solution for Injection",2014-04-04,"PPA0465/322/001","PCO Manufacturing","TINZAPARINSODIUM"
"4226","innohep 10,000 IU in 0.5 ml, solution for injection","20000 international unit(s)/millilitre Solution for injection",1997-01-24,"PA0046/060/010","Leo Laboratories Limited","Tinzaparinsodium|Tinzaparinsodium"
"4227","innohep 10,000 IU/ml solution for injection","10000 international unit(s)/millilitre Solution for injection",1991-10-21,"PA0046/060/002","Leo Laboratories Limited","Tinzaparinsodium"
"4228","innohep 12,000 IU in 0.6 ml, Solution for injection","20,000 international unit(s)/millilitre Solution for injection",2014-11-07,"PA0046/060/013","Leo Laboratories Limited","Tinzaparinsodium"
"4229","INNOHEP 14,000 IU IN 0.7 ML","20000 IU/ML                                                                                                Solution for Injection",2018-01-12,"PPA1151/265/003","Imbat Limited","TINZAPARINSODIUM"
"4230","innohep 14,000 IU in 0.7 ml, solution for injection","20000 international unit(s)/millilitre Solution for injection",1997-01-24,"PA0046/060/011","Leo Laboratories Limited","Tinzaparinsodium|Tinzaparinsodium"
"4231","INNOHEP 14000IU IN 0.7ML","20000 IU/ML                                                                                                Solution for Injection",2016-07-01,"PPA0465/322/003","PCO Manufacturing","TINZAPARINSODIUM"
"4232","innohep 16,000 IU in 0.8 ml, Solution for injection","20,000 international unit(s)/millilitre Solution for injection",2014-11-07,"PA0046/060/014","Leo Laboratories Limited","Tinzaparinsodium"
"4233","INNOHEP 18,000 IU IN 0.9 ML","20000 IU/ML                                                                                                Solution for Injection",2018-01-12,"PPA1151/265/004","Imbat Limited","TINZAPARINSODIUM"
"4234","innohep 18,000 IU in 0.9 ml, solution for injection","20000 international unit(s)/millilitre Solution for injection",1997-01-24,"PA0046/060/004","Leo Laboratories Limited","Tinzaparinsodium|Tinzaparinsodium"
"4235","INNOHEP 18000IU IN 0.9ML","20000 IU/ML                                                                                                Solution for Injection",2016-07-01,"PPA0465/322/004","PCO Manufacturing","TINZAPARINSODIUM"
"4236","innohep 2,500 IU, solution for injection","10000 international unit(s)/millilitre Solution for injection",1997-12-11,"PA0046/060/008","Leo Laboratories Limited","Tinzaparinsodium|Tinzaparinsodium"
"4237","innohep 20,000 IU/ml Solution for Injection","20000 international unit(s)/millilitre Solution for injection",1995-02-15,"PA0046/060/003","Leo Laboratories Limited","Tinzaparinsodium"
"4238","innohep 3,500 IU, solution for injection","10000 international unit(s)/millilitre Solution for injection",1997-12-11,"PA0046/060/009","Leo Laboratories Limited","Tinzaparinsodium|Tinzaparinsodium"
"4239","innohep 4,500 IU, solution for injection","10000 international unit(s)/millilitre Solution for injection",1997-12-11,"PA0046/060/007","Leo Laboratories Limited","Tinzaparinsodium|Tinzaparinsodium"
"4240","innohep 8,000 IU in 0.4 ml, Solution for injection","20,000 international unit(s)/millilitre Solution for injection",2014-11-07,"PA0046/060/012","Leo Laboratories Limited","Tinzaparinsodium"
"4241","INNOVACE","2.5 Milligram                                                                                            Tablets",1987-07-22,"PA1286/011/001","Merck Sharp & Dohme Ireland (Human Health) Limited","ENALAPRILMALEATE"
"4242","INNOVACE","5 Milligram                                                                                            Tablets",1985-09-16,"PA1286/011/002","Merck Sharp & Dohme Ireland (Human Health) Limited","ENALAPRILMALEATE"
"4243","INNOVACE","10 Milligram                                                                                            Tablets",1985-09-16,"PA1286/011/003","Merck Sharp & Dohme Ireland (Human Health) Limited","ENALAPRILMALEATE"
"4244","INNOVACE","20 Milligram                                                                                            Tablets",1985-09-16,"PA1286/011/004","Merck Sharp & Dohme Ireland (Human Health) Limited","ENALAPRILMALEATE"
"4245","Innozide 20 mg/12.5 mg Tablets","20/12.5 milligram(s) Tablet",1991-12-16,"PA1286/012/001","Merck Sharp & Dohme Ireland (Human Health) Limited","Hydrochlorothiazide|Enalaprilmaleate"
"4246","INOMAX","400 ppm mo Litre                                                                                                Inhalation Gas",2001-08-01,"EU/1/01/194/001","AGA AB","NITRICOXIDE"
"4247","INOMAX","800 ppm Inhalation Gas",2011-03-18,"EU/1/01/194/003-004","INO Therapeutics AB","NITRICOXIDE"
"4248","Inovelon","40 milligram(s)/millilitre Oral suspension",2011-11-21,"EU/1/06/378/017","Eisai GmbH","Rufinamide"
"4249","Inovelon","100/200/40 milligram(s) Film-coated tablet",2007-01-16,"EU/1/06/378/1-16","Eisai  Ltd.","Rufinamide"
"4250","INSOMNIGER","10 Milligram                                                                                            Tablets",1997-07-25,"PA0405/004/003","Generics (UK) Limited","TEMAZEPAM"
"4251","INSOMNIGER","20 Milligram                                                                                            Tablets",1997-07-25,"PA0405/004/004","Generics (UK) Limited","TEMAZEPAM"
"4252","INSPRA","50 Milligram                                                                                            Tablets",2009-03-30,"DPR1328/016/002","B & S Healthcare","EPLERENONE"
"4253","INSPRA","25 Milligram                                                                                            Film Coated Tablet",2009-11-06,"PPA1151/132/001","Imbat Limited","EPLERENONE"
"4254","INSPRA","50 Milligram                                                                                            Film Coated Tablet",2013-09-13,"PPA1151/132/002","Imbat Limited","EPLERENONE"
"4255","INSPRA 25 mg film-coated tablets","25 milligram(s) Film-coated tablet",2004-08-20,"PA0822/020/001","Pfizer Healthcare Ireland","Eplerenone"
"4256","INSPRA 50 mg film-coated tablets","50 milligram(s) Film-coated tablet",2004-08-20,"PA0822/020/002","Pfizer Healthcare Ireland","Eplerenone"
"4257","INSTANYL","50 Microgram                                                                                            Nasal Spray Solution",2011-06-29,"EU/1/09/531/010-013","Takeda Danmark A/S","FENTANYLCITRATE"
"4258","INSTANYL","100 Microgram                                                                                            Nasal Spray Solution",2011-06-29,"EU/1/09/531/014-017","Takeda Danmark A/S","FENTANYLCITRATE"
"4259","INSTANYL","200 Microgram                                                                                            Nasal Spray Solution",2011-06-29,"EU/1/09/531/018-021","Takeda Danmark A/S","FENTANYLCITRATE"
"4260","INSTANYL","0.5 Micromol Nasal Spray Solution",2009-07-20,"EU/1/09/531/1-3","Takeda Danmark A/S","FENTANYLCITRATE"
"4261","INSTANYL","1.0 Micromol Nasal Spray Solution",2009-07-20,"EU/1/09/531/4-6","Takeda Danmark A/S","FENTANYLCITRATE"
"4262","INSTANYL","2.0 Micromol Nasal Spray Solution",2009-07-20,"EU/1/09/531/7-9","Takeda Danmark A/S","FENTANYLCITRATE"
"4263","INSTILLAGEL","6 Millilitre                                                                                           Gel",1981-12-21,"PA0328/001/001","Farco-Pharma GmbH","LIDOCAINEHYDROCHLORIDE|CHLORHEXIDINEDIGLUCONATE(ASCHLORHEXIDINEDIGLUCONATESOLUTION(20%W/V)PH.EUR.|METHYLPARAHYDROXYBENZOATE|PROPYLPARAHYDROXYBENZOATEPH.EUR.(0431)"
"4264","INSTILLAGEL","11 Millilitre                                                                                           Gel",1981-12-21,"PA0328/001/002","Farco-Pharma GmbH","LIDOCAINEHYDROCHLORIDE|CHLORHEXIDINEDIGLUCONATE(ASCHLORHEXIDINEDIGLUCONATESOLUTION(20%W/V)PH.EUR.|METHYLPARAHYDROXYBENZOATE|PROPYLPARAHYDROXYBENZOATEPH.EUR.(0431)"
"4265","INSULATARD","100 IU/ML                                                                                                Suspension for Injection",2003-08-13,"EU/1/02/233/003-004","Novo Nordisk A/S","INSULINHUMAN"
"4266","INSULATARD","IU/ml IU/ML                                                                                                Suspension for Injection",2002-10-07,"EU/1/02/233/1-15","Novo Nordisk A/S","INSULINHUMAN"
"4267","INSULATARD FLEXPEN","100 IU/ML                                                                                                Suspension for Injection",2002-10-07,"EU/1/02/233/013","Novo Nordisk A/S","INSULINHUMAN"
"4268","INSULATARD INNOLET","100 IU/ML                                                                                                Suspension for Injection",2002-10-07,"EU/1/02/233/010-012","Novo Nordisk A/S","INSULINHUMAN"
"4269","INSULATARD PENFILL","100 IU/ML                                                                                                Suspension for Injection",2002-10-07,"EU/1/02/233/005-007","Novo Nordisk A/S","INSULINHUMAN"
"4270","INSULIN LISPRO SANOFI (PREVIOUSLY ADMELOG)","100 Units/ml                                                                                             Solution for Injection",2017-07-19,"EU/1/17/1203/001-008","sanofi-aventis groupe","INSULINLISPRO"
"4271","INSUMAN BASAL","International Unit                                                                                   Suspension for Injection",1998-11-11,"EU/1/97/030/029","Sanofi-Aventis Deutschland GmbH","INSULINHUMAN"
"4272","INSUMAN BASAL","40 International Unit                                                                                   Suspension for Injection",1998-11-11,"EU/1/97/030/037","Sanofi-Aventis Deutschland GmbH","INSULINHUMAN"
"4273","Insuman Basal","100 unit(s)/millilitre Suspension for injection",1999-02-18,"EU/1/97/030/057","Sanofi-Aventis Deutschland GmbH","Insulinhuman"
"4274","Insuman Basal","100 unit(s)/millilitre Suspension for injection",1999-02-18,"EU/1/97/030/058","Sanofi-Aventis Deutschland GmbH","Insulinhuman"
"4275","INSUMAN BASAL","100 IU/ML                                                                                                Solution for Injection",2000-03-20,"EU/1/97/030/069","Sanofi-Aventis Deutschland GmbH","INSULINHUMAN"
"4276","INSUMAN BASAL","100 IU/ML                                                                                                Suspension for Injection",2000-03-20,"EU/1/97/030/070","Sanofi-Aventis Deutschland GmbH","INSULINHUMAN"
"4277","INSUMAN BASAL","100 IU/ML                                                                                                Suspension for Injection",2000-03-20,"EU/1/97/030/071","Sanofi-Aventis Deutschland GmbH","INSULINHUMAN"
"4278","INSUMAN BASAL","100 IU/ML                                                                                                Suspension for Injection",2000-03-20,"EU/1/97/030/072","Sanofi-Aventis Deutschland GmbH","INSULINHUMAN"
"4279","INSUMAN BASAL 100IU/ML","100 International Unit                                                                                   Suspension for Injection",1998-11-11,"EU/1/97/030/033","Sanofi-Aventis Deutschland GmbH","INSULINHUMAN"
"4280","INSUMAN BASAL 100IU/ML","100 International Unit                                                                                   Suspension for Injection",1998-11-11,"EU/1/97/030/034","Sanofi-Aventis Deutschland GmbH","INSULINHUMAN"
"4281","INSUMAN BASAL 100IU/ML","100 International Unit                                                                                   Suspension for Injection",1997-11-11,"EU/1/97/030/035","Sanofi-Aventis Deutschland GmbH","INSULINHUMAN"
"4282","INSUMAN BASAL 40IU/ML","40 International Unit                                                                                   Suspension for Injection",1998-11-11,"EU/1/97/030/036","Sanofi-Aventis Deutschland GmbH","INSULINHUMAN"
"4283","INSUMAN COMB 15","100 IU/ML                                                                                                Suspension for Injection",2000-03-20,"EU/1/97/030/073","Sanofi-Aventis Deutschland GmbH","INSULINHUMAN"
"4284","INSUMAN COMB 15","100 IU/ML                                                                                                Suspension for Injection",2000-03-20,"EU/1/97/030/074","Sanofi-Aventis Deutschland GmbH","INSULINHUMAN"
"4285","INSUMAN COMB 15","100 IU/ML                                                                                                Suspension for Injection",2000-03-20,"EU/1/97/030/075","Sanofi-Aventis Deutschland GmbH","INSULINHUMAN"
"4286","INSUMAN COMB 15","100 IU/ML                                                                                                Suspension for Injection",2000-03-20,"EU/1/97/030/076","Sanofi-Aventis Deutschland GmbH","INSULINHUMAN"
"4287","INSUMAN COMB 15","100 Units/ml                                                                                             Suspension for Injection",1999-02-18,"EU/1/97/030/059","Sanofi-Aventis Deutschland GmbH","INSULINHUMAN"
"4288","INSUMAN COMB 15","100 Units/ml                                                                                             Suspension for Injection",1999-02-18,"EU/1/97/030/060","Sanofi-Aventis Deutschland GmbH","INSULINHUMAN"
"4289","INSUMAN COMB 15 100 IU/ML","100 International Unit                                                                                   Suspension for Injection",1998-11-11,"EU/1/97/030/038","Sanofi-Aventis Deutschland GmbH","INSULINHUMAN"
"4290","INSUMAN COMB 15 100IU/ML","100 International Unit                                                                                   Suspension for Injection",1998-11-11,"EU/1/97/030/039","Sanofi-Aventis Deutschland GmbH","INSULINHUMAN"
"4291","INSUMAN COMB 15 100IU/ML","100 International Unit                                                                                   Suspension for Injection",1998-11-11,"EU/1/97/030/040","Sanofi-Aventis Deutschland GmbH","INSULINHUMAN"
"4292","INSUMAN COMB 15 40IU/ML","40 International Unit                                                                                   Suspension for Injection",1998-11-11,"EU/1/97/030/041","Sanofi-Aventis Deutschland GmbH","INSULINHUMAN"
"4293","INSUMAN COMB 15 40IU/ML","40 International Unit                                                                                   Suspension for Injection",1998-11-11,"EU/1/97/030/042","Sanofi-Aventis Deutschland GmbH","INSULINHUMAN"
"4294","Insuman Comb 25","100 unit(s)/millilitre Suspension for injection",1999-02-18,"EU/1/97/030/061","Sanofi-Aventis Deutschland GmbH","Insulinhuman"
"4295","Insuman Comb 25","100 unit(s)/millilitre Suspension for injection",1999-02-18,"EU/1/97/030/062","Sanofi-Aventis Deutschland GmbH","Insulinhuman"
"4296","INSUMAN COMB 25","100 IU/ML                                                                                                Suspension for Injection",2000-03-20,"EU/1/97/030/077","Sanofi-Aventis Deutschland GmbH","INSULINHUMAN"
"4297","INSUMAN COMB 25","100 IU/ML                                                                                                Suspension for Injection",2000-03-20,"EU/1/97/030/078","Sanofi-Aventis Deutschland GmbH","INSULINHUMAN"
"4298","INSUMAN COMB 25","100 IU/ML                                                                                                Suspension for Injection",2000-03-20,"EU/1/97/030/079","Sanofi-Aventis Deutschland GmbH","INSULINHUMAN"
"4299","INSUMAN COMB 25","100 IU/ML                                                                                                Suspension for Injection",2000-03-20,"EU/1/97/030/080","Sanofi-Aventis Deutschland GmbH","INSULINHUMAN"
"4300","INSUMAN COMB 25 100IU/ML","100 International Unit                                                                                   Suspension for Injection",1998-11-11,"EU/1/97/030/043","Sanofi-Aventis Deutschland GmbH","INSULINHUMAN"
"4301","INSUMAN COMB 25 100IU/ML","100 International Unit                                                                                   Suspension for Injection",1998-11-11,"EU/1/97/030/044","Sanofi-Aventis Deutschland GmbH","INSULINHUMAN"
"4302","INSUMAN COMB 25 100IU/ML","100 International Unit                                                                                   Suspension for Injection",1998-11-11,"EU/1/97/030/045","Sanofi-Aventis Deutschland GmbH","INSULINHUMAN"
"4303","INSUMAN COMB 25 40IU/ML","40 International Unit                                                                                   Suspension for Injection",1998-11-11,"EU/1/97/030/046","Sanofi-Aventis Deutschland GmbH","INSULINHUMAN"
"4304","INSUMAN COMB 25 40IU/ML","40 International Unit                                                                                   Suspension for Injection",1998-11-11,"EU/1/97/030/047","Sanofi-Aventis Deutschland GmbH","INSULINHUMAN"
"4305","INSUMAN COMB 30","100 IU/ML                                                                                                Suspension for Injection",2009-02-19,"EU/1/97/030/170-189","Sanofi-Aventis Deutschland GmbH","INSULINHUMANHR1799"
"4306","INSUMAN COMB 50","100 IU/ML                                                                                                Suspension for Injection",2000-03-20,"EU/1/97/030/081","Sanofi-Aventis Deutschland GmbH","INSULINHUMAN"
"4307","INSUMAN COMB 50","100 IU/ML                                                                                                Suspension for Injection",2000-03-20,"EU/1/97/030/082","Sanofi-Aventis Deutschland GmbH","INSULINHUMAN"
"4308","INSUMAN COMB 50","100 IU/ML                                                                                                Suspension for Injection",2000-03-20,"EU/1/97/030/083","Sanofi-Aventis Deutschland GmbH","INSULINHUMAN"
"4309","INSUMAN COMB 50","100 IU/ML                                                                                                Suspension for Injection",2000-03-20,"EU/1/97/030/084","Sanofi-Aventis Deutschland GmbH","INSULINHUMAN"
"4310","Insuman Comb 50","100 unit(s)/millilitre Suspension for injection",1999-02-18,"EU/1/97/030/063","Sanofi-Aventis Deutschland GmbH","Insulinhuman"
"4311","Insuman Comb 50","100 unit(s)/millilitre Suspension for injection",1999-02-18,"EU/1/97/030/064","Sanofi-Aventis Deutschland GmbH","Insulinhuman"
"4312","INSUMAN COMB 50 100IU/ML","100 International Unit                                                                                   Suspension for Injection",1998-11-11,"EU/1/97/030/048","Sanofi-Aventis Deutschland GmbH","INSULINHUMAN"
"4313","INSUMAN COMB 50 100IU/ML","100 International Unit                                                                                   Suspension for Injection",1998-11-11,"EU/1/97/030/049","Sanofi-Aventis Deutschland GmbH","INSULINHUMAN"
"4314","INSUMAN COMB 50 100IU/ML","100 International Unit                                                                                   Suspension for Injection",1998-11-11,"EU/1/97/030/050","Sanofi-Aventis Deutschland GmbH","INSULINHUMAN"
"4315","INSUMAN COMB 50 40IU/ML","40 International Unit                                                                                   Suspension for Injection",1998-11-11,"EU/1/97/030/051","Sanofi-Aventis Deutschland GmbH","INSULINHUMAN"
"4316","INSUMAN COMB 50 40IU/ML","40 International Unit                                                                                   Suspension for Injection",1998-11-11,"EU/1/97/030/052","Sanofi-Aventis Deutschland GmbH","INSULINHUMAN"
"4317","INSUMAN IMPLANTABLE","400 IU/ML                                                                                                Solution for Infusion",2013-09-19,"EU/1/97/030/202-203","Sanofi-Aventis Deutschland GmbH","INSULINHUMAN"
"4318","INSUMAN INFUSAT 100IU/ML","100 International Unit                                                                                   Solution for Injection",1998-11-11,"EU/1/97/030/053","Sanofi-Aventis Deutschland GmbH","INSULINHUMAN"
"4319","INSUMAN INFUSAT 100IU/ML","100 International Unit                                                                                   Solution for Injection",1998-11-11,"EU/1/97/030/054","Sanofi-Aventis Deutschland GmbH","INSULINHUMAN"
"4320","INSUMAN RAPID","100 Units/ml                                                                                             Solution for Injection",1999-02-18,"EU/1/97/030/055","Sanofi-Aventis Deutschland GmbH","INSULINHUMAN"
"4321","INSUMAN RAPID","100 Units/ml                                                                                             Solution for Injection",1999-02-18,"EU/1/97/030/056","Sanofi-Aventis Deutschland GmbH","INSULINHUMAN"
"4322","Insuman Rapid","100 international unit(s) Solution for injection",2010-01-12,"EU/1/97/030/030","Sanofi-Aventis Deutschland GmbH","Insulinhuman"
"4323","Insuman Rapid","40 international unit(s) Solution for injection",1998-11-11,"EU/1/97/030/031","Sanofi-Aventis Deutschland GmbH","Insulinhuman"
"4324","INSUMAN RAPID","100 IU/ML                                                                                                Solution for Injection",2000-03-20,"EU/1/97/030/065","Sanofi-Aventis Deutschland GmbH","INSULINHUMAN"
"4325","INSUMAN RAPID","100 IU/ML                                                                                                Solution for Injection",2000-03-20,"EU/1/97/030/066","Sanofi-Aventis Deutschland GmbH","INSULINHUMAN"
"4326","INSUMAN RAPID","100 IU/ML                                                                                                Solution for Injection",2000-03-20,"EU/1/97/030/067","Sanofi-Aventis Deutschland GmbH","INSULINHUMAN"
"4327","INSUMAN RAPID","100 IU/ML                                                                                                Solution for Injection",2000-03-20,"EU/1/97/030/068","Sanofi-Aventis Deutschland GmbH","INSULINHUMAN"
"4328","INSUMAN RAPID","100 IU/ML International Unit                                                                                   Solution for Injection",1997-11-11,"EU/1/97/030/028","Sanofi-Aventis Deutschland GmbH","INSULINHUMAN"
"4329","INSUMAN RAPID 40IU/ML","40 International Unit                                                                                   Solution for Injection",1998-11-11,"EU/1/97/030/032","Sanofi-Aventis Deutschland GmbH","INSULINHUMAN"
"4330","Intal Spincaps 20mg Inhalation Powder Capsule","20 mg/caps milligram(s) Powder for Inhalation",1980-11-03,"PA0018/018/001","Fisons Limited","CROMOGLICATESODIUM"
"4331","Integrilin","0.75 milligram(s)/millilitre ZZZ Infus/Pdr/Oral Soln",NA,"EU/1/99/109/001","Schering Plough Europe",""
"4332","INTEGRILIN","2 Mg/Ml Solution for Infusion",1999-07-01,"EU/1/99/109/002","Glaxo Group Limited","EPTIFIBATIDE"
"4333","INTELENCE","200 Milligram                                                                                            Tablets",2011-11-24,"EU/1/08/468/002","Janssen-Cilag International NV","ETRAVIRINE"
"4334","INTELENCE","25 Milligram                                                                                            Tablets",2013-05-27,"EU/1/08/468/003","Janssen-Cilag International NV","ETRAVIRINE"
"4335","INTELENCE","100 Milligram                                                                                            Tablets",2008-08-28,"EU/1/08/468/1","Janssen-Cilag International NV","ETRAVIRINE"
"4336","INTRALIPID","20 %w/v                                                                                                 Emulsion for Infusion",1989-04-27,"PA0566/019/005","Fresenius Kabi Limited","SOYAOIL"
"4337","Intralipid 10 % w/v Emulsion for Infusion","10 percent weight/volume Emulsion for infusion",2012-11-30,"PA0566/019/013","Fresenius Kabi Limited","Soyabeanoil,refined"
"4338","Intralipid 10% Emulsion for Infusion","10 percent Emulsion for infusion",2001-02-23,"PA0566/019/010","Fresenius Kabi Limited","Soyabeanoil,refined"
"4339","Intralipid 20 % Emulsion for Infusion","20 percent Emulsion for infusion",2001-02-23,"PA0566/019/011","Fresenius Kabi Limited","Soyabeanoil,refined"
"4340","Intralipid 20 % w/v Emulsion for Infusion Biofine bag","20 percent weight/volume Emulsion for infusion",2012-11-30,"PA0566/019/014","Fresenius Kabi Limited","Soyabeanoil,refined"
"4341","Intrarosa","6.5 milligram(s) Pessary",NA,"EU/1/17/1255/001","BSI","Prasterone"
"4342","INTRATECT","50 g/l                                                                                                  Solution for Infusion",2006-02-03,"PA0592/007/001","Biotest Pharma GmbH","HUMANPLASMAPROTEIN&gt;96%IMMUNOGLOBULINS"
"4343","Intratect 100 g/l, solution for infusion","100 gram(s)/litre Solution for infusion",2013-02-15,"PA0592/007/002","Biotest Pharma GmbH","Humanplasmaprotein|Immunoglobuling"
"4344","INTRONA","1,000,000 International Unit                                                                                   Pdr+Solv for Soln for Inj",2000-03-09,"EU/1/99/127/001","Schering Plough Europe","INTERFERONALFA-2B"
"4345","IntronA","3,000,000 international unit(s) Powder and solvent for solution for injection",NA,"EU/1/99/127/002","Merck Sharp & Dohme BV","Interferonalfa-2b"
"4346","IntronA","3,000,000 international unit(s) Powder and solvent for solution for injection",NA,"EU/1/99/127/003","Merck Sharp & Dohme BV","Interferonalfa-2b"
"4347","IntronA","5,000,000 international unit(s) Powder and solvent for solution for injection",NA,"EU/1/99/127/004","Merck Sharp & Dohme BV","Interferonalfa-2b"
"4348","IntronA","5,000,000 international unit(s) Powder and solvent for solution for injection",NA,"EU/1/99/127/005","Merck Sharp & Dohme BV","Interferonalfa-2b"
"4349","IntronA","10,000,000 international unit(s) Powder and solvent for solution for injection",NA,"EU/1/99/127/006","Merck Sharp & Dohme BV","Interferonalfa-2b"
"4350","IntronA","10,000,000 international unit(s) Powder and solvent for solution for injection",NA,"EU/1/99/127/007","Merck Sharp & Dohme BV","Interferonalfa-2b"
"4351","IntronA","10,000,000 international unit(s) Powder and solvent for solution for injection",NA,"EU/1/99/127/008","Merck Sharp & Dohme BV","Interferonalfa-2b"
"4352","IntronA","18,000,000 international unit(s) Powder and solvent for solution for injection",NA,"EU/1/99/127/009","Merck Sharp & Dohme BV","Interferonalfa-2b"
"4353","IntronA","30,000,000 international unit(s) Powder and solvent for solution for injection",NA,"EU/1/99/127/010","Merck Sharp & Dohme BV","Interferonalfa-2b"
"4354","IntronA","3,000,000 international unit(s) Solution for injection",NA,"EU/1/99/127/011","Merck Sharp & Dohme BV","Interferonalfa-2b"
"4355","IntronA","3,000,000 international unit(s) Solution for injection",NA,"EU/1/99/127/012","Merck Sharp & Dohme BV","Interferonalfa-2b"
"4356","IntronA","3,000,000 international unit(s) Solution for injection",NA,"EU/1/99/127/013","Merck Sharp & Dohme BV","Interferonalfa-2b"
"4357","IntronA","3,000,000 international unit(s) Solution for injection",NA,"EU/1/99/127/014","Merck Sharp & Dohme BV","Interferonalfa-2b"
"4358","IntronA","5,000,000 international unit(s) Solution for injection",NA,"EU/1/99/127/015","Merck Sharp & Dohme BV","Interferonalfa-2b"
"4359","IntronA","5,000,000 international unit(s) Solution for injection",NA,"EU/1/99/127/016","Merck Sharp & Dohme BV","Interferonalfa-2b"
"4360","IntronA","5,000,000 international unit(s) Solution for injection",NA,"EU/1/99/127/017","Merck Sharp & Dohme BV","Interferonalfa-2b"
"4361","IntronA","5,000,000 international unit(s) Solution for injection",NA,"EU/1/99/127/018","Merck Sharp & Dohme BV","Interferonalfa-2b"
"4362","IntronA","10,000,000 international unit(s) Solution for injection",NA,"EU/1/99/127/019","Merck Sharp & Dohme BV","Interferonalfa-2b"
"4363","IntronA","10,000,000 international unit(s) Solution for injection",NA,"EU/1/99/127/020","Merck Sharp & Dohme BV","Interferonalfa-2b"
"4364","IntronA","10,000,000 international unit(s) Solution for injection",NA,"EU/1/99/127/021","Merck Sharp & Dohme BV","Interferonalfa-2b"
"4365","IntronA","10,000,000 international unit(s) Solution for injection",NA,"EU/1/99/127/022","Merck Sharp & Dohme BV","Interferonalfa-2b"
"4366","IntronA","18,000,000 international unit(s) Solution for injection",NA,"EU/1/99/127/023","Merck Sharp & Dohme BV","Interferonalfa-2b"
"4367","IntronA","18,000,000 international unit(s) Solution for injection",NA,"EU/1/99/127/024","Merck Sharp & Dohme BV","Interferonalfa-2b"
"4368","IntronA","18,000,000 international unit(s) Solution for injection",NA,"EU/1/99/127/025","Merck Sharp & Dohme BV","Interferonalfa-2b"
"4369","IntronA","18,000,000 international unit(s) Solution for injection",NA,"EU/1/99/127/026","Merck Sharp & Dohme BV","Interferonalfa-2b"
"4370","IntronA","25,000,000 international unit(s) Solution for injection",NA,"EU/1/99/127/027","Merck Sharp & Dohme BV","Interferonalfa-2b"
"4371","IntronA","25,000,000 international unit(s) Solution for injection",NA,"EU/1/99/127/028","Merck Sharp & Dohme BV","Interferonalfa-2b"
"4372","IntronA","25,000,000 international unit(s) Solution for injection",NA,"EU/1/99/127/029","Merck Sharp & Dohme BV","Interferonalfa-2b"
"4373","IntronA","25,000,000 international unit(s) Solution for injection",NA,"EU/1/99/127/030","Merck Sharp & Dohme BV","Interferonalfa-2b"
"4374","IntronA","18,000,000 international unit(s) Solution for injection",NA,"EU/1/99/127/031","Merck Sharp & Dohme BV","Interferonalfa-2b"
"4375","IntronA","18,000,000 *** AWAITING VALUE *** Solution for injection",NA,"EU/1/99/127/032","Merck Sharp & Dohme BV","Interferonalfa-2b"
"4376","IntronA","18,000,000 international unit(s) Solution for injection",NA,"EU/1/99/127/033","Merck Sharp & Dohme BV","Interferonalfa-2b"
"4377","IntronA","30,000,000 international unit(s) Solution for injection",NA,"EU/1/99/127/034","Merck Sharp & Dohme BV","Interferonalfa-2b"
"4378","IntronA","international unit(s) Solution for injection",NA,"EU/1/99/127/035","Merck Sharp & Dohme BV","Interferonalfa-2b"
"4379","INTRONA","30,000,000 International Unit                                                                                   Solution for Injection",2000-03-09,"EU/1/99/127/036","Schering Plough Europe","INTERFERONALFA-2B"
"4380","IntronA","60,000,000 international unit(s) Solution for injection",NA,"EU/1/99/127/037","Merck Sharp & Dohme BV","Interferonalfa-2b"
"4381","INTRONA","60,000,000 International Unit                                                                                   Solution for Injection",2000-03-09,"EU/1/99/127/038","Schering Plough Europe","INTERFERONALFA-2B"
"4382","IntronA","60,000,000 international unit(s) Solution for injection",NA,"EU/1/99/127/039","Merck Sharp & Dohme BV","Interferonalfa-2b"
"4383","Intuniv","1 milligram(s) Modified-release tablet",2015-09-17,"EU/1/15/1040/001-002","Shire Pharmaceuticals Ireland Limited","GUANFACINEHYDROCHLORIDE"
"4384","INTUNIV","2 Milligram                                                                                            Modified-release Tablets",2015-09-17,"EU/1/15/1040/003-005","Shire Pharmaceuticals Ireland Limited","GUANFACINEHYDROCHLORIDE"
"4385","INTUNIV","3 Milligram                                                                                            Modified-release Tablets",2015-09-17,"EU/1/15/1040/006-007","Shire Pharmaceuticals Ireland Limited","GUANFACINEHYDROCHLORIDE"
"4386","INTUNIV","4 Milligram                                                                                            Modified-release Tablets",2015-09-17,"EU/1/15/1040/008-009","Shire Pharmaceuticals Ireland Limited","GUANFACINEHYDROCHLORIDE"
"4387","INVANZ","1 Grams                                                                                                Concentrate for Soln for Inf",2002-04-18,"EU/1/02/216/001","Merck Sharp & Dohme BV,","ERTAPENEMSODIUM"
"4388","INVEGA  ((NOTE - THIS EU # TO BE DELETED AS RESULT OF VARIATION AT EOP KH 29.06.2017))","1.5 Milligram                                                                                            Tablet Prolonged Release",2007-06-26,"EU/1/07/395/077-95","Janssen-Cilag International NV","PALIPERIDONE"
"4389","INVEGA 12 MG PROLONGED-RELEASE TABLETS","12 Milligram                                                                                            Tablet Prolonged Release",2007-06-25,"EU/1/07/395/16-20","Janssen-Cilag International NV","PALIPERIDONE"
"4390","INVEGA 3 MG PROLONGED-RELEASE TABLETS","3 Milligram                                                                                            Tablet Prolonged Release",2007-06-25,"EU/1/07/395/1-5","Janssen-Cilag International NV","PALIPERIDONE"
"4391","INVEGA 6 MG PROLONGED-RELEASE TABLETS","6 Milligram                                                                                            Tablet Prolonged Release",2007-06-25,"EU/1/07/395/6-10","Janssen-Cilag International NV","PALIPERIDONE"
"4392","INVEGA 9 MG PROLONGED-RELEASE TABLETS","9 Milligram                                                                                            Tablet Prolonged Release",2007-06-25,"EU/1/07/395/11-15","Janssen-Cilag International NV","PALIPERIDONE"
"4393","INVIRASE","200 Milligram                                                                                            Capsule",1996-10-07,"EU/1/96/026/001","Roche Registration GmbH","SAQUINAVIR"
"4394","INVIRASE","500 Milligram                                                                                            Coated Tablets",2005-05-25,"EU/1/96/026/002","Roche Registration GmbH","SAQUINAVIR"
"4395","Invokana","100 milligram(s) Film-coated tablet",NA,"EU/1/13/884/001-004","Janssen-Cilag International NV","Canagliflozin"
"4396","INVOKANA","300 Milligram                                                                                            Film Coated Tablet",2013-11-15,"EU/1/13/884/005-008","Janssen-Cilag International NV","CANAGLIFLOZIN"
"4397","IOA","2.5/1.5 Milligram                                                                                            Film Coated Tablet",2011-11-16,"EU/1/11/689/001-002","NV Organon","NOMEGESTROLACETATE|ESTRADIOLHEMIHYDRATE"
"4398","IODINE LINIMENT STRONG SOLUTION","10 6 %w/v                                                                                                 Cutaneous Solution",1992-10-13,"PA0206/026/001","Ovelle Limited","IODINE|POTASSIUMIODIDE"
"4399","IODINE TINCTURE","2.5/2.5 %w/v                                                                                                 Cutaneous Solution",1992-10-13,"PA0206/025/001","Ovelle Limited","IODINE|POTASSIUMIODIDE"
"4400","IOMERON 150","150 Micromol Solution for Injection",1999-03-28,"PA1826/006/001","Bracco Imaging spa","IOMEPROL"
"4401","IOMERON 200","200 Micromol Solution for Injection",1999-03-28,"PA1826/006/002","Bracco Imaging spa","IOMEPROL"
"4402","IOMERON 250","250 Micromol Solution for Injection",1999-03-28,"PA1826/006/003","Bracco Imaging spa","IOMEPROL"
"4403","IOMERON 300","300 Micromol Solution for Injection",1999-03-28,"PA1826/006/004","Bracco Imaging spa","IOMEPROL"
"4404","IOMERON 350","350 Micromol Solution for Injection",1999-03-28,"PA1826/006/005","Bracco Imaging spa","IOMEPROL"
"4405","IOMERON 400","400 Micromol Solution for Injection",1999-03-28,"PA1826/006/006","Bracco Imaging spa","IOMEPROL"
"4406","IONOLYTE","Unknown Solution for Infusion",2015-10-02,"PA0566/074/001","Fresenius Kabi Limited","SODIUMACETATETRIHYDRATE|SODIUMCHLORIDE|POTASSIUMCHLORIDE|MAGNESIUMCHLORIDEHEXAHYDRATE|SODIUMHYDROXIDE"
"4407","IOPIDINE","5 Mg/Ml Eye Drops Solution",1995-04-21,"PA0896/014/001","Novartis Ireland Limited","APRACLONIDINEHYDROCHLORIDE"
"4408","IOPIDINE","1 %w/v                                                                                                 Eye Drops Solution",1996-05-21,"PA0896/014/002","Novartis Ireland Limited","APRACLONIDINEHYDROCHLORIDE"
"4409","IPRAMOL STERI-NEB","0.5/2.5 mg/mg Nebuliser Solution",2005-04-15,"PA0282/079/001","Norton Healthcare Limited T/A IVAX Pharmaceuticals UK","IPRATROPIUMBROMIDEMONOHYDRATE|SALBUTAMOLSULFATE"
"4410","IPRATROPIUM STERI-NEB","250 Microgram/ML                                                                                         Nebuliser Solution",1997-11-14,"PA0282/085/001","Norton Healthcare Limited T/A IVAX Pharmaceuticals UK","IPRATROPIUMBROMIDE"
"4411","IPV Infanrix suspension for injection in pre-filled syringe Diphtheria, tetanus, pertussis (acellular, component) and poliomyelitis (inactivated) vaccine (adsorbed)","0.5 millilitre(s) Suspension for injection in pre-filled syringe",2005-08-05,"PA1077/108/001","GlaxoSmithKline (Ireland) Limited","Pertussistoxoid|Filamentoushaemagglutinin|Pertactin|Diphtheriatoxoid|Tetanustoxoid|Poliovirustype1inactivated|Poliovirustype2inactivated|Poliovirustype3inactivated"
"4412","IPV-Boostrix– Suspension for injection in a pre-filled syringeDiphtheria, tetanus, pertussis (acellular, component) and poliomyelitis (inactivated) vaccine (adsorbed, reduced antigen(s) content)","0.5 millilitre(s) Suspension for injection in pre-filled syringe",2004-12-10,"PA1077/101/001","GlaxoSmithKline (Ireland) Limited","Diphtheriatoxoid|Tetanustoxoid|Pertussistoxoid|Filamentoushaemagglutinin(fha)|Pertactin(prn,or69kdaomp)|Poliovirustype1inactivated|Poliovirustype2inactivated|Poliovirustype3inactivated"
"4413","IRBESAN","75 Milligram                                                                                            Film Coated Tablet",2009-06-19,"PA0711/155/001","Rowex Ltd","IRBESARTAN"
"4414","IRBESAN","150 Milligram                                                                                            Film Coated Tablet",2009-06-19,"PA0711/155/002","Rowex Ltd","IRBESARTAN"
"4415","IRBESAN","300 Milligram                                                                                            Film Coated Tablet",2009-06-19,"PA0711/155/003","Rowex Ltd","IRBESARTAN"
"4416","IRBESARTAN ACCORD","75 Milligram                                                                                            Film Coated Tablet",2012-08-03,"PA1390/053/001","Accord Healthcare Limited","IRBESARTAN"
"4417","IRBESARTAN ACCORD","150 Milligram                                                                                            Film Coated Tablet",2012-08-03,"PA1390/053/002","Accord Healthcare Limited","IRBESARTAN"
"4418","IRBESARTAN ACCORD","300 Milligram                                                                                            Film Coated Tablet",2012-08-03,"PA1390/053/003","Accord Healthcare Limited","IRBESARTAN"
"4419","IRBESARTAN CLONMEL","75 Milligram                                                                                            Film Coated Tablet",2010-09-10,"PA0126/205/001","Clonmel Healthcare Ltd","IRBESARTAN"
"4420","IRBESARTAN CLONMEL","150 Milligram                                                                                            Film Coated Tablet",2010-09-10,"PA0126/205/002","Clonmel Healthcare Ltd","IRBESARTAN"
"4421","IRBESARTAN CLONMEL","300 Milligram                                                                                            Film Coated Tablet",2010-09-10,"PA0126/205/003","Clonmel Healthcare Ltd","IRBESARTAN"
"4422","IRBESARTAN HCT ZENTIVA","150/12.5 Milligram                                                                                            Tablets",2007-01-19,"EU/1/06/377/1-5,11-16","sanofi-aventis groupe","IRBESARTAN|HYDROCHLOROTHIAZIDE"
"4423","IRBESARTAN HCT ZENTIVA","300/25 Milligram                                                                                            Tablets",2007-01-19,"EU/1/06/377/23-28","Sanofi aventis","IRBESARTAN|HYDROCHLOROTHIAZIDE"
"4424","IRBESARTAN HCT ZENTIVA","300/12.5 Milligram                                                                                            Tablets",2007-01-19,"EU/1/06/377/6-10,17-22","Sanofi aventis","IRBESARTAN|HYDROCHLOROTHIAZIDE"
"4425","IRBESARTAN NICHE","150 Milligram                                                                                            Film Coated Tablet",2013-02-15,"PA1063/056/001","Niche Generics Limited","IRBESARTAN"
"4426","IRBESARTAN NICHE","300 Milligram                                                                                            Film Coated Tablet",2013-02-15,"PA1063/056/002","Niche Generics Limited","IRBESARTAN"
"4427","IRBESARTAN PHARMATHEN","75 Milligram                                                                                            Film Coated Tablet",2012-04-13,"EU/1/12/765/001-002","Pharmathen S.A.","IRBESARTAN"
"4428","IRBESARTAN PHARMATHEN","150 Milligram                                                                                            Film Coated Tablet",2012-04-13,"EU/1/12/765/003-004","Pharmathen S.A.","IRBESARTAN"
"4429","IRBESARTAN PHARMATHEN","300 Milligram                                                                                            Film Coated Tablet",2012-04-13,"EU/1/12/765/005-006","Pharmathen S.A.","IRBESARTAN"
"4430","IRBESARTAN ROWA","75 Milligram                                                                                            Tablets",2010-11-05,"PA0074/080/001","Rowa Pharmaceuticals Limited","IRBESARTAN"
"4431","IRBESARTAN ROWA","150 Milligram                                                                                            Tablets",2010-11-05,"PA0074/080/002","Rowa Pharmaceuticals Limited","IRBESARTAN"
"4432","IRBESARTAN ROWA","300 Milligram                                                                                            Tablets",2010-11-05,"PA0074/080/003","Rowa Pharmaceuticals Limited","IRBESARTAN"
"4433","IRBESARTAN TEVA","75 Milligram                                                                                            Film Coated Tablet",2009-10-30,"EU/1/09/576/1-13","Teva B.V.","IRBESARTAN"
"4434","IRBESARTAN TEVA","150 Milligram                                                                                            Film Coated Tablet",2009-10-30,"EU/1/09/576/14-26","Teva B.V.","IRBESARTAN"
"4435","IRBESARTAN TEVA","300 Milligram                                                                                            Film Coated Tablet",2009-10-30,"EU/1/09/576/27-39","Teva B.V.","IRBESARTAN"
"4436","Irbesartan Winthrop","300 milligram(s) Tablet",2007-01-19,"EU/1/06/376/11-15","Zentiva k.s.","Irbesartan"
"4437","Irbesartan Winthrop","75 milligram(s) Tablet",2007-01-19,"EU/1/06/376/1-5","Zentiva k.s.","Irbesartan"
"4438","Irbesartan Winthrop","75 milligram(s) Film-coated tablet",2007-01-19,"EU/1/06/376/1-5-16-21","Zentiva k.s.","Irbesartan"
"4439","Irbesartan Winthrop","75 milligram(s) Film-coated tablet",2007-01-19,"EU/1/06/376/16-21","Zentiva k.s.","Irbesartan"
"4440","Irbesartan Winthrop","150 milligram(s) Film-coated tablet",2007-01-19,"EU/1/06/376/22-27","Zentiva k.s.","Irbesartan"
"4441","Irbesartan Winthrop","300 milligram(s) Film-coated tablet",2007-01-19,"EU/1/06/376/28-33","Zentiva k.s.","Irbesartan"
"4442","Irbesartan Winthrop","150 milligram(s) Tablet",2007-01-19,"EU/1/06/376/6-10","Zentiva k.s.","Irbesartan"
"4443","IRBESARTAN/HYDROCHLOROTHIAZIDE TEVA","150/12.5 Milligram                                                                                            Film Coated Tablet",2009-11-26,"EU/1/09/583/1-24","Teva B.V.","IRBESARTAN|HYDROCHLOROTHIAZIDE,MICRONISED"
"4444","IRBESARTAN/HYDROCHLOROTHIAZIDE TEVA","300/12.5 Milligram                                                                                            Film Coated Tablet",2009-11-26,"EU/1/09/583/25-48","Teva B.V.","IRBESARTAN|HYDROCHLOROTHIAZIDE,MICRONISED"
"4445","IRBESARTAN/HYDROCHLOROTHIAZIDE TEVA","300/25 Milligram                                                                                            Film Coated Tablet",2009-11-26,"EU/1/09/583/49-72","Teva B.V.","IRBESARTAN|HYDROCHLOROTHIAZIDE,MICRONISED"
"4446","IRESSA","250 Milligram                                                                                            Film Coated Tablet",2009-06-24,"EU/1/09/526/001","AstraZeneca AB","GEFITINIB"
"4447","IREVEN","75 Milligram                                                                                            Prolonged Release Capsules",2008-07-04,"PA1368/002/001","Pharmathen S.A.","VENLAFAXINEHYDROCHLORIDE"
"4448","IREVEN","150 Milligram                                                                                            Prolonged Release Capsules",2008-07-04,"PA1368/002/002","Pharmathen S.A.","VENLAFAXINEHYDROCHLORIDE"
"4449","IRINOTECAN","20 Milligram                                                                                            Concentrate for Soln for Inf",2008-05-02,"PA1422/001/001","Fresenius Kabi Oncology Plc","IRINOTECANHYDROCHLORIDETRIHYDRATE"
"4450","IRINOTECAN HYDROCHLORIDE","20 Mg/Ml Concentrate for Soln for Inf",2016-07-15,"PA1390/113/001","Accord Healthcare Limited","IRINOTECANHYDROCHLORIDETRIHYDRATE"
"4451","IRINOTECAN HYDROCHLORIDE","20 Mg/Ml Concentrate for Soln for Inf",2008-05-16,"PA1986/068/001","Teva B.V.","IRINOTECANHYDROCHLORIDETRIHYDRATE"
"4452","IRINOTECAN HYDROCHLORIDE","20 Mg/Ml Concentrate for Soln for Inf",2004-04-06,"PA0437/051/001","Hospira  UK Limited","IRINOTECANHYDROCHLORIDETRIHYDRATE"
"4453","IRINOTECAN HYDROCHLORIDE 20 MG/ML CONCENTRATE FOR","20 Micromol Solution for Infusion",2008-11-03,"PA1422/016/001","Fresenius Kabi Oncology Plc","IRINOTECANHYDROCHLORIDETRIHYDRATE"
"4454","IRINOTECAN KOANAA","20 Mg/Ml Concentrate for Soln for Inf",2017-07-07,"PA2041/004/001","Koanaa Healthcare Limited","IRINOTECANHYDROCHLORIDETRIHYDRATE"
"4455","Irish Botanica Echinacea Oral Liquid",".  Liquid",2017-05-26,"TR1723/001/001","The Natural Way (Irish Botanica)","TINCTUREFROMDRIEDECHINACEAPURPUREA(L.)MOENCHRADIX(1:3)"
"4456","IRPRESTAN","75 Milligram                                                                                            Film Coated Tablet",2009-07-03,"PA1380/021/001","Actavis Group PTC ehf","IRBESARTAN"
"4457","IRPRESTAN","150 Milligram                                                                                            Film Coated Tablet",2009-07-03,"PA1380/021/002","Actavis Group PTC ehf","IRBESARTAN"
"4458","IRPRESTAN","300 Milligram                                                                                            Film Coated Tablet",2009-07-03,"PA1380/021/003","Actavis Group PTC ehf","IRBESARTAN"
"4459","IRPREZIDE","150/12.5 Milligram                                                                                            Film Coated Tablet",2011-02-11,"PA1380/080/001","Actavis Group PTC ehf","IRBESARTAN|HYDROCHLOROTHIAZIDE"
"4460","IRPREZIDE","300/12.5 Milligram                                                                                            Film Coated Tablet",2011-02-11,"PA1380/080/002","Actavis Group PTC ehf","IRBESARTAN|HYDROCHLOROTHIAZIDE"
"4461","IRPREZIDE","300/25 Milligram                                                                                            Film Coated Tablet",2011-02-11,"PA1380/080/003","Actavis Group PTC ehf","IRBESARTAN|HYDROCHLOROTHIAZIDE"
"4462","IRUXOL MONO","1.2 Units/Gram                                                                                           Ointment",1990-09-03,"PA0518/007/001","T.J. Smith & Nephew","PROTEASE|CLOSTRIDIOPEPTIDASEA"
"4463","ISANIVA","75 Microgram                                                                                            Film Coated Tablet",2013-09-13,"PA1380/133/001","Actavis Group PTC ehf","DESOGESTRELMICRONIZED"
"4464","ISCOVER","75 Milligram                                                                                            Film Coated Tablet",1998-07-15,"EU/1/98/070/001","sanofi-aventis groupe","CLOPIDOGRELHYDROGENSULFATE"
"4465","ISCOVER","300 Milligram                                                                                            Film Coated Tablet",2008-04-16,"EU/1/98/070/8-10","sanofi-aventis groupe","CLOPIDOGRELHYDROGENSULFATE"
"4466","Isentress","25 milligram(s) Chewable tablet",NA,"EU/1/07/436/003","Merck Sharp & Dohme Ltd","Raltegravir"
"4467","ISENTRESS","100 Milligram                                                                                            Tablets Chewable",2013-04-12,"EU/1/07/436/004","Merck Sharp & Dohme BV","RALTEGRAVIR"
"4468","ISENTRESS","100 Milligram                                                                                            Granules for Oral Suspension",2014-08-22,"EU/1/07/436/005","Merck Sharp & Dohme BV","RALTEGRAVIR"
"4469","ISENTRESS","600 Milligram                                                                                            Film Coated Tablet",2017-07-13,"EU/1/07/436/006","Merck Sharp & Dohme BV","RALTEGRAVIR"
"4470","ISENTRESS","400 Milligram                                                                                            Film Coated Tablet",2007-12-20,"EU/1/07/436/1-2","Merck Sharp and Dohme Limited","RALTEGRAVIRPOTASSIUM"
"4471","ISOKET","0.1 %w/v                                                                                                 Concentrate for Soln for Inf",1984-11-13,"PA2118/003/002","Merus Labs Luxco II S.à.R.L.","ISOSORBIDEDINITRATE"
"4472","ISOKET","0.05 %w/v                                                                                                 Solution for Infusion",1989-01-09,"PA2118/003/003","Merus Labs Luxco II S.à.R.L.","ISOSORBIDEDINITRATE"
"4473","ISOKET AMPOULES","0.1 %w/v                                                                                                 Concentrate for Soln for Inf",1982-12-01,"PA2118/003/001","Merus Labs Luxco II S.à.R.L.","ISOSORBIDEDINITRATE"
"4474","ISOMEL SR","60 Milligram                                                                                            Tablet Prolonged Release",1998-08-14,"PA2261/002/001","Dexcel Pharma GmbH","ISOSORBIDEMONONITRATE"
"4475","ISOMONIT RETARD","60 Milligram                                                                                            Tablet Prolonged Release",1998-12-10,"PA0711/023/001","Rowex Ltd","ISOSORBIDEMONONITRATE"
"4476","ISOPTIN","40 Milligram                                                                                            Film Coated Tablet",1980-04-01,"PA2010/003/001","Mylan IRE Healthcare Limited","VERAPAMILHYDROCHLORIDE"
"4477","ISOPTIN","80 Milligram                                                                                            Film Coated Tablet",1980-04-01,"PA2010/003/002","Mylan IRE Healthcare Limited","VERAPAMILHYDROCHLORIDE"
"4478","ISOPTIN","2.5 Mg/Ml Solution for Inj/Inf",1980-04-01,"PA2010/003/004","Mylan IRE Healthcare Limited","VERAPAMILHYDROCHLORIDE"
"4479","Isoptin 120 mg Film-coated Tablets","120 milligram(s) Film-coated tablet",1980-04-01,"PA2010/003/003","Mylan IRE Healthcare Limited","VERAPAMILHYDROCHLORIDE"
"4480","ISOPTIN SR","240 Milligram                                                                                            Prolonged Release Capsules",1987-05-07,"PA2010/003/005","Mylan IRE Healthcare Limited","VERAPAMILHYDROCHLORIDE"
"4481","ISOTREX","0.05 %w/w                                                                                                 Gel",1992-08-18,"PA1077/122/001","GlaxoSmithKline (Ireland) Limited","ISOTRETINOIN"
"4482","Isotrexin 20 mg/g + 0.5 mg/g Gel","20+0.5 milligram(s)/gram Gel",1998-10-02,"PA1077/123/001","GlaxoSmithKline (Ireland) Limited","Isotretinoin|Erythromycin"
"4483","ISTIN","5 Milligram                                                                                            Tablets",2006-10-06,"PPA1151/010/001","Imbat Limited","AMLODIPINEBESYLATE"
"4484","ISTIN","10 Milligram                                                                                            Tablets",2006-10-06,"PPA1151/010/002","Imbat Limited","AMLODIPINEBESYLATE"
"4485","Istin 10 mg  Tablets","10 milligram(s) Tablet",1989-08-09,"PA0822/209/002","Pfizer Healthcare Ireland","Amlodipinebesilate"
"4486","Istin 10 mg Tablets","10 milligram(s) Tablet",2000-11-17,"PPA0465/065/002","PCO Manufacturing","Amlodipine"
"4487","Istin 10mg Tablets","10 milligram(s) Tablet",2011-09-30,"PPA1097/061/002","Lexon (UK) Ltd","Amlodipinebesilate"
"4488","Istin 5 mg Tablets","5 milligram(s) Tablet",2000-11-17,"PPA0465/065/001","PCO Manufacturing","Amlodipine"
"4489","Istin 5mg Tablets","5 milligram(s) Tablet",1989-08-09,"PA0822/209/001","Pfizer Healthcare Ireland","Amlodipinebesilate"
"4490","Istin 5mg Tablets","5 milligram(s) Tablet",2011-09-30,"PPA1097/061/001","Lexon (UK) Ltd","Amlodipinebesilate"
"4491","ISTOLDE","5 Milligram                                                                                            Tablets",2008-11-28,"PA1380/014/001","Actavis Group PTC ehf","AMLODIPINEBESILATE"
"4492","ISTOLDE","10 Milligram                                                                                            Tablets",2008-11-28,"PA1380/014/002","Actavis Group PTC ehf","AMLODIPINEBESILATE"
"4493","ITAMI","140 Milligram                                                                                            Medicated Plaster",2017-11-10,"PA0814/002/001","Fidia Farmaceutici S.p.A.","DICLOFENACSODIUM"
"4494","Itraconazole 10mg/ml Oral Solution","10 milligram(s)/millilitre Oral solution",2013-10-18,"PA1338/009/001","Focus Pharmaceuticals Ltd","Itraconazole"
"4495","Itraconazole 10mg/ml oral solution","10 milligram(s)/millilitre Oral solution",2013-05-10,"PA0298/023/001","Athlone Laboratories Ltd","Itraconazole"
"4496","IVABRADINE  JENSONR","5 Milligram                                                                                            Film Coated Tablet",2016-11-11,"EU/1/16/1145/001-017","JensonR + Limited","IVABRADINEHYDROCHLORIDE"
"4497","IVABRADINE  JENSONR","7.5 Milligram                                                                                            Film Coated Tablet",2016-11-11,"EU/1/16/1145/018-034","JensonR + Limited","IVABRADINEHYDROCHLORIDE"
"4498","IVABRADINE ACCORD","5 Milligram                                                                                            Film Coated Tablet",2017-05-22,"EU/1/17/1190/001-007","Accord Healthcare Limited","IVABRADINEHYDROCHLORIDE"
"4499","IVABRADINE ACCORD","7.5 Milligram                                                                                            Film Coated Tablet",2017-05-22,"EU/1/17/1190/008-014","Accord Healthcare Limited","IVABRADINEHYDROCHLORIDE"
"4500","IVABRADINE ACTAVIS","5 Milligram                                                                                            Film Coated Tablet",2017-08-11,"PA1380/198/001","Actavis Group PTC ehf","IVABRADINE"
"4501","IVABRADINE ACTAVIS","7.5 Milligram                                                                                            Film Coated Tablet",2017-08-11,"PA1380/198/002","Actavis Group PTC ehf","IVABRADINE"
"4502","Ivabradine Anpharm","5 milligram(s) Film-coated tablet",NA,"EU/1/15/1041/001-007","Anpharm Przedsiebiorstwo Farmaceutyczne S.A","Ivabradinehydrochloride"
"4503","IVABRADINE ANPHARM","7.5 Milligram                                                                                            Film Coated Tablet",2015-09-08,"EU/1/15/1041/008-014","Anpharm Przedsiebiorstwo Farmaceutyczne S.A","IVABRADINEHYDROCHLORIDE"
"4504","IVABRADINE CHANELLE MEDICAL","5 Milligram                                                                                            Film Coated Tablet",2017-01-27,"PA0688/046/001","Chanelle Medical","IVABRADINE"
"4505","IVABRADINE CHANELLE MEDICAL","7.5 Milligram                                                                                            Film Coated Tablet",2017-01-27,"PA0688/046/002","Chanelle Medical","IVABRADINE"
"4506","Ivabradine Krka 5 mg Film-coated Tablets","5 milligram(s) Film-coated tablet",2017-03-01,"PA1347/065/001","Krka d.d., Novo mesto","Ivabradine"
"4507","Ivabradine Krka 7.5 mg Film-coated Tablets","7.5 milligram(s) Film-coated tablet",2017-03-01,"PA1347/065/002","Krka d.d., Novo mesto","Ivabradine"
"4508","IVABRADINE MYLAN","5 Milligram                                                                                            Film Coated Tablet",2016-12-16,"PA0577/186/001","McDermott Laboratories Ltd t/a Gerard Laboratories","IVABRADINEOXALATE"
"4509","IVABRADINE MYLAN","7.5 Milligram                                                                                            Film Coated Tablet",2016-12-16,"PA0577/186/002","McDermott Laboratories Ltd t/a Gerard Laboratories","IVABRADINEOXALATE"
"4510","IVABRADINE ROWEX","5 Milligram                                                                                            Film Coated Tablet",2016-02-10,"PA0711/265/001","Rowex Ltd","IVABRADINE"
"4511","IVABRADINE ROWEX","7.5 Milligram                                                                                            Film Coated Tablet",2016-02-10,"PA0711/265/002","Rowex Ltd","IVABRADINE"
"4512","IVABRADINE ZENTIVA","5 Milligram                                                                                            Film Coated Tablet",2016-11-11,"EU/1/16/1144/001-007","Zentiva k.s.","IVABRADINEHYDROCHLORIDE"
"4513","IVABRADINE ZENTIVA","7.5 Milligram                                                                                            Film Coated Tablet",2016-11-11,"EU/1/16/1144/008-014","Zentiva k.s.","IVABRADINEHYDROCHLORIDE"
"4514","IVEMEND","115 Milligram                                                                                            Pdr for Soln for Infusion",2008-01-11,"EU/1/07/437/001-2","Merck Sharp and Dohme Limited","FOSAPREPITANTDIMEGLUMINE"
"4515","IVEMEND","150 Milligram                                                                                            Pdr for Soln for Infusion",2010-08-31,"EU/1/07/437/003-004","Merck Sharp & Dohme Ltd","FOSAPREPITANTDIMEGLUMINE"
"4516","Ixiaro","6 microgram(s) Suspension for injection",2009-03-31,"EU/1/08/501/1-2","Intercell Austria AG","Inactivatedjevirus"
"4517","IXPRIM","37.5/325 Milligram                                                                                            Tablets Effervescent",2008-12-12,"PA2242/006/002","Grunenthal Pharma Ltd","PARACETAMOL|TRAMADOLHYDROCHLORIDE"
"4518","IXPRIM","37.5/325 Milligram                                                                                            Film Coated Tablet",2017-03-31,"PPA1097/010/001","Lexon (UK) Ltd","TRAMADOLHYDROCHLORIDE|PARACETAMOL"
"4519","IXPRIM","37.5/325 Milligram                                                                                            Film Coated Tablet",2014-07-18,"PPA1562/121/001","LTT Pharma Limited","TRAMADOLHYDROCHLORIDE|PARACETAMOL"
"4520","IXPRIM","37.5/325 Milligram                                                                                            Film Coated Tablet",2016-09-02,"PPA1633/044/001","Primecrown 2010 Ltd","TRAMADOLHYDROCHLORIDE|PARACETAMOL"
"4521","IXPRIM 37.5 mg/325 mg, film coated-tablets","37.5/325 milligram(s) Film-coated tablet",2008-02-15,"PA2242/006/001","Grunenthal Pharma Ltd","Tramadolhydrochloride|Paracetamol"
"4522","IZBA","30 Microgram/ML                                                                                         Eye Drops Solution",2014-02-20,"EU/1/13/905/001-002","Novartis Europharm Limited","TRAVOPROST"
"4523","Jakavi","5 milligram(s) Tablet",2012-08-23,"EU/1/12/773/001","Novartis Europharm Ltd","Ruxolitinib(asphosphate)"
"4524","JAKAVI","15 Milligram                                                                                            Tablets",2012-08-23,"EU/1/12/773/002","Novartis Europharm Limited","RUXOLITINIB(ASPHOSPHATE)"
"4525","JAKAVI","20 Milligram                                                                                            Tablets",2012-08-23,"EU/1/12/773/003","Novartis Europharm Limited","RUXOLITINIB(ASPHOSPHATE)"
"4526","JAKAVI","10 Milligram                                                                                            Tablets",2014-10-03,"EU/1/12/773/013-016","Novartis Europharm Limited","RUXOLITINIB(ASPHOSPHATE)"
"4527","Jalra","50 milligram(s) Tablet",NA,"EU/1/08/485/1-11","Novartis Europharm Limited","Vildagliptin"
"4528","Janumet","50/850 milligram(s) Film-coated tablet",2008-07-16,"EU/1/08/455/1-7","Merck Sharp and Dohme Limited","Sitagliptinphosphate|METFORMINHYDROCHLORIDE"
"4529","JANUMET","50/1000 Milligram                                                                                            Film Coated Tablet",2008-07-16,"EU/1/08/455/8-14","Merck Sharp & Dohme BV","SITAGLIPTINPHOSPHATE|METFORMINHYDROCHLORIDE"
"4530","JANUVIA","100 Milligram                                                                                            Tablets",2007-03-21,"EU/1/07/383/13-18","Merck Sharp & Dohme BV","SITAGLIPTINPHOSPHATEMONOHYDRATE"
"4531","Januvia","25 milligram(s) Tablet",2007-03-21,"EU/1/07/383/1-6","Merck Sharp and Dohme Limited","Sitagliptinphosphatemonohydrate"
"4532","JANUVIA","50 Milligram                                                                                            Tablets",2007-03-21,"EU/1/07/383/7-12","Merck Sharp & Dohme BV","SITAGLIPTINPHOSPHATEMONOHYDRATE"
"4533","Jardiance","25 milligram(s) Film-coated tablet",NA,"EU/1/14/930/001-009","Boehringer Ingelheim International GmbH","Empagliflozin"
"4534","JARDIANCE","10 Milligram                                                                                            Film Coated Tablet",2014-05-22,"EU/1/14/930/010-018","Boehringer Ingelheim International GmbH",""
"4535","JAVLOR","25 Mg/Ml Concentrate for Soln for Inf",2009-09-21,"EU/1/09/550/1-12","Pierre Fabre Medicament","VINFLUNINEDITARTRATE"
"4536","Jaydess 13.5 mg intrauterine delivery system","13.5 milligram(s) Intrauterine delivery system",2013-02-08,"PA1410/068/001","Bayer Limited","Levonorgestrel,micronized"
"4537","JENTADUETO","2.5/850 Milligram                                                                                            Film Coated Tablet",2012-07-20,"EU/1/12/780/001-014","Boehringer Ingelheim International GmbH","LINAGLIPTIN|METFORMIN"
"4538","JENTADUETO","2.5/1000 Milligram                                                                                            Film Coated Tablet",2012-07-20,"EU/1/12/780/015-028","Boehringer Ingelheim International GmbH","LINAGLIPTIN|METFORMIN"
"4539","JETREA","0.5/0.2 Mg/Ml Solution for Injection",2013-05-27,"EU/1/13/819/001","ThromboGenics NV","OCRIPLASMIN"
"4540","JETREA","0.375/0.3 Mg/Ml Solution for Injection",2015-04-24,"EU/1/13/819/002","ThromboGenics NV","OCRIPLASMIN"
"4541","JEVTANA","60/1.5 Mg/Ml Concentrate and solvent for solution for infusion",2011-03-17,"EU/1/11/676/001","Sanofi aventis","CABAZITAXEL"
"4542","JEXT","150 Microgram                                                                                            Solution for injection in pre-filled pen",2011-02-18,"PA1255/006/001","ALK-Abello A/S","EPINEPHRINE"
"4543","JEXT","300 Microgram                                                                                            Solution for injection in pre-filled pen",2011-02-18,"PA1255/006/002","ALK-Abello A/S","EPINEPHRINE"
"4544","JINARC","15 Milligram                                                                                            Tablets",2015-05-27,"EU/1/15/1000/001-002","Otsuka Pharmaceutical Europe Ltd","TOLVAPTAN"
"4545","JINARC","30 Milligram                                                                                            Tablets",2015-05-27,"EU/1/15/1000/003-004","Otsuka Pharmaceutical Europe Ltd","TOLVAPTAN"
"4546","JINARC","15 + 45 Milligram                                                                                            Tablets",2015-05-27,"EU/1/15/1000/005-007","Otsuka Pharmaceutical Europe Ltd","TOLVAPTAN"
"4547","JINARC","30 + 60 Milligram                                                                                            Tablets",2015-05-27,"EU/1/15/1000/008-010","Otsuka Pharmaceutical Europe Ltd","TOLVAPTAN"
"4548","JINARC","30 + 90 Milligram                                                                                            Tablets",2015-05-27,"EU/1/15/1000/011-013","Otsuka Pharmaceutical Europe Ltd","TOLVAPTAN"
"4549","JORVEZA","1 Milligram                                                                                            Orodispersible Tablet",2018-01-08,"EU/1/17/1254/001-005","Dr. Falk Pharma GmbH","SODIUMHYDROXIDE"
"4550","JULUCA","50/25 Milligram                                                                                            Film Coated Tablet",2018-05-16,"EU/1/18/1282/001-002","ViiV Healthcare UK Ltd","DOLUTEGRAVIR|SODIUMSTARCHGLYCOLATEEP|IRONOXIDEYELLOW(E172)"
"4551","JUNIOR PARAPAED PARACETAMOL","120 ml/5ml                                                                                               Oral Suspension",1982-12-01,"PA0281/002/001","Pinewood Laboratories Ltd,","PARACETAMOL"
"4552","JUNYELT, CONCENTRATE FOR SOLUTION FOR INFUSION","Unknown Concentrate for Soln for Inf",2017-03-24,"PA1968/006/001","Laboratoire AGUETTANT","ZINCGLUCONATE|COPPERGLUCONATE|MANGANESEGLUCONATE|POTASSIUMIODIDE|SODIUMSELENITE"
"4553","JYLAMVO","2 Mg/Ml Oral Solution",2017-03-29,"EU/1/17/1172/001","Therakind Limited",""
"4554","KABIVEN","%w/v                                                                                                 Emulsion for Infusion",2006-07-28,"PA0566/003/003","Fresenius Kabi Limited","SOYBEANOIL|GLUCOSEANHYDROUS|ALANINE|ARGININE|ASPARTICACID|GLUTAMICACID|AMINOACETICACID|HISTIDINE|ISOLEUCINE|LEUCINE|LYSINE|DL-METHIONINE|PHENYLALANINE|PROLINE|SERINE|THREONINE|TRYPTOPHAN,L-|TYROSINE|VALINE|CALCIUMCHLORIDEDIHYDRATE|SODIUMGLYCEROPHOSPHATEANHYDROUS|MAGNESIUMSULFATE|POTASSIUMCHLORIDE|SODIUMACETATE"
"4555","KABIVEN","%w/v                                                                                                 Emulsion for Infusion",1999-11-12,"PA0566/003/001","Fresenius Kabi Limited","SOYBEANOIL|GLUCOSEANHYDROUS|ALANINE|ARGININE|ASPARTICACID|GLUTAMICACID|GLYCINEHYDROCHLORIDE|HISTIDINE|ISOLEUCINE|LEUCINE|LYSINE|L-METHIONINE|PHENYLALANINE|PROLINE|SERINE|THREONINE|TRYPTOPHAN,L-|TYROSINE|VALINE|CALCIUMCHLORIDEDIHYDRATE|SODIUMGLYCEROPHOSPHATEANHYDROUS|MAGNESIUMSULFATE|POTASSIUMCHLORIDE|SODIUMACETATE"
"4556","KABIVEN PERIPHERAL","%w/v                                                                                                 Emulsion for Infusion",2000-09-29,"PA0566/003/002","Fresenius Kabi Limited","SOYBEANOIL|GLUCOSEANHYDROUS|ALANINE|ARGININE|ASPARTICACID|GLUTAMICACID|GLYCINE|HISTIDINE|ISOLEUCINE|LEUCINE|LYSINE|METHIONINE|PHENYLALANINE|PROLINE|SERINE|THREONINE|TRYPTOPHAN,L-|TYROSINE|VALINE|CALCIUMCHLORIDEDIHYDRATE|SODIUMGLYCEROPHOSPHATEANHYDROUS|POTASSIUMCHLORIDE|SODIUMACETATE"
"4557","KABIVEN PERIPHERAL","%w/v                                                                                                 Emulsion for Infusion",2006-07-28,"PA0566/003/004","Fresenius Kabi Limited","SOYAOIL|GLUCOSEANHYDROUS|ALANINE|ARGININE|ASPARTICACID|GLUTAMICACID|GLYCINE|HISTIDINE|ISOLEUCINE|LEUCINE|LYSINE|DL-METHIONINE|PHENYLALANINE|PROLINE|SERINE|THREONINE|TRYPTOPHAN,L-|TYROSINE|VALINE|CALCIUMCHLORIDEDIHYDRATE|SODIUMGLYCEROPHOSPHATEANHYDROUS|MAGNESIUMSULFATE|POTASSIUMCHLORIDE|SODIUMACETATE"
"4558","Kadcyla","100 milligram(s) Powder for solution for infusion",2014-01-30,"EU/1/13/885/001","Roche Registration GmbH","Trastuzumabemtansine"
"4559","KADCYLA","160 Milligram                                                                                            Pdr for Soln for Infusion",2014-01-30,"EU/1/13/885/002","Roche Registration GmbH","TRASTUZUMABEMTANSINE"
"4560","KALCIPOS-D FORTE","500mg/800 International Unit                                                                                   Tablets Chewable",2015-01-16,"PPA1151/162/001","Imbat Limited","CALCIUMCARBONATE|COLECALCIFEROL"
"4561","Kalcipos-D forte 500 mg/800 IU chewable tablets","500/800 ZZZ mg/IU Chewable tablet",2010-05-21,"PA2010/040/002","Mylan IRE Healthcare Limited","Calcium|Cholecalciferol"
"4562","Kalcipos-D forte 500mg/800 IU film-coated tablets","500mg/800 international unit(s) Film-coated tablet",2012-05-11,"PA2010/040/001","Mylan IRE Healthcare Limited","CALCIUMCARBONATE|Cholecalciferol"
"4563","KALETRA","133,3/33,3 Milligram                                                                                            Capsule",2001-03-20,"EU/1/01/172/001","AbbVie Deutschland GmbH & Co. KG","RITONAVIR|LOPINAVIR"
"4564","KALETRA","80+20 Mg/Ml Infus/Pdr/Oral Soln",2001-03-20,"EU/1/01/172/003","AbbVie Deutschland GmbH & Co. KG","RITONAVIR|LOPINAVIR"
"4565","KALETRA","100/25 Milligram                                                                                            Film Coated Tablet",2008-03-18,"EU/1/01/172/006","AbbVie Deutschland GmbH & Co. KG","LOPINAVIR|RITONAVIR"
"4566","KALETRA","200/50 Milligram                                                                                            Tablets",2006-07-27,"EU/1/01/172/4-5,7-8","AbbVie Deutschland GmbH & Co. KG","LOPINAVIR|RITONAVIR"
"4567","KALIUM PHOSPHORICUM (KALI. PHOS.) (6C & 30C)","6C & 30C Unknown Tablets",2009-11-20,"HOR0407/045/001","Weleda (UK) Limited","KALIUMPHOSPHORICUM"
"4568","KALMS DAY","Film Coated Tablet",2013-05-10,"TR0257/002/001","GR Lane Health Products Ltd","VALERIANDRYHYDROALCOHOLICEXTRACT|HOPSDRYEXTRACT"
"4569","KALMS NIGHT","Unknown",2013-05-03,"TR0257/001/001","GR Lane Health Products Ltd","VALERIANDRYHYDROALCOHOLICEXTRACT"
"4570","Kalydeco","150 milligram(s) Film-coated tablet",2012-07-23,"EU/1/12/782/001-002","Vertex Pharmaceuticals (U.K.) Limited","Ivacaftor"
"4571","Kalydeco","50 milligram(s) Granules",2015-11-16,"EU/1/12/782/003","Vertex Pharmaceuticals (U.K.) Limited","Ivacaftor"
"4572","Kalydeco","75 milligram(s) Granules",2015-11-16,"EU/1/12/782/004","Vertex Pharmaceuticals (U.K.) Limited","Ivacaftor"
"4573","KAMILLOSAN CHAMOMILE","10.5 %w/w                                                                                                 Ointment",2000-02-18,"PA1186/007/001","Chefaro Ireland DAC","CHAMOMILE"
"4574","KAMIREN","4 Milligram                                                                                            Tablet Prolonged Release",2006-03-03,"PA1347/038/001","Krka d.d., Novo mesto","DOXAZOSINMESILATE"
"4575","KANJINTI","150 Milligram                                                                                            Pdr/Conc/Soln for Infus",2018-05-16,"EU/1/18/1281/001","Amgen Europe B.V.","TRASTUZUMAB"
"4576","KANJINTI","420 Milligram                                                                                            Pdr/Conc/Soln for Infus",2018-05-16,"EU/1/18/1281/002","Amgen Europe B.V.","TRASTUZUMAB"
"4577","KANUMA","2 milligram(s)/millilitre Concentrate for solution for infusion",2015-08-28,"EU/1/15/1033/001","Alexion Europe SAS","Sebelipasealfa"
"4578","KAPAKE","15/500 Milligram                                                                                            Tablets",2010-12-21,"PA1329/003/001","Galen Limited","PARACETAMOL|CODEINEPHOSPHATEHEMIHYDRATE"
"4579","Kapake 30mg/500mg Tablets","500/30 milligram(s) Tablet",1993-10-26,"PA1329/003/002","Galen Limited","Codeinephosphate|Paracetamol"
"4580","KARVEA","75 Milligram                                                                                            Tablets",1997-08-27,"EU/1/97/049/001","Bristol Myers Squibb Pharma EEIG","IRBESARTAN"
"4581","KARVEA","75 Milligram                                                                                            Tablets",1997-08-27,"EU/1/97/049/002","Bristol Myers Squibb Pharma EEIG","IRBESARTAN"
"4582","KARVEA","75 Milligram                                                                                            Tablets",1997-08-27,"EU/1/97/049/003","Bristol Myers Squibb Pharma EEIG","IRBESARTAN"
"4583","KARVEA","150 Milligram                                                                                            Tablets",1997-08-27,"EU/1/97/049/004","Bristol Myers Squibb Pharma EEIG","IRBESARTAN"
"4584","KARVEA","150 Milligram                                                                                            Tablets",1997-08-27,"EU/1/97/049/005","Bristol Myers Squibb Pharma EEIG","IRBESARTAN"
"4585","KARVEA","150 Milligram                                                                                            Tablets",1997-08-27,"EU/1/97/049/006","Bristol Myers Squibb Pharma EEIG","IRBESARTAN"
"4586","KARVEA","300 Milligram                                                                                            Tablets",1997-08-27,"EU/1/97/049/007","sanofi-aventis groupe","IRBESARTAN"
"4587","KARVEA","300 Milligram                                                                                            Tablets",1997-08-27,"EU/1/97/049/008","Bristol Myers Squibb Pharma EEIG","IRBESARTAN"
"4588","KARVEA","300 Milligram                                                                                            Tablets",1997-08-27,"EU/1/97/049/009","Bristol Myers Squibb Pharma EEIG","IRBESARTAN"
"4589","KARVEZIDE","300/25 Milligram                                                                                            Tablets",2006-08-28,"EU/1/98/85/23-28","sanofi-aventis groupe","IRBESARTAN|HYDROCHLOROTHIAZIDE"
"4590","KARVEZIDE","150 Milligram                                                                                            Tablets",1998-10-16,"EU/1/98/085/001","sanofi-aventis groupe","IRBESARTAN|HYDROCHLOROTHIAZIDE"
"4591","KARVEZIDE","150 Milligram                                                                                            Tablets",1998-10-16,"EU/1/98/085/002","sanofi-aventis groupe","IRBESARTAN|HYDROCHLOROTHIAZIDE"
"4592","KARVEZIDE","150 Milligram                                                                                            Tablets",1998-10-16,"EU/1/98/085/003","sanofi-aventis groupe","IRBESARTAN|HYDROCHLOROTHIAZIDE"
"4593","KARVEZIDE","300 Milligram                                                                                            Tablets",1998-10-16,"EU/1/98/085/004","sanofi-aventis groupe","IRBESARTAN|HYDROCHLOROTHIAZIDE"
"4594","KARVEZIDE","300 Milligram                                                                                            Tablets",1998-10-16,"EU/1/98/085/005","sanofi-aventis groupe","IRBESARTAN|HYDROCHLOROTHIAZIDE"
"4595","KARVEZIDE","300 Milligram                                                                                            Tablets",1998-10-16,"EU/1/98/085/006","sanofi-aventis groupe","IRBESARTAN|HYDROCHLOROTHIAZIDE"
"4596","KAY-CEE-L SYRUP","7.5 %w/v                                                                                                 Oral Solution",1977-02-01,"PA0143/004/001","Geistlich Sons Limited","POTASSIUMCHLORIDE"
"4597","KEFLEX","250 Milligram                                                                                            Capsules Hard",1977-04-14,"PA1226/002/001","Flynn Pharma Ltd","CEFALEXINMONOHYDRATE"
"4598","KEFLEX","125 Anhyd mg/5ml                                                                                         Powder for Oral Suspension",1977-04-14,"PA1226/002/002","Flynn Pharma Ltd","CEFALEXINMONOHYDRATE"
"4599","KEFLEX","250 mg/5 m Anhyd mg/5ml                                                                                         Powder for Oral Suspension",1977-04-14,"PA1226/002/003","Flynn Pharma Ltd","CEFALEXINMONOHYDRATE"
"4600","KEFLEX","500 mg Anhyd Milligrams                                                                                     Film Coated Tablet",1977-04-14,"PA1226/002/004","Flynn Pharma Ltd","CEFALEXINMONOHYDRATE"
"4601","KEFLEX","250 Milligram                                                                                            Capsules Hard",2016-09-02,"PPA1562/181/001","LTT Pharma Limited","CEFALEXINMONOHYDRATE"
"4602","KEFLEX","250 Milligram                                                                                            Capsule",2012-03-16,"PPA1151/166/001","Imbat Limited","CEFALEXIN"
"4603","KEFLEX","500 Milligram                                                                                            Film Coated Tablet",2012-07-06,"PPA1151/166/002","Imbat Limited","CEFALEXIN"
"4604","KEFLEX","500 Milligram                                                                                            Film Coated Tablet",2018-08-17,"PPA1097/049/001","Lexon (UK) Ltd","CEFALEXIN"
"4605","KEFORT","150 Base Milligrams                                                                                      Film Coated Tablet",2010-11-12,"PA1239/014/001","Laboratorios LICONSA, S.A.","IBANDRONATESODIUMMONOHYDRATE"
"4606","KEMADRIN","5 Milligram                                                                                            Tablets",1979-04-01,"PA1691/005/001","Aspen Pharma Trading Limited","PROCYCLIDINEHYDROCHLORIDE"
"4607","Kemadrin 5 mg Tablets","5 milligram(s) Tablet",2016-11-11,"PPA1562/196/001","LTT Pharma Limited","PROCYCLIDINEHYDROCHLORIDE"
"4608","Kengrexal","50 milligram(s) ZZZ Pdr/Conc/Soln/Inj/Inf",2015-03-23,"EU/1/15/994/001","The Medicines Company UK Limited","Cangrelortetrasodium"
"4609","KENTERA","3.9 mg Milligram                                                                                            Transdermal Patch",2004-08-12,"EU/1/03/270/1-2","Nicobrand","OXYBUTYNIN"
"4610","KENTERA (4MG/24H)","90.7 mg/g Gel",2011-08-24,"EU/1/03/270/004-005","Nicobrand","OXYBUTYNINHYDROCHLORIDE"
"4611","KEPPRA","500 Milligram                                                                                            Film Coated Tablet",2000-09-29,"EU/1/00/146/006-013","UCB Pharma S.A.","LEVETIRACETAM"
"4612","KEPPRA","750 Milligram                                                                                            Film Coated Tablet",2000-09-29,"EU/1/00/146/014-019","UCB Pharma S.A.","LEVETIRACETAM"
"4613","KEPPRA","1000 Milligram                                                                                            Film Coated Tablet",2000-09-29,"EU/1/00/146/020-026","UCB Pharma S.A.","LEVETIRACETAM"
"4614","KEPPRA","100 Mg/Ml Oral Solution",2003-03-03,"EU/1/00/146/027","UCB Pharma S.A.","LEVETIRACETAM"
"4615","KEPPRA","100 Mg/Ml Concentrate for Soln for Inf",2006-03-29,"EU/1/00/146/030","UCB Pharma S.A.","LEVETIRACETAM"
"4616","Keppra levetiracetam","250 milligram(s) Film-coated tablet",2000-09-29,"EU/1/00/146/001","UCB Pharma S.A.","Levetiracetam"
"4617","KERAL","12.5 Milligram                                                                                            Film Coated Tablet",1998-03-06,"PA0865/002/001","Menarini International Operations Luxembourg S.A.","DEXKETOPROFEN"
"4618","KERAL","25 Milligram                                                                                            Film Coated Tablet",1998-03-06,"PA0865/002/002","Menarini International Operations Luxembourg S.A.","DEXKETOPROFEN"
"4619","KERAL","50 mg/2ml Solution for Inj/Inf",2004-03-19,"PA0865/002/003","Menarini International Operations Luxembourg S.A.","DEXKETOPROFEN"
"4620","KERAL","12.5 Milligram                                                                                            Granules for oral solution",2011-09-02,"PA0865/002/004","Menarini International Operations Luxembourg S.A.","DEXKETOPROFENTROMETAMOL"
"4621","KERAL 25 MG ORAL SOLUTION","25 Milligram                                                                                            Oral Solution",2017-05-12,"PA0865/002/006","Menarini International Operations Luxembourg S.A.","DEXKETOPROFEN"
"4622","Keral 25mg granules for oral solution","25 milligram(s) Granules for oral solution",2011-09-02,"PA0865/002/005","Menarini International Operations Luxembourg S.A.","Dexketoprofentrometamol"
"4623","KETALAR","10 Mg/Ml Solution for Inj/Inf",1980-04-01,"PA0822/013/001","Pfizer Healthcare Ireland","KETAMINEHYDROCHLORIDE"
"4624","KETALAR","50 Mg/Ml Solution for Inj/Inf",1980-04-01,"PA0822/013/002","Pfizer Healthcare Ireland","KETAMINEHYDROCHLORIDE"
"4625","KETEK","400 Milligram                                                                                            Tablets",2001-07-09,"EU/1/01/191/001","Aventis Pharma S.A.",""
"4626","KETEK","400 Milligram                                                                                            Tablets",2001-07-09,"EU/1/01/191/002","Aventis Pharma S.A.",""
"4627","KETEK","400 Milligram                                                                                            Tablets",2001-07-09,"EU/1/01/191/003","Aventis Pharma S.A.",""
"4628","KETEK","400 Milligram                                                                                            Tablets",2001-07-09,"EU/1/01/191/004","Aventis Pharma S.A.",""
"4629","KETOCONAZOLE","200 Milligram                                                                                            Tablets",2015-01-15,"EU/1/14/965/001","Laboratoire HRA Pharma",NA
"4630","Ketofall 0.25 mg/ml eye drops, solution in single-dose container","0.25 milligram(s)/millilitre Eye drops, solution",2016-10-14,"PA1815/002/001","Pharma Stulln GmbH","Ketotifenhydrogenfumarate|Ketotifenhydrogenfumarate"
"4631","KETOPINE","2 %w/w                                                                                                 Shampoo",2006-09-29,"PA0281/125/001","Pinewood Laboratories Ltd,","KETOCONAZOLE"
"4632","KETOVITE","0 %v/v                                                                                                 Tablets",1988-03-07,"PA1806/002/001","Essential Pharmaceuticals Limited","THIAMINEHYDROCHLORIDE|RIBOFLAVIN|PYRIDOXINEHYDROCHLORIDE|NICOTINAMIDE|CALCIUMPANTOTHENATE|ASCORBICACID|INOSITOL|BIOTIN|FOLICACID|MENADIOLDIACETATE|TOCOPHERYLACETATE"
"4633","KETOVITE LIQUID","0 %v/v                                                                                                 Infus/Pdr/Oral Soln",1987-11-10,"PA1806/001/001","Essential Pharmaceuticals Limited","RETINOLPALMITATE|ERGOCALCIFEROL|CHOLINECHLORIDE|CYANOCOBALAMIN"
"4634","KETOZOL 2% w/w Dandruff Shampoo","2 percent Shampoo",2005-12-02,"PA0711/076/002","Rowex Ltd","Ketoconazole"
"4635","KEVZARA","150 Milligram                                                                                            Solution for Injection",2017-06-23,"EU/1/17/1196/001-002","Sanofi-Aventis Groupe","SARILUMAB"
"4636","KEVZARA","200 Milligram                                                                                            Solution for Injection",2017-06-23,"EU/1/17/1196/003-008","Sanofi-Aventis Groupe","SARILUMAB"
"4637","Keytruda","50 milligram(s) Powder for solution for infusion",2015-07-17,"EU/1/15/1024/001","Merck Sharp & Dohme Ltd","Pembrolizumab"
"4638","Keytruda","25 milligram(s)/millilitre Concentrate for solution for infusion",2016-08-18,"EU/1/15/1024/002","Merck Sharp & Dohme Ltd","Pembrolizumab"
"4639","Kigabeq","100 milligram(s) Soluble tablet",2018-09-20,"EU/1/18/1302/001","Orphelia Pharma SA","Vigabatrin"
"4640","Kigabeq","500 milligram(s) Soluble tablet",2018-09-20,"EU/1/18/1302/002","Orphelia Pharma SA","Vigabatrin"
"4641","KINERET","150 Mg/Ml Solution for Injection",2002-03-08,"EU/1/02/203/001","Amgen Europe B.V.","ANAKINRA"
"4642","KINERET","150 Mg/Ml Solution for Injection",2002-03-08,"EU/1/02/203/002","Amgen Europe B.V.","ANAKINRA"
"4643","KINERET","150 Mg/Ml Solution for Injection",2002-03-08,"EU/1/02/203/003","Amgen Europe B.V.","ANAKINRA"
"4644","KINERET","150 Mg/Ml Solution for Injection",2002-03-08,"EU/1/02/203/004","Amgen Europe B.V.","ANAKINRA"
"4645","KINERET","100mg/0.67 Millilitre                                                                                           Solution for Injection",2013-11-15,"EU/1/02/203/005-007","Swedish Orphan Biovitrum International AB","ANAKINRA"
"4646","KINZALKOMB","40/12.5                                                                                                      Tablets",2002-04-19,"EU/1/02/214/001","Bayer AG","TELMISARTAN|HYDROCHLOROTHIAZIDE"
"4647","KINZALKOMB","80/12.5 mg/mg Tablets",2002-04-19,"EU/1/02/214/006-010","Bayer AG","TELMISARTAN|HYDROCHLOROTHIAZIDE"
"4648","KINZALKOMB","80/25 mg/mg Tablets",2008-03-27,"EU/1/02/214/11-15","Bayer AG","TELMISARTAN|HYDROCHLOROTHIAZIDE"
"4649","KINZALMONO","40 Milligram                                                                                            Tablets",1998-12-16,"EU/1/98/091/001","Bayer AG","TELMISARTAN"
"4650","KINZALMONO","80 Milligram                                                                                            Tablets",1998-12-16,"EU/1/98/091/005-008","Bayer AG","TELMISARTAN"
"4651","KINZALMONO","20 Milligram                                                                                            Tablets",1999-09-07,"EU/1/98/091/009-012","Bayer AG","TELMISARTAN"
"4652","KIOVIG","100 Mg/Ml Solution for Infusion",2006-01-19,"EU/1/05/329/1-5","Baxter","HUMANNORMALIMMUNOGLOBULIN"
"4653","KIRNOM XL","400 Microgram                                                                                            Prolonged Release Capsules",2010-09-24,"PA1339/020/001","Wockhardt UK Limited","TAMSULOSINHYDROCHLORIDE"
"4654","KISPLYX","4 Milligram                                                                                            Capsules Hard",2016-08-25,"EU/1/16/1128/001","Eisai Europe Ltd","LENVATINIBMESILATE"
"4655","KISPLYX","10 Milligram                                                                                            Capsules Hard",2016-08-25,"EU/1/16/1128/002","Eisai Europe Ltd","LENVATINIBMESILATE"
"4656","Kisqali","200 milligram(s) Film-coated tablet",2017-08-22,"EU/1/17/1221/001-012","Novartis Europharm Limited","Riboclclib"
"4657","KIVEXA","600mg milligram(s) Tablet",NA,"EU/1/04/298/1-2","ViiV Healthcare BV","Abacavirsulfate|Lamivudine"
"4658","KIWIHERB VALERIAN","",2017-10-06,"TR1734/006/001","Phytomed (UK) Ltd","VALERIANAOFFICINALIS"
"4659","Klacid 250 mg Film-coated Tablets","250 milligram(s) Film-coated tablet",1989-11-20,"PA2010/004/001","Mylan IRE Healthcare Limited","Clarithromycin"
"4660","Klacid 250mg/5ml Granules for Oral Suspension","250 mg/5ml Granules for oral suspension",1998-06-26,"PA2010/004/006","Mylan IRE Healthcare Limited","Clarithromycin"
"4661","Klacid Forte 500 mg Film-coated Tablets","500 milligram(s) Film-coated tablet",2002-01-11,"PPA0465/051/002","PCO Manufacturing","Clarithromycin"
"4662","Klacid Forte 500mg Film-coated Tablets","500 milligram(s) Film-coated tablet",1995-04-13,"PA2010/004/002","Mylan IRE Healthcare Limited","Clarithromycin"
"4663","Klacid IV 500mg Powder for Concentrate for Solution for Infusion","500 milligram(s) ZZZ Pdr/Conc/Soln for Infus",1994-11-10,"PA2010/004/003","Mylan IRE Healthcare Limited","Clarithromycin"
"4664","KLACID LA","500 Milligram                                                                                            Modified-release Tablets",2014-07-18,"PPA0465/051/004","PCO Manufacturing","CLARITHROMYCIN"
"4665","Klacid LA 500mg Modified release tablets","500 milligram(s) Modified-release tablet",1997-03-21,"PA2010/004/004","Mylan IRE Healthcare Limited","Clarithromycin"
"4666","Klacid Paediatric Suspension 125mg/5ml, Granules for Oral Suspension","125 mg/5ml Granules for oral suspension",1996-11-22,"PA2010/004/005","Mylan IRE Healthcare Limited","Clarithromycin"
"4667","KLARAM LA","500 Milligram                                                                                            Tablet Prolonged Release",2011-12-05,"PA1380/102/001","Actavis Group PTC ehf","CLARITHROMYCINCITRATE"
"4668","KLARIGER","500 Milligram                                                                                            Film Coated Tablet",2006-03-31,"PA0577/093/002","McDermott Laboratories Ltd t/a Gerard Laboratories","CLARITHROMYCIN"
"4669","KLEAN-PREP POWDER FOR ORAL SOLUTION","Per Cent                                                                                             Powder for Oral Solution",1988-06-30,"PA0294/017/001","Helsinn Birex Pharmaceuticals Limited","SODIUMSULFATEANHYDROUS|SODIUMBICARBONATE|SODIUMCHLORIDE|POTASSIUMCHLORIDE|MACROGOL"
"4670","KLIOGEST","2/1 Milligram                                                                                            Film Coated Tablet",1987-11-18,"PA0218/022/001","Novo Nordisk A/S","ESTRADIOLHEMIHYDRATE|NORETHISTERONEACETATE"
"4671","KOGENATE BAYER","250IU International Unit                                                                                   Infus/Pdr/Oral Soln",2000-08-04,"EU/1/00/143/001","Bayer AG","OCTOCOGALFA|R-DNA(BABYHAMSTERKIDNEYEXPRESSIONSYSTEM)"
"4672","KOGENATE BAYER","500 International Unit                                                                                   Pdr+Solv for Soln for Inj",2000-08-04,"EU/1/00/143/002","Bayer AG","OCTOCOGALFA"
"4673","KOGENATE BAYER","1000 International Unit                                                                                   Pdr+Solv for Soln for Inj",2000-08-04,"EU/1/00/143/003","Bayer AG","OCTOCOGALFA"
"4674","KOGENATE BAYER","250 International Unit                                                                                   Pdr+Solv for Soln for Inj",2000-09-21,"EU/1/00/143/004","Bayer AG","OCTOCOGALFA"
"4675","KOGENATE BAYER","IU International Unit                                                                                   Pdr+Solv for Soln for Inj",2004-09-21,"EU/1/00/143/005","Bayer AG","OCTOCOGALFA"
"4676","KOGENATE BAYER","IU International Unit                                                                                   Pdr+Solv for Soln for Inj",2004-09-21,"EU/1/00/143/006","Bayer AG","OCTOCOGALFA"
"4677","KOGENATE BAYER","3000 International Unit                                                                                   Pdr+Solv for Soln for Inj",2010-08-16,"EU/1/00/143/012-013","Bayer AG","OCTOCOGALFA"
"4678","KOGENATE BAYER","2000 International Unit                                                                                   Pdr+Solv for Soln for Inj",2007-12-18,"EU/1/00/143/10-11","Bayer AG","OCTOCOGALFA"
"4679","Kolbam","50 milligram(s) Capsule, hard",2014-05-28,"EU/1/13/895/001","Retrophin Europe Limited","Cholicacid"
"4680","KOLBAM","250 Milligram                                                                                            Capsules Hard",2014-05-28,"EU/1/13/895/002","Retrophin Europe Limited","CHOLICACID"
"4681","KOMBOGLYZE","2.5/850 Milligram                                                                                            Film Coated Tablet",2011-11-24,"EU/1/11/731/001-006","AstraZeneca AB","SAXAGLIPTIN|METFORMINHYDROCHLORIDE"
"4682","KOMBOGLYZE","2.5/1000 Milligram                                                                                            Film Coated Tablet",2011-11-24,"EU/1/11/731/007-012","Bristol-Myers Squibb / AstraZeneca EEIG","SAXAGLIPTIN|METFORMINHYDROCHLORIDE"
"4683","Konakion MM Ampoules 10 mg/ml Solution for Injection and Oral Solution","10 milligram(s)/millilitre Solution for injection",1990-04-06,"PA2239/002/001","Cheplapharm Arzneimittel GmbH","Phytomenadione"
"4684","Konakion MM Paediatric Ampoules 2 mg/ 0.2 ml oral solution or solution for injection","2 mg/ 0.2 ml ZZZ Milligrams per Ampule Solution for injection",1995-04-20,"PA2239/002/002","Cheplapharm Arzneimittel GmbH","Phytomenadione"
"4685","KONVERGE","40/5 mg/mg Film Coated Tablet",2013-08-02,"PPA0465/313/001","PCO Manufacturing","OLMESARTANMEDOXOMIL|AMLODIPINEBESYLATE"
"4686","KONVERGE","40/10 mg/mg Film Coated Tablet",2013-08-02,"PPA0465/313/002","PCO Manufacturing","OLMESARTANMEDOXOMIL|AMLODIPINEBESILATE"
"4687","KONVERGE","20/5 mg/mg Film Coated Tablet",2013-08-02,"PPA0465/313/003","PCO Manufacturing","OLMESARTANMEDOXOMIL|AMLODIPINEBESYLATE"
"4688","KONVERGE","20/5 mg/mg Film Coated Tablet",2009-06-19,"PA0865/017/001","Menarini International Operations Luxembourg S.A.","OLMESARTANMEDOXOMIL|AMLODIPINEBESYLATE"
"4689","KONVERGE","40/5 mg/mg Film Coated Tablet",2009-06-19,"PA0865/017/002","Menarini International Operations Luxembourg S.A.","OLMESARTANMEDOXOMIL|AMLODIPINEBESYLATE"
"4690","KONVERGE","40/10 mg/mg Film Coated Tablet",2009-06-19,"PA0865/017/003","Menarini International Operations Luxembourg S.A.","OLMESARTANMEDOXOMIL|AMLODIPINEBESYLATE"
"4691","KONVERGE","20/5 Milligram                                                                                            Film Coated Tablet",2016-09-16,"PPA1562/175/001","LTT Pharma Limited","OLMESARTANMEDOXOMIL|AMLODIPINEBESYLATE"
"4692","KONVERGE","40/5 Milligram                                                                                            Film Coated Tablet",2016-09-16,"PPA1562/175/002","LTT Pharma Limited","OLMESARTANMEDOXOMIL|AMLODIPINEBESYLATE"
"4693","KONVERGE","40/10 Milligram                                                                                            Film Coated Tablet",2016-09-16,"PPA1562/175/003","LTT Pharma Limited","OLMESARTANMEDOXOMIL|AMLODIPINEBESYLATE"
"4694","KONVERGE","20/5 mg/mg Film Coated Tablet",2015-12-04,"PPA1463/104/001","IMED Healthcare Ltd.","OLMESARTANMEDOXOMIL|AMLODIPINEBESYLATE"
"4695","KONVERGE","40/5 mg/mg Film Coated Tablet",2015-12-04,"PPA1463/104/002","IMED Healthcare Ltd.","OLMESARTANMEDOXOMIL|AMLODIPINEBESYLATE"
"4696","KONVERGE","40/10 mg/mg Film Coated Tablet",2015-12-04,"PPA1463/104/003","IMED Healthcare Ltd.","OLMESARTANMEDOXOMIL|AMLODIPINEBESYLATE"
"4697","KONVERGE","40/5 mg/mg Film Coated Tablet",2015-10-23,"PPA1151/255/001","Imbat Limited","OLMESARTANMEDOXOMIL|AMLODIPINEBESYLATE"
"4698","KONVERGE","40/10 mg/mg Film Coated Tablet",2015-10-23,"PPA1151/255/002","Imbat Limited","OLMESARTANMEDOXOMIL|AMLODIPINEBESYLATE"
"4699","KONVERGE PLUS","20/5/12.5 Milligram                                                                                            Film Coated Tablet",2016-09-02,"PPA1562/174/001","LTT Pharma Limited","OLMESARTANMEDOXOMIL|AMLODIPINEASAMLODIPINEBESILATE|HYDROCHLOROTHIAZIDE"
"4700","KONVERGE PLUS","40/5/12.5 Milligram                                                                                            Film Coated Tablet",2016-09-02,"PPA1562/174/002","LTT Pharma Limited","OLMESARTANMEDOXOMIL|AMLODIPINEASAMLODIPINEBESILATE|HYDROCHLOROTHIAZIDE"
"4701","KONVERGE PLUS","40/10/12.5 Milligram                                                                                            Film Coated Tablet",2016-09-02,"PPA1562/174/003","LTT Pharma Limited","OLMESARTANMEDOXOMIL|AMLODIPINEASAMLODIPINEBESILATE|HYDROCHLOROTHIAZIDE"
"4702","KONVERGE PLUS","40/10/25 Milligram                                                                                            Film Coated Tablet",2016-09-02,"PPA1562/174/004","LTT Pharma Limited","OLMESARTANMEDOXOMIL|AMLODIPINEASAMLODIPINEBESILATE|HYDROCHLOROTHIAZIDE"
"4703","KONVERGE PLUS","20/5/12.5 Milligram                                                                                            Film Coated Tablet",2011-09-23,"PA0865/019/001","Menarini International Operations Luxembourg S.A.","OLMESARTANMEDOXOMIL|AMLODIPINEBESILATE|HYDROCHLOROTHIAZIDE"
"4704","KONVERGE PLUS","40/5/12.5 Milligram                                                                                            Film Coated Tablet",2011-09-23,"PA0865/019/002","Menarini International Operations Luxembourg S.A.","OLMESARTANMEDOXOMIL|AMLODIPINEBESILATE|HYDROCHLOROTHIAZIDE"
"4705","KONVERGE PLUS","40/10/12.5 Milligram                                                                                            Film Coated Tablet",2011-09-23,"PA0865/019/003","Menarini International Operations Luxembourg S.A.","OLMESARTANMEDOXOMIL|AMLODIPINEBESILATE|HYDROCHLOROTHIAZIDE"
"4706","KONVERGE PLUS","40/5/25 Milligram                                                                                            Film Coated Tablet",2011-09-23,"PA0865/019/004","Menarini International Operations Luxembourg S.A.","OLMESARTANMEDOXOMIL|AMLODIPINEBESILATE|HYDROCHLOROTHIAZIDE"
"4707","KONVERGE PLUS","40/10/25 Milligram                                                                                            Film Coated Tablet",2011-09-23,"PA0865/019/005","Menarini International Operations Luxembourg S.A.","OLMESARTANMEDOXOMIL|AMLODIPINEBESILATE|HYDROCHLOROTHIAZIDE"
"4708","KONVERGE PLUS","20/5/12.5 Milligram                                                                                            Film Coated Tablet",2017-01-20,"PPA0465/421/001","PCO Manufacturing","OLMESARTANMEDOXOMIL|AMLODPINEBESILATE|HYDROCHLOROTHIAZIDE"
"4709","KONVERGE PLUS","40/5/12.5 Milligram                                                                                            Film Coated Tablet",2017-01-20,"PPA0465/421/002","PCO Manufacturing","OLMESARTANMEDOXOMIL|AMLODIPINEBESILATE|HYDROCHLOROTHIAZIDE"
"4710","KONVERGE PLUS","40/10/12.5 Milligram                                                                                            Film Coated Tablet",2017-01-20,"PPA0465/421/003","PCO Manufacturing","OLMESARTANMEDOXOMIL|AMLODIPINEBESILATE|HYDROCHLOROTHIAZIDE"
"4711","KONVERGE PLUS","40/5/25 Milligram                                                                                            Film Coated Tablet",2017-01-20,"PPA0465/421/004","PCO Manufacturing","OLMESARTANMEDOXOMIL|AMLODIPINEBESILATE|HYDROCHLOROTHIAZIDE"
"4712","KONVERGE PLUS","40/10/25 Milligram                                                                                            Film Coated Tablet",2017-01-20,"PPA0465/421/005","PCO Manufacturing","OLMESARTANMEDOXOMIL|AMLODIPINEBESILATE|HYDROCHLOROTHIAZIDE"
"4713","Kopen 250mg Tablets","250 milligram(s) Tablet",1987-07-24,"PA0298/007/001","Athlone Laboratories Ltd","Phenoxymethylpenicillin"
"4714","Kopen Sugar Free 125mg/5ml Powder for Oral Solution","125 mg/5ml Powder for oral solution",1988-04-11,"PA0298/007/002","Athlone Laboratories Ltd","Phenoxymethylpenicillinpotassium"
"4715","Kopen Sugar Free 250mg/5ml Powder for Oral Solution","250 mg/5ml Powder for oral solution",1988-04-11,"PA0298/007/003","Athlone Laboratories Ltd","Phenoxymethylpenicillinpotassium"
"4716","Kovaltry","250 international unit(s) Powder and solvent for solution for injection",2016-02-18,"EU/1/15/1076/001-002","Bayer AG","Octocogalfa"
"4717","KOVALTRY","500 International Unit                                                                                   Pdr+Solv for Soln for Inj",2016-02-18,"EU/1/15/1076/003-004","Bayer Pharma AG","OCTOCOGALFA"
"4718","KOVALTRY","1000 International Unit                                                                                   Pdr+Solv for Soln for Inj",2016-02-18,"EU/1/15/1076/005-006","Bayer Pharma AG","OCTOCOGALFA"
"4719","KOVALTRY","2000 International Unit                                                                                   Pdr+Solv for Soln for Inj",2016-02-18,"EU/1/15/1076/007-008","Bayer Pharma AG","OCTOCOGALFA"
"4720","KOVALTRY","3000 International Unit                                                                                   Pdr+Solv for Soln for Inj",2016-02-18,"EU/1/15/1076/009-010","Bayer Pharma AG","OCTOCOGALFA"
"4721","KRYPTOSCAN (81MKR)","74 - 740 MBq Radionuclide Generator",2006-05-26,"PA0690/007/001","Mallinckrodt Medical B.V.","KRYPTON(81MKR)"
"4722","Kuvan","100 milligram(s) Powder for oral solution",2017-07-13,"EU/1/08/481/004","BioMarin International Limited","Sapropterinhydrochloride"
"4723","Kuvan","500 milligram(s) Powder for oral solution",2017-07-13,"EU/1/08/481/005","BioMarin International Limited","Sapropterinhydrochloride"
"4724","Kuvan","100 milligram(s) Tablet",2008-12-02,"EU/1/08/481/1-3","BioMarin International Limited","Sapropterindihydrochloride"
"4725","KWELLS","300 Microgram                                                                                            Tablets",1979-04-01,"PA1410/048/002","Bayer Limited","HYOSCINEHYDROBROMIDE"
"4726","Kyleena 19.5 mg intrauterine delivery system","19.5 milligram(s) Intrauterine delivery system",2016-12-16,"PA1410/081/001","Bayer Limited","Levonorgestrel,micronized"
"4727","Kymriah","1.2 x 106 - 6 x 108 cells Dispersion for infusion",2018-08-23,"EU/1/18/1297/001","Novartis Europharm Limited","AUTOGLASTCELLSTRANSDUCEDWITHLENTIVIRALVECTORCONTAININGACHIMERICANTIGENRECEPTORDIRECTEDAGAINSTCD1"
"4728","KYNTHEUM (PREVIOUSLY KNOWN BRODALUMAB)","210mg(140mg/ml) Milligram                                                                                            Solution for injection in pre-filled syringe",2017-07-17,"EU/1/16/1155/001","LEO Pharma A/S","BRODALUMAB"
"4729","Kyprolis","60 milligram(s) Powder for solution for injection",2015-11-19,"EU/1/15/1060/001","Amgen Europe B.V.","Carfilzomib"
"4730","KYTRIL","1 Mg/Ml Solution for Injection",1997-04-23,"PA1967/003/001","Atnahs Pharma UK Limited","GRANISETRONHYDROCHLORIDE"
"4731","KYTRIL","3 Mg/Ml Solution for Injection",1991-12-16,"PA1967/003/002","Atnahs Pharma UK Limited","GRANISETRONHYDROCHLORIDE"
"4732","Kytril 1mg film-coated tablets","1 milligram(s) Film-coated tablet",1994-02-15,"PA1967/003/003","Atnahs Pharma UK Limited","Granisetronhydrochloride"
"4733","Kytril 2mg film-coated tablets","2 milligram(s) Film-coated tablet",1998-05-01,"PA1967/003/004","Atnahs Pharma UK Limited","Granisetronhydrochloride"
"4734","LACOSAMIDE ACCORD","50 Milligram                                                                                            Film Coated Tablet",2017-09-18,"EU/1/17/1230/001-004","Accord Healthcare Limited","LACOSAMIDE"
"4735","LACOSAMIDE ACCORD","100 Milligram                                                                                            Film Coated Tablet",2017-09-18,"EU/1/17/1230/005-008","Accord Healthcare Limited","LACOSAMIDE"
"4736","LACOSAMIDE ACCORD","150 Milligram                                                                                            Film Coated Tablet",2017-09-18,"EU/1/17/1230/009-012","Accord Healthcare Limited","LACOSAMIDE"
"4737","LACOSAMIDE ACCORD","200 Milligram                                                                                            Film Coated Tablet",2017-09-18,"EU/1/17/1230/013-016","Accord Healthcare Limited","LACOSAMIDE"
"4738","LACRI-LUBE Eye Ointment","percent weight/weight Eye ointment",1984-01-25,"PA0148/038/001","Allergan Pharmaceuticals Ireland","WHITESOFTPARAFFIN|PARAFFIN,LIQUID|WOOLALCOHOLS"
"4739","LACTECON","3.335 g/5ml                                                                                                Oral Solution",2000-12-08,"PA2010/014/001","Mylan IRE Healthcare Limited","LACTULOSE"
"4740","LACTULOSE","10 g/15ml",2011-06-03,"PA0773/004/001","Fresenius Kabi Austria GmbH","LACTULOSE"
"4741","LACTULOSE","3.335 g/5ml                                                                                                Oral Solution",2016-10-28,"PA1240/017/001","Bristol Laboratories Limited","LACTULOSE"
"4742","LACTULOSE FRESENIUS","670 Mg/Ml Oral Solution",2010-11-26,"PA0773/003/001","Fresenius Kabi Austria GmbH","LACTULOSE"
"4743","LAEVOLAC PLUM","10 g/15ml Oral Solution",2014-07-11,"PA0773/005/001","Fresenius Kabi Austria GmbH","LACTULOSE,LIQUID"
"4744","LAMBERTS DEVILS CLAW TABLETS","450 Milligram                                                                                            Film Coated Tablet",2018-03-16,"TR2029/003/001","Lamberts Healthcare Limited","DEVIL'SCLAWEXTRACT(ASDRYROOT)"
"4745","LAMBERTS ECHINACEA COLD & FLU RELIEF TABLETS","Film Coated Tablet",2018-01-12,"TR2029/002/001","Lamberts Healthcare Limited","ECHINACEAPURPUREAROOTDRYEXTRACT"
"4746","LAMBERTS VALERIAN","Film Coated Tablet",2016-12-23,"TR2029/001/001","Lamberts Healthcare Limited","VALERIANEXTRACT"
"4747","LAMICTAL","25 Milligram                                                                                            Tablets",2014-07-04,"PPA1463/066/004","IMED Healthcare Ltd.","LAMOTRIGINE"
"4748","LAMICTAL","100 Milligram                                                                                            Tablets",2014-07-04,"PPA1463/066/005","IMED Healthcare Ltd.","LAMOTRIGINE"
"4749","LAMICTAL","25 Milligram                                                                                            Dispersable Tablet",2014-08-15,"PPA1463/066/006","IMED Healthcare Ltd.","LAMOTRIGINE"
"4750","LAMICTAL","25 Milligram                                                                                            Dispersable Tablet",2010-04-23,"PPA1500/046/001","Profind Wholesale Ltd","LAMOTRIGINE"
"4751","LAMICTAL","200 Milligram                                                                                            Tablets",2012-08-03,"PPA1562/011/004","LTT Pharma Limited","LAMOTRIGINE"
"4752","LAMICTAL","50 Milligram                                                                                            Tablets",2017-02-16,"PPA1097/007/002","Lexon (UK) Ltd","LAMOTRIGINE"
"4753","LAMICTAL","100 Milligram                                                                                            Tablets",2017-05-05,"PPA1097/007/003","Lexon (UK) Ltd","LAMOTRIGINE"
"4754","LAMICTAL","25 Milligram                                                                                            Tablets",2017-05-05,"PPA1097/007/007","Lexon (UK) Ltd","LAMOTRIGINE"
"4755","LAMICTAL","25 Milligram                                                                                            Chewable/Dispersible tablet",2012-09-14,"PPA0565/050/001","WPR Healthcare Limited","LAMOTRIGINE"
"4756","LAMICTAL","50 Milligram                                                                                            Chewable/Dispersible tablet",2012-09-14,"PPA0565/050/002","WPR Healthcare Limited","LAMOTRIGINE"
"4757","LAMICTAL","100 Milligram                                                                                            Chewable/Dispersible tablet",2012-09-14,"PPA0565/050/003","WPR Healthcare Limited","LAMOTRIGINE"
"4758","LAMICTAL","25 Milligram                                                                                            Dispersable Tablet",2009-08-21,"PPA1151/115/001","Imbat Limited","LAMOTRIGINE"
"4759","LAMICTAL","5 Milligram                                                                                            Dispersable Tablet",2011-05-20,"PPA1151/115/005","Imbat Limited","LAMOTRIGINE"
"4760","LAMICTAL","25 Milligram                                                                                            Tablets",2014-01-24,"PPA1151/115/006","Imbat Limited","LAMOTRIGINE"
"4761","LAMICTAL","50 Milligram                                                                                            Tablets",2014-01-24,"PPA1151/115/007","Imbat Limited","LAMOTRIGINE"
"4762","LAMICTAL","100 Milligram                                                                                            Tablets",2014-01-24,"PPA1151/115/008","Imbat Limited","LAMOTRIGINE"
"4763","LAMICTAL","200 Milligram                                                                                            Tablets",2014-01-24,"PPA1151/115/009","Imbat Limited","LAMOTRIGINE"
"4764","LAMICTAL","5 Milligram                                                                                            Chewable/Dispersible tablet",1994-05-16,"PA1077/061/006","GlaxoSmithKline (Ireland) Limited","LAMOTRIGINE"
"4765","LAMICTAL","25 Milligram                                                                                            Chewable/Dispersible tablet",1994-05-16,"PA1077/061/007","GlaxoSmithKline (Ireland) Limited","LAMOTRIGINE"
"4766","LAMICTAL","50 Milligram                                                                                            Chewable/Dispersible tablet",1997-05-30,"PA1077/061/008","GlaxoSmithKline (Ireland) Limited","LAMOTRIGINE"
"4767","LAMICTAL","100 Milligram                                                                                            Chewable/Dispersible tablet",1994-05-16,"PA1077/061/009","GlaxoSmithKline (Ireland) Limited","LAMOTRIGINE"
"4768","LAMICTAL","200 Milligram                                                                                            Chewable/Dispersible tablet",1997-05-30,"PA1077/061/010","GlaxoSmithKline (Ireland) Limited","LAMOTRIGINE"
"4769","LAMICTAL","25 Milligram                                                                                            Tablets",1990-11-05,"PA1077/061/001","GlaxoSmithKline (Ireland) Limited","LAMOTRIGINE"
"4770","LAMICTAL","50 Milligram                                                                                            Tablets",1990-11-05,"PA1077/061/002","GlaxoSmithKline (Ireland) Limited","LAMOTRIGINE"
"4771","LAMICTAL","100 Milligram                                                                                            Tablets",1990-11-05,"PA1077/061/003","GlaxoSmithKline (Ireland) Limited","LAMOTRIGINE"
"4772","LAMICTAL","200 Milligram                                                                                            Tablets",1994-07-21,"PA1077/061/004","GlaxoSmithKline (Ireland) Limited","LAMOTRIGINE"
"4773","LAMICTAL","5 Milligram                                                                                            Dispersable Tablet",2003-07-11,"PPA0465/092/005","PCO Manufacturing","LAMOTRIGINE"
"4774","LAMICTAL","25 Milligram                                                                                            Dispersable Tablet",2003-07-11,"PPA0465/092/006","PCO Manufacturing","LAMOTRIGINE"
"4775","LAMICTAL","100 Milligram                                                                                            Dispersable Tablet",2003-07-11,"PPA0465/092/007","PCO Manufacturing","LAMOTRIGINE"
"4776","LAMICTAL","50 Milligram                                                                                            Dispersable Tablet",2007-03-16,"PPA0465/092/008","PCO Manufacturing","LAMOTRIGINE"
"4777","LAMICTAL","100 Milligram                                                                                            Tablets",2013-05-31,"PPA0465/092/010","PCO Manufacturing","LAMOTRIGINE"
"4778","LAMICTAL","25 Milligram                                                                                            Tablets",2014-05-09,"PPA0465/092/011","PCO Manufacturing","LAMOTRIGINE"
"4779","LAMICTAL","50 Milligram                                                                                            Tablets",2014-05-09,"PPA0465/092/012","PCO Manufacturing","LAMOTRIGINE"
"4780","LAMICTAL","200 Milligram                                                                                            Tablets",2015-02-20,"PPA0465/092/013","PCO Manufacturing","LAMOTRIGINE"
"4781","Lamictal 100 mg chewable/dispersible tablets","100 milligram(s) Chewable/dispersible tablet",2017-05-19,"PPA1097/007/005","Lexon (UK) Ltd","Lamotrigine"
"4782","Lamictal 100 mg Dispersible/Chewable Tablets","100 milligram(s) Dispersible tablet",2011-03-25,"PPA1151/115/003","Imbat Limited","Lamotrigine"
"4783","Lamictal 100 mg Tablets","100 milligram(s) Tablet",2014-11-03,"PPA1633/041/003","Primecrown 2010 Limited","Lamotrigine"
"4784","Lamictal 2 mg chewable/dispersible tablets","2 milligram(s) Chewable/dispersible tablet",2001-10-19,"PA1077/061/005","GlaxoSmithKline (Ireland) Limited","Lamotrigine"
"4785","Lamictal 200 mg chewable/dispersible tablets","200 milligram(s) Chewable/dispersible tablet",2017-03-31,"PPA1097/007/006","Lexon (UK) Ltd","Lamotrigine"
"4786","Lamictal 200 mg Dispersible Chewable Tablets","200 milligram(s) Dispersible tablet",2011-03-25,"PPA1151/115/004","Imbat Limited","Lamotrigine"
"4787","Lamictal 200mg chewable/dispersible tablets","200 milligram(s) Dispersible tablet",2007-03-16,"PPA0465/092/009","PCO Manufacturing","Lamotrigine"
"4788","Lamictal 25 mg chewable/dispersible tablets","25 milligram(s) Chewable/dispersible tablet",2017-02-16,"PPA1097/007/001","Lexon (UK) Ltd","Lamotrigine"
"4789","Lamictal 25 mg Tablets","25 milligram(s) Tablet",2014-11-03,"PPA1633/041/001","Primecrown 2010 Limited","Lamotrigine"
"4790","Lamictal 50 mg chewable/dispersible tablets","50 milligram(s) Chewable/dispersible tablet",2017-05-19,"PPA1097/007/004","Lexon (UK) Ltd","Lamotrigine"
"4791","Lamictal 50 mg Tablets","50 milligram(s) Tablet",2014-11-03,"PPA1633/041/002","Primecrown 2010 Limited","Lamotrigine"
"4792","Lamictal 50mg Dispersible/Chewable Tablet","50 milligram(s) Dispersible tablet",2011-02-25,"PPA1151/115/002","Imbat Limited","Lamotrigine"
"4793","LAMICTAL DISPERSIBLE","50 Milligram                                                                                            Tablets Chewable",2012-08-03,"PPA1463/066/001","IMED Healthcare Ltd.","LAMOTRIGINE"
"4794","LAMICTAL DISPERSIBLE","100 Milligram                                                                                            Tablets Chewable",2012-08-03,"PPA1463/066/002","IMED Healthcare Ltd.","LAMOTRIGINE"
"4795","LAMICTAL DISPERSIBLE","200 Milligram                                                                                            Tablets Chewable",2012-08-03,"PPA1463/066/003","IMED Healthcare Ltd.","LAMOTRIGINE"
"4796","LAMISIL","250 Milligram                                                                                            Tablets",2007-06-08,"PPA1151/029/001","Imbat Limited","TERBINAFINEHYDROCHLORIDE"
"4797","LAMISIL","1 %w/w                                                                                                 Cream",2011-09-23,"PPA1151/029/002","Imbat Limited","TERBINAFINEHYDROCHLORIDE"
"4798","LAMISIL","250 Milligram                                                                                            Tablets",2003-04-17,"PPA0465/096/001","PCO Manufacturing","TERBINAFINE"
"4799","LAMISIL","250 Milligram                                                                                            Tablets",1994-12-12,"PA0896/015/001","Novartis Ireland Limited","TERBINAFINE"
"4800","LAMISIL","1%w/w %w/w                                                                                                 Cream",1993-07-12,"PA0678/121/001","GlaxoSmithKline Consumer Healthcare (Ireland) Limited","TERBINAFINEHYDROCHLORIDE"
"4801","Lamisil 1% w/w Cream","1 percent weight/weight Cream",2005-12-02,"PPA0465/151/001","PCO Manufacturing","TERBINAFINEHYDROCHLORIDE"
"4802","LAMISIL AT","1.0 %w/w                                                                                                 Cream",2003-01-24,"PA0678/121/002","GlaxoSmithKline Consumer Healthcare (Ireland) Limited","TERBINAFINEHYDROCHLORIDE"
"4803","LAMISIL ONCE","1 Per Cent                                                                                             Cutaneous Solution",2006-09-29,"PA0678/121/003","GlaxoSmithKline Consumer Healthcare (Ireland) Limited","TERBINAFINEHYDROCHLORIDE"
"4804","LAMIVUDINE TEVA","100 Milligram                                                                                            Film Coated Tablet",2009-10-23,"EU/1/09/566/1-5","Teva B.V.","LAMIVUDINE"
"4805","LAMIVUDINE TEVA PHARMA B.V.","150 Milligram                                                                                            Film Coated Tablet",2009-12-10,"EU/1/09/596/1-7","Teva B.V.","LAMIVUDINE"
"4806","LAMIVUDINE TEVA PHARMA B.V.","300 Milligram                                                                                            Film Coated Tablet",2009-12-10,"EU/1/09/596/8-14","Teva B.V.","LAMIVUDINE"
"4807","LAMIVUDINE/ZIDOVUDINE TEVA","150/300 Milligram                                                                                            Film Coated Tablet",2011-02-28,"EU/1/10/663/001-002","Teva B.V.","LAMIVUDINE|ZIDOVUDINE"
"4808","LAMORO","5 Milligram                                                                                            Dispersable Tablet",2007-02-16,"PA0281/128/001","Pinewood Laboratories Ltd,","LAMOTRIGINE"
"4809","LAMORO","25 Milligram                                                                                            Dispersable Tablet",2007-02-16,"PA0281/128/002","Pinewood Laboratories Ltd,","LAMOTRIGINE"
"4810","LAMORO","50 Milligram                                                                                            Dispersable Tablet",2007-02-16,"PA0281/128/003","Pinewood Laboratories Ltd,","LAMOTRIGINE"
"4811","LAMORO","100 Milligram                                                                                            Dispersable Tablet",2007-02-16,"PA0281/128/004","Pinewood Laboratories Ltd,","LAMOTRIGINE"
"4812","LAMORO","200 Milligram                                                                                            Dispersable Tablet",2007-02-16,"PA0281/128/005","Pinewood Laboratories Ltd,","LAMOTRIGINE"
"4813","LAMOT","200 Milligram                                                                                            Tablets",2006-06-30,"PA0577/077/004","McDermott Laboratories Ltd t/a Gerard Laboratories","LAMOTRIGINE"
"4814","LAMZEDE","10 Milligram                                                                                            Pdr for Soln for Infusion",2018-03-23,"EU/1/17/1258/001-003","Chiesi Farmaceutici S.p.A.","VELMANASEALFA"
"4815","Lanoxin 250 microgram Tablets","250 milligram(s) Tablet",1980-04-01,"PA1691/001/004","Aspen Pharma Trading Limited","Digoxin"
"4816","LANOXIN PG","50 Microgram/ML                                                                                         Oral Solution",1980-04-01,"PA1691/001/002","Aspen Pharma Trading Limited","DIGOXIN"
"4817","Lanoxin PG 62.5 microgram Tablets","62.5 microgram(s) Tablet",1980-04-01,"PA1691/001/003","Aspen Pharma Trading Limited","Digoxin"
"4818","LANOXIN SOLUTION FOR INJECTION","0.25 %v/v                                                                                                 Solution for Injection",1980-04-01,"PA1691/001/001","Aspen Pharma Trading Limited","DIGOXIN"
"4819","LANSOPRAZOLE","15 Milligram                                                                                            Capsules Gastro-Resistant",2017-02-16,"PPA0565/063/001","WPR Healthcare Limited","LANSOPRAZOLE"
"4820","LANSOPRAZOLE","30 Milligram                                                                                            Capsules Gastro-Resistant",2017-02-16,"PPA0565/063/002","WPR Healthcare Limited","LANSOPRAZOLE"
"4821","Lansoprazole 15 mg Orodispersible Tablet","15 milligram(s) Orodispersible tablet",2014-02-14,"PA0711/244/001","Rowex Ltd","Lansoprazole"
"4822","Lansoprazole 30 mg Orodispersible Tablet","30 milligram(s) Orodispersible tablet",2014-02-14,"PA0711/244/002","Rowex Ltd","Lansoprazole"
"4823","LANSOPRAZOLE ACTAVIS","15 Milligram                                                                                            Capsules Gastro-Resistant",2012-02-24,"PA1380/131/001","Actavis Group PTC ehf","LANSOPRAZOLE"
"4824","LANSOPRAZOLE ACTAVIS","30 Milligram                                                                                            Capsules Gastro-Resistant",2012-02-24,"PA1380/131/002","Actavis Group PTC ehf","LANSOPRAZOLE"
"4825","Lansoprazole Krka 15 mg Gastro-resistant Capsules, hard","15 milligram(s) Gastro-resistant capsule",2005-09-23,"PA1347/062/001","Krka d.d., Novo mesto","Lansoprazole"
"4826","Lansoprazole Krka 30 mg Gastro-resistant Capsules, hard","30 milligram(s) Gastro-resistant capsule",2005-09-23,"PA1347/062/002","Krka d.d., Novo mesto","Lansoprazole"
"4827","LANSOPRAZOLE MYLAN","15 Milligram                                                                                            Capsules Gastro-Resistant",2011-08-12,"PA0577/151/001","McDermott Laboratories Ltd t/a Gerard Laboratories","LANSOPRAZOLE"
"4828","LANSOPRAZOLE MYLAN","30 Milligram                                                                                            Capsules Gastro-Resistant",2011-08-12,"PA0577/151/002","McDermott Laboratories Ltd t/a Gerard Laboratories","LANSOPRAZOLE"
"4829","LANSOPRAZOLE PINEWOOD","15 Milligram                                                                                            Capsules Gastro-Resistant",2013-11-25,"PA0281/151/001","Pinewood Laboratories Ltd,","LANSOPRAZOLE(I.N.N.)"
"4830","LANSOPRAZOLE PINEWOOD","30 Milligram                                                                                            Capsules Gastro-Resistant",2013-11-25,"PA0281/151/002","Pinewood Laboratories Ltd,","LANSOPRAZOLE"
"4831","LANSOPRAZOLE TEVA","15 Milligram                                                                                            Orodispersible Tablet",2010-01-29,"PA0749/024/003","Teva Pharma B.V.","LANSOPRAZOLE"
"4832","LANSOPRAZOLE TEVA","30 Milligram                                                                                            Orodispersible Tablet",2010-01-29,"PA0749/024/004","Teva Pharma B.V.","LANSOPRAZOLE"
"4833","Lansoprazole Teva Pharma 15mg Gastro-resistant Capsules, hard","15 milligram(s) Gastro-resistant capsule",2015-02-27,"PA1986/008/001","Teva B.V.","Lansoprazole"
"4834","Lansoprazole Teva Pharma 30mg Gastro-resistant Capsules, hard","30 milligram(s) Gastro-resistant capsule",2015-02-27,"PA1986/008/002","Teva B.V.","Lansoprazole"
"4835","LANTUS","100IU/ml international unit(s) Solution for injection",NA,"EU/1/00/134/001","Sanofi-Aventis Deutschland GmbH","Insulinglargine"
"4836","LANTUS","100 IU/ML                                                                                                Solution for Injection",2000-06-09,"EU/1/00/134/002","Sanofi-Aventis Deutschland GmbH","INSULINGLARGINE"
"4837","LANTUS","100 IU/ML                                                                                                Solution for Injection",2000-06-09,"EU/1/00/134/003","Sanofi-Aventis Deutschland GmbH","INSULINGLARGINE"
"4838","LANTUS","100 IU/ML                                                                                                Solution for Injection",2000-06-09,"EU/1/00/134/004","Sanofi-Aventis Deutschland GmbH","INSULINGLARGINE"
"4839","Lantus","100 international unit(s)/millilitre Solution for injection",2000-06-09,"EU/1/00/134/005","Sanofi-Aventis Deutschland GmbH","Insulinglargine"
"4840","Lantus","100 international unit(s)/millilitre Solution for injection",2000-06-09,"EU/1/00/134/006","Sanofi-Aventis Deutschland GmbH","Insulinglargine"
"4841","Lantus","100 international unit(s)/millilitre Solution for injection",2000-06-09,"EU/1/00/134/007","Sanofi-Aventis Deutschland GmbH","Insulinglargine"
"4842","Lantus","100 international unit(s)/millilitre Solution for injection",2000-06-09,"EU/1/00/134/8-37","Sanofi-Aventis Deutschland GmbH","Insulinglargine"
"4843","Lanvis 40mg Tablets","40 milligram(s) Tablet",1979-04-01,"PA1691/006/001","Aspen Pharma Trading Limited","Tioguanine"
"4844","Lanzol 15 mg hard gastro-resistant capsules","15 milligram(s) Gastro-resistant capsule",2005-03-11,"PA0711/067/001","Rowex Ltd","Lansoprazole"
"4845","Lanzol 30 mg hard gastro-resistant capsules","30 milligram(s) Gastro-resistant capsule",2005-03-11,"PA0711/067/002","Rowex Ltd","Lansoprazole"
"4846","Lapainol 10 mg/ml solution for injection","10 micromole(s) Solution for injection",2007-08-03,"PA1353/002/001","Orpha-Devel Handels und Vertriebs GmbH","Nalbuphinehydrochloride"
"4847","LARIG","25 Milligram                                                                                            Dispersable Tablet",2005-10-13,"PA0711/085/002","Rowex Ltd","LAMOTRIGINE"
"4848","LARIG","50 Milligram                                                                                            Dispersable Tablet",2005-10-13,"PA0711/085/003","Rowex Ltd","LAMOTRIGINE"
"4849","LARIG","100 Milligram                                                                                            Dispersable Tablet",2005-10-13,"PA0711/085/004","Rowex Ltd","LAMOTRIGINE"
"4850","LARIG","200 Milligram                                                                                            Dispersable Tablet",2005-10-13,"PA0711/085/005","Rowex Ltd","LAMOTRIGINE"
"4851","Lartruvo","10 milligram(s)/millilitre Concentrate for solution for infusion",2016-11-09,"EU/1/16/1143/001","Eli Lilly Nederland B.V.","Olaratumab"
"4852","Lasix 20mg/2ml Solution for Injection or Infusion","20mg/2ml milligram(s)/millilitre Solution for injection/infusion",1977-04-01,"PA0540/052/002","Sanofi-Aventis Ireland Limited T/A SANOFI","Frusemide"
"4853","LASSARS","24/2 %w/w                                                                                                 Cutaneous Paste",1983-04-01,"PA0206/014/001","Ovelle Limited","ZINCOXIDE|SALICYLICACID"
"4854","LASSARS","23/2 %w/w                                                                                                 Cream",1983-04-01,"PA0206/014/002","Ovelle Limited","ZINCOXIDE|SALICYLICACID"
"4855","Latacris 50 microgram/ml eye drops, solution","50 microgram(s)/millilitre Eye drops, solution",2011-08-26,"PA2122/001/001","NTC Srl","Latanoprost"
"4856","LATANEAU PLUS","50mcg/ml + 5 Mg/Ml Eye Drops Solution",2011-05-27,"PA1608/001/001","Alapis S.A.","LATANOPROST|TIMOLOLMALEATE"
"4857","LATANOPROST","50 Microgram/ML                                                                                         Eye Drops Solution",2014-07-04,"PA0405/068/001","Generics (UK) Limited","LATANOPROST"
"4858","LATANOPROST / TIMOLOL","50mcg/ml + 5 Mg/Ml Eye Drops Solution",2011-08-26,"PA1380/090/001","Actavis Group PTC ehf","LATANOPROST|TIMOLOLMALEATE"
"4859","Latanoprost Actavis 50 microgram/ml eye drops, solution","50 microgram(s)/millilitre Eye drops, solution",NA,"PA1380/107/001","Actavis Group PTC ehf","Latanoprost"
"4860","Latanoprost Teva 50 micrograms/ml eye drop solution","50 microgram(s)/millilitre Eye drops, solution",2012-10-19,"PA0749/173/001","Teva Pharma B.V.","Latanoprost"
"4861","LATANOPROST/TIMOLOL ZENTIVA","50mcg/ml + 5 Mg/Ml Eye Drops Solution",2013-05-17,"PA1701/002/001","Zentiva k.s.","LATANOPROST|TIMOLOLMALEATE"
"4862","Latop 50 microgram/ml eye drops, solution","50 microgram(s)/millilitre Eye drops, solution",2011-09-09,"PA0711/177/001","Rowex Ltd","Latanoprost"
"4863","LATOP-COMP","50mcg/ml + 5 Mg/Ml Eye Drops Solution",2011-05-20,"PA0711/184/001","Rowex Ltd","LATANOPROST|TIMOLOLMALEATE"
"4864","Latuda","18.5 milligram(s) Film-coated tablet",2014-03-21,"EU/1/14/913/001-007","Aziende Chimiche Riunite Angelini Francesco - ACRAF S.p.A","Lurasidonehydrochloride"
"4865","LATUDA","37 Milligram                                                                                            Film Coated Tablet",2014-03-21,"EU/1/14/913/008-014","Aziende Chimiche Riunite Angelini Francesco - ACRAF S.p.A","LURASIDONEHYDROCHLORIDE"
"4866","LATUDA","74 Milligram                                                                                            Film Coated Tablet",2014-03-21,"EU/1/14/913/015-021","Aziende Chimiche Riunite Angelini Francesco - ACRAF S.p.A","LURASIDONEHYDROCHLORIDE"
"4867","Laventair","55/22 microcurie(s) Powder for Inhalation",2014-05-08,"EU/1/14/899/001-003","Glaxo Group Limited","Umeclidiniumbromide|Vilanteroltrifenatate"
"4868","Laxaclear 5.9 g, powder for oral solution","5.9 gram(s) Powder for oral solution",2013-08-16,"PA0294/022/001","Helsinn Birex Pharmaceuticals Limited","Macrogol3350"
"4869","Laxido Orange, powder for oral solution","13.8 gram(s) Powder for oral solution",2008-07-21,"PA1329/002/001","Galen Limited","Macrogol3350|Sodiumchloride|Sodiumhydrogencarbonate|Potassiumchloride"
"4870","LAXIDO PAEDIATRIC PLAIN","6.9 Grams                                                                                                Powder for Oral Solution",2015-05-22,"PA1329/002/003","Galen Limited","MACROGOL3350|SODIUMCHLORIDE|SODIUMBICARBONATE|POTASSIUMCHLORIDE"
"4871","Laxido, powder for oral solution","13.7 gram(s) Powder for oral solution",2008-07-21,"PA1329/002/002","Galen Limited","Macrogol3350|Macrogol3350|Sodiumchloride|Sodiumchloride|Sodiumhydrogencarbonate|Sodiumhydrogencarbonate|Potassiumchloride|Potassiumchloride"
"4872","LAXOSE","3.35 g/5ml                                                                                                Oral Solution",1996-05-07,"PA0281/079/001","Pinewood Laboratories Ltd,","LACTULOSE"
"4873","LECALPIN","10 Milligram                                                                                            Film Coated Tablet",2009-09-11,"PA1380/036/001","Actavis Group PTC ehf","LERCANIDIPINEHCI"
"4874","LECALPIN","20 Milligram                                                                                            Film Coated Tablet",2009-09-11,"PA1380/036/002","Actavis Group PTC ehf","LERCANIDIPINEHCI"
"4875","Ledaga","160 ZZZ Micrograms/g Gel",2017-03-03,"EU/1/16/1171/001","Actelion Registration Ltd.","CHLORMETHINEHYDROCHLORIDE"
"4876","LEDERMIX FOR DENTAL USE","3 %v/v                                                                                                 Dental Solution",1983-04-01,"PA1321/002/001","Henry Schein UK Holdings Limited","DEMECLOCYCLINEHYDROCHLORIDEINPASTE|TRIAMCINOLONEACETONIDEINPASTE|DEMECLOCYCLINEHYDROCHLORIDEINPOWDER|TRIAMCINOLONEACETONIDEINPOWDER|EUGENOLINHARDENERF|EUGENOLINHARDENERS"
"4877","LEFLUNOMIDE","10 Milligram                                                                                            Film Coated Tablet",2011-08-12,"PA1619/002/001","Aspire Pharma Limited","LEFLUNOMIDE"
"4878","LEFLUNOMIDE","20 Milligram                                                                                            Film Coated Tablet",2011-08-12,"PA1619/002/002","Aspire Pharma Limited","LEFLUNOMIDE"
"4879","Leflunomide 10 mg Film Coated Tablets","10 milligram(s) Tablet",2011-05-03,"PA1333/011/001","Morningside Healthcare Limited","Leflunomide"
"4880","Leflunomide 100 mg Film Coated Tablets","100 milligram(s) Tablet",2011-05-03,"PA1333/011/003","Morningside Healthcare Limited","Leflunomide"
"4881","Leflunomide 20 mg Film Coated Tablets","20 milligram(s) Tablet",2011-05-03,"PA1333/011/002","Morningside Healthcare Limited","Leflunomide"
"4882","LEFLUNOMIDE MEDAC","10 Milligram                                                                                            Film Coated Tablet",2010-07-27,"EU/1/10/637/001-004","Medac Gesellschaft fur Klinische Spezialpraparate mbH","LEFLUNOMIDE"
"4883","LEFLUNOMIDE MEDAC","20 Milligram                                                                                            Film Coated Tablet",2010-07-27,"EU/1/10/637/005-009","Medac Gesellschaft fur Klinische Spezialpraparate mbH","LEFLUNOMIDE"
"4884","LEFLUNOMIDE MEDAC","15 Milligram                                                                                            Film Coated Tablet",2013-07-25,"EU/1/10/637/010-012","Medac Gesellschaft fur Klinische Spezialpraparate mbH","LEFLUNOMIDE"
"4885","LEFLUNOMIDE RATIOPHARM","20 Milligram                                                                                            Film Coated Tablet",2010-11-29,"EU/1/10/654/003-004","Ratiopharm GmbH",""
"4886","Leflunomide Winthrop","100 milligram(s) Film-coated tablet",NA,"EU/1/09/604/10","Zentiva k.s.","Leflunomide"
"4887","Leflunomide Winthrop","10 milligram(s) Film-coated tablet",2010-01-08,"EU/1/09/604/1-4","Zentiva k.s.","Leflunomide"
"4888","Leflunomide Winthrop","20 milligram(s) Film-coated tablet",2010-01-08,"EU/1/09/604/5-9","Zentiva k.s.","Leflunomide"
"4889","LEGANTO","1/24 mg/24 hours Transdermal Patch",2011-06-16,"EU/1/11/695/001-009","UCB Pharma S.A.","ROTIGOTINE"
"4890","LEGANTO","2/24 mg/24 hours Transdermal Patch",2011-06-16,"EU/1/11/695/010-018","UCB Pharma S.A.","ROTIGOTINE"
"4891","LEGANTO","3/24 mg/24 hours Transdermal Patch",2011-06-16,"EU/1/11/695/019-027","UCB Pharma S.A.","ROTIGOTINE"
"4892","LEGANTO","4/24 mg/24 hours Transdermal Patch",2011-06-16,"EU/1/11/695/028-036","UCB Pharma S.A.","ROTIGOTINE"
"4893","LEGANTO","6/24 mg/24 hours Transdermal Patch",2011-06-16,"EU/1/11/695/037-046","UCB Pharma S.A.","ROTIGOTINE"
"4894","LEGANTO","8/24 mg/24 hours Transdermal Patch",2011-06-16,"EU/1/11/695/046-054","UCB Pharma S.A.","ROTIGOTINE"
"4895","LEGANTO","Transdermal Patch",2011-06-16,"EU/1/11/695/055","UCB Pharma S.A.",""
"4896","Lemilvo 10mg tablets","10 milligram(s) Tablet",2015-07-10,"PA1380/174/002","Actavis Group PTC ehf","Aripiprazole"
"4897","Lemilvo 15mg tablets","15 milligram(s) Tablet",2015-07-10,"PA1380/174/003","Actavis Group PTC ehf","Aripiprazole"
"4898","Lemilvo 30mg tablets","30 milligram(s) Tablet",2015-07-10,"PA1380/174/004","Actavis Group PTC ehf","Aripiprazole"
"4899","Lemilvo 5mg tablets","5 milligram(s) Tablet",2015-07-10,"PA1380/174/001","Actavis Group PTC ehf","Aripiprazole"
"4900","LEMSIP CHESTY COUGH","50 MG/5ml                                                                                               Oral Solution",2006-04-07,"PA0979/026/001","Reckitt Benckiser Ireland Ltd","GUAIFENESIN"
"4901","LEMSIP COLD & FLU","500 Milligram                                                                                            Tablets",2010-07-21,"PA0979/051/001","Reckitt Benckiser Ireland Ltd","PARACETAMOLDC"
"4902","LEMSIP COLD & FLU HEADCOLD","500 Milligram                                                                                            Powder for Oral Solution",1994-11-09,"PA0979/014/001","Reckitt Benckiser Ireland Ltd","PARACETAMOL"
"4903","LEMSIP COLD & FLU HOT LEMON","500 Milligram                                                                                            Powder for Oral Solution",1978-04-01,"PA0979/013/001","Reckitt Benckiser Ireland Ltd","PARACETAMOL"
"4904","LEMSIP COLD AND FLU CAPSULES WITH CAFFEINE","500/65 Milligram                                                                                            Capsule",2003-10-17,"PA0979/024/001","Reckitt Benckiser Ireland Ltd","PARACETAMOL|CAFFEINE"
"4905","LEMSIP COUGH AND COLD CAPSULES WITH CAFFEINE","500mg/100m Milligram                                                                                            Capsules Hard",2007-06-22,"PA0979/029/001","Reckitt Benckiser Ireland Ltd","PARACETAMOL|GUAIFENESIN|CAFFEINEANHYDROUS"
"4906","LEMSIP DECONGESTANT & FLU BLACKCURRANT","500 / 6.1 Milligram                                                                                            Tablets",2010-08-06,"PA0979/050/002","Reckitt Benckiser Ireland Ltd","PARACETAMOL|PHENYLEPHRINEHYDROCHLORIDE"
"4907","LEMSIP DECONGESTANT & FLU CAPSULES WITH CAFFEINE","500/6.1/25 Milligram                                                                                            Capsule",2007-11-30,"PA0979/027/001","Reckitt Benckiser Ireland Ltd","PARACETAMOL|CAFFEINE|PHENYLEPHRINEHYDROCHLORIDE"
"4908","LEMSIP DECONGESTANT & FLU LEMON","500 / 6.1 Milligram                                                                                            Tablets",2010-08-06,"PA0979/050/001","Reckitt Benckiser Ireland Ltd","PARACETAMOL|PHENYLEPHRINEHYDROCHLORIDE"
"4909","LEMSIP DRY COUGH","0.25 ml/5ml                                                                                               Oral Solution",2006-04-07,"PA0979/025/001","Reckitt Benckiser Ireland Ltd","GLYCEROL"
"4910","Lemsip Max Cold and Flu Blackcurrant 1000 mg Powder for Oral Solution","1000 milligram(s) Powder for oral solution",2007-11-23,"PA0979/021/003","Reckitt Benckiser Ireland Ltd","Paracetamol|Paracetamol"
"4911","LEMSIP MAX COLD AND FLU HOT LEMON","1000 Milligram                                                                                            Powder for Oral Solution",1999-10-01,"PA0979/021/001","Reckitt Benckiser Ireland Ltd","PARACETAMOL"
"4912","LEMSIP MAX COUGH & COLD","1000/200 Milligram                                                                                            Powder for Oral Solution",2007-06-22,"PA0979/028/001","Reckitt Benckiser Ireland Ltd","PARACETAMOL|GUAIFENESIN"
"4913","LEMSIP MAX SINUS & FLU HOT LEMON","%v/v                                                                                                 Powder for Oral Solution",1996-05-09,"PA0979/020/001","Reckitt Benckiser Ireland Ltd","PARACETAMOL|PSEUDOEPHEDRINEHYDROCHLORIDE"
"4914","LEMSIP MULTIRELIEF CAPSULES","500/6.1/100 Milligram                                                                                            Capsules Hard",2010-08-06,"PA0979/053/001","Reckitt Benckiser Ireland Ltd","PARACETAMOL|PHENYLEPHRINEHYDROCHLORIDE|GUAIFENESIN"
"4915","Lemtrada","12 milligram(s) Concentrate for solution for infusion",2013-09-12,"EU/1/13/869/001","Sanofi Belgium","Alemtuzumab"
"4916","Lenalidomide Accord","2.5 milligram(s) Capsule, hard",2018-09-20,"EU/1/18/1316/001-002","Accord Healthcare Limited","Lenalidomide"
"4917","Lenalidomide Accord","5 milligram(s) Capsule, hard",2018-09-20,"EU/1/18/1316/003-004","Accord Healthcare Limited","Lenalidomide"
"4918","Lenalidomide Accord","7.5 milligram(s) Capsule, hard",2018-09-20,"EU/1/18/1316/005","Accord Healthcare Limited","Lenalidomide"
"4919","Lenalidomide Accord","10 milligram(s) Capsule, hard",2018-09-20,"EU/1/18/1316/006-007","Accord Healthcare Limited","Lenalidomide"
"4920","Lenalidomide Accord","15 milligram(s) Capsule, hard",2018-09-20,"EU/1/18/1316/008-009","Accord Healthcare Limited","Lenalidomide"
"4921","Lenalidomide Accord","20 milligram(s) Capsule, hard",2018-09-20,"EU/1/18/1316/010","Accord Healthcare Limited","Lenalidomide"
"4922","Lenalidomide Accord","25 milligram(s) Capsule, hard",2018-09-20,"EU/1/18/1316/011","Accord Healthcare Limited","Lenalidomide"
"4923","Lenvima","4 milligram(s) Capsule, hard",2015-05-28,"EU/1/15/1002/001","Eisai Europe Ltd","Lenvatinibmesylate"
"4924","LENVIMA","10 Milligram                                                                                            Capsules Hard",2015-05-28,"EU/1/15/1002/002","Eisai Europe Ltd","LENVATINIBMESYLATE"
"4925","LENZETTO","1.53 Milligram                                                                                            Unknown",2015-08-13,"PA1330/017/001","Gedeon Richter Plc","ESTRADIOLHEMIHYDRATE"
"4926","Leonore 100 micrograms/20 micrograms Coated Tablets","100/20 microgram(s) Coated tablet",2008-02-29,"PA0711/127/001","Rowex Ltd","Levonorgestrel|Ethinylestradiol"
"4927","LERCANIDIPINE CLONMEL","10 Milligram                                                                                            Film Coated Tablet",2010-03-19,"PA0126/187/001","Clonmel Healthcare Ltd","LERCANIDIPINEHCIHEMIHYDRATE"
"4928","LERCANIDIPINE CLONMEL","20 Milligram                                                                                            Film Coated Tablet",2010-03-19,"PA0126/187/002","Clonmel Healthcare Ltd","LERCANIDIPINEHCIHEMIHYDRATE"
"4929","LERCANIDIPINE MYLAN","10 Milligram                                                                                            Film Coated Tablet",2011-06-03,"PA0577/155/001","McDermott Laboratories Ltd t/a Gerard Laboratories","LERCANIDIPINEHYDROCHLORIDE"
"4930","LERCANIDIPINE MYLAN","20 Milligram                                                                                            Film Coated Tablet",2011-06-03,"PA0577/155/002","McDermott Laboratories Ltd t/a Gerard Laboratories","LERCANIDIPINEHYDROCHLORIDE"
"4931","LERCANIDIPINE TEVA","10 Milligram                                                                                            Film Coated Tablet",2010-07-21,"PA0749/115/001","Teva Pharma B.V.","LERCANIDIPINEHYDROCHLORIDE"
"4932","LERCANIDIPINE TEVA","20 Milligram                                                                                            Film Coated Tablet",2010-07-21,"PA0749/115/002","Teva Pharma B.V.","LERCANIDIPINEHYDROCHLORIDE"
"4933","LERCARIL","20/10 Milligram                                                                                            Film Coated Tablet",2017-03-01,"PPA1097/003/001","Lexon (UK) Ltd","ENALAPRILMALEATE|LERCANIDIPINEHYDROCHLORIDE"
"4934","Lercaril 10 mg/10 mg film-coated tablets","10/10 milligram(s) Film-coated tablet",2008-08-22,"PA1404/002/001","Recordati Ireland Limited","Lercanidipinehydrochloride|Enalaprilmaleate"
"4935","Lercaril 20 mg/10 mg film-coated tablets","20/10 milligram(s) Film-coated tablet",2008-08-22,"PA1404/002/002","Recordati Ireland Limited","Enalaprilmaleate|Lercanidipinehydrochloride"
"4936","Lercaril 20 mg/20 mg Film-coated Tablets","20/20 milligram(s) Film-coated tablet",2014-07-11,"PA1404/002/003","Recordati Ireland Limited","Enalaprilmaleate|Lercanidipinehydrochloride"
"4937","LESCOL","20 Milligram                                                                                            Capsules Hard",1995-09-19,"PA0896/016/001","Novartis Ireland Limited","FLUVASTATIN"
"4938","LESCOL","40 Milligram                                                                                            Capsules Hard",1995-09-19,"PA0896/016/002","Novartis Ireland Limited","FLUVASTATIN"
"4939","LESCOL XL","80 Base Milligrams                                                                                      Tablet Prolonged Release",2002-01-23,"PA0896/016/003","Novartis Ireland Limited","FLUVASTATIN"
"4940","LESCOL XL","80 Milligram                                                                                            Tablet Prolonged Release",2014-12-05,"PPA0465/404/001","PCO Manufacturing","FLUVASTATIN"
"4941","LESCOL XL","80 Milligram                                                                                            Tablet Prolonged Release",2010-11-12,"PPA1562/039/001","LTT Pharma Limited","FLUVASTATINSODIUM"
"4942","LESCOL XL","80 Milligram                                                                                            Tablet Prolonged Release",2015-03-13,"PPA1463/101/001","IMED Healthcare Ltd.","FLUVASTATINSODIUM"
"4943","LESTACE","2.5 Milligram                                                                                            Tablets",2009-01-23,"PA1380/007/001","Actavis Group PTC ehf","LISINOPRILDIHYDRATE"
"4944","LESTACE","5 Milligram                                                                                            Tablets",2009-01-23,"PA1380/007/002","Actavis Group PTC ehf","LISINOPRILDIHYDRATE"
"4945","LESTACE","10 Milligram                                                                                            Tablets",2009-01-23,"PA1380/007/003","Actavis Group PTC ehf","LISINOPRILDIHYDRATE"
"4946","LESTACE","20 Milligram                                                                                            Tablets",2009-01-23,"PA1380/007/004","Actavis Group PTC ehf","LISINOPRILDIHYDRATE"
"4947","LETROZOLE","2.5 Milligram                                                                                            Film Coated Tablet",2009-03-20,"PA1390/031/001","Accord Healthcare Limited","LETROZOLE"
"4948","LETROZOLE","2.5 Milligram                                                                                            Film Coated Tablet",2011-07-22,"PA1422/007/001","Fresenius Kabi Oncology Plc","LETROZOLE"
"4949","LETROZOLE","2.5 Milligram                                                                                            Film Coated Tablet",2010-08-06,"PA0126/198/001","Clonmel Healthcare Ltd","LETROZOLE"
"4950","Letrozole Actavis 2.5 mg Film-coated Tablets","2.5 milligram(s) Film-coated tablet",2009-09-25,"PA1380/038/001","Actavis Group PTC ehf","Letrozole"
"4951","LETROZOLE BLUEFISH","2.5 Milligram                                                                                            Film Coated Tablet",2010-03-26,"PA1436/013/001","Bluefish Pharmaceuticals AB","LETROZOLE"
"4952","LETROZOLE MEDIPHA SANTE","2.5 Milligram                                                                                            Film Coated Tablet",2011-02-25,"PA1566/001/001","Medipha Sante SN","LETROZOLE"
"4953","LETROZOLE MYLAN","2.5 Milligram                                                                                            Film Coated Tablet",2011-05-13,"PA0577/116/001","McDermott Laboratories Ltd t/a Gerard Laboratories","LETROZOLE"
"4954","LETROZOLE SYNTHON","2.5 Milligram                                                                                            Film Coated Tablet",2008-12-12,"PA0840/009/001","Synthon BV","LETROZOLE"
"4955","LETROZOLE TEVA","2.5 Milligram                                                                                            Film Coated Tablet",2010-06-04,"PA0749/085/001","Teva Pharma B.V.","LETROZOLE"
"4956","LETZO","2.5 Milligram                                                                                            Film Coated Tablet",2010-11-19,"PA0711/190/001","Rowex Ltd","LETROZOLE"
"4957","Leucovorin-Teva 10mg/ml Concentrate for Solution for Infusion","10 milligram(s)/millilitre Concentrate for solution for infusion",2001-05-04,"PA0749/001/001","Teva Pharma B.V.","Calciumfolinate"
"4958","LEUKERAN","2 Milligram                                                                                            Film Coated Tablet",1979-04-01,"PA1691/007/001","Aspen Pharma Trading Limited","CHLORAMBUCIL"
"4959","LEUPREX 3","5 Milligram                                                                                            Implant",2009-08-28,"PA0711/188/001","Rowex Ltd","LEUPRORELINACETATE"
"4960","LEUPRORELIN 1-MONTH DEPOT","3.75 Milligram                                                                                            Pdr+Solv for PR for Susp for Inj",2013-01-04,"PA1766/001/001","GP-Pharm, S.A.","LEUPRORELINACETATE"
"4961","LEUPRORELIN 3-MONTH DEPOT","22.5 Milligram                                                                                            Pdr+Solv for PR for Susp for Inj",2015-06-19,"PA1766/001/002","GP-Pharm, S.A.","LEUPRORELINACETATE"
"4962","Levact 100mg Powder for Concentrate for Solution for Infusion","100 milligram(s) ZZZ Pdr/Conc/Soln for Infus",2010-10-08,"PA0731/005/002","Astellas Pharma GmbH","Bendamustinehydrochloride"
"4963","Levact 25mg Powder for Concentrate for Solution for Infusion","25 milligram(s) ZZZ Pdr/Conc/Soln for Infus",2010-10-08,"PA0731/005/001","Astellas Pharma GmbH","Bendamustinehydrochloride"
"4964","Levemir","100 unit(s)/millilitre Solution for injection",NA,"EU/1/04/278/010-011","Novo Nordisk A/S","Insulindetermir"
"4965","LEVEMIR (INSULIN DETEMIR)","100 U/ml Units/ml                                                                                             Solution for Injection",2004-06-01,"EU/1/04/278/1-9","Novo Nordisk A/S","INSULINDETEMIR"
"4966","LEVETIRACETAM","100 Mg/Ml Oral Solution",2011-12-05,"EU/1/11/738/001-003","Actavis Group PTC ehf","LEVETIRACETAM"
"4967","Levetiracetam 100mg/ml concentrate for solution for infusion","100 milligram(s)/millilitre Concentrate for solution for infusion",2018-10-26,"PA0997/012/001","Intrapharm Laboratories Limited","Levetiracetam"
"4968","LEVETIRACETAM ACCORD","250 Milligram                                                                                            Film Coated Tablet",2011-10-03,"EU/1/11/712/001-007","Accord Healthcare Limited","LEVETIRACETAM"
"4969","LEVETIRACETAM ACCORD","500 Milligram                                                                                            Film Coated Tablet",2011-10-03,"EU/1/11/712/008-013","Accord Healthcare Limited","LEVETIRACETAM"
"4970","LEVETIRACETAM ACCORD","750 Milligram                                                                                            Film Coated Tablet",2011-10-03,"EU/1/11/712/015-021","Accord Healthcare Limited","LEVETIRACETAM"
"4971","LEVETIRACETAM ACCORD","1000 Milligram                                                                                            Film Coated Tablet",2011-10-03,"EU/1/11/712/022-028","Accord Healthcare Limited","LEVETIRACETAM"
"4972","LEVETIRACETAM ACTAVIS","250 Milligram                                                                                            Film Coated Tablet",2011-10-03,"EU/1/11/713/001-010","Actavis Group PTC ehf","LEVETIRACETAM"
"4973","LEVETIRACETAM ACTAVIS","500 Milligram                                                                                            Film Coated Tablet",2011-10-03,"EU/1/11/713/011-020","Actavis Group PTC ehf","LEVETIRACETAM"
"4974","LEVETIRACETAM ACTAVIS","750 Milligram                                                                                            Film Coated Tablet",2011-10-03,"EU/1/11/713/021-030","Actavis Group PTC ehf","LEVETIRACETAM"
"4975","LEVETIRACETAM ACTAVIS","1000 Milligram                                                                                            Film Coated Tablet",2011-10-03,"EU/1/11/713/031-040","Actavis Group PTC ehf","LEVETIRACETAM"
"4976","LEVETIRACETAM BLUEFISH","250 Milligram                                                                                            Film Coated Tablet",2011-10-28,"PA1436/020/001","Bluefish Pharmaceuticals AB","LEVETIRACETAM"
"4977","LEVETIRACETAM BLUEFISH","500 Milligram                                                                                            Film Coated Tablet",2011-10-28,"PA1436/020/002","Bluefish Pharmaceuticals AB","LEVETIRACETAM"
"4978","LEVETIRACETAM BLUEFISH","1000 Milligram                                                                                            Film Coated Tablet",2011-10-28,"PA1436/020/003","Bluefish Pharmaceuticals AB","LEVETIRACETAM"
"4979","LEVETIRACETAM BRISTOL LABS","100 Unknown Infus/Pdr/Oral Soln",2017-03-24,"PA1240/029/001","Bristol Laboratories Limited","LEVETIRACETAM"
"4980","Levetiracetam Clonmel 1000 mg film-coated tablets","1000 milligram(s) Film-coated tablet",2011-11-18,"PA0126/218/004","Clonmel Healthcare Ltd","Levetiracetam"
"4981","Levetiracetam Clonmel 250 mg film-coated tablets","250 milligram(s) Film-coated tablet",2011-11-18,"PA0126/218/001","Clonmel Healthcare Ltd","Levetiracetam"
"4982","Levetiracetam Clonmel 500 mg film-coated tablets","500 milligram(s) Film-coated tablet",2011-11-18,"PA0126/218/002","Clonmel Healthcare Ltd","Levetiracetam"
"4983","Levetiracetam Hospira","100 milligram(s)/millilitre Concentrate for solution for infusion",2014-02-20,"EU/1/13/889/001-002","Hospira  UK Limited","Levetiracetam"
"4984","LEVETIRACETAM MYLAN","250 Milligram                                                                                            Film Coated Tablet",2012-04-27,"PA0577/143/001","McDermott Laboratories Ltd t/a Gerard Laboratories","LEVETIRACETAM"
"4985","LEVETIRACETAM MYLAN","500 Milligram                                                                                            Film Coated Tablet",2012-04-27,"PA0577/143/002","McDermott Laboratories Ltd t/a Gerard Laboratories","LEVETIRACETAM"
"4986","LEVETIRACETAM MYLAN","1000 Milligram                                                                                            Film Coated Tablet",2012-04-27,"PA0577/143/003","McDermott Laboratories Ltd t/a Gerard Laboratories","LEVETIRACETAM"
"4987","LEVETIRACETAM RATIOPHARM","100 Mg/Ml Oral Solution",2011-08-26,"EU/1/11/702/001-003","Ratiopharm GmbH","LEVETIRACETAM"
"4988","LEVETIRACETAM RATIOPHARM","250 Milligram                                                                                            Film Coated Tablet",2011-08-26,"EU/1/11/702/004-009","Ratiopharm GmbH","LEVETIRACETAM"
"4989","LEVETIRACETAM RATIOPHARM","500 Milligram                                                                                            Film Coated Tablet",2011-08-26,"EU/1/11/702/010-017","Ratiopharm GmbH","LEVETIRACETAM"
"4990","LEVETIRACETAM RATIOPHARM","750 Milligram                                                                                            Film Coated Tablet",2011-08-26,"EU/1/11/702/018-024","Ratiopharm GmbH","LEVETIRACETAM"
"4991","LEVETIRACETAM RATIOPHARM","1000 Milligram                                                                                            Film Coated Tablet",2011-08-26,"EU/1/11/702/025-031","Ratiopharm GmbH","LEVETIRACETAM"
"4992","LEVETIRACETAM SUN","100 Mg/Ml Concentrate for Soln for Inf",2011-12-14,"EU/1/11/741/001","Sun Phamaceutical Industries Europe B.V.","LEVETIRACETAM"
"4993","LEVETIRACETAM TEVA","250 Milligram                                                                                            Film Coated Tablet",2011-08-26,"EU/1/11/701/001-004","Teva B.V.","LEVETIRACETAM"
"4994","LEVETIRACETAM TEVA","500 Milligram                                                                                            Film Coated Tablet",2011-08-26,"EU/1/11/701/008-014","Teva B.V.","LEVETIRACETAM"
"4995","LEVETIRACETAM TEVA","750 Milligram                                                                                            Film Coated Tablet",2011-08-26,"EU/1/11/701/015-021","Teva Pharma B.V.","LEVETIRACETAM"
"4996","LEVETIRACETAM TEVA","1000 Milligram                                                                                            Film Coated Tablet",2011-08-26,"EU/1/11/701/022-028","Teva B.V.","LEVETIRACETAM"
"4997","LEVETIRACETAM THAME","100 Mg/Ml Oral Solution",2015-08-28,"PA1861/015/001","SYRI Limited, t/a Thame Laboratories","LEVETIRACETAM"
"4998","Levetiracetam Wockhardt 100 mg/ml Oral Solution","100 milligram(s)/millilitre Oral solution",2011-06-29,"PA1339/056/001","Wockhardt UK Limited","Levetiracetam"
"4999","Levetiracetam Wockhardt 100mg/ml concentrate for solution for infusion","100 milligram(s)/millilitre Concentrate for solution for infusion",2014-12-05,"PA1339/054/001","Wockhardt UK Limited","Levetiracetam"
"5000","LEVITRA","10 Milligram                                                                                            Orodispersible Tablet",2010-09-01,"EU/1/03/248/013-15","Bayer AG","VARDENAFILHYDROCHLORIDETRIHYDRATE"
"5001","LEVITRA","5 mg milligram(s) Tablet",NA,"EU/1/03/248/1-12","Bayer AG","Vardenafil(ashydrochloridetrihydrate)"
"5002","LEVOBUPIVACAINE","0.625 Mg/Ml Solution for Infusion",2014-10-24,"PA2059/009/001","Fresenius Kabi Deutschland GmbH","LEVOBUPIVACAINEHYDROCHLORIDE"
"5003","LEVOBUPIVACAINE","1.25 Mg/Ml Solution for Infusion",2014-10-24,"PA2059/009/002","Fresenius Kabi Deutschland GmbH","LEVOBUPIVACAINEHYDROCHLORIDE"
"5004","LEVOBUPIVACAINE","2.5 Mg/Ml Solution for Inj/Inf",NA,"PA2059/009/003","Fresenius Kabi Deutschland GmbH","LEVOBUPIVACAINEHYDROCHLORIDE"
"5005","LEVOBUPIVACAINE","5 Mg/Ml Solution for Inj/Inf",NA,"PA2059/009/004","Fresenius Kabi Deutschland GmbH","LEVOBUPIVACAINEHYDROCHLORIDE"
"5006","LEVOBUPIVACAINE","7.5 Mg/Ml Solution for Infusion",NA,"PA2059/009/005","Fresenius Kabi Deutschland GmbH","LEVOBUPIVACAINEHYDROCHLORIDE"
"5007","LEVOCETIRIZINE","5 Milligram                                                                                            Film Coated Tablet",2011-05-03,"PPA1151/149/001","Imbat Limited","LEVOCETIRIZINEDIHYDROCHLORIDE"
"5008","LEVOCETIRIZINE DIHYDROCHLORIDE","5 Milligram                                                                                            Film Coated Tablet",2012-09-07,"PA1240/003/001","Bristol Laboratories Limited","LEVOCETIRIZINEDIHYDROCHLORIDE"
"5009","Levocetirizine Glenmark 5 mg Film-coated Tablets","5 milligram(s) Film-coated tablet",2010-05-28,"PA1462/004/001","Glenmark Pharmaceuticals Europe Limited","Levocetirizinedihydrochloride"
"5010","LEVOCETIRIZINE KRKA","5 Milligram                                                                                            Film Coated Tablet",2011-07-15,"PA1347/043/001","Krka d.d., Novo mesto","LEVOCETIRIZINEDIHYDROCHLORIDE"
"5011","LEVODOPA/CARBIDOPA/ENTACAPONE MYLAN","50/12.5/200 Milligram                                                                                            Film Coated Tablet",2016-02-19,"PA0405/090/001","Generics (UK) Limited","LEVODOPA|CARBIDOPA|ENTACAPONE"
"5012","LEVODOPA/CARBIDOPA/ENTACAPONE MYLAN","75/18.75/200 Milligram                                                                                            Film Coated Tablet",2016-02-19,"PA0405/090/002","Generics (UK) Limited","LEVODOPA|CARBIDOPA|ENTACAPONE"
"5013","LEVODOPA/CARBIDOPA/ENTACAPONE MYLAN","100/25/200 Milligram                                                                                            Film Coated Tablet",2016-02-19,"PA0405/090/003","Generics (UK) Limited","LEVODOPA|CARBIDOPA|ENTACAPONE"
"5014","LEVODOPA/CARBIDOPA/ENTACAPONE MYLAN","125/31.25/200 Milligram                                                                                            Film Coated Tablet",2016-02-19,"PA0405/090/004","Generics (UK) Limited","LEVODOPA|CARBIDOPA|ENTACAPONE"
"5015","LEVODOPA/CARBIDOPA/ENTACAPONE MYLAN","150/37.5/200 Milligram                                                                                            Film Coated Tablet",2016-02-19,"PA0405/090/005","Generics (UK) Limited","LEVODOPA|CARBIDOPA|ENTACAPONE"
"5016","LEVODOPA/CARBIDOPA/ENTACAPONE MYLAN","175/43.75/200 Milligram                                                                                            Film Coated Tablet",2016-02-19,"PA0405/090/006","Generics (UK) Limited","LEVODOPA|CARBIDOPA|ENTACAPONE"
"5017","LEVODOPA/CARBIDOPA/ENTACAPONE MYLAN","200/50/200 Milligram                                                                                            Film Coated Tablet",2016-02-19,"PA0405/090/007","Generics (UK) Limited","LEVODOPA|CARBIDOPA|ENTACAPONE"
"5018","LEVODOPA/CARBIDOPA/ENTACAPONE ORION","Milligram                                                                                            Film Coated Tablet",2011-09-30,"EU/1/11/706/007-011","Orion Corporation","ENTACAPONE|LEVODOPA|CARBIDOPAMONOHYDRATE"
"5019","LEVODOPA/CARBIDOPA/ENTACAPONE ORION","100/25/200 Milligram                                                                                            Film Coated Tablet",2011-09-30,"EU/1/11/706/012-017","Orion Corporation","ENTACAPONE|LEVODOPA|CARBIDOPAMONOHYDRATE"
"5020","LEVODOPA/CARBIDOPA/ENTACAPONE ORION","125/31.25/200 Milligram                                                                                            Film Coated Tablet",NA,"EU/1/11/706/018-022","Orion Corporation","ENTACAPONE|LEVODOPA|CARBIDOPAMONOHYDRATE"
"5021","LEVODOPA/CARBIDOPA/ENTACAPONE ORION","150/37.5/200 Milligram                                                                                            Film Coated Tablet",NA,"EU/1/11/706/023-028","Orion Corporation","ENTACAPONE|LEVODOPA|CARBIDOPAMONOHYDRATE"
"5022","LEVODOPA/CARBIDOPA/ENTACAPONE ORION","200/50/200 Milligram                                                                                            Film Coated Tablet",NA,"EU/1/11/706/029-033","Orion Corporation","ENTACAPONE|LEVODOPA|CARBIDOPAMONOHYDRATE"
"5023","LEVODOPA/CARBIDOPA/ENTACAPONE ORION","175/43.75/200 Milligram                                                                                            Film Coated Tablet",2013-06-27,"EU/1/11/706/034-38","Orion Corporation","ENTACAPONE|LEVODOPA|CARBIDOPAMONOHYDRATE"
"5024","LEVODOPA/CARBIDOPA/ENTACAPONE SANDOZ","50/12.5/200 Milligram                                                                                            Film Coated Tablet",2013-11-11,"EU/1/13/859/001-006","Orion Corporation","ENTACAPONE|LEVODOPA|CARBIDOPAMONOHYDRATE"
"5025","LEVODOPA/CARBIDOPA/ENTACAPONE SANDOZ","75/18.75/200 Milligram                                                                                            Film Coated Tablet",2013-11-11,"EU/1/13/859/007-011","Orion Corporation","ENTACAPONE|LEVODOPA|CARBIDOPAMONOHYDRATE"
"5026","LEVODOPA/CARBIDOPA/ENTACAPONE SANDOZ","100/25/200 Milligram                                                                                            Film Coated Tablet",2013-11-11,"EU/1/13/859/012-017","Orion Corporation","ENTACAPONE|LEVODOPA|CARBIDOPAMONOHYDRATE"
"5027","LEVODOPA/CARBIDOPA/ENTACAPONE SANDOZ","125/31.25/200 Milligram                                                                                            Film Coated Tablet",2013-11-11,"EU/1/13/859/018-022","Orion Corporation","ENTACAPONE|LEVODOPA|CARBIDOPAMONOHYDRATE"
"5028","LEVODOPA/CARBIDOPA/ENTACAPONE SANDOZ","150/37.5/200 Milligram                                                                                            Film Coated Tablet",2013-11-11,"EU/1/13/859/023-028","Orion Corporation","ENTACAPONE|LEVODOPA|CARBIDOPAMONOHYDRATE"
"5029","LEVODOPA/CARBIDOPA/ENTACAPONE SANDOZ","175/43.75/200 Milligram                                                                                            Film Coated Tablet",2013-11-11,"EU/1/13/859/029-033","Orion Corporation","ENTACAPONE|LEVODOPA|CARBIDOPAMONOHYDRATE"
"5030","LEVODOPA/CARBIDOPA/ENTACAPONE SANDOZ","200/50/200 Milligram                                                                                            Film Coated Tablet",2013-11-11,"EU/1/13/859/034-038","Orion Corporation","ENTACAPONE|LEVODOPA|CARBIDOPAMONOHYDRATE"
"5031","LEVOFLOXACIN","5 Mg/Ml Solution for Infusion",2011-02-04,"PA2059/010/002","Fresenius Kabi Deutschland GmbH","LEVOFLOXACIN"
"5032","LEVOFLOXACIN","5 Mg/Ml Solution for Infusion",2012-04-20,"PA1217/008/001","Hikma Farmaceutica (Portugal) SA","LEVOFLOXACINHEMIHYDRATE"
"5033","LEVOFLOXACIN","5 Mg/Ml Solution for Infusion",2012-04-20,"PA1217/008/002","Hikma Farmaceutica (Portugal) SA","LEVOFLOXACINHEMIHYDRATE"
"5034","Levofloxacin 5mg/ml solution for infusion","5 milligram(s)/millilitre Solution for infusion",2012-07-20,"PA1122/013/001","Noridem Enterprises Ltd","Levofloxacinhemihydrate"
"5035","Levofloxacin 5mg/ml Solution for infusion, glass bottle","5 milligram(s)/millilitre Solution for infusion",2012-09-28,"PA2299/040/001","Baxter Holding B.V.","Levofloxacinhemihydrate"
"5036","Levofloxacin 5mg/ml solution for infusion, LDPE bottles","5 milligram(s)/millilitre Solution for infusion",2009-07-24,"PA2059/010/001","Fresenius Kabi Deutschland GmbH","Levofloxacin"
"5037","Levofloxacin 5mg/ml Solution for infusion, Non PVC bag","5 milligram(s)/millilitre Solution for infusion",2012-09-28,"PA1389/013/002","Claris Lifesciences (UK) Limited","Levofloxacinhemihydrate"
"5038","Levofloxacin Bluefish 250 mg film-coated tablets","250 milligram(s) Film-coated tablet",2011-02-11,"PA1436/019/001","Bluefish Pharmaceuticals AB","Levofloxacin"
"5039","Levofloxacin Bluefish 500 mg film-coated tablets","500 milligram(s) Film-coated tablet",2011-02-11,"PA1436/019/002","Bluefish Pharmaceuticals AB","Levofloxacin"
"5040","LEVOFLOXACIN KRKA","250 Milligram                                                                                            Film Coated Tablet",2015-03-27,"PA1347/048/001","Krka d.d., Novo mesto","LEVOFLOXACINHEMIHYDRATE"
"5041","LEVOFLOXACIN KRKA","500 Milligram                                                                                            Film Coated Tablet",2015-03-27,"PA1347/048/002","Krka d.d., Novo mesto","LEVOFLOXACINHEMIHYDRATE"
"5042","Levonorgestrel Rowex 1.5mg Tablet","1.5 milligram(s) Tablet",2016-05-26,"PA0711/267/001","Rowex Ltd","Levonorgestrel"
"5043","Levosert 52 mg Intrauterine Delivery System","52 milligram(s) Intrauterine delivery system",2015-02-13,"PA1330/022/001","Gedeon Richter Plc","Levonorgestrelmicronized"
"5044","LEVOTHYROXINE","25 Micrograms/5ml Oral Solution",2016-04-01,"PA1339/044/002","Wockhardt UK Limited","LEVOTHYROXINESODIUM"
"5045","LEVOTHYROXINE","50 Micrograms/5ml Oral Solution",2016-04-01,"PA1339/044/003","Wockhardt UK Limited","LEVOTHYROXINESODIUM"
"5046","Levothyroxine 100 micrograms per 5 ml oral solution","100 Micrograms/5ml Oral solution",2012-07-06,"PA0899/020/004","Mercury Pharmaceuticals Ltd","Levothyroxinesodium"
"5047","Levothyroxine 100 micrograms/5 ml Oral Solution","100 Micrograms/5ml Oral solution",2018-06-29,"PA2282/002/003","JensonR+ (Ireland) Limited","Levothyroxinesodium"
"5048","Levothyroxine 100 micrograms/5ml Oral Solution","100 Micrograms/5ml Oral solution",2016-04-01,"PA1339/044/004","Wockhardt UK Limited","Levothyroxinesodium"
"5049","Levothyroxine 25 micrograms per 5 ml oral solution","25 Micrograms/5ml ZZZ Infus/Pdr/Oral Soln",2012-07-06,"PA0899/020/002","Mercury Pharmaceuticals Ltd","Levothyroxinesodium"
"5050","Levothyroxine 25 micrograms/5 ml Oral Solution","25 Micrograms/5ml Oral solution",2018-06-29,"PA2282/002/001","JensonR+ (Ireland) Limited","Levothyroxinesodium"
"5051","Levothyroxine 50 micrograms per 5 ml oral solution","50 Micrograms/5ml ZZZ Infus/Pdr/Oral Soln",2012-07-06,"PA0899/020/003","Mercury Pharmaceuticals Ltd","Levothyroxinesodium"
"5052","Levothyroxine 50 micrograms/5 ml Oral Solution","50 Micrograms/5ml Oral solution",2018-06-29,"PA2282/002/002","JensonR+ (Ireland) Limited","Levothyroxinesodium"
"5053","LEVOTHYROXINE CLONMEL","25 Microgram                                                                                            Tablets",2015-09-11,"PA0126/257/001","Clonmel Healthcare Ltd","LEVOTHYROXINESODIUM"
"5054","LEVOTHYROXINE CLONMEL","50 Microgram                                                                                            Tablets",2015-09-11,"PA0126/257/002","Clonmel Healthcare Ltd","LEVOTHYROXINESODIUM"
"5055","LEVOTHYROXINE CLONMEL","100 Microgram                                                                                            Tablets",2015-09-11,"PA0126/257/003","Clonmel Healthcare Ltd","LEVOTHYROXINESODIUM"
"5056","LEVOTHYROXINE TEVA","25 Microgram                                                                                            Tablets",2012-11-23,"PA0749/143/001","Teva Pharma B.V.","LEVOTHYROXINESODIUM"
"5057","LEVOTHYROXINE TEVA","50 Microgram                                                                                            Tablets",2012-11-23,"PA0749/143/002","Teva Pharma B.V.","LEVOTHYROXINESODIUM"
"5058","LEVOTHYROXINE TEVA","100 Microgram                                                                                            Tablets",2012-11-23,"PA0749/143/003","Teva Pharma B.V.","LEVOTHYROXINESODIUM"
"5059","LEXAPRO","5 Milligram                                                                                            Film Coated Tablet",2002-10-11,"PA0805/002/001","H. Lundbeck A/S","ESCITALOPRAM"
"5060","LEXAPRO","10 Milligram                                                                                            Film Coated Tablet",2002-10-11,"PA0805/002/002","H. Lundbeck A/S","ESCITALOPRAM"
"5061","LEXAPRO","15 Milligram                                                                                            Film Coated Tablet",2002-10-11,"PA0805/002/003","H. Lundbeck A/S","ESCITALOPRAM"
"5062","LEXAPRO","20 Milligram                                                                                            Film Coated Tablet",2002-10-11,"PA0805/002/004","H. Lundbeck A/S","ESCITALOPRAM"
"5063","LEXAPRO","10 Milligram                                                                                            Film Coated Tablet",2005-03-18,"PPA0465/129/001","PCO Manufacturing","ESCITALOPRAM"
"5064","LEXAPRO","20 Milligram                                                                                            Film Coated Tablet",2005-03-21,"PPA0465/129/002","PCO Manufacturing","ESCITALOPRAM"
"5065","LEXAPRO","15 Milligram                                                                                            Film Coated Tablet",2011-07-08,"PPA0465/129/004","PCO Manufacturing","ESCITALOPRAM"
"5066","LEXAPRO","5 Milligram                                                                                            Film Coated Tablet",2009-06-25,"PPA1151/025/002","Imbat Limited","ESCITALOPRAM"
"5067","LEXAPRO","20 Milligram                                                                                            Film Coated Tablet",2009-06-25,"PPA1151/025/003","Imbat Limited","ESCITALOPRAM"
"5068","LEXAPRO","10 Milligram                                                                                            Film Coated Tablet",2010-05-28,"PPA1151/025/004","Imbat Limited","ESCITALOPRAM"
"5069","LEXAPRO","15 Milligram                                                                                            Film Coated Tablet",2011-04-08,"PPA1151/025/005","Imbat Limited","ESCITALOPRAMOXALATE"
"5070","LEXAPRO","15 Milligram                                                                                            Film Coated Tablet",2011-05-20,"PPA1633/014/003","Primecrown 2010 Ltd","ESCITALOPRAM"
"5071","LEXOTAN","1.5 Milligram                                                                                            Tablets",1980-10-31,"PA2307/003/001","Roche Products (Ireland) Ltd","BROMAZEPAM"
"5072","LEXOTAN","3 Milligram                                                                                            Tablets",1980-10-31,"PA2307/003/002","Roche Products (Ireland) Ltd","BROMAZEPAM"
"5073","LG-OCTAPLAS","%v/v                                                                                                 Solution for Infusion",2001-03-09,"PA2219/002/001","Octapharma (IP) SPRL","HUMANPLASMAPROTEIN"
"5074","Librium 10mg Hard Capsule","10 milligram(s) Capsule",1977-04-01,"PA2010/041/002","Mylan IRE Healthcare Limited","CHLORDIAZEPOXIDEHYDROCHLORIDE"
"5075","Librium 5mg Hard Capsules","5 milligram(s) Capsule",1977-04-01,"PA2010/041/001","Mylan IRE Healthcare Limited","CHLORDIAZEPOXIDEHYDROCHLORIDE"
"5076","LIDOCAINE","10 Mg/Ml Solution for injection in pre-filled syringe",2018-07-20,"PA1968/009/001","Laboratoire AGUETTANT","LIDOCAINEHYDROCHLORIDE"
"5077","LIDOCAINE","20 Mg/Ml Solution for injection in pre-filled syringe",2018-07-20,"PA1968/009/002","Laboratoire AGUETTANT","LIDOCAINEHYDROCHLORIDE"
"5078","Lidocaine 700 mg Medicated Plaster","700 milligram(s) Medicated plaster",2016-07-08,"PA2242/008/001","Grunenthal Pharma Ltd","Lidocaine"
"5079","Lidocaine Hydrochloride 1% w/v Solution for Injection","1 percent Solution for injection",2018-10-05,"PA2059/003/001","Fresenius Kabi Deutschland GmbH","LidocaineHydrochlorideMonohydrate"
"5080","Lidocaine Hydrochloride 2% w/v Solution for Injection","2 percent Solution for injection",2018-10-05,"PA2059/003/002","Fresenius Kabi Deutschland GmbH","LidocaineHydrochlorideMonohydrate"
"5081","LIDOCAINE HYDROCHLORIDE INJECTION BP MINIJET","%w/v                                                                                                 Solution for Injection",1978-02-24,"PA0255/004/002","International Medication Systems (UK) Ltd","LIDOCAINEHYDROCHLORIDE"
"5082","LIDOCAINE HYDROCHLORIDE INJECTION BP MINIJET","2 %w/v                                                                                                 Solution for Injection",1977-09-08,"PA0255/004/005","International Medication Systems (UK) Ltd","LIDOCAINEHYDROCHLORIDE"
"5083","LIDOTEC","5 Per Cent                                                                                             Medicated Plaster",2017-01-27,"PA2242/009/001","Grunenthal Pharma Ltd","LIDOCAINE"
"5084","Lifmior","10 milligram(s) Powder and solvent for solution for injection",2017-02-13,"EU/1/16/1165/001","Pfizer Europe MA EEIG","Etanercept"
"5085","Lifmior","25 milligram(s) Powder and solvent for solution for injection",2017-02-13,"EU/1/16/1165/002-004","Pfizer Europe MA EEIG","Etanercept"
"5086","Lifmior","25 milligram(s) Solution for injection in pre-filled syringe",2017-02-13,"EU/1/16/1165/005-007","Pfizer Europe MA EEIG","Etanercept"
"5087","Lifmior","50 milligram(s) Solution for injection in pre-filled syringe",2017-02-13,"EU/1/16/1165/008-010","Pfizer Europe MA EEIG","Etanercept"
"5088","Lifmior","50 milligram(s) Solution for injection in pre-filled pen",2017-02-13,"EU/1/16/1165/011-013","Pfizer Europe MA EEIG","Etanercept"
"5089","LIGNOSPAN SPECIAL","1.8 ml Millilitre                                                                                           Solution for Injection",1988-02-16,"PA0196/013/001","Septodont","LIDOCAINEHYDROCHLORIDE|EPINEPHRINE"
"5090","LIGNOSPAN SPECIAL","2.2 ml Millilitre                                                                                           Solution for Injection",1988-02-16,"PA0196/013/002","Septodont","LIDOCAINEHYDROCHLORIDE"
"5091","LINEZOLID","2 Mg/Ml Solution for Infusion",2015-11-06,"PA0405/094/001","Generics (UK) Limited","LINEZOLID"
"5092","LINEZOLID","2 Mg/Ml Solution for Infusion",2014-12-05,"PA2059/011/001","Fresenius Kabi Deutschland GmbH","LINEZOLID"
"5093","LINEZOLID","600 Milligram                                                                                            Film Coated Tablet",2016-09-23,"PA1339/062/001","Wockhardt UK Limited","LINEZOLID(FORMII)"
"5094","LINEZOLID","600 Milligram                                                                                            Film Coated Tablet",2015-10-23,"PA1390/098/001","Accord Healthcare Limited","LINEZOLID(FORMIII)"
"5095","LINEZOLID","2 Mg/Ml Solution for Infusion",2017-11-10,"PA1390/098/003","Accord Healthcare Limited","LINEZOLID"
"5096","LINEZOLID","2 Mg/Ml Solution for Infusion",2012-03-16,"PA0749/113/001","Teva Pharma B.V.","LINEZOLID"
"5097","Linezolid 2 mg/ml solution for infusion","2 milligram(s)/millilitre Solution for infusion",2017-01-27,"PA1347/057/002","Krka d.d., Novo mesto","Linezolid"
"5098","Linezolid 2 mg/ml Solution for Infusion","2 milligram(s)/millilitre Solution for infusion",2017-06-23,"PA2299/042/001","Baxter Holding B.V.","Linezolid"
"5099","Linezolid 600 mg film-coated tablets","600 milligram(s) Film-coated tablet",2015-03-13,"PA2315/002/001","Accord Healthcare Ireland Ltd.","Linezolid"
"5100","Linezolid 600 mg Film-Coated Tablets","600 milligram(s) Film-coated tablet",2014-08-08,"PA0711/230/001","Rowex Ltd","Linezolid"
"5101","Linezolid 600mg film-coated tablets","600 milligram(s) Film-coated tablet",2017-06-16,"PA2059/011/002","Fresenius Kabi Deutschland GmbH","Linezolid"
"5102","LINEZOLID CLONMEL","600 Milligram                                                                                            Film Coated Tablet",2013-08-23,"PA0126/238/001","Clonmel Healthcare Ltd","LINEZOLID"
"5103","LINEZOLID CLONMEL","2 Mg/Ml Solution for Infusion",2015-10-02,"PA0126/238/002","Clonmel Healthcare Ltd","LINEZOLID"
"5104","Linezolid Krka 600 mg film-coated tablets","600 milligram(s) Film-coated tablet",2015-09-11,"PA1347/057/001","Krka d.d., Novo mesto","Linezolid"
"5105","LINEZOLID PFIZER","2 Mg/Ml Solution for Infusion",2015-02-13,"PA0822/181/001","Pfizer Healthcare Ireland","LINEZOLID"
"5106","LINEZOLID PFIZER","600 Milligram                                                                                            Film Coated Tablet",2015-02-13,"PA0822/181/002","Pfizer Healthcare Ireland","LINEZOLID"
"5107","LINEZOLID PFIZER","100 MG/5ml                                                                                               Granules for Oral Suspension",2015-02-13,"PA0822/181/003","Pfizer Healthcare Ireland","LINEZOLID"
"5108","Linezolid Rowex 2 mg/ml solution for infusion","2 milligram(s)/millilitre Solution for infusion",2015-07-31,"PA0711/230/002","Rowex Ltd","Linezolid"
"5109","LINEZOLID TEVA","600 Milligram                                                                                            Film Coated Tablet",2014-11-14,"PA0749/204/001","Teva Pharma B.V.","LINEZOLID"
"5110","LINOFORCE","Granules",2014-05-09,"TR0725/006/001","Bioforce (UK) Ltd","LINUMUSITATISSIMUML.,SEMEN(LINSEEDS,WHOLE)|CASSIASENNAL.AND/ORCASSIAANGUSTIFOLIAVAHL,FOLIUM(SENNALEAVES,COMMINUTED)|RHAMNUSFRANGULAL.,CORTEX(FRANGULABARK,COMMIMNUTED)"
"5111","Lioresal 10 mg Tablets","10 milligram(s) Tablet",NA,"PA0896/017/001","Novartis Ireland Limited","Baclofen"
"5112","LIORESAL 5MG/5ML ORAL SOLUTION","5 MG/5ml                                                                                               Oral Solution",1984-04-18,"PA0896/017/002","Novartis Ireland Limited","BACLOFEN"
"5113","LIPANTIL MICRO","67 Milligram                                                                                            Capsules Hard",1998-07-13,"PA2010/015/001","Mylan IRE Healthcare Limited","FENOFIBRATE"
"5114","Lipantil Micro 200mg capsules, hard","200 milligram(s) Capsule, hard",1998-07-13,"PA2010/015/002","Mylan IRE Healthcare Limited","Fenofibrate"
"5115","Lipantil Micro 200mg capsules, hard","200 milligram(s) Capsule, hard",2015-04-17,"PPA1633/036/001","Primecrown 2010 Limited","Fenofibrate"
"5116","LIPANTIL SUPRA","145 Milligram                                                                                            Film Coated Tablet",2012-06-28,"PPA1151/180/001","Imbat Limited","FENOFIBRATE"
"5117","LIPANTIL SUPRA","145 Milligram                                                                                            Film Coated Tablet",2005-07-29,"PA2010/015/003","Mylan IRE Healthcare Limited","FENOFIBRATE"
"5118","LIPANTIL SUPRA","215 Milligram                                                                                            Film Coated Tablet",2005-03-18,"PA2010/015/004","Mylan IRE Healthcare Limited","FENOFIBRATE"
"5119","LIPANTIL SUPRA","145 Milligram                                                                                            Film Coated Tablet",2015-05-29,"PPA0465/409/001","PCO Manufacturing","FENOFIBRATE"
"5120","LIPANTIL SUPRA","215mg milligram(s) Tablet",NA,"PA0810/001/006","Fournier Pharmaceuticals Limited","Fenofibrate"
"5121","Lipantil Supra 145mg film-coated tablets","145 milligram(s) Film-coated tablet",2014-09-19,"PPA1562/124/001","LTT Pharma Limited","Fenofibrate"
"5122","Lipantil Supra 145mg film-coated tablets","145 milligram(s) Film-coated tablet",2015-04-17,"PPA1633/036/002","Primecrown 2010 Limited","Fenofibrate"
"5123","LIPERCOSYL","10/5 Milligram                                                                                            Capsules Hard",2018-01-26,"PA0568/032/001","Les Laboratoires Servier","ATORVASTATINCALCIUMTRIHYDRATE|PERINDOPRILARGININE"
"5124","LIPERCOSYL","20/5 Milligram                                                                                            Capsules Hard",2018-01-26,"PA0568/032/002","Les Laboratoires Servier","ATORVASTATINCALCIUMTRIHYDRATE|PERINDOPRILARGININE"
"5125","LIPERCOSYL","40/5 Milligram                                                                                            Capsules Hard",2018-01-26,"PA0568/032/003","Les Laboratoires Servier","ATORVASTATINCALCIUMTRIHYDRATE|PERINDOPRILARGININE"
"5126","LIPERCOSYL","10/10 Milligram                                                                                            Capsules Hard",2018-01-26,"PA0568/032/004","Les Laboratoires Servier","ATORVASTATINCALCIUMTRIHYDRATE|PERINDOPRILARGININE"
"5127","LIPERCOSYL","20/10 Milligram                                                                                            Capsules Hard",2018-01-26,"PA0568/032/005","Les Laboratoires Servier","ATORVASTATINCALCIUMTRIHYDRATE|PERINDOPRILARGININE"
"5128","LIPERCOSYL","40/10 Milligram                                                                                            Capsules Hard",2018-01-26,"PA0568/032/006","Les Laboratoires Servier","ATORVASTATINCALCIUMTRIHYDRATE|PERINDOPRILARGININE"
"5129","Lipertance 10mg/5mg/5mg film-coated tablets","10/5/5 milligram(s) Film-coated tablet",2015-10-23,"PA0568/028/001","Les Laboratoires Servier","Atorvastatincalciumtrihydrate|Amlodipinebesylate|Perindoprilarginine"
"5130","Lipertance 20mg/10mg/10mg film-coated tablets","20/10/10 milligram(s) Film-coated tablet",2015-10-23,"PA0568/028/004","Les Laboratoires Servier","Atorvastatincalciumtrihydrate|Amlodipinebesylate|Perindoprilarginine"
"5131","Lipertance 20mg/10mg/5mg film-coated tablets","20/10/5 milligram(s) Film-coated tablet",2015-10-23,"PA0568/028/003","Les Laboratoires Servier","Atorvastatincalciumtrihydrate|Amlodipinebesylate|Perindoprilarginine"
"5132","Lipertance 20mg/5mg/5mg film-coated tablets","20/5/5 milligram(s) Film-coated tablet",2015-10-23,"PA0568/028/002","Les Laboratoires Servier","Atorvastatincalciumtrihydrate|Amlodipinebesylate|Perindoprilarginine"
"5133","Lipertance 40mg/10mg/10mg film-coated tablets","40/10/10 milligram(s) Film-coated tablet",2015-10-23,"PA0568/028/005","Les Laboratoires Servier","Atorvastatincalciumtrihydrate|Amlodipinebesylate|Perindoprilarginine"
"5134","LIPIODOL ULTRA FLUID","38 %w/v                                                                                                 Solution for Injection",1996-05-07,"PA0686/004/001","GUERBET","POPPYSEEDOILIODISEDFATTYACIDETHYLESTERS"
"5135","LIPITOR","10 Milligram                                                                                            Film Coated Tablet",2001-07-13,"PPA0465/075/001","PCO Manufacturing","ATORVASTATIN-CALCIUM"
"5136","LIPITOR","20 Milligram                                                                                            Film Coated Tablet",2001-07-13,"PPA0465/075/002","PCO Manufacturing","ATORVASTATIN-CALCIUM"
"5137","LIPITOR","40 Milligram                                                                                            Film Coated Tablet",2001-07-13,"PPA0465/075/003","PCO Manufacturing","ATORVASTATIN-CALCIUM"
"5138","LIPITOR","80 Milligram                                                                                            Film Coated Tablet",2005-07-29,"PPA0465/075/004","PCO Manufacturing","ATORVASTATINCALCIUM"
"5139","LIPITOR","10 Milligram                                                                                            Film Coated Tablet",2013-05-10,"PPA1562/099/001","LTT Pharma Limited","ATORVASTATINCALCIUM"
"5140","LIPITOR","20 Milligram                                                                                            Film Coated Tablet",2013-05-10,"PPA1562/099/002","LTT Pharma Limited","ATORVASTATINCALCIUM"
"5141","LIPITOR","40 Milligram                                                                                            Film Coated Tablet",2013-05-10,"PPA1562/099/003","LTT Pharma Limited","ATORVASTATIN"
"5142","LIPITOR","80 Milligram                                                                                            Film Coated Tablet",2013-05-10,"PPA1562/099/004","LTT Pharma Limited","ATORVASTATIN"
"5143","Lipitor 10 mg chewable tablets","10 milligram(s) Chewable tablet",2010-11-12,"PA1740/001/006","Pfizer Ireland Pharmaceuticals","Atorvastatin"
"5144","Lipitor 10 mg film-coated tablets","10 milligram(s) Film-coated tablet",1997-11-14,"PA1740/001/001","Pfizer Ireland Pharmaceuticals","Atorvastatincalciumtrihydrate"
"5145","Lipitor 20 mg film-coated tablets","20 milligram(s) Film-coated tablet",1997-11-14,"PA1740/001/002","Pfizer Ireland Pharmaceuticals","Atorvastatincalciumtrihydrate"
"5146","Lipitor 20mg chewable tablets","20 milligram(s) Chewable tablet",2010-11-12,"PA1740/001/007","Pfizer Ireland Pharmaceuticals","Atorvastatin"
"5147","Lipitor 40mg chewable tablets","40 milligram(s) Chewable tablet",2010-11-12,"PA1740/001/008","Pfizer Ireland Pharmaceuticals","Atorvastatin"
"5148","Lipitor 40mg film-coated tablets","40 milligram(s) Film-coated tablet",1997-11-14,"PA1740/001/003","Pfizer Ireland Pharmaceuticals","Atorvastatincalciumtrihydrate"
"5149","Lipitor 5mg chewable tablets","5 milligram(s) Chewable tablet",2010-11-12,"PA1740/001/005","Pfizer Ireland Pharmaceuticals","Atorvastatin"
"5150","Lipitor 80mg film-coated tablets","80 milligram(s) Film-coated tablet",1997-11-14,"PA1740/001/004","Pfizer Ireland Pharmaceuticals","Atorvastatincalciumtrihydrate"
"5151","LIPOCOMB","40 /10 Milligram                                                                                            Capsules Hard",2014-08-08,"PA1470/004/003","EGIS Pharmaceuticals PLC","ROSUVASTATINZINC|EZETIMIBE"
"5152","Lipocomb 10 mg/10 mg hard capsules","10 /10 milligram(s) Capsule, hard",2014-08-08,"PA1470/004/001","EGIS Pharmaceuticals PLC","Rosuvastatinzinc|Ezetimibe"
"5153","Lipocomb 20 mg/10 mg hard capsules","20 /10 milligram(s) Capsule, hard",2014-08-08,"PA1470/004/002","EGIS Pharmaceuticals PLC","Rosuvastatinzinc|Ezetimibe"
"5154","LIPOSIC","2 mg/g Eyegel",2002-03-22,"PA0555/008/001","Bausch & Lomb UK Limited","CARBOMER"
"5155","LIPROLOG","200 Units/ml                                                                                             Infus/Pdr/Oral Soln",2014-10-01,"EU/1/01/195/028-029","Eli Lilly and Company Limited",""
"5156","LIPROLOG","100 Units/ml                                                                                             Suspension for Injection",2008-07-11,"EU/1/01/195/22-27","Eli Lilly Nederland B.V.","INSULINLISPRO"
"5157","LIPROLOG","100 Units/ml                                                                                             Solution for Injection",2001-08-01,"EU/1/01/195/001","Eli Lilly Nederland B.V.","INSULINLISPRO"
"5158","LIPROLOG","100 Units/ml                                                                                             Solution for Injection",2001-08-01,"EU/1/01/195/002","Eli Lilly Nederland B.V.","INSULINLISPRO"
"5159","LIPROLOG MIX25","100 Units/ml                                                                                             Suspension for Injection",2001-08-01,"EU/1/01/195/003","Eli Lilly Nederland B.V.","INSULINLISPRO"
"5160","LIPROLOG MIX25 PEN","100 Units/ml                                                                                             Suspension for Injection",2001-08-01,"EU/1/01/195/006","Eli Lilly Nederland B.V.","INSULINLISPRO"
"5161","LIPROLOG MIX50","100 Units/ml                                                                                             Suspension for Injection",2001-08-01,"EU/1/01/195/004","Eli Lilly Nederland B.V.","INSULINLISPRO"
"5162","LIPROLOG MIX50 PEN","100 Units/ml                                                                                             Suspension for Injection",2001-08-01,"EU/1/01/195/007","Eli Lilly Nederland B.V.","INSULINLISPRO"
"5163","LIPROLOG-PEN","100 Units/ml                                                                                             Solution for Injection",2001-08-01,"EU/1/01/195/005","Eli Lilly Nederland B.V.","INSULINLISPRO"
"5164","LIQUID MEDICAL OXYGEN","100 %v/v                                                                                                 Unknown",2018-05-04,"PA1848/005/001","SOL S.p.A.","OXYGEN"
"5165","LIQUID MEDICAL OXYGEN","100 %v/v                                                                                                 Unknown",2018-05-04,"PA1848/005/002","SOL S.p.A.","OXYGEN"
"5166","LIQUIVISC","2.5 mg/g Eyegel",2003-08-22,"PA1107/002/001","Laboratoires Thea","CARBOMER"
"5167","Lisa 2 mg/0.03 mg Film-coated tablet","2.0/0.03 milligram(s) Film-coated tablet",2018-08-10,"PA1474/012/001","Laboratorios Leon Farma, S.A.","Dienogestmicronized|Ethinylestradiolmicronized"
"5168","LISINOPRIL","1 Mg/Ml Oral Solution",2015-07-31,"PA1806/003/001","Essential Pharmaceuticals Limited","LISINOPRILDIHYDRATE"
"5169","Lisinopril 10 mg Tablets","10 milligram(s) Tablet",2011-09-09,"PA0577/161/003","McDermott Laboratories Ltd t/a Gerard Laboratories","Lisinopril(asdihydrate)"
"5170","Lisinopril 2.5 mg Tablets","2.5 milligram(s) Tablet",2011-09-09,"PA0577/161/001","McDermott Laboratories Ltd t/a Gerard Laboratories","Lisinopril(asdihydrate)"
"5171","Lisinopril 20 mg Tablets","20 milligram(s) Tablet",2011-09-09,"PA0577/161/004","McDermott Laboratories Ltd t/a Gerard Laboratories","Lisinopril(asdihydrate)"
"5172","Lisinopril 5 mg Tablets","5 milligram(s) Tablet",2011-09-09,"PA0577/161/002","McDermott Laboratories Ltd t/a Gerard Laboratories","Lisinopril(asdihydrate)"
"5173","Lisinopril/Hydrochlorothiazide 10 mg/12.5 mg Tablets","10/12.5 milligram(s) Tablet",2012-07-13,"PA0577/165/001","McDermott Laboratories Ltd t/a Gerard Laboratories","Lisinopril(asdihydrate)|Hydrochlorothiazide"
"5174","Lisinopril/Hydrochlorothiazide 20 mg/12.5 mg Tablets","20/12.5 milligram(s) Tablet",2012-07-13,"PA0577/165/002","McDermott Laboratories Ltd t/a Gerard Laboratories","Lisinopril(asdihydrate)|Hydrochlorothiazide"
"5175","LISOPRESS","2.5mg Milligram                                                                                            Tablets",2002-02-08,"PA1330/013/001","Gedeon Richter Plc","LISINOPRILDIHYDRATE"
"5176","LISOPRESS","5mg Milligram                                                                                            Tablets",2002-02-08,"PA1330/013/002","Gedeon Richter Plc","LISINOPRILDIHYDRATE"
"5177","LISOPRESS","10mg Milligram                                                                                            Tablets",2002-02-08,"PA1330/013/003","Gedeon Richter Plc","LISINOPRILDIHYDRATE"
"5178","LISOPRESS","20mg Milligram                                                                                            Tablets",2002-02-08,"PA1330/013/004","Gedeon Richter Plc","LISINOPRILDIHYDRATE"
"5179","LISPRIL","5 Milligram                                                                                            Tablets",2003-05-02,"PA0711/047/002","Rowex Ltd","LISINOPRILDIHYDRATE"
"5180","LISPRIL","10 Milligram                                                                                            Tablets",2003-05-02,"PA0711/047/003","Rowex Ltd","LISINOPRILDIHYDRATE"
"5181","LISPRIL","20 Milligram                                                                                            Tablets",2003-05-02,"PA0711/047/004","Rowex Ltd","LISINOPRILDIHYDRATE"
"5182","LISPRIL-HYDROCHLOROTHIAZIDE","10/12.5 Milligram                                                                                            Tablets",2004-01-26,"PA0711/051/001","Rowex Ltd","LISINOPRILDIHYDRATE|HYDROCHLOROTHIAZIDE"
"5183","LISPRIL-HYDROCHLOROTHIAZIDE","20/12.5 Milligram                                                                                            Tablets",2004-01-26,"PA0711/051/002","Rowex Ltd","LISINOPRILDIHYDRATE|HYDROCHLOROTHIAZIDE"
"5184","LITAK","2 mg/ml milligram(s)/millilitre Solution for injection",NA,"EU/1/04/275/002","Lipomed GmbH","Cladribine"
"5185","Lithium Chloride 0.15 mmol/ml.  Solution for Injection","0.15 millimole(s)/millilitre Solution for injection",2005-01-14,"PA1183/001/001","LiDCO Ltd","Lithiumchloride"
"5186","LIVAZO","2 Base Milligrams                                                                                      Film Coated Tablet",2010-11-05,"PA1532/001/001","Kowa Pharmaceutical Europe Co. Ltd","PITAVASTATINCALCIUM"
"5187","LIVAZO","4 Base Milligrams                                                                                      Film Coated Tablet",2010-11-05,"PA1532/001/002","Kowa Pharmaceutical Europe Co. Ltd","PITAVASTATINCALCIUM"
"5188","LIVAZO","1 Base Milligrams                                                                                      Film Coated Tablet",2010-11-05,"PA1532/001/003","Kowa Pharmaceutical Europe Co. Ltd","PITAVASTATINCALCIUM"
"5189","LIVIAL","2.5 Milligram                                                                                            Tablets",2001-09-07,"PPA0465/081/001","PCO Manufacturing","TIBOLONE"
"5190","LIVIAL","2.5 Milligram                                                                                            Tablets",2014-02-21,"PPA1562/105/001","LTT Pharma Limited","TIBOLONE"
"5191","LIVIAL","2.5 Milligram                                                                                            Tablets",2009-06-12,"PPA1151/103/001","Imbat Limited","TIBOLONE"
"5192","Livial 2.5 mg tablets","2.5 milligram(s) Tablet",1987-12-09,"PA1286/059/001","Merck Sharp & Dohme Ireland (Human Health) Limited","Tibolone"
"5193","Lixiana","15 milligram(s) Film-coated tablet",2015-06-19,"EU/1/15/993/001","Daiichi Sankyo Europe GmbH","Edoxabantosilate"
"5194","LIXIANA","30 Milligram                                                                                            Film Coated Tablet",2015-06-19,"EU/1/15/993/002","Daiichi Sankyo Europe GmbH","EDOXABANTOSILATE"
"5195","LIXIANA","60 Milligram                                                                                            Film Coated Tablet",2015-06-19,"EU/1/15/993/003","Daiichi Sankyo Europe GmbH","EDOXABANTOSILATE"
"5196","LOCERYL","5.0 %w/v                                                                                                 Medicated Nail Lacquer",1993-03-25,"PA0590/018/001","Galderma (UK) Ltd","AMOROLFINE"
"5197","LOCERYL","5 %w/v                                                                                                 Medicated Nail Lacquer",2009-08-07,"PPA0465/234/001","PCO Manufacturing","AMOROLFINE"
"5198","LOCERYL","5 %w/v                                                                                                 Medicated Nail Lacquer",2013-10-18,"PPA1463/081/001","IMED Healthcare Ltd.","AMOROLFINE"
"5199","LOCERYL","5 %w/v                                                                                                 Medicated Nail Lacquer",2011-06-03,"PPA1562/053/001","LTT Pharma Limited","AMOROLFINE"
"5200","LOCERYL","5 %w/v                                                                                                 Medicated Nail Lacquer",2013-12-20,"PPA1151/214/001","Imbat Limited","AMOROLFINE"
"5201","LOCOID CREAM","0.1 %w/w                                                                                                 Cream",1977-10-14,"PA1025/006/001","LEO Pharma A/S","HYDROCORTISONEBUTYRATE"
"5202","LOCOID LIPOCREAM","0.1 %w/w                                                                                                 Cream",1984-05-04,"PA1025/006/002","LEO Pharma A/S","HYDROCORTISONEBUTYRATE"
"5203","LOCOID OINTMENT","0.1 %w/w                                                                                                 Ointment",1977-10-14,"PA1025/006/003","LEO Pharma A/S","HYDROCORTISONEBUTYRATE"
"5204","LOCOID SCALP LOTION","0.1 %w/v                                                                                                 Cutaneous Solution",1977-10-14,"PA1025/006/004","LEO Pharma A/S","HYDROCORTISONEBUTYRATE"
"5205","LOGYNON","Milligram                                                                                            Tablets",2013-07-19,"PPA0465/311/001","PCO Manufacturing","LEVONORGESTREL|ETHINYLESTRADIOL|LEVONORGESTREL|ETHINYLESTRADIOL|LEVONORGESTREL|ETHINYLESTRADIOL"
"5206","LOGYNON","%v/v                                                                                                 Tablets",1981-08-26,"PA1410/005/001","Bayer Limited","LEVONORGESTREL|ETHINYLESTRADIOL|LEVONORGESTREL|ETHINYLESTRADIOL|LEVONORGESTREL|ETHINYLESTRADIOL"
"5207","LOGYNON","Unknown Tablets",2014-07-04,"PPA1151/218/001","Imbat Limited","LEVONORGESTREL|ETHINYLESTRADIOL|ETHINYLESTRADIOL|LEVONORGESTREL|ETHINYLESTRADIOL|LEVONORGESTREL"
"5208","LOGYNON","Unknown Tablets",2012-10-26,"PPA1463/072/001","IMED Healthcare Ltd.","LEVONORGESTREL|ETHINYLESTRADIOL|LEVONORGESTREL|ETHINYLESTRADIOL|LEVONORGESTREL|ETHINYLESTRADIOL"
"5209","LOGYNON","Unknown Tablets",2014-10-17,"PPA1562/127/001","LTT Pharma Limited","LEVONORGESTREL|ETHINYLESTRADIOL|LEVONORGESTREL|ETHINYLESTRADIOL|LEVONORGESTREL|ETHINYLESTRADIOL"
"5210","Lojuxta","5 milligram(s) Capsule, hard",NA,"EU/1/13/851/001","Amryt Pharmaceuticals DAC","Lomitapidemesylate"
"5211","Lojuxta","10 milligram(s) Capsule, hard",NA,"EU/1/13/851/002","Amryt Pharmaceuticals DAC","Lomitapidemesylate"
"5212","Lojuxta","20 milligram(s) Capsule, hard",NA,"EU/1/13/851/003","Amryt Pharmaceuticals DAC","Lomitapidemesylate"
"5213","Lojuxta","30 *** AWAITING VALUE *** ZZZ Infus/Pdr/Oral Soln",2016-02-18,"EU/1/13/851/004","Amryt Pharmaceuticals DAC","Lomitapidemesylate"
"5214","Lojuxta","40 *** AWAITING VALUE *** ZZZ Infus/Pdr/Oral Soln",2016-02-18,"EU/1/13/851/005","Amryt Pharmaceuticals DAC","Lomitapidemesylate"
"5215","Lojuxta","60 *** AWAITING VALUE *** ZZZ Infus/Pdr/Oral Soln",2016-02-18,"EU/1/13/851/006","Amryt Pharmaceuticals DAC","Lomitapidemesylate"
"5216","LOKELMA","5 Grams                                                                                                Powder for Oral Suspension",2018-03-22,"EU/1/17/1173/001-002","ZS Texas Ltd.","SODIUMZIRCONIUMCYCLOSILICATE"
"5217","LOKELMA","10 Grams                                                                                                Powder for Oral Suspension",2018-03-22,"EU/1/17/1173/003-004","ZS Texas Ltd.","SODIUMZIRCONIUMCYCLOSILICATE"
"5218","LOMEXIN 2% W/V CUTANEOUS SPRAY, SOLUTION","2 %w/v                                                                                                 Cutaneous Spray Solution",1988-07-25,"PA0812/002/005","Recordati Industria Chimica e Farmaceutica SpA","FENTICONAZOLENITRATE"
"5219","LOMEXIN 2% W/W CREAM","2 %w/w                                                                                                 Cream",1988-07-25,"PA0812/002/001","Recordati Industria Chimica e Farmaceutica SpA","FENTICONAZOLENITRATE"
"5220","LOMEXIN 2% W/W CUTANEOUS POWDER","2 %w/w                                                                                                 Cutaneous Powder",1988-07-25,"PA0812/002/004","Recordati Industria Chimica e Farmaceutica SpA","FENTICONAZOLENITRATE"
"5221","LOMOTIL","2.5/0.025 Milligram                                                                                            Tablets",1980-05-24,"PA0899/007/001","Mercury Pharmaceuticals Ltd","DIPHENOXYLATEHYDROCHLORIDE|ATROPINESULFATE"
"5222","LONITEN","5 Milligram                                                                                            Tablets",1980-02-07,"PA0822/130/001","Pfizer Healthcare Ireland","MINOXIDIL"
"5223","LONQTIV","700 Milligram                                                                                            Medicated Plaster",2017-03-31,"PA2242/011/001","Grunenthal Pharma Ltd","LIDOCAINE"
"5224","Lonquex","6 milligram(s) Solution for injection",NA,"EU/1/13/856/001-002","UAB ""Sicor Biotech","Xm22drugsubstancelipegfilgrastim"
"5225","Lonsurf","15/6.14 milligram(s) Film-coated tablet",2016-04-25,"EU/1/16/1096/001-003","Taiho Pharma Europe, Limited","Trifluridine"
"5226","LONSURF","20/8.19 Milligram                                                                                            Film Coated Tablet",2016-04-25,"EU/1/16/1096/004-006","Taiho Pharma Europe, Limited","TRIFLURIDINE"
"5227","LOPID","300 Milligram                                                                                            Capsules Hard",1989-02-06,"PA0822/014/001","Pfizer Healthcare Ireland","GEMFIBROZIL"
"5228","LOPID","600mg Milligram                                                                                            Film Coated Tablet",1989-02-06,"PA0822/014/002","Pfizer Healthcare Ireland","GEMFIBROZIL"
"5229","Lopid 600 mg film-coated tablet","600 milligram(s) Film-coated tablet",2013-07-26,"PPA0465/320/001","PCO Manufacturing","Gemfibrozil"
"5230","LOPINAVIR/RITONAVIR MYLAN","100mg/25 Milligram                                                                                            Infus/Pdr/Oral Soln",2016-01-14,"EU/1/15/1067/001-003","Mylan S.A.S.","LOPINAVIR|RITONAVIR"
"5231","LOPINAVIR/RITONAVIR MYLAN","200mg/50 Milligram                                                                                            Infus/Pdr/Oral Soln",2016-01-14,"EU/1/15/1067/004-008","Mylan S.A.S.","LOPINAVIR|RITONAVIR"
"5232","LOPINAVIR/RITONAVIR SANDOZ","200/50 Milligram                                                                                            Film Coated Tablet",2015-08-13,"PA0711/239/001","Rowex Ltd","LOPINAVIR(AMORPHOUS)|RITONAVIR"
"5233","LORAT","10 Milligram                                                                                            Tablets",2005-09-23,"PA0711/088/001","Rowex Ltd","LORATADINE"
"5234","Lorazepam 1mg tablets","1 milligram(s) Tablet",2012-12-18,"PA1333/013/001","Morningside Healthcare Limited","Lorazepam"
"5235","Lorazepam 2.5mg tablets","2.5 milligram(s) Tablet",2012-12-18,"PA1333/013/002","Morningside Healthcare Limited","Lorazepam"
"5236","Losamel 20 mg gastro-resistant tablets","20 milligram(s) Gastro-resistant tablet",2002-06-28,"PA0126/115/001","Clonmel Healthcare Ltd","Omeprazole"
"5237","LOSARTAN KRKA","25 Milligram                                                                                            Film Coated Tablet",2012-01-27,"PA1347/020/001","Krka d.d., Novo mesto","LOSARTANPOTASSIUM"
"5238","LOSARTAN KRKA","50 Milligram                                                                                            Film Coated Tablet",2012-01-27,"PA1347/020/002","Krka d.d., Novo mesto","LOSARTANPOTASSIUM"
"5239","LOSARTAN KRKA","100 Milligram                                                                                            Film Coated Tablet",2012-01-27,"PA1347/020/003","Krka d.d., Novo mesto","LOSARTANPOTASSIUM"
"5240","LOSARTAN MYLAN","12.5 Milligram                                                                                            Film Coated Tablet",2011-08-19,"PA0577/160/001","McDermott Laboratories Ltd t/a Gerard Laboratories","LOSARTANPOTASSIUM"
"5241","LOSARTAN MYLAN","50 Milligram                                                                                            Film Coated Tablet",2011-08-19,"PA0577/160/002","McDermott Laboratories Ltd t/a Gerard Laboratories","LOSARTANPOTASSIUM"
"5242","LOSARTAN MYLAN","100 Milligram                                                                                            Film Coated Tablet",2011-08-19,"PA0577/160/003","McDermott Laboratories Ltd t/a Gerard Laboratories","LOSARTANPOTASSIUM"
"5243","Losartan Potassium 100 mg Film-coated Tablets","100 milligram(s) Film-coated tablet",2009-04-08,"PA1390/003/003","Accord Healthcare Limited","Losartanpotassium"
"5244","Losartan Potassium 100mg Film-Coated Tablets","100 milligram(s) Film-coated tablet",2011-10-07,"PA1339/029/003","Wockhardt UK Limited","Losartanpotassium"
"5245","Losartan Potassium 25 mg Film-coated Tablets","25 milligram(s) Film-coated tablet",2009-04-08,"PA1390/003/001","Accord Healthcare Limited","Losartanpotassium"
"5246","Losartan Potassium 25mg Film-Coated Tablets","25 milligram(s) Film-coated tablet",2011-10-07,"PA1339/029/001","Wockhardt UK Limited","Losartanpotassium"
"5247","Losartan Potassium 50 mg Film-coated Tablets","50 milligram(s) Film-coated tablet",2009-04-08,"PA1390/003/002","Accord Healthcare Limited","Losartanpotassium"
"5248","Losartan Potassium 50mg Film-Coated Tablets","50 milligram(s) Film-coated tablet",2011-10-07,"PA1339/029/002","Wockhardt UK Limited","Losartanpotassium"
"5249","Losartan Potassium Pinewood 100 mg film-coated tablets","100 milligram(s) Film-coated tablet",2007-10-12,"PA0281/154/003","Pinewood Laboratories Ltd,","Losartanpotassium"
"5250","Losartan Potassium Pinewood 12.5 mg film-coated tablets","12.5 milligram(s) Film-coated tablet",2007-10-12,"PA0281/154/001","Pinewood Laboratories Ltd,","Losartanpotassium"
"5251","Losartan Potassium Pinewood 50 mg film-coated tablets","50 milligram(s) Film-coated tablet",2007-10-12,"PA0281/154/002","Pinewood Laboratories Ltd,","Losartanpotassium"
"5252","Losartan Teva 100 mg Film-coated Tablets","100 milligram(s) Film-coated tablet",2008-06-20,"PA0749/090/004","Teva Pharma B.V.","Losartanpotassium"
"5253","Losartan Teva 50 mg Film-coated Tablets","50 milligram(s) Film-coated tablet",2008-06-20,"PA0749/090/003","Teva Pharma B.V.","Losartanpotassium"
"5254","Losartan/Hydrochlorothiazide 100 mg/ 25 mg Film-Coated Tablets","100/25 milligram(s) Film-coated tablet",2009-03-20,"PA0711/139/002","Rowex Ltd","Hydrochlorothiazide|Losartanpotassium"
"5255","Losartan/Hydrochlorothiazide 50 mg/ 12.5 mg Film-Coated Tablets","50/12.5 milligram(s) Film-coated tablet",2009-03-20,"PA0711/139/001","Rowex Ltd","Hydrochlorothiazide|Losartanpotassium"
"5256","LOSARTAN/HYDROCHLOROTHIAZIDE KRKA","50/12.5 Milligram                                                                                            Film Coated Tablet",2013-11-08,"PA1347/040/001","Krka d.d., Novo mesto","LOSARTANPOTASSIUM|HYDROCHLOROTHIAZIDE"
"5257","LOSARTAN/HYDROCHLOROTHIAZIDE KRKA","100/12.5 Milligram                                                                                            Film Coated Tablet",2013-11-08,"PA1347/040/002","Krka d.d., Novo mesto","LOSARTANPOTASSIUM|HYDROCHLOROTHIAZIDE"
"5258","LOSARTAN/HYDROCHLOROTHIAZIDE KRKA","100/25 Milligram                                                                                            Film Coated Tablet",2013-11-08,"PA1347/040/003","Krka d.d., Novo mesto","LOSARTANPOTASSIUM|HYDROCHOLOTHIAZIDE"
"5259","LOSARTAN/HYDROCHLOROTHIAZIDE TEVA","100/25 Milligram                                                                                            Tablets",2008-01-25,"PA0749/026/002","Teva Pharma B.V.","LOSARTANPOTASSIUM|HYDROCHLOROTHIAZIDE"
"5260","Losartan/Hydrochlorothiazide Teva 50mg/12.5mg Film-Coated Tablets","50/12.5 milligram(s) Film-coated tablet",2008-01-25,"PA0749/026/001","Teva Pharma B.V.","Losartanpotassium|Hydrochlorothiazide"
"5261","Losec Control 20 mg gastro-resistant tablets","20 milligram(s) Gastro-resistant tablet",2011-12-21,"PA1410/066/001","Bayer Limited","Omeprazolemagnesium"
"5262","LOSEC MUPS","10 Milligram                                                                                            Tablets Gastro-Resistant",1999-09-17,"PA0970/044/006","AstraZeneca UK Limited","OMEPRAZOLEMAGNESIUM"
"5263","Losec MUPS 20 mg gastro-resistant tablets","20 milligram(s) Gastro-resistant tablet",1999-09-17,"PA0970/044/007","AstraZeneca UK Limited","Omeprazolemagnesium"
"5264","Losec MUPS 20 mg gastro-resistant tablets","20 milligram(s) Gastro-resistant tablet",2018-06-14,"PPA1463/123/001","IMED Healthcare Ltd.","Omeprazole"
"5265","Losec MUPS 20mg Gastro-Resistant Tablets","20 milligram(s) Gastro-resistant tablet",2006-09-08,"PPA1151/007/001","Imbat Limited","Omeprazolemagnesium"
"5266","Losec MUPS 20mg Gastro-resistant Tablets","20 milligram(s) Gastro-resistant tablet",2017-01-20,"PPA0465/423/001","PCO Manufacturing","Omeprazolemagnesium"
"5267","Losec MUPS 40 mg gastro-resistant Tablets","40 milligram(s) Gastro-resistant tablet",2017-08-25,"PPA0465/423/002","PCO Manufacturing","Omeprazolemagnesium"
"5268","Losec MUPS 40 mg gastro-resistant Tablets","40 milligram(s) Gastro-resistant tablet",1999-09-17,"PA0970/044/008","AstraZeneca UK Limited","Omeprazolemagnesium"
"5269","Losec MUPS 40 mg gastro-resistant tablets","40 milligram(s) Gastro-resistant tablet",2018-06-14,"PPA1463/123/002","IMED Healthcare Ltd.","Omeprazole"
"5270","LOTANOS","50 Milligram                                                                                            Film Coated Tablet",2006-09-22,"PA0711/123/003","Rowex Ltd","LOSARTANPOTASSIUM"
"5271","LOTANOS","100 Milligram                                                                                            Film Coated Tablet",2006-09-22,"PA0711/123/005","Rowex Ltd","LOSARTANPOTASSIUM"
"5272","LOTANOS COMP","100/25 Milligram                                                                                            Film Coated Tablet",2008-05-02,"PA0074/072/002","Rowa Pharmaceuticals Limited","LOSARTANPOTASSIUM|HYDROCHLOROTHIAZIDE"
"5273","Lotanos Comp 50 mg/12.5 mg film-coated tablets","50/12.5 milligram(s) Film-coated tablet",2008-05-02,"PA0074/072/001","Rowa Pharmaceuticals Limited","Losartanpotassium|Hydrochlorothiazide"
"5274","LOTEMAX","0.5 %w/v                                                                                                 Eye Drops Suspension",2006-11-10,"PA1245/001/001","Dr. Gerhard Mann, chem.-pharm. Fabrik GmbH","LOTEPREDNOLETABONATE"
"5275","Low Centyl K 1.25 mg/573 mg modified-release tablets","1.25/573 milligram(s) Modified-release tablet",NA,"PA0046/019/002","Leo Laboratories Limited","Bendroflumethiazide|Potassiumchloride"
"5276","LOXENTIA","40 Milligram                                                                                            Capsules Gastro-Resistant",2015-05-15,"PA1347/051/003","Krka d.d., Novo mesto","DULOXETINEHYDROCHLORIDE"
"5277","LOXENTIA","20 Milligram                                                                                            Capsules Gastro-Resistant",2015-05-15,"PA1347/051/001","Krka d.d., Novo mesto","DULOXETINEHYDROCHLORIDE"
"5278","LUCENTIS","10 Mg/Ml Solution for Injection",2007-01-22,"EU/1/06/374/001","Novartis Europharm Limited","RANIBIZUMAB"
"5279","Lucomet SR 750 mg prolonged release tablet","750 milligram(s) Prolonged-release tablet",2014-10-24,"PA1876/001/001","Consilient Health Limited","METFORMINHYDROCHLORIDE"
"5280","LUMARK","1 Millilitre                                                                                           Radio-Pharm Precursor",2015-06-19,"EU/1/15/1013/001","IDB Holland B.V.,","LUTETIUM,ISOTOPEOFMASS177"
"5281","Lumigan","0.3 milligram(s)/millilitre Eye drops, solution",2002-03-08,"EU/1/02/205/001-2","Allergan Pharmaceuticals Ireland","Bimatoprost"
"5282","LUMIGAN","0.1 Mg/Ml Eye Drops Solution",2010-01-07,"EU/1/02/205/3-4","Allergan Pharmaceuticals Ireland","BIMATOPROST"
"5283","LUMINITY","6.52 Mg/Ml Suspension for Injection",2006-09-20,"EU/1/06/361/01-2","Lantheus MI UK Limited","PERFLUTREN"
"5284","LUSDUNA ((FORMELY KNOWN AS INSULIN GLARGINE MSD))","100 Units/ml                                                                                             Solution for injection in pre-filled pen",2017-01-04,"EU/1/16/1162/001-003","Merck Sharp & Dohme BV","INSULINGLARGINE"
"5285","LUSTRAL","50 Milligram                                                                                            Film Coated Tablet",2001-09-07,"PPA0465/062/001","PCO Manufacturing","SERTRALINEHYDROCHLORIDE"
"5286","LUSTRAL","100 Milligram                                                                                            Film Coated Tablet",2001-09-07,"PPA0465/062/002","PCO Manufacturing","SERTRALINEHYDROCHLORIDE"
"5287","LUSTRAL","50 Milligram                                                                                            Film Coated Tablet",1991-08-19,"PA0822/001/004","Pfizer Healthcare Ireland","SERTRALINEHYDROCHLORIDE"
"5288","LUSTRAL","100 Milligram                                                                                            Film Coated Tablet",1991-08-19,"PA0822/001/005","Pfizer Healthcare Ireland","SERTRALINEHYDROCHLORIDE"
"5289","LUSTRAL","100 Milligram                                                                                            Film Coated Tablet",2005-01-07,"PPA1151/002/001","Imbat Limited","SERTRALINEHYDROCHLORIDE"
"5290","LUSTRAL","50 Milligram                                                                                            Film Coated Tablet",2005-01-07,"PPA1151/002/002","Imbat Limited","SERTRALINEHYDROCHLORIDE"
"5291","Lutathera","370 ZZZ MBq/ml Solution for infusion",NA,"EU/1/17/1226/001","Advanced Accelerator Applications","177lu-dotao-tyr3-octeeotate"
"5292","Lutinus 100 mg vaginal tablets","100 milligram(s) Vaginal tablet",2010-02-05,"PA1009/022/001","Ferring Ireland Ltd","Progesterone"
"5293","Lutrate 1 month Depot 3.75mg Powder and Solvent for Prolonged-Release Suspension for Injection","3.75 milligram(s) Powder and solvent for suspension for injection",2015-07-17,"PA0899/044/001","Mercury Pharmaceuticals Ltd","LEUPRORELINACETATE"
"5294","LUTRATE 3 MONTH DEPOT","22.5 Milligram                                                                                            Pdr+Solv for Susp for Inj",2015-07-17,"PA0899/044/002","Mercury Pharmaceuticals Ltd","LEUPRORELINACETATE"
"5295","Luveris","75 international unit(s) Powder and solvent for solution for infusion",2000-11-29,"EU/1/00/155/001","Merck Europe B.V.","Lutropinalfa"
"5296","Luveris","75 international unit(s) Powder for oral suspension",2000-11-29,"EU/1/00/155/002","Merck Europe B.V.","Lutropinalfa"
"5297","Luveris","75 international unit(s) Powder for oral solution",2000-11-29,"EU/1/00/155/003","Merck Europe B.V.","Lutropinalfa"
"5298","Luveris","75 international unit(s) Powder for oral solution",2000-11-29,"EU/1/00/155/004","Serono Europe Limited","Lutropinalfa"
"5299","Luveris","75 international unit(s) Powder for oral solution",2000-11-29,"EU/1/00/155/005","Merck Europe B.V.","Lutropinalfa"
"5300","Luveris","75 international unit(s) Powder for oral solution",2000-11-29,"EU/1/00/155/006","Merck Europe B.V.","Lutropinalfa"
"5301","Luveris","450 international unit(s) Solution for injection",2009-05-26,"EU/1/00/155/007","Merck Europe B.V.","Lutropinalfa"
"5302","LYCIMOR","300 Base Milligrams                                                                                      Capsules Hard",2013-02-15,"PA1380/130/001","Actavis Group PTC ehf","LYMECYCLINE"
"5303","LYCLEAR CREME RINSE","1 %w/w                                                                                                 Cutaneous Solution",1995-07-05,"PA1186/003/001","Chefaro Ireland DAC","PERMETHRIN"
"5304","LYCLEAR DERMAL","5 %w/w                                                                                                 Cream",1995-07-05,"PA1077/066/001","GlaxoSmithKline (Ireland) Limited","PERMETHRIN"
"5305","LYCOPODIUM","6C & 30C  Tablets",2010-12-17,"HOR0407/028/001","Weleda (UK) Limited","LYCOPODIUMCLAVATUM"
"5306","LYMPHOSEEK","50 Microgram                                                                                            Kit for radiopharmaceutical preparation",2014-11-19,"EU/1/14/955/001","Norgine B.V.","TILMANOCEPT"
"5307","LYNPARZA","50 Milligram                                                                                            Capsules Hard",2014-12-16,"EU/1/14/959/001","AstraZeneca AB","OLAPARIB"
"5308","LYNPARZA","100 Milligram                                                                                            Film Coated Tablet",2018-05-08,"EU/1/14/959/002-003","AstraZeneca AB","OLAPARIB"
"5309","LYNPARZA","150 Milligram                                                                                            Film Coated Tablet",2018-05-08,"EU/1/14/959/004-005","AstraZeneca AB","OLAPARIB"
"5310","LYRICA","20 Mg/Ml Oral Solution",2010-06-08,"EU/1/04/279/044","Pfizer Europe MA EEIG","PREGABALIN"
"5311","LYRICA","25,50,75,150,300 percent volume/volume Capsule, hard",2004-07-06,"EU/1/04/279/1-25","Pfizer Limited","Pregabalin"
"5312","LYRICA","225 Milligram                                                                                            Capsules Hard",2006-05-15,"EU/1/4/279/33-35","Pfizer Limited","PREGABALIN"
"5313","LYRINEL XL","5 Milligram                                                                                            Tablet Prolonged Release",2004-08-27,"PA0748/052/001","Janssen-Cilag Ltd","OXYBUTYNINHYDROCHLORIDE"
"5314","LYRINEL XL","10 Milligram                                                                                            Tablet Prolonged Release",2004-08-27,"PA0748/052/002","Janssen-Cilag Ltd","OXYBUTYNINHYDROCHLORIDE"
"5315","LYSODREN","500 mg Milligram                                                                                            Tablets",2004-05-20,"EU/1/04/273/001","Laboratoire HRA Pharma","MITOTANE"
"5316","LYSOPADOL","17.86 Mg/Ml Oromucosal Spray, Soln",2014-02-14,"PA0540/186/002","Sanofi-Aventis Ireland Limited T/A SANOFI","AMBROXOLHYDROCHLORIDE"
"5317","Lysopadol Blackcurrant 20 mg Lozenges","20 milligram(s) Lozenge",2012-06-01,"PA0540/185/001","Sanofi-Aventis Ireland Limited T/A SANOFI","AMBROXOLHYDROCHLORIDE"
"5318","LYSOPADOL LEMON","20 Milligram                                                                                            Lozenges",2012-06-01,"PA0540/187/001","Sanofi-Aventis Ireland Limited T/A SANOFI","AMBROXOLHYDROCHLORIDE"
"5319","LYSOPADOL MINT","20 Milligram                                                                                            Lozenges",2004-02-10,"PA0540/186/001","Sanofi-Aventis Ireland Limited T/A SANOFI","AMBROXOLHYDROCHLORIDE"
"5320","LYXUMIA","10 Microgram                                                                                            Solution for injection in pre-filled pen",2013-02-01,"EU/1/12/811/001","Sanofi-Aventis Groupe","LIXISENATIDE"
"5321","LYXUMIA","20 Microgram                                                                                            Solution for injection in pre-filled pen",2013-02-01,"EU/1/12/811/002-005","Sanofi-Aventis Groupe","LIXISENATIDE"
"5322","MAALOX","200/175 MG/5ml                                                                                               Oral Suspension",1982-04-19,"PA0540/110/001","Sanofi-Aventis Ireland Limited T/A SANOFI","MAGNESIUMHYDROXIDE|ALUMINIUMHYDROXIDE"
"5323","MAALOX","400/400 Milligram                                                                                            Tablets Chewable",1982-04-19,"PA0540/110/004","Sanofi-Aventis Ireland Limited T/A SANOFI","MAGNESIUMHYDROXIDE|ALUMINIUMHYDROXIDEGEL,DRIED"
"5324","MAALOX PLUS","200/175/25 MG/5ml                                                                                               Oral Suspension",1975-11-10,"PA0540/109/001","Sanofi-Aventis Ireland Limited T/A SANOFI","ALUMINIUMHYDROXIDE|MAGNESIUMHYDROXIDE|DIMETICONE,ACTIVATED"
"5325","MAALOX PLUS","200/200/25 Milligram                                                                                            Tablets Chewable",1975-11-10,"PA0540/109/002","Sanofi-Aventis Ireland Limited T/A SANOFI","ALUMINIUMOXIDE,HYDRATEDPH.EUR|MAGNESIUMHYDROXIDEPH.EUR.|DIMETICONEPH.EUR.(ASSIMETICONEPH.EUR.)"
"5326","MABTHERA","100 mg milligram(s) ZZZ Infus/Pdr/Oral Soln",1998-06-02,"EU/1/98/067/001","Roche Registration GmbH","Rituximab"
"5327","Mabthera","500 milligram(s) Concentrate for solution for infusion",1998-06-02,"EU/1/98/067/002","Roche Registration GmbH","Rituximab"
"5328","MabThera","1400 milligram(s) Solution for injection",2014-03-21,"EU/1/98/067/003","Roche Registration GmbH","Rituximab"
"5329","MabThera","1600 milligram(s) Solution for injection",2016-05-26,"EU/1/98/067/004","Roche Registration GmbH","Rituximab"
"5330","MACI","500000/100 Unknown Implant",2013-06-27,"EU/1/13/847/001","Genzyme Europe B.V.","AUTOLOGOUSCHONDROCYTES"
"5331","MACO PHARMA SODIUM CHLORIDE","%w/v                                                                                                 Solution for Infusion",2001-12-03,"PA0931/004/001","Maco Pharma (UK) Ltd","SODIUMCHLORIDE|GLUCOSEMONOHYDRATE"
"5332","MacroBID 100mg Prolonged-Release Capsules","100 milligram(s) Prolonged-release capsule",1994-10-14,"PA0899/014/001","Mercury Pharmaceuticals Ltd","Nitrofurantoin"
"5333","MACRODANTIN","50 Milligram                                                                                            Capsules Hard",1977-04-01,"PA0899/012/001","Mercury Pharmaceuticals Ltd","NITROFURANTOIN"
"5334","MACRODANTIN","100 Milligram                                                                                            Capsules Hard",1977-04-01,"PA0899/012/002","Mercury Pharmaceuticals Ltd","NITROFURANTOIN"
"5335","Macrolief 13.125g + 351mg + 179mg + 47mg  sachet, powder for oral solution","13.8 gram(s) Powder for oral solution",2013-07-19,"PA0711/224/001","Rowex Ltd","Sodiumhydrogencarbonate|Sodiumchloride|Macrogol3350|Potassiumchloride"
"5336","MACROSOFT","10 Grams                                                                                                Powder for Oral Solution",2015-01-30,"PA0540/192/001","Sanofi-Aventis Ireland Limited T/A SANOFI","MACROGOL4000"
"5337","MACUGEN","0.3 Milligram                                                                                            Solution for Injection",2006-01-31,"EU/1/05/325/001","Pfizer Limited","PEGAPTANIBSODIUM"
"5338","MADOPAR","200/50 Milligram                                                                                            Capsules Hard",1979-04-01,"PA2307/004/001","Roche Products (Ireland) Ltd","LEVODOPA|BENSERAZIDEHYDROCHLORIDE"
"5339","MADOPAR","50/12.5 Milligram                                                                                            Tablets",1987-04-08,"PA2307/004/002","Roche Products (Ireland) Ltd","LEVODOPA|BENSERAZIDEHYDROCHLORIDE"
"5340","MADOPAR","100/25 Milligram                                                                                            Tablets",1987-04-08,"PA2307/004/003","Roche Products (Ireland) Ltd","LEVODOPA|BENSERAZIDEHYDROCHLORIDE"
"5341","MAGNASPARTATE","243 Milligram                                                                                            Powder for Oral Solution",2015-05-15,"PA1748/002/001","Kora Corporation Ltd t/a Kora Healthcare","MAGNESIUMASPARTATEDIHYDRATE"
"5342","MAGNESIUM SULFATE","38.5 %w/w                                                                                                 Cutaneous Paste",1995-04-21,"PA0484/021/001","Foran Healthcare Limited","MAGNESIUMSULFATE"
"5343","MAGNESIUM SULPHATE","50 %w/v                                                                                                 Solution for Injection and Concentrate for Infusion",2006-05-26,"PA1176/001/001","Aurum Pharmaceutical Limited","MAGNESIUMSULFATEHEPTAHYDRATE"
"5344","MAGNESIUM VERLA 5 MMOL GRANULES FOR ORAL SOLUTION","5 mMol.                                                                                                Granules for oral solution",1997-02-25,"PA0074/062/001","Rowa Pharmaceuticals Limited","MAGNESIUMASPARTATEDIHYDRATE"
"5345","MAJOVEN XL","37.5 Milligram                                                                                            Prolonged Release Capsules",2017-01-27,"PA1240/021/001","Bristol Laboratories Limited","VENLAFAXINE(FORMB)"
"5346","MAJOVEN XL","75 Milligram                                                                                            Prolonged Release Capsules",2017-01-27,"PA1240/021/002","Bristol Laboratories Limited","VENLAFAXINE(FORMB)"
"5347","MAJOVEN XL","150 Milligram                                                                                            Prolonged Release Capsules",2017-01-27,"PA1240/021/003","Bristol Laboratories Limited","VENLAFAXINE(FORMB)"
"5348","MALARONE","250 / 100 Milligram                                                                                            Film Coated Tablet",2005-12-02,"PA1077/111/001","GlaxoSmithKline (Ireland) Limited","ATOVAQUONE|PROGUANILHYDROCHLORIDE"
"5349","MALARONE","250/100 Milligram                                                                                            Film Coated Tablet",2014-03-28,"PPA1463/095/001","IMED Healthcare Ltd.","ATOVAQUONE|PROGUANILHYDROCHLORIDE"
"5350","MANERIX","150 Milligram                                                                                            Film Coated Tablet",1991-07-04,"PA2010/023/001","Mylan IRE Healthcare Limited","MOCLOBEMIDE"
"5351","MANNITOL","10 Per Cent                                                                                             Solution for Infusion",2007-09-14,"PA0167/037/015","Baxter Healthcare Limited","MANNITOL"
"5352","MANNITOL","15 %w/v                                                                                                 Solution for Infusion",2010-04-09,"PA0167/037/017","Baxter Healthcare Limited","MANNITOL"
"5353","MANNITOL INTRAVENOUS INFUSION BP","20 %w/v                                                                                                 Solution for Infusion",1984-06-29,"PA0167/037/009","Baxter Healthcare Limited","MANNITOL"
"5354","Marcain 0.25% w/v with Adrenaline (Epinephrine, 5 micrograms per ml) (1:200,000) Solution for Injection","0.25/0.5%w percent volume/volume Solution for injection",NA,"PA1691/025/001","Aspen Pharma Trading Limited","Adrenalinetartrate|BUPIVACAINEHYDROCHLORIDE"
"5355","MARCAIN 0.5% WITH ADRENALINE","0.5%/0.55% %v/v                                                                                                 Solution for Injection",1988-05-31,"PA1691/025/002","Aspen Pharma Trading Limited","BUPIVACAINEHYDROCHLORIDE|EPINEPHRINEBITARTRATE"
"5356","MARCAIN HEAVY STERIPACK 0.5% W/V","5mg/80mg/m %v/v                                                                                                 Solution for Injection",1987-04-02,"PA1691/024/003","Aspen Pharma Trading Limited","BUPIVACAINEHYDROCHLORIDE"
"5357","MARCAIN POLYAMP STERIPACK","0.25 %w/v                                                                                                 Solution for Injection",1988-09-19,"PA1691/024/001","Aspen Pharma Trading Limited","BUPIVACAINEHYDROCHLORIDE"
"5358","MARCAIN POLYAMP STERIPACK","0.5 %w/v                                                                                                 Solution for Injection",1988-09-19,"PA1691/024/002","Aspen Pharma Trading Limited","BUPIVACAINEHYDROCHLORIDE"
"5359","Marcain Polyamp Steripack 0.5% w/v Solution for Injection","0.5 percent weight/volume Solution for injection",1998-09-19,"PA0970/045/002","AstraZeneca UK Limited","BUPIVACAINEHYDROCHLORIDE"
"5360","MARIXINO","10 Milligram                                                                                            Film Coated Tablet",NA,"EU/1/13/820/1-13","Krka d.d., Novo mesto","MEMANTINEHYDROCHLORIDE"
"5361","MARIXINO","20 Milligram                                                                                            Film Coated Tablet",NA,"EU/1/13/820/14-26","Krka d.d., Novo mesto","MEMANTINEHYDROCHLORIDE"
"5362","MARVIOL 150/30 MICROGRAM TABLETS.","150/30 Microgram                                                                                            Tablets",1983-04-13,"PA1286/051/001","Merck Sharp & Dohme Ireland (Human Health) Limited","DESOGESTREL|ETHINYLESTRADIOL"
"5363","MASSAGE BALM WITH ARNICA","%v/v                                                                                                 Cutaneous Solution",1992-10-12,"PA0407/021/001","Weleda (UK) Limited","ARNICAMONTANA|BETULAALBA|BIRCHLEAF"
"5364","MATEVER","250 Milligram                                                                                            Film Coated Tablet",2011-10-03,"EU/1/11/711/001-006","Pharmathen S.A.","LEVETIRACETAM"
"5365","MATEVER","500 Milligram                                                                                            Film Coated Tablet",2011-10-03,"EU/1/11/711/007-014","Pharmathen S.A.","LEVETIRACETAM"
"5366","MATEVER","750 Milligram                                                                                            Film Coated Tablet",2011-10-03,"EU/1/11/711/015-022","Pharmathen S.A.","LEVETIRACETAM"
"5367","MATEVER","1000 Milligram                                                                                            Film Coated Tablet",2011-10-03,"EU/1/11/711/023-029","Pharmathen S.A.","LEVETIRACETAM"
"5368","MATEVER","100 Mg/Ml Concentrate for Soln for Inf",2011-10-03,"EU/1/11/711/030","Pharmathen S.A.","LEVETIRACETAM"
"5369","MATRIFEN","12 Microgram per hour Transdermal Patch",2006-10-13,"PA2229/007/001","Takeda Products Ireland Ltd",""
"5370","MATRIFEN","25 Microgram per hour Transdermal Patch",2006-10-13,"PA2229/007/002","Takeda Products Ireland Ltd",""
"5371","MATRIFEN","50 Microgram per hour Transdermal Patch",2006-10-13,"PA2229/007/003","Takeda Products Ireland Ltd",""
"5372","MATRIFEN","75 Microgram per hour Transdermal Patch",2006-10-13,"PA2229/007/004","Takeda Products Ireland Ltd",""
"5373","MATRIFEN","100 Microgram per hour Transdermal Patch",NA,"PA2229/007/005","Takeda Products Ireland Ltd",""
"5374","Mavenclad","10 milligram(s) Tablet",2017-08-22,"EU/1/17/1212/001-006","Merck Serono Europe Limited","Cladribine"
"5375","Maviret (previously ABT-493/ABT-530)","100/40 milligram(s) Film-coated tablet",2017-07-26,"EU/1/17/1213/001","AbbVie Ltd","Glecaprevir|Pibrentasvir"
"5376","MAXIBAR","98.45%w/w %w/w                                                                                                 Powder for Oral Suspension",1992-11-03,"PA1826/002/001","Bracco Imaging spa","BARIUMSULFATE"
"5377","MAXIDEX","0.1 %w/v                                                                                                 Eye Drops Suspension",1984-01-05,"PA0896/018/001","Novartis Ireland Limited","DEXAMETHASONE"
"5378","MAXIDEX","0.1 %w/w                                                                                                 Eye Ointment",1984-01-05,"PA0896/018/002","Novartis Ireland Limited","DEXAMETHASONE"
"5379","Maxilief Effervescent TabletsParacetamol 500mgCodeine Phosphate Hemihydrate 8mgCaffeine 30mg","500/8/30 milligram(s) Effervescent tablet",2002-10-11,"PA0126/113/001","Clonmel Healthcare Ltd","Paracetamol|Codeinephosphate|Codeinephosphatehemihydrate|Caffeine"
"5380","MAXITROL","Unknown Eye Ointment",1988-04-01,"PA0896/019/002","Novartis Ireland Limited","NEOMYCINSULFATE|POLYMYXINBSULFATE|DEXAMETHASONE"
"5381","MAXITROL 0.1% W/V, 6000 IU/ML, 3500 IU/ML EYE","%w/v                                                                                                 Eye Drops Suspension",1988-04-01,"PA0896/019/001","Novartis Ireland Limited","DEXAMETHASONE|POLYMYXINBSULFATE|NEOMYCINSULFATE"
"5382","MAXOLON","5 Mg/Ml Solution for Injection",1994-04-01,"PA1142/011/001","Amdipharm Limited","METOCLOPRAMIDEHYDROCHLORIDE"
"5383","MAXOLON","10 Milligram                                                                                            Tablets",1979-04-01,"PA1142/011/003","Amdipharm Limited","METOCLOPRAMIDEHYDROCHLORIDE"
"5384","MEDIAM STANNOUS AGENT","4.0 ; 6.8 Milligram                                                                                            Pdr for Soln for Infusion",1999-01-22,"PA1229/002/001","MEDiAM","STANNOUSFLUORIDE|MEDRONICACID"
"5385","MEDICAL AIR","21 %v/v                                                                                                 Medicinal gas, compressed",1985-09-27,"PA0208/009/001","BOC Gases Ireland Ltd","OXYGEN"
"5386","MEDICAL CARBON DIOXIDE","99.5 %w/v                                                                                                 Medicinal gas, compressed",1980-04-01,"PA0208/006/001","BOC Gases Ireland Ltd","CARBONDIOXIDE"
"5387","MEDICAL HELIUM","99.5 %v/v                                                                                                 Medicinal gas, compressed",1980-04-01,"PA0208/008/001","BOC Gases Ireland Ltd","HELIUM"
"5388","MEDICAL LIQUID OXYGEN","99.5 %v/v                                                                                                 Medicinal gas, liquefied",1980-04-01,"PA0208/002/001","BOC Gases Ireland Ltd","OXYGEN"
"5389","MEDICAL NITROUS OXIDE",">98 %v/v                                                                                                 Medicinal gas, compressed",1980-04-01,"PA0208/001/001","BOC Gases Ireland Ltd","NITROUSOXIDE"
"5390","MEDICAL OXYGEN","99.5 %v/v                                                                                                 Medicinal gas, compressed",1980-04-01,"PA0208/003/001","BOC Gases Ireland Ltd","OXYGEN"
"5391","MEDICAL OXYGEN","100 %v/v                                                                                                 Medicinal gas, compressed",2018-05-04,"PA1848/005/003","SOL S.p.A.","OXYGEN"
"5392","MEDICAL OXYGEN","100 %v/v                                                                                                 Inhalation Gas",2015-05-29,"PA1357/001/001","Industrial Pressure Testing Ltd","OXYGEN"
"5393","MEDICINAL AIR SYNTHETIC SOL","21.75 %v/v                                                                                                 Medicinal gas, compressed",2016-05-20,"PA1848/002/001","SOL S.p.A.","OXYGEN"
"5394","MEDICINAL OXYGEN/CARBON DIOXIDE MIXTURES","Per Cent                                                                                             Medicinal gas, compressed",1985-09-27,"PA0208/004/001","BOC Gases Ireland Ltd","OXYGEN|CARBONDIOXIDE"
"5395","MEDIJEL","0.66/0.05 %w/w                                                                                                 Oromucosal Gel",1984-04-30,"PA0302/001/001","D.D.D. Limited","LIDOCAINEHYDROCHLORIDE|AMINOACRIDINEHYDROCHLORIDE"
"5396","MEDIKINET","5 Milligram                                                                                            Tablets",2011-02-25,"PA1555/001/006","Medice Arzneimittel Putter GmbH & Co. K.G","METHYLPHENIDATEHYDROCHLORIDE"
"5397","MEDIKINET","10 Milligram                                                                                            Tablets",2011-02-25,"PA1555/001/007","Medice Arzneimittel Putter GmbH & Co. K.G","METHYLPHENIDATEHYDROCHLORIDE"
"5398","MEDIKINET","20 Milligram                                                                                            Tablets",2011-02-25,"PA1555/001/008","Medice Arzneimittel Putter GmbH & Co. K.G","METHYLPHENIDATEHYDROCHLORIDE"
"5399","MEDIKINET MR","5 Milligram                                                                                            Capsules Modified Release",2011-05-20,"PA1555/001/001","Medice Arzneimittel Putter GmbH & Co. K.G","METHYLPHENIDATEHYDROCHLORIDE"
"5400","MEDIKINET MR","10 Milligram                                                                                            Capsules Modified Release",2011-05-20,"PA1555/001/002","Medice Arzneimittel Putter GmbH & Co. K.G","METHYLPHENIDATEHYDROCHLORIDE"
"5401","MEDIKINET MR","20 Milligram                                                                                            Capsules Modified Release",2011-05-20,"PA1555/001/003","Medice Arzneimittel Putter GmbH & Co. K.G","METHYLPHENIDATEHYDROCHLORIDE"
"5402","MEDIKINET MR","30 Milligram                                                                                            Capsules Modified Release",2011-05-20,"PA1555/001/004","Medice Arzneimittel Putter GmbH & Co. K.G","METHYLPHENIDATEHYDROCHLORIDE"
"5403","MEDIKINET MR","40 Milligram                                                                                            Capsules Modified Release",2011-05-20,"PA1555/001/005","Medice Arzneimittel Putter GmbH & Co. K.G","METHYLPHENIDATEHYDROCHLORIDE"
"5404","MEFAC","250 Milligram                                                                                            Capsule",1988-04-28,"PA0074/015/001","Rowa Pharmaceuticals Limited","MEFENAMICACID"
"5405","MEFAC","500 mg Milligram                                                                                            Tablets",1988-04-28,"PA0074/015/002","Rowa Pharmaceuticals Limited","MEFENAMICACID"
"5406","MEFENAMIC ACID","250 Milligram                                                                                            Capsules Hard",1987-05-21,"PA0405/014/001","Generics (UK) Limited","MEFENAMICACID"
"5407","MEGACE","40 Mg/Ml Oral Suspension",2013-11-04,"PPA0465/323/001","PCO Manufacturing","MEGESTROLACETATE"
"5408","MEGACE","160 Milligram                                                                                            Tablets",2017-01-20,"PPA0465/323/002","PCO Manufacturing","MEGESTROLACETATE"
"5409","MEGACE","160 Milligram                                                                                            Tablets",2017-01-20,"PPA1562/194/001","LTT Pharma Limited","MEGESTROLACETATE"
"5410","Megace 160 mg Tablets","160 milligram(s) Tablet",1989-02-06,"PA1696/002/001","PharmaSwiss Ceska republika s.r.o.","Megestrolacetate"
"5411","MEGACE 40 MG/ML ORAL SUSPENSION","40 Mg/Ml Oral Suspension",1998-12-10,"PA1696/002/002","PharmaSwiss Ceska republika s.r.o.","MEGESTROLACETATE"
"5412","Mekinist 0.5 mg film-coated tablets","0.5 milligram(s) Film-coated tablet",2014-06-30,"EU/1/14/931/01-02","Novartis Europharm Limited","Trametinib"
"5413","Mekinist 1 mg film-coated tablets","1 milligram(s) Film-coated tablet",2014-06-30,"EU/1/14/931/03-04","Novartis Europharm Limited","Trametinib"
"5414","Mekinist 2 mg film-coated tablets","2 milligram(s) Film-coated tablet",2014-06-30,"EU/1/14/931/05-06","Novartis Europharm Limited","Trametinib"
"5415","Mektovi","15 milligram(s) Film-coated tablet",2018-09-20,"EU/1/18/1315/001","Pierre Fabre Medicament","BINMETINIB"
"5416","MELCAM","7.5 Milligram                                                                                            Tablets",2004-11-19,"PA0711/060/001","Rowex Ltd","MELOXICAM"
"5417","MELCAM","15 Milligram                                                                                            Tablets",2004-11-19,"PA0711/060/002","Rowex Ltd","MELOXICAM"
"5418","Melfen 200mg Film-coated tablets","200 milligram(s) Film-coated tablet",1980-07-11,"PA0126/012/001","Clonmel Healthcare Ltd","Ibuprofen"
"5419","Melfen 400mg Film-coated tablets","400 milligram(s) Film-coated tablet",1980-07-11,"PA0126/012/002","Clonmel Healthcare Ltd","Ibuprofen"
"5420","MELOXICAM CHANELLE MEDICAL","7.5 Milligram                                                                                            Tablets",2005-12-02,"PA0688/005/001","Chanelle Medical","MELOXICAM"
"5421","MELOXICAM CHANELLE MEDICAL","15 Milligram                                                                                            Tablets",2005-12-02,"PA0688/005/002","Chanelle Medical","MELOXICAM"
"5422","MELPHALAN TEVA","50 Milligram                                                                                            Pdr+Solv for soln for inf/inj",2018-05-04,"PA1986/077/001","Teva B.V.","MELPHALAN"
"5423","MEMANTINE ACCORD","10 Milligram                                                                                            Film Coated Tablet",2014-12-04,"EU/1/13/880/001-008","Accord Healthcare Limited","MEMANTINEHYDROCHLORIDE"
"5424","MEMANTINE ACCORD","5+10+15+20 Milligram                                                                                            Film Coated Tablet",2014-12-04,"EU/1/13/880/013","Accord Healthcare Limited","MEMANTINEHYDROCHLORIDE"
"5425","MEMANTINE ACCORD","20 Milligram                                                                                            Film Coated Tablet",2014-12-04,"EU/1/13/880/09-12","Accord Healthcare Limited","MEMANTINEHYDROCHLORIDE"
"5426","Memantine Clonmel 10mg Film-coated Tablet","10 milligram(s) Film-coated tablet",2013-09-20,"PA0126/255/002","Clonmel Healthcare Ltd","MEMANTINEHYDROCHLORIDE"
"5427","Memantine Clonmel 10mg/ml Oral Solution","10 milligram(s)/millilitre Oral solution",2013-08-23,"PA0126/255/001","Clonmel Healthcare Ltd","MEMANTINEHYDROCHLORIDE"
"5428","Memantine Hydrochloride 10mg/ml Oral Solution","10 milligram(s)/millilitre Oral solution",2013-11-08,"PA0577/176/001","McDermott Laboratories Ltd t/a Gerard Laboratories","MEMANTINEHYDROCHLORIDE"
"5429","MEMANTINE HYDROCHLORIDE NICHE","10 Milligram                                                                                            Film Coated Tablet",2014-07-18,"PA1063/057/001","Niche Generics Limited","MEMANTINEHYDROCHLORIDE"
"5430","MEMANTINE HYDROCHLORIDE NICHE","20 Milligram                                                                                            Film Coated Tablet",2014-07-18,"PA1063/057/002","Niche Generics Limited","MEMANTINEHYDROCHLORIDE"
"5431","MEMANTINE LEK","10 Milligram                                                                                            Film Coated Tablet",NA,"EU/1/13/826/001-006","Pharmathen S.A.","MEMANTINEHYDROCHLORIDE"
"5432","MEMANTINE LEK","20 Milligram                                                                                            Film Coated Tablet",NA,"EU/1/13/826/007-011","Pharmathen S.A.","MEMANTINEHYDROCHLORIDE"
"5433","MEMANTINE MERZ","10 Milligram                                                                                            Film Coated Tablet",2012-11-22,"EU/1/12/799/001-012","Merz Pharmaceuticals GmbH","MEMANTINEHYDROCHLORIDE|MEMANTINE(FREEBASE)"
"5434","MEMANTINE MERZ","20 Milligram                                                                                            Film Coated Tablet",2012-11-22,"EU/1/12/799/013-024","Merz Pharmaceuticals GmbH","MEMANTINEHYDROCHLORIDE|MEMANTINE(FREEBASE)"
"5435","MEMANTINE MERZ","5+10+15+20 Milligram                                                                                            Film Coated Tablet",2012-11-22,"EU/1/12/799/025-026","Merz Pharmaceuticals GmbH","MEMANTINEHYDROCHLORIDE|MEMANTINE(FREEBASE)"
"5436","MEMANTINE MERZ","5 mg/pump actuation Oral Solution",2012-11-22,"EU/1/12/799/027-029","Merz Pharmaceuticals GmbH","MEMANTINEHYDROCHLORIDE|MEMANTINE(FREEBASE)"
"5437","Memantine Mylan","10 milligram(s) Film-coated tablet",2013-04-22,"EU/1/13/827/001-018","Mylan S.A.S.","MEMANTINEHYDROCHLORIDE"
"5438","Memantine Mylan","20 milligram(s) Film-coated tablet",2013-04-22,"EU/1/13/827/019-036","Mylan S.A.S.","MEMANTINEHYDROCHLORIDE"
"5439","MEMANTINE RATIOPHARM","10 Milligram                                                                                            Film Coated Tablet",2013-09-13,"EU/1/13/836/001-12","Ratiopharm GmbH","MEMANTINEHYDROCHLORIDE"
"5440","MEMANTINE RATIOPHARM","20 Milligram                                                                                            Film Coated Tablet",2013-09-13,"EU/1/13/836/013-22","Ratiopharm GmbH","MEMANTINEHYDROCHLORIDE"
"5441","MEMANTINE RATIOPHARM","5+10+15+20 Milligram                                                                                            Film Coated Tablet",2013-09-13,"EU/1/13/836/023","Ratiopharm GmbH","MEMANTINEHYDROCHLORIDE"
"5442","Menitorix powder and solvent for solution for injection.Haemophilus type b and Meningococcal group C conjugate vaccine","0.5 millilitre(s) Powder and solvent for solution for injection",2008-02-15,"PA1077/116/001","GlaxoSmithKline (Ireland) Limited","Conjugateofhaemophilusinfluenzaetypebcapsularpolysaccharide(polyribosylribitolphosphate)andtetanus|Conjugateofneisseriameningitidesccapsularpolysaccharideandtetanustoxoid(meantt/psratio:1)"
"5443","MENJUGATE LIQUID","10 Microgram                                                                                            Suspension for Injection",2015-05-08,"PA0919/004/003","GSK Vaccines S.r.l.","MENINGOCOCCALGROUPCOLIGOSACCHARIDE|CORYNEBACTERIUMDIPHTHERIAECRM197PROTEIN"
"5444","MENJUGATE LIQUID","10 Microgram                                                                                            Suspension for Injection",2015-05-08,"PA0919/004/004","GSK Vaccines S.r.l.","MENINGOCOCCALGROUPCOLIGOSACCHARIDE|CORYNEBACTERIUMDIPHTHERIAECRM197PROTEIN"
"5445","MENOFORCE SAGE","Tablets",2013-05-03,"TR0725/004/001","Bioforce (UK) Ltd","DRYEXTRACTSALVIAOFFICINALISL."
"5446","MENOPUR","75/75IU IU/ML                                                                                                Pdr+Solv for Soln for Inj",2001-05-04,"PA1009/015/001","Ferring Ireland Ltd","FOLLICLE-STIMULATINGHORMONE,HUMAN|LUTEINISINGHORMONE"
"5447","MENOPUR","600 International Unit                                                                                   Pdr+Solv for Soln for Inj",2011-06-17,"PA1009/015/002","Ferring Ireland Ltd","MENOTROPHINBP"
"5448","MENOPUR","1200 International Unit                                                                                   Pdr+Solv for Soln for Inj",2011-06-17,"PA1009/015/003","Ferring Ireland Ltd","MENOTROPHINBP"
"5449","MENTHOL AND WINTERGREEN","5.00 0.2 2.00 13.18 %w/w                                                                                                 Cream",1988-09-01,"PA0206/022/001","Ovelle Limited","METHYLSALICYLATE|LEVOMENTHOL|OLEORESINCAPSICUM|TURPENTINEOIL"
"5450","Mentholatum Deep Heat Cream","percent weight/weight Cream",1990-07-16,"PA0076/002/001","The Mentholatum Company Ltd.","Turpentineoil|Racementhol|Methylsalicylate|Eucalyptus"
"5451","MENTHOLATUM DEEP HEAT SPRAY","Unknown Cutaneous Spray Solution",1993-10-18,"PA0076/003/001","The Mentholatum Company Ltd.","METHYLNICOTINATE|GLYCOLSALICYLATE|ETHYLSALICYLATE|METHYLSALICYLATE"
"5452","MENVEO","0.5 Millilitre                                                                                           Pdr+Solv for Soln for Inj",2010-03-15,"EU/1/10/614/002-003","GSK Vaccines S.r.l.","MENINGOCOCCALGROUPAOLIGOSACCHARIDE|MENINGOCOCCALGROUPCOLIGOSACCHARIDE|MENINGOCOCCALGROUPW-135OLIGOSACCHARIDE|MENINGOCOCCALGROUPYOLIGOSACCHARDIE"
"5453","MEPACT","4 Milligram                                                                                            Powder for suspension for infusion",2009-03-06,"EU/1/08/502/001","Takeda France SAS","MIFAMURTIDE"
"5454","Mepsevii","2 milligram(s)/millilitre Concentrate for solution for infusion",2018-08-23,"EU/1/18/1301/001","Ultragenyx Germany GmbH","RECOMBINANTHUMANBETAGLUCURONIDASE;RHGUS"
"5455","MEPTID","100 Mg/Ml Solution for Injection",1983-10-10,"PA0968/005/001","Almirall, S.A.","MEPTAZINOLHYDROCHLORIDE"
"5456","MEPTID","200 mg Milligram                                                                                            Tablets",1988-05-24,"PA0968/005/002","Almirall, S.A.","MEPTAZINOLHYDROCHLORIDE"
"5457","MERCILON 150/20 MICROGRAM TABLETS.","150/20 Microgram                                                                                            Tablets",1988-05-30,"PA1286/052/001","Merck Sharp & Dohme Ireland (Human Health) Limited","DESOGESTREL|ETHINYLESTRADIOL"
"5458","MERCURIUS  VIVUS","6c-200c                                                                                                      Infus/Pdr/Oral Soln",2009-12-22,"HOR1154/013/001","Helios Homeopathy Ltd","MERCURY"
"5459","MEROCAINE","1.4 / 10 Milligram                                                                                            Lozenges",1982-03-10,"PA0540/178/001","Sanofi-Aventis Ireland Limited T/A SANOFI","CETYLPYRIDINIUMCHLORIDE|BENZOCAINE"
"5460","MEROCETS","1.4 Milligram                                                                                            Lozenges",1988-07-25,"PA0540/176/001","Sanofi-Aventis Ireland Limited T/A SANOFI","CETYLPYRIDINIUMCHLORIDE"
"5461","MEROCETS PLUS","1.4 Milligram                                                                                            Lozenges",1998-04-19,"PA0540/177/001","Sanofi-Aventis Ireland Limited T/A SANOFI","CETYLPYRIDINIUMCHLORIDE|MENTHOL|EUCALYPTUSGLOBULUS"
"5462","MERONEM I.V.","500 Milligram                                                                                            Pdr for Soln Inj/Inf",1995-05-19,"PA0822/190/001","Pfizer Healthcare Ireland","MEROPENEMTRIHYDRATE"
"5463","Meronem I.V. 1g Powder for solution for injection or infusion","1 gram(s) Powder for solution for injection/infusion",1995-05-19,"PA0822/190/002","Pfizer Healthcare Ireland","Meropenemtrihydrate"
"5464","MEROPENEM","500 Milligram                                                                                            Pdr for Soln Inj/Inf",2010-11-19,"PA1217/006/001","Hikma Farmaceutica (Portugal) SA","MEROPENEM"
"5465","MEROPENEM","1 Grams                                                                                                Pdr for Soln Inj/Inf",2010-11-19,"PA1217/006/002","Hikma Farmaceutica (Portugal) SA","MEROPENEM"
"5466","MEROPENEM","500 Milligram                                                                                            Pdr for Soln Inj/Inf",2010-10-01,"PA2059/012/001","Fresenius Kabi Deutschland GmbH","MEROPENEMTRIHYDRATE"
"5467","MEROPENEM","1 Grams                                                                                                Pdr for Soln Inj/Inf",2010-10-01,"PA2059/012/002","Fresenius Kabi Deutschland GmbH","MEROPENEMTRIHYDRATE"
"5468","MEROPENEM","500 Milligram                                                                                            Pdr for Soln Inj/Inf",2012-02-24,"PA2168/002/001","Acino AG","MEROPENEMTRIHYDRATE"
"5469","MEROPENEM","1 Grams                                                                                                Pdr for Soln Inj/Inf",2012-02-24,"PA2168/002/002","Acino AG","MEROPENEMTRIHYDRATE"
"5470","MEROPENEM","500 Milligram                                                                                            Pdr for Soln Inj/Inf",2012-04-20,"PA1610/001/001","Venus Pharma GmbH","MEROPENEMTRIHYDRATE"
"5471","MEROPENEM","1 Grams                                                                                                Pdr for Soln Inj/Inf",2012-04-20,"PA1610/001/002","Venus Pharma GmbH","MEROPENEMTRIHYDRATE"
"5472","MEROPENEM","0.5 Grams                                                                                                Pdr for Soln Inj/Inf",2018-02-16,"PA1390/107/001","Accord Healthcare Limited","MEROPENEMTRIHYDRATE(STERILE)"
"5473","MEROPENEM","1 Grams                                                                                                Pdr for Soln Inj/Inf",2018-02-16,"PA1390/107/002","Accord Healthcare Limited","MEROPENEMTRIHYDRATE(STERILE)"
"5474","Meropenem 1g Powder for Solution for Injection or Infusion","1 gram(s) Powder for solution for injection/infusion",2012-09-07,"PA1122/015/002","Noridem Enterprises Ltd","Meropenemtrihydrate"
"5475","Meropenem 500mg Powder for Solution for Injection or Infusion","500 milligram(s) Powder for solution for injection/infusion",2012-09-07,"PA1122/015/001","Noridem Enterprises Ltd","Meropenemtrihydrate"
"5476","MEROPENEM HOSPIRA","500 Milligram                                                                                            Pdr for Soln Inj/Inf",2010-11-12,"PA0437/064/001","Hospira  UK Limited","MEROPENEMTRIHYDRATE"
"5477","MEROPENEM HOSPIRA","1 Grams                                                                                                Pdr for Soln Inj/Inf",2010-11-12,"PA0437/064/002","Hospira  UK Limited","MEROPENEMTRIHYDRATE"
"5478","Meropenem Milpharm 1g Powder for solution for injection or infusion","1 gram(s) Powder for solution for injection/infusion",2016-03-11,"PA1445/014/002","Aurobindo Pharma (Malta) Limited","Meropenemtrihydrate"
"5479","Meropenem Milpharm 500mg Powder for solution for injection or infusion","500 gram(s) Powder for solution for injection/infusion",2016-03-11,"PA1445/014/001","Aurobindo Pharma (Malta) Limited","Meropenemtrihydrate"
"5480","MEROPONIA","500 Milligram                                                                                            Pdr for Soln Inj/Inf",2013-01-11,"PA0126/225/001","Clonmel Healthcare Ltd","MEROPENEMTRIHYDRATE"
"5481","MEROPONIA","1 Grams                                                                                                Pdr for Soln Inj/Inf",2013-01-11,"PA0126/225/002","Clonmel Healthcare Ltd","MEROPENEMTRIHYDRATE"
"5482","MESTINON","60 Milligram                                                                                            Tablets",2015-08-13,"PPA1562/166/001","LTT Pharma Limited","PYRIDOSTIGMINEBROMIDE"
"5483","Mestinon 60mg Tablets","60 milligram(s) Tablet",1979-04-01,"PA2010/052/001","Mylan IRE Healthcare Limited","Pyridostigminebromide"
"5484","METALYSE","30 Milligram                                                                                            Pdr+Solv for Soln for Inj",2001-02-23,"EU/1/00/169/004","Boehringer Ingelheim International GmbH","TENECTEPLASE"
"5485","METALYSE","40 Milligram                                                                                            Pdr+Solv for Soln for Inj",2001-02-23,"EU/1/00/169/005","Boehringer Ingelheim International GmbH","TENECTEPLASE"
"5486","METALYSE","50 Milligram                                                                                            Pdr+Solv for Soln for Inj",2001-02-23,"EU/1/00/169/006","Boehringer Ingelheim International GmbH","TENECTEPLASE"
"5487","METARAMINOL","10  Infus/Pdr/Oral Soln",2018-03-23,"PA2100/001/001","GH Pharma (UK) Limited","METARAMINOLTARTRATE"
"5488","METASTRON 37 MBQ/ML SOLUTION FOR INJECTION","37.5 MBq/ml                                                                                               Solution for Injection",1991-08-20,"PA0240/006/001","GE Healthcare Limited","STRONTIUM(89SR)CHLORIDE"
"5489","METATONE TONIC","300 N/A Syrup",1975-07-14,"PA1186/004/001","Chefaro Ireland DAC","THIAMINEHYDROCHLORIDE|CALCIUMGLYCEROPHOSPHATE|POTASSIUMGLYCEROPHOSPHATE|SODIUMGLYCEROPHOSPHATE|MANGANESEGLYCEROPHOSPHATE"
"5490","Metformin Aurobindo 1000 mg film-coated tablets","1000 milligram(s) Film-coated tablet",2009-04-03,"PA1445/021/003","Aurobindo Pharma (Malta) Limited","METFORMINHYDROCHLORIDE"
"5491","Metformin Aurobindo 500 mg film-coated tablets","500 milligram(s) Film-coated tablet",2009-04-03,"PA1445/021/001","Aurobindo Pharma (Malta) Limited","METFORMINHYDROCHLORIDE"
"5492","Metformin Aurobindo 850 mg film-coated tablets","850 milligram(s) Film-coated tablet",2009-04-03,"PA1445/021/002","Aurobindo Pharma (Malta) Limited","METFORMINHYDROCHLORIDE"
"5493","Metformin Bluefish 1000 mg, film-coated tablets","1000 milligram(s) Film-coated tablet",2009-03-27,"PA1436/009/003","Bluefish Pharmaceuticals AB","METFORMINHYDROCHLORIDE"
"5494","Metformin Bluefish 500 mg, Film-coated tablets","500 milligram(s) Film-coated tablet",2009-03-27,"PA1436/009/001","Bluefish Pharmaceuticals AB","METFORMINHYDROCHLORIDE"
"5495","Metformin Bluefish 850 mg, film-coated tablets","850 milligram(s) Film-coated tablet",2009-03-27,"PA1436/009/002","Bluefish Pharmaceuticals AB","METFORMINHYDROCHLORIDE"
"5496","METFORMIN HYDROCHLORIDE","500 MG/5ml                                                                                               Infus/Pdr/Oral Soln",2007-10-12,"PA0312/011/001","Rosemont Pharmaceuticals Ltd","METFORMINHYDROCHLORIDE"
"5497","METFORMIN MYLAN","500 Milligram                                                                                            Film Coated Tablet",2010-04-23,"PA0577/132/001","McDermott Laboratories Ltd t/a Gerard Laboratories","METFORMINHYDROCHLORIDE"
"5498","METFORMIN MYLAN","850 Milligram                                                                                            Film Coated Tablet",2010-04-23,"PA0577/132/002","McDermott Laboratories Ltd t/a Gerard Laboratories","METFORMINHYDROCHLORIDE"
"5499","METFORMIN MYLAN","1000 Milligram                                                                                            Film Coated Tablet",2010-04-23,"PA0577/132/003","McDermott Laboratories Ltd t/a Gerard Laboratories","METFORMINHYDROCHLORIDE"
"5500","Metformin Teva 1000 mg Film-coated tablets","1000 milligram(s) Film-coated tablet",2014-11-03,"PA0749/185/003","Teva Pharma B.V.","METFORMINHYDROCHLORIDE"
"5501","Metformin Teva 500 mg Film-coated Tablets","500 milligram(s) Film-coated tablet",2014-11-03,"PA0749/185/001","Teva Pharma B.V.","METFORMINHYDROCHLORIDE"
"5502","Metformin Teva 850 mg Film-coated Tablets","850 milligram(s) Film-coated tablet",2014-11-03,"PA0749/185/002","Teva Pharma B.V.","METFORMINHYDROCHLORIDE"
"5503","Methadone Hydrochloride 5 mg tablets","5 milligram(s) Tablet",2018-09-21,"PA2101/003/001","Ascot Laboratories Ltd","Methadonehydrochloride"
"5504","Methadone Hydrochloride Sugar Free 1mg/1ml Oral Solution","1 milligram(s)/millilitre Oral solution",1998-07-27,"PA0312/007/002","Rosemont Pharmaceuticals Ltd","Methadonehydrochloride"
"5505","METHADONE MIXTURE DTF (SUGAR FREE)","1 Mg/Ml Oral Solution",1996-01-26,"PA0361/007/006","Martindale Pharmaceuticals Ltd","METHADONEHYDROCHLORIDE"
"5506","METHOFILL","50 Mg/Ml Solution for Injection",2016-02-19,"PA1390/099/001","Accord Healthcare Limited","METHOTREXATE"
"5507","METHOFILL","7.5 Milligram                                                                                            Solution for Injection",2017-08-04,"PA1390/099/002","Accord Healthcare Limited",""
"5508","METHOFILL","10 Milligram                                                                                            Solution for Injection",2017-08-04,"PA1390/099/003","Accord Healthcare Limited",""
"5509","METHOFILL","12.5 Milligram                                                                                            Solution for Injection",2017-08-04,"PA1390/099/004","Accord Healthcare Limited",""
"5510","METHOFILL","15 Milligram                                                                                            Solution for Injection",2017-08-04,"PA1390/099/005","Accord Healthcare Limited",""
"5511","METHOFILL","17.5 Milligram                                                                                            Solution for Injection",2017-08-04,"PA1390/099/006","Accord Healthcare Limited",""
"5512","METHOFILL","20 Milligram                                                                                            Solution for Injection",2017-08-04,"PA1390/099/007","Accord Healthcare Limited",""
"5513","METHOFILL","22.5 Milligram                                                                                            Solution for Injection",2017-08-04,"PA1390/099/008","Accord Healthcare Limited",""
"5514","METHOFILL","25 Milligram                                                                                            Solution for Injection",2017-08-04,"PA1390/099/009","Accord Healthcare Limited",""
"5515","METHOFILL","27.5 Milligram                                                                                            Solution for Injection",2017-08-04,"PA1390/099/010","Accord Healthcare Limited",""
"5516","METHOFILL","30 Milligram                                                                                            Solution for Injection",2017-08-04,"PA1390/099/011","Accord Healthcare Limited",""
"5517","METHOTREXATE","2.5 Milligram                                                                                            Tablets",2016-07-01,"PA1390/116/001","Accord Healthcare Limited",""
"5518","METHOTREXATE","10 Milligram                                                                                            Tablets",2016-07-01,"PA1390/116/002","Accord Healthcare Limited",""
"5519","METHOTREXATE","25 Mg/Ml Solution for Injection",2012-09-28,"PA1390/051/001","Accord Healthcare Limited",""
"5520","METHOTREXATE","100 Mg/Ml Concentrate for Soln for Inf",2014-10-17,"PA1390/051/002","Accord Healthcare Limited",""
"5521","METHOTREXATE","2.5 Milligram                                                                                            Tablets",2008-10-03,"PA1327/009/001","Orion Corporation","METHOTREXATE"
"5522","METHOTREXATE","10 Milligram                                                                                            Tablets",2008-10-03,"PA1327/009/002","Orion Corporation","METHOTREXATE"
"5523","METHOTREXATE","10 Milligram                                                                                            Tablets",2011-03-21,"PA1333/009/001","Morningside Healthcare Limited","METHOTREXATE"
"5524","METHOTREXATE","2.5 Milligram                                                                                            Tablets",2012-02-24,"PA1333/009/002","Morningside Healthcare Limited","METHOTREXATE"
"5525","METHOTREXATE","2 Mg/Ml Oral Solution",2015-06-19,"PA0312/034/001","Rosemont Pharmaceuticals Ltd","METHOTREXATEDISODIUM"
"5526","METHOTREXATE","2.5 Milligram                                                                                            Tablets",2013-09-19,"DPR1392/070/001","Eurodrug Ltd","METHOTREXATE"
"5527","Methotrexate 1 g/10 ml Injection","1g/10ml milligram(s)/millilitre Solution for injection",1988-03-09,"PA0822/206/006","Pfizer Healthcare Ireland","Methotrexate"
"5528","Methotrexate 10 mg Tablets","10 milligram(s) Tablet",1986-05-22,"PA0822/206/005","Pfizer Healthcare Ireland","Methotrexate"
"5529","Methotrexate 2.5 mg Tablets","2.5 milligram(s) Tablet",1983-05-23,"PA0899/031/001","Mercury Pharmaceuticals Ltd","Methotrexate"
"5530","Methotrexate 2.5mg Tablets","2.5 milligram(s) Tablet",1986-05-22,"PA0822/206/004","Pfizer Healthcare Ireland","Methotrexate"
"5531","Methotrexate 5 g/50 ml Injection","5g/50ml milligram(s)/millilitre Solution for injection",1999-07-26,"PA0822/206/007","Pfizer Healthcare Ireland","Methotrexate"
"5532","Methotrexate 5 mg/2 ml Injection","5mg/2ml milligram(s)/millilitre Solution for injection",1984-12-12,"PA0822/206/001","Pfizer Healthcare Ireland","Methotrexate"
"5533","Methotrexate 500 mg/20 ml Injection","500mg/20ml milligram(s)/millilitre Solution for injection",1986-07-28,"PA0822/206/003","Pfizer Healthcare Ireland","Methotrexate"
"5534","Methotrexate 50mg/2ml Injection","50mg/2ml milligram(s)/millilitre Solution for injection",1984-12-12,"PA0822/206/002","Pfizer Healthcare Ireland","Methotrexate"
"5535","Methotrexate Orion 10 mg Tablets","10 milligram(s) Tablet",2016-10-21,"PA1327/019/002","Orion Corporation","Methotrexatedisodium"
"5536","Methotrexate Orion 2.5 mg Tablets","2.5 milligram(s) Tablet",2016-10-21,"PA1327/019/001","Orion Corporation","Methotrexatedisodium"
"5537","METHYLTHIONINIUM CHLORIDE PROVEBLUE","5 Mg/Ml Solution for Injection",2011-05-06,"EU/1/11/682/001","Provepharm SAS","METHYLTHIONINIUMCHLORIDE"
"5538","METIDATE XL","18 Milligram                                                                                            Tablet Prolonged Release",2012-04-13,"PA0711/200/001","Rowex Ltd","METHYLPHENIDATEHYDROCHLORIDE|METHYLPHENIDATEHYDROCHLORIDE"
"5539","METIDATE XL","36 Milligram                                                                                            Tablet Prolonged Release",2012-04-13,"PA0711/200/002","Rowex Ltd","METHYLPHENIDATEHYDROCHLORIDE|METHYLPHENIDATEHYDROCHLORIDE"
"5540","METIDATE XL","54 Milligram                                                                                            Tablet Prolonged Release",2012-04-13,"PA0711/200/003","Rowex Ltd","METHYLPHENIDATEHYDROCHLORIDE|METHYLPHENIDATEHYDROCHLORIDE"
"5541","METIDATE XL","27 Milligram                                                                                            Tablet Prolonged Release",2012-11-16,"PA0711/200/004","Rowex Ltd","METHYLPHENIDATEHYDROCHLORIDE|METHYLPHENIDATEHYDROCHLORIDE"
"5542","METOCLOPRAMIDE","5 Mg/Ml Solution for Injection",1984-10-11,"PA0073/084/001","Mercury Pharmaceuticals (Ireland) Ltd","METOCLOPRAMIDEHYDROCHLORIDE"
"5543","METOCLOPRAMIDE HYDROCHLORIDE","10 Milligram                                                                                            Tablets",2016-03-11,"PA1390/120/001","Accord Healthcare Limited","METOCLOPRAMIDEHYDROCHLORIDE"
"5544","METOCOR","50 Milligram                                                                                            Tablets",1995-07-14,"PA0711/008/001","Rowex Ltd","METOPROLOLTARTRATE"
"5545","METOCOR","100 Milligram                                                                                            Tablets",1995-07-14,"PA0711/008/002","Rowex Ltd","METOPROLOLTARTRATE"
"5546","METOJECT","50 Mg/Ml Solution for Injection",2012-10-12,"PA0623/014/001","Medac Gesellschaft fur Klinische Spezialpraparate mbH","METHOTREXATE"
"5547","Metoject 10 mg solution for injection in pre-filled pen","10 milligram(s) Solution for injection in pre-filled pen",2018-04-13,"PA0623/014/003","Medac Gesellschaft fur Klinische Spezialpraparate mbH","Methotrexate"
"5548","Metoject 15 mg solution for injection in pre-filled pen","15 milligram(s) Solution for injection in pre-filled pen",2018-04-13,"PA0623/014/004","Medac Gesellschaft fur Klinische Spezialpraparate mbH","Methotrexate"
"5549","Metoject 20 mg solution for injection in pre-filled pen","20 milligram(s) Solution for injection in pre-filled pen",2018-04-13,"PA0623/014/005","Medac Gesellschaft fur Klinische Spezialpraparate mbH","Methotrexate"
"5550","Metoject 25 mg solution for injection in pre-filled pen","25 milligram(s) Solution for injection in pre-filled pen",2018-04-13,"PA0623/014/006","Medac Gesellschaft fur Klinische Spezialpraparate mbH","Methotrexate"
"5551","Metoject 7.5 mg solution for injection in pre-filled pen","7.5 milligram(s) Solution for injection in pre-filled pen",2018-04-13,"PA0623/014/002","Medac Gesellschaft fur Klinische Spezialpraparate mbH","Methotrexate"
"5552","Metophage 500 mg Film-Coated Tablets","500 milligram(s) Film-coated tablet",2008-12-19,"PA0711/147/001","Rowex Ltd","METFORMINHYDROCHLORIDE"
"5553","Metophage 850 mg Film-Coated Tablets","850 milligram(s) Film-coated tablet",2008-12-19,"PA0711/147/002","Rowex Ltd","METFORMINHYDROCHLORIDE"
"5554","Metopirone 250mg Capsules, soft","250 milligram(s) Capsule, soft",2012-02-03,"PA1166/003/001","Laboratoire HRA Pharma","METYRAPONE"
"5555","METRONIDAZOLE","0.5 %w/v                                                                                                 Unknown",2001-06-06,"PA0736/002/001","B. Braun Melsungen AG","METRONIDAZOLE|SODIUMCHLORIDE|SODIUMPHOSPHATEDIBASICDODECAHYDRATE"
"5556","METROTOP","8 Mg/Ml Gel",1991-04-19,"PA0501/008/001","Ayrton Saunders Ltd","METRONIDAZOLE"
"5557","METVIX","160 Milligram                                                                                            Cream",2002-03-22,"PA0590/020/001","Galderma (UK) Ltd","METHYLAMINOLEVULINATEHYDROCHLORIDE"
"5558","MEZAVANT XL","1200 Milligram                                                                                            Gastro-resistant, prolonged release granules",2013-01-16,"DPR1633/016/001","Primecrown 2010 Ltd","MESALAZINE"
"5559","MEZAVANT XL","1200 Milligram                                                                                            Tablet Prolonged Release",2007-02-23,"PA0689/004/001","Shire Pharmaceutical Contracts Limited","MESALAZINE"
"5560","MEZAVANT XL","1200 Milligram                                                                                            Tablet Prolonged Release",2012-06-28,"PPA0465/289/001","PCO Manufacturing","MESALAZINE"
"5561","MEZAVANT XL","1200 Milligram                                                                                            Tablet Prolonged Release",2014-02-14,"PPA1463/093/001","IMED Healthcare Ltd.","MESALAZINE"
"5562","MEZAVANT XL","1200 Milligram                                                                                            Tablet Prolonged Release",2014-09-19,"PPA1562/114/001","LTT Pharma Limited","MESALAZINE"
"5563","Mezavant XL 1200mg gastro-resistant, prolonged release tablets","1200 milligram(s) Prolonged-release tablet",2011-06-03,"PPA1151/153/001","Imbat Limited","Mesalazine"
"5564","MIACALCIC","100 IU/ML                                                                                                Solution for Inj/Inf",1987-05-07,"PA1994/004/001","Essential Pharma Ltd","CALCITONIN,SALMON"
"5565","MIACALCIC","50 IU/ML                                                                                                Solution for Inj/Inf",1987-05-07,"PA1994/004/002","Essential Pharma Ltd","CALCITONIN,SALMON"
"5566","MIAKARIL","200 International Unit                                                                                   Nasal Spray Solution",2000-01-07,"PA0896/021/001","Novartis Ireland Limited","CALCITONIN,SALMON"
"5567","MIBG (I123) 74 MBq/ml Solution for Injection","74 ZZZ MBq/ml Solution for injection",2000-02-18,"PA0690/005/001","Mallinckrodt Medical B.V.","Meta-iodo-benzylguanidine(i-131)"
"5568","MICARDIS","80 Milligram                                                                                            Tablets",1998-12-16,"EU/1/98/090/005-008","Boehringer Ingelheim International GmbH","TELMISARTAN"
"5569","MICARDIS","20 Milligram                                                                                            Tablets",1999-09-07,"EU/1/98/090/009-012","Boehringer Ingelheim International GmbH","TELMISARTAN"
"5570","MICARDISPLUS","40/12.5 mg/mg Tablets",2002-04-19,"EU/1/02/213/001-005","Boehringer Ingelheim International GmbH","TELMISARTAN|HYDROCHLOROTHIAZIDE"
"5571","MICARDISPLUS","80/12.5 mg/mg Tablets",2002-04-19,"EU/1/02/213/006-010","Boehringer Ingelheim International GmbH","TELMISARTAN|HYDROCHLOROTHIAZIDE"
"5572","MICARDISPLUS","80/25 mg/mg Tablets",2008-03-27,"EU/1/02/213/17-23","Boehringer Ingelheim International GmbH","TELMISARTAN|HYDROCHLOROTHIAZIDE"
"5573","MICOLETTE MICRO-ENEMA","45, 450, 625 MG/5ml                                                                                               Rectal Solution",1991-11-26,"PA0281/115/001","Pinewood Laboratories Ltd,","SODIUMLAURYLSULFOACETATE|GLYCEROL|SODIUMCITRATE"
"5574","MICROLAX SODIUM CITRATE","450 & 45 MG/5ml                                                                                               Rectal Solution",1998-01-23,"PA0330/035/001","Johnson & Johnson (Ireland) Limited","SODIUMCITRATE|SODIUMLAURYLSULFOACETATE"
"5575","MICROLITE","100/20 Microgram                                                                                            Tablets",1998-04-03,"PA1410/007/001","Bayer Limited","ETHINYLESTRADIOL|LEVONORGESTREL"
"5576","MIDAZOLAM","1 Mg/Ml Solution for Injection",2009-03-06,"PA1390/010/001","Accord Healthcare Limited","MIDAZOLAM"
"5577","MIDAZOLAM","5 Mg/Ml Solution for Injection",2009-03-06,"PA1390/010/002","Accord Healthcare Limited","MIDAZOLAM"
"5578","MIDAZOLAM","2 Mg/Ml Solution for Inj/Inf",1998-10-02,"PA0073/147/002","Mercury Pharmaceuticals (Ireland) Ltd","MIDAZOLAM"
"5579","Midazolam 5 mg/ml Solution for injection or infusion","5 milligram(s)/millilitre Solution for injection/infusion",2011-01-14,"PA0361/021/001","Martindale Pharmaceuticals Ltd","MIDAZOLAMHYDROCHLORIDE"
"5580","Midazolam 5mg/ml Solution for Injection/Infusion","5 milligram(s)/millilitre Solution for injection/infusion",1998-10-02,"PA0073/147/001","Mercury Pharmaceuticals (Ireland) Ltd","Midazolam"
"5581","MIDAZOLAM INJECTION BP","2 Mg/Ml Solution for Inj/Inf",2006-09-01,"PA1390/010/005","Accord Healthcare Limited","MIDAZOLAM"
"5582","MIDAZOLAM INJECTION BP","5 Mg/Ml Solution for Inj/Inf",2006-09-01,"PA1390/010/006","Accord Healthcare Limited","MIDAZOLAM"
"5583","MIDON","2.5 Milligram                                                                                            Tablets",2015-06-12,"PPA1562/159/001","LTT Pharma Limited","MIDODRINEHYDROCHLORIDE"
"5584","Midon 2.5 mg Tablets","2.5 milligram(s) Tablet",2011-07-22,"PPA0465/276/001","PCO Manufacturing","MIDODRINEHYDROCHLORIDE"
"5585","Midon 2.5 mg Tablets","2.5 milligram(s) Tablet",1990-03-26,"PA2229/008/001","Takeda Products Ireland Ltd","MIDODRINEHYDROCHLORIDE"
"5586","Midon 5 mg Tablets","5 milligram(s) Tablet",2011-09-16,"PPA0465/276/002","PCO Manufacturing","MIDODRINEHYDROCHLORIDE"
"5587","Midon 5mg Tablets","5 milligram(s) Tablet",1990-03-26,"PA2229/008/002","Takeda Products Ireland Ltd","MIDODRINEHYDROCHLORIDE"
"5588","Midon 5mg Tablets","5 milligram(s) Tablet",2017-08-25,"PPA1097/026/001","Lexon (UK) Ltd","MIDODRINEHYDROCHLORIDE"
"5589","Mifegyne 600 mg Tablets","600 milligram(s) Tablet",2018-11-30,"PA2252/002/002","Nordic Group B.V.","Mifepristone"
"5590","MIGLUSTAT GENORPH","100 Milligram                                                                                            Capsules Hard",2017-11-10,"EU/1/17/1232/001","Gen.Orph","MIGLUSTAT"
"5591","Migraleve Film-coated Tablets","500   8  6.25 milligram(s) Film-coated tablet",1978-04-01,"PA0330/030/003","Johnson & Johnson (Ireland) Limited","Paracetamol|Codeinephosphate|BUCLIZINEHYDROCHLORIDE"
"5592","MIGRALEVE PINK","500/8/6.25 Milligram                                                                                            Film Coated Tablet",1978-04-01,"PA0330/030/001","Johnson & Johnson (Ireland) Limited","PARACETAMOL|CODEINEPHOSPHATE|BUCLIZINEHYDROCHLORIDE"
"5593","MIGRALEVE YELLOW","500/8 Milligram                                                                                            Film Coated Tablet",1978-04-01,"PA0330/030/002","Johnson & Johnson (Ireland) Limited","PARACETAMOL|CODEINEPHOSPHATE"
"5594","MIGUAR","2.5 Milligram                                                                                            Film Coated Tablet",2002-05-17,"PA0865/008/001","Menarini International Operations Luxembourg S.A.","FROVATRIPTANSUCCINATEMONOHYDRATE"
"5595","Milk of Magnesia Traditional Mint Flavoured Liquid, 415 mg/5 ml, oral suspension","415 mg/5ml Oral suspension",1992-08-20,"PA1186/010/001","Chefaro Ireland DAC","Magnesiumhydroxide"
"5596","MILRINONE","1 Mg/Ml Solution for Injection",2016-09-16,"PA1339/068/001","Wockhardt UK Limited","MILRINONE"
"5597","MIMPARA","1 Milligram                                                                                            Granules",2017-08-28,"EU/1/04/292/013","Amgen Europe B.V.","CINACALCETHYDROCHLORIDE"
"5598","MIMPARA","2.5 Milligram                                                                                            Granules",2017-08-28,"EU/1/04/292/014","Amgen Europe B.V.","CINACALCETHYDROCHLORIDE"
"5599","MIMPARA","5 Milligram                                                                                            Granules",2017-08-28,"EU/1/04/292/015","Amgen Europe B.V.","CINACALCETHYDROCHLORIDE"
"5600","MIMPARA","30mg milligram(s) Coated tablet",NA,"EU/1/04/292/1-12","Amgen Europe B.V.","Cinacalcethydrochloride"
"5601","MINATEV LA","500 Milligram                                                                                            Tablet Prolonged Release",2012-09-24,"PA0749/147/001","Teva Pharma B.V.","CLARITHROMYCIN"
"5602","MINESSE","60/15 Microgram                                                                                            Film Coated Tablet",2000-06-23,"PA0822/144/001","Pfizer Healthcare Ireland","GESTODENE|ETHINYLESTRADIOL"
"5603","MINIMS ARTIFICIAL TEARS","0.35 + 0.44 %w/w                                                                                                 Eye Drops Solution",1992-03-23,"PA0555/016/001","Bausch & Lomb UK Limited","SODIUMCHLORIDE|HYDROXYETHYLCELLULOSE"
"5604","MINIMS ATROPINE SULPHATE","1 %w/v                                                                                                 Eye Drops Solution",1979-04-01,"PA0555/017/001","Bausch & Lomb UK Limited","ATROPINESULFATE"
"5605","MINIMS CHLORAMPHENICOL 0.5 % EYE DROPS, SOLUTION","0.5 Per Cent                                                                                             Eye Drops Solution",1977-04-01,"PA0555/013/001","Bausch & Lomb UK Limited","CHLORAMPHENICOL"
"5606","MINIMS CYCLOPENTOLATE HYDROCHLORIDE","1.0 %w/v                                                                                                 Eye Drops Solution",1979-04-01,"PA0555/018/001","Bausch & Lomb UK Limited","CYCLOPENTOLATEHYDROCHLORIDE"
"5607","MINIMS FLUORESCEIN SODIUM","1 %w/v                                                                                                 Eye Drops Solution",1983-04-01,"PA0555/019/001","Bausch & Lomb UK Limited","FLUORESCEINSODIUM"
"5608","MINIMS FLUORESCEIN SODIUM","2.0 %w/v                                                                                                 Eye Drops Solution",1983-04-01,"PA0555/019/002","Bausch & Lomb UK Limited","FLUORESCEINSODIUM"
"5609","MINIMS LIDOCAINE & FLUORESCEIN","4.0/0.25 % %w/v                                                                                                 Eye Drops Solution",1983-03-24,"PA0555/012/001","Bausch & Lomb UK Limited","LIDOCAINEHYDROCHLORIDE|FLUORESCEINSODIUM"
"5610","Minims Oxybuprocaine Hydrochloride 0.4% w/v Eye Drops Solution","0.4 percent weight/volume Eye drops, solution",1980-04-01,"PA0555/020/001","Bausch & Lomb UK Limited","OXYBUPROCAINEHYDROCHLORIDE"
"5611","MINIMS PHENYLEPHRINE HYDROCHLORIDE","10 %w/v                                                                                                 Eye Drops Solution",1979-04-01,"PA0555/014/001","Bausch & Lomb UK Limited","PHENYLEPHRINEHYDROCHLORIDE"
"5612","MINIMS PHENYLEPHRINE HYDROCHLORIDE","2.5 %w/v                                                                                                 Eye Drops Solution",1990-04-19,"PA0555/014/002","Bausch & Lomb UK Limited","PHENYLEPHRINEHYDROCHLORIDE"
"5613","MINIMS PILOCARPINE NITRATE","2.0 %w/v                                                                                                 Eye Drops Solution",1979-04-01,"PA0555/022/001","Bausch & Lomb UK Limited","PILOCARPINENITRATE"
"5614","MINIMS POVIDONE IODINE","5 %w/v                                                                                                 Eye Drops Solution",2012-12-14,"PA0555/010/001","Bausch & Lomb UK Limited","IODINATEDPOVIDONE"
"5615","MINIMS PREDNISOLONE SODIUM PHOSPHATE","0.5 %w/v                                                                                                 Eye Drops Solution",1982-02-18,"PA0555/023/001","Bausch & Lomb UK Limited","PREDNISOLONESODIUMPHOSPHATE"
"5616","MINIMS PROXYMETACAINE HYDROCHLORIDE W/V, EYE DROPS","0.5 %w/v                                                                                                 Eye Drops Solution",2001-03-09,"PA0555/024/001","Bausch & Lomb UK Limited","PROXYMETACAINEHYDROCHLORIDE"
"5617","MINIMS SALINE","0.9 %w/v                                                                                                 Eye Drops Solution",1983-04-01,"PA0555/025/001","Bausch & Lomb UK Limited","SODIUMCHLORIDE"
"5618","MINIMS TETRACAINE HYDROCHLORIDE","0.5 %w/v                                                                                                 Eye Drops Solution",1980-04-01,"PA0555/021/001","Bausch & Lomb UK Limited","TETRACAINEHYDROCHLORIDE"
"5619","MINIMS TETRACAINE HYDROCHLORIDE","1.0 %w/v                                                                                                 Eye Drops Solution",1980-04-01,"PA0555/021/002","Bausch & Lomb UK Limited","TETRACAINEHYDROCHLORIDE"
"5620","MINIMS TROPICAMIDE 0.5% W/V EYE DROPS SOLUTION","0.5% %w/v                                                                                                 Eye Drops Solution",1982-11-01,"PA0555/015/001","Bausch & Lomb UK Limited","TROPICAMIDE"
"5621","MINIMS TROPICAMIDE 1.0% W/V EYE DROPS SOLUTION","1.0 % %w/v                                                                                                 Eye Drops Solution",1987-11-01,"PA0555/015/002","Bausch & Lomb UK Limited","TROPICAMIDE"
"5622","MINOCIN SA","100 Milligram                                                                                            Capsules Modified Release",2014-01-24,"PPA0465/329/001","PCO Manufacturing","MINOCYCLINEHYDROCHLORIDEDIHYDRATE"
"5623","MINOCIN SA","100 Milligram                                                                                            Capsule",2009-07-24,"PPA1151/088/001","Imbat Limited","MINOCYCLINEHYDROCHLORIDEDIHYDRATE"
"5624","MINOCIN SA","100 Milligram                                                                                            Capsules Modified Release",2014-10-17,"PPA1562/132/001","LTT Pharma Limited","MINOCYCLINEHYDROCHLORIDE"
"5625","MINOCIN SA","100 Milligram                                                                                            Capsules Modified Release",2014-07-11,"PPA1463/097/001","IMED Healthcare Ltd.","MINOCYCLINEHYDROCHLORIDEDIHYDRATE"
"5626","MINOCIN SA","100 Milligram                                                                                            Capsule",2013-02-08,"PPA1633/027/001","Primecrown 2010 Ltd","MINOCYCLINEHYDROCHLORIDEDIHYDRATE"
"5627","Minocin SA 100 mg Modified Release Capsules","100 mg milligram(s) Capsule",1993-06-23,"PA1332/023/001","Meda Health Sales Ireland Limited","MINOCYCLINEHYDROCHLORIDE"
"5628","MINOSIL","100 Milligram                                                                                            Capsules Modified Release",2007-06-08,"PA0281/132/001","Pinewood Laboratories Ltd,","MINOCYCLINEHYDROCHLORIDE"
"5629","MINOX","50 Milligram                                                                                            Film Coated Tablet",1986-05-09,"PA0711/013/001","Rowex Ltd","MINOCYCLINEHYDROCHLORIDE"
"5630","MINOX","50 Milligram                                                                                            Film Coated Tablet",2010-12-03,"PPA1151/138/001","Imbat Limited","MINOCYCLINEHYDROCHLORIDE"
"5631","Minulet 75 micrograms/30 micrograms coated tablets","30/75mcg microgram(s) Coated tablet",1988-03-25,"PA0822/093/001","Pfizer Healthcare Ireland","Ethinyloestradiol|Gestodene"
"5632","MIOCHOL-E","20 Milligram",1999-05-14,"PA1245/002/001","Dr. Gerhard Mann, chem.-pharm. Fabrik GmbH","ACETYLCHOLINECHLORIDE"
"5633","MIRAMEL","0.088 Milligram                                                                                            Tablets",2009-03-06,"PA0126/173/001","Clonmel Healthcare Ltd","PRAMIPEXOLEDIHYDROCHLORIDEMONOHYDRATE"
"5634","MIRAMEL","0.18 Milligram                                                                                            Tablets",2009-03-06,"PA0126/173/002","Clonmel Healthcare Ltd","PRAMIPEXOLEDIHYDROCHLORIDEMONOHYDRATE"
"5635","MIRAMEL","0.7 Milligram                                                                                            Tablets",2009-03-06,"PA0126/173/003","Clonmel Healthcare Ltd","PRAMIPEXOLEDIHYDROCHLORIDEMONOHYDRATE"
"5636","MIRAP","15 Milligram                                                                                            Film Coated Tablet",2004-08-27,"PA0711/062/001","Rowex Ltd","MIRTAZAPINE"
"5637","MIRAP","30 Milligram                                                                                            Film Coated Tablet",2004-08-27,"PA0711/062/002","Rowex Ltd","MIRTAZAPINE"
"5638","MIRAP","45 Milligram                                                                                            Film Coated Tablet",2004-08-27,"PA0711/062/003","Rowex Ltd","MIRTAZAPINE"
"5639","MIRAP DIS TAB","45 Milligram                                                                                            Orodispersible Tablet",2007-08-03,"PA0711/094/003","Rowex Ltd","MIRTAZAPINE"
"5640","MIRAP DISTAB","15 Milligram                                                                                            Orodispersible Tablet",2007-08-03,"PA0711/094/001","Rowex Ltd","MIRTAZAPINE"
"5641","MIRAP DISTAB","30 Milligram                                                                                            Orodispersible Tablet",2007-08-03,"PA0711/094/002","Rowex Ltd","MIRTAZAPINE"
"5642","MIRAPEXIN","0.088 Milligram                                                                                            Tablets",1998-02-23,"EU/1/97/051/001","Boehringer Ingelheim International GmbH","PRAMIPEXOLEDIHYDROXHLORIDE"
"5643","MIRAPEXIN","0.088 Milligram                                                                                            Tablets",1998-02-23,"EU/1/97/051/002","Boehringer Ingelheim International GmbH","PRAMIPEXOLEDIHYDROXHLORIDE"
"5644","MIRAPEXIN","0.18 Milligram                                                                                            Tablets",1998-02-23,"EU/1/97/051/003","Boehringer Ingelheim International GmbH","PRAMIPEXOLEDIHYDROXHLORIDE"
"5645","MIRAPEXIN","0.18 Milligram                                                                                            Tablets",1998-02-23,"EU/1/97/051/004","Boehringer Ingelheim International GmbH","PRAMIPEXOLEDIHYDROXHLORIDE"
"5646","MIRAPEXIN","0.7 Milligram                                                                                            Tablets",1998-02-23,"EU/1/97/051/005","Boehringer Ingelheim International GmbH","PRAMIPEXOLEDIHYDROXHLORIDE"
"5647","MIRAPEXIN","0.7 Milligram                                                                                            Tablets",1998-02-23,"EU/1/97/051/006","Boehringer Ingelheim International GmbH","PRAMIPEXOLEDIHYDROXHLORIDE"
"5648","MIRAPEXIN","0.88 Milligram                                                                                            Tablets",1998-02-23,"EU/1/97/051/007","Boehringer Ingelheim International GmbH","PRAMIPEXOLEDIHYDROXHLORIDE"
"5649","MIRAPEXIN","1.1 Milligram                                                                                            Tablets",1998-02-23,"EU/1/97/051/009","Boehringer Ingelheim International GmbH","PRAMIPEXOLEDIHYDROXHLORIDE"
"5650","MIRAPEXIN","1.1 Milligram                                                                                            Tablets",1998-02-23,"EU/1/97/051/010","Boehringer Ingelheim International GmbH","PRAMIPEXOLEDIHYDROXHLORIDE"
"5651","MIRAPEXIN","0.35 Base Milligrams                                                                                      Tablets",1999-10-26,"EU/1/97/051/011","Boehringer Ingelheim International GmbH","PRAMIPEXOLEDIHYDROXHLORIDE"
"5652","MIRAPEXIN","0.35 Milligram                                                                                            Tablets",1999-10-26,"EU/1/97/051/012","Boehringer Ingelheim International GmbH","PRAMIPEXOLEDIHYDROXHLORIDE"
"5653","MIRAPEXIN","1.57 Milligram                                                                                            Tablet Prolonged Release",2010-06-10,"EU/1/97/051/028-30","Boehringer Ingelheim International GmbH","PRAMIPEXOLEDIHYDROCHLORIDEMONOHYDRATE,MILLED"
"5654","MIRAPEXIN","2.62 Milligram                                                                                            Tablet Prolonged Release",2010-06-10,"EU/1/97/051/031-33","Boehringer Ingelheim International GmbH","PRAMIPEXOLEDIHYDROCHLORIDEMONOHYDRATE,MILLED"
"5655","MIRAPEXIN","0.26 Milligram                                                                                            Tablet Prolonged Release",2009-10-08,"EU/1/97/051/13-15","Boehringer Ingelheim International GmbH","PRAMIPEXOLEDIHYDROCHLORIDEMONOHYDRATE,MILLED"
"5656","MIRAPEXIN","0.52 Milligram                                                                                            Tablet Prolonged Release",2009-10-08,"EU/1/97/051/16-18","Boehringer Ingelheim International GmbH","PRAMIPEXOLEDIHYDROCHLORIDEMONOHYDRATE,MILLED"
"5657","MIRAPEXIN","1.05 Milligram                                                                                            Tablet Prolonged Release",2009-10-08,"EU/1/97/051/19-21","Boehringer Ingelheim International GmbH","PRAMIPEXOLEDIHYDROCHLORIDEMONOHYDRATE,MILLED"
"5658","MIRAPEXIN","2.1 Milligram                                                                                            Tablet Prolonged Release",2009-10-08,"EU/1/97/051/22-24","Boehringer Ingelheim International GmbH","PRAMIPEXOLEDIHYDROCHLORIDEMONOHYDRATE,MILLED"
"5659","MIRAPEXIN","3.15 Milligram                                                                                            Tablet Prolonged Release",2009-10-08,"EU/1/97/051/25-27","Boehringer Ingelheim International GmbH","PRAMIPEXOLEDIHYDROCHLORIDEMONOHYDRATE,MILLED"
"5660","Mircera","50/1 microgram(s)/millilitre Solution for injection",NA,"EU/1/07/400/001","Roche Registration GmbH","Ro0503821"
"5661","Mircera","100/1 microgram(s)/millilitre Solution for injection",NA,"EU/1/07/400/002","Roche Registration GmbH","Ro0503821"
"5662","Mircera","200/1 microgram(s)/millilitre Solution for injection",NA,"EU/1/07/400/003","Roche Registration GmbH","Ro0503821"
"5663","Mircera","300/1 microgram(s)/millilitre Solution for injection",NA,"EU/1/07/400/004","Roche Registration GmbH","Ro0503821"
"5664","Mircera","400/1 microgram(s)/millilitre Solution for injection",NA,"EU/1/07/400/005","Roche Registration GmbH","Ro0503821"
"5665","Mircera","600/1 microgram(s)/millilitre Solution for injection",NA,"EU/1/07/400/006","Roche Registration GmbH","Ro0503821"
"5666","Mircera","1000/1 microgram(s)/millilitre Solution for injection",NA,"EU/1/07/400/007","Roche Registration GmbH","Ro0503821"
"5667","Mircera","50/0.3 microgram(s)/millilitre Solution for injection",NA,"EU/1/07/400/008","Roche Registration GmbH","Ro0503821"
"5668","Mircera","75/0.3 microgram(s)/millilitre Solution for injection",NA,"EU/1/07/400/009","Roche Registration GmbH","Ro0503821"
"5669","Mircera","100/0.3 microgram(s)/millilitre Solution for injection",NA,"EU/1/07/400/10","Roche Registration GmbH","Ro0503821"
"5670","Mircera","150/0.3 microgram(s)/millilitre Solution for injection",NA,"EU/1/07/400/11","Roche Registration GmbH","Ro0503821"
"5671","Mircera","200/0.3 microgram(s)/millilitre Solution for injection",NA,"EU/1/07/400/12","Roche Registration GmbH","Ro0503821"
"5672","Mircera","250/0.3 microgram(s)/millilitre Solution for injection",NA,"EU/1/07/400/13","Roche Registration GmbH","Ro0503821"
"5673","Mircera","400/0.6 microgram(s)/millilitre Solution for injection",NA,"EU/1/07/400/14","Roche Registration GmbH","Ro0503821"
"5674","Mircera","600/0.6 microgram(s)/millilitre Solution for injection",NA,"EU/1/07/400/15","Roche Registration GmbH","Ro0503821"
"5675","Mircera","800/0.6 microgram(s)/millilitre Solution for injection",NA,"EU/1/07/400/16","Roche Registration GmbH","Ro0503821"
"5676","Mircera","30/0.3 microgram(s)/millilitre Solution for injection",NA,"EU/1/07/400/17","Roche Registration GmbH","Methoxypeg-epoetinbeta"
"5677","Mircera","40/0.3 microgram(s)/millilitre Solution for injection",NA,"EU/1/07/400/18","Roche Registration GmbH","Methoxypeg-epoetinbeta"
"5678","Mircera","60/0.3 microgram(s)/millilitre Solution for injection",NA,"EU/1/07/400/19","Roche Registration GmbH","Methoxypeg-epoetinbeta"
"5679","Mircera","120/0.3 microgram(s)/millilitre Solution for injection",NA,"EU/1/07/400/20","Roche Registration GmbH","Methoxypeg-epoetinbeta"
"5680","Mircera","360/0.6 microgram(s)/millilitre Solution for injection",NA,"EU/1/07/400/21","Roche Registration GmbH","Methoxypeg-epoetinbeta"
"5681","Mirena 52 mg Intrauterine Delivery System","52 milligram(s) Intrauterine delivery system",2012-08-24,"PPA0465/292/001","PCO Manufacturing","Levonorgestrel"
"5682","Mirena 52 mg Intrauterine Delivery System","52 milligram(s) Intrauterine Device",1998-08-28,"PA1410/008/001","Bayer Limited","Levonorgestrel"
"5683","Mirena 52 mg Intrauterine Delivery System","52 milligram(s) Intrauterine delivery system",2017-03-10,"PPA1463/111/001","IMED Healthcare Ltd.","Levonorgestrel"
"5684","Mirena 52 mg Intrauterine Delivery System","52 milligram(s) Intrauterine Device",2017-10-27,"PPA1151/262/001","Imbat Limited","Levonorgestrel"
"5685","MIRPRESOC","20 Milligram                                                                                            Tablets",2010-11-26,"PA1239/017/001","Laboratorios LICONSA, S.A.","TELMISARTAN"
"5686","MIRPRESOC","40 Milligram                                                                                            Tablets",2010-11-26,"PA1239/017/002","Laboratorios LICONSA, S.A.","TELMISARTAN"
"5687","MIRPRESOC","80 Milligram                                                                                            Tablets",2010-11-26,"PA1239/017/003","Laboratorios LICONSA, S.A.","TELMISARTAN"
"5688","Mirtazapine 15 mg Film-Coated Tablets","15 milligram(s) Film-coated tablet",2006-02-17,"PA1390/140/001","Accord Healthcare Limited","Mirtazapine"
"5689","Mirtazapine 30 mg Film-Coated Tablets","30 milligram(s) Film-coated tablet",2006-02-17,"PA1390/140/002","Accord Healthcare Limited","Mirtazapine"
"5690","Mirtazapine 45 mg Film-Coated Tablets","45 milligram(s) Film-coated tablet",2006-02-17,"PA1390/140/003","Accord Healthcare Limited","Mirtazapine"
"5691","MIRTAZAPINE BLUEFISH","15 Milligram                                                                                            Orodispersible Tablet",2008-04-25,"PA1436/001/001","Bluefish Pharmaceuticals AB","MIRTAZAPINE"
"5692","MIRTAZAPINE BLUEFISH","30 Milligram                                                                                            Orodispersible Tablet",2008-04-25,"PA1436/001/002","Bluefish Pharmaceuticals AB","MIRTAZAPINE"
"5693","MIRTAZAPINE BLUEFISH","45 Milligram                                                                                            Orodispersible Tablet",2008-04-25,"PA1436/001/003","Bluefish Pharmaceuticals AB","MIRTAZAPINE"
"5694","Mirvaso","3 milligram(s)/gram Gel",2014-02-21,"EU/1/13/904/001-003","Galderma International","Brimonidine"
"5695","Mistra 2mg/0.03mg Film-Coated Tablets","2/0.03 milligram(s) Film-coated tablet",NA,"PA1330/018/001","Gedeon Richter Plc","Dienogest|Ethinylestradiol"
"5696","Mitomycin medac 20 mg powder and solvent for intravesical solution","20 milligram(s) ZZZ Pdr+Solv/Soln/Intravesical Use",2016-04-08,"PA0623/016/001","Medac Gesellschaft fur Klinische Spezialpraparate mbH","Mitomycin"
"5697","Mitomycin medac 40 mg powder and solvent for intravesical solution","40 milligram(s) ZZZ Pdr+Solv/Soln/Intravesical Use",2016-04-08,"PA0623/016/002","Medac Gesellschaft fur Klinische Spezialpraparate mbH","Mitomycin"
"5698","Mitomycin-C Kyowa 10 mg, Powder for Solution for Injection","10 milligram(s) Powder for solution for injection",2003-12-12,"PA1049/011/001","Kyowa Kirin Limited","Mitomycin"
"5699","Mitomycin-C Kyowa 40 mg, Powder for Solution for Injection","40 milligram(s) Powder for solution for injection",2003-12-12,"PA1049/011/002","Kyowa Kirin Limited","Mitomycin"
"5700","MITOXANA","1 Grams                                                                                                Pdr/Conc/Soln for Infus",1996-12-03,"PA0167/135/001","Baxter Healthcare Limited","IFOSFAMIDE"
"5701","MITOXANA","2 Grams                                                                                                Pdr/Conc/Soln for Infus",1996-12-03,"PA0167/135/002","Baxter Healthcare Limited","IFOSFAMIDE"
"5702","Mitoxantrone 2 mg/ml Concentrate for Solution for Infusion","2 ZZZ Base mg/ml Concentrate for solution for infusion",2003-02-21,"PA0822/217/001","Pfizer Healthcare Ireland","MITOXANTRONEHYDROCHLORIDE"
"5703","Mivacron 2mg/ml Solution for Injection","2 milligram(s)/millilitre Solution for injection",1995-03-31,"PA1691/031/001","Aspen Pharma Trading Limited","Mivacuriumchloride"
"5704","MIXTARD","100 IU/ML                                                                                                Suspension for Injection",2003-08-13,"EU/1/02/231/003-35,37","Novo Nordisk A/S","INSULINHUMAN|INSULINHUMAN"
"5705","MIXTARD","100 %v/v                                                                                                 Suspension for Injection",2002-10-07,"EU/1/02/231/1-25","Novo Nordisk A/S","INSULINHUMAN"
"5706","M-M-RVAXPRO","%v/v                                                                                                 Pdr+Solv for Susp for Inj",2006-05-05,"EU/1/06/337/1-13","Sanofi Pasteur MSD","MEASLESVIRUSLIVEATTENUATEDDERIVEDFROMTHEEDMONSTONBSTRAIN|MUMPSVIRUSLIVEATTENUATEDJERYLLYNNSTRAIN|RUBELLAVIRUS(WISTARRA27/3STRAIN)LIVEATTENUATED"
"5707","MOBIC","7.5 Milligram                                                                                            Tablets",1996-05-07,"PA0775/001/004","Boehringer Ingelheim International GmbH","MELOXICAM"
"5708","MOBIC","15 Milligram                                                                                            Tablets",1996-05-07,"PA0775/001/005","Boehringer Ingelheim International GmbH","MELOXICAM"
"5709","MOBIGLAN","7.5 Milligram                                                                                            Tablets",2005-12-16,"PA1063/020/001","Niche Generics Limited","MELOXICAM"
"5710","Mobiglan 15 mg Tablets","15 milligram(s) Tablet",2005-12-16,"PA1063/020/002","Niche Generics Limited","Meloxicam"
"5711","MODAFINIL","100 Milligram                                                                                            Tablets",2010-05-21,"PA1457/014/001","Fannin Limited","MODAFINIL"
"5712","MODAFINIL","200 Milligram                                                                                            Tablets",2010-05-21,"PA1457/014/002","Fannin Limited","MODAFINIL"
"5713","Modafinil 100 mg Tablets","100 milligram(s) Tablet",2015-06-12,"PA0688/033/001","Chanelle Medical","Modafinil"
"5714","Modafinil 200 mg Tablets","200 milligram(s) Tablet",2015-06-12,"PA0688/033/002","Chanelle Medical","Modafinil"
"5715","MODECATE","25 Mg/Ml Solution for Injection",1977-02-22,"PA0002/031/005","Bristol-Myers Squibb Pharmaceuticals uc","FLUPHENAZINEDECANOATE"
"5716","MODECATE CONCENTRATE","100 Mg/Ml Solution for Injection",1979-01-25,"PA0002/031/001","Bristol-Myers Squibb Pharmaceuticals uc","FLUPHENAZINEDECANOATE"
"5717","MODERIBA","200 Milligram                                                                                            Film Coated Tablet",2010-06-18,"PA1824/006/001","AbbVie Limited","RIBAVIRIN"
"5718","MODERIBA","400 Milligram                                                                                            Film Coated Tablet",2010-06-18,"PA1824/006/002","AbbVie Limited","RIBAVIRIN"
"5719","MODERIBA","600 Milligram                                                                                            Film Coated Tablet",2010-06-18,"PA1824/006/003","AbbVie Limited","RIBAVIRIN"
"5720","MODIGRAF","0.2 Milligram                                                                                            Granules for Oral Suspension",NA,"EU/1/09/523/001","Astellas Pharma Europe BV","TACROLIMUS"
"5721","MODIGRAF","1 Milligram                                                                                            Granules for Oral Suspension",NA,"EU/1/09/523/002","Astellas Pharma Europe BV","TACROLIMUS"
"5722","MODRASONE","0.05 %w/w                                                                                                 Cream",1984-08-13,"PA1619/005/001","Aspire Pharma Limited","ALCLOMETASONEDIPROPIONATE"
"5723","MODRASONE","0.05 %w/w                                                                                                 Ointment",1984-08-13,"PA1619/005/002","Aspire Pharma Limited","ALCLOMETASONEDIPROPIONATE"
"5724","MODURET 25 MG/2.5 MG TABLETS","25/2.5 Milligram                                                                                            Tablets",1997-05-19,"PA1286/014/001","Merck Sharp & Dohme Ireland (Human Health) Limited","HYDROCHLOROTHIAZIDE|AMILORIDEHYDROCHLORIDE"
"5725","Mogadon 5 mg Tablets","5 milligram(s) Tablet",1977-04-01,"PA2010/024/001","Mylan IRE Healthcare Limited","Nitrazepam"
"5726","MOLAXOLE","Powder for Oral Solution",2013-11-08,"PPA1633/034/001","Primecrown 2010 Ltd","MACROGOL3350|SODIUMCHLORIDE|SODIUMHYDROGENCARBONATE|POTASSIUMCHLORIDE"
"5727","Molaxole powder for oral solution","13.125/350 milligram(s) Powder for oral solution",2009-12-04,"PA2010/025/001","Mylan IRE Healthcare Limited","Macrogol3350|Sodiumchloride|Sodiumhydrogencarbonate|Potassiumchloride"
"5728","MOLIPAXIN","150 Milligram                                                                                            Film Coated Tablet",1985-12-02,"PA0540/056/004","Sanofi-Aventis Ireland Limited T/A SANOFI","TRAZODONEHYDROCHLORIDE"
"5729","Molipaxin 100mg Capsules","100 milligram(s) Capsule, hard",1977-02-02,"PA0540/056/002","Sanofi-Aventis Ireland Limited T/A SANOFI","Trazodonehydrochloride"
"5730","Molipaxin 50mg Capsules","50 milligram(s) Capsule, hard",1977-02-02,"PA0540/056/001","Sanofi-Aventis Ireland Limited T/A SANOFI","Trazodonehydrochloride"
"5731","MOMETASONE","50 Mcg/Acutuation                                                                                       Nasal Spray Suspension",2013-02-22,"PA0711/196/001","Rowex Ltd","MOMETASONEFUROATE"
"5732","MOMETASONE FUROATE","0.1 %w/w                                                                                                 Cream",2012-07-20,"PA1352/018/001","Auden Mckenzie (Pharma Division) Ltd","MOMETASONEFUROATE"
"5733","MOMETASONE FUROATE","0.1 %w/w                                                                                                 Ointment",2012-07-20,"PA1352/018/002","Auden Mckenzie (Pharma Division) Ltd","MOMETASONEFUROATE"
"5734","MONOPOST UNIDOSE","50 Microgram/ML                                                                                         Eye Drops Solution",2012-09-24,"PA1107/007/001","Laboratoires Thea","LATANOPROST"
"5735","MONOTRIM","10 Mg/Ml Oral Suspension",1982-04-16,"PA1161/002/001","Chemidex Pharma Limited","TRIMETHOPRIM"
"5736","MONOTRIM","100 Milligram                                                                                            Tablets",1982-11-01,"PA1161/002/002","Chemidex Pharma Limited","TRIMETHOPRIM"
"5737","MONOTRIM","200 Milligram                                                                                            Tablets",1982-04-16,"PA1161/002/003","Chemidex Pharma Limited","TRIMETHOPRIM"
"5738","Monotrim Suspension","50 mg/5ml Oral suspension",NA,"PA0108/026/003","Abbott Healthcare Products Ltd","Trimethoprim"
"5739","MONOVER","100 Mg/Ml Solution for Inj/Inf",2010-04-09,"PA0982/002/002","Pharmacosmos A/S","IRON(III)ISOMALTOSIDE1000"
"5740","Monover 100mg/ml solution for injection/infusion (ampoules)","100 milligram(s)/millilitre Solution for injection/infusion",2010-04-09,"PA0982/002/001","Pharmacosmos A/S","Iron"
"5741","MONOVO","1 mg/g Ointment",2011-11-18,"PA1548/001/001","Almirall Hermal GmbH","MOMETASONEFUROATE"
"5742","MONOVO","1 mg/g Cream",2011-11-18,"PA1548/002/001","Almirall Hermal GmbH","MOMETASONEFUROATE"
"5743","MONOVO","1 mg/g Cutaneous Emulsion",2012-04-27,"PA1548/003/001","Almirall Hermal GmbH","MOMETASONEFUROATE"
"5744","MONTELAIR","10 Milligram                                                                                            Film Coated Tablet",2010-10-29,"PA0126/215/003","Clonmel Healthcare Ltd","MONTELUKASTSODIUM"
"5745","MONTELAIR","4 Milligram                                                                                            Tablets Chewable",2010-10-29,"PA0126/215/001","Clonmel Healthcare Ltd","MONTELUKASTSODIUM"
"5746","Montelair 5 mg Chewable Tablets","5 milligram(s) Chewable tablet",2010-10-29,"PA0126/215/002","Clonmel Healthcare Ltd","Montelukastsodium"
"5747","MONTELUKAST","10 Milligram                                                                                            Film Coated Tablet",2012-04-20,"PA1445/015/001","Aurobindo Pharma (Malta) Limited","MONTELUKASTSODIUM"
"5748","MONTELUKAST","4 Milligram                                                                                            Tablets Chewable",2010-10-22,"PA1347/039/001","Krka d.d., Novo mesto","MONTELUKASTSODIUM"
"5749","MONTELUKAST","5 Milligram                                                                                            Tablets Chewable",2010-10-22,"PA1347/039/002","Krka d.d., Novo mesto","MONTELUKASTSODIUM"
"5750","MONTELUKAST","10 Milligram                                                                                            Film Coated Tablet",2010-10-22,"PA1347/039/003","Krka d.d., Novo mesto","MONTELUKASTSODIUM"
"5751","MONTELUKAST","10 Milligram                                                                                            Film Coated Tablet",2014-11-28,"PPA0565/054/003","WPR Healthcare Limited","MONTELUKASTSODIUM"
"5752","Montelukast 10 mg film-coated tablets","10 milligram(s) Film-coated tablet",2011-12-16,"PA1390/030/003","Accord Healthcare Limited","Montelukast"
"5753","MONTELUKAST ACTAVIS","10 Milligram                                                                                            Film Coated Tablet",2010-06-25,"PA1380/070/001","Actavis Group PTC ehf","MONTELUKAST"
"5754","MONTELUKAST MYLAN","4 Milligram                                                                                            Tablets Chewable",2011-05-20,"PA0577/131/001","McDermott Laboratories Ltd t/a Gerard Laboratories","MONTELUKASTSODIUM"
"5755","MONTELUKAST MYLAN","10 Milligram                                                                                            Film Coated Tablet",2010-10-08,"PA0577/119/001","McDermott Laboratories Ltd t/a Gerard Laboratories","MONTELUKASTSODIUM"
"5756","Montelukast Mylan 5 mg Chewable Tablets","5 milligram(s) Chewable tablet",2011-05-20,"PA0577/131/002","McDermott Laboratories Ltd t/a Gerard Laboratories","Montelukastsodium"
"5757","Montelukast Paediatric 4mg Chewable Tablets","4 milligram(s) Chewable tablet",2011-06-03,"PA1390/030/001","Accord Healthcare Limited","Montelukastsodium"
"5758","MONTELUKAST Paediatric 4mg Chewable Tablets","4 milligram(s) Chewable tablet",2012-06-01,"PA1445/015/002","Aurobindo Pharma (Malta) Limited","Montelukastsodium"
"5759","MONTELUKAST Paediatric 5mg Chewable Tablets","5 milligram(s) Chewable tablet",2012-06-01,"PA1445/015/003","Aurobindo Pharma (Malta) Limited","Montelukastsodium"
"5760","Montelukast Paediatric 5mg Chewable Tablets","5 milligram(s) Chewable tablet",2011-06-03,"PA1390/030/002","Accord Healthcare Limited","Montelukastsodium"
"5761","MONTELUKAST PAEDIATRIC ACTAVIS","4 Milligram                                                                                            Tablets Chewable",2010-06-25,"PA1380/070/002","Actavis Group PTC ehf","MONTELUKAST"
"5762","MONTELUKAST PAEDIATRIC ACTAVIS","5 Milligram                                                                                            Tablets Chewable",2010-06-25,"PA1380/070/003","Actavis Group PTC ehf","MONTELUKAST"
"5763","MONTELUKAST TEVA","4 Milligram                                                                                            Tablets Chewable",2008-05-16,"PA0749/048/001","Teva Pharma B.V.","MONTELUKASTSODIUM"
"5764","MONTELUKAST TEVA","5 Milligram                                                                                            Tablets Chewable",2008-05-16,"PA0749/048/002","Teva Pharma B.V.","MONTELUKASTSODIUM"
"5765","MONTELUKAST TEVA","10 Milligram                                                                                            Film Coated Tablet",2008-06-09,"PA0749/048/003","Teva Pharma B.V.","MONTELUKASTSODIUM"
"5766","MONTELUKAST TEVA","4 Milligram                                                                                            Granules",2011-09-30,"PA0749/048/004","Teva Pharma B.V.","MONTELUKASTSODIUM"
"5767","MONURIL","3 Grams                                                                                                Granules for oral solution",1995-11-13,"PA1441/002/002","Zambon S.p.A.","FOSFOMYCINTROMETAMOL"
"5768","Morphine Sulfate 10mg/5ml Oral Solution","10 mg/5ml Oral solution",2015-10-30,"PA1339/051/002","Wockhardt UK Limited","Morphinesulphate|Morphinesulphate"
"5769","Morphine sulfate 10mg/ml Solution for Injection","10 milligram(s)/millilitre Solution for injection",2018-11-30,"PA2165/003/001","AS KALCEKS","Morphinesulphate"
"5770","Morphine sulfate 15mg/ml Solution for Injection","15 milligram(s)/millilitre Solution for injection",2018-11-30,"PA2165/003/002","AS KALCEKS","Morphinesulphate"
"5771","Morphine Sulfate 20mg/ml Oral Solution","20 milligram(s)/millilitre Oral solution",2014-11-28,"PA1339/051/001","Wockhardt UK Limited","Morphinesulphate"
"5772","Morphine sulfate 30mg/ml Solution for Injection","30 milligram(s)/millilitre Solution for injection",2018-11-30,"PA2165/003/003","AS KALCEKS","Morphinesulphate|Morphinesulphate"
"5773","MORPHINE SULPHATE","10 Mg/Ml Solution for Injection",1978-04-01,"PA0073/020/001","Mercury Pharmaceuticals (Ireland) Ltd","MORPHINESULFATE"
"5774","MORPHINE SULPHATE","1 MG/5ml                                                                                               Solution for Injection",1995-05-18,"PA0073/020/003","Mercury Pharmaceuticals (Ireland) Ltd","MORPHINESULFATE"
"5775","MORPHINE SULPHATE","30 Mg/Ml Solution for Injection",1995-03-14,"PA0073/020/004","Mercury Pharmaceuticals (Ireland) Ltd","MORPHINESULFATE"
"5776","Morphine Sulphate 60 mg/ml Solution for Injection","60 milligram(s)/millilitre Solution for injection",1995-06-26,"PA0073/020/008","Mercury Pharmaceuticals (Ireland) Ltd","Morphinesulfate"
"5777","MORPHINE SULPHATE INJECTION BP","10mg in 1 Millilitre                                                                                           Solution for Injection",2006-06-02,"PA0361/004/004","Martindale Pharmaceuticals Ltd","MORPHINESULFATE"
"5778","MORPHINE SULPHATE INJECTION BP","30 Mg/Ml Solution for Injection",2006-06-02,"PA0361/004/005","Martindale Pharmaceuticals Ltd","MORPHINESULFATE"
"5779","MORSADEX","50/2 Mg/Ml Solution for Inj/Inf",2017-12-15,"PA2165/002/001","AS KALCEKS","DEXKETOPROFENTROMETAMOL"
"5780","MOTILIUM","10 Milligram                                                                                            Film Coated Tablet",2017-10-20,"PPA0465/272/002","PCO Manufacturing","DOMPERIDONE"
"5781","MOTILIUM","10 Milligram                                                                                            Film Coated Tablet",2007-10-05,"PA0330/040/002","Johnson & Johnson (Ireland) Limited","DOMPERIDONE"
"5782","Motilium 1mg/ml Oral Suspension","1 milligram(s)/millilitre Oral suspension",1990-12-03,"PA0823/051/006","McNeil Healthcare (Ireland) Ltd","Domperidone"
"5783","MOTILIUM FASTMELTS","10 Milligram                                                                                            Orodispersible Tablet",2008-01-11,"PA0330/040/001","Johnson & Johnson (Ireland) Limited","DOMPERIDONE"
"5784","Motilium Rx 10 mg Film-coated Tablets","10 milligram(s) Film-coated tablet",1990-12-03,"PA0823/051/007","McNeil Healthcare (Ireland) Ltd","Domperidone"
"5785","Moventig","12.5 milligram(s) Film-coated tablet",2014-12-08,"EU/1/14/962/001-003","Kyowa Kirin Limited","Naloxegoloxalate"
"5786","MOVENTIG","25 Milligram                                                                                            Film Coated Tablet",2014-12-08,"EU/1/14/962/004-007","Kyowa Kirin Holdings B.V.","NALOXEGOLOXALATE"
"5787","MOVICOL","6.9 Grams                                                                                                Powder for Oral Solution",2009-04-01,"DPR1392/032/001","Eurodrug Ltd","MACROGOL3350|SODIUMCHLORIDE|SODIUMBICARBONATE|POTASSIUMCHLORIDE"
"5788","MOVICOL","13.8 Grams                                                                                                Powder for Oral Solution",2005-12-22,"PPA0465/159/001","PCO Manufacturing","MACROGOL3350|SODIUMBICARBONATE|SODIUMCHLORIDE|POTASSIUMCHLORIDE"
"5789","MOVICOL","13.8 Grams                                                                                                Powder for Oral Solution",2009-05-08,"PPA1151/089/001","Imbat Limited","MACROGOL35000|SODIUMCHLORIDE|SODIUMBICARBONATE|POTASSIUMCHLORIDE"
"5790","MOVICOL","13.8 Grams                                                                                                Powder for Oral Solution",2010-04-16,"PPA1463/035/001","IMED Healthcare Ltd.","MACROGOL3350|SODIUMBICARBONATE|SODIUMCHLORIDE|POTASSIUMCHLORIDE"
"5791","MOVICOL","13.8 Grams                                                                                                Powder for Oral Solution",2009-05-28,"PPA1562/004/001","LTT Pharma Limited","MACROGOL3350|SODIUMBICARBONATE|SODIUMCHLORIDE|POTASSIUMCHLORIDE"
"5792","MOVICOL","13.8 Grams                                                                                                Powder for Oral Solution",2010-07-16,"PPA1633/007/001","Primecrown 2010 Ltd","MACROGOL3350|SODIUMBICARBONATE|SODIUMCHLORIDE|POTASSIUMCHLORIDE"
"5793","MOVICOL","13.8 Grams                                                                                                Powder for Oral Solution",2017-03-01,"PPA1925/002/001","Novalus Healthcare Limited","MACROGOL3350|SODIUMBICARBONATE|SODIUMCHLORIDE|POTASSIUMCHLORIDE"
"5794","Movicol  Paediatric Chocolate Flavour 6.9 g sachet, powder for oral solution","6.9 gram(s) Powder for oral solution",2004-11-05,"PA1336/006/002","Norgine B.V.","Macrogol3350|Sodiumchloride|Sodiumhydrogencarbonate(E500)|Potassiumchloride"
"5795","Movicol 13.8g sachet, powder for oral solution","13.8 gram(s) Powder for oral solution",1996-12-03,"PA1336/006/005","Norgine B.V.","Macrogol3350|Sodiumbicarbonate|Sodiumchloride|Potassiumchloride"
"5796","MOVICOL CHOCOLATE","13.9 Grams                                                                                                Powder for Oral Solution",2011-05-20,"PPA1151/089/002","Imbat Limited","MACROGOL3350|SODIUMCHLORIDE|SODIUMHYDROGENCARBONATE|POTASSIUMCHLORIDE"
"5797","MOVICOL Chocolate 13.9g sachet, powder for oral solution","13.9 gram(s) Powder for oral solution",2008-11-13,"PA1336/006/001","Norgine B.V.","Macrogol3350|Sodiumchloride|Sodiumhydrogencarbonate|Potassiumchloride"
"5798","Movicol Liquid Orange Flavour, Concentrate for Oral Solution","13.9/25 milligram(s)/millilitre Concentrate for oral solution",2012-01-06,"PA1336/002/004","Norgine B.V.","Sodiumchloride|Macrogol3350|Sodiumhydrogencarbonate|Potassiumchloride"
"5799","MOVICOL PAEDIATRIC","6.9 Grams                                                                                                Powder for Oral Solution",2011-01-28,"PPA0465/159/002","PCO Manufacturing","MACROGOL3350|SODIUMCHLORIDE|SODIUMBICARBONATE|POTASSIUMCHLORIDE"
"5800","MOVICOL PAEDIATRIC PLAIN","6.9 Grams                                                                                                Powder for Oral Solution",2011-05-24,"DPR0465/042/001","PCO Manufacturing","MACROGOL3350|SODIUMCHLORIDE|SODIUMHYDROGENCARBONATE(E500)|POTASSIUMCHLORIDE"
"5801","MOVICOL PAEDIATRIC PLAIN","6.9 Grams                                                                                                Powder for Oral Solution",2011-04-20,"DPR1633/005/001","Primecrown 2010 Ltd","MACROGOL|SODIUMCHLORIDE|SODIUMHYDROGENCARBONATE(E500)|POTASSIUMCHLORIDE"
"5802","Movicol Paediatric Plain 6.9 g sachet, powder for oral solution","6.9 gram(s) Powder for oral solution",2006-01-27,"PA1336/006/003","Norgine B.V.","Macrogol3350|Sodiumchloride|Sodiumhydrogencarbonate(E500)|Potassiumchloride"
"5803","MOVICOL PAEDIATRIC PLAIN 6.9G POWDER FOR ORAL SOLUTION","6.9 Grams                                                                                                Powder for Oral Solution",2016-07-15,"PPA1151/089/003","Imbat Limited","MACROGOL3350|SODIUMCHLORIDE|SODIUMHYDROGENCARBONATE(E500)|POTASSIUMCHLORIDE"
"5804","MOVICOL PAEDIATRIC PLAIN SACHET","6.9 Grams                                                                                                Powder for Oral Solution",2011-06-22,"DPR1463/034/001","IMED Healthcare Ltd.","MACROGOL3350|SODIUMCHLORIDE|SODIUMHYDROGENCARBONATE(E500)|POTASSIUMCHLORIDE"
"5805","Movicol Plain 13.7g sachet, powder for oral solution","13.7 gram(s) Powder for oral solution",2009-02-13,"PA1336/006/004","Norgine B.V.","Macrogol3350|Sodiumchlorideph.eur.|Sodiumhydrogencarbonate|Potassiumchloride"
"5806","Movicol Ready to Take 13.9 g/25 ml oral solution in sachet","13.9g/25 millilitre(s) Oral solution",2016-09-02,"PA1336/002/006","Norgine B.V.","Potassiumchloride|Sodiumhydrogencarbonate|Sodiumchloride|Macrogol3350"
"5807","MOVIPREP","N/A Powder for Oral Solution",2006-12-15,"PA1336/001/001","Norgine B.V.","MACROGOL3350|SODIUMSULFATEANHYDROUS|SODIUMCHLORIDE|POTASSIUMCHLORIDE|ASCORBICACID|SODIUMASCORBATE"
"5808","MOVIPREP","Unknown Powder for Oral Solution",2017-04-13,"PPA0465/428/001","PCO Manufacturing","MACROGOL3350|SODIUMSULPHATEANHYDROUS|SODIUMCHLORIDE|POTASSIUMCHLORIDE|ASCORBICACID|SODIUMASCORBATE"
"5809","MOVIPREP","Unknown Powder for Oral Solution",2018-05-18,"PPA1633/070/001","Primecrown 2010 Ltd","MACROGOL3350|SODIUMSULFATEANHYDROUS|SODIUMCHLORIDE|POTASSIUMCHLORIDE|ASCORBICACID|SODIUMASCORBATE"
"5810","MOVIPREP ORANGE","Powder for Oral Solution",2011-02-18,"PA1336/001/002","Norgine B.V.","MACROGOL3350|SODIUMSULFATEANHYDROUS|SODIUMCHLORIDE|POTASSIUMCHLORIDE|ASCORBICACID|SODIUMASCORBATE"
"5811","MOVIPREP, powder for oral solution","*** AWAITING VALUE *** Powder for oral solution",2016-04-15,"PPA1562/168/001","LTT Pharma Limited","Macrogol3350|Potassiumchloride|Ascorbicacid|Sodiumsulfateanhydrous|Sodiumchloride|Sodiumascorbate"
"5812","MOVYMIA","20micrograms/80 Microlitre                                                                                         Solution for Injection",2017-01-11,"EU/1/16/1161/001-002","Stada Arzneimittel AG","TERIPARATIDE"
"5813","MOXIFLOXACIN","400/250 Mg/Ml Solution for Infusion",2014-01-17,"PA2059/013/001","Fresenius Kabi Deutschland GmbH","MOXIFLOXACINHCI,ANHYDROUS"
"5814","MOXIFLOXACIN","400/250 Mg/Ml Solution for Infusion",2014-01-17,"PA2059/013/002","Fresenius Kabi Deutschland GmbH","MOXIFLOXACINHCI,ANHYDROUS"
"5815","Moxivig 0.5% w/v eye drops, solution","0.5 percent weight/volume Eye drops, solution",2009-07-31,"PA0013/132/001","Novartis Pharmaceuticals UK Ltd","Moxifloxacinhydrochloride"
"5816","MOZOBIL","20 Micromol Solution for Injection",2009-07-31,"EU/1/09/537/001","Genzyme Europe B.V.","PLERIXAFOR"
"5817","MST CONTINUS","20 Milligram                                                                                            Granules Prolonged Release",1993-05-26,"PA1688/004/008","Mundipharma Pharmaceuticals Limited","MORPHINESULFATE"
"5818","MST CONTINUS","30 Milligram                                                                                            Granules Prolonged Release",1992-07-02,"PA1688/004/009","Mundipharma Pharmaceuticals Limited","MORPHINESULFATE"
"5819","MST CONTINUS","60 Milligram                                                                                            Granules Prolonged Release",1996-11-18,"PA1688/004/010","Mundipharma Pharmaceuticals Limited","MORPHINESULFATE"
"5820","MST Continus 10 mg Prolonged-release tablets","10 milligram(s) Prolonged-release tablet",1982-04-19,"PA1688/004/002","Mundipharma Pharmaceuticals Limited","Morphinesulfate"
"5821","MST Continus 100mg Prolonged-release tablets","100 milligram(s) Prolonged-release tablet",1983-11-29,"PA1688/004/006","Mundipharma Pharmaceuticals Limited","Morphinesulfate"
"5822","MST Continus 15 mg Prolonged-release tablets","15 milligram(s) Prolonged-release tablet",1993-05-26,"PA1688/004/003","Mundipharma Pharmaceuticals Limited","Morphinesulfate"
"5823","MST Continus 30 mg Prolonged-release tablets","30 milligram(s) Prolonged-release tablet",1982-04-19,"PA1688/004/004","Mundipharma Pharmaceuticals Limited","Morphinesulfate"
"5824","MST Continus 5 mg prolonged-release tablets","5 milligram(s) Prolonged-release tablet",1993-05-26,"PA1688/004/001","Mundipharma Pharmaceuticals Limited","Morphinesulfate"
"5825","MST Continus 60 mg Prolonged-release tablets","60 milligram(s) Prolonged-release tablet",1983-11-29,"PA1688/004/005","Mundipharma Pharmaceuticals Limited","Morphinesulfate"
"5826","MUCODYNE","250 MG/5ml                                                                                               Syrup",1984-09-24,"PA0869/009/003","Ipsen Pharmaceuticals Limited","CARBOCISTEINE"
"5827","Mucodyne 375 mg Capsules, Hard","375 milligram(s) Capsule, hard",NA,"PA0869/009/001","Ipsen Pharmaceuticals Limited","Carbocisteine"
"5828","MUCODYNE PAEDIATRIC SYRUP 125MG/5ML","125 MG/5ml                                                                                               Syrup",1980-04-01,"PA0869/009/002","Ipsen Pharmaceuticals Limited","CARBOCISTEINE"
"5829","MULTAQ","400 Milligram                                                                                            Film Coated Tablet",2009-11-26,"EU/1/09/591/1-4","Sanofi-Aventis Groupe","DRONEDARONEHYDROCHLORIDE"
"5830","MULTIHANCE","0.5M Micromol Solution for Injection",1998-04-03,"PA1826/001/001","Bracco Imaging spa","GADOBENATEDIMEGLUMINE"
"5831","MULTIHANCE","529 Micromol Solution for Injection",2008-07-04,"PA1826/001/002","Bracco Imaging spa","GADOBENATEDIMEGLUMINE"
"5832","MUNTEL","5 Milligram                                                                                            Film Coated Tablet",2004-07-02,"PA0891/006/001","UCB (Pharma) Ireland Limited","LEVOCETIRIZINEDIHYDROCHLORIDE"
"5833","MURINE IRRITATION & REDNESS RELIEF","0.012 %w/v                                                                                                 Eye Drops Solution",1983-04-01,"PA1118/001/001","Prestige Brands (UK) Limited","NAPHAZOLINEHYDROCHLORIDE"
"5834","MUSE 1000 microgram urethral stick","1000 microgram(s) Urethral stick",1999-02-05,"PA2010/028/004","Mylan IRE Healthcare Limited","Alprostadil"
"5835","MUSE 125 microgram urethral stick","125 microgram(s) Urethral stick",1999-02-05,"PA2010/028/001","Mylan IRE Healthcare Limited","Alprostadil"
"5836","MUSE 250 microgram urethral stick","250 microgram(s) Urethral stick",1999-02-05,"PA2010/028/002","Mylan IRE Healthcare Limited","Alprostadil"
"5837","MUSE 500 microgram urethral stick","500 microgram(s) Urethral stick",1999-02-05,"PA2010/028/003","Mylan IRE Healthcare Limited","Alprostadil"
"5838","MVASI","25 milligram(s)/millilitre Concentrate for solution for infusion",2018-01-15,"EU/1/17/1246/001-002","Amgen Europe B.V.","Bevacizumab"
"5839","MYALEPTA","11.3 Milligram                                                                                            Pdr for Soln for Injection",2018-07-30,"EU/1/18/1276/001-002","Aegerion Pharmaceuticals Ltd","METRELEPTIN"
"5840","MYCAMINE","50 Milligram                                                                                            Solution for Infusion",2008-04-25,"EU/1/08/448/001","Astellas Pharma GmbH","MICAFUNGINSODIUM"
"5841","MYCAMINE 100 MG POWDER FOR SOLUTION FOR INFUSION","100 Milligram                                                                                            Solution for Infusion",2008-04-25,"EU/1/08/448/002","Astellas Pharma GmbH","MICAFUNGINSODIUM"
"5842","MYCLAUSEN","500 Milligram                                                                                            Film Coated Tablet",2010-10-07,"EU/1/10/647/001-002","Herbert J. Passauer GmbH & Co. KG","MYCOPHENOLATEMOFETIL"
"5843","MYCLAUSEN","250 Milligram                                                                                            Capsules Hard",NA,"EU/1/10/647/003-004","Herbert J. Passauer GmbH & Co. KG","MYCOPHENOLATEMOFETIL"
"5844","Mycobutin 150mg Hard Capsules","150 milligram(s) Capsule, hard",2001-01-12,"PA0822/109/001","Pfizer Healthcare Ireland","Rifabutin"
"5845","Mycolat 250 mg Capsules","250 milligram(s) Capsule, hard",2008-05-02,"PA0711/129/001","Rowex Ltd","Mycophenolatemofetil"
"5846","Mycolat 500 mg Film-Coated Tablets","500 milligram(s) Film-coated tablet",2008-11-14,"PA0711/129/002","Rowex Ltd","Mycophenolatemofetil"
"5847","MYCOPHENOLATE MOFETIL","500 Milligram                                                                                            Film Coated Tablet",2008-11-28,"PA1390/001/001","Accord Healthcare Limited","MYCOPHENOLATEMOFETIL"
"5848","Mycophenolate Mofetil 500mg Film-Coated Tablets","500 milligram(s) Film-coated tablet",2011-04-08,"PA1339/028/001","Wockhardt UK Limited","Mycophenolatemofetil"
"5849","MYCOPHENOLATE MOFETIL ACCORD","250 Milligram                                                                                            Capsule",2011-12-16,"PA1390/044/001","Accord Healthcare Limited","MYCOPHENOLATEMOFETIL"
"5850","MYCOPHENOLATE MOFETIL CLONMEL","250 Milligram                                                                                            Capsules Hard",2010-10-08,"PA0126/195/001","Clonmel Healthcare Ltd","MYCOPHENOLATEMOFETIL"
"5851","MYCOPHENOLATE MOFETIL CLONMEL","500 Milligram                                                                                            Film Coated Tablet",2010-10-08,"PA0126/195/002","Clonmel Healthcare Ltd","MYCOPHENOLATEMOFETIL"
"5852","MYCOPHENOLATE MOFETIL TEVA","250 Milligram                                                                                            Capsules Hard",2008-02-21,"EU/1/07/439/1-2","Teva B.V.","MYCOPHENOLATEMOFETIL"
"5853","MYCOPHENOLATE MOFETIL TEVA","500 Milligram                                                                                            Film Coated Tablet",2008-02-21,"EU/1/07/439/3-4","Teva B.V.","MYCOPHENOLATEMOFETIL"
"5854","MYCOSTATIN","100,000 IU/ML                                                                                                Oral Suspension",1977-04-01,"PA0002/007/007","Bristol-Myers Squibb Pharmaceuticals uc","NYSTATIN"
"5855","MYCOSTATIN","100,000 Units/ml                                                                                             Oral Suspension",2008-02-22,"PPA1151/068/001","Imbat Limited","NYSTATIN"
"5856","MYDRILATE","0.5 %w/v                                                                                                 Eye Drops Solution",1979-04-01,"PA0997/004/001","Intrapharm Laboratories Limited","CYCLOPENTOLATEHYDROCHLORIDE"
"5857","MYDRILATE","1.0 %w/v                                                                                                 Eye Drops Solution",1979-04-01,"PA0997/004/002","Intrapharm Laboratories Limited","CYCLOPENTOLATEHYDROCHLORIDE"
"5858","MYFENAX","250 Milligram                                                                                            Capsules Hard",2008-02-21,"EU/1/07/438/1-2","Teva B.V.","MYCOPHENOLATEMOFETIL"
"5859","MYFENAX","500 Milligram                                                                                            Film Coated Tablet",2008-02-21,"EU/1/07/438/3-4","Teva B.V.","MYCOPHENOLATEMOFETIL"
"5860","Myfortic 180 mg gastro-resistant tablets","180 milligram(s) Gastro-resistant tablet",2004-07-02,"PA0896/023/001","Novartis Ireland Limited","Mycophenolicacid"
"5861","Myfortic 360 mg gastro-resistant tablets","360 milligram(s) Gastro-resistant tablet",2004-07-02,"PA0896/023/002","Novartis Ireland Limited","Mycophenolicacid"
"5862","MYLERAN","2 Milligram                                                                                            Film Coated Tablet",1979-04-01,"PA1691/008/001","Aspen Pharma Trading Limited","BUSULFAN"
"5863","Mylite 100 micrograms / 20 micrograms coated tablets","100/20 microgram(s) Coated tablet",2012-02-24,"PA0577/183/001","McDermott Laboratories Ltd t/a Gerard Laboratories","Levonorgestrel|Ethinylestradiol"
"5864","MYLOTARG","5 Milligram                                                                                            Pdr/Conc/Soln for Infus",2018-04-19,"EU/1/18/1277/001","Pfizer Europe MA EEIG","GEMTUZUMABOZOGAMICIN"
"5865","Mymicyas 50 mg Powder for Concentrate for Solution for Infusion","50 milligram(s) ZZZ Pdr/Conc/Soln for Infus",2017-07-07,"PA0405/087/001","Generics (UK) Limited","Caspofunginacetate"
"5866","Mymicyas 70 mg Powder for Concentrate for Solution for Infusion","70 milligram(s) ZZZ Pdr/Conc/Soln for Infus",2017-07-07,"PA0405/087/002","Generics (UK) Limited","Caspofunginacetate"
"5867","MYOCET","50 Base Milligrams                                                                                      Pdr+Solv/Conc/Dispersion/Inf",2000-07-13,"EU/1/00/141/001","Teva B.V.","DOXORUBICINHYDROCHLORIDE"
"5868","MYOVIEW","230 Microgram                                                                                            Kit for radiopharmaceutical preparation",2001-08-02,"PA0240/007/002","GE Healthcare Limited","TETROFOSMIN"
"5869","Myozyme","5 milligram(s)/millilitre ZZZ Pdr/Conc/Soln for Infus",NA,"EU/1/06/333/1-3","Genzyme Europe B.V.","Alglucosidasealfa"
"5870","MYPREG","25 Milligram                                                                                            Capsules Hard",2018-05-18,"PA0405/106/001","Generics (UK) Limited","PREGABALIN"
"5871","MYPREG","50 Milligram                                                                                            Capsules Hard",2018-05-18,"PA0405/106/002","Generics (UK) Limited","PREGABALIN"
"5872","MYPREG","75 Milligram                                                                                            Capsules Hard",2018-05-18,"PA0405/106/003","Generics (UK) Limited","PREGABALIN"
"5873","MYPREG","100 Milligram                                                                                            Capsules Hard",2018-05-18,"PA0405/106/004","Generics (UK) Limited","PREGABALIN"
"5874","MYPREG","150 Milligram                                                                                            Capsules Hard",2018-05-18,"PA0405/106/005","Generics (UK) Limited","PREGABALIN"
"5875","MYPREG","200 Milligram                                                                                            Capsules Hard",2018-05-18,"PA0405/106/006","Generics (UK) Limited","PREGABALIN"
"5876","MYPREG","225 Milligram                                                                                            Capsules Hard",2018-05-18,"PA0405/106/007","Generics (UK) Limited","PREGABALIN"
"5877","MYPREG","300 Milligram                                                                                            Capsules Hard",2018-05-18,"PA0405/106/008","Generics (UK) Limited","PREGABALIN"
"5878","MYSILDECARD","20 Milligram                                                                                            Film Coated Tablet",2016-09-15,"EU/1/16/1134/001-003","Mylan S.A.S.","SILDENAFILCITRATE"
"5879","MYSIMBA","8mg/90 Milligram                                                                                            Tablet Prolonged Release",2015-03-26,"EU/1/14/988/001","Orexigen Therapeutics Ireland Limited","NALTREXONEHYDROCHLORIDE|BUPROPIONHYDROCHLORIDE"
"5880","MYSODELLE","200 Microgram                                                                                            Vaginal Device",2013-12-09,"PA1009/025/001","Ferring Ireland Ltd","MISOPROSTOL"
"5881","MYSOLINE","250 Milligram                                                                                            Tablets",1979-04-01,"PA1777/001/001","Laboratoires SERB","PRIMIDONE"
"5882","MYZAAR","50 Milligram                                                                                            Film Coated Tablet",2008-01-25,"PA0577/087/002","McDermott Laboratories Ltd t/a Gerard Laboratories","LOSARTANPOTASSIUM"
"5883","MYZAAR","100 Milligram                                                                                            Film Coated Tablet",2008-01-25,"PA0577/087/003","McDermott Laboratories Ltd t/a Gerard Laboratories","LOSARTANPOTASSIUM"
"5884","NABUMETONE TILLOMED","500 Milligram                                                                                            Film Coated Tablet",2017-07-14,"PA0644/005/001","Tillomed Laboratories Limited","NABUMETONE"
"5885","NACSYS","600 Milligram                                                                                            Tablets Effervescent",2017-06-02,"PA2166/001/001","Alpex Pharma (UK) Limited","ACETYLCYSTEINE"
"5886","Nadroparin calcium Aspen  Forte 15,200 I.U. anti-Xa/0.8ml solution for injection in a pre-filled syringe.","15,200 international unit(s)/millilitre Solution for injection in pre-filled syringe",2018-05-04,"PA1691/019/002","Aspen Pharma Trading Limited","Nadroparincalcium"
"5887","Nadroparin calcium Aspen 2,850 I.U. anti-Xa/ 0.3 ml solution for injection in a pre-filled syringe","2,850 international unit(s) Solution for injection",2018-05-04,"PA1691/020/001","Aspen Pharma Trading Limited","Nadroparincalcium"
"5888","Nadroparin Calcium Aspen 3,800 I.U. anti-Xa/ 0.4 ml solution for injection in a pre-filled syringe","3,800 international unit(s) Solution for injection",2018-05-04,"PA1691/020/002","Aspen Pharma Trading Limited","Nadroparincalcium"
"5889","Nadroparin Calcium Aspen 5,700 I.U. anti-Xa/ 0.6 ml solution for injection in a pre-filled syringe","5,700 international unit(s) Solution for injection",2018-05-04,"PA1691/020/003","Aspen Pharma Trading Limited","Nadroparincalcium"
"5890","Nadroparin Calcium Aspen 7,600 I.U. anti-Xa/ 0.8 ml solution for injection in a pre-filled syringe","7,600 international unit(s) Solution for injection",2018-05-04,"PA1691/020/004","Aspen Pharma Trading Limited","Nadroparincalcium"
"5891","Nadroparin calcium Aspen 9,500 I.U. anti-Xa/ 1.0 ml solution for injection in a vial","9,500 international unit(s) Solution for injection",NA,"PA1691/021/001","Aspen Pharma Trading Limited","Nadroparincalcium"
"5892","Nadroparin calcium Aspen 9,500 I.U. anti-Xa/ 1.0 ml solution for injection in a vial","9,500 international unit(s) Solution for injection",NA,"PA1691/021/002","Aspen Pharma Trading Limited","Nadroparincalcium"
"5893","Nadroparin calcium Aspen Forte 11,400 I.U. anti-Xa/0.6ml solution for injection in a pre-filled syringe.","11,400 international unit(s)/millilitre Solution for injection in pre-filled syringe",2018-05-04,"PA1691/019/001","Aspen Pharma Trading Limited","Nadroparincalcium"
"5894","Nadroparin calcium Aspen Forte 19,000 I.U. anti-Xa/ml solution for injection in a pre-filled syringe","19,000 international unit(s)/millilitre Solution for injection in pre-filled syringe",2018-05-04,"PA1691/019/003","Aspen Pharma Trading Limited","Nadroparincalcium"
"5895","NAGLAZYME","1 Mg/Ml Concentrate for Soln for Inf",2006-01-24,"EU/1/05/324/001","BioMarin International Limited","GALSULFASE"
"5896","NAILDERM","250 Milligram                                                                                            Tablets",2005-06-17,"PA0577/068/001","McDermott Laboratories Ltd t/a Gerard Laboratories","TERBINAFINEHYDROCHLORIDE"
"5897","NALOXONE","0.40 anhyd mg/ml                                                                                          Solution for Inj/Inf",2007-12-19,"PA0736/026/001","B. Braun Melsungen AG","NALOXONEHYDROCHLORIDEDIHYDRATE"
"5898","Naloxone 400 microgram/ml solution for injection or infusion","0.4 micromole(s) Solution for injection/infusion",2008-10-17,"PA1353/003/001","Orpha-Devel Handels und Vertriebs GmbH","NALOXONEHYDROCHLORIDE"
"5899","NALOXONE HYDROCHLORIDE INJECTION USP","Microgram/ML                                                                                         Solution for Inj/Inf",1989-10-03,"PA0073/111/002","Mercury Pharmaceuticals (Ireland) Ltd","NALOXONEHYDROCHLORIDE"
"5900","NALOXONE HYDROCHLORIDE MINIJET","400 Microgram/ML                                                                                         Solution for Injection",1988-04-18,"PA0255/036/001","International Medication Systems (UK) Ltd","NALOXONEHYDROCHLORIDE"
"5901","NALTREXONE","50 Milligram                                                                                            Film Coated Tablet",2005-03-11,"PA0934/003/001","AOP Orphan Pharmaceuticals AG","NALTREXONEHYDROCHLORIDE"
"5902","NALTREXONE HYDROCHLORIDE","50 Milligram                                                                                            Film Coated Tablet",2010-05-21,"PA1390/020/001","Accord Healthcare Limited","NALTREXONEHYDROCHLORIDE"
"5903","NANOCIS","Milligram                                                                                            Pdr+Solv for Soln for Inj",1999-07-07,"PA0677/006/001","CIS bio International","RHENIUMSULPHIDE"
"5904","NanoFix 1000 IU, 1000 IU powder and solvent for solution for injection","1000 international unit(s) Powder and solvent for solution for injection",2010-10-15,"PA2219/009/002","Octapharma (IP) SPRL","Factorix,human"
"5905","NanoFix 500 IU, 500 IU powder and solvent for solution for injection","500 international unit(s) Powder and solvent for solution for injection",2010-10-15,"PA2219/009/001","Octapharma (IP) SPRL","Factorix,human"
"5906","Naprosyn EC 250mg Gastro-resistant Tablets","250 milligram(s) Gastro-resistant tablet",1990-07-04,"PA1967/002/001","Atnahs Pharma UK Limited","Naproxen"
"5907","Naprosyn EC 500mg Gastro-resistant Tablets","500 milligram(s) Gastro-resistant tablet",1990-07-04,"PA1967/002/002","Atnahs Pharma UK Limited","Naproxen"
"5908","Naproxen sodium Krka 550 mg film-coated tablets","550 milligram(s) Film-coated tablet",2018-01-19,"PA1347/090/001","Krka d.d., Novo mesto","NAPROXENSODIUM"
"5909","NARAVERG","2.5 Milligram                                                                                            Film Coated Tablet",2008-05-16,"PA0749/065/001","Teva Pharma B.V.","NARATRIPTANHYDROCHLORIDE"
"5910","NARCAN","1.8 Milligram                                                                                            Nasal Spray Solution",2018-03-23,"PA2162/001/001","Adapt Pharma Operations Limited","NALOXONEHYDROCHLORIDEDIHYDRATE"
"5911","NARCAN","3.6 Milligram                                                                                            Nasal Spray Solution",2018-03-23,"PA2162/001/002","Adapt Pharma Operations Limited","NALOXONEHYDROCHLORIDEDIHYDRATE"
"5912","NAROPIN","2 Mg/Ml Solution for Injection",1996-06-26,"PA1691/026/001","Aspen Pharma Trading Limited","ROPIVACAINEHYDROCHLORIDE"
"5913","NAROPIN","7.5 Mg/Ml Solution for Injection",1996-06-26,"PA1691/026/002","Aspen Pharma Trading Limited","ROPIVACAINEHYDROCHLORIDE"
"5914","NAROPIN","10 Mg/Ml Solution for Injection",1996-06-26,"PA1691/026/003","Aspen Pharma Trading Limited","ROPIVACAINEHYDROCHLORIDE"
"5915","NASACORT","55 Mcg/Acutuation                                                                                       Nasal Spray Suspension",1998-02-06,"PA0540/011/001","Sanofi-Aventis Ireland Limited T/A SANOFI","TRIAMCINOLONEACETONIDE"
"5916","NASACORT","55 Mcg/Dose                                                                                             Nasal Spray Suspension",2008-04-02,"DPR0465/016/001","PCO Manufacturing","TRIAMCINOLONEACETONIDE"
"5917","NASACORT","55 Microgram                                                                                            Nasal Spray Suspension",2007-09-03,"DPR1392/016/001","Eurodrug Ltd","TRIAMCINOLONEACETONIDE"
"5918","NASACORT","55 Mcg/Acutuation                                                                                       Nasal Spray Suspension",2018-05-25,"PPA1633/069/001","Primecrown 2010 Ltd","TRIAMCINOLONEACETONIDE"
"5919","NASACORT 55 micrograms/dose, nasal spray, suspension","55 microgram(s) Nasal spray, suspension",2004-09-10,"PPA0465/141/001","PCO Manufacturing","Triamcinoloneacetonide|Triamcinoloneacetonide"
"5920","NASACORT ALLERGY","55 Mcg/Dose                                                                                             Nasal Spray Suspension",2011-12-09,"PA0540/011/002","Sanofi-Aventis Ireland Limited T/A SANOFI","TRIAMCINOLONEACETONIDE"
"5921","Naseptin 0.1% & 0.5% w/w Nasal Cream","0.1%/0.5%w percent volume/volume Cream",1983-04-01,"PA0943/002/001","Alliance Pharmaceuticals Ltd.","Chlorhexidinehydrochloride|Neomycinsulfate"
"5922","NASOBEC AQUEOUS","50 Microgram                                                                                            Nasal Spray Suspension",1999-03-04,"PA1986/055/001","Teva B.V.","BECLOMETASONEDIPROPIONATE"
"5923","NASOFAN AQUEOUS","50 Microgram                                                                                            Nasal Spray Suspension",2005-11-28,"PA0282/090/001","Norton Healthcare Limited T/A IVAX Pharmaceuticals UK","FLUTICASONEPROPIONATE"
"5924","NASONEX","50 Microgram                                                                                            Nasal Drops Susp",2007-08-03,"DPR0465/008/001","PCO Manufacturing","MOMETASONEFUROATE"
"5925","NASONEX","50 Microgram                                                                                            Nasal Spray Suspension",2018-02-16,"PPA1633/065/001","Primecrown 2010 Ltd","MOMETASONEFUROATE"
"5926","NASONEX","50 Microgram                                                                                            Nasal Spray Suspension",2016-09-02,"PPA1562/173/001","LTT Pharma Limited","MOMETASONEFUROATE"
"5927","NASONEX","50 Mcg/Acutuation                                                                                       Nasal Spray Suspension",2008-02-01,"PPA1151/062/001","Imbat Limited","MOMETASONEFUROATE"
"5928","NASONEX","50 Microgram                                                                                            Nasal Spray Suspension",2015-05-22,"PPA1463/102/001","IMED Healthcare Ltd.","MOMETASONEFUROATE"
"5929","NASONEX 50 micrograms/actuation Nasal Spray, Suspension","50 ZZZ Mcg/Dose Nasal spray, suspension",2005-08-19,"PPA0465/146/001","PCO Manufacturing","Mometasonefuroate"
"5930","NASONEX AQUEOUS","50 Microgram                                                                                            Nasal Spray Suspension",1998-01-23,"PA1286/038/001","Merck Sharp & Dohme Ireland (Human Health) Limited","MOMETASONEFUROATE"
"5931","NAT. MUR. 6X","6X  Liquid",2017-04-07,"HOR0652/001/001","New Vistas Healthcare Ltd","NATMUR6X"
"5932","Natpar","25 microgram(s) Powder and solvent for solution for injection",2017-04-24,"EU/1/15/1078/001","Shire Pharmaceuticals Ireland Limited","Parathyroidhormone(rdna)"
"5933","NATPAR","50 Microgram                                                                                            Pdr+Solv for Soln for Inj",2017-04-24,"EU/1/15/1078/002","Shire Pharmaceuticals Ireland Limited","PARATHYROIDHORMONE(RDNA)"
"5934","NATPAR","75 Microgram                                                                                            Pdr+Solv for Soln for Inj",2017-04-24,"EU/1/15/1078/003","Shire Pharmaceuticals Ireland Limited","PARATHYROIDHORMONE(RDNA)"
"5935","NATPAR","100 Microgram                                                                                            Pdr+Solv for Soln for Inj",2017-04-24,"EU/1/15/1078/004","Shire Pharmaceuticals Ireland Limited","PARATHYROIDHORMONE(RDNA)"
"5936","NATRILIX SR","1.5 Milligram                                                                                            Tablet Prolonged Release",2009-05-08,"PPA1151/096/001","Imbat Limited","INDAPAMIDE"
"5937","Natrilix SR 1.5 mg, prolonged-release film-coated tablets","1.5 milligram(s) Prolonged-release tablet",1996-05-01,"PA0568/005/001","Les Laboratoires Servier","Indapamide|Indapamide"
"5938","NATRIUM MURIATICUM (NAT. MUR.) TABLETS","6C & 30C  Tablets",2009-11-20,"HOR0407/007/001","Weleda (UK) Limited","NATRIUMCHLORATUM"
"5939","NATURE’S BOUNTY HYPERICUM","Capsules Hard",2016-11-11,"TR1563/061/002","Holland & Barrett International Limited","ST.JOHN'SWORTDRYEXTRACT(ASDRYEXTRACT)FROMST.JOHN'SWORTAERIALPART(HYPERICUMPERFORATUML)"
"5940","NATURE'S BOUNTY AGNUS CASTUS PMS RELIEF","Tablets",2014-05-30,"TR1563/045/001","Holland & Barrett International Limited","AGNUSCASTUSEXTRACT(ASDRYROOT)FROMAGNUSCASTUSFRUIT(VITEXAGNUS-CASTUSL)"
"5941","NATURE'S BOUNTY DEVIL'S CLAW","Unknown Capsules Hard",2013-05-03,"TR1563/018/001","Holland & Barrett International Limited","DEVIL'SCLAWEXTRACT(ASDRYROOT)"
"5942","NATURE'S BOUNTY ECHINACEA COLD AND FLU","Unknown Capsule",2014-01-17,"TR1563/019/001","Holland & Barrett International Limited","ECHINACEAROOTEXTRACT(ASDRYROOT)FROMECHINACEAROOT(ECHINACEAPURPUREAL)"
"5943","NATURE'S BOUNTY LEMON BALM","Capsules Hard",2014-09-05,"TR1563/020/001","Holland & Barrett International Limited","DRYEXTRACTFROMMELISSAOFFICINALISL.FOLIUM(LEMONBALMLEAF)"
"5944","NATURE'S BOUNTY MILK THISTLE","Unknown Capsules Hard",2014-09-26,"TR1563/052/001","Holland & Barrett International Limited","MILKTHISTLEEXTRACT(ASDRYROOT)"
"5945","NATURE'S BOUNTY VALERIAN","Unknown Capsules Hard",2013-02-01,"TR1563/017/001","Holland & Barrett International Limited","VALERIANDRYHYDROALCOHOLICEXTRACTPH.EUR."
"5946","NAVELBINE","10 Base mg/ml                                                                                           Concentrate for Soln for Inf",1996-06-26,"PA1287/001/005","PIERRE FABRE Ltd","VINORELBINETARTRATE"
"5947","NAVELBINE 20 mg soft capsule","20 ZZZ Base Milligrams Capsule, soft",NA,"PA1287/001/001","PIERRE FABRE Ltd","Vinorelbinetartrate"
"5948","NAVELBINE 30 mg soft capsule","30 ZZZ Base Milligrams Capsule, soft",NA,"PA1287/001/002","PIERRE FABRE Ltd","Vinorelbinetartrate"
"5949","NAVELBINE 80 mg soft capsule","80 ZZZ Base Milligrams Capsule, soft",NA,"PA1287/001/004","PIERRE FABRE Ltd","Vinorelbinetartrate"
"5950","NEBIDO","250 Milligram                                                                                            Solution for Injection",2004-11-12,"PA1410/020/001","Bayer Limited","TESTOSTERONEUNDECANOATE"
"5951","NEBILET","5 Milligram                                                                                            Tablets",2014-03-14,"PPA0465/327/001","PCO Manufacturing","NEBIVOLOLHYDROCHLORIDE"
"5952","NEBILET","5 Milligram                                                                                            Tablets",1996-05-20,"PA0865/005/001","Menarini International Operations Luxembourg S.A.","NEBIVOLOL"
"5953","NEBILET","5 Milligram                                                                                            Tablets",2008-10-10,"PPA1151/083/001","Imbat Limited","NEBIVOLOLHYDROCHLORIDE"
"5954","NEBILET","5 Milligram                                                                                            Tablets",2017-07-28,"PPA1463/113/001","IMED Healthcare Ltd.","NEBIVOLOL"
"5955","NEBILET PLUS","5/25 Milligram                                                                                            Film Coated Tablet",2009-03-13,"PA0865/015/002","Menarini International Operations Luxembourg S.A.","NEBIVOLOL|HYDROCHLOROTHIAZIDE"
"5956","Nebilet Plus 5 mg / 12.5 mg film-coated tablets","5/12.5 milligram(s) Film-coated tablet",2009-03-13,"PA0865/015/001","Menarini International Operations Luxembourg S.A.","Hydrochlorothiazide|Nebivolol"
"5957","NEBIMEL","5 Milligram                                                                                            Tablets",2007-11-16,"PA0126/165/001","Clonmel Healthcare Ltd","NEBIVOLOLHYDROCHLORIDE"
"5958","NEBIVOLOL","10 Milligram                                                                                            Tablets",2014-01-17,"PA1462/011/001","Glenmark Pharmaceuticals Europe Limited","NEBIVOLOL"
"5959","NEBIVOLOL TEVA","5 Milligram                                                                                            Tablets",2009-06-19,"PA0749/078/001","Teva Pharma B.V.","NEBIVOLOLHYDROCHLORIDE"
"5960","Nebol 5 mg Tablets","5 milligram(s) Tablet",2008-01-11,"PA0711/120/001","Rowex Ltd","Nebivolol"
"5961","Nefopam 30mg film-coated tablets","30 milligram(s) Film-coated tablet",2016-07-08,"PA2318/001/001","Rivopharm Limited","NEFOPAMHYDROCHLORIDE"
"5962","NEFOPAM HYDROCHLORIDE","30 Milligram                                                                                            Film Coated Tablet",2018-04-13,"PA1648/007/001","Brown & Burk UK Ltd","NEFOPAMHYDROCHLORIDE"
"5963","NEFROSOL SOLUTION FOR HAEMOFILTRATION","Unknown Solution for Haemofiltration",2017-05-19,"PA2146/001/001","B. Braun Avitum AG","SODIUMCHLORIDEPH.EUR.|SODIUMBICARBONATE|CALCIUMCHLORIDEDIHYDRATE|MAGNESIUMCHLORIDEHEXAHYDRATE|GLUCOSEMONOHYDRATE"
"5964","NEFROSOL WITH 2 MMOL/L POTASSIUM","2 mmol/L Solution for Haemofiltration",2017-05-19,"PA2146/001/002","B. Braun Avitum AG","SODIUMCHLORIDEPH.EUR.|SODIUMBICARBONATE|CALCIUMCHLORIDEDIHYDRATE|MAGNESIUMCHLORIDEHEXAHYDRATE|GLUCOSEMONOHYDRATE|POTASSIUMCHLORIDE"
"5965","NEFROSOL WITH 4 MMOL/L POTASSIUM","4 mmol/L Solution for Haemofiltration",2017-05-19,"PA2146/001/003","B. Braun Avitum AG","SODIUMCHLORIDEPH.EUR.|SODIUMBICARBONATE|CALCIUMCHLORIDEDIHYDRATE|MAGNESIUMCHLORIDEHEXAHYDRATE|GLUCOSEMONOHYDRATE|POTASSIUMCHLORIDE"
"5966","NeisVac-C   0.5 ml  Suspension for injection in pre-filled syringe. Meningococcal Group C Polysaccharide Conjugate Vaccine Adsorbed","0.5 millilitre(s) Suspension for injection",2001-07-13,"PA0822/183/001","Pfizer Healthcare Ireland","Neisseriameningitidisc|Tetanustoxoid"
"5967","NELET","5 Milligram                                                                                            Tablets",2009-06-05,"PA0577/106/001","McDermott Laboratories Ltd t/a Gerard Laboratories","NEBIVOLOL"
"5968","Nelsons Arnicare Arnica Cream","1X (0.9) percent weight/weight Cream",2018-11-09,"HOA1149/008/001","A. Nelson & Company Limited","Arnicamontana"
"5969","Nelsons Rhus tox Cream","6X (9) percent Cream",2018-11-09,"HOA1149/010/001","A. Nelson & Company Limited","Rhustoxicodendron(ghp)"
"5970","NEMDATINE","5 Milligram                                                                                            Film Coated Tablet",NA,"EU/1/13/824/001-002","Actavis Group PTC ehf","MEMANTINEHYDROCHLORIDE"
"5971","NEMDATINE","10 Milligram                                                                                            Film Coated Tablet",NA,"EU/1/13/824/003-010","Actavis Group PTC ehf","MEMANTINEHYDROCHLORIDE"
"5972","NEMDATINE","15 Milligram                                                                                            Film Coated Tablet",NA,"EU/1/13/824/011-013","Actavis Group PTC ehf","MEMANTINEHYDROCHLORIDE"
"5973","NEMDATINE","20 Milligram                                                                                            Film Coated Tablet",NA,"EU/1/13/824/014-017","Actavis Group PTC ehf","MEMANTINEHYDROCHLORIDE"
"5974","NEMDATINE","5+10+15+20 Milligram                                                                                            Film Coated Tablet",2013-04-22,"EU/1/13/824/018","Actavis Group PTC ehf","MEMANTINEHYDROCHLORIDE|MEMANTINEHYDROCHLORIDE|MEMANTINEHYDROCHLORIDE|MEMANTINEHYDROCHLORIDE"
"5975","NEOCLARITYN","5 Milligram                                                                                            Tablets",2001-01-15,"EU/1/00/161/001","Merck Sharp & Dohme Ltd","DESLORATIDINE"
"5976","NEOCLARITYN","5 Milligram                                                                                            Tablets",2001-01-15,"EU/1/00/161/002","Merck Sharp & Dohme Ltd","DESLORATIDINE"
"5977","NEOCLARITYN","5 Milligram                                                                                            Tablets",2001-01-15,"EU/1/00/161/003","Merck Sharp & Dohme Ltd","DESLORATIDINE"
"5978","NEOCLARITYN","5 Milligram                                                                                            Tablets",2001-01-15,"EU/1/00/161/004","Merck Sharp & Dohme Ltd","DESLORATIDINE"
"5979","NEOCLARITYN","5 Milligram                                                                                            Tablets",2001-01-15,"EU/1/00/161/005","Merck Sharp & Dohme Ltd","DESLORATIDINE"
"5980","NEOCLARITYN","5 Milligram                                                                                            Tablets",2001-01-15,"EU/1/00/161/006","Merck Sharp & Dohme Ltd","DESLORATIDINE"
"5981","NEOCLARITYN","5 Milligram                                                                                            Tablets",2001-01-15,"EU/1/00/161/007","Merck Sharp & Dohme Ltd","DESLORATIDINE"
"5982","NEOCLARITYN","5 Milligram                                                                                            Tablets",2001-01-15,"EU/1/00/161/008","Merck Sharp & Dohme Ltd","DESLORATIDINE"
"5983","NEOCLARITYN","5 Milligram                                                                                            Tablets",2001-01-15,"EU/1/00/161/009","Merck Sharp & Dohme Ltd","DESLORATIDINE"
"5984","NEOCLARITYN","5 Milligram                                                                                            Tablets",2001-01-15,"EU/1/00/161/010","Merck Sharp & Dohme Ltd","DESLORATIDINE"
"5985","NEOCLARITYN","5 Milligram                                                                                            Tablets",2001-01-15,"EU/1/00/161/011","Merck Sharp & Dohme Ltd","DESLORATIDINE"
"5986","NEOCLARITYN","5 Milligram                                                                                            Tablets",2001-01-15,"EU/1/00/161/012","Merck Sharp & Dohme Ltd","DESLORATIDINE"
"5987","NEOCLARITYN","5 Milligram                                                                                            Tablets",2001-01-15,"EU/1/00/161/013","Merck Sharp & Dohme Ltd","DESLORATIDINE"
"5988","NEOCLARITYN","0.5 Mg/Ml Syrup",2002-04-16,"EU/1/00/161/014","Merck Sharp and Dohme Limited","DESLORATIDINE"
"5989","NEOCLARITYN","0.5mg/ml Mg/Ml Syrup",2002-04-16,"EU/1/00/161/015","Merck Sharp and Dohme Limited","DESLORATIDINE"
"5990","NEOCLARITYN","0.5 Mg/Ml Syrup",2002-04-16,"EU/1/00/161/016","Merck Sharp and Dohme Limited","DESLORATIDINE"
"5991","NEOCLARITYN","0.5 Mg/Ml Syrup",2002-04-16,"EU/1/00/161/017","Merck Sharp & Dohme Ltd","DESLORATIDINE"
"5992","NEOCLARITYN","0.5 Mg/Ml Syrup",2002-04-16,"EU/1/00/161/018","Merck Sharp and Dohme Limited","DESLORATIDINE"
"5993","NEOCLARITYN","0.5 Mg/Ml Syrup",2002-04-16,"EU/1/00/161/019","Merck Sharp and Dohme Limited","DESLORATIDINE"
"5994","NEOCLARITYN","0.5 Mg/Ml Syrup",2002-04-16,"EU/1/00/161/020","Merck Sharp and Dohme Limited","DESLORATIDINE"
"5995","NEOCLARITYN","0.5 Mg/Ml Syrup",2002-04-16,"EU/1/00/161/021","Merck Sharp and Dohme Limited","DESLORATIDINE"
"5996","NEOCLARITYN","5 Milligram                                                                                            Oral Lyophilisate",2002-04-16,"EU/1/00/161/022","Merck Sharp and Dohme Limited","DESLORATIDINE"
"5997","NEOCLARITYN","5 Milligram                                                                                            Oral Lyophilisate",2002-04-16,"EU/1/00/161/023","Merck Sharp and Dohme Limited","DESLORATIDINE"
"5998","NEOCLARITYN","5 Milligram                                                                                            Oral Lyophilisate",2002-04-16,"EU/1/00/161/024","Merck Sharp and Dohme Limited","DESLORATIDINE"
"5999","NEOCLARITYN","5 Milligram                                                                                            Oral Lyophilisate",2002-04-16,"EU/1/00/161/025","Merck Sharp and Dohme Limited","DESLORATIDINE"
"6000","NEOCLARITYN","5 Milligram                                                                                            Oral Lyophilisate",2002-04-16,"EU/1/00/161/026","Merck Sharp and Dohme Limited","DESLORATIDINE"
"6001","NEOCLARITYN","5 Milligram                                                                                            Oral Lyophilisate",2002-04-16,"EU/1/00/161/027","Merck Sharp and Dohme Limited","DESLORATIDINE"
"6002","NEOCLARITYN","5 Milligram                                                                                            Oral Lyophilisate",2002-04-16,"EU/1/00/161/028","Merck Sharp and Dohme Limited","DESLORATIDINE"
"6003","NEOCLARITYN","5 Milligram                                                                                            Oral Lyophilisate",2002-04-16,"EU/1/00/161/029","Merck Sharp and Dohme Limited","DESLORATIDINE"
"6004","NEOCLARITYN","5 Milligram                                                                                            Oral Lyophilisate",2002-04-16,"EU/1/00/161/030","Merck Sharp and Dohme Limited","DESLORATIDINE"
"6005","NEOCLARITYN","5 Milligram                                                                                            Oral Lyophilisate",2002-04-16,"EU/1/00/161/031","Merck Sharp and Dohme Limited","DESLORATIDINE"
"6006","NEOCLARITYN","5 Milligram                                                                                            Oral Lyophilisate",2002-04-16,"EU/1/00/161/032","Merck Sharp and Dohme Limited","DESLORATIDINE"
"6007","NEOCLARITYN","5 Milligram                                                                                            Oral Lyophilisate",2002-04-16,"EU/1/00/161/033","Merck Sharp and Dohme Limited","DESLORATIDINE"
"6008","NEOCLARITYN","5 Milligram                                                                                            Oral Lyophilisate",2002-04-16,"EU/1/00/161/034","Merck Sharp and Dohme Limited","DESLORATIDINE"
"6009","NEOCLARITYN","2.5 Milligram                                                                                            Orodispersible Tablet",2007-04-23,"EU/1/00/161/35-46","Merck Sharp & Dohme Ltd","DESLORATIDINE"
"6010","NEOCLARITYN","5 Milligram                                                                                            Orodispersible Tablet",2007-04-23,"EU/1/00/161/47-58","Merck Sharp & Dohme Ltd","DESLORATIDINE"
"6011","NEOCLARITYN","0.5 Mg/Ml",2007-04-23,"EU/1/00/161/59-67","Merck Sharp and Dohme Limited","DESLORATADINE,MICRONIZED"
"6012","NEO-CYTAMEN","1000 Microgram/ML                                                                                         Solution for Injection",1995-05-06,"PA1638/004/001","RPH Pharmaceuticals AB","HYDROXOCOBALAMIN"
"6013","NEOFORDEX","40 Milligram                                                                                            Tablets",2016-03-16,"EU/1/15/1053/001","Laboratoires CTRS","DEXAMETHASONEACETATE"
"6014","NEOMERCAZOLE","5 Milligram                                                                                            Tablets",1995-03-13,"PA1142/002/001","Amdipharm Limited","CARBIMAZOLE"
"6015","NEOMERCAZOLE","20 Milligram                                                                                            Tablets",1995-03-13,"PA1142/002/002","Amdipharm Limited","CARBIMAZOLE"
"6016","Neophyr 1000 ppm mol/mol, medicinal gas, compressed","1000 ppm mole(s) Medicinal gas, compressed",2013-04-12,"PA1848/001/001","SOL S.p.A.","Nitricoxide"
"6017","Neophyr 225 ppm mol/mol, medicinal gas, compressed","225 ppm mole(s) Medicinal gas, compressed",2013-04-12,"PA1848/001/003","SOL S.p.A.","Nitricoxide"
"6018","Neophyr 450 ppm mol/mol, medicinal gas, compressed","450 ppm mole(s) Medicinal gas, compressed",2013-04-12,"PA1848/001/002","SOL S.p.A.","Nitricoxide"
"6019","NEORAL","25 Milligram                                                                                            Capsules, Soft",1995-10-16,"PPA0465/136/001","PCO Manufacturing","CICLOSPORIN"
"6020","NEORAL","50 Milligram                                                                                            Capsules, Soft",1995-10-16,"PPA0465/136/002","PCO Manufacturing","CICLOSPORIN"
"6021","NEORAL","100 Milligram                                                                                            Capsules, Soft",2005-03-11,"PPA0465/136/003","PCO Manufacturing","CICLOSPORIN"
"6022","Neoral 100 mg/ml concentrate for oral solution","100 milligram(s)/millilitre Concentrate for oral solution",1995-10-16,"PA0896/024/004","Novartis Ireland Limited","Ciclosporin"
"6023","Neoral 100mg Soft Capsules","100 milligram(s) Capsule, soft",1995-10-16,"PA0896/024/003","Novartis Ireland Limited","Ciclosporin"
"6024","Neoral 25 mg Soft Capsules","25 milligram(s) Capsule, soft",1995-10-16,"PA0896/024/001","Novartis Ireland Limited","Ciclosporin"
"6025","Neoral 50mg Soft Capsules","50 milligram(s) Capsule, soft",1995-10-16,"PA0896/024/002","Novartis Ireland Limited","Ciclosporin"
"6026","NEORECORMON","%v/v                                                                                                 Solution for Injection",1998-04-02,"EU/1/97/031/025","Roche Registration Limited","EPOETINBETA"
"6027","NEORECORMON","%v/v                                                                                                 Solution for Injection",1998-04-02,"EU/1/97/031/026","Roche Registration Limited","EPOETINBETA"
"6028","NEORECORMON","%v/v                                                                                                 Solution for Injection",1998-04-02,"EU/1/97/031/027","Roche Registration Limited","EPOETINBETA"
"6029","NEORECORMON","%v/v                                                                                                 Solution for Injection",1998-04-02,"EU/1/97/031/028","Roche Registration Limited","EPOETINBETA"
"6030","NEORECORMON","%v/v                                                                                                 Solution for Injection",1998-04-02,"EU/1/97/031/029","Roche Registration Limited","EPOETINBETA"
"6031","NEORECORMON","%v/v                                                                                                 Solution for Injection",1998-04-02,"EU/1/97/031/030","Roche Registration Limited","EPOETINBETA"
"6032","NEORECORMON","%v/v                                                                                                 Solution for Injection",1998-04-02,"EU/1/97/031/031","Roche Registration Limited","EPOETINBETA"
"6033","NEORECORMON","%v/v                                                                                                 Solution for Injection",1998-04-02,"EU/1/97/031/032","Roche Registration Limited","EPOETINBETA"
"6034","NEORECORMON","%v/v                                                                                                 Solution for Injection",1998-04-02,"EU/1/97/031/033","Roche Registration Limited","EPOETINBETA"
"6035","NEORECORMON","%v/v                                                                                                 Solution for Injection",1998-04-02,"EU/1/97/031/034","Roche Registration Limited","EPOETINBETA"
"6036","NEORECORMON","%v/v                                                                                                 Solution for Injection",1998-04-02,"EU/1/97/031/035","Roche Registration Limited","EPOETINBETA"
"6037","NEORECORMON","%v/v                                                                                                 Solution for Injection",1998-04-02,"EU/1/97/031/036","Roche Registration Limited","EPOETINBETA"
"6038","NEORECORMON","%v/v                                                                                                 Solution for Injection",1998-04-02,"EU/1/97/031/037","Roche Registration Limited","EPOETINBETA"
"6039","NEORECORMON","%v/v                                                                                                 Solution for Injection",1998-04-02,"EU/1/97/031/038","Roche Registration Limited","EPOETINBETA"
"6040","NEORECORMON","60,000 International Unit                                                                                   Pdr+Solv for Soln for Inj",2000-02-10,"EU/1/97/031/039","Roche Registration GmbH","EPOETINBETA"
"6041","NEORECORMON","60,000 International Unit                                                                                   Pdr+Solv for Soln for Inj",2000-02-10,"EU/1/97/031/040","Roche Registration GmbH","EPOETINBETA"
"6042","NEORECORMON","4000 International Unit                                                                                   Solution for Injection",2000-02-10,"EU/1/97/031/041","Roche Registration GmbH","EPOETINBETA"
"6043","NEORECORMON","4,000 International Unit                                                                                   Solution for Injection",2000-02-10,"EU/1/97/031/042","Roche Registration GmbH","EPOETINBETA"
"6044","NEORECORMON","6000 International Unit                                                                                   Solution for Injection",2000-02-10,"EU/1/97/031/043","Roche Registration GmbH","EPOETINBETA"
"6045","NEORECORMON","6,000 International Unit                                                                                   Solution for Injection",2000-02-10,"EU/1/97/031/044","Roche Registration GmbH","EPOETINBETA"
"6046","NEORECORMON","500 International Unit                                                                                   Pdr+Solv for Soln for Inj",1997-07-16,"EU/1/97/031/001","Roche Registration GmbH","EPOETINBETA"
"6047","NEORECORMON","500 International Unit                                                                                   Pdr+Solv for Soln for Inj",1997-07-16,"EU/1/97/031/002","Roche Registration GmbH","EPOETINBETA"
"6048","NEORECORMON","500 International Unit                                                                                   Pdr+Solv for Soln for Inj",1997-07-16,"EU/1/97/031/003","Roche Registration GmbH","EPOETINBETA"
"6049","NEORECORMON","1000 International Unit                                                                                   Pdr+Solv for Soln for Inj",1997-07-16,"EU/1/97/031/004","Roche Registration GmbH","EPOETINBETA"
"6050","NEORECORMON","1000 International Unit                                                                                   Pdr+Solv for Soln for Inj",1997-07-16,"EU/1/97/031/005","Roche Registration GmbH","EPOETINBETA"
"6051","NEORECORMON","2000 International Unit                                                                                   Pdr+Solv for Soln for Inj",1997-07-16,"EU/1/97/031/007","Roche Registration GmbH","EPOETINBETA"
"6052","NEORECORMON","2000 International Unit                                                                                   Pdr+Solv for Soln for Inj",1997-07-16,"EU/1/97/031/008","Roche Registration GmbH","EPOETINBETA"
"6053","NEORECORMON","2000 International Unit                                                                                   Pdr+Solv for Soln for Inj",1997-07-16,"EU/1/97/031/009","Roche Registration GmbH","EPOETINBETA"
"6054","NEORECORMON","5000 International Unit                                                                                   Pdr+Solv for Soln for Inj",1997-07-16,"EU/1/97/031/010","Roche Registration GmbH","EPOETINBETA"
"6055","NEORECORMON","5000 International Unit                                                                                   Pdr+Solv for Soln for Inj",1997-07-16,"EU/1/97/031/011","Roche Registration GmbH","EPOETINBETA"
"6056","NEORECORMON","10,000 International Unit                                                                                   Pdr+Solv for Soln for Inj",1997-07-16,"EU/1/97/031/012","Roche Registration GmbH","EPOETINBETA"
"6057","NEORECORMON","10,000 International Unit                                                                                   Pdr+Solv for Soln for Inj",1997-07-16,"EU/1/97/031/013","Roche Registration GmbH","EPOETINBETA"
"6058","NEORECORMON","30, 000 IU International Unit                                                                                   Solution for Injection",2004-03-31,"EU/1/97/31/45-46","Roche Registration GmbH","EPOETINBETA"
"6059","NEORECORMON FOR RECO-PEN","20,000 International Unit                                                                                   Unknown",1997-07-16,"EU/1/97/031/024","Roche Registration GmbH","EPOETINBETA"
"6060","NEORECORMON FOR RECO-PEN","10,000 International Unit                                                                                   Pdr+Solv for Soln for Inj",1997-07-16,"EU/1/97/031/021","Roche Registration GmbH","EPOETINBETA"
"6061","NEORECORMON FOR RECO-PEN","10,000 International Unit                                                                                   Pdr+Solv for Soln for Inj",1997-07-16,"EU/1/97/031/022","Roche Registration GmbH","EPOETINBETA"
"6062","NEORECORMON MULTIDOSE","50000 International Unit                                                                                   Pdr+Solv for Soln for Inj",1997-07-16,"EU/1/97/031/019","Roche Registration GmbH","EPOETINBETA"
"6063","NEORECORMON MULTIDOSE","100,000 International Unit                                                                                   Pdr+Solv for Soln for Inj",1997-07-16,"EU/1/97/031/020","Roche Registration GmbH","EPOETINBETA"
"6064","NEORECORMON RECOPEN","20,000 International Unit                                                                                   Pdr for Soln for Injection",1997-07-16,"EU/1/97/031/023","Roche Registration GmbH","EPOETINBETA"
"6065","NEOSTIGMINE METILSULFATE","2.5/1 Mg/Ml Solution for Injection",1979-04-01,"PA0073/037/001","Mercury Pharmaceuticals (Ireland) Ltd","NEOSTIGMINEMETILSULFATE"
"6066","NEOTIGASON","10 Milligram                                                                                            Capsule",1992-06-16,"PA1380/050/001","Actavis Group PTC ehf","ACITRETIN"
"6067","NEOTIGASON","25 Milligram                                                                                            Capsule",1992-06-16,"PA1380/050/002","Actavis Group PTC ehf","ACITRETIN"
"6068","Neotigason 10mg capsules","10 milligram(s) Capsule",2018-04-06,"PPA1097/013/001","Lexon (UK) Ltd","Acitretin"
"6069","Neotigason 25mg capsules","25 milligram(s) Capsule",2018-04-06,"PPA1097/013/002","Lexon (UK) Ltd","Acitretin"
"6070","Neparvis","24mg/26 milligram(s) Film-coated tablet",2016-05-26,"EU/1/16/1103/001","Novartis Europharm Limited","Sacubitril/valsartan(lcz696-aba)"
"6071","NEPARVIS","49mg/51 Milligram                                                                                            Film Coated Tablet",2016-05-26,"EU/1/16/1103/002-004","Novartis Europharm Limited","SACUBITRIL/VALSARTAN(LCZ696-ABA)"
"6072","NEPARVIS","97mg/103 Milligram                                                                                            Film Coated Tablet",2016-05-26,"EU/1/16/1103/005-007","Novartis Europharm Limited","SACUBITRIL/VALSARTAN(LCZ696-ABA)"
"6073","Nepramel 20 mg gastro-resistant capsules, hard","20 milligram(s) Gastro-resistant capsule, hard",2010-11-12,"PA0126/208/001","Clonmel Healthcare Ltd","Esomeprazolemagnesiumdihydrate"
"6074","Nepramel 40 mg gastro-resistant capsules, hard","40 milligram(s) Gastro-resistant capsule",2010-11-12,"PA0126/208/002","Clonmel Healthcare Ltd","Esomeprazolemagnesiumdihydrate"
"6075","Nerlynx","40 milligram(s) Film-coated tablet",NA,"EU/1/18/1311/001","PUMA Biotechnology Ltd.","Neratinib"
"6076","NEULASTA","6 Milligram                                                                                            Solution for Injection",2002-08-22,"EU/1/02/227/001-002","Amgen Europe B.V.","PEGFILGRASTIM"
"6077","NEUPOGEN 300","30 Units/ml                                                                                             Solution for Injection",1991-06-11,"PA1026/001/001","Amgen Europe B.V.","FILGRASTIM"
"6078","NEUPOGEN SINGLEJECT","30 MU/0.5m Units/ml                                                                                             Solution for Injection",2001-11-16,"PA1026/001/007","Amgen Europe B.V.","FILGRASTIM"
"6079","NEUPOGEN SINGLEJECT","48 MU/0.5m Units/ml                                                                                             Solution for Injection",2001-11-16,"PA1026/001/008","Amgen Europe B.V.","FILGRASTIM"
"6080","NEUPRO","8 Milligram                                                                                            Transdermal Patch",2006-02-15,"EU/1/05/331/10-12,32-37","UCB Pharma S.A.","ROTIGOTINE"
"6081","NEUPRO","2 Milligram                                                                                            Transdermal Patch",2006-02-15,"EU/1/05/331/1-3,14-20","UCB Pharma S.A.","ROTIGOTINE"
"6082","NEUPRO","1 mg/24 hours Transdermal Patch",2008-08-29,"EU/1/05/331/38-46","UCB Pharma S.A.","ROTIGOTINE"
"6083","NEUPRO","4 Milligram                                                                                            Transdermal Patch",2006-02-15,"EU/1/05/331/4-6,21-25","UCB Pharma S.A.","ROTIGOTINE"
"6084","NEUPRO","3 mg/24 hours Transdermal Patch",2008-08-29,"EU/1/05/331/47-55","UCB Pharma S.A.","ROTIGOTINE"
"6085","NEUPRO","6 Milligram                                                                                            Transdermal Patch",2006-02-15,"EU/1/05/331/7-9,26-31","UCB Pharma S.A.","ROTIGOTINE"
"6086","Neuraceq","300 ZZZ MBq/ml Solution for injection",2014-02-20,"EU/1/13/906/001","Piramal imaging Limited","Florbetaben"
"6087","NeuroBloc","5,000 unit(s)/millilitre Solution for injection",2001-01-22,"EU/1/00/166/001","Sloan Pharma S.a.r.l.","Botulinumtoxintypeb"
"6088","NEUROBLOC","5000 U/ml unit(s)/millilitre Solution for injection",2001-01-22,"EU/1/00/166/002","Sloan Pharma S.a.r.l.",""
"6089","NEUROBLOC","5000 U/ml unit(s)/millilitre Solution for injection",2001-01-22,"EU/1/00/166/003","Sloan Pharma S.a.r.l.","Botulinumtoxintypeb"
"6090","NEURONTIN","300 Milligram                                                                                            Capsules Hard",2003-01-24,"PPA0465/097/001","PCO Manufacturing","GABAPENTIN"
"6091","NEURONTIN","400 Milligram                                                                                            Capsules Hard",2003-01-24,"PPA0465/097/002","PCO Manufacturing","GABAPENTIN"
"6092","NEURONTIN","100 Milligram                                                                                            Capsules Hard",2005-07-08,"PPA0465/097/003","PCO Manufacturing","GABAPENTIN"
"6093","NEURONTIN","600 Milligram                                                                                            Film Coated Tablet",2009-09-18,"PPA0465/097/004","PCO Manufacturing","GABAPENTIN"
"6094","NEURONTIN","100 Milligram                                                                                            Capsules Hard",2013-11-08,"PPA1463/084/001","IMED Healthcare Ltd.","GABAPENTIN"
"6095","NEURONTIN","300 Milligram                                                                                            Capsules Hard",2013-11-08,"PPA1463/084/002","IMED Healthcare Ltd.","GABAPENTIN"
"6096","NEURONTIN","600 Milligram                                                                                            Film Coated Tablet",2013-11-08,"PPA1463/084/003","IMED Healthcare Ltd.","GABAPENTIN"
"6097","NEURONTIN","100 Milligram                                                                                            Capsules Hard",2014-05-23,"PPA1151/224/001","Imbat Limited","GABAPENTIN"
"6098","NEURONTIN","300 Milligram                                                                                            Capsules Hard",2014-06-13,"PPA1151/224/002","Imbat Limited","GABAPENTIN"
"6099","Neurontin 100 mg hard capsules","100 mg milligram(s) Capsule, hard",2006-02-10,"PA0822/015/001","Pfizer Healthcare Ireland","Gabapentin"
"6100","Neurontin 300 mg hard capsules","300 mg milligram(s) Capsule, hard",2006-02-10,"PA0822/015/002","Pfizer Healthcare Ireland","Gabapentin"
"6101","Neurontin 400 mg hard capsules","400 mg milligram(s) Capsule, hard",2006-02-10,"PA0822/015/003","Pfizer Healthcare Ireland","Gabapentin"
"6102","Neurontin 600mg film-coated tablets","600mg milligram(s) Film-coated tablet",2006-02-10,"PA0822/015/004","Pfizer Healthcare Ireland","Gabapentin"
"6103","Neurontin 800 mg film-coated tablets","800mg milligram(s) Film-coated tablet",2006-02-10,"PA0822/015/005","Pfizer Healthcare Ireland","Gabapentin"
"6104","NEUROSTIL","100 Milligram                                                                                            Capsules Hard",2008-09-26,"PA0749/164/001","Teva Pharma B.V.","GABAPENTIN"
"6105","NEUROSTIL","300 Milligram                                                                                            Capsules Hard",2008-09-26,"PA0749/164/002","Teva Pharma B.V.","GABAPENTIN"
"6106","NEUROSTIL","400 Milligram                                                                                            Capsules Hard",2008-09-26,"PA0749/164/003","Teva Pharma B.V.","GABAPENTIN"
"6107","NEUTROGENA T/GEL","5 Micromol Shampoo",1987-04-09,"PA0330/014/001","Johnson & Johnson (Ireland) Limited","COALTAREXTRACT"
"6108","NEVANAC","1                                                                                                      Eye Drops Suspension",2007-12-11,"EU/1/07/433/001","Novartis Europharm Limited","NEPAFENAC"
"6109","NEVANAC","3 Mg/Ml Eye Drops Suspension",2013-05-03,"EU/1/07/433/002","Novartis Europharm Limited","NEPAFENAC"
"6110","NEVIRAPINE","200 Milligram                                                                                            Tablets",2014-05-16,"PA1339/047/001","Wockhardt UK Limited","NEVIRAPINEANHYDROUS"
"6111","NEVIRAPINE TEVA","200 Milligram                                                                                            Tablets",2009-11-30,"EU/1/09/598/1-4","Teva B.V.","NEVIRAPINEANHYDROUS"
"6112","NEXAVAR","200 Milligram                                                                                            Film Coated Tablet",2006-07-19,"EU/1/06/342/01","Bayer AG","SORAFENIB(ASTOSYLATE)"
"6113","NEXAZOLE","40 Milligram                                                                                            Capsules Gastro-Resistant",2010-02-12,"PA0281/146/002","Pinewood Laboratories Ltd,","ESOMEPRAZOLEMAGNESIUMDIHYDRATE"
"6114","Nexazole 20 mg gastro-resistant capsules, hard","20 milligram(s) Gastro-resistant capsule",2010-02-12,"PA0281/146/001","Pinewood Laboratories Ltd,","Esomeprazolemagnesiumdihydrate"
"6115","NEXIUM","20 Milligram                                                                                            Tablets Gastro-Resistant",NA,"DPR1633/018/001","Primecrown 2010 Ltd","ESOMEPRAZOLE"
"6116","NEXIUM","40 Milligram                                                                                            Tablets Gastro-Resistant",NA,"DPR1633/018/002","Primecrown 2010 Ltd","ESOMEPRAZOLE"
"6117","NEXIUM","40 Milligram                                                                                            Pdr for Soln Inj/Inf",2004-02-06,"PA0970/027/003","AstraZeneca UK Limited","ESOMEPRAZOLE"
"6118","NEXIUM","10 Milligram                                                                                            Granules for Oral Suspension",2008-08-01,"PA0970/027/004","AstraZeneca UK Limited","ESOMEPRAZOLE"
"6119","NEXIUM","40 Milligram                                                                                            Tablets Gastro-Resistant",2002-02-08,"PPA0465/083/002","PCO Manufacturing","ESOMEPRAZOLE"
"6120","NEXIUM","40 Milligram                                                                                            Tablets Gastro-Resistant",2008-04-11,"PPA1463/002/002","IMED Healthcare Ltd.","ESOMEPRAZOLE"
"6121","NEXIUM","40 Milligram                                                                                            Tablets Gastro-Resistant",2011-09-30,"PPA1562/065/002","LTT Pharma Limited","ESOMEPRAZOLEMAGNESIUMTRIHYDRATE"
"6122","NEXIUM","40 Milligram                                                                                            Tablets Gastro-Resistant",2018-08-24,"PPA1097/031/002","Lexon (UK) Ltd","ESOMEPRAZOLE"
"6123","NEXIUM","40 Milligram                                                                                            Tablets Gastro-Resistant",2006-09-22,"PPA1151/017/002","Imbat Limited","ESOMEPRAZOLEMAGNESIUMTRIHYDRATE"
"6124","NEXIUM","40 Milligram                                                                                            Tablets Gastro-Resistant",2010-05-28,"PPA1633/001/002","Primecrown 2010 Ltd","ESOMEPRAZOLE"
"6125","Nexium 20 mg gastro-resistant tablets","20 milligram(s) Gastro-resistant tablet",2010-05-28,"PPA1633/001/001","Primecrown 2010 Limited","Esomeprazole"
"6126","Nexium 20 mg Gastro-resistant Tablets","20 milligram(s) Gastro-resistant tablet",2006-09-22,"PPA1151/017/001","Imbat Limited","Esomeprazolemagnesiumtrihydrate"
"6127","Nexium 20 mg gastro-resistant tablets","20 milligram(s) Gastro-resistant tablet",2017-10-27,"PPA1097/031/001","Lexon (UK) Ltd","Esomeprazole"
"6128","Nexium 20 mg gastro-resistant tablets","20 milligram(s) Gastro-resistant tablet",2011-09-30,"PPA1562/065/001","LTT Pharma Limited","Esomeprazolemagnesiumtrihydrate"
"6129","Nexium 20 mg Gastro-resistant Tablets","20 milligram(s) Gastro-resistant tablet",2008-04-11,"PPA1463/002/001","IMED Healthcare Ltd.","Esomeprazole"
"6130","Nexium 20 mg Gastro-Resistant Tablets","20 milligram(s) Gastro-resistant tablet",2002-02-08,"PPA0465/083/001","PCO Manufacturing","Esomeprazole"
"6131","Nexium 20 mg gastro-resistant tablets","20 milligram(s) Gastro-resistant tablet",2000-08-18,"PA0970/027/001","AstraZeneca UK Limited","Esomeprazole"
"6132","Nexium 40 mg gastro-resistant tablets","40 milligram(s) Gastro-resistant tablet",2000-08-18,"PA0970/027/002","AstraZeneca UK Limited","Esomeprazole"
"6133","NEXIUM CONTROL","20 Milligram                                                                                            Tablets Gastro-Resistant",2013-08-26,"EU/1/13/860/001-003","Pfizer Consumer Healthcare Ltd","ESOMEPRAZOLEMAGNESIUMTRIHYDRATE"
"6134","NEXOBRID","2 Grams                                                                                                Powder for Cutaneous Soln",2013-01-07,"EU/1/12/803/001","Teva Pharma GmbH","PARTIALLYPURIFIEDBROMELAIN"
"6135","NEXOBRID","5 Grams                                                                                                Powder for Cutaneous Soln",2013-01-07,"EU/1/12/803/002","Teva Pharma GmbH","PARTIALLYPURIFIEDBROMELAIN"
"6136","Nicam 4% w/w Gel","4 percent weight/weight Gel",1992-10-13,"PA0278/021/001","Dermal Laboratories Ltd","Nicotinamide"
"6137","NICOCHEW FRUIT","2 Milligram                                                                                            Medicated Chewing Gum",2012-09-14,"PA0126/263/001","Clonmel Healthcare Ltd","NICOTINERESINATE"
"6138","NICOCHEW FRUIT","4 Milligram                                                                                            Medicated Chewing Gum",2012-09-14,"PA0126/263/002","Clonmel Healthcare Ltd","NICOTINERESINATE"
"6139","NICOCHEW MINT","2 Milligram                                                                                            Medicated Chewing Gum",2012-09-14,"PA0126/263/003","Clonmel Healthcare Ltd","NICOTINERESINATE"
"6140","NICOCHEW MINT","4 Milligram                                                                                            Medicated Chewing Gum",2012-09-14,"PA0126/263/004","Clonmel Healthcare Ltd","NICOTINERESINATE"
"6141","Nicorandil 10mg Tablets","10 milligram(s) Tablet",2011-08-05,"PA2261/003/001","Dexcel Pharma GmbH","Nicorandil"
"6142","Nicorandil 20mg Tablets","20 milligram(s) Tablet",2011-08-05,"PA2261/003/002","Dexcel Pharma GmbH","Nicorandil"
"6143","NICORETTE","2 Milligram                                                                                            Medicated Chewing Gum",2017-10-27,"PPA0465/187/005","PCO Manufacturing","NICOTINE"
"6144","NICORETTE","4 Milligram                                                                                            Medicated Chewing Gum",2017-10-27,"PPA0465/187/006","PCO Manufacturing","NICOTINE"
"6145","NICORETTE","2 Milligram                                                                                            Medicated Chewing Gum",2007-10-14,"PA0330/037/014","Johnson & Johnson (Ireland) Limited","NICOTINERESIN"
"6146","NICORETTE","4 Milligram                                                                                            Medicated Chewing Gum",1997-10-14,"PA0330/037/015","Johnson & Johnson (Ireland) Limited","NICOTINERESIN"
"6147","NICORETTE","2 Milligram                                                                                            Medicated Chewing Gum",2009-05-08,"PPA1151/106/001","Imbat Limited","NICOTINE"
"6148","NICORETTE","4 Milligram                                                                                            Medicated Chewing Gum",2009-05-08,"PPA1151/106/002","Imbat Limited","NICOTINE"
"6149","NICORETTE COOLS","2 Milligram                                                                                            Lozenges",2011-12-16,"PA0330/037/011","Johnson & Johnson (Ireland) Limited","NICOTINE"
"6150","NICORETTE COOLS","4 Milligram                                                                                            Lozenges",2011-12-16,"PA0330/037/012","Johnson & Johnson (Ireland) Limited","NICOTINE"
"6151","NICORETTE FRESHFRUIT","2 Milligram                                                                                            Medicated Chewing Gum",2006-05-26,"PA0330/037/003","Johnson & Johnson (Ireland) Limited","NICOTINERESIN"
"6152","NICORETTE FRESHFRUIT","4 Milligram                                                                                            Medicated Chewing Gum",2006-05-26,"PA0330/037/004","Johnson & Johnson (Ireland) Limited","NICOTINERESIN"
"6153","NICORETTE FRESHMINT","2 Base Milligrams                                                                                      Medicated Chewing Gum",2004-12-17,"PA0330/037/001","Johnson & Johnson (Ireland) Limited","NICOTINERESIN"
"6154","NICORETTE FRESHMINT","4 Base Milligrams                                                                                      Medicated Chewing Gum",2004-12-17,"PA0330/037/002","Johnson & Johnson (Ireland) Limited","NICOTINERESIN"
"6155","NICORETTE FRESHMINT","2 Milligram                                                                                            Medicated Chewing Gum",2009-05-08,"PPA1151/106/003","Imbat Limited","NICOTINE"
"6156","NICORETTE FRESHMINT","4 Milligram                                                                                            Medicated Chewing Gum",2009-05-08,"PPA1151/106/004","Imbat Limited","NICOTINE"
"6157","NICORETTE FRUIT","2 Milligram                                                                                            Lozenges",2017-12-22,"PA0330/037/017","Johnson & Johnson (Ireland) Limited","NICOTINERESINATE"
"6158","NICORETTE FRUIT","4 Milligram                                                                                            Lozenges",2017-12-22,"PA0330/037/018","Johnson & Johnson (Ireland) Limited","NICOTINERESINATE"
"6159","NICORETTE ICY WHITE","2 Milligram                                                                                            Medicated Chewing Gum",2010-08-06,"PA0330/037/008","Johnson & Johnson (Ireland) Limited","NICOTINERESINATE"
"6160","NICORETTE ICY WHITE","4 Milligram                                                                                            Medicated Chewing Gum",2010-08-06,"PA0330/037/009","Johnson & Johnson (Ireland) Limited","NICOTINERESINATE"
"6161","NICORETTE INHALER","15 Milligram                                                                                            Inhalation Cartridge for Oromucosal Use",2011-06-03,"PA0330/037/010","Johnson & Johnson (Ireland) Limited","NICOTINE"
"6162","NICORETTE INVISI","10 mg/16 h Milligram                                                                                            Transdermal Patch",2008-09-05,"PA0330/037/005","Johnson & Johnson (Ireland) Limited","NICOTINE"
"6163","NICORETTE INVISI","15 mg/16 h Milligram                                                                                            Transdermal Patch",2008-09-05,"PA0330/037/006","Johnson & Johnson (Ireland) Limited","NICOTINE"
"6164","NICORETTE INVISI EXTRA STRENGTH","25 mg / 16 Milligram                                                                                            Transdermal Patch",2008-09-05,"PA0330/037/007","Johnson & Johnson (Ireland) Limited","NICOTINE"
"6165","Nicorette Quickmist 1mg/spray Oromucosal Spray, Solution","1 milligram(s) Oromucosal spray, solution",2012-08-03,"PA0330/037/013","Johnson & Johnson (Ireland) Limited","Nicotine"
"6166","Nicorette QuickMist Cool Berry 1 mg/spray, oromucosal spray, solution","1 milligram(s)/dose Oromucosal spray, solution",2017-07-14,"PA0330/037/016","Johnson & Johnson (Ireland) Limited","Nicotine"
"6167","NICOTINELL COOL MINT","2 Milligram                                                                                            Medicated Chewing Gum",2001-04-06,"PA0678/125/001","GlaxoSmithKline Consumer Healthcare (Ireland) Limited","NICOTINE"
"6168","Nicotinell Cool Mint 4 mg, medicated chewing-gum","4 milligram(s) Medicated chewing-gum",2001-04-06,"PA0678/125/002","GlaxoSmithKline Consumer Healthcare (Ireland) Limited","Nicotine"
"6169","Nicotinell Fruit 2 mg, medicated chewing-gums","2 milligram(s) Medicated chewing-gum",2001-04-06,"PA0678/124/001","GlaxoSmithKline Consumer Healthcare (Ireland) Limited","Nicotine"
"6170","Nicotinell Fruit 4 mg, medicated chewing-gum","4 milligram(s) Medicated chewing-gum",2001-04-06,"PA0678/124/002","GlaxoSmithKline Consumer Healthcare (Ireland) Limited","Nicotine"
"6171","NICOTINELL MINT","1mg Milligram                                                                                            Lozenges",1999-08-11,"PA0678/123/004","GlaxoSmithKline Consumer Healthcare (Ireland) Limited","NICOTINE"
"6172","NICOTINELL MINT","2 Milligram                                                                                            Lozenges",2003-11-04,"PA0678/123/005","GlaxoSmithKline Consumer Healthcare (Ireland) Limited","NICOTINE"
"6173","Nicotinell Spearmint 2 mg medicated chewing-gum","2 milligram(s) Medicated chewing-gum",2012-02-10,"PA0678/134/001","GlaxoSmithKline Consumer Healthcare (Ireland) Limited","Nicotine"
"6174","Nicotinell Spearmint 4 mg medicated chewing-gum","4 milligram(s) Medicated chewing-gum",2012-02-10,"PA0678/134/002","GlaxoSmithKline Consumer Healthcare (Ireland) Limited","Nicotine"
"6175","Nicotinell Tropical Fruit 2 mg medicated chewing-gum","2 milligram(s) Medicated chewing-gum",2012-01-20,"PA0678/135/001","GlaxoSmithKline Consumer Healthcare (Ireland) Limited","Nicotine"
"6176","Nicotinell Tropical Fruit 4 mg medicated chewing-gum","4 milligram(s) Medicated chewing-gum",2012-01-20,"PA0678/135/002","GlaxoSmithKline Consumer Healthcare (Ireland) Limited","Nicotine"
"6177","Nicotinell TTS 10, 7mg/24 hours Transdermal Patch","7 milligram(s)/24 hours Transdermal patch",1995-11-02,"PA0678/123/001","GlaxoSmithKline Consumer Healthcare (Ireland) Limited","Nicotine"
"6178","Nicotinell TTS 20, 14mg/24 hours Transdermal Patch","14 milligram(s)/24 hours Transdermal patch",1995-11-02,"PA0678/123/002","GlaxoSmithKline Consumer Healthcare (Ireland) Limited","Nicotine"
"6179","Nicotinell TTS 30, 21mg/24 hours Transdermal Patch","21 milligram(s)/24 hours Transdermal patch",1995-11-02,"PA0678/123/003","GlaxoSmithKline Consumer Healthcare (Ireland) Limited","Nicotine"
"6180","NIF-TEN","50/20 Milligram                                                                                            Capsules Hard",1988-09-29,"PA0970/014/001","AstraZeneca UK Limited","ATENOLOL|NIFEDIPINE"
"6181","NIGHT NURSE","500 Milligram                                                                                            Capsule",1990-02-08,"PA0678/021/001","GlaxoSmithKline Consumer Healthcare (Ireland) Limited","PARACETAMOL|PROMETHAZINEHYDROCHLORIDE|DEXTROMETHORPHANHYDROBROMIDE"
"6182","NIGHT NURSE COLD REMEDY","160ml Millilitre                                                                                           Oral Solution",1990-02-08,"PA0678/014/001","GlaxoSmithKline Consumer Healthcare (Ireland) Limited","PARACETAMOL|PROMAZINEHYDROCHLORIDE|DEXTROMETHORPHANHYDROBROMIDE"
"6183","NIMBEX","2 Mg/Ml Solution for Inj/Inf",1996-05-01,"PA1691/030/001","Aspen Pharma Trading Limited","CISATRACURIUM"
"6184","Nimenrix","5 microgram(s) Powder and solvent for solution for injection",2012-04-20,"EU/1/12/767/001-007","Pfizer Limited","N.meningitidisserogroupapolysaccharideconjugatedtotetanustoxoid|N.meningitidisserogroupcpolysaccharideconjugatedtotetanustoxoid|N.meningitidisserogroupwpolysaccharideconjugatedtotetanustoxoid|N.meningitidisserogroupypolysaccharideconjugatedtotetanustoxoid"
"6185","NIMOTOP","30 Milligram                                                                                            Film Coated Tablet",1994-02-15,"PA1410/030/001","Bayer Limited","NIMODIPINE"
"6186","Nimotop 0.02% w/v Concentrate for Solution for Infusion","0.02 percent weight/volume Concentrate for solution for infusion",1994-02-15,"PA1410/030/002","Bayer Limited","Nimodipine"
"6187","NIMVASTID","4.5 Milligram                                                                                            Capsules Hard",2009-05-11,"EU/1/09/525/14-19","Krka d.d., Novo mesto","RIVASTIGMINEHYDROGENTARTRATE"
"6188","NIMVASTID","1.5 Milligram                                                                                            Capsules Hard",2009-05-11,"EU/1/09/525/1-7","Krka d.d., Novo mesto","RIVASTIGMINEHYDROGENTARTRATE"
"6189","NIMVASTID","6 Milligram                                                                                            Capsules Hard",2009-05-11,"EU/1/09/525/20-25","Krka d.d., Novo mesto","RIVASTIGMINEHYDROGENTARTRATE"
"6190","NIMVASTID","1.5 Milligram                                                                                            Orodispersible Tablet",2009-05-11,"EU/1/09/525/26-31","Krka d.d., Novo mesto","RIVASTIGMINEHYDROGENTARTRATE"
"6191","NIMVASTID","3 Milligram                                                                                            Orodispersible Tablet",2009-05-11,"EU/1/09/525/32-36","Krka d.d., Novo mesto","RIVASTIGMINEHYDROGENTARTRATE"
"6192","NIMVASTID","4.5 Milligram                                                                                            Orodispersible Tablet",2009-05-11,"EU/1/09/525/37-41","Krka d.d., Novo mesto","RIVASTIGMINEHYDROGENTARTRATE"
"6193","NIMVASTID","6 Milligram                                                                                            Orodispersible Tablet",2009-05-11,"EU/1/09/525/42-46","Krka d.d., Novo mesto","RIVASTIGMINEHYDROGENTARTRATE"
"6194","NIMVASTID","3 Milligram                                                                                            Capsules Hard",2009-05-11,"EU/1/09/525/8-13","Krka d.d., Novo mesto","RIVASTIGMINEHYDROGENTARTRATE"
"6195","NINLARO","2.3 Milligram                                                                                            Capsules Hard",2016-11-21,"EU/1/16/1094/001","Takeda Pharma A/S","IXAZOMIBCITRATE"
"6196","NINLARO","3 Milligram                                                                                            Capsules Hard",2016-11-21,"EU/1/16/1094/002","Takeda Pharma A/S","IXAZOMIBCITRATE"
"6197","NINLARO","4 Milligram                                                                                            Capsules Hard",2016-11-21,"EU/1/16/1094/003","Takeda Pharma A/S","IXAZOMIBCITRATE"
"6198","Niopam 150, Solution for Injection, glass bottles","150 milligram(s) Solution for injection",1986-11-19,"PA1826/004/001","Bracco Imaging spa","Iopamidol"
"6199","NIOPAM GLASS BOTTLES","200 Milligram                                                                                            Solution for Injection",1983-03-10,"PA1826/004/002","Bracco Imaging spa","IOPAMIDOL"
"6200","NIOPAM GLASS BOTTLES","300 Milligram                                                                                            Solution for Injection",1983-03-10,"PA1826/004/003","Bracco Imaging spa","IOPAMIDOL"
"6201","NIOPAM GLASS BOTTLES","340 Milligram                                                                                            Solution for Injection",1989-11-06,"PA1826/004/004","Bracco Imaging spa","IOPAMIDOL"
"6202","NIOPAM GLASS BOTTLES","370 Milligram                                                                                            Solution for Injection",1983-03-10,"PA1826/004/005","Bracco Imaging spa","IOPAMIDOL"
"6203","NIPENT  10 mg powder for solution for injection, powder for solution for infusion","10 milligram(s) Powder for solution for injection/infusion",1993-04-21,"PA0822/228/001","Pfizer Healthcare Ireland","Pentostatin"
"6204","NIQUITIN","7 mg/24 hours Transdermal Patch",1999-05-31,"PA1186/018/001","Chefaro Ireland DAC","NICOTINE"
"6205","NIQUITIN","14 mg/24 hours Transdermal Patch",1999-05-31,"PA1186/018/002","Chefaro Ireland DAC","NICOTINE"
"6206","NIQUITIN","21 mg/24 hours Transdermal Patch",1999-05-31,"PA1186/018/003","Chefaro Ireland DAC","NICOTINE"
"6207","NIQUITIN","2 Milligram                                                                                            Lozenges",1999-05-31,"PA1186/018/007","Chefaro Ireland DAC","NICOTINEPOLACRILEXUSP"
"6208","NIQUITIN","4 Milligram                                                                                            Lozenges",1999-05-31,"PA1186/018/008","Chefaro Ireland DAC","NICOTINEPOLACRILEXUSP"
"6209","NIQUITIN","2 Milligram                                                                                            Lozenges",2004-11-05,"PA1186/018/009","Chefaro Ireland DAC","NICOTINERESINATE"
"6210","NIQUITIN","4 Milligram                                                                                            Lozenges",2004-11-05,"PA1186/018/010","Chefaro Ireland DAC","NICOTINERESINATE"
"6211","NIQUITIN CLEAR","7 mg/24 hours Transdermal Patch",2002-09-27,"PA1186/018/004","Chefaro Ireland DAC","NICOTINE"
"6212","NIQUITIN CLEAR","14 mg/24 hours Transdermal Patch",2002-09-27,"PA1186/018/005","Chefaro Ireland DAC","NICOTINE"
"6213","NIQUITIN CLEAR","21 mg/24 hours Transdermal Patch",2002-09-27,"PA1186/018/006","Chefaro Ireland DAC","NICOTINE"
"6214","NiQuitin Fresh Mint 2mg Medicated Chewing Gum","2 milligram(s) Medicated chewing-gum",2015-07-24,"PA1186/019/001","Chefaro Ireland DAC","Nicotineresinate"
"6215","NiQuitin Fresh Mint 4mg Medicated Chewing Gum","4 milligram(s) Medicated chewing-gum",2015-07-24,"PA1186/019/002","Chefaro Ireland DAC","Nicotineresinate"
"6216","NIQUITIN MINI CITRUS FLAVOUR","1.5 Milligram                                                                                            Lozenges",2015-01-23,"PA1186/018/016","Chefaro Ireland DAC","NICOTINERESINATE|NICOTINERESINATE"
"6217","NIQUITIN MINI MINT","1.5 Milligram                                                                                            Lozenges",2009-05-08,"PA1186/018/011","Chefaro Ireland DAC","NICOTINE"
"6218","NIQUITIN MINI MINT","4 Milligram                                                                                            Lozenges",2009-05-08,"PA1186/018/012","Chefaro Ireland DAC","NICOTINE"
"6219","NIQUITIN STRIPS MINT","2.5 Milligram",2011-08-12,"PA1186/018/013","Chefaro Ireland DAC","NICOTINE"
"6220","NiQuitin Tropical Fruit 2 mg medicated chewing gum","2 milligram(s) Medicated chewing-gum",2015-07-24,"PA1186/019/003","Chefaro Ireland DAC","Nicotineresinate"
"6221","NiQuitin Tropical Fruit 4 mg medictated chewing gum","4 milligram(s) Medicated chewing-gum",2015-07-24,"PA1186/019/004","Chefaro Ireland DAC","Nicotineresinate"
"6222","NITHIODOTE","30/250 Mg/Ml Solution for Injection",2018-07-06,"PA2249/003/001","Hope Pharmaceuticals Ltd","SODIUMNITRITE|SODIUMTHIOSULFATE"
"6223","NITISINONE MENDELIKABS (FORMELY KNOWN NITISINONE MDK)","2 Milligram                                                                                            Capsules Hard",2017-08-24,"EU/1/17/1217/001","Mendelikabs Europe Limited","NITISINONE"
"6224","NITISINONE MENDELIKABS (FORMELY KNOWN NITISINONE MDK)","5 Milligram                                                                                            Capsules Hard",2017-08-24,"EU/1/17/1217/002","Mendelikabs Europe Limited","NITISINONE"
"6225","NITISINONE MENDELIKABS (FORMELY KNOWN NITISINONE MDK)","10 Milligram                                                                                            Capsules Hard",2017-08-24,"EU/1/17/1217/003","Mendelikabs Europe Limited","NITISINONE"
"6226","Nitoman 25 mg Tablets","25 milligram(s) Tablet",1994-04-01,"PA1703/001/001","Lundbeck UK LLP","Tetrabenazine"
"6227","NITROCINE","1 Mg/Ml Solution for Infusion",1983-05-23,"PA2118/001/001","Merus Labs Luxco II S.à.R.L.","GLYCERYLTRINITRATE"
"6228","NITROCINE 1 MG/ML SOLUTION FOR INFUSION, VIAL","1 Mg/Ml Solution for Infusion",1983-08-02,"PA2118/001/002","Merus Labs Luxco II S.à.R.L.","GLYCERYLTRINITRATE"
"6229","NITROLINGUAL PUMP SPRAY","400 Microgram                                                                                            Sublingual Spray",1996-05-08,"PA2243/001/001","G. Pohl-Boskamp GmbH & Co. KG","GLYCERYLTRINITRATE"
"6230","NITROLINGUAL PUMPSPRAY","400 Microgram                                                                                            Sublingual Spray",2013-01-11,"PPA0465/300/001","PCO Manufacturing","GLYCERYLTRINITRATE"
"6231","NITROUS OXIDE MEDICINAL SOL","100 %v/v                                                                                                 Medicinal gas, liquefied",2016-07-08,"PA1848/004/001","SOL S.p.A.","NITROUSOXIDE"
"6232","NITYR","10 Milligram                                                                                            Tablets",2018-07-26,"EU/1/18/1290/001","Cycle Pharmaceuticals Ltd.","NITISINONE|LACTOSEMONOHYDRATE(PHARMATOSE200M)"
"6233","Nivestim","120/0.2 microgram(s)/millilitre Solution for injection",2010-06-08,"EU/1/10/631/001-3","Pfizer Europe MA EEIG","Filgrastim"
"6234","Nivestim","300/0.5 microgram(s)/millilitre Solution for injection",2010-06-08,"EU/1/10/631/004-6","Pfizer Europe MA EEIG","Filgrastim"
"6235","Nivestim","480/0.5 microgram(s)/millilitre Solution for injection",2010-06-08,"EU/1/10/631/007-9","Pfizer Europe MA EEIG","Filgrastim"
"6236","NIZORAL","20 mg/g Shampoo",2009-04-17,"PPA1151/093/001","Imbat Limited","KETOCONAZOLE"
"6237","Nizoral  20 mg/g Cream","20 milligram(s)/gram Cream",1987-11-10,"PA0330/041/002","Johnson & Johnson (Ireland) Limited","Ketoconazole"
"6238","Nizoral 20mg/g shampoo","20mg/g  Shampoo",1990-04-05,"PA0330/041/003","Johnson & Johnson (Ireland) Limited","Ketoconazole"
"6239","NIZORAL CREAM","20 mg/g Cream",2017-06-16,"PPA1097/017/001","Lexon (UK) Ltd","KETOCONAZOLE"
"6240","NIZORAL DANDRUFF","20 mg/g Shampoo",1999-11-26,"PA0330/041/001","Johnson & Johnson (Ireland) Limited","KETOCONAZOLE"
"6241","NIZORAL DANDRUFF","20 mg/g Shampoo",1996-05-20,"PPA0465/042/001","PCO Manufacturing","KETOCONAZOLE"
"6242","NOCTAMID","1 Milligram                                                                                            Tablets",2013-04-05,"PPA1151/192/001","Imbat Limited","LORMETAZEPAM"
"6243","Noctamid Tablets 1 mg","1 milligram(s) Tablet",1982-11-01,"PA1410/009/001","Bayer Limited","Lormetazepam"
"6244","Noletil XL 200mg Prolonged-release Tablets","200 milligram(s) Prolonged-release tablet",2012-11-23,"PA1436/024/001","Bluefish Pharmaceuticals AB","Quetiapinehemifumarate"
"6245","Noletil XL 300mg Prolonged-release Tablets","300 milligram(s) Prolonged-release tablet",2012-11-23,"PA1436/024/002","Bluefish Pharmaceuticals AB","Quetiapinehemifumarate"
"6246","Noletil XL 400mg Prolonged-release Tablets","400 milligram(s) Prolonged-release tablet",2012-11-23,"PA1436/024/003","Bluefish Pharmaceuticals AB","Quetiapinehemifumarate"
"6247","NOLPACID","20 Milligram                                                                                            Tablets Gastro-Resistant",2013-11-25,"PA1347/032/001","Krka d.d., Novo mesto","PANTOPRAZOLE"
"6248","NOLPAZA","20 Milligram                                                                                            Tablets Gastro-Resistant",2009-03-13,"PA1347/006/001","Krka d.d., Novo mesto","PANTOPRAZOLESODIUMSESQUIHYDRATE"
"6249","NOLPAZA","40 Milligram                                                                                            Tablets Gastro-Resistant",2009-03-13,"PA1347/006/002","Krka d.d., Novo mesto","PANTOPRAZOLESODIUMSESQUIHYDRATE"
"6250","Nolvadex D 20 mg Film-coated Tablets","20 milligram(s) Film-coated tablet",NA,"PA0970/015/002","AstraZeneca UK Limited","TAMOXIFENCITRATE"
"6251","Nolxado 10 mg/5 mg prolonged-release tablets","10mg/5 milligram(s) Prolonged-release capsule",2017-05-19,"PA1347/085/001","Krka d.d., Novo mesto","OXYCODONEHYDROCHLORIDE|Naloxonehydrochloridedihydrate"
"6252","Nolxado 20 mg/10 mg prolonged-release tablets","20mg/10 milligram(s) Prolonged-release capsule",2017-05-19,"PA1347/085/002","Krka d.d., Novo mesto","Naloxonehydrochloridedihydrate|OXYCODONEHYDROCHLORIDE"
"6253","Nolxado 40 mg/20 mg prolonged-release tablets","40mg/20 milligram(s) Prolonged-release capsule",2017-05-19,"PA1347/085/003","Krka d.d., Novo mesto","OXYCODONEHYDROCHLORIDE|Naloxonehydrochloridedihydrate"
"6254","NON DROWSY SINUTAB","500/30 Milligram                                                                                            Tablets",2009-07-31,"PPA1151/114/001","Imbat Limited","PARACETAMOL|PSEUDOEPHEDRINEHYDROCHLORIDE"
"6255","NONAFACT","%v/v                                                                                                 Pdr+Solv for Soln for Inj",2001-07-03,"EU/1/01/186/001","Sanquin Plasma Products B.V.","FACTORIX,HUMAN"
"6256","NONAFACT","%v/v                                                                                                 Pdr+Solv for Soln for Inj",2001-07-03,"EU/1/01/186/002","Sanquin Plasma Products B.V.","FACTORIX,HUMAN"
"6257","NON-DROWSY SINUTAB TABLETS, PARACETAMOL 500MG,","30/500 Milligram                                                                                            Tablets",1998-02-06,"PA0330/038/001","Johnson & Johnson (Ireland) Limited",""
"6258","Non-drowsy Sinutab TabletsParacetamol 500 mgPseudoephedrine hydrochloride 30 mg","500/30 milligram(s) Tablet",2006-09-08,"PPA0465/184/001","PCO Manufacturing","PSEUDOEPHEDRINEHYDROCHLORIDE|Paracetamol"
"6259","NON-DROWSY SUDAFED DECONGESTANT","30 MG/5ml                                                                                               Syrup",1978-06-23,"PA0823/009/001","McNeil Healthcare (Ireland) Ltd","PSEUDOEPHEDRINEHYDROCHLORIDE"
"6260","NON-DROWSY SUDAFED DECONGESTANT","60 Milligram                                                                                            Film Coated Tablet",2009-09-18,"PPA1151/131/001","Imbat Limited","PSEUDOEPHEDRINEHYDROCHLORIDE"
"6261","Non-Drowsy Sudafed Decongestant 60 mg Film-Coated Tablets","60 milligram(s) Tablet",1979-04-01,"PA0330/057/002","Johnson & Johnson (Ireland) Limited","PSEUDOEPHEDRINEHYDROCHLORIDE"
"6262","NON-DROWSY SUDAPLUS","30/500 Milligram                                                                                            Tablets",2011-06-29,"PA0330/039/001","Johnson & Johnson (Ireland) Limited","PARACETAMOL|PSEUDOEPHEDRINEHYDROCHLORIDE"
"6263","NON-DROWSY SUDAPRO HEAD COLD","200/30 Milligram                                                                                            Film Coated Tablet",2016-01-29,"PA0823/068/001","McNeil Healthcare (Ireland) Ltd","IBUPROFEN|PSEUDOEPHEDRINEHYDROCHLORIDE"
"6264","Noqturina 25 microgram oral lyophilisate","25 microgram(s) Oral lyophilisate",NA,"PA1009/027/001","Ferring Ireland Ltd","DESMOPRESSINACETATE"
"6265","Noqturina 50 microgram oral lyophilisate","50 microgram(s) Oral lyophilisate",NA,"PA1009/027/002","Ferring Ireland Ltd","DESMOPRESSINACETATE"
"6266","NORADRENALINE (NOREPINEPHRINE)","0.08 Mg/Ml Solution for Infusion",2016-02-05,"PA1968/001/001","Laboratoire AGUETTANT","NORADRENALINETARTRATE"
"6267","NORADRENALINE (NOREPINEPHRINE)","0.25 Mg/Ml Solution for Infusion",2016-02-05,"PA1968/001/002","Laboratoire AGUETTANT","NORADRENALINETARTRATE"
"6268","NORADRENALINE (NOREPINEPHRINE)","1 Mg/Ml Concentrate for Soln for Inf",2015-04-17,"PA1339/069/001","Wockhardt UK Limited","NORADRENALINETARTRATE"
"6269","Noradrenaline (Norepinephrine) 1:1000 Concentrate For Solution For Infusion","1 milligram(s)/millilitre Concentrate for solution for infusion",1995-04-10,"PA0822/219/001","Pfizer Healthcare Ireland","Noradrenalineacidtartrate"
"6270","NORDIMET","7.5 Milligram                                                                                            Solution for injection in pre-filled pen",2016-08-18,"EU/1/16/1124/001","Nordic Group BV","METHOTREXATE"
"6271","NORDIMET","10 Milligram                                                                                            Solution for injection in pre-filled pen",2016-08-18,"EU/1/16/1124/002","Nordic Group BV","METHOTREXATE"
"6272","NORDIMET","12.5 Milligram                                                                                            Solution for injection in pre-filled pen",2016-08-18,"EU/1/16/1124/003","Nordic Group BV","METHOTREXATE"
"6273","NORDIMET","15 Milligram                                                                                            Solution for injection in pre-filled pen",2016-08-18,"EU/1/16/1124/004","Nordic Group BV","METHOTREXATE"
"6274","NORDIMET","17.5 Milligram                                                                                            Solution for injection in pre-filled pen",2016-08-18,"EU/1/16/1124/005","Nordic Group BV","METHOTREXATE"
"6275","NORDIMET","20 Milligram                                                                                            Solution for injection in pre-filled pen",2016-08-18,"EU/1/16/1124/006","Nordic Group BV","METHOTREXATE"
"6276","NORDIMET","22.5 Milligram                                                                                            Solution for injection in pre-filled pen",2016-08-18,"EU/1/16/1124/007","Nordic Group BV","METHOTREXATE"
"6277","NORDIMET","25 Milligram                                                                                            Solution for injection in pre-filled pen",2016-08-18,"EU/1/16/1124/008","Nordic Group BV","METHOTREXATE"
"6278","Norditropin FlexPro 10 mg/1.5 ml, solution for injection in pre-filled pen","10/1.5 milligram(s)/millilitre Solution for injection",2011-05-27,"PA0218/040/012","Novo Nordisk A/S","Somatropin"
"6279","Norditropin FlexPro 15 mg/1.5 ml, solution for injection in pre-filled pen","15/1.5 milligram(s)/millilitre Solution for injection",2011-05-27,"PA0218/040/013","Novo Nordisk A/S","Somatropin|Somatropin"
"6280","Norditropin FlexPro 5 mg/1.5 ml, solution for injection in pre-filled pen","5/1.5 milligram(s)/millilitre Solution for injection",2011-05-27,"PA0218/040/011","Novo Nordisk A/S","Somatropin"
"6281","Norditropin NordiFlex 10 mg/1.5 ml solution for injection in pre-filled pen","10mg/1.5ml micromole(s) Solution for injection",2004-09-10,"PA0218/040/009","Novo Nordisk A/S","Somatropin"
"6282","Norditropin NordiFlex 15 mg/1.5 ml solution for injection in pre-filled pen","15mg/1.5ml micromole(s) Solution for injection",2004-09-10,"PA0218/040/010","Novo Nordisk A/S","Somatropin"
"6283","Norditropin NordiFlex 5 mg/1.5 ml solution for injection in pre-filled pen","5mg/1.5ml micromole(s) Solution for injection",2004-09-10,"PA0218/040/008","Novo Nordisk A/S","Somatropin"
"6284","Norditropin SimpleXx 10 mg/1.5 ml, solution for injection in cartridge","10mg/1.5ml  Solution for injection",1999-10-15,"PA0218/040/006","Novo Nordisk A/S","Somatropin"
"6285","Norditropin SimpleXx 15 mg/1.5 ml, solution for injection in cartridge","15mg/1.5ml  Solution for injection",1999-10-15,"PA0218/040/007","Novo Nordisk A/S","Somatropin"
"6286","Norditropin SimpleXx 5 mg/1.5 ml, solution for injection in cartridge","5mg/1.5ml  Solution for injection",1999-10-15,"PA0218/040/005","Novo Nordisk A/S","Somatropin"
"6287","Nordurine 0.1 mg Tablets","0.1 milligram(s) Tablet",NA,"PA1009/017/001","Ferring Ireland Ltd","DESMOPRESSINACETATE"
"6288","Nordurine 0.2 mg Tablets","0.2 milligram(s) Tablet",NA,"PA1009/017/002","Ferring Ireland Ltd","DESMOPRESSINACETATE"
"6289","Noriday 350 micrograms Tablet","350 microgram(s) Tablet",2013-08-02,"PPA0465/310/001","PCO Manufacturing","Norethisterone"
"6290","Noriday 350 micrograms tablet","350 microgram(s) Tablet",2015-02-06,"PPA1151/220/001","Imbat Limited","Norethisterone"
"6291","Noriday 350 micrograms Tablets","350 microgram(s) Tablet",1979-04-01,"PA0822/131/001","Pfizer Healthcare Ireland","Norethisterone"
"6292","NORLEVO","1.5 Milligram                                                                                            Tablets",2012-03-02,"PPA1151/177/001","Imbat Limited","LEVONORGESTREL"
"6293","NORLEVO","1.5 Milligram                                                                                            Tablets",2013-11-08,"PPA1463/087/001","IMED Healthcare Ltd.","LEVONORGESTREL"
"6294","NORLEVO","1.5 Milligram                                                                                            Tablets",2014-07-04,"PPA1562/120/001","LTT Pharma Limited","LEVONORGESTREL"
"6295","NORLEVO","1.5 Milligram                                                                                            Tablets",2012-11-16,"PPA1633/025/001","Primecrown 2010 Ltd","LEVONORGESTREL"
"6296","NORLEVO 1.5 mg tablet","1.5 milligram(s) Tablet",2012-06-01,"PPA0465/288/001","PCO Manufacturing","Levonorgestrel"
"6297","NORLEVO® 1.5 mg tablet","1.5 milligram(s) Tablet",2005-08-26,"PA1166/002/001","Laboratoire HRA Pharma","Levonorgestrel"
"6298","Normacol 62% w/w Granules","62 percent weight/weight Granules",1984-09-25,"PA1336/007/001","Norgine B.V.","Sterculia"
"6299","Normacol Plus Granules Sterculia 62% w/w Frangula 8% w/w","62.0/8.0 percent weight/weight Granules",1984-09-25,"PA1336/012/001","Norgine B.V.","Sterculia|Frangula"
"6300","NORMOSANG","25 Mg/Ml Concentrate for Soln for Inf",1999-06-11,"PA0928/001/001","Orphan Europe","HUMANHEMIN"
"6301","Norprolac 150 microgram tablets","150 microgram(s) Tablet",NA,"PA1009/020/003","Ferring Ireland Ltd","Quinagolide"
"6302","Norprolac 25 microgram + 50 microgram tablets","25 + 50 microgram(s) Tablet",NA,"PA1009/020/001","Ferring Ireland Ltd","Quinagolide|Quinagolide"
"6303","Norprolac 75 microgram tablets","75 microgram(s) Tablet",NA,"PA1009/020/002","Ferring Ireland Ltd","Quinagolide"
"6304","Nortem 10mg Tablets","10 milligram(s) Tablet",1993-12-13,"PA0282/055/001","Norton Healthcare Limited T/A IVAX Pharmaceuticals UK","Temazepam"
"6305","Nortem 20mg Tablets","20 milligram(s) Tablet",1993-12-13,"PA0282/055/002","Norton Healthcare Limited T/A IVAX Pharmaceuticals UK","Temazepam"
"6306","NORTENOLOL","25 Milligram                                                                                            Film Coated Tablet",1999-05-27,"PA0644/003/001","Tillomed Laboratories Limited","ATENOLOL"
"6307","NORTENOLOL","50 Milligram                                                                                            Film Coated Tablet",1999-05-27,"PA0644/003/002","Tillomed Laboratories Limited","ATENOLOL"
"6308","NORTENOLOL","100 Milligram                                                                                            Film Coated Tablet",1999-05-27,"PA0644/003/003","Tillomed Laboratories Limited","ATENOLOL"
"6309","Nortriptyline 10 mg Film-coated Tablets","10 milligram(s) Film-coated tablet",2016-03-11,"PA1887/005/001","Alissa Healthcare Research Limited","NORTRIPTYLINEHYDROCHLORIDE"
"6310","Nortriptyline 25 mg Film-coated Tablets","25 milligram(s) Film-coated tablet",2016-03-11,"PA1887/005/002","Alissa Healthcare Research Limited","NORTRIPTYLINEHYDROCHLORIDE"
"6311","NORVIR","80 Mg/Ml Infus/Pdr/Oral Soln",1996-08-26,"EU/1/96/016/001","AbbVie Deutschland GmbH & Co. KG","RITONAVIR"
"6312","NORVIR","100 Milligram                                                                                            Powder for Oral Suspension",2015-08-14,"EU/1/96/016/009","AbbVie Ltd","RITONAVIR"
"6313","NORVIR","100 Milligram                                                                                            Film Coated Tablet",2010-01-25,"EU/1/96/016/5-6","AbbVie Ltd","RITONAVIR"
"6314","NORVIR SOFT CAPSULES","100 Milligram                                                                                            Capsule",1999-11-29,"EU/1/96/016/003","AbbVie Ltd","RITONAVIR"
"6315","NOTIABOLFEN XL","200 Milligram                                                                                            Tablet Prolonged Release",2011-11-25,"PA1390/046/001","Accord Healthcare Limited","QUETIAPINEFUMARATE"
"6316","NOTIABOLFEN XL","300 Milligram                                                                                            Tablet Prolonged Release",2011-11-25,"PA1390/046/002","Accord Healthcare Limited","QUETIAPINEFUMARATE"
"6317","NOTIABOLFEN XL","400 Milligram                                                                                            Tablet Prolonged Release",2011-11-25,"PA1390/046/003","Accord Healthcare Limited","QUETIAPINEFUMARATE"
"6318","NOTIABOLFEN XL","150 Milligram                                                                                            Tablet Prolonged Release",2016-09-09,"PA1390/046/005","Accord Healthcare Limited","QUETIAPINEFUMARATE"
"6319","Notiabolfen XL 50 mg prolonged-release tablets","50 milligram(s) Prolonged-release tablet",2013-09-13,"PA1390/046/004","Accord Healthcare Limited","Quetiapinefumarate|Quetiapinefumarate"
"6320","NOVATHIRTEEN","2.500 International Unit                                                                                   Pdr+Solv for Soln for Inj",2012-09-03,"EU/1/12/775/001","Novo Nordisk A/S","RFXIIIDRUGSUBSTANCE"
"6321","NOVOEIGHT","250 International Unit                                                                                   Pdr+Solv for Soln for Inj",2013-11-13,"EU/1/13/888/001","Novo Nordisk A/S","TUROCTOCOGALFA"
"6322","NOVOEIGHT","500 International Unit                                                                                   Pdr+Solv for Soln for Inj",2013-11-13,"EU/1/13/888/002","Novo Nordisk A/S","TUROCTOCOGALFA"
"6323","NOVOEIGHT","1000 International Unit                                                                                   Pdr+Solv for Soln for Inj",2013-11-13,"EU/1/13/888/003","Novo Nordisk A/S","TUROCTOCOGALFA"
"6324","NOVOEIGHT","1500 International Unit                                                                                   Pdr+Solv for Soln for Inj",2013-11-13,"EU/1/13/888/004","Novo Nordisk A/S","TUROCTOCOGALFA"
"6325","NOVOEIGHT","2000 International Unit                                                                                   Pdr+Solv for Soln for Inj",2013-11-13,"EU/1/13/888/005","Novo Nordisk A/S","TUROCTOCOGALFA"
"6326","NOVOEIGHT","3000 International Unit                                                                                   Pdr+Solv for Soln for Inj",2013-11-13,"EU/1/13/888/006","Novo Nordisk A/S","TUROCTOCOGALFA"
"6327","NOVOFEM","%v/v                                                                                                 Film Coated Tablet",2002-02-08,"PA0218/053/001","Novo Nordisk A/S","ESTRADIOLHEMIHYDRATE|NORETHISTERONEACETATE"
"6328","Novolizer Budesonide 400 micrograms inhalation powder","400 microgram(s) Powder for Inhalation",2005-12-22,"PA2010/032/002","Mylan IRE Healthcare Limited","Budesonide|Budesonide"
"6329","Novolizer Formoterol 12 micrograms /dose inhalation powder","12 microgram(s) Powder for Inhalation",2008-10-17,"PA1332/022/002","Meda Health Sales Ireland Limited","Formoterolfumatratedihydrate"
"6330","Novolizer Formoterol 6 micrograms/dose inhalation powder","6 microgram(s) Powder for Inhalation",2008-10-17,"PA1332/022/001","Meda Health Sales Ireland Limited","Formoterolfumatratedihydrate"
"6331","Novolizer Salbutamol 100 micrograms/dose inhalation powder","100 microgram(s) Powder for Inhalation",2004-09-30,"PA2010/033/001","Mylan IRE Healthcare Limited","Salbutamol"
"6332","Novolizer® Budesonide 200 micrograms Inhalation Powder","200 microgram(s) Powder for Inhalation",2005-12-22,"PA2010/032/001","Mylan IRE Healthcare Limited","Budesonide"
"6333","NOVOMIX 30 FEXPEN","100 U/ml Units/ml                                                                                             Suspension for Injection",2004-08-24,"EU/1/00/0142/9-10,23-25","Novo Nordisk A/S","INSULINASPART"
"6334","NOVOMIX 30 PENFILL","100 U/ml unit(s)/millilitre Suspension for injection",2000-08-01,"EU/1/00/142/004","Novo Nordisk A/S","Insulinaspart"
"6335","NOVOMIX 30 PENFILL","100 Units/ml                                                                                             Suspension for Injection",2000-08-01,"EU/1/00/142/005","Novo Nordisk A/S","INSULINASPART"
"6336","NOVOMIX 50 FLEXPEN","100 Units/ml                                                                                             Suspension for Injection",2000-08-01,"EU/1/00/142/14-16","Novo Nordisk A/S","INSULINASPART"
"6337","NOVOMIX 50 PENFILL","100 Units/ml                                                                                             Suspension for Injection",2005-10-05,"EU/1/00/142/11-13","Novo Nordisk A/S","INSULINASPART"
"6338","NOVOMIX 70 FLEXPEN","100 U/ml Units/ml                                                                                             Suspension for Injection",2000-08-01,"EU/1/00/142/0020-23","Novo Nordisk A/S","INSULINASPART"
"6339","NOVOMIX 70 PENFILL","100 Units/ml                                                                                             Suspension for Injection",2000-08-01,"EU/1/00/142/017-19","Novo Nordisk A/S","INSULINASPART"
"6340","NOVOMIX 70 PENFILL/NOVOMIX50 FLEXPEN","100 Units/ml                                                                                             Suspension for Injection",2005-10-05,"EU/1/00/142/17","Novo Nordisk A/S","INSULINASPART"
"6341","NOVONORM","0.5 mg milligram(s) Tablet",1998-08-17,"EU/1/98/076/001","Novo Nordisk A/S","Repaglinide"
"6342","NOVONORM","0.5 Milligram                                                                                            Tablets",1998-08-17,"EU/1/98/076/002","Novo Nordisk A/S","REPAGLINIDE"
"6343","NOVONORM","0.5 Milligram                                                                                            Tablets",1998-08-17,"EU/1/98/076/003","Novo Nordisk A/S","REPAGLINIDE"
"6344","NOVONORM","0.5 Milligram                                                                                            Tablets",1998-08-17,"EU/1/98/076/004","Novo Nordisk A/S","REPAGLINIDE"
"6345","NOVONORM","0.5 Milligram                                                                                            Tablets",1998-08-17,"EU/1/98/076/005","Novo Nordisk A/S","REPAGLINIDE"
"6346","NOVONORM","0.5 Milligram                                                                                            Tablets",1998-08-17,"EU/1/98/076/006","Novo Nordisk A/S","REPAGLINIDE"
"6347","NOVONORM","0.5 Milligram                                                                                            Tablets",1998-08-17,"EU/1/98/076/007","Novo Nordisk A/S","REPAGLINIDE"
"6348","NOVONORM","1.0 Milligram                                                                                            Tablets",1998-08-17,"EU/1/98/076/008","Novo Nordisk A/S","REPAGLINIDE"
"6349","NOVONORM","1.0 Milligram                                                                                            Tablets",1998-08-17,"EU/1/98/076/009","Novo Nordisk A/S","REPAGLINIDE"
"6350","NOVONORM","1.0 Milligram                                                                                            Tablets",1998-08-17,"EU/1/98/076/010","Novo Nordisk A/S","REPAGLINIDE"
"6351","NOVONORM","1.0 Milligram                                                                                            Tablets",1998-08-17,"EU/1/98/076/011","Novo Nordisk A/S","REPAGLINIDE"
"6352","NOVONORM","1.0 Milligram                                                                                            Tablets",1998-08-17,"EU/1/98/076/012","Novo Nordisk A/S","REPAGLINIDE"
"6353","NOVONORM","1.0 Milligram                                                                                            Tablets",1998-08-17,"EU/1/98/076/013","Novo Nordisk A/S","REPAGLINIDE"
"6354","NOVONORM","1.0 Milligram                                                                                            Tablets",1998-08-17,"EU/1/98/076/014","Novo Nordisk A/S","REPAGLINIDE"
"6355","NOVONORM","2 Milligram                                                                                            Tablets",1998-08-17,"EU/1/98/076/015","Novo Nordisk A/S","REPAGLINIDE"
"6356","NOVONORM","2.0 Milligram                                                                                            Tablets",1998-08-17,"EU/1/98/076/016","Novo Nordisk A/S","REPAGLINIDE"
"6357","NOVONORM","2.0 Milligram                                                                                            Tablets",1998-08-17,"EU/1/98/076/017","Novo Nordisk A/S","REPAGLINIDE"
"6358","NOVONORM","2.0 Milligram                                                                                            Tablets",1998-08-17,"EU/1/98/076/018","Novo Nordisk A/S","REPAGLINIDE"
"6359","NOVONORM","2.0 Milligram                                                                                            Tablets",1998-08-17,"EU/1/98/076/019","Novo Nordisk A/S","REPAGLINIDE"
"6360","NOVONORM","2.0 Milligram                                                                                            Tablets",1998-08-17,"EU/1/98/076/020","Novo Nordisk A/S","REPAGLINIDE"
"6361","NOVONORM","2.0 Milligram                                                                                            Tablets",1998-08-17,"EU/1/98/076/021","Novo Nordisk A/S","REPAGLINIDE"
"6362","NOVORAPID","100 U/ml Units/ml                                                                                             Solution for Injection",2004-08-24,"EU/1/99/119/1,3,","Novo Nordisk A/S","INSULINASPART"
"6363","NovoRapid","100 U/ml unit(s)/millilitre Solution for injection",1999-09-07,"EU/1/99/119/001","Novo Nordisk A/S","Insulinaspart"
"6364","NOVORAPID","100 Units/ml                                                                                             Solution for Injection",2003-06-04,"EU/1/99/119/012","Novo Nordisk A/S","INSULINASPART"
"6365","NOVORAPID INNOLET","100U/ml Units/ml                                                                                             Solution for Inj/Inf",2003-06-04,"EU/1/99/119/013","Novo Nordisk A/S","INSULINASPART"
"6366","NOVORAPID NOVOLET","100 U/ml Units/ml                                                                                             Solution for Injection",1999-09-07,"EU/1/99/119/005","Novo Nordisk A/S","INSULINASPART"
"6367","NOVORAPID PENFILL","100 Units/ml                                                                                             Solution for Injection",1999-09-07,"EU/1/99/119/003","Novo Nordisk A/S","INSULINASPART"
"6368","NovoSeven","0.6 micromole(s) Powder and solvent for solution for injection",1996-02-23,"EU/1/96/006/001","Novo Nordisk A/S","Factorviiahuman,recombinant"
"6369","NovoSeven","2.4 milligram(s) Powder and solvent for solution for injection",1996-02-23,"EU/1/96/006/002","Novo Nordisk A/S","Factorviiahuman,recombinant"
"6370","NovoSeven","4.8 milligram(s) Powder and solvent for solution for injection",1996-02-23,"EU/1/96/006/003","Novo Nordisk A/S","Factorviiahuman,recombinant"
"6371","NovoSeven (100 KIU)","2 milligram(s) Powder and solvent for solution for injection",NA,"EU/1/96/006/005","Novo Nordisk A/S","Eptacogalfa(activated)"
"6372","NovoSeven (250 KIU)","5 milligram(s) Powder and solvent for solution for injection",NA,"EU/1/96/006/006","Novo Nordisk A/S","Eptacogalfa(activated)"
"6373","NovoSeven (50 KIU)","1 milligram(s) Powder and solvent for solution for injection",NA,"EU/1/96/006/004","Novo Nordisk A/S","Eptacogalfa(activated)"
"6374","NOXAFIL","40 Mg/Ml Oral Suspension",2005-10-25,"EU/1/05/320/001","Merck Sharp and Dohme Limited","POSACONAZOLE"
"6375","NOXAFIL","100 Milligram                                                                                            Tablets Gastro-Resistant",2014-04-23,"EU/1/05/320/002-003","Merck Sharp & Dohme Ltd","POSACONAZOLE"
"6376","NOXAFIL","300 Mg/Ml Concentrate for Soln for Inf",2014-09-18,"EU/1/05/320/004","Merck Sharp and Dohme Limited","POSACONAZOLE"
"6377","NOZINAN","25 Mg/Ml Solution for Inj/Inf",1983-01-21,"PA0540/115/001","Sanofi-Aventis Ireland Limited T/A SANOFI","LEVOMEPROMAZINEHYDROCHLORIDE"
"6378","Nplate 250 µg/500 µg","microgram(s) Powder and solvent for solution for injection",2010-01-11,"EU/1/08/497/5-8","Amgen Europe B.V.","Romiplostim"
"6379","Nplate 250 micrograms","250 microgram(s) Powder for solution for injection",2010-01-11,"EU/1/08/497/1,3","Amgen Europe B.V.","Romiplostim"
"6380","Nplate 500 micrograms","500 microgram(s) Powder for solution for injection",2010-01-11,"EU/1/08/497/2,4","Amgen Europe B.V.","Romiplostim"
"6381","Nucala","100 milligram(s) Powder for solution for injection",2015-12-02,"EU/1/15/1043/001-002","GlaxoSmithKline Trading Services Limited","Mepolizumab"
"6382","Nuelin SA 175 mg Prolonged-release Tablets","175 milligram(s) Tablet",1980-11-25,"PA0057/005/004","3M Health Care Limited","Theophylline"
"6383","Nuelin SA 250 mg Prolonged-release Tablets","250 milligram(s) Tablet",1980-09-09,"PA0057/005/005","3M Health Care Limited","Theophylline"
"6384","Nulojix","250 milligram(s) ZZZ Pdr/Conc/Soln for Infus",NA,"EU/1/11/694/001-002","Bristol-Myers Squibb Pharma EEIG","Belatacept"
"6385","Numeta G13%E Preterm Emulsion for Infusion","*** AWAITING VALUE *** Emulsion for infusion",NA,"PA0167/139/004","Baxter Healthcare Limited","Alanine|Arginine|Asparticacid|Cysteine|Glutamicacid|GLYCINE|Histidine|Isoleucine|Leucine|Lysinemonohydrate|Methionine|Ornithinehydrochloride|Phenylalanine|Proline|Serine|Taurine|Tryptophan|Tyrosine|Valine|Potassiumacetate|Calciumchloridedihydrate|Magnesiumacetatetetrahydrate|Sodiumglycerophosphate,hydrated|Glucosemonohydrate|Refinedoliveoil+refinedsoybeanoil|Threonine"
"6386","Numeta G16%E Emulsion for Infusion","*** AWAITING VALUE *** Emulsion for infusion",NA,"PA0167/139/002","Baxter Healthcare Limited","Aminoacidchamber|Alanine|Arginine|Asparticacid|Cysteinedab|Glutamicacid|GLYCINE|Histidine|Isoleucine|Leucine|Lysinemonohydratedab|Methionine|Ornithinehydrochloridedab|Phenylalanine|Proline|Serine|Taurine|Threonine|Tryptophan|Tyrosine|Valine|Sodiumchlorideph.eur.|Potassiumacetate|Calciumchloridedihydrate|Magnesiumacetatetetrahydrate|Sodiumglycerophosphate,hydrated|Glucosechamber|Glucosemonohydrate|Lipidchamber|Oliveoil,refined|SOYABEANOIL,REFINEDPH.EUR."
"6387","Numeta G19% E Emulsion for infusion","*** AWAITING VALUE *** Emulsion for infusion",NA,"PA0167/139/003","Baxter Healthcare Limited","Aminoacidchamber|Alanine|Arginine|Asparticacid|Cysteinedab|Glutamicacid|GLYCINE|Histidine|Isoleucine|Leucine|Lysinemonohydratedab|Methionine|Ornithinehydrochloridedab|Phenylalanine|Proline|Serine|Taurine|Threonine|Tryptophan|Tyrosine|Valine|Sodiumchloride|Potassiumacetate|Calciumchloridedihydrate|Magnesiumacetatetetrahydrate|Sodiumglycerophosphate,hydrated|Glucosechamber|Glucosemonohydrate|Lipidchamber|Oliveoil,refined|SOYABEANOIL,REFINEDPH.EUR."
"6388","NUMIENT","23.75 Milligram                                                                                            Capsules Modified Release",2015-11-19,"EU/1/15/1044/001-003","Amneal Pharma Europe Limited","LEVODOPA|CARBIDOPA"
"6389","NUMIENT","36.25 Milligram                                                                                            Capsules Modified Release",2015-11-19,"EU/1/15/1044/004-006","Amneal Pharma Europe Limited","LEVODOPA|CARBIDOPA"
"6390","NUMIENT","48.75 Milligram                                                                                            Capsules Modified Release",2015-11-19,"EU/1/15/1044/007-009","Amneal Pharma Europe Limited","LEVODOPA|CARBIDOPA"
"6391","NUMIENT","61.25 Milligram                                                                                            Capsules Modified Release",2015-11-19,"EU/1/15/1044/010-012","Amneal Pharma Europe Limited","LEVODOPA|CARBIDOPA"
"6392","Nuprin 75mg gastro-resistant tablets","75 milligram(s) Gastro-resistant tablet",2011-07-15,"PA1380/094/002","Actavis Group PTC ehf","Acetylsalicylicacid"
"6393","NUROFEN","200 Milligram                                                                                            Coated Tablets",2017-08-25,"PPA0465/430/002","PCO Manufacturing","IBUPROFEN"
"6394","NUROFEN","200 Milligram                                                                                            Coated Tablets",2004-12-17,"PA0979/032/006","Reckitt Benckiser Ireland Ltd","IBUPROFEN"
"6395","NUROFEN","200 Milligram                                                                                            Coated Tablets",2015-03-27,"PPA1151/245/001","Imbat Limited","IBUPROFEN"
"6396","NUROFEN 5% W/W GEL.","5 %w/w                                                                                                 Gel",2000-03-31,"PA0979/032/003","Reckitt Benckiser Ireland Ltd","IBUPROFEN"
"6397","NUROFEN ADVANCE","200 Milligram                                                                                            Film Coated Tablet",2001-07-13,"PA0043/006/006","Crookes Healthcare Ltd","IBUPROFENLYSINATE"
"6398","NUROFEN COLD & FLU","200mg,30mg %v/v                                                                                                 Tablets",1994-04-18,"PA0979/033/001","Reckitt Benckiser Ireland Ltd","IBUPROFEN|PSEUDOEPHEDRINEHYDROCHLORIDE"
"6399","NUROFEN COLD & FLU","200/30 Milligram                                                                                            Film Coated Tablet",2014-11-24,"PPA0465/337/002","PCO Manufacturing","IBUPROFEN|PSEUDOEPHEDRINEHYDROCHLORIDE"
"6400","NUROFEN COLD & FLU","200/30 Milligram                                                                                            Film Coated Tablet",2017-07-21,"PPA1151/261/001","Imbat Limited","IBUPROFEN|PSEUDOEPHEDRINEHYDROCHLORIDE"
"6401","Nurofen Cold and Flu","200mg,30mg percent volume/volume Tablet",NA,"PA0043/012/001","Crookes Healthcare Ltd","Ibuprofen|PSEUDOEPHEDRINEHYDROCHLORIDE"
"6402","NUROFEN DURANCE","200 Milligram                                                                                            Medicated Plaster",2017-06-30,"PA0979/032/018","Reckitt Benckiser Ireland Ltd","IBUPROFEN"
"6403","NUROFEN EXPRESS","200 Milligram                                                                                            Coated Tablets",2011-05-27,"PA0979/032/010","Reckitt Benckiser Ireland Ltd","SODIUMIBUPROFENDIHYDRATE"
"6404","NUROFEN EXPRESS","400 Milligram                                                                                            Tablets",2017-08-04,"PPA0465/430/001","PCO Manufacturing","SODIUMIBUPROFENDIHYDRATE"
"6405","NUROFEN EXPRESS MAXIMUM STRENGTH","400 Milligram                                                                                            Coated Tablets",2011-05-27,"PA0979/032/011","Reckitt Benckiser Ireland Ltd","SODIUMIBUPROFENDIHYDRATE"
"6406","NUROFEN FOR CHILDREN","60 Milligram                                                                                            Suppositories",2008-09-12,"PA0979/032/007","Reckitt Benckiser Ireland Ltd","IBUPROFEN"
"6407","Nurofen for children 100 mg chewable capsules, Soft","100 milligram(s) Capsule, soft",2014-02-14,"PA0979/069/001","Reckitt Benckiser Ireland Ltd","Ibuprofen"
"6408","NUROFEN FOR CHILDREN COLD & FLU & PAIN ORANGE","100 MG/5ml                                                                                               Oral Suspension",2014-10-24,"PA0979/066/001","Reckitt Benckiser Ireland Ltd","IBUPROFEN"
"6409","NUROFEN FOR CHILDREN COLD & FLU & PAIN STRAWBERRY","100 MG/5ml                                                                                               Oral Suspension",2014-10-24,"PA0979/067/001","Reckitt Benckiser Ireland Ltd","IBUPROFEN"
"6410","NUROFEN FOR CHILDREN MELTLETS","100 Milligram                                                                                            Orodispersible Tablet",2004-07-30,"PA0979/032/005","Reckitt Benckiser Ireland Ltd","IBUPROFEN"
"6411","NUROFEN FOR CHILDREN MELTLETS","100mg milligram(s) Tablet",NA,"PA0043/006/010","Crookes Healthcare Ltd","Ibuprofen"
"6412","NUROFEN FOR CHILDREN ORANGE","100 MG/5ml                                                                                               Oral Suspension",1998-12-21,"PA0979/032/001","Reckitt Benckiser Ireland Ltd","IBUPROFEN"
"6413","NUROFEN FOR CHILDREN ORANGE","100 MG/5ml                                                                                               Oral Suspension",2014-08-15,"PPA0465/337/001","PCO Manufacturing","IBUPROFEN"
"6414","NUROFEN FOR CHILDREN ORANGE","100 MG/5ml                                                                                               Oral Suspension",2013-10-11,"PPA1151/196/001","Imbat Limited","IBUPROFEN"
"6415","NUROFEN FOR CHILDREN SACHETS","100 MG/5ml                                                                                               Oral Suspension",2010-07-22,"PA0979/032/008","Reckitt Benckiser Ireland Ltd","IBUPROFEN"
"6416","Nurofen for Children Six Plus Orange 200mg/5ml Oral Suspension","200/5 milligram(s)/millilitre Oral suspension",2010-12-21,"PA0979/056/001","Reckitt Benckiser Ireland Ltd","Ibuprofen"
"6417","Nurofen for Children Six Plus Strawberry 200mg/5ml Oral Suspension","200/5 milligram(s)/millilitre Oral suspension",2010-12-21,"PA0979/056/002","Reckitt Benckiser Ireland Ltd","Ibuprofen"
"6418","NUROFEN FOR CHILDREN STRAWBERRY","100 MG/5ml                                                                                               Oral Suspension",2008-09-26,"PA0979/032/009","Reckitt Benckiser Ireland Ltd","IBUPROFEN"
"6419","NUROFEN LONG LASTING","300 mg Milligram                                                                                            Prolonged Release Capsules",1992-10-13,"PA0979/032/015","Reckitt Benckiser Ireland Ltd","IBUPROFEN"
"6420","NUROFEN PLUS","200mg, 12. percent volume/volume Tablet",NA,"PA0043/024/001","Crookes Healthcare Ltd","Ibuprofen|Codeinephosphate"
"6421","NUROFEN PLUS","200/12.8 Milligram                                                                                            Film Coated Tablet",2009-10-30,"PPA1151/126/001","Imbat Limited","IBUPROFEN|CODEINEPHOSPHATEHEMIHYDRATE"
"6422","Nurofen Plus Tablets Ibuprofen 200mg Codeine Phosphate Hemihydrate 12.8mg","200/12.8 milligram(s) Tablet",1997-03-21,"PA0979/034/001","Reckitt Benckiser Ireland Ltd","Ibuprofen|Codeinephosphatehemihydrate"
"6423","Nurofen Plus TabletsIbuprofen 200mgCodeine Phosphate Hemihydrate 12.8 mg","200 & 12.8 milligram(s) Film-coated tablet",2015-05-29,"PPA0465/410/001","PCO Manufacturing","Ibuprofen|Codeinephosphatehemihydrate"
"6424","Nurofen Rapid Relief 200mg Liquid Capsules","200 milligram(s) Capsule, soft",2009-07-24,"PA0979/032/012","Reckitt Benckiser Ireland Ltd","Ibuprofen"
"6425","Nurofen Rapid Relief Maximum Strength 400mg Liquid Capsules","400 milligram(s) Capsule, soft",2009-07-24,"PA0979/032/013","Reckitt Benckiser Ireland Ltd","Ibuprofen"
"6426","NUROFEN SINUS AND PAIN","200 / 30 Milligram                                                                                            Film Coated Tablet",2014-06-20,"PA0979/065/001","Reckitt Benckiser Ireland Ltd","IBUPROFEN|PSEUDOEPHEDRINEHYDROCHLORIDE"
"6427","NU-SEALS","75 Milligram                                                                                            Tablets Gastro-Resistant",2013-02-08,"PPA0490/003/001","Blackhall Pharmaceutical","ACETYLSALICYLICACID"
"6428","NU-SEALS","75 Milligram                                                                                            Tablets Gastro-Resistant",2006-10-20,"PPA1151/012/001","Imbat Limited","ACETYLSALICYLICACID"
"6429","Nu-Seals 300 mg Gastro-resistant Tablets","300 milligram(s) Gastro-resistant tablet",NA,"PA0943/006/002","Alliance Pharmaceuticals Ltd.","Acetylsalicylicacid"
"6430","Nu-seals 75 mg gastro-resistant tablets","75 milligram(s) Gastro-resistant tablet",NA,"PA0943/006/001","Alliance Pharmaceuticals Ltd.","Acetylsalicylicacid"
"6431","NUTRAPLUS","100 mg/g Cream",1991-01-29,"PA0590/004/001","Galderma (UK) Ltd","UREA"
"6432","NUTRIFLEX BASAL","Unknown Solution for Infusion",2000-01-07,"PA0736/005/001","B. Braun Melsungen AG","ISOLEUCINE|LEUCINE|LYSINEHYDROCHLORIDE|L-METHIONINE|PHENYLALANINE|THREONINE|TRYPTOPHAN,L-|VALINE|ARGININEGLUTAMATE|ALANINE|ASPARTICACID|GLUTAMICACID|AMINOACETICACID|PROLINE|SERINE|MAGNESIUMACETATETETRAHYDRATE|SODIUMACETATETRIHYDRATE|POTASSIUMPHOSPHATEMONOBASIC|POTASSIUMHYDROXIDE|SODIUMHYDROXIDE|GLUCOSEMONOHYDRATE|CALCIUMCHLORIDEDIHYDRATE|SODIUMCHLORIDE|HISTIDINEHYPROCHLORIDEMONOHYDRATE"
"6433","NUTRIFLEX LIPID PERI","Unknown Emulsion for Infusion",1999-11-26,"PA0736/013/001","B. Braun Melsungen AG","GLUCOSEMONOHYDRATE|SOYAOIL|MEDIUMCHAINTRIGLYCERIDES|ISOLEUCINE|LEUCINE|LYSINEHYDROCHLORIDE|METHIONINE|PHENYLALANINE|THREONINE|TRYPTOPHAN,L-|VALINE|ARGININE|HISTIDINEHYPROCHLORIDEMONOHYDRATE|ALANINE|ASPARTICACID|GLUTAMICACID|GLYCINE|PROLINE|SERINE|CALCIUMCHLORIDEDIHYDRATE|MAGNESIUMACETATETETRAHYDRATE|SODIUMACETATE|SODIUMCHLORIDE|POTASSIUMACETATE|SODIUMHYDROXIDE|SODIUMDIHYDROGENPHOSPHATEDIHYDRATE|ZINCACETATEDIHYDRATE"
"6434","NUTRIFLEX LIPID SPECIAL WITHOUT ELECTROLYTES","N/A Emulsion for Infusion",1999-11-26,"PA0736/017/001","B. Braun Melsungen AG","GLUCOSEMONOHYDRATE|SOYAOIL|MEDIUMCHAINTRIGLYCERIDES|ISOLEUCINE|LEUCINE|LYSINEMONOHYDRATE|METHIONINE|PHENYLALANINE|THREONINE|TRYPTOPHAN,L-|VALINE|ARGININE|HISTIDINE|ALANINE|ASPARTICACID|GLUTAMICACID|GLYCINE|PROLINE|SERINE"
"6435","Nutriflex Omega plus Emulsion for infusion","*** AWAITING VALUE *** Emulsion for infusion",2011-06-23,"PA0736/033/001","B. Braun Melsungen AG","Tryptophan|Phenylalanine|Sodiumdihydrogenphosphatedihydrate|Glutamicacid|Histidinehyprochloridemonohydrate|Alanine|Methionine|Sodiumacetatetrihydrate|Glucosemonohydrate|Zincacetatedihydrate|Calciumchloridedihydrate|Omega-3triglycerides|Potassiumacetate|Arginine|Sodiumhydroxide|Serine|Threonine|Asparticacid|Valine|Sodiumchloride|Magnesiumacetatetrihydrate|Isoleucine|Lysinehydrochloride|Proline|Leucine|Triglycerides,mediumchain|SOYABEANOIL,REFINEDPH.EUR."
"6436","Nutriflex Omega Special Emulsion for infusion","*** AWAITING VALUE *** Emulsion for infusion",2011-06-23,"PA0736/032/001","B. Braun Melsungen AG","Sodiumacetatetrihydrate|Sodiumchloride|Potassiumacetate|Magnesiumacetatetrihydrate|Sodiumhydroxide|Zincacetatedihydrate|Histidinehyprochloridemonohydrate|Sodiumdihydrogenphosphatedihydrate|Omega-3triglycerides|Lysinehydrochloride|GLYCINE|Calciumchloridedihydrate|Isoleucine|Methionine|Alanine|Serine|Valine|Phenylalanine|Proline|Triglycerides,mediumchain|Glutamicacid|Threonine|Tryptophan|Asparticacid|SOYABEANOIL,REFINEDPH.EUR.|Arginine|Leucine|Glucosemonohydrate"
"6437","NUTRIFLEX PERI","N/A Solution for Infusion",2000-01-07,"PA0736/006/001","B. Braun Melsungen AG","ISOLEUCINE|LEUCINE|LYSINEHYDROCHLORIDE|L-METHIONINE|PHENYLALANINE|THREONINE|TRYPTOPHAN,L-|VALINE|ARGININEGLUTAMATE|ALANINE|ASPARTICACID|GLUTAMICACID|AMINOACETICACID|PROLINE|SERINE|MAGNESIUMACETATETETRAHYDRATE|SODIUMACETATETRIHYDRATE|POTASSIUMPHOSPHATEMONOBASIC|POTASSIUMHYDROXIDE|SODIUMHYDROXIDE|GLUCOSEMONOHYDRATE|CALCIUMCHLORIDEDIHYDRATE|SODIUMCHLORIDE|HISTIDINEHYPROCHLORIDEMONOHYDRATE"
"6438","NUTRIFLEX PLUS","Unknown Solution for Infusion",2000-01-07,"PA0736/007/001","B. Braun Melsungen AG","ISOLEUCINE|LEUCINE|LYSINEHYDROCHLORIDE|L-METHIONINE|PHENYLALANINE|THREONINE|TRYPTOPHAN,L-|VALINE|ARGININEGLUTAMATE|ALANINE|ASPARTICACID|GLUTAMICACID|AMINOACETICACID|PROLINE|SERINE|MAGNESIUMACETATETETRAHYDRATE|SODIUMACETATETRIHYDRATE|SODIUMDIHYDROGENPHOSPHATEDIHYDRATE|POTASSIUMHYDROXIDE|SODIUMHYDROXIDE|GLUCOSEMONOHYDRATE|CALCIUMCHLORIDEDIHYDRATE|HISTIDINEHYPROCHLORIDEMONOHYDRATE"
"6439","NUTRIFLEX SPECIAL","N/A Solution for Infusion",2000-01-07,"PA0736/008/001","B. Braun Melsungen AG","ISOLEUCINE|LEUCINE|LYSINEHYDROCHLORIDE|L-METHIONINE|PHENYLALANINE|THREONINE|TRYPTOPHAN,L-|VALINE|ARGININEGLUTAMATE|ALANINE|ASPARTICACID|GLUTAMICACID|AMINOACETICACID|PROLINE|SERINE|MAGNESIUMACETATETETRAHYDRATE|SODIUMACETATETRIHYDRATE|POTASSIUMPHOSPHATEMONOBASIC|POTASSIUMHYDROXIDE|SODIUMHYDROXIDE|GLUCOSEMONOHYDRATE|CALCIUMCHLORIDEDIHYDRATE|HISTIDINEHYPROCHLORIDEMONOHYDRATE"
"6440","Nutrineal Solution for Peritoneal Dialysis 4 with 1.1% Amino Acids","1.1 percent Solution for peritoneal dialysis",1994-08-08,"PA0167/086/001","Baxter Healthcare Limited","Sodiumchloride|L-histidine|L-tryptophan|L-arginine|L-valine|L-tyrosine|Sodium(s)-lactatesolution|L-lysinehydrochloride|L-leucine|L-isoleucine|L-proline|Glycine|L-phenylalanine|L-threonine|L-serine|L-methionine|L-alanine|Magnesiumchloride|Calciumchloride"
"6441","NutropinAq","10/2 milligram(s)/millilitre Solution for injection",2001-02-16,"EU/1/00/164/003-004","Ipsen Pharma","Somatropin"
"6442","NutropinAq","10/2 milligram(s)/millilitre Solution for injection",2001-02-16,"EU/1/00/164/005","Ipsen Pharma","Somatropin"
"6443","NuvaRing 0.120 mg/0.015 mg per 24 hours, vaginal delivery system","0.120/0.01 milligram(s)/24 hours Vaginal Device",2002-05-31,"PA1286/053/001","Merck Sharp & Dohme Ireland (Human Health) Limited","Etonogestrel|Ethinylestradiol"
"6444","Nuwiq","250 international unit(s) Powder and solvent for solution for injection",2014-07-24,"EU/1/14/936/001","Octapharma AB","Simoctocogalfa"
"6445","NUWIQ","500 International Unit                                                                                   Pdr+Solv for Soln for Inj",2014-07-24,"EU/1/14/936/002","Octapharma A","SIMOCTOCOGALFA"
"6446","NUWIQ","1000 International Unit                                                                                   Pdr+Solv for Soln for Inj",2014-07-24,"EU/1/14/936/003","Octapharma A","SIMOCTOCOGALFA"
"6447","NUWIQ","2000 International Unit                                                                                   Pdr+Solv for Soln for Inj",2014-07-24,"EU/1/14/936/004","Octapharma A","SIMOCTOCOGALFA"
"6448","NUWIQ","2500 International Unit                                                                                   Pdr+Solv for Soln for Inj",2018-03-23,"EU/1/14/936/005","Octapharma AB","SIMOCTOCOGALFA"
"6449","NUWIQ","3000 International Unit                                                                                   Pdr+Solv for Soln for Inj",2018-03-23,"EU/1/14/936/006","Octapharma AB","SIMOCTOCOGALFA"
"6450","NUWIQ","4000 International Unit                                                                                   Pdr+Solv for Soln for Inj",2018-03-23,"EU/1/14/936/007","Octapharma AB","SIMOCTOCOGALFA"
"6451","NUX VOM","6C-MM N/A",2011-03-11,"HOR1149/023/001","A. Nelson & Company Limited","STRYCHNOSNUX-VOMICA"
"6452","NUX VOMICA - TABLETS","6C & 30C Milligram                                                                                            Tablets",2010-06-11,"HOR0407/016/001","Weleda (UK) Limited","STRYCHNOSNUX-VOMICA"
"6453","Nytamel 10 mg Film-coated Tablets","10 milligram(s) Tablet",2002-03-22,"PA0126/117/002","Clonmel Healthcare Ltd","ZOLPIDEMTARTRATE"
"6454","Nytamel 5 mg Film-coated Tablets","5 milligram(s) Tablet",2002-03-22,"PA0126/117/001","Clonmel Healthcare Ltd","ZOLPIDEMTARTRATE"
"6455","Nytol One-A-Night 50 mg Tablets","50 milligram(s) Tablet",2017-05-26,"PA1186/016/001","Chefaro Ireland DAC","DIPHENHYDRAMINEHYDROCHLORIDE"
"6456","NYXOID","1.8 Milligram                                                                                            Nasal Spray Solution",2017-11-10,"EU/1/17/1238/001","Mudipharma Corporation Limited","NALOXONEHYDROCHLORIDEDIHYDRATE"
"6457","Obizur","500 unit(s)/millilitre Powder and solvent for solution for injection",2015-11-11,"EU/1/15/1035/001-003","Baxter Innovations GmbH","Susoctocogalfa"
"6458","Ocaliva","5 milligram(s) Tablet",NA,"EU/1/16/1139/001","Intercept Italia SRL","Obeticholicacid"
"6459","OCALIVA","10 Milligram                                                                                            Tablets",2016-12-12,"EU/1/16/1139/002","Intercept Italia SRL","OBETICHOLICACID"
"6460","OCCLUSAL","26 %w/w                                                                                                 Cutaneous Solution",1994-05-31,"PA0943/007/002","Alliance Pharmaceuticals Ltd.","SALICYLICACID"
"6461","Ocrevus","300 milligram(s) Concentrate for solution for infusion",NA,"EU/1/17/1231/001-002","Roche Registration GmbH","Ocrelizumab"
"6462","OCTANATE","250 International Unit                                                                                   Pdr+Solv for Soln for Inj",2004-06-04,"PA2219/004/001","Octapharma (IP) SPRL","HUMANPLASMAFRAKTION(FACTORVIII)"
"6463","OCTANATE","500 International Unit                                                                                   Pdr+Solv for Soln for Inj",2014-11-28,"PA2219/004/002","Octapharma (IP) SPRL","HUMANCOAGULATIONFACTORVIII"
"6464","OCTANATE","1000 International Unit                                                                                   Pdr+Solv for Soln for Inj",2014-11-28,"PA2219/004/003","Octapharma (IP) SPRL","HUMANCOAGULATIONFACTORVIII"
"6465","OCTAPLEX","500 International Unit                                                                                   Pdr+Solv for soln for Inf",2004-07-02,"PA2219/005/001","Octapharma (IP) SPRL","HUMANPLASMACOAGULATIONFACTORII|HUMANPLASMACOAGULATIONFACTORVII|HUMANPLASMACOAGULATIONFACTORIX|HUMANPLASMACOAGULATIONFACTORX|PROTEINC|PROTEINS"
"6466","OCTAPLEX","1000 International Unit                                                                                   Pdr+Solv for soln for Inf",2015-11-13,"PA2219/005/002","Octapharma (IP) SPRL","HUMANCOAGULATIONFACTORII|HUMANCOAGULATIONFACTORVII|HUMANCOAGULATIONFACTORIX|HUMANCOAGULATIONFACTORX|PROTEINC|PROTEINS"
"6467","Octostim 1.5 mg/ml Nasal Spray","1.5 milligram(s)/millilitre Nasal spray, solution",NA,"PA1009/014/002","Ferring Ireland Ltd","DESMOPRESSINACETATE"
"6468","Octostim 15 micrograms/ml Solution for injection","15 microgram(s)/millilitre Solution for injection",NA,"PA1009/014/001","Ferring Ireland Ltd","DESMOPRESSINACETATE"
"6469","OCTREOSCAN","111 MBq/ml                                                                                               Kit for radiopharmaceutical preparation",1995-06-08,"PA0690/001/001","Mallinckrodt Medical B.V.","INDIUM(111IN)CHLORIDESOLUTION|PENTETREOTIDE"
"6470","Octreotide 100 micrograms/1 ml Solution for Injection","0.1 milligram(s)/millilitre Solution for injection",2007-06-22,"PA0822/218/002","Pfizer Healthcare Ireland","OCTREOTIDEACETATE"
"6471","Octreotide 200 micrograms/ml Solution for Injection","0.2 milligram(s)/millilitre Solution for injection",2007-06-22,"PA0822/218/003","Pfizer Healthcare Ireland","OCTREOTIDEACETATE"
"6472","Octreotide 50 micrograms/1 ml Solution for Injection","0.05 milligram(s)/millilitre Solution for injection",2007-06-22,"PA0822/218/001","Pfizer Healthcare Ireland","OCTREOTIDEACETATE"
"6473","Octreotide 500 micrograms/1 ml Solution for Injection","0.5 milligram(s)/millilitre Solution for injection",2007-06-22,"PA0822/218/004","Pfizer Healthcare Ireland","OCTREOTIDEACETATE"
"6474","Odefsey (Formely: Emtricitabine Rilpivirine Tenofovir alafenamide Gilead)","200mg/25mg/25 milligram(s) Film-coated tablet",2016-06-21,"EU/1/16/1112/001-002","Gilead Sciences Ireland UC","Emtricitabine|Rilpivirine|Tenofoviralafenamide"
"6475","ODOMZO","200 Milligram                                                                                            Capsules Hard",2015-08-14,"EU/15/1030/001-002","Sun Pharmaceutical Industries Europe B.V.","SONIDEGIB"
"6476","ODRIK 0.5MG HARD CAPSULES","0.5 Milligram                                                                                            Capsules Hard",1992-11-25,"PA2010/005/001","Mylan IRE Healthcare Limited","TRANDOLAPRIL"
"6477","ODRIK 1 MG HARD CAPSULES","1.0 Milligram                                                                                            Capsules Hard",1992-11-25,"PA2010/005/002","Mylan IRE Healthcare Limited","TRANDOLAPRIL"
"6478","ODRIK 2 MG HARD CAPSULES","2 Milligram                                                                                            Capsules Hard",1992-11-25,"PA2010/005/003","Mylan IRE Healthcare Limited","TRANDOLAPRIL"
"6479","OESTROGEL","0.06 %w/w                                                                                                 Gel",1997-12-11,"PA1341/002/001","Besins Healthcare S.A.","ESTRADIOL"
"6480","OFCRAM SR","200 Milligram                                                                                            Prolonged Release Capsules",2013-11-04,"PA1338/013/001","Focus Pharmaceuticals Ltd","DIPYRIDAMOLE"
"6481","Ofev","100 milligram(s) Capsule, soft",2015-01-15,"EU/1/14/979/001-002","Boehringer Ingelheim International GmbH","Nintedanib"
"6482","Ofev","150 milligram(s) Capsule, soft",2015-01-15,"EU/1/14/979/003-004","Boehringer Ingelheim International GmbH","Nintedanib"
"6483","OILATUM CREAM","6.0/15.0 %w/w                                                                                                 Cream",2003-03-07,"PA0678/112/001","GlaxoSmithKline Consumer Healthcare (Ireland) Limited","LIQUIDPARAFFINLIGHT|WHITESOFTPARAFFIN"
"6484","OILATUM EMOLLIENT","63.4 %w/w                                                                                                 Bath Additive",1984-10-01,"PA0678/113/001","GlaxoSmithKline Consumer Healthcare (Ireland) Limited","LIQUIDPARAFFINLIGHT"
"6485","OILATUM JUNIOR EMOLLIENT","63.4 %w/w                                                                                                 Bath Additive",1998-02-06,"PA0678/113/002","GlaxoSmithKline Consumer Healthcare (Ireland) Limited","LIQUIDPARAFFINLIGHT"
"6486","OILATUM JUNIOR FLARE-UP","%v/v                                                                                                 Bath Additive",1989-05-25,"PA0678/115/001","GlaxoSmithKline Consumer Healthcare (Ireland) Limited","LIQUIDPARAFFINLIGHT|BENZALKONIUMCHLORIDE|TRICLOSAN"
"6487","OILATUM PLUS","52.5/6/2 %w/w                                                                                                 Bath Additive",1989-05-25,"PA0678/115/002","GlaxoSmithKline Consumer Healthcare (Ireland) Limited","BENZALKONIUMCHLORIDE|TRICLOSAN|LIQUIDPARAFFINLIGHT"
"6488","OILATUM SHOWER GEL","70 %w/w                                                                                                 Gel",1991-06-10,"PA0678/113/003","GlaxoSmithKline Consumer Healthcare (Ireland) Limited","LIGHTLIQUIDPARAFFIN"
"6489","OLANZAPINE","2.5 Milligram                                                                                            Film Coated Tablet",2009-11-27,"PA0126/210/001","Clonmel Healthcare Ltd","OLANZAPINE"
"6490","OLANZAPINE","5 Milligram                                                                                            Film Coated Tablet",2009-11-27,"PA0126/210/002","Clonmel Healthcare Ltd","OLANZAPINE"
"6491","OLANZAPINE","7.5 Milligram                                                                                            Film Coated Tablet",2009-11-27,"PA0126/210/003","Clonmel Healthcare Ltd","OLANZAPINE"
"6492","OLANZAPINE","10 Milligram                                                                                            Film Coated Tablet",2009-11-27,"PA0126/210/004","Clonmel Healthcare Ltd","OLANZAPINE"
"6493","OLANZAPINE","15 Milligram                                                                                            Film Coated Tablet",2009-11-27,"PA0126/210/005","Clonmel Healthcare Ltd","OLANZAPINE"
"6494","OLANZAPINE","20 Milligram                                                                                            Film Coated Tablet",2009-11-27,"PA0126/210/006","Clonmel Healthcare Ltd","OLANZAPINE"
"6495","OLANZAPINE ACCORD","2.5 Milligram                                                                                            Film Coated Tablet",2011-12-05,"PA1390/045/001","Accord Healthcare Limited","OLANZAPINE(FORM-1)"
"6496","OLANZAPINE ACCORD","5 Milligram                                                                                            Film Coated Tablet",2011-12-05,"PA1390/045/002","Accord Healthcare Limited","OLANZAPINE(FORM-1)"
"6497","OLANZAPINE ACCORD","7.5 Milligram                                                                                            Film Coated Tablet",2011-12-05,"PA1390/045/003","Accord Healthcare Limited","OLANZAPINEFORM1"
"6498","OLANZAPINE ACCORD","10 Milligram                                                                                            Film Coated Tablet",2011-12-05,"PA1390/045/004","Accord Healthcare Limited","OLANZAPINE(FORM-1)"
"6499","OLANZAPINE ACCORD","15 Milligram                                                                                            Film Coated Tablet",2011-12-05,"PA1390/045/005","Accord Healthcare Limited","OLANZAPINE(FORM-1)"
"6500","OLANZAPINE ACTAVIS","2.5 Milligram                                                                                            Film Coated Tablet",2009-12-18,"PA1380/043/001","Actavis Group PTC ehf","OLANZAPINE"
"6501","OLANZAPINE ACTAVIS","5 Milligram                                                                                            Film Coated Tablet",2009-12-18,"PA1380/043/002","Actavis Group PTC ehf","OLANZAPINE"
"6502","OLANZAPINE ACTAVIS","7.5 Milligram                                                                                            Film Coated Tablet",2009-12-18,"PA1380/043/003","Actavis Group PTC ehf","OLANZAPINE"
"6503","OLANZAPINE ACTAVIS","10 Milligram                                                                                            Film Coated Tablet",2009-12-18,"PA1380/043/004","Actavis Group PTC ehf","OLANZAPINE"
"6504","OLANZAPINE ACTAVIS","15 Milligram                                                                                            Film Coated Tablet",2009-12-18,"PA1380/043/005","Actavis Group PTC ehf","OLANZAPINE"
"6505","Olanzapine Actavis 10mg Orodispersible Tablets","10 milligram(s) Orodispersible tablet",2010-08-06,"PA1380/104/002","Actavis Group PTC ehf","Olanzapine"
"6506","Olanzapine Actavis 15mg Orodispersible Tablets","15 milligram(s) Orodispersible tablet",2010-08-06,"PA1380/104/003","Actavis Group PTC ehf","Olanzapine"
"6507","Olanzapine Actavis 20mg Orodispersible Tablets","20 milligram(s) Orodispersible tablet",2010-08-06,"PA1380/104/004","Actavis Group PTC ehf","Olanzapine"
"6508","Olanzapine Actavis 5 mg Orodispersible Tablets","5 milligram(s) Orodispersible tablet",2010-08-06,"PA1380/104/001","Actavis Group PTC ehf","Olanzapine"
"6509","OLANZAPINE APOTEX","2.5 Milligram                                                                                            Film Coated Tablet",2010-06-10,"EU/1/10/635/001","Apotex Europe B.V.","OLANZAPINE"
"6510","OLANZAPINE APOTEX","5 Milligram                                                                                            Film Coated Tablet",2010-06-10,"EU/1/10/635/002-3","Apotex Europe B.V.","OLANZAPINE"
"6511","OLANZAPINE APOTEX","7.5 Milligram                                                                                            Film Coated Tablet",2010-06-10,"EU/1/10/635/004-5","Apotex Europe B.V.","OLANZAPINE"
"6512","OLANZAPINE APOTEX","10 Milligram                                                                                            Film Coated Tablet",2010-06-10,"EU/1/10/635/006-7","Apotex Europe B.V.","OLANZAPINE"
"6513","OLANZAPINE APOTEX","5 Milligram                                                                                            Orodispersible Tablet",2010-06-10,"EU/1/10/635/008-9","Apotex Europe B.V.","OLANZAPINE"
"6514","OLANZAPINE APOTEX","10 Milligram                                                                                            Orodispersible Tablet",2010-06-10,"EU/1/10/635/010-11","Apotex Europe B.V.","OLANZAPINE"
"6515","OLANZAPINE APOTEX","15 Milligram                                                                                            Orodispersible Tablet",2010-06-10,"EU/1/10/635/012","Apotex Europe B.V.","OLANZAPINE"
"6516","OLANZAPINE APOTEX","20 Milligram                                                                                            Orodispersible Tablet",2010-06-10,"EU/1/10/635/013-14","Apotex Europe B.V.","OLANZAPINE"
"6517","OLANZAPINE GLENMARK","10 Milligram                                                                                            Tablets",2009-12-03,"EU/1/09/587/10-12","Glenmark Pharmaceuticals Europe Limited","OLANZAPINE"
"6518","OLANZAPINE GLENMARK","2.5 Milligram                                                                                            Tablets",2009-12-03,"EU/1/09/587/1-3","Glenmark Pharmaceuticals Europe Limited","OLANZAPINE"
"6519","OLANZAPINE GLENMARK","15 Milligram                                                                                            Tablets",2009-12-03,"EU/1/09/587/13-15","Glenmark Pharmaceuticals Europe Limited","OLANZAPINE"
"6520","OLANZAPINE GLENMARK","20 Milligram                                                                                            Tablets",2009-12-03,"EU/1/09/587/16-17","Glenmark Pharmaceuticals Europe Limited","OLANZAPINE"
"6521","OLANZAPINE GLENMARK","5 Milligram                                                                                            Tablets",2009-12-03,"EU/1/09/587/4-6","Glenmark Pharmaceuticals Europe Limited","OLANZAPINE"
"6522","OLANZAPINE GLENMARK","7.5 Milligram                                                                                            Tablets",2009-12-03,"EU/1/09/587/7-9","Glenmark Pharmaceuticals Europe Limited","OLANZAPINE"
"6523","OLANZAPINE GLENMARK EUROPE","20 Milligram                                                                                            Orodispersible Tablet",2009-12-03,"EU/1/09/588/10-12","Glenmark Pharmaceuticals Europe Limited","OLANZAPINE"
"6524","OLANZAPINE GLENMARK EUROPE","5 Milligram                                                                                            Orodispersible Tablet",2009-12-03,"EU/1/09/588/1-3","Glenmark Pharmaceuticals Europe Limited","OLANZAPINE"
"6525","OLANZAPINE GLENMARK EUROPE","10 Milligram                                                                                            Orodispersible Tablet",2009-12-03,"EU/1/09/588/4-6","Glenmark Pharmaceuticals Europe Limited","OLANZAPINE"
"6526","OLANZAPINE GLENMARK EUROPE","15 Milligram                                                                                            Orodispersible Tablet",2009-12-03,"EU/1/09/588/7-9","Glenmark Pharmaceuticals Europe Limited","OLANZAPINE"
"6527","OLANZAPINE MYLAN","7.5 Milligram                                                                                            Film Coated Tablet",2008-10-07,"EU/1/08/475/13-17","Generics (UK) Limited","OLANZAPINE"
"6528","OLANZAPINE MYLAN","2.5 Milligram                                                                                            Film Coated Tablet",2008-10-07,"EU/1/08/475/1-6","Generics (UK) Limited","OLANZAPINE"
"6529","OLANZAPINE MYLAN","10 Milligram                                                                                            Film Coated Tablet",2008-10-07,"EU/1/08/475/18-24","Generics (UK) Limited","OLANZAPINE"
"6530","OLANZAPINE MYLAN","15 Milligram                                                                                            Film Coated Tablet",2008-10-07,"EU/1/08/475/25-29","Generics (UK) Limited","OLANZAPINE"
"6531","OLANZAPINE MYLAN","20 Milligram                                                                                            Film Coated Tablet",2008-10-07,"EU/1/08/475/30-34","Generics (UK) Limited","OLANZAPINE"
"6532","OLANZAPINE MYLAN","5 Milligram                                                                                            Film Coated Tablet",2008-10-07,"EU/1/08/475/7-12","Generics (UK) Limited","OLANZAPINE"
"6533","OLANZAPINE TEVA","5 Milligram                                                                                            Film Coated Tablet",2007-12-12,"EU/1/07/427/049","Teva B.V.","OLANZAPINE"
"6534","OLANZAPINE TEVA","7.5 Milligram                                                                                            Film Coated Tablet",2007-12-12,"EU/1/07/427/050","Teva B.V.","OLANZAPINE"
"6535","OLANZAPINE TEVA","10 Milligram                                                                                            Film Coated Tablet",2007-12-12,"EU/1/07/427/11-14","Teva B.V.","OLANZAPINE"
"6536","OLANZAPINE TEVA","2.5 Milligram                                                                                            Film Coated Tablet",2007-12-12,"EU/1/07/427/1-3","Teva B.V.","OLANZAPINE"
"6537","OLANZAPINE TEVA","15 Milligram                                                                                            Film Coated Tablet",2007-12-12,"EU/1/07/427/16-19","Teva B.V.","OLANZAPINE"
"6538","OLANZAPINE TEVA","20 Milligram                                                                                            Film Coated Tablet",2007-12-12,"EU/1/07/427/20-22","Teva B.V.","OLANZAPINE"
"6539","OLANZAPINE TEVA","5 Milligram                                                                                            Orodispersible Tablet",2007-12-12,"EU/1/07/427/23-26","Teva B.V.","OLANZAPINE"
"6540","OLANZAPINE TEVA","10 Milligram                                                                                            Orodispersible Tablet",2007-12-12,"EU/1/07/427/27-30","Teva B.V.","OLANZAPINE"
"6541","OLANZAPINE TEVA","15 Milligram                                                                                            Orodispersible Tablet",2007-12-12,"EU/1/07/427/31-34","Teva B.V.","OLANZAPINE"
"6542","OLANZAPINE TEVA","20 Milligram                                                                                            Orodispersible Tablet",2007-12-12,"EU/1/07/427/35-37","Teva B.V.","OLANZAPINE"
"6543","OLAZAX","5 Milligram                                                                                            Tablets",2009-12-11,"EU/1/09/597/001","Glenmark Pharmaceuticals s.r.o.","OLANZAPINEI"
"6544","OLAZAX","7.5 Milligram                                                                                            Tablets",2009-12-11,"EU/1/09/597/002","Glenmark Pharmaceuticals s.r.o.","OLANZAPINEI"
"6545","OLAZAX","10 Milligram                                                                                            Tablets",2009-12-11,"EU/1/09/597/003","Glenmark Pharmaceuticals s.r.o.","OLANZAPINEI"
"6546","OLAZAX","15 Milligram                                                                                            Tablets",2009-12-11,"EU/1/09/597/004","Glenmark Pharmaceuticals s.r.o.","OLANZAPINEI"
"6547","OLAZAX","20 Milligram                                                                                            Tablets",2009-12-11,"EU/1/09/597/005","Glenmark Pharmaceuticals s.r.o.","OLANZAPINEI"
"6548","OLAZAX DISPERZI","5 Milligram                                                                                            Orodispersible Tablet",2009-12-10,"EU/1/09/592/001","Glenmark Pharmaceuticals s.r.o.","OLANZAPINE"
"6549","OLAZAX DISPERZI","7.5 Milligram                                                                                            Orodispersible Tablet",2009-12-10,"EU/1/09/592/002","Glenmark Pharmaceuticals s.r.o.","OLANZAPINE"
"6550","OLAZAX DISPERZI","10 Milligram                                                                                            Orodispersible Tablet",2009-12-10,"EU/1/09/592/003","Glenmark Pharmaceuticals s.r.o.","OLANZAPINE"
"6551","OLAZAX DISPERZI","15 Milligram                                                                                            Orodispersible Tablet",2009-12-10,"EU/1/09/592/004","Glenmark Pharmaceuticals s.r.o.","OLANZAPINE"
"6552","OLAZAX DISPERZI","20 Milligram                                                                                            Orodispersible Tablet",2009-12-10,"EU/1/09/592/005","Glenmark Pharmaceuticals s.r.o.","OLANZAPINE"
"6553","OLBAS FOR CHILDREN","%w/w                                                                                                 Inhalation Vapour Liquid",2012-08-03,"PA0257/015/004","GR Lane Health Products Ltd","MELALEUCALEUCADENDRON|EUCALYPTUSGLOBULUS|LEVOMENTHOL|MINTOIL,PARTLYDEMENTHOLISED|METHYLSALICYLATE"
"6554","Olbas Inhaler nasal stick","percent volume/volume Nasal stick",1997-09-05,"PA0257/015/003","GR Lane Health Products Ltd","CajuputOil|Levomenthol|EucalyptusOil|Peppermintoil"
"6555","Olbas Oil","*** AWAITING VALUE *** Inhalation vapour, liquid",1988-09-01,"PA0257/015/001","GR Lane Health Products Ltd","CajuputOil|CloveOil|EucalyptusOil|JuniperOil|Levomenthol|Mintoil,partlydementholised|MethylSalicylate"
"6556","OLBAS PASTILLES","%v/v                                                                                                 Lozenges",1996-06-10,"PA0257/015/002","GR Lane Health Products Ltd","OILOFEUCALIPTUS|OILOFPEPPERMINT|MENTHOL|JUNIPERBERRYOIL|METHYLSALICYLATE|CLOVEOIL"
"6557","Olena 20mg Dispersible Tablets","20 milligram(s) Dispersible tablet",2013-10-04,"PA0899/042/001","Mercury Pharmaceuticals Ltd","FLUOXETINEHYDROCHLORIDE"
"6558","Olmesartan /Amlodipine Mylan 20 mg/ 5 mg film coated tablets","20mg/5 milligram(s) Film-coated tablet",2018-05-18,"PA0577/185/001","McDermott Laboratories Ltd t/a Gerard Laboratories","Olmesartanmedoxomil|Amlodpinebesilate"
"6559","Olmesartan /Amlodipine Mylan 40 mg/ 10 mg film coated tablets","40mg/10 milligram(s) Film-coated tablet",2018-05-18,"PA0577/185/003","McDermott Laboratories Ltd t/a Gerard Laboratories","Olmesartanmedoxomil|Amlodpinebesilate"
"6560","Olmesartan /Amlodipine Mylan 40 mg/ 5 mg film coated tablets","40mg/5 milligram(s) Film-coated tablet",2018-05-18,"PA0577/185/002","McDermott Laboratories Ltd t/a Gerard Laboratories","Olmesartanmedoxomil|Amlodpinebesilate"
"6561","Olmesartan Hydrochlorothiazide Rowex 20mg/12.5mg Film-coated tablets","20/12.5 milligram(s) Film-coated tablet",2015-08-13,"PA0711/240/001","Rowex Ltd","Olmesartanmedoxomil|Hydrochlorothiazide"
"6562","Olmesartan Hydrochlorothiazide Rowex 20mg/25mg Film-coated tablets","20/25 milligram(s) Film-coated tablet",2015-08-13,"PA0711/240/002","Rowex Ltd","Olmesartanmedoxomil|Hydrochlorothiazide"
"6563","Olmesartan Hydrochlorothiazide Rowex 40mg/12.5mg Film-coated tablets","40/12.5 milligram(s) Film-coated tablet",2015-08-13,"PA0711/240/003","Rowex Ltd","Olmesartanmedoxomil|Hydrochlorothiazide"
"6564","Olmesartan Hydrochlorothiazide Rowex 40mg/25mg Film-coated tablets","40/25 milligram(s) Film-coated tablet",2015-08-13,"PA0711/240/004","Rowex Ltd","Olmesartanmedoxomil|Hydrochlorothiazide"
"6565","OLMESARTAN KRKA","10  Film Coated Tablet",2016-06-10,"PA1347/060/001","Krka d.d., Novo mesto","OLMESARTANMEDOXOMIL"
"6566","OLMESARTAN KRKA","20 Milligram                                                                                            Film Coated Tablet",2016-06-10,"PA1347/060/002","Krka d.d., Novo mesto","OLMESARTANMEDOXOMIL"
"6567","OLMESARTAN KRKA","40 Milligram                                                                                            Film Coated Tablet",2016-06-10,"PA1347/060/003","Krka d.d., Novo mesto","OLMESARTANMEDOXOMIL"
"6568","OLMESARTAN MEDOXOMIL","10 Milligram                                                                                            Film Coated Tablet",2016-01-29,"PA1390/105/001","Accord Healthcare Limited","OLMESARTANMEDOXOMIL"
"6569","OLMESARTAN MEDOXOMIL","20 Milligram                                                                                            Film Coated Tablet",2016-01-29,"PA1390/105/002","Accord Healthcare Limited","OLMESARTANMEDOXOMIL"
"6570","OLMESARTAN MEDOXOMIL","40 Milligram                                                                                            Film Coated Tablet",2016-01-29,"PA1390/105/003","Accord Healthcare Limited","OLMESARTANMEDOXOMIL"
"6571","OLMESARTAN MEDOXOMIL","10 Milligram                                                                                            Film Coated Tablet",2015-07-10,"PA1462/013/001","Glenmark Pharmaceuticals Europe Limited","OLMESARTANMEDOXOMIL"
"6572","OLMESARTAN MEDOXOMIL","20 Milligram                                                                                            Film Coated Tablet",2015-07-10,"PA1462/013/002","Glenmark Pharmaceuticals Europe Limited","OLMESARTANMEDOXOMIL"
"6573","OLMESARTAN MEDOXOMIL","40 Milligram                                                                                            Film Coated Tablet",2015-07-10,"PA1462/013/003","Glenmark Pharmaceuticals Europe Limited","OLMESARTANMEDOXOMIL"
"6574","OLMESARTAN MEDOXOMIL","10 Milligram                                                                                            Film Coated Tablet",2015-01-09,"PA0405/065/001","Generics (UK) Limited","OLMESARTANMEDOXOMIL"
"6575","OLMESARTAN MEDOXOMIL","20 Milligram                                                                                            Film Coated Tablet",2015-01-09,"PA0405/065/002","Generics (UK) Limited","OLMESARTANMEDOXOMIL"
"6576","OLMESARTAN MEDOXOMIL","40 Milligram                                                                                            Film Coated Tablet",2015-01-09,"PA0405/065/003","Generics (UK) Limited","OLMESARTANMEDOXOMIL"
"6577","Olmesartan Medoxomil Clonmel 10 mg film-coated tablet","10 milligram(s) Film-coated tablet",2016-05-20,"PA0126/273/001","Clonmel Healthcare Ltd","Olmesartanmedoxomil"
"6578","Olmesartan Medoxomil Clonmel 20 mg film-coated tablet","20 milligram(s) Film-coated tablet",2016-05-20,"PA0126/273/002","Clonmel Healthcare Ltd","Olmesartanmedoxomil"
"6579","Olmesartan Medoxomil Clonmel 40 mg film-coated tablet","40 milligram(s) Film-coated tablet",2016-05-20,"PA0126/273/003","Clonmel Healthcare Ltd","Olmesartanmedoxomil"
"6580","OLMESARTAN MEDOXOMIL TEVA","10 Milligram                                                                                            Film Coated Tablet",2010-07-09,"PA0749/108/001","Teva Pharma B.V.","OLMESARTANMEDOXOMIL"
"6581","OLMESARTAN MEDOXOMIL TEVA","20 Milligram                                                                                            Film Coated Tablet",2010-07-09,"PA0749/108/002","Teva Pharma B.V.","OLMESARTANMEDOXOMIL"
"6582","OLMESARTAN MEDOXOMIL TEVA","40 Milligram                                                                                            Film Coated Tablet",2010-07-09,"PA0749/108/003","Teva Pharma B.V.","OLMESARTANMEDOXOMIL"
"6583","Olmesartan medoxomil/Amlodipine 20 mg/5 mg film-coated tablets","20/5 ZZZ mg/mg Film-coated tablet",2018-01-05,"PA1390/131/001","Accord Healthcare Limited","Olmesartanmedoxomil|Amlodipine(asamlodipinebesilateph.eur.)"
"6584","Olmesartan medoxomil/Amlodipine 40 mg/10 mg film-coated tablets","40/10 ZZZ mg/mg Film-coated tablet",2018-01-05,"PA1390/131/003","Accord Healthcare Limited","Amlodipine(asamlodipinebesilateph.eur.)|Olmesartanmedoxomil"
"6585","Olmesartan medoxomil/Amlodipine 40 mg/5 mg film-coated tablets","40/5 ZZZ mg/mg Film-coated tablet",2018-01-05,"PA1390/131/002","Accord Healthcare Limited","Amlodipine(asamlodipinebesilateph.eur.)|Olmesartanmedoxomil"
"6586","Olmesartan Medoxomil/Hydrochlorothiazide 20 mg/12.5 mg film-coated tablets","20/12.5 *** AWAITING VALUE *** Film-coated tablet",2017-08-18,"PA1390/127/001","Accord Healthcare Limited","Hydrochlorothiazideep|Olmesartanmedoxomil"
"6587","OLMESARTAN MEDOXOMIL/HYDROCHLOROTHIAZIDE ACCORD","20/25 Milligram                                                                                            Film Coated Tablet",2017-08-18,"PA1390/127/002","Accord Healthcare Limited","OLMESARTANMEDOXOMIL|HYDROCHLOROTHIAZIDEEP"
"6588","OLMESARTAN MEDOXOMIL/HYDROCHLOROTHIAZIDE ACCORD","40/12.5 Milligram                                                                                            Film Coated Tablet",2017-08-18,"PA1390/127/003","Accord Healthcare Limited","OLMESARTANMEDOXOMIL|HYDROCHLOROTHIAZIDEEP"
"6589","OLMESARTAN MEDOXOMIL/HYDROCHLOROTHIAZIDE ACCORD","40/25 Milligram                                                                                            Film Coated Tablet",2017-08-18,"PA1390/127/004","Accord Healthcare Limited","OLMESARTANMEDOXOMIL|HYDROCHLOROTHIAZIDEEP"
"6590","OLMESARTAN ROWEX","10 Milligram                                                                                            Film Coated Tablet",2016-04-15,"PA0711/255/001","Rowex Ltd","OLMESARTANMEDOXOMIL"
"6591","OLMESARTAN ROWEX","20 Milligram                                                                                            Film Coated Tablet",2016-04-15,"PA0711/255/002","Rowex Ltd","OLMESARTANMEDOXOMIL"
"6592","OLMESARTAN ROWEX","40 Milligram                                                                                            Film Coated Tablet",2016-04-15,"PA0711/255/003","Rowex Ltd","OLMESARTANMEDOXOMIL"
"6593","Olmesartan/Amlodipine Clonmel 20 mg/5 mg film-coated tablets","20/5 milligram(s) Film-coated tablet",2017-12-15,"PA0126/293/001","Clonmel Healthcare Ltd","Olmesartanmedoxomil|Amlodipinebesilate"
"6594","Olmesartan/Amlodipine Clonmel 40 mg/10 mg film-coated tablets","40/10 milligram(s) Film-coated tablet",2017-12-15,"PA0126/293/003","Clonmel Healthcare Ltd","Olmesartanmedoxomil|Amlodipinebesilate"
"6595","Olmesartan/Amlodipine Clonmel 40 mg/5 mg film-coated tablets","40/5 milligram(s) Film-coated tablet",2017-12-15,"PA0126/293/002","Clonmel Healthcare Ltd","Olmesartanmedoxomil|Amlodipinebesilate"
"6596","OLMESARTAN/AMLODIPINE KRKA","20/5 mg/mg Film Coated Tablet",2017-08-18,"PA1347/075/001","Krka d.d., Novo mesto","OLMESARTANMEDOXOMIL|AMLODIPINEBESILATE"
"6597","OLMESARTAN/AMLODIPINE KRKA","40/5 mg/mg Film Coated Tablet",2017-08-18,"PA1347/075/002","Krka d.d., Novo mesto","OLMESARTANMEDOXOMIL|AMLODIPINEBESILATE"
"6598","OLMESARTAN/AMLODIPINE KRKA","40/10 mg/mg Film Coated Tablet",2017-08-18,"PA1347/075/003","Krka d.d., Novo mesto","OLMESARTANMEDOXOMIL|AMLODIPINEBESILATE"
"6599","Olmesartan/Hydrochlorothiazide Clonmel 20 mg/12.5 mg film-coated tablets","20/12.5 milligram(s) Film-coated tablet",2016-05-20,"PA0126/260/001","Clonmel Healthcare Ltd","Olmesartanmedoxomil|Hydrochlorothiazide"
"6600","Olmesartan/Hydrochlorothiazide Clonmel 20 mg/25 mg film-coated tablets","20/25 milligram(s) Film-coated tablet",2016-05-20,"PA0126/260/002","Clonmel Healthcare Ltd","Olmesartanmedoxomil|Hydrochlorothiazide"
"6601","Olmesartan/Hydrochlorothiazide Clonmel 40 mg/12.5 mg film-coated tablets","40/12.5 milligram(s) Film-coated tablet",2016-05-20,"PA0126/260/003","Clonmel Healthcare Ltd","Olmesartanmedoxomil|Hydrochlorothiazide"
"6602","Olmesartan/Hydrochlorothiazide Clonmel 40 mg/25 mg film-coated tablets","40/25 milligram(s) Film-coated tablet",2016-05-20,"PA0126/260/004","Clonmel Healthcare Ltd","Olmesartanmedoxomil|Hydrochlorothiazide"
"6603","OLMESARTAN/HYDROCHLOROTHIAZIDE KRKA","20mg/12.5 Milligram                                                                                            Film Coated Tablet",2016-07-08,"PA1347/061/001","Krka d.d., Novo mesto","OLMESARTANMEDOXOMIL|HYDROCHLOROTHIAZIDE"
"6604","OLMESARTAN/HYDROCHLOROTHIAZIDE KRKA","20mg/25 Milligram                                                                                            Film Coated Tablet",2016-07-08,"PA1347/061/002","Krka d.d., Novo mesto","OLMESARTANMEDOXOMIL|HYDROCHLOROTHIAZIDE"
"6605","OLMESARTAN/HYDROCHLOROTHIAZIDE KRKA","40mg/12.5 Milligram                                                                                            Film Coated Tablet",2016-07-08,"PA1347/061/003","Krka d.d., Novo mesto","OLMESARTANMEDOXOMIL|HYDROCHLOROTHIAZIDE"
"6606","OLMESARTAN/HYDROCHLOROTHIAZIDE KRKA","40mg/25 Milligram                                                                                            Film Coated Tablet",2016-07-08,"PA1347/061/004","Krka d.d., Novo mesto","OLMESARTANMEDOXOMIL|HYDROCHLOROTHIAZIDE"
"6607","Olmesartan/Hydrochlorothiazide STADA Arzneimittel AG 20 mg/12.5 mg film-coated tablets","20/12.5 milligram(s) Film-coated tablet",2017-03-10,"PA0593/039/001","Stada Arzneimittel AG","Olmesartanmedoxomil|Hydrochlorothiazide"
"6608","Olmesartan/Hydrochlorothiazide STADA Arzneimittel AG 20 mg/25 mg film-coated tablets","20/25 milligram(s) Film-coated tablet",2017-03-10,"PA0593/039/002","Stada Arzneimittel AG","Olmesartanmedoxomil|Hydrochlorothiazide"
"6609","Olmesartan/Hydrochlorothiazide STADA Arzneimittel AG 40 mg/12.5 mg film-coated tablets","40/12.5 milligram(s) Film-coated tablet",2017-03-10,"PA0593/039/003","Stada Arzneimittel AG","Olmesartanmedoxomil|Hydrochlorothiazide"
"6610","Olmesartan/Hydrochlorothiazide STADA Arzneimittel AG 40 mg/25 mg film-coated tablets","40/25 milligram(s) Film-coated tablet",2017-03-10,"PA0593/039/004","Stada Arzneimittel AG","Olmesartanmedoxomil|Hydrochlorothiazide"
"6611","Olumiant","2 milligram(s) Film-coated tablet",NA,"EU/1/16/1170/001-008","Eli Lilly Nederland B.V.","Baricitinib"
"6612","OLUMIANT","4 Milligram                                                                                            Film Coated Tablet",2017-02-13,"EU/1/16/1170/009-016","Eli Lilly Nederland B.V.","BARICITINIB"
"6613","OMACOR","1000 Milligram                                                                                            Capsules, Soft",2014-06-20,"PPA0465/335/001","PCO Manufacturing","OMEGA-3-ACIDETHYLESTERS90"
"6614","OMACOR","1000 Milligram                                                                                            Capsules, Soft",2011-02-18,"PPA1463/042/001","IMED Healthcare Ltd.","OMEGA-3-ACIDETHYLESTERS"
"6615","OMACOR","1000 Milligram                                                                                            Capsules, Soft",2016-11-11,"PPA1562/189/001","LTT Pharma Limited","OMEGA-3-ACIDETHYLESTERS"
"6616","Omacor 1000 mg Soft Capsules","1000 milligram(s) Capsule, soft",2003-08-08,"PA1099/001/001","Pronova BioPharma Norge AS","Omega-3-acidethylesters"
"6617","Omeflex peri emulsion for infusion","0 *** AWAITING VALUE *** Emulsion for infusion",2017-02-10,"PA0736/033/002","B. Braun Melsungen AG","Isoleucine|Leucine|Lysinehydrochloride|Methionine|Phenylalanine|Threonine|Tryptophan|Valine|Arginine|Histidinehyprochloridemonohydrate|Alanine|Asparticacid|Glutamicacid|Glycine|Proline|Serine|Sodiumhydroxide|Sodiumchloride|Sodiumacetatetrihydrate|Potassiumacetate|Magnesiumacetatetetrahydrate|Calciumchloridedihydrate|Glucosemonohydrate|Sodiumdihydrogenphosphatedihydrate|Zincacetatedihydrate|Triglycerides,mediumchain|SOYABEANOIL,REFINEDPH.EUR.|Soyabeanoil,refined|Omega-3-acidtriglycerides"
"6618","Omeflex plus emulsion for infusion","0 *** AWAITING VALUE *** Emulsion for infusion",2017-02-03,"PA0736/039/001","B. Braun Melsungen AG","Isoleucine|Leucine|Lysinehydrochloride|Methionine|Phenylalanine|Threonine|Tryptophan|Valine|Arginine|Histidinehyprochloridemonohydrate|Alanine|Asparticacid|Glutamicacid|GLYCINE|Proline|Serine|Sodiumhydroxide|Sodiumchloride|Potassiumacetate|Magnesiumacetatetetrahydrate|Calciumchloridedihydrate|Glucosemonohydrate|Sodiumdihydrogenphosphatedihydrate|Zincacetatedihydrate|Triglyceridesmedium-chain|Omega-3-acidtriglycerides"
"6619","Omeflex special emulsion for infusion","0 *** AWAITING VALUE *** Emulsion for infusion",2017-02-03,"PA0736/040/001","B. Braun Melsungen AG","Isoleucine|Leucine|Lysinehydrochloride|Methionine|Phenylalanine|Threonine|Tryptophan|Valine|Arginine|Histidinehyprochloridemonohydrate|Alanine|Asparticacid|Glutamicacid|GLYCINE|Proline|Serine|Sodiumhydroxide|Sodiumchloride|Sodiumacetatetrihydrate|Potassiumacetate|Magnesiumacetatetetrahydrate|Calciumchloridedihydrate|Glucosemonohydrate|Sodiumdihydrogenphosphatedihydrate|Zincacetatedihydrate|Triglycerides,mediumchain|Soya-beanoil,refined|Soyabeanoil,refined|Omega-3-acidtriglycerides"
"6620","Omeflex special without electrolytes emulsion for infusion","0 millilitre(s) Emulsion for infusion",2017-02-03,"PA0736/038/001","B. Braun Melsungen AG","Isoleucine|Leucine|Lysinemonohydrate|Methionine|Phenylalanine|Threonine|Tryptophan|Valine|Arginine|Histidine|Alanine|Asparticacid|Glutamicacid|GLYCINE|Proline|Serine|Glucosemonohydrate|Triglyceridesmedium-chain|SOYABEANOIL,REFINEDPH.EUR.|Omega-3-acidtriglycerides"
"6621","OMEPRAZOLE","10 Milligram                                                                                            Tablets Gastro-Resistant",2015-08-21,"PA0577/178/001","McDermott Laboratories Ltd t/a Gerard Laboratories","OMEPRAZOLEMAGNESIUM"
"6622","OMEPRAZOLE","10 Milligram                                                                                            Capsules Gastro-Resistant",2015-06-12,"PPA0565/056/002","WPR Healthcare Limited","OMEPRAZOLE"
"6623","Omeprazole 10 mg Gastro-resistant Capsules, hard","10 milligram(s) Gastro-resistant capsule",2017-02-03,"PA0405/102/001","Generics (UK) Limited","Omeprazole"
"6624","Omeprazole 20 mg Gastro-resistant Capsules, hard","20 milligram(s) Gastro-resistant capsule",2017-02-03,"PA0405/102/002","Generics (UK) Limited","Omeprazole"
"6625","Omeprazole 20 mg Gastro-resistant Capsules, hard","20 milligram(s) Gastro-resistant capsule",2015-04-17,"PPA0565/056/001","WPR Healthcare Limited","Omeprazole"
"6626","Omeprazole 20 mg gastro-resistant tablets","20 milligram(s) Gastro-resistant tablet",2015-08-21,"PA0577/178/002","McDermott Laboratories Ltd t/a Gerard Laboratories","Omeprazolemagnesium"
"6627","Omeprazole 40 mg Gastro-resistant Capsules, hard","40 milligram(s) Gastro-resistant capsule",2017-02-03,"PA0405/102/003","Generics (UK) Limited","Omeprazole"
"6628","Omeprazole 40 mg Gastro-resistant Capsules, hard","40 milligram(s) Gastro-resistant capsule",2015-06-12,"PPA0565/056/003","WPR Healthcare Limited","Omeprazole"
"6629","Omeprazole 40 mg gastro-resistant tablets","40 milligram(s) Gastro-resistant tablet",2015-08-21,"PA0577/178/003","McDermott Laboratories Ltd t/a Gerard Laboratories","Omeprazolemagnesium"
"6630","Omeprazole Actavis 10 mg gastro-resistant capsules, hard","10 milligram(s) Gastro-resistant capsule",2010-03-19,"PA1380/085/001","Actavis Group PTC ehf","Omeprazole"
"6631","Omeprazole Actavis 20 mg gastro-resistant capsules, hard","20 milligram(s) Gastro-resistant capsule",2010-03-19,"PA1380/085/002","Actavis Group PTC ehf","Omeprazole"
"6632","Omeprazole Actavis 40 mg gastro-resistant capsules, hard","40 milligram(s) Gastro-resistant capsule",2010-03-19,"PA1380/085/003","Actavis Group PTC ehf","Omeprazole"
"6633","Omeprazole Bluefish 10 mg gastro-resistant capsules","10 milligram(s) Gastro-resistant capsule",2007-06-01,"PA1436/007/001","Bluefish Pharmaceuticals AB","Omeprazole"
"6634","Omeprazole Bluefish 20 mg gastro-resistant capsules","20 milligram(s) Gastro-resistant capsule",2007-06-01,"PA1436/007/002","Bluefish Pharmaceuticals AB","Omeprazole"
"6635","Omeprazole Bluefish 40 mg gastro-resistant capsules","40 milligram(s) Gastro-resistant capsule",2007-06-01,"PA1436/007/003","Bluefish Pharmaceuticals AB","Omeprazole"
"6636","OMEPRAZOLE MYLAN","10 Milligram                                                                                            Capsules Gastro-Resistant",2011-05-06,"PA0577/150/001","McDermott Laboratories Ltd t/a Gerard Laboratories","OMEPRAZOLE"
"6637","Omeprazole Mylan 20 mg Gastro-resistant capsules, hard","20 milligram(s) Gastro-resistant capsule",2011-05-06,"PA0577/150/002","McDermott Laboratories Ltd t/a Gerard Laboratories","Omeprazole"
"6638","Omeprazole Mylan 40 mg Gastro-resistant capsules, hard","40 milligram(s) Gastro-resistant capsule",2011-05-06,"PA0577/150/003","McDermott Laboratories Ltd t/a Gerard Laboratories","Omeprazole"
"6639","Omeprazole Pinewood 20 mg gastro-resistant capsules, hard","20 milligram(s) Gastro-resistant capsule",2003-11-18,"PA0281/152/001","Pinewood Laboratories Ltd,","Omeprazole"
"6640","OMEPRAZOLE ROWA","10 Milligram                                                                                            Capsules Gastro-Resistant",2005-02-04,"PA0074/075/001","Rowa Pharmaceuticals Limited","OMEPRAZOLE"
"6641","Omeprazole Rowa 20 mg Gastro-resistant Capsules, hard","20 milligram(s) Gastro-resistant capsule",2005-02-04,"PA0074/075/002","Rowa Pharmaceuticals Limited","Omeprazole"
"6642","Omeprazole Rowa 40 mg Gastro-Resistant Capsules, hard","40 milligram(s) Gastro-resistant capsule",2005-02-04,"PA0074/075/003","Rowa Pharmaceuticals Limited","Omeprazole"
"6643","Omeprazole Teva 10 mg Gastro-resistant Capsules, hard","10 milligram(s) Gastro-resistant capsule",2013-02-15,"PA0749/160/001","Teva Pharma B.V.","Omeprazole"
"6644","Omeprazole Teva 20 mg Gastro-resistant Capsules, hard","20 milligram(s) Gastro-resistant capsule",2013-02-15,"PA0749/160/002","Teva Pharma B.V.","Omeprazole"
"6645","Omeprazole Teva 40 mg Gastro-resistant Capsules, hard","40 milligram(s) Gastro-resistant capsule",2013-02-15,"PA0749/160/003","Teva Pharma B.V.","Omeprazole"
"6646","OMEPRAZOLE TEVA PHARMA","10 Milligram                                                                                            Capsules Gastro-Resistant",2007-06-01,"PA0749/092/001","Teva Pharma B.V.","OMEPRAZOLE"
"6647","Omeprazole Teva Pharma 20 mg Gastro-resistant capsules, hard","20 milligram(s) Gastro-resistant capsule",2007-06-01,"PA0749/092/002","Teva Pharma B.V.","Omeprazole"
"6648","Omeprazole Teva Pharma 40 mg Gastro-resistant capsules, hard","40 milligram(s) Gastro-resistant capsule",2007-06-01,"PA0749/092/003","Teva Pharma B.V.","Omeprazole"
"6649","OMESAR","10 Milligram                                                                                            Film Coated Tablet",2003-09-19,"PA0865/011/001","Menarini International Operations Luxembourg S.A.","OLMESARTANMEDOXOMIL"
"6650","OMESAR","20 Milligram                                                                                            Film Coated Tablet",2003-09-19,"PA0865/011/002","Menarini International Operations Luxembourg S.A.","OLMESARTANMEDOXOMIL"
"6651","OMESAR","40 Milligram                                                                                            Film Coated Tablet",2003-09-19,"PA0865/011/003","Menarini International Operations Luxembourg S.A.","OLMESARTANMEDOXOMIL"
"6652","OMESAR","10 Milligram                                                                                            Film Coated Tablet",2011-07-22,"PPA0465/271/001","PCO Manufacturing","OLMESARTANMEDOXOMIL"
"6653","OMESAR","20 Milligram                                                                                            Film Coated Tablet",2011-04-01,"PPA0465/263/001","PCO Manufacturing","OLMESARTANMEDOXOMIL"
"6654","OMESAR","40 Milligram                                                                                            Film Coated Tablet",2011-04-08,"PPA0465/263/002","PCO Manufacturing","OLMESARTANMEDOXOMIL"
"6655","OMESAR","10 Milligram                                                                                            Film Coated Tablet",2015-05-29,"PPA1151/154/002","Imbat Limited","OLMESARTANMEDOXOMIL"
"6656","OMESAR","20 Milligram                                                                                            Film Coated Tablet",2015-05-29,"PPA1151/154/003","Imbat Limited","OLMESARTANMEDOXOMIL"
"6657","Omesar 10 mg film-coated tablets","10 milligram(s) Film-coated tablet",2014-11-24,"PPA1463/047/003","IMED Healthcare Ltd.","Olmesartanmedoxomil"
"6658","Omesar 10 mg film-coated tablets","10 milligram(s) Film-coated tablet",2015-01-16,"PPA1562/140/001","LTT Pharma Limited","Olmesartanmedoxomil"
"6659","Omesar 20 mg Film Coated Tablets","20 milligram(s) Film-coated tablet",2011-10-07,"PPA1463/047/002","IMED Healthcare Ltd.","Olmesartanmedoxomil"
"6660","Omesar 40 mg film-coated tablets","40 milligram(s) Film-coated tablet",2015-01-16,"PPA1562/140/002","LTT Pharma Limited","Olmesartanmedoxomil"
"6661","Omesar 40mg Film-coated Tablets","40 milligram(s) Film-coated tablet",2011-08-12,"PPA1463/047/001","IMED Healthcare Ltd.","Olmesartanmedoxomil"
"6662","OMESAR PLUS","20/12.5 Milligram                                                                                            Coated Tablets",2011-08-19,"PPA0465/273/001","PCO Manufacturing","OLMESARTANMEDOXOMIL|HYDROCHLOROTHIAZIDE"
"6663","OMESAR PLUS","20/25 Milligram                                                                                            Film Coated Tablet",2013-01-04,"PPA0465/273/002","PCO Manufacturing","OLMESARTANMEDOXOMIL|HYDROCHLOROTHIAZIDE"
"6664","OMESAR PLUS","40/12.5 Milligram                                                                                            Film Coated Tablet",2016-01-16,"PPA0465/273/003","PCO Manufacturing","OLMESARTANMEDOXOMIL|HYDROCHLOROTHIAZIDE"
"6665","OMESAR PLUS","40/25 Milligram                                                                                            Film Coated Tablet",2016-01-16,"PPA0465/273/004","PCO Manufacturing","OLMESARTANMEDOXOMIL|HYDROCHLOROTHIAZIDE"
"6666","OMESAR PLUS","20/12.5 Milligram                                                                                            Film Coated Tablet",2006-03-03,"PA0865/014/001","Menarini International Operations Luxembourg S.A.","OLMESARTANMEDOXOMIL|HYDROCHLOROTHIAZIDE"
"6667","OMESAR PLUS","20/25 Milligram                                                                                            Film Coated Tablet",2006-03-03,"PA0865/014/002","Menarini International Operations Luxembourg S.A.","OLMESARTANMEDOXOMIL|HYDROCHLOROTHIAZIDE"
"6668","OMESAR PLUS","40/12.5 Milligram                                                                                            Film Coated Tablet",2010-06-25,"PA0865/014/003","Menarini International Operations Luxembourg S.A.","OLMESARTANMEDOXOMIL|HYDROCHLOROTHIAZIDE"
"6669","OMESAR PLUS","40/25 Milligram                                                                                            Film Coated Tablet",2010-06-25,"PA0865/014/004","Menarini International Operations Luxembourg S.A.","OLMESARTANMEDOXOMIL|HYDROCHLOROTHIAZIDE"
"6670","Omesar Plus 20mg/12.5mg film-coated tablets","20/12.5 milligram(s) Film-coated tablet",2017-04-13,"PPA1097/006/001","Lexon (UK) Ltd","Hydrochlorothiazide|Olmesartanmedoxomil"
"6671","Omesar Plus 20mg/25mg film-coated tablets","20/25 milligram(s) Film-coated tablet",2017-04-13,"PPA1097/006/002","Lexon (UK) Ltd","Hydrochlorothiazide|Olmesartanmedoxomil"
"6672","Omesar Plus 40 mg /25 mg Film-coated Tablets","40/25 milligram(s) Film-coated tablet",2017-04-13,"PPA1097/006/004","Lexon (UK) Ltd","Olmesartanmedoxomil|Hydrochlorothiazide"
"6673","Omesar Plus 40mg/12.5mg film-coated tablets","40/12.5 milligram(s) Film-coated tablet",2017-04-13,"PPA1097/006/003","Lexon (UK) Ltd","Hydrochlorothiazide|Olmesartanmedoxomil"
"6674","Omidria","10mg/ml + 3 milligram(s)/millilitre Concentrate for solution",2015-07-28,"EU/1/15/1018/001","Omeros London Limited","Phenylephrinehydrochloride|Ketorolactrometamol"
"6675","OMNEXEL","400 Microgram                                                                                            Tablet Prolonged Release",2005-03-18,"PA1241/006/001","Astellas Pharma Co. Ltd","TAMSULOSINHYDROCHLORIDE"
"6676","OMNEXEL","400 Microgram                                                                                            Tablet Prolonged Release",2007-09-14,"PPA1151/020/001","Imbat Limited","TAMSULOSINHYDROCHLORIDE"
"6677","OMNEXEL","400 Microgram                                                                                            Tablet Prolonged Release",2009-08-28,"PPA1463/025/001","IMED Healthcare Ltd.","TAMSULOSINHYDROCHLORIDE"
"6678","Omnexel 400 micrograms, prolonged release Tablets, film-coated","400 microgram(s) Prolonged-release tablet",2005-11-18,"PPA0465/171/001","PCO Manufacturing","Tamsulosinhydrochloride"
"6679","Omnipaque 140 mg I/ml Solution for Injection (Glass)","140 milligram(s) Solution for injection",1999-07-07,"PA0735/006/001","GE Healthcare AS","Iohexol"
"6680","Omnipaque 180 mg I/ml Solution for Injection (Glass)","180 milligram(s) Solution for injection",1990-03-29,"PA0735/006/002","GE Healthcare AS","Iohexol"
"6681","Omnipaque 240 mg I/ml Solution for Injection (Glass)","240 milligram(s) Solution for injection",1990-03-29,"PA0735/006/004","GE Healthcare AS","Iohexol"
"6682","Omnipaque 240 mg I/ml Solution for Injection (Polypropylene)","240 milligram(s) Solution for injection",2000-03-23,"PA0735/006/023","GE Healthcare AS","Iohexol"
"6683","Omnipaque 300 mg I/ml Solution for Injection (Glass)","300 milligram(s) Solution for injection",1990-03-29,"PA0735/006/008","GE Healthcare AS","Iohexol"
"6684","Omnipaque 300 mg I/ml Solution for Injection (Polypropylene)","300 milligram(s) Solution for injection",1993-11-16,"PA0735/006/018","GE Healthcare AS","Iohexol"
"6685","Omnipaque 350 mg I/ml Solution for Injection (Glass)","350 milligram(s) Solution for injection",1990-03-29,"PA0735/006/013","GE Healthcare AS","Iohexol"
"6686","Omnipaque 350 mg I/ml Solution for Injection (Polypropylene)","350 milligram(s) Solution for injection",1993-11-11,"PA0735/006/020","GE Healthcare AS","Iohexol"
"6687","OMNITROPE","1.3 Mg/Ml Pdr+Solv for soln for Inf",2006-04-12,"EU/1/06/332/001","Sandoz GmbH","SOMATROPIN"
"6688","OMNITROPE","5 Mg/Ml Pdr+Solv for Soln for Inj",2006-04-12,"EU/1/06/332/002-003","Sandoz GmbH","SOMATROPIN"
"6689","OMNITROPE","5/1.5 Mg/Ml Solution for Injection",2007-04-20,"EU/1/06/332/004-006","Sandoz GmbH","SOMATROPIN"
"6690","OMNITROPE","10/1.5 Mg/Ml Solution for Injection",2007-09-19,"EU/1/06/332/007-009","Sandoz GmbH","SOMATROPIN"
"6691","OMNITROPE","15/1.5 Mg/Ml Solution for Injection",2011-06-16,"EU/1/06/332/010-012","Sandoz GmbH","SOMATROPIN"
"6692","ONBREZ BREEZHALER","150 Microgram                                                                                            Inhalation Powder, Capsule",2009-11-30,"EU/1/09/593/1-5","Novartis Europharm Limited","INDACATEROLMALEATE"
"6693","ONBREZ BREEZHALER","300 Microgram                                                                                            Inhalation Powder, Capsule",2009-11-30,"EU/1/09/593/6-10","Novartis Europharm Limited","INDACATEROLMALEATE"
"6694","Oncaspar","750 international unit(s)/millilitre Solution for injection",2016-01-14,"EU/1/15/1070/001","Sigma-Tau Pharma Ltd","Pegaspargase"
"6695","Oncaspar","750 unit(s)/millilitre Powder for solution for injection/infusion",2017-12-08,"EU/1/15/1070/002","Baxalta Innovations GmbH","Pegaspargase"
"6696","ONDANSETRON","2 Micromol Solution for Injection",2005-12-22,"PA0281/126/001","Pinewood Laboratories Ltd,","ONDANSETRONHYDROCHLORIDEDIHYDRATE"
"6697","ONDANSETRON","2 Milligram                                                                                            Solution for Injection",2006-09-29,"PA0577/083/001","McDermott Laboratories Ltd t/a Gerard Laboratories","ONDANSETRON"
"6698","ONDANSETRON","4 Milligram                                                                                            Film Coated Tablet",2007-09-14,"PA0749/009/001","Teva Pharma B.V.","ONDANSETRON"
"6699","ONDANSETRON","8 Milligram                                                                                            Film Coated Tablet",2005-04-29,"PA0749/009/002","Teva Pharma B.V.","ONDANSETRON"
"6700","ONDANSETRON","2 Mg/Ml Solution for Injection",2008-07-21,"PA1122/004/001","Noridem Enterprises Ltd","ONDANSETRON"
"6701","ONDANSETRON","2 Mg/Ml Solution for Inj/Inf",2010-06-04,"PA1390/011/001","Accord Healthcare Limited","ONDANSETRON"
"6702","Ondansetron 2mg/ml Solution for Injection","2 milligram(s)/millilitre Solution for injection",2009-11-13,"PA2299/037/001","Baxter Holding B.V.","Ondansetronhydrochloridedihydrate"
"6703","Ondansetron 2mg/ml Solution for Injection or Infusion","2 milligram(s)/millilitre Solution for injection/infusion",2005-04-15,"PA0711/068/001","Rowex Ltd","Ondansetronhydrochloridedihydrate"
"6704","Ondansetron 2mg/ml Solution for Injection, glass ampoules","2 milligram(s)/millilitre Solution for injection",2008-07-21,"PA1122/004/002","Noridem Enterprises Ltd","Ondansetron"
"6705","Ondansetron 4 mg Film-coated Tablets","4 milligram(s) Film-coated tablet",2010-02-12,"PA0711/151/001","Rowex Ltd","Ondansetron"
"6706","Ondansetron 4mg/5ml syrup","4/5 milligram(s)/millilitre Oral solution",2018-08-17,"PA1861/010/001","SYRI Limited, t/a Thame Laboratories","Ondansetronhydrochloridedihydrate"
"6707","Ondansetron 8 mg Film-coated Tablets","8 milligram(s) Film-coated tablet",2010-02-12,"PA0711/151/002","Rowex Ltd","Ondansetron"
"6708","Ondansetron Kabi 2 mg/ml solution for injection","2 milligram(s)/millilitre Solution for injection",2007-07-06,"PA0566/039/001","Fresenius Kabi Limited","Ondansetronhydrochloridedihydrate"
"6709","ONDRAN","4 Milligram                                                                                            Tablets",2005-12-22,"PA0281/127/001","Pinewood Laboratories Ltd,","ONDANSETRONHYDROCHLORIDEDIHYDRATE"
"6710","ONDRAN","8 Milligram                                                                                            Tablets",2005-12-22,"PA0281/127/002","Pinewood Laboratories Ltd,","ONDANSETRONHYDROCHLORIDEDIHYDRATE"
"6711","ONE-ALPHA","1 mcg Microgram                                                                                            Capsule",1978-03-02,"PA0046/024/001","Leo Laboratories Limited","ALFACALCIDOL"
"6712","ONE-ALPHA","0.25 Microgram                                                                                            Capsule",1978-03-15,"PA0046/024/002","Leo Laboratories Limited","ALFACALCIDOL"
"6713","ONE-ALPHA","2 Microgram/ML                                                                                         Oral Drops Solution",1999-07-26,"PA0046/024/009","Leo Laboratories Limited","ALFACALCIDOL"
"6714","ONE-ALPHA","1 Microgram                                                                                            Capsules, Soft",2014-12-05,"PPA1562/139/001","LTT Pharma Limited","ALFACALCIDOL"
"6715","ONE-ALPHA","0.25 Microgram                                                                                            Capsules, Soft",2009-07-10,"PPA1151/116/001","Imbat Limited","ALFACALCIDOL"
"6716","One-Alpha 0.25 microgram soft Capsules","0.25 microgram(s) Capsule",2004-09-10,"PPA0465/134/001","PCO Manufacturing","1-alpha-hydroxicholecalciferol"
"6717","One-Alpha 1 microgram Soft Capsules","1 microgram(s) Capsule",2004-09-10,"PPA0465/134/002","PCO Manufacturing","1-alpha-hydroxicholecalciferol"
"6718","ONGENTYS","25 Milligram                                                                                            Capsules Hard",2016-06-24,"EU/1/15/1066/001","BIAL - Portela & Cª, S.A.","OPICAPONE"
"6719","ONGENTYS","50 Milligram                                                                                            Capsules Hard",2016-06-24,"EU/1/15/1066/002-007","BIAL - Portela & Cª, S.A.","OPICAPONE"
"6720","ONGLYZA","2.5 Milligram                                                                                            Film Coated Tablet",2011-02-28,"EU/1/09/545/011-015","Bristol-Myers Squibb / AstraZeneca EEIG","SAXAGLITPIN"
"6721","ONGLYZA","5 Milligram                                                                                            Film Coated Tablet",2009-10-01,"EU/1/09/545/1-10","Bristol-Myers Squibb / AstraZeneca EEIG","SAXAGLIPTIN"
"6722","Onivyde","5 milligram(s)/millilitre Concentrate for solution for infusion",2016-10-14,"EU/1/16/1130/001","Baxter Innovations GmbH","Irinotecanhydrochloridetrihydrate"
"6723","Ontruzant","150 milligram(s) ZZZ Pdr/Conc/Soln for Infus",2017-11-15,"EU/1/17/1241/001","Samsung Bioepis UK Limited","Trastuzumab"
"6724","ONYTEC","80 mg/g Medicated Nail Lacquer",2012-09-28,"PA1005/002/001","Polichem S.A.","CICLOPIROX"
"6725","Opatanol","1 milligram(s)/millilitre Eye drops, solution",2002-05-17,"EU/1/02/217/001","Novartis Europharm Limited","Olopatadinehydrochloride"
"6726","OPATANOL","1 Mg/Ml Eye Drops Solution",2002-05-17,"EU/1/02/217/002","Novartis Europharm Limited","OLOPATADINEHYDROCHLORIDE"
"6727","Opdivo","10 milligram(s)/millilitre Concentrate for solution for infusion",2015-06-19,"EU/1/15/1014/001-002","Bristol-Myers Squibb Pharma EEIG","Nivolumab|Nivolumab"
"6728","OPRYMEA","0.26 Milligram                                                                                            Tablet Prolonged Release",NA,"EU/1/08/469/026-029","Krka d.d., Novo mesto","PRAMIPEXOLE"
"6729","OPRYMEA","0.52 Milligram                                                                                            Tablet Prolonged Release",NA,"EU/1/08/469/030-033","Krka d.d., Novo mesto","PRAMIPEXOLE"
"6730","OPRYMEA","1.05 Milligram                                                                                            Tablet Prolonged Release",NA,"EU/1/08/469/034-037","Krka d.d., Novo mesto","PRAMIPEXOLE"
"6731","OPRYMEA","1.57 Milligram                                                                                            Tablet Prolonged Release",NA,"EU/1/08/469/038-041","Krka d.d., Novo mesto","PRAMIPEXOLE"
"6732","OPRYMEA","2.1 Milligram                                                                                            Tablet Prolonged Release",NA,"EU/1/08/469/042-045","Krka d.d., Novo mesto","PRAMIPEXOLE"
"6733","OPRYMEA","2.62 Milligram                                                                                            Tablet Prolonged Release",2015-02-17,"EU/1/08/469/046-049","Krka d.d., Novo mesto","PRAMIPEXOLEDIHYDROCHLORIDEMONOHYDRATE"
"6734","OPRYMEA","3.15 Milligram                                                                                            Tablet Prolonged Release",2015-02-17,"EU/1/08/469/050-053","Krka d.d., Novo mesto","PRAMIPEXOLEDIHYDROCHLORIDEMONOHYDRATE"
"6735","OPRYMEA 0.088 MG TABLETS","0.088 Milligram                                                                                            Tablets",2008-09-12,"EU/1/08/469/1-5","Krka d.d., Novo mesto","PRAMIPEXOLE"
"6736","OPRYMEA 0.18 MG TABLETS","0.18 Milligram                                                                                            Tablets",2008-09-12,"EU/1/08/469/6-10","Krka d.d., Novo mesto","PRAMIPEXOLE"
"6737","OPRYMEA 0.35 MG TABLETS","0.35 Milligram                                                                                            Tablets",2008-09-12,"EU/1/08/469/11-15","Krka d.d., Novo mesto","PRAMIPEXOLE"
"6738","OPRYMEA 0.7 MG TABLETS","0.7 Milligram                                                                                            Tablets",2008-09-12,"EU/1/08/469/16-20","Krka d.d., Novo mesto","PRAMIPEXOLE"
"6739","OPRYMEA 1.1 MG TABLETS","1.1 Milligram                                                                                            Tablets",2008-09-12,"EU/1/08/469/21-25","Krka d.d., Novo mesto","PRAMIPEXOLE"
"6740","Opsumit","10 milligram(s) Film-coated tablet",NA,"EU/1/13/893/001-003","Janssen Pharmaceutica N.V.","Macitentan"
"6741","OPTAFLU (FCC VACCINE)","%v/v                                                                                                 Suspension for Injection",2007-06-01,"EU/1/07/394/1-6","Seqirus GmbH","INFLUENZAVACCINE"
"6742","Opticrom 2 % w/v Eye Drops, solution","2 percent weight/volume Eye drops, solution",1975-12-15,"PA0540/116/001","Sanofi-Aventis Ireland Limited T/A SANOFI","Sodiumcromoglicate"
"6743","Opticrom allergy 2% w/v eye drops, solution","2 percent weight/volume Eye drops, solution",2011-05-06,"PA0540/116/002","Sanofi-Aventis Ireland Limited T/A SANOFI","Sodiumcromoglicate"
"6744","OPTICROM ALLERGY SINGLE DOSE","2.0 %w/v                                                                                                 Eye Drops Solution",2015-01-23,"PA0540/116/003","Sanofi-Aventis Ireland Limited T/A SANOFI","SODIUMCROMOGLICATE"
"6745","Optilast, 0.5 mg/ml Eye Drops, solution","0.5 micromole(s) Eye drops, solution",1998-08-28,"PA2010/047/001","Mylan IRE Healthcare Limited","Azelastinehydrochloride"
"6746","OPTINATE","75 Milligram                                                                                            Film Coated Tablet",2009-12-18,"PA1390/191/002","Accord Healthcare Limited","RISEDRONATESODIUM"
"6747","OPTINATE ONCE A WEEK","35 Milligram                                                                                            Film Coated Tablet",2009-12-18,"PA1390/191/001","Accord Healthcare Limited","RISEDRONATESODIUM"
"6748","OPTINATE PLUS CA & D","35 & 1000/880 IU Milligram                                                                                            Granules Effervescent",2011-07-08,"PA1635/005/001","Warner Chilcott UK Limited","RISEDRONATESODIUM|CALCIUMCARBONATE|COLECALCIFEROLCONCENTRATE(OILYFORM)[VITAMIND3]"
"6749","Optiray 240 mg I/ml Solution for injection or infusion","240 micromole(s) Solution for injection/infusion",1993-04-22,"PA0686/007/001","Guerbet","Ioversol"
"6750","OPTIRAY 240 PFS","240 Micromol Solution for Injection",2000-04-14,"PA0686/007/002","GUERBET","IOVERSOL"
"6751","OPTIRAY 300","300 Micromol Solution for Inj/Inf",1993-04-22,"PA0686/007/003","GUERBET","IOVERSOL"
"6752","OPTIRAY 300 PFS","300 Micromol Solution for Injection",2000-04-14,"PA0686/007/004","GUERBET","IOVERSOL"
"6753","OPTIRAY 320","320 Micromol Solution for Inj/Inf",1993-04-22,"PA0686/007/005","GUERBET","IOVERSOL"
"6754","OPTIRAY 350","350 Micromol Solution for Inj/Inf",1993-04-22,"PA0686/007/006","GUERBET","IOVERSOL"
"6755","OPTIRAY 350 PFS","350 Micromol Solution for Injection",2000-04-14,"PA0686/007/007","GUERBET","IOVERSOL"
"6756","OPTISON","1 Mg/Ml Dispersion for Injection",1998-05-18,"EU/1/98/065/001","GE Healthcare AS","PERFLUTREN|HUMANALBUMINMICROSPHERES"
"6757","OPTISON","Mg/Ml Dispersion for Injection",1998-05-18,"EU/1/98/065/002","GE Healthcare AS","PERFLUTREN|HUMANALBUMINMICROSPHERES"
"6758","OPTISULIN","100 IU/ml IU/ML                                                                                                Solution for Injection",2000-06-27,"EU/1/00/133/001","Aventis Pharma Deutschland GmbH","INSULINGLARGINE"
"6759","OPTISULIN","100 IU/ML                                                                                                Solution for Injection",2000-06-27,"EU/1/00/133/002","Aventis Pharma Deutschland GmbH","INSULINGLARGINE"
"6760","OPTISULIN","100 IU/ML                                                                                                Solution for Injection",2000-06-27,"EU/1/00/133/003","Aventis Pharma Deutschland GmbH","INSULINGLARGINE"
"6761","OPTISULIN","100 IU/ML                                                                                                Solution for Injection",2000-06-27,"EU/1/00/133/004","Aventis Pharma Deutschland GmbH","INSULINGLARGINE"
"6762","OPTISULIN","100 IU/ML                                                                                                Solution for Injection",2000-06-27,"EU/1/00/133/005","Aventis Pharma Deutschland GmbH","INSULINGLARGINE"
"6763","OPTISULIN","100 IU/ML                                                                                                Solution for Injection",2000-06-27,"EU/1/00/133/006","Aventis Pharma Deutschland GmbH","INSULINGLARGINE"
"6764","OPTISULIN","100 IU/ML                                                                                                Solution for Injection",2000-06-27,"EU/1/00/133/007","Aventis Pharma Deutschland GmbH","INSULINGLARGINE"
"6765","OPTREX CLEAR EYES","12.5/0.01 %w/v                                                                                                 Eye Drops Solution",1980-04-01,"PA0275/002/001","Optrex Limited","HAMAMELISWATER|NAPHAZOLINEHYDROCHLORIDE"
"6766","OPTREX EYE DROPS SOLUTION","13 %v/v                                                                                                 Eye Drops Solution",1983-04-01,"PA0275/006/001","Optrex Limited","HAMAMELISWATER|ETHANOL"
"6767","OPTREX EYE LOTION","13 %v/v                                                                                                 Eye Lotion",1983-04-01,"PA0275/005/001","Optrex Limited","HAMAMELISWATER|ETHANOL"
"6768","OPTRUMA","60 Milligram                                                                                            Tablets",1998-08-05,"EU/1/98/074/001","Eli Lilly Nederland B.V.","RALOXIFENE"
"6769","OPTRUMA","60 Milligram                                                                                            Tablets",1998-08-05,"EU/1/98/074/002","Eli Lilly Nederland B.V.","RALOXIFENE"
"6770","OPTRUMA","60 Milligram                                                                                            Tablets",1998-08-05,"EU/1/98/074/003","Eli Lilly Nederland B.V.","RALOXIFENE"
"6771","OPTRUMA","60 Milligram                                                                                            Tablets",1998-08-05,"EU/1/98/074/004","Eli Lilly Nederland B.V.","RALOXIFENE"
"6772","ORALAIR","100/300 Unknown Tablet Sublingual",2010-02-19,"PA2113/001/001","STALLERGENES","GRASSPOLLENALLERGENEXTRACT"
"6773","ORALAIR","300 Unknown Tablet Sublingual",2010-02-19,"PA2113/001/002","STALLERGENES","GRASSPOLLENALLERGENEXTRACT"
"6774","ORALDENE GARGLE/MOUTHWASH","0.1 %w/v                                                                                                 Oromucosal Solution",1990-03-26,"PA0330/024/001","Johnson & Johnson (Ireland) Limited","HEXETIDINE"
"6775","ORALDENE ICEMINT MOUTHWASH","0.1 %w/v                                                                                                 Mouth Wash",2002-04-19,"PA0330/024/002","Johnson & Johnson (Ireland) Limited","HEXETIDINE"
"6776","Oramorph Concentrated Oral Solution 20mg/ml","20 milligram(s)/millilitre ZZZ Infus/Pdr/Oral Soln",NA,"PA0007/044/002","Boehringer Ingelheim Limited","Morphinesulfate"
"6777","Oramorph Oral Solution 10 mg/5 ml","10 mg/5ml Oral solution",NA,"PA0007/044/001","Boehringer Ingelheim Limited","Morphinesulfate"
"6778","ORAMOX","125 MG/5ml                                                                                               Powder for Oral Suspension",1988-09-27,"PA0298/019/001","Athlone Laboratories Ltd","AMOXICILLINTRIHYDRATE"
"6779","ORAMOX","250 MG/5ml                                                                                               Powder for Oral Suspension",1988-09-27,"PA0298/019/002","Athlone Laboratories Ltd","AMOXICILLINTRIHYDRATE"
"6780","Oramox 250mg Hard Capsules","250 milligram(s) Capsule",1988-09-27,"PA0298/019/003","Athlone Laboratories Ltd","Amoxicillintrihydrate"
"6781","Oramox 500mg Hard Capsules","500 milligram(s) Capsule",1988-09-27,"PA0298/019/004","Athlone Laboratories Ltd","Amoxicillintrihydrate"
"6782","ORAQIX","25/25 Milligram                                                                                            Gel",2005-07-22,"PA1045/004/001","Dentsply Limited","LIDOCAINE|PRILOCAINE"
"6783","Orbactiv","400 milligram(s) ZZZ Pdr/Conc/Soln for Infus",2015-03-19,"EU/1/15/989/001","Rempex London Ltd","Oritavancin"
"6784","ORENCIA","125 Milligram                                                                                            Solution for injection in pre-filled syringe",2012-10-04,"EU/1/07/389/004-009","Bristol-Myers Squibb Pharma EEIG","ABATACEPT"
"6785","ORENCIA","250 Milligram                                                                                            Solution for Infusion",2007-05-21,"EU/1/07/389/1-3","Bristol Myers Squibb Pharma EEIG","ABATACEPT"
"6786","ORFADIN","20 Milligram                                                                                            Capsules Hard",2015-05-05,"EU/1/04/303/004","Swedish Orphan Biovitrum International AB","NITISINONE"
"6787","ORFADIN","4 Mg/Ml Oral Suspension",2015-06-19,"EU/1/04/303/005","Swedish Orphan Biovitrum International AB","NITISINONE"
"6788","ORFADIN","percent volume/volume Capsule, hard",2005-02-21,"EU/1/04/303/1-3","Swedish Orphan International AB","Nitisinone"
"6789","ORGALUTRAN","%v/v                                                                                                 Solution for Injection",2000-05-17,"EU/1/00/130/001","Merck Sharp & Dohme Ltd","GANIRELIX"
"6790","ORGALUTRAN","%v/v                                                                                                 Solution for Injection",2000-05-17,"EU/1/00/130/002","Merck Sharp & Dohme Ltd","GANIRELIX"
"6791","Orgaran 750 anti-Xa units/0.6ml Solution for injection","750 anti-Xa units/0. international unit(s) Solution for injection",1993-10-21,"PA1691/016/001","Aspen Pharma Trading Limited","Danaparoidsodium"
"6792","ORKAMBI","200/125 Milligram                                                                                            Film Coated Tablet",2015-11-19,"EU/1/15/1059/001","Vertex Pharmaceuticals (U.K.) Limited","LUMACAFTOR|IVACAFTOR"
"6793","ORKAMBI","100/125 Milligram                                                                                            Film Coated Tablet",2018-01-08,"EU/1/15/1059/005","Vertex Pharmaceuticals (Europe) Limited","LUMACAFTOR|IVACAFTOR"
"6794","Orlistat 120mg Capsules, hard","120 milligram(s) Capsule, hard",2016-01-15,"PA1887/004/001","Alissa Healthcare Research Limited","Orlistat"
"6795","OROXINE","25 Microgram                                                                                            Tablets",2014-09-12,"PA1691/013/001","Aspen Pharma Trading Limited","LEVOTHYROXINESODIUM"
"6796","OROXINE","50 Microgram                                                                                            Tablets",2014-09-12,"PA1691/013/002","Aspen Pharma Trading Limited","LEVOTHYROXINESODIUM"
"6797","OROXINE","75 Microgram                                                                                            Tablets",2014-09-12,"PA1691/013/003","Aspen Pharma Trading Limited","LEVOTHYROXINESODIUM"
"6798","OROXINE","100 Microgram                                                                                            Tablets",2014-09-12,"PA1691/013/004","Aspen Pharma Trading Limited","LEVOTHYROXINESODIUM"
"6799","OROXINE","125 Microgram                                                                                            Tablets",2014-09-12,"PA1691/013/005","Aspen Pharma Trading Limited","LEVOTHYROXINESODIUM"
"6800","OROXINE","150 Microgram                                                                                            Tablets",2014-09-12,"PA1691/013/006","Aspen Pharma Trading Limited","LEVOTHYROXINESODIUM"
"6801","OROXINE","175 Microgram                                                                                            Tablets",2014-09-12,"PA1691/013/007","Aspen Pharma Trading Limited","LEVOTHYROXINESODIUM"
"6802","OROXINE","200 Microgram                                                                                            Tablets",2014-09-12,"PA1691/013/008","Aspen Pharma Trading Limited","LEVOTHYROXINESODIUM"
"6803","ORPHACOL","50 Milligram                                                                                            Capsules Hard",2013-09-12,"EU/1/13/870/001-003","Laboratoires CTRS","CHOLICACID"
"6804","ORPHACOL","250 Milligram                                                                                            Capsules Hard",2013-09-12,"EU/1/13/870/004-006","Laboratoires CTRS","CHOLICACID"
"6805","ORUVAIL","200 Milligram                                                                                            Prolonged Release Capsules",1984-08-14,"PA0540/119/003","Sanofi-Aventis Ireland Limited T/A SANOFI","KETOPROFEN"
"6806","OSBONELLE","150 Milligram                                                                                            Film Coated Tablet",2011-01-21,"PA1380/117/002","Actavis Group PTC ehf","IBANDRONATESODIUMMONOHYDRATE"
"6807","OSLIF BREEZHALER","150 Microgram                                                                                            Inhalation Powder, Capsule",2009-11-30,"EU/1/09/586/1-5","Novartis Europharm Limited","INDACATEROLMALEATE"
"6808","OSLIF BREEZHALER","300 Microgram                                                                                            Inhalation Powder, Capsule",2009-11-30,"EU/1/09/586/6-10","Novartis Europharm Limited","INDACATEROLMALEATE"
"6809","OSMOHALE","0/5/10/20/ Milligram                                                                                            Inhalation Powder, Capsule",2007-10-12,"PA1382/001/001","Pharmaxis Pharmaceuticals Ltd","MANNITOL"
"6810","Ospemifene","60 milligram(s) Film-coated tablet",2015-01-15,"EU/1/14/978/001-002","Shionogi Ltd","Ospemifene"
"6811","OSSEOR","2 g %v/v                                                                                                 Granules for Oral Suspension",2004-10-14,"EU/1/04/287/001","Les Laboratoires Servier","STRONTIUMRANELATE"
"6812","OSTEOCIS","3.0 Milligram                                                                                            Kit for radiopharmaceutical preparation",2000-05-26,"PA0677/007/001","CIS bio International","OXIDRONATEDISODIUM"
"6813","OSTEOFOS D3","1200mg/800 %v/v                                                                                                 Powder for Oral Solution",2002-06-28,"PA0865/007/001","Menarini International Operations Luxembourg S.A.","CALCIUMPHOSPHATE|COLECALCIFEROL"
"6814","OSTEOFOS D3","1200mg/800 I.U International Unit                                                                                   Powder for Oral Suspension",2011-02-25,"PPA1151/147/001","Imbat Limited","CALCIUMPHOSPHATE|COLECALCIFEROL"
"6815","Osteofos D3 1200mg/800 I.U. powder for oral suspension","1200mg/800 international unit(s) Powder for oral suspension",2014-07-11,"PPA1463/096/001","IMED Healthcare Ltd.","Colecalciferol|Calciumphosphate"
"6816","OSTEOMEL ONCE WEEKLY","70 Milligram                                                                                            Tablets",2005-09-09,"PA0126/148/002","Clonmel Healthcare Ltd","ALENDRONATESODIUMTRIHYDRATE"
"6817","OSTULEX","200 International Unit                                                                                   Nasal Spray Solution",2000-01-07,"PA0896/025/001","Novartis Ireland Limited","CALCITONIN,SALMON"
"6818","Otezla","10+20+30 milligram(s) Film-coated tablet",2015-02-15,"EU/1/14/981/001","Celgene Europe Ltd","Apremilast"
"6819","Otezla","30 milligram(s) Film-coated tablet",2015-02-15,"EU/1/14/981/002-003","Celgene Europe Ltd","Apremilast"
"6820","OTRIFLU","12.5 Milligram                                                                                            Film Coated Tablet",2009-12-22,"PA0678/137/001","GlaxoSmithKline Consumer Healthcare (Ireland) Limited","DICLOFENACPOTASSIUM"
"6821","OTRIVINE ADULT","0.1 %w/v                                                                                                 Nasal Drops Soln",1984-05-24,"PA0678/120/001","GlaxoSmithKline Consumer Healthcare (Ireland) Limited","XYLOMETAZOLINEHYDROCHLORIDE"
"6822","OTRIVINE ADULT","0.1 %w/v                                                                                                 Nasal Spray Solution",1984-05-24,"PA0678/120/002","GlaxoSmithKline Consumer Healthcare (Ireland) Limited","XYLOMETAZOLINEHYDROCHLORIDE"
"6823","OTRIVINE ADULT MENTHOL","0.1 %w/v                                                                                                 Nasal Spray Solution",1998-07-13,"PA0678/120/004","GlaxoSmithKline Consumer Healthcare (Ireland) Limited","XYLOMETAZOLINEHYDROCHLORIDE"
"6824","OTRIVINE ADULT METERED DOSE SINUSITIS","0.1 %w/v                                                                                                 Nasal Spray Solution",1991-02-27,"PA0678/120/003","GlaxoSmithKline Consumer Healthcare (Ireland) Limited","XYLOMETAZOLINEHYDROCHLORIDE"
"6825","Otrivine Adult Mucus Relief Menthol 0.1%w/v Nasal Spray","0.1 percent weight/volume Nasal spray, solution",2014-07-04,"PA0678/120/005","GlaxoSmithKline Consumer Healthcare (Ireland) Limited","XYLOMETAZOLINEHYDROCHLORIDE"
"6826","OTRIVINE EXTRA DUAL RELIEF","0.5/0.6 Mg/Ml Nasal Spray Solution",2012-12-18,"PA0678/131/001","GlaxoSmithKline Consumer Healthcare (Ireland) Limited","IPRATROPIUMBROMIDE|XYLOMETAZOLINEHYDROCHLORIDE"
"6827","OTRIVINE-ANTISTIN XYLOMETAXOLINE & ANTAZOLINE","0.5 %w/v                                                                                                 Eye Drops Solution",1983-04-01,"PA1107/008/001","Laboratoires Thea","XYLOMETAZOLINEHYDROCHLORIDE|ANTAZOLINESULFATE"
"6828","OVALEAP","300/0.5 IU/ML                                                                                                Solution for Injection",2013-09-27,"EU/1/13/871/001","Teva Pharma B.V.","FOLLITROPINALFA"
"6829","OVALEAP","450/0.75 IU/ML                                                                                                Solution for Injection",2013-09-27,"EU/1/13/871/002","Teva B.V.","FOLLITROPINALFA"
"6830","OVALEAP","900/1.5 IU/ML                                                                                                Solution for Injection",2013-09-27,"EU/1/13/871/003","Teva B.V.","FOLLITROPINALFA"
"6831","OVESTIN 1MG PER GRAM","0.1% w/w %w/w                                                                                                 Vaginal Cream",1993-08-16,"PA1691/017/001","Aspen Pharma Trading Limited","ESTRIOL"
"6832","OVITRELLE","250 Micrograms/g                                                                                         Pdr+Solv for Soln for Inj",2001-02-07,"EU/1/00/165/001","Ares-Serono (Europe) Limited","CHORIOGONADOTROPINALFA"
"6833","OVITRELLE","250 Micrograms/g                                                                                         Pdr+Solv for soln for Inf",2001-02-07,"EU/1/00/165/002","Ares-Serono (Europe) Limited","CHORIOGONADOTROPINALFA"
"6834","OVITRELLE","250 Micrograms/g                                                                                         Pdr+Solv for soln for Inf",2001-02-07,"EU/1/00/165/003","Ares-Serono (Europe) Limited","CHORIOGONADOTROPINALFA"
"6835","OVITRELLE","250 Micrograms/g                                                                                         Pdr+Solv for Susp for Inj",2001-02-07,"EU/1/00/165/004","Ares-Serono (Europe) Limited","CHORIOGONADOTROPINALFA"
"6836","OVITRELLE","250 Microgram                                                                                            Pdr+Solv for Soln for Inj",2001-02-07,"EU/1/00/165/005","Ares-Serono (Europe) Limited","CHORIOGONADOTROPINALFA"
"6837","OVITRELLE","250 Microgram                                                                                            Pdr+Solv for Soln for Inj",2001-02-07,"EU/1/00/165/006","Ares-Serono (Europe) Limited","CHORIOGONADOTROPINALFA"
"6838","OVITRELLE","250 Microgram                                                                                            Solution for Injection",2003-10-24,"EU/1/00/165/007","Ares-Serono (Europe) Limited","CHORIOGONADOTROPINALFA"
"6839","OVITRELLE","250/0.5 Microgram/ML                                                                                         Solution for injection in pre-filled syringe",2011-06-23,"EU/1/00/165/008","Merck Serono Europe Limited","CHORIOGONADOTROPINALFA"
"6840","OVRANETTE","150/30 Microgram                                                                                            Coated Tablets",2017-08-25,"PPA0465/431/001","PCO Manufacturing","LEVONORGESTREL|ETHINYLESTRADIOL"
"6841","Ovranette 150 micrograms/30 micrograms coated tablets","150/30 microgram(s) Coated tablet",1984-04-01,"PA0822/094/001","Pfizer Healthcare Ireland","Levonorgestrel|Ethinyloestradiol"
"6842","OVREENA","30/150 Microgram                                                                                            Coated Tablets",2006-01-20,"PA1330/015/001","Gedeon Richter Plc","ETHINYLESTRADIOL|LEVONORGESTREL"
"6843","OXALIPLATIN","5 Mg/Ml Concentrate for Soln for Inf",2009-07-24,"PA1422/004/001","Fresenius Kabi Oncology Plc","OXALIPLATIN"
"6844","OXALIPLATIN","5 Mg/Ml Concentrate for Soln for Inf",2010-03-19,"PA1390/023/001","Accord Healthcare Limited","OXALIPLATIN"
"6845","OXALIPLATIN MEDAC","5 Mg/Ml Pdr for Soln for Infusion",2007-02-23,"PA0623/008/001","Medac Gesellschaft fur Klinische Spezialpraparate mbH","OXALIPLATIN"
"6846","OXERVATE","20 Microgram/ML                                                                                         Eye Drops Solution",2017-07-06,"EU/1/17/1197/01","Dompe farmaceutici SpA","RECOMBINANTHUMANNERVEGROWTHFACTOR(RHNGF)"
"6847","OXIS TURBOHALER","6 Mcg/Acutuation                                                                                       Powder for Inhalation",1997-06-13,"PA0970/048/001","AstraZeneca UK Limited","FORMOTEROLFUMATRATEDIHYDRATE"
"6848","OXIS TURBOHALER","12 Mcg/Dose                                                                                             Powder for Inhalation",1997-06-13,"PA0970/048/002","AstraZeneca UK Limited","FORMOTEROLFUMATRATEDIHYDRATE"
"6849","OXYARGIN","5 / 2.5 Milligram                                                                                            Tablet Prolonged Release",2017-11-17,"PA0405/105/001","Generics (UK) Limited","OXYCODONEHYDROCHLORIDE|NALOXONEHYDROCHLORIDEDIHYDRATE"
"6850","OXYARGIN","10 / 5 Milligram                                                                                            Tablet Prolonged Release",2017-11-17,"PA0405/105/002","Generics (UK) Limited","OXYCODONEHYDROCHLORIDE|NALOXONEHYDROCHLORIDEDIHYDRATE"
"6851","OXYARGIN","20 / 10 Milligram                                                                                            Tablet Prolonged Release",2017-11-17,"PA0405/105/003","Generics (UK) Limited","OXYCODONEHYDROCHLORIDE|NALOXONEHYDROCHLORIDEDIHYDRATE"
"6852","OXYARGIN","30 / 15 Milligram                                                                                            Tablet Prolonged Release",2017-11-17,"PA0405/105/004","Generics (UK) Limited","OXYCODONEHYDROCHLORIDE|NALOXONEHYDROCHLORIDEDIHYDRATE"
"6853","OXYARGIN","40 / 20 Milligram                                                                                            Tablet Prolonged Release",2017-11-17,"PA0405/105/005","Generics (UK) Limited","OXYCODONEHYDROCHLORIDE|NALOXONEHYDROCHLORIDEDIHYDRATE"
"6854","OXYBUTYNIN HYDROCHLORIDE","5 Milligram                                                                                            Tablets",1996-05-01,"PA0740/001/001","Genthon BV","OXYBUTYNINHYDROCHLORIDE"
"6855","OXYBUTYNIN HYDROCHLORIDE","2.5 Milligram                                                                                            Tablets",2012-05-04,"PA1390/059/001","Accord Healthcare Limited","OXYBUTYNINHYDROCHLORIDE"
"6856","OXYBUTYNIN HYDROCHLORIDE","5 Milligram                                                                                            Tablets",2012-05-04,"PA1390/059/002","Accord Healthcare Limited","OXYBUTYNINHYDROCHLORIDE"
"6857","OXYBUTYNIN HYDROCHLORIDE","2.5 MG/5ml                                                                                               Oral Solution",2015-03-27,"PA1861/011/001","SYRI Limited, t/a Thame Laboratories","OXYBUTYNINHYDROCHLORIDE"
"6858","OXYBUTYNIN HYDROCHLORIDE","5 MG/5ml                                                                                               Oral Solution",2015-03-27,"PA1861/011/002","SYRI Limited, t/a Thame Laboratories","OXYBUTYNINHYDROCHLORIDE"
"6859","OXYCODONE HYDROCHLORIDE","10 Mg/Ml Solution for Inj/Inf",2010-07-16,"PA1339/025/001","Wockhardt UK Limited","OXYCODONEHYDROCHLORIDE"
"6860","Oxycodone hydrochloride 50mg/ml solution for injection or infusion","50 milligram(s)/millilitre Solution for injection/infusion",2013-08-09,"PA1339/025/002","Wockhardt UK Limited","OXYCODONEHYDROCHLORIDE"
"6861","OXYCODONE HYDROCHLORIDE ROWEX","5 Milligram                                                                                            Capsules Hard",2017-12-08,"PA0711/286/001","Rowex Ltd","OXYCODONEHYDROCHLORIDE"
"6862","OXYCODONE HYDROCHLORIDE ROWEX","10 Milligram                                                                                            Capsules Hard",2017-12-08,"PA0711/286/002","Rowex Ltd","OXYCODONEHYDROCHLORIDE"
"6863","OXYCODONE HYDROCHLORIDE ROWEX","20 Milligram                                                                                            Capsules Hard",2017-12-08,"PA0711/286/003","Rowex Ltd","OXYCODONEHYDROCHLORIDE"
"6864","OXYCODONE LANNACHER SR","5 Milligram                                                                                            Tablet Prolonged Release",2010-09-24,"PA0947/003/001","Lannacher Heilmittel Ges.m.b.H","OXYCODONEHYDROCHLORIDE"
"6865","OXYCODONE LANNACHER SR","10 Milligram                                                                                            Tablet Prolonged Release",2010-09-24,"PA0947/003/002","Lannacher Heilmittel Ges.m.b.H","OXYCODONEHYDROCHLORIDE"
"6866","OXYCODONE LANNACHER SR","20 Milligram                                                                                            Tablet Prolonged Release",2010-09-24,"PA0947/003/003","Lannacher Heilmittel Ges.m.b.H","OXYCODONEHYDROCHLORIDE"
"6867","OXYCODONE LANNACHER SR","40 Milligram                                                                                            Tablet Prolonged Release",2010-09-24,"PA0947/003/004","Lannacher Heilmittel Ges.m.b.H","OXYCODONEHYDROCHLORIDE"
"6868","OXYCODONE LANNACHER SR","80 Milligram                                                                                            Tablet Prolonged Release",2010-09-24,"PA0947/003/005","Lannacher Heilmittel Ges.m.b.H","OXYCODONEHYDROCHLORIDE"
"6869","OxyContin 10 mg prolonged release tablets","10 milligram(s) Prolonged-release tablet",1998-05-28,"PA1688/005/002","Mundipharma Pharmaceuticals Limited","OXYCODONEHYDROCHLORIDE"
"6870","OxyContin 20 mg prolonged release tablets","20 milligram(s) Prolonged-release tablet",1998-05-28,"PA1688/005/003","Mundipharma Pharmaceuticals Limited","OXYCODONEHYDROCHLORIDE"
"6871","OxyContin 40 mg prolonged release tablets","40 milligram(s) Prolonged-release tablet",1998-05-28,"PA1688/005/004","Mundipharma Pharmaceuticals Limited","OXYCODONEHYDROCHLORIDE"
"6872","OxyContin 5 mg prolonged release tablets","5 milligram(s) Prolonged-release tablet",2002-11-22,"PA1688/005/001","Mundipharma Pharmaceuticals Limited","OXYCODONEHYDROCHLORIDE"
"6873","OxyContin 80 mg prolonged release tablets","80 milligram(s) Prolonged-release tablet",1998-05-28,"PA1688/005/005","Mundipharma Pharmaceuticals Limited","OXYCODONEHYDROCHLORIDE"
"6874","OXYDON","20 Milligram                                                                                            Tablet Prolonged Release",2007-12-19,"PA0711/115/001","Rowex Ltd","OXYCODONEHYDROCHLORIDE"
"6875","OXYDON","40 Milligram                                                                                            Tablet Prolonged Release",2007-12-19,"PA0711/115/002","Rowex Ltd","OXYCODONEHYDROCHLORIDE"
"6876","OXYDON","80 Milligram                                                                                            Tablet Prolonged Release",2007-12-19,"PA0711/115/003","Rowex Ltd","OXYCODONEHYDROCHLORIDE"
"6877","OXYDON","5 Milligram                                                                                            Tablet Prolonged Release",2009-01-23,"PA0711/115/004","Rowex Ltd","OXYCODONEHYDROCHLORIDE"
"6878","OXYDON","10 Milligram                                                                                            Tablet Prolonged Release",2009-01-23,"PA0711/115/005","Rowex Ltd","OXYCODONEHYDROCHLORIDE"
"6879","OxyNorm 10 mg capsules","10 milligram(s) Capsule, hard",NA,"PA1688/006/005","Mundipharma Pharmaceuticals Limited","OXYCODONEHYDROCHLORIDE"
"6880","OxyNorm 10 mg/ml, solution for injection or infusion","10 milligram(s)/millilitre Solution for injection/infusion",2006-12-15,"PA1688/006/001","Mundipharma Pharmaceuticals Limited","OXYCODONEHYDROCHLORIDE"
"6881","OxyNorm 20 mg capsules","20 milligram(s) Capsule, hard",NA,"PA1688/006/006","Mundipharma Pharmaceuticals Limited","OXYCODONEHYDROCHLORIDE"
"6882","OxyNorm 5 mg capsules","5 milligram(s) Capsule, hard",NA,"PA1688/006/004","Mundipharma Pharmaceuticals Limited","OXYCODONEHYDROCHLORIDE"
"6883","OxyNorm 50 mg/ml, solution for injection or infusion","50 milligram(s)/millilitre Solution for injection/infusion",2011-09-02,"PA1688/006/010","Mundipharma Pharmaceuticals Limited","OXYCODONEHYDROCHLORIDE|OxycodoneHydrochloride"
"6884","OXYNORM CONCENTRATE","10 Micromol Oral Solution",2000-04-28,"PA1688/006/003","Mundipharma Pharmaceuticals Limited","OXYCODONEHYDROCHLORIDE"
"6885","OXYNORM DISPERSA","5 Milligram                                                                                            Orodispersible Tablet",2010-07-16,"PA1688/006/007","Mundipharma Pharmaceuticals Limited","OXYCODONEHYDROCHLORIDE"
"6886","OXYNORM DISPERSA","10 Milligram                                                                                            Orodispersible Tablet",2010-07-16,"PA1688/006/008","Mundipharma Pharmaceuticals Limited","OXYCODONEHYDROCHLORIDE"
"6887","OXYNORM DISPERSA","20 Milligram                                                                                            Orodispersible Tablet",2010-07-16,"PA1688/006/009","Mundipharma Pharmaceuticals Limited","OXYCODONEHYDROCHLORIDE"
"6888","OXYNORM LIQUID","1 Mg/Ml Oral Solution",2000-04-28,"PA1688/006/002","Mundipharma Pharmaceuticals Limited","OXYCODONEHYDROCHLORIDE"
"6889","OXYTOCIN","10 IU/ML                                                                                                Concentrate for Soln for Inf",2014-07-18,"PA1339/057/001","Wockhardt UK Limited","OXYTOCIN"
"6890","OZEMPIC","1.34 Mg/Ml",2018-02-08,"EU/1/17/1251/001","Novo Nordisk A/S","SEMATILIDE"
"6891","Ozempic","1.34 milligram(s)/millilitre Solution for infusion in pre-filled syringe",NA,"EU/1/17/1251/002-005","Novo Nordisk A/S","semaglutide"
"6892","Ozurdex","700 microgram(s) ZZZ Infus/Pdr/Oral Soln",NA,"EU/1/10/638/001","Allergan Pharmaceuticals Ireland","Dexamethasone"
"6893","Pabal 100 micrograms/ml, solution for injection","100 microgram(s)/millilitre Solution for injection",2006-12-08,"PA1009/021/001","Ferring Ireland Ltd","Carbetocin"
"6894","Pabrinex Intravenous High Potency Concentrate for Solution for Infusion","Concentrate for solution for infusion",1987-08-20,"PA2288/001/001","Kyowa Kirin Holdings B.V.","Thiaminehydrochloride|Riboflavine|Pyridoxinehydrochloride|Nicotinamide|Ascorbicacid|Glucose(asmonohydrate)"
"6895","PACLITAXEL","6 Mg/Ml Concentrate for Soln for Inf",2010-06-18,"PA1390/021/001","Accord Healthcare Limited","PACLITAXEL"
"6896","PACLITAXEL","6 Mg/Ml Concentrate for Soln for Inf",2009-04-03,"PA0566/049/001","Fresenius Kabi Limited","PACLITAXEL"
"6897","PACLITAXEL","6 Mg/Ml Concentrate for Soln for Inf",2005-02-11,"PA0437/052/001","Hospira  UK Limited","PACLITAXEL"
"6898","Paclitaxel 6 mg/ml concentrate for solution for infusion","6 milligram(s)/millilitre Concentrate for solution for infusion",2008-07-04,"PA1380/059/001","Actavis Group PTC ehf","Paclitaxel"
"6899","Paclitaxel 6 mg/ml concentrate for solution for infusion","6 milligram(s)/millilitre Concentrate for solution for infusion",2015-06-26,"PA1809/021/001","Cipla (EU) Limited","Paclitaxel"
"6900","Paclitaxel 6mg/ml Concentrate for Solution for Infusion","6 milligram(s)/millilitre Concentrate for solution for infusion",2010-01-08,"PA0946/003/001","Peckforton Pharmaceuticals Ltd","Paclitaxel"
"6901","PADOLIEVE","500 Milligram                                                                                            Film Coated Tablet",2014-10-03,"PA1750/002/001","Stasisport Pharma N.V.","PARACETAMOL"
"6902","PADOLIEVE MAX","1000 Milligram                                                                                            Film Coated Tablet",2014-10-03,"PA1750/002/002","Stasisport Pharma N.V.","PARACETAMOL"
"6903","Padviram 600 mg/200 mg/245 mg film-coated tablets","600/200/245 milligram(s) Film-coated tablet",2017-10-20,"PA0711/277/001","Rowex Ltd","Emtricitabine|Efavirenz|Tenofovirdisoproxilsuccinate"
"6904","Paedisol Solution for Infusion","0 gram(s)/litre Solution for infusion",2016-09-16,"PA0566/070/001","Fresenius Kabi Limited","Sodiumchloride|Potassiumchloride|Calciumchloridedihydrate|Magnesiumchloridehexahydrate|Sodiumacetatetrihydrate|Glucosemonohydrate"
"6905","PAGLITAZ","15 Milligram                                                                                            Tablets",2012-03-21,"EU/1/11/721/001-007","Krka d.d., Novo mesto","PIOGLITAZONEHYDROCHLORIDE"
"6906","PAGLITAZ","30 Milligram                                                                                            Tablets",2012-03-21,"EU/1/11/721/008-014","Krka d.d., Novo mesto","PIOGLITAZONEHYDROCHLORIDE"
"6907","PAGLITAZ","45 Milligram                                                                                            Tablets",2012-03-21,"EU/1/11/721/015-021","Krka d.d., Novo mesto","PIOGLITAZONEHYDROCHLORIDE"
"6908","PALEXIA","4 Mg/Ml Oral Solution",2013-01-25,"PA2242/012/010","Grunenthal Pharma Ltd","TAPENTADOLHYDROCHLORIDE"
"6909","PALEXIA","20 Mg/Ml Oral Solution",2013-01-25,"PA2242/012/011","Grunenthal Pharma Ltd","TAPENTADOLHYDROCHLORIDE"
"6910","PALEXIA","25 Milligram                                                                                            Film Coated Tablet",2015-02-13,"PA2242/012/012","Grunenthal Pharma Ltd","TAPENTADOLHYDROCHLORIDE"
"6911","PALEXIA","50 Milligram                                                                                            Film Coated Tablet",2010-12-21,"PA2242/012/001","Grunenthal Pharma Ltd","TAPENTADOLHYDROCHLORIDE"
"6912","PALEXIA","75 Milligram                                                                                            Film Coated Tablet",2010-12-21,"PA2242/012/002","Grunenthal Pharma Ltd","TAPENTADOLHYDROCHLORIDE"
"6913","PALEXIA","100 Milligram                                                                                            Film Coated Tablet",2010-12-21,"PA2242/012/003","Grunenthal Pharma Ltd","TAPENTADOLHYDROCHLORIDE"
"6914","PALEXIA SR","50 Milligram                                                                                            Tablet Prolonged Release",2010-12-21,"PA2242/012/004","Grunenthal Pharma Ltd","TAPENTADOLHYDROCHLORIDE"
"6915","PALEXIA SR","100 Milligram                                                                                            Tablet Prolonged Release",2010-12-21,"PA2242/012/005","Grunenthal Pharma Ltd","TAPENTADOLHYDROCHLORIDE"
"6916","PALEXIA SR","150 Milligram                                                                                            Tablet Prolonged Release",2010-12-21,"PA2242/012/006","Grunenthal Pharma Ltd","TAPENTADOLHYDROCHLORIDE"
"6917","PALEXIA SR","200 Milligram                                                                                            Tablet Prolonged Release",2010-12-21,"PA2242/012/007","Grunenthal Pharma Ltd","TAPENTADOLHYDROCHLORIDE"
"6918","PALEXIA SR","250 Milligram                                                                                            Tablet Prolonged Release",2010-12-21,"PA2242/012/008","Grunenthal Pharma Ltd","TAPENTADOLHYDROCHLORIDE"
"6919","PALEXIA SR 25mg prolonged-release tablets","25 milligram(s) Prolonged-release tablet",2012-05-25,"PA2242/012/009","Grunenthal Pharma Ltd","Tapentadolhydrochloride"
"6920","PALIPERIDONE","25 Milligram                                                                                            Suspension for Injection",2014-12-05,"EU/1/14/971/001","Janssen-Cilag International NV","PALIPERIDONEPALMITATE(R092670)"
"6921","PALIPERIDONE","50 Milligram                                                                                            Suspension for Injection",2014-12-05,"EU/1/14/971/002","Janssen-Cilag International NV","PALIPERIDONEPALMITATE(R092670)"
"6922","PALIPERIDONE","75 Milligram                                                                                            Suspension for Injection",2014-12-05,"EU/1/14/971/003","Janssen-Cilag International NV","PALIPERIDONEPALMITATE(R092670)"
"6923","PALIPERIDONE","100 Milligram                                                                                            Suspension for Injection",2014-12-05,"EU/1/14/971/004","Janssen-Cilag International NV","PALIPERIDONEPALMITATE(R092670)"
"6924","PALIPERIDONE","150 Milligram                                                                                            Suspension for Injection",2014-12-05,"EU/1/14/971/005","Janssen-Cilag International NV","PALIPERIDONEPALMITATE(R092670)"
"6925","PALIPERIDONE JANSSEN","150 and 100 Milligram                                                                                            Suspension for Injection",2014-12-05,"EU/1/14/971/006","Janssen-Cilag International NV","PALIPERIDONEPALMITATE(R092670)|PALIPERIDONEPALMITATE(R092670)"
"6926","Paliperidone Krka 3 mg prolonged-release tablets","3 milligram(s) Prolonged-release tablet",2018-06-22,"PA1347/081/001","Krka d.d., Novo mesto","Paliperidone"
"6927","Paliperidone Krka 6 mg prolonged-release tablets","6 milligram(s) Prolonged-release tablet",2018-06-22,"PA1347/081/002","Krka d.d., Novo mesto","Paliperidone"
"6928","Paliperidone Krka 9 mg prolonged-release tablets","9 milligram(s) Prolonged-release tablet",2018-06-22,"PA1347/081/003","Krka d.d., Novo mesto","Paliperidone"
"6929","Palladone 1.3 mg capsules","1.3 milligram(s) Capsule, hard",1995-12-07,"PA1688/007/001","Mundipharma Pharmaceuticals Limited","HYDROMORPHONEHYDROCHLORIDE"
"6930","Palladone 2.6 mg capsules","2.6 milligram(s) Capsule, hard",1995-12-07,"PA1688/007/002","Mundipharma Pharmaceuticals Limited","HYDROMORPHONEHYDROCHLORIDE"
"6931","Palladone SR 16 mg Prolonged-release Capsules","16 milligram(s) Prolonged-release capsule, hard",1993-03-02,"PA1688/007/010","Mundipharma Pharmaceuticals Limited","HYDROMORPHONEHYDROCHLORIDE"
"6932","Palladone SR 2 mg prolonged release capsules","2 milligram(s) Prolonged-release capsule",1995-12-07,"PA1688/007/007","Mundipharma Pharmaceuticals Limited","HYDROMORPHONEHYDROCHLORIDE"
"6933","Palladone SR 24 mg Prolonged-release Capsules","24 milligram(s) Prolonged-release capsule, hard",1993-03-02,"PA1688/007/011","Mundipharma Pharmaceuticals Limited","HYDROMORPHONEHYDROCHLORIDE"
"6934","Palladone SR 4 mg Prolonged-release Capsules","4 milligram(s) Prolonged-release capsule, hard",1993-03-02,"PA1688/007/008","Mundipharma Pharmaceuticals Limited","HYDROMORPHONEHYDROCHLORIDE"
"6935","Palladone SR 8 mg Prolonged-release Capsules","8 milligram(s) Prolonged-release capsule, hard",1993-03-02,"PA1688/007/009","Mundipharma Pharmaceuticals Limited","HYDROMORPHONEHYDROCHLORIDE"
"6936","PALONOSETRON","250 Microgram                                                                                            Solution for Injection",2016-10-28,"PA2059/014/001","Fresenius Kabi Deutschland GmbH","PALONOSETRONHYDROCHLORIDE"
"6937","PALONOSETRON","250 Microgram",2016-10-28,"PA2059/014/002","Fresenius Kabi Deutschland GmbH","PALONOSETRONHYDROCHLORIDE"
"6938","PALONOSETRON","250 Microgram                                                                                            Solution for Injection",2016-09-09,"PA1226/012/001","Flynn Pharma Ltd","PALONOSETRON(ASHYDROCHLORIDE)"
"6939","PALONOSETRON ACCORD","250 Microgram                                                                                            Solution for Injection",2016-01-18,"EU/1/16/1104/001","Accord Healthcare Limited","PALONOSETRONHYDROCHLORIDE"
"6940","Palonosetron Hospira","250 Micrograms/5ml Solution for injection",2016-04-08,"EU/1/16/1100/001","Pfizer Europe MA EEIG",NA
"6941","Panadeine Extra Strength TabletsParacetamol 500 mgCodeine Phosphate hemihydrate 12.8 mg","500/12.8 milligram(s) Film-coated tablet",2012-06-28,"PA0678/026/003","GlaxoSmithKline Consumer Healthcare (Ireland) Limited","Paracetamol|Codeinephosphatehemihydrate"
"6942","PANADOL","500 Milligram                                                                                            Film Coated Tablet",2006-08-11,"PA0678/107/001","GlaxoSmithKline Consumer Healthcare (Ireland) Limited","PARACETAMOL"
"6943","PANADOL","500 Milligram                                                                                            Film Coated Tablet",2017-05-05,"PPA1097/016/001","Lexon (UK) Ltd","PARACETAMOL"
"6944","PANADOL ACTIFAST TABLETS 500MG","500 Milligram                                                                                            Film Coated Tablet",2001-12-14,"PA0678/039/012","GlaxoSmithKline Consumer Healthcare (Ireland) Limited","PARACETAMOL"
"6945","PANADOL BABY","2.4 %w/v                                                                                                 Oral Suspension",1992-12-22,"PA0678/039/003","GlaxoSmithKline Consumer Healthcare (Ireland) Limited","PARACETAMOL"
"6946","PANADOL COLD & FLU HOT BLACKCURRANT","600/40 Milligram                                                                                            Powder for Oral Solution",1987-10-20,"PA0678/011/002","GlaxoSmithKline Consumer Healthcare (Ireland) Limited","PARACETAMOL|ASCORBICACID"
"6947","PANADOL COLD & FLU HOT LEMON","600/40 Milligram                                                                                            Powder for Oral Solution",1987-10-20,"PA0678/011/001","GlaxoSmithKline Consumer Healthcare (Ireland) Limited","PARACETAMOL|ASCORBICACID"
"6948","PANADOL COLD & FLU HOT LEMON WITH HONEY","600/40 Milligram                                                                                            Powder for Oral Solution",1990-05-21,"PA0678/011/003","GlaxoSmithKline Consumer Healthcare (Ireland) Limited","PARACETAMOL|ASCORBICACID"
"6949","PANADOL COLD & FLU RELIEF ORANGE","500/65 Milligram                                                                                            Tablets Effervescent",2015-02-13,"PA0678/105/002","GlaxoSmithKline Consumer Healthcare (Ireland) Limited","PARACETAMOL|CAFFEINE"
"6950","PANADOL COLD AND FLU","500/65 Milligram                                                                                            Film Coated Tablet",2007-05-25,"PA0678/105/001","GlaxoSmithKline Consumer Healthcare (Ireland) Limited","PARACETAMOL|CAFFEINE"
"6951","PANADOL EXTRA","500/65 Milligram                                                                                            Film Coated Tablet",1994-06-14,"PA0678/027/001","GlaxoSmithKline Consumer Healthcare (Ireland) Limited","PARACETAMOL|CAFFEINE"
"6952","PANADOL EXTRA SOLUBLE","500mg/65mg Milligram                                                                                            Tablets Effervescent",2001-11-02,"PA0678/039/010","GlaxoSmithKline Consumer Healthcare (Ireland) Limited","PARACETAMOL|CAFFEINE"
"6953","PANADOL FEVER AND CONGESTION","500/30 Milligram                                                                                            Film Coated Tablet",2003-11-28,"PA0678/094/001","GlaxoSmithKline Consumer Healthcare (Ireland) Limited","PARACETAMOL|PSEUDOEPHEDRINEHYDROCHLORIDE"
"6954","PANADOL HEAD COLD","600/40 Milligram                                                                                            Powder for Oral Solution",2006-10-20,"PA0678/106/001","GlaxoSmithKline Consumer Healthcare (Ireland) Limited","PARACETAMOL|ASCORBICACID"
"6955","PANADOL MAX STRENGTH COLD & FLU HOT BERRY PLUS VITAMIN C","1000/70 Milligram                                                                                            Powder for Oral Solution",2009-03-13,"PA0678/011/004","GlaxoSmithKline Consumer Healthcare (Ireland) Limited","PARACETAMOL|ASCORBICACID"
"6956","PANADOL MAX STRENGTH COLD AND FLU HOT LEMON","1000 Milligram                                                                                            Powder for Oral Solution",2006-05-26,"PA0678/039/013","GlaxoSmithKline Consumer Healthcare (Ireland) Limited","PARACETAMOL"
"6957","PANADOL MAX STRENGTH FEVER AND CONGESTION HOT LEMON","1000/40/10 Milligram                                                                                            Powder for Oral Solution",1999-02-19,"PA0678/035/001","GlaxoSmithKline Consumer Healthcare (Ireland) Limited","PARACETAMOL|ASCORBICACID|PHENYLEPHRINEHYDROCHLORIDE"
"6958","PANADOL NIGHT","500/25 mg/tablet Tablets",1998-09-18,"PA0678/039/008","GlaxoSmithKline Consumer Healthcare (Ireland) Limited","PARACETAMOL|DIPHENHYDRAMINEHYDROCHLORIDE"
"6959","PANADOL ORIGINAL","500 Milligram                                                                                            Film Coated Tablet",1978-04-01,"PA0678/039/005","GlaxoSmithKline Consumer Healthcare (Ireland) Limited","PARACETAMOL"
"6960","Panadol Sinus Relief Film Coated TabletsParacetamol 500mgCaffeine 25mgPhenylephrine Hydrochloride 5mg","500/25/5 milligram(s) Film-coated tablet",1992-08-20,"PA0678/044/001","GlaxoSmithKline Consumer Healthcare (Ireland) Limited","Caffeine|Phenylephrinehydrochloride|Paracetamol"
"6961","PANADOL SOLUBLE","500 Milligram                                                                                            Soluble tablet",2007-06-29,"PA0678/039/014","GlaxoSmithKline Consumer Healthcare (Ireland) Limited","PARACETAMOL"
"6962","PANADOL SOLUBLE MAX 1000MG PARACETAMOL","1000 mg Milligram                                                                                            Granules Effervescent",1992-08-20,"PA0678/028/002","GlaxoSmithKline Consumer Healthcare (Ireland) Limited","PARACETAMOL"
"6963","PANADOL WITH CAFFEINE","500/65 Milligram                                                                                            Film Coated Tablet",1997-06-27,"PA0678/037/001","GlaxoSmithKline Consumer Healthcare (Ireland) Limited","PARACETAMOL|CAFFEINE"
"6964","PANADOL WOMAN","500/65 Milligram                                                                                            Film Coated Tablet",2009-11-13,"PA0678/102/001","GlaxoSmithKline Consumer Healthcare (Ireland) Limited","PARACETAMOL|CAFFEINEANHYDROUS"
"6965","PANAGRAM MAX","1 Grams                                                                                                Tablets",2003-09-19,"PA0678/039/009","GlaxoSmithKline Consumer Healthcare (Ireland) Limited","PARACETAMOL"
"6966","Pancuronium Bromide 2 mg/ml Solution for Injection","2 milligram(s)/millilitre Solution for injection",1991-03-07,"PA0822/205/001","Pfizer Healthcare Ireland","Pancuroniumbromide"
"6967","PANDEMIC INFLUENZA VACCINE (H5N1) MEDIMMUNE - PANDEMIC INFLUENZA VACCINE H5N1 (LIVE ATTENUATED, NASAL)","Nasal Spray Suspension",2016-05-20,"EU/1/16/1089/001","AstraZeneca AB","STRAIN.A/VIETNAM/1203/2004(H5N1)STRAIN(LIVEATTENUATED)"
"6968","PANDEMIC INFLUENZA VACCINE H5N1 BAXTER","7.5/0.5 Microgram/ML                                                                                         Suspension for Injection",2009-10-16,"EU/1/09/571/001","Nanotherapeutics UK limited","A/VIETNAM/1203/2004(H5N1)"
"6969","Panretin","0.1 percent weight/weight Gel",2000-10-11,"EU/1/00/149/001","Eisai  Ltd.","Alitretinoin"
"6970","Pantium 20 mg Gastro-resistant tablets","20 milligram(s) Gastro-resistant tablet",2008-10-03,"PA0126/175/001","Clonmel Healthcare Ltd","Pantoprazolesodiumsesquihydrate"
"6971","Pantium 40mg Gastro-Resistant Tablets","40 milligram(s) Gastro-resistant tablet",2008-10-03,"PA0126/175/002","Clonmel Healthcare Ltd","Pantoprazolesodiumsesquihydrate"
"6972","Pantoflux 20mg gastro-resistant tablets","20 milligram(s) Gastro-resistant tablet",2008-06-09,"PA1380/002/001","Actavis Group PTC ehf","Pantoprazolesodiumsesquihydrate"
"6973","Pantoflux 40 mg gastro-resistant tablets","40 milligram(s) Gastro-resistant tablet",2008-06-09,"PA1380/002/002","Actavis Group PTC ehf","Pantoprazolesodiumsesquihydrate"
"6974","PANTOLOC CONTROL","20 Milligram                                                                                            Tablets Gastro-Resistant",2009-06-12,"EU/1/09/519/001","Takeda GmbH","PANTOPRAZOLESODIUMSESQUIHYDRATE"
"6975","PANTOLOC CONTROL","20 Milligram                                                                                            Tablets Gastro-Resistant",2009-06-12,"EU/1/09/519/002","Takeda GmbH","PANTOPRAZOLESODIUMSESQUIHYDRATE"
"6976","PANTOLOC CONTROL","20 Milligram                                                                                            Tablets Gastro-Resistant",2009-06-12,"EU/1/09/519/003","Takeda GmbH","PANTOPRAZOLESODIUMSESQUIHYDRATE"
"6977","PANTOLOC CONTROL","20 Milligram                                                                                            Tablets Gastro-Resistant",2009-06-12,"EU/1/09/519/004","Takeda GmbH","PANTOPRAZOLESODIUMSESQUIHYDRATE"
"6978","PANTOPRAZOLE","20 Milligram                                                                                            Tablets Gastro-Resistant",2010-08-13,"PA1339/021/001","Wockhardt UK Limited","PANTOPRAZOLESODIUMSESQUIHYDRATE"
"6979","PANTOPRAZOLE","40 Milligram                                                                                            Tablets Gastro-Resistant",2010-08-13,"PA1339/021/002","Wockhardt UK Limited","PANTOPRAZOLESODIUMSESQUIHYDRATE"
"6980","PANTOPRAZOLE","20 Milligram                                                                                            Tablets Gastro-Resistant",2017-02-16,"PPA0565/064/001","WPR Healthcare Limited","PANTOPRAZOLESODIUMSESQUIHYDRATE"
"6981","PANTOPRAZOLE","40 Milligram                                                                                            Tablets Gastro-Resistant",2017-02-16,"PPA0565/064/002","WPR Healthcare Limited","PANTOPRAZOLESODIUMSESQUIHYDRATE"
"6982","Pantoprazole 40 mg Powder for Solution for Injection","40 milligram(s) Powder for solution for injection",2011-06-03,"PA1618/001/001","Laboratorio Reig Jofre, S.A.","Pantoprazolesodiumsesquihydrate|Equivalenttopantoprazole"
"6983","Pantoprazole Azevedos 40 mg powder for solution for injection/infusion","40 milligram(s) Powder for solution for injection/infusion",2013-05-24,"PA1852/001/001","Laboratórios Azevedos - Indústria Farmacêutica S.A","Pantoprazolesodiumsesquihydrate"
"6984","Pantoprazole Bluefish 20 mg gastro-resistant tablets","20 milligram(s) Gastro-resistant tablet",2010-12-03,"PA1436/008/001","Bluefish Pharmaceuticals AB","Pantoprazolesodiumsesquihydrate"
"6985","Pantoprazole Bluefish 40 mg gastro-resistant tablets","40 milligram(s) Gastro-resistant tablet",2010-12-03,"PA1436/008/002","Bluefish Pharmaceuticals AB","Pantoprazolesodiumsesquihydrate"
"6986","Pantoprazole Mylan 20 mg Gastro-resistant Tablets","20 milligram(s) Gastro-resistant tablet",2011-09-30,"PA0577/146/001","McDermott Laboratories Ltd t/a Gerard Laboratories","Pantoprazolesodiumsesquihydrate"
"6987","Pantoprazole Mylan 40 mg Gastro-resistant Tablets","40 milligram(s) Gastro-resistant tablet",2011-09-30,"PA0577/146/002","McDermott Laboratories Ltd t/a Gerard Laboratories","Pantoprazolesodiumsesquihydrate"
"6988","PANTOPRAZOLE NORIDEM","40 Milligram                                                                                            Pdr for Soln for Injection",2011-12-21,"PA1122/011/001","Noridem Enterprises Ltd","PANTOPRAZOLESODIUMSESQUIHYDRATE"
"6989","Pantoprazole Teva Pharma 20 mg gastro-resistant tablets","20 milligram(s) Gastro-resistant tablet",2010-12-17,"PA0749/144/001","Teva Pharma B.V.","Pantoprazolesodiumsesquihydrate"
"6990","Pantoprazole Teva Pharma 40 mg gastro-resistant tablets","40 milligram(s) Gastro-resistant tablet",2010-12-17,"PA0749/144/002","Teva Pharma B.V.","Pantoprazolesodiumsesquihydrate"
"6991","PANTOZOL CONTROL","20 Milligram                                                                                            Tablets Gastro-Resistant",2009-06-12,"EU/1/09/517/001","Takeda GmbH","PANTOPRAZOLESODIUMSESQUIHYDRATE"
"6992","PANTOZOL CONTROL","20 Milligram                                                                                            Tablets Gastro-Resistant",2009-06-12,"EU/1/09/517/002","Takeda GmbH","PANTOPRAZOLESODIUMSESQUIHYDRATE"
"6993","PANTOZOL CONTROL","20 Milligram                                                                                            Tablets Gastro-Resistant",2009-06-12,"EU/1/09/517/003","Takeda GmbH","PANTOPRAZOLESODIUMSESQUIHYDRATE"
"6994","PANTOZOL CONTROL","20 Milligram                                                                                            Tablets Gastro-Resistant",2009-06-12,"EU/1/09/517/004","Takeda GmbH","PANTOPRAZOLESODIUMSESQUIHYDRATE"
"6995","PANTUP","20 Milligram                                                                                            Tablets Gastro-Resistant",2014-10-17,"PA0074/069/001","Rowa Pharmaceuticals Limited","PANTOPRAZOLESODIUMSESQUIHYDRATE"
"6996","PANTUP","40 Milligram                                                                                            Tablets Gastro-Resistant",2014-10-17,"PA0074/069/002","Rowa Pharmaceuticals Limited","PANTOPRAZOLESODIUMSESQUIHYDRATE"
"6997","Pantup Relief 20 mg Gastro-resistant tablets","20 milligram(s) Gastro-resistant tablet",2011-03-25,"PA0711/142/003","Rowex Ltd","Pantoprazolesodiumsesquihydrate"
"6998","Panzyga, 100 mg/ml solution for infusion","100 milligram(s)/millilitre Solution for infusion",2016-04-15,"PA2219/010/001","Octapharma (IP) SPRL","Humannormalimmunoglobulin"
"6999","PARACETAMOL","10 Mg/Ml Solution for Infusion",2010-12-21,"PA2059/015/001","Fresenius Kabi Deutschland GmbH","PARACETAMOL"
"7000","PARACETAMOL","10 Mg/Ml Solution for Infusion",2010-12-21,"PA2059/015/002","Fresenius Kabi Deutschland GmbH","PARACETAMOL"
"7001","PARACETAMOL","500 MG/5ml                                                                                               Oral Solution",2016-07-01,"PA1339/067/001","Wockhardt UK Limited","PARACETAMOL"
"7002","PARACETAMOL","500 Milligram                                                                                            Tablets Effervescent",2010-03-05,"PA1390/016/001","Accord Healthcare Limited","PARACETAMOL"
"7003","PARACETAMOL","500 Milligram                                                                                            Tablets",2015-07-10,"PA1390/016/003","Accord Healthcare Limited","PARACETAMOL"
"7004","PARACETAMOL","500 Milligram                                                                                            Film Coated Tablet",2011-06-29,"PA1380/123/001","Actavis Group PTC ehf","PARACETAMOL"
"7005","PARACETAMOL","10 Mg/Ml Solution for Infusion",2012-09-07,"PA0711/228/001","Rowex Ltd","PARACETAMOL"
"7006","PARACETAMOL","10 Mg/Ml Solution for Infusion",2012-03-09,"PA0736/035/001","B. Braun Melsungen AG","PARACETAMOL"
"7007","PARACETAMOL","500 Milligram                                                                                            Film Coated Tablet",1989-03-02,"PA0822/167/001","Pfizer Healthcare Ireland","PARACETAMOL"
"7008","PARACETAMOL","250 Milligram                                                                                            Suppositories",2010-12-21,"PA1113/004/001","Phoenix Labs","PARACETAMOL"
"7009","PARACETAMOL","500 Milligram                                                                                            Suppositories",2010-12-21,"PA1113/004/002","Phoenix Labs","PARACETAMOL"
"7010","PARACETAMOL","80 Milligram                                                                                            Suppositories",2012-02-10,"PA1113/004/003","Phoenix Labs","PARACETAMOL"
"7011","PARACETAMOL","125 Milligram                                                                                            Suppositories",2012-02-10,"PA1113/004/004","Phoenix Labs","PARACETAMOL"
"7012","PARACETAMOL","500 Milligram                                                                                            Film Coated Tablet",1992-08-20,"PA1186/009/001","Chefaro Ireland DAC","PARACETAMOL"
"7013","PARACETAMOL","10 Mg/Ml Solution for Infusion",2011-04-01,"PA0931/010/001","Maco Pharma (UK) Ltd","PARACETAMOL"
"7014","PARACETAMOL","500 Milligram                                                                                            Tablets",1986-07-02,"PA0126/065/001","Clonmel Healthcare Ltd","PARACETAMOL"
"7015","PARACETAMOL","500 Milligram                                                                                            Capsules Hard",2002-11-22,"PA0004/058/002","The Boots Company Plc","PARACETAMOL"
"7016","PARACETAMOL & CAFFEINE","500/65 mg/mg Tablets",2014-12-12,"PA1240/009/001","Bristol Laboratories Limited","PARACETAMOL|ANHYDROUSCAFFEINE"
"7017","PARACETAMOL & CAFFEINE GALPHARM","500/65 Milligram                                                                                            Tablets",2013-05-17,"PA1754/002/001","Galpharm Healthcare Limited","PARACETAMOL|CAFFEINE"
"7018","PARACETAMOL / GUAIFENESIN / PHENYLEPHRIN","500/200/10 Milligram                                                                                            Powder for Oral Solution",2011-10-07,"PA0441/042/001","Procter & Gamble (Health & Beauty Care) Limited","PARACETAMOL|GUAIFENESIN|PHENYLEPHRINEHYDROCHLORIDE"
"7019","Paracetamol 10 mg/ml Solution for Infusion","10 milligram(s)/millilitre Solution for infusion",2017-12-08,"PA1390/144/001","Accord Healthcare Limited","PARACETAMOL"
"7020","Paracetamol 1000mg, Phenylephrine hydrochloride 12.2mg, Powder for oral solution, Lemon flavourParacetamol 1000mg, Phenylephrine HCl 12.2mgPowder for oral solution","1000/12.2 milligram(s) Powder for oral solution",2011-12-16,"PA2294/001/001","WICK Pharma - Zweigniederlassung der Procter & Gamble GmbH","Paracetamol|Phenylephrinehydrochloride"
"7021","PARACETAMOL 120mg/ 5ml Infant Oral Suspension","120 mg/5ml Oral suspension",2010-11-12,"PA0823/010/009","McNeil Healthcare (Ireland) Ltd","Paracetamol"
"7022","PARACETAMOL 120mg/ 5ml Sugar-Free Infant Oral Suspension","120 mg/5ml Oral suspension",2010-11-05,"PA0823/010/010","McNeil Healthcare (Ireland) Ltd","Paracetamol"
"7023","PARACETAMOL ACTAVIS","10 Mg/Ml Solution for Infusion",2010-10-01,"PA1380/093/001","Actavis Group PTC ehf","PARACETAMOL"
"7024","Paracetamol Actavis Rx 500 mg film-coated tablets","500 milligram(s) Film-coated tablet",2011-06-29,"PA2315/009/001","Accord Healthcare Ireland Ltd.","PARACETAMOL"
"7025","Paracetamol Adult 500mg/5ml oral suspension","500 mg/5ml Oral suspension",2012-04-05,"PA0312/020/001","Rosemont Pharmaceuticals Ltd","Paracetamol"
"7026","PARACETAMOL GENMED","500 Milligram                                                                                            Tablets",2010-06-18,"PA1519/001/001","Genmed B.V.","PARACETAMOL"
"7027","PARACETAMOL TABLETS FROM THE MAKERS OF DISPRIN","500 Milligram                                                                                            Tablets",2001-10-19,"PA0979/022/001","Reckitt Benckiser Ireland Ltd","PARACETAMOL"
"7028","Paracetamol/Codeine 500 mg/30 mg, effervescent tablets","500/30 milligram(s) Effervescent tablet",2014-12-05,"PA1240/014/001","Bristol Laboratories Limited","PARACETAMOL|Codeinephosphatehemihydrate"
"7029","PARACETAMOL/DIPHENHYDRAMINE HYDROCHLORIDE","500mg/25 Milligram                                                                                            Film Coated Tablet",2017-01-06,"PA0688/039/001","Chanelle Medical","PARACETAMOL|DIPHENHYDRAMINEHYDROCHLORIDE"
"7030","PARACETAMOL/DIPHENHYDRAMINE HYDROCHLORIDE","500mg/25 Milligram                                                                                            Film Coated Tablet",2017-01-06,"PA0688/037/001","Chanelle Medical","PARACETAMOL|DIPHENHYDRAMINEHYDROCHLORIDE"
"7031","PARACODIN","10 mg/g Oral Drops Solution",1991-10-04,"PA1235/004/001","Teofarma S.R.L.","DIHYDROCODEINEHYDRORHODANIDE"
"7032","PARACODIN","0.2 %w/w                                                                                                 Syrup",1991-10-04,"PA1235/004/002","Teofarma S.R.L.","DIHYDROCODEINEBITARTRATE"
"7033","PARACODIN","10mg Milligram                                                                                            Tablets",1978-04-01,"PA1235/004/003","Teofarma S.R.L.","DIHYDROCODEINEBITARTRATE"
"7034","Paraextra Hard CapsulesParacetamol 500mgCaffeine 32mg","500/32 milligram(s) Capsule, hard",2005-12-02,"PA0822/169/001","Pfizer Healthcare Ireland","Caffeine|Paracetamol"
"7035","Paraeze Hard CapsulesParacetamol 500mgCaffeine 32mg","500/32 milligram(s) Capsule, hard",1982-12-23,"PA0822/168/001","Pfizer Healthcare Ireland","Caffeine|Paracetamol"
"7036","PARALIEF","500 Milligram                                                                                            Tablets Effervescent",2015-08-28,"PA0126/020/004","Clonmel Healthcare Ltd","PARACETAMOL"
"7037","PARALIEF","1000 Milligram                                                                                            Tablets Effervescent",2015-08-28,"PA0126/020/005","Clonmel Healthcare Ltd","PARACETAMOL"
"7038","Paralief 500mg Tablets","500 milligram(s) Tablet",1981-05-08,"PA0126/020/001","Clonmel Healthcare Ltd","Paracetamol"
"7039","PARALIEF COLD & FLU","300/25/5 Milligram                                                                                            Capsules Hard",2016-03-11,"PA0126/272/001","Clonmel Healthcare Ltd","PARACETAMOL|CAFFEINE|PHENYLEPHRINEHYDROCHLORIDE"
"7040","Paralief Extra Film-coated Tablets Paracetamol 500 mg Caffeine 65 mg","500/65 milligram(s) Film-coated tablet",2018-06-01,"PA0688/050/001","Chanelle Medical","Paracetamol"
"7041","PARALIEF HOT LEMON DRINK","600 Milligram                                                                                            Powder for Oral Solution",2017-09-26,"PA0126/020/006","Clonmel Healthcare Ltd","PARACETAMOL"
"7042","Paralief Night Film-coated Tablets Paracetamol 500 mgDiphenhydramine hydrochloride 25 mg","500mg/25 milligram(s) Film-coated tablet",2017-01-06,"PA0688/038/001","Chanelle Medical","PARACETAMOL|DIPHENHYDRAMINEHYDROCHLORIDE"
"7043","PARALIEF SINUS TABLETS","500/30 Milligram                                                                                            Tablets",2017-01-27,"PA0688/034/001","Chanelle Medical","PARACETAMOL|PSEUDOEPHEDRINEHYDROCHLORIDE"
"7044","Paralink 180mg Suppositories","180 mg milligram(s) Suppository",1988-12-30,"PA0095/007/002","Ricesteele Manufacturing Ltd","Paracetamol"
"7045","Paralink 500mg Suppositories","500 milligram(s) Suppository",1988-12-30,"PA0095/007/004","Ricesteele Manufacturing Ltd","Paracetamol"
"7046","Paralink Paracetamol Oral Solution 120mg/5ml","120mg mg/5ml Oral solution",1984-03-01,"PA0095/007/001","Ricesteele Manufacturing Ltd","Paracetamol"
"7047","Paralink Six Plus Paracetamol 250 mg/5 ml oral solution","250 mg/5ml Oral solution",2009-07-31,"PA0095/007/006","Ricesteele Manufacturing Ltd","Paracetamol"
"7048","PARAMAX","500mg/5mg Milligram                                                                                            Tablets",1995-09-11,"PA0540/154/001","Sanofi-Aventis Ireland Limited T/A SANOFI","PARACETAMOL|METOCLOPRAMIDEHYDROCHLORIDE"
"7049","Paratabs 500 mg Tablets","500 milligram(s) Tablet",1982-02-26,"PA0281/074/001","Pinewood Laboratories Ltd,","Paracetamol"
"7050","PARAVANCE EXTRA","500/65 Milligram                                                                                            Capsule",2017-05-12,"PA0979/068/001","Reckitt Benckiser Ireland Ltd","PARACETAMOL|CAFFEINE"
"7051","PARICALCITOL","2 Microgram/ML                                                                                         Solution for Injection",2015-05-29,"PA1555/002/001","Medice Arzneimittel Putter GmbH & Co. K.G","PARICALCITOL"
"7052","PARICALCITOL","5 Microgram/ML                                                                                         Solution for Injection",2015-05-29,"PA1555/002/003","Medice Arzneimittel Putter GmbH & Co. K.G","PARICALCITOL"
"7053","PARIET 10 mg gastro-resistant tablet","10 milligram(s) Gastro-resistant tablet",1998-10-30,"PA0748/041/001","Janssen-Cilag Ltd","Rabeprazolesodium"
"7054","PARIET 20 mg gastro-resistant tablet","20 milligram(s) Gastro-resistant tablet",1998-10-30,"PA0748/041/002","Janssen-Cilag Ltd","Rabeprazolesodium"
"7055","PARLODEL","2.5 Milligram                                                                                            Tablets",NA,"PA1332/016/001","Meda Health Sales Ireland Limited","BROMOCRIPTINEMESILATE"
"7056","PARLODEL","5 mg Milligram                                                                                            Capsules Hard",NA,"PA1332/016/002","Meda Health Sales Ireland Limited","BROMOCRIPTINEMESILATE"
"7057","PARNATE","10 Base Milligrams                                                                                      Coated Tablets",1978-04-01,"PA0899/016/001","Mercury Pharmaceuticals Ltd","TRANYLCYPROMINESULFATE"
"7058","Paroser 20mg film-coated tablet","20 milligram(s) Film-coated tablet",2004-04-29,"PA1513/007/001","Apotex Europe B.V.","Paroxetinehydrochloride"
"7059","PAROX","20 Milligram                                                                                            Film Coated Tablet",2002-06-17,"PA0711/052/001","Rowex Ltd","PAROXETINEHYDROCHLORIDE"
"7060","PAROX","10 Milligram                                                                                            Film Coated Tablet",2007-01-19,"PA0711/052/003","Rowex Ltd","PAROXETINEHCIANHYDRATE"
"7061","PAROX","30 Milligram                                                                                            Film Coated Tablet",2007-01-19,"PA0711/052/004","Rowex Ltd","PAROXETINEHCIANHYDRATE"
"7062","PARSABIV","2.5 Milligram                                                                                            Solution for Injection",2016-11-11,"EU/1/16/1142/001-004","Amgen Europe B.V.","ETELCALCETIDEHYDROCHLORIDE"
"7063","PARSABIV","5.0 Milligram                                                                                            Solution for Injection",2016-11-11,"EU/1/16/1142/005-008","Amgen Europe B.V.","ETELCALCETIDEHYDROCHLORIDE"
"7064","PARSABIV","10.0 Milligram                                                                                            Solution for Injection",2016-11-11,"EU/1/16/1142/009-012","Amgen Europe B.V.","ETELCALCETIDEHYDROCHLORIDE"
"7065","PARVOLEX","200 Mg/Ml Concentrate for Soln for Inf",1993-07-07,"PA1113/008/001","Phoenix Labs","ACETYLCYSTEINE"
"7066","Peace & Calm Oral Liquid",".  Liquid",2015-03-27,"TR1723/002/001","The Natural Way (Irish Botanica)","VALERIANTINCTURE1:260%"
"7067","PECFENT","100 Microgram                                                                                            Nasal Spray Solution",2010-08-31,"EU/1/10/644/001-002","Kyowa Kirin Holdings B.V.","FENTANYL,ASCITRATESALT"
"7068","PECFENT","400 Microgram                                                                                            Nasal Spray Solution",2010-08-31,"EU/1/10/644/003-004","Kyowa Kirin Holdings B.V.","FENTANYL,ASCITRATESALT"
"7069","PECTODRILL SUGAR FREE FOR CHESTY COUGHS","250/5 Mg/Ml Oral Solution",2006-03-24,"PA0329/009/002","Pierre Fabre Medicament","CARBOCISTEINE"
"7070","PEDAMED 100 MG/G CREAM","100 mg/g Cream",1986-08-26,"PA0095/012/001","Ricesteele Manufacturing Ltd","ZINCUNDECYLENATE"
"7071","PEDAMED 100 MG/G CUTANEOUS POWDER","100 mg/g Cutaneous Powder",1986-08-26,"PA0095/012/002","Ricesteele Manufacturing Ltd","ZINCUNDECYLENATE"
"7072","PEDEA","5 mg/ml Mg/Ml Solution for Injection",2004-09-16,"EU/1/04/284/001","Orphan Europe Sarl","IBUPROFEN"
"7073","PEDITRACE CONCENTRATE FOR SOLUTION FOR INFUSION","%v/v                                                                                                 Solution for Infusion",1995-11-13,"PA0566/009/001","Fresenius Kabi Limited","ZINCCHLORIDE|CUPRICCHLORIDEDIHYDRATE|MANGANESECHLORIDETETRAHYDRATE|SODIUMSELENITEPENTAHYDRATE|SODIUMFLUORIDE|POTASSIUMIODIDE"
"7074","PEGASYS","180 Microgram                                                                                            Solution for Injection",2002-06-20,"EU/1/02/221/003-004","Roche Registration GmbH","PEGINTERFERON-ALFA-2A"
"7075","PEGASYS","90mcg/0.5 Millilitre                                                                                           Solution for Injection",NA,"EU/1/02/221/017","Roche Registration GmbH","PEGINTERFERON-ALFA-2A"
"7076","Pegasys (PEGINTERFERON-ALFA-2A)","135 microgram(s) Solution for injection",2002-06-20,"EU/1/02/221/001-002","Roche Registration GmbH","Peginterferon-alfa-2a"
"7077","PegInron","*** AWAITING VALUE *** Powder and solvent for solution for injection",NA,"EU/1/00/131/035","Merck Sharp & Dohme BV","Peginterferonalfa-2b"
"7078","PegIntron","0.5 ml 80 mcg ampoule *** AWAITING VALUE *** Powder and solvent for solution for injection",NA,"EU/1/00/131/036","Merck Sharp & Dohme BV","Peginterferonalfa-2b"
"7079","PegIntron","0.5 ml 80 mcg ampoule *** AWAITING VALUE *** Powder and solvent for solution for injection",NA,"EU/1/00/131/037","Merck Sharp & Dohme BV","Peginterferonalfa-2b"
"7080","PegIntron","*** AWAITING VALUE *** Powder and solvent for solution for injection",NA,"EU/1/00/131/038","Merck Sharp & Dohme BV","Peginterferonalfa-2b"
"7081","PegIntron","5 millilitre(s) Powder and solvent for solution for injection",NA,"EU/1/00/131/039","Merck Sharp & Dohme BV","Peginterferonalfa-2b"
"7082","PegIntron","5 millilitre(s) Powder and solvent for solution for injection",NA,"EU/1/00/131/040","Merck Sharp & Dohme BV","Peginterferonalfa-2b"
"7083","PegIntron","5 millilitre(s) Powder and solvent for solution for injection",NA,"EU/1/00/131/041","Merck Sharp & Dohme BV","Peginterferonalfa-2b"
"7084","PegIntron","5 millilitre(s) Powder and solvent for solution for injection",NA,"EU/1/00/131/042","Merck Sharp & Dohme BV","Peginterferonalfa-2b"
"7085","PegIntron","*** AWAITING VALUE *** Powder and solvent for solution for injection",NA,"EU/1/00/131/043","Merck Sharp & Dohme BV","Peginterferonalfa-2b"
"7086","PegIntron","*** AWAITING VALUE *** Powder and solvent for solution for injection",NA,"EU/1/00/131/044","Merck Sharp & Dohme BV","Peginterferonalfa-2b"
"7087","PegIntron","5 millilitre(s) Powder and solvent for solution for injection",NA,"EU/1/00/131/045","Merck Sharp & Dohme BV","Peginterferonalfa-2b"
"7088","PegIntron","5 millilitre(s) Powder and solvent for solution for injection",NA,"EU/1/00/131/046","Merck Sharp & Dohme BV","Peginterferonalfa-2b"
"7089","PegIntron","*** AWAITING VALUE *** Powder and solvent for solution for injection",NA,"EU/1/00/131/047","Merck Sharp & Dohme BV","Peginterferonalfa-2b"
"7090","PegIntron","unknown *** AWAITING VALUE *** Powder and solvent for solution for injection",NA,"EU/1/00/131/048","Merck Sharp & Dohme BV","Peginterferonalfa-2b"
"7091","PegIntron","*** AWAITING VALUE *** Powder and solvent for solution for injection",NA,"EU/1/00/131/049","Merck Sharp & Dohme BV","Peginterferonalfa-2b"
"7092","PegIntron","*** AWAITING VALUE *** Powder and solvent for solution for injection",NA,"EU/1/00/131/050","Merck Sharp & Dohme BV","Peginterferonalfa-2b"
"7093","PEGINTRON","50mcg microgram(s) Powder and solvent for solution for injection",NA,"EU/1/00/131/001","Merck Sharp & Dohme BV","Peginterferonalfa-2b"
"7094","PegIntron","50 microgram(s) Powder and solvent for solution for injection",NA,"EU/1/00/131/002","Merck Sharp & Dohme BV","Peginterferonalfa-2b"
"7095","PegIntron","50 ZZZ Micrograms/g Powder and solvent for suspension for injection",NA,"EU/1/00/131/003","Merck Sharp & Dohme BV","Peginterferonalfa-2b"
"7096","PegIntron","50 microgram(s) Powder and solvent for solution for injection",NA,"EU/1/00/131/004","Merck Sharp & Dohme BV","Peginterferonalfa-2b"
"7097","PegIntron","50 microgram(s) Powder and solvent for solution for injection",NA,"EU/1/00/131/005","Merck Sharp & Dohme BV","Peginterferonalfa-2b"
"7098","PegIntron","80 microgram(s) Powder and solvent for solution for injection",NA,"EU/1/00/131/006","Merck Sharp & Dohme BV","Peginterferonalfa-2b"
"7099","PegIntron","80 microgram(s) Powder and solvent for solution for injection",NA,"EU/1/00/131/007","Merck Sharp & Dohme BV","Peginterferonalfa-2b"
"7100","PegIntron","80 microgram(s) Powder and solvent for solution for injection",NA,"EU/1/00/131/008","Merck Sharp & Dohme BV","Peginterferonalfa-2b"
"7101","PegIntron","80 microgram(s) Powder and solvent for solution for injection",NA,"EU/1/00/131/009","Merck Sharp & Dohme BV","Peginterferonalfa-2b"
"7102","PegIntron","80 microgram(s) Powder and solvent for solution for injection",NA,"EU/1/00/131/010","Merck Sharp & Dohme BV","Peginterferonalfa-2b"
"7103","PegIntron","100 microgram(s) Powder and solvent for solution for injection",NA,"EU/1/00/131/011","Merck Sharp & Dohme BV","Peginterferonalfa-2b"
"7104","PegIntron","100 microgram(s) Powder and solvent for solution for injection",NA,"EU/1/00/131/012","Merck Sharp & Dohme BV","Peginterferonalfa-2b"
"7105","PegIntron","100 microgram(s) Powder and solvent for solution for injection",NA,"EU/1/00/131/013","Merck Sharp & Dohme BV","Peginterferonalfa-2b"
"7106","PegIntron","100 microgram(s) Powder and solvent for solution for injection",NA,"EU/1/00/131/014","Merck Sharp & Dohme BV","Peginterferonalfa-2b"
"7107","PegIntron","100 microgram(s) Powder and solvent for solution for injection",NA,"EU/1/00/131/015","Merck Sharp & Dohme BV","Peginterferonalfa-2b"
"7108","PegIntron","120 microgram(s) Powder and solvent for solution for injection",NA,"EU/1/00/131/016","Merck Sharp & Dohme BV","Peginterferonalfa-2b"
"7109","PegIntron","120 microgram(s) Powder and solvent for solution for injection",NA,"EU/1/00/131/017","Merck Sharp & Dohme BV","Peginterferonalfa-2b"
"7110","PegIntron","120 ZZZ Micrograms/g Powder and solvent for solution for injection",NA,"EU/1/00/131/018","Merck Sharp & Dohme BV","Peginterferonalfa-2b"
"7111","PegIntron","120 microgram(s) Powder and solvent for solution for injection",NA,"EU/1/00/131/019","Merck Sharp & Dohme BV","Peginterferonalfa-2b"
"7112","PegIntron","120 microgram(s) Powder and solvent for solution for injection",NA,"EU/1/00/131/020","Merck Sharp & Dohme BV","Peginterferonalfa-2b"
"7113","PegIntron","150 microgram(s) Powder and solvent for solution for injection",NA,"EU/1/00/131/021","Merck Sharp & Dohme BV","Peginterferonalfa-2b"
"7114","PegIntron","150 microgram(s) Powder and solvent for solution for injection",NA,"EU/1/00/131/022","Merck Sharp & Dohme BV","Peginterferonalfa-2b"
"7115","PegIntron","150 microgram(s) Powder and solvent for solution for injection",NA,"EU/1/00/131/023","Merck Sharp & Dohme BV","Peginterferonalfa-2b"
"7116","PegIntron","150 microgram(s) Powder and solvent for solution for injection",NA,"EU/1/00/131/024","Merck Sharp & Dohme BV","Peginterferonalfa-2b"
"7117","PegIntron","150 microgram(s) Powder and solvent for solution for injection",NA,"EU/1/00/131/025","Merck Sharp & Dohme BV","Peginterferonalfa-2b"
"7118","PEGINTRON","120microgr microgram(s) Powder and solvent for suspension for injection",NA,"EU/1/00/131/031","Merck Sharp & Dohme BV","Peginterferonalfa-2b"
"7119","PegIntron","*** AWAITING VALUE *** Powder and solvent for solution for injection",NA,"EU/1/00/131/032","Merck Sharp & Dohme BV","Peginterferonalfa-2b"
"7120","PegIntron","*** AWAITING VALUE *** Powder and solvent for solution for injection",NA,"EU/1/00/131/033","Merck Sharp & Dohme BV","Peginterferonalfa-2b"
"7121","PegIntron","*** AWAITING VALUE *** Powder and solvent for solution for injection",NA,"EU/1/00/131/034","Merck Sharp & Dohme BV","Peginterferonalfa-2b"
"7122","Peglax 10 g powder for oral solution in sachet","10 gram(s) Powder for oral solution",2013-06-28,"PA2028/003/001","Casen-Recordati S.L.","Macrogol4000"
"7123","Pelgraz","6 milligram(s) Solution for injection in pre-filled syringe",2018-09-21,"EU/1/18/1313/001","Accord Healthcare Limited","Pegfilgrastim"
"7124","PEMETREXED","500 Milligram                                                                                            Pdr/Conc/Soln for Infus",2016-02-05,"PA0405/075/001","Generics (UK) Limited","PEMETREXEDDISODIUM"
"7125","PEMETREXED","25 Mg/Ml Concentrate for Soln for Inf",2018-01-19,"PA1082/004/001","BioOrganics BV","PEMETREXED"
"7126","PEMETREXED ACCORD","100 Milligram                                                                                            Pdr/Conc/Soln for Infus",2016-01-18,"EU/1/15/1071/001","Accord Healthcare Limited","PEMETREXEDDISODIUM|PEMETREXED"
"7127","PEMETREXED ACCORD","500 Milligram                                                                                            Pdr/Conc/Soln for Infus",2016-01-18,"EU/1/15/1071/002","Accord Healthcare Limited","PEMETREXEDDISODIUM|PEMETREXED"
"7128","PEMETREXED ACCORD","1000 Milligram                                                                                            Pdr/Conc/Soln for Infus",2016-01-18,"EU/1/15/1071/003","Accord Healthcare Limited","PEMETREXEDDISODIUM|PEMETREXED"
"7129","Pemetrexed Clonmel 25 mg/ml concentrate for solution for infusion","25 milligram(s)/millilitre Concentrate for solution for infusion",2016-02-05,"PA0126/270/001","Clonmel Healthcare Ltd","Pemetrexed"
"7130","PEMETREXED FRESCNIUS KABI","100 Milligram                                                                                            Concentrate for Soln for Inf",2016-07-22,"EU/1/16/1115/001","Fresenius Kabi Oncology Plc","PEMETREXED"
"7131","PEMETREXED FRESCNIUS KABI","500 Milligram                                                                                            Concentrate for Soln for Inf",2016-07-22,"EU/1/16/1115/002","Fresenius Kabi Oncology Plc","PEMETREXED"
"7132","PEMETREXED GENTHON","25 Mg/Ml Concentrate for Soln for Inf",2017-12-22,"PA0740/016/001","Genthon BV","PEMETREXED"
"7133","Pemetrexed Hospira","100 milligram(s) ZZZ Pdr/Conc/Soln for Infus",2015-11-20,"EU/1/15/1057/001","Pfizer Europe MA EEIG","Pemetrexeddisodium"
"7134","Pemetrexed Hospira","500 milligram(s) ZZZ Pdr/Conc/Soln for Infus",2015-11-20,"EU/1/15/1057/002","Pfizer Europe MA EEIG","Pemetrexeddisodium"
"7135","Pemetrexed Hospira","1000 milligram(s) ZZZ Pdr/Conc/Soln for Infus",2015-11-20,"EU/1/15/1057/003","Pfizer Europe MA EEIG","Pemetrexeddisodium"
"7136","Pemetrexed Hospira Limited","100 milligram(s) ZZZ Pdr/Conc/Soln for Infus",2017-04-24,"EU/1/17/1183/001","Pfizer Europe MA EEIG","Pemetrexedditromethamine"
"7137","Pemetrexed Hospira Limited","500 milligram(s) ZZZ Pdr/Conc/Soln for Infus",2017-04-24,"EU/1/17/1183/002","Pfizer Europe MA EEIG","Pemetrexedditromethamine"
"7138","Pemetrexed Hospira Limited","1,000 milligram(s) ZZZ Pdr/Conc/Soln for Infus",2017-04-24,"EU/1/17/1183/003","Pfizer Europe MA EEIG","Pemetrexedditromethamine"
"7139","PEMETREXED KRKA","100 Milligram                                                                                            Pdr/Conc/Soln for Infus",2018-05-22,"EU/1/18/1283/001","Krka d.d., Novo mesto","PEMETREXEDDISODIUMHEPTAHYDRATE"
"7140","PEMETREXED KRKA","500 Milligram                                                                                            Pdr/Conc/Soln for Infus",2018-05-22,"EU/1/18/1283/002","Krka d.d., Novo mesto","PEMETREXEDDISODIUMHEPTAHYDRATE"
"7141","PEMETREXED LILLY","100 Milligram                                                                                            Pdr/Conc/Soln for Infus",2015-09-14,"EU/1/15/1034/001","Eli Lilly Nederland B.V.","PEMETREXEDDISODIUMHEPTAHYDRATE"
"7142","PEMETREXED LILLY","500 Milligram                                                                                            Pdr/Conc/Soln for Infus",2015-09-14,"EU/1/15/1034/002","Eli Lilly Nederland B.V.","PEMETREXEDDISODIUMHEPTAHYDRATE"
"7143","PEMETREXED MEDAC","100 Milligram                                                                                            Pdr/Conc/Soln for Infus",2015-11-27,"EU/1/15/1038/001","Medac Gesellschaft fur Klinische Spezialpraparate mbH","PEMETREXED"
"7144","PEMETREXED MEDAC","500 Milligram                                                                                            Pdr/Conc/Soln for Infus",2015-11-27,"EU/1/15/1038/002","Medac Gesellschaft fur Klinische Spezialpraparate mbH","PEMETREXED"
"7145","PEMETREXED MEDAC","500 Milligram                                                                                            Pdr/Conc/Soln for Infus",2015-11-27,"EU/1/15/1038/003","Medac Gesellschaft fur Klinische Spezialpraparate mbH","PEMETREXED"
"7146","PEMETREXED SANDOZ","100 Milligram                                                                                            Pdr/Conc/Soln for Infus",2015-09-18,"EU/1/15/1037/001","Sandoz GmbH","PEMETREXED"
"7147","PEMETREXED SANDOZ","500 Milligram                                                                                            Pdr/Conc/Soln for Infus",2015-09-18,"EU/1/15/1037/002","Sandoz GmbH","PEMETREXED"
"7148","PEMETREXED SANDOZ","1000 Milligram                                                                                            Pdr/Conc/Soln for Infus",2015-09-18,"EU/1/15/1037/003","Sandoz GmbH","PEMETREXED"
"7149","PEMETREXED SEACROSS","100 Milligram                                                                                            Pdr/Conc/Soln for Infus",2017-05-26,"PA1840/004/001","Seacross Pharmaceuticals Limited","PEMETREXED"
"7150","PEMETREXED SEACROSS","500 Milligram                                                                                            Pdr/Conc/Soln for Infus",2017-05-26,"PA1840/004/002","Seacross Pharmaceuticals Limited","PEMETREXED"
"7151","PEMETREXED TEVA","100 Milligram                                                                                            Pdr/Conc/Soln for Infus",2016-01-08,"PA1986/005/001","Teva B.V.","PEMETREXEDDIACID"
"7152","PEMETREXED TEVA","500 Milligram                                                                                            Pdr/Conc/Soln for Infus",2016-01-08,"PA1986/005/002","Teva B.V.","PEMETREXEDDIACID"
"7153","Pemetrexed Teva 25 mg/ml Concentrate for Solution for Infusion","25 milligram(s)/millilitre Concentrate for solution for infusion",2017-06-23,"PA1986/005/003","Teva B.V.","Pemetrexed"
"7154","Pendrex 2mg Tablets","2 milligram(s) Tablet",2008-02-29,"PA0711/118/001","Rowex Ltd","Perindopriltert-butylamine"
"7155","Pendrex 4mg Tablets","4 milligram(s) Tablet",2008-02-29,"PA0711/118/002","Rowex Ltd","Perindopriltert-butylamine"
"7156","Pendrex 8 mg tablets","8 milligram(s) Tablet",2008-02-29,"PA0711/118/004","Rowex Ltd","Perindopriltert-butylamine"
"7157","Pendrex Plus 4mg/1.25mg Tablets","4/1.25 ZZZ mg/mg Tablet",2010-07-16,"PA0711/171/001","Rowex Ltd","Perindopriltert-butylamine|Indapamide"
"7158","PENTACIS","9.10 mg Milligram                                                                                            Pdr for Soln for Injection",1999-03-04,"PA0677/002/001","CIS bio International","CALCIUMTRISODIUMPENTETATE"
"7159","PENTASA","500 Milligram                                                                                            Tablet Prolonged Release",2009-08-21,"PPA0465/235/001","PCO Manufacturing","MESALAZINE"
"7160","PENTASA","500 Milligram                                                                                            Tablet Prolonged Release",2009-05-15,"PPA1151/092/001","Imbat Limited","MESALAZINE"
"7161","PENTASA","500 Milligram                                                                                            Tablet Prolonged Release",2016-07-29,"PPA1463/110/001","IMED Healthcare Ltd.","MESALAZINE"
"7162","Pentasa 1 g prolonged-release tablets","1 gram(s) Prolonged-release tablet",2011-01-07,"PA1009/006/007","Ferring Ireland Ltd","Mesalazine"
"7163","Pentasa 10 mg/ml Rectal Suspension","10 milligram(s)/millilitre Rectal suspension",1989-02-02,"PA1009/006/003","Ferring Ireland Ltd","Mesalazine"
"7164","Pentasa 1g Suppositories","1 gram(s) Suppository",1992-12-21,"PA1009/006/002","Ferring Ireland Ltd","Mesalazine"
"7165","Pentasa 500 mg prolonged-release tablets","500 milligram(s) Prolonged-release tablet",1992-12-21,"PA1009/006/005","Ferring Ireland Ltd","Mesalazine"
"7166","PENTASA SACHET","2 Grams                                                                                                Granules Prolonged Release",2007-12-19,"PA1009/006/006","Ferring Ireland Ltd","MESALAZINE"
"7167","PENTASA SACHET","4 Grams                                                                                                Granules Prolonged Release",2014-11-07,"PA1009/006/008","Ferring Ireland Ltd","MESALAZINE"
"7168","PENTASA SACHET","1 Grams                                                                                                Granules Prolonged Release",1998-11-27,"PA1009/006/001","Ferring Ireland Ltd","MESALAZINE"
"7169","PENTASA SACHET","2 Grams                                                                                                Granules Prolonged Release",2015-04-17,"PPA0465/235/002","PCO Manufacturing","MESALAZINE"
"7170","PENTASA SACHET","1 Grams                                                                                                Granules Prolonged Release",2014-07-02,"DPR1392/071/001","Eurodrug Ltd","MESALAZINE"
"7171","PENTASA SACHET","1000 Milligram                                                                                            Granules Prolonged Release",2009-07-09,"DPR0465/036/001","PCO Manufacturing","MESALAZINE"
"7172","Pentavac Diphtheria, tetanus, pertussis (acellular, component), poliomyelitis (inactivated) and Haemophilus influenzae type b conjugate vaccine (adsorbed)","0.5 millilitre(s) Powder for suspension for injection",2001-03-23,"PA2131/005/001","Sanofi Pasteur","PurifiedDiphtheriaToxoidPh.Eur.|Purifiedtetanustoxoid|Adsorbedpurifiedpertussistoxoid|Adsorbedpurifiedfilamentoushaemagglutinin|InactivatedPoliomyelitisVirusPh.Eur|Inactivatedtype1poliovirus|Inactivatedtype2poliovirus|Inactivatedtype3poliovirus|Haemophilusinfluenzaetypeb,conjugatewithtetanusprotein"
"7173","Penthrox 99.9%, 3 mL inhalation vapour, liquid","99.9%, 3 millilitre(s) Inhalation vapour, liquid",2015-11-06,"PA1921/001/001","Medical Developments UK Ltd","Methoxyflurane"
"7174","Pepcid AC","10 milligram(s) Film-coated tablet",1996-09-24,"PA0330/053/001","Johnson & Johnson (Ireland) Limited","Famotidine"
"7175","PEPCID DUO MILLIGRAM","Milligram                                                                                            Tablets Chewable",2000-09-29,"PA0330/047/001","Johnson & Johnson (Ireland) Limited","FAMOTIDINE|MAGNESIUMHYDROXIDE|CALCIUMCARBONATE"
"7176","Percarnil 4 mg Tablets","4 milligram(s) Tablet",2008-12-12,"PA2315/049/001","Accord Healthcare Ireland Ltd.","Perindopriltert-butylamine"
"7177","Percarnil 8 mg Tablets","8 milligram(s) Tablet",2008-12-12,"PA2315/049/002","Accord Healthcare Ireland Ltd.","Perindopriltert-butylamine"
"7178","Percarnil Arginine 10 mg Film-coated Tablets","10 milligram(s) Film-coated tablet",2016-01-29,"PA2315/048/003","Accord Healthcare Ireland Ltd.","Perindoprilarginine"
"7179","Percarnil Arginine 2.5 mg Film-coated Tablets","2.5 milligram(s) Film-coated tablet",2016-01-29,"PA2315/048/001","Accord Healthcare Ireland Ltd.","Perindoprilarginine"
"7180","Percarnil Arginine 5 mg Film-coated Tablets","5 milligram(s) Film-coated tablet",2016-01-29,"PA2315/048/002","Accord Healthcare Ireland Ltd.","Perindoprilarginine"
"7181","PERDAMEL","0.5 Milligram                                                                                            Film Coated Tablet",2007-09-21,"PA0126/169/002","Clonmel Healthcare Ltd","RISPERIDONE"
"7182","PERDAMEL","1 Milligram                                                                                            Film Coated Tablet",2007-09-21,"PA0126/169/003","Clonmel Healthcare Ltd","RISPERIDONE"
"7183","PERDAMEL","2 Milligram                                                                                            Film Coated Tablet",2007-09-21,"PA0126/169/004","Clonmel Healthcare Ltd","RISPERIDONE"
"7184","PERDAMEL","3 Milligram                                                                                            Film Coated Tablet",2007-09-21,"PA0126/169/005","Clonmel Healthcare Ltd","RISPERIDONE"
"7185","PERDAMEL","4 Milligram                                                                                            Film Coated Tablet",2007-09-21,"PA0126/169/006","Clonmel Healthcare Ltd","RISPERIDONE"
"7186","Pergoveris","300IU/150 international unit(s) Solution for injection in pre-filled pen",2017-05-08,"EU/1/07/396/004","Merck Europe B.V.","Lutropinalfa|Follitropinalfa"
"7187","Pergoveris","450IU/225 international unit(s) Solution for injection in pre-filled pen",2017-05-08,"EU/1/07/396/005","Merck Europe B.V.","Lutropinalfa|Follitropinalfa"
"7188","Pergoveris","900IU/450 international unit(s) Solution for injection in pre-filled pen",2017-05-08,"EU/1/07/396/006","Merck Europe B.V.","Lutropinalfa|Follitropinalfa"
"7189","Pergoveris","150/75 international unit(s) Powder and solvent for solution for injection",2007-06-25,"EU/1/07/396/1-3","Serono Europe Limited","Lutropinalfa|Follitropinalfa"
"7190","Perinal Cutaneous Spray","0.2/1.0 percent weight/weight Cutaneous spray, solution",1992-06-05,"PA0278/017/001","Dermal Laboratories Ltd","Hydrocortisone|LIDOCAINEHYDROCHLORIDE"
"7191","PERINDOPRIL ARGININE MYLAN","2.5 Milligram                                                                                            Film Coated Tablet",2011-06-23,"PA0577/128/001","McDermott Laboratories Ltd t/a Gerard Laboratories","PERINDOPRILARGININE"
"7192","PERINDOPRIL ARGININE MYLAN","5 Milligram                                                                                            Film Coated Tablet",2011-06-23,"PA0577/128/002","McDermott Laboratories Ltd t/a Gerard Laboratories","PERINDOPRILARGININE"
"7193","PERINDOPRIL ARGININE MYLAN","10 Milligram                                                                                            Film Coated Tablet",2011-06-23,"PA0577/128/003","McDermott Laboratories Ltd t/a Gerard Laboratories","PERINDOPRILARGININE"
"7194","Perindopril Arginine/Amlodipine Servier 10 mg/10 mg Tablets","10mg/10 milligram(s) Tablet",2008-07-04,"PA0568/019/004","Les Laboratoires Servier","Perindoprilarginine|Amlodipinebesylate"
"7195","Perindopril Arginine/Amlodipine Servier 10 mg/5 mg Tablets","10mg/5 milligram(s) Tablet",2008-07-04,"PA0568/019/003","Les Laboratoires Servier","Perindoprilarginine|Amlodipinebesylate"
"7196","Perindopril Arginine/Amlodipine Servier 5mg/10mg tablets","5mg/10 milligram(s) Tablet",2008-07-04,"PA0568/019/002","Les Laboratoires Servier","Perindoprilarginine|Amlodipinebesylate"
"7197","Perindopril Arginine/Amlodipine Servier 5mg/5mg tablets","5mg/5 milligram(s) Tablet",2008-07-04,"PA0568/019/001","Les Laboratoires Servier","Perindoprilarginine|Amlodipinebesylate"
"7198","PERINDOPRIL ARGININE/INDAPAMIDE MYLAN","2.5/0.625                                                                                                      Film Coated Tablet",2011-08-19,"PA0577/130/001","McDermott Laboratories Ltd t/a Gerard Laboratories","PERINDOPRILARGININE|INDAPAMIDE"
"7199","PERINDOPRIL ARGININE/INDAPAMIDE MYLAN","5/1.25                                                                                                      Film Coated Tablet",2011-08-19,"PA0577/130/002","McDermott Laboratories Ltd t/a Gerard Laboratories","PERINDOPRILARGININE|INDAPAMIDE"
"7200","PERINDOPRIL KRKA","2 Milligram                                                                                            Tablets",2010-08-06,"PA1347/041/001","Krka d.d., Novo mesto","PERINDOPRILTERT-BUTYLAMINE"
"7201","PERINDOPRIL KRKA","4 Milligram                                                                                            Tablets",2010-08-06,"PA1347/041/002","Krka d.d., Novo mesto","PERINDOPRILTERT-BUTYLAMINE"
"7202","PERINDOPRIL KRKA","8 Milligram                                                                                            Tablets",2010-08-06,"PA1347/041/003","Krka d.d., Novo mesto","PERINDOPRILTERT-BUTYLAMINE"
"7203","PERINDOPRIL TERT-BUTYLAMINE/AMLODIPINE HCS","4mg/5mg Milligram                                                                                            Tablets",2017-08-18,"PA2096/002/001","HCS bvba","PERINDOPRILTERT-BUTYLAMINE|AMLODIPINEBESILATE"
"7204","PERINDOPRIL TERT-BUTYLAMINE/AMLODIPINE HCS","4mg/10mg Milligram                                                                                            Tablets",2017-08-18,"PA2096/002/002","HCS bvba","PERINDOPRILTERT-BUTYLAMINE|AMLODIPINEBESILATE"
"7205","PERINDOPRIL TERT-BUTYLAMINE/AMLODIPINE HCS","8mg/5mg Milligram                                                                                            Tablets",2017-08-18,"PA2096/002/003","HCS bvba","PERINDOPRILTERT-BUTYLAMINE|AMLODIPINEBESILATE"
"7206","PERINDOPRIL TERT-BUTYLAMINE/AMLODIPINE HCS","8mg/10mg Milligram                                                                                            Tablets",2017-08-18,"PA2096/002/004","HCS bvba","PERINDOPRILTERT-BUTYLAMINE|AMLODIPINEBESILATE"
"7207","Perindopril Tosilate Teva 10mg Film-coated Tablets","10 milligram(s) Film-coated tablet",2013-01-25,"PA0749/168/003","Teva Pharma B.V.","Perindopriltosilate"
"7208","Perindopril Tosilate Teva 5mg Film-coated Tablets","5 milligram(s) Film-coated tablet",2013-01-25,"PA0749/168/002","Teva Pharma B.V.","Perindopriltosilate"
"7209","PERINDOPRIL TOSILATE/AMLODIPINE TEVA","5/5 Unknown Tablets",2014-06-13,"PA0749/197/001","Teva Pharma B.V.","PERINDOPRILTOSILATE|AMLODIPINEBESILATE"
"7210","PERINDOPRIL TOSILATE/AMLODIPINE TEVA","5/10 Unknown Tablets",2014-06-13,"PA0749/197/002","Teva Pharma B.V.","PERINDOPRILTOSILATE|AMLODIPINEBESILATE"
"7211","PERINDOPRIL TOSILATE/AMLODIPINE TEVA","10/5 Unknown Tablets",2014-06-13,"PA0749/197/003","Teva Pharma B.V.","PERINDOPRILTOSILATE|AMLODIPINEBESILATE"
"7212","PERINDOPRIL TOSILATE/AMLODIPINE TEVA","10/10                                                                                                      Tablets",2014-06-13,"PA0749/197/004","Teva Pharma B.V.","PERINDOPRILTOSILATE|AMLODIPINEBESILATE"
"7213","PERINDOPRIL TOSILATE/INDAPAMIDE TEVA","2.5/0.625                                                                                                      Film Coated Tablet",2013-02-22,"PA0749/170/001","Teva Pharma B.V.","PERINDOPRILTOSILATE|INDAPAMIDE"
"7214","PERINDOPRIL TOSILATE/INDAPAMIDE TEVA","5/1.25                                                                                                      Film Coated Tablet",2013-02-22,"PA0749/170/002","Teva Pharma B.V.","PERINDOPRILTOSILATE|INDAPAMIDE"
"7215","PERINDOPRIL TOSILATE/INDAPAMIDE TEVA","10mg/2.5 Milligram                                                                                            Film Coated Tablet",2017-01-13,"PA1986/025/001","Teva B.V.","PERINDOPRILTOSILATE|INDAPAMIDE"
"7216","PERIOCHIP","2.5 Milligram                                                                                            Dental Insert",1998-03-06,"PA0895/004/001","Dexcel-Pharma Limited","CHLORHEXIDINEGLUCONATE"
"7217","PERIZAM","1 Mg/Ml Oral Suspension",2015-03-13,"PA0312/033/001","Rosemont Pharmaceuticals Ltd","CLOBAZAM"
"7218","PERIZAM","2 Mg/Ml Oral Suspension",2015-03-13,"PA0312/033/002","Rosemont Pharmaceuticals Ltd","CLOBAZAM"
"7219","Perjeta","420 milligram(s) Concentrate for solution for infusion",2013-03-04,"EU/1/13/813/001","Roche Registration GmbH","Pertuzumab"
"7220","PERRIGO COLD & FLU","500mg/200mg/10 Milligram                                                                                            Powder for Oral Solution",2018-02-16,"PA1891/003/001","Omega Pharma Ltd","PARACETAMOL|GUAIFENESIN|PHENYLEPHRINEHYDROCHLORIDE"
"7221","Perrigo Cold & Flu Multi Relief Max Powder for Oral SolutionParacetamol 1000 mg, Guaifenesin 200 mg, Phenylephrine 12.2 mg","1000/200/12.2 milligram(s) Powder for oral solution",2009-12-22,"PA1120/001/003","Wrafton Laboratories Ltd. t/a Perrigo","Paracetamol|Guaifenesin|Phenylephrinehydrochloride"
"7222","PERRIGO COLD & FLU TABLETS","250/100/5 Milligram                                                                                            Tablets",2010-07-21,"PA1120/001/001","Wrafton Laboratories Ltd. t/a Perrigo","PARACETAMOL|GUAIFENESIN|PHENYLEPHRINEHYDROCHLORIDE"
"7223","PERRIGO COLD AND FLU MULTI-RELIEF, PARACETAMOL, GUAIFENESIN, PHENYLEPHRINE","500/100/6.1 Milligram                                                                                            Capsules Hard",2009-02-20,"PA1120/001/002","Wrafton Laboratories Ltd. t/a Perrigo","PARACETAMOL|GUAIFENESIN|PHENYLEPHRINEHYDROCHLORIDE"
"7224","PERSANTIN RETARD","200mg Milligram                                                                                            Capsules Modified Release",1998-08-28,"PA0007/008/007","Boehringer Ingelheim Limited","DIPYRIDAMOLE"
"7225","PETHIDINE","50 Milligram                                                                                            Tablets",1996-12-13,"PA0361/008/001","Martindale Pharmaceuticals Ltd","PETHIDINEHYDROCHLORIDE"
"7226","PETHIDINE HYDROCHLORIDE","50 Mg/Ml Solution for Injection",2006-02-17,"PA1390/050/001","Accord Healthcare Limited","PETHIDINEHYDROCHLORIDE"
"7227","Pethidine Hydrochloride 50mg/ml Solution for Injection","50/1 milligram(s)/millilitre Solution for injection",1978-04-01,"PA0073/014/001","Mercury Pharmaceuticals (Ireland) Ltd","PETHIDINEHYDROCHLORIDE"
"7228","PETHIDINE INJECTION BP 100MG/2ML","100mg/2ml Micromol Solution for Injection",1996-12-13,"PA0361/008/003","Martindale Pharmaceuticals Ltd","PETHIDINEHYDROCHLORIDE"
"7229","PETHIDINE INJECTION BP 50MG/ML","50 Micromol Solution for Injection",1996-12-13,"PA0361/008/002","Martindale Pharmaceuticals Ltd","PETHIDINEHYDROCHLORIDE"
"7230","PEVANTI","2.5 Milligram                                                                                            Tablets",2015-01-30,"PA0899/043/001","Mercury Pharmaceuticals Ltd","PREDNISOLONE"
"7231","PEVANTI","5 Milligram                                                                                            Tablets",2015-01-30,"PA0899/043/002","Mercury Pharmaceuticals Ltd","PREDNISOLONE"
"7232","PEVANTI","10 Milligram                                                                                            Tablets",2015-01-30,"PA0899/043/003","Mercury Pharmaceuticals Ltd","PREDNISOLONE"
"7233","PEVANTI","20 Milligram                                                                                            Tablets",2015-01-30,"PA0899/043/004","Mercury Pharmaceuticals Ltd","PREDNISOLONE"
"7234","PEVANTI","25 Milligram                                                                                            Tablets",2015-01-30,"PA0899/043/005","Mercury Pharmaceuticals Ltd","PREDNISOLONE"
"7235","PEYONA","20 Mg/Ml Solution for Infusion",2009-07-02,"EU/1/09/528/001","Chiesi Farmaceutici S.p.A.","CAFFEINECITRATE"
"7236","PHARMATON","N/A Capsules, Soft",1984-01-04,"PA0540/188/001","Sanofi-Aventis Ireland Limited T/A SANOFI","PANAXGINSENG|RETINOL|COLECALCIFEROL|TOCOPHEROL(ALL-RAC-A),VITAMINE|ASCORBICACID|THIAMINEMONONITRATE|RIBOFLAVIN|NICOTINAMIDE|PYRIDOXINEHYDROCHLORIDE|FOLICACID|CYANOCOBALAMIN|BIOTIN|ANHYDROUSDIBASICCALCIUMPHOSPHATE|FERROUSSULFATE|MAGNESIUMSULFATEDRIED|ZINCSULFATE|COPPERSULFATE|SODIUMSELENITEANHYDROUS|LECITHIN"
"7237","PHARMATON","%v/v                                                                                                 Capsule",2006-08-18,"PPA0465/178/001","PCO Manufacturing","PANAXGINSENG|RETINOLPALMITATE|TOCOPHERYLACETATE|THIAMINEMONONITRATE|RIBOFLAVIN|NICOTINAMIDE|PYRIDOXINEHYDROCHLORIDE|FOLICACID|CYANOCOBALAMIN|BIOTIN|CALCIUMPHOSPHATEDIBASIC|MAGNESIUMSULFATEDRIED|LECITHIN|ASCORBICACID|COLECALCIFEROLCONCENTRATE(OILYFORM)[VITAMIND3]|COPPER(ASDRIEDCOPPERSULPAHTE)|ZINC(ASZINCSULPHATEMONOHYDRATE)|IRON(ASDRIEDFERROUSSULPHATE)|SELENIUM|THIAMINEMONONITRATE"
"7238","PHARMATON","N/A Capsules, Soft",2008-01-11,"PPA1151/040/001","Imbat Limited","PANAXGINSENG|RETINOLPALMITATE|COLECALCIFEROL|TOCOPHERYLACETATE|ASCORBICACID|THIAMINEMONONITRATE|RIBOFLAVIN|NICOTINAMIDE|PYRIDOXINEHYDROCHLORIDE|FOLICACID|CYANOCOBALAMIN|BIOTIN|CALCIUMPHOSPHATE|FERROUSSULFATE|MAGNESIUMSULFATE|ZINCSULFATE|COPPERSULPHATE|MANGANESESULFATE|SODIUMSELENITE|LECITHIN"
"7239","Pharmaton Capsules","*** AWAITING VALUE *** Capsule, soft",2012-07-13,"PPA1562/081/001","LTT Pharma Limited","Panaxginsengextract|Vitaminapalmitate|Cholecalciferol|D,1-a-tocopherol|Ascorbicacid|Thiaminenitrate|Riboflavin|Nicotinamide|Pyridoxinehydrochloride|Folicacid|Cyanocobalamin|Biotin|Anhydrousdibasiccalciumphosphate|Ferroussulphate|Magnesiumsulfatedried|Zincsulphate|Coppersulfate|Sodiumselenite|Lecithin"
"7240","PHARMATON CAPSULES","Unknown Capsules, Soft",2010-08-13,"PPA1463/037/001","IMED Healthcare Ltd.","PANAXGINSENG|RETINOLPALMITATE|COLECALCIFEROL|TOCOPHERYLACETATE|ASCORBICACID|THIAMINEMONONITRATE|RIBOFLAVIN|NICOTINAMIDE|PYRIDOXINEHYDROCHLORIDE|FOLICACID|CYANOCOBALAMIN|BIOTIN|ANHYDROUSDIBASICCALCIUMPHOSPHATE|IRON|MAGNESIUM|ZINC(ASZINCSULPHATEMONOHYDRATE)|COPPER(ASDRIEDCOPPERSULPAHTE)|SELENIUM|LECITHIN"
"7241","PHEBURANE","483 mg/g Granules",2013-07-31,"EU/1/13/822/001","Lucane Pharma","SODIUM4-PHENYLBUTYRATE"
"7242","PHENERGAN","5mg/5ml MG/5ml                                                                                               Oral Solution",1979-04-01,"PA0540/121/001","Sanofi-Aventis Ireland Limited T/A SANOFI","PROMETHAZINEHYDROCHLORIDE"
"7243","Phenergan 25mg Film-Coated Tablets","25 milligram(s) Film-coated tablet",1979-04-01,"PA0540/121/003","Sanofi-Aventis Ireland Limited T/A SANOFI","PROMETHAZINEHYDROCHLORIDE"
"7244","PHENOBARBITAL","60 Milligram                                                                                            Tablets",1977-04-01,"PA0126/019/003","Clonmel Healthcare Ltd","PHENOBARBITAL"
"7245","Phenobarbital 15 mg Tablets","15 milligram(s) Tablet",1977-04-01,"PA0126/019/001","Clonmel Healthcare Ltd","PHENOBARBITAL"
"7246","Phenobarbital 30 mg Tablets","30 milligram(s) Tablet",1977-04-01,"PA0126/019/002","Clonmel Healthcare Ltd","PHENOBARBITAL"
"7247","PHENOBARBITAL SODIUM","15 Mg/Ml Solution for Injection",1994-05-16,"PA0361/005/001","Martindale Pharmaceuticals Ltd","PHENOBARBITALSODIUM"
"7248","PHENOBARBITAL SODIUM","30 Mg/Ml Solution for Injection",1994-05-16,"PA0361/005/002","Martindale Pharmaceuticals Ltd","PHENOBARBITALSODIUM"
"7249","PHENOBARBITAL SODIUM","60 Micromol Solution for Injection",1994-05-16,"PA0361/005/003","Martindale Pharmaceuticals Ltd","PHENOBARBITALSODIUM"
"7250","PHENOXYMETHYLPENICILLIN","250 Milligram                                                                                            Film Coated Tablet",2011-04-01,"PA1333/005/001","Morningside Healthcare Limited","PHENOXYMETHYLPENICILLIN"
"7251","Phenoxymethylpenicillin Sugar Free 125mg/5ml Powder for Oral solution","125 ZZZ Base mg/5ml Powder for oral solution",2012-03-16,"PA1648/001/001","Brown & Burk UK LTD","Phenoxymethylpenicillinpotassium"
"7252","Phenoxymethylpenicillin Sugar Free 250mg/5ml Powder for Oral solution","250 ZZZ Base mg/5ml Powder for oral solution",2012-03-16,"PA1648/001/002","Brown & Burk UK LTD","Phenoxymethylpenicillinpotassium"
"7253","Phenylephrine 50 micrograms/ml, solution for injection in pre-filled syringe","50 microgram(s)/millilitre Solution for injection in pre-filled syringe",2015-11-27,"PA1968/007/001","Laboratoire AGUETTANT","Phenylephrinehydrochloride"
"7254","PHENYTOIN","250mg/5ml Mg/Ml Solution for Inj/Inf",2017-10-13,"PA1390/122/001","Accord Healthcare Limited","PHENYTOINSODIUM"
"7255","PHOLCODEX","5 MG/5ml                                                                                               Oral Solution",1980-06-04,"PA0281/004/001","Pinewood Laboratories Ltd,","PHOLCODINE"
"7256","PHORPAIN","5%w/w %w/w                                                                                                 Gel",1997-11-14,"PA0899/004/002","Mercury Pharmaceuticals Ltd","IBUPROFEN"
"7257","PHORPAIN","5 %w/w                                                                                                 Gel",2011-11-18,"PA0899/004/004","Mercury Pharmaceuticals Ltd","IBUPROFEN"
"7258","PHOSEX","1000 Milligram                                                                                            Tablets",2011-10-07,"PA0982/003/001","Pharmacosmos A/S","CALCIUMACETATE"
"7259","PHOSPHOROUS (PHOS.)","6C & 30C  Tablets",2009-11-20,"HOR0407/008/001","Weleda (UK) Limited","PHOSPHORUS"
"7260","Phospho-soda 24.4g/10.8g Oral solution","24.4/10.8 gram(s) Oral solution",1998-07-06,"PA2028/004/001","Casen-Recordati S.L.","Sodiumphosphatedibasicdodecahydrate|Sodiumphosphatedibasicdihydrate"
"7261","Phoxilium 1.2 mmol/l phosphate Solution for haemodialysis/haemofiltration","1.2 ZZZ mmol/L Solution for haemodialysis/haemofiltration",2009-04-17,"PA0785/007/001","Gambro Lundia AB","Calciumchloridedihydrate|Magnesiumchloridehexahydrate|Sodiumchlorideph.eur.|Sodiumhydrogencarbonate|Potassiumchloride|Disodiumphosphatedihydrate"
"7262","Phyllocontin Continus 225 mg Prolonged Release Tablets","225 milligram(s) Prolonged-release tablet",1984-04-01,"PA1688/008/001","Mundipharma Pharmaceuticals Limited","AMINOPHYLLINEHYDRATE"
"7263","Phymet DTF 1 mg/ml Syrup","1 mg/ml millilitre(s) Syrup",1998-07-13,"PA1077/074/001","GlaxoSmithKline (Ireland) Limited","Methadonehydrochloride"
"7264","PHYSIONEAL 35 GLUCOSE","1.36 %w/v                                                                                                 Soln for Peritoneal Dialysis",2004-01-09,"PA0167/101/004","Baxter Healthcare Limited","GLUCOSEMONOHYDRATE|SODIUMCHLORIDE|CALCIUMCHLORIDEDIHYDRATE|MAGNESIUMCHLORIDEHEXAHYDRATE|SODIUMLACTATE|SODIUMBICARBONATE"
"7265","PHYSIONEAL 35 GLUCOSE","2.27 %w/v                                                                                                 Soln for Peritoneal Dialysis",2004-01-09,"PA0167/101/005","Baxter Healthcare Limited","GLUCOSEMONOHYDRATE|SODIUMCHLORIDE|CALCIUMCHLORIDEDIHYDRATE|MAGNESIUMCHLORIDEHEXAHYDRATE|SODIUMLACTATE|SODIUMBICARBONATE"
"7266","PHYSIONEAL 35 GLUCOSE","3.86 %w/v                                                                                                 Soln for Peritoneal Dialysis",2004-01-09,"PA0167/101/006","Baxter Healthcare Limited","GLUCOSEMONOHYDRATE|SODIUMCHLORIDE|CALCIUMCHLORIDEDIHYDRATE|MAGNESIUMCHLORIDEHEXAHYDRATE|SODIUMLACTATE|SODIUMBICARBONATE"
"7267","PHYSIONEAL 35 GLUCOSE CLEAR-FLEX 1.36%W/V","13.6 Micromol Solution for Dialysis",2004-09-10,"PA0167/101/007","Baxter Healthcare Limited","GLUCOSEMONOHYDRATE|CALCIUMCHLORIDEDIHYDRATE|MAGNESIUMCHLORIDEANHYDROUS|SODIUMCHLORIDEPH.EUR.|SODIUMBICARBONATE|SODIUMLACTATE"
"7268","PHYSIONEAL 35 GLUCOSE CLEAR-FLEX 2.27%W/V","22.7 Micromol Solution for Dialysis",2004-09-10,"PA0167/101/008","Baxter Healthcare Limited","GLUCOSEMONOHYDRATE|SODIUMCHLORIDE|CALCIUMCHLORIDEDIHYDRATE|MAGNESIUMCHLORIDEANHYDROUS|SODIUMLACTATE|SODIUMBICARBONATE"
"7269","PHYSIONEAL 35 GLUCOSE CLEAR-FLEX 3.86%W/V","38.6 Micromol Solution for Dialysis",2004-09-10,"PA0167/101/009","Baxter Healthcare Limited","GLUCOSEMONOHYDRATE|SODIUMCHLORIDE|CALCIUMCHLORIDEDIHYDRATE|MAGNESIUMCHLORIDEANHYDROUS|SODIUMLACTATE|SODIUMBICARBONATE"
"7270","PHYSIONEAL 40 GLUCOSE","1.36 %w/v                                                                                                 Solution for Dialysis",1999-11-12,"PA0167/101/001","Baxter Healthcare Limited","GLUCOSEMONOHYDRATE|CALCIUMCHLORIDEDIHYDRATE|MAGNESIUMCHLORIDEHEXAHYDRATE|SODIUMCHLORIDE|SODIUMBICARBONATE|SODIUMLACTATE"
"7271","PHYSIONEAL 40 GLUCOSE","2.27% %w/v                                                                                                 Solution for Dialysis",1999-11-12,"PA0167/101/002","Baxter Healthcare Limited","GLUCOSEMONOHYDRATE|CALCIUMCHLORIDEDIHYDRATE|MAGNESIUMCHLORIDEHEXAHYDRATE|SODIUMCHLORIDE|SODIUMBICARBONATE|SODIUMLACTATE"
"7272","PHYSIONEAL 40 GLUCOSE","3.86% %w/v                                                                                                 Solution for Dialysis",1999-11-12,"PA0167/101/003","Baxter Healthcare Limited","GLUCOSEMONOHYDRATE|CALCIUMCHLORIDEDIHYDRATE|MAGNESIUMCHLORIDEHEXAHYDRATE|SODIUMCHLORIDE|SODIUMBICARBONATE|SODIUMLACTATE"
"7273","PHYSIONEAL 40 GLUCOSE CLEAR-FLEX 1.36%W/V","13.6 Micromol Solution for Dialysis",2004-09-10,"PA0167/101/010","Baxter Healthcare Limited","GLUCOSEMONOHYDRATE|SODIUMCHLORIDE|CALCIUMCHLORIDEDIHYDRATE|MAGNESIUMCHLORIDEANHYDROUS|SODIUMLACTATE|SODIUMBICARBONATE"
"7274","PHYSIONEAL 40 GLUCOSE CLEAR-FLEX 2.27%W/V","22.7 Micromol Solution for Dialysis",2004-09-10,"PA0167/101/011","Baxter Healthcare Limited","GLUCOSEMONOHYDRATE|SODIUMCHLORIDE|CALCIUMCHLORIDEDIHYDRATE|MAGNESIUMCHLORIDEANHYDROUS|SODIUMLACTATE|SODIUMBICARBONATE"
"7275","PHYSIONEAL 40 GLUCOSE CLEAR-FLEX 3.86%W/V","38.6 Micromol Solution for Dialysis",2004-09-10,"PA0167/101/012","Baxter Healthcare Limited","GLUCOSEMONOHYDRATE|SODIUMCHLORIDE|CALCIUMCHLORIDEDIHYDRATE|MAGNESIUMCHLORIDEANHYDROUS|SODIUMLACTATE|SODIUMBICARBONATE"
"7276","Picato","150 ZZZ Micrograms/g Gel",2012-11-15,"EU/1/12/796/001","Leo Laboratories Limited","Ingenolmebutate"
"7277","PICATO","500 Micrograms/g                                                                                         Gel",2012-11-15,"EU/1/12/796/002","Leo Laboratories Limited","INGENOLMEBUTATE"
"7278","Pickles 50% w/w Ointment","50 percent weight/weight Ointment",1992-04-23,"PA1904/001/001","Optima Consumer Health Limited","Salicylicacid"
"7279","PICOLAX","0.01/3.5/1 Grams                                                                                                Powder for Oral Solution",1983-02-24,"PA1009/003/001","Ferring Ireland Ltd","SODIUMPICOSULFATE|MAGNESIUMOXIDE|CITRICACID"
"7280","PILOCARPINE","2%w/v %w/v                                                                                                 Eye Drops Solution",1988-09-01,"PA0361/010/001","Martindale Pharmaceuticals Ltd","PILOCARPINEHYDROCHLORIDE"
"7281","PILOCARPINE","4 %w/v                                                                                                 Eye Drops Solution",1988-09-01,"PA0361/010/002","Martindale Pharmaceuticals Ltd","PILOCARPINEHYDROCHLORIDE"
"7282","PINACLOR","250 Anhyd Milligrams                                                                                     Capsules Hard",1999-05-14,"PA0281/155/001","Pinewood Laboratories Ltd,","CEFACLOR"
"7283","PINACLOR","500 Anhyd Milligrams                                                                                     Capsules Hard",1999-05-14,"PA0281/155/002","Pinewood Laboratories Ltd,","CEFACLOR"
"7284","PINACLOR","125 Anhyd mg/5ml                                                                                         Granules for Oral Suspension",1999-05-14,"PA0281/155/003","Pinewood Laboratories Ltd,","CEFACLOR"
"7285","PINACLOR","250 Anhyd mg/5ml                                                                                         Granules for Oral Suspension",1999-05-14,"PA0281/155/004","Pinewood Laboratories Ltd,","CEFACLOR"
"7286","PINADONE METHADONE  DTF SUGAR FREE","1 Mg/Ml Oral Solution",1995-11-15,"PA0281/061/001","Pinewood Laboratories Ltd,","METHADONEHYDROCHLORIDE"
"7287","Pinamox 125 mg/5 ml Powder for Oral Suspension","125 mg/5ml Powder for oral suspension",1988-05-18,"PA0298/010/001","Athlone Laboratories Ltd","Amoxicillintrihydrate"
"7288","Pinamox 250 mg/5 ml Powder for Oral Suspension","250 mg/5ml Powder for oral suspension",1988-05-18,"PA0298/010/002","Athlone Laboratories Ltd","Amoxicillintrihydrate"
"7289","Pinamox 250mg hard capsules","250 milligram(s) Capsule",1988-06-29,"PA0298/010/003","Athlone Laboratories Ltd","Amoxicillintrihydrate"
"7290","Pinamox 500mg hard Capsules","500 milligram(s) Capsule",1988-06-29,"PA0298/010/004","Athlone Laboratories Ltd","Amoxicillintrihydrate"
"7291","PIOGLITAZONE ACCORD","15 Base Milligrams                                                                                      Tablets",2012-03-21,"EU/1/11/722/001-010","Accord Healthcare Limited","PIOGLITAZONEHYDROCHLORIDE"
"7292","PIOGLITAZONE ACCORD","30 Base Milligrams                                                                                      Tablets",2012-03-21,"EU/1/11/722/011-020","Accord Healthcare Limited","PIOGLITAZONEHYDROCHLORIDE"
"7293","PIOGLITAZONE ACCORD","45 Base Milligrams                                                                                      Tablets",2012-03-21,"EU/1/11/722/021-030","Accord Healthcare Limited","PIOGLITAZONEHYDROCHLORIDE"
"7294","PIOGLITAZONE ACTAVIS","15 Milligram                                                                                            Tablets",2012-03-15,"EU/1/12/755/001-009","Actavis Group PTC ehf","PIOGLITAZONEHYDROCHLORIDE"
"7295","PIOGLITAZONE ACTAVIS","30 Milligram                                                                                            Tablets",2012-03-15,"EU/1/12/755/010-018","Actavis Group PTC ehf","PIOGLITAZONEHYDROCHLORIDE"
"7296","PIOGLITAZONE ACTAVIS","45 Milligram                                                                                            Tablets",2012-03-15,"EU/1/12/755/019-027","Actavis Group PTC ehf","PIOGLITAZONEHYDROCHLORIDE"
"7297","Pioglitazone Hydrochloride 30mg Tablets","30 milligram(s) Tablet",2018-07-20,"PA1339/040/002","Wockhardt UK Limited","Pioglitazonehydrochloride"
"7298","Pioglitazone Hydrochloride 45mg Tablets","45 milligram(s) Tablet",2018-07-20,"PA1339/040/003","Wockhardt UK Limited","Pioglitazonehydrochloride"
"7299","PIOGLITAZONE TEVA","15 Milligram                                                                                            Tablets",2012-03-26,"EU/1/12/757/001-010","Teva B.V.","PIOGLITAZONEHYDROCHLORIDE"
"7300","PIOGLITAZONE TEVA","30 Milligram                                                                                            Tablets",2012-03-26,"EU/1/12/757/011-020","Teva B.V.","PIOGLITAZONEHYDROCHLORIDE"
"7301","PIOGLITAZONE TEVA","45 Milligram                                                                                            Tablets",2012-03-26,"EU/1/12/757/021-030","Teva B.V.","PIOGLITAZONEHYDROCHLORIDE"
"7302","PIOGLITAZONE TEVA PHARMA","15 Milligram                                                                                            Tablets",2012-03-26,"EU/1/12/758/001-010","Teva B.V.","PIOGLITAZONEHYDROCHLORIDE"
"7303","PIOGLITAZONE TEVA PHARMA","30 Milligram                                                                                            Tablets",2012-03-26,"EU/1/12/758/011-020","Teva B.V.","PIOGLITAZONEHYDROCHLORIDE"
"7304","PIOGLITAZONE TEVA PHARMA","45 Milligram                                                                                            Tablets",2012-03-26,"EU/1/12/758/021-030","Teva B.V.","PIOGLITAZONEHYDROCHLORIDE"
"7305","PIPERACILLIN & TAZOBACTAM","2/0.25 Grams                                                                                                Pdr for Soln for Infusion",2011-11-18,"PA1122/012/001","Noridem Enterprises Ltd","PIPERACILLINSODIUM|TAZOBACTAMSODIUM"
"7306","PIPERACILLIN & TAZOBACTAM","4 / 0.5 Grams                                                                                                Pdr for Soln for Infusion",2011-11-18,"PA1122/012/002","Noridem Enterprises Ltd","PIPERACILLINSODIUM|TAZOBACTAMSODIUM"
"7307","Piperacillin Tazobactam 2 g/0.25 g powder for solution for infusion","2/0.25 gram(s) Powder for solution for infusion",2010-02-26,"PA0405/053/001","Generics (UK) Limited","PIPERACILLINSODIUM|Tazobactam(assodiumsalt)"
"7308","Piperacillin Tazobactam 4 g/0.5 g powder for solution for infusion","4/0.5 gram(s) Powder for solution for infusion",2010-02-26,"PA0405/053/002","Generics (UK) Limited","PIPERACILLINSODIUM|Tazobactam(assodiumsalt)"
"7309","PIPERACILLIN WITH TAZOBACTAM","2.25 Grams                                                                                                Pdr for Soln for Injection",2009-06-19,"PA1339/001/001","Wockhardt UK Limited","PIPERACILLINSODIUM|TAZOBACTAMSODIUM"
"7310","PIPERACILLIN WITH TAZOBACTAM","4.5 Grams                                                                                                Pdr for Soln for Injection",2009-06-19,"PA1339/001/002","Wockhardt UK Limited","PIPERACILLINSODIUM|TAZOBACTAMSODIUM"
"7311","PIPERACILLIN/TAZOBACTAM","4/0.5 Grams                                                                                                Pdr for Soln for Infusion",2014-10-17,"PA1947/001/001","Stravencon Ltd","PIPERACILLINSODIUM|TAZOBACTAMSODIUM"
"7312","PIPERACILLIN/TAZOBACTAM","2000/250 Milligram                                                                                            Pdr for Soln Inj/Inf",2008-09-05,"PA0437/069/001","Hospira  UK Limited","PIPERACILLINSODIUM|TAZOBACTAMSODIUM"
"7313","PIPERACILLIN/TAZOBACTAM","4000/500 Milligram                                                                                            Pdr for Soln Inj/Inf",2008-09-05,"PA0437/069/002","Hospira  UK Limited","PIPERACILLINSODIUM|TAZOBACTAMSODIUM"
"7314","Piperacillin/Tazobactam 2 g/0.25g powder for solution for infusion","2/0.25 gram(s) Powder for solution for infusion",2008-11-28,"PA2059/016/001","Fresenius Kabi Deutschland GmbH","Piperacillinsodiumsterile|Tazobactamsodiumsterile"
"7315","Piperacillin/Tazobactam 4 g/0.5 g powder for solution for infusion","4/0.5 gram(s) Powder for solution for infusion",2008-11-28,"PA2059/016/002","Fresenius Kabi Deutschland GmbH","Piperacillinsodiumsterile|Tazobactamsodiumsterile"
"7316","Piperacillin/Tazobactam Aurobindo 2 g / 0.25 g powder for solution for infusion","2/0.25 gram(s) Powder for solution for injection/infusion",2010-02-26,"PA1445/005/001","Aurobindo Pharma (Malta) Limited","Piperacillin|Tazobactam"
"7317","Piperacillin/Tazobactam Aurobindo 4 g / 0.5 g powder for solution for infusion","4/0.5 gram(s) Powder for solution for injection/infusion",2010-02-26,"PA1445/005/002","Aurobindo Pharma (Malta) Limited","Piperacillin|Tazobactam"
"7318","PIPERCIN","4/0.5 Grams                                                                                                Pdr for Soln for Infusion",2009-02-13,"PA0126/180/002","Clonmel Healthcare Ltd","PIPERACILLINSODIUM|TAZOBACTAM(ASSODIUMSALT)"
"7319","Piperin 2 g/0.25g Powder for Solution for Infusion","2 / 0.25 gram(s) Powder for solution for infusion",2008-10-10,"PA0711/113/001","Rowex Ltd","Tazobactam|Piperacillin"
"7320","Piperin 4 g / 0.5 g Powder for Solution for Infusion","4 / 0.5 gram(s) Powder for solution for infusion",2008-10-10,"PA0711/113/002","Rowex Ltd","Piperacillin|Tazobactam"
"7321","PIPEXUS","0.26 Milligram                                                                                            Tablet Prolonged Release",2016-09-16,"PA0274/003/001","Macarthys Laboratories Limited","PRAMIPEXOLEDIHYDROCHLORIDEMONOHYDRATE"
"7322","PIPEXUS","0.52 Milligram                                                                                            Tablet Prolonged Release",2016-09-16,"PA0274/003/002","Macarthys Laboratories Limited","PRAMIPEXOLEDIHYDROCHLORIDEMONOHYDRATE"
"7323","PIPEXUS","1.05 Milligram                                                                                            Tablet Prolonged Release",2016-09-16,"PA0274/003/003","Macarthys Laboratories Limited","PRAMIPEXOLEDIHYDROCHLORIDEMONOHYDRATE"
"7324","PIPEXUS","1.57 Milligram                                                                                            Prolonged Release Capsules",2016-09-16,"PA0274/003/004","Macarthys Laboratories Limited","PRAMIPEXOLEDIHYDROCHLORIDEMONOHYDRATE"
"7325","PIPEXUS","2.1 Milligram                                                                                            Tablet Prolonged Release",2016-09-16,"PA0274/003/005","Macarthys Laboratories Limited","PRAMIPEXOLEDIHYDROCHLORIDEMONOHYDRATE"
"7326","PIPEXUS","2.62 Milligram                                                                                            Tablet Prolonged Release",2016-09-16,"PA0274/003/006","Macarthys Laboratories Limited","PRAMIPEXOLEDIHYDROCHLORIDEMONOHYDRATE"
"7327","PIPEXUS","3.15 Milligram                                                                                            Tablet Prolonged Release",2016-09-16,"PA0274/003/007","Macarthys Laboratories Limited","PRAMIPEXOLEDIHYDROCHLORIDEMONOHYDRATE"
"7328","PIRITON","4 mg Milligram                                                                                            Tablets",2018-03-16,"PPA1151/266/001","Imbat Limited","CHLORPHENIRAMINEMALEATE"
"7329","PIRITON 4MG TABLETS","4 Milligram                                                                                            Tablets",1985-06-10,"PA0678/080/001","GlaxoSmithKline Consumer Healthcare (Ireland) Limited","CHLORPHENIRAMINEMALEATE"
"7330","Pitressin 20 PU/ml Solution for Injection","20 unit(s)/millilitre Solution for injection",1979-04-01,"PA0899/001/001","Mercury Pharmaceuticals Ltd","Argipressin"
"7331","PIVMECILLINAM LEO 400 MG FILM-COATED TABLETS","400 Milligram                                                                                            Film Coated Tablet",2016-12-02,"PA1025/008/001","LEO Pharma A/S","PIVMECILLINAMHYDROCHLORIDE"
"7332","PIXUVRI","29 Milligram                                                                                            Pdr for Soln for Infusion",2012-05-10,"EU/1/12/764/001","CTI Life Sciences, Ltd","PIXANTRONE"
"7333","Plaquenil 200 mg Film-coated Tablets","200 milligram(s) Film-coated tablet",1977-04-01,"PA0077/021/001","Sanofi-aventis Ireland Ltd","HYDROXYCHLOROQUINESULFATE"
"7334","Plaquenil 200mg Film-coated Tablets","200 milligram(s) Film-coated tablet",1977-04-01,"PA0540/155/001","Sanofi-Aventis Ireland Limited T/A SANOFI","HYDROXYCHLOROQUINESULFATE"
"7335","Plasma-Lyte 148 & Glucose 5% w/v solution for infusion","5 percent weight/volume Solution for infusion",2007-06-01,"PA0167/040/005","Baxter Healthcare Limited","Glucosemonohydrate|Sodiumchloride|Potassiumchloride|Magnesiumchloridehexahydrate|Sodiumacetatetrihydrate|Sodiumgluconate"
"7336","PLASMA-LYTE® 148 (PH 7.4) SOLUTION FOR INFUSION","Unknown Solution for Infusion",2017-07-07,"PA0167/144/001","Baxter Healthcare Limited","SODIUMCHLORIDE|POTASSIUMCHLORIDE|MAGNESIUMCHLORIDEHEXAHYDRATE|SODIUMACETATETRIHYDRATE|GLUCONATESODIUM"
"7337","PLAVIX","75 Milligram                                                                                            Film Coated Tablet",1998-07-15,"EU/1/98/069/001-007","Sanofi Pharma Bristol-Myers Squibb SNC","CLOPIDOGRELHYDROGENSULFATE"
"7338","PLAVIX","300 Milligram                                                                                            Film Coated Tablet",2008-04-14,"EU/1/98/069/008-010","Sanofi Pharma Bristol-Myers Squibb SNC","CLOPIDOGRELHYDROGENSULFATE"
"7339","Plegridy","63/94 microgram(s) Solution for injection in pre-filled syringe",NA,"EU/1/14/934/001","Biogen Netherlands B.V.","Peginterferonbeta-1a"
"7340","PLEGRIDY","63/94 Microgram                                                                                            Solution for Injection",2014-07-18,"EU/1/14/934/002","Biogen Netherlands B.V.","PEGINTERFERONBETA-1A"
"7341","PLEGRIDY","125 Microgram                                                                                            Solution for Injection",2014-07-18,"EU/1/14/934/003-006","Biogen Netherlands B.V.","PEGINTERFERONBETA-1A"
"7342","PLENADREN","5 Milligram                                                                                            Modified-release Tablets",2011-11-03,"EU/1/11/715/001","DuoCort Pharma AB","HYDROCORTISONE"
"7343","PLENADREN, HYDROCORTISONE","20 Milligram                                                                                            Modified-release Tablets",2011-11-03,"EU/1/11/715/002","DuoCort Pharma AB","HYDROCORTISONE"
"7344","PLENDIL","5 Milligram                                                                                            Tablet Prolonged Release",2015-01-23,"PPA0465/405/001","PCO Manufacturing","FELODIPINE"
"7345","PLENDIL","5 Milligram                                                                                            Tablet Prolonged Release",2015-05-15,"PPA1562/157/001","LTT Pharma Limited","FELODIPINE"
"7346","PLENDIL","10 Milligram                                                                                            Tablet Prolonged Release",2015-05-15,"PPA1562/157/002","LTT Pharma Limited","FELODIPINE"
"7347","Plendil 10 mg prolonged-release tablets","10 milligram(s) Prolonged-release tablet",2017-08-25,"PPA0465/405/002","PCO Manufacturing","Felodipine"
"7348","Plendil 10 mg prolonged-release tablets","10 milligram(s) Prolonged-release tablet",1993-05-18,"PA0970/049/003","AstraZeneca UK Limited","Felodipine"
"7349","Plendil 2.5 mg prolonged-release tablets","2.5 milligram(s) Prolonged-release tablet",1997-05-19,"PA0970/049/001","AstraZeneca UK Limited","Felodipine"
"7350","Plendil 5 mg prolonged-release tablets","5 milligram(s) Prolonged-release tablet",1993-05-18,"PA0970/049/002","AstraZeneca UK Limited","Felodipine"
"7351","Plenvu powder for oral solution","0 gram(s) Powder for oral solution",2017-12-01,"PA1336/005/001","Norgine B.V.","Potassiumchloride|Ascorbicacid|Macrogol3350|Sodiumsulfateanhydrous|Sodiumascorbate|Sodiumchloride"
"7352","PLIAGLIS","70+70 mg/g Cream",2012-07-20,"PA0590/026/001","Galderma (UK) Ltd","LIDOCAINE|TETRACAINE"
"7353","PNEUMOVAX 23 SOLUTION FOR INJECTION IN A VIAL","25mcg/0.5m %v/v                                                                                                 Solution for Injection",2001-05-04,"PA1286/055/001","Merck Sharp & Dohme Ireland (Human Health) Limited","PNEUMOCOCCALVACCINE"
"7354","PNEUMOVAX 23 solution for injection in pre-filled syringePneumococcal Polysaccharide Vaccine","25/0.5 microgram(s)/millilitre Solution for injection in pre-filled syringe",2015-05-22,"PA1286/055/002","Merck Sharp & Dohme Ireland (Human Health) Limited","Pneumococcalpolysaccharideserotype1|Pneumococcalpolysaccharidetype2(2)|Pneumococcalpolysaccharidetype3(3)|Pneumococcalpolysaccharideserotype4|Pneumococcalpolysaccharideserotype5|Pneumococcalpolysaccharideserotype6b|Pneumococcalpolysaccharideserotype7f|Pneumococcalpolysaccharidetype8(8)|Pneumococcalpolysaccharidetype9n|Pneumococcalpolysaccharideserotype9v|Pneumococcalpolysaccharidetype20(20)|Pneumococcaloligosaccharideserotype18c|Pneumococcalpolysaccharidetype14(14)|Pneumococcalpolysaccharidetype22(22f)|Pneumococcalpolysaccharideserotype23f|Pneumococcalpolysaccharidetype10a|Pneumococcalpolysaccharidetype11a|Pneumococcalpolysaccharidetype12f|Pneumococcalpolysaccharidetype15b|Pneumococcalpolysaccharidetype17f|Pneumococcalpolysaccharidetype19a|Pneumococcalpolysaccharidetype19f|Pneumococcalpolysaccharidetype33f"
"7355","POLIBAR","96.5 %w/w                                                                                                 powder for rectal suspension",1992-10-13,"PA1826/003/001","Bracco Imaging spa","BARIUMSULFATE"
"7356","POLYFAX OINTMENT, 10,000 IU POLYMYXIN B SULPHATE + 500 IU BACITRACIN ZINC.","International Unit                                                                                   Unknown",1977-04-01,"PA0585/013/001","Pliva Pharma Limited","POLYMYXINBSULFATE|BACITRACINZINC"
"7357","Ponalgic 250mg Hard Capsules","250 milligram(s) Capsule",1987-10-23,"PA0073/097/001","Mercury Pharmaceuticals (Ireland) Ltd","Mefenamicacid"
"7358","PONALGIC FORTE","500 Milligram                                                                                            Film Coated Tablet",1987-10-23,"PA0073/097/002","Mercury Pharmaceuticals (Ireland) Ltd","MEFENAMICACID"
"7359","Ponstan 250 mg Capsules","250 milligram(s) Capsule, hard",1974-12-20,"PA1161/001/001","Chemidex Pharma Limited","Mefenamicacid"
"7360","PONSTAN FORTE","500 Milligram                                                                                            Film Coated Tablet",1997-01-24,"PA1161/001/002","Chemidex Pharma Limited","MEFENAMICACID"
"7361","PORTRAZZA","16 Mg/Ml Concentrate for Soln for Inf",2016-02-15,"EU/1/15/1084/001","Eli Lilly Nederland B.V.","NECITUMUMAB"
"7362","POTACTASOL","1 Milligram                                                                                            Pdr/Conc/Soln for Infus",2011-01-06,"EU/1/10/660/001","Actavis Group PTC ehf","TOPOTECANHYDROCHLORIDE"
"7363","POTACTASOL","4 Milligram                                                                                            Pdr/Conc/Soln for Infus",2011-01-06,"EU/1/10/660/002","Actavis Group PTC ehf","TOPOTECANHYDROCHLORIDE"
"7364","POTASSIUM CHLORIDE","15 %w/v                                                                                                 Concentrate for Soln for Inf",1988-11-18,"PA0073/106/001","Mercury Pharmaceuticals (Ireland) Ltd","POTASSIUMCHLORIDE"
"7365","POTASSIUM CHLORIDE","15 %w/v                                                                                                 Concentrate for Soln for Inf",2010-07-16,"PA0566/058/001","Fresenius Kabi Limited","POTASSIUMCHLORIDE"
"7366","POTASSIUM CHLORIDE","15 %w/v                                                                                                 Concentrate for Soln for Inf",1991-11-26,"PA0179/030/002","B. Braun Medical Limited","POTASSIUMCHLORIDE"
"7367","POTASSIUM CHLORIDE","15 %w/v                                                                                                 Concentrate for Soln for Inf",2008-11-14,"PA1122/003/001","Noridem Enterprises Ltd","POTASSIUMCHLORIDE"
"7368","POTASSIUM CHLORIDE & GLUCOSE","0.3/5 %w/v                                                                                                 Solution for Infusion",2005-12-02,"PA0931/006/001","Maco Pharma (UK) Ltd","POTASSIUMCHLORATE|GLUCOSEMONOHYDRATE"
"7369","POTASSIUM CHLORIDE & GLUCOSE","0.15/5 %w/v                                                                                                 Solution for Infusion",2005-12-02,"PA0931/006/002","Maco Pharma (UK) Ltd","POTASSIUMCHLORIDE|GLUCOSEMONOHYDRATE"
"7370","POTASSIUM CHLORIDE & SODIUM CHLORIDE","0.15/0.9 %w/v                                                                                                 Solution for Infusion",2005-12-02,"PA0931/007/001","Maco Pharma (UK) Ltd","POTASSIUMCHLORIDE|SODIUMCHLORIDE"
"7371","POTASSIUM CHLORIDE 0.15% AND GLUCOSE 5%","0.15/5.0 %v/v                                                                                                 Solution for Infusion",2003-04-17,"PA0167/051/009","Baxter Healthcare Limited","POTASSIUMCHLORIDE|GLUCOSEMONOHYDRATE"
"7372","Potassium Chloride 0.15% w/v & Glucose 5% w/v Solution for Infusion","0.15 + 5 percent weight/volume Solution for infusion",2015-09-11,"PA0566/071/001","Fresenius Kabi Limited","Potassiumchloride|Glucosemonohydrate"
"7373","Potassium Chloride 0.15% w/v & Sodium Chloride 0.9% w/v Solution for Infusion","0.15% w/v + 0.9% w/v percent weight/volume Solution for infusion",2014-11-03,"PA0566/067/001","Fresenius Kabi Limited","Potassiumchloride|Sodiumchloride"
"7374","Potassium Chloride 0.15% w/v & Sodium Chloride 0.9% w/v Solution for Infusion - BP","0.15/0.9 percent weight/volume Solution for infusion",2007-11-09,"PA0167/052/012","Baxter Healthcare Limited","Potassiumchloride|Sodiumchloride|Sodiumchloride"
"7375","Potassium Chloride 0.15% w/v and Glucose 5% w/v solution for infusion","1.5/55.0 gram(s)/litre Solution for infusion",2012-07-27,"PA0736/036/001","B. Braun Melsungen AG","Potassiumchloride|Glucosemonohydrate"
"7376","Potassium Chloride 0.15% w/v and Sodium Chloride 0.9% w/v Solution for Infusion","0.15/0.9 percent weight/volume Solution for infusion",2012-08-24,"PA0736/037/001","B. Braun Melsungen AG","Potassiumchloride|Sodiumchloride"
"7377","Potassium Chloride 0.15% w/v, Sodium Chloride 0.18% w/v, Glucose 4% w/v Solution for Infusion","0.15/0.18/4% percent weight/volume Solution for infusion",2011-06-10,"PA0167/004/009","Baxter Healthcare Limited","Glucoseanhydrous|Sodiumchloride|Potassiumchloride"
"7378","POTASSIUM CHLORIDE 0.3% AND GLUCOSE 5%","0.3/5.0 %v/v                                                                                                 Solution for Infusion",2003-04-17,"PA0167/051/010","Baxter Healthcare Limited","POTASSIUMCHLORIDE|GLUCOSEMONOHYDRATE"
"7379","Potassium Chloride 0.3% w/v & Glucose 5% w/v Solution for Infusion","0.3 + 5 percent weight/volume Solution for infusion",2015-09-11,"PA0566/071/002","Fresenius Kabi Limited","Potassiumchloride|Glucosemonohydrate"
"7380","Potassium Chloride 0.3% w/v & Sodium Chloride 0.9% w/v Solution for Infusion","0.3% w/v + 0.9% w/v percent weight/volume Solution for infusion",2014-11-03,"PA0566/067/002","Fresenius Kabi Limited","Potassiumchloride|Sodiumchloride"
"7381","Potassium Chloride 0.3% w/v & Sodium Chloride 0.9% w/v Solution for Infusion BP","0.3 / 0.9 percent weight/volume Solution for infusion",2003-03-07,"PA0167/052/011","Baxter Healthcare Limited","Potassiumchloride|Sodiumchloride"
"7382","Potassium Chloride 0.3% w/v and Glucose 5% w/v Solution for Infusion","3.0/55.0 gram(s)/litre Solution for infusion",2012-07-27,"PA0736/036/002","B. Braun Melsungen AG","Potassiumchloride|Glucosemonohydrate"
"7383","Potassium Chloride 0.3% w/v and Sodium Chloride 0.9% w/v Solution for Infusion","0.3/0.9 percent weight/volume Solution for infusion",2012-08-24,"PA0736/037/002","B. Braun Melsungen AG","Potassiumchloride|Sodiumchloride"
"7384","POTASSIUM CHLORIDE AND SODIUM CHLORIDE","0.3  0.9 %w/v                                                                                                 Solution for Infusion",2002-12-17,"PA0931/005/001","Maco Pharma (UK) Ltd","POTASSIUMCHLORIDE|SODIUMCHLORIDE"
"7385","POTASSIUM CHLORIDE AND SODIUM CHLORIDE IN GLUCOSE","0.3/0.18/4 %w/v                                                                                                 Solution for Infusion",2008-04-11,"PA0167/004/008","Baxter Healthcare Limited","POTASSIUMCHLORIDE|SODIUMCHLORIDE|GLUCOSEMONOHYDRATE"
"7386","POTASSIUM CHLORIDE SODIUM CHLORIDE & GLUCOSE","0.3/0.18/4 %w/v                                                                                                 Solution for Infusion",2005-12-02,"PA0931/008/002","Maco Pharma (UK) Ltd","POTASSIUMCHLORIDE|SODIUMCHLORIDE|GLUCOSEMONOHYDRATE"
"7387","POTASSIUM CHLORIDE, SODIUM CHLORIDE & GLUCOSE","0.15 0.18 4 %w/v                                                                                                 Solution for Infusion",2005-12-02,"PA0931/008/001","Maco Pharma (UK) Ltd","POTASSIUMCHLORIDE|SODIUMCHLORIDE|GLUCOSEMONOHYDRATE"
"7388","POTASSIUM IODIDE G.L. PHARMA","65 Milligram                                                                                            Tablets",2012-08-03,"PA1770/001/001","G.L. Pharma GmbH","POTASSIUMIODIDE"
"7389","POTASSIUM PHOSPHATE","1 + 0.6 mMol/ml                                                                                              Concentrate for Soln for Inf",1993-02-24,"PA0179/005/001","B. Braun Medical Limited","POTASSIUMPHOSPHATEMONOBASIC|POTASSIUMPHOSPHATEDIBASIC"
"7390","PRADAXA","150 Milligram                                                                                            Capsules Hard",2011-08-01,"EU/1/08/442/009-013","Boehringer Ingelheim International GmbH","DABIGATRANETEXILATEMESILATE"
"7391","Pradaxa","75 milligram(s) Capsule, hard",2008-03-18,"EU/1/08/442/1-4","Boehringer Ingelheim International GmbH","Dabigatranetexilate"
"7392","PRADAXA","110 Milligram                                                                                            Capsules Hard",2008-03-18,"EU/1/08/442/5-8","Boehringer Ingelheim International GmbH","DABIGATRANETEXILATE"
"7393","PRALUENT","75 Milligram                                                                                            Solution for injection in pre-filled pen",2015-09-23,"EU/1/15/1031/001-003","sanofi-aventis groupe","ALIROCUMAB"
"7394","PRALUENT","75 Milligram                                                                                            Solution for injection in pre-filled syringe",2015-09-23,"EU/1/15/1031/004-006","sanofi-aventis groupe","ALIROCUMAB"
"7395","PRALUENT","150 Milligram                                                                                            Solution for injection in pre-filled pen",2015-09-23,"EU/1/15/1031/007-009","sanofi-aventis groupe","ALIROCUMAB"
"7396","PRALUENT","150 Milligram                                                                                            Solution for injection in pre-filled syringe",2015-09-23,"EU/1/15/1031/010-012","sanofi-aventis groupe","ALIROCUMAB"
"7397","PRAMIPEXOLE ACCORD","0.088 Milligram                                                                                            Tablets",2011-09-30,"EU/1/11/728/001-002","Accord Healthcare Limited","PRAMIPEXOLEDIHYDROCHLORIDEMONOHYDRATE"
"7398","PRAMIPEXOLE ACCORD","0.18 Milligram                                                                                            Tablets",2011-09-30,"EU/1/11/728/003-004","Accord Healthcare Limited","PRAMIPEXOLEDIHYDROCHLORIDEMONOHYDRATE"
"7399","PRAMIPEXOLE ACCORD","0.35 Milligram                                                                                            Tablets",2011-09-30,"EU/1/11/728/005-006","Accord Healthcare Limited","PRAMIPEXOLEDIHYDROCHLORIDEMONOHYDRATE"
"7400","PRAMIPEXOLE ACCORD","0.7 Milligram                                                                                            Tablets",2011-09-30,"EU/1/11/728/007-008","Accord Healthcare Limited","PRAMIPEXOLEDIHYDROCHLORIDEMONOHYDRATE"
"7401","PRAMIPEXOLE ACCORD","1.1 Milligram                                                                                            Tablets",2011-09-30,"EU/1/11/728/009-010","Accord Healthcare Limited","PRAMIPEXOLEDIHYDROCHLORIDEMONOHYDRATE"
"7402","PRAMIPEXOLE BLUEFISH","0.18 Milligram                                                                                            Tablets",2010-07-16,"PA1436/012/001","Bluefish Pharmaceuticals AB","PRAMIPEXOLEDIHYDROCHLORIDEMONOHYDRATE"
"7403","PRAMIPEXOLE BLUEFISH","0.7 Milligram                                                                                            Tablets",2010-07-16,"PA1436/012/002","Bluefish Pharmaceuticals AB","PRAMIPEXOLEDIHYDROCHLORIDEMONOHYDRATE"
"7404","Pramipexole Mylan 0.088 mg tablets","0.088 milligram(s) Tablet",2010-11-19,"PA0577/138/001","McDermott Laboratories Ltd t/a Gerard Laboratories","Pramipexoledihydrochloridemonohydrate"
"7405","PRAMIPEXOLE TEVA","0.7 Milligram                                                                                            Tablets",2008-12-18,"EU/1/08/490/13-16","Teva B.V.","PRAMIPEXOLEDIHYDROCHLORIDEMONOHYDRATE"
"7406","PRAMIPEXOLE TEVA","0.088 Milligram                                                                                            Tablets",2008-12-18,"EU/1/08/490/1-4","Teva B.V.","PRAMIPEXOLEDIHYDROCHLORIDEMONOHYDRATE"
"7407","PRAMIPEXOLE TEVA","0.18 Milligram                                                                                            Tablets",2008-12-18,"EU/1/08/490/5-8","Teva B.V.","PRAMIPEXOLEDIHYDROCHLORIDEMONOHYDRATE"
"7408","PRAMIPEXOLE TEVA","0.35 Milligram                                                                                            Tablets",2008-12-18,"EU/1/08/490/9-12","Teva B.V.","PRAMIPEXOLEDIHYDROCHLORIDEMONOHYDRATE"
"7409","PRANDIN","0.5mg milligram(s) Tablet",2001-01-29,"EU/1/00/162/001","Novo Nordisk A/S","Repaglinide"
"7410","PRANDIN","0.5 Milligram                                                                                            Tablets",2001-01-29,"EU/1/00/162/002","Novo Nordisk A/S","REPAGLINIDE"
"7411","PRANDIN","0.5 Milligram                                                                                            Tablets",2001-01-29,"EU/1/00/162/003","Novo Nordisk A/S","REPAGLINIDE"
"7412","PRANDIN","0.5 Milligram                                                                                            Tablets",2001-01-29,"EU/1/00/162/004","Novo Nordisk A/S","REPAGLINIDE"
"7413","PRANDIN","0.5 Milligram                                                                                            Tablets",2001-01-29,"EU/1/00/162/005","Novo Nordisk A/S","REPAGLINIDE"
"7414","PRANDIN","0.5 Milligram                                                                                            Tablets",2001-01-29,"EU/1/00/162/006","Novo Nordisk A/S","REPAGLINIDE"
"7415","PRANDIN","1 Milligram                                                                                            Tablets",2001-01-29,"EU/1/00/162/007","Novo Nordisk A/S","REPAGLINIDE"
"7416","PRANDIN","1 Milligram                                                                                            Tablets",2001-01-29,"EU/1/00/162/008","Novo Nordisk A/S","REPAGLINIDE"
"7417","PRANDIN","1 Milligram                                                                                            Tablets",2001-01-29,"EU/1/00/162/009","Novo Nordisk A/S","REPAGLINIDE"
"7418","PRANDIN","1 Milligram                                                                                            Tablets",2001-01-29,"EU/1/00/162/010","Novo Nordisk A/S","REPAGLINIDE"
"7419","PRANDIN","1 Milligram                                                                                            Tablets",2001-01-29,"EU/1/00/162/011","Novo Nordisk A/S","REPAGLINIDE"
"7420","PRANDIN","1 Milligram                                                                                            Tablets",2001-01-29,"EU/1/00/162/012","Novo Nordisk A/S","REPAGLINIDE"
"7421","PRANDIN","2 Milligram                                                                                            Tablets",2001-01-29,"EU/1/00/162/013","Novo Nordisk A/S","REPAGLINIDE"
"7422","PRANDIN","2 Milligram                                                                                            Tablets",2001-01-29,"EU/1/00/162/014","Novo Nordisk A/S","REPAGLINIDE"
"7423","PRANDIN","2 Milligram                                                                                            Tablets",2001-01-29,"EU/1/00/162/015","Novo Nordisk A/S","REPAGLINIDE"
"7424","PRANDIN","2 Milligram                                                                                            Tablets",2001-01-29,"EU/1/00/162/016","Novo Nordisk A/S","REPAGLINIDE"
"7425","PRANDIN","2 Milligram                                                                                            Tablets",2001-01-29,"EU/1/00/162/017","Novo Nordisk A/S","REPAGLINIDE"
"7426","PRANDIN","2 Milligram                                                                                            Tablets",2001-01-29,"EU/1/00/162/018","Novo Nordisk A/S","REPAGLINIDE"
"7427","PRAPEXIN","0.26 Milligram                                                                                            Tablet Prolonged Release",2014-08-15,"PA0711/242/001","Rowex Ltd","PRAMIPEXOLEDIHYDROCHLORIDEMONOHYDRATE"
"7428","PRAPEXIN","0.52 Milligram                                                                                            Tablet Prolonged Release",2014-08-15,"PA0711/242/002","Rowex Ltd","PRAMIPEXOLEDIHYDROCHLORIDEMONOHYDRATE"
"7429","PRAPEXIN","1.05 Milligram                                                                                            Tablet Prolonged Release",2014-08-15,"PA0711/242/003","Rowex Ltd","PRAMIPEXOLEDIHYDROCHLORIDEMONOHYDRATE"
"7430","PRAPEXIN","2.1 Milligram                                                                                            Tablet Prolonged Release",2014-08-15,"PA0711/242/004","Rowex Ltd","PRAMIPEXOLEDIHYDROCHLORIDEMONOHYDRATE"
"7431","PRAPEXIN","3.15 Milligram                                                                                            Tablet Prolonged Release",2014-08-15,"PA0711/242/005","Rowex Ltd","PRAMIPEXOLEDIHYDROCHLORIDEMONOHYDRATE"
"7432","PRASUGREL KRKA","5 Milligram                                                                                            Film Coated Tablet",2018-08-17,"PA1347/080/001","Krka d.d., Novo mesto","PRASUGREL"
"7433","PRASUGREL KRKA","10 Milligram                                                                                            Film Coated Tablet",2018-08-17,"PA1347/080/002","Krka d.d., Novo mesto","PRASUGREL"
"7434","PRASUGREL MYLAN","5 Milligram                                                                                            Film Coated Tablet",2018-05-16,"EU/1/18/1273/001","Mylan S.A.S.","PRASUGREL"
"7435","PRASUGREL MYLAN","10 Milligram                                                                                            Film Coated Tablet",2018-05-16,"EU/1/18/1273/002","Mylan S.A.S.","PRASUGREL"
"7436","PRASUGREL ROWEX","5 Milligram                                                                                            Film Coated Tablet",2018-08-17,"PA0711/282/001","Rowex Ltd","PRASUGRELBESILATE"
"7437","PRASUGREL ROWEX","10 Milligram                                                                                            Film Coated Tablet",2018-08-17,"PA0711/282/002","Rowex Ltd","PRASUGRELBESILATE"
"7438","PRAVAFENIX","40/160 Milligram                                                                                            Capsules Hard",2011-04-14,"EU/1/11/679/001-006","Laboratoires SMB S.A.","FENOFIBRATE|PRAVASTATINSODIUM"
"7439","PRAVAMEL","10 Milligram                                                                                            Film Coated Tablet",2004-09-24,"PA0126/140/001","Clonmel Healthcare Ltd","PRAVASTATINSODIUM"
"7440","PRAVAMEL","20 Milligram                                                                                            Film Coated Tablet",2004-09-24,"PA0126/140/002","Clonmel Healthcare Ltd","PRAVASTATINSODIUM"
"7441","PRAVAMEL","40 Milligram                                                                                            Film Coated Tablet",2004-09-24,"PA0126/140/003","Clonmel Healthcare Ltd","PRAVASTATINSODIUM"
"7442","PRAVASTATIN MYLAN","10 Milligram                                                                                            Tablets",2010-12-17,"PA0577/136/001","McDermott Laboratories Ltd t/a Gerard Laboratories","PRAVASTATINSODIUM"
"7443","PRAVASTATIN MYLAN","20 Milligram                                                                                            Tablets",2010-12-17,"PA0577/136/002","McDermott Laboratories Ltd t/a Gerard Laboratories","PRAVASTATINSODIUM"
"7444","PRAVASTATIN MYLAN","40 Milligram                                                                                            Tablets",2010-12-17,"PA0577/136/003","McDermott Laboratories Ltd t/a Gerard Laboratories","PRAVASTATINSODIUM"
"7445","PRAVASTATIN SODIUM","10 Milligram                                                                                            Tablets",2008-09-26,"PA1390/002/001","Accord Healthcare Limited","PRAVASTATINSODIUM"
"7446","PRAVASTATIN SODIUM","20 Milligram                                                                                            Tablets",2008-09-26,"PA1390/002/002","Accord Healthcare Limited","PRAVASTATINSODIUM"
"7447","PRAVASTATIN SODIUM","40 Milligram                                                                                            Tablets",2008-09-26,"PA1390/002/003","Accord Healthcare Limited","PRAVASTATINSODIUM"
"7448","PRAVASTATIN SODIUM","10 Milligram                                                                                            Tablets",2014-11-14,"PPA0565/052/001","WPR Healthcare Limited","PRAVASTATINSODIUM"
"7449","PRAVASTATIN SODIUM","20 Milligram                                                                                            Tablets",2014-11-14,"PPA0565/052/002","WPR Healthcare Limited","PRAVASTATINSODIUM"
"7450","PRAVASTATIN SODIUM","40 Milligram                                                                                            Tablets",2014-11-14,"PPA0565/052/003","WPR Healthcare Limited","PRAVASTATINSODIUM"
"7451","Pravastatin sodium 10 mg Tablets","10 milligram(s) Tablet",2008-04-25,"PA2315/003/001","Accord Healthcare Ireland Ltd.","Pravastatinsodium"
"7452","Pravastatin Sodium 10 mg Tablets","10 milligram(s) Tablet",2005-09-30,"PA0436/046/001","Norton Waterford","Pravastatinsodium"
"7453","Pravastatin Sodium 20 mg Tablets","20 milligram(s) Tablet",2005-09-30,"PA0436/046/002","Norton Waterford","Pravastatinsodium"
"7454","Pravastatin sodium 20 mg Tablets","20 milligram(s) Tablet",2008-04-25,"PA2315/003/002","Accord Healthcare Ireland Ltd.","Pravastatinsodium"
"7455","Pravastatin Sodium 40 mg Tablets","40 milligram(s) Tablet",2005-09-30,"PA0436/046/003","Norton Waterford","Pravastatinsodium"
"7456","Pravastatin sodium 40mg Tablets","40 milligram(s) Tablet",2008-04-25,"PA2315/003/003","Accord Healthcare Ireland Ltd.","Pravastatinsodium"
"7457","PRAVAT","10 Milligram                                                                                            Tablets",2005-04-29,"PA1513/008/001","Apotex Europe B.V.","PRAVASTATINSODIUM"
"7458","PRAVAT","20 Milligram                                                                                            Tablets",2005-04-29,"PA1513/008/002","Apotex Europe B.V.","PRAVASTATINSODIUM"
"7459","PRAVAT","40 Milligram                                                                                            Tablets",2005-04-29,"PA1513/008/003","Apotex Europe B.V.","PRAVASTATINSODIUM"
"7460","PRAVITIN","10 Milligram                                                                                            Tablets",2004-05-14,"PA0711/058/001","Rowex Ltd","PRAVASTATINSODIUM"
"7461","PRAVITIN","20 Milligram                                                                                            Tablets",2004-05-14,"PA0711/058/002","Rowex Ltd","PRAVASTATINSODIUM"
"7462","PRAVITIN","40 Milligram                                                                                            Tablets",2004-05-14,"PA0711/058/004","Rowex Ltd","PRAVASTATINSODIUM"
"7463","Praxbind","50 microgram(s)/millilitre Solution for injection/infusion",2015-11-20,"EU/1/15/1056/001","Boehringer Ingelheim International GmbH","Idarucizumab"
"7464","Praxilene 100 mg Capsules","100 milligram(s) Capsule",1980-04-01,"PA2286/003/001","Merck Serono (Ireland) Limited","NAFTIDROFURYLOXALATE"
"7465","PRECONCEIVE","400 Microgram                                                                                            Tablets",1997-07-25,"PA0257/055/001","GR Lane Health Products Ltd","FOLICACID"
"7466","PRED FORTE","1 %w/v                                                                                                 Eye Drops Suspension",1978-04-01,"PA0148/027/001","Allergan Pharmaceuticals Ireland","PREDNISOLONEACETATE"
"7467","PRED MILD STERILE OPHTHALMIC SUSPENSION","0.12 %w/v                                                                                                 Eye Drops Suspension",1977-04-01,"PA0148/024/001","Allergan Pharmaceuticals Ireland","PREDNISOLONEACETATE"
"7468","PREDNESOL","5 Milligram                                                                                            Tablets",1978-10-27,"PA1113/001/001","Phoenix Labs","PREDNISOLONESODIUMPHOSPHATE"
"7469","PREDNISOLONE","20 Milligram                                                                                            Rectal Foam",1989-11-28,"PA1161/008/001","Chemidex Pharma Limited","PREDNISOLONE"
"7470","PREDNISOLONE","5 Milligram                                                                                            Soluble tablet",2014-11-14,"PA1338/017/001","Focus Pharmaceuticals Ltd","PREDNISOLONESODIUMPHOSPHATE"
"7471","PREDNISOLONE","5 Milligram                                                                                            Tablets",1982-09-01,"PA0126/027/001","Clonmel Healthcare Ltd","PREDNISOLONE"
"7472","PREDNISOLONE","1 Milligram                                                                                            Tablets",1988-05-11,"PA0126/027/002","Clonmel Healthcare Ltd","PREDNISOLONE"
"7473","PREGABALIN","25 Milligram                                                                                            Capsules Hard",2017-08-04,"PA1240/022/001","Bristol Laboratories Limited","PREGABALIN"
"7474","PREGABALIN","50 Milligram                                                                                            Capsules Hard",2017-08-04,"PA1240/022/002","Bristol Laboratories Limited","PREGABALIN"
"7475","PREGABALIN","75 Milligram                                                                                            Capsules Hard",2017-08-04,"PA1240/022/003","Bristol Laboratories Limited","PREGABALIN"
"7476","PREGABALIN","100 Milligram                                                                                            Capsules Hard",2017-08-04,"PA1240/022/004","Bristol Laboratories Limited","PREGABALIN"
"7477","PREGABALIN","150 Milligram                                                                                            Capsules Hard",2017-08-04,"PA1240/022/005","Bristol Laboratories Limited","PREGABALIN"
"7478","PREGABALIN","200 Milligram                                                                                            Capsules Hard",2017-08-04,"PA1240/022/006","Bristol Laboratories Limited","PREGABALIN"
"7479","PREGABALIN","225 Milligram                                                                                            Capsules Hard",2017-08-04,"PA1240/022/007","Bristol Laboratories Limited","PREGABALIN"
"7480","PREGABALIN","300 Milligram                                                                                            Capsules Hard",2017-08-04,"PA1240/022/008","Bristol Laboratories Limited","PREGABALIN"
"7481","PREGABALIN ACCORD","25 Milligram                                                                                            Capsule",2015-08-28,"EU/1/15/1027/001-011","Accord Healthcare Limited","PREGABALIN"
"7482","PREGABALIN ACCORD","50 Milligram                                                                                            Capsule",2015-08-28,"EU/1/15/1027/012-022","Accord Healthcare Limited","PREGABALIN"
"7483","PREGABALIN ACCORD","75 Milligram                                                                                            Capsule",2015-08-28,"EU/1/15/1027/023-033","Accord Healthcare Limited","PREGABALIN"
"7484","PREGABALIN ACCORD","100 Milligram                                                                                            Capsule",2015-08-28,"EU/1/15/1027/034-044","Accord Healthcare Limited","PREGABALIN"
"7485","PREGABALIN ACCORD","150 Milligram                                                                                            Capsule",2015-08-28,"EU/1/15/1027/045-055","Accord Healthcare Limited","PREGABALIN"
"7486","PREGABALIN ACCORD","200 Milligram                                                                                            Capsule",2015-08-28,"EU/1/15/1027/056-066","Accord Healthcare Limited","PREGABALIN"
"7487","PREGABALIN ACCORD","225 Milligram                                                                                            Capsule",2015-08-28,"EU/1/15/1027/067-077","Accord Healthcare Limited","PREGABALIN"
"7488","PREGABALIN ACCORD","300 Milligram                                                                                            Capsule",2015-08-28,"EU/1/15/1027/078-088","Accord Healthcare Limited","PREGABALIN"
"7489","Pregabalin clonmel 100 mg capsules, hard","100 milligram(s) Capsule, hard",2018-01-12,"PA0126/290/004","Clonmel Healthcare Ltd","Pregabalin"
"7490","Pregabalin clonmel 150 mg capsules, hard","150 milligram(s) Capsule, hard",2018-01-12,"PA0126/290/005","Clonmel Healthcare Ltd","Pregabalin"
"7491","Pregabalin clonmel 200 mg capsules, hard","200 milligram(s) Capsule, hard",2018-01-12,"PA0126/290/006","Clonmel Healthcare Ltd","Pregabalin"
"7492","Pregabalin clonmel 225 mg capsules, hard","225 milligram(s) Capsule, hard",2018-01-12,"PA0126/290/007","Clonmel Healthcare Ltd","Pregabalin"
"7493","Pregabalin clonmel 25 mg capsules, hard","25 milligram(s) Capsule, hard",2018-01-12,"PA0126/290/001","Clonmel Healthcare Ltd","Pregabalin"
"7494","Pregabalin clonmel 300 mg capsules, hard","300 milligram(s) Capsule, hard",2018-01-12,"PA0126/290/008","Clonmel Healthcare Ltd","Pregabalin"
"7495","Pregabalin clonmel 50 mg capsules, hard","50 milligram(s) Capsule, hard",2018-01-12,"PA0126/290/002","Clonmel Healthcare Ltd","Pregabalin"
"7496","Pregabalin clonmel 75 mg capsules, hard","75 milligram(s) Capsule, hard",2018-01-12,"PA0126/290/003","Clonmel Healthcare Ltd","Pregabalin"
"7497","PREGABALIN KRKA","200 Milligram                                                                                            Capsules Hard",2015-01-09,"PA1347/050/006","Krka d.d., Novo mesto","PREGABALIN"
"7498","PREGABALIN KRKA","225 Milligram                                                                                            Capsules Hard",2015-01-09,"PA1347/050/007","Krka d.d., Novo mesto","PREGABALIN"
"7499","PREGABALIN KRKA","300 Milligram                                                                                            Capsules Hard",2015-01-09,"PA1347/050/008","Krka d.d., Novo mesto","PREGABALIN"
"7500","PREGABALIN KRKA","25 Milligram                                                                                            Capsules Hard",2015-01-09,"PA1347/050/001","Krka d.d., Novo mesto","PREGABALIN"
"7501","PREGABALIN KRKA","50 Milligram                                                                                            Capsules Hard",2015-01-09,"PA1347/050/002","Krka d.d., Novo mesto","PREGABALIN"
"7502","PREGABALIN KRKA","100 Milligram                                                                                            Capsules Hard",2015-01-09,"PA1347/050/004","Krka d.d., Novo mesto","PREGABALIN"
"7503","Pregabalin Krka 150mg Hard Capsules","150 milligram(s) Capsule, hard",2015-01-09,"PA1347/050/005","Krka d.d., Novo mesto","Pregabalin"
"7504","Pregabalin Krka 75mg Hard Capsules","75 milligram(s) Capsule, hard",2015-01-09,"PA1347/050/003","Krka d.d., Novo mesto","Pregabalin"
"7505","Pregabalin Mylan","25 milligram(s) Capsule, hard",2015-06-25,"EU/1/15/997/001-008","Mylan S.A.S.","Pregabalin"
"7506","Pregabalin Mylan","50 milligram(s) Capsule, hard",2015-06-25,"EU/1/15/997/009-015","Mylan S.A.S.","Pregabalin"
"7507","Pregabalin Mylan","75 milligram(s) Capsule, hard",2015-06-25,"EU/1/15/997/016-022","Mylan S.A.S.","Pregabalin"
"7508","Pregabalin Mylan","100 milligram(s) Capsule, hard",2015-06-25,"EU/1/15/997/023-027","Mylan S.A.S.","Pregabalin"
"7509","Pregabalin Mylan","150 milligram(s) Capsule, hard",2015-06-25,"EU/1/15/997/028-034","Mylan S.A.S.","Pregabalin"
"7510","Pregabalin Mylan","200 milligram(s) Capsule, hard",2015-06-25,"EU/1/15/997/035-039","Mylan S.A.S.","Pregabalin"
"7511","Pregabalin Mylan","225 milligram(s) Capsule, hard",2015-06-25,"EU/1/15/997/040-044","Mylan S.A.S.","Pregabalin"
"7512","Pregabalin Mylan","300 milligram(s) Capsule, hard",2015-06-25,"EU/1/15/997/045-050","Mylan S.A.S.","Pregabalin"
"7513","Pregabalin Mylan Pharma","25 milligram(s) Capsule, hard",2015-06-25,"EU/1/15/998/001-008","Mylan S.A.S.","Pregabalin"
"7514","Pregabalin Mylan Pharma","50 milligram(s) Capsule, hard",2015-06-25,"EU/1/15/998/009-015","Mylan S.A.S.","Pregabalin"
"7515","Pregabalin Mylan Pharma","75 milligram(s) Capsule, hard",2015-06-25,"EU/1/15/998/016-022","Mylan S.A.S.","Pregabalin"
"7516","Pregabalin Mylan Pharma","100 milligram(s) Capsule, hard",2015-06-25,"EU/1/15/998/023-027","Mylan S.A.S.","Pregabalin"
"7517","Pregabalin Mylan Pharma","150 milligram(s) Capsule, hard",2015-06-25,"EU/1/15/998/028-034","Mylan S.A.S.","Pregabalin"
"7518","Pregabalin Mylan Pharma","200 milligram(s) Capsule, hard",2015-06-25,"EU/1/15/998/035-039","Mylan S.A.S.","Pregabalin"
"7519","Pregabalin Mylan Pharma","225 milligram(s) Capsule, hard",2015-06-25,"EU/1/15/998/040-044","Mylan S.A.S.","Pregabalin"
"7520","Pregabalin Mylan Pharma","300 milligram(s) Capsule, hard",2015-06-25,"EU/1/15/998/045-050","Mylan S.A.S.","Pregabalin"
"7521","Pregabalin Pfizer","25 milligram(s) Capsule, hard",2014-04-10,"EU/1/14/916/001-007","Pfizer Europe MA EEIG","Pregabalin"
"7522","PREGABALIN PFIZER","50 Milligram                                                                                            Capsules Hard",2014-04-10,"EU/1/14/916/008-013","Pfizer Europe MA EEIG","PREGABALIN"
"7523","PREGABALIN PFIZER","75 Milligram                                                                                            Capsules Hard",2014-04-10,"EU/1/14/916/014-019","Pfizer Europe MA EEIG","PREGABALIN"
"7524","PREGABALIN PFIZER","100 Milligram                                                                                            Capsules Hard",2014-04-10,"EU/1/14/916/020-023","Pfizer Europe MA EEIG","PREGABALIN"
"7525","PREGABALIN PFIZER","150 Milligram                                                                                            Capsules Hard",2014-04-10,"EU/1/14/916/024-029","Pfizer Limited","PREGABALIN"
"7526","PREGABALIN PFIZER","200 Milligram                                                                                            Capsules Hard",2014-04-10,"EU/1/14/916/030-033","Pfizer Europe MA EEIG","PREGABALIN"
"7527","PREGABALIN PFIZER","225 Milligram                                                                                            Capsules Hard",2014-04-10,"EU/1/14/916/034-037","Pfizer Europe MA EEIG","PREGABALIN"
"7528","PREGABALIN PFIZER","300 Milligram                                                                                            Capsules Hard",2014-04-10,"EU/1/14/916/038-043","Pfizer Europe MA EEIG","PREGABALIN"
"7529","PREGABALIN SANDOZ","25 Milligram                                                                                            Capsules Hard",2015-06-19,"EU/1/15/1011/001-010","Sandoz GmbH","PREGABALIN"
"7530","PREGABALIN SANDOZ","50 Milligram                                                                                            Capsules Hard",2015-06-19,"EU/1/15/1011/011-017","Sandoz GmbH","PREGABALIN"
"7531","PREGABALIN SANDOZ","75 Milligram                                                                                            Capsules Hard",2015-06-19,"EU/1/15/1011/018-033","Sandoz GmbH","PREGABALIN"
"7532","PREGABALIN SANDOZ","100 Milligram                                                                                            Capsules Hard",2015-06-19,"EU/1/15/1011/034-041","Sandoz GmbH","PREGABALIN"
"7533","PREGABALIN SANDOZ","150 Milligram                                                                                            Capsules Hard",2015-06-19,"EU/1/15/1011/042-056","Sandoz GmbH","PREGABALIN"
"7534","PREGABALIN SANDOZ","200 Milligram                                                                                            Capsules Hard",2015-06-19,"EU/1/15/1011/057-062","Sandoz GmbH","PREGABALIN"
"7535","PREGABALIN SANDOZ","225 Milligram                                                                                            Capsules Hard",2015-06-19,"EU/1/15/1011/063-068","Sandoz GmbH","PREGABALIN"
"7536","PREGABALIN SANDOZ","300 Milligram                                                                                            Capsules Hard",2015-06-19,"EU/1/15/1011/069-083","Sandoz GmbH","PREGABALIN"
"7537","PREGABALIN SANDOZ GMBH","25 Milligram                                                                                            Capsules Hard",2015-06-19,"EU/1/15/1012/001-010","Sandoz GmbH","PREGABALIN"
"7538","PREGABALIN SANDOZ GMBH","50 Milligram                                                                                            Capsules Hard",2015-06-19,"EU/1/15/1012/011-017","Sandoz GmbH","PREGABALIN"
"7539","PREGABALIN SANDOZ GMBH","75 Milligram                                                                                            Capsules Hard",2015-06-19,"EU/1/15/1012/018-033","Sandoz GmbH","PREGABALIN"
"7540","PREGABALIN SANDOZ GMBH","100 Milligram                                                                                            Capsules Hard",2015-06-19,"EU/1/15/1012/034-041","Sandoz GmbH","PREGABALIN"
"7541","PREGABALIN SANDOZ GMBH","150 Milligram                                                                                            Capsules Hard",2015-06-19,"EU/1/15/1012/042-056","Sandoz GmbH","PREGABALIN"
"7542","PREGABALIN SANDOZ GMBH","200 Milligram                                                                                            Capsules Hard",2015-06-19,"EU/1/15/1012/057-062","Sandoz GmbH","PREGABALIN"
"7543","PREGABALIN SANDOZ GMBH","225 Milligram                                                                                            Capsules Hard",2015-06-19,"EU/1/15/1012/063-068","Sandoz GmbH","PREGABALIN"
"7544","PREGABALIN SANDOZ GMBH","300 Milligram                                                                                            Capsules Hard",2015-06-19,"EU/1/15/1012/069-083","Sandoz GmbH","PREGABALIN"
"7545","Pregabalin Teva 100mg Capsules, hard","100 milligram(s) Capsule, hard",2015-07-24,"PA1986/001/004","Teva B.V.","Pregabalin"
"7546","Pregabalin Teva 150 mg Capsules, hard","150 milligram(s) Capsule, hard",2015-07-24,"PA1986/001/005","Teva B.V.","Pregabalin"
"7547","Pregabalin Teva 200 mg Capsules, hard","200 milligram(s) Capsule, hard",2015-07-24,"PA1986/001/006","Teva B.V.","Pregabalin"
"7548","Pregabalin Teva 25mg Capsules, hard","25 milligram(s) Capsule, hard",2015-07-24,"PA1986/001/001","Teva B.V.","Pregabalin"
"7549","Pregabalin Teva 300 mg Capsules, hard","300 milligram(s) Capsule, hard",2015-07-24,"PA1986/001/008","Teva B.V.","Pregabalin"
"7550","Pregabalin Teva 50 mg Capsules, hard","50 milligram(s) Capsule, hard",2015-07-24,"PA1986/001/002","Teva B.V.","Pregabalin"
"7551","Pregabalin Teva 75mg Capsules, hard","75 milligram(s) Capsule, hard",2015-07-24,"PA1986/001/003","Teva B.V.","Pregabalin"
"7552","Pregabalin Wockhardt 100mg Hard Capsules","100 milligram(s) Capsule, hard",2015-10-02,"PA1339/059/004","Wockhardt UK Limited","Pregabalin"
"7553","Pregabalin Wockhardt 150mg Hard Capsules","150 milligram(s) Capsule, hard",2015-10-02,"PA1339/059/005","Wockhardt UK Limited","Pregabalin"
"7554","Pregabalin Wockhardt 20 mg/ml Oral Solution","20 milligram(s)/millilitre Oral solution",2018-03-16,"PA1339/074/001","Wockhardt UK Limited","Pregabalin"
"7555","Pregabalin Wockhardt 200mg Hard Capsules","200 milligram(s) Capsule, hard",2015-10-02,"PA1339/059/006","Wockhardt UK Limited","Pregabalin"
"7556","Pregabalin Wockhardt 225mg Hard Capsules","225 milligram(s) Capsule, hard",2015-10-02,"PA1339/059/007","Wockhardt UK Limited","Pregabalin"
"7557","Pregabalin Wockhardt 25mg Hard Capsules","25 milligram(s) Capsule, hard",2015-10-02,"PA1339/059/001","Wockhardt UK Limited","Pregabalin"
"7558","Pregabalin Wockhardt 300mg Hard Capsules","300 milligram(s) Capsule, hard",2015-10-02,"PA1339/059/008","Wockhardt UK Limited","Pregabalin"
"7559","Pregabalin Wockhardt 50mg Hard Capsules","50 milligram(s) Capsule, hard",2015-10-02,"PA1339/059/002","Wockhardt UK Limited","Pregabalin"
"7560","Pregabalin Wockhardt 75mg Hard Capsules","75 milligram(s) Capsule, hard",2015-10-02,"PA1339/059/003","Wockhardt UK Limited","Pregabalin"
"7561","PREGABALIN ZENTIVA","25 Milligram                                                                                            Capsules Hard",2015-07-17,"EU/1/15/1021/001-005","Zentiva k.s.","PREGABALIN"
"7562","PREGABALIN ZENTIVA","50 Milligram                                                                                            Capsules Hard",2015-07-17,"EU/1/15/1021/006-010","Zentiva k.s.","PREGABALIN"
"7563","PREGABALIN ZENTIVA","75 Milligram                                                                                            Capsules Hard",2015-07-17,"EU/1/15/1021/011-013","Zentiva k.s.","PREGABALIN"
"7564","PREGABALIN ZENTIVA","100 Milligram                                                                                            Capsules Hard",2015-07-17,"EU/1/15/1021/014-016","Zentiva k.s.","PREGABALIN"
"7565","PREGABALIN ZENTIVA","150 Milligram                                                                                            Capsules Hard",2015-07-17,"EU/1/15/1021/017-019","Zentiva k.s.","PREGABALIN"
"7566","PREGABALIN ZENTIVA","200 Milligram                                                                                            Capsules Hard",2015-07-17,"EU/1/15/1021/020-022","Zentiva k.s.","PREGABALIN"
"7567","PREGABALIN ZENTIVA","225 Milligram                                                                                            Capsules Hard",2015-07-17,"EU/1/15/1021/023-025","Zentiva k.s.","PREGABALIN"
"7568","PREGABALIN ZENTIVA","300 Milligram                                                                                            Capsules Hard",2015-07-17,"EU/1/15/1021/026-028","Zentiva k.s.","PREGABALIN"
"7569","PREGABALIN ZENTIVA K.S.","25 Milligram                                                                                            Capsules Hard",2017-02-27,"EU/1/16/1166/001-005","Zentiva k.s.","PREGABALIN"
"7570","PREGABALIN ZENTIVA K.S.","50 Milligram                                                                                            Capsules Hard",2017-02-27,"EU/1/16/1166/006-010","Zentiva k.s.","PREGABALIN"
"7571","PREGABALIN ZENTIVA K.S.","75 Milligram                                                                                            Capsules Hard",2017-02-27,"EU/1/16/1166/011-013","Zentiva k.s.","PREGABALIN"
"7572","PREGABALIN ZENTIVA K.S.","100 Milligram                                                                                            Capsules Hard",2017-02-27,"EU/1/16/1166/014-016","Zentiva k.s.","PREGABALIN"
"7573","PREGABALIN ZENTIVA K.S.","150 Milligram                                                                                            Capsules Hard",2017-02-27,"EU/1/16/1166/017-019","Zentiva k.s.","PREGABALIN"
"7574","PREGABALIN ZENTIVA K.S.","200 Milligram                                                                                            Capsules Hard",2017-02-27,"EU/1/16/1166/020-022","Zentiva k.s.","PREGABALIN"
"7575","PREGABALIN ZENTIVA K.S.","225 Milligram                                                                                            Capsules Hard",2017-02-27,"EU/1/16/1166/023-025","Zentiva k.s.","PREGABALIN"
"7576","PREGABALIN ZENTIVA K.S.","300 Milligram                                                                                            Capsules Hard",2017-02-27,"EU/1/16/1166/026-028","Zentiva k.s.","PREGABALIN"
"7577","PREGNYL 5000 I.U. POWDER AND SOLVENT FOR SOLUTION","5000IU International Unit                                                                                   Pdr+Solv for Soln for Inj",1979-04-01,"PA0964/005/002","NV Organon","CHORIONICGONADOTROPHIN"
"7578","Premarin 0.3 mg Prolonged-release tablets","0.3 milligram(s) Prolonged-release tablet",1988-07-25,"PA0822/095/001","Pfizer Healthcare Ireland","Conjugatedestrogens"
"7579","Premarin 0.625 mg Prolonged-release tablets","0.625 milligram(s) Prolonged-release tablet",1988-07-25,"PA0822/095/002","Pfizer Healthcare Ireland","Conjugatedestrogens"
"7580","Premarin 1.25 mg Prolonged-release tablets","1.25 milligram(s) Prolonged-release tablet",1988-07-25,"PA0822/095/003","Pfizer Healthcare Ireland","Conjugatedestrogens"
"7581","PREMIQUE 2.5","0.625/2.5 Milligram                                                                                            Coated Tablets",1998-05-28,"PA0822/096/002","Pfizer Healthcare Ireland","ESTROGENSCONJUGATED|PRESERVEDCONDENSEDURINEDESICCATED(PCUD)|MEDROXYPROGESTERONEACETATE"
"7582","PREMIQUE 5","0.625mg/5m %v/v                                                                                                 Coated Tablets",1998-05-28,"PA0822/096/003","Pfizer Healthcare Ireland","ESTROGENSCONJUGATED|PRESERVEDCONDENSEDURINEDESICCATED(PCUD)|MEDROXYPROGESTERONEACETATE"
"7583","PREMPAK-C","0.625 Milligram                                                                                            Coated Tablets",1988-11-16,"PA0822/097/001","Pfizer Healthcare Ireland","ESTROGENSCONJUGATED|NORGESTREL"
"7584","PREMPAK-C","1.25/0.150 Milligram                                                                                            Coated Tablets",1988-11-16,"PA0822/097/002","Pfizer Healthcare Ireland","ESTROGENSCONJUGATED|NORGESTREL"
"7585","PRENOPATCH","5 Microgram per hour Transdermal Patch",2017-07-14,"PA0126/304/001","Clonmel Healthcare Ltd","BUPRENORPHINE"
"7586","PRENOPATCH","10 Microgram per hour Transdermal Patch",2017-07-14,"PA0126/304/002","Clonmel Healthcare Ltd","BUPRENORPHINE"
"7587","PRENOPATCH","20 Microgram per hour Transdermal Patch",2017-07-14,"PA0126/304/003","Clonmel Healthcare Ltd","BUPRENORPHINE"
"7588","PRENOXAD","0.91 Mg/Ml Solution for injection in pre-filled syringe",2016-06-24,"PA1176/003/001","Aurum Pharmaceutical Limited","NALOXONEHYDROCHLORIDEDIHYDRATE"
"7589","PREPANDEMIC INFLUENZA","7.5 Microgram                                                                                            Suspension for Injection",2010-11-29,"EU/1/10/657/001-002","GSK Vaccines S.r.l.","H5N1(A/VIETNAM/1194/2004)"
"7590","PREPANDRIX","3.75 Microgram                                                                                            Emulsion for Injection",2009-08-07,"EU/1/08/453/002","GlaxoSmithKline Biologicals S.A.","PURIFIEDANTIGENFRACTIONSOFINACTIVATEDSPLITVIRIONSA/INDONESIA/05/2005(H5N1)/PR8-IBCDC-RG2"
"7591","PREPANDRIX SUSPENSION","3.75 Microgram                                                                                            Emulsion for Injection",2008-05-14,"EU/1/08/453/1","GlaxoSmithKline Biologicals S.A.","PURIFIEDANTIGENFRACTIONSOFINACTIVATEDSPLITVIRIONSA/VIETNAM/1194/2004NIBRG-14(H5N1)"
"7592","PRESTIM","10/2.5 Milligram                                                                                            Tablets",1997-02-09,"PA2010/034/001","Mylan IRE Healthcare Limited","BENDROFLUMETHIAZIDE|TIMOLOLMALEATE"
"7593","PRETERAX","2/0.625 Unknown Tablets",2001-12-03,"PA0568/008/001","Les Laboratoires Servier","PERINDOPRILTERT-BUTYLAMINESALT|INDAPAMIDE"
"7594","PREVENAR","0.5 ml Millilitre                                                                                           Suspension for Injection",2001-02-02,"EU/1/00/167/001","Pfizer Limited","PNEUMOCOCCALPOLYSACCHARIDETYPE4(4)|PNEUMOCOCCALTYPE6B|PNEUMOCOCCALPOLYSACCHARIDETYPE9V|PNEUMOCOCCALPOLYSACCHARIDETYPE14(14)|PNEUMOCOCCALPOLYSACCHARIDETYPE56(18C)|PNEUMOCOCCALPOLYSACCHARIDETYPE19(19F)|PNEUMOCOCCALPOLYSACCHARIDETYPE23(23F)"
"7595","PREVENAR","0.5 Millilitre                                                                                           Suspension for Injection",2001-02-02,"EU/1/00/167/002","Pfizer Limited","PNEUMOCOCCALPOLYSACCHARIDETYPE4(4)|PNEUMOCOCCALTYPE6B|PNEUMOCOCCALPOLYSACCHARIDETYPE9V|PNEUMOCOCCALPOLYSACCHARIDETYPE14(14)|PNEUMOCOCCALPOLYSACCHARIDETYPE56(18C)|PNEUMOCOCCALPOLYSACCHARIDETYPE19(19F)|PNEUMOCOCCALPOLYSACCHARIDETYPE23(23F)"
"7596","PREVENAR","0.5 Millilitre                                                                                           Suspension for Injection",2001-02-02,"EU/1/00/167/003","Pfizer Limited","PNEUMOCOCCALPOLYSACCHARIDETYPE4(4)|PNEUMOCOCCALTYPE6B|PNEUMOCOCCALPOLYSACCHARIDETYPE9V|PNEUMOCOCCALPOLYSACCHARIDETYPE14(14)|PNEUMOCOCCALPOLYSACCHARIDETYPE56(18C)|PNEUMOCOCCALPOLYSACCHARIDETYPE19(19F)|PNEUMOCOCCALPOLYSACCHARIDETYPE23(23F)"
"7597","PREVENAR","0.5 Millilitre                                                                                           Suspension for Injection",2007-08-31,"EU/1/00/167/008","Pfizer Limited","PNEUMOCOCCALPOLYSACCHARIDESEROTYPE4|PNEUMOCOCCALPOLYSACCHARIDESEROTYPE6B|PNEUMOCOCCALPOLYSACCHARIDESEROTYPE9V|PNEUMOCOCCALPOLYSACCHARIDESEROTYPE14|PNEUMOCOCCALOLIGOSACCHARIDESEROTYPE18C|PNEUMOCOCCALPOLYSACCHARIDESEROTYPE19F|PNEUMOCOCCALPOLYSACCHARIDESEROTYPE23F|CRM197CARRIERPROTEIN"
"7598","PREVENAR","0.5 Millilitre                                                                                           Suspension for Injection",2001-02-02,"EU/1/00/167/4-7","Pfizer Limited","PNEUMOCOCCALPOLYSACCHARIDETYPE4(4)|PNEUMOCOCCALTYPE6B|PNEUMOCOCCALPOLYSACCHARIDETYPE9V|PNEUMOCOCCALPOLYSACCHARIDETYPE14(14)|PNEUMOCOCCALPOLYSACCHARIDETYPE56(18C)|PNEUMOCOCCALPOLYSACCHARIDETYPE19(19F)|PNEUMOCOCCALPOLYSACCHARIDETYPE23(23F)"
"7599","Prevenar 13","*** AWAITING VALUE *** Suspension for injection",2009-12-09,"EU/1/09/590/1-6","Pfizer Europe MA EEIG","Polysaccharideserotype19a|Polysaccharideserotype5|Oligosaccharideserotype18c|Polysaccharideserotype6b|Polysaccharideserotype4|Polysaccharideserotype7f|Polysaccharideserotype6a|Polysaccharideserotype14|Polysaccharideserotype23f|Polysaccharideserotype19f|Polysaccharideserotype9v|Polysaccharideserotype3|Polysaccharideserotype1"
"7600","PREVENELLE","1500 Microgram                                                                                            Tablets",2015-08-13,"PPA1151/249/001","Imbat Limited","LEVONORGESTREL"
"7601","Prevenelle 1500 microgram Tablet","1500 microgram(s) Tablet",2006-02-03,"PA1330/021/001","Gedeon Richter Plc","Levonorgestrel"
"7602","PREVORA","100 Mg/Ml Dental Solution",2006-05-05,"PA1205/001/001","CHX Technologies Europe Limited","CHLORHEXIDINEDIACETATE"
"7603","PREVYMIS","240 Milligram                                                                                            Film Coated Tablet",2018-01-08,"EU/1/17/1245/001","Merck Sharp & Dohme BV","LETERMOVIR"
"7604","PREVYMIS","480 Milligram                                                                                            Film Coated Tablet",2018-01-08,"EU/1/17/1245/002","Merck Sharp & Dohme BV","LETERMOVIR"
"7605","PREVYMIS","240 Milligram                                                                                            Concentrate for Soln for Inf",2018-01-08,"EU/1/17/1245/003","Merck Sharp & Dohme BV","LETERMOVIR"
"7606","PREVYMIS","480 Milligram                                                                                            Concentrate for Soln for Inf",2018-01-08,"EU/1/17/1245/004","Merck Sharp & Dohme BV","LETERMOVIR"
"7607","PREZISTA","300 Milligram                                                                                            Tablets",2007-02-12,"EU/1/06/380/001","Janssen-Cilag International NV","DARUNAVIR"
"7608","PREZISTA","400 Milligram                                                                                            Film Coated Tablet",2009-01-29,"EU/1/06/380/003","Janssen-Cilag International NV","DARUNAVIR"
"7609","PREZISTA","150 Milligram                                                                                            Film Coated Tablet",2009-06-23,"EU/1/06/380/004","Janssen-Cilag International NV","DARUNAVIR(ASETHANOLATE)"
"7610","PREZISTA","75 Milligram                                                                                            Film Coated Tablet",2009-06-23,"EU/1/06/380/005","Janssen-Cilag International NV","DARUNAVIR(ASETHANOLATE)"
"7611","PREZISTA","100 Mg/Ml Oral Suspension",2012-11-14,"EU/1/06/380/006","Janssen-Cilag International NV",""
"7612","PREZISTA","800 Milligram                                                                                            Film Coated Tablet",NA,"EU/1/06/380/007","Janssen-Cilag International NV","DARUNAVIR(ASETHANOLATE)"
"7613","PREZISTA 600 MG FILM-COATED TABLETS","600 Milligram                                                                                            Film Coated Tablet",2009-01-29,"EU/1/06/380/002","Janssen-Cilag International NV","DARUNAVIR(ASETHANOLATE)"
"7614","Priadel 200mg Prolonged-release Tablets","200 milligram(s) Prolonged-release tablet",1988-04-19,"PA0540/156/001","Sanofi-Aventis Ireland Limited T/A SANOFI","Lithiumcarbonate"
"7615","Priadel 400mg Prolonged-release Tablets","400 milligram(s) Prolonged-release tablet",1978-04-01,"PA0540/156/002","Sanofi-Aventis Ireland Limited T/A SANOFI","Lithiumcarbonate"
"7616","PRIALT","100 microg Micromol Solution for Infusion",2005-02-21,"EU/1/04/302/1-3","RIEMSER Pharma GmbH","ZICONOTIDE"
"7617","Priligy 30 mg Film-Coated Tablets","30 milligram(s) Film-coated tablet",NA,"PA1833/001/001","A. Menarini Pharmaceuticals Ireland Ltd","Dapoxetine"
"7618","Priligy 60 mg Film-Coated Tablets","60 milligram(s) Film-coated tablet",NA,"PA1833/001/002","A. Menarini Pharmaceuticals Ireland Ltd","Dapoxetine"
"7619","PRIMACINE","125 MG/5ml                                                                                               Granules for Oral Suspension",1998-11-13,"PA0281/026/007","Pinewood Laboratories Ltd,","ERYTHROMYCINETHYLSUCCINATE"
"7620","PRIMACINE","250 MG/5ml                                                                                               Granules for Oral Suspension",1998-11-13,"PA0281/026/008","Pinewood Laboratories Ltd,","ERYTHROMYCINETHYLSUCCINATE"
"7621","PRIMACINE","500 MG/5ml                                                                                               Granules for Oral Suspension",1998-11-13,"PA0281/026/009","Pinewood Laboratories Ltd,","ERYTHROMYCINETHYLSUCCINATE"
"7622","PRIMAXIN IV","500/500 Milligram                                                                                            Pdr for Soln for Infusion",1998-10-16,"PA1286/019/001","Merck Sharp & Dohme Ireland (Human Health) Limited","IMIPENEMMONOHYDRATE|CILASTATINSODIUM"
"7623","Primene 10% Solution for Infusion","10 percent Solution for infusion",1995-05-19,"PA0167/090/006","Baxter Healthcare Limited","L-isoleucine|L-leucine|L-valine|L-lysine|L-methionine|L-threonine|L-tryptophan|L-arginine|L-histidine|L-alanine|L-asparticacid|Cysteine|L-glutamicacid|Glycine|L-proline|L-serine|L-tyrosine|Ornithinehydrochloride|Taurine|L-phenylalanine"
"7624","PRIMOLUT N","5 Milligram                                                                                            Tablets",1978-04-01,"PA1410/010/001","Bayer Limited","NORETHISTERONE"
"7625","PRIMOVIST","0.25 mMol/ml                                                                                              Solution for Injection",2004-11-19,"PA1410/021/002","Bayer Limited","GADOXETICACID,DISODIUM"
"7626","Primovist 0.25 mmol/ml, solution for injection, pre-filled syringe","0.25 millimole(s)/millilitre Solution for injection",2004-11-19,"PA1410/021/001","Bayer Limited","Gadoxeticacid,disodium"
"7627","PRIORIX","0 Per Cent                                                                                             Solution for Injection",1998-07-27,"PA1077/036/001","GlaxoSmithKline (Ireland) Limited","MEASLESVIRUS-SCHWARZSTRAINLIVEATTENUATED|MUMPSVACCINERIT4385LIVEATTENUATED|RUBELLAVIRUS(RA27/3STRAIN)"
"7628","Priorix-Tetra – powder and solvent for solution for injection in pre-filled syringeMeasles, mumps, rubella and varicella vaccine (live)","0 *** AWAITING VALUE *** Powder and solvent for solution for injection",2007-08-10,"PA1077/117/001","GlaxoSmithKline (Ireland) Limited","Liveattenuatedmeaslesvirus(schwarzstrain)|Liveattenuatedmeaslesvirus(schwarzstrain)|Liveattenuatedmumpsvirus(rit4385strain)|Liveattenuatedmumpsvirus(rit4385strain)|Liveattenuatedrubellavirus(wistarra27/3strain)|Liveattenuatedrubellavirus(wistarra27/3strain)|Liveattenuatedvaricellavirus(okastrain)|Liveattenuatedvaricellavirus(okastrain)"
"7629","Priorix-Tetra – powder and solvent for solution for injectionMeasles, mumps, rubella and varicella vaccine (live)","0 *** AWAITING VALUE *** Powder and solvent for solution for injection",2007-08-10,"PA1077/117/003","GlaxoSmithKline (Ireland) Limited","Liveattenuatedmeaslesvirus(schwarzstrain)|Liveattenuatedmeaslesvirus(schwarzstrain)|Liveattenuatedmumpsvirus(rit4385strain)|Liveattenuatedmumpsvirus(rit4385strain)|Liveattenuatedrubellavirus(wistarra27/3strain)|Liveattenuatedrubellavirus(wistarra27/3strain)|Liveattenuatedvaricellavirus(okastrain)|Liveattenuatedvaricellavirus(okastrain)"
"7630","PRISMASOL","2 Unknown solution for haemodialysis/haemofiltration",2003-12-12,"PA0785/006/001","Gambro Lundia AB","CALCIUMCHLORIDEDIHYDRATE|MAGNESIUMCHLORIDEHEXAHYDRATE|GLUCOSE(ASMONOHYDRATE)|LACTICACID|SODIUMCHLORIDEPH.EUR.|POTASSIUMCHLORIDE|SODIUMHYDROGENCARBONATE"
"7631","PRISMASOL","4 Unknown solution for haemodialysis/haemofiltration",2003-12-12,"PA0785/006/002","Gambro Lundia AB","CALCIUMCHLORIDEDIHYDRATE|MAGNESIUMCHLORIDEHEXAHYDRATE|GLUCOSE(ASMONOHYDRATE)|LACTICACID|SODIUMCHLORIDE|POTASSIUMCHLORIDE|SODIUMHYDROGENCARBONATE"
"7632","PRISMASOL","2 Unknown solution for haemodialysis/haemofiltration",2007-10-05,"PA0785/006/003","Gambro Lundia AB","CALCIUMCHLORIDEDIHYDRATE|MAGNESIUMCHLORIDEHEXAHYDRATE|GLUCOSE(ASMONOHYDRATE)|LACTICACID|SODIUMCHLORIDE|POTASSIUMCHLORIDE|SODIUMHYDROGENCARBONATE"
"7633","PRISMASOL","4 Unknown solution for haemodialysis/haemofiltration",2007-10-05,"PA0785/006/004","Gambro Lundia AB","CALCIUMCHLORIDEDIHYDRATE|MAGNESIUMCHLORIDEHEXAHYDRATE|GLUCOSE(ASMONOHYDRATE)|LACTICACID|SODIUMCHLORIDE|POTASSIUMCHLORIDE|SODIUMHYDROGENCARBONATE"
"7634","PRITOR","40 Milligram                                                                                            Tablets",1998-12-11,"EU/1/98/089/001","Bayer AG","TELMISARTAN"
"7635","PRITOR","80 Milligram                                                                                            Tablets",1998-12-11,"EU/1/98/089/006-010","Bayer AG","TELMISARTAN"
"7636","PRITOR","20 Milligram                                                                                            Tablets",1999-09-15,"EU/1/98/089/011-014","Bayer AG","TELMISARTAN"
"7637","PritorPlus","40/12.5 ZZZ mg/mg Tablet",2002-04-22,"EU/1/02/215/001","Bayer Pharma AG","Telmisartan|Hydrochlorothiazide"
"7638","PRITORPLUS","80/12.5 mg/mg Tablets",2002-04-22,"EU/1/02/215/006-010","Bayer AG","TELMISARTAN|HYDROCHLOROTHIAZIDE"
"7639","PRITORPLUS","80/25 mg/mg Tablets",2008-04-01,"EU/1/02/215/15-21","Bayer AG","TELMISARTAN|HYDROCHLOROTHIAZIDE"
"7640","PRIVIGEN (HUMAN NORMAL IMMUNOGLOBULIN)","100 Micromol Solution for Infusion",2008-04-29,"EU/1/08/446/1-3","CSL Behring GmbH","HUMANNORMALIMMUNOGLOBULIN"
"7641","PROCORALAN","5 Milligram                                                                                            Tablets",2005-10-25,"EU/1/05/316/1-7","Les Laboratoires Servier","IVABRADINE"
"7642","PROCORALAN","7.5 Milligram                                                                                            Tablets",2005-10-25,"EU/1/05/316/8-14","Les Laboratoires Servier","IVABRADINE"
"7643","PROCTOFOAM H.C.","1 / 1 %w/w                                                                                                 Rectal Foam",1978-04-01,"PA2010/035/001","Mylan IRE Healthcare Limited","HYDROCORTISONEACETATE|PRAMOCAINEHYDROCHLORIDE"
"7644","PROCTOSEDYL","5/5/10/10 Milligram                                                                                            Suppositories",1978-04-01,"PA0540/062/002","Sanofi-Aventis Ireland Limited T/A SANOFI","HYDROCORTISONE|CINCHOCAINEHYDROCHLORIDE|ESCULOSIDE|FRAMYCETINSULFATE"
"7645","Proctosedyl Ointment","0.5/0.5/1/1 percent weight/weight Ointment",NA,"PA0540/062/001","Sanofi-Aventis Ireland Limited T/A SANOFI","Hydrocortisone|Framycetinsulfate|Aesculin|Cinchocainehydrochloride"
"7646","PROCYSBI","25 Milligram                                                                                            Capsules Hard",2013-09-06,"EU/1/13/861/001","Chiesi Farmaceutici S.p.A.","CYSTEAMINEBITARTRATE"
"7647","PROCYSBI","75 Milligram                                                                                            Capsules Hard",2013-09-06,"EU/1/13/861/002","Chiesi Farmaceutici S.p.A.","CYSTEAMINEBITARTRATE"
"7648","PRO-EPANUTIN","75 Mg/Ml Solution for Injection and Concentrate for Infusion",1998-07-27,"PA0822/019/001","Pfizer Healthcare Ireland","FOSPHENYTOINSODIUM"
"7649","Profal 5 mg film-coated tablets","5 milligram(s) Film-coated tablet",2009-01-09,"PA2315/045/001","Accord Healthcare Ireland Ltd.","Finasteride"
"7650","Profloxin 250 mg film-coated Tablets","250 milligram(s) Tablet",2005-01-28,"PA0126/203/001","Clonmel Healthcare Ltd","CIPROFLOXACINHYDROCHLORIDE"
"7651","PROFLOXIN 500 MG FILM-COATED TABLETS","500 Milligram                                                                                            Tablets",2005-01-28,"PA0126/203/002","Clonmel Healthcare Ltd","CIPROFLOXACINHYDROCHLORIDE"
"7652","PROGESTERONE","400 Milligram                                                                                            Pessary",2017-03-31,"PA1380/201/001","Actavis Group PTC ehf","PROGESTERONE"
"7653","PROGRAF","5 Mg/Ml Concentrate for Soln for Inf",1996-02-16,"PA1241/014/004","Astellas Pharma Co. Ltd","TACROLIMUS"
"7654","PROGRAF","0.5 Milligram                                                                                            Capsules Hard",2017-12-15,"PPA0465/435/001","PCO Manufacturing","TACROLIMUS"
"7655","Prograf 0.5 mg hard capsules","0.5 milligram(s) Capsule, hard",1998-12-10,"PA1241/014/001","Astellas Pharma Co. Ltd","Tacrolimus"
"7656","Prograf 1 mg hard capsules","1 milligram(s) Capsule, hard",1996-02-16,"PA1241/014/002","Astellas Pharma Co. Ltd","Tacrolimus"
"7657","Prograf 5 mg hard capsules","5 milligram(s) Capsule, hard",1996-02-16,"PA1241/014/003","Astellas Pharma Co. Ltd","Tacrolimus"
"7658","ProHance, 279.3 mg/ml, Solution for Injection, 10 ml vial","279.3 milligram(s)/millilitre Solution for injection",1993-02-23,"PA0788/001/002","Bracco International B.V.","Gadoteridol"
"7659","ProHance, 279.3 mg/ml, Solution for Injection, 15 ml vial","279.3 milligram(s)/millilitre Solution for injection",1993-02-23,"PA0788/001/003","Bracco International B.V.","Gadoteridol"
"7660","ProHance, 279.3 mg/ml, solution for injection, 20 ml vial","279.3 milligram(s)/millilitre Solution for injection",1993-02-23,"PA0788/001/004","Bracco International B.V.","Gadoteridol"
"7661","Prolastin1000mg, powder and solvent for solution for infusion","1000 milligram(s) Powder and solvent for solution for infusion",2007-01-05,"PA1405/002/001","Grifols Deutschland GmbH","Alpha-1-proteinaseinhibitor"
"7662","Prolia","60 milligram(s)/millilitre Solution for injection",2002-03-19,"EU/1/10/618/1-4","Amgen Europe B.V.","Denosumab"
"7663","PROMETAX","1.5 Milligram                                                                                            Capsule",1998-12-04,"EU/1/98/092/001","Novartis Europharm Limited","RIVASTIGMINEHYDROGENTARTRATE"
"7664","PROMETAX","1.5 Milligram                                                                                            Capsule",1998-12-04,"EU/1/98/092/002","Novartis Europharm Limited","RIVASTIGMINEHYDROGENTARTRATE"
"7665","PROMETAX","1.5 Milligram                                                                                            Capsule",1998-12-04,"EU/1/98/092/003","Novartis Europharm Limited","RIVASTIGMINEHYDROGENTARTRATE"
"7666","PROMETAX","3 Milligram                                                                                            Capsule",1998-12-04,"EU/1/98/092/004","Novartis Europharm Limited","RIVASTIGMINEHYDROGENTARTRATE"
"7667","PROMETAX","3 Milligram                                                                                            Capsule",1998-12-04,"EU/1/98/092/005","Novartis Europharm Limited","RIVASTIGMINEHYDROGENTARTRATE"
"7668","PROMETAX","3 Milligram                                                                                            Capsule",1998-12-04,"EU/1/98/092/006","Novartis Europharm Limited","RIVASTIGMINEHYDROGENTARTRATE"
"7669","PROMETAX","4.5 Milligram                                                                                            Capsule",1998-12-04,"EU/1/98/092/007","Novartis Europharm Limited","RIVASTIGMINEHYDROGENTARTRATE"
"7670","PROMETAX","4.5 Milligram                                                                                            Capsule",1998-12-04,"EU/1/98/092/008","Novartis Europharm Limited","RIVASTIGMINEHYDROGENTARTRATE"
"7671","PROMETAX","4.5 Milligram                                                                                            Capsule",1998-12-04,"EU/1/98/092/009","Novartis Europharm Limited","RIVASTIGMINEHYDROGENTARTRATE"
"7672","PROMETAX","6.0 Milligram                                                                                            Capsule",1998-12-04,"EU/1/98/092/010","Novartis Europharm Limited","RIVASTIGMINEHYDROGENTARTRATE"
"7673","PROMETAX","6.0 Milligram                                                                                            Capsule",1998-12-04,"EU/1/98/092/011","Novartis Europharm Limited","RIVASTIGMINEHYDROGENTARTRATE"
"7674","PROMETAX","6.0 Milligram                                                                                            Capsule",1998-12-04,"EU/1/98/092/012","Novartis Europharm Limited","RIVASTIGMINEHYDROGENTARTRATE"
"7675","PROMETAX","2 Base mg/ml                                                                                           Oral Solution",2000-05-11,"EU/1/98/092/013","Novartis Europharm Limited","RIVASTIGMINEHYDROGENTARTRATE"
"7676","PROMETAX","13.3 mg/24 hours Transdermal Patch",NA,"EU/1/98/092/027-030","Novartis Europharm Limited","RIVASTIGMINE"
"7677","PROMETAX","4.6 Mg/day                                                                                               Transdermal Patch",2007-09-25,"EU/1/98/092/19-22","Novartis Europharm Limited","RIVASTIGMINEBASE"
"7678","PROMETAX","9.5 Mg/day                                                                                               Transdermal Patch",2007-09-25,"EU/1/98/092/23-26","Novartis Europharm Limited","RIVASTIGMINEBASE"
"7679","Propafenone Hydrochloride 150mg Film-coated tablets","150 milligram(s) Film-coated tablet",2011-01-14,"PA1390/054/001","Accord Healthcare Limited","PROPAFENONEHYDROCHLORIDE"
"7680","Propafenone Hydrochloride 300mg Film-coated tablets","300 milligram(s) Film-coated tablet",2011-01-14,"PA1390/054/002","Accord Healthcare Limited","PROPAFENONEHYDROCHLORIDE"
"7681","PROPESS","10 Milligram                                                                                            Unknown",2018-07-06,"PA1009/029/001","Ferring Ireland Ltd","DINOPROSTONE"
"7682","Propinorm XL 30 mg Modified-Release Capsules","30 milligram(s) Capsules Modified Release",2007-09-28,"PA1142/009/001","Amdipharm Limited","Propiverinehydrochloride|Gelatin"
"7683","Propofol 1 % (10 mg/1 ml) Fresenius emulsion for injection or infusion, ampoule","1 percent weight/volume Emulsion for injection/infusion",1998-05-01,"PA0566/021/001","Fresenius Kabi Limited","Propofol"
"7684","Propofol 1 % (10 mg/1 ml) Fresenius emulsion for injection or infusion, vial","1 percent weight/volume Emulsion for injection/infusion",1998-05-01,"PA0566/021/002","Fresenius Kabi Limited","Propofol"
"7685","Propofol 10 mg/ml Emulsion for injection/infusion","10 milligram(s)/millilitre Emulsion for injection/infusion",2011-08-19,"PA2299/038/001","Baxter Holding B.V.","Propofol"
"7686","Propofol 2 % (20 mg/1 ml) Fresenius emulsion for injection or infusion, ampoule","2 percent weight/volume Emulsion for injection/infusion",NA,"PA0566/021/003","Fresenius Kabi Limited","Propofol"
"7687","Propofol 2 % (20 mg/1 ml) Fresenius emulsion for injection or infusion, vial","2 percent weight/volume Emulsion for injection/infusion",NA,"PA0566/021/004","Fresenius Kabi Limited","Propofol"
"7688","Propofol 20 mg/ml Emulsion for injection/infusion","20 milligram(s)/millilitre Emulsion for injection/infusion",2011-08-19,"PA2299/038/002","Baxter Holding B.V.","Propofol"
"7689","PROPOFOL-LIPURO","0.5 Per Cent                                                                                             Emulsion for Inj/Inf",2008-07-21,"PA0736/018/004","B. Braun Melsungen AG","PROPOFOL"
"7690","PROPOFOL-LIPURO","1% Per Cent                                                                                             Emulsion for Injection",2000-05-12,"PA0736/018/001","B. Braun Melsungen AG","PROPOFOL"
"7691","PROPOFOL-LIPURO","1% Per Cent                                                                                             Emulsion for Injection",2000-05-12,"PA0736/018/002","B. Braun Melsungen AG","PROPOFOL"
"7692","PROPOFOL-LIPURO 2%","20 Mg/Ml Emulsion for Inj/Inf",2004-03-09,"PA0736/018/003","B. Braun Melsungen AG","PROPOFOL"
"7693","Propoven 1% emulsion for injection or infusion in pre-filled syringe (glass syringe)","1 percent Emulsion for injection/infusion",2013-04-18,"PA2059/017/006","Fresenius Kabi Deutschland GmbH","Propofol"
"7694","Propoven 1% emulsion for injection/infusion in pre-filled syringe","1 percent Emulsion for injection/infusion",2013-04-18,"PA2059/017/004","Fresenius Kabi Deutschland GmbH","Propofol"
"7695","Propoven 2% emulsion for injection/infusion in pre-filled syringe","2 percent Emulsion for injection/infusion",2013-04-18,"PA2059/017/005","Fresenius Kabi Deutschland GmbH","Propofol"
"7696","PROPYLTHIOURACIL","50 Milligram                                                                                            Tablets",2017-02-10,"PA1888/002/001","Halewood Chemicals Limited","PROPYLTHIOURACIL"
"7697","PROQUAD","%v/v                                                                                                 Pdr+Solv for Susp for Inj",2006-04-06,"EU/1/05/323/1-13","Sanofi Pasteur MSD","MUMPSVIRUSLIVEATTENUATEDJERYLLYNNSTRAIN|RUBELLAVIRUS(WISTARRA27/3STRAIN)LIVEATTENUATED|VARICELLAVIRUSVACCINELIVE(OKA/MERCK)"
"7698","PROSCAR","5 Milligram                                                                                            Film Coated Tablet",2007-12-19,"PPA1151/043/001","Imbat Limited","FINASTERIDE"
"7699","Proscar 5 mg Film-Coated Tablets","5 milligram(s) Film-coated tablet",2003-01-10,"PPA0465/098/001","PCO Manufacturing","Finasteride"
"7700","Proscar 5mg Film-coated tablets","5 milligram(s) Film-coated tablet",1992-08-10,"PA1286/017/001","Merck Sharp & Dohme Ireland (Human Health) Limited","Finasteride"
"7701","Proscar 5mg Film-coated tablets","5 milligram(s) Film-coated tablet",2012-01-06,"PPA1562/072/001","LTT Pharma Limited","Finasteride"
"7702","Prosentio 100 mg tablets","100 milligram(s) Tablet",2012-07-06,"PA0126/190/001","Clonmel Healthcare Ltd","Modafinil"
"7703","Prosentio 200 mg tablets","200 milligram(s) Tablet",2012-07-06,"PA0126/190/002","Clonmel Healthcare Ltd","Modafinil"
"7704","PROSTAP 3 DCS 11.25 mg Powder and Solvent for Prolonged-release Suspension for Injection in Pre-filled Syringe","11.25 milligram(s) Powder and solvent for suspension for injection",2011-04-08,"PA2229/009/001","Takeda Products Ireland Ltd","LEUPRORELINACETATE"
"7705","PROSTAP 6 ADVANCED SYSTEM","30 Milligram                                                                                            Unknown",2011-04-08,"PA2229/009/002","Takeda Products Ireland Ltd","LEUPRORELINACETATE"
"7706","PROSTAP SR DCS","3.75 Milligram                                                                                            Pdr+Solv for Susp for Inj",2011-04-08,"PA2229/009/003","Takeda Products Ireland Ltd","LEUPRORELINACETATE"
"7707","Prostasan soft capsules","*** AWAITING VALUE *** Capsule, soft",2012-05-25,"TR2309/002/001","A. Vogel Ireland Limited","Sabalisserrulataeextractumspissum"
"7708","PROSTIN E2","1 Mg/Ml Concentrate for Soln for Inf",1979-04-01,"PA0822/133/003","Pfizer Healthcare Ireland","DINOPROSTONE"
"7709","PROSTIN E2","3 Milligram                                                                                            Vaginal Tablets",1985-05-28,"PA0822/133/004","Pfizer Healthcare Ireland","DINOPROSTONE"
"7710","PROSTIN E2","1 Milligram                                                                                            Vaginal Gel",1987-03-13,"PA0822/178/001","Pfizer Healthcare Ireland","DINOPROSTONE"
"7711","PROSTIN E2","2 Milligram                                                                                            Vaginal Gel",1987-03-13,"PA0822/178/002","Pfizer Healthcare Ireland","DINOPROSTONE"
"7712","Protamine sulphate LEO Pharma 1400 anti-heparin IU/ml solution for injection and infusion","1400 international unit(s)/millilitre Solution for injection",2006-11-27,"PA1025/002/001","LEO Pharma A/S","Protaminesulphate"
"7713","PROTAPHANE","40/100 IU/ML                                                                                                Suspension for Injection",2003-08-13,"EU/1/02/234/016-017","Novo Nordisk A/S","INSULINHUMAN"
"7714","Protaphane","international unit(s)/millilitre Suspension for injection",2002-10-07,"EU/1/02/234/1-15","Novo Nordisk A/S","Insulinhuman"
"7715","PROTELOS","2g %v/v                                                                                                 Granules for Oral Suspension",2004-09-21,"EU/1/04/288/1-6","Les Laboratoires Servier","STRONTIUMRANELATE"
"7716","PROTHIADEN","25mg Milligram                                                                                            Capsules Hard",1977-01-12,"PA1235/005/001","Teofarma S.R.L.","DOSULEPINHYDROCHLORIDE"
"7717","PROTHIADEN","75mg Milligram                                                                                            Coated Tablets",1977-01-12,"PA1235/005/002","Teofarma S.R.L.","DOSULEPINHYDROCHLORIDE"
"7718","Prothromplex TOTAL 600 IU powder and solvent for solution for injection","600 international unit(s) Powder and solvent for solution for injection",2014-11-03,"PA2004/005/001","Baxalta Innovations GmbH","Humancoagulationfactorix|Proteinc|Humancoagulationfactorvii|Humancoagulationfactorx|Humancoagulationfactorii"
"7719","Protium 20 mg gastro-resistant tablets","20 milligram(s) Gastro-resistant tablet",1999-01-22,"PA2229/010/001","Takeda Products Ireland Ltd","Pantoprazolesodiumsesquihydrate"
"7720","Protium 40 mg gastro-resistant Tablets","40 milligram(s) Gastro-resistant tablet",1995-09-28,"PA2229/010/002","Takeda Products Ireland Ltd","Pantoprazolesodiumsesquihydrate"
"7721","Protium i.v. 40 mg Powder for Solution for Injection","40 milligram(s) Powder for solution for injection",1998-03-20,"PA2229/010/003","Takeda Products Ireland Ltd","Pantoprazolesodiumsesquihydrate"
"7722","PROTIZOLE","20 Milligram                                                                                            Tablets Gastro-Resistant",2008-12-08,"PA0577/105/001","McDermott Laboratories Ltd t/a Gerard Laboratories","PANTOPRAZOLESODIUMSESQUIHYDRATE"
"7723","PROTIZOLE","40 Milligram                                                                                            Tablets Gastro-Resistant",2008-12-08,"PA0577/105/002","McDermott Laboratories Ltd t/a Gerard Laboratories","PANTOPRAZOLESODIUMSESQUIHYDRATE"
"7724","PROTOPIC","0.03% Per Cent                                                                                             Ointment",2002-02-28,"EU/1/02/201/001","LEO Pharma A/S","TACROLIMUS"
"7725","PROTOPIC","0.03% Per Cent                                                                                             Ointment",2002-02-28,"EU/1/02/201/002","LEO Pharma A/S","TACROLIMUS"
"7726","PROTOPIC","0.1% Per Cent                                                                                             Ointment",2002-02-28,"EU/1/02/201/003","LEO Pharma A/S","TACROLIMUS"
"7727","PROTOPIC","0.1% Per Cent                                                                                             Ointment",2002-02-28,"EU/1/02/201/004","LEO Pharma A/S","TACROLIMUS"
"7728","PROTOPIC","0.03 Per Cent                                                                                             Ointment",2003-04-09,"EU/1/02/201/005","LEO Pharma A/S","TACROLIMUS"
"7729","PROTOPIC","0.1 Per Cent                                                                                             Ointment",2003-04-09,"EU/1/02/201/006","LEO Pharma A/S","TACROLIMUS"
"7730","PROURSAN","250 Milligram                                                                                            Capsules Hard",2017-05-12,"PA2179/002/001","PRO.MED.CS Praha a.s.","URSODEOXYCHOLICACID"
"7731","Proursan 500 mg film-coated tablets","500 milligram(s) Film-coated tablet",2018-07-20,"PA2179/001/001","PRO.MED.CS Praha a.s.","Ursodeoxycholicacid"
"7732","PROVERA","2.5 Milligram                                                                                            Tablets",1993-10-27,"PA0822/134/001","Pfizer Healthcare Ireland","MEDROXYPROGESTERONEACETATE"
"7733","PROVERA","5 Milligram                                                                                            Tablets",1979-04-01,"PA0822/134/002","Pfizer Healthcare Ireland","MEDROXYPROGESTERONEACETATE"
"7734","PROVERA","10 Milligram                                                                                            Tablets",1989-04-01,"PA0822/134/003","Pfizer Healthcare Ireland","MEDROXYPROGESTERONEACETATE"
"7735","PROVERA","100 Milligram                                                                                            Tablets",1979-04-01,"PA0822/134/004","Pfizer Healthcare Ireland","MEDROXYPROGESTERONEACETATE"
"7736","Provera Tablets 100 mg","100 milligram(s) Tablet",1999-04-01,"PA0936/072/004","Pharmacia Healthcare Ireland","Medroxyprogesteroneacetate"
"7737","PROVIGIL","100mg Milligram                                                                                            Tablets",1998-05-01,"PA0749/198/001","Teva Pharma B.V.","MODAFINIL"
"7738","PROVIGIL","200mg Milligram                                                                                            Tablets",1998-05-01,"PA0749/198/002","Teva Pharma B.V.","MODAFINIL"
"7739","PROVIGIL","100 Milligram                                                                                            Tablets",2015-06-05,"PPA0465/415/001","PCO Manufacturing","MODAFINIL"
"7740","PROVIGIL","100 Milligram                                                                                            Tablets",2017-09-26,"PPA1463/115/001","IMED Healthcare Ltd.","MODAFINIL"
"7741","PROVIGIL","100 Milligram                                                                                            Tablets",2018-08-17,"PPA1151/267/001","Imbat Limited","MODAFINIL"
"7742","PROVIGIL","200 Milligram                                                                                            Tablets",2017-08-04,"PPA1097/024/001","Lexon (UK) Ltd","MODAFINIL"
"7743","PROVIGIL","100 Milligram                                                                                            Tablets",2017-07-21,"PPA1097/024/002","Lexon (UK) Ltd","MODAFINIL"
"7744","PROZAC","20 Milligram                                                                                            Capsules Hard",2012-10-19,"PPA1562/091/001","LTT Pharma Limited","FLUOXETINEHYDROCHLORIDE"
"7745","PROZAC","20 Milligram                                                                                            Capsules Hard",1996-10-10,"PPA0465/040/001","PCO Manufacturing","FLUOXETINEHYDROCHLORIDE"
"7746","PROZAC","20 Milligram                                                                                            Capsules Hard",2008-07-25,"DPR0465/017/001","PCO Manufacturing","FLUOXETINEHYDROCHLORIDE"
"7747","PROZAC","20 Milligram                                                                                            Capsules Hard",2008-10-03,"DPR1392/027/001","Eurodrug Ltd","FLUOXETINEHYDROCHLORIDE"
"7748","PROZAC","20 Milligram                                                                                            Capsules Hard",2008-05-02,"DPR1463/018/001","IMED Healthcare Ltd.","FLUOXETINEHYDROCHLORIDE"
"7749","PROZAC","20 Milligram                                                                                            Capsules Hard",2010-08-03,"DPR1633/003/001","Primecrown 2010 Ltd","FLUOXETINEHYDROCHLORIDE"
"7750","PROZAC","20 Milligram                                                                                            Capsules Hard",2009-07-29,"DPR1596/008/001","Clear Pharmacy","FLUOXETINEHYDROCHLORIDE"
"7751","Prozac 20 mg hard capsules","20 milligram(s) Capsule, hard",1989-02-09,"PA2276/004/002","Eli Lilly Nederland B.V.","FLUOXETINEHYDROCHLORIDE"
"7752","Prozac 20 mg per 5 ml oral solution","20 mg/5ml Oral solution",1994-02-23,"PA2276/004/001","Eli Lilly Nederland B.V.","FLUOXETINEHYDROCHLORIDE"
"7753","Prozac 20mg Hard Capsules","20 milligram(s) Capsule, hard",2014-05-23,"PPA1151/221/001","Imbat Limited","Fluoxetine"
"7754","PROZAMEL","20 Milligram                                                                                            Capsules Hard",2003-05-02,"PA0126/110/001","Clonmel Healthcare Ltd","FLUOXETINEHYDROCHLORIDE"
"7755","PROZIT","20 Milligram                                                                                            Capsules Hard",2001-05-04,"PA1063/012/001","Niche Generics Limited","FLUOXETINEHYDROCHLORIDE"
"7756","Psoriderm Cream","6.0 percent weight/weight Cream",1980-12-01,"PA0278/004/001","Dermal Laboratories Ltd","Coaltar"
"7757","PSORIDERM EMULSION","40 %w/v                                                                                                 Bath Additive",1980-12-01,"PA0278/004/002","Dermal Laboratories Ltd","COALTAR"
"7758","PSORIDERM SCALP LOTION","2.5 %w/v                                                                                                 Shampoo",1980-12-01,"PA0278/004/003","Dermal Laboratories Ltd","COALTAR"
"7759","PULMICORT RESPULES","0.5 mg/2ml Nebuliser Solution",1991-02-27,"PA0970/050/003","AstraZeneca UK Limited","BUDESONIDE"
"7760","PULMICORT RESPULES","1 mg/2ml Nebuliser Solution",1991-02-27,"PA0970/050/004","AstraZeneca UK Limited","BUDESONIDE"
"7761","PULMICORT TURBOHALER","100 Mcg/Acutuation                                                                                       Powder for Inhalation",1992-01-21,"PA0970/050/005","AstraZeneca UK Limited","BUDESONIDE"
"7762","PULMICORT TURBOHALER","200 Mcg/Acutuation                                                                                       Powder for Inhalation",1990-01-12,"PA0970/050/006","AstraZeneca UK Limited","BUDESONIDE"
"7763","PULMICORT TURBOHALER","400 Mcg/Acutuation                                                                                       Powder for Inhalation",1990-01-12,"PA0970/050/007","AstraZeneca UK Limited","BUDESONIDE"
"7764","Pulmocis Kit for the preparation of technetium [99mTc] Human albumin maccroaggregates injection","2.0 milligram(s) Powder for suspension for injection",2001-10-19,"PA0677/003/001","CIS bio International","Humanalbuminmacroaggregated"
"7765","PULMOTEC","1.340 Grams                                                                                                Kit for radiopharmaceutical preparation",2000-09-29,"PA1034/001/001","Cyclomedica Ireland Ltd","CARBONGRAPHITE"
"7766","PULMOZYME","2500/2.5 Units/ml                                                                                             Nebuliser Solution",2018-08-17,"PPA0465/433/001","PCO Manufacturing","DORNASEALFA"
"7767","PULMOZYME 2500 U/2.5ML NEBULISER SOLUTION","2500 U/ 2.5ml Units/ml                                                                                             Nebuliser Solution",1994-03-14,"PA2307/005/001","Roche Products (Ireland) Ltd","DORNASEALFA"
"7768","PULSATILLA","6C & 30C  Tablets",2010-09-10,"HOR0407/015/001","Weleda (UK) Limited","PULSATILLAPRATENSIS"
"7769","PUREGON","50 IU/0.5 International Unit                                                                                   Solution for Injection",1999-04-26,"EU/1/96/008/017","Merck Sharp and Dohme Limited","FOLLITROPINBETA"
"7770","PUREGON","50 IU/0.5 International Unit                                                                                   Solution for Injection",1999-04-26,"EU/1/96/008/018","Merck Sharp and Dohme Limited","FOLLITROPINBETA"
"7771","PUREGON","50 IU/0.5 International Unit                                                                                   Solution for Injection",1999-04-26,"EU/1/96/008/019","Merck Sharp and Dohme Limited","FOLLITROPINBETA"
"7772","PUREGON","75 IU/0.5 International Unit                                                                                   Solution for Injection",1999-04-26,"EU/1/96/008/020","Merck Sharp and Dohme Limited","FOLLITROPINBETA"
"7773","PUREGON","75 IU/0.5 International Unit                                                                                   Solution for Injection",1999-04-26,"EU/1/96/008/021","Merck Sharp and Dohme Limited","FOLLITROPINBETA"
"7774","PUREGON","75 IU/0.5 International Unit                                                                                   Solution for Injection",1999-04-26,"EU/1/96/008/022","Merck Sharp and Dohme Limited","FOLLITROPINBETA"
"7775","PUREGON","100 IU/0.5 International Unit                                                                                   Solution for Injection",1999-04-26,"EU/1/96/008/023","Merck Sharp and Dohme Limited","FOLLITROPINBETA"
"7776","PUREGON","100 IU/0.5 International Unit                                                                                   Solution for Injection",1999-04-26,"EU/1/96/008/024","Merck Sharp and Dohme Limited","FOLLITROPINBETA"
"7777","PUREGON","100 IU/0.5 International Unit                                                                                   Solution for Injection",1999-04-26,"EU/1/96/008/025","Merck Sharp and Dohme Limited","FOLLITROPINBETA"
"7778","PUREGON","150 IU/0.5 International Unit                                                                                   Solution for Injection",1999-04-26,"EU/1/96/008/026","Merck Sharp and Dohme Limited","FOLLITROPINBETA"
"7779","PUREGON","150 IU/0.5 International Unit                                                                                   Solution for Injection",1999-04-26,"EU/1/96/008/027","Merck Sharp and Dohme Limited","FOLLITROPINBETA"
"7780","PUREGON","150 IU/0.5 International Unit                                                                                   Solution for Injection",1999-04-26,"EU/1/96/008/028","Merck Sharp and Dohme Limited","FOLLITROPINBETA"
"7781","PUREGON","200 IU/0.5 International Unit                                                                                   Solution for Injection",1999-04-26,"EU/1/96/008/029","Merck Sharp and Dohme Limited","FOLLITROPINBETA"
"7782","PUREGON","200 IU/0.5 International Unit                                                                                   Solution for Injection",1999-04-26,"EU/1/96/008/030","Merck Sharp and Dohme Limited","FOLLITROPINBETA"
"7783","PUREGON","200 IU/0.5 International Unit                                                                                   Solution for Injection",1999-04-26,"EU/1/96/008/031","Merck Sharp and Dohme Limited","FOLLITROPINBETA"
"7784","PUREGON","225 IU/0.5 International Unit                                                                                   Solution for Injection",1999-04-26,"EU/1/96/008/032","Merck Sharp and Dohme Limited","FOLLITROPINBETA"
"7785","PUREGON","225 IU/0.5 International Unit                                                                                   Solution for Injection",1999-04-26,"EU/1/96/008/033","Merck Sharp and Dohme Limited","FOLLITROPINBETA"
"7786","PUREGON","225 IU/0.5 International Unit                                                                                   Solution for Injection",1999-04-26,"EU/1/96/008/034","Merck Sharp and Dohme Limited","FOLLITROPINBETA"
"7787","PUREGON","300 IU/0.3 International Unit                                                                                   Solution for Injection",2000-02-10,"EU/1/96/008/038","Merck Sharp and Dohme Limited","FOLLITROPINBETA"
"7788","PUREGON","600 IU/0.7 International Unit                                                                                   Solution for Injection",2000-02-10,"EU/1/96/008/039","Merck Sharp and Dohme Limited","FOLLITROPINBETA"
"7789","PUREGON","150 IU/0.1 International Unit                                                                                   Solution for Injection",1996-05-03,"EU/1/96/008/040","Merck Sharp and Dohme Limited","FOLLITROPINBETA"
"7790","PUREGON","900 IU/1.0 International Unit                                                                                   Solution for Injection",1996-05-03,"EU/1/96/008/041","Merck Sharp and Dohme Limited","FOLLITROPINBETA"
"7791","PURI-NETHOL","50 Milligram                                                                                            Tablets",1979-04-01,"PA1691/009/001","Aspen Pharma Trading Limited","MERCAPTOPURINE"
"7792","PURI-NETHOL","50 Milligram                                                                                            Tablets",2017-03-01,"PPA1562/193/001","LTT Pharma Limited","MERCAPTOPURINE"
"7793","PURINOL","100 Milligram                                                                                            Tablets",1982-11-01,"PA0281/103/001","Pinewood Laboratories Ltd,","ALLOPURINOL"
"7794","PURINOL","300 Milligram                                                                                            Tablets",1982-11-01,"PA0281/103/002","Pinewood Laboratories Ltd,","ALLOPURINOL"
"7795","Pylobactell","100 milligram(s) Soluble tablet",1998-05-07,"EU/1/98/064/01","Torbet Laboratories Limited","13c-urea"
"7796","Qlaira film-coated tablets","*** AWAITING VALUE *** Film-coated tablet",NA,"PA1410/058/001","Bayer Limited","Estradiolvalerate|Estradiolvalerate|Dienogest|Dienogest|Estradiolvalerate"
"7797","QTERN","5/10 Milligram                                                                                            Film Coated Tablet",2016-07-15,"EU/1/16/1108/001-004","AstraZeneca AB","SAXAGLIPTIN|DAPAGLIFLOZIN"
"7798","QUADRAMET","Per Cent                                                                                             Solution for Injection",1998-02-05,"EU/1/97/057/001","CIS bio International","SAMARIUM(153SM)EDTMP"
"7799","Quadrivalent Influenza Vaccine (split virion, inactivated), suspension for injection in pre-filled syringeQuadrivalent influenza vaccine (split virion, inactivated)","15 microgram(s) Solution for injection in pre-filled syringe",NA,"PA2131/013/001","Sanofi Pasteur","A/Michigan/45/2015(H1N1)pdm09-likestrain(A/Michigan/45/2015,NYMCX-275)|A/SINGAPORE/IMFIMH-16-0019/2016(H3N2)-LIKESTRAIN(A/SINGAPORE/INFIMH-16-0019/2016,NIB-104)|B/COLORADO/06/2017-LIKESTRAIN(B/MARYLAND/15/2016,WILDTYPE)|B/PHUKET/3073/2013-LIKESTRAIN(B/PHUKET/3073/2013,WILDTYPE)"
"7800","QUEDUTE","0.5 Milligram                                                                                            Capsules, Soft",2016-08-26,"PA0711/276/001","Rowex Ltd","DUTASTERIDE"
"7801","QUENTIAX SR","150 Milligram                                                                                            Tablet Prolonged Release",2015-01-09,"PA1347/045/001","Krka d.d., Novo mesto","QUETIAPINEHEMIFUMARATE"
"7802","QUENTIAX SR","200 Milligram                                                                                            Tablet Prolonged Release",2015-01-09,"PA1347/045/002","Krka d.d., Novo mesto","QUETIAPINEHEMIFUMARATE"
"7803","QUENTIAX SR","300 Milligram                                                                                            Tablet Prolonged Release",2015-01-09,"PA1347/045/003","Krka d.d., Novo mesto","QUETIAPINEHEMIFUMARATE"
"7804","QUENTIAX SR","50 Milligram                                                                                            Tablet Prolonged Release",2015-11-13,"PA1347/045/004","Krka d.d., Novo mesto","QUETIAPINE"
"7805","QUENTIAX SR","400 Milligram                                                                                            Tablet Prolonged Release",2018-08-17,"PA1347/045/005","Krka d.d., Novo mesto","QUETIAPINEHEMIFUMARATE"
"7806","Questran 4g/sachet, Powder for oral suspension","4 gram(s) Powder for oral suspension",1979-04-01,"PA2255/002/001","Bristol-Myers Squibb Pharmaceuticals uc","Colestyramineresin"
"7807","QUETEX","25 Milligram                                                                                            Film Coated Tablet",2009-06-19,"PA0711/156/001","Rowex Ltd","QUETIAPINEFUMARATE"
"7808","QUETEX","100 Milligram                                                                                            Film Coated Tablet",2009-11-06,"PA0711/156/003","Rowex Ltd","QUETIAPINEHEMIFUMARATE"
"7809","QUETEX","200 Milligram                                                                                            Film Coated Tablet",2009-11-06,"PA0711/156/004","Rowex Ltd","QUETIAPINEFUMARATE"
"7810","QUETEX","300 Milligram                                                                                            Film Coated Tablet",2009-11-06,"PA0711/156/005","Rowex Ltd","QUETIAPINEFUMARATE"
"7811","Quetex XR 200 mg prolonged-release tablets","200 milligram(s) Prolonged-release tablet",2015-11-19,"PA0711/258/002","Rowex Ltd","Quetiapinehemifumarate|Quetiapinehemifumarate"
"7812","Quetex XR 300 mg prolonged-release tablets","300 milligram(s) Prolonged-release tablet",2015-11-19,"PA0711/258/003","Rowex Ltd","Quetiapinehemifumarate"
"7813","Quetex XR 400 mg prolonged-release tablets","400 milligram(s) Prolonged-release tablet",2015-11-19,"PA0711/258/004","Rowex Ltd","Quetiapinehemifumarate|Quetiapinehemifumarate"
"7814","Quetex XR 50 mg prolonged-release tablets","50 milligram(s) Prolonged-release tablet",2015-11-19,"PA0711/258/001","Rowex Ltd","Quetiapinehemifumarate|Quetiapinehemifumarate"
"7815","QUETIAPINE","25 Milligram                                                                                            Film Coated Tablet",2011-02-04,"PA1390/027/001","Accord Healthcare Limited","QUETIAPINE"
"7816","QUETIAPINE","100 Milligram                                                                                            Film Coated Tablet",2011-02-04,"PA1390/027/002","Accord Healthcare Limited","QUETIAPINE"
"7817","QUETIAPINE","200 Milligram                                                                                            Film Coated Tablet",2011-02-04,"PA1390/027/004","Accord Healthcare Limited","QUETIAPINE"
"7818","QUETIAPINE","300 Milligram                                                                                            Film Coated Tablet",2011-02-04,"PA1390/027/005","Accord Healthcare Limited","QUETIAPINE"
"7819","Quetiapine Actavis 100 mg Film-coated Tablets","100 milligram(s) Film-coated tablet",2009-05-01,"PA1380/018/002","Actavis Group PTC ehf","Quetiapinefumarate"
"7820","Quetiapine Actavis 150 mg Film-coated Tablets","150 milligram(s) Film-coated tablet",2009-05-01,"PA1380/018/003","Actavis Group PTC ehf","Quetiapinefumarate"
"7821","Quetiapine Actavis 200 mg Film-coated Tablets","200 milligram(s) Film-coated tablet",2009-05-01,"PA1380/018/004","Actavis Group PTC ehf","Quetiapinefumarate"
"7822","Quetiapine Actavis 25 mg Film-coated Tablets","25 milligram(s) Film-coated tablet",2009-05-01,"PA1380/018/001","Actavis Group PTC ehf","Quetiapinefumarate"
"7823","Quetiapine Actavis 300 mg Film-coated Tablets","300 milligram(s) Film-coated tablet",2009-05-01,"PA1380/018/005","Actavis Group PTC ehf","Quetiapinefumarate"
"7824","QUETIAPINE FAIR-MED","25 Milligram                                                                                            Film Coated Tablet",2012-07-13,"PA1789/002/001","Fair-Med Healthcare GmbH","QUETIAPINE"
"7825","QUETIAPINE FAIR-MED","100 Milligram                                                                                            Film Coated Tablet",2012-07-13,"PA1789/002/002","Fair-Med Healthcare GmbH","QUETIAPINE"
"7826","QUETIAPINE FAIR-MED","150 Milligram                                                                                            Film Coated Tablet",2012-07-13,"PA1789/002/003","Fair-Med Healthcare GmbH","QUETIAPINE"
"7827","QUETIAPINE FAIR-MED","200 Milligram                                                                                            Film Coated Tablet",2012-07-13,"PA1789/002/004","Fair-Med Healthcare GmbH","QUETIAPINE"
"7828","QUETIAPINE FAIR-MED","300 Milligram                                                                                            Film Coated Tablet",2012-07-13,"PA1789/002/005","Fair-Med Healthcare GmbH","QUETIAPINE"
"7829","QUETIAPINE FAIR-MED STARTERPACK","25/100/200 Milligram                                                                                            Film Coated Tablet",2012-07-13,"PA1789/002/006","Fair-Med Healthcare GmbH","QUETIAPINE|QUETIAPINE|QUETIAPINE"
"7830","QUETIAPINE KRKA","25 Milligram                                                                                            Film Coated Tablet",2013-06-21,"PA1347/027/001","Krka d.d., Novo mesto","QUETIAPINE"
"7831","QUETIAPINE KRKA","100 Milligram                                                                                            Film Coated Tablet",2013-06-21,"PA1347/027/002","Krka d.d., Novo mesto","QUETIAPINE"
"7832","QUETIAPINE KRKA","200 Milligram                                                                                            Film Coated Tablet",2013-06-21,"PA1347/027/003","Krka d.d., Novo mesto","QUETIAPINE"
"7833","QUETIAPINE KRKA","300 Milligram                                                                                            Film Coated Tablet",2013-06-21,"PA1347/027/004","Krka d.d., Novo mesto","QUETIAPINE"
"7834","Quetiapine Rosemont 20mg/ml Oral Suspension","20 milligram(s)/millilitre Oral suspension",2016-07-08,"PA0312/028/005","Rosemont Pharmaceuticals Ltd","Quetiapinefumarate"
"7835","QUETIAPINE ROWEX","50 Milligram                                                                                            Tablet Prolonged Release",2013-09-13,"PA0711/231/001","Rowex Ltd","QUETIAPINEHEMIFUMARATE"
"7836","QUETIAPINE ROWEX","200 Milligram                                                                                            Tablet Prolonged Release",2012-10-05,"PA0711/156/006","Rowex Ltd","QUETIAPINEHEMIFUMARATE"
"7837","QUETIAPINE ROWEX","300 Milligram                                                                                            Tablet Prolonged Release",2012-10-05,"PA0711/156/007","Rowex Ltd","QUETIAPINEHEMIFUMARATE"
"7838","QUETIAPINE ROWEX","400 Milligram                                                                                            Tablet Prolonged Release",2012-10-05,"PA0711/156/008","Rowex Ltd","QUETIAPINEHEMIFUMARATE"
"7839","QUIET LIFE","Per Cent                                                                                             Tablets",1992-11-27,"PA0257/001/001","GR Lane Health Products Ltd","HUMULUSLUPULUS|LEONURUSCARDIACA|VALERIANDRYHYDROALCOHOLICEXTRACTPH.EUR.|PASSIFLORAINCARNATA|THIAMINEHYDROCHLORIDE|RIBOFLAVIN|NICOTINAMIDE"
"7840","Quinine Sulphate 300mg Coated Tablets","300 milligram(s) Coated tablet",1985-07-04,"PA1986/052/001","Teva B.V.","Quininesulfate"
"7841","QUINODERM","10 + 0.5 %w/w                                                                                                 Cream",1981-04-24,"PA0943/022/001","Alliance Pharmaceuticals Ltd.","BENZOYLPEROXIDEHYDROUS|POTASSIUMHYDROXYQUINOLINSULFATE"
"7842","QUINODERM","5 + 0.5 %w/w                                                                                                 Cream",1987-02-03,"PA0943/022/002","Alliance Pharmaceuticals Ltd.","BENZOYLPEROXIDEHYDROUS|POTASSIUMHYDROXYQUINOLINSULFATE"
"7843","Quinsair","240 ZZZ Milligrams per Ampule Nebuliser solution",2015-03-26,"EU/1/14/973/001","Chiesi Farmaceutici S.p.A.","Levofloxacin"
"7844","QUODIXOR","150 Base Milligrams                                                                                      Film Coated Tablet",2010-12-03,"PA0281/159/001","Pinewood Laboratories Ltd,","IBANDRONATESODIUMMONOHYDRATE"
"7845","QUTENZA CUTANEOUS PATCH","179 Milligram                                                                                            Unknown",2009-05-15,"EU/1/09/524/1-2","Grunenthal GmbH","CAPSAICIN"
"7846","RABEPRAZOLE KRKA","10 Milligram                                                                                            Tablets Gastro-Resistant",2013-08-09,"PA1347/030/001","Krka d.d., Novo mesto","RABEPRAZOLESODIUM"
"7847","RABEPRAZOLE KRKA","20 Milligram                                                                                            Tablets Gastro-Resistant",2013-08-09,"PA1347/030/002","Krka d.d., Novo mesto","RABEPRAZOLESODIUM"
"7848","RABEPRAZOLE SODIUM","10 Milligram                                                                                            Tablets Gastro-Resistant",2010-09-03,"PA1390/157/001","Accord Healthcare Limited","RABEPRAZOLESODIUM"
"7849","RABEPRAZOLE SODIUM","20 Milligram                                                                                            Tablets Gastro-Resistant",2010-09-03,"PA1390/157/002","Accord Healthcare Limited","RABEPRAZOLESODIUM"
"7850","RABIES VACCINE PASTEUR MERIEUX","2.5 IU/ML                                                                                                Suspension for Injection",1994-12-12,"PA2131/004/001","Sanofi Pasteur","RABIESVACCINE"
"7851","RABIPUR","2.5 IU/ML                                                                                                Pdr+Solv for Soln for Inj",2004-04-02,"PA0877/003/001","GSK Vaccines GmbH","RABIESVIRUS(FLURYLEP)INACTIVATED"
"7852","RABIPUR","= 2,5 IE Unknown Infus/Pdr/Oral Soln",2016-07-08,"PA0877/003/002","GSK Vaccines GmbH","RABIESVIRUS(FLURYLEP)INACTIVATED"
"7853","RAENER","2.0/0.03 Milligram                                                                                            Film Coated Tablet",2018-08-10,"PA1474/011/001","Laboratorios Leon Farma, S.A.","DIENOGESTMICRONIZED|ETHINYLESTRADIOLMICRONIZED"
"7854","RALGEX","10/1/0.12% %v/v                                                                                                 Cream",1992-06-16,"PA0257/057/001","GR Lane Health Products Ltd","GLYCOLMONOSALICYLATE|METHYLNICOTINATE|CAPSICUMOLEORESIN"
"7855","RALGEX HEAT SPRAY","6.0/1.6 %w/v                                                                                                 Cutaneous Spray Solution",1990-12-11,"PA0257/072/001","GR Lane Health Products Ltd","GLYCOLMONOSALICYLATE|METHYLNICOTINATE"
"7856","RALOXIFENE HYDROCHLORIDE ACTAVIS","60 Milligram                                                                                            Film Coated Tablet",2015-01-30,"PA1380/155/001","Actavis Group PTC ehf","RALOXIFENEHYDROCHLORIDE"
"7857","RALOXIFENE TEVA","60 Milligram                                                                                            Film Coated Tablet",2010-04-29,"EU/1/10/627/1-3","Teva B.V.","RALOXIFENEHYDROCHLORIDE"
"7858","RAMIC","2.5 Milligram                                                                                            Capsules Hard",2005-06-10,"PA0281/119/002","Pinewood Laboratories Ltd,","RAMIPRIL"
"7859","RAMIC","5 Milligram                                                                                            Capsules Hard",2005-06-10,"PA0281/119/003","Pinewood Laboratories Ltd,","RAMIPRIL"
"7860","RAMIC","10 Milligram                                                                                            Capsules Hard",2005-06-10,"PA0281/119/004","Pinewood Laboratories Ltd,","RAMIPRIL"
"7861","RAMILO","1.25 Milligram                                                                                            Tablets",2004-09-10,"PA0711/063/001","Rowex Ltd","RAMIPRIL"
"7862","RAMILO","2.5 Milligram                                                                                            Tablets",2004-09-10,"PA0711/063/002","Rowex Ltd","RAMIPRIL"
"7863","Ramilo 10 mg Tablets","10 milligram(s) Tablet",2004-09-10,"PA0711/063/004","Rowex Ltd","Ramipril"
"7864","Ramilo 5 mg tablets","5 milligram(s) Tablet",2004-09-10,"PA0711/063/003","Rowex Ltd","Ramipril"
"7865","RAMIPRIL","1.25 Milligram                                                                                            Capsules Hard",2013-03-15,"PA1390/047/001","Accord Healthcare Limited","RAMIPRIL"
"7866","RAMIPRIL","2.5 Milligram                                                                                            Capsules Hard",2013-03-15,"PA1390/047/002","Accord Healthcare Limited","RAMIPRIL"
"7867","RAMIPRIL","5 Milligram                                                                                            Capsules Hard",2013-03-15,"PA1390/047/003","Accord Healthcare Limited","RAMIPRIL"
"7868","RAMIPRIL","10 Milligram                                                                                            Capsules Hard",2013-03-15,"PA1390/047/004","Accord Healthcare Limited","RAMIPRIL"
"7869","Ramipril 2.5mg/5ml Oral Solution","2.5 mg/5ml Oral solution",2011-11-18,"PA0312/026/001","Rosemont Pharmaceuticals Ltd","Ramipril"
"7870","Ramipril Actavis 10 mg Hard Capsules","10 milligram(s) Capsule",2005-07-01,"PA2315/050/007","Accord Healthcare Ireland Ltd.","Ramipril"
"7871","Ramipril Actavis 2.5 mg Hard Capsules","2.5 milligram(s) Capsule, hard",2005-07-01,"PA2315/050/005","Accord Healthcare Ireland Ltd.","Ramipril"
"7872","Ramipril Actavis 5 mg Hard Capsules","5 milligram(s) Capsule",2005-07-01,"PA2315/050/006","Accord Healthcare Ireland Ltd.","Ramipril"
"7873","RAMIPRIL KRKA","1.25 Milligram                                                                                            Tablets",2010-11-26,"PA1347/042/001","Krka d.d., Novo mesto","RAMIPRIL"
"7874","RAMIPRIL KRKA","2.5 Milligram                                                                                            Tablets",2010-11-26,"PA1347/042/002","Krka d.d., Novo mesto","RAMIPRIL"
"7875","RAMIPRIL KRKA","5 Milligram                                                                                            Tablets",2010-11-26,"PA1347/042/003","Krka d.d., Novo mesto","RAMIPRIL"
"7876","RAMIPRIL KRKA","10 Milligram                                                                                            Tablets",2010-11-26,"PA1347/042/004","Krka d.d., Novo mesto","RAMIPRIL"
"7877","RAMIPRIL TEVA PHARMA","1.25 Milligram                                                                                            Tablets",2013-05-31,"PA0749/177/001","Teva Pharma B.V.","RAMIPRIL"
"7878","RAMIPRIL TEVA PHARMA","2.5 Milligram                                                                                            Tablets",2013-05-31,"PA0749/177/002","Teva Pharma B.V.","RAMIPRIL"
"7879","RAMIPRIL TEVA PHARMA","5 Milligram                                                                                            Tablets",2013-05-31,"PA0749/177/003","Teva Pharma B.V.","RAMIPRIL"
"7880","RAMIPRIL TEVA PHARMA","10 Milligram                                                                                            Tablets",2013-05-31,"PA0749/177/004","Teva Pharma B.V.","RAMIPRIL"
"7881","RAMIPRIL/AMLODIPINE KRKA 10 MG/ 10 MG","10mg/10mg Milligram                                                                                            Capsules Hard",2017-05-05,"PA1347/072/004","Krka d.d., Novo mesto","RAMIPRIL|AMLODIPINEBESILATE"
"7882","RAMIPRIL/AMLODIPINE KRKA 10 MG/ 5 MG","10mg/5mg Milligram                                                                                            Capsules Hard",2017-05-05,"PA1347/072/003","Krka d.d., Novo mesto","RAMIPRIL|AMLODIPINEBESILATE"
"7883","RAMIPRIL/AMLODIPINE KRKA 5 MG/ 10 MG","5mg/10mg Milligram                                                                                            Capsules Hard",2017-05-05,"PA1347/072/002","Krka d.d., Novo mesto","RAMIPRIL|AMLODIPINEBESILATE"
"7884","RAMIPRIL/AMLODIPINE KRKA 5 MG/ 5 MG","5mg/5mg Milligram                                                                                            Capsules Hard",2017-05-05,"PA1347/072/001","Krka d.d., Novo mesto","RAMIPRIL|AMLODIPINEBESILATE"
"7885","RAMITACE","2.5 Milligram                                                                                            Tablets",2006-10-13,"PA0126/163/001","Clonmel Healthcare Ltd","RAMIPRIL"
"7886","RAMITACE","5 Milligram                                                                                            Tablets",2006-10-13,"PA0126/163/002","Clonmel Healthcare Ltd","RAMIPRIL"
"7887","RAMITACE","10 Milligram                                                                                            Tablets",2006-10-13,"PA0126/163/003","Clonmel Healthcare Ltd","RAMIPRIL"
"7888","Ranexa","375 milligram(s) Prolonged-release tablet",2008-07-09,"EU/1/08/462/1,2,7,8","Menarini International Operations Luxembourg S.A.","Ranolazine"
"7889","RANEXA 500 MG PROLONGED-RELEASE TABLETS","500 Milligram                                                                                            Tablet Prolonged Release",2008-07-09,"EU/1/08/462/3,4,9,10","Menarini International Operations Luxembourg S.A.","RANOLAZINE"
"7890","RANEXA 750 MG PROLONGED-RELEASE TABLETS","750 Milligram                                                                                            Tablet Prolonged Release",2008-07-09,"EU/1/08/462/5,6,11,12","Menarini International Operations Luxembourg S.A.","RANOLAZINE"
"7891","RANITIC","150 Milligram                                                                                            Film Coated Tablet",1998-02-10,"PA0711/024/001","Rowex Ltd","RANITIDINEHYDROCHLORIDE"
"7892","RANITIC","300 Milligram                                                                                            Film Coated Tablet",1998-02-10,"PA0711/024/002","Rowex Ltd","RANITIDINEHYDROCHLORIDE"
"7893","Ranitic 75 mg Film-coated Tablets","75 milligram(s) Film-coated tablet",2003-05-16,"PA0711/024/004","Rowex Ltd","RANITIDINEHYDROCHLORIDE"
"7894","RANITIDINE","150 mg/10ml Oral Solution",2008-01-11,"PA1338/001/001","Focus Pharmaceuticals Ltd","RANITIDINEHYDROCHLORIDE"
"7895","RANITIDINE","150 Milligram                                                                                            Tablets Effervescent",2009-10-23,"PA1390/017/001","Accord Healthcare Limited","RANITIDINEHYDROCHLORIDE"
"7896","RANITIDINE","300 Milligram                                                                                            Tablets Effervescent",2009-10-23,"PA1390/017/002","Accord Healthcare Limited","RANITIDINEHYDROCHLORIDE"
"7897","RANITIDINE","150 Milligram                                                                                            Film Coated Tablet",2012-11-16,"PA1390/017/004","Accord Healthcare Limited","RANITIDINEHYDROCHLORIDE(FORMII)"
"7898","RANITIDINE","300 Milligram                                                                                            Film Coated Tablet",2012-11-16,"PA1390/017/005","Accord Healthcare Limited","RANITIDINEHYDROCHLORIDE(FORMII)"
"7899","RANITIDINE","150 mg/10ml Oral Solution",2014-10-10,"PPA1562/130/001","LTT Pharma Limited","RANITIDINEHYDROCHLORIDE"
"7900","Ranitidine 150 mg/10 ml Oral Solution","150 milligram/ 10 millilitre Oral solution",2007-05-18,"PA0312/010/001","Rosemont Pharmaceuticals Ltd","Ranitidine"
"7901","Ranitidine 50mg/2ml Solution for Injection and Infusion","50/2 milligram(s)/millilitre Solution for injection/infusion",2008-11-13,"PA0943/021/001","Alliance Pharmaceuticals Ltd.","RANITIDINEHYDROCHLORIDE"
"7902","RANOPINE","150 Milligram                                                                                            Film Coated Tablet",1997-11-28,"PA0281/156/001","Pinewood Laboratories Ltd,","RANITIDINEHYDROCHLORIDE"
"7903","RANOPINE","300 Milligram                                                                                            Film Coated Tablet",1997-11-28,"PA0281/156/002","Pinewood Laboratories Ltd,","RANITIDINEHYDROCHLORIDE"
"7904","Rapamune","1 milligram(s)/millilitre Oral solution",2001-03-13,"EU/1/01/171/001","Pfizer Europe MA EEIG","Sirolimus"
"7905","Rapamune","1 micromole(s) Oral solution",2001-03-13,"EU/1/01/171/002","Pfizer Europe MA EEIG","Sirolimus"
"7906","Rapamune","5 micromole(s) Oral solution",2001-03-13,"EU/1/01/171/005","Pfizer Europe MA EEIG","Sirolimus"
"7907","Rapamune","1 milligram(s) Coated tablet",2002-04-12,"EU/1/01/171/007","Pfizer Europe MA EEIG","Sirolimus"
"7908","Rapamune","1 milligram(s) Coated tablet",2002-04-12,"EU/1/01/171/008","Pfizer Europe MA EEIG","Sirolimus"
"7909","Rapamune","2 milligram(s) Coated tablet",2003-01-10,"EU/1/01/171/009-010","Pfizer Europe MA EEIG","Sirolimus"
"7910","Rapamune","0.5 milligram(s) Coated tablet",2010-07-06,"EU/1/01/171/013-014","Pfizer Europe MA EEIG","Sirolimus"
"7911","Rapamune","0.5 milligram(s) Coated tablet",2005-01-24,"EU/1/01/171/14","Pfizer Europe MA EEIG","Sirolimus"
"7912","Rapifen 500 micrograms/ml solution for injection or infusion","500 microgram(s)/millilitre Solution for injection/infusion",1992-06-09,"PA2187/001/001","Piramal Critical Care Limited","ALFENTANILHYDROCHLORIDE"
"7913","RAPILYSIN","10 UN %v/v                                                                                                 Pdr+Solv for Soln for Inj",1996-08-29,"EU/1/96/018/001","Actavis Group PTC ehf","RETEPLASE"
"7914","Rapiscan","400 microgram(s) Solution for injection",2010-09-06,"EU/1/10/643/001","GE Healthcare AS","Regadenoson"
"7915","RAPORSIN","4 Milligram                                                                                            Tablet Prolonged Release",2009-05-22,"PA1380/058/001","Actavis Group PTC ehf","DOXAZOSINMESILATE"
"7916","RAPORSIN","8 Milligram                                                                                            Tablet Prolonged Release",2011-09-09,"PA1380/058/002","Actavis Group PTC ehf","DOXAZOSIN"
"7917","RAPYDAN","70/70 Milligram                                                                                            Medicated Plaster",2008-01-25,"PA1591/001/001","Eurocept International BV","LIDOCAINE|TETRACAINE"
"7918","RASAGILINE ACCORD","1 Milligram                                                                                            Tablets",2015-11-27,"PA1390/110/001","Accord Healthcare Limited","RASAGILINETARTRATE"
"7919","RASAGILINE ACTAVIS","1 Milligram                                                                                            Tablets",2016-01-08,"PA1380/185/001","Actavis Group PTC ehf","RASAGILINETARTRATE"
"7920","RASAGILINE APOTEX","1 Milligram                                                                                            Tablets",2017-09-01,"PA1513/011/001","Apotex Europe B.V.","RASAGILINEMESILATE"
"7921","RASAGILINE CLONMEL","1 Milligram                                                                                            Tablets",2016-02-26,"PA0126/276/001","Clonmel Healthcare Ltd","RASAGILINEHEMITARTRATE"
"7922","RASAGILINE FLYNN","1 Base Milligrams                                                                                      Tablets",2016-06-10,"PA1226/011/001","Flynn Pharma Ltd","RASAGILINETARTRATE"
"7923","Rasagiline Krka 1 mg tablets","1 milligram(s) Tablet",NA,"PA1347/088/001","Krka d.d., Novo mesto","Rasagilinehemitartrate"
"7924","RASAGILINE MYLAN","1 Milligram                                                                                            Tablets",2016-04-04,"EU/1/16/1090/001-012","Mylan S.A.S.","RASAGILINETARTRATE"
"7925","RASAGILINE RATIOPHARM","1 Milligram                                                                                            Tablets",2015-01-12,"EU/1/14/977/001-007","Teva B.V.","RASAGILINEMESILATE"
"7926","RASAGILINE ROWEX","1 Milligram                                                                                            Tablets",2015-11-27,"PA0711/264/001","Rowex Ltd","RASAGILINETARTRATE"
"7927","Rasagiline Teva 1mg tablets","1 milligram(s) Tablet",2015-12-04,"PA1986/017/001","Teva B.V.","Rasagilinemesilate"
"7928","RASILEZ","300 Milligram                                                                                            Film Coated Tablet",2007-08-22,"EU/1/07/405/11-20,31-40","Noden Pharma DAC","ALISKIRENHEMIFUMARATE"
"7929","Rasilez HCT","150/25 milligram(s) Film-coated tablet",NA,"EU/1/08/491/021-040","Noden Pharma DAC","Aliskirenhemifumarate|Hydrochlorothiazide"
"7930","RASILEZ HCT","300/12.5 Milligram                                                                                            Film Coated Tablet",2009-01-16,"EU/1/08/491/041-060","Noden Pharma DAC","ALISKIRENHEMIFUMARATE|HYDROCHLOROTHIAZIDE"
"7931","RASILEZ HCT","300/25 Milligram                                                                                            Film Coated Tablet",2009-01-16,"EU/1/08/491/061-080","Noden Pharma DAC","ALISKIRENHEMIFUMARATE|HYDROCHLOROTHIAZIDE"
"7932","RATIOGRASTIM 30 MIU/0.5 ML SOLUTION FOR INJECTION","30/0.5 MU/ml                                                                                                Solution injection or concentrate for solution infusion",2008-09-15,"EU/1/08/444/1-4","Ratiopharm GmbH","FILGRASTIM"
"7933","RATIOGRASTIM 48 MIU/0.8 ML SOLUTION FOR INJECTION","48/0.8 MU/ml                                                                                                Solution injection or concentrate for solution infusion",2008-09-15,"EU/1/08/444/5-8","Ratiopharm GmbH","FILGRASTIM"
"7934","Ravicti","1.1 gram(s)/millilitre Oral liquid",2015-11-27,"EU/1/15/1062/001-004","Horizon Pharma Ireland Limited","Glycerolphenylbutyrate"
"7935","RAXONE","150 Milligram                                                                                            Film Coated Tablet",2015-09-08,"EU/1/15/1020/001","Santhera Pharmaceuticals (Deutschland) GmbH","IDEBENONE"
"7936","RAZOLAGER","15 Milligram                                                                                            Capsules Gastro-Resistant",2005-04-08,"PA0577/065/001","McDermott Laboratories Ltd t/a Gerard Laboratories","LANSOPRAZOLE"
"7937","RAZOLAGER","30 Milligram                                                                                            Capsules Gastro-Resistant",2005-04-08,"PA0577/065/002","McDermott Laboratories Ltd t/a Gerard Laboratories","LANSOPRAZOLE"
"7938","RAZOLE","10 Milligram                                                                                            Tablets Gastro-Resistant",2009-09-11,"PA0074/073/001","Rowa Pharmaceuticals Limited","RABEPRAZOLESODIUM"
"7939","RAZOLE","20 Milligram                                                                                            Tablets Gastro-Resistant",2009-09-11,"PA0074/073/002","Rowa Pharmaceuticals Limited","RABEPRAZOLESODIUM"
"7940","Reagila","1.5 milligram(s) Capsule, hard",2017-07-13,"EU/1/17/1209/001-010","Gedeon Richter Ltd","Cariprazinehydrochloride"
"7941","REAGILA","3 Milligram                                                                                            Capsules Hard",2017-07-13,"EU/1/17/1209/011-020","Gedeon Richter Plc.","CARIPRAZINEHYDROCHLORIDE"
"7942","REAGILA","4.5 Milligram                                                                                            Capsules Hard",2017-07-13,"EU/1/17/1209/021-028","Gedeon Richter Plc.","CARIPRAZINEHYDROCHLORIDE"
"7943","REAGILA","6 Milligram                                                                                            Capsules Hard",2017-07-13,"EU/1/17/1209/029-036","Gedeon Richter Plc.","CARIPRAZINEHYDROCHLORIDE"
"7944","REBETOL","200mg milligram(s) Capsule",1999-05-07,"EU/1/99/107/001-003","Merck Sharp & Dohme BV","Ribavirin|Interferonalfa-2b"
"7945","Rebetol","40 mg/ml milligram(s)/millilitre Capsule",1999-05-07,"EU/1/99/107/004","Merck Sharp & Dohme BV","Ribavirin|Interferonalfa-2b"
"7946","Rebetol","200 milligram(s) Capsule",1999-05-07,"EU/1/99/107/005","Merck Sharp & Dohme BV","Ribavirin|Interferonalfa-2b"
"7947","REBIF","22/0.5 Microgram/ML                                                                                         Solution for Injection",2009-01-16,"EU/1/98/063/008,18","Merck Serono Europe Limited","INTERFERONBETA-1-A"
"7948","REBIF","44/0.5 Microgram/ML                                                                                         Solution for Injection",2009-01-16,"EU/1/98/063/009,019","Merck Serono Europe Limited","INTERFERONBETA-1-A"
"7949","REBIF","8.8/0.1,22 Microgram/ML                                                                                         Solution for Injection",2009-01-16,"EU/1/98/063/010","Merck Serono Europe Limited","INTERFERONBETA-1-A"
"7950","REBIF","8.8 & 22 Mcg/Dose                                                                                             Solution for Injection",2003-01-16,"EU/1/98/063/017","Merck Serono Europe Limited","INTERFERONBETA-1A"
"7951","REBIF","22 mcg Microgram                                                                                            Solution for Injection",1998-05-04,"EU/1/98/063/001,11-13","Merck Serono Europe Limited","INTERFERONBETA-1A"
"7952","REBIF","22 Microgram                                                                                            Solution for Injection",1998-05-04,"EU/1/98/063/002","Merck Serono Europe Limited","INTERFERONBETA-1A"
"7953","REBIF","22 Microgram                                                                                            Solution for Injection",1998-05-04,"EU/1/98/063/003","Merck Serono Europe Limited","INTERFERONBETA-1A"
"7954","REBIF","44 Microgram                                                                                            Solution for Injection",1999-03-29,"EU/1/98/063/004","Merck Serono Europe Limited","INTERFERONBETA-1A"
"7955","REBIF","44 Microgram                                                                                            Solution for Injection",1999-03-29,"EU/1/98/063/005","Merck Serono Europe Limited","INTERFERONBETA-1A"
"7956","REBIF","44 Microgram                                                                                            Solution for Injection",1999-03-29,"EU/1/98/063/006","Merck Serono Europe Limited","INTERFERONBETA-1A"
"7957","REBIF STARTER PACK","8.8 Microgram                                                                                            Solution for Injection",2006-01-19,"EU/1/98/063/007","Serono Europe Limited","INTERFERONBETA-1A"
"7958","RECIVIT","67 Microgram                                                                                            Tablet Sublingual",2015-08-28,"PA0549/018/001","Ethypharm","FENTANYL"
"7959","RECIVIT","133 Microgram                                                                                            Tablet Sublingual",2015-08-28,"PA0549/018/002","Ethypharm","FENTANYL"
"7960","RECIVIT","267 Microgram                                                                                            Tablet Sublingual",2015-08-28,"PA0549/018/003","Ethypharm","FENTANYL"
"7961","RECIVIT","400 Microgram                                                                                            Tablet Sublingual",2015-08-28,"PA0549/018/004","Ethypharm","FENTANYL"
"7962","RECIVIT","533 Microgram                                                                                            Tablet Sublingual",2015-08-28,"PA0549/018/005","Ethypharm","FENTANYL"
"7963","RECIVIT","800 Microgram                                                                                            Tablet Sublingual",2015-08-28,"PA0549/018/006","Ethypharm","FENTANYL"
"7964","RECOMBINATE ANTHIHAEMOPHILIC FACTOR","1000 IU International Unit                                                                                   Pdr+Solv for Soln for Inj",1993-10-26,"PA2004/006/003","Baxalta Innovations GmbH","FACTORVIII,HUMANRECOMBINANT"
"7965","RECOMBINATE ANTIHAEMOPHILIC FACTOR","250 IU International Unit                                                                                   Pdr+Solv for Soln for Inj",1993-10-26,"PA2004/006/001","Baxalta Innovations GmbH","FACTORVIII,HUMANRECOMBINANT"
"7966","RECOMBINATE ANTIHAEMOPHILIC FACTOR","500 IU International Unit                                                                                   Pdr+Solv for Soln for Inj",1993-10-26,"PA2004/006/002","Baxalta Innovations GmbH","FACTORVIII,HUMANRECOMBINANT"
"7967","RECTOGESIC","4 mg/g Rectal Ointment",2006-09-29,"PA1049/004/001","Kyowa Kirin Ltd","GLYCERYLTRINITRATE"
"7968","RECTOGESIC","4 mg/g Rectal Ointment",2015-02-13,"PPA1562/147/001","LTT Pharma Limited","GLYCERYLTRINITRATE"
"7969","REDOXON DOUBLE ACTION","1000/10mg Milligram                                                                                            Tablets Effervescent",2001-11-02,"PA1410/050/001","Bayer Limited","ASCORBICACID|ZINCCITRATETRIHYDRATE"
"7970","REFACTO","2000 International Unit                                                                                   Pdr+Solv for Soln for Inj",2002-12-19,"EU/1/99/103/004","Pfizer Europe MA EEIG","RECOMBINANTANTIHEMOPHILICFACTOR"
"7971","REFACTO","500 International Unit                                                                                   Pdr+Solv for Soln for Inj",1999-04-13,"EU/1/99/103/002","Pfizer Europe MA EEIG","RECOMBINANTANTIHEMOPHILICFACTOR"
"7972","REFACTO AF","1000 IU International Unit                                                                                   Pdr+Solv for Soln for Inj",1999-04-13,"EU/1/99/103/003","Pfizer Europe MA EEIG","RECOMBINANTANTIHEMOPHILICFACTOR"
"7973","REFACTO AF","250 iu international unit(s) Powder and solvent for solution for injection",1999-04-13,"EU/1/99/103/001","Pfizer Europe MA EEIG","Recombinantantihemophilicfactor"
"7974","REFACTO AF","3000 International Unit                                                                                   Pdr+Solv for Soln for Inj",2011-05-06,"EU/1/99/103/005","Pfizer Europe MA EEIG","MOROCTOCOGALFA"
"7975","REFACTO AF","500 International Unit                                                                                   Pdr+Solv for Soln for Inj",2011-05-06,"EU/1/99/103/006","Pfizer Europe MA EEIG","MOROCTOCOGALFA"
"7976","REFACTO AF","1000 International Unit                                                                                   Pdr+Solv for Soln for Inj",2011-05-06,"EU/1/99/103/007","Pfizer Europe MA EEIG","MOROCTOCOGALFA"
"7977","REFACTO AF","2000 International Unit                                                                                   Pdr+Solv for Soln for Inj",2011-05-06,"EU/1/99/103/008","Pfizer Europe MA EEIG","MOROCTOCOGALFA"
"7978","REFIXIA (FORMELY KNOWN NONACOG BETA PEGOL)","500 International Unit                                                                                   Pdr+Solv for Soln for Inj",2017-06-02,"EU/1/17/1193/001","Novo Nordisk A/S","NONACOGBETAPEGOL"
"7979","REFIXIA (FORMELY KNOWN NONACOG BETA PEGOL)","1000 International Unit                                                                                   Pdr+Solv for Soln for Inj",2017-06-02,"EU/1/17/1193/002","Novo Nordisk A/S","NONACOGBETAPEGOL"
"7980","REFIXIA (FORMELY KNOWN NONACOG BETA PEGOL)","2000 International Unit                                                                                   Pdr+Solv for Soln for Inj",2017-06-02,"EU/1/17/1193/003","Novo Nordisk A/S","NONACOGBETAPEGOL"
"7981","REFRESH OPHTHALMIC","1.4 + 0.6 %w/v                                                                                                 Eye Drops Solution",1989-03-07,"PA0148/047/001","Allergan Pharmaceuticals Ireland","POLYVINYLALCOHOL"
"7982","REGAINE EXTRA STRENGTH","5 %w/v                                                                                                 Cutaneous Solution",1995-02-07,"PA0823/048/002","McNeil Healthcare (Ireland) Ltd","MINOXIDIL"
"7983","Regaine for Men Extra Strength Scalp Foam 5% w/w Cutaneous Foam","5 percent weight/weight Cutaneous foam",2012-08-03,"PA0823/048/003","McNeil Healthcare (Ireland) Ltd","Minoxidil"
"7984","Regaine for Women Extra Strength Scalp Foam 5%w/w Cutaneous Foam","5 percent weight/weight Cutaneous foam",2016-01-29,"PA0823/048/004","McNeil Healthcare (Ireland) Ltd","Minoxidil"
"7985","Regaine for Women Regular Strength 2% w/v Cutaneous Solution","2 percent weight/volume Cutaneous solution",NA,"PA0823/048/001","McNeil Healthcare (Ireland) Ltd","Minoxidil"
"7986","REGIOCIT","18/140 mmol/L Solution for Haemofiltration",2014-11-14,"PA0785/008/001","Gambro Lundia AB","SODIUMCITRATE|SODIUMCHLORIDE"
"7987","REGURIN","20 Milligram                                                                                            Coated Tablets",2011-09-09,"PPA0465/281/001","PCO Manufacturing","TROSPIUMCHLORIDE"
"7988","REGURIN","20 Milligram                                                                                            Coated Tablets",2012-06-06,"DPR1392/068/001","Eurodrug Ltd","TROSPIUMCHLORIDE"
"7989","Regurin 20 mg coated tablets","20 milligram(s) Coated tablet",2001-05-04,"PA1288/001/001","Madaus GmbH","Trospiumchloride"
"7990","REGURIN 20MG COATED TABLETS","20 Milligram                                                                                            Coated Tablets",2007-11-23,"PPA1151/038/001","Imbat Limited","TROSPIUMCHLORIDE"
"7991","REKOVELLE","12/0.36 Microgram/ML                                                                                         Solution for Injection",2016-12-12,"EU/1/16/1150/001","Ferring Pharmaceuticals A/S","FOLLITROPINDELTA"
"7992","REKOVELLE","36/1.08 Microgram/ML                                                                                         Solution for Injection",2016-12-12,"EU/1/16/1150/002","Ferring Pharmaceuticals A/S","FOLLITROPINDELTA"
"7993","REKOVELLE","72/2.16 Microgram/ML                                                                                         Solution for Injection",2016-12-12,"EU/1/16/1150/003","Ferring Pharmaceuticals A/S","FOLLITROPINDELTA"
"7994","RELENZA","5 Mg/Dose                                                                                              Powder for Inhalation",1999-07-07,"PA1077/011/001","GlaxoSmithKline (Ireland) Limited","ZANAMIVIR"
"7995","Relestat, 0.5 mg/ml, eye drops, solution","0.5 micromole(s) Eye drops, solution",2003-08-22,"PA0148/062/001","Allergan Pharmaceuticals Ireland","Epinastinehydrochloride"
"7996","Reletrans 10 micrograms/hour Transdermal Patches","10 ZZZ Microgram per hour Transdermal patch",2016-02-05,"PA0711/236/002","Rowex Ltd","Buprenorphine"
"7997","Reletrans 15 micrograms/hour Transdermal Patches","15 ZZZ Microgram per hour Transdermal patch",2016-02-05,"PA0711/236/003","Rowex Ltd","Buprenorphine"
"7998","Reletrans 20 micrograms/hour Transdermal Patches","20 ZZZ Microgram per hour Transdermal patch",2016-02-05,"PA0711/236/004","Rowex Ltd","Buprenorphine"
"7999","Reletrans 5 micrograms/hour Transdermal Patches","5 ZZZ Microgram per hour Transdermal patch",2016-02-05,"PA0711/236/001","Rowex Ltd","Buprenorphine"
"8000","RELIFEX","500 MG/5ml                                                                                               Oral Suspension",1990-12-17,"PA1332/006/001","Meda Health Sales Ireland Limited","NABUMETONE"
"8001","RELIFEX","500 Milligram                                                                                            Film Coated Tablet",2005-12-09,"PPA0465/131/001","PCO Manufacturing","NABUMETONE"
"8002","RELIFEX","500 Milligram                                                                                            Film Coated Tablet",1984-03-15,"PA2010/036/001","Mylan IRE Healthcare Limited","NABUMETONE"
"8003","RELIFEX","1 Grams                                                                                                Film Coated Tablet",2009-10-16,"PA2010/036/002","Mylan IRE Healthcare Limited","NABUMETONE"
"8004","RELIFEX","500 Milligram                                                                                            Film Coated Tablet",2009-11-13,"PPA1151/121/001","Imbat Limited","NABUMETONE"
"8005","RELISTOR","8 Milligram                                                                                            Solution for injection in pre-filled syringe",2010-09-06,"EU/1/08/463/004-008","PharmaSwiss Ceska republika s.r.o.","METHYLNALTREXONEBROMIDE"
"8006","RELISTOR","12 Milligram                                                                                            Solution for injection in pre-filled syringe",2010-09-06,"EU/1/08/463/8-11","PharmaSwiss Ceska republika s.r.o.","METHYLNALTREXONEBROMIDE"
"8007","RELISTOR 12 MG /0.6 ML SOLUTION FOR INJECTION.","12/0.6                                                                                                      Solution for Injection",2008-07-02,"EU/1/08/463/1-3","PharmaSwiss Ceska republika s.r.o.","METHYLNALTREXONEBROMIDE"
"8008","RELPAX 20mg film-coated tablets","20 milligram(s) Film-coated tablet",2001-11-16,"PA0822/006/001","Pfizer Healthcare Ireland","ELETRIPTAN"
"8009","RELPAX 40 mg film-coated tablets","40 milligram(s) Film-coated tablet",2017-07-28,"PPA1097/020/001","Lexon (UK) Ltd","ELETRIPTAN"
"8010","RELPAX 40mg film-coated tablets","40 milligram(s) Film-coated tablet",2001-11-16,"PA0822/006/002","Pfizer Healthcare Ireland","ELETRIPTAN"
"8011","Relvar Ellipta","92mcg/22 microgram(s) Powder for Inhalation",2013-11-13,"EU/1/13/886/001-003","Glaxo Group Limited","Fluticasonefuroatemicronised|Vilanteroltrifenatatemicronised"
"8012","Relvar Ellipta","184mcg/22 microgram(s) Powder for Inhalation",2013-11-13,"EU/1/13/886/004-006","Glaxo Group Limited","Fluticasonefuroatemicronised|Vilanteroltrifenatatemicronised"
"8013","REMEGEL","800 Milligram                                                                                            Tablets Chewable",1992-10-13,"PA1138/022/001","SSL International plc","CALCIUMCARBONATE"
"8014","Remicade","100 milligram(s) ZZZ Pdr/Conc/Soln for Infus",NA,"EU/1/99/116/001-5","Janssen Biologics B.V.","Infliximab"
"8015","REMIFENTANIL","1 Milligram                                                                                            Pdr/Conc/Soln/Inj/Inf",2010-10-01,"PA0566/052/001","Fresenius Kabi Limited","REMIFENTANILHCI"
"8016","REMIFENTANIL","2 Milligram                                                                                            Pdr/Conc/Soln/Inj/Inf",2010-10-01,"PA0566/052/002","Fresenius Kabi Limited","REMIFENTANILHCI"
"8017","REMIFENTANIL","5 Milligram                                                                                            Pdr/Conc/Soln/Inj/Inf",2010-10-01,"PA0566/052/003","Fresenius Kabi Limited","REMIFENTANILHCI"
"8018","REMIFENTANIL","1 Milligram                                                                                            Pdr/Conc/Soln/Inj/Inf",2010-10-08,"PA1339/030/001","Wockhardt UK Limited","REMIFENTANILHYDROCHLORIDE"
"8019","REMIFENTANIL","2 Milligram                                                                                            Pdr/Conc/Soln/Inj/Inf",2010-10-08,"PA1339/030/002","Wockhardt UK Limited","REMIFENTANILHYDROCHLORIDE"
"8020","REMIFENTANIL","5 Milligram                                                                                            Pdr/Conc/Soln/Inj/Inf",2010-10-08,"PA1339/030/003","Wockhardt UK Limited","REMIFENTANILHYDROCHLORIDE"
"8021","REMIFENTANIL","1 Milligram                                                                                            Pdr/Conc/Soln/Inj/Inf",2011-04-01,"PA1380/112/001","Actavis Group PTC ehf","REMIFENTANIL"
"8022","REMIFENTANIL","2 Milligram                                                                                            Pdr/Conc/Soln/Inj/Inf",2011-04-01,"PA1380/112/002","Actavis Group PTC ehf","REMIFENTANIL"
"8023","REMIFENTANIL","5 Milligram                                                                                            Pdr/Conc/Soln/Inj/Inf",2011-04-01,"PA1380/112/003","Actavis Group PTC ehf","REMIFENTANIL"
"8024","REMIFENTANIL NORIDEM","1 Milligram                                                                                            Pdr/Conc/Soln/Inj/Inf",2011-12-21,"PA1122/014/001","Noridem Enterprises Ltd","REMIFENTANILHYDROCHLORIDE"
"8025","REMIFENTANIL NORIDEM","2 Milligram                                                                                            Pdr/Conc/Soln/Inj/Inf",2011-12-21,"PA1122/014/002","Noridem Enterprises Ltd","REMIFENTANILHYDROCHLORIDE"
"8026","REMIFENTANIL NORIDEM","5 Milligram                                                                                            Pdr/Conc/Soln/Inj/Inf",2011-12-21,"PA1122/014/003","Noridem Enterprises Ltd","REMIFENTANILHYDROCHLORIDE"
"8027","REMINYL","4 Mg/Ml Oral Solution",2000-09-15,"PA0535/006/001","Shire Pharmaceuticals Limited","GALANTAMINEHYDROBROMIDE"
"8028","REMINYL XL","8 Milligram                                                                                            Capsules Hard",2004-11-19,"PA0535/006/005","Shire Pharmaceuticals Limited","GALANTAMINEHYDROBROMIDE"
"8029","REMINYL XL","16 Milligram                                                                                            Capsules Hard",2004-11-19,"PA0535/006/006","Shire Pharmaceuticals Limited","GALANTAMINEHYDROBROMIDE"
"8030","REMINYL XL","24 Milligram                                                                                            Capsules Hard",2004-11-19,"PA0535/006/007","Shire Pharmaceuticals Limited","GALANTAMINE"
"8031","REMINYL XL","8 Milligram                                                                                            Prolonged Release Capsules",2014-05-30,"PPA1562/113/001","LTT Pharma Limited","GALANTAMINEHYDROBROMIDE"
"8032","REMINYL XL","16 Milligram                                                                                            Prolonged Release Capsules",2014-11-07,"PPA1562/113/002","LTT Pharma Limited","GALANTAMINEHYDROBROMIDE"
"8033","REMINYL XL","24 Milligram                                                                                            Prolonged Release Capsules",2015-01-23,"PPA1562/113/003","LTT Pharma Limited","GALANTAMINEHYDROBROMIDE"
"8034","Reminyl XL 16 mg prolonged-release capsules, hard","16 milligram(s) Capsule, hard",2017-06-16,"PPA0465/166/004","PCO Manufacturing","GALANTAMINEHYDROBROMIDE"
"8035","Reminyl XL 24 mg prolonged-release capsules, hard","24 milligram(s) Prolonged-release capsule",2013-05-31,"PPA0465/166/003","PCO Manufacturing","Galantamine"
"8036","Reminyl XL 8 mg prolonged-release capsules, hard","8 milligram(s) Prolonged-release capsule",2009-09-25,"PPA0465/166/002","PCO Manufacturing","Galantamine"
"8037","Remsima","100 milligram(s) ZZZ Pdr/Conc/Soln for Infus",2013-09-10,"EU/1/13/853/001","Celltrion Healthcare Hungary Kft.","Infliximab"
"8038","RENAGEL","403 Milligram                                                                                            Capsule",2000-01-28,"EU/1/99/123/001","Genzyme Europe B.V.","SEVELAMER"
"8039","RENAGEL","403 Milligram                                                                                            Capsule",2000-01-28,"EU/1/99/123/002","Genzyme Europe B.V.","SEVELAMER"
"8040","RENAGEL","403 Milligram                                                                                            Capsule",2000-01-28,"EU/1/99/123/003","Genzyme Europe B.V.","SEVELAMER"
"8041","RENAGEL","403 Milligram                                                                                            Capsule",2000-01-28,"EU/1/99/123/004","Genzyme Europe B.V.","SEVELAMER"
"8042","RENAGEL","400 Milligram                                                                                            Tablets",2001-04-23,"EU/1/99/123/006","Genzyme Europe B.V.","SEVELAMER"
"8043","RENAGEL","400 Milligram                                                                                            Tablets",2001-04-23,"EU/1/99/123/007","Genzyme Europe B.V.","SEVELAMER"
"8044","RENAGEL","800 Mg/Ml Capsule",2001-04-23,"EU/1/99/123/008","Genzyme Europe B.V.","SEVELAMER"
"8045","RENAGEL","800 Milligram                                                                                            Tablets",2001-04-23,"EU/1/99/123/009","Genzyme Europe B.V.","SEVELAMER"
"8046","RENAGEL","800 Milligram                                                                                            Tablets",2001-04-23,"EU/1/99/123/010","Genzyme Europe B.V.","SEVELAMER"
"8047","RENAGEL","800 Milligram                                                                                            Tablets",2001-04-23,"EU/1/99/123/011","Genzyme Europe B.V.","SEVELAMER"
"8048","RENAGEL 400MG","400 Mg/Ml Tablets",2001-04-23,"EU/1/99/123/005","Genzyme Europe B.V.","SEVELAMER"
"8049","RENNIE DEFLATINE CHEWABLE TABLETS","680/80/25m Milligram                                                                                            Tablets Chewable",1994-05-16,"PA1410/051/001","Bayer Limited","CALCIUMCARBONATE|MAGNESIUMCARBONATE|DIMETICONE,ACTIVATED"
"8050","Rennie Direct 680 mg/80 mg oral powder","680/80 milligram(s) Oral powder",2018-08-17,"PA1410/053/005","Bayer Limited","Magnesiumcarbonateheavy|Calciumcarbonate"
"8051","RENNIE DUAL ACTION CHEWABLE TABLETS","625/73.5/150 Milligram                                                                                            Tablets Chewable",2009-02-06,"PA1410/052/003","Bayer Limited","ALGINICACID|CALCIUMCARBONATE|MAGNESIUMCARBONATE"
"8052","RENNIE ICE","680/80 Milligram                                                                                            Tablets Chewable",2011-01-28,"PA1410/053/004","Bayer Limited","CALCIUMCARBONATE|HEAVYMAGNESIUMCARBONATE"
"8053","RENNIE ORANGE","500 Milligram                                                                                            Tablets Chewable",1990-11-26,"PA1410/054/001","Bayer Limited","CALCIUMCARBONATE"
"8054","RENNIE PEPPERMINT 680MG/80MG CHEWABLE TABLETS","680/80 Milligram                                                                                            Tablets Chewable",1983-04-01,"PA1410/053/001","Bayer Limited","CALCIUMCARBONATE|MAGNESIUMCARBONATE"
"8055","RENNIE SPEARMINT 680MG / 80MG CHEWABLE TABLETS","680/80 Milligram                                                                                            Tablets Chewable",1991-02-27,"PA1410/053/002","Bayer Limited","CALCIUMCARBONATE|MAGNESIUMCARBONATE"
"8056","Rennie Sugar Free 680mg / 80mg Chewable tablets","680/80 milligram(s) Chewable tablet",1991-02-27,"PA1410/053/003","Bayer Limited","Magnesiumcarbonate|CALCIUMCARBONATE"
"8057","RENOCIS","1 Milligrams per Ampule Kit for radiopharmaceutical preparation",1999-03-19,"PA0677/005/001","CIS bio International","DIMERCAPTOSUCCINICACID"
"8058","Renvela","0.8 gram(s) Powder for oral suspension",2018-09-20,"EU/1/09/521/008","Genzyme Europe B.V.","Sevelamercarbonate"
"8059","RENVELA","800 Milligram                                                                                            Tablets",2009-06-10,"EU/1/09/521/1-3","Genzyme Europe B.V.","SEVELAMERCARBONATE"
"8060","RENVELA","1.6 Grams                                                                                                Powder for Oral Suspension",2009-06-10,"EU/1/09/521/4-5","Genzyme Europe B.V.","SEVELAMERCARBONATE"
"8061","RENVELA","2.4 Grams                                                                                                Powder for Oral Suspension",2009-06-10,"EU/1/09/521/6-7","Genzyme Europe B.V.","SEVELAMERCARBONATE"
"8062","ReoPro 2 mg/mL solution for injection or infusion","2 milligram(s)/millilitre Solution for injection/infusion",1995-07-12,"PA0502/003/001","Janssen Biologics B.V.","ABCIXIMAB"
"8063","REPAGLINIDE ACCORD","0.5 Milligram                                                                                            Tablets",2011-12-22,"EU/1/11/743/001-005","Accord Healthcare Limited","REPAGLINIDE"
"8064","REPAGLINIDE ACCORD","1 Milligram                                                                                            Tablets",2011-12-22,"EU/1/11/743/006-010","Accord Healthcare Limited","REPAGLINIDE"
"8065","REPAGLINIDE ACCORD","2 Milligram                                                                                            Tablets",2011-12-22,"EU/1/11/743/011-015","Accord Healthcare Limited","REPAGLINIDE"
"8066","REPAGLINIDE KRKA","2 Milligram                                                                                            Tablets",2009-11-04,"EU/1/09/579/13-18","Krka d.d., Novo mesto","REPAGLINIDE"
"8067","REPAGLINIDE KRKA","0.5 Milligram                                                                                            Tablets",2009-11-04,"EU/1/09/579/1-6","Krka d.d., Novo mesto","REPAGLINIDE"
"8068","REPAGLINIDE KRKA","1 Milligram                                                                                            Tablets",2009-11-04,"EU/1/09/579/7-12","Krka d.d., Novo mesto","REPAGLINIDE"
"8069","REPAGLINIDE TEVA","2 Milligram                                                                                            Tablets",2009-06-29,"EU/1/09/530/11-15","Teva B.V.","REPAGLINIDE"
"8070","REPAGLINIDE TEVA","0.5 Milligram                                                                                            Tablets",2009-06-29,"EU/1/09/530/1-5","Teva B.V.","REPAGLINIDE"
"8071","REPAGLINIDE TEVA","1 Milligram                                                                                            Tablets",2009-06-29,"EU/1/09/530/6-10","Teva Pharma B.V.","REPAGLINIDE"
"8072","Repatha","140 milligram(s)/millilitre Solution for injection in pre-filled syringe",2015-07-17,"EU/1/15/1016/001-005","Amgen Europe B.V.","Evolocumab"
"8073","REPATHA","420 Milligram                                                                                            Unknown",2017-02-17,"EU/1/15/1016/006-007","Amgen Europe B.V.","EVOLOCUMAB"
"8074","REPEVAX, suspension for injection, in pre-filled syringe Diphtheria, Tetanus, Pertussis (acellular, component) and Poliomyelitis (inactivated) Vaccine (adsorbed, reduced antigen(s) content)","0 *** AWAITING VALUE *** Suspension for injection",2003-07-25,"PA2131/006/001","Sanofi Pasteur","Tetanustoxoid|Diphtheriatoxoid|Pertussistoxoid|Filamentoushaemagglutinin(fha)|Pertactin|Poliovirustype1inactivated|Poliovirustype2inactivated|Poliovirustype3inactivated|Adsorbedaluminiumphosphate|Adsorbedfimbriaetypes2+3"
"8075","REPLAGAL 1MG/ML","1mg/ml Mg/Ml Concentrate for Soln for Inf",2001-08-03,"EU/1/01/189/001","TKT Europe AB","AGALSIDASEALFA"
"8076","REPSO","20 Milligram                                                                                            Film Coated Tablet",2011-03-14,"EU/1/11/674/006-010","Teva B.V.","LEFLUNOMIDE"
"8077","REQUIP","0.25 Milligram                                                                                            Film Coated Tablet",1996-12-03,"PA1077/037/001","GlaxoSmithKline (Ireland) Limited","ROPINIROLEHYDROCHLORIDE"
"8078","REQUIP","1 Milligram                                                                                            Film Coated Tablet",1996-12-03,"PA1077/037/003","GlaxoSmithKline (Ireland) Limited","ROPINIROLEHYDROCHLORIDE"
"8079","REQUIP","2 Milligram                                                                                            Film Coated Tablet",1996-12-03,"PA1077/037/004","GlaxoSmithKline (Ireland) Limited","ROPINIROLEHYDROCHLORIDE"
"8080","REQUIP","5 Milligram                                                                                            Film Coated Tablet",1996-12-03,"PA1077/037/005","GlaxoSmithKline (Ireland) Limited","ROPINIROLEHYDROCHLORIDE"
"8081","REQUIP-MODUTAB","2 Milligram                                                                                            Tablet Prolonged Release",2008-02-01,"PA1077/037/006","GlaxoSmithKline (Ireland) Limited","ROPINIROLEHYDROCHLORIDE"
"8082","REQUIP-MODUTAB","4 Milligram                                                                                            Tablet Prolonged Release",2008-02-01,"PA1077/037/008","GlaxoSmithKline (Ireland) Limited","ROPINIROLEHYDROCHLORIDE"
"8083","REQUIP-MODUTAB","8 Milligram                                                                                            Tablet Prolonged Release",2008-02-01,"PA1077/037/009","GlaxoSmithKline (Ireland) Limited","ROPINIROLEHYDROCHLORIDE"
"8084","REQUIP-MODUTAB","8 Base Milligrams                                                                                      Tablet Prolonged Release",2011-08-12,"PPA0465/279/001","PCO Manufacturing","ROPINIROLEHYDROCHLORIDE"
"8085","REQUIP-MODUTAB","2 Milligram                                                                                            Tablet Prolonged Release",2013-09-20,"PPA0465/279/002","PCO Manufacturing","ROPINIROLEHYDROCHLORIDE"
"8086","REQUIP-MODUTAB","4 Milligram                                                                                            Tablet Prolonged Release",2013-09-20,"PPA0465/279/003","PCO Manufacturing","ROPINIROLEHYDROCHLORIDE"
"8087","Requip-Modutab 2 mg Prolonged-Release Tablets","2 milligram(s) Prolonged-release tablet",2014-06-20,"PPA1562/115/001","LTT Pharma Limited","Ropinirole"
"8088","Requip-Modutab 4 mg Prolonged-Release Tablets","4 milligram(s) Prolonged-release tablet",2014-06-20,"PPA1562/115/002","LTT Pharma Limited","Ropinirole"
"8089","Requip-Modutab 8 mg Prolonged-Release Tablets","8 milligram(s) Prolonged-release tablet",2014-06-20,"PPA1562/115/003","LTT Pharma Limited","Ropinirole"
"8090","Requip-Modutab 8 mg prolonged-release tablets","8 milligram(s) Prolonged-release tablet",2018-11-23,"PPA2306/002/001","Originalis B.V.","Ropinirole"
"8091","RESOLOR","1 Milligram                                                                                            Film Coated Tablet",2009-10-15,"EU/1/09/581/001","Shire Pharmaceuticals Ireland Limited","PRUCALOPRIDESUCCINATE(R108512)"
"8092","RESOLOR","2 Milligram                                                                                            Film Coated Tablet",2009-10-15,"EU/1/09/581/002","Shire Pharmaceuticals Ireland Limited","PRUCALOPRIDESUCCINATE(R108512)"
"8093","RESPREEZA","1000 Milligram                                                                                            Pdr+Solv for Soln for Inj",2015-08-20,"EU/1/15/1006/001","CSL Behring GmbH","HUMANALPHA1-PROTEINASEINHIBITOR"
"8094","RESTANDOL TESTOCAPS 40 MG SOFT CAPSULES.","40 Milligram                                                                                            Capsules, Soft",1978-11-24,"PA1286/054/001","Merck Sharp & Dohme Ireland (Human Health) Limited","TESTOSTERONEUNDECANOATE"
"8095","Retacrit","3333 international unit(s)/millilitre Solution for injection",2007-12-18,"EU/1/07/431/1-6","Pfizer Europe MA EEIG","Epoetinzeta"
"8096","Retacrit","40,000 international unit(s)/millilitre Solution for injection",NA,"EU/1/07/431/17-19","Pfizer Europe MA EEIG","Epoetinzeta"
"8097","Retacrit","10,000 international unit(s)/millilitre Solution for injection",2007-12-18,"EU/1/07/431/7-16","Pfizer Europe MA EEIG","Epoetinzeta"
"8098","RETROVIR","100 mg/10ml Oral Solution",1993-12-20,"PA1716/001/002","ViiV Healthcare UK Ltd","ZIDOVUDINE"
"8099","Retrovir 10 mg/ml IV Concentrate for Solution for Infusion","10 milligram(s)/millilitre Concentrate for solution for infusion",1993-07-12,"PA1716/001/003","ViiV Healthcare UK Ltd","Zidovudine"
"8100","Retrovir 100 mg capsules, hard","100 milligram(s) Capsule, hard",1987-06-08,"PA1716/001/001","ViiV Healthcare UK Ltd","Zidovudine"
"8101","Revatio","20 milligram(s) Tablet",2005-10-28,"EU/1/05/318/001","Pfizer Europe MA EEIG","Sildenafilcitrate"
"8102","REVATIO","0.8 Mg/Ml Solution for Injection",2009-12-10,"EU/1/05/318/002","Pfizer Europe MA EEIG","SILDENAFILCITRATEFORPARENTERALUSE"
"8103","Revatio","10 milligram(s)/millilitre Powder for oral suspension",2012-03-21,"EU/1/05/318/003","Pfizer Europe MA EEIG","Sildenafilcitrate"
"8104","REVAXIS","0.5 Millilitre                                                                                           Suspension for Injection",2000-02-18,"PA2131/007/001","Sanofi Pasteur","DIPHTHERIATOXOID|TETANUSTOXOID|POLIOVIRUS,TYPE1|POLIOVIRUS,TYPE2|POLIOVIRUS,TYPE3"
"8105","REVESTIVE","5 Milligram                                                                                            Pdr+Solv for Soln for Inj",2012-08-30,"EU/1/12/787/001","Shire Pharmaceuticals Ireland Limited","TEDUGLUTIDE"
"8106","REVESTIVE","1.25 Milligram                                                                                            Pdr+Solv for Soln for Inj",2017-06-23,"EU/1/12/787/003","Shire Pharmaceuticals Ireland Limited",""
"8107","Revinty Ellipta","92/22 microgram(s) Powder for Inhalation",2014-06-17,"EU/1/14/929/001-003","Glaxo Group Limited","Fluticasonefuroatemicronised|Vilanterol"
"8108","Revinty Ellipta","184/22 microgram(s) Powder for Inhalation",2014-06-17,"EU/1/14/929/004-006","Glaxo Group Limited","Fluticasonefuroatemicronised|Vilanterol"
"8109","REVLIMID","5 Milligram                                                                                            Capsules Hard",2007-06-14,"EU/1/07/391/001","Celgene Europe Ltd","LENALIDOMIDE"
"8110","REVLIMID","10 Milligram                                                                                            Capsules Hard",2007-06-14,"EU/1/07/391/002","Celgene Europe B.V.","LENALIDOMIDE"
"8111","REVLIMID","15 Milligram                                                                                            Capsules Hard",2007-06-14,"EU/1/07/391/003","Celgene Europe B.V.","LENALIDOMIDE"
"8112","REVLIMID","25 Milligram                                                                                            Capsules Hard",2007-06-14,"EU/1/07/391/004","Celgene Europe B.V.","LENALIDOMIDE"
"8113","REVLIMID","2.5 Milligram                                                                                            Capsules Hard",2012-09-10,"EU/1/07/391/005","Celgene Europe B.V.","LENALIDOMIDE"
"8114","REVLIMID","7.5 Milligram                                                                                            Capsules Hard",2012-09-10,"EU/1/07/391/006","Celgene Europe B.V.","LENALIDOMIDE"
"8115","REVLIMID","20 Milligram                                                                                            Capsules Hard",2015-02-19,"EU/1/07/391/009","Celgene Europe B.V.","LENALIDOMIDE"
"8116","REVOLADE","75 Milligram                                                                                            Film Coated Tablet",2013-09-19,"EU/1/10/612/007-009","Novartis Europharm Limited","ELTROMBOPAG(SB-497115)"
"8117","REVOLADE","25 Milligram",2016-04-04,"EU/1/10/612/013","Novartis Europharm Limited","ELTROMBOPAGOLAMINE"
"8118","REVOLADE","25 Milligram                                                                                            Film Coated Tablet",2010-03-11,"EU/1/10/612/1-3","Novartis Europharm Limited","ELTROMBOPAGOLAMINE"
"8119","REVOLADE","50 Milligram                                                                                            Film Coated Tablet",2010-03-11,"EU/1/10/612/4-6","Novartis Europharm Limited","ELTROMBOPAGOLAMINE"
"8120","REYATAZ","50 Milligram                                                                                            Oral Powder",2016-06-21,"EU/1/03/267/012","Bristol Myers Squibb Pharma EEIG","ATAZANAVIRSULFATE"
"8121","REYATAZ","50 mg Milligram                                                                                            Capsules Hard",2004-03-31,"EU/1/03/267/01-7","Bristol Myers Squibb Pharma EEIG","ATAZANAVIR"
"8122","REYATAZ","300 Milligram                                                                                            Capsules Hard",2008-04-17,"EU/1/03/267/8-9","Bristol Myers Squibb Pharma EEIG","ATAZANAVIRSULFATE"
"8123","REZOLSTA","800/150 Milligram                                                                                            Film Coated Tablet",2014-11-19,"EU/1/14/967/001","Janssen-Cilag International NV","DARUNAVIR|COBICISTAT"
"8124","Rhesonativ 625 IU/ml, solution for injection","625 international unit(s)/millilitre Solution for injection",2006-04-28,"PA2219/003/001","Octapharma (IP) SPRL","Anti-dimmunoglobulin"
"8125","Rhinex Relief  50 micrograms/actuation Nasal spray, suspension","50 ZZZ Mcg/Acutuation Nasal spray, suspension",2018-07-20,"PA0711/279/001","Rowex Ltd","Mometasonefuroate"
"8126","RHINOCORT TURBOHALER","100 Mcg/Acutuation                                                                                       Nasal Powder",1995-09-19,"PA0970/051/001","AstraZeneca UK Limited","BUDESONIDE"
"8127","Rhinolast 140 micrograms per Spray, Nasal Spray","0.1 percent weight/volume Nasal spray, solution",NA,"PA2010/037/001","Mylan IRE Healthcare Limited","Azelastinehydrochloride"
"8128","Rhinolast Hayfever 140 micrograms per spray, nasal spray solution","0.1 percent weight/volume Nasal spray, solution",NA,"PA2010/037/002","Mylan IRE Healthcare Limited","Azelastinehydrochloride"
"8129","RHINOLAST S","1 Mg/Ml Nasal Spray Solution",2012-10-26,"PA1332/015/003","Meda Health Sales Ireland Limited","AZELASTINEHYDROCHLORIDE"
"8130","Rhinolast S nasal spray, solution","1.5 milligram(s)/millilitre Nasal spray, solution",2013-09-13,"PA2010/037/003","Mylan IRE Healthcare Limited","Azelastinehydrochloride"
"8131","Rhophylac 300 micrograms / 2 ml, solution for injection in pre-filled syringe","300 microgram(s) Solution for injection",2003-10-17,"PA0800/006/002","CSL Behring GmbH","Anti-dimmunoglobulin"
"8132","RHUS TOX","6X-MM Unknown",2010-10-29,"HOR1149/025/001","A. Nelson & Company Limited","RHUSTOXICODENDRON"
"8133","RHUS TOX.","6C & 30C  Tablets",2010-09-10,"HOR0407/017/001","Weleda (UK) Limited","TOXICODENDRONQUERCIFOLIUM"
"8134","RIARIFY","87/5/9 Mcg/Dose                                                                                             Pressurised Inhalation Soln",2018-04-23,"EU/1/18/1275/001-005","Chiesi Farmaceutici S.p.A.","BECLOMETASONEDIPROPIONATE|FORMOTEROLFUMARATEDIHYDRATE|GLYCLOPYRAMIDE"
"8135","RIASTAP","1 Grams                                                                                                Pdr for Soln Inj/Inf",2010-09-24,"PA0800/007/001","CSL Behring GmbH","HUMANFIBRINOGEN"
"8136","RIBAVIRIN MYLAN","200 Milligram                                                                                            Capsules Hard",2010-06-10,"EU/1/10/634/1-4","Mylan S.A.S.","RIBAVIRIN"
"8137","RIBAVIRIN TEVA","200 Milligram                                                                                            Capsules Hard",2009-03-31,"EU/1/09/509/1-4","Teva Pharma B.V.","RIBAVIRIN"
"8138","RIBAVIRIN TEVA PHARMA BV","200 Milligram                                                                                            Film Coated Tablet",2009-07-01,"EU/1/09/527/1-8","Teva Pharma B.V.","RIBAVIRIN"
"8139","RIBAVIRIN TEVA PHARMA BV","400 Milligram                                                                                            Film Coated Tablet",2009-07-01,"EU/1/09/527/9-16","Teva Pharma B.V.","RIBAVIRIN"
"8140","Ridate Once a Week 35mg film-coated tablets","35 milligram(s) Film-coated tablet",2010-08-06,"PA0711/189/001","Rowex Ltd","Risedronatesodium"
"8141","Ridate Plus Ca & D 35 mg Film-Coated Tablets + 1000 mg/880 IU Effervescent Tablets","35 milligram(s) Film-coated tablet",2012-03-30,"PA0711/191/001","Rowex Ltd","Monosodiumrisedronatehemipentahydrate|CALCIUMCARBONATE|Cholecalciferol|Risedronatesodium"
"8142","Ridonex 10mg orodispersible tablets","10 milligram(s) Orodispersible tablet",2016-09-16,"PA0126/291/001","Clonmel Healthcare Ltd","Domperidone"
"8143","RIFADIN","600 Milligram                                                                                            Pdr+Solv for soln for Inf",1983-10-04,"PA0540/066/003","Sanofi-Aventis Ireland Limited T/A SANOFI","RIFAMPICIN"
"8144","RIFADIN","100 MG/5ml                                                                                               Oral Suspension",1977-02-23,"PA0540/066/004","Sanofi-Aventis Ireland Limited T/A SANOFI","RIFAMPICIN"
"8145","RIFADIN","150 Milligram                                                                                            Capsule",1977-02-14,"PA0540/066/001","Sanofi-Aventis Ireland Limited T/A SANOFI","RIFAMPICIN"
"8146","Rifadin 300mg Capsules","300 milligram(s) Capsule",1977-02-14,"PA0540/066/002","Sanofi-Aventis Ireland Limited T/A SANOFI","Rifampicin"
"8147","RIFATER","50 /300 /120 Milligram                                                                                            Tablets",1987-02-09,"PA0540/067/001","Sanofi-Aventis Ireland Limited T/A SANOFI","ISONIAZID|PYRAZINAMIDE|RIFAMPICIN"
"8148","RIFAXIMIN ALFASIGMA","550 Milligram                                                                                            Film Coated Tablet",2012-12-18,"PA2206/001/001","Alfasigma S.p.A","RIFAXIMIN"
"8149","RIFINAH 150/100 MG FILM-COATED TABLETS","150/100 Milligram                                                                                            Film Coated Tablet",1977-04-01,"PA0540/068/001","Sanofi-Aventis Ireland Limited T/A SANOFI","RIFAMPICIN|ISONIAZID"
"8150","RIFINAH 300/150 MG FILM-COATED TABLETS.","300 / 150 Milligram                                                                                            Film Coated Tablet",1977-04-01,"PA0540/068/002","Sanofi-Aventis Ireland Limited T/A SANOFI","RIFAMPICIN|ISONIAZID"
"8151","RILUTEK","50 Milligram                                                                                            Tablets",1996-06-10,"EU/1/96/010/001","Aventis Pharma S.A","RILUZOLE"
"8152","RILUZOLE ZENTIVA","50 Milligram                                                                                            Film Coated Tablet",2012-05-07,"EU/1/12/768/001","Aventis Pharma S.A.","RILUZOLE"
"8153","RIMICORIM","300 Milligram                                                                                            Capsules Hard",2013-04-05,"PA2062/002/001","Kinedexe UK Limited","LYMECYCLINE"
"8154","RINATEC 21 micrograms per metered dose, Nasal Spray Solution","21 ZZZ Mcg/Dose Nasal spray, solution",1997-03-21,"PA0540/189/001","Sanofi-Aventis Ireland Limited T/A SANOFI","Ipratropiumbromide"
"8155","Ringer’s Solution for Infusion, Viaflo container","0 milligram(s)/litre Solution for infusion",2003-07-11,"PA0167/054/005","Baxter Healthcare Limited","Sodiumchloride|Sodiumchloride|Potassiumchloride|Potassiumchloride|Calciumchloridedihydrate|Calciumchloridedihydrate"
"8156","RINOZAL","5 Milligram                                                                                            Film Coated Tablet",2009-10-09,"PA0126/179/001","Clonmel Healthcare Ltd","LEVOCETIRIZINEDIHYDROCHLORIDE"
"8157","RIPRAZO","150 Milligram                                                                                            Film Coated Tablet",2007-08-22,"EU/1/07/409/1-10","Novartis Europharm Limited","ALISKIRENHEMIFUMARATE"
"8158","RIPRAZO","300 Milligram                                                                                            Film Coated Tablet",2007-08-22,"EU/1/07/409/11-20","Novartis Europharm Limited","ALISKIRENHEMIFUMARATE"
"8159","Risedronate Bluefish Once a Week 35 mg film-coated tablets","35 milligram(s) Film-coated tablet",2011-03-21,"PA1436/017/001","Bluefish Pharmaceuticals AB","Risedronatesodiumhemipentahydrate"
"8160","RISEDRONATE MYLAN ONCE A WEEK","35 Milligram                                                                                            Film Coated Tablet",2010-11-26,"PA0577/127/001","McDermott Laboratories Ltd t/a Gerard Laboratories","RISEDRONATESODIUM"
"8161","RISEDRONATE ONCE A WEEK","35 Milligram                                                                                            Film Coated Tablet",2011-08-05,"PA0577/159/001","McDermott Laboratories Ltd t/a Gerard Laboratories","RISEDRONATESODIUM"
"8162","Risedronate Pinewood 5 mg film-coated tablets","5 milligram(s) Film-coated tablet",2010-11-26,"PA0281/158/001","Pinewood Laboratories Ltd,","Risedronatesodium"
"8163","Risedronate Pinewood Once a week 35 mg film-coated tablets","35 milligram(s) Film-coated tablet",2010-11-26,"PA0281/158/003","Pinewood Laboratories Ltd,","Risedronatesodium"
"8164","Risedronate Sodium Actavis once weekly 35mg Film-Coated Tablets","35 milligram(s) Film-coated tablet",2010-10-01,"PA2315/031/001","Accord Healthcare Ireland Ltd.","Risedronatesodium|Risedronatesodium"
"8165","RISEDRONATE SODIUM ADAMED PHARMA ONCE A WEEK","35 Milligram                                                                                            Film Coated Tablet",2010-11-05,"PA1525/004/001","Zaklad Farmaceutyczny Adamed Pharma S.A.","RISEDRONATESODIUM"
"8166","RISEDRONATE/CALCIUM MYLAN","35/500 Milligram                                                                                            Film Coated Tablet",2012-10-26,"PA0577/167/001","McDermott Laboratories Ltd t/a Gerard Laboratories","CALCIUM|RISEDRONATESODIUM"
"8167","RISONATE ONCE WEEKLY","35 Milligram                                                                                            Film Coated Tablet",2008-12-12,"PA0749/064/001","Teva Pharma B.V.","RISEDRONATESODIUM"
"8168","RISONTEL ONCE A WEEK","35 Milligram                                                                                            Film Coated Tablet",2010-10-08,"PA0126/197/001","Clonmel Healthcare Ltd","RISEDRONATESODIUM"
"8169","RISPATAL","1 Mg/Ml Infus/Pdr/Oral Soln",2006-12-15,"PA0688/007/008","Chanelle Medical","RISPERIDONE"
"8170","RISPERDAL","6 Milligram                                                                                            Film Coated Tablet",2001-09-21,"PPA0465/078/005","PCO Manufacturing","RISPERIDONE"
"8171","RISPERDAL 0.5 mg film-coated tablets","0.5 milligram(s) Film-coated tablet",1996-12-13,"PA0748/003/009","Janssen-Cilag Ltd","Risperidone"
"8172","RISPERDAL 1 mg film-coated tablets","1 milligram(s) Film-coated tablet",1996-12-13,"PA0748/003/004","Janssen-Cilag Ltd","Risperidone"
"8173","RISPERDAL 1 mg/ml oral solution","1 milligram(s)/millilitre Oral solution",1996-12-13,"PA0748/003/001","Janssen-Cilag Ltd","Risperidone"
"8174","RISPERDAL 2 mg film-coated tablets","2 milligram(s) Film-coated tablet",1996-12-13,"PA0748/003/005","Janssen-Cilag Ltd","Risperidone"
"8175","RISPERDAL 3 mg film-coated tablets","3 milligram(s) Film-coated tablet",1996-12-13,"PA0748/003/006","Janssen-Cilag Ltd","Risperidone"
"8176","RISPERDAL 4 mg film-coated tablets","4 milligram(s) Film-coated tablet",1996-12-13,"PA0748/003/007","Janssen-Cilag Ltd","Risperidone"
"8177","RISPERDAL 6 mg film-coated tablets","6 milligram(s) Film-coated tablet",1996-12-13,"PA0748/003/002","Janssen-Cilag Ltd","Risperidone"
"8178","RISPERDAL CONSTA","25 Milligram                                                                                            Pdr+Solv for Susp for Inj",2015-07-24,"PPA1151/247/001","Imbat Limited","RISPERIDONE"
"8179","RISPERDAL CONSTA","37.5 Milligram                                                                                            Pdr+Solv for Susp for Inj",2015-07-24,"PPA1151/247/002","Imbat Limited","RISPERIDONE"
"8180","RISPERDAL CONSTA","50 Milligram                                                                                            Pdr+Solv for Susp for Inj",2015-07-24,"PPA1151/247/003","Imbat Limited","RISPERIDONE"
"8181","RISPERDAL CONSTA 25 mg powder and solvent for prolonged-release suspension for injection","25 milligram(s) Powder and solvent for suspension for injection",1996-12-13,"PA0748/003/010","Janssen-Cilag Ltd","Risperidone"
"8182","RISPERDAL CONSTA 25 mg powder and solvent for prolonged-release suspension for injection","25 milligram(s) Powder and solvent for prolonged-release suspension for injection",2011-08-05,"PPA0465/274/001","PCO Manufacturing","Risperidone"
"8183","RISPERDAL CONSTA 37.5 mg powder and solvent for prolonged-release suspension for injection","37.5 milligram(s) Suspension for injection",2011-08-05,"PPA0465/274/002","PCO Manufacturing","Risperidone"
"8184","RISPERDAL CONSTA 37.5 mg powder and solvent for prolonged-release suspension for injection","37.5 milligram(s) Powder and solvent for suspension for injection",1996-12-13,"PA0748/003/011","Janssen-Cilag Ltd","Risperidone"
"8185","RISPERDAL CONSTA 50 mg powder and solvent for prolonged-release suspension for injection","50 milligram(s) Powder and solvent for suspension for injection",1996-12-13,"PA0748/003/012","Janssen-Cilag Ltd","Risperidone"
"8186","RISPERDAL CONSTA 50 mg powder and solvent for prolonged-release suspension for injection","50 milligram(s) Suspension for injection",2011-08-05,"PPA0465/274/003","PCO Manufacturing","Risperidone"
"8187","RISPERIDONE","0.5 Milligram                                                                                            Film Coated Tablet",2009-01-09,"PA1390/008/001","Accord Healthcare Limited","RISPERIDONE"
"8188","RISPERIDONE","1 Milligram                                                                                            Film Coated Tablet",2009-01-09,"PA1390/008/002","Accord Healthcare Limited","RISPERIDONE"
"8189","RISPERIDONE","2 Milligram                                                                                            Film Coated Tablet",2009-01-09,"PA1390/008/003","Accord Healthcare Limited","RISPERIDONE"
"8190","RISPERIDONE","3 Milligram                                                                                            Film Coated Tablet",2009-01-09,"PA1390/008/004","Accord Healthcare Limited","RISPERIDONE"
"8191","RISPERIDONE","4 Milligram                                                                                            Film Coated Tablet",2009-01-09,"PA1390/008/005","Accord Healthcare Limited","RISPERIDONE"
"8192","RISPERIDONE","6 Milligram                                                                                            Film Coated Tablet",2009-01-09,"PA1390/008/006","Accord Healthcare Limited","RISPERIDONE"
"8193","Risperidone 0.5mg film-coated tablets","0.5 milligram(s) Film-coated tablet",2008-11-28,"PA1339/014/001","Wockhardt UK Limited","Risperidone"
"8194","Risperidone 1mg film-coated tablets","1 milligram(s) Film-coated tablet",2008-11-28,"PA1339/014/002","Wockhardt UK Limited","Risperidone"
"8195","Risperidone 1mg/ml Oral Solution","1 milligram(s)/millilitre Oral solution",2008-11-28,"PA1339/014/007","Wockhardt UK Limited","Risperidone"
"8196","Risperidone 1mg/ml Oral Solution","1 milligram(s)/millilitre Oral solution",2006-12-15,"PA0688/006/008","Chanelle Medical","Risperidone|Risperidone"
"8197","Risperidone 2mg film-coated tablets","2 milligram(s) Film-coated tablet",2008-11-28,"PA1339/014/003","Wockhardt UK Limited","Risperidone"
"8198","Risperidone 3mg film-coated tablets","3 milligram(s) Film-coated tablet",2008-11-28,"PA1339/014/004","Wockhardt UK Limited","Risperidone"
"8199","Risperidone 4mg film-coated tablets","4 milligram(s) Film-coated tablet",2008-11-28,"PA1339/014/005","Wockhardt UK Limited","Risperidone"
"8200","Risperidone 6mg film-coated tablets","6 milligram(s) Film-coated tablet",2008-11-28,"PA1339/014/006","Wockhardt UK Limited","Risperidone"
"8201","RISPEVA","1 Milligram                                                                                            Film Coated Tablet",2007-11-23,"PA0749/049/007","Teva Pharma B.V.","RISPERIDONE"
"8202","RISPEVA","2 Milligram                                                                                            Film Coated Tablet",2007-11-23,"PA0749/049/008","Teva Pharma B.V.","RISPERIDONE"
"8203","RISPEVA","3 Milligram                                                                                            Film Coated Tablet",2007-11-23,"PA0749/049/009","Teva Pharma B.V.","RISPERIDONE"
"8204","RISPEVA","4 Milligram                                                                                            Film Coated Tablet",2007-11-23,"PA0749/049/010","Teva Pharma B.V.","RISPERIDONE"
"8205","RISPEVA","0.5 Milligram                                                                                            Film Coated Tablet",2015-06-05,"PA1986/021/001","Teva B.V.","RISPERIDONE"
"8206","RISPONE","0.5 Milligram                                                                                            Film Coated Tablet",2007-08-24,"PA0711/106/002","Rowex Ltd","RISPERIDONE"
"8207","RISPONE","6 Milligram                                                                                            Film Coated Tablet",2007-12-14,"PA0711/106/005","Rowex Ltd","RISPERIDONE"
"8208","RISPONE","1 Milligram                                                                                            Film Coated Tablet",2007-09-14,"PA0711/106/006","Rowex Ltd","RISPERIDONE"
"8209","RISPONE","2 Milligram                                                                                            Film Coated Tablet",2007-09-14,"PA0711/106/007","Rowex Ltd","RISPERIDONE"
"8210","RISPONE","3 Milligram                                                                                            Film Coated Tablet",2007-09-14,"PA0711/106/008","Rowex Ltd","RISPERIDONE"
"8211","RISPONE","4 Milligram                                                                                            Film Coated Tablet",2007-09-14,"PA0711/106/009","Rowex Ltd","RISPERIDONE"
"8212","Rispone 1 mg/ml oral solution","1 milligram(s)/millilitre Oral solution",2006-10-13,"PA0711/106/001","Rowex Ltd","Risperidone"
"8213","Ristaben","100 milligram(s) Film-coated tablet",2010-03-15,"EU/1/10/621/13-18","Merck Sharp & Dohme BV,","Sitagliptinasmonohydratephosphatesalt"
"8214","Ristaben","25 milligram(s) Film-coated tablet",2010-03-15,"EU/1/10/621/1-6","Merck Sharp & Dohme BV","Sitagliptinasmonohydratephosphatesalt"
"8215","Ristaben","50 milligram(s) Film-coated tablet",2010-03-15,"EU/1/10/621/7-12","Merck Sharp & Dohme BV,","Sitagliptinasmonohydratephosphatesalt"
"8216","RISTFOR","50/850 Milligram                                                                                            Film Coated Tablet",2010-03-15,"EU/1/10/620/1-8","Merck Sharp & Dohme BV","SITAGLIPTINPHOSPHATE(ASMONOHYDRATEPHOSPHATESALT)|METFORMINHYDROCHLORIDE"
"8217","Ristfor","50/1000 milligram(s) Film-coated tablet",2010-03-15,"EU/1/10/620/9-16","Merck Sharp and Dohme Limited","Sitagliptinphosphate(asmonohydratephosphatesalt)|METFORMINHYDROCHLORIDE"
"8218","RITALIN","10 Milligram                                                                                            Tablets",1980-04-01,"PA0896/026/001","Novartis Ireland Limited","METHYLPHENIDATEHYDROCHLORIDE"
"8219","Ritalin® LA 20mg prolonged-release capsules","20 milligram(s) Prolonged-release capsule",2003-07-11,"PA0896/026/002","Novartis Ireland Limited","Methylphenidatehydrochloride"
"8220","Ritalin® LA 30mg prolonged-release capsules","30 milligram(s) Prolonged-release capsule",2003-07-11,"PA0896/026/003","Novartis Ireland Limited","Methylphenidatehydrochloride"
"8221","Ritalin® LA 40mg prolonged-release capsules","40 milligram(s) Prolonged-release capsule",2003-07-11,"PA0896/026/004","Novartis Ireland Limited","Methylphenidatehydrochloride"
"8222","RITEMVIA (PREVIOUSLY VYPANRA)","500 Milligram                                                                                            Concentrate for Soln for Inf",2017-07-13,"EU/1/17/1207/001","Celltrion Healthcare Hungary Kft.","RITUXIMAB"
"8223","RITONAVIR","100 Base Milligrams                                                                                      Film Coated Tablet",2017-04-07,"PA1390/130/001","Accord Healthcare Limited","RITONAVIR"
"8224","RITONAVIR MYLAN (PREVIOUSLY RITONAVIR JENSONR+))","100 Milligram                                                                                            Film Coated Tablet",2017-11-10,"EU/1/17/1242/001-003","Mylan S.A.S.","RITONAVIR"
"8225","RITUZENA (PREVIOUSLY TUXELLA)","500 Milligram                                                                                            Concentrate for Soln for Inf",2017-07-13,"EU/1/17/1206/001","Celltrion Healthcare Hungary Kft.","RITUXIMAB"
"8226","RIVAROXABAN ROWEX","10 Milligram                                                                                            Film Coated Tablet",2017-12-22,"PA0711/275/001","Rowex Ltd","RIVAROXABAN"
"8227","RIVAROXABAN ROWEX","15 Milligram                                                                                            Film Coated Tablet",2017-12-22,"PA0711/275/002","Rowex Ltd","RIVAROXABAN"
"8228","RIVAROXABAN ROWEX","20 Milligram                                                                                            Film Coated Tablet",2017-12-22,"PA0711/275/003","Rowex Ltd","RIVAROXABAN"
"8229","RIVASTIGMINE - 1 A PHARMA","1.5 Milligram                                                                                            Capsules Hard",2009-12-11,"EU/1/09/585/001-4","1 A Pharma GmbH","SDZENA713HTA(RIVASTIGMINEHYDROGENTARTRATE)"
"8230","RIVASTIGMINE - 1 A PHARMA","3.0 Milligram                                                                                            Capsules Hard",2009-12-11,"EU/1/09/585/005-8","1 A Pharma GmbH","SDZENA713HTA(RIVASTIGMINEHYDROGENTARTRATE)"
"8231","RIVASTIGMINE - 1 A PHARMA","4.5 Milligram                                                                                            Capsules Hard",2009-12-11,"EU/1/09/585/009-12","1 A Pharma GmbH","SDZENA713HTA(RIVASTIGMINEHYDROGENTARTRATE)"
"8232","RIVASTIGMINE - 1 A PHARMA","6.0 Milligram                                                                                            Capsules Hard",2009-12-11,"EU/1/09/585/013-16","1 A Pharma GmbH","SDZENA713HTA(RIVASTIGMINEHYDROGENTARTRATE)"
"8233","RIVASTIGMINE 1 A PHARMA (120ML)","2 Mg/Ml Oral Solution",2009-12-11,"EU/1/09/585/018","1 A Pharma GmbH","SDZENA713HTA(RIVASTIGMINEHYDROGENTARTRATE)"
"8234","RIVASTIGMINE 1 A PHARMA (50ML)","2 Micromol Oral Solution",2009-12-11,"EU/1/09/585/017","1 A Pharma GmbH","SDZENA713HTA(RIVASTIGMINEHYDROGENTARTRATE)"
"8235","Rivastigmine 1.5 mg hard capsules","1.5 milligram(s) Capsule, hard",2018-04-20,"PA2315/052/001","Accord Healthcare Ireland Ltd.","Rivastigmine"
"8236","Rivastigmine 3 mg hard capsules","3 milligram(s) Capsule, hard",2018-04-20,"PA2315/052/002","Accord Healthcare Ireland Ltd.","Rivastigmine"
"8237","Rivastigmine 4.5 mg hard capsules","4.5 milligram(s) Capsule, hard",2018-04-20,"PA2315/052/003","Accord Healthcare Ireland Ltd.","Rivastigmine"
"8238","Rivastigmine 6 mg hard capsules","6 milligram(s) Capsule, hard",2018-04-20,"PA2315/052/004","Accord Healthcare Ireland Ltd.","Rivastigmine"
"8239","RIVASTIGMINE ACTAVIS","1.5 Milligram                                                                                            Capsules Hard",2011-06-16,"EU/1/11/693/001-004","Actavis Group PTC ehf","RIVASTIGMINEHYDROGENTARTRATE"
"8240","RIVASTIGMINE ACTAVIS","3 Milligram                                                                                            Capsules Hard",2011-06-16,"EU/1/11/693/005-008","Actavis Group PTC ehf","RIVASTIGMINEHYDROGENTARTRATE"
"8241","RIVASTIGMINE ACTAVIS","4.5 Milligram                                                                                            Capsules Hard",2011-06-16,"EU/1/11/693/009-012","Actavis Group PTC ehf","RIVASTIGMINEHYDROGENTARTRATE"
"8242","RIVASTIGMINE ACTAVIS","6 Milligram                                                                                            Capsules Hard",2011-06-16,"EU/1/11/693/013-016","Actavis Group PTC ehf","RIVASTIGMINEHYDROGENTARTRATE"
"8243","RIVASTIGMINE ACTAVIS","4.6 mg/24 hours Transdermal Patch",2013-04-17,"EU/1/11/693/017-20","Actavis Group PTC ehf","RIVASTIGMINE"
"8244","RIVASTIGMINE ACTAVIS","9.5 mg/24 hours Transdermal Patch",2013-04-17,"EU/1/11/693/021-24","Actavis Group PTC ehf","RIVASTIGMINE"
"8245","RIVASTIGMINE HEXAL","6.0 Milligram                                                                                            Capsules Hard",2009-12-11,"EU/1/09/589/13-16","Hexal AG","SDZENA713HTA(RIVASTIGMINEHYDROGENTARTRATE)"
"8246","RIVASTIGMINE HEXAL","1.5 Milligram                                                                                            Capsules Hard",2009-12-11,"EU/1/09/589/1-4","Hexal AG","SDZENA713HTA(RIVASTIGMINEHYDROGENTARTRATE)"
"8247","RIVASTIGMINE HEXAL","3.0 Milligram                                                                                            Capsules Hard",2009-12-11,"EU/1/09/589/5-8","Hexal AG","SDZENA713HTA(RIVASTIGMINEHYDROGENTARTRATE)"
"8248","RIVASTIGMINE HEXAL","4.5 Milligram                                                                                            Capsules Hard",2009-12-11,"EU/1/09/589/9-12","Hexal AG","SDZENA713HTA(RIVASTIGMINEHYDROGENTARTRATE)"
"8249","RIVASTIGMINE HEXAL (120 ML)","2 Mg/Ml Oral Drops Solution",2009-12-11,"EU/1/09/589/018","Hexal AG","SDZENA713HTA(RIVASTIGMINEHYDROGENTARTRATE)"
"8250","RIVASTIGMINE HEXAL (50 ML)","2 Mg/Ml Oral Drops Solution",2009-12-11,"EU/1/09/589/017","Hexal AG","SDZENA713HTA(RIVASTIGMINEHYDROGENTARTRATE)"
"8251","RIVASTIGMINE SANDOZ","6.0 Milligram                                                                                            Capsules Hard",2009-12-11,"EU/1/09/599/13-16","Sandoz Pharmaceuticals GmbH","SDZENA713HTA(RIVASTIGMINEHYDROGENTARTRATE)"
"8252","RIVASTIGMINE SANDOZ","1.5 Milligram                                                                                            Capsules Hard",2009-12-11,"EU/1/09/599/1-4","Sandoz Pharmaceuticals GmbH","SDZENA713HTA(RIVASTIGMINEHYDROGENTARTRATE)"
"8253","RIVASTIGMINE SANDOZ","3.0 Milligram                                                                                            Capsules Hard",2009-12-11,"EU/1/09/599/5-8","Sandoz Pharmaceuticals GmbH","SDZENA713HTA(RIVASTIGMINEHYDROGENTARTRATE)"
"8254","RIVASTIGMINE SANDOZ","4.5 Milligram                                                                                            Capsules Hard",2009-12-11,"EU/1/09/599/9-12","Sandoz Pharmaceuticals GmbH","SDZENA713HTA(RIVASTIGMINEHYDROGENTARTRATE)"
"8255","RIVASTIGMINE SANDOZ (120 ML)","2 Mg/Ml Oral Solution",2009-12-11,"EU/1/09/599/018","Sandoz Pharmaceuticals GmbH","SDZENA713HTA(RIVASTIGMINEHYDROGENTARTRATE)"
"8256","RIVASTIGMINE SANDOZ (50 ML)","2 Mg/Ml Oral Solution",2009-12-11,"EU/1/09/599/017","Sandoz Pharmaceuticals GmbH","SDZENA713HTA(RIVASTIGMINEHYDROGENTARTRATE)"
"8257","Rivastigmine Sandoz 4.6mg/24 hours Transdermal Patch","4.6 milligram(s)/24 hours Transdermal patch",2013-12-20,"PA0711/222/001","Rowex Ltd","Rivastigmine"
"8258","Rivastigmine Sandoz 9.5mg/24 hours Transdermal Patch","9.5 milligram(s)/24 hours Transdermal patch",2013-12-20,"PA0711/222/002","Rowex Ltd","Rivastigmine"
"8259","Rivotril  0.5 mg Tablets","0.5 milligram(s) Tablet",1977-04-01,"PA2307/006/001","Roche Products (Ireland) Ltd","Clonazepam"
"8260","RIVOTRIL 2MG TABLETS","2 Milligram                                                                                            Tablets",1977-04-01,"PA0050/014/002","Roche Products Limited","CLONAZEPAM"
"8261","RIXATHON","100 Milligram                                                                                            Concentrate for Soln for Inf",2017-06-15,"EU/1/17/1185/001-002","Sandoz GmbH","RITUXIMAB"
"8262","RIXATHON","500 Milligram                                                                                            Concentrate for Soln for Inf",2017-06-15,"EU/1/17/1185/003-004","Sandoz GmbH","RITUXIMAB"
"8263","RIXIMYO","100 Milligram                                                                                            Concentrate for Soln for Inf",2017-06-15,"EU/1/17/1184/001-002","Sandoz GmbH","RITUXIMAB"
"8264","RIXIMYO","500 Milligram                                                                                            Concentrate for Soln for Inf",2017-06-15,"EU/1/17/1184/003-004","Sandoz GmbH","RITUXIMAB"
"8265","RIXUBIS","250 International Unit                                                                                   Pdr+Solv for Soln for Inj",2014-12-19,"EU/1/14/970/001","Baxter","NONACOGGAMMA"
"8266","RIXUBIS","500 International Unit                                                                                   Pdr+Solv for Soln for Inj",2014-12-19,"EU/1/14/970/002","Baxter","NONACOGGAMMA"
"8267","RIXUBIS","1000 International Unit                                                                                   Pdr+Solv for Soln for Inj",2014-12-19,"EU/1/14/970/003","Baxter","NONACOGGAMMA"
"8268","RIXUBIS","2000 International Unit                                                                                   Pdr+Solv for Soln for Inj",2014-12-19,"EU/1/14/970/004","Baxter","NONACOGGAMMA"
"8269","RIXUBIS","3000 International Unit                                                                                   Pdr+Solv for Soln for Inj",2014-12-19,"EU/1/14/970/005","Baxter","NONACOGGAMMA"
"8270","RIZATRIPTAN MSD","5 Milligram                                                                                            Tablets",2011-06-03,"PA1286/043/001","Merck Sharp & Dohme Ireland (Human Health) Limited","RIZATRIPTANBENZOATE"
"8271","RIZATRIPTAN MSD","10 Milligram                                                                                            Tablets",2011-06-03,"PA1286/043/002","Merck Sharp & Dohme Ireland (Human Health) Limited","RIZATRIPTANBENZOATE"
"8272","RIZATRIPTAN MSD","5 Milligram                                                                                            Oral Lyophilisate",2011-06-03,"PA1286/043/003","Merck Sharp & Dohme Ireland (Human Health) Limited","RIZATRIPTANBENZOATE"
"8273","RIZATRIPTAN MSD","10 Milligram                                                                                            Oral Lyophilisate",2011-06-03,"PA1286/043/004","Merck Sharp & Dohme Ireland (Human Health) Limited","RIZATRIPTANBENZOATE"
"8274","ROACCUTANE","20 Milligram                                                                                            Capsules, Soft",2016-04-01,"PPA1463/105/001","IMED Healthcare Ltd.","ISOTRETINOIN"
"8275","Roaccutane 10mg soft capsules","10 milligram(s) Capsule, soft",2006-11-20,"PA2307/007/001","Roche Products (Ireland) Ltd","Isotretinoin"
"8276","Roaccutane 20 mg soft capsules","20 milligram(s) Capsule, soft",1983-04-19,"PA2307/007/002","Roche Products (Ireland) Ltd","Isotretinoin"
"8277","RoActemra","162 milligram(s) Solution for injection in pre-filled syringe",2014-04-23,"EU/1/08/492/007","Roche Registration GmbH","Tocilizumab"
"8278","RoActemra","20 milligram(s)/millilitre Concentrate for solution for infusion",2009-01-16,"EU/1/08/492/1-6","Roche Registration GmbH","Tocilizumab"
"8279","ROBITUSSIN CHESTY COUGH ORAL SOLUTION","100 MG/5ml                                                                                               Oral Solution",1983-04-01,"PA0822/170/001","Pfizer Healthcare Ireland","GUAIFENESIN"
"8280","ROBITUSSIN DRY COUGH","7.5 MG/5ml                                                                                               Oral Solution",1985-12-18,"PA0822/172/001","Pfizer Healthcare Ireland","DEXTROMETHORPHANHYDROBROMIDE"
"8281","ROBITUSSIN PLUS","100/30 MG/5ml                                                                                               Oral Solution",1985-07-29,"PA0822/171/001","Pfizer Healthcare Ireland","GUAIFENESIN|PSEUDOEPHEDRINEHYDROCHLORIDE"
"8282","ROCEPHIN","1 g Grams                                                                                                Pdr for Soln Inj/Inf",1983-11-02,"PA2307/008/001","Roche Products (Ireland) Ltd","CEFTRIAXONESODIUM"
"8283","ROCEPHIN","1 Grams                                                                                                Pdr+Solv for Soln for Inj",2005-05-06,"PA2307/008/002","Roche Products (Ireland) Ltd","CEFTRIAXONESODIUM"
"8284","Rocuronium 10 mg/ml solution for injection / infusion","10 milligram(s)/millilitre Solution for injection/infusion",2008-11-28,"PA2059/018/001","Fresenius Kabi Deutschland GmbH","Rocuroniumbromide"
"8285","Rocuronium 10 mg/ml solution for injection/infusion","10 milligram(s)/millilitre Solution for injection/infusion",2008-11-13,"PA0736/029/001","B. Braun Melsungen AG","Rocuroniumbromide"
"8286","ROCURONIUM BROMIDE","10 Mg/Ml Solution for Inj/Inf",2011-04-08,"PA1862/001/001","Ibigen Srl","ROCURONIUMBROMIDE"
"8287","ROCURONIUM BROMIDE","10 Mg/Ml Solution for Inj/Inf",2014-08-22,"PA0437/072/001","Hospira  UK Limited","ROCURONIUMBROMIDE"
"8288","Rocuronium bromide 10 mg/ml solution for injection/infusion","10 milligram(s)/millilitre Solution for injection/infusion",2018-07-20,"PA0405/108/001","Generics (UK) Limited","Rocuroniumbromide"
"8289","ROLPRYNA SR","2 Milligram                                                                                            Tablet Prolonged Release",2011-06-10,"PA1347/012/001","Krka d.d., Novo mesto","ROPINIROLEHYDROCHLORIDE"
"8290","ROLPRYNA SR","4 Milligram                                                                                            Tablet Prolonged Release",2011-06-10,"PA1347/012/002","Krka d.d., Novo mesto","ROPINIROLEHYDROCHLORIDE"
"8291","ROLPRYNA SR","8 Milligram                                                                                            Tablet Prolonged Release",2011-06-10,"PA1347/012/003","Krka d.d., Novo mesto","ROPINIROLEHYDROCHLORIDE"
"8292","Rolufta","55 microgram(s) ZZZ Infus/Pdr/Oral Soln",2017-03-20,"EU/1/17/1174/001-003","GlaxoSmithKline Trading Services Limited","Umeclidinium"
"8293","ROLYPREXA","2.5 Milligram                                                                                            Film Coated Tablet",2008-05-23,"PA0711/124/001","Rowex Ltd","OLANZAPINE"
"8294","ROLYPREXA","5 Milligram                                                                                            Film Coated Tablet",2008-05-23,"PA0711/124/002","Rowex Ltd","OLANZAPINE"
"8295","ROLYPREXA","7.5 Milligram                                                                                            Film Coated Tablet",2008-05-23,"PA0711/124/003","Rowex Ltd","OLANZAPINE"
"8296","ROLYPREXA","10 Milligram                                                                                            Film Coated Tablet",2008-05-23,"PA0711/124/004","Rowex Ltd","OLANZAPINE"
"8297","ROLYPREXA","15 Milligram                                                                                            Film Coated Tablet",2008-05-23,"PA0711/124/005","Rowex Ltd","OLANZAPINE"
"8298","ROLYPREXA DISTAB","5 Milligram                                                                                            Orodispersible Tablet",2011-09-16,"PA0711/195/001","Rowex Ltd","OLANZAPINE"
"8299","ROLYPREXA DISTAB","10 Milligram                                                                                            Orodispersible Tablet",2011-09-16,"PA0711/195/002","Rowex Ltd","OLANZAPINE"
"8300","ROLYPREXA DISTAB","15 Milligram                                                                                            Orodispersible Tablet",2011-09-16,"PA0711/195/003","Rowex Ltd","OLANZAPINE"
"8301","ROLYPREXA DISTAB","20 Milligram                                                                                            Orodispersible Tablet",2011-09-16,"PA0711/195/004","Rowex Ltd","OLANZAPINE"
"8302","Romax Once Weekly 70mg Tablets","70 milligram(s) Tablet",2011-10-07,"PA1445/017/001","Aurobindo Pharma (Malta) Limited","Sodiumalendronate"
"8303","ROPIVACAINE","2 Mg/Ml Solution for Injection",2010-08-06,"PA2059/021/001","Fresenius Kabi Deutschland GmbH","ROPIVACAINEHYDROCHLORIDE"
"8304","ROPIVACAINE","7.5 Mg/Ml Solution for Injection",2010-08-06,"PA2059/021/002","Fresenius Kabi Deutschland GmbH","ROPIVACAINEHYDROCHLORIDE"
"8305","ROPIVACAINE","2 Mg/Ml Solution for Infusion",2012-02-17,"PA0899/041/002","Mercury Pharmaceuticals Ltd","ROPIVACAINEHYDROCHLORIDE"
"8306","Ropivacaine 10 mg/ml solution for injection","10 milligram(s)/millilitre Solution for injection",2012-02-17,"PA0899/041/005","Mercury Pharmaceuticals Ltd","ROPIVACAINEHYDROCHLORIDE"
"8307","Ropivacaine 2 mg/ml solution for injection","2 milligram(s)/millilitre Solution for injection",2012-02-17,"PA0899/041/001","Mercury Pharmaceuticals Ltd","ROPIVACAINEHYDROCHLORIDE"
"8308","Ropivacaine 5 mg/ml solution for injection","5 milligram(s)/millilitre Solution for injection",2012-02-17,"PA0899/041/003","Mercury Pharmaceuticals Ltd","ROPIVACAINEHYDROCHLORIDE"
"8309","Ropivacaine 7.5 mg/ml solution for injection","7.5 milligram(s)/millilitre Solution for injection",2012-02-17,"PA0899/041/004","Mercury Pharmaceuticals Ltd","ROPIVACAINEHYDROCHLORIDE"
"8310","ROPIVACAINE READYFUSOR","10  Solution for Infusion",2018-05-18,"PA2284/001/001","BioQ Pharma B.V.","ROPIVACAINEHYDROCHLORIDE"
"8311","ROSUVA","40 Milligram                                                                                            Film Coated Tablet",2010-06-18,"PA0711/176/004","Rowex Ltd","ROSUVASTATIN"
"8312","Rosuva 10 mg film-coated tablets","10 milligram(s) Film-coated tablet",2010-06-18,"PA0711/176/002","Rowex Ltd","Rosuvastatin(ascalcium)"
"8313","Rosuva 20 mg film-coated tablets","20 milligram(s) Film-coated tablet",2010-06-18,"PA0711/176/003","Rowex Ltd","Rosuvastatin(ascalcium)"
"8314","Rosuva 5 mg film-coated tablets","5 milligram(s) Film-coated tablet",2010-06-18,"PA0711/176/001","Rowex Ltd","Rosuvastatin(ascalcium)"
"8315","ROSUVASTATIN","40 Milligram                                                                                            Film Coated Tablet",2017-07-28,"PA1240/025/004","Bristol Laboratories Limited","ROSUVASTATIN(ASCALCIUM)"
"8316","ROSUVASTATIN","40 Milligram                                                                                            Film Coated Tablet",2017-06-09,"PA2115/001/004","NewLine Pharma S.L.","ROSUVASTATIN(ASCALCIUM)"
"8317","ROSUVASTATIN","40 Milligram                                                                                            Film Coated Tablet",2017-04-07,"PA1380/202/004","Actavis Group PTC ehf","ROSUVASTATINCALCIUM"
"8318","ROSUVASTATIN","40 Milligram                                                                                            Film Coated Tablet",2015-08-28,"PA1390/101/004","Accord Healthcare Limited","ROSUVASTATINCALCIUM"
"8319","Rosuvastatin 10 mg film-coated tablets","10 milligram(s) Film-coated tablet",NA,"PA1390/101/002","Accord Healthcare Limited","Rosuvastatincalcium"
"8320","Rosuvastatin 10 mg Film-coated Tablets","10 milligram(s) Film-coated tablet",2017-04-07,"PA1380/202/002","Actavis Group PTC ehf","Rosuvastatincalcium"
"8321","Rosuvastatin 10 mg Film-coated Tablets","10 milligram(s) Film-coated tablet",2017-06-09,"PA2115/001/002","NewLine Pharma S.L.","Rosuvastatin(ascalcium)"
"8322","Rosuvastatin 10 mg Film-coated Tablets","10 milligram(s) Film-coated tablet",2017-07-28,"PA1240/025/002","Bristol Laboratories Limited","Rosuvastatin(ascalcium)"
"8323","Rosuvastatin 20 mg Film-coated Tablets","20 milligram(s) Film-coated tablet",2017-07-28,"PA1240/025/003","Bristol Laboratories Limited","Rosuvastatin(ascalcium)"
"8324","Rosuvastatin 20 mg Film-coated Tablets","20 milligram(s) Film-coated tablet",2017-06-09,"PA2115/001/003","NewLine Pharma S.L.","Rosuvastatin(ascalcium)"
"8325","Rosuvastatin 20 mg Film-coated Tablets","20 milligram(s) Film-coated tablet",2017-04-07,"PA1380/202/003","Actavis Group PTC ehf","Rosuvastatincalcium"
"8326","Rosuvastatin 20 mg film-coated tablets","20 milligram(s) Film-coated tablet",NA,"PA1390/101/003","Accord Healthcare Limited","Rosuvastatincalcium"
"8327","Rosuvastatin 5 mg film-coated tablets","5 milligram(s) Film-coated tablet",NA,"PA1390/101/001","Accord Healthcare Limited","Rosuvastatincalcium"
"8328","Rosuvastatin 5 mg Film-coated Tablets","5 milligram(s) Film-coated tablet",2017-04-07,"PA1380/202/001","Actavis Group PTC ehf","Rosuvastatincalcium"
"8329","Rosuvastatin 5 mg Film-coated Tablets","5 milligram(s) Film-coated tablet",2017-06-09,"PA2115/001/001","NewLine Pharma S.L.","Rosuvastatin(ascalcium)"
"8330","Rosuvastatin 5 mg Film-coated Tablets","5 milligram(s) Film-coated tablet",2017-07-28,"PA1240/025/001","Bristol Laboratories Limited","Rosuvastatin(ascalcium)"
"8331","ROSUVASTATIN ACTAVIS","40 Milligram                                                                                            Film Coated Tablet",2010-11-26,"PA1380/113/004","Actavis Group PTC ehf","ROSUVASTATIN"
"8332","Rosuvastatin Actavis 10 mg film-coated tablets","10 milligram(s) Film-coated tablet",2010-11-26,"PA1380/113/002","Actavis Group PTC ehf","Rosuvastatin(ascalcium)"
"8333","Rosuvastatin Actavis 20 mg film-coated tablets","20 milligram(s) Film-coated tablet",2010-11-26,"PA1380/113/003","Actavis Group PTC ehf","Rosuvastatin(ascalcium)"
"8334","Rosuvastatin Actavis 5 mg Film-coated Tablets","5 milligram(s) Film-coated tablet",2010-11-26,"PA1380/113/001","Actavis Group PTC ehf","Rosuvastatin(ascalcium)"
"8335","ROSUVASTATIN CLONMEL","40 Milligram                                                                                            Film Coated Tablet",2015-02-27,"PA0126/261/004","Clonmel Healthcare Ltd","ROSUVASTATINCALCIUM"
"8336","Rosuvastatin Clonmel 10mg film-coated tablets","10 milligram(s) Film-coated tablet",2015-02-27,"PA0126/261/002","Clonmel Healthcare Ltd","Rosuvastatincalcium"
"8337","Rosuvastatin Clonmel 20mg film-coated tablets","20 milligram(s) Film-coated tablet",2015-02-27,"PA0126/261/003","Clonmel Healthcare Ltd","Rosuvastatincalcium"
"8338","Rosuvastatin Clonmel 5mg film-coated tablets","5 milligram(s) Film-coated tablet",2015-02-27,"PA0126/261/001","Clonmel Healthcare Ltd","Rosuvastatincalcium"
"8339","ROSUVASTATIN DSM SINOCHEM","40 Milligram                                                                                            Film Coated Tablet",2016-10-14,"PA1832/004/004","DSM Sinochem Pharmaceuticals Netherlands B.V.","ROSUVASTATINCALCIUM"
"8340","Rosuvastatin DSM Sinochem 10 mg film-coated tablets","10 milligram(s) Film-coated tablet",2016-10-14,"PA1832/004/002","DSM Sinochem Pharmaceuticals Netherlands B.V.","Rosuvastatincalcium"
"8341","Rosuvastatin DSM Sinochem 20 mg film-coated tablets","20 milligram(s) Film-coated tablet",2016-10-14,"PA1832/004/003","DSM Sinochem Pharmaceuticals Netherlands B.V.","Rosuvastatincalcium"
"8342","Rosuvastatin DSM Sinochem 5 mg film-coated tablets","5 milligram(s) Film-coated tablet",2016-10-14,"PA1832/004/001","DSM Sinochem Pharmaceuticals Netherlands B.V.","Rosuvastatincalcium"
"8343","ROSUVASTATIN KRKA","40 Milligram                                                                                            Film Coated Tablet",2011-07-08,"PA1347/016/004","Krka d.d., Novo mesto","ROSUVASTATIN"
"8344","Rosuvastatin Krka 10 mg film-coated tablets","10 milligram(s) Film-coated tablet",2011-07-08,"PA1347/016/002","Krka d.d., Novo mesto","Rosuvastatin"
"8345","Rosuvastatin Krka 20 mg film-coated tablets","20 milligram(s) Film-coated tablet",2011-07-08,"PA1347/016/003","Krka d.d., Novo mesto","Rosuvastatin"
"8346","Rosuvastatin Krka 5 mg film-coated tablets","5 milligram(s) Film-coated tablet",2011-07-08,"PA1347/016/001","Krka d.d., Novo mesto","Rosuvastatin"
"8347","ROSUVASTATIN MYLAN","40 Milligram                                                                                            Film Coated Tablet",2011-10-07,"PA0577/140/004","McDermott Laboratories Ltd t/a Gerard Laboratories","ROSUVASTATINCALCIUM"
"8348","Rosuvastatin Mylan 10 mg film-coated tablets","10 milligram(s) Film-coated tablet",2011-10-07,"PA0577/140/002","McDermott Laboratories Ltd t/a Gerard Laboratories","Rosuvastatincalcium"
"8349","Rosuvastatin Mylan 20 mg film-coated tablets","20 milligram(s) Film-coated tablet",2011-10-07,"PA0577/140/003","McDermott Laboratories Ltd t/a Gerard Laboratories","Rosuvastatincalcium"
"8350","Rosuvastatin Mylan 5 mg film-coated tablets","5 milligram(s) Film-coated tablet",2011-10-07,"PA0577/140/001","McDermott Laboratories Ltd t/a Gerard Laboratories","Rosuvastatincalcium"
"8351","Rosuvastatin Pinewood 10 mg Film-coated Tablets","10 milligram(s) Film-coated tablet",2017-07-28,"PA0281/157/002","Pinewood Laboratories Ltd,","Rosuvastatin(ascalcium)"
"8352","Rosuvastatin Pinewood 20 mg Film-coated Tablets","20 milligram(s) Film-coated tablet",2017-07-28,"PA0281/157/003","Pinewood Laboratories Ltd,","Rosuvastatin(ascalcium)"
"8353","Rosuvastatin Pinewood 40 mg Film-coated Tablets","40 milligram(s) Film-coated tablet",2017-07-28,"PA0281/157/004","Pinewood Laboratories Ltd,","Rosuvastatin(ascalcium)"
"8354","Rosuvastatin Pinewood 5 mg Film-coated Tablets","5 milligram(s) Film-coated tablet",2017-07-28,"PA0281/157/001","Pinewood Laboratories Ltd,","Rosuvastatin(ascalcium)"
"8355","Rosuvastatin Teva Pharma 10 mg Film-coated Tablets","10 milligram(s) Film-coated tablet",2015-11-06,"PA1986/024/002","Teva B.V.","Rosuvastatin(ascalcium)"
"8356","Rosuvastatin Teva Pharma 20 mg Film-coated Tablets","20 milligram(s) Film-coated tablet",2015-11-06,"PA1986/024/003","Teva B.V.","Rosuvastatin(ascalcium)"
"8357","Rosuvastatin Teva Pharma 40 mg Film-coated Tablets","40 milligram(s) Film-coated tablet",2015-11-06,"PA1986/024/004","Teva B.V.","Rosuvastatin(ascalcium)"
"8358","Rosuvastatin Teva Pharma 5 mg Film-coated Tablets","5 milligram(s) Film-coated tablet",2015-11-06,"PA1986/024/001","Teva B.V.","Rosuvastatin(ascalcium)"
"8359","ROSUVASTATIN/AMLODIPINE KRKA","10/5 Milligram                                                                                            Film Coated Tablet",2016-01-22,"PA1347/053/001","Krka d.d., Novo mesto","ROSUVASTATINCALCIUM|AMLODIPINEBESILATE"
"8360","ROSUVASTATIN/AMLODIPINE KRKA","10/10 Milligram                                                                                            Film Coated Tablet",2016-01-22,"PA1347/053/002","Krka d.d., Novo mesto","ROSUVASTATINCALCIUM|AMLODIPINEBESILATE"
"8361","ROSUVASTATIN/AMLODIPINE KRKA","20/5 Milligram                                                                                            Film Coated Tablet",2016-01-22,"PA1347/053/003","Krka d.d., Novo mesto","ROSUVASTATINCALCIUM|AMLODIPINEBESILATE"
"8362","ROSUVASTATIN/AMLODIPINE KRKA","20/10 Milligram                                                                                            Film Coated Tablet",2016-01-22,"PA1347/053/004","Krka d.d., Novo mesto","ROSUVASTATINCALCIUM|AMLODIPINEBESILATE"
"8363","ROSUVASTATIN/AMLODIPINE KRKA","15/5 Milligram                                                                                            Film Coated Tablet",2016-01-22,"PA1347/053/005","Krka d.d., Novo mesto","ROSUVASTATINCALCIUM|AMLODIPINEBESILATE"
"8364","ROSUVASTATIN/AMLODIPINE KRKA","15/10 Milligram                                                                                            Film Coated Tablet",2016-01-22,"PA1347/053/006","Krka d.d., Novo mesto","ROSUVASTATINCALCIUM|AMLODIPINEBESILATE"
"8365","ROTARIX","%v/v                                                                                                 Powder for Oral Suspension",2006-02-21,"EU/1/05/330/1-4","GlaxoSmithKline Biologicals S.A.","ROTAVIRUSLIVEATTENUATED,RIX4414STRAIN,HUMAN"
"8366","ROTARIX","Oral Suspension",2008-09-01,"EU/1/05/330/5-11","GlaxoSmithKline Biologicals S.A.","HUMANROTAVIRUS,LIVEATTENUATED"
"8367","ROTATEQ","Per Cent                                                                                             Unknown",2006-06-27,"EU/1/06/348/01","Sanofi Pasteur MSD","ROTAVIRUSVACCINE,LIVE,PENTAVALENTGI|ROTAVIRUSVACCINE,LIVE,PENTAVALENTG2|ROTAVIRUSVACCINE,LIVE,PENTAVALENTG3|ROTAVIRUSVACCINE,LIVE,PENTAVALENTG4|ROTAVIRUSVACCINE,LIVE,PENTAVALENTP1"
"8368","Roteas","15 milligram(s) Film-coated tablet",2017-04-20,"EU/1/16/1152/001-002","Daiichi Sankyo Europe GmbH","Edoxabantosilate"
"8369","ROTEAS","30 Milligram                                                                                            Film Coated Tablet",2017-04-20,"EU/1/16/1152/003-015","Daiichi Sankyo Europe GmbH","EDOXABANTOSILATE"
"8370","ROTEAS","60 Milligram                                                                                            Film Coated Tablet",2017-04-20,"EU/1/16/1152/016-028","Daiichi Sankyo Europe GmbH","EDOXABANTOSILATE"
"8371","Rowa Cold & Flu 500 mg/30 mg Granules for Oral Suspension","500mg/30 milligram(s) Granules for oral suspension",2012-08-31,"PA0711/198/001","Rowex Ltd","Acetylsalicylicacid|PSEUDOEPHEDRINEHYDROCHLORIDE|Pseudoephedrinehydrochloride"
"8372","ROWACHOL","%v/v                                                                                                 Capsules Gastro-Resistant",1983-04-01,"PA0074/008/001","Rowa Pharmaceuticals Limited","MENTHOL|MENTHONE|ALPHAPINENE|BORNEOL|CINEOLE|CAMPHENE|BETAPINENE"
"8373","ROWACHOL","%v/v                                                                                                 Oral Drops Solution",1983-04-01,"PA0074/008/002","Rowa Pharmaceuticals Limited","MENTHOL|MENTHONE|ALPHAPINENE|BORNEOL|CINEOLE|CAMPHENE|BETAPINENE"
"8374","Rowalief 500 mg Film-Coated Tablets","500 milligram(s) Film-coated tablet",2012-12-14,"PA0074/065/001","Rowa Pharmaceuticals Limited","Paracetamol"
"8375","Rowalief Max 1000 mg Film-Coated Tablets","1000 milligram(s) Film-coated tablet",2012-12-14,"PA0074/065/002","Rowa Pharmaceuticals Limited","Paracetamol"
"8376","ROWAROLAN","%v/v                                                                                                 Cutaneous Powder",1999-02-05,"PA0074/046/001","Rowa Pharmaceuticals Limited","CALCIUMCARBONATE"
"8377","ROWASIP COLD & FLU WITH DECONGESTANT","500/12.2 mg/mg Powder for Oral Solution",2014-12-12,"PA0711/227/001","Rowex Ltd","PARACETAMOL|PHENYLEPHRINEHYDROCHLORIDE"
"8378","ROWASIP MAX STRENGTH COLD AND FLU WITH DECONGESTANT","1000/12.2 Milligram                                                                                            Powder for Oral Solution",2014-12-12,"PA0711/227/002","Rowex Ltd","PARACETAMOL|PHENYLEPHRINEHYDROCHLORIDE"
"8379","Rowatanal Cream","percent volume/volume Cream",1996-05-09,"PA0074/016/001","Rowa Pharmaceuticals Limited","Zincoxide|Bismuthsubgallate|Menthol"
"8380","ROWATINEX","12.5 %v/v                                                                                                 Capsules Gastro-Resistant",1983-04-01,"PA0074/009/001","Rowa Pharmaceuticals Limited","ALPHAPINENE|CAMPHENE|CINEOLE|FENCHONE|BORNEOL|ANETHOLE|BETAPINENE"
"8381","ROWATINEX","%v/v                                                                                                 Oral Drops Solution",1983-04-01,"PA0074/009/002","Rowa Pharmaceuticals Limited","ALPHAPINENE|CAMPHENE|CINEOLE|FENCHONE|BORNEOL|ANETHOLE|BETAPINENE"
"8382","ROXINA","0.02/3 mg/mg Film Coated Tablet",2017-01-13,"PA1330/020/001","Gedeon Richter Plc","ETHINYLESTRADIOL|DROSPIRENONE"
"8383","ROZEX","7.5 mg/g Gel",2009-09-04,"PPA0465/222/001","PCO Manufacturing","METRONIDAZOLE"
"8384","ROZEX","7.5 mg/g Cream",2017-06-23,"PPA0465/222/002","PCO Manufacturing","METRONIDAZOLE"
"8385","ROZEX","0.75 %w/w                                                                                                 Gel",1991-06-26,"PA0590/010/001","Galderma (UK) Ltd","METRONIDAZOLE"
"8386","ROZEX","7.5 mg/g Gel",2017-07-07,"PPA1097/022/001","Lexon (UK) Ltd","METRONIDAZOLE"
"8387","ROZEX CREAM","7.5 mg/g Cream",1998-03-06,"PA0590/010/002","Galderma (UK) Ltd","METRONIDAZOLE"
"8388","Rubraca","200 milligram(s) Film-coated tablet",2018-05-24,"EU/1/17/1250/001","Clovis Oncology UK Ltd.","Rucaparibcamsylate"
"8389","RUBRACA","250 Milligram                                                                                            Film Coated Tablet",2018-05-24,"EU/1/17/1250/002","Clovis Oncology UK Ltd.","RUCAPARIBCAMSYLATE"
"8390","RUBRACA","300 Milligram                                                                                            Film Coated Tablet",2018-05-24,"EU/1/17/1250/003","Clovis Oncology UK Ltd.","RUCAPARIBCAMSYLATE"
"8391","RUCONEST","2100 Unknown Pdr for Soln for Injection",2010-10-28,"EU/1/10/641/001","Pharming Group N.V.","CONESTATALFA"
"8392","RUCONEST","2100 Unknown Pdr+Solv for Soln for Inj",2017-01-11,"EU/1/10/641/002","Pharming Group N.V.","CONESTATALFA"
"8393","RUPAFIN","10 Milligram                                                                                            Tablets",2004-01-09,"PA1129/001/001","J Uriach y Compania S.A.","RUPATADINE(ASFUMARATE)"
"8394","RUPAFIN","1 Mg/Ml Oral Solution",2012-03-23,"PA1129/001/002","J Uriach y Compania S.A.","RUPATADINE(ASFUMARATE)"
"8395","RUTA GRAV","6C-MM N/A",2010-10-29,"HOR1149/026/001","A. Nelson & Company Limited","RUTAGRAVEOLENS"
"8396","RUTA GRAVEOLENS","6C & 30C  Tablets",2010-12-03,"HOR0407/025/001","Weleda (UK) Limited","RUTAGRAVEOLENS"
"8397","RXULTI","0.25 milligram(s) Film-coated tablet",2018-07-26,"EU/1/18/1294/001","Otsuka Pharmaceutical Europe Ltd","BREXPIPRAZOLE"
"8398","RXULTI","0.5 milligram(s) Film-coated tablet",2018-07-26,"EU/1/18/1294/002","Otsuka Pharmaceutical Europe Ltd","BREXPIPRAZOLE"
"8399","RXULTI","1 milligram(s) Film-coated tablet",2018-07-26,"EU/1/18/1294/003-004","Otsuka Pharmaceutical Europe Ltd","BREXPIPRAZOLE"
"8400","RXULTI","2 milligram(s) Film-coated tablet",2018-07-26,"EU/1/18/1294/005","Otsuka Pharmaceutical Europe Ltd","BREXPIPRAZOLE"
"8401","RXULTI","3 milligram(s) Film-coated tablet",2018-07-26,"EU/1/18/1294/006","Otsuka Pharmaceutical Europe Ltd","BREXPIPRAZOLE"
"8402","RXULTI","4 milligram(s) Film-coated tablet",2018-07-26,"EU/1/18/1294/007","Otsuka Pharmaceutical Europe Ltd","BREXPIPRAZOLE"
"8403","Rydapt","25 milligram(s) Capsule, soft",2017-09-18,"EU/1/17/1218/001","Novartis Europharm Limited","Midostaurin"
"8404","RYTHMODAN RETARD","250 Milligram                                                                                            Tablet Prolonged Release",1981-07-02,"PA0540/069/004","Sanofi-Aventis Ireland Limited T/A SANOFI","DISOPYRAMIDEPHOSPHATE"
"8405","RYZODEG","100 Units/ml                                                                                             Solution for Injection",NA,"EU/1/12/806/1,4,5,7,8","Novo Nordisk A/S","INSULINDEGLUDEC(IDEG)|INSULINASPART(IASP)"
"8406","SABRIL","500 Milligram                                                                                            Film Coated Tablet",1989-12-14,"PA0540/023/001","Sanofi-Aventis Ireland Limited T/A SANOFI","VIGABATRIN"
"8407","SABRIL","500 Milligram                                                                                            Granules for oral solution",1992-08-24,"PA0540/023/002","Sanofi-Aventis Ireland Limited T/A SANOFI","VIGABATRIN"
"8408","Sabril 500mg Film Coated Tablets","500 milligram(s) Film-coated tablet",2008-02-01,"PPA0465/203/001","PCO Manufacturing","Vigabatrin"
"8409","SAFLUTAN","15 Microgram/ML                                                                                         Eye Drops Solution",2013-11-25,"PPA0465/324/001","PCO Manufacturing","TAFLUPROST"
"8410","Saflutan 15 micrograms/ml, eye drops, solution in single-dose container","15 microgram(s)/millilitre Eye drops, solution in single-dose container",2011-02-18,"PA0879/006/001","Santen OY","Tafluprost"
"8411","Saizen 5.83 mg/ml Solution for Injection","5.83 milligram(s)/millilitre Solution for injection",2011-02-25,"PA2286/006/001","Merck Serono (Ireland) Limited","Somatropin"
"8412","Saizen 8 mg click.easy powder and solvent for solution for injection","8 milligram(s) Powder and solvent for solution for injection",1998-10-02,"PA2286/006/003","Merck Serono (Ireland) Limited","Somatropin,recombinanthumangrowthhormone"
"8413","Saizen 8 mg/ml Solution for Injection","8 milligram(s)/millilitre Solution for injection",2011-02-25,"PA2286/006/002","Merck Serono (Ireland) Limited","Somatropin"
"8414","Salactol Collodion","16.7/16.7 percent weight/weight Cutaneous solution",1981-02-19,"PA0278/006/001","Dermal Laboratories Ltd","Lacticacid|Salicylicacid"
"8415","SALACTOL COLLODION","Cutaneous Solution",2009-05-26,"DPR1392/039/001","Eurodrug Ltd","SALICYLICACID|LACTICACID"
"8416","SALAMOL CFC-FREE INHALER","100 Microgram                                                                                            Pressurised Inhalation Suspension",2001-05-17,"PA0436/032/001","Norton Waterford","SALBUTAMOLSULFATE"
"8417","Salamol CFC-Free Inhaler 100 micrograms Pressurised Inhalation, Suspension","100 microgram(s) Pressurised inhalation, suspension",2008-06-20,"PPA1151/074/001","Imbat Limited","Salbutamol"
"8418","SALAMOL EASI-BREATHE","100 Microgram                                                                                            Pressurised Inhalation Suspension",2008-12-08,"PPA1151/074/002","Imbat Limited","SALBUTAMOLSULFATE"
"8419","SALAMOL EASI-BREATHE CFC-FREE INHALER","100 Microgram                                                                                            Pressurised Inhalation Suspension",2001-05-17,"PA0436/032/002","Norton Waterford","SALBUTAMOLSULFATE"
"8420","SALAMOL STERI-NEB","2.5/2.5 Mg/Ml Nebuliser Solution",1992-11-16,"PA0282/082/001","Norton Healthcare Limited T/A IVAX Pharmaceuticals UK","SALBUTAMOLSULFATE"
"8421","SALAMOL STERI-NEB","5/2.5 Mg/Ml Nebuliser Solution",1993-01-04,"PA0282/082/002","Norton Healthcare Limited T/A IVAX Pharmaceuticals UK","SALBUTAMOL"
"8422","SALATAC","12.0/4.0 %w/w                                                                                                 Gel",1989-11-21,"PA0278/015/001","Dermal Laboratories Ltd","SALICYLICACID|LACTICACID"
"8423","SALATAC","12.0/4.0 %w/w                                                                                                 Gel",2012-07-18,"DPR1463/038/001","IMED Healthcare Ltd.","SALICYLICACID|LACTICACID"
"8424","SALATAC GEL","12.0/4.0 %w/w                                                                                                 Gel",2013-08-08,"DPR0465/045/001","PCO Manufacturing","SALICYLICACID|LACTICACID"
"8425","SALAZOPYRIN","500 Milligram                                                                                            Tablets",1977-04-01,"PA0822/196/002","Pfizer Healthcare Ireland","SULFASALAZINE"
"8426","SALAZOPYRIN EN","500 Milligram                                                                                            Tablets Gastro-Resistant",1977-04-01,"PA0822/196/001","Pfizer Healthcare Ireland","SULFASALAZINE"
"8427","SALAZOPYRIN EN","500 Milligram                                                                                            Tablets Gastro-Resistant",2012-04-20,"PPA1463/059/001","IMED Healthcare Ltd.","SULFASALAZINE"
"8428","Salazopyrin EN Tabs 500 mg Gastro-resistant tablets","500 milligram(s) Gastro-resistant tablet",2005-09-09,"PPA0465/160/001","PCO Manufacturing","Sulfasalazine"
"8429","Salbul 100 micrograms/dose pressurised inhalation, suspension","100 microgram(s) Pressurised inhalation, suspension",2009-11-13,"PA0711/128/001","Rowex Ltd","Salbutamol"
"8430","SALBUTAMOL CFC-FREE INHALER","100 Microgram                                                                                            Pressurised Inhalation Suspension",2011-07-27,"PA1987/001/001","Valeas SPA Industria Chimica e Farmaceutica","SALBUTAMOL"
"8431","SALINE STERI-NEB 0.9 % W/V NEBULISER SOLUTION","0.9 %w/v                                                                                                 Nebuliser Solution",1994-02-18,"PA0282/084/001","Norton Healthcare Limited T/A IVAX Pharmaceuticals UK","SODIUMCHLORIDE"
"8432","SALMETEROL NEOLAB","25 Microgram                                                                                            Pressurised Inhalation Suspension",2011-05-20,"PA1585/003/001","Fannin (UK) Ltd","SALMETEROL"
"8433","SALOFALK","250 Milligram                                                                                            Suppositories",1989-02-08,"PA0573/004/002","Dr. Falk Pharma GmbH","MESALAZINE"
"8434","SALOFALK","250 Milligram                                                                                            Tablets Gastro-Resistant",1989-10-11,"PA0573/004/003","Dr. Falk Pharma GmbH","MESALAZINE"
"8435","SALOFALK","500 Milligram                                                                                            Gastro-resistant, prolonged release granules",2003-08-08,"PA0573/003/001","Dr. Falk Pharma GmbH","MESALAZINE"
"8436","SALOFALK","1000 Milligram                                                                                            Gastro-resistant, prolonged release granules",2003-08-08,"PA0573/003/002","Dr. Falk Pharma GmbH","MESALAZINE"
"8437","SALOFALK","3 Grams                                                                                                Gastro-resistant, prolonged release granules",2011-07-15,"PA0573/003/006","Dr. Falk Pharma GmbH","MESALAZINE"
"8438","SALOFALK","1.5 Grams                                                                                                Gastro-resistant, prolonged release granules",2013-08-23,"PA0573/003/007","Dr. Falk Pharma GmbH","MESALAZINE"
"8439","Salofalk 1g Suppositories","1 gram(s) Suppository",2010-06-18,"PA0573/004/004","Dr. Falk Pharma GmbH","Mesalazine"
"8440","Salofalk 1g/Actuation Rectal Foam","1 gram(s) Rectal foam",2009-01-09,"PA0573/004/005","Dr. Falk Pharma GmbH","Mesalazine"
"8441","SALOFALK ENEMA","4g/60ml Grams                                                                                                Rectal Suspension",1989-02-08,"PA0573/004/001","Dr. Falk Pharma GmbH","MESALAZINE"
"8442","SALVACYL","11.25 Milligram                                                                                            Pdr+Solv for PR for Susp for Inj",2015-08-21,"PA0869/008/001","Ipsen Pharmaceuticals Limited","TRIPTORELINEMBONATE"
"8443","SAMSCA","7.5 Milligram                                                                                            Tablets",2017-09-18,"EU/1/09/539/005-006","Otsuka Pharmaceutical Europe Ltd","TOLVAPTAN(OPC-41061)"
"8444","SAMSCA","15 Milligram                                                                                            Tablets",2009-08-03,"EU/1/09/539/1-2","Otsuka Pharmaceutical Europe Ltd","TOLVAPTAN"
"8445","SAMSCA","30 Milligram                                                                                            Tablets",2009-08-03,"EU/1/09/539/3-4","Otsuka Pharmaceutical Europe Ltd","TOLVAPTAN"
"8446","SANCUSO","3.1 mg/24 hours Transdermal Patch",2012-04-20,"EU/1/12/766/001","Kyowa Kirin Holdings B.V.","GRANISETRON"
"8447","Sandimmun 100 mg/ml concentrate for oral solution","100 milligram(s)/millilitre Concentrate for oral solution",1984-05-07,"PA0896/027/001","Novartis Ireland Limited","Ciclosporin"
"8448","Sandimmun 100mg Soft Capsules","100 milligram(s) Capsule, soft",1988-03-21,"PA0896/027/004","Novartis Ireland Limited","Ciclosporin"
"8449","Sandimmun 25mg Soft Capsules","25 milligram(s) Capsule, soft",1988-03-21,"PA0896/027/003","Novartis Ireland Limited","Ciclosporin"
"8450","Sandimmun 50 mg/ml Concentrate for Solution for Infusion","50 milligram(s)/millilitre Concentrate for solution for infusion",1984-10-03,"PA0896/027/002","Novartis Ireland Limited","Ciclosporin"
"8451","Sandimmun 50mg Soft Capsules","50 milligram(s) Capsule, soft",1991-12-16,"PA0896/027/005","Novartis Ireland Limited","Ciclosporin"
"8452","Sandostatin 100 micrograms/ml solution for injection / infusion","100 microgram(s)/millilitre Solution for injection/infusion",1988-11-18,"PA0896/028/002","Novartis Ireland Limited","OCTREOTIDEACETATE"
"8453","SANDOSTATIN 50 mcg/ml solution for injection / infusion","50 microgram(s)/millilitre Solution for injection/infusion",1988-11-18,"PA0896/028/001","Novartis Ireland Limited","OCTREOTIDEACETATE"
"8454","Sandostatin 500 micrograms/ml solution for injection / infusion","500 microgram(s)/millilitre Solution for injection/infusion",1988-11-18,"PA0896/028/003","Novartis Ireland Limited","OCTREOTIDEACETATE"
"8455","Sandostatin LAR 10 mg Powder and Solvent for Suspension for Injection","10 milligram(s) Powder and solvent for suspension for injection",1998-07-13,"PA0896/028/004","Novartis Ireland Limited","OCTREOTIDEACETATE"
"8456","Sandostatin LAR 20 mg Powder and Solvent for Suspension for Injection","20 milligram(s) Powder and solvent for suspension for injection",1998-07-13,"PA0896/028/005","Novartis Ireland Limited","OCTREOTIDEACETATE"
"8457","Sandostatin LAR 30 mg Powder and Solvent for Suspension for Injection","30 milligram(s) Powder and solvent for suspension for injection",1998-07-13,"PA0896/028/006","Novartis Ireland Limited","OCTREOTIDEACETATE"
"8458","SANOMIGRAN","500 Microgram                                                                                            Coated Tablets",1994-09-07,"PA1113/012/001","Phoenix Labs","PIZOTIFENMALEATE"
"8459","Sanomigran 1.5mg Tablets","1.5 milligram(s) Coated tablet",1994-09-07,"PA1113/012/002","Phoenix Labs","Pizotifenhydrogenmaleate"
"8460","Sapvit-D3 400 IU/drop oral drops, solution","400 international unit(s) Oral drops, solution",2017-09-29,"PA0773/006/001","Fresenius Kabi Austria GmbH","Cholecalciferol"
"8461","SASTRAVI","50/12.5/200 Milligram                                                                                            Film Coated Tablet",2014-09-26,"PA1380/154/001","Actavis Group PTC ehf","LEVODOPA|CARBIDOPA|ENTACAPONE"
"8462","SASTRAVI","75/18.75/200 Milligram                                                                                            Film Coated Tablet",2014-09-26,"PA1380/154/002","Actavis Group PTC ehf","LEVODOPA|CARBIDOPA|ENTACAPONE"
"8463","SASTRAVI","100/25/200 Milligram                                                                                            Film Coated Tablet",2014-09-26,"PA1380/154/003","Actavis Group PTC ehf","LEVODOPA|CARBIDOPA|ENTACAPONE"
"8464","SASTRAVI","125/31.25/200 Milligram                                                                                            Film Coated Tablet",2014-09-26,"PA1380/154/004","Actavis Group PTC ehf","LEVODOPA|CARBIDOPA|ENTACAPONE"
"8465","SASTRAVI","150/37.5/200 Milligram                                                                                            Film Coated Tablet",2014-09-26,"PA1380/154/005","Actavis Group PTC ehf","LEVODOPA|CARBIDOPA|ENTACAPONE"
"8466","SASTRAVI","175/43.75/200 Milligram                                                                                            Film Coated Tablet",2014-09-26,"PA1380/154/006","Actavis Group PTC ehf","LEVODOPA|CARBIDOPA|ENTACAPONE"
"8467","SASTRAVI","200/50/200 Milligram                                                                                            Film Coated Tablet",2014-09-26,"PA1380/154/007","Actavis Group PTC ehf","LEVODOPA|CARBIDOPA|ENTACAPONE"
"8468","SATIVEX","27 + 25 Mg/Ml Oromucosal Spray",2014-07-18,"PA1042/001/001","GW Pharma Ltd","DELTA-9-TETRAHYDROCANNABINOLBOTANICALDRUGSUBSTANCE(THCBDS)|CANNABIDIOLBOTANICALDRUGSUBSTANCE(CBDBDS)"
"8469","Savene","500 milligram(s) Powder and solvent for solution for infusion",2006-06-07,"EU/1/06/350/001","Clinigen Healthcare Limited","Dexrazoxane"
"8470","Savlon Antiseptic Cream Cetrimide 0.5% w/wChlorhexidine Digluconate 0.1% w/w","0.5/0.1 percent weight/weight Cream",1991-06-26,"PA0678/139/002","GlaxoSmithKline Consumer Healthcare (Ireland) Limited","Cetrimide|Chlorhexidinegluconate"
"8471","SAVLON ANTISEPTIC LIQUID.","%v/v                                                                                                 Cutaneous Solution Concentrate",1991-06-26,"PA0678/139/001","GlaxoSmithKline Consumer Healthcare (Ireland) Limited","CETRIMONIUMBROMIDE|CHLORHEXIDINEGLUCONATE"
"8472","SAVLON ANTISPETIC WOUND WASH","0.45 %w/v                                                                                                 Cutaneous Spray Solution",1992-11-27,"PA0678/133/001","GlaxoSmithKline Consumer Healthcare (Ireland) Limited","CHLORHEXIDINEGLUCONATE"
"8473","SAVLON DRY ANTISEPTIC","1.14 %w/w                                                                                                 Cutaneous Spray Powder",1986-05-12,"PA0678/126/001","GlaxoSmithKline Consumer Healthcare (Ireland) Limited","POVIDONE-IODINE"
"8474","SAVLON DRY ANTISEPTIC","1.14 %w/w                                                                                                 Cutaneous Spray Powder",2009-11-02,"DPR1392/055/001","Eurodrug Ltd","POVIDONE-IODINE"
"8475","SAXENDA","6 Mg/Ml Solution for injection in pre-filled pen",2015-03-23,"EU/1/15/992/001-003","Novo Nordisk A/S","LIRAGLUTIDE"
"8476","SCANDONEST","3 %w/v                                                                                                 Solution for Injection",1999-04-16,"PA0196/015/001","Septodont","MEPIVACAINEHYDROCHLORIDE"
"8477","SCENESSE","16 Milligram                                                                                            Implant",2014-12-22,"EU/1/14/969/001","Clinuval (UK) Limited","AFAMELANOTIDE"
"8478","SCHERIPROCT","1/1 Milligram                                                                                            Suppositories",1978-04-01,"PA1410/071/002","Bayer Limited","PREDNISOLONECAPROATE|CINCHOCAINEHYDROCHLORIDE"
"8479","SCHERIPROCT","1.5 + 5 mg/g Rectal Ointment",2015-06-12,"PPA0465/408/001","PCO Manufacturing","PREDNISOLONECAPROATE|CINCHOCAINEHYDROCHLORIDE"
"8480","SCHERIPROCT","1 + 1 Milligram                                                                                            Suppositories",2009-10-30,"PPA1151/123/002","Imbat Limited","PREDNISOLONE|CINCHOCAINEHYDROCHLORIDE"
"8481","SCHERIPROCT","1.5 + 5 mg/g Rectal Ointment",2015-09-03,"PPA1562/164/001","LTT Pharma Limited","PREDNISOLONECAPROATE|CINCHOCAINEHYDROCHLORIDE"
"8482","SCHERIPROCT","1.5/5 mg/g Rectal Ointment",2012-08-31,"PPA1633/018/001","Primecrown 2010 Ltd","PREDNISOLONECAPROATE|CINCHOCAINEHYDROCHLORIDE"
"8483","Scheriproct 1.5mg/g + 5mg/g rectal ointment","1.5 + 5 milligram(s)/gram Rectal ointment",2009-10-30,"PPA1151/123/001","Imbat Limited","Cinchocainehydrochloride|PREDNISOLONECAPROATE"
"8484","Scheriproct 1.5mg/g + 5mg/g rectal ointment","1.5mg/g + 5mg/g milligram(s)/gram Rectal ointment",NA,"PA1410/071/001","Bayer Limited","Cinchocainehydrochloride|PREDNISOLONECAPROATE"
"8485","Scheriproct Ointment","percent weight/weight Ointment",1978-04-01,"PA0012/026/001","HE Clissmann","PREDNISOLONECAPROATE|Cinchocainehydrochloride"
"8486","Scheriproct Suppositories","1/1/5mg percent volume/volume Suppository",1978-04-01,"PA0012/026/002","HE Clissmann","PREDNISOLONECAPROATE|Cinchocainehydrochloride"
"8487","SCHOLL ATHLETE’S FOOT CREAM","1 %w/v                                                                                                 Cream",1986-11-19,"PA0455/001/001","Scholl Consumer Products Limited","TOLNAFTATE"
"8488","SCHOLL ATHLETE’S FOOT POWDER","1 %w/w                                                                                                 Cutaneous Powder",1986-11-19,"PA0455/001/002","Scholl Consumer Products Limited","TOLNAFTATE"
"8489","SCHOLLMED ONCE WEEKLY FUNGAL NAIL TREATMENT","5 %w/v                                                                                                 Medicated Nail Lacquer",2018-05-18,"PA0979/070/001","Reckitt Benckiser Ireland Ltd","AMOROLFINEHYDROCHLORIDE"
"8490","SCINTIMUN","1.0 Milligram                                                                                            Kit for radiopharmaceutical preparation",2010-01-11,"EU/1/09/602/1-2","CIS bio International","BESILESOMAB"
"8491","SEA LEGS","12.5 Milligram                                                                                            Tablets",2000-07-21,"PA0257/073/001","GR Lane Health Products Ltd","MECLOZINEHYDROCHLORIDE"
"8492","SEBIVO","20 Mg/Ml",2009-01-20,"EU/1/07/388/003","Novartis Europharm Limited","TELBIVUDINE"
"8493","SEBIVO","600 Milligram                                                                                            Coated Tablets",2007-04-24,"EU/1/07/388/01","Novartis Europharm Limited","TELBIVUDINE"
"8494","SECLODIN","400 Milligram                                                                                            Capsules, Soft",2003-06-03,"PA0822/162/001","Pfizer Healthcare Ireland","IBUPROFEN"
"8495","SECLODIN","400 Milligram                                                                                            Tablets",2003-01-24,"PA0822/162/002","Pfizer Healthcare Ireland","IBUPROFEN"
"8496","SEEBRI BREEZHALER","44 Microgram                                                                                            Inhalation Powder, Capsule",2012-09-28,"EU/1/12/788/001-006","Novartis Europharm Limited","GLYCOPYRRONIUMBROMIDE"
"8497","SEGLUROMET","2.5mg/850mg Milligram                                                                                            Film Coated Tablet",2018-03-23,"EU/1/18/1265/001-007","Merck Sharp & Dohme BV","ERTUGLIFLOZINL-PYROGLUTAMICACID|METFORMINHYDROCHLORIDE"
"8498","SEGLUROMET","2.5mg/1000mg Milligram                                                                                            Film Coated Tablet",2018-03-23,"EU/1/18/1265/008-014","Merck Sharp & Dohme BV","ERTUGLIFLOZINL-PYROGLUTAMICACID|METFORMINHYDROCHLORIDE"
"8499","SEGLUROMET","7.5mg/850mg Milligram                                                                                            Film Coated Tablet",2018-03-23,"EU/1/18/1265/015-021","Merck Sharp & Dohme BV","ERTUGLIFLOZINL-PYROGLUTAMICACID|METFORMINHYDROCHLORIDE"
"8500","SEGLUROMET","7.5mg/1000mg Milligram                                                                                            Film Coated Tablet",2018-03-23,"EU/1/18/1265/022-028","Merck Sharp & Dohme BV","ERTUGLIFLOZINL-PYROGLUTAMICACID|METFORMINHYDROCHLORIDE"
"8501","SeHCAT 370kBq capsules","370 ZZZ K.bequerel Capsule, hard",1989-11-15,"PA0240/003/002","GE Healthcare Limited","Tauroselcholicacid"
"8502","Selectol 200mg Tablets","200 milligram(s) Tablet",2017-06-30,"PPA1097/019/001","Lexon (UK) Ltd","CELIPROLOLHYDROCHLORIDE"
"8503","Selectol Tablets 200 mg","200 milligram(s) Tablet",1989-02-01,"PA0540/126/001","Sanofi-Aventis Ireland Limited T/A SANOFI","CELIPROLOLHYDROCHLORIDE"
"8504","Selectol Tablets 400mg","400mg milligram(s) Tablet",1993-10-11,"PA0540/126/002","Sanofi-Aventis Ireland Limited T/A SANOFI","CELIPROLOLHYDROCHLORIDE"
"8505","SELESYN","100 Microgram                                                                                            Oral Solution",2006-05-26,"PA1131/001/001","biosyn Arzneimittel GmbH","SODIUMSELENITEPENTAHYDRATE"
"8506","SELESYN","500 microgram/10ml Oral Solution",2006-05-26,"PA1131/001/002","biosyn Arzneimittel GmbH","SODIUMSELENITEPENTAHYDRATE"
"8507","SELESYN","100 Microgram                                                                                            Solution for Injection",2006-05-26,"PA1131/001/003","biosyn Arzneimittel GmbH","SODIUMSELENITEPENTAHYDRATE"
"8508","SELESYN","500 microgram/10ml Solution for Injection",2006-05-26,"PA1131/001/004","biosyn Arzneimittel GmbH","SODIUMSELENITEPENTAHYDRATE"
"8509","Selincro","18 milligram(s) Film-coated tablet",2013-02-27,"EU/1/12/815/001-005","H. Lundbeck A/S","Nalmefene"
"8510","SELSUN","2.5 %w/v                                                                                                 Shampoo",1983-04-01,"PA0540/169/001","Sanofi-Aventis Ireland Limited T/A SANOFI","SELENIUMSULFIDE"
"8511","SEMGLEE","100 Units/ml                                                                                             Solution for Injection",2018-03-23,"EU/1/18/1270/001-004","Mylan S.A.S.","INSULINGLARGINE"
"8512","SENOKOT","7.5 MG/5ml                                                                                               Syrup",2006-05-19,"PA0979/016/003","Reckitt Benckiser Ireland Ltd","SENNOSIDEB"
"8513","SENOKOT","7.5 Milligram                                                                                            Tablets",2015-07-01,"PPA0465/414/001","PCO Manufacturing","SENNOSIDEB"
"8514","SENOKOT","7.5 Milligram                                                                                            Tablets",2009-07-24,"PPA1151/113/001","Imbat Limited","SENNA"
"8515","Senokot 7.5mg Tablets","7.5mg milligram(s) Tablet",1983-04-01,"PA0979/016/002","Reckitt Benckiser Ireland Ltd","Sennapodspowdered"
"8516","SEPIOGLIN","15 Milligram                                                                                            Tablets",2012-03-09,"EU/1/12/754/001-007","Vaia S.A.","PIOGLITAZONEHYDROCHLORIDE"
"8517","SEPIOGLIN","30 Milligram                                                                                            Tablets",2012-03-09,"EU/1/12/754/008-014","Vaia S.A.","PIOGLITAZONEHYDROCHLORIDE"
"8518","SEPIOGLIN","45 Milligram                                                                                            Tablets",2012-03-09,"EU/1/12/754/015-021","Vaia S.A.","PIOGLITAZONEHYDROCHLORIDE"
"8519","SEPTABENE","1.5+5.0 Mg/Ml Oromucosal Spray, Soln",2015-07-10,"PA1347/049/001","Krka d.d., Novo mesto","BENZYDAMINEHYDROCHLORIDE|CETYLPYRIDINIUMCHLORIDE"
"8520","SEPTABENE","3mg/1 Milligram                                                                                            Lozenges",2017-04-28,"PA1347/063/001","Krka d.d., Novo mesto","BENZYDAMINEHYDROCHLORIDE|CETYLPYRIDINIUMCHLORIDE(ASMONOHYDRATE)"
"8521","Septanazal 1 mg/ 50 mg in 1 ml nasal spray solution","1/50 milligram(s)/millilitre Nasal spray, solution",2016-12-02,"PA1347/058/002","Krka d.d., Novo mesto","XYLOMETAZOLINEHYDROCHLORIDE|Dexpanthenol"
"8522","Septanazal for children 0.5 mg/ 50 mg in 1 ml nasal spray solution","0.5/50 milligram(s)/millilitre Nasal spray, solution",2016-12-02,"PA1347/058/001","Krka d.d., Novo mesto","XYLOMETAZOLINEHYDROCHLORIDE|Dexpanthenol"
"8523","Septrin 80 mg/400 mg per ampoule, concentrate for solution for infusion","480 ZZZ Milligrams per Ampule Solution for infusion",1975-11-14,"PA1691/010/005","Aspen Pharma Trading Limited","Sulfamethoxazole|Trimethoprim"
"8524","Septrin 80 mg/400 mg Tablets","80/400 milligram(s) Tablet",1975-11-14,"PA1691/010/001","Aspen Pharma Trading Limited","Sulfamethoxazole|Trimethoprim"
"8525","Septrin Adult 80 mg/400 mg per 5 ml Oral Suspension","80400 mg/5ml Oral suspension",1975-11-14,"PA1691/010/004","Aspen Pharma Trading Limited","Sulphamethoxazole|Trimethoprim"
"8526","Septrin Forte 160 mg/800 mg Tablets","160/800 milligram(s) Tablet",1977-06-14,"PA1691/010/002","Aspen Pharma Trading Limited","Sulphamethoxazole|Trimethoprim"
"8527","Septrin Paediatric 40 mg/200 mg per 5 ml Oral Suspension","40200 mg/5ml Oral suspension",1975-11-14,"PA1691/010/003","Aspen Pharma Trading Limited","Sulphamethoxazole|Trimethoprim"
"8528","SERC","16 Milligram                                                                                            Tablets",2008-09-26,"PPA1151/079/001","Imbat Limited","BETAHISTINEDIHYDROCHLORIDE"
"8529","SERC","8 Milligram                                                                                            Tablets",2013-02-08,"PPA1633/026/001","Primecrown 2010 Ltd","BETAHISTINEDIHYDROCHLORIDE"
"8530","SERC","16 Milligram                                                                                            Tablets",2013-02-08,"PPA1633/026/002","Primecrown 2010 Ltd","BETAHISTINEDIHYDROCHLORIDE"
"8531","Serc 16mg Tablets","16 milligram(s) Tablet",1990-10-15,"PA2010/016/002","Mylan IRE Healthcare Limited","BETAHISTINEHYDROCHLORIDE"
"8532","Serc 8mg Tablets","8 milligram(s) Tablet",1979-04-01,"PA2010/016/001","Mylan IRE Healthcare Limited","BETAHISTINEHYDROCHLORIDE"
"8533","Sereflo 25 microgram/125 microgram per actuation pressurised inhalation, suspension","25 / 125 microgram(s)/dose Pressurised inhalation, suspension",2017-03-10,"PA1585/007/001","Fannin (UK) Ltd","FLUTICASONEPROPIONATE|SALMETEROLXINAFOATE"
"8534","Sereflo 25 microgram/250 microgram per actuation pressurised inhalation, suspension","25/250 microgram(s)/dose Pressurised inhalation, suspension",2017-03-10,"PA1585/007/002","Fannin (UK) Ltd","FLUTICASONEPROPIONATE|SALMETEROLXINAFOATE"
"8535","SERETIDE","50/100 Microgram                                                                                            Powder for Inhalation",2016-10-07,"PPA1562/141/003","LTT Pharma Limited","SALMETEROLXINAFOATE|FLUTICASONEPROPIONATE"
"8536","SERETIDE 100 DISKUS","50/100 Microgram                                                                                            Powder for Inhalation",2012-02-10,"PPA1463/006/003","IMED Healthcare Ltd.","SALMETEROLXINAFOATE|FLUTICASONEPROPIONATE"
"8537","SERETIDE 100 DISKUS","50/100 Mcg/Dose                                                                                             Powder for Inhalation",2009-06-25,"PPA1151/006/003","Imbat Limited","SALMETEROLXINAFOATE|FLUTICASONEPROPIONATE"
"8538","SERETIDE 100 DISKUS","50/100 Microgram                                                                                            Powder for Inhalation",2003-01-24,"PPA0465/091/001","PCO Manufacturing","SALMETEROLXINAFOATE|FLUTICASONEPROPIONATE"
"8539","Seretide 100 Diskus 50 microgram/100 microgram / dose inhalation powder, pre-dispensed","50/100mcg microgram(s) Powder for Inhalation",1999-01-22,"PA1077/046/001","GlaxoSmithKline (Ireland) Limited","SALMETEROLXINAFOATE|FLUTICASONEPROPIONATE"
"8540","SERETIDE 125 EVOHALER","25/125 Microgram                                                                                            Pressurised Inhalation Suspension",2004-02-06,"PPA0465/091/005","PCO Manufacturing","SALMETEROLXINAFOATE|FLUTICASONEPROPIONATE"
"8541","SERETIDE 125 EVOHALER","25/125 Mcg/Dose                                                                                             Pressurised Inhalation Suspension",2016-07-01,"PPA1463/006/004","IMED Healthcare Ltd.","SALMETEROLXINAFOATE|FLUTICASONEPROPIONATE"
"8542","Seretide 125 Evohaler 25 microgram/125 microgram/dose pressurised inhalation, suspension","25/125 microgram(s)/dose Pressurised inhalation, suspension",2001-02-23,"PA1077/046/005","GlaxoSmithKline (Ireland) Limited","SALMETEROLXINAFOATE|SALMETEROLXINAFOATE|FLUTICASONEPROPIONATE"
"8543","SERETIDE 250 DISKUS","50/250 Microgram                                                                                            Powder for Inhalation",2003-01-24,"PPA0465/091/002","PCO Manufacturing","SALMETEROLXINAFOATE|FLUTICASONEPROPIONATE"
"8544","SERETIDE 250 DISKUS","50/250 Microgram                                                                                            Powder for Inhalation",2011-02-04,"PPA1463/006/002","IMED Healthcare Ltd.","SALMETEROLXINAFOATE|FLUTICASONEPROPIONATE"
"8545","SERETIDE 250 DISKUS","50/250 Microgram                                                                                            Powder for Inhalation",2015-01-23,"PPA1562/141/001","LTT Pharma Limited","SALMETEROLXINAFOATE|FLUTICASONEPROPIONATE"
"8546","SERETIDE 250 DISKUS","50/250 Mcg/Dose                                                                                             Powder for Inhalation",2007-11-23,"PPA1151/006/002","Imbat Limited","SALMETEROL|FLUTICASONEPROPIONATE"
"8547","SERETIDE 250 DISKUS","50/250mcg Microgram                                                                                            Powder for Inhalation",2017-08-25,"PPA1633/063/001","Primecrown 2010 Ltd","SALMETEROLXINAFOATE|FLUTICASONEPROPIONATE"
"8548","Seretide 250 Diskus 50 microgram/250 microgram/dose inhalation powder, pre-dispensed","50/250mcg microgram(s) Powder for Inhalation",1999-01-22,"PA1077/046/002","GlaxoSmithKline (Ireland) Limited","SALMETEROLXINAFOATE|FLUTICASONEPROPIONATE"
"8549","SERETIDE 250 EVOHALER","25/250 Microgram                                                                                            Pressurised Inhalation Suspension",2004-02-06,"PPA0465/091/006","PCO Manufacturing","SALMETEROLXINAFOATE|FLUTICASONEPROPIONATE"
"8550","SERETIDE 250 EVOHALER","25/250 Mcg/Dose                                                                                             Pressurised Inhalation Suspension",2011-03-25,"PPA1151/006/004","Imbat Limited","SALMETEROLXINAFOATE|FLUTICASONEPROPIONATE"
"8551","SERETIDE 250 EVOHALER","25/250 Mcg/Dose                                                                                             Pressurised Inhalation Suspension",2016-07-01,"PPA1463/006/005","IMED Healthcare Ltd.","SALMETEROLXINAFOATE|FLUTICASONEPROPIONATE"
"8552","Seretide 250 Evohaler 25 microgram/250 microgram/dose pressurised inhalation, suspension","25/250 microgram(s)/dose Pressurised inhalation, suspension",2001-02-21,"PA1077/046/006","GlaxoSmithKline (Ireland) Limited","SALMETEROLXINAFOATE|SALMETEROLXINAFOATE|FLUTICASONEPROPIONATE"
"8553","SERETIDE 50 EVOHALER","25/50 Microgram                                                                                            Pressurised Inhalation Suspension",2004-02-06,"PPA0465/091/004","PCO Manufacturing","SALMETEROLXINAFOATE|FLUTICASONEPROPIONATE"
"8554","Seretide 50 Evohaler 25 microgram/50 microgram/dose pressurised inhalation, suspension","25/50 microgram(s)/dose Pressurised inhalation, suspension",2001-02-23,"PA1077/046/004","GlaxoSmithKline (Ireland) Limited","SALMETEROLXINAFOATE|SALMETEROLXINAFOATE|FLUTICASONEPROPIONATE"
"8555","SERETIDE 500 DISKUS","50/500 Microgram                                                                                            Powder for Inhalation",2003-01-24,"PPA0465/091/003","PCO Manufacturing","SALMETEROLXINAFOATE|FLUTICASONEPROPIONATE"
"8556","SERETIDE 500 DISKUS","50/500 Microgram                                                                                            Inhalation Powder",2009-01-23,"PPA1463/006/001","IMED Healthcare Ltd.","SALMETEROLXINAFOATE|FLUTICASONEPROPIONATE"
"8557","SERETIDE 500 DISKUS","50/500 Microgram                                                                                            Powder for Inhalation",2015-01-23,"PPA1562/141/002","LTT Pharma Limited","SALMETEROLXINAFOATE|FLUTICASONEPROPIONATE"
"8558","SERETIDE 500 DISKUS","50/500 Mcg/Dose                                                                                             Powder for Inhalation",2004-06-25,"PPA1151/006/001","Imbat Limited","SALMETEROLXINAFOATE|FLUTICASONEPROPIONATE"
"8559","SERETIDE 500 DISKUS","50/500mcg Microgram                                                                                            Powder for Inhalation",2017-08-25,"PPA1633/063/002","Primecrown 2010 Ltd","SALMETEROLXINAFOATE|FLUTICASONEPROPIONATE"
"8560","Seretide 500 Diskus 50 microgram/500 microgram/dose inhalation powder, pre-dispensed","50/500mcg microgram(s) Powder for Inhalation",1999-01-22,"PA1077/046/003","GlaxoSmithKline (Ireland) Limited","SALMETEROLXINAFOATE|FLUTICASONEPROPIONATE"
"8561","SERETRAL","50 Milligram                                                                                            Film Coated Tablet",2008-03-28,"PA0749/023/001","Teva Pharma B.V.","SERTRALINEHYDROCHLORIDE"
"8562","SERETRAL","100 Milligram                                                                                            Film Coated Tablet",2008-03-28,"PA0749/023/002","Teva Pharma B.V.","SERTRALINEHYDROCHLORIDE"
"8563","SEREVENT DISKUS","50 Microgram                                                                                            Inhalation Powder, Capsule",1997-01-21,"PA1077/047/003","GlaxoSmithKline (Ireland) Limited","SALMETEROLXINAFOATE"
"8564","SEREVENT EVOHALER","25 Mcg/Acutuation                                                                                       Pressurised Inhalation Suspension",2006-08-25,"PA1077/047/005","GlaxoSmithKline (Ireland) Limited","SALMETEROLXINAFOATE"
"8565","SEREVENT EVOHALER","25 Microgram                                                                                            Pressurised Inhalation Suspension",2011-08-05,"PPA1151/151/001","Imbat Limited","SALMETEROLXINAFOATE"
"8566","SERIMEL","50 Milligram                                                                                            Film Coated Tablet",2005-07-22,"PA0126/135/001","Clonmel Healthcare Ltd","SERTRALINEHYDROCHLORIDE"
"8567","SERIMEL","100 Milligram                                                                                            Film Coated Tablet",2005-07-22,"PA0126/135/002","Clonmel Healthcare Ltd","SERTRALINEHYDROCHLORIDE"
"8568","SERLAN","50 Milligram                                                                                            Film Coated Tablet",2005-03-11,"PA0711/065/001","Rowex Ltd","SERTRALINE"
"8569","SERLAN","100 Milligram                                                                                            Film Coated Tablet",2005-03-11,"PA0711/065/002","Rowex Ltd","SERTRALINEHYDROCHLORIDE"
"8570","Seropia 100 mg film-coated tablets","100 milligram(s) Film-coated tablet",2009-07-24,"PA0126/185/002","Clonmel Healthcare Ltd","Quetiapinefumarate"
"8571","Seropia 200 mg film-coated tablets","200 milligram(s) Film-coated tablet",2009-07-24,"PA0126/185/003","Clonmel Healthcare Ltd","Quetiapinefumarate"
"8572","Seropia 25 mg film-coated tablets","25 milligram(s) Film-coated tablet",2009-07-24,"PA0126/185/001","Clonmel Healthcare Ltd","Quetiapinefumarate"
"8573","Seropia 300 mg film-coated tablets","300 milligram(s) Film-coated tablet",2009-07-24,"PA0126/185/004","Clonmel Healthcare Ltd","Quetiapinefumarate"
"8574","SEROPIA XR","50 Milligram                                                                                            Tablet Prolonged Release",2015-04-02,"PA0126/275/001","Clonmel Healthcare Ltd","QUETIAPINEHEMIFUMARATE"
"8575","SEROPIA XR","150 Milligram                                                                                            Tablet Prolonged Release",2015-04-02,"PA0126/275/002","Clonmel Healthcare Ltd","QUETIAPINEHEMIFUMARATE"
"8576","SEROPIA XR","200 Milligram                                                                                            Tablet Prolonged Release",2015-04-02,"PA0126/275/003","Clonmel Healthcare Ltd","QUETIAPINEHEMIFUMARATE"
"8577","SEROPIA XR","300 Milligram                                                                                            Tablet Prolonged Release",2015-04-02,"PA0126/275/004","Clonmel Healthcare Ltd","QUETIAPINEHEMIFUMARATE"
"8578","SEROPIA XR","400 Milligram                                                                                            Tablet Prolonged Release",2015-04-02,"PA0126/275/005","Clonmel Healthcare Ltd","QUETIAPINEHEMIFUMARATE"
"8579","SEROQUEL","25 Milligram                                                                                            Film Coated Tablet",2000-02-04,"PA0970/018/001","AstraZeneca UK Limited","QUETIAPINEFUMARATE"
"8580","SEROQUEL","100 Milligram                                                                                            Film Coated Tablet",2000-02-04,"PA0970/018/002","AstraZeneca UK Limited","QUETIAPINEFUMARATE"
"8581","SEROQUEL","200 Milligram                                                                                            Film Coated Tablet",2000-02-04,"PA0970/018/003","AstraZeneca UK Limited","QUETIAPINEFUMARATE"
"8582","SEROQUEL","300 Milligram                                                                                            Film Coated Tablet",2000-02-04,"PA0970/018/007","AstraZeneca UK Limited","QUETIAPINEFUMARATE"
"8583","SEROQUEL","100 Milligram                                                                                            Film Coated Tablet",2012-06-28,"PPA1151/036/008","Imbat Limited","QUETIAPINEFUMARATE"
"8584","SEROQUEL","200 Milligram                                                                                            Film Coated Tablet",2007-08-24,"PPA1151/036/001","Imbat Limited","QUETIAPINEFUMARATE"
"8585","Seroquel 25mg Film-Coated Tablets","25 milligram(s) Film-coated tablet",2008-02-01,"PPA1151/036/002","Imbat Limited","Quetiapinefumarate"
"8586","SEROQUEL XR","50 Milligram                                                                                            Tablet Prolonged Release",2010-01-25,"PPA1151/036/004","Imbat Limited","QUETIAPINEFUMARATE"
"8587","SEROQUEL XR","200 Milligram                                                                                            Tablet Prolonged Release",2010-01-25,"PPA1151/036/005","Imbat Limited","QUETIAPINEFUMARATE"
"8588","SEROQUEL XR","300 Milligram                                                                                            Tablet Prolonged Release",2010-01-25,"PPA1151/036/006","Imbat Limited","QUETIAPINEFUMARATE"
"8589","SEROQUEL XR","400 Milligram                                                                                            Tablet Prolonged Release",2010-01-25,"PPA1151/036/007","Imbat Limited","QUETIAPINEFUMARATE"
"8590","SEROQUEL XR","50 Milligram                                                                                            Tablet Prolonged Release",2017-12-15,"PPA0465/438/001","PCO Manufacturing","QUETIAPINEFUMARATE"
"8591","SEROQUEL XR","150 Milligram                                                                                            Tablet Prolonged Release",2017-12-15,"PPA0465/438/002","PCO Manufacturing","QUETIAPINEFUMARATE"
"8592","SEROQUEL XR","200 Milligram                                                                                            Tablet Prolonged Release",2017-12-15,"PPA0465/438/003","PCO Manufacturing","QUETIAPINEFUMARATE"
"8593","SEROQUEL XR","300 Milligram                                                                                            Tablet Prolonged Release",2017-12-15,"PPA0465/438/004","PCO Manufacturing","QUETIAPINEFUMARATE"
"8594","SEROQUEL XR","50 Milligram                                                                                            Tablet Prolonged Release",2008-02-15,"PA0970/018/008","AstraZeneca UK Limited","QUETIAPINEFUMARATE"
"8595","SEROQUEL XR","200 Milligram                                                                                            Tablet Prolonged Release",2008-02-15,"PA0970/018/009","AstraZeneca UK Limited","QUETIAPINEFUMARATE"
"8596","SEROQUEL XR","300 Milligram                                                                                            Tablet Prolonged Release",2008-02-15,"PA0970/018/010","AstraZeneca UK Limited","QUETIAPINEFUMARATE"
"8597","SEROQUEL XR","400 Milligram                                                                                            Tablet Prolonged Release",2008-02-15,"PA0970/018/011","AstraZeneca UK Limited","QUETIAPINEFUMARATE"
"8598","SEROQUEL XR","150 Milligram                                                                                            Tablet Prolonged Release",2008-02-15,"PA0970/018/012","AstraZeneca UK Limited","QUETIAPINEFUMARATE"
"8599","SEROXAT","20 MG/5ml                                                                                               Oral Suspension",1998-05-06,"PA1077/097/001","GlaxoSmithKline (Ireland) Limited","PAROXETINEHYDROCHLORIDEHEMIHYDRATE"
"8600","SEROXAT","20 Milligram                                                                                            Film Coated Tablet",1999-12-22,"PPA0465/055/001","PCO Manufacturing","PAROXETINEHYDROCHLORIDEHEMIHYDRATE"
"8601","SEROXAT","30 Milligram                                                                                            Film Coated Tablet",1999-08-23,"PPA0465/055/002","PCO Manufacturing","PAROXETINEHYDROCHLORIDEHEMIHYDRATE"
"8602","SEROXAT","20 Milligram                                                                                            Film Coated Tablet",2007-11-09,"PPA1151/034/001","Imbat Limited","PAROXETINEHYDROCHLORIDEHEMIHYDRATE"
"8603","SEROXAT","30 Milligram                                                                                            Film Coated Tablet",2011-01-21,"PPA1151/034/003","Imbat Limited","PAROXETINEHYDROCHLORIDE"
"8604","SEROXAT","30 Milligram                                                                                            Film Coated Tablet",2011-08-05,"PPA1562/030/004","LTT Pharma Limited","PAROXETINEHYDROCHLORIDEHEMIHYDRATE"
"8605","SEROXAT","20 Milligram                                                                                            Film Coated Tablet",2008-12-12,"PPA1463/009/001","IMED Healthcare Ltd.","PAROXETINEHYDROCHLORIDE"
"8606","SEROXAT","30 Milligram                                                                                            Film Coated Tablet",2014-09-19,"PPA1463/009/002","IMED Healthcare Ltd.","PAROXETINEHYDROCHLORIDEHEMIHYDRATE"
"8607","Seroxat 10 mg film-coated tablets","10 milligram(s) Film-coated tablet",2004-03-05,"PA1077/097/004","GlaxoSmithKline (Ireland) Limited","Paroxetinehydrochloridehemihydrate"
"8608","Seroxat 20 mg film-coated tablets","20 milligram(s) Film-coated tablet",1991-03-19,"PA1077/097/002","GlaxoSmithKline (Ireland) Limited","Paroxetinehydrochloridehemihydrate|Paroxetinehydrochloridehemihydrate"
"8609","Seroxat 20 mg film-coated tablets","20 milligram(s) Film-coated tablet",2011-08-05,"PPA1097/040/001","Lexon (UK) Ltd","Paroxetinehydrochloridehemihydrate"
"8610","Seroxat 30 mg film-coated tablets","30 milligram(s) Film-coated tablet",1991-03-19,"PA1077/097/003","GlaxoSmithKline (Ireland) Limited","Paroxetinehydrochloridehemihydrate|Paroxetinehydrochloridehemihydrate"
"8611","SERTRALINE","50 Milligram                                                                                            Film Coated Tablet",2016-04-08,"PA1390/126/001","Accord Healthcare Limited","SERTRALINEHYDROCHLORIDE"
"8612","SERTRALINE","100 Milligram                                                                                            Film Coated Tablet",2016-04-08,"PA1390/126/002","Accord Healthcare Limited","SERTRALINEHYDROCHLORIDE"
"8613","Sertraline 100 mg Film-coated Tablets","100 milligram(s) Film-coated tablet",2006-06-16,"PA1390/126/004","Accord Healthcare Limited","Sertralinehydrochloride"
"8614","Sertraline 50 mg Film-coated Tablets","50 milligram(s) Film-coated tablet",2006-06-16,"PA1390/126/003","Accord Healthcare Limited","Sertralinehydrochloride"
"8615","SERTRALINE BLUEFISH","50 Milligram                                                                                            Film Coated Tablet",2013-05-24,"PA1436/021/001","Bluefish Pharmaceuticals AB","SERTRALINEHYDROCHLORIDE"
"8616","SERTRALINE BLUEFISH","100 Milligram                                                                                            Film Coated Tablet",2013-05-24,"PA1436/021/002","Bluefish Pharmaceuticals AB","SERTRALINEHYDROCHLORIDE"
"8617","SERTRALINE KRKA","50 Milligram                                                                                            Film Coated Tablet",2011-07-22,"PA1347/019/001","Krka d.d., Novo mesto","SERTRALINEHYDROCHLORIDE"
"8618","SERTRALINE KRKA","100 Milligram                                                                                            Film Coated Tablet",2011-07-22,"PA1347/019/002","Krka d.d., Novo mesto","SERTRALINEHYDROCHLORIDE"
"8619","SETININ XL","50 Milligram                                                                                            Tablet Prolonged Release",2012-03-02,"PA1380/103/001","Actavis Group PTC ehf","QUETIAPINEFUMARATE"
"8620","SETININ XL","200 Milligram                                                                                            Tablet Prolonged Release",2012-03-02,"PA1380/103/003","Actavis Group PTC ehf","QUETIAPINEFUMARATE"
"8621","SETININ XL","300 Milligram                                                                                            Tablet Prolonged Release",2012-03-02,"PA1380/103/004","Actavis Group PTC ehf","QUETIAPINEFUMARATE"
"8622","SETININ XL","400 Milligram                                                                                            Tablet Prolonged Release",2012-03-02,"PA1380/103/005","Actavis Group PTC ehf","QUETIAPINEFUMARATE"
"8623","SETOFILM","4 Milligram",2010-08-20,"PA1336/003/001","Norgine B.V.","ONDANSETRON"
"8624","SETOFILM","8 Milligram",2010-08-20,"PA1336/003/002","Norgine B.V.","ONDANSETRON"
"8625","Sevelamer Carbonate 800 mg film coated tablets","800 milligram(s) Film-coated tablet",2015-11-19,"PA0405/093/001","Generics (UK) Limited","Sevelamercarbonate"
"8626","SEVELAMER CARBONATE GENTHON","800 Milligram                                                                                            Film Coated Tablet",2014-07-25,"PA0740/014/001","Genthon BV","SEVELAMERCARBONATE"
"8627","SEVELAMER CARBONATE ROWEX","800 Milligram                                                                                            Film Coated Tablet",2015-02-20,"PA0711/246/001","Rowex Ltd","SEVELAMERCARBONATEANHYDROUS"
"8628","SEVELAMER CARBONATE ZENTIVA","800 mg/g Film Coated Tablet",2015-01-15,"EU/1/14/952/001","Genzyme Europe B.V.","SEVELAMERCARBONATE|SEVELAMERCARBONATE"
"8629","SEVELAMER CARBONATE ZENTIVA","2.4 Grams                                                                                                Powder for Oral Suspension",2015-01-15,"EU/1/14/952/002-003","Genzyme Europe B.V.","SEVELAMERCARBONATE"
"8630","Sevelamer carbonate Zentiva","0.8 gram(s) Powder for oral suspension",2018-09-20,"EU/1/14/952/005","Genzyme Europe B.V.","Sevelamercarbonate"
"8631","SEVELAMER HYDROCHLORIDE ZENTIVA","800 Milligram                                                                                            Film Coated Tablet",2015-02-26,"EU/1/14/953/001","Genzyme Europe B.V.","SEVELAMERHYDROCHLORIDE"
"8632","SEVIKAR","20/5                                                                                                      Film Coated Tablet",2008-11-28,"PA1595/005/001","Daiichi Sankyo Ireland Ltd","OLMESARTANMEDOXOMIL|AMLODIPINE"
"8633","SEVIKAR","40/5                                                                                                      Film Coated Tablet",2008-11-28,"PA1595/005/002","Daiichi Sankyo Ireland Ltd","OLMESARTANMEDOXOMIL|AMLODIPINE"
"8634","SEVIKAR","40/10                                                                                                      Film Coated Tablet",2008-11-28,"PA1595/005/003","Daiichi Sankyo Ireland Ltd","OLMESARTANMEDOXOMIL|AMLODIPINE"
"8635","SEVIKAR PLUS","20/5/12.5 Milligram                                                                                            Film Coated Tablet",2011-02-25,"PA1595/003/001","Daiichi Sankyo Ireland Ltd","OLMESARTANMEDOXOMIL|AMLODIPINEBESILATE|HYDROCHLOROTHIAZIDE"
"8636","SEVIKAR PLUS","40/5/12.5 Milligram                                                                                            Film Coated Tablet",2011-02-25,"PA1595/003/002","Daiichi Sankyo Ireland Ltd","OLMESARTANMEDOXOMIL|AMLODIPINEBESILATE|HYDROCHLOROTHIAZIDE"
"8637","SEVIKAR PLUS","40/10/12.5 Milligram                                                                                            Film Coated Tablet",2011-02-25,"PA1595/003/003","Daiichi Sankyo Ireland Ltd","OLMESARTANMEDOXOMIL|AMLODIPINEBESILATE|HYDROCHLOROTHIAZIDE"
"8638","SEVIKAR PLUS","40/5/25 Milligram                                                                                            Film Coated Tablet",2011-02-25,"PA1595/003/004","Daiichi Sankyo Ireland Ltd","OLMESARTANMEDOXOMIL|AMLODIPINEBESILATE|HYDROCHLOROTHIAZIDE"
"8639","SEVIKAR PLUS","40/10/25 Milligram                                                                                            Film Coated Tablet",2011-02-25,"PA1595/003/005","Daiichi Sankyo Ireland Ltd","OLMESARTANMEDOXOMIL|AMLODIPINEBESILATE|HYDROCHLOROTHIAZIDE"
"8640","SEVOFLURANE","100 Per Cent                                                                                             Inhalation Vapour Liquid",2017-04-07,"PA0688/036/001","Chanelle Medical","SEVOFLURANE"
"8641","Sevoflurane 100% Inhalation Vapour, liquid","100 percent volume/volume Inhalation vapour, liquid",2012-01-13,"PA2187/003/001","Piramal Critical Care Limited","Sevoflurane"
"8642","SEVOFLURANE BAXTER","100 Per Cent                                                                                             Inhalation Vapour Liquid",2010-05-21,"PA0167/140/001","Baxter Healthcare Limited","SEVOFLURANE"
"8643","Sevorane 100% v/v Inhalation Gas","100 percent volume/volume Inhalation Gas",1995-04-19,"PA1824/004/001","AbbVie Limited","Sevoflurane"
"8644","Sevredol 10mg Film-Coated Tablets","10 milligram(s) Film-coated tablet",1989-11-29,"PA1688/009/001","Mundipharma Pharmaceuticals Limited","Morphinesulfate"
"8645","Sevredol 20 mg Film-Coated Tablets","20 milligram(s) Film-coated tablet",1989-11-29,"PA1688/009/002","Mundipharma Pharmaceuticals Limited","Morphinesulfate"
"8646","Sevredol 50 mg Film-Coated Tablets","50 milligram(s) Film-coated tablet",1996-06-10,"PA1688/009/003","Mundipharma Pharmaceuticals Limited","Morphinesulfate"
"8647","Shingrix","*** AWAITING VALUE *** Powder and suspension for suspension for injection",2018-03-21,"EU/1/18/1272/001-002","GlaxoSmithKline Biologicals S.A.","Recombinantvaricellazostervirussurfaceglycoproteine"
"8648","Sialanar","0.4 milligram(s)/millilitre Oral solution",2016-09-15,"EU/1/16/1135/001","Proveca Limited","Glycopyrroniumbromide"
"8649","SIBELIUM","5 Milligram                                                                                            Tablets",2009-01-30,"PA0748/031/002","Janssen-Cilag Ltd","FLUNARIZINEDIHYDROCHLORIDE"
"8650","SIDENA","25 Milligram                                                                                            Tablets",2009-10-09,"PA0711/170/001","Rowex Ltd","SILDENAFILCITRATE"
"8651","Sidena 100mg tablets","100 milligram(s) Tablet",2009-10-09,"PA0711/170/003","Rowex Ltd","Sildenafilcitrate"
"8652","Sidena 50mg tablets","50 milligram(s) Tablet",2009-10-09,"PA0711/170/002","Rowex Ltd","Sildenafilcitrate"
"8653","SIFROL","0.088 Milligram                                                                                            Tablets",1997-10-14,"EU/1/97/050/001","Boehringer Ingelheim International GmbH","PRAMIPEXOLEDIHYDROXHLORIDE"
"8654","SIFROL","0.088 Milligram                                                                                            Tablets",1997-10-14,"EU/1/97/050/002","Boehringer Ingelheim International GmbH","PRAMIPEXOLEDIHYDROXHLORIDE"
"8655","SIFROL","0.18 Milligram                                                                                            Tablets",1997-10-14,"EU/1/97/050/003","Boehringer Ingelheim International GmbH","PRAMIPEXOLEDIHYDROXHLORIDE"
"8656","SIFROL","0.18 Milligram                                                                                            Tablets",1997-10-14,"EU/1/97/050/004","Boehringer Ingelheim International GmbH","PRAMIPEXOLEDIHYDROXHLORIDE"
"8657","SIFROL","0.7 Milligram                                                                                            Tablets",1997-10-14,"EU/1/97/050/005","Boehringer Ingelheim International GmbH","PRAMIPEXOLEDIHYDROXHLORIDE"
"8658","SIFROL","0.7 Milligram                                                                                            Tablets",1997-10-14,"EU/1/97/050/006","Boehringer Ingelheim International GmbH","PRAMIPEXOLEDIHYDROXHLORIDE"
"8659","SIFROL","1.1 Milligram                                                                                            Tablets",1997-10-14,"EU/1/97/050/009","Boehringer Ingelheim International GmbH","PRAMIPEXOLEDIHYDROXHLORIDE"
"8660","SIFROL","1.1 Milligram                                                                                            Tablets",1997-10-14,"EU/1/97/050/010","Boehringer Ingelheim International GmbH","PRAMIPEXOLEDIHYDROXHLORIDE"
"8661","SIFROL","0.35 Milligram                                                                                            Tablets",1999-11-16,"EU/1/97/050/011","Boehringer Ingelheim International GmbH","PRAMIPEXOLEDIHYDROXHLORIDE"
"8662","SIFROL","0.35 Milligram                                                                                            Tablets",1999-11-16,"EU/1/97/050/012","Boehringer Ingelheim International GmbH","PRAMIPEXOLEDIHYDROXHLORIDE"
"8663","SIFROL","1.57 Milligram                                                                                            Tablet Prolonged Release",2010-06-14,"EU/1/97/050/028-30","Boehringer Ingelheim International GmbH","PRAMIPEXOLEDIHYDROCHLORIDEMONOHYDRATE,MILLED"
"8664","SIFROL","2.62 Milligram                                                                                            Tablet Prolonged Release",2010-06-14,"EU/1/97/050/031-33","Boehringer Ingelheim International GmbH","PRAMIPEXOLEDIHYDROCHLORIDEMONOHYDRATE,MILLED"
"8665","SIFROL","0.26 Milligram                                                                                            Tablet Prolonged Release",2009-10-08,"EU/1/97/050/13-15","Boehringer Ingelheim International GmbH","PRAMIPEXOLEDIHYDROCHLORIDEMONOHYDRATE,MILLED"
"8666","SIFROL","0.52 Milligram                                                                                            Tablet Prolonged Release",2009-10-08,"EU/1/97/050/16-18","Boehringer Ingelheim International GmbH","PRAMIPEXOLEDIHYDROCHLORIDEMONOHYDRATE,MILLED"
"8667","SIFROL","1.05 Milligram                                                                                            Tablet Prolonged Release",2009-10-08,"EU/1/97/050/19-21","Boehringer Ingelheim International GmbH","PRAMIPEXOLEDIHYDROCHLORIDEMONOHYDRATE,MILLED"
"8668","SIFROL","2.1 Milligram                                                                                            Tablet Prolonged Release",2009-10-08,"EU/1/97/050/22-24","Boehringer Ingelheim International GmbH","PRAMIPEXOLEDIHYDROCHLORIDEMONOHYDRATE,MILLED"
"8669","SIFROL","3.15 Milligram                                                                                            Tablet Prolonged Release",2009-10-08,"EU/1/97/050/25-27","Boehringer Ingelheim International GmbH","PRAMIPEXOLEDIHYDROCHLORIDEMONOHYDRATE,MILLED"
"8670","SIGNIFOR","0.3 Milligram                                                                                            Solution for Injection",2012-04-24,"EU/1/12/753/001-004","Novartis Europharm Limited","PASIREOTIDEDISAPARTATE"
"8671","SIGNIFOR","0.6 Milligram                                                                                            Solution for Injection",2012-04-24,"EU/1/12/753/005-008","Novartis Europharm Limited","PASIREOTIDEDISAPARTATE"
"8672","SIGNIFOR","0.9 Milligram                                                                                            Solution for Injection",2012-04-24,"EU/1/12/753/009-012","Novartis Europharm Limited","PASIREOTIDEDISAPARTATE"
"8673","SIGNIFOR","20 Milligram                                                                                            Pdr+Solv for Susp for Inj",2014-11-19,"EU/1/12/753/013","Novartis Europharm Limited","PASIREOTIDEPAMOATE"
"8674","SIGNIFOR","40 Milligram                                                                                            Pdr+Solv for Susp for Inj",2014-11-19,"EU/1/12/753/014-015","Novartis Europharm Limited","PASIREOTIDEPAMOATE"
"8675","SIGNIFOR","60 Milligram                                                                                            Pdr+Solv for Susp for Inj",2014-11-19,"EU/1/12/753/016-017","Novartis Europharm Limited","PASIREOTIDEPAMOATE"
"8676","SIGNIFOR","10 Milligram                                                                                            Pdr+Solv for Susp for Inj",2017-09-18,"EU/1/12/753/018","Novartis Europharm Limited","PASIREOTIDEPAMOATE"
"8677","SIGNIFOR","30 Milligram                                                                                            Pdr+Solv for Susp for Inj",2017-09-18,"EU/1/12/753/019","Novartis Europharm Limited","PASIREOTIDEPAMOATE"
"8678","SIKLOS","1000 Milligram                                                                                            Film Coated Tablet",2007-06-29,"EU/1/07/397/001","OLT Pharma","HYDROXYCARBAMIDE"
"8679","SIKLOS","100 Milligram                                                                                            Film Coated Tablet",2011-02-28,"EU/1/07/397/002-004","Addmedica","HYDROXYCARBAMIDE"
"8680","SILAPO","3333 IU/ML                                                                                                Solution for Injection",2007-12-18,"EU/1/07/432/1-6","Stada Arzneimittel AG","EPOETINZETA"
"8681","SILAPO","40,000 IU/ML                                                                                                Solution for Injection",2007-12-18,"EU/1/07/432/17-19","Stada Arzneimittel AG","EPOETINZETA"
"8682","SILAPO","10,000 IU/ML                                                                                                Solution for Injection",2007-12-18,"EU/1/07/432/7-16","Stada Arzneimittel AG","EPOETINZETA"
"8683","SILCARFIL","20 Milligram                                                                                            Film Coated Tablet",2016-11-25,"PA0711/266/001","Rowex Ltd","SILDENAFILCITRATE"
"8684","SILCOCKS BASE CREAM","15/20 %w/w                                                                                                 Cream",1989-04-20,"PA0206/020/001","Ovelle Limited","EMULSIFYINGWAX|CETOSTEARYLALCOHOL|SODIUMLAURYLSULFATE|PURIFIEDWATER(PH.EUR.)|WHITESOFTPARAFFIN"
"8685","SILDENAFIL ACCORD","25 Milligram                                                                                            Film Coated Tablet",2011-05-06,"PA1390/029/001","Accord Healthcare Limited","SILDENAFILCITRATE"
"8686","Sildenafil Accord 100mg film-coated tablets","100 milligram(s) Film-coated tablet",2011-05-06,"PA1390/029/003","Accord Healthcare Limited","Sildenafilcitrate"
"8687","Sildenafil Accord 50mg film-coated tablets","50 milligram(s) Film-coated tablet",2011-05-06,"PA1390/029/002","Accord Healthcare Limited","Sildenafilcitrate"
"8688","Sildenafil Actavis","100 milligram(s) Film-coated tablet",2009-12-10,"EU/1/09/595/11-15","Actavis Group PTC ehf","Sildenafilcitrate"
"8689","SILDENAFIL ACTAVIS","25 Milligram                                                                                            Film Coated Tablet",2009-12-10,"EU/1/09/595/1-5","Actavis Group PTC ehf","SILDENAFILCITRATE"
"8690","Sildenafil Actavis","50 milligram(s) Film-coated tablet",2009-12-10,"EU/1/09/595/6-10","Actavis Group PTC ehf","Sildenafilcitrate"
"8691","SILDENAFIL CLONMEL","25 Milligram                                                                                            Film Coated Tablet",2011-05-03,"PA0126/199/001","Clonmel Healthcare Ltd","SILDENAFILBASE(ASCITRATE)"
"8692","SILDENAFIL CLONMEL","20 Milligram                                                                                            Film Coated Tablet",2016-12-02,"PA0126/199/004","Clonmel Healthcare Ltd","SILDENAFILCITRATE"
"8693","Sildenafil Clonmel 100mg Film-coated tablets","100 milligram(s) Film-coated tablet",2011-05-03,"PA0126/199/003","Clonmel Healthcare Ltd","Sildenafilbase(ascitrate)"
"8694","Sildenafil Clonmel 50mg Film-coated tablets","50 milligram(s) Film-coated tablet",2011-05-03,"PA0126/199/002","Clonmel Healthcare Ltd","Sildenafilbase(ascitrate)"
"8695","SILDENAFIL MYLAN","25 Milligram                                                                                            Film Coated Tablet",2010-11-19,"PA0577/141/001","McDermott Laboratories Ltd t/a Gerard Laboratories","SILDENAFILCITRATE"
"8696","Sildenafil Mylan 100 mg film-coated tablets","100 milligram(s) Film-coated tablet",2010-11-19,"PA0577/141/003","McDermott Laboratories Ltd t/a Gerard Laboratories","Sildenafilcitrate"
"8697","Sildenafil Mylan 50 mg film-coated tablets","50 milligram(s) Film-coated tablet",2010-11-19,"PA0577/141/002","McDermott Laboratories Ltd t/a Gerard Laboratories","Sildenafilcitrate"
"8698","SILDENAFIL PFIZER","25 Milligram                                                                                            Film Coated Tablet",2012-07-06,"PA0822/153/001","Pfizer Healthcare Ireland","SILDENAFILCITRATE"
"8699","Sildenafil Pfizer 100 mg Film-coated Tablets","100 milligram(s) Film-coated tablet",2012-07-06,"PA0822/153/003","Pfizer Healthcare Ireland","Sildenafilcitrate"
"8700","Sildenafil Pfizer 50 mg film-coated Tablets","50 milligram(s) Film-coated tablet",2012-07-06,"PA0822/153/002","Pfizer Healthcare Ireland","Sildenafilcitrate"
"8701","SILDENAFIL RATIOPHARM","25 Milligram                                                                                            Film Coated Tablet",2009-12-23,"EU/1/09/603/1-4","Ratiopharm GmbH","SILDENAFIL"
"8702","Sildenafil ratiopharm","50 milligram(s) Film-coated tablet",2009-12-23,"EU/1/09/603/5-8","Ratiopharm GmbH","Sildenafil"
"8703","Sildenafil ratiopharm","100 milligram(s) Film-coated tablet",2009-12-23,"EU/1/09/603/9-12","Ratiopharm GmbH","Sildenafil"
"8704","SILDENAFIL TEVA","100 Milligram                                                                                            Film Coated Tablet",2009-11-30,"EU/1/09/584/14-18","Teva B.V.","SILDENAFILCITRATE"
"8705","SILDENAFIL TEVA","25 Milligram                                                                                            Film Coated Tablet",2009-11-30,"EU/1/09/584/1-6","Teva B.V.","SILDENAFILCITRATE"
"8706","SILDENAFIL TEVA","50 Milligram                                                                                            Film Coated Tablet",2009-11-30,"EU/1/09/584/8-12","Teva B.V.","SILDENAFILCITRATE"
"8707","SILDENAFIL TEVA","20 Milligram                                                                                            Film Coated Tablet",2016-12-02,"PA1986/031/001","Teva B.V.","SILDENAFIL"
"8708","SILGARD","Per Cent                                                                                             Suspension for Injection",2006-09-20,"EU/1/06/358/01-21","Merck Sharp and Dohme Limited","HPVTYPE6L1PROTEIN|HPVTYPE11L1PROTEIN|HPVTYPE16L1|HPVTYPE18L1|AMORPHOUSALUMINUMHYDROXYPHOSPHATESULPHATEADJUVANT"
"8709","SILICA","6c-200c",2009-12-22,"HOR1154/018/001","Helios Homeopathy Ltd","SILICIAPRECIPITATED"
"8710","SILICA (SIL.)","6C & 30C  Tablets",2009-11-20,"HOR0407/009/001","Weleda (UK) Limited","ACIDUMSILICICUM"
"8711","Silkis 3 micrograms per g ointment","3 microgram(s) Ointment",2006-07-07,"PA0590/021/001","Galderma (UK) Ltd","Calcitriol"
"8712","Silodyx","4 milligram(s) Capsule, hard",2010-01-29,"EU/1/09/607/1-7","Recordati Ireland Limited","Silodosin"
"8713","SILODYX","8 Milligram                                                                                            Capsules Hard",2010-01-29,"EU/1/09/607/8-14","Recordati Ireland Limited","SILODOSIN"
"8714","SIMALVIA","60/300 mg/mg Capsules, Soft",2014-12-05,"PA1927/001/001","Laboratoires Galeniques Vernin","ALVERINECITRATE|SIMETICONE"
"8715","SIMBRINZA","10 Mg/Ml Eye Drops Suspension",2014-07-18,"EU/1/14/933/001-002","Novartis Europharm Limited","BRINZOLAMIDE|BRIMONIDINETARTRATE"
"8716","Simponi","100 milligram(s)/millilitre Solution for injection",NA,"EU/1/09/546/005-008","Janssen Biologics B.V.","Golimumab"
"8717","Simponi","50 milligram(s) Solution for injection",2009-10-01,"EU/1/09/546/1-4","Janssen Biologics B.V.","Golimumab(cnto148)"
"8718","SIMTAN","5 Milligram                                                                                            Film Coated Tablet",2003-07-25,"PA0126/125/001","Clonmel Healthcare Ltd","SIMVASTATIN"
"8719","SIMTAN","10 Milligram                                                                                            Film Coated Tablet",2003-07-25,"PA0126/125/002","Clonmel Healthcare Ltd","SIMVASTATIN"
"8720","SIMTAN","20 Milligram                                                                                            Film Coated Tablet",2003-07-25,"PA0126/125/003","Clonmel Healthcare Ltd","SIMVASTATIN"
"8721","SIMTAN","40 Milligram                                                                                            Film Coated Tablet",2003-07-25,"PA0126/125/004","Clonmel Healthcare Ltd","SIMVASTATIN"
"8722","SIMULECT","20 Milligram                                                                                            Pdr for Soln for Infusion",1998-10-09,"EU/1/98/084/001","Novartis Europharm Limited","BASILIXIMAB"
"8723","SIMULECT","10 Milligram                                                                                            Pdr for Soln for Infusion",2003-03-07,"EU/1/98/084/002","Novartis Europharm Limited","BASILIXIMAB"
"8724","SIMVASTATIN","10 Milligram                                                                                            Film Coated Tablet",2004-04-29,"PA0577/054/001","McDermott Laboratories Ltd t/a Gerard Laboratories","SIMVASTATIN"
"8725","SIMVASTATIN","20 Milligram                                                                                            Film Coated Tablet",2004-04-29,"PA0577/054/002","McDermott Laboratories Ltd t/a Gerard Laboratories","SIMVASTATIN"
"8726","SIMVASTATIN","40 Milligram                                                                                            Film Coated Tablet",2004-04-29,"PA0577/054/003","McDermott Laboratories Ltd t/a Gerard Laboratories","SIMVASTATIN"
"8727","SIMVASTATIN","80 Milligram                                                                                            Film Coated Tablet",2004-04-29,"PA0577/054/004","McDermott Laboratories Ltd t/a Gerard Laboratories","SIMVASTATIN"
"8728","Simvastatin 20 mg film-coated tablets","20 milligram(s) Film-coated tablet",2001-10-19,"PA0740/003/003","Genthon B.V.","Simvastatin"
"8729","Simvastatin 40 mg film-coated tablets","40 milligram(s) Film-coated tablet",2001-10-19,"PA0740/003/004","Genthon B.V.","Simvastatin"
"8730","Simvastatin Actavis 10 mg film-coated tablets","10 milligram(s) Film-coated tablet",2009-06-19,"PA1380/062/001","Actavis Group PTC ehf","Simvastatin"
"8731","Simvastatin Actavis 20 mg film-coated tablets","20 milligram(s) Film-coated tablet",2009-06-19,"PA1380/062/002","Actavis Group PTC ehf","Simvastatin"
"8732","Simvastatin Actavis 40 mg film-coated tablets","40 milligram(s) Film-coated tablet",2009-06-19,"PA1380/062/003","Actavis Group PTC ehf","Simvastatin"
"8733","Simvastatin Bluefish 10 mg film-coated tablets","10 milligram(s) Film-coated tablet",2008-11-21,"PA1436/003/001","Bluefish Pharmaceuticals AB","Simvastatin"
"8734","Simvastatin Bluefish 20mg film-coated tablets","20 milligram(s) Film-coated tablet",2008-11-21,"PA1436/003/002","Bluefish Pharmaceuticals AB","Simvastatin"
"8735","Simvastatin Bluefish 40mg film-coated tablets","40 milligram(s) Film-coated tablet",2008-11-21,"PA1436/003/003","Bluefish Pharmaceuticals AB","Simvastatin"
"8736","SIMVASTATIN KRKA","10 Milligram                                                                                            Film Coated Tablet",2003-06-30,"PA1347/028/001","Krka d.d., Novo mesto","SIMVASTATIN"
"8737","SIMVASTATIN KRKA","20 Milligram                                                                                            Film Coated Tablet",2003-06-30,"PA1347/028/002","Krka d.d., Novo mesto","SIMVASTATIN"
"8738","SIMVASTATIN KRKA","40 Milligram                                                                                            Film Coated Tablet",2003-06-30,"PA1347/028/003","Krka d.d., Novo mesto","SIMVASTATIN"
"8739","Simvastatin Rosemont 20mg/5ml Oral Suspension","20 mg/5ml Oral suspension",2013-08-23,"PA0312/031/001","Rosemont Pharmaceuticals Ltd","Simvastatin"
"8740","Simvastatin Rosemont 40mg/5ml Oral Suspension","40 mg/5ml Oral suspension",2013-08-23,"PA0312/031/002","Rosemont Pharmaceuticals Ltd","Simvastatin"
"8741","Simvastatin Teva 10 mg Film-coated Tablets","10 milligram(s) Film-coated tablet",2007-10-26,"PA0749/052/002","Teva Pharma B.V.","Simvastatin"
"8742","Simvastatin Teva 20 mg Film-coated Tablets","20 milligram(s) Film-coated tablet",2007-10-26,"PA0749/052/003","Teva Pharma B.V.","Simvastatin"
"8743","Simvastatin Teva 40 mg Film-coated Tablets","40 milligram(s) Film-coated tablet",2007-10-26,"PA0749/052/004","Teva Pharma B.V.","Simvastatin"
"8744","SINEMET","12.5/50 Milligram                                                                                            Tablets",1990-02-08,"PA1286/009/002","Merck Sharp & Dohme Ireland (Human Health) Limited","CARBIDOPA|LEVODOPA"
"8745","Sinemet 10mg/100mg Tablets","10/100 milligram(s) Tablet",1979-04-01,"PA1286/009/003","Merck Sharp & Dohme Ireland (Human Health) Limited","Carbidopa|Levodopa|Levodopa"
"8746","Sinemet 25mg/250mg Tablets","25/250 milligram(s) Tablet",1979-04-01,"PA1286/009/005","Merck Sharp & Dohme Ireland (Human Health) Limited","Levodopa|Carbidopa|Carbidopa"
"8747","SINEMET 62.5","12.5/50 Milligram                                                                                            Tablet Prolonged Release",2007-06-20,"DPR1392/007/001","Eurodrug Ltd","CARBIDOPA|LEVODOPA"
"8748","SINEMET CR","50/200 Milligram                                                                                            Tablet Prolonged Release",2009-11-02,"DPR1392/007/004","Eurodrug Ltd","LEVODOPA|CARBIDOPA"
"8749","SINEMET CR","200/50 Milligram                                                                                            Tablets",1991-12-10,"PA1286/009/006","Merck Sharp & Dohme Ireland (Human Health) Limited","LEVODOPA|CARBIDOPA"
"8750","SINEMET CR","50/200 Milligram                                                                                            Tablet Prolonged Release",2004-04-30,"PPA1151/001/001A","Imbat Limited","LEVODOPA|CARBIDOPA"
"8751","SINEMET PLUS","25/100 Milligram                                                                                            Tablets",2004-05-21,"PPA1151/001/003","Imbat Limited","LEVODOPA|CARBIDOPA"
"8752","SINEMET PLUS","25/100 Milligram                                                                                            Tablets",2006-04-07,"PPA0465/148/003","PCO Manufacturing","CARBIDOPA|LEVODOPA"
"8753","SINEMET PLUS","25/100 Milligram                                                                                            Tablet Prolonged Release",2007-06-20,"DPR1392/007/003","Eurodrug Ltd","CARBIDOPA|LEVODOPA"
"8754","Sinemet Plus 25mg/100mg Tablets","25/100 milligram(s) Tablet",1981-03-02,"PA1286/009/004","Merck Sharp & Dohme Ireland (Human Health) Limited","Levodopa|Levodopa|Carbidopa|Carbidopa"
"8755","SINGULAIR","10 Milligram                                                                                            Film Coated Tablet",1998-02-20,"PA1286/046/004","Merck Sharp & Dohme Ireland (Human Health) Limited","MONTELUKASTSODIUM"
"8756","SINGULAIR","10 Milligram                                                                                            Film Coated Tablet",2009-05-06,"DPR1392/035/001","Eurodrug Ltd","MONTELUKASTSODIUM"
"8757","SINGULAIR","10 Milligram                                                                                            Film Coated Tablet",2013-07-26,"PPA1151/203/003","Imbat Limited","MONTELUKAST"
"8758","SINGULAIR","10 Milligram                                                                                            Film Coated Tablet",2014-02-28,"PPA1562/104/001","LTT Pharma Limited","MONTELUKASTSODIUM"
"8759","Singulair 10 mg Film-coated Tablets","10 milligram(s) Film-coated tablet",2012-05-11,"PPA1463/064/003","IMED Healthcare Ltd.","Montelukast"
"8760","Singulair 10mg film-coated tablets","10 milligram(s) Film-coated tablet",2004-03-19,"PPA0465/111/001","PCO Manufacturing","Montelukast"
"8761","SINGULAIR ALLERGY","10 Milligram                                                                                            Film Coated Tablet",2004-03-31,"PA1286/046/005","Merck Sharp & Dohme Ireland (Human Health) Limited","MONTELUKASTSODIUM"
"8762","SINGULAIR PAEDIATRIC","4 Milligram                                                                                            Tablets Chewable",1998-02-20,"PA1286/046/001","Merck Sharp & Dohme Ireland (Human Health) Limited","MONTELUKASTSODIUM"
"8763","SINGULAIR PAEDIATRIC","4 Milligram                                                                                            Granules",2003-03-07,"PA1286/046/002","Merck Sharp & Dohme Ireland (Human Health) Limited","MONTELUKASTSODIUM"
"8764","SINGULAIR PAEDIATRIC","5 Milligram                                                                                            Tablets Chewable",1998-02-20,"PA1286/046/003","Merck Sharp & Dohme Ireland (Human Health) Limited","MONTELUKASTSODIUM"
"8765","SINGULAIR PAEDIATRIC","4 Milligram                                                                                            Tablets Chewable",2013-07-26,"PPA1151/203/001","Imbat Limited","MONTELUKASTSODIUM"
"8766","SINGULAIR PAEDIATRIC","5 Milligram                                                                                            Tablets Chewable",2013-07-26,"PPA1151/203/002","Imbat Limited","MONTELUKASTSODIUM"
"8767","Singulair Paediatric 4 mg Chewable Tablets","4 milligram(s) Chewable tablet",2012-05-11,"PPA1463/064/001","IMED Healthcare Ltd.","Montelukast"
"8768","Singulair Paediatric 4 mg chewable tablets","4 milligram(s) Chewable tablet",2012-08-17,"PPA0465/111/003","PCO Manufacturing","Montelukast"
"8769","Singulair Paediatric 5 mg chewable tablets","5 milligram(s) Chewable tablet",2007-01-19,"PPA0465/111/002","PCO Manufacturing","Montelukastsodium"
"8770","Singulair Paediatric 5 mg Chewable Tablets","5 milligram(s) Chewable tablet",2012-05-11,"PPA1463/064/002","IMED Healthcare Ltd.","Montelukast"
"8771","SIRDUPLA","25mcg/125 Microgram                                                                                            Pressurised Inhalation Suspension",2017-02-03,"PA0405/100/001","Generics (UK) Limited","SALMETEROLXINAFOATE|FLUTICASONEPROPIONATE"
"8772","SIRDUPLA","25mcg/250 Microgram                                                                                            Pressurised Inhalation Suspension",2017-02-03,"PA0405/100/002","Generics (UK) Limited","SALMETEROLXINAFOATE|FLUTICASONEPROPIONATE"
"8773","Sirturo","100 milligram(s) Tablet",NA,"EU/1/13/901/001","Janssen-Cilag International NV","Bedaquilinefumarate"
"8774","SITAGLIPTIN TEVA","100 Milligram                                                                                            Film Coated Tablet",2016-09-02,"PA1986/020/001","Teva B.V.","SITAGLIPTIN"
"8775","SIVATIN","10 Milligram                                                                                            Film Coated Tablet",2002-04-19,"PA0711/050/001","Rowex Ltd","SIMVASTATIN"
"8776","SIVATIN","20 Milligram                                                                                            Film Coated Tablet",2002-04-19,"PA0711/050/002","Rowex Ltd","SIMVASTATIN"
"8777","SIVATIN","40 Milligram                                                                                            Film Coated Tablet",2002-04-19,"PA0711/050/003","Rowex Ltd","SIMVASTATIN"
"8778","Sivextro","200 milligram(s) Film-coated tablet",NA,"EU/1/15/991/001","Merck Sharp & Dohme Ltd","Tedizolidphosphate"
"8779","SIVEXTRO","200 Milligram                                                                                            Pdr/Conc/Soln for Infus",2015-03-23,"EU/1/15/991/002-003","Merck Sharp & Dohme BV","TEDIZOLIDPHOSPHATE"
"8780","SIX PLUS PARAPAED PARACETAMOL ORAL SUSPENSION 250","250 MG/5ml                                                                                               Oral Suspension",1994-05-20,"PA0281/002/003","Pinewood Laboratories Ltd,","PARACETAMOL"
"8781","Skilarence","30 milligram(s) Gastro-resistant tablet",NA,"EU/1/17/1201/001","Almirall, S.A.","Dimethylfumarate"
"8782","SKILARENCE","120 Milligram                                                                                            Tablets Gastro-Resistant",2017-06-23,"EU/1/17/1201/002-011","Almirall, S.A.","DIMETHYLFUMARATE"
"8783","SKINOREN","15 Per Cent                                                                                             Gel",2003-06-30,"PA1410/072/002","Bayer Limited","AZELAICACID"
"8784","SKUDEXA","75mg/25 Unknown Granules for oral solution",2018-04-06,"PA0865/020/003","Menarini International Operations Luxembourg S.A.","TRAMADOLHYDROCHLORIDE|DEXKETOPROFENTROMETAMOL"
"8785","Skudexa 75 mg/25 mg film-coated tablets","75/25 milligram(s) Film-coated tablet",2016-02-26,"PA0865/020/001","Menarini International Operations Luxembourg S.A.","Tramadolhydrochloride|Dexketoprofentrometamol"
"8786","Slenyto","1 milligram(s) Prolonged-release tablet",2018-09-20,"EU/1/18/1318/001-002","RAD Neurim Pharmaceuticals EEC Limited","Melatonin"
"8787","Slenyto","5 milligram(s) Prolonged-release tablet",2018-09-20,"EU/1/18/1318/003-004","RAD Neurim Pharmaceuticals EEC Limited","Melatonin"
"8788","SLOW K","600 Milligram                                                                                            Tablet Prolonged Release",1977-02-17,"PA1994/002/001","Essential Pharma Ltd","POTASSIUMCHLORIDE"
"8789","SmofKabiven Central emulsion for infusion, Biofine bags","0 gram(s) Emulsion for infusion",2009-11-27,"PA0566/046/002","Fresenius Kabi Limited","Soyabeanoil,refined|Mediumchaintriglycerides|Refinedsoyabeanoil|Fishoil,richinomega-3acids|L-alanine|L-arginine|Glycine(aminoaceticacid)|L-histidine|L-isoleucine|L-leucine|L-lysine|L-methionine|L-phenylalanine|L-proline|L-serine|Taurine|L-threonine|L-tryptophan|L-tyrosine|L-valine|Calciumchloride|Sodiumglycerophosphate|Magnesiumsulfate|Potassiumchloride|Sodiumacetate|Zincsulfate|Glucose"
"8790","SmofKabiven Central emulsion for infusion, Excel bags","0 gram(s) Emulsion for infusion",2009-08-28,"PA0566/046/001","Fresenius Kabi Limited","L-alanine|L-arginine|GLYCINE|L-histidine|L-isoleucine|L-leucine|L-lysine|L-methionine|L-phenylalanine|L-proline|L-serine|Taurine|L-threonine|L-tryptophan|L-tyrosine|L-valine|Calciumchloride|Sodiumglycerophophatehydrate|Magnesiumsulphateheptahydrate|Potassiumchloride|Sodiumacetatetrihydrate|Zincsulphateheptahydrate|Glucosemonohydrate|Soyabeanoil,refined|Triglycerides,mediumchain|Oliveoil,refined|Fishoil,richinomega-3acids"
"8791","SmofKabiven Electrolyte Free Central emulsion for infusion, Biofine bags","0 *** AWAITING VALUE *** Emulsion for infusion",2009-11-27,"PA0566/047/002","Fresenius Kabi Limited","L-alanine|L-arginine|GLYCINE|L-histidine|L-isoleucine|L-leucine|L-lysineacetate|L-methionine|L-phenylalanine|L-proline|L-serine|Taurine|L-threonine|L-tryptophan|L-tyrosine|L-valine|Glucosemonohydrate|Soyabeanoil,refined|Triglycerides,mediumchain|Oliveoil,refined|Fishoil,richinomega-3acids"
"8792","SmofKabiven Electrolyte Free Central emulsion for infusion, Excel bags","0 gram(s) Emulsion for infusion",2009-08-28,"PA0566/047/001","Fresenius Kabi Limited","L-alanine|L-arginine|GLYCINE|L-histidine|L-isoleucine|L-leucine|L-lysineacetate|L-methionine|L-phenylalanine|L-proline|L-serine|Taurine|L-threonine|L-tryptophan|L-tyrosine|L-valine|Glucosemonohydrate|Soyabeanoil,refined|Soya-beanoil,refined|Triglycerides,mediumchain|Oliveoil,refined|Fishoil,richinomega-3acids"
"8793","SmofKabiven extra Nitrogen Electrolyte free, emulsion for infusion","0 *** AWAITING VALUE *** Emulsion for infusion",2017-08-25,"PA0566/076/002","Fresenius Kabi Limited","Alanine|Arginine|GLYCINE|Histidine|Isoleucine|Leucine|Lysineacetate|Methionine|Phenylalanine|Proline|Serine|Taurine|Tryptophan|Tyrosine|Valine|GLUCOSEMONOHYDRATE|Soya-beanoil,refined|Soyabeanoil,refined|Triglyceridesmedium-chain|Oliveoil,refined|Fishoil,richinomega-3acids"
"8794","SmofKabiven extra Nitrogen, emulsion for infusion","0 *** AWAITING VALUE *** Emulsion for infusion",2017-08-25,"PA0566/076/001","Fresenius Kabi Limited","Alanine|Arginine|GLYCINE|Histidine|Isoleucine|Leucine|Lysineacetate|Methionine|Phenylalanine|Proline|Serine|Taurine|Tryptophan|Tyrosine|Valine|Calciumchloridedihydrate|Sodiumglycerophophatehydrate|Magnesiumsulfateheptahydrate|Potassiumchloride|Sodiumacetatetrihydrate|Zincsulphateheptahydrate|GLUCOSEMONOHYDRATE|Soya-beanoil,refined|Soyabeanoil,refined|Triglyceridesmedium-chain|Oliveoil,refined|Fishoil,richinomega-3acids"
"8795","SmofKabiven Peripheral, emulsion for infusion, Biofine bag","0 *** AWAITING VALUE *** Emulsion for infusion",2009-09-18,"PA0566/051/002","Fresenius Kabi Limited","SOYABEANOIL,REFINEDPH.EUR.|Mediumchaintriglycerides|Refinedoliveoil|Fishoil,richinomega-3acids|Isoleucine|Leucine|Methionine|Lysineacetate|Phenylalanine|Threonine|Tryptophan|Valine|Arginine|Histidine|Alanine|GLYCINE|Proline|Serine|Tyrosine|Taurine|Calciumchloridedihydrate|Sodiumglycerophophatehydrate|MAGNESIUMSULPHATEHEPTAHYDRATE|Potassiumchloride|Sodiumacetatetrihydrate|Zincsulphateheptahydrate|Glucosemonohydrate"
"8796","SmofKabiven Peripheral, emulsion for infusion, Excel bag","0 *** AWAITING VALUE *** Emulsion for infusion",2009-02-13,"PA0566/051/001","Fresenius Kabi Limited","SoyaBeanOil,RefinedPh.Eur|Mediumchaintriglycerides|Refinedoliveoil|Fishoil,richinomega-3acids|Isoleucine|Leucine|Methionine|Lysineacetate|Phenylalanine|Threonine|Tryptophan|Valine|Arginine|Histidine|Alanine|GLYCINE|Proline|Serine|Tyrosine|Taurine|Calciumchloridedihydrate|Sodiumglycerophophatehydrate|MAGNESIUMSULPHATEHEPTAHYDRATE|Potassiumchloride|Sodiumacetatetrihydrate|Zincsulphateheptahydrate|Glucosemonohydrate"
"8797","SMOFLIPID","20% Per Cent                                                                                             Emulsion for Infusion",2004-10-27,"PA0566/035/001","Fresenius Kabi Limited","SOYBEANOIL|TRIGLYCERIDES,MEDIUMCHAIN|REFINEDOLIVEOIL|PURIFIEDFISHOIL"
"8798","SMOFLIPID","20% Per Cent                                                                                             Emulsion for Infusion",2007-08-03,"PA0566/035/002","Fresenius Kabi Limited","SOYAOIL|MEDIUMCHAINTRIGLYCERIDES|REFINEDOLIVEOIL|PURIFIEDFISHOIL"
"8799","SODIUM BICARBONATE","8.4 %w/v                                                                                                 Solution for Injection",1977-09-08,"PA0255/001/004","International Medication Systems (UK) Ltd","SODIUMBICARBONATE"
"8800","SODIUM CHLORIDE","0.9 %w/v                                                                                                 Intravenous Inf Solution",1983-04-01,"PA0167/008/005","Baxter Healthcare Limited","SODIUMCHLORIDE"
"8801","SODIUM CHLORIDE","0.9 %w/v                                                                                                 Solution for Infusion",2003-08-22,"PA0566/032/001","Fresenius Kabi Limited","SODIUMCHLORIDE"
"8802","SODIUM CHLORIDE","0.9 %w/v                                                                                                 Solution for Infusion",2003-08-22,"PA0566/032/002","Fresenius Kabi Limited","SODIUMCHLORIDE"
"8803","SODIUM CHLORIDE","0.9 %w/v                                                                                                 Solution for Infusion",2003-08-22,"PA0566/032/003","Fresenius Kabi Limited","SODIUMCHLORIDE"
"8804","SODIUM CHLORIDE","0.9 %w/v                                                                                                 Solution for Infusion",2003-08-22,"PA0566/032/004","Fresenius Kabi Limited","SODIUMCHLORIDE"
"8805","SODIUM CHLORIDE","0.9 %w/v                                                                                                 Solution for Infusion",2009-08-28,"PA0566/032/005","Fresenius Kabi Limited","SODIUMCHLORIDE"
"8806","SODIUM CHLORIDE","0.9 %v/w                                                                                                 Solvent for Parenteral Use",2009-08-28,"PA0566/032/006","Fresenius Kabi Limited","SODIUMCHLORIDE"
"8807","SODIUM CHLORIDE","0.9 %w/v                                                                                                 Solution for Infusion",1999-05-31,"PA0931/001/001","Maco Pharma (UK) Ltd","SODIUMCHLORIDE"
"8808","SODIUM CHLORIDE (NORMAL SALINE)","0.9 %w/v                                                                                                 Eye Drops Solution",2000-07-07,"PA0361/012/001","Martindale Pharmaceuticals Ltd","SODIUMCHLORIDE"
"8809","Sodium Chloride 0.3 % w/v and Glucose 3.3% w/v Solution for Infusion BP","0.3   3.3 percent weight/volume Solution for infusion",2004-06-18,"PA0167/050/022","Baxter Healthcare Limited","Sodiumchloride|Glucosemonohydrate"
"8810","Sodium Chloride 0.45 % w/v and Glucose 2.5% w/v Solution for Infusion BP","0.45  2.5 percent weight/volume Solution for infusion",2004-11-12,"PA0167/050/021","Baxter Healthcare Limited","Sodiumchloride|Sodiumchloride|Glucosemonohydrate|Glucosemonohydrate"
"8811","Sodium Chloride 0.45 % w/v and Glucose 5.0 % w/v Solution for Infusion BP","0.45/5 percent weight/volume Solution for infusion",2013-05-03,"PA0167/050/024","Baxter Healthcare Limited","Sodiumchloride|Glucose"
"8812","Sodium Chloride 0.45% w/v Solution for Infusion","0.45 percent weight/volume Solution for infusion",2010-07-02,"PA0167/008/016","Baxter Healthcare Limited","Sodiumchloride"
"8813","Sodium Chloride 0.9 % w/v and Glucose 5% w/v Solution for Infusion BP (Viaflo container)","0.9/5 %w/v percent weight/volume Solution for infusion",2004-04-27,"PA0167/050/020","Baxter Healthcare Limited","Sodiumchloride|Sodiumchloride|Glucosemonohydrate|Glucosemonohydrate"
"8814","Sodium Chloride 0.9% w/v Intravenous Infusion BP","0.9 percent weight/volume Solution for infusion",2003-01-10,"PA0167/008/015","Baxter Healthcare Limited","Sodiumchloride|Sodiumchloride"
"8815","Sodium Chloride 0.9% w/v Intravenous Infusion BP Solution for Infusion","0.9 percent weight/volume Solution for infusion",1998-02-06,"PA0736/003/001","B. Braun Melsungen AG","Sodiumchloride"
"8816","SODIUM CHLORIDE AND GLUCOSE","0.18/4 %w/v                                                                                                 Solution for Infusion",2007-08-24,"PA0167/050/023","Baxter Healthcare Limited","SODIUMCHLORIDE|GLUCOSEMONOHYDRATE"
"8817","SODIUM CHLORIDE BP","0.9 %w/v                                                                                                 Solution for injection and solvent for parenteral use",2008-03-14,"PA1122/002/001","Noridem Enterprises Ltd","SODIUMCHLORIDE"
"8818","SODIUM CHLORIDE INTRAVENOUS INFUSION BP","0.9 %w/v                                                                                                 Solution for Infusion",1983-04-01,"PA0179/002/007","B. Braun Medical Limited","SODIUMCHLORIDE"
"8819","SODIUM CHLORIDE INTRAVENOUS INFUSION BP","0.9 %w/v                                                                                                 Solution for Infusion",2007-03-30,"PA0179/002/031","B. Braun Medical Limited","SODIUMCHLORIDE"
"8820","SODIUM DIHYDROGEN PHOSPHATE MONOHYDRATE, DISODIUM PHOSPHATE ANHYDROUS MAYOLY SPINDLER","1500 Milligram                                                                                            Tablets",2017-09-01,"PA1993/003/001","Laboratoires Mayoly Spindler","SODIUMPHOSPHATEMONOBASIC|SODIUMPHOSPHATEDIBASIC,ANHYDROUS"
"8821","SODIUM IODIDE (I131) CAPSULE T","%v/v                                                                                                 Capsule",2001-06-29,"PA0690/006/002","Mallinckrodt Medical B.V.","SODIUMIODIDE(131I)"
"8822","SODIUM PYRROLIDONE CARBOXYLATE","2.5 %w/w                                                                                                 Cream",2006-08-11,"PA0943/013/001","Alliance Pharmaceuticals Ltd.","SODIUMPYRROLIDONECARBOXYLATE"
"8823","SOFRADEX EAR/EYE DROPS.","5.0/0.05/0 Mg/Ml Ear/Eye Drops, solution",1977-04-01,"PA0540/070/002","Sanofi-Aventis Ireland Limited T/A SANOFI","FRAMYCETINSULFATE|GRAMICIDIN|DEXAMETHASONE"
"8824","SOLARAZE","3 %w/w                                                                                                 Gel",2003-07-11,"PA0968/004/001","Almirall, S.A.","DICLOFENACSODIUM"
"8825","SOLARAZE","3 %w/w                                                                                                 Gel",2018-07-06,"PPA1097/052/001","Lexon (UK) Ltd","DICLOFENACSODIUM"
"8826","SOLARAZE","3 %w/w                                                                                                 Gel",2011-09-30,"PPA1633/015/001","Primecrown 2010 Ltd","DICLOFENACSODIUM"
"8827","SOLIAN","200 Milligram                                                                                            Tablets",2009-12-18,"PPA1151/129/001","Imbat Limited","AMISULPRIDE"
"8828","SOLIAN","50 Milligram                                                                                            Tablets",2014-06-13,"PPA1151/129/002","Imbat Limited","AMISULPRIDE"
"8829","SOLIAN","100 Milligram                                                                                            Tablets",2013-10-04,"PPA1151/129/003","Imbat Limited","AMISULPRIDE"
"8830","SOLIAN","50 Milligram                                                                                            Tablets",2014-09-19,"PPA1562/126/001","LTT Pharma Limited","AMISULPRIDE"
"8831","SOLIAN","100 Milligram                                                                                            Tablets",2014-09-19,"PPA1562/126/002","LTT Pharma Limited","AMISULPRIDE"
"8832","SOLIAN","200 Milligram                                                                                            Tablets",2014-09-19,"PPA1562/126/003","LTT Pharma Limited","AMISULPRIDE"
"8833","SOLIAN","400 Milligram                                                                                            Film Coated Tablet",2014-09-19,"PPA1562/126/004","LTT Pharma Limited","AMISULPRIDE"
"8834","SOLIAN","100 Milligram                                                                                            Tablets",2001-04-06,"PA0540/158/002","Sanofi-Aventis Ireland Limited T/A SANOFI","AMISULPRIDE"
"8835","SOLIAN","200 Milligram                                                                                            Tablets",1998-07-27,"PA0540/158/003","Sanofi-Aventis Ireland Limited T/A SANOFI","AMISULPRIDE"
"8836","SOLIAN","400 Milligram                                                                                            Film Coated Tablet",2001-04-06,"PA0540/158/004","Sanofi-Aventis Ireland Limited T/A SANOFI","AMISULPRIDE"
"8837","Solian 100mg Tablets","100 milligram(s) Tablet",2016-12-23,"PPA0465/412/003","PCO Manufacturing","Amisulpride"
"8838","Solian 200mg Tablets","200 milligram(s) Tablet",2015-05-08,"PPA0465/412/001","PCO Manufacturing","Amisulpride"
"8839","Solian 400mg Film-coated Tablets","400 milligram(s) Film-coated tablet",2016-12-23,"PPA0465/412/004","PCO Manufacturing","Amisulpride"
"8840","Solian 50mg Tablets","50 milligram(s) Tablet",2016-12-23,"PPA0465/412/002","PCO Manufacturing","Amisulpride"
"8841","Solian 50mg Tablets","50 milligram(s) Tablet",NA,"PA0540/158/001","Sanofi-Aventis Ireland Limited T/A SANOFI","Amisulpride"
"8842","SOLIFENACIN APOTEX","5 Milligram                                                                                            Film Coated Tablet",2017-08-18,"PA1513/010/001","Apotex Europe B.V.","SOLIFENACINSUCCINATE"
"8843","SOLIFENACIN APOTEX","10 Milligram                                                                                            Film Coated Tablet",2017-08-18,"PA1513/010/002","Apotex Europe B.V.","SOLIFENACINSUCCINATE"
"8844","Solifenacin Clonmel 10 mg Film-coated Tablets","10 milligram(s) Film-coated tablet",2017-07-28,"PA0126/288/002","Clonmel Healthcare Ltd","Solifenacinsuccinate"
"8845","Solifenacin Clonmel 5 mg Film-coated Tablets","5 milligram(s) Film-coated tablet",2017-07-28,"PA0126/288/001","Clonmel Healthcare Ltd","Solifenacinsuccinate"
"8846","SOLIFENACIN SUCCINATE","5 Milligram                                                                                            Film Coated Tablet",2016-03-04,"PA1390/119/001","Accord Healthcare Limited","SOLIFENACINSUCCINATE"
"8847","SOLIFENACIN SUCCINATE","10 Milligram                                                                                            Film Coated Tablet",2016-03-04,"PA1390/119/002","Accord Healthcare Limited","SOLIFENACINSUCCINATE"
"8848","Solifenacin succinate 10mg film-coated tablets","10 milligram(s) Film-coated tablet",2015-10-09,"PA0405/074/002","Generics (UK) Limited","Solifenacinsuccinate"
"8849","Solifenacin succinate 5mg film-coated tablets","5 milligram(s) Film-coated tablet",2015-10-09,"PA0405/074/001","Generics (UK) Limited","Solifenacinsuccinate"
"8850","SOLIFENACIN SUCCINATE ROWEX","5 Milligram                                                                                            Film Coated Tablet",2018-04-13,"PA0711/280/001","Rowex Ltd","SOLIFENACINSUCCINATE"
"8851","SOLIFENACIN SUCCINATE ROWEX","10 Milligram                                                                                            Film Coated Tablet",2018-04-13,"PA0711/280/002","Rowex Ltd","SOLIFENACINSUCCINATE"
"8852","SOLIFENACIN TAD","5 Milligram                                                                                            Film Coated Tablet",2017-11-24,"PA0876/008/001","TAD Pharma GmbH","SOLIFENACINSUCCINATE"
"8853","SOLIFENACIN TAD","10 Milligram                                                                                            Film Coated Tablet",2017-11-24,"PA0876/008/002","TAD Pharma GmbH","SOLIFENACINSUCCINATE"
"8854","Solifenacin Teva 10mg film coated tablets","10 milligram(s) Film-coated tablet",2017-03-31,"PA1986/039/002","Teva B.V.","Solifenacinsuccinate"
"8855","Solifenacin Teva 5mg film coated tablets","5 milligram(s) Film-coated tablet",2017-03-31,"PA1986/039/001","Teva B.V.","Solifenacinsuccinate"
"8856","SOLIRIS","300 Milligram                                                                                            Concentrate for Soln for Inf",2007-06-20,"EU/1/07/393/001","Alexion Europe SAS","ECULIZUMAB"
"8857","Solivito N Powder for Concentrate for Solution for Infusion","10 millilitre(s) ZZZ Pdr/Conc/Soln for Infus",1999-12-10,"PA0566/016/001","Fresenius Kabi Limited","Thiaminemononitrate|Riboflavinsodiumphosphate|Nicotinamide|Pyridoxinehydrochloride|Sodiumpantothenate|Biotin|Folicacid|Cyanocobalamin|Sodiumascorbate"
"8858","SOLPADEINE","500/8/30 Milligram                                                                                            Tablets",1993-10-29,"PA1186/011/003","Chefaro Ireland DAC","PARACETAMOL|CODEINEPHOSPHATEHEMIHYDRATE|CAFFEINE"
"8859","SOLPADEINE CAPSULES","500830 Milligram                                                                                            Capsules Hard",1992-08-24,"PA1186/011/002","Chefaro Ireland DAC","PARACETAMOL|CAFFEINE|CODEINEPHOSPHATEHEMIHYDRATE"
"8860","SOLPADEINE SOLUBLE TABLETS","500/30/8 Milligram                                                                                            Tablets Effervescent",1978-04-01,"PA1186/011/001","Chefaro Ireland DAC","PARACETAMOL|CAFFEINE|CODEINEPHOSPHATEHEMIHYDRATE"
"8861","SOLPADOL","500/30 Milligram                                                                                            Tablets Effervescent",1991-06-26,"PA0540/159/003","Sanofi-Aventis Ireland Limited T/A SANOFI","PARACETAMOL|CODEINEPHOSPHATEHEMIHYDRATE"
"8862","SOLPADOL","500/30 Milligram                                                                                            Tablets Effervescent",2014-02-28,"PPA1151/191/002","Imbat Limited","PARACETAMOL|CODEINEPHOSPHATEHEMIHYDRATE"
"8863","SOLPADOL CAPLETS","500/30 Milligram                                                                                            Tablets",1991-06-26,"PA0540/159/001","Sanofi-Aventis Ireland Limited T/A SANOFI","PARACETAMOL|CODEINEPHOSPHATEHEMIHYDRATE"
"8864","Solpadol Caplets 500 mg/30 mg Tablets","500/30 milligram(s) Tablet",2014-02-28,"PPA1151/191/001","Imbat Limited","Paracetamol|Codeinephosphatehemihydrate"
"8865","Solpa-Extra 500 mg/65 mg Soluble Tablets","500/65 milligram(s) Tablet",2017-01-27,"PA1186/017/001","Chefaro Ireland DAC","Caffeine|PARACETAMOL"
"8866","SOLPA-PLUS TABLETS PARACETAMOL 500MG CODEINE PHOSPHATE HEMIHYDRATE 12.8MG","500/12.8 Milligram                                                                                            Film Coated Tablet",2017-03-20,"PA1186/011/005","Chefaro Ireland DAC","PARACETAMOL|CODEINEPHOSPHATEHEMIHYDRATE"
"8867","SOLPA-PLUS WITH CAFFEINE SOLUBLE TABLETS PARACETAMOL 500MG, CODEINE PHOSPHATE HEMIHYDRATE 12.8MG, CAFFEINE 30MG","500mg/30mg/12.8 Milligram                                                                                            Tablets Effervescent",2017-03-10,"PA1186/011/004","Chefaro Ireland DAC","PARACETAMOL|CODEINEPHOSPHATEHEMIHYDRATE|CAFFEINE"
"8868","SOLPA-SINUS","500/30 Milligram                                                                                            Film Coated Tablet",2003-11-28,"PA1186/012/001","Chefaro Ireland DAC","PARACETAMOL|PSEUDOEPHEDRINEHYDROCHLORIDE"
"8869","Solu-Cortef Powder for Solution for Injection or Infusion 100mg","100 milligram(s) Powder and solvent for solution for injection/infusion",1978-04-01,"PA0822/137/001","Pfizer Healthcare Ireland","HYDROCORTISONEPH.EUR."
"8870","Solu-Medrone powder and solvent for solution for injection or concentrate for solution for infusion 1000 mg/vial","1000 milligram/vial Powder and solvent for solution for injection",NA,"PA0822/136/004","Pfizer Healthcare Ireland","MethylprednisoloneHydrogenSuccinatePh.Eur."
"8871","Solu-Medrone powder and solvent for solution for injection or concentrate for solution for infusion 125 mg/vial","125 milligram/vial Powder and solvent for solution for injection",NA,"PA0822/136/002","Pfizer Healthcare Ireland","MethylprednisoloneHydrogenSuccinatePh.Eur."
"8872","Solu-Medrone powder and solvent for solution for injection or concentrate for solution for infusion 40 mg/vial","40 milligram/vial Powder and solvent for solution for injection",NA,"PA0822/136/001","Pfizer Healthcare Ireland","MethylprednisoloneHydrogenSuccinatePh.Eur."
"8873","Solu-Medrone powder and solvent for solution for injection or concentrate for solution for infusion 500 mg/vial","500 milligram/vial Powder and solvent for solution for injection",NA,"PA0822/136/003","Pfizer Healthcare Ireland","MethylprednisoloneHydrogenSuccinatePh.Eur."
"8874","SOLUPRICK NEGATIVE CONTROL","Unknown",2006-04-28,"PA1255/003/002","ALK-Abello A/S",""
"8875","SOLUPRICK POSITIVE CONTROL","10 Milligram                                                                                            Unknown",2006-04-28,"PA1255/003/001","ALK-Abello A/S","HISTAMINEDIHYDROCHLORIDE"
"8876","SOLUPRICK SQ TIMOTHY GRASS (PHLEUM PRATENSE)","10 HEP Unknown Unknown",2008-06-09,"PA1255/005/001","ALK-Abello A/S","PHLEUMPRATENSE"
"8877","SOMAC CONTROL","20 Milligram                                                                                            Tablets Gastro-Resistant",2009-06-12,"EU/1/09/516/001","Takeda GmbH","PANTOPRAZOLESODIUMSESQUIHYDRATE"
"8878","SOMAC CONTROL","20 Milligram                                                                                            Tablets Gastro-Resistant",2009-06-12,"EU/1/09/516/002","Takeda GmbH","PANTOPRAZOLESODIUMSESQUIHYDRATE"
"8879","SOMAC CONTROL","20 Milligram                                                                                            Tablets Gastro-Resistant",2009-06-12,"EU/1/09/516/003","Takeda GmbH","PANTOPRAZOLESODIUMSESQUIHYDRATE"
"8880","SOMAC CONTROL","20 Milligram                                                                                            Tablets Gastro-Resistant",2009-06-12,"EU/1/09/516/004","Takeda GmbH","PANTOPRAZOLESODIUMSESQUIHYDRATE"
"8881","SOMAKIT TOC","40 Microgram                                                                                            Kit for radiopharmaceutical preparation",2016-12-08,"EU/1/16/1141/001","Advanced Accelerator Applications","EDOTEOTIDE"
"8882","SOMATROPIN BIOPARTNERS","2 Milligram                                                                                            Pdr+Solv for Susp for Inj",2013-08-05,"EU/1/13/849/001","BioPartners GmbH","SOMATROPIN,RECOMBINANTHUMANGROWTHHORMONE"
"8883","SOMATROPIN BIOPARTNERS","4 Milligram                                                                                            Pdr+Solv for Susp for Inj",2013-08-05,"EU/1/13/849/002","BioPartners GmbH","SOMATROPIN,RECOMBINANTHUMANGROWTHHORMONE"
"8884","SOMATROPIN BIOPARTNERS","7 Milligram                                                                                            Pdr+Solv for Susp for Inj",2013-08-05,"EU/1/13/849/003","BioPartners GmbH","SOMATROPIN,RECOMBINANTHUMANGROWTHHORMONE"
"8885","SOMATROPIN BIOPARTNERS","10 Milligram                                                                                            Pdr+Solv for Susp for Inj",2013-08-05,"EU/1/13/849/004-005","BioPartners GmbH","SOMATROPIN,RECOMBINANTHUMANGROWTHHORMONE"
"8886","SOMATROPIN BIOPARTNERS","20 Milligram                                                                                            Pdr+Solv for Susp for Inj",2013-08-05,"EU/1/13/849/006-007","BioPartners GmbH","SOMATROPIN,RECOMBINANTHUMANGROWTHHORMONE"
"8887","Somatuline Autogel 120mg, solution for injection in a pre-filled syringe","120 milligram(s) Solution for injection",2002-02-22,"PA0869/004/004","Ipsen Pharmaceuticals Limited","Lanreotideacetate"
"8888","Somatuline Autogel 60 mg, solution for injection in a prefilled syringe","60 milligram(s) Solution for injection",2002-02-22,"PA0869/004/002","Ipsen Pharmaceuticals Limited","Lanreotideacetate"
"8889","Somatuline Autogel 90mg, solution for injection in a pre-filled syringe","90 milligram(s) Solution for injection",2002-02-22,"PA0869/004/003","Ipsen Pharmaceuticals Limited","Lanreotideacetate"
"8890","SOMATULINE LA","30 Milligram                                                                                            Pdr+Solv for Susp for Inj",1998-06-15,"PA0869/004/001","Ipsen Pharmaceuticals Limited","LANREOTIDEACETATE"
"8891","Somavert","25 milligram(s) Powder and solvent for solution for injection",2015-07-17,"EU/1/02/240/009-010","Pfizer Europe MA EEIG","Pegvisomant"
"8892","Somavert","30 milligram(s) Powder and solvent for solution for injection",2015-07-17,"EU/1/02/240/011-012","Pfizer Limited","Pegvisomant"
"8893","Somavert","10, 15, 20 milligram(s) Powder and solvent for solution for injection",2002-11-13,"EU/1/02/240/1-3","Pfizer Europe MA EEIG","Pegvisomant"
"8894","SONOVUE","8 Microlitre                                                                                         Pdr+Solv for soln for Inf",2001-03-26,"EU/1/01/177/002","Bracco International B.V.","SULPHURHEXAFLUORIDE"
"8895","SOOLANTRA","10 mg/g Cream",2015-04-24,"PA0590/028/001","Galderma (UK) Ltd","IVERMECTIN"
"8896","SOOLANTRA","10 mg/g Cream",2017-10-20,"PPA1097/030/001","Lexon (UK) Ltd","IVERMECTIN"
"8897","SOOTHAKE TOOTHACHE TINCTURE","0.7/10.0 %w/w                                                                                                 Gingival solution",2003-04-04,"PA1904/004/001","Optima Consumer Health Limited","LIDOCAINEHYDROCHLORIDE|CLOVEOIL"
"8898","SOPROL","5 Milligram                                                                                            Film Coated Tablet",2001-01-12,"PA0749/180/001","Teva Pharma B.V.","BISOPROLOLFUMARATE"
"8899","SOPROL","10 Milligram                                                                                            Film Coated Tablet",2001-01-12,"PA0749/180/002","Teva Pharma B.V.","BISOPROLOLFUMARATE"
"8900","SORMON","60 Milligram                                                                                            Tablet Prolonged Release",1999-08-23,"PA0405/037/001","Generics (UK) Limited","ISOSORBIDE-5-MONONITRATE"
"8901","SOTACOR","80 Milligram                                                                                            Tablets",2008-05-23,"PPA1151/066/001","Imbat Limited","SOTALOLHYDROCHLORIDE"
"8902","Sotoger 80mg Tablets","80 milligram(s) Tablet",1996-06-24,"PA0577/021/001","McDermott Laboratories Ltd t/a Gerard Laboratories","SOTALOLHYDROCHLORIDE"
"8903","Sovaldi","400 milligram(s) Film-coated tablet",2014-01-16,"EU/1/13/894/001-002","Gilead Sciences International","Sofosbuvir"
"8904","Spasmonal 60mg hard Capsules","60 milligram(s) Capsule, hard",1993-10-18,"PA2010/043/001","Mylan IRE Healthcare Limited","ALVERINECITRATE"
"8905","SPASMONAL FORTE","120 Milligram                                                                                            Capsules Hard",2009-10-14,"DPR1392/050/001","Eurodrug Ltd","ALVERINECITRATE"
"8906","Spasmonal Forte 120mg Hard Capsules","120 milligram(s) Capsule, hard",2000-04-14,"PA2010/043/002","Mylan IRE Healthcare Limited","ALVERINECITRATE"
"8907","Spectrila","10.000 international unit(s) Powder and solvent for solution for injection/infusion",2016-01-14,"EU/1/15/1072/001-002","Medac Gesellschaft fur Klinische Spezialpraparate mbH","Recombinantl-asparaginase"
"8908","SPEDRA","50 Milligram                                                                                            Tablets",2013-06-21,"EU/1/13/841/001-003","Menarini International Operations Luxembourg S.A.","AVANAFIL"
"8909","SPEDRA","100 Milligram                                                                                            Tablets",2013-06-21,"EU/1/13/841/004-007","Menarini International Operations Luxembourg S.A.","AVANAFIL"
"8910","SPEDRA","200 Milligram                                                                                            Tablets",2013-06-21,"EU/1/13/841/008-010","Menarini International Operations Luxembourg S.A.","AVANAFIL"
"8911","Spherox 10-70 spheroids/ cm2 implantation suspension","10-70 soheroids/ square centimeter Implantation suspension",2017-07-10,"EU/1/17/1181/001-002","co.don AG","Spheroidsofhumanautologousmatrix-associatedchondrocytes"
"8912","SPINRAZA","12 Milligram                                                                                            Solution for Injection",2017-05-30,"EU/1/17/1188/001","Biogen Idec Research Limited","NUSINERSEN"
"8913","SPIOLTO RESPIMAT","2.5/2.5 Microgram                                                                                            Inhalation Solution",2018-06-01,"PPA1097/048/001","Lexon (UK) Ltd","TIOTROPIUM|OLODATEROL"
"8914","Spiolto Respimat 2.5 microgram/2.5 microgram, inhalation solution","2.5/2.5 microgram(s) ZZZ Solution for Inhalation",2015-06-19,"PA0775/009/001","Boehringer Ingelheim International GmbH","Olodaterolhydrochloride|Tiotropiumbromidemonohydrate"
"8915","SPIRIVA","18 Microgram                                                                                            Inhalation Powder, Capsule",2007-08-24,"PPA0465/186/001","PCO Manufacturing","TIOTROPIUMBROMIDE"
"8916","SPIRIVA","18 Microgram                                                                                            Inhalation Powder, Capsule",2006-11-27,"PPA1151/018/001","Imbat Limited","TIOTROPIUMBROMIDE"
"8917","SPIRIVA","18 Microgram                                                                                            Inhalation Powder, Capsule",2011-02-11,"PPA1463/044/001","IMED Healthcare Ltd.","TIOTROPIUMBROMIDE"
"8918","SPIRIVA","18 Microgram                                                                                            Inhalation Powder, Capsule",2012-08-17,"PPA1633/020/001","Primecrown 2010 Ltd","TIOTROPIUMBROMIDE"
"8919","SPIRIVA 18 microgram, inhalation powder, hard capsule","18 microgram(s) ZZZ Inhalation Powder, Capsule",2002-06-28,"PA0775/002/001","Boehringer Ingelheim International GmbH","Tiotropium"
"8920","SPIRIVA RESPIMAT","2.5 Microgram                                                                                            Solution for Inhalation",2012-07-06,"PPA0465/286/001","PCO Manufacturing","TIOTROPIUM"
"8921","SPIRIVA RESPIMAT","2.5 Microgram                                                                                            Solution for Inhalation",NA,"DPR1463/045/001","IMED Healthcare Ltd.","TIOTROPIUMBROMIDE"
"8922","SPIRIVA RESPIMAT","2.5 Microgram                                                                                            Solution for Inhalation",2011-04-14,"DPR1633/008/001","Primecrown 2010 Ltd","TIOTROPIUM"
"8923","SPIRIVA RESPIMAT","2.5 Microgram                                                                                            Solution for Inhalation",2009-10-14,"DPR1392/049/001","Eurodrug Ltd","TIOTROPIUM"
"8924","SPIRIVA RESPIMAT","2.5 Microgram                                                                                            Solution for Inhalation",2009-06-04,"DPR0465/032/001","PCO Manufacturing","TIOTROPIUM"
"8925","SPIRIVA RESPIMAT","2.5 Microgram                                                                                            Solution for Inhalation",2012-11-16,"PPA1463/044/002","IMED Healthcare Ltd.","TIOTROPIUM"
"8926","SPIRIVA RESPIMAT","2.5 Microgram                                                                                            Solution for Inhalation",2011-09-30,"PPA1151/018/002","Imbat Limited","TIOTROPIUM"
"8927","Spiriva Respimat 2.5 microgram, inhalation solution","2.5 microgram(s) Inhalation solution",2007-09-14,"PA0775/002/002","Boehringer Ingelheim International GmbH","Tiotropium"
"8928","SPIRONOLACTONE","25 Milligram                                                                                            Film Coated Tablet",2016-01-29,"PA1390/117/001","Accord Healthcare Limited","SPIRONOLACTONE"
"8929","SPIRONOLACTONE","50 Milligram                                                                                            Film Coated Tablet",2016-01-29,"PA1390/117/002","Accord Healthcare Limited","SPIRONOLACTONE"
"8930","SPIRONOLACTONE","100 Milligram                                                                                            Film Coated Tablet",2016-01-29,"PA1390/117/003","Accord Healthcare Limited","SPIRONOLACTONE"
"8931","SPORANOX","100 Milligram                                                                                            Capsule",2014-08-22,"PPA0465/400/001","PCO Manufacturing","ITRACONAZOLE"
"8932","SPORANOX","10mg/ml Mg/Ml Oral Solution",1997-09-05,"PA0748/009/001","Janssen-Cilag Ltd","ITRACONAZOLE"
"8933","SPORANOX","100 Milligram                                                                                            Capsules Hard",2008-02-01,"PPA1151/058/001","Imbat Limited","ITRACONAZOLE"
"8934","Sporanox 100 mg Capsules","100 milligram(s) Capsule",2012-07-06,"PPA1097/063/001","Lexon (UK) Ltd","Itraconazole"
"8935","Sporanox 100mg Capsules","100 milligram(s) Capsule, hard",1991-12-16,"PA0748/009/002","Janssen-Cilag Ltd","Itraconazole"
"8936","SPORANOX I.V.","10 Mg/Ml Concentrate for Soln for Inf",2003-08-22,"PA0748/009/004","Janssen-Cilag Ltd","ITRACONAZOLE"
"8937","SPRILON","1.0/12.5 %w/w                                                                                                 Cutaneous Spray Solution",1996-05-21,"PA0501/005/001","Ayrton Saunders Ltd","DIMETICONE|ZINCOXIDE"
"8938","SPRYCEL","100 Milligram                                                                                            Film Coated Tablet",NA,"EU/1/06/363/010-11","Bristol Myers Squibb Pharma EEIG","DASATINIB"
"8939","SPRYCEL","80 Milligram                                                                                            Film Coated Tablet",2010-10-25,"EU/1/06/363/012-013","Bristol Myers Squibb Pharma EEIG","DASATINIB"
"8940","SPRYCEL","140 Milligram                                                                                            Film Coated Tablet",2010-10-25,"EU/1/06/363/014-015","Bristol Myers Squibb Pharma EEIG","DASATINIB"
"8941","SPRYCEL","10 Mg/Ml Powder for Oral Suspension",2018-07-02,"EU/1/06/363/016","Bristol-Myers Squibb Pharma EEIG","DASATINIB"
"8942","SPRYCEL","20 Milligram                                                                                            Tablets",2006-11-20,"EU/1/06/363/1-4-7","Bristol Myers Squibb Pharma EEIG","DASATINIB"
"8943","SPRYCEL","50 Milligram                                                                                            Tablets",2006-11-20,"EU/1/06/363/2-5-8","Bristol Myers Squibb Pharma EEIG","DASATINIB"
"8944","SPRYCEL","70 Milligram                                                                                            Tablets",2006-01-20,"EU/1/06/363/3-6-9","Bristol Myers Squibb Pharma EEIG","DASATINIB"
"8945","SRIVASSO","18 Microgram                                                                                            Inhalation Powder, Capsule",2015-08-13,"PA0775/008/001","Boehringer Ingelheim International GmbH","TIOTROPIUMBROMIDEMONOHYDRATE"
"8946","STALEVO","Milligram                                                                                            Film Coated Tablet",2003-10-17,"EU/1/03/260/001-004,13,16","Orion Corporation","LEVODOPA|CARBIDOPA|ENTACAPONE"
"8947","STALEVO","Infus/Pdr/Oral Soln",0001-01-01,"EU/1/03/260/005-008,14,17","Orion Corporation",""
"8948","STALEVO","Infus/Pdr/Oral Soln",0001-01-01,"EU/1/03/260/009-012,15,18","Orion Corporation",""
"8949","STALEVO","175/43.75 Milligram                                                                                            Film Coated Tablet",2011-08-24,"EU/1/03/260/034-038","Orion Corporation","ENTACAPONE|LEVODOPA|CARBIDOPA"
"8950","STALEVO","200/50/200 Milligram                                                                                            Film Coated Tablet",2008-04-21,"EU/1/03/260/19-23","Orion Corporation","ENTACAPONE|LEVODOPA|CARBIDOPA"
"8951","STALEVO","75/18.75/200 Milligram                                                                                            Film Coated Tablet",2009-03-27,"EU/1/03/260/24-28","Orion Corporation","ENTACAPONE|LEVODOPA|CARBIDOPAMONOHYDRATE"
"8952","STALEVO","25/31.25/200 Milligram                                                                                            Film Coated Tablet",2009-03-27,"EU/1/03/260/29-33","Orion Corporation","ENTACAPONE|LEVODOPA|CARBIDOPAMONOHYDRATE"
"8953","STAMARIL YELLOW FEVER VACCINE (LIVE)","1000 Unknown Suspension for Injection",NA,"PA2131/008/001","Sanofi Pasteur","YELLOWFEVERVIRUS17D-204STRAIN"
"8954","STAMICIS","1 Milligram                                                                                            Lyophilisate for solution for injection",2008-12-12,"PA0677/018/001","CIS bio International","TETRAKIS(2-METHOXYISOBUTYLISONITRILE)COPPER(I)TETRAFLUOROLBORATE"
"8955","STANDARDISED BETADINE ANTISEPTIC","10 Mg/Ml Cutaneous Solution",1983-04-01,"PA0501/006/010","Ayrton Saunders Ltd","POVIDONE-IODINE"
"8956","Standardised Betadine Antiseptic 100mg/ml Cutaneous Solution","10 percent weight/volume Cutaneous solution",1993-04-01,"PA0696/002/003","Seton Healthcare Group PLC","Povidone-iodine"
"8957","STARLIX FILM-COATED","60 Milligram                                                                                            Tablets",2001-04-03,"EU/1/01/174/001","Novartis Europharm Limited","NATEGLINIDE"
"8958","STARLIX FILM-COATED","60 Milligram                                                                                            Tablets",2001-04-03,"EU/1/01/174/003","Novartis Europharm Limited","NATEGLINIDE"
"8959","STARLIX FILM-COATED","60 Milligram                                                                                            Tablets",2001-04-03,"EU/1/01/174/004","Novartis Europharm Limited","NATEGLINIDE"
"8960","STARLIX FILM-COATED","60 Milligram                                                                                            Tablets",2001-04-03,"EU/1/01/174/005","Novartis Europharm Limited","NATEGLINIDE"
"8961","STARLIX FILM-COATED","60 Milligram                                                                                            Tablets",2001-04-03,"EU/1/01/174/006","Novartis Europharm Limited","NATEGLINIDE"
"8962","STARLIX FILM-COATED","60 Milligram                                                                                            Tablets",2001-04-03,"EU/1/01/174/007","Novartis Europharm Limited","NATEGLINIDE"
"8963","STARLIX FILM-COATED","120 Milligram                                                                                            Tablets",2001-04-03,"EU/1/01/174/008","Novartis Europharm Limited","NATEGLINIDE"
"8964","STARLIX FILM-COATED","120 Milligram                                                                                            Tablets",2001-04-03,"EU/1/01/174/009","Novartis Europharm Limited","NATEGLINIDE"
"8965","STARLIX FILM-COATED","120 Milligram                                                                                            Tablets",2001-04-03,"EU/1/01/174/010","Novartis Europharm Limited","NATEGLINIDE"
"8966","STARLIX FILM-COATED","120 Milligram                                                                                            Tablets",2001-04-03,"EU/1/01/174/011","Novartis Europharm Limited","NATEGLINIDE"
"8967","STARLIX FILM-COATED","120 Milligram                                                                                            Tablets",2001-04-03,"EU/1/01/174/012","Novartis Europharm Limited","NATEGLINIDE"
"8968","STARLIX FILM-COATED","120 Milligram                                                                                            Tablets",2001-04-03,"EU/1/01/174/013","Novartis Europharm Limited","NATEGLINIDE"
"8969","STARLIX FILM-COATED","120 Milligram                                                                                            Tablets",2001-04-03,"EU/1/01/174/014","Novartis Europharm Limited","NATEGLINIDE"
"8970","STARLIX FILM-COATED","180 Milligram                                                                                            Tablets",2001-04-03,"EU/1/01/174/015","Novartis Europharm Limited","NATEGLINIDE"
"8971","STARLIX FILM-COATED","180 Milligram                                                                                            Tablets",2001-04-03,"EU/1/01/174/016","Novartis Europharm Limited","NATEGLINIDE"
"8972","STARLIX FILM-COATED","180 Milligram                                                                                            Tablets",2001-04-03,"EU/1/01/174/017","Novartis Europharm Limited","NATEGLINIDE"
"8973","STARLIX FILM-COATED","180 Milligram                                                                                            Tablets",2001-04-03,"EU/1/01/174/018","Novartis Europharm Limited","NATEGLINIDE"
"8974","STARLIX FILM-COATED","180 Milligram                                                                                            Tablets",2001-04-03,"EU/1/01/174/019","Novartis Europharm Limited","NATEGLINIDE"
"8975","STARLIX FILM-COATED","180 Milligram                                                                                            Tablets",2001-04-03,"EU/1/01/174/020","Novartis Europharm Limited","NATEGLINIDE"
"8976","STARLIX FILM-COATED","180 Milligram                                                                                            Tablets",2001-04-03,"EU/1/01/174/021","Novartis Europharm Limited","NATEGLINIDE"
"8977","Stayveer","62.5 milligram(s) Film-coated tablet",NA,"EU/1/13/832/001","Marklas Nederland BV","Bosentanmonohydrate"
"8978","STAYVEER","125 Milligram                                                                                            Film Coated Tablet",2013-06-24,"EU/1/13/832/002","Marklas Nederland BV","BOSENTANMONOHYDRATE"
"8979","Steglatro","5 milligram(s) Film-coated tablet",2018-03-21,"EU/1/18/1267/001-006","Merck Sharp & Dohme BV","Ertugliflozinl-pyroglutamicacid"
"8980","Steglatro","15 milligram(s) Film-coated tablet",2018-03-21,"EU/1/18/1267/007-012","Merck Sharp & Dohme BV","Ertugliflozinl-pyroglutamicacid"
"8981","Steglujan","5/100 milligram(s) Film-coated tablet",2018-03-23,"EU/1/18/1266/001-006","Merck Sharp & Dohme BV","Sitagliptinphosphatemonohydrate|Ertugliflozinl-pyroglutamicacid"
"8982","Steglujan","15/100 milligram(s) Film-coated tablet",2018-03-23,"EU/1/18/1266/007-012","Merck Sharp & Dohme BV","Sitagliptinphosphatemonohydrate|Ertugliflozinl-pyroglutamicacid"
"8983","STELARA","45 milligram(s) Solution for injection in pre-filled syringe",NA,"EU/1/08/494/003","Janssen-Cilag International NV","Ustekinumab"
"8984","STELARA","90 milligram(s) Solution for injection in pre-filled syringe",2010-03-11,"EU/1/08/494/004","Janssen-Cilag International NV","Ustekinumab"
"8985","STELARA","130 milligram(s) Concentrate for solution for infusion",2016-11-11,"EU/1/08/494/005","Janssen-Cilag International NV","Ustekinumab"
"8986","STELARA","45 milligram(s) Solution for injection",2009-01-16,"EU/1/08/494/1","Janssen-Cilag International NV","Ustekinumab"
"8987","STELARA","90 milligram(s) Solution for injection",2009-01-16,"EU/1/08/494/2","Janssen-Cilag International NV","Ustekinumab"
"8988","STELAZINE","1 Milligram                                                                                            Film Coated Tablet",1977-04-01,"PA0899/003/001","Mercury Pharmaceuticals Ltd","TRIFLUOPERAZINE"
"8989","STELAZINE","5 Milligram                                                                                            Film Coated Tablet",1977-04-01,"PA0899/003/002","Mercury Pharmaceuticals Ltd","TRIFLUOPERAZINE"
"8990","STELAZINE 1MG/5ML SYRUP.","1 MG/5ml                                                                                               Syrup",1997-04-01,"PA0899/003/006","Mercury Pharmaceuticals Ltd","TRIFLUOPERAZINE"
"8991","STEMETIL","12.5 Mg/Ml Solution for Injection",1977-04-01,"PA0540/127/002","Sanofi-Aventis Ireland Limited T/A SANOFI","PROCHLORPERAZINEMESILATE"
"8992","STEMETIL","5 Milligram                                                                                            Tablets",1977-04-01,"PA0540/127/005","Sanofi-Aventis Ireland Limited T/A SANOFI","PROCHLORPERAZINEMALEATE"
"8993","Sterets Tisept Sachets 0.015% w/v and 0.15% w/v Cutaneous Solution","0.015/0.15 percent volume/volume Cutaneous solution",1988-05-30,"PA1175/014/001","Medlock Medical Ltd","Chlorhexidinegluconate|Cetrimide"
"8994","Sterets Unisept 0.05% w/v Cutaneous Solution","0.05%w/v percent weight/volume Cutaneous solution",1988-05-30,"PA1175/015/001","Medlock Medical Ltd","Chlorhexidinegluconate"
"8995","STERILE CONCENTRATE FOR CARDIOPLEGIA INFUSION","Grams                                                                                                Concentrate for Soln for Inf",2001-09-07,"PA0361/014/001","Martindale Pharmaceuticals Ltd","MAGNESIUMCHLORIDEANHYDROUS|POTASSIUMCHLORIDE|PROCAINEHYDROCHLORIDE"
"8996","STERILE DOBUTAMINE HYDROCHLORIDE CONCENTRATE","12.5 Mg/Ml Concentrate for Soln for Inf",1996-01-03,"PA0437/036/001","Hospira  UK Limited","DOBUTAMINEHYDROCHLORIDE"
"8997","STERILE DOPAMINE CONCENTRATE BP","40 Mg/Ml Concentrate for Soln for Inf",1989-08-17,"PA0073/108/001","Mercury Pharmaceuticals (Ireland) Ltd","DOPAMINEHYDROCHLORIDE"
"8998","STERILE DOPAMINE CONCENTRATE BP","160 Mg/Ml Concentrate for Soln for Inf",1989-08-17,"PA0073/108/002","Mercury Pharmaceuticals (Ireland) Ltd","DOPAMINEHYDROCHLORIDE"
"8999","STERILE SODIUM CHLORIDE CONCENTRATE","30 %w/v                                                                                                 Concentrate for Soln for Inf",2006-05-05,"PA0274/001/001","Macarthys Laboratories Limited","SODIUMCHLORIDEPH.EUR."
"9000","Stesolid rectal solution 10mg","10 milligram(s) Rectal solution",1992-10-14,"PA1390/141/002","Accord Healthcare Limited","Diazepam"
"9001","Stesolid rectal solution 5mg","5 milligram(s) Rectal solution",1992-10-14,"PA1390/141/001","Accord Healthcare Limited","Diazepam"
"9002","Stieprox 15 mg/g Shampoo","15 milligram(s)/gram Shampoo",2001-10-05,"PA1077/130/001","GlaxoSmithKline (Ireland) Limited","CICLOPIROXOLAMINE"
"9003","STILNOCT","10 Milligram                                                                                            Film Coated Tablet",2017-01-20,"PPA0465/420/001","PCO Manufacturing","ZOLPIDEMTARTRATE"
"9004","STILNOCT","10 Milligram                                                                                            Film Coated Tablet",2007-05-04,"PPA1151/030/001","Imbat Limited","ZOLPIDEMTARTRATE"
"9005","STILNOCT","5 Milligram                                                                                            Tablets",2009-03-13,"PPA1151/030/002","Imbat Limited","ZOLPIDEMTARTRATE"
"9006","Stilnoct 10 mg Film-coated Tablets","10mg milligram(s) Tablet",1998-02-25,"PA0077/147/002","Sanofi-aventis Ireland Ltd","ZOLPIDEMTARTRATE"
"9007","Stilnoct 10mg Film-coated Tablets","10 milligram(s) Film-coated tablet",1993-02-25,"PA0540/160/002","Sanofi-Aventis Ireland Limited T/A SANOFI","ZOLPIDEMTARTRATE"
"9008","Stilnoct 5 mg Film-coated Tablets","5mg milligram(s) Tablet",1998-02-25,"PA0077/147/001","Sanofi-aventis Ireland Ltd","ZOLPIDEMTARTRATE"
"9009","Stilnoct 5mg Film Coated Tablets","5 milligram(s) Tablet",1993-02-25,"PA0540/160/001","Sanofi-Aventis Ireland Limited T/A SANOFI","ZOLPIDEMTARTRATE"
"9010","Stirlescent 250mg Effervescent Tablets","250 milligram(s) Effervescent tablet",2016-01-29,"PA1944/002/001","Stirling Anglian Pharmaceuticals Ltd","Naproxen"
"9011","STIVARGA","40 Milligram                                                                                            Film Coated Tablet",2013-08-26,"EU/1/13/858/001-002","Bayer Pharma AG","REGORAFENIB"
"9012","STOCRIN","50mg Milligram                                                                                            Capsule",1999-05-28,"EU/1/99/111/001","Merck Sharp and Dohme Limited","EFAVIRENZ"
"9013","STOCRIN","100mg Milligram                                                                                            Capsule",1999-05-28,"EU/1/99/111/002","Merck Sharp & Dohme BV,","EFAVIRENZ"
"9014","STOCRIN","200 Milligram                                                                                            Capsule",1999-05-28,"EU/1/99/111/003","Merck Sharp & Dohme BV,","EFAVIRENZ"
"9015","STOCRIN","200 Milligram                                                                                            Capsule",1999-05-28,"EU/1/99/111/004","Merck Sharp & Dohme BV,","EFAVIRENZ"
"9016","STOCRIN","30 Micromol Oral Solution",2001-10-24,"EU/1/99/111/005","Merck Sharp & Dohme BV,","EFAVIRENZ"
"9017","STOCRIN","50 Milligram                                                                                            Tablets",2006-11-24,"EU/1/99/111/010","Merck Sharp & Dohme BV,","EFAVIRENZ"
"9018","STOCRIN","200 Milligram                                                                                            Tablets",2006-11-24,"EU/1/99/111/011","Merck Sharp & Dohme BV,","EFAVIRENZ"
"9019","STOCRIN FILM-COATED","%v/v                                                                                                 Tablets",2002-08-22,"EU/1/99/111/6-7","Merck Sharp & Dohme BV,","EFAVIRENZ"
"9020","STOCRIN FILM-COATED","%v/v                                                                                                 Tablets",2002-08-22,"EU/1/99/111/8-9","Merck Sharp & Dohme BV,","EFAVIRENZ"
"9021","STRATTERA","10 Milligram                                                                                            Capsules Hard",2009-10-05,"DPR0465/038/001","PCO Manufacturing","ATOMOXETINEHYDROCHLORIDE"
"9022","STRATTERA","25 Milligram                                                                                            Capsules Hard",2009-10-05,"DPR0465/038/002","PCO Manufacturing","ATOMOXETINEHYDROCHLORIDE"
"9023","STRATTERA","40 Milligram                                                                                            Capsules Hard",2009-10-05,"DPR0465/038/003","PCO Manufacturing","ATOMOXETINEHYDROCHLORIDE"
"9024","STRATTERA","10 Milligram                                                                                            Capsules Hard",2006-02-10,"PA2276/007/001","Eli Lilly Nederland B.V.","ATOMOXETINEHYDROCHLORIDE"
"9025","STRATTERA","18 Milligram                                                                                            Capsules Hard",2006-02-10,"PA2276/007/002","Eli Lilly Nederland B.V.","ATOMOXETINEHYDROCHLORIDE"
"9026","STRATTERA","25 Milligram                                                                                            Capsules Hard",2006-02-10,"PA2276/007/003","Eli Lilly Nederland B.V.","ATOMOXETINEHYDROCHLORIDE"
"9027","STRATTERA","40 Milligram                                                                                            Capsules Hard",2006-02-10,"PA2276/007/004","Eli Lilly Nederland B.V.","ATOMOXETINEHYDROCHLORIDE"
"9028","STRATTERA","60 Milligram                                                                                            Capsules Hard",2006-02-10,"PA2276/007/005","Eli Lilly Nederland B.V.","ATOMOXETINEHYDROCHLORIDE"
"9029","STRATTERA","80 Milligram                                                                                            Capsules Hard",2006-02-10,"PA2276/007/006","Eli Lilly Nederland B.V.","ATOMOXETINEHYDROCHLORIDE"
"9030","STRATTERA","100 Milligram                                                                                            Capsules Hard",2006-02-10,"PA2276/007/007","Eli Lilly Nederland B.V.","ATOMOXETINEHYDROCHLORIDE"
"9031","Strattera 4mg/ml Oral Solution","4 milligram(s)/millilitre Oral solution",2014-11-07,"PA2276/007/008","Eli Lilly Nederland B.V.","ATOMOXETINE"
"9032","STRENSIQ","40 Mg/Ml Solution for Injection",2015-08-28,"EU/1/15/1015/001-002","Alexion Europe SAS","ASFOTASEALFA"
"9033","STRENSIQ","100 Mg/Ml Solution for Injection",2015-08-28,"EU/1/15/1015/003-004","Alexion Europe SAS","ASFOTASEALFA"
"9034","STREPSILS +PLUS ANAESTHETIC","0.6/1.2/10 Milligram                                                                                            Lozenges",1995-10-03,"PA0979/040/001","Reckitt Benckiser Ireland Ltd","2,4-DICHLOROBENZYLALCOHOL|AMYLMETACRESOLB.P.|LIDOCAINEHYDROCHLORIDEPH.EUR."
"9035","STREPSILS +PLUS ANAESTHETIC THROAT SPRAY","0.29 / 0.5 Milligram                                                                                            Oromucosal Spray",1996-07-25,"PA0979/040/002","Reckitt Benckiser Ireland Ltd","AMYLMETACRESOL|DICHLOROBENZYLALCOHOL|LIDOCAINE"
"9036","STREPSILS EXTRA BLACKCURRANT","2.4 Milligram                                                                                            Lozenges",2005-06-10,"PA0979/042/001","Reckitt Benckiser Ireland Ltd","HEXYLRESORCINOL"
"9037","STREPSILS EXTRA BLACKCURRANT","2.4mg milligram(s) Lozenge",NA,"PA0043/041/001","Crookes Healthcare Ltd","Hexylresorcinol"
"9038","STREPSILS HONEY AND LEMON","0.6/1.2 Milligram                                                                                            Lozenges",1986-10-16,"PA0979/038/002","Reckitt Benckiser Ireland Ltd","AMYLMETACRESOL|DICHLOROBENZYLALCOHOL"
"9039","STREPSILS INTENSIVE","8.75 Milligram                                                                                            Lozenges",2003-03-07,"PA0979/041/001","Reckitt Benckiser Ireland Ltd","FLURBIPROFEN"
"9040","STREPSILS INTENSIVE","8.75 Mg/Dose                                                                                              Oromucosal Spray, Soln",2014-11-03,"PA0979/041/005","Reckitt Benckiser Ireland Ltd","FLURBIPROFEN"
"9041","STREPSILS INTENSIVE","percent volume/volume Lozenge",NA,"PA0043/025/001","Crookes Healthcare Ltd","Flurbiprofen"
"9042","STREPSILS INTENSIVE ORANGE SUGAR FREE","8.75 Milligram                                                                                            Lozenges",2014-07-04,"PA0979/041/004","Reckitt Benckiser Ireland Ltd","FLURBIPROFEN"
"9043","STREPSILS ORANGE WITH VITAMIN C","100 Milligram                                                                                            Lozenges",1985-09-24,"PA0979/039/001","Reckitt Benckiser Ireland Ltd","AMYLMETACRESOLB.P.|2,4-DICHLOROBENZYLALCOHOL|ASCORBICACID"
"9044","STREPSILS ORIGINAL","percent volume/volume Lozenge",NA,"PA0043/003/001","Crookes Healthcare Ltd","Amylmetacresol|Dichlorobenzylalcohol"
"9045","STREPSILS SORE THROAT AND BLOCKED NOSE","0.6/1.2/8 Milligram                                                                                            Lozenges",1991-01-30,"PA0979/060/001","Reckitt Benckiser Ireland Ltd","AMYLMETACRESOL|LEVOMENTHOL|DICHLOROBENZYLALCOHOL"
"9046","STREPSILS STRAWBERRY SUGAR FREE","N/A Lozenges",1997-05-02,"PA0979/038/003","Reckitt Benckiser Ireland Ltd","AMYLMETACRESOL|DICHLOROBENZYLALCOHOL"
"9047","STREPSILS SUGAR FREE","percent volume/volume Lozenge",NA,"PA0043/003/003","Crookes Healthcare Ltd","Amylmetacresol|Dichlorobenzylalcohol"
"9048","STREPSILS WARM","0.6/1.2 Milligram                                                                                            Lozenges",2009-07-24,"PA0979/058/001","Reckitt Benckiser Ireland Ltd","AMYLMETACRESOL|2,4-DICHLOROBENZYLALCOHOL"
"9049","Strepsils with Vitamin C 100mg Lozenges","percent volume/volume Lozenge",NA,"PA0043/009/001","Crookes Healthcare Ltd","Amylmetacresol|Dichlorobenzylalcohol|Vitaminc|Levomenthol"
"9050","STRIBILD","150/150/200/245 Milligram                                                                                            Film Coated Tablet",NA,"EU/1/13/830/001","Gilead Sciences International","ELVITEGRAVIR|COBICISTAT|EMTRICITABINE|TENOFOVIRDISOPROXIL"
"9051","Strimvelis","1-10 million ZZZ 20 Milligram Dispersion for infusion",NA,"EU/1/16/1097/001","Orchard Therapeutics (Netherlands) B.V.","Autologouscd34+enrichedcellfraction"
"9052","Striverdi Respimat 2.5 microgram, inhalation solution","2.5 microgram(s) Inhalation solution",2013-10-18,"PA0775/006/001","Boehringer Ingelheim International GmbH","Olodaterol"
"9053","STUGERON","15 Milligram                                                                                            Tablets",1993-04-19,"PA0330/044/001","Johnson & Johnson (Ireland) Limited","CINNARIZINE"
"9054","Stugeron 25 mg Tablets","25 milligram(s) Tablet",1979-04-01,"PA0330/044/002","Johnson & Johnson (Ireland) Limited","Cinnarizine"
"9055","SUBCUVIA","160 g/l                                                                                                  Solution for Injection",2005-06-24,"PA2004/007/001","Baxalta Innovations GmbH","HUMANPLASMAPROTEIN&gt;95%IMMUNOGLOBULINS"
"9056","Sublimaze 50 micrograms/ml, Solution for Injection","50 microgram(s)/millilitre Solution for injection",1997-06-10,"PA2187/002/001","Piramal Critical Care Limited","FENTANYLCITRATE"
"9057","SUBOXONE","16/4 Milligram                                                                                            Tablet Sublingual",2006-09-26,"EU/1/06/359/005-006","RB Pharmaceuticals Limited","BUPRENORPHINEHYDROCHLORIDE|NALOXONEHYDROCHLORIDEDIHYDRATE"
"9058","SUBOXONE","2/0.5 Milligram                                                                                            Tablet Sublingual",2006-09-26,"EU/1/06/359/01-02","RB Pharmaceuticals Limited","BUPRENORPHINEHYDROCHLORIDE|NALOXONEHYDROCHLORIDE"
"9059","SUBOXONE","8/2 Milligram                                                                                            Tablet Sublingual",2006-09-26,"EU/1/06/359/03-04","RB Pharmaceuticals Limited","BUPRENORPHINEHYDROCHLORIDE|NALOXONEHYDROCHLORIDE"
"9060","SUBUTEX","0.4 Milligram                                                                                            Tablet Sublingual",2002-08-16,"PA1657/001/001","RB Pharmaceuticals Limited","BUPRENORPHINEHYDROCHLORIDE"
"9061","SUBUTEX","2 Milligram                                                                                            Tablet Sublingual",2002-08-16,"PA1657/001/002","RB Pharmaceuticals Limited","BUPRENORPHINEHYDROCHLORIDE"
"9062","SUBUTEX","8 Milligram                                                                                            Tablet Sublingual",2002-08-16,"PA1657/001/003","RB Pharmaceuticals Limited","BUPRENORPHINEHYDROCHLORIDE"
"9063","Sudafed 0.1% w/v Nasal spray solution","0.1 percent weight/volume Nasal spray, solution",2003-06-30,"PA0330/027/001","Johnson & Johnson (Ireland) Limited","XYLOMETAZOLINEHYDROCHLORIDE"
"9064","SUDOCREM, ANTISEPTIC HEALING CREAM","%w/w                                                                                                 Cream",1978-04-01,"PA0247/001/001","Forest Tosara Limited","ZINCOXIDE|WOOLFAT|BENZYLBENZOATE|BENZYLCINNAMATE|BENZYLALCOHOL"
"9065","SULFUR","6C & 30C  Tablets",2009-11-20,"HOR0407/010/001","Weleda (UK) Limited","SULFUR"
"9066","SULFUR","4X - MM",2011-06-30,"HOR1149/029/001","A. Nelson & Company Limited","SULFUR"
"9067","Suliqua","100units/ml and 50 microgram(s)/millilitre Solution for injection in pre-filled pen",2017-01-11,"EU/1/16/1157/001-002","sanofi-aventis groupe","Insulinglargine|Lixisenatide"
"9068","SULIQUA","100units/ml and 33 Microgram/ML                                                                                         Solution for injection in pre-filled pen",2017-01-11,"EU/1/16/1157/003-004","sanofi-aventis groupe","INSULINGLARGINE|LIXISENATIDE"
"9069","SUMATRAN 100 mg Tablets","100 milligram(s) Tablet",2006-01-27,"PA0711/081/002","Rowex Ltd","Sumatriptan"
"9070","SUMATRAN 50 mg Tablets","50 milligram(s) Tablet",2006-01-27,"PA0711/081/001","Rowex Ltd","Sumatriptan"
"9071","Sumatran Relief 50mg Tablets","50 milligram(s) Tablet",2017-08-04,"PA0711/272/001","Rowex Ltd","Sumatriptansuccinate"
"9072","SUMATRIPTAN","50 Milligram                                                                                            Film Coated Tablet",2013-06-14,"PA1390/093/001","Accord Healthcare Limited","SUMATRIPTANSUCCINATE"
"9073","SUMATRIPTAN","100 Milligram                                                                                            Film Coated Tablet",2013-06-14,"PA1390/093/002","Accord Healthcare Limited","SUMATRIPTANSUCCINATE"
"9074","SUPRANE","240ml Millilitre                                                                                           Inhalation Vapour Solution",1999-12-16,"PA0167/105/001","Baxter Healthcare Limited","DESFLURANE"
"9075","SUPRAX","200 Milligram                                                                                            Tablets",1989-01-05,"PA0540/016/002","Sanofi-Aventis Ireland Limited T/A SANOFI","CEFIXIME"
"9076","SUPRECUR","150 Mcg/Dose                                                                                             Nasal Spray Solution",1991-02-27,"PA0540/073/002","Sanofi-Aventis Ireland Limited T/A SANOFI","BUSERELINACETATE"
"9077","SUPREFACT","1 Micromol Solution for Injection",1986-08-28,"PA0540/074/001","Sanofi-Aventis Ireland Limited T/A SANOFI","BUSERELINACETATE"
"9078","SURMONTIL 25MG FILM-COATED TABLETS","25 Milligram                                                                                            Film Coated Tablet",1978-04-01,"PA0540/128/005","Sanofi-Aventis Ireland Limited T/A SANOFI","TRIMIPRAMINEMALEATE"
"9079","SURMONTIL 50MG HARD CAPSULES","50 Milligram                                                                                            Capsules Hard",1978-04-01,"PA0540/128/003","Sanofi-Aventis Ireland Limited T/A SANOFI","TRIMIPRAMINEMALEATE"
"9080","SUSTIVA","50mg Milligram                                                                                            Capsule",1999-05-28,"EU/1/99/110/001","Bristol-Myers Squibb Pharma","EFAVIRENZ"
"9081","SUSTIVA","100 Milligram                                                                                            Capsule",1999-05-28,"EU/1/99/110/002","Bristol-Myers Squibb Pharma","EFAVIRENZ"
"9082","SUSTIVA","200 Milligram                                                                                            Capsule",1999-05-28,"EU/1/99/110/003","Bristol-Myers Squibb Pharma","EFAVIRENZ"
"9083","SUSTIVA","200 Milligram                                                                                            Capsule",1999-05-28,"EU/1/99/110/004","Bristol-Myers Squibb Pharma","EFAVIRENZ"
"9084","SUSTIVA","30 Mg/Ml Oral Solution",2001-10-18,"EU/1/99/110/005","Bristol-Myers Squibb Pharma","EFAVIRENZ"
"9085","SUSTIVA","300 Milligram                                                                                            Coated Tablets",2002-08-22,"EU/1/99/110/006","Bristol-Myers Squibb Pharma","EFAVIRENZ"
"9086","SUSTIVA","300 Milligram                                                                                            Coated Tablets",2002-08-22,"EU/1/99/110/007","Bristol-Myers Squibb Pharma","EFAVIRENZ"
"9087","SUSTIVA","600 Milligram                                                                                            Coated Tablets",2002-08-22,"EU/1/99/110/008","Bristol-Myers Squibb Pharma","EFAVIRENZ"
"9088","SUSTIVA","600 Milligram                                                                                            Coated Tablets",2002-08-22,"EU/1/99/110/009","Bristol-Myers Squibb Pharma","EFAVIRENZ"
"9089","Sutent","12.5 milligram(s) Capsule, hard",2006-07-19,"EU/1/06/347/001","Pfizer Europe MA EEIG","Sunitinibmalate"
"9090","Sutent","25 milligram(s) Capsule, hard",2006-07-19,"EU/1/06/347/002","Pfizer Europe MA EEIG","Sunitinibmalate"
"9091","Sutent","50 milligram(s) Capsule, hard",2006-07-19,"EU/1/06/347/003","Pfizer Europe MA EEIG","Sunitinibmalate"
"9092","Sutent","37.5 milligram(s) Capsule, hard",2009-05-29,"EU/1/06/347/7-8","Pfizer Europe MA EEIG","Sunitinibmalate"
"9093","SUXAMETHONIUM CHLORIDE","50/1 Mg/Ml Solution for Injection",1988-12-20,"PA0073/110/001","Mercury Pharmaceuticals (Ireland) Ltd","SUXAMETHONIUMCHLORIDE"
"9094","SYCREST","5 Milligram                                                                                            Tablet Sublingual",2010-09-01,"EU/1/10/640/001-003","NV Organon","ASENAPINEMALEATE"
"9095","SYCREST","10 Milligram                                                                                            Tablet Sublingual",2010-09-01,"EU/1/10/640/004-006","NV Organon","ASENAPINEMALEATE"
"9096","Sylvant","100 milligram(s) ZZZ Pdr/Conc/Soln for Infus",2014-05-22,"EU/1/14/928/001","Janssen-Cilag International NV","Siltuximab"
"9097","SYLVANT","400 Milligram                                                                                            Pdr/Conc/Soln for Infus",2014-05-22,"EU/1/14/928/002","Janssen-Cilag International NV","SILTUXIMAB"
"9098","SYMBICORT TURBOHALER","200mcg/6 Mcg/Dose                                                                                             Powder for Inhalation",2011-06-03,"PPA1151/152/002","Imbat Limited","BUDESONIDE|FORMOTEROLFUMATRATEDIHYDRATE"
"9099","SYMBICORT TURBOHALER","400mcg/12 Mcg/Dose                                                                                             Powder for Inhalation",2011-06-03,"PPA1151/152/003","Imbat Limited","BUDESONIDE|FORMOTEROLFUMATRATEDIHYDRATE"
"9100","SYMBICORT TURBOHALER","200/6 Microgram                                                                                            Powder for Inhalation",2011-09-23,"PPA1463/051/001","IMED Healthcare Ltd.","BUDESONIDE|FORMOTEROLFUMATRATEDIHYDRATE"
"9101","SYMBICORT TURBOHALER","100/6 Mcg/Acutuation                                                                                       Powder for Inhalation",2010-10-29,"PPA1463/051/002","IMED Healthcare Ltd.","BUDESONIDE|FORMOTEROLFUMATRATEDIHYDRATE"
"9102","SYMBICORT TURBOHALER","400/12 Microgram                                                                                            Powder for Inhalation",2015-05-15,"PPA1463/051/003","IMED Healthcare Ltd.","BUDESONIDE|FORMOTEROLFUMARATEDIHYDRATE"
"9103","Symbicort Turbohaler, 100 micrograms /6 micrograms/inhalation, inhalation powder","100/6 microgram(s)/dose Powder for Inhalation",2012-08-31,"PPA0465/225/003","PCO Manufacturing","Formoterolfumatratedihydrate|Budesonide"
"9104","Symbicort Turbohaler, 100 micrograms /6 micrograms/inhalation, inhalation powder","100/6 microgram(s) Powder for Inhalation",2001-02-23,"PA0970/028/001","AstraZeneca UK Limited","Budesonide|Budesonide|Formoterolfumatratedihydrate|Formoterolfumaratedihydrate"
"9105","Symbicort Turbohaler, 200 micrograms/6 micrograms/inhalation, inhalation powder","200/6 microgram(s)/dose Powder for Inhalation",2009-08-07,"PPA0465/225/001","PCO Manufacturing","Formoterolfumatratedihydrate|Budesonide"
"9106","Symbicort Turbohaler, 400 micrograms/12 micrograms/inhalation, inhalation powder","400/12 microgram(s)/dose Powder for Inhalation",2009-08-07,"PPA0465/225/002","PCO Manufacturing","Budesonide|Formoterolfumatratedihydrate"
"9107","Symbicort Turbohaler, 400 micrograms/12 micrograms/inhalation, inhalation powder","400/12 microgram(s) Powder for Inhalation",2003-03-21,"PA0970/028/003","AstraZeneca UK Limited","Budesonide|Formoterolfumatratedihydrate"
"9108","SYMBICORT, 200 MICROGRAMS/6 MICROGRAMS PER INHALATION, PRESSURISED INHALATION, SUSPENSION","200/6 Mcg/Acutuation                                                                                       Pressurised Inhalation Suspension",2016-07-22,"PA0970/028/004","AstraZeneca UK Limited","BUDESONIDEMICRONISED|FORMOTEROLFUMARATEDIHYDRATE(MICRONISED)"
"9109","Symbicort® Turbohaler; 200 micrograms/6 micrograms/inhalation, inhalation powder","200/6 microgram(s) Powder for Inhalation",2001-02-23,"PA0970/028/002","AstraZeneca UK Limited","Budesonide|Budesonide|Formoterolfumatratedihydrate|Formoterolfumatratedihydrate"
"9110","Symtuza","800/150/200/10 milligram(s) Film-coated tablet",2017-09-21,"EU/1/17/1225/001","Janssen-Cilag International NV","Darunavirethanolate|Cobicistat|Emtricitabine|Tenofoviralafenamide"
"9111","SYNACTHEN","250 mcg/ml Microgram/ML                                                                                         Solution for Injection",1978-04-01,"PA2206/002/001","Alfasigma S.p.A","TETRACOSACTIDEACETATE"
"9112","SYNAGIS","50 Milligram                                                                                            Pdr+Solv for Soln for Inj",1999-08-13,"EU/1/99/117/001","AbbVie Deutschland GmbH & Co. KG","PALIVIZUMAB"
"9113","SYNAGIS","100mg Milligram                                                                                            Pdr+Solv for Soln for Inj",1999-08-13,"EU/1/99/117/002","AbbVie Deutschland GmbH & Co. KG","PALIVIZUMAB"
"9114","SYNAGIS","100 Mg/Ml Solution for Injection",2014-08-22,"EU/1/99/117/003-004","AbbVie Deutschland GmbH & Co. KG","PALIVIZUMAB"
"9115","Synarel 200 micrograms/dose Nasal Spray Solution","200 ZZZ Mcg/Dose Nasal spray, solution",1997-03-07,"PA0822/138/001","Pfizer Healthcare Ireland","Nafarelin"
"9116","SYNDOL FILM COATED TABLETS","mg/tablet Film Coated Tablet",1975-09-03,"PA0540/175/001","Sanofi-Aventis Ireland Limited T/A SANOFI","PARACETAMOL|CODEINEPHOSPHATEHEMIHYDRATE|DOXYLAMINESUCCINATE|CAFFEINE"
"9117","Synflorix","1 microgram(s) Suspension for injection",2009-03-30,"EU/1/09/508/1-9","GlaxoSmithKline Biologicals S.A.","Pneumococcalpolysaccharideserotype1|Pneumococcalpolysaccharideserotype4|Pneumococcalpolysaccharideserotype5|Pneumococcalpolysaccharideserotype6b|Pneumococcalpolysaccharideserotype7f|Pneumococcalpolysaccharideserotype9v|Pneumococcalpolysaccharideserotype14|Pneumococcalpolysaccharideserotype19f|Pneumococcalpolysaccharideserotype23f|Pneumococcalpolysaccharideserotype18c"
"9118","Synjardy","5/850 milligram(s) Film-coated tablet",NA,"EU/1/15/1003/001-009","Boehringer Ingelheim International GmbH","METFORMINHYDROCHLORIDE|Empagliflozin"
"9119","SYNJARDY","5/1000 Milligram                                                                                            Film Coated Tablet",2015-05-27,"EU/1/15/1003/010-018","Boehringer Ingelheim International GmbH","EMPAGLIFLOZIN|METFORMINHYDROCHLORIDE"
"9120","SYNJARDY","12.5/850 Milligram                                                                                            Film Coated Tablet",2015-05-27,"EU/1/15/1003/019-027","Boehringer Ingelheim International GmbH","EMPAGLIFLOZIN|METFORMINHYDROCHLORIDE"
"9121","SYNJARDY","12.5/1000 Milligram                                                                                            Film Coated Tablet",2015-05-27,"EU/1/15/1003/028-036","Boehringer Ingelheim International GmbH","EMPAGLIFLOZIN|METFORMINHYDROCHLORIDE"
"9122","Syntocinon Ampoules 10 IU/ml Concentrate for solution for Infusion or solution for intramuscular Injection","10 international unit(s)/millilitre Solution for injection/infusion",1979-04-01,"PA2206/003/002","Alfasigma S.p.A","Oxytocin|Oxytocin"
"9123","Syntocinon Ampoules 5 IU/ml Concentrate for solution for infusion or Solution for intramuscular injection","5 international unit(s)/millilitre Solution for injection/infusion",1979-04-01,"PA2206/003/001","Alfasigma S.p.A","Oxytocin|Oxytocin"
"9124","Syntometrine 500 micrograms/5 IU Solution for Injection","500mcgs/5I percent volume/volume Solution for injection",1979-04-01,"PA0943/025/001","Alliance Pharmaceuticals Ltd.","Oxytocin|ERGOMETRINEMALEATE"
"9125","SYRISAL","1 mMol/ml                                                                                              Oral Solution",2016-09-30,"PA1861/001/001","SYRI Limited, t/a Thame Laboratories","SODIUMCHLORIDE"
"9126","TACFORIUS","0.5 Milligram                                                                                            Prolonged Release Capsules",2017-12-08,"EU/1/17/1244/001-006","Teva B.V.","TACROLIMUSMONOHYDRATE"
"9127","TACFORIUS","1 Milligram                                                                                            Prolonged Release Capsules",2017-12-08,"EU/1/17/1244/007-014","Teva B.V.","TACROLIMUSMONOHYDRATE"
"9128","TACFORIUS","3 Milligram                                                                                            Prolonged Release Capsules",2017-12-08,"EU/1/17/1244/015-020","Teva B.V.","TACROLIMUSMONOHYDRATE"
"9129","TACFORIUS","5 Milligram                                                                                            Prolonged Release Capsules",2017-12-08,"EU/1/17/1244/021-026","Teva B.V.","TACROLIMUSMONOHYDRATE"
"9130","TACHOSIL","%v/v                                                                                                 Sponge",2004-06-08,"EU/1/04/277/1-4","Nycomed Austria GmbH","FACTORI(FIBRINOGEN)"
"9131","TACNI","0.5 Milligram                                                                                            Capsules Hard",2011-08-05,"PA0749/138/001","Teva Pharma B.V.","TACROLIMUS"
"9132","TACNI","1 Milligram                                                                                            Capsules Hard",2011-08-05,"PA0749/138/002","Teva Pharma B.V.","TACROLIMUS"
"9133","TACNI","5 Milligram                                                                                            Capsules Hard",2011-08-05,"PA0749/138/003","Teva Pharma B.V.","TACROLIMUS"
"9134","Tacrolimus 0.1% Ointment","0.1 percent Ointment",2017-11-24,"PA1390/019/006","Accord Healthcare Limited","Tacrolimus"
"9135","TADALAFIL","5 Milligram                                                                                            Film Coated Tablet",2016-05-20,"PA1390/108/001","Accord Healthcare Limited","TADALAFIL"
"9136","TADALAFIL","10 Milligram                                                                                            Film Coated Tablet",2016-05-20,"PA1390/108/002","Accord Healthcare Limited","TADALAFIL"
"9137","TADALAFIL","20 Milligram                                                                                            Film Coated Tablet",2016-05-20,"PA1390/108/003","Accord Healthcare Limited","TADALAFIL"
"9138","TADALAFIL","2.5 Milligram                                                                                            Film Coated Tablet",2017-05-12,"PA1240/030/001","Bristol Laboratories Limited","TADALAFIL"
"9139","TADALAFIL","5 Milligram                                                                                            Film Coated Tablet",2017-05-12,"PA1240/030/002","Bristol Laboratories Limited","TADALAFIL"
"9140","TADALAFIL","10 Milligram                                                                                            Film Coated Tablet",2017-05-12,"PA1240/030/003","Bristol Laboratories Limited","TADALAFIL"
"9141","TADALAFIL","20 Microspheres                                                                                         Film Coated Tablet",2017-05-12,"PA1240/030/004","Bristol Laboratories Limited","TADALAFIL"
"9142","Tadalafil Actavis 10mg Film-coated Tablets","10 milligram(s) Film-coated tablet",2016-06-24,"PA2315/004/003","Accord Healthcare Ireland Ltd.","Tadalafil"
"9143","Tadalafil Actavis 2.5mg Film-coated Tablets","2.5 milligram(s) Film-coated tablet",2016-06-24,"PA2315/004/001","Accord Healthcare Ireland Ltd.","Tadalafil"
"9144","Tadalafil Actavis 20 mg Film-coated Tablets","20 milligram(s) Film-coated tablet",2016-06-24,"PA2315/004/004","Accord Healthcare Ireland Ltd.","Tadalafil"
"9145","Tadalafil Actavis 5mg Film-coated Tablets","5 milligram(s) Film-coated tablet",2016-06-24,"PA2315/004/002","Accord Healthcare Ireland Ltd.","Tadalafil"
"9146","Tadalafil Clonmel 10 mg Film-coated Tablets","10 milligram(s) Film-coated tablet",2017-01-20,"PA0126/283/003","Clonmel Healthcare Ltd","Tadalafil"
"9147","Tadalafil Clonmel 2.5 mg Film-coated Tablets","2.5 milligram(s) Film-coated tablet",2017-01-20,"PA0126/283/001","Clonmel Healthcare Ltd","Tadalafil"
"9148","Tadalafil Clonmel 20 mg Film-coated Tablets","20 milligram(s) Film-coated tablet",2017-01-20,"PA0126/283/004","Clonmel Healthcare Ltd","Tadalafil"
"9149","Tadalafil Clonmel 5 mg Film-coated Tablets","5 milligram(s) Film-coated tablet",2017-01-20,"PA0126/283/002","Clonmel Healthcare Ltd","Tadalafil"
"9150","TADALAFIL GENERICS ((PREVIOUSLY KNOWN TADALAFIL MYLAN PHARMA))","20 Milligram                                                                                            Film Coated Tablet",2017-01-09,"EU/1/16/1153/001-004","Mylan S.A.S.","TADALAFIL"
"9151","TADALAFIL KRKA","2.5 Milligram                                                                                            Film Coated Tablet",2017-06-09,"PA1347/071/001","Krka d.d., Novo mesto","TADALAFIL"
"9152","TADALAFIL KRKA","5 Milligram                                                                                            Film Coated Tablet",2017-06-09,"PA1347/071/002","Krka d.d., Novo mesto","TADALAFIL"
"9153","TADALAFIL KRKA","10 Milligram                                                                                            Film Coated Tablet",2017-06-09,"PA1347/071/003","Krka d.d., Novo mesto","TADALAFIL"
"9154","TADALAFIL KRKA","20 Milligram                                                                                            Film Coated Tablet",2017-06-09,"PA1347/071/004","Krka d.d., Novo mesto","TADALAFIL"
"9155","TADALAFIL LILLY","2.5 Milligram                                                                                            Film Coated Tablet",2017-03-22,"EU/1/17/1177/001","Eli Lilly Nederland B.V.","TADALAFIL"
"9156","TADALAFIL LILLY","5 Milligram                                                                                            Film Coated Tablet",2017-03-22,"EU/1/17/1177/002-004","Eli Lilly Nederland B.V.","TADALAFIL"
"9157","TADALAFIL LILLY","10 Milligram                                                                                            Film Coated Tablet",2017-03-22,"EU/1/17/1177/005","Eli Lilly Nederland B.V.","TADALAFIL"
"9158","TADALAFIL LILLY","20 Milligram                                                                                            Film Coated Tablet",2017-03-22,"EU/1/17/1177/006-009","Eli Lilly Nederland B.V.","TADALAFIL"
"9159","TADALAFIL MYLAN","10 Milligram                                                                                            Film Coated Tablet",2014-11-21,"EU/1/14/961/001","Mylan S.A.S.","TADALAFIL"
"9160","TADALAFIL MYLAN","20 Milligram                                                                                            Film Coated Tablet",2014-11-21,"EU/1/14/961/003-006","Mylan S.A.S.","TADALAFIL"
"9161","TADALAFIL MYLAN","2.5 Milligram                                                                                            Film Coated Tablet",2014-11-21,"EU/1/14/961/008-009","Mylan S.A.S.","TADALAFIL"
"9162","TADALAFIL MYLAN","5 Milligram                                                                                            Film Coated Tablet",2014-11-21,"EU/1/14/961/012-016","Mylan S.A.S.","TADALAFIL"
"9163","TADALAFIL ROWEX","2.5 Milligram                                                                                            Film Coated Tablet",2016-01-20,"PA0711/261/001","Rowex Ltd","TADALAFIL"
"9164","TADALAFIL ROWEX","5 Milligram                                                                                            Film Coated Tablet",2016-01-20,"PA0711/261/002","Rowex Ltd","TADALAFIL"
"9165","TADALAFIL ROWEX","10 Milligram                                                                                            Film Coated Tablet",2016-01-20,"PA0711/261/003","Rowex Ltd","TADALAFIL"
"9166","TADALAFIL ROWEX","20 Milligram                                                                                            Film Coated Tablet",2016-01-20,"PA0711/261/004","Rowex Ltd","TADALAFIL"
"9167","Tafinlar 50 mg hard capsules","50 milligram(s) Capsule, hard",2013-08-26,"EU/1/13/865/001-002","Novartis Europharm Limited","Dabrafenib"
"9168","Tafinlar 75 mg hard capsules","75 milligram(s) Capsule, hard",2013-08-26,"EU/1/13/865/003-004","Novartis Europharm Limited","Dabrafenib"
"9169","TAGRISSO","40 Milligram                                                                                            Film Coated Tablet",2016-02-02,"EU/1/16/1086/001","AstraZeneca AB","OSIMERTINIBMESYLATE"
"9170","TAGRISSO","80 Milligram                                                                                            Film Coated Tablet",2016-02-02,"EU/1/16/1086/002","AstraZeneca AB","OSIMERTINIBMESYLATE"
"9171","Taltz","80 milligram(s) Solution for injection in pre-filled pen",2016-04-25,"EU/1/15/1085/001-003","Eli Lilly Nederland B.V.","Ixekizumab"
"9172","TALTZ","80 Milligram                                                                                            Solution for injection in pre-filled syringe",2016-04-25,"EU/1/15/1085/004-006","Eli Lilly Nederland B.V.","IXEKIZUMAB"
"9173","Tambocor","50 milligram(s) Tablet",NA,"PA0057/044/003","3M Health Care Limited","Flecainideacetate"
"9174","Tambocor 10 mg/ml Solution for Injection","10 micromole(s) Solution for injection",1984-12-13,"PA0057/044/001","3M Health Care Limited","Flecainideacetate"
"9175","Tambocor 10 mg/ml Solution for Injection or Infusion","10 milligram(s)/millilitre Solution for injection/infusion",1984-12-13,"PA2010/026/001","Mylan IRE Healthcare Limited","Flecainideacetate"
"9176","Tambocor 100 mg Tablets","100 milligram(s) Tablet",1984-12-13,"PA2010/026/003","Mylan IRE Healthcare Limited","Flecainideacetate"
"9177","Tambocor 50 mg Tablets","50 milligram(s) Tablet",1999-10-01,"PA2010/026/002","Mylan IRE Healthcare Limited","Flecainideacetate"
"9178","Tamiflu","75 milligram(s) Capsule, hard",NA,"EU/1/02/222/001","Roche Registration GmbH","Oseltamivirphosphate"
"9179","Tamiflu","12 micromole(s) Powder for oral suspension",NA,"EU/1/02/222/002","Roche Registration GmbH","Oseltamivirphosphate"
"9180","Tamiflu","30 milligram(s) Capsule, hard",NA,"EU/1/02/222/003","Roche Registration GmbH","Oseltamivir"
"9181","Tamiflu","45 milligram(s) Capsule, hard",NA,"EU/1/02/222/004","Roche Registration GmbH","Oseltamivir"
"9182","Tamiflu","6 milligram(s)/millilitre Powder for oral suspension",NA,"EU/1/02/222/005","Roche Registration GmbH","Oseltamivirphosphate"
"9183","TAMNEXYL XL","400 Microgram                                                                                            Tablet Prolonged Release",2011-07-15,"PA0126/224/001","Clonmel Healthcare Ltd","TAMSULOSINHYDROCHLORIDE"
"9184","Tamnic 400 micrograms Modified-release Capsules, hard","400 microgram(s) Capsules Modified Release",2006-04-28,"PA0126/151/001","Clonmel Healthcare Ltd","Tamsulosinhydrochloride"
"9185","Tamox 10 mg Film-coated tablets","10 ZZZ Base Milligrams Film-coated tablet",1992-02-25,"PA0711/022/001","Rowex Ltd","TAMOXIFENCITRATE"
"9186","Tamox 20 mg Film-coated tablets","20 ZZZ Base Milligrams Film-coated tablet",1992-02-25,"PA0711/022/002","Rowex Ltd","TAMOXIFENCITRATE"
"9187","TAMOXIFEN","20 Milligram                                                                                            Tablets",1986-03-14,"PA0405/001/002","Generics (UK) Limited","TAMOXIFENCITRATE"
"9188","TAMOXIFEN ROSEMONT","10 MG/5ml                                                                                               Oral Solution",2002-05-17,"PA0312/008/001","Rosemont Pharmaceuticals Ltd","TAMOXIFENCITRATE"
"9189","TAMSU 400 micrograms modified-release capsules, hard","400 microgram(s) Capsules Modified Release",2005-12-02,"PA0711/079/001","Rowex Ltd","Tamsulosinhydrochloride"
"9190","TAMSULOSIN","400 Microgram                                                                                            Capsules Modified Release",2006-03-24,"PA0577/073/001","McDermott Laboratories Ltd t/a Gerard Laboratories","TAMSULOSINHYDROCHLORIDE"
"9191","TAMSULOSIN HYDROCHLORIDE","400 Microgram                                                                                            Capsules Modified Release",2006-01-20,"PA0840/013/001","Synthon BV","TAMSULOSINHYDROCHLORIDE"
"9192","Tandemact","30&45/4 milligram(s) Tablet",2007-01-08,"EU/1/06/366/005-16","Takeda Pharma A/S","Pioglitazone|Glimepiride"
"9193","Tandemact","30/2 milligram(s) Tablet",2008-03-31,"EU/1/06/366/17-22","Takeda Pharma A/S","Pioglitazonehydrochloride|Glimepiride"
"9194","TANTUM VERDE EUCALYPTUS TASTE","3 Milligram                                                                                            Lozenges",2010-11-05,"PA0959/001/004","Aziende Chimiche Riunite Angelini Francesco","BENZYDAMINEHYDROCHLORIDE"
"9195","TANTUM VERDE LEMON TASTE","3.0 Milligram                                                                                            Lozenges",2000-09-01,"PA0959/001/002","Aziende Chimiche Riunite Angelini Francesco","BENZYDAMINEHYDROCHLORIDE"
"9196","TANTUM VERDE MINT TASTE 3MG LOZENGES","3.0 Milligram                                                                                            Lozenges",2000-09-01,"PA0959/001/001","Aziende Chimiche Riunite Angelini Francesco","BENZYDAMINEHYDROCHLORIDE"
"9197","TANTUM VERDE ORANGE-HONEY TASTE","3 Milligram                                                                                            Lozenges",2010-11-05,"PA0959/001/003","Aziende Chimiche Riunite Angelini Francesco","BENZYDAMINEHYDROCHLORIDE"
"9198","TAPTIQOM","15+5 Unknown Eye Drops Solution",2014-11-28,"PA0879/003/001","Santen OY","TAFLUPROST|TIMOLOLMALEATE"
"9199","Tarceva","25/100/150 milligram(s) Coated tablet",2005-09-19,"EU/1/05/311/01-3","Roche Registration Limited","Erlotinibhydrochloride"
"9200","Targaxan 550 mg film-coated tablets","550 milligram(s) Film-coated tablet",2013-02-22,"PA1336/009/001","Norgine B.V.","Rifaximin"
"9201","TARGIN","5 / 2.5 Milligram                                                                                            Tablet Prolonged Release",2009-09-25,"PA1688/010/001","Mundipharma Pharmaceuticals Limited","OXYCODONEHYDROCHLORIDE|NALOXONEHYDROCHLORIDEDIHYDRATE"
"9202","TARGIN","10 / 5 Milligram                                                                                            Tablet Prolonged Release",2009-03-06,"PA1688/010/002","Mundipharma Pharmaceuticals Limited","OXYCODONEHYDROCHLORIDE|NALOXONEHYDROCHLORIDEDIHYDRATE"
"9203","TARGIN","20 / 10 Milligram                                                                                            Tablet Prolonged Release",2009-03-06,"PA1688/010/003","Mundipharma Pharmaceuticals Limited","OXYCODONEHYDROCHLORIDE|NALOXONEHYDROCHLORIDEDIHYDRATE"
"9204","TARGIN","40 / 20 Milligram                                                                                            Tablet Prolonged Release",2009-09-25,"PA1688/010/004","Mundipharma Pharmaceuticals Limited","OXYCODONEHYDROCHLORIDE|NALOXONEHYDROCHLORIDEDIHYDRATE"
"9205","TARGIN","15 / 7.5 Milligram                                                                                            Tablet Prolonged Release",2014-01-31,"PA1688/010/006","Mundipharma Pharmaceuticals Limited","OXYCODONEHYDROCHLORIDE|NALOXONEHYDROCHLORIDE"
"9206","TARGIN","30 / 15 Milligram                                                                                            Tablet Prolonged Release",2014-01-31,"PA1688/010/007","Mundipharma Pharmaceuticals Limited","OXYCODONEHYDROCHLORIDE|NALOXONEHYDROCHLORIDE"
"9207","TARGIN","60/30 Milligram                                                                                            Tablet Prolonged Release",2016-02-16,"PA1688/010/008","Mundipharma Pharmaceuticals Limited","OXYCODONEHYDROCHLORIDE|NALOXONEHYDROCHLORIDE"
"9208","TARGIN","80/40 Milligram                                                                                            Tablet Prolonged Release",2016-02-16,"PA1688/010/009","Mundipharma Pharmaceuticals Limited","OXYCODONEHYDROCHLORIDE|NALOXONEHYDROCHLORIDE"
"9209","TARGOCID","200 Milligram                                                                                            Pdr+Solv for Soln for Inj",1990-02-23,"PA0540/021/001","Sanofi-Aventis Ireland Limited T/A SANOFI","TEICOPLANIN"
"9210","TARGOCID","400 Milligram                                                                                            Pdr+Solv for Soln for Inj",1990-02-23,"PA0540/021/002","Sanofi-Aventis Ireland Limited T/A SANOFI","TEICOPLANIN"
"9211","TARGOCID","400 Milligram                                                                                            Pdr+Solv for soln for inf/inj",2015-09-03,"PPA1463/103/001","IMED Healthcare Ltd.","TEICOPLANIN"
"9212","TARGOCID","200 Milligram                                                                                            Pdr+Solv for soln for inf/inj",2015-09-11,"PPA1463/103/002","IMED Healthcare Ltd.","TEICOPLANIN"
"9213","Targretin","percent volume/volume Capsule",2001-03-29,"EU/1/01/178/001","Eisai GmbH","Bexarotene"
"9214","TARIVID 200 MG FILM- COATED TABLETS","200 Milligram                                                                                            Film Coated Tablet",1988-06-27,"PA0540/076/003","Sanofi-Aventis Ireland Limited T/A SANOFI","OFLOXACIN"
"9215","Tarivid IV 2 mg/ml Solution for Infusion","2 milligram(s)/millilitre Solution for infusion",1989-08-21,"PA0540/076/002","Sanofi-Aventis Ireland Limited T/A SANOFI","Ofloxacinhydrochloride"
"9216","Tasigna","200 milligram(s) Capsule, hard",2007-11-19,"EU/1/07/422/001-004","Novartis Europharm Limited","Nilotinib"
"9217","TASIGNA","150 Milligram                                                                                            Capsules Hard",2010-12-20,"EU/1/07/422/005-006","Novartis Europharm Limited","NILOTINIB(ASHYDROCHLORIDEMONOHYDRATE)"
"9218","TASIGNA","50 Milligram                                                                                            Capsules Hard",2017-11-15,"EU/1/07/422/015","Novartis Europharm Limited","NILOTINIB(ASHYDROCHLORIDEMONOHYDRATE)"
"9219","Tasmar","100 milligram(s) Film-coated tablet",1997-08-27,"EU/1/97/044/001","Meda Actiebolag","Tolcapone"
"9220","Tasmar","100 milligram(s) Film-coated tablet",1997-08-27,"EU/1/97/044/002","Meda Actiebolag","Tolcapone"
"9221","Tasmar","100 milligram(s) Film-coated tablet",1997-08-27,"EU/1/97/044/003","Meda Actiebolag","Tolcapone"
"9222","Tasmar","200 milligram(s) Film-coated tablet",1997-08-27,"EU/1/97/044/004","Meda Actiebolag","Tolcapone"
"9223","Tasmar","200 milligram(s) Film-coated tablet",1997-08-27,"EU/1/97/044/005","Meda Actiebolag","Tolcapone"
"9224","Tasmar","200 milligram(s) Film-coated tablet",1997-08-27,"EU/1/97/044/006","Meda Actiebolag","Tolcapone"
"9225","TAUROLIN","2 %w/v                                                                                                 solution for intraperitoneal lavage after dilution or solution for instillation",1987-03-13,"PA0143/015/001","Geistlich Sons Limited","TAUROLIDINE"
"9226","TAVAGER","500 Milligram                                                                                            Film Coated Tablet",2009-03-06,"PA0577/104/002","McDermott Laboratories Ltd t/a Gerard Laboratories","LEVOFLOXACIN"
"9227","TAVANIC","500 Milligram                                                                                            Film Coated Tablet",2017-01-20,"PPA1562/190/001","LTT Pharma Limited","LEVOFLOXACIN"
"9228","Tavanic 250 mg film-coated tablets","250 milligram(s) Film-coated tablet",1998-01-09,"PA0540/077/002","Sanofi-Aventis Ireland Limited T/A SANOFI","Levofloxacin"
"9229","Tavanic 5 mg/ml solution for infusion","5 milligram(s)/millilitre Solution for infusion",NA,"PA0540/077/001","Sanofi-Aventis Ireland Limited T/A SANOFI","Levofloxacin"
"9230","Tavanic 500 mg film-coated tablets","500 milligram(s) Film-coated tablet",1998-01-09,"PA0540/077/003","Sanofi-Aventis Ireland Limited T/A SANOFI","Levofloxacin"
"9231","Tavanic 500 mg film-coated tablets","500 milligram(s) Film-coated tablet",2013-01-25,"PPA0465/302/001","PCO Manufacturing","Levofloxacin"
"9232","TAXOTERE","20mg/0.5ml Mg/Ml Concentrate for Soln for Inf",1995-11-27,"EU/1/95/002/001","Aventis Pharma S.A.","DOCETAXELTRIHYDRATE"
"9233","TAXOTERE","80 Mg/Ml Concentrate for Soln for Inf",1995-11-27,"EU/1/95/002/002","Aventis Pharma S.A.","DOCETAXELTRIHYDRATE"
"9234","TAXOTERE","20 Mg/Ml Concentrate and solvent for solution for infusion",2009-11-30,"EU/1/95/002/003","Aventis Pharma S.A.","DOCETAXELTRIHYDRATE"
"9235","TAXOTERE","80/4 Mg/Ml Concentrate and solvent for solution for infusion",2009-11-30,"EU/1/95/002/004","Aventis Pharma S.A.","DOCETAXELTRIHYDRATE"
"9236","TCP FIRST AID ANTISEPTIC CREAM","25, 0.5, 0.3 %v/v                                                                                                 Cream",1988-09-07,"PA1186/005/001","Chefaro Ireland DAC","TRICLOSAN|CHLOROXYLENOL|PHENOL|HALOGENATEDPHENOLS|SODIUMSALICYLATE"
"9237","TCP LIQUID ANTISEPTIC","0.175/0.68 %w/v                                                                                                 Cutaneous Solution",1986-08-08,"PA1186/005/002","Chefaro Ireland DAC","PHENOL|HALOGENATEDPHENOLS"
"9238","TDAPBOOSTER","< 2 International Unit                                                                                   Suspension for Injection",2013-07-04,"PA2160/002/001","AJ Vaccines A/S","DIPHTHERIATOXOID,PURIFIED|TETANUSTOXOID,PURIFIED|PERTUSSISTOXOID,PURIFIED|ALUMINIUMHYDROXIDE,HYDRATECORR.TOALUMINIUM"
"9239","Tears Naturale eye drops, solution (Dextran 70 0.1% w/v, Hypromellose 0.3% w/v)","percent volume/volume Eye drops, solution",1980-03-13,"PA2274/001/001","Alcon Laboratories Ireland Limited","Hypromellose|Dextran70"
"9240","Tecentriq","1200 milligram(s) Concentrate for solution for infusion",NA,"EU/1/17/1220/001","Roche Registration GmbH","Atezolizumab"
"9241","Tecfidera","120 milligram(s) Gastro-resistant capsule",2014-01-30,"EU/1/13/837/001","Biogen Idec Limited","Dimethylfumarate"
"9242","TECFIDERA","240 Milligram                                                                                            Capsules Gastro-Resistant",2014-01-30,"EU/1/13/837/002","Biogen Idec Research Limited","DIMETHYLFUMARATE"
"9243","TECHNESCAN DMSA","1.2 Milligram                                                                                            Kit for radiopharmaceutical preparation",1999-01-22,"PA0690/011/001","Mallinckrodt Medical B.V.","DIMERCAPTOSUCCINICACID"
"9244","TECHNESCAN DTPA","20.8 Milligram                                                                                            Kit for radiopharmaceutical preparation",1999-01-22,"PA0690/015/001","Mallinckrodt Medical B.V.","PENTETICACID"
"9245","TECHNESCAN HDP","3 Milligram                                                                                            Kit for radiopharmaceutical preparation",1993-11-19,"PA0690/004/001","Mallinckrodt Medical B.V.","OXIDRONATEDISODIUM"
"9246","TECHNESCAN LYOMAA","N/A Pdr for Soln for Injection",2002-04-05,"PA0690/012/001","Mallinckrodt Medical B.V.","HUMANALBUMINMACROAGGREGATED"
"9247","TECHNESCAN MAG3","1 Milligram                                                                                            Pdr for Soln for Injection",1992-03-02,"PA0690/018/001","Mallinckrodt Medical B.V.","BETIATIDE"
"9248","TECHNESCAN MIBI","1 Milligram                                                                                            Kit for radiopharmaceutical preparation",2008-11-21,"PA0690/020/001","Mallinckrodt Medical B.V.","TETRAKIS(2-METHYLOPROPYL-ISOCYANIDE)COPPER(I)TETRAFLUOROBORATE"
"9249","TECHNESCAN PYP","20 Milligram                                                                                            Kit for radiopharmaceutical preparation",2001-06-29,"PA0690/010/001","Mallinckrodt Medical B.V.","SODIUMPYROPHOSPHATE"
"9250","Teedex Oral SolutionParacetamol 120mg/5mlDiphenhydramine Hydrochloride 12.5mg/5ml","120 mg/5ml Oral solution",1978-04-01,"PA0095/003/001","Ricesteele Manufacturing Ltd","Diphenhydraminehydrochloride|PARACETAMOL"
"9251","Teetha Teething Gel","12c  Oral gel",2018-11-16,"HOA1149/007/001","A. Nelson & Company Limited","Chamomillarecutita|Aconitumnapellus|Atropabelladonna"
"9252","TEETHA TEETHING GRANULES","6C Unknown Granules",2017-12-15,"HOA1149/002/001","A. Nelson & Company Limited","CHAMOMILLA(GHP)"
"9253","TEFIN","75 Milligram                                                                                            Suppositories",2012-08-31,"PA1684/001/001","Carysfort Healthcare Limited","IBUPROFEN"
"9254","TEFIN","150 Milligram                                                                                            Suppositories",2012-08-31,"PA1684/001/002","Carysfort Healthcare Limited","IBUPROFEN"
"9255","Tegretol 100mg Tablets","100 milligram(s) Tablet",1979-04-01,"PA0896/030/002","Novartis Ireland Limited","Carbamazepine"
"9256","Tegretol 100mg/5ml Oral Suspension","100 mg/5ml Oral suspension",1974-12-30,"PA0896/030/001","Novartis Ireland Limited","Carbamazepine"
"9257","Tegretol 200mg Tablets","200 milligram(s) Tablet",1979-04-01,"PA0896/030/003","Novartis Ireland Limited","Carbamazepine"
"9258","Tegretol 400mg Tablets","400 milligram(s) Tablet",1979-04-01,"PA0896/030/004","Novartis Ireland Limited","Carbamazepine"
"9259","Tegretol SR 200mg prolonged release tablets","200 milligram(s) Prolonged-release tablet",1993-05-31,"PA0896/030/005","Novartis Ireland Limited","Carbamazepine"
"9260","Tegretol SR 400mg prolonged release tablets","400 milligram(s) Prolonged-release tablet",1993-05-31,"PA0896/030/006","Novartis Ireland Limited","Carbamazepine"
"9261","Tegsedi (Inotersen-Ionis)","284 milligram(s) Solution for injection",2018-07-06,"EU/1/18/1296/001-002","Akcea Therapeutics UK Ltd","INOTERSEN"
"9262","TEICOPLANIN","100 Milligram                                                                                            Pdr for Soln Inj/Inf",2017-11-10,"PA0405/076/001","Generics (UK) Limited","TEICOPLANIN"
"9263","TEICOPLANIN","200 Milligram                                                                                            Pdr for Soln Inj/Inf",2017-11-10,"PA0405/076/002","Generics (UK) Limited","TEICOPLANIN"
"9264","TEICOPLANIN","400 Milligram                                                                                            Pdr for Soln Inj/Inf",2017-11-10,"PA0405/076/003","Generics (UK) Limited","TEICOPLANIN"
"9265","TEICOPLANIN","200 Milligram                                                                                            Pdr+Solv for soln for inf/inj",2015-05-22,"PA1122/009/001","Noridem Enterprises Ltd","TEICOPLANIN"
"9266","TEICOPLANIN","400 Milligram                                                                                            Pdr+Solv for soln for inf/inj",2015-05-22,"PA1122/009/002","Noridem Enterprises Ltd","TEICOPLANIN"
"9267","TEICOPLANIN","200 Milligram                                                                                            Pdr+Solv for soln for inf/inj",2015-10-09,"PA0711/204/002","Rowex Ltd","TEICOPLANIN"
"9268","TEICOPLANIN","400 Milligram                                                                                            Pdr+Solv for soln for inf/inj",2015-10-09,"PA0711/204/003","Rowex Ltd","TEICOPLANIN"
"9269","TEICOPLANIN HIKMA","200 Milligram                                                                                            Pdr for Soln for Injection",2018-04-06,"PA1217/010/001","Hikma Farmaceutica (Portugal) SA","TEICOPLANIN"
"9270","TEICOPLANIN HIKMA","400 Milligram                                                                                            Pdr for Soln for Injection",2018-04-06,"PA1217/010/002","Hikma Farmaceutica (Portugal) SA","TEICOPLANIN"
"9271","TEKCIS","2-50 Gig.bequerel                                                                                         Radionuclide Generator",2011-10-21,"PA0677/020/001","CIS bio International","SODIUMPERTECHNETATE(99MTC)"
"9272","TELFAST","120 Milligram                                                                                            Film Coated Tablet",2010-10-29,"PPA0465/253/001","PCO Manufacturing","FEXOFENADINEHYDROCHLORIDE"
"9273","TELFAST","180 Milligram                                                                                            Film Coated Tablet",2010-10-29,"PPA0465/253/002","PCO Manufacturing","FEXOFENADINEHYDROCHLORIDE"
"9274","TELFAST","30mg Milligram                                                                                            Film Coated Tablet",2004-02-10,"PA0540/078/001","Sanofi-Aventis Ireland Limited T/A SANOFI","FEXOFENADINEHYDROCHLORIDE"
"9275","TELFAST","120 Milligram                                                                                            Film Coated Tablet",1997-11-11,"PA0540/078/002","Sanofi-Aventis Ireland Limited T/A SANOFI","FEXOFENADINEHYDROCHLORIDE"
"9276","TELFAST","180 Milligram                                                                                            Film Coated Tablet",1997-11-11,"PA0540/078/003","Sanofi-Aventis Ireland Limited T/A SANOFI","FEXOFENADINEHYDROCHLORIDE"
"9277","TELFAST","120 Milligram                                                                                            Film Coated Tablet",2010-01-29,"PPA1562/019/001","LTT Pharma Limited","FEXOFENADINEHYDROCHLORIDE"
"9278","TELFAST","120 Milligram                                                                                            Film Coated Tablet",2008-09-05,"PPA1151/080/001","Imbat Limited","FEXOFENADINEHYDROCHLORIDE"
"9279","TELFAST","180 Milligram                                                                                            Film Coated Tablet",2008-09-05,"PPA1151/080/002","Imbat Limited","FEXOFENADINEHYDROCHLORIDE"
"9280","Telfast 180mg film-coated tablets","180 milligram(s) Film-coated tablet",2010-01-29,"PPA1097/057/001","Lexon (UK) Ltd","Fexofenadinehydrochloride"
"9281","TELMISARTAN","20 Milligram                                                                                            Tablets",2016-05-26,"PA1240/019/001","Bristol Laboratories Limited","TELMISARTAN"
"9282","TELMISARTAN","40 Milligram                                                                                            Tablets",2016-05-26,"PA1240/019/002","Bristol Laboratories Limited","TELMISARTAN"
"9283","TELMISARTAN","80 Milligram                                                                                            Tablets",2016-05-26,"PA1240/019/003","Bristol Laboratories Limited","TELMISARTAN"
"9284","TELMISARTAN ACTAVIS","20 Milligram                                                                                            Tablets",2010-09-30,"EU/1/10/639/001-010","Actavis Group PTC ehf","TELMISARTAN"
"9285","TELMISARTAN ACTAVIS","40 Milligram                                                                                            Tablets",2010-09-30,"EU/1/10/639/011-020","Actavis Group PTC ehf","TELMISARTAN"
"9286","TELMISARTAN ACTAVIS","80 Milligram                                                                                            Tablets",2010-09-30,"EU/1/10/639/021-030","Actavis Group PTC ehf","TELMISARTAN"
"9287","Telmisartan Clonmel 20mg film-coated tablets","20 milligram(s) Film-coated tablet",2011-06-29,"PA0126/228/001","Clonmel Healthcare Ltd","Telmisartan"
"9288","Telmisartan Clonmel 40mg film-coated tablets","40 milligram(s) Film-coated tablet",2011-06-29,"PA0126/228/002","Clonmel Healthcare Ltd","Telmisartan"
"9289","Telmisartan Clonmel 80mg film-coated tablets","80 milligram(s) Film-coated tablet",2011-06-29,"PA0126/228/003","Clonmel Healthcare Ltd","Telmisartan"
"9290","TELMISARTAN FAIR-MED","20 Milligram                                                                                            Tablets",2015-08-28,"PA1789/008/001","Fair-Med Healthcare GmbH","TELMISARTAN"
"9291","TELMISARTAN FAIR-MED","40 Milligram                                                                                            Tablets",2015-08-28,"PA1789/008/002","Fair-Med Healthcare GmbH","TELMISARTAN"
"9292","TELMISARTAN FAIR-MED","80 Milligram                                                                                            Tablets",2015-08-28,"PA1789/008/003","Fair-Med Healthcare GmbH","TELMISARTAN"
"9293","TELMISARTAN HYDROCHLOROTHIAZIDE CHEMO IBERICA","80/12.5 mg/mg Tablets",2014-02-28,"PA1814/001/002","Chemo Iberica S.L.","TELMISARTAN|HYDROCHLOROTHIAZIDE"
"9294","TELMISARTAN HYDROCHLOROTHIAZIDE CHEMO IBERICA","80/25 mg/mg Tablets",2014-02-28,"PA1814/001/003","Chemo Iberica S.L.","TELMISARTAN|HYDROCHLOROTHIAZIDE"
"9295","TELMISARTAN HYDROCHLOROTHIAZIDE ROWA","40/12.5 mg/mg Tablets",2014-04-04,"PA0074/081/001","Rowa Pharmaceuticals Limited","TELMISARTAN|HYDROCHLOROTHIAZIDE"
"9296","TELMISARTAN HYDROCHLOROTHIAZIDE ROWA","80/12.5 mg/mg Tablets",2014-04-04,"PA0074/081/002","Rowa Pharmaceuticals Limited","TELMISARTAN|HYDROCHLOROTHIAZIDE"
"9297","TELMISARTAN HYDROCHLOROTHIAZIDE ROWA","80/25 mg/mg Tablets",2014-04-04,"PA0074/081/003","Rowa Pharmaceuticals Limited","TELMISARTAN|HYDROCHLOROTHIAZIDE"
"9298","Telmisartan Mylan 20 mg tablets","20 milligram(s) Tablet",2012-02-10,"PA0577/135/001","McDermott Laboratories Ltd t/a Gerard Laboratories","Telmisartan"
"9299","Telmisartan Mylan 40 mg Tablets","40 milligram(s) Tablet",2012-02-10,"PA0577/135/002","McDermott Laboratories Ltd t/a Gerard Laboratories","Telmisartan"
"9300","Telmisartan Mylan 80 mg Tablets","80 milligram(s) Tablet",2012-02-10,"PA0577/135/003","McDermott Laboratories Ltd t/a Gerard Laboratories","Telmisartan"
"9301","TELMISARTAN ROWEX","20 Milligram                                                                                            Tablets",2011-03-25,"PA0711/186/001","Rowex Ltd","TELMISARTAN"
"9302","TELMISARTAN ROWEX","40 Milligram                                                                                            Tablets",2011-03-25,"PA0711/186/002","Rowex Ltd","TELMISARTAN"
"9303","Telmisartan Rowex 80mg Tablets","80 milligram(s) Tablet",2011-03-25,"PA0711/186/003","Rowex Ltd","Telmisartan"
"9304","TELMISARTAN TEVA","20 Milligram                                                                                            Tablets",2010-01-26,"EU/1/09/610/1-10","Teva B.V.","TELMISARTAN"
"9305","TELMISARTAN TEVA","40 Milligram                                                                                            Tablets",2010-01-26,"EU/1/09/610/11-20","Teva B.V.","TELMISARTAN"
"9306","TELMISARTAN TEVA","80 Milligram                                                                                            Tablets",2010-01-26,"EU/1/09/610/21-30","Teva B.V.","TELMISARTAN"
"9307","TELMISARTAN TEVA PHARMA","20 Milligram                                                                                            Tablets",2011-10-03,"EU/1/11/719/001-020","Teva B.V.","TELMISARTAN"
"9308","TELMISARTAN TEVA PHARMA","40 Milligram                                                                                            Tablets",2011-10-03,"EU/1/11/719/021-040","Teva B.V.","TELMISARTAN"
"9309","TELMISARTAN TEVA PHARMA","80 Milligram                                                                                            Tablets",2011-10-03,"EU/1/11/719/041-060","Teva B.V.","TELMISARTAN"
"9310","Telmisartan/Amlodipine","*** AWAITING VALUE *** Not Currently Available",NA,"IC0048A","IC Company",""
"9311","Telmisartan/Hydrochlorothiazide 40mg/12.5mg tablets","40/12.5 milligram(s) Tablet",2016-02-26,"PA1390/106/001","Accord Healthcare Limited","Telmisartan|Hydrochlorothiazide"
"9312","Telmisartan/Hydrochlorothiazide 80mg/12.5mg tablets","80/12.5 milligram(s) Tablet",2016-02-26,"PA1390/106/002","Accord Healthcare Limited","Hydrochlorothiazide|Telmisartan"
"9313","Telmisartan/Hydrochlorothiazide 80mg/25mg tablets","80/25 milligram(s) Tablet",2016-02-26,"PA1390/106/003","Accord Healthcare Limited","Hydrochlorothiazide|Telmisartan"
"9314","Telmisartan/Hydrochlorothiazide Chemo IbÉrica 40 mg/12.5 mg  tablets","40/12.5 ZZZ mg/mg Tablet",2014-02-28,"PA1814/001/001","Chemo Iberica S.L.","Hydrochlorothiazide|Telmisartan"
"9315","TELMISARTAN/HYDROCHLOROTHIAZIDE CLONMEL","80/25 mg/mg Tablets",2014-02-21,"PA0126/259/003","Clonmel Healthcare Ltd","TELMISARTAN|HYDROCHLOROTHIAZIDE"
"9316","TELMISARTAN/HYDROCHLOROTHIAZIDE CLONMEL","40/12.5 mg/mg Tablets",2014-02-21,"PA0126/259/001","Clonmel Healthcare Ltd","TELMISARTAN|HYDROCHLOROTHIAZIDE"
"9317","Telmisartan/Hydrochlorothiazide Clonmel 80mg/12.5mg tablets","80/12.5 ZZZ mg/mg Tablet",2014-02-21,"PA0126/259/002","Clonmel Healthcare Ltd","Telmisartan|Hydrochlorothiazide"
"9318","TELMISARTAN/HYDROCHLOROTHIAZIDE ROWEX","40/12.5 mg/mg Film Coated Tablet",2013-07-04,"PA0711/211/001","Rowex Ltd","TELMISARTAN|HYDROCHLOROTHIAZIDE"
"9319","TELMISARTAN/HYDROCHLOROTHIAZIDE ROWEX","80/12.5 mg/mg Film Coated Tablet",2013-07-04,"PA0711/211/002","Rowex Ltd","TELMISARTAN|HYDROCHLOROTHIAZIDE"
"9320","TELMISARTAN/HYDROCHLOROTHIAZIDE ROWEX","80/25 mg/mg Film Coated Tablet",2013-07-04,"PA0711/211/003","Rowex Ltd","TELMISARTAN|HYDROCHLOROTHIAZIDE"
"9321","TELZIR","percent volume/volume Not Currently Available",2004-08-12,"EU/1/04/282/1-2","ViiV Healthcare BV","Fosamprevanircalcium"
"9322","TEMGESIC","0.2 Base Milligrams                                                                                      Tablet Sublingual",1980-06-24,"PA1657/002/001","RB Pharmaceuticals Limited","BUPRENORPHINEHYDROCHLORIDE"
"9323","TEMGESIC","300 Microgram/ML                                                                                         Solution for Injection",1978-02-14,"PA1657/002/002","RB Pharmaceuticals Limited","BUPRENORPHINEHYDROCHLORIDE"
"9324","Temodal","5 milligram(s) Capsule, hard",1999-01-26,"EU/1/98/096/001-002","Merck Sharp & Dohme BV","Temozolomide"
"9325","Temodal","20 milligram(s) Capsule",1999-01-26,"EU/1/98/096/003-004","Merck Sharp & Dohme BV","Temozolomide"
"9326","Temodal","100 milligram(s) Capsule",1999-01-26,"EU/1/98/096/005-006","Merck Sharp & Dohme BV,","Temozolomide"
"9327","Temodal","250 milligram(s) Capsule",1999-01-26,"EU/1/98/096/007-008","Merck Sharp and Dohme Limited","Temozolomide"
"9328","Temodal","140 milligram(s) Capsule, hard",NA,"EU/1/98/096/009-010","Merck Sharp & Dohme BV","Temozolomide"
"9329","Temodal","180 milligram(s) Capsule, hard",NA,"EU/1/98/096/011-012","Merck Sharp & Dohme BV","Temozolomide"
"9330","Temodal","2.5 milligram(s)/millilitre Powder for solution for infusion",NA,"EU/1/98/096/023","Merck Sharp & Dohme BV","Temozolomide"
"9331","TEMOMEDAC","250 Milligram                                                                                            Capsules Hard",2010-01-25,"EU/1/09/605/11-12","Medac Gesellschaft fur Klinische Spezialpraparate mbH","TEMOZOLOMIDE"
"9332","TEMOMEDAC","5 Milligram                                                                                            Capsules Hard",2010-01-25,"EU/1/09/605/1-2","Medac Gesellschaft fur Klinische Spezialpraparate mbH","TEMOZOLOMIDE"
"9333","TEMOMEDAC","20 Milligram                                                                                            Capsules Hard",2010-01-25,"EU/1/09/605/3-4","Medac Gesellschaft fur Klinische Spezialpraparate mbH","TEMOZOLOMIDE"
"9334","TEMOMEDAC","100 Milligram                                                                                            Capsules Hard",2010-01-25,"EU/1/09/605/5-6","Medac Gesellschaft fur Klinische Spezialpraparate mbH","TEMOZOLOMIDE"
"9335","TEMOMEDAC","140 Milligram                                                                                            Capsules Hard",2010-01-25,"EU/1/09/605/7-8","Medac Gesellschaft fur Klinische Spezialpraparate mbH","TEMOZOLOMIDE"
"9336","TEMOMEDAC","180 Milligram                                                                                            Capsules Hard",2010-01-25,"EU/1/09/605/9-10","Medac Gesellschaft fur Klinische Spezialpraparate mbH","TEMOZOLOMIDE"
"9337","TEMOZOLOMIDE ACCORD","140 Milligram                                                                                            Capsules Hard",2010-03-15,"EU/1/10/615/13-16","Accord Healthcare Limited","TEMOZOLOMIDE"
"9338","TEMOZOLOMIDE ACCORD","5 Milligram                                                                                            Capsules Hard",2010-03-15,"EU/1/10/615/1-4","Accord Healthcare Limited","TEMOZOLOMIDE"
"9339","TEMOZOLOMIDE ACCORD","180 Milligram                                                                                            Capsules Hard",2010-03-15,"EU/1/10/615/17-20","Accord Healthcare Limited","TEMOZOLOMIDE"
"9340","TEMOZOLOMIDE ACCORD","250 Milligram                                                                                            Capsules Hard",2010-03-15,"EU/1/10/615/21-24","Accord Healthcare Limited","TEMOZOLOMIDE"
"9341","TEMOZOLOMIDE ACCORD","20 Milligram                                                                                            Capsules Hard",2010-03-15,"EU/1/10/615/5-8","Accord Healthcare Limited","TEMOZOLOMIDE"
"9342","TEMOZOLOMIDE ACCORD","100 Milligram                                                                                            Capsules Hard",2010-03-15,"EU/1/10/615/9-12","Accord Healthcare Limited","TEMOZOLOMIDE"
"9343","TEMOZOLOMIDE CLONMEL","5 Milligram                                                                                            Capsules Hard",2010-05-21,"PA0126/188/001","Clonmel Healthcare Ltd","TEMOZOLOMIDE"
"9344","TEMOZOLOMIDE CLONMEL","20 Milligram                                                                                            Capsules Hard",2010-05-21,"PA0126/188/002","Clonmel Healthcare Ltd","TEMOZOLOMIDE"
"9345","TEMOZOLOMIDE CLONMEL","100 Milligram                                                                                            Capsules Hard",2010-05-21,"PA0126/188/003","Clonmel Healthcare Ltd","TEMOZOLOMIDE"
"9346","TEMOZOLOMIDE CLONMEL","140 Milligram                                                                                            Capsules Hard",2010-05-21,"PA0126/188/004","Clonmel Healthcare Ltd","TEMOZOLOMIDE"
"9347","TEMOZOLOMIDE CLONMEL","180 Milligram                                                                                            Capsules Hard",2010-05-21,"PA0126/188/005","Clonmel Healthcare Ltd","TEMOZOLOMIDE"
"9348","TEMOZOLOMIDE CLONMEL","250 Milligram                                                                                            Capsules Hard",2010-05-21,"PA0126/188/006","Clonmel Healthcare Ltd","TEMOZOLOMIDE"
"9349","TEMOZOLOMIDE FAIR-MED","5 Milligram                                                                                            Capsules Hard",2013-06-28,"PA1789/005/001","Fair-Med Healthcare GmbH","TEMOZOLOMIDE"
"9350","TEMOZOLOMIDE FAIR-MED","20 Milligram                                                                                            Capsules Hard",2013-06-28,"PA1789/005/002","Fair-Med Healthcare GmbH","TEMOZOLOMIDE"
"9351","TEMOZOLOMIDE FAIR-MED","100 Milligram                                                                                            Capsules Hard",2013-06-28,"PA1789/005/003","Fair-Med Healthcare GmbH","TEMOZOLOMIDE"
"9352","TEMOZOLOMIDE FAIR-MED","140 Milligram                                                                                            Capsules Hard",2013-06-28,"PA1789/005/004","Fair-Med Healthcare GmbH","TEMOZOLOMIDE"
"9353","TEMOZOLOMIDE FAIR-MED","180 Milligram                                                                                            Capsules Hard",2013-06-28,"PA1789/005/005","Fair-Med Healthcare GmbH","TEMOZOLOMIDE"
"9354","TEMOZOLOMIDE FAIR-MED","250 Milligram                                                                                            Capsules Hard",2013-06-28,"PA1789/005/006","Fair-Med Healthcare GmbH","TEMOZOLOMIDE"
"9355","TEMOZOLOMIDE HEXAL","140 Milligram                                                                                            Capsules Hard",2010-03-15,"EU/1/10/616/13-16","Hexal AG","TEMOZOLOMIDE"
"9356","TEMOZOLOMIDE HEXAL","5 Milligram                                                                                            Capsules Hard",2010-03-15,"EU/1/10/616/1-4","Hexal AG","TEMOZOLOMIDE"
"9357","TEMOZOLOMIDE HEXAL","180 Milligram                                                                                            Capsules Hard",2010-03-15,"EU/1/10/616/17-20","Hexal AG","TEMOZOLOMIDE"
"9358","TEMOZOLOMIDE HEXAL","250 Milligram                                                                                            Capsules Hard",2010-03-15,"EU/1/10/616/21-24","Hexal AG","TEMOZOLOMIDE"
"9359","TEMOZOLOMIDE HEXAL","20 Milligram                                                                                            Capsules Hard",2010-03-15,"EU/1/10/616/5-8","Hexal AG","TEMOZOLOMIDE"
"9360","TEMOZOLOMIDE HEXAL","100 Milligram                                                                                            Capsules Hard",2010-03-15,"EU/1/10/616/9-12","Hexal AG","TEMOZOLOMIDE"
"9361","TEMOZOLOMIDE SANDOZ","140 Milligram                                                                                            Capsules Hard",2010-03-15,"EU/1/10/617/13-16","Sandoz GmbH","TEMOZOLOMIDE"
"9362","TEMOZOLOMIDE SANDOZ","5 Milligram                                                                                            Capsules Hard",2010-03-15,"EU/1/10/617/1-4","Sandoz GmbH","TEMOZOLOMIDE"
"9363","TEMOZOLOMIDE SANDOZ","180 Milligram                                                                                            Capsules Hard",2010-03-15,"EU/1/10/617/17-20","Sandoz GmbH","TEMOZOLOMIDE"
"9364","TEMOZOLOMIDE SANDOZ","250 Milligram                                                                                            Capsules Hard",2010-03-15,"EU/1/10/617/21-24","Sandoz GmbH","TEMOZOLOMIDE"
"9365","TEMOZOLOMIDE SANDOZ","20 Milligram                                                                                            Capsules Hard",2010-03-15,"EU/1/10/617/5-8","Sandoz GmbH","TEMOZOLOMIDE"
"9366","TEMOZOLOMIDE SANDOZ","100 Milligram                                                                                            Capsules Hard",2010-03-15,"EU/1/10/617/9-12","Sandoz GmbH","TEMOZOLOMIDE"
"9367","TEMOZOLOMIDE SUN","5 Milligram                                                                                            Capsules Hard",2011-07-13,"EU/1/11/697/001-002","Sun Phamaceutical Industries Europe B.V.","TEMOZOLOMIDE"
"9368","TEMOZOLOMIDE SUN","20 Milligram                                                                                            Capsules Hard",2011-07-13,"EU/1/11/697/003-004","Sun Phamaceutical Industries Europe B.V.","TEMOZOLOMIDE"
"9369","TEMOZOLOMIDE SUN","100 Milligram                                                                                            Capsules Hard",2011-07-13,"EU/1/11/697/005-006","Sun Phamaceutical Industries Europe B.V.","TEMOZOLOMIDE"
"9370","TEMOZOLOMIDE SUN","140 Milligram                                                                                            Capsules Hard",2011-07-13,"EU/1/11/697/007-008","Sun Phamaceutical Industries Europe B.V.","TEMOZOLOMIDE"
"9371","TEMOZOLOMIDE SUN","180 Milligram                                                                                            Capsules Hard",2011-07-13,"EU/1/11/697/009-010","Sun Phamaceutical Industries Europe B.V.","TEMOZOLOMIDE"
"9372","TEMOZOLOMIDE SUN","250 Milligram                                                                                            Capsules Hard",2011-07-13,"EU/1/11/697/011-012","Sun Phamaceutical Industries Europe B.V.","TEMOZOLOMIDE"
"9373","TEMOZOLOMIDE TEVA","250 Milligram                                                                                            Capsules Hard",2010-01-28,"EU/1/09/606/11-12","Teva B.V.","TEMOZOLOMIDE"
"9374","TEMOZOLOMIDE TEVA","5 Milligram                                                                                            Capsules Hard",2010-01-28,"EU/1/09/606/1-2","Teva B.V.","TEMOZOLOMIDE"
"9375","TEMOZOLOMIDE TEVA","20 Milligram                                                                                            Capsules Hard",2010-01-28,"EU/1/09/606/3-4","Teva B.V.","TEMOZOLOMIDE"
"9376","TEMOZOLOMIDE TEVA","100 Milligram                                                                                            Capsules Hard",2010-01-28,"EU/1/09/606/5-6","Teva B.V.","TEMOZOLOMIDE"
"9377","TEMOZOLOMIDE TEVA","140 Milligram                                                                                            Capsules Hard",2010-01-28,"EU/1/09/606/7-8","Teva B.V.","TEMOZOLOMIDE"
"9378","TEMOZOLOMIDE TEVA","180 Milligram                                                                                            Capsules Hard",2010-01-28,"EU/1/09/606/9-10","Teva B.V.","TEMOZOLOMIDE"
"9379","TENDROTIL SR","2 Milligram                                                                                            Prolonged Release Capsules",2012-09-28,"PA1380/119/001","Actavis Group PTC ehf","TOLTERODINETARTRATE"
"9380","TENDROTIL SR","4 Milligram                                                                                            Prolonged Release Capsules",2012-09-28,"PA1380/119/002","Actavis Group PTC ehf","TOLTERODINETARTRATE"
"9381","Tenofovir disoproxil 245 mg film coated tablets","245 milligram(s) Film-coated tablet",2017-04-21,"PA1390/118/001","Accord Healthcare Limited","Tenofovirdisoproxil"
"9382","Tenofovir disoproxil Mylan","245 milligram(s) Film-coated tablet",2016-12-08,"EU/1/16/1129/001","Mylan S.A.S.","Tenofovirdisoproxil"
"9383","Tenofovir disoproxil Rowex 245 mg Film-coated tablets","245 milligram(s) Film-coated tablet",2017-03-31,"PA0711/260/001","Rowex Ltd","Tenofovirdisoproxil"
"9384","Tenofovir Disoproxil Teva 245 mg Film-coated Tablets","245 milligram(s) Film-coated tablet",2015-08-21,"PA1986/003/001","Teva B.V.","Tenofovirdisoproxil"
"9385","Tenofovir disoproxil Zentiva","245 milligram(s) Film-coated tablet",2016-09-15,"EU/1/16/1127/001-002","Zentiva k.s.","Tenofovirdisoproxilphosphate"
"9386","Tenoret 50mg/12.5mg Film-coated Tablets","50/12.5 milligram(s) Film-coated tablet",1985-01-21,"PA0970/021/001","AstraZeneca UK Limited","Chlorthalidone|Atenolol"
"9387","Tenoretic 100mg/25mg Film-coated Tablets","100/25 milligram(s) Film-coated tablet",1979-05-17,"PA0970/020/001","AstraZeneca UK Limited","Atenolol|Chlorthalidone"
"9388","Tenormin 100 mg Film-coated Tablets","100 milligram(s) Film-coated tablet",1978-05-17,"PA0970/019/004","AstraZeneca UK Limited","Atenolol"
"9389","Tenormin 25 mg Film-coated Tablets","25 milligram(s) Film-coated tablet",1992-08-14,"PA0970/019/002","AstraZeneca UK Limited","Atenolol"
"9390","Tenormin 50 mg Film-coated Tablets","50 milligram(s) Film-coated tablet",1976-02-04,"PA0970/019/003","AstraZeneca UK Limited","Atenolol"
"9391","Tentin 5mg tablets","5 milligram(s) Tablet",2014-10-24,"PA1555/003/001","Medice Arzneimittel Putter GmbH & Co. K.G","DEXAMPHETAMINESULFATE"
"9392","Tepadina","15 milligram(s) ZZZ Pdr/Conc/Soln for Infus",2010-03-15,"EU/1/10/622/001","Adienne S.r.l.","Thiotepa"
"9393","TEPADINA","100 Milligram                                                                                            Pdr/Conc/Soln for Infus",2010-03-15,"EU/1/10/622/002","ADIENNE S.r.l.","THIOTEPA"
"9394","TERAZOSIN","2 Milligram                                                                                            Tablets",2009-04-17,"PA1390/012/002","Accord Healthcare Limited","TERAZOSIN"
"9395","TERAZOSIN","5 Milligram                                                                                            Tablets",2009-04-17,"PA1390/012/003","Accord Healthcare Limited","TERAZOSIN"
"9396","TERAZOSIN","5 Milligram                                                                                            Tablets",2016-11-11,"PPA1562/195/001","LTT Pharma Limited","TERAZOSIN"
"9397","TERBASIL","250 Base Milligrams                                                                                      Tablets",2006-05-05,"PA1390/142/001","Accord Healthcare Limited","TERBINAFINEHYDROCHLORIDE"
"9398","TERBINAFINE","250 Milligram                                                                                            Tablets",2008-05-16,"PA1339/018/001","Wockhardt UK Limited","TERBINAFINEHYDROCHLORIDE"
"9399","TERBINAFINE LICONSA 250 MG TABLETS","250 Milligram                                                                                            Tablets",2007-01-12,"PA1067/004/001","Laboratorios Velvian S.L","TERBINAFINE"
"9400","TERBINAFINE ROWA","250 Milligram                                                                                            Tablets",2007-01-12,"PA0074/084/001","Rowa Pharmaceuticals Limited","TERBINAFINE"
"9401","TERIPARATIDE TEVA","20/80 Unknown Solution for injection in pre-filled pen",2018-06-22,"PA1986/022/001","Teva B.V.","TERIPARATIDE"
"9402","TERIPARATIDE TEVA PHARMA","20/80 Unknown Solution for injection in pre-filled pen",2018-06-22,"PA1986/053/001","Teva B.V.","TERIPARATIDE"
"9403","Ternaf 250 mg Tablets","250 milligram(s) Tablet",2005-03-11,"PA0711/071/002","Rowex Ltd","Terbinafine"
"9404","TERROSA","20microgram/80 Microlitre                                                                                         Solution for Injection",2017-01-04,"EU/1/16/1159/001-002","Gedeon Richter Plc","TERIPARATIDE"
"9405","TESAVEL","100 Milligram                                                                                            Film Coated Tablet",2008-01-10,"EU/1/07/435/13-18","Merck Sharp & Dohme BV","SITAGLIPTINASMONOHYDRATEPHOSPHATESALT"
"9406","TESAVEL","25 milligram(s) Film-coated tablet",2008-01-10,"EU/1/07/435/1-6","Merck Sharp and Dohme Limited","Sitagliptinasmonohydratephosphatesalt"
"9407","TESAVEL","50 Milligram                                                                                            Film Coated Tablet",2008-01-10,"EU/1/07/435/7-12","Merck Sharp & Dohme BV","SITAGLIPTINASMONOHYDRATEPHOSPHATESALT"
"9408","TESTARZON","20 mg/g Gel",2018-04-13,"PA1009/028/001","Ferring Ireland Ltd","TESTOSTERONE"
"9409","TESTIM 50 mg Transdermal Gel","50 milligram(s) Gel",2005-04-22,"PA2311/001/001","Endo Ventures Ltd","Testosterone"
"9410","Testogel 16.2 mg/g, gel","16.2 milligram(s)/gram Gel",2015-12-11,"PA1054/002/004","Laboratoires Besins International","Testosterone"
"9411","Testogel 25 mg gel in sachet","25 milligram(s) Gel",2003-06-03,"PA1054/002/001","Laboratoires Besins International","Testosterone"
"9412","Testogel 50 mg gel in sachet","50 milligram(s) Gel",2003-06-03,"PA1054/002/002","Laboratoires Besins International","Testosterone"
"9413","Tetagam P, prefilled syringeSolution for injection for intramuscular use","250 international unit(s)/millilitre Solution for injection",2014-10-17,"PA0800/009/002","CSL Behring GmbH","HumanTetanusImmunoglobulinPh.Eur.|Humanplasmaprotein|Immunoglobulins|Tetanusantibodies"
"9414","Tetrabenazine 25mg Tablets","25 milligram(s) Tablet",2010-09-24,"PA0934/004/001","AOP Orphan Pharmaceuticals AG","Tetrabenazine"
"9415","TETRALYSAL","300 Base Milligrams                                                                                      Capsules Hard",2010-10-01,"PPA0465/256/001","PCO Manufacturing","LYMECYCLINE"
"9416","TETRALYSAL","300 Milligram                                                                                            Capsules Hard",NA,"DPR1633/020/001","Primecrown 2010 Ltd","LYMECYCLINE"
"9417","TETRALYSAL","300 Base Milligrams                                                                                      Capsules Hard",1982-02-26,"PA0590/012/002","Galderma (UK) Ltd","LYMECYCLINE"
"9418","TETRALYSAL","300 Milligram                                                                                            Capsules Hard",2013-07-05,"PPA1633/029/001","Primecrown 2010 Ltd","LYMECYCLINE"
"9419","TETRALYSAL","300 Milligram                                                                                            Capsules Hard",2013-07-04,"PPA1463/080/001","IMED Healthcare Ltd.","LYMECYCLINE"
"9420","TETRALYSAL","300 Milligram                                                                                            Capsules Hard",2013-04-18,"PPA1151/195/001","Imbat Limited","LYMECYCLINE"
"9421","Tetravac, suspension for injectionDiphtheria, tetanus, pertussis (acellular, component) and poliomyelitis (inactivated) vaccine, adsorbed","0.5 millilitre(s) Suspension for injection",2001-03-23,"PA2131/009/001","Sanofi Pasteur","Purifiedtetanustoxoid|PurifiedDiphtheriaToxoidPh.Eur.|Adsorbedpurifiedpertussistoxoid|Adsorbedpurifiedfilamentoushaemagglutinin|InactivatedPoliomyelitisVirusPh.Eur|Inactivatedtype1poliovirus|Inactivatedtype2poliovirus|Inactivatedtype3poliovirus"
"9422","TEURO","100 Milligram                                                                                            Solution for injection in pre-filled syringe",2018-07-11,"PA1995/002/001","Laboratorios Farmacéuticos ROVI, S.A.","ENOXAPARINSODIUM"
"9423","TEURO","20 Milligram                                                                                            Solution for injection in pre-filled syringe",2018-07-11,"PA1995/002/002","Laboratorios Farmacéuticos ROVI, S.A.","ENOXAPARINSODIUM"
"9424","TEURO","40 Milligram                                                                                            Solution for injection in pre-filled syringe",2018-07-11,"PA1995/002/003","Laboratorios Farmacéuticos ROVI, S.A.","ENOXAPARINSODIUM"
"9425","TEURO","60 Milligram                                                                                            Solution for injection in pre-filled syringe",2018-07-11,"PA1995/002/004","Laboratorios Farmacéuticos ROVI, S.A.","ENOXAPARINSODIUM"
"9426","TEURO","80 Milligram                                                                                            Solution for injection in pre-filled syringe",2018-07-11,"PA1995/002/005","Laboratorios Farmacéuticos ROVI, S.A.","ENOXAPARINSODIUM"
"9427","TEVAGRASTIM","30/0.5 MU/ml                                                                                                Solution for Inj/Inf",2008-09-15,"EU/1/08/445/1-4","Teva Generics GmbH","FILGRASTIM"
"9428","TEVAGRASTIM","MU/ml                                                                                                Solution for Injection",2008-09-15,"EU/1/08/445/5-8","Teva Generics GmbH","FILGRASTIM"
"9429","TEVANATE ONCE WEEKLY","70 Milligram                                                                                            Tablets",2006-12-08,"PA0749/016/001","Teva Pharma B.V.","ALENDRONICACID"
"9430","TEVAQUEL","100 Milligram                                                                                            Film Coated Tablet",2009-02-20,"PA0749/060/002","Teva Pharma B.V.","QUETIAPINEFUMARATE"
"9431","TEVAQUEL","200 Milligram                                                                                            Film Coated Tablet",2009-02-20,"PA0749/060/004","Teva Pharma B.V.","QUETIAPINEFUMARATE"
"9432","TEVAQUEL","300 Milligram                                                                                            Film Coated Tablet",2009-02-20,"PA0749/060/005","Teva Pharma B.V.","QUETIAPINEFUMARATE"
"9433","Tevaquel 25 mg Film-coated Tablets","25 milligram(s) Film-coated tablet",2009-02-20,"PA0749/060/001","Teva Pharma B.V.","Quetiapinefumarate"
"9434","Tevaquel XL 200 mg Prolonged-release Tablets","200 milligram(s) Prolonged-release tablet",2012-04-13,"PA0749/060/007","Teva Pharma B.V.","Quetiapinefumarate"
"9435","Tevaquel XL 300 mg Prolonged-release Tablets","300 milligram(s) Prolonged-release tablet",2012-04-13,"PA0749/060/008","Teva Pharma B.V.","Quetiapinefumarate"
"9436","Tevaquel XL 400 mg Prolonged-release Tablets","400 milligram(s) Prolonged-release tablet",2012-04-13,"PA0749/060/009","Teva Pharma B.V.","Quetiapinefumarate"
"9437","Tevaquel XL 50 mg Prolonged-release Tablets","50 milligram(s) Prolonged-release tablet",2012-04-13,"PA0749/060/006","Teva Pharma B.V.","Quetiapinefumarate"
"9438","TEVAX 10 MG, PROLONGED RELEASE TABLETS","10 Milligram                                                                                            Tablet Prolonged Release",2007-08-10,"PA0749/051/001","Teva Pharma B.V.","ALFUZOSINHYDROCHLORIDE"
"9439","TEVETEN","600 Milligram                                                                                            Film Coated Tablet",2005-08-05,"PPA0465/147/002","PCO Manufacturing","EPROSARTAN"
"9440","TEVETEN","600 Milligram                                                                                            Film Coated Tablet",2014-01-31,"PPA1463/091/001","IMED Healthcare Ltd.","EPROSARTANMESYLATE"
"9441","TEVETEN 400 MG, FILM-COATED TABLETS","400 Milligram                                                                                            Film Coated Tablet",1997-09-05,"PA2010/017/001","Mylan IRE Healthcare Limited","EPROSARTANMESYLATE"
"9442","Teveten 600 mg, film-coated tablets","600 milligram(s) Film-coated tablet",1997-09-05,"PA2010/017/002","Mylan IRE Healthcare Limited","Eprosartanmesylate"
"9443","Teveten 600mg film-coated tablets","600 milligram(s) Film-coated tablet",2009-08-07,"PPA1151/118/001","Imbat Limited","Eprosartan"
"9444","Teveten Plus 600 mg/12.5 mg film-coated tablets","600/12.5 milligram(s) Film-coated tablet",2005-01-28,"PA2010/018/001","Mylan IRE Healthcare Limited","Eprosartan|Hydrochlorothiazide"
"9445","Teysuno","15/4.35/11.8 milligram(s) Capsule, hard",2011-03-14,"EU/1/11/669/001-002","Taiho Pharma Europe, Limited","Tegafur|Gimeracil|Oteracil(asmonopotassiumsalt)"
"9446","TEYSUNO","20/5.8/15 Milligram                                                                                            Capsules Hard",2011-03-14,"EU/1/11/669/003-004","Taiho Pharma Europe, Limited","TEGAFUR|GIMERACIL|OTERACIL(ASMONOPOTASSIUMSALT)"
"9447","Thalidomide Celgene","50 milligram(s) Capsule, hard",NA,"EU/1/08/443/1","Celgene Europe Ltd","Thalidomide"
"9448","Thallous (Tl201) chloride injection 37MBq/ml solution for injection","*** AWAITING VALUE *** Not Currently Available",1981-08-25,"PA0690/016/001","Mallinckrodt Medical B.V.","Thallouschloride(201tl)"
"9449","THAMICARB","84 Mg/Ml Oral Solution",2014-10-17,"PA1861/002/001","SYRI Limited, t/a Thame Laboratories","SODIUMBICARBONATE"
"9450","THIOPENTAL SODIUM","500 Milligram                                                                                            Pdr for Soln for Injection",1992-06-09,"PA1049/014/001","Kyowa Kirin Ltd","THIOPENTALSODIUM"
"9451","THORENS 10 000 I.U. /ml oral drops, solution","10 000 international unit(s)/millilitre Oral drops, solution",2014-02-14,"PA1776/001/001","Italfarmaco S.p.A.","Cholecalciferol"
"9452","THORENS 25 000 I.U. /2.5 ml oral solution","25 000 IU international unit(s)/millilitre Oral solution",2014-02-14,"PA1776/001/002","Italfarmaco S.p.A.","Cholecalciferol"
"9453","THORINANE","20 Milligram                                                                                            Solution for injection in pre-filled syringe",2016-09-15,"EU/1/16/1131/001-002","Techdow Pharma Netherlands B.V","ENOXAPARINSODIUM"
"9454","THORINANE","40 Milligram                                                                                            Solution for injection in pre-filled syringe",2016-09-15,"EU/1/16/1131/003-004","Techdow Pharma Netherlands B.V","ENOXAPARINSODIUM"
"9455","THORINANE","60 Milligram                                                                                            Solution for injection in pre-filled syringe",2016-09-15,"EU/1/16/1131/005-006","Techdow Pharma Netherlands B.V","ENOXAPARINSODIUM"
"9456","THORINANE","80 Milligram                                                                                            Solution for injection in pre-filled syringe",2016-09-15,"EU/1/16/1131/007-008","Techdow Pharma Netherlands B.V","ENOXAPARINSODIUM"
"9457","THORINANE","100 Milligram                                                                                            Solution for injection in pre-filled syringe",2016-09-15,"EU/1/16/1131/009-010","Techdow Pharma Netherlands B.V","ENOXAPARINSODIUM"
"9458","THUJA","6C & 30C  Tablets",2010-09-10,"HOR0407/020/001","Weleda (UK) Limited","THUJAOCCIDENTALIS"
"9459","THWART","%w/w                                                                                                 Cutaneous Solution",2002-04-05,"PA0943/009/001","Alliance Pharmaceuticals Ltd.","SALICYLICACID"
"9460","Thymanax","25 milligram(s) Film-coated tablet",NA,"EU/1/08/498/1-8","Servier (Irleand) Industries Limited","Agomelatine"
"9461","Thymoglobuline 25 mg powder for solution for infusion","25 milligram(s) Powder for solution for infusion",2009-10-09,"PA0611/003/001","Genzyme Europe B.V.","Rabbitanti-humanthymocyteimmunoglobulin"
"9462","THYROGEN","0.9 mg milligram(s) Powder for solution for injection",2000-03-09,"EU/1/99/122/001","Genzyme Europe B.V.","Thyrotropinalfa"
"9463","THYROGEN","0.9mg milligram(s) Powder for solution for injection",2000-03-09,"EU/1/99/122/002","Genzyme Europe B.V.","Thyrotropinalfa"
"9464","TIBOLONE ARISTO","2.5 Milligram                                                                                            Tablets",2018-01-26,"PA1983/003/001","Aristo Pharma GmbH","TIBOLONE"
"9465","TicoVac 0.5 ml Suspension for injection in a pre-filled syringeTick-Borne Encephalitis Vaccine (whole Virus, inactivated)","0.5 millilitre(s) Suspension for injection",2004-06-25,"PA0822/184/001","Pfizer Healthcare Ireland","Tbevirusantigen"
"9466","TicoVac Junior 0.25 ml Suspension for injection in a pre-filled syringeTick-Borne Encephalitis Vaccine (whole Virus, inactivated)","0.25 millilitre(s) Suspension for injection",2004-06-25,"PA0822/184/002","Pfizer Healthcare Ireland","Tbevirusantigen"
"9467","Tienam I.V. 60ml","500/500 milligram(s) Powder for solution for infusion",NA,"PA0035/070/004","Merck Sharp and Dohme Limited","Imipenem|Cilastatinsodium"
"9468","TIGER BALM RED OINTMENT","11/10/7/5 %v/v                                                                                                 Ointment",1991-10-15,"PA1186/014/001","Chefaro Ireland DAC","CAMPHOR|MENTHOL|MELALEUCALEUCADENDRON|CLOVEOIL"
"9469","TIGER BALM WHITE OINTMENT","8 g N/A Ointment",1999-07-26,"PA1186/014/002","Chefaro Ireland DAC","CAMPHOR|LEVOMENTHOL|MELALEUCALEUCADENDRON|CLOVEOIL"
"9470","TIMLATAN","50mcg/ml + 5 Mg/Ml Eye Drops Solution",2011-08-26,"PA1696/004/001","PharmaSwiss Ceska republika s.r.o.","LATANOPROST|TIMOLOLMALEATE"
"9471","TIMOFLUID 1 MG/G EYE GEL IN SINGLE-DOSE CONTAINER","1 mg/g Eyegel",2010-05-14,"PA1107/003/001","Laboratoires Thea","TIMOLOL"
"9472","TIMOLOL","0.25 %w/v                                                                                                 Eye Drops Solution",2010-12-10,"PA1339/017/001","Wockhardt UK Limited","TIMOLOLMALEATE"
"9473","TIMOLOL","0.5 %w/v                                                                                                 Eye Drops Solution",2010-12-10,"PA1339/017/002","Wockhardt UK Limited","TIMOLOLMALEATE"
"9474","TIMOLOL","0.25 %w/v                                                                                                 Eye Drops Solution",2013-02-15,"PA1648/002/001","Brown & Burk UK Ltd","TIMOLOLMALEATE"
"9475","TIMOLOL","0.5 %w/v                                                                                                 Eye Drops Solution",2013-02-15,"PA1648/002/002","Brown & Burk UK Ltd","TIMOLOLMALEATE"
"9476","TIMOPTOL","0.25 Base %w/v                                                                                            Eye Drops Solution",1978-08-24,"PA0879/007/001","Santen OY","TIMOLOLMALEATE"
"9477","TIMOPTOL","0.5 Base %w/v                                                                                            Eye Drops Solution",1978-08-24,"PA0879/007/002","Santen OY","TIMOLOLMALEATE"
"9478","TINADERM","1 %w/w                                                                                                 Cream",1983-07-19,"PA1410/080/001","Bayer Limited","TOLNAFTATE"
"9479","TIOCONAZOLE","283 Mg/Ml Medicated Nail Lacquer",2015-09-03,"PA1884/002/001","Creo Pharma Limited","TIOCONAZOLE"
"9480","TIPOL","75 Milligram                                                                                            Suppositories",2013-09-06,"PA1684/002/001","Carysfort Healthcare Limited","PARACETAMOL"
"9481","TIPOL","125 Milligram                                                                                            Suppositories",2013-09-06,"PA1684/002/002","Carysfort Healthcare Limited","PARACETAMOL"
"9482","TIPOL","250 Milligram                                                                                            Suppositories",2013-09-06,"PA1684/002/003","Carysfort Healthcare Limited","PARACETAMOL"
"9483","TIPOL","500 Milligram                                                                                            Suppositories",2013-09-06,"PA1684/002/004","Carysfort Healthcare Limited","PARACETAMOL"
"9484","TIPOL 500MG GRANULES IN SACHETS","500 Milligram                                                                                            Granules",2011-08-26,"PA1684/004/002","Carysfort Healthcare Limited","PARACETAMOL"
"9485","TIPOL JUNIOR 250MG GRANULES IN SACHETS","250 Milligram                                                                                            Granules",2011-08-26,"PA1684/004/001","Carysfort Healthcare Limited","PARACETAMOL"
"9486","TIPOL MAX","1000 Milligram                                                                                            Suppositories",2013-09-06,"PA1684/002/005","Carysfort Healthcare Limited","PARACETAMOL"
"9487","TIPOL MAX 1000MG GRANULES IN SACHETS","1000 Milligram                                                                                            Granules",2011-08-26,"PA1684/004/003","Carysfort Healthcare Limited","PARACETAMOL"
"9488","TIPURIC","100 Milligram                                                                                            Tablets",1983-07-27,"PA0126/038/001","Clonmel Healthcare Ltd","ALLOPURINOL"
"9489","TIPURIC","300 Milligram                                                                                            Tablets",1983-07-27,"PA0126/038/002","Clonmel Healthcare Ltd","ALLOPURINOL"
"9490","TIRITEK ALLERGY","10 Milligram                                                                                            Film Coated Tablet",2004-02-06,"PA0688/030/001","Chanelle Medical","CETIRIZINEHYDROCHLORIDE"
"9491","TISEPT","0.015/0.15%w/v *** AWAITING VALUE *** Cutaneous solution",NA,"PA0483/001/001","Seton Prebbles Ltd","Chlorhexidinegluconate|Cetrimide"
"9492","TISSEEL","Unknown Solution for Sealant",2010-11-19,"PA0167/129/005","Baxter Healthcare Limited","HUMANFIBRINOGEN|APROTININ|HUMANFACTORXIII|HUMANTHROMBIN|CALCIUMCHLORIDEDIHYDRATE"
"9493","TISSEEL LYO","Unknown Powder and Solvent for Sealant",2011-01-21,"PA0167/129/006","Baxter Healthcare Limited","HUMANFIBRINOGEN|HUMANFACTORXIII|APROTININ|HUMANTHROMBIN|CALCIUMCHLORIDEDIHYDRATE"
"9494","Tivicay","50 milligram(s) Film-coated tablet",NA,"EU/1/13/892/001-002","ViiV Healthcare UK Ltd","Dolutegravir"
"9495","TIVICAY","10 Milligram                                                                                            Film Coated Tablet",2017-02-23,"EU/1/13/892/003-004","ViiV Healthcare UK Ltd","DOLUTEGRAVIR"
"9496","TIVICAY","25 Milligram                                                                                            Film Coated Tablet",2017-02-23,"EU/1/13/892/005-006","ViiV Healthcare UK Ltd","DOLUTEGRAVIR"
"9497","Tizaflex 2 mg tablets","2 milligram(s) Tablet",2009-05-28,"PA2315/051/001","Accord Healthcare Ireland Ltd.","Tizanidinehydrochloride"
"9498","Tizaflex 4 mg tablets","4 milligram(s) Tablet",2009-05-28,"PA2315/051/002","Accord Healthcare Ireland Ltd.","Tizanidinehydrochloride"
"9499","TOBI 300 mg/5 mL Nebuliser SolutionTobramycin 300 mg/5 ml Nebuliser Solution","300 mg/5ml Nebuliser solution",2000-09-15,"PA0896/031/001","Novartis Ireland Limited","Tobramycin"
"9500","TOBI PODHALER","28 Milligram                                                                                            Inhalation Powder, Capsule",2011-07-20,"EU/1/10/652/001-003","Novartis Europharm Limited","TOBRAMYCIN"
"9501","Tobramycin 40 mg/ml Solution for Injection","40 micromole(s) Solution for injection",1993-07-14,"PA0822/207/001","Pfizer Healthcare Ireland","Tobramycin"
"9502","TOILAX MICRO ENEMA","10/5 Mg/Ml Rectal Suspension",1981-01-21,"PA1327/007/001","Orion Corporation","BISACODYL"
"9503","TOLTERODINE TARTRATE","1 Milligram                                                                                            Film Coated Tablet",2012-09-07,"PA1390/055/001","Accord Healthcare Limited","TOLTERODINETARTRATE"
"9504","TOLTERODINE TARTRATE","2 Milligram                                                                                            Film Coated Tablet",2012-09-07,"PA1390/055/002","Accord Healthcare Limited","TOLTERODINETARTRATE"
"9505","TOLTERTAN SR","2 Milligram                                                                                            Prolonged Release Capsules",2012-11-16,"PA0126/231/001","Clonmel Healthcare Ltd","TOLTERODINETARTRATE"
"9506","TOLTERTAN SR","4 Milligram                                                                                            Prolonged Release Capsules",2012-11-16,"PA0126/231/002","Clonmel Healthcare Ltd","TOLTERODINETARTRATE"
"9507","TOLUCOMBI","40/12.5 mg/mg Tablets",2013-03-13,"EU/1/13/821/001-010","Krka d.d., Novo mesto","TELMISARTAN|HYDROCHLOROTHIAZIDE"
"9508","TOLUCOMBI","80/12.5 mg/mg Tablets",2013-03-13,"EU/1/13/821/011-020","Krka d.d., Novo mesto","TELMISARTAN|HYDROCHLOROTHIAZIDE"
"9509","TOLUCOMBI","80/25 mg/mg Tablets",2013-03-13,"EU/1/13/821/021-030","Krka d.d., Novo mesto","TELMISARTAN|HYDROCHLOROTHIAZIDE"
"9510","TOLURA","20 Milligram                                                                                            Tablets",2010-06-04,"EU/1/10/632/001-7","Krka d.d., Novo mesto","TELMISARTAN"
"9511","TOLURA","40 Milligram                                                                                            Tablets",2010-06-04,"EU/1/10/632/008-14","Krka d.d., Novo mesto","TELMISARTAN"
"9512","TOLURA","80 Milligram                                                                                            Tablets",2010-06-04,"EU/1/10/632/015-21","Krka d.d., Novo mesto","TELMISARTAN"
"9513","Tolusitol 2 mg Prolonged-Release Capsules, Hard","2 milligram(s) Prolonged-release capsule",2012-05-11,"PA0711/212/001","Rowex Ltd","Tolterodinetartrate|Tolterodinetartrate"
"9514","Tolusitol 4 mg Prolonged-Release Capsules, Hard","4 milligram(s) Prolonged-release capsule",2012-05-11,"PA0711/212/002","Rowex Ltd","Tolterodinetartrate"
"9515","Tomudex 2mg Powder for Solution for Infusion","2 milligram(s) Powder for suspension for injection",1996-01-08,"PA0437/062/001","Hospira  UK Limited","Raltitrexed"
"9516","TONPULAR XL","75 Milligram                                                                                            Prolonged Release Capsules",2010-01-08,"PA1339/023/001","Wockhardt UK Limited","VENLAFAXINE"
"9517","Tonpular XL 150 mg prolonged-release hard capsules","150 milligram(s) Prolonged-release capsule",2010-01-08,"PA1339/023/002","Wockhardt UK Limited","Venlafaxine"
"9518","TOOKAD","183 Milligram                                                                                            Pdr for Soln for Injection",2017-11-10,"EU/1/17/1228/001","STEBA Biotech S.A.","PADELIPORFIN"
"9519","TOOKAD","366 Milligram                                                                                            Pdr for Soln for Injection",2017-11-10,"EU/1/17/1228/002","STEBA Biotech S.A.","PADELIPORFIN"
"9520","TOPAMAX","25 Milligram                                                                                            Film Coated Tablet",1997-06-13,"PA0748/012/001","Janssen-Cilag Ltd","TOPIRAMATE"
"9521","TOPAMAX","50 Milligram                                                                                            Film Coated Tablet",1997-06-13,"PA0748/012/002","Janssen-Cilag Ltd","TOPIRAMATE"
"9522","TOPAMAX","100 Milligram                                                                                            Film Coated Tablet",1997-06-13,"PA0748/012/003","Janssen-Cilag Ltd","TOPIRAMATE"
"9523","TOPAMAX","200 Milligram                                                                                            Film Coated Tablet",1997-06-13,"PA0748/012/004","Janssen-Cilag Ltd","TOPIRAMATE"
"9524","TOPAMAX","25 Milligram                                                                                            Film Coated Tablet",2007-03-16,"PPA0465/196/001","PCO Manufacturing","TOPIRAMATE"
"9525","TOPAMAX","50 Milligram                                                                                            Film Coated Tablet",2007-03-16,"PPA0465/196/002","PCO Manufacturing","TOPIRAMATE"
"9526","TOPAMAX","100 Milligram                                                                                            Film Coated Tablet",2007-03-16,"PPA0465/196/003","PCO Manufacturing","TOPIRAMATE"
"9527","TOPAMAX","200 Milligram                                                                                            Film Coated Tablet",2007-03-16,"PPA0465/196/004","PCO Manufacturing","TOPIRAMATE"
"9528","TOPAMAX","50 Milligram                                                                                            Film Coated Tablet",2016-03-11,"PPA1463/106/001","IMED Healthcare Ltd.","TOPIRAMATE"
"9529","TOPAMAX","100 Milligram                                                                                            Film Coated Tablet",2016-03-11,"PPA1463/106/002","IMED Healthcare Ltd.","TOPIRAMATE"
"9530","TOPAMAX","25 Milligram                                                                                            Film Coated Tablet",2014-02-21,"PPA1151/209/001","Imbat Limited","TOPIRAMATE"
"9531","TOPAMAX","50 Milligram                                                                                            Film Coated Tablet",2014-02-21,"PPA1151/209/002","Imbat Limited","TOPIRAMATE"
"9532","TOPAMAX","200 Milligram                                                                                            Film Coated Tablet",2018-03-09,"PPA1151/209/004","Imbat Limited","TOPIRAMATE"
"9533","TOPAMAX","25 Milligram                                                                                            Tablets",2006-09-22,"PPA1633/054/001","Primecrown 2010 Ltd","TOPIRAMATE"
"9534","TOPAMAX","50 Milligram                                                                                            Tablets",2006-09-22,"PPA1633/054/002","Primecrown 2010 Ltd","TOPIRAMATE"
"9535","TOPAMAX","100 Milligram                                                                                            Tablets",2006-09-22,"PPA1633/054/003","Primecrown 2010 Ltd","TOPIRAMATE"
"9536","TOPAMAX 100 mg Film-coated Tablets","100 milligram(s) Film-coated tablet",2014-02-21,"PPA1151/209/003","Imbat Limited","Topiramate"
"9537","Topamax 100 mg Film-coated Tablets","100 milligram(s) Film-coated tablet",2017-07-14,"PPA1097/002/005","Lexon (UK) Ltd","Topiramate"
"9538","TOPAMAX 200mg Film-coated Tablets","200 milligram(s) Film-coated tablet",2016-12-23,"PPA1097/002/002","Lexon (UK) Ltd","Topiramate"
"9539","TOPAMAX 50mg Film-coated Tablets","50 milligram(s) Film-coated tablet",2016-12-23,"PPA1097/002/001","Lexon (UK) Ltd","Topiramate"
"9540","Topamax Sprinkle 15 mg Hard Capsules","15 milligram(s) Capsule, hard",1999-06-25,"PA0748/012/007","Janssen-Cilag Ltd","Topiramate"
"9541","Topamax Sprinkle 25 mg Hard Capsules","25 milligram(s) Capsule, hard",1999-06-25,"PA0748/012/008","Janssen-Cilag Ltd","Topiramate"
"9542","Topamax Sprinkle 50 mg Hard Capsules","50 milligram(s) Capsule, hard",1999-06-25,"PA0748/012/009","Janssen-Cilag Ltd","Topiramate"
"9543","TOPOTECAN ACCORD","1 Mg/Ml Concentrate for Soln for Inf",2012-05-04,"PA1390/036/002","Accord Healthcare Limited","TOPOTECAN(ASHYDROCHLORIDE)"
"9544","TOPOTECAN ACTAVIS","1 Milligram                                                                                            Pdr/Conc/Soln for Infus",2009-07-24,"EU/1/09/536/001","Actavis Group PTC ehf","TOPOTECANHYDROCHLORIDE"
"9545","TOPOTECAN ACTAVIS","4 Milligram                                                                                            Pdr/Conc/Soln for Infus",2009-07-24,"EU/1/09/536/002","Actavis Group PTC ehf","TOPOTECANHYDROCHLORIDE"
"9546","Topotecan Hospira","1 milligram(s)/millilitre Concentrate for solution for infusion",2010-06-10,"EU/1/10/633/001-2","Pfizer Europe MA EEIG","Topotecan(ashydrochloride)"
"9547","TOPOTECAN TEVA","1 Mg/Ml Concentrate for Soln for Inf",2009-09-21,"EU/1/09/552/001-4","Teva B.V.","TOPOTECANHYDROCHLORIDE"
"9548","Torisel","25 micromole(s) Solution for infusion",2007-11-19,"EU/1/07/424/001","Pfizer Limited","Temsirolimus"
"9549","TOSTRAN","2 %w/w                                                                                                 Gel",2006-08-04,"PA1049/005/001","Kyowa Kirin Ltd","TESTOSTERONE"
"9550","Toujeo","300 unit(s)/millilitre Solution for injection in pre-filled pen",2015-04-24,"EU/1/00/133/033-035","Sanofi-Aventis Deutschland GmbH","Insulinglargine"
"9551","TOVANOR BREEZHALER","44 Microgram                                                                                            Inhalation Powder, Capsule",2012-09-28,"EU/1/12/790/001-006","Novartis Europharm Limited","GLYCOPYRRONIUMBROMIDE"
"9552","TOVIAZ (FESOTERODINE)","4 Milligram                                                                                            Prolonged Release Capsules",2007-04-20,"EU/1/07/386/1-5","Pfizer Europe MA EEIG","FESOTERODINEFUMARATE"
"9553","TOVIAZ (FESOTERODINE)","8 Milligram                                                                                            Prolonged Release Capsules",2007-04-20,"EU/1/07/386/6-10","Pfizer Europe MA EEIG","FESOTERODINEFUMARATE"
"9554","Tracleer","62.5 milligram(s) Tablet",NA,"EU/1/02/220/001","Actelion Registration Ltd.","Bosentan"
"9555","TRACLEER","62.5 Milligram                                                                                            Tablets",2002-05-15,"EU/1/02/220/002","Actelion Registration Ltd","BOSENTAN"
"9556","TRACLEER","62.5 Milligram                                                                                            Tablets",2002-05-15,"EU/1/02/220/003","Actelion Registration Ltd","BOSENTAN"
"9557","TRACLEER","125 Milligram                                                                                            Tablets",2002-05-15,"EU/1/02/220/004","Actelion Registration Ltd","BOSENTAN"
"9558","TRACLEER","125 Milligram                                                                                            Tablets",2002-05-15,"EU/1/02/220/005","Actelion Registration Ltd","BOSENTAN"
"9559","TRACLEER","32 Milligram                                                                                            Dispersable Tablet",2009-07-01,"EU/1/02/220/006","Actelion Registration Ltd","BOSENTAN"
"9560","TRACRIUM","10 Mg/Ml Solution for Inj/Inf",1983-09-28,"PA1691/029/001","Aspen Pharma Trading Limited","ATRACURIUMBESILATE"
"9561","TRACRIUM","10 Mg/Ml Solution for Inj/Inf",2010-07-22,"PA1691/029/002","Aspen Pharma Trading Limited","ATRACURIUMBESILATE"
"9562","TRACTOCILE","6.75 mg/0.9 ml milligram(s)/millilitre Solution for injection",2000-01-20,"EU/1/99/124/001","Ferring AB","Atosibanacetate"
"9563","TRACTOCILE","37.5 mg/5 Mg/Ml Concentrate for Soln for Inf",2000-01-20,"EU/1/99/124/002","Ferring AB","ATOSIBANACETATE"
"9564","TRADOL","50 Milligram                                                                                            Capsules Hard",1999-06-25,"PA0711/029/001","Rowex Ltd","TRAMADOLHYDROCHLORIDE"
"9565","TRADOL","50 Milligram                                                                                            Tablets Effervescent",1999-06-25,"PA0711/029/002","Rowex Ltd","TRAMADOLHYDROCHLORIDE"
"9566","Tradol 50mg/ml Solution for Injection or Infusion","50 milligram(s)/millilitre Solution for injection/infusion",1999-06-25,"PA0711/029/003","Rowex Ltd","Tramadolhydrochloride"
"9567","TRADOL PLUS","37.5/325 Milligram                                                                                            Tablets",2016-02-12,"PA0711/256/001","Rowex Ltd","TRAMADOLHYDROCHLORIDE|PARACETAMOL"
"9568","Tradol SR 100 mg Prolonged Release Tablets","100 milligram(s) Prolonged-release tablet",2005-09-09,"PA0711/029/005","Rowex Ltd","Tramadolhydrochloride"
"9569","Tradol SR 150 mg Prolonged Release Tablets","150 milligram(s) Prolonged-release tablet",2005-09-09,"PA0711/029/006","Rowex Ltd","Tramadolhydrochloride"
"9570","Tradol SR 200 mg Prolonged Release Tablets","200 milligram(s) Prolonged-release tablet",2005-09-09,"PA0711/029/007","Rowex Ltd","Tramadolhydrochloride"
"9571","TRAJENTA","5 Milligram                                                                                            Film Coated Tablet",2011-08-24,"EU/1/11/707/001-011","Boehringer Ingelheim International GmbH","LINAGLIPTIN"
"9572","Tramadol 50mg Capsules","50 milligram(s) Capsule, hard",2008-03-28,"PA1128/003/001","Relon Chem Limited","Tramadolhydrochloride"
"9573","TRAMADOL HYDROCHLORIDE","50 Milligram                                                                                            Capsules Hard",2010-08-06,"PA1380/096/001","Actavis Group PTC ehf","TRAMADOLHYDROCHLORIDE"
"9574","TRAMADOL HYDROCHLORIDE/PARACETAMOL","37.5/325 Milligram                                                                                            Film Coated Tablet",2016-06-10,"PA1418/002/001","Athlone Pharmaceuticals Limited","PARACETAMOL|TRAMADOLHYDROCHLORIDE"
"9575","TRAMADOL HYDROCHLORIDE/PARACETAMOL","37.5/325 Milligram                                                                                            Film Coated Tablet",2014-03-07,"PA0405/066/001","Generics (UK) Limited","TRAMADOLHYDROCHLORIDE|PARACETAMOL90%DCL(COMPAPL)"
"9576","Tramadol hydrochloride/Paracetamol Amneal 37.5 mg/ 325 mg, film-coated tablets","37.5/325 milligram(s) Film-coated tablet",2017-11-10,"PA1897/011/001","Amneal Pharma Europe Limited","Tramadolhydrochloride|Paracetamol"
"9577","TRAMADOL KRKA","50 Milligram                                                                                            Capsules Hard",2018-03-16,"PA1347/079/001","Krka d.d., Novo mesto","TRAMADOLHYDROCHLORIDE"
"9578","TRAMADOL/PARACETAMOL ACTAVIS","37.5/325 Milligram                                                                                            Film Coated Tablet",2015-01-09,"PA1380/158/001","Actavis Group PTC ehf","TRAMADOLHYDROCHLORIDE|PARACETAMOL"
"9579","TRAMADOL/PARACETAMOL KRKA","37.5/325 Milligram                                                                                            Film Coated Tablet",2015-01-23,"PA1347/052/001","Krka d.d., Novo mesto","PARACETAMOL|TRAMADOLHYDROCHLORIDE"
"9580","TRAMADOL/PARACETAMOL ROWA","37.5/325 Unknown Film Coated Tablet",2017-07-07,"PA0074/070/001","Rowa Pharmaceuticals Limited","TRAMADOLHYDROCHLORIDEEP|PARACETAMOL"
"9581","TRAMAKE","50 Milligram                                                                                            Tablets",2000-02-04,"PA1329/004/001","Galen Limited","TRAMADOLHYDROCHLORIDE"
"9582","TRAMAKE","100 Milligram                                                                                            Tablets",2000-02-04,"PA1329/004/002","Galen Limited","TRAMADOLHYDROCHLORIDE"
"9583","TRAMAPINE","50 Milligram                                                                                            Capsules Hard",2001-07-13,"PA0281/100/001","Pinewood Laboratories Ltd,","TRAMADOLHYDROCHLORIDE"
"9584","TRANDATE","5 Mg/Ml Solution for Injection",1993-07-19,"PA1638/006/001","RPH Pharmaceuticals AB","LABETALOLHYDROCHLORIDE"
"9585","TRANDATE","100 Milligram                                                                                            Film Coated Tablet",1993-07-19,"PA1638/006/002","RPH Pharmaceuticals AB","LABETALOLHYDROCHLORIDE"
"9586","TRANDATE","200 Milligram                                                                                            Film Coated Tablet",1993-07-19,"PA1638/006/003","RPH Pharmaceuticals AB","LABETALOLHYDROCHLORIDE"
"9587","TRANEXAMIC ACID","100 Mg/Ml Solution for Injection",2016-12-16,"PA1390/115/001","Accord Healthcare Limited","TRANEXAMICACID"
"9588","Tranexamic Acid 100 mg/ml solution for injection","100 milligram(s)/millilitre Solution for injection",2014-12-05,"PA1862/002/001","Ibigen Srl","Tranexamicacid"
"9589","Tranexamic Acid 500mg/5ml Solution for Injection","500 mg/5ml Solution for injection",2013-03-22,"PA1338/012/001","Focus Pharmaceuticals Ltd","Tranexamicacid"
"9590","TRANSIDERM-NITRO","5/24 Unknown Transdermal Patch",1985-04-11,"PA0896/032/001","Novartis Ireland Limited","GLYCERYLTRINITRATE"
"9591","TRANSIDERM-NITRO","10/24 Unknown Transdermal Patch",1985-04-11,"PA0896/032/002","Novartis Ireland Limited","GLYCERYLTRINITRATE"
"9592","TRANSIDERM-NITRO","15/24 Unknown Transdermal Patch",1995-01-11,"PA0896/032/003","Novartis Ireland Limited","GLYCERYLTRINITRATE"
"9593","TRANSISOFT","8.50 Grams                                                                                                Powder for Oral Solution",2016-09-16,"PA1993/002/001","Laboratoires Mayoly Spindler","MACROGOL3350"
"9594","TRANSLARNA","125 Milligram                                                                                            Granules for Oral Suspension",2014-07-31,"EU/1/13/902/001","PTC Therapeutics International Limited","ATALUREN"
"9595","TRANSLARNA","250 Milligram                                                                                            Granules for Oral Suspension",2014-07-31,"EU/1/13/902/002","PTC Therapeutics International Limited","ATALUREN"
"9596","TRANSLARNA","1000 Milligram                                                                                            Granules for Oral Suspension",2014-07-31,"EU/1/13/902/003","PTC Therapeutics International Limited","ATALUREN"
"9597","TRANSTEC","%v/v                                                                                                 Transdermal Patch",2002-05-03,"PA1032/001/001","Grunenthal GmbH","BUPRENORPHINE"
"9598","TRANSTEC","%v/v                                                                                                 Transdermal Patch",2002-05-03,"PA1032/001/002","Grunenthal GmbH","BUPRENORPHINE"
"9599","TRANSTEC","%v/v                                                                                                 Transdermal Patch",2002-05-03,"PA1032/001/003","Grunenthal GmbH","BUPRENORPHINE"
"9600","TRANSTEC TRANSDERMAL PATCH","35 Microgram per hour Transdermal Patch",2014-05-02,"PPA0465/315/001","PCO Manufacturing","BUPRENORPHINE"
"9601","TRANSTEC TRANSDERMAL PATCH","52.5 Microgram per hour Transdermal Patch",2014-05-02,"PPA0465/315/002","PCO Manufacturing","BUPRENORPHINE"
"9602","TRANSTEC TRANSDERMAL PATCH","70 Microgram per hour Transdermal Patch",2014-05-02,"PPA0465/315/003","PCO Manufacturing","BUPRENORPHINE"
"9603","TRANTALOL ATENOLOL","25 Milligram                                                                                            Tablets",1989-08-16,"PA0281/083/003","Pinewood Laboratories Ltd,","ATENOLOL"
"9604","TRANTALOL ATENOLOL 100MG TABLETS","100 Milligram                                                                                            Tablets",1996-01-03,"PA0281/083/002","Pinewood Laboratories Ltd,","ATENOLOL"
"9605","TRANTALOL ATENOLOL 50MG TABLETS","50 Milligram                                                                                            Tablets",1996-01-03,"PA0281/083/001","Pinewood Laboratories Ltd,","ATENOLOL"
"9606","TRANZILEVE","5 Microgram per hour Transdermal Patch",2017-07-14,"PA1887/006/001","Alissa Healthcare Research Limited","BUPRENORPHINE"
"9607","TRANZILEVE","10 Microgram per hour Transdermal Patch",2017-07-14,"PA1887/006/002","Alissa Healthcare Research Limited","BUPRENORPHINE"
"9608","TRANZILEVE","20 Microgram per hour Transdermal Patch",2017-07-14,"PA1887/006/003","Alissa Healthcare Research Limited","BUPRENORPHINE"
"9609","Trasylol 10,000 KIU/ml, solution for injection or infusion","10,000 ZZZ Kallidogenase Inactivator Units Solution for injection/infusion",2018-03-29,"PA2252/001/001","Nordic Group B.V.","APROTININCONCENTRATEDSOLUTION"
"9610","TRAVATAN","40 Microgram/ML                                                                                         Eye Drops Solution",2001-11-27,"EU/1/01/199/001","Novartis Europharm Limited","TRAVOPROST"
"9611","TRAVATAN","40 Microgram/ML                                                                                         Eye Drops Solution",2001-11-27,"EU/1/01/199/002","Novartis Europharm Limited","TRAVOPROST"
"9612","TRAVOCORT","1/0.1 / 1 %v/v                                                                                                 Cream",1981-03-27,"PA1410/073/001","Bayer Limited","ISOCONAZOLENITRATE|DIFLUCORTOLONEVALERATE"
"9613","TRAVOPROST SANDOZ","40 Microgram/ML                                                                                         Eye Drops Solution",2014-07-18,"PA0711/213/001","Rowex Ltd","TRAVOPOST"
"9614","TRAXAM","3 %w/w                                                                                                 Gel",1987-10-06,"PA0899/019/001","Mercury Pharmaceuticals Ltd","FELBINAC"
"9615","TRAXAM","3 %w/w                                                                                                 Gel",2008-09-26,"PPA1151/081/001","Imbat Limited","FELBINAC"
"9616","TRAXAM GEL 3% W/W","3 %v/w                                                                                                 Gel",2009-06-12,"PPA0465/215/001","PCO Manufacturing","FELBINAC"
"9617","Trazimera","150 milligram(s) Concentrate for solution for infusion",2018-07-26,"EU/1/18/1295/001","Pfizer Limited","Trastuzumab"
"9618","TRAZODONE HYDROCHLORIDE","50/5 Mg/Ml Oral Solution",2017-03-10,"PA1887/007/001","Alissa Healthcare Research Limited","TRAZODONEHYDROCHLORIDE"
"9619","TRAZODONE HYDROCHLORIDE","50 Milligram                                                                                            Capsules Hard",2016-12-16,"PA1240/015/001","Bristol Laboratories Limited","TRAZODONEHYDROCHLORIDE"
"9620","TRAZODONE HYDROCHLORIDE","100 Milligram                                                                                            Capsules Hard",2016-12-16,"PA1240/015/002","Bristol Laboratories Limited","TRAZODONEHYDROCHLORIDE"
"9621","TRAZODONE HYDROCHLORIDE","150 Milligram                                                                                            Film Coated Tablet",2016-12-16,"PA1240/015/003","Bristol Laboratories Limited","TRAZODONEHYDROCHLORIDE"
"9622","Trazodone Hydrochloride 100 mg tablets","100 milligram(s) Tablet",2018-06-22,"PA1390/128/002","Accord Healthcare Limited","Trazodonehydrochloride"
"9623","Trazodone Hydrochloride 150 mg tablets","150 milligram(s) Tablet",2018-06-22,"PA1390/128/003","Accord Healthcare Limited","Trazodonehydrochloride"
"9624","Trazodone Hydrochloride 50 mg tablets","50 milligram(s) Tablet",2018-06-22,"PA1390/128/001","Accord Healthcare Limited","Trazodonehydrochloride"
"9625","Trazodone Hydrochloride 50mg/5ml Oral Solution","50/5 milligram(s)/millilitre Oral solution",2011-06-03,"PA1338/005/001","Focus Pharmaceuticals Ltd","Trazodonehydrochloride"
"9626","TRAZODONE HYDROCHLORIDE ORAL SOLUTION","50/5 Mg/Ml Oral Solution",2011-06-03,"PA0073/154/001","Mercury Pharmaceuticals (Ireland) Ltd","TRAZODONEHYDROCHLORIDE"
"9627","Treclin 1 %  / 0.025 % w/w Gel","1/0.025 percent weight/weight Gel",2013-03-22,"PA2010/044/001","Mylan IRE Healthcare Limited","Clindamycin|Tretinoin"
"9628","Trelegy Ellipta","92 microgram(s) Powder for Inhalation",2017-11-15,"EU/1/17/1236/001-003","GlaxoSmithKline Trading Services Limited","Fluticasonefuroate|Umeclidiniumbromide|Vilanterol"
"9629","Tremfya","100 milligram(s) Solution for injection in pre-filled syringe",2017-11-10,"EU/1/17/1234/001","Janssen-Cilag International NV","Guselkumab"
"9630","TREOSULFAN","5 Grams                                                                                                Pdr for Soln Inj/Inf",1984-03-05,"PA0623/001/002","Medac Gesellschaft fur Klinische Spezialpraparate mbH","TREOSULFAN"
"9631","Tresiba","100 unit(s)/millilitre Solution for injection",2013-01-21,"EU/1/12/807/1,4,5,7,8","Novo Nordisk A/S","Insulindegludec(ideg)"
"9632","TRESIBA","200 Units/ml                                                                                             Solution for Injection",NA,"EU/1/12/807/9,12,13,15","Novo Nordisk A/S","INSULINDEGLUDEC(IDEG)"
"9633","TREVACLYN 1000 MG/20 MG MODIFIED-RELEASE TABLETS.","1000/20 Milligram                                                                                            Modified-release Tablets",2008-07-03,"EU/1/08/458/1-11","Merck Sharp and Dohme Limited","NICOTINICACID|LAROPIPRANT"
"9634","TREVICTA","175 Milligram                                                                                            Prolonged-release suspension for injection",2016-05-26,"EU/1/14/971/007","Janssen-Cilag International NV","PALIPERIDONEPALMITATE(R092670)"
"9635","TREVICTA","263 Milligram                                                                                            Prolonged-release suspension for injection",2016-05-26,"EU/1/14/971/008","Janssen-Cilag International NV","PALIPERIDONEPALMITATE(R092670)"
"9636","TREVICTA","350 Milligram                                                                                            Prolonged-release suspension for injection",2016-05-26,"EU/1/14/971/009","Janssen-Cilag International NV","PALIPERIDONEPALMITATE(R092670)"
"9637","TREVICTA","525 Milligram                                                                                            Prolonged-release suspension for injection",2016-05-26,"EU/1/14/971/010","Janssen-Cilag International NV","PALIPERIDONEPALMITATE(R092670)"
"9638","TRIALIX","5/6 Milligram                                                                                            Tablets",1995-05-18,"PA0540/081/001","Sanofi-Aventis Ireland Limited T/A SANOFI","RAMIPRIL|PIRETANIDE"
"9639","TRIAPIN","5/5 mg/mg Tablet Prolonged Release",2016-02-19,"PPA1151/253/001","Imbat Limited","RAMIPRIL|FELODIPINE"
"9640","TRIAPIN","5/5 mg/mg Tablet Prolonged Release",2014-08-15,"PPA1463/098/001","IMED Healthcare Ltd.","RAMIPRIL|FELODIPINE"
"9641","TRIAPIN","5/5 Milligram                                                                                            Tablet Prolonged Release",2014-10-17,"PPA1562/128/001","LTT Pharma Limited","FELODIPINE|RAMIPRIL"
"9642","TRIAPIN","5/5 Milligram                                                                                            Tablet Prolonged Release",2016-03-11,"PPA1633/042/001","Primecrown 2010 Ltd","FELODIPINE"
"9643","Triapin 2.5mg/2.5mg prolonged release tablet","2.5/2.5 milligram(s) Prolonged-release tablet",1998-07-13,"PA0540/082/001","Sanofi-Aventis Ireland Limited T/A SANOFI","Felodipine|Ramipril"
"9644","Triapin 2.5mg/2.5mg prolonged release tablet","2.5/2.5 milligram(s) Prolonged-release tablet",2013-10-25,"PPA0465/318/001","PCO Manufacturing","Felodipine|Ramipril"
"9645","Triapin 5mg/5mg prolonged release tablet","5/5 milligram(s) Prolonged-release tablet",2014-02-14,"PPA0465/332/001","PCO Manufacturing","Felodipine|Ramipril"
"9646","Triapin 5mg/5mg prolonged release tablet","5/5 milligram(s) Prolonged-release tablet",1998-07-13,"PA0540/082/002","Sanofi-Aventis Ireland Limited T/A SANOFI","Felodipine|Ramipril"
"9647","TRIAXIS","Unknown Suspension for Injection",NA,"PA2131/010/001","Sanofi Pasteur","TETANUSTOXOID|DIPHTHERIATOXOID|PERTUSSISTOXOID|FILAMENTOUSHAEMAGGLUTININ|PERTACTIN|FIMBRIAETYPES2AND3|ADSORBEDALUMINIUMPHOSPHATE"
"9648","Triaxis, suspension for injection in a pre-filled syringeDiphtheria, Tetanus, Pertussis (acellular component) Vaccine (adsorbed, reduced antigen(s) content)","0 international unit(s) Suspension for injection",NA,"PA2131/010/002","Sanofi Pasteur","Diphtheriatoxoid|Tetanustoxoid|Pertussistoxoid|Filamentoushaemagglutinin|Pertactin(prn)|Fimbriaetypes2and3"
"9649","TRIIODOTHYRONINE","20 Microgram                                                                                            Pdr for Soln for Injection",1993-10-19,"PA0701/002/001","Mercury Pharma Group Limited","LIOTHYRONINESODIUM"
"9650","TRILEPTAL","300 Milligram                                                                                            Film Coated Tablet",2013-06-14,"PPA0465/308/001","PCO Manufacturing","OXCARBAZEPINE"
"9651","TRILEPTAL","600 Milligram                                                                                            Film Coated Tablet",2013-06-14,"PPA0465/308/002","PCO Manufacturing","OXCARBAZEPINE"
"9652","TRILEPTAL","60 Mg/Ml Oral Suspension",2016-07-22,"PPA0465/308/003","PCO Manufacturing","OXCARBAZEPINE"
"9653","TRILEPTAL","60 Mg/Ml Oral Suspension",2018-04-27,"PPA1097/047/001","Lexon (UK) Ltd","OXCARBAZEPINE"
"9654","Trileptal 150 mg Film-coated tablets","150 milligram(s) Film-coated tablet",2000-02-18,"PA0896/033/001","Novartis Ireland Limited","Oxcarbazepine"
"9655","Trileptal 300 mg Film-coated tablets","300 milligram(s) Film-coated tablet",2000-02-18,"PA0896/033/002","Novartis Ireland Limited","Oxcarbazepine"
"9656","Trileptal 60 mg/ml Oral Suspension","60 milligram(s)/millilitre Oral suspension",2000-02-18,"PA0896/033/004","Novartis Ireland Limited","Oxcarbazepine"
"9657","Trileptal 600 mg Film-coated tablets","600 milligram(s) Film-coated tablet",2000-02-18,"PA0896/033/003","Novartis Ireland Limited","Oxcarbazepine"
"9658","TRIMBOW","87µg/5µg/9 Milligram                                                                                            Pressurised Inhalation Soln",2017-07-17,"EU/1/17/1208/001-003","Chiesi Farmaceutici S.p.A.","BECLOMETASONEDIPROPIONATEANHYDROUS|FORMOTEROLFUMARATEDIHYDRATE|GLYCOPYRRONIUMBROMIDE"
"9659","TRIMBOW","87µg/5µg/9 Microgram                                                                                            Pressurised Inhalation Soln",2017-07-17,"EU/1/17/1208/004","Chiesi Farmaceutici S.p.A.","BECLOMETASONEDIPROPIONATEANHYDROUS|FORMOTEROLFUMARATEDIHYDRATE|GLYCOPYRRONIUMBROMIDE"
"9660","TRIMBOW","87µg/5µg/9 Microgram                                                                                            Pressurised Inhalation Soln",2017-07-17,"EU/1/17/1208/005","Chiesi Farmaceutici S.p.A.","BECLOMETASONEDIPROPIONATEANHYDROUS|FORMOTEROLFUMARATEDIHYDRATE|GLYCOPYRRONIUMBROMIDE"
"9661","TRIMEGA","1000 Milligram                                                                                            Capsules, Soft",2012-08-17,"PA0126/236/001","Clonmel Healthcare Ltd","OMEGA-3-ACIDETHYLESTER90+ATOCPHEROL(ASANTIOXIDANT)0.30%-0.44%ISINCLUDED"
"9662","TRI-MINULET COATED TABLETS","%v/v                                                                                                 Coated Tablets",1988-05-18,"PA0822/099/001","Pfizer Healthcare Ireland","ETHINYLESTRADIOL|GESTODENE|ETHINYLESTRADIOL|GESTODENE|ETHINYLESTRADIOL|GESTODENE"
"9663","TRIMOPTIN","100 Milligram                                                                                            Tablets",2004-07-30,"PA0298/014/001","Athlone Laboratories Ltd","TRIMETHOPRIM"
"9664","TRIMOPTIN","200 Milligram                                                                                            Tablets",2004-07-30,"PA0298/014/002","Athlone Laboratories Ltd","TRIMETHOPRIM"
"9665","TRINOMIA","100/20/2.5 Milligram                                                                                            Capsules Hard",2015-02-06,"PA1744/002/001","Ferrer Internacional, S.A","ACETYLSALICYLICACID|ATORVASTATINCALCIUMTRIHYDRATE|RAMIPRIL"
"9666","TRINOMIA","100/20/5 Milligram                                                                                            Capsules Hard",2015-02-06,"PA1744/002/002","Ferrer Internacional, S.A","ACETYLSALICYLICACID|ATORVASTATINCALCIUMTRIHYDRATE|RAMIPRIL"
"9667","TRINOMIA","100/20/10 Milligram                                                                                            Capsules Hard",2015-02-06,"PA1744/002/003","Ferrer Internacional, S.A","ACETYLSALICYLICACID|ATORVASTATINCALCIUMTRIHYDRATE|RAMIPRIL"
"9668","TRINOMIA","100mg/40mg/2.5 Milligram                                                                                            Capsules Hard",2017-06-30,"PA1744/002/004","Ferrer Internacional, S.A","RAMIPRIL|ACETYLSALICYLICACID|ATORVASTATINCALCIUMTRIHYDRATE"
"9669","TRINOMIA","100mg/40mg/5 Milligram                                                                                            Capsules Hard",2017-06-30,"PA1744/002/005","Ferrer Internacional, S.A","RAMIPRIL|ACETYLSALICYLICACID|ATORVASTATINCALCIUMTRIHYDRATE"
"9670","TRINOMIA","100mg/40mg/10 Milligram                                                                                            Capsules Hard",2017-06-30,"PA1744/002/006","Ferrer Internacional, S.A","RAMIPRIL|ACETYLSALICYLICACID|ATORVASTATINCALCIUMTRIHYDRATE"
"9671","TRINORDIOL TABLETS","%v/v                                                                                                 Coated Tablets",1981-02-02,"PA0822/100/001","Pfizer Healthcare Ireland","LEVONORGESTREL|ETHINYLESTRADIOL|LEVONORGESTREL|ETHINYLESTRADIOL|LEVONORGESTREL|ETHINYLESTRADIOL"
"9672","TRIOMEL / NITROGEN WITH ELECTROLYTES","9g/L / 1070kcal/L Unknown Emulsion for Infusion",2010-04-09,"PA0167/137/005","Baxter Healthcare Limited","REFINEDOLIVEOIL+REFINEDSOYBEANOIL|ALANINE|ARGININE|ASPARTICACID|GLUTAMICACID|GLYCINE|HISTIDINE|ISOLEUCINE|LEUCINE|LYSINE|METHIONINE|PHENYLALANINE|PROLINE|SERINE|THREONINE|TRYPTOPHAN,L-|TYROSINE|VALINE|GLUCOSEMONOHYDRATE|SODIUMACETATETRIHYDRATE|SODIUMGLYCEROPHOSPHATE,HYDRATED|POTASSIUMCHLORIDE|MAGNESIUMCHLORIDEHEXAHYDRATE|CALCIUMCHLORIDEDIHYDRATE"
"9673","TRIOMEL / NITROGEN WITH ELECTROLYTES","7g/L / 1140kcal/L Unknown Emulsion for Infusion",2010-04-09,"PA0167/137/003","Baxter Healthcare Limited","REFINEDOLIVEOIL+REFINEDSOYBEANOIL|ALANINE|ARGININE|ASPARTICACID|GLUTAMICACID|GLYCINE|HISTIDINE|ISOLEUCINE|LEUCINE|LYSINE|METHIONINE|PHENYLALANINE|PROLINE|SERINE|THREONINE|TRYPTOPHAN,L-|TYROSINE|VALINE|GLUCOSEMONOHYDRATE|SODIUMACETATE(ASTRIHYDRATE)|SODIUMGLYCEROPHOSPHATE,HYDRATED|POTASSIUMCHLORIDE|MAGNESIUMCHLORIDEHEXAHYDRATE|CALCIUMCHLORIDEDIHYDRATE"
"9674","TRIOMEL 5G/L NITROGEN 990KCAL/L WITH ELECTROLYTES","Unknown Emulsion for Infusion",2010-04-09,"PA0167/137/002","Baxter Healthcare Limited","REFINEDOLIVEOIL+REFINEDSOYBEANOIL|ALANINE|ARGININE|ASPARTICACID|GLUTAMICACID|GLYCINE|HISTIDINE|ISOLEUCINE|LEUCINE|LYSINE|METHIONINE|PHENYLALANINE|PROLINE|SERINE|THREONINE|TRYPTOPHAN,L-|TYROSINE|VALINE|SODIUMACETATETRIHYDRATE|SODIUMGLYCEROPHOSPHATE,HYDRATED|POTASSIUMCHLORIDE|MAGNESIUMCHLORIDEHEXAHYDRATE|CALCIUMCHLORIDEDIHYDRATE|GLUCOSEMONOHYDRATE"
"9675","TRIOMEL 7G/L NITROGEN 1140KCAL/L","Unknown Emulsion for Infusion",2010-04-09,"PA0167/137/004","Baxter Healthcare Limited","REFINEDOLIVEOIL+REFINEDSOYBEANOIL|ALANINE|ARGININE|ASPARTICACID|GLUTAMICACID|GLYCINE|HISTIDINE|ISOLEUCINE|LEUCINE|LYSINE|METHIONINE|PHENYLALANINE|PROLINE|SERINE|THREONINE|TRYPTOPHAN,L-|TYROSINE|VALINE|GLUCOSEMONOHYDRATE"
"9676","TRIOMEL 9G/L NITROGEN 1070KCAL/L","Unknown Emulsion for Infusion",2010-04-09,"PA0167/137/006","Baxter Healthcare Limited","REFINEDOLIVEOIL+REFINEDSOYBEANOIL|ALANINE|ARGININE|ASPARTICACID|GLUTAMICACID|GLYCINE|HISTIDINE|ISOLEUCINE|LEUCINE|LYSINE|METHIONINE|PHENYLALANINE|PROLINE|SERINE|THREONINE|TRYPTOPHAN,L-|TYROSINE|VALINE|GLUCOSEMONOHYDRATE"
"9677","TRIOMEL PERIPHERAL/NITROGEN WITH ELECTROLYTES","4gl/700kcal/L Unknown Emulsion for Infusion",2010-04-09,"PA0167/137/001","Baxter Healthcare Limited","REFINEDOLIVEOIL+REFINEDSOYBEANOIL|ALANINE|ARGININE|ASPARTICACID|GLUTAMICACID|GLYCINE|HISTIDINE|ISOLEUCINE|LEUCINE|LYSINE|METHIONINE|PHENYLALANINE|PROLINE|SERINE|THREONINE|TRYPTOPHAN,L-|TYROSINE|VALINE|SODIUMACETATETRIHYDRATE|SODIUMGLYCEROPHOSPHATE,HYDRATED|POTASSIUMCHLORIDE|MAGNESIUMCHLORIDEHEXAHYDRATE|CALCIUMCHLORIDEDIHYDRATE|GLUCOSEMONOHYDRATE"
"9678","TRIREGOL","Milligram                                                                                            Coated Tablets",2005-02-11,"PA1330/016/001","Gedeon Richter Plc","ETHINYLESTRADIOL|LEVONORGESTREL|ETHINYLESTRADIOL|LEVONORGESTREL|ETHINYLESTRADIOL|LEVONORGESTREL"
"9679","TRISENOX","1 Mg/Ml Concentrate for Soln for Inf",2002-03-05,"EU/1/02/204/001","Teva B.V.","ARSENICTRIOXIDE"
"9680","TRISEQUENS FILM-COATED TABLETS","2 2 1 1 mg/tablet Film Coated Tablet",1977-05-21,"PA0218/008/001","Novo Nordisk A/S","ESTRADIOLHEMIHYDRATE|NORETHISTERONEACETATE|ESTRADIOLHEMIHYDRATE|ESTRADIOLHEMIHYDRATE"
"9681","TRITACE","1.25 Milligram                                                                                            Tablets",2003-11-18,"PA0540/084/005","Sanofi-Aventis Ireland Limited T/A SANOFI","RAMIPRIL"
"9682","TRITACE","2.5 Milligram                                                                                            Tablets",2003-11-18,"PA0540/084/006","Sanofi-Aventis Ireland Limited T/A SANOFI","RAMIPRIL"
"9683","TRITACE","5 Milligram                                                                                            Tablets",2003-11-18,"PA0540/084/007","Sanofi-Aventis Ireland Limited T/A SANOFI","RAMIPRIL"
"9684","TRITACE","10 Milligram                                                                                            Tablets",2003-11-18,"PA0540/084/008","Sanofi-Aventis Ireland Limited T/A SANOFI","RAMIPRIL"
"9685","TRIUMEQ","50/600/300 milligram(s) Film-coated tablet",2014-09-01,"EU/1/14/940/001-002","ViiV Healthcare UK Ltd","Dolutegravir|Abacavir|Lamivudine"
"9686","Trizivir","milligram(s) Tablet",2000-12-28,"EU/1/00/156/001","ViiV Healthcare BV","Lamivudine|Abacavirsulfate|Zidovudine"
"9687","Trizivir","150/300 milligram(s) Tablet",NA,"EU/1/00/156/002","ViiV Healthcare BV","Abacavirsulfate|Zidovudine|Lamivudine"
"9688","Trizivir","150/300 milligram(s) Tablet",NA,"EU/1/00/156/003-4","ViiV Healthcare BV","Abacavirsulfate|Zidovudine|Lamivudine"
"9689","TROPEX","5 %w/v                                                                                                 Ear Drops Solution",1976-03-24,"PA0074/002/001","Rowa Pharmaceuticals Limited","PHENAZONE"
"9690","TROSPIUM CHLORIDE","20 Milligram                                                                                            Film Coated Tablet",2011-06-17,"PA1986/062/001","Teva B.V.","TROSPIUMCHLORIDE"
"9691","TROSYL","283 Mg/Ml nail solution",1985-02-06,"PA0822/197/001","Pfizer Healthcare Ireland","TIOCONAZOLE"
"9692","TROSYL","283 Mg/Ml nail solution",2015-03-13,"PPA1562/152/001","LTT Pharma Limited","TIOCONAZOLE"
"9693","Trosyl 283mg/ml Nail Solution","283 milligram(s)/millilitre Cutaneous solution",2010-08-27,"PPA0465/247/001","PCO Manufacturing","Tioconazole"
"9694","Truberzi","75 milligram(s) Film-coated tablet",2016-09-19,"EU/1/16/1126/001-002","Allergan Pharmaceuticals International Limited","Eluxadoline"
"9695","TRUBERZI (ORIGINALLY KNOWN ELUXADOLINE - APTALIS)","100 Milligram                                                                                            Film Coated Tablet",2016-09-19,"EU/1/16/1126/003-004","Allergan Pharmaceuticals International Limited","ELUXADOLINE"
"9696","Trulicity",".75 milligram(s) Solution for injection",2014-11-21,"EU/1/14/956/001-005","Eli Lilly Nederland B.V.","Dulaglutide"
"9697","TRULICITY","1.5 Milligram                                                                                            Solution for Injection",2014-11-21,"EU/1/14/956/006-010","Eli Lilly Nederland B.V.","DULAGLUTIDE"
"9698","Trumenba","60 microgram(s) Suspension for injection",2017-05-24,"EU/1/17/1187/001-006","Pfizer Europe MA EEIG","Neisseriameningitidisserogroupbrecombinantlipoprotein(rlp2086;subfamilyb)|Neisseriameningitidisserogroupbrecombinantlipoprotein(rlp2086;subfamilya)"
"9699","TRUOXIN","400/100 Mg/Ml Solution for Infusion",2008-04-11,"PA1217/002/002","Hikma Farmaceutica (Portugal) SA","CIPROFLOXACIN"
"9700","Truoxin 250 mg Film-coated Tablets","250 milligram(s) Film-coated tablet",2001-12-03,"PA1457/013/001","Fannin Limited","CIPROFLOXACINHYDROCHLORIDE"
"9701","Truoxin 500 mg Film-coated Tablets","500 milligram(s) Film-coated tablet",2001-12-03,"PA1457/013/002","Fannin Limited","CIPROFLOXACINHYDROCHLORIDE"
"9702","Truoxin I.V. 200mg/100ml solution for infusion","200/100 milligram(s)/millilitre Solution for infusion",2007-08-03,"PA1217/002/001","Hikma Farmaceutica (Portugal) SA","Ciprofloxacin"
"9703","TRUSITEV SR","2 Milligram                                                                                            Prolonged Release Capsules",2012-11-16,"PA0749/191/001","Teva Pharma B.V.","TOLTERODINETARTARE"
"9704","TRUSITEV SR","4 Milligram                                                                                            Prolonged Release Capsules",2012-11-16,"PA0749/191/002","Teva Pharma B.V.","TOLTERODINETARTARE"
"9705","TRUSOPT","20 Micromol Eye Drops Solution",1995-04-20,"PA0879/004/001","Santen OY","DORZOLAMIDE"
"9706","TRUSOPT","20 Mg/Ml Eye Drops Solution",2009-06-18,"DPR0465/035/001","PCO Manufacturing","DORZOLAMIDE"
"9707","TRUSOPT EYE DROPS SOLUTION","20 Mg/Ml Eye Drops Solution",2009-10-14,"DPR1392/053/001","Eurodrug Ltd","DORZOLAMIDE"
"9708","TRUSOPT Preservative-Free 20 mg/ml eye drops, solution, single-dose container","20 micromole(s) Eye drops, solution",2006-06-02,"PA0879/004/002","Santen OY","Dorzolamide"
"9709","Truvada","245/200 milligram(s) Tablet",2005-02-21,"EU/1/04/305/001","Gilead Sciences International","Tenofovirdisoproxilfumarate|Emtricitabine"
"9710","TRUXIMA","500 Milligram                                                                                            Concentrate for Soln for Inf",2017-02-17,"EU/1/16/1167/001","Celltrion Healthcare Hungary Kft.","RITUXIMAB"
"9711","TRUXIMA","100 Milligram                                                                                            Concentrate for Soln for Inf",0001-01-01,"EU/1/16/1167/002","Celltrion Healthcare Hungary Kft.",""
"9712","TRYDONIS","87/5/9 Mcg/Dose                                                                                             Pressurised Inhalation Soln",2018-04-26,"EU/1/18/1274/001-005","Chiesi Farmaceutici S.p.A.","BECLOMETASONEDIPROPIONATE|FORMOTEROLFUMARATEDIHYDRATE|GLYCOPYRRONIUM"
"9713","TUBERCULIN PPD RT23 ""SSI""","2 T.U. /0.1 ml Unknown Solution for Injection",1997-04-23,"PA2160/004/001","AJ Vaccines A/S","TUBERCULINPPD"
"9714","TWINRIX ADULT","20 %v/v                                                                                                 Suspension for Injection",1996-09-20,"EU/1/96/020/001","SmithKline Beecham Biologicals","HEPATITISAVACCINE|HEPATITISBSURFACEANTIGEN,RECOMINANT"
"9715","TWINRIX ADULT","20                                                                                                      Suspension for Injection",1996-09-20,"EU/1/96/020/002","SmithKline Beecham Biologicals","HEPATITISAVACCINE|HEPATITISBSURFACEANTIGEN,RECOMINANT"
"9716","TWINRIX ADULT","20                                                                                                      Suspension for Injection",1996-09-20,"EU/1/96/020/003","SmithKline Beecham Biologicals","HEPATITISAVACCINE|HEPATITISBSURFACEANTIGEN,RECOMINANT"
"9717","TWINRIX ADULT","20                                                                                                      Suspension for Injection",1996-09-20,"EU/1/96/020/004","SmithKline Beecham Biologicals","HEPATITISAVACCINE|HEPATITISBSURFACEANTIGEN,RECOMINANT"
"9718","TWINRIX ADULT","20                                                                                                      Suspension for Injection",1996-09-20,"EU/1/96/020/005","SmithKline Beecham Biologicals","HEPATITISAVACCINE|HEPATITISBSURFACEANTIGEN,RECOMINANT"
"9719","TWINRIX ADULT","20                                                                                                      Suspension for Injection",1996-09-20,"EU/1/96/020/006","SmithKline Beecham Biologicals","HEPATITISAVACCINE|HEPATITISBSURFACEANTIGEN,RECOMINANT"
"9720","TWINRIX ADULT","20 %v/v                                                                                                 Suspension for Injection",1997-11-17,"EU/1/96/020/007","SmithKline Beecham Biologicals","HEPATITISAVACCINE|HEPATITISBSURFACEANTIGEN,RECOMINANT"
"9721","TWINRIX ADULT","20                                                                                                      Suspension for Injection",1997-11-17,"EU/1/96/020/008","SmithKline Beecham Biologicals","HEPATITISAVACCINE|HEPATITISBSURFACEANTIGEN,RECOMINANT"
"9722","TWINRIX ADULT","20                                                                                                      Suspension for Injection",1997-11-17,"EU/1/96/020/009","SmithKline Beecham Biologicals","HEPATITISAVACCINE|HEPATITISBSURFACEANTIGEN,RECOMINANT"
"9723","TWINRIX PAEDIATRIC","0.5 Millilitre                                                                                           Suspension for Injection",1997-02-10,"EU/1/97/029/001","SmithKline Beecham Biologicals","HEPATITISAVACCINE|HEPATITISBSURFACEANTIGEN,RECOMINANT"
"9724","TWINRIX PAEDIATRIC","0.5 Millilitre                                                                                           Suspension for Injection",1997-02-10,"EU/1/97/029/002","SmithKline Beecham Biologicals","HEPATITISAVACCINE|HEPATITISBSURFACEANTIGEN,RECOMINANT"
"9725","TWINRIX PAEDIATRIC","0.5 Millilitre                                                                                           Suspension for Injection",1997-02-10,"EU/1/97/029/003","SmithKline Beecham Biologicals","HEPATITISAVACCINE|HEPATITISBSURFACEANTIGEN,RECOMINANT"
"9726","TWINRIX PAEDIATRIC","0.5 Millilitre                                                                                           Suspension for Injection",1997-02-10,"EU/1/97/029/004","SmithKline Beecham Biologicals","HEPATITISAVACCINE|HEPATITISBSURFACEANTIGEN,RECOMINANT"
"9727","TWINRIX PAEDIATRIC","0.5 Millilitre                                                                                           Suspension for Injection",1997-02-10,"EU/1/97/029/005","SmithKline Beecham Biologicals","HEPATITISAVACCINE|HEPATITISBSURFACEANTIGEN,RECOMINANT"
"9728","TWINRIX PAEDIATRIC","%v/v                                                                                                 Suspension for Injection",1997-11-19,"EU/1/97/029/006","SmithKline Beecham Biologicals","HEPATITISAVACCINE|HEPATITISBSURFACEANTIGEN,RECOMINANT"
"9729","TWINRIX PAEDIATRIC","Suspension for Injection",1997-11-19,"EU/1/97/029/007","SmithKline Beecham Biologicals","HEPATITISAVACCINE|HEPATITISBSURFACEANTIGEN,RECOMINANT"
"9730","TWYNSTA","40/5 mg/mg Tablets",2010-10-07,"EU/1/10/648/001-007","Boehringer Ingelheim International GmbH","TELMISARTAN|AMLODIPINEBESILATE"
"9731","TWYNSTA","40mg/10mg                                                                                                      Tablets",2010-10-07,"EU/1/10/648/008-014","Boehringer Ingelheim International GmbH","TELMISARTAN|AMLODIPINEBESILATE"
"9732","TWYNSTA","80mg/5mg                                                                                                      Tablets",2010-10-07,"EU/1/10/648/015-021","Boehringer Ingelheim International GmbH","TELMISARTAN|AMLODIPINEBESILATE"
"9733","TWYNSTA","80mg/10mg                                                                                                      Tablets",2010-10-07,"EU/1/10/648/022-028","Boehringer Ingelheim International GmbH","TELMISARTAN|AMLODIPINEBESILATE"
"9734","TYBOST","150 Milligram                                                                                            Film Coated Tablet",2013-09-19,"EU/1/13/872/001-002","Gilead Sciences International","COBICISTATONSILICONDIOXIDE"
"9735","Tyedra 1500 micrograms tablet","1500 microgram(s) Tablet",2013-11-29,"PA1474/013/001","Laboratorios Leon Farma, S.A.","Levonorgestrelmicronized"
"9736","TYGACIL","50 Milligram                                                                                            Pdr/Conc/Soln for Infus",2006-04-24,"EU/1/06/336/01","Pfizer Europe MA EEIG","TIGECYCLINE"
"9737","TYLEX","30/500 Milligram                                                                                            Capsules Hard",1997-02-21,"PA0891/014/001","UCB (Pharma) Ireland Limited","CODEINEPHOSPHATEHEMIHYDRATE|PARACETAMOL"
"9738","TYLEX 30 MG/500 MG EFFERVESCENT TABLETS","30/500 Milligram                                                                                            Tablets Effervescent",1996-10-22,"PA0891/014/002","UCB (Pharma) Ireland Limited","CODEINEPHOSPHATEHEMIHYDRATE|PARACETAMOL"
"9739","Tymbrineb 300 mg/5 ml Nebuliser Solution","300 mg/5ml Nebuliser solution",2012-11-23,"PA0749/117/001","Teva Pharma B.V.","Tobramycin"
"9740","Typhim Vi Solution for InjectionTyphoid Polysaccharide Vaccine","25/0.5 microgram(s) Solution for injection",1992-08-18,"PA2131/011/001","Sanofi Pasteur","Salmonellatyphi,viantigen"
"9741","Tyrozets Lozenges","1/5 milligram(s) Lozenge",1977-04-01,"PA0330/043/001","Johnson & Johnson (Ireland) Limited","Benzocaine|Tyrothricin"
"9742","Tysabri","20 micromole(s) ZZZ Infus/Pdr/Oral Soln",NA,"EU/1/06/346/001","Elan Pharma Ltd","Natalizumab"
"9743","Tyvense 20mg Capsules, hard","20 milligram(s) Capsule, hard",NA,"PA1575/005/001","Shire Pharmaceuticals Ireland Limited","Lisdexamfetaminedimesylate"
"9744","Tyvense 30 mg Capsules, Hard","30 milligram(s) Capsule, hard",NA,"PA1575/005/002","Shire Pharmaceuticals Ireland Limited","Lisdexamfetaminedimesylate"
"9745","Tyvense 40mg Capsules, hard","40 milligram(s) Capsule, hard",NA,"PA1575/005/003","Shire Pharmaceuticals Ireland Limited","Lisdexamfetaminedimesylate"
"9746","Tyvense 50 mg Capsules, Hard","50 milligram(s) Capsule, hard",NA,"PA1575/005/004","Shire Pharmaceuticals Ireland Limited","Lisdexamfetaminedimesylate"
"9747","Tyvense 60mg Capsules, hard","60 milligram(s) Capsule, hard",NA,"PA1575/005/005","Shire Pharmaceuticals Ireland Limited","Lisdexamfetaminedimesylate"
"9748","Tyvense 70 mg Capsules, Hard","70 milligram(s) Capsule, hard",NA,"PA1575/005/006","Shire Pharmaceuticals Ireland Limited","Lisdexamfetaminedimesylate"
"9749","Tyverb","250 milligram(s) Film-coated tablet",2008-06-10,"EU/1/07/440/1-2","Novartis Europharm Limited","Lapatinibditosylatemonohydrate"
"9750","UCEDANE","200 Milligram                                                                                            Dispersable Tablet",2017-06-23,"EU/1/17/1202/001","Lucane Pharma","CARGLUMICACID"
"9751","Udenyca","6 milligram(s) Solution for injection in pre-filled syringe",2018-09-21,"EU/1/18/1303/001","ERA Consulting GmbH","Pegfilgrastim"
"9752","Ulipristal Acetate Gedeon Richter","5 milligram(s) Tablet",2018-08-27,"EU/1/18/1309/001-005","Gedeon Richter Plc","Ulipristalacetate"
"9753","ULTIBRO BREEZHALER","85/43 Microgram                                                                                            Inhalation Powder, Capsule",2013-09-19,"EU/1/13/862/001-006","Novartis Europharm Limited","INDACATEROLMALEATE|GLYCOPYRRONIUMBROMIDE"
"9754","Ultiva 1 mg Powder for Concentrate for Solution for Infusion","1 milligram(s) Powder for concentrate for solution for infusion",1999-05-27,"PA1691/032/001","Aspen Pharma Trading Limited","Remifentanilhydrochloride"
"9755","Ultiva 2 mg Powder for Concentrate for Solution for Infusion","2 milligram(s) Pdr/Conc/Soln for Infus",1999-05-27,"PA1691/032/002","Aspen Pharma Trading Limited","Remifentanilhydrochloride"
"9756","Ultiva 5 mg Powder for Concentrate for Solution for Infusion","5 milligram(s) Pdr/Conc/Soln/Inj/Inf",1999-05-27,"PA1691/032/003","Aspen Pharma Trading Limited","Remifentanilhydrochloride"
"9757","Ultraproct 0.92mg/g + 0.95mg/g + 5mg/g Rectal Ointment","0.92mg/g +0.95mg/g + 5mg/g milligram(s)/gram Rectal ointment",1978-04-01,"PA1410/074/001","Bayer Limited","FLUOCORTOLONEPIVALATE|Fluocortolonecaproate|Cinchocainehydrochloride"
"9758","Ultra-TechneKow FM 2.15-43.00 GBq radionuclide generator","2.15-43.00 ZZZ Gig.bequerel Radionuclide generator",2000-04-28,"PA0690/017/001","Mallinckrodt Medical B.V.","Molybdenum-99"
"9759","Ultravist 240mg/ml Solution for Injection (50ml)","240 milligram(s)/millilitre Solution for injection",1986-09-24,"PA1410/011/001","Bayer Limited","Iopromide"
"9760","Ultravist 300mg/ml Solution for Injection (20ml)","300 milligram(s)/millilitre Solution for injection",1986-09-24,"PA1410/011/002","Bayer Limited","Iopromide|Iopromide"
"9761","Ultravist 300mg/ml Solution for Injection (50ml, 75ml, 100ml, 150ml, 200ml and 500ml)","300 milligram(s)/millilitre Solution for injection",1986-09-24,"PA1410/011/003","Bayer Limited","Iopromide|Iopromide"
"9762","Ultravist 370mg/ml Solution for Injection (50 ml, 100ml, 150 ml, and 200 ml)","370 milligram(s)/millilitre Solution for injection",1986-09-24,"PA1410/011/004","Bayer Limited","Iopromide"
"9763","Ulunar Breezhaler","85/43 milligram(s) Inhalation powder, hard capsule",2014-05-16,"EU/1/14/917/001-006","Novartis Europharm Limited","Indacaterolmaleate|Glycopyrroniumbromide"
"9764","UNIFLU PLUS WITH VITAMIN C TABLETS","500 Milligram                                                                                            Tablets",1998-10-30,"PA1113/006/001","Phoenix Labs","PARACETAMOL|CODEINEPHOSPHATEHEMIHYDRATE|DIPHENHYDRAMINEHYDROCHLORIDE|PHENYLEPHRINEHYDROCHLORIDE|CAFFEINE|ASCORBICACID"
"9765","UNIFLU WITH VITAMIN C TABLETS","Milligram                                                                                            Tablets",1978-04-01,"PA1113/005/001","Phoenix Labs","CAFFEINE|DIPHENHYDRAMINEHYDROCHLORIDE|PARACETAMOL|PHENYLEPHRINEHYDROCHLORIDE|ASCORBICACID"
"9766","UNIPHYLLIN Continus 200 mg Prolonged-Release Tablets","200 milligram(s) Prolonged-release tablet",1983-02-04,"PA1688/011/001","Mundipharma Pharmaceuticals Limited","Theophylline"
"9767","UNIPHYLLIN Continus 300 mg Prolonged-Release Tablets","300 milligram(s) Prolonged-release tablet",1989-03-08,"PA1688/011/002","Mundipharma Pharmaceuticals Limited","Theophylline"
"9768","UNIPHYLLIN Continus 400 mg Prolonged-Release Tablets","400 milligram(s) Prolonged-release tablet",1983-06-20,"PA1688/011/003","Mundipharma Pharmaceuticals Limited","Theophylline"
"9769","UNISEPT","0.05%w/v percent weight/volume Cutaneous solution",NA,"PA0483/002/001","Seton Prebbles Ltd","Chlorhexidinegluconate"
"9770","Uptravi","200 microgram(s) Film-coated tablet",2016-05-12,"EU/1/15/1083/001-003","Janssen-Cilag International NV","Selexipag"
"9771","Uptravi","400 microgram(s) Film-coated tablet",NA,"EU/1/15/1083/004","Janssen-Cilag International NV","Selexipag"
"9772","Uptravi","600 microgram(s) Film-coated tablet",NA,"EU/1/15/1083/005","Janssen-Cilag International NV","Selexipag"
"9773","Uptravi","800 microgram(s) Film-coated tablet",NA,"EU/1/15/1083/006","Janssen-Cilag International NV","Selexipag"
"9774","UPTRAVI","1000 Microgram                                                                                            Film Coated Tablet",2016-06-12,"EU/1/15/1083/007","Actelion Registration Ltd","SELEXIPAG"
"9775","Uptravi","1200 microgram(s) Film-coated tablet",NA,"EU/1/15/1083/008","Janssen-Cilag International NV","Selexipag"
"9776","Uptravi","1400 microgram(s) Film-coated tablet",NA,"EU/1/15/1083/009","Janssen-Cilag International NV","Selexipag"
"9777","Uptravi","1600 microgram(s) Film-coated tablet",NA,"EU/1/15/1083/010","Janssen-Cilag International NV","Selexipag"
"9778","UREA","10 %w/w                                                                                                 Cream",1975-01-07,"PA0943/005/001","Alliance Pharmaceuticals Ltd.","UREA"
"9779","URISPAS","200 Milligram                                                                                            Film Coated Tablet",1990-10-15,"PA1404/001/001","Recordati Ireland Limited","FLAVOXATEHYDROCHLORIDE"
"9780","Urispas 200mg Film-coated Tablets","200 milligram(s) Tablet",1995-10-15,"PA0535/004/001","Shire Pharmaceuticals Limited","FLAVOXATEHYDROCHLORIDE"
"9781","UROGRAFIN","30 Per Cent                                                                                             Solution for Infusion",1988-04-01,"PA1410/012/001","Bayer Limited","AMIDOTRIZOICACID|MEGLUMINE|SODIUMHYDROXIDE"
"9782","Urokinase medac 10,000 IU, powder for solution for infusion","10,000 international unit(s) Powder for solution for infusion",2016-04-29,"PA0623/017/001","Medac Gesellschaft fur Klinische Spezialpraparate mbH","Urokinase(purifiedbulk)"
"9783","Urokinase medac 100,000 IU, powder for solution for infusion","100,000 international unit(s) Powder for solution for infusion",2016-04-29,"PA0623/017/003","Medac Gesellschaft fur Klinische Spezialpraparate mbH","Urokinase(purifiedbulk)"
"9784","Urokinase medac 250,000 IU powder for solution for infusion","250,000 international unit(s) Powder for solution for infusion",2016-04-29,"PA0623/017/004","Medac Gesellschaft fur Klinische Spezialpraparate mbH","Urokinase(purifiedbulk)"
"9785","Urokinase medac 50,000 IU, powder for solution for infusion","50,000 international unit(s) Powder for solution for infusion",2016-04-29,"PA0623/017/002","Medac Gesellschaft fur Klinische Spezialpraparate mbH","Urokinase(purifiedbulk)"
"9786","Urokinase medac 500,000 IU, powder for solution for infusion","500,000 international unit(s) Powder for solution for infusion",2016-04-29,"PA0623/017/005","Medac Gesellschaft fur Klinische Spezialpraparate mbH","Urokinase(purifiedbulk)"
"9787","UROMITEXAN","100 Mg/Ml Solution for Inj/Inf",1996-09-25,"PA0167/118/001","Baxter Healthcare Limited","MESNA"
"9788","UROMITEXAN","400 Milligram                                                                                            Film Coated Tablet",1996-04-30,"PA0167/118/002","Baxter Healthcare Limited","MESNA"
"9789","UROMITEXAN","600 Milligram                                                                                            Film Coated Tablet",1996-04-30,"PA0167/118/003","Baxter Healthcare Limited","MESNA"
"9790","Urorec","4 milligram(s) Capsule, hard",2010-01-29,"EU/1/09/608/1-7","Recordati Ireland Limited","Silodosin"
"9791","UROREC","8 Milligram                                                                                            Capsules Hard",2010-01-29,"EU/1/09/608/8-14","Recordati Ireland Limited","SILODOSIN"
"9792","UROSTEMOL CAPSULES","Capsules Hard",2016-10-07,"TR1186/005/001","Chefaro Ireland DAC","PUMPKINSEED,CRUSHED|PUMPKINSEEDOIL"
"9793","UROSTEMOL FEMINA CAPSULES","Capsules Hard",2016-03-24,"TR1186/006/001","Chefaro Ireland DAC","PUMPKINSEEDOIL|DRYEXTRACTOFFRAGRANTSUMACHBARK|DRYEXTRACTOFHOPSTROBILE"
"9794","UROSTEMOL MEN CAPSULES","Capsules Hard",2016-03-24,"TR1186/007/001","Chefaro Ireland DAC","PUMPKINSEED,CRUSHED|PUMPKINSEEDOIL|DRYEXTRACTOFSAWPALMETTOFRUIT"
"9795","UROSTEMOL PROSTA","Capsules Hard",2016-10-07,"TR1186/004/001","Chefaro Ireland DAC","PUMPKINSEEDSOFTEXTRACT"
"9796","Ursodeoxycholic Acid 250mg Capsules, hard","250 milligram(s) Capsule, hard",2016-02-05,"PA1142/018/001","Amdipharm Limited","Ursodeoxycholicacid"
"9797","Ursodeoxycholic acid Strides 250mg Hard Capsules","250 milligram(s) Capsule, hard",2014-01-31,"PA1650/014/001","Strides Arcolab International Limited","Ursodeoxycholicacid"
"9798","URSOFALK","250 Milligram                                                                                            Capsules Hard",2006-11-20,"PPA0465/183/001","PCO Manufacturing","URSODEOXYCHOLICACID"
"9799","URSOFALK","250 MG/5ml                                                                                               Oral Suspension",2011-01-14,"PA0573/005/002","Dr. Falk Pharma GmbH","URSODEOXYCHOLICACID"
"9800","URSOFALK","500 Milligram                                                                                            Film Coated Tablet",2011-08-19,"PA0573/005/003","Dr. Falk Pharma GmbH","URSODEOXYCHOLICACID"
"9801","URSOFALK","250 Milligram                                                                                            Capsules Hard",2011-12-21,"PPA1633/016/001","Primecrown 2010 Ltd","URSODEOXYCHOLICACID"
"9802","URSOFALK","250 Milligram                                                                                            Capsules Hard",2015-12-04,"PPA1562/167/001","LTT Pharma Limited","URSODEOXYCHOLICACID"
"9803","URSOFALK","250 Milligram                                                                                            Capsules Hard",2011-09-09,"PPA1463/056/001","IMED Healthcare Ltd.","URSODEOXYCHOLICACID"
"9804","URSOFALK","250 Milligram                                                                                            Capsules Hard",2017-03-31,"PPA1097/012/001","Lexon (UK) Ltd","URSODEOXYCHOLICACID"
"9805","URSOFALK","250 Milligram                                                                                            Capsules Hard",2009-07-24,"PPA1151/059/001","Imbat Limited","URSODEOXYCHOLICACID"
"9806","Ursofalk® 250 mg Hard Capsules","250 milligram(s) Capsule, hard",1984-11-14,"PA0573/005/001","Dr. Falk Pharma GmbH","Ursodeoxycholicacid"
"9807","UTROGESTAN","100 Milligram                                                                                            Capsules, Soft",1988-02-09,"PA1341/001/001","Besins Healthcare S.A.","PROGESTERONE"
"9808","VAGIFEM","10 Microgram                                                                                            Vaginal Tablets",2010-03-19,"PA0218/030/002","Novo Nordisk A/S","ESTRADIOLHEMIHYDRATE"
"9809","VALACICLOVIR","500 Milligram                                                                                            Film Coated Tablet",2009-05-28,"PA1390/160/001","Accord Healthcare Limited","VALACICLOVIRHYDROCHLORIDEMONOHYDRATE"
"9810","Valaciclovir Bluefish 500 mg film-coated tablets","500 milligram(s) Film-coated tablet",2009-08-28,"PA1436/005/001","Bluefish Pharmaceuticals AB","Valaciclovirhydrochloridemonohydrate"
"9811","VALACICLOVIR TEVA","500 Milligram                                                                                            Film Coated Tablet",2008-05-30,"PA0749/036/001","Teva Pharma B.V.","VALACICLOVIR"
"9812","VALCYTE","450 Milligram                                                                                            Film Coated Tablet",2002-09-13,"PA2307/009/001","Roche Products (Ireland) Ltd","VALGANCICLOVIR"
"9813","VALCYTE","50 Mg/Ml Powder for Oral Solution",2008-08-15,"PA2307/009/002","Roche Products (Ireland) Ltd","VALGANCICLOVIRHYDROCHLORIDE"
"9814","Valdoxan","25 milligram(s) Film-coated tablet",NA,"EU/1/08/499/1-8","Les Laboratoires Servier","Agomelatine"
"9815","VALDRIAN","Capsules Hard",2011-09-23,"TR1492/001/001","Bio-Health Limited","VALERIANROOTPOWDER"
"9816","Valerian Complex Stress Relief Oral Drops","*** AWAITING VALUE *** Oral drops, solution",2014-05-02,"TR0725/020/001","Bioforce (UK) Ltd","Tinctureofvalerianroot(valerianaofficinalisl.)(1:10-11)extractionsolvent:ethanol58%v/v|Tinctureofhopstrobile(humuluslupulusl.)(1:12-13)extractionsolvent:ethanol65%v/v"
"9817","Valganciclovir 450mg Film-coated Tablets","450 milligram(s) Film-coated tablet",2015-01-30,"PA0405/067/001","Generics (UK) Limited","Valganciclovir"
"9818","VALGANCICLOVIR ACCORD","450 Milligram                                                                                            Film Coated Tablet",2016-04-29,"PA1390/103/001","Accord Healthcare Limited","VALGANCICLOVIRHYDROCHLORIDE"
"9819","VALGANCICLOVIR ROWEX","450 Milligram                                                                                            Film Coated Tablet",2015-01-09,"PA0711/233/001","Rowex Ltd","VALGANCICLOVIRHYDROCHLORIDE"
"9820","VALOID","50 Milligram                                                                                            Tablets",1979-04-01,"PA1142/001/002","Amdipharm Limited","CYCLIZINEHYDROCHLORIDE"
"9821","Valoid 50 mg/ml Solution for Injection","50/1 ZZZ Base mg/ml Solution for injection",1979-04-01,"PA1142/001/001","Amdipharm Limited","CYCLIZINELACTATE"
"9822","VALOTIX 500MG FILM-COATED TABLETS","500 Milligram                                                                                            Film Coated Tablet",2009-04-24,"PA0711/173/001","Rowex Ltd","VALACICLOVIR"
"9823","VALSARTAN / HYDROCHLOROTHIAZIDE","80/12.5 mg/mg Film Coated Tablet",2011-08-12,"PA1380/101/001","Actavis Group PTC ehf","VALSARTAN|HYDROCHLOROTHIAZIDE"
"9824","VALSARTAN / HYDROCHLOROTHIAZIDE","160/12.5 mg/mg Film Coated Tablet",2011-08-12,"PA1380/101/002","Actavis Group PTC ehf","VALSARTAN|HYDROCHLOROTHIAZIDE"
"9825","VALSARTAN / HYDROCHLOROTHIAZIDE","160/25 mg/mg Film Coated Tablet",2011-08-12,"PA1380/101/003","Actavis Group PTC ehf","VALSARTAN|HYDROCHLOROTHIAZIDE"
"9826","VALSARTAN ACTAVIS","40 Milligram                                                                                            Film Coated Tablet",2009-01-30,"PA1380/022/001","Actavis Group PTC ehf","VALSARTAN"
"9827","VALSARTAN ACTAVIS","80 Milligram                                                                                            Film Coated Tablet",2009-01-30,"PA1380/022/002","Actavis Group PTC ehf","VALSARTAN"
"9828","VALSARTAN ACTAVIS","160 Milligram                                                                                            Film Coated Tablet",2009-01-30,"PA1380/022/003","Actavis Group PTC ehf","VALSARTAN"
"9829","VALSARTAN KRKA","40 Milligram                                                                                            Film Coated Tablet",2012-06-22,"PA1347/010/006","Krka d.d., Novo mesto","VALSARTAN"
"9830","VALSARTAN KRKA","80 Milligram                                                                                            Film Coated Tablet",2012-06-22,"PA1347/010/007","Krka d.d., Novo mesto","VALSARTAN"
"9831","VALSARTAN KRKA","160 Milligram                                                                                            Film Coated Tablet",2012-06-22,"PA1347/010/008","Krka d.d., Novo mesto","VALSARTAN"
"9832","VALSARTAN KRKA","320 Milligram                                                                                            Film Coated Tablet",2012-06-22,"PA1347/010/009","Krka d.d., Novo mesto","VALSARTAN"
"9833","VALSARTAN MYLAN","320 Milligram                                                                                            Film Coated Tablet",2011-09-23,"PA0577/134/004","McDermott Laboratories Ltd t/a Gerard Laboratories","VALSARTAN"
"9834","Valsartan Mylan 160mg Film-coated Tablets","160 milligram(s) Film-coated tablet",2011-09-23,"PA0577/134/003","McDermott Laboratories Ltd t/a Gerard Laboratories","Valsartan"
"9835","Valsartan Mylan 40mg Film-coated Tablets","40 milligram(s) Film-coated tablet",2011-09-23,"PA0577/134/001","McDermott Laboratories Ltd t/a Gerard Laboratories","Valsartan"
"9836","Valsartan Mylan 80mg Film-coated Tablets","80 milligram(s) Film-coated tablet",2011-09-23,"PA0577/134/002","McDermott Laboratories Ltd t/a Gerard Laboratories","Valsartan"
"9837","VALSARTAN ROWA","40 Milligram                                                                                            Film Coated Tablet",2011-04-21,"PA0074/083/001","Rowa Pharmaceuticals Limited","VALSARTAN"
"9838","VALSARTAN ROWA","80 Milligram                                                                                            Film Coated Tablet",2011-04-21,"PA0074/083/002","Rowa Pharmaceuticals Limited","VALSARTAN"
"9839","VALSARTAN ROWA","160 Milligram                                                                                            Film Coated Tablet",2011-04-21,"PA0074/083/003","Rowa Pharmaceuticals Limited","VALSARTAN"
"9840","VALSARTAN ROWA","320 Milligram                                                                                            Film Coated Tablet",2011-04-21,"PA0074/083/004","Rowa Pharmaceuticals Limited","VALSARTAN"
"9841","VALSARTAN TEVA","40 Milligram                                                                                            Film Coated Tablet",2009-08-28,"PA0749/084/001","Teva Pharma B.V.","VALSARTAN"
"9842","VALSARTAN TEVA","80 Milligram                                                                                            Film Coated Tablet",2009-08-28,"PA0749/084/002","Teva Pharma B.V.","VALSARTAN"
"9843","VALSARTAN TEVA","160 Milligram                                                                                            Film Coated Tablet",2009-08-28,"PA0749/084/003","Teva Pharma B.V.","VALSARTAN"
"9844","VALSARTAN/HYDROCHLOROTHIAZIDE","80/12.5 mg/mg Film Coated Tablet",2008-07-04,"PA0749/047/001","Teva Pharma B.V.","VALSARTAN|HYDROCHLOROTHIAZIDE"
"9845","VALSARTAN/HYDROCHLOROTHIAZIDE","160/25 mg/mg Film Coated Tablet",2008-07-04,"PA0749/047/002","Teva Pharma B.V.","VALSARTAN|HYDROCHLOROTHIAZIDE"
"9846","VALSARTAN/HYDROCHLOROTHIAZIDE KRKA","80/12.5 mg/mg Film Coated Tablet",2010-04-09,"PA1347/004/001","Krka d.d., Novo mesto","VALSARTAN|HYDROCHLOROTHIAZIDE"
"9847","VALSARTAN/HYDROCHLOROTHIAZIDE KRKA","160/12.5 mg/mg Film Coated Tablet",2010-04-09,"PA1347/004/002","Krka d.d., Novo mesto","VALSARTAN|HYDROCHLOROTHIAZIDE"
"9848","VALSARTAN/HYDROCHLOROTHIAZIDE KRKA","160/25 mg/mg Film Coated Tablet",2010-04-09,"PA1347/004/003","Krka d.d., Novo mesto","VALSARTAN|HYDROCHLOROTHIAZIDE"
"9849","VALSARTAN/HYDROCHLOROTHIAZIDE KRKA","320/12.5 mg/mg Film Coated Tablet",2011-01-14,"PA1347/004/004","Krka d.d., Novo mesto","VALSARTAN|HYDROCHLOROTHIAZIDE"
"9850","VALSARTAN/HYDROCHLOROTHIAZIDE KRKA","320/25 mg/mg Film Coated Tablet",2011-01-14,"PA1347/004/005","Krka d.d., Novo mesto","VALSARTAN|HYDROCHLOROTHIAZIDE"
"9851","VALSARTAN/HYDROCHLOROTHIAZIDE TEVA","160/12.5 Milligram                                                                                            Film Coated Tablet",2011-06-03,"PA0749/047/003","Teva Pharma B.V.","VALSARTAN|HYDROCHLOROTHIAZIDE"
"9852","VALSOL PLUS","80/12.5 mg/mg Film Coated Tablet",2010-10-01,"PA1239/007/001","Laboratorios LICONSA, S.A.","VALSARTAN|HYDROCHLOROTHIAZIDE"
"9853","VALSOL PLUS","160/25 mg/mg Film Coated Tablet",2010-10-01,"PA1239/007/003","Laboratorios LICONSA, S.A.","VALSARTAN|HYDROCHLOROTHIAZIDE"
"9854","VALTAN","40 Milligram                                                                                            Film Coated Tablet",2010-03-31,"PA0126/211/001","Clonmel Healthcare Ltd","VALSARTAN"
"9855","VALTAN","80 Milligram                                                                                            Film Coated Tablet",2010-03-31,"PA0126/211/002","Clonmel Healthcare Ltd","VALSARTAN"
"9856","VALTAN","160 Milligram                                                                                            Film Coated Tablet",2010-03-31,"PA0126/211/003","Clonmel Healthcare Ltd","VALSARTAN"
"9857","Valtan Comp 80mg/12.5mg Film-coated tablets","80/12.5 ZZZ mg/mg Film-coated tablet",2010-11-19,"PA0126/216/001","Clonmel Healthcare Ltd","Hydrochlorothiazide|Valsartan"
"9858","VALTREX","250 Milligram                                                                                            Film Coated Tablet",1999-09-07,"PA1077/082/001","GlaxoSmithKline (Ireland) Limited","VALACICLOVIRHYDROCHLORIDE"
"9859","VALTREX","500 Milligram                                                                                            Film Coated Tablet",1994-12-20,"PA1077/082/002","GlaxoSmithKline (Ireland) Limited","VALACICLOVIRHYDROCHLORIDE"
"9860","Vaminolact solution for infusion, 100 ml bottle","100 millilitre(s) Solution for infusion",1991-06-10,"PA0566/013/001","Fresenius Kabi Limited","Alanine|Arginine|Asparticacid|Cysteine|Glutamicacid|Glycine|Histidine|Isoleucine|Leucine|Lysine|Methionine|Phenylalanine|Proline|Serine|Threonine|Tryptophan|Tyrosine|Valine|Taurine"
"9861","Vaminolact solution for infusion, 500 ml bottle","500 millilitre(s) Solution for infusion",1991-06-10,"PA0566/013/002","Fresenius Kabi Limited","Alanine|Arginine|Cysteine|Glutamicacid|Glycine|Histidine|Isoleucine|Leucine|Lysine|Methionine|Phenylalanine|Proline|Serine|Threonine|Tryptophan|Tyrosine|Valine|Taurine"
"9862","Vancocin 1 g powder for concentrate for solution for infusion and powder for oral solution","1 gram(s) Concentrate for solution for infusion",2010-06-11,"PA1226/005/004","Flynn Pharma Ltd","VANCOMYCINHYDROCHLORIDE"
"9863","Vancocin 500 mg powder for concentrate for solution for infusion and powder for oral solution","500 milligram(s) Concentrate for solution for infusion",1981-05-08,"PA1226/005/003","Flynn Pharma Ltd","VANCOMYCINHYDROCHLORIDE"
"9864","VANCOCIN MATRIGEL","125 Milligram                                                                                            Capsule",1986-06-16,"PA1226/005/001","Flynn Pharma Ltd","VANCOMYCINHYDROCHLORIDE"
"9865","VANCOMYCIN","500 Milligram                                                                                            Pdr/Conc/Soln for Infus",2015-02-27,"PA1380/180/001","Actavis Group PTC ehf","VANCOMYCINHYDROCHLORIDE"
"9866","VANCOMYCIN","1000 Milligram                                                                                            Pdr/Conc/Soln for Infus",2015-02-27,"PA1380/180/002","Actavis Group PTC ehf","VANCOMYCINHYDROCHLORIDE"
"9867","VANCOMYCIN","500 Milligram                                                                                            Pdr/Conc/Soln for Infus",2016-04-29,"PA1852/004/001","Laboratórios Azevedos - Indústria Farmacêutica S.A","VANCOMYCINHYDROCHLORIDE"
"9868","VANCOMYCIN","1000 Milligram                                                                                            Pdr/Conc/Soln for Infus",2016-04-29,"PA1852/004/002","Laboratórios Azevedos - Indústria Farmacêutica S.A","VANCOMYCINHYDROCHLORIDE"
"9869","VANCOMYCIN","500 Milligram                                                                                            Pdr/Conc/Soln for Infus",2011-09-16,"PA0566/060/001","Fresenius Kabi Limited","VANCOMYCINHYDROCHLORIDE"
"9870","VANCOMYCIN","1000 Milligram                                                                                            Pdr/Conc/Soln for Infus",2011-09-16,"PA0566/060/002","Fresenius Kabi Limited","VANCOMYCINHYDROCHLORIDE"
"9871","VANCOMYCIN","500 Milligram                                                                                            Pdr/Conc/Soln for Infus",2013-05-03,"PA0405/092/001","Generics (UK) Limited","VANCOMYCINHYDROCHLORIDE"
"9872","VANCOMYCIN","1000 Milligram                                                                                            Pdr/Conc/Soln for Infus",2013-05-03,"PA0405/092/002","Generics (UK) Limited","VANCOMYCINHYDROCHLORIDE"
"9873","Vancomycin 1000 mg Powder for concentrate for solution for infusion","1 gram(s) ZZZ Pdr/Conc/Soln for Infus",2013-01-04,"PA1217/009/002","Hikma Farmaceutica (Portugal) SA","VANCOMYCINHYDROCHLORIDE"
"9874","Vancomycin 1000 mg Powder for concentrate for solution for infusion and oral solution","1000 milligram(s) ZZZ Pdr/Conc/Soln for Infus",2011-06-03,"PA1122/008/002","Noridem Enterprises Ltd","VANCOMYCINHYDROCHLORIDE"
"9875","Vancomycin 500 mg Powder for concentrate for solution for infusion","500 milligram(s) ZZZ Pdr/Conc/Soln for Infus",2013-01-04,"PA1217/009/001","Hikma Farmaceutica (Portugal) SA","VANCOMYCINHYDROCHLORIDE"
"9876","Vancomycin 500 mg Powder for concentrate for solution for infusion and oral solution","500 milligram(s) ZZZ Pdr/Conc/Soln for Infus",2011-06-03,"PA1122/008/001","Noridem Enterprises Ltd","VANCOMYCINHYDROCHLORIDE"
"9877","VANCOMYCIN HYDROCHLORIDE","500 Milligram                                                                                            Pdr/Conc/Soln for Infus",1990-10-15,"PA0437/023/001","Hospira  UK Limited","VANCOMYCINHYDROCHLORIDE"
"9878","VANCOMYCIN HYDROCHLORIDE","1 Grams                                                                                                Pdr/Conc/Soln for Infus",1997-04-04,"PA0437/023/002","Hospira  UK Limited","VANCOMYCINHYDROCHLORIDE"
"9879","VANCOMYCIN MYLAN","500 Milligram                                                                                            Pdr for Soln for Infusion",2011-10-28,"PA0577/163/001","McDermott Laboratories Ltd t/a Gerard Laboratories","VANCOMYCINHYDROCHLORIDE"
"9880","VANCOMYCIN MYLAN","1 Grams                                                                                                Pdr for Soln for Infusion",2011-10-28,"PA0577/163/002","McDermott Laboratories Ltd t/a Gerard Laboratories","VANCOMYCINHYDROCHLORIDE"
"9881","VANIQA 11.5%","15 Grams                                                                                                Cream",2001-03-28,"EU/1/01/173/001","Almirall, S.A.","EFLORNITHINE"
"9882","VANIQA 11.5%","30 Grams                                                                                                Cream",2001-03-28,"EU/1/01/173/002","Almirall, S.A.","EFLORNITHINE"
"9883","VANIQA 11.5%","60 Grams                                                                                                Cream",2001-03-28,"EU/1/01/173/003","Almirall, S.A.","EFLORNITHINE"
"9884","VANTAVO","70/2800 mg/IU Tablets",2009-10-16,"EU/1/09/572/1-5","Merck Sharp & Dohme BV","ALENDRONICACID|VITAMIND3100.000IU/G"
"9885","Vantobra","170 milligram(s) Nebuliser solution",2015-03-18,"EU/1/14/932/001","PARI Pharma GmbH","Tobramycin"
"9886","VAQTA ADULT","50IU/1ml Units/ml                                                                                             Solution for Injection",1996-12-13,"PA1286/056/002","Merck Sharp & Dohme Ireland (Human Health) Limited","STRAINCR326FHEPATITISAVIRUS,INACTIVATED50U"
"9887","VAQTA PAEDIATRIC/ADOLESCENT","25IU/0.5 m Units/ml                                                                                             Solution for Injection",1996-12-13,"PA1286/056/001","Merck Sharp & Dohme Ireland (Human Health) Limited","HEPATITISAVACCINE"
"9888","VARDENAFIL ACCORD","5 Milligram                                                                                            Film Coated Tablet",2017-07-07,"PA1390/121/001","Accord Healthcare Limited","VARDENAFILHYDROCHLORIDETRIHYDRATE"
"9889","VARDENAFIL ACCORD","10 Milligram                                                                                            Film Coated Tablet",2017-07-07,"PA1390/121/002","Accord Healthcare Limited","VARDENAFILHYDROCHLORIDETRIHYDRATE"
"9890","VARDENAFIL ACCORD","20 Milligram                                                                                            Film Coated Tablet",2017-07-07,"PA1390/121/003","Accord Healthcare Limited","VARDENAFILHYDROCHLORIDETRIHYDRATE"
"9891","Vardenafil Chanelle 10 mg Orodispersible Tablets","10 milligram(s) Orodispersible tablet",2018-01-19,"PA0688/051/001","Chanelle Medical","Vardenafilhydrochloridetrihydrate"
"9892","VARDENAFIL KRKA","5 Milligram                                                                                            Film Coated Tablet",2017-04-28,"PA1347/073/001","Krka d.d., Novo mesto","VARDENAFILHYDROCHLORIDETRIHYDRATE"
"9893","VARDENAFIL KRKA","10 Milligram                                                                                            Film Coated Tablet",2017-04-28,"PA1347/073/002","Krka d.d., Novo mesto","VARDENAFILHYDROCHLORIDETRIHYDRATE"
"9894","VARDENAFIL KRKA","20 Milligram                                                                                            Film Coated Tablet",2017-04-28,"PA1347/073/003","Krka d.d., Novo mesto","VARDENAFILHYDROCHLORIDETRIHYDRATE"
"9895","VARGATEF","100 Milligram                                                                                            Capsules, Soft",2014-11-21,"EU/1/14/954/001-003","Boehringer Ingelheim International GmbH","NINTEDANIB"
"9896","VARGATEF","150 Milligram                                                                                            Capsules, Soft",2014-11-21,"EU/1/14/954/004","Boehringer Ingelheim International GmbH","NINTEDANIB"
"9897","VARIQUEL SOLUTION","0.2 Mg/Ml Solution for Injection",2013-10-25,"PA0943/027/001","Alliance Pharmaceuticals Ltd.","TERLIPRESSINACETATE"
"9898","VARIVAX powder and solvent for suspension for injection Varicella Vaccine (live)","=1350 plaque forming unit Powder and solvent for suspension for injection",2003-11-04,"PA1286/057/001","Merck Sharp & Dohme Ireland (Human Health) Limited","Varicellavirus(okastrain)liveattenuated"
"9899","Varuby","90 milligram(s) Film-coated tablet",2017-04-20,"EU/1/17/1180/001","Tesaro UK Limited","Rolapitant"
"9900","VASTAREL","20 Milligram                                                                                            Film Coated Tablet",1987-04-08,"PA0568/033/001","Les Laboratoires Servier","TRIMETAZIDINEDIHYDROCHLORIDE"
"9901","VASTAREL","35 Milligram                                                                                            Modified-release Tablets",2005-11-04,"PA0568/033/002","Les Laboratoires Servier","TRIMETAZIDINEDIHYDROCHLORIDE"
"9902","VATAN","40 Milligram                                                                                            Film Coated Tablet",2010-09-24,"PA0711/183/001","Rowex Ltd","VALSARTAN"
"9903","VATAN","80 Milligram                                                                                            Film Coated Tablet",2010-09-24,"PA0711/183/002","Rowex Ltd","VALSARTAN"
"9904","VATAN","160 Milligram                                                                                            Film Coated Tablet",2010-09-24,"PA0711/183/003","Rowex Ltd","VALSARTAN"
"9905","Vaxelis","*** AWAITING VALUE *** Suspension for injection",2016-02-15,"EU/1/15/1079/001-007","MCM Vaccine B.V.","Diphtheriatoxoidadsorbed|Tetanustoxoidadsorbed"
"9906","VECTAVIR COLD SORE","1 %w/w                                                                                                 Cream",2001-02-28,"PA1186/020/001","Chefaro Ireland DAC","PENCICLOVIR"
"9907","VECTIBIX","20 Mg/Ml Concentrate for Soln for Inf",2007-12-03,"EU/1/07/423/001-003","Amgen Europe B.V.","PANITUMUMAB"
"9908","VEDIXAL","37.5 Milligram                                                                                            Tablets",2006-06-23,"PA0711/161/002","Rowex Ltd","VENLAFAXINE"
"9909","VEDIXAL","75 Milligram                                                                                            Tablets",2006-06-23,"PA0711/161/004","Rowex Ltd","VENLAFAXINE"
"9910","VEDIXAL XL","75 Milligram                                                                                            Prolonged Release Capsules",2015-03-06,"PA1445/016/001","Aurobindo Pharma (Malta) Limited","VENLAFAXINEHYDROCHLORIDE"
"9911","VEDIXAL XL","150 Milligram                                                                                            Prolonged Release Capsules",2015-03-06,"PA1445/016/002","Aurobindo Pharma (Malta) Limited","VENLAFAXINEHYDROCHLORIDE"
"9912","VEDROP","50 Mg/Ml Oral Solution",2009-07-24,"EU/1/09/533/1-3","Orphan Europe Sarl","TOCOFERSOLAND-ALPHATOCOPHERYLPOLYETHYLENEGLYCOL1000SUCCINATE"
"9913","Veganin Plus Tablets","500/30/8 milligram(s) Film-coated tablet",2002-09-27,"PA1186/006/001","Chefaro Ireland DAC","Paracetamol|Caffeine|Codeinephosphate"
"9914","VELCADE","3.5 mg Milligram                                                                                            Solution for Injection",2004-05-20,"EU/1/04/274/001","Janssen-Cilag International NV","BORTEZOMIB"
"9915","VELCADE","1 Milligram                                                                                            Pdr for Soln for Injection",2012-09-20,"EU/1/04/274/002","Janssen-Cilag International NV","PS-341ASBORONICACID(BORTEZOMIB)"
"9916","VELETRI","0.5 Milligram                                                                                            Pdr for Soln for Infusion",2016-09-16,"PA2094/001/001","Actelion Registration Ltd","EPOPROSTENOL"
"9917","VELETRI","1.5 Milligram                                                                                            Pdr for Soln for Infusion",2016-09-16,"PA2094/001/002","Actelion Registration Ltd","EPOPROSTENOL"
"9918","Velmetia","50/850 milligram(s) Film-coated tablet",2008-07-16,"EU/1/08/456/1-7","Merck Sharp and Dohme Limited","Sitagliptinphosphate|METFORMINHYDROCHLORIDE"
"9919","VELMETIA","50/1000 Milligram                                                                                            Film Coated Tablet",2008-07-16,"EU/1/08/456/8-14","Merck Sharp & Dohme BV","SITAGLIPTINPHOSPHATE|METFORMINHYDROCHLORIDE"
"9920","Velphoro","500 milligram(s) Chewable tablet",NA,"EU/1/14/943/001-004","Vifor Fresenuis Medical Care Renal Pharma France","Mixtureofiron(iii)-oxyhydroxide,sucrose,starches"
"9921","VELTASSA","8.4 Milligram                                                                                            Powder for Oral Suspension",2017-07-19,"EU/1/17/1179/001-003","Vifor Fresenius Medical Care Renal Pharma France","PATIROMERSORBITEXCALCIUM"
"9922","VELTASSA","16.8 Milligram                                                                                            Powder for Oral Suspension",2017-07-19,"EU/1/17/1179/004-006","Vifor Fresenius Medical Care Renal Pharma France","PATIROMERSORBITEXCALCIUM"
"9923","VELTASSA","25.2 Milligram                                                                                            Powder for Oral Suspension",2017-07-19,"EU/1/17/1179/007-008","Vifor Fresenius Medical Care Renal Pharma France","PATIROMERSORBITEXCALCIUM"
"9924","Vemlidy (formely Tenofovir alafenamide)","25 milligram(s) Film-coated tablet",2017-01-09,"EU/1/16/1154/001-002","Gilead Sciences International","Tenofoviralafenamide"
"9925","Venaforce Varicose Veins gastro-resistant tablets",".  Gastro-resistant tablet",2011-12-16,"TR2309/011/001","A. Vogel Ireland Limited","Extract(asdryextract)fromfreshhorsechesnutseeds(aesculushippocastanuml.semen)"
"9926","Venclyxto","10 milligram(s) Film-coated tablet",2016-12-05,"EU/1/16/1138/001-002","AbbVie Ltd","Venetoclax"
"9927","Venclyxto","50 milligram(s) Film-coated tablet",2016-12-05,"EU/1/16/1138/003-004","AbbVie Ltd","Venetoclax"
"9928","Venclyxto","100 milligram(s) Film-coated tablet",2016-12-05,"EU/1/16/1138/005-007","AbbVie Ltd","Venetoclax"
"9929","VENEX XL","37.5 Milligram                                                                                            Prolonged Release Capsules",2017-11-10,"PA0126/285/001","Clonmel Healthcare Ltd","VENLAFAXINEHYDROCHLORIDE"
"9930","VENEX XL","75 Milligram                                                                                            Prolonged Release Capsules",2017-11-10,"PA0126/285/002","Clonmel Healthcare Ltd","VENLAFAXINEHYDROCHLORIDE"
"9931","VENEX XL","150 Milligram                                                                                            Prolonged Release Capsules",2017-11-10,"PA0126/285/003","Clonmel Healthcare Ltd","VENLAFAXINEHYDROCHLORIDE"
"9932","VENEX XL","225 Milligram                                                                                            Prolonged Release Capsules",2017-11-10,"PA0126/285/004","Clonmel Healthcare Ltd","VENLAFAXINEHYDROCHLORIDE"
"9933","Venlablue XL 150mg Prolonged Release Capsules, Hard","150 milligram(s) Prolonged-release capsule",2010-04-09,"PA1436/006/002","Bluefish Pharmaceuticals AB","Venlafaxinehydrochloride"
"9934","Venlablue XL 75 mg, prolonged-release capsules, hard","75 milligram(s) Prolonged-release capsule",2010-04-09,"PA1436/006/001","Bluefish Pharmaceuticals AB","Venlafaxinehydrochloride"
"9935","VENLAFEX XL","37.5 Milligram                                                                                            Prolonged Release Capsules",2010-11-12,"PA1347/036/001","Krka d.d., Novo mesto","VENLAFAXINEHYDROCHLORIDE"
"9936","VENLAFEX XL","75 Milligram                                                                                            Prolonged Release Capsules",2010-11-12,"PA1347/036/002","Krka d.d., Novo mesto","VENLAFAXINEHYDROCHLORIDE"
"9937","VENLAFEX XL","150 Milligram                                                                                            Prolonged Release Capsules",2010-11-12,"PA1347/036/003","Krka d.d., Novo mesto","VENLAFAXINEHYDROCHLORIDE"
"9938","VENLALIC XL","37.5 Milligram                                                                                            Tablet Prolonged Release",2010-06-04,"PA0274/004/001","Macarthys Laboratories Limited","VENLAFAXINEHYDROCHLORIDE"
"9939","VENLALIC XL","75 Milligram                                                                                            Tablet Prolonged Release",2007-09-14,"PA0274/004/002","Macarthys Laboratories Limited","VENLAFAXINEHYDROCHLORIDE"
"9940","VENLALIC XL","150 Milligram                                                                                            Tablet Prolonged Release",2007-09-14,"PA0274/004/003","Macarthys Laboratories Limited","VENLAFAXINEHYDROCHLORIDE"
"9941","VENLALIC XL","225 Milligram                                                                                            Tablet Prolonged Release",2007-09-14,"PA0274/004/004","Macarthys Laboratories Limited","VENLAFAXINEHYDROCHLORIDE"
"9942","VENLOFEX","75 Milligram                                                                                            Prolonged Release Capsules",2008-10-17,"PA0577/100/001","McDermott Laboratories Ltd t/a Gerard Laboratories","VENLAFAXINEHYDROCHLORIDE"
"9943","VENLOFEX","150 Milligram                                                                                            Prolonged Release Capsules",2008-10-17,"PA0577/100/002","McDermott Laboratories Ltd t/a Gerard Laboratories","VENLAFAXINEHYDROCHLORIDE"
"9944","VENOFER","20 Mg/Ml Solution for Injection",2000-03-20,"PA0949/001/001","Vifor France","IRONSUCROSE"
"9945","VENOFER","Unknown Solution for Injection",2009-09-11,"PA0949/001/002","Vifor France","IRONSUCROSE"
"9946","VENOS EXPECTORANT","Grams                                                                                                Oral Solution",1987-11-10,"PA1986/074/001","Teva B.V.","GUAIFENESIN|LIQUIDGLUCOSE|TREACLE"
"9947","VENOS HONEY AND LEMON","%v/v                                                                                                 Oral Solution",1978-04-01,"PA1986/075/001","Teva B.V.","AMMONIUMCHLORIDE|IPECACUANHAFLUIDEXTRACT|CITRUSLIMON|HONEY|LIQUIDGLUCOSE"
"9948","VENSIR XL","75 Milligram                                                                                            Prolonged Release Capsules",2008-08-15,"PA1333/002/001","Morningside Healthcare Limited","VENLAFAXINEHYDROCHLORIDE"
"9949","VENSIR XL","150 Milligram                                                                                            Prolonged Release Capsules",2008-08-15,"PA1333/002/002","Morningside Healthcare Limited","VENLAFAXINEHYDROCHLORIDE"
"9950","VENTAMOL CFC-FREE","100 Microgram                                                                                            Pressurised Inhalation Suspension",2005-04-15,"PA0436/008/010","Norton Waterford","SALBUTAMOLSULFATE"
"9951","VENTAVIS","20 Microgram/ML                                                                                         Nebuliser Solution",2014-07-18,"EU/1/03/255/009-010,012","Bayer AG","ILOPROSTTROMETANOL"
"9952","VENTAVIS","10 Microgram                                                                                            Nebuliser Solution",2003-09-16,"EU/1/03/255/1-3","Bayer AG","ILOPROSTTROMETANOL"
"9953","VENTOLIN","2.0 MG/5ml                                                                                               Oral Solution",1975-11-10,"PA1077/049/012","GlaxoSmithKline (Ireland) Limited","SALBUTAMOLSULFATE"
"9954","VENTOLIN","500 Microgram/ML                                                                                         Solution for Injection",1975-11-10,"PA1077/049/001","GlaxoSmithKline (Ireland) Limited","SALBUTAMOLSULFATE"
"9955","Ventolin 1mg/ml Concentrate for Solution for Intravenous Infusion","1 milligram(s)/millilitre Concentrate for solution for infusion",1975-11-10,"PA1077/049/002","GlaxoSmithKline (Ireland) Limited","SALBUTAMOLSULFATE"
"9956","VENTOLIN DISKUS","200 Base Micrograms                                                                                      Powder for Inhalation",1996-12-13,"PA1077/049/011","GlaxoSmithKline (Ireland) Limited","SALBUTAMOLSULFATE"
"9957","VENTOLIN EVOHALER","100 Microgram                                                                                            Pressurised Inhalation Suspension",1999-10-01,"PA1077/049/010","GlaxoSmithKline (Ireland) Limited","SALBUTAMOLSULFATE"
"9958","VENTOLIN EVOHALER","100 Microgram                                                                                            Pressurised Inhalation Suspension",2001-04-20,"PPA0465/064/001","PCO Manufacturing","SALBUTAMOL"
"9959","VENTOLIN EVOHALER","100 Microgram                                                                                            Pressurised Inhalation Suspension",2018-04-06,"PPA1633/066/001","Primecrown 2010 Ltd","SALBUTAMOLSULFATE"
"9960","VENTOLIN EVOHALER","100 Microgram                                                                                            Pressurised Inhalation Suspension",2009-05-08,"PPA1097/054/001","Lexon (UK) Ltd","SALBUTAMOLSULFATE"
"9961","VENTOLIN EVOHALER","100 Microgram                                                                                            Pressurised Inhalation Suspension",2008-08-01,"PPA1463/007/001","IMED Healthcare Ltd.","SALBUTAMOLSULFATE"
"9962","Ventolin Evohaler 100 micrograms Pressurised Inhalation, suspension","100 microgram(s) Pressurised inhalation, suspension",2007-06-08,"PPA1151/035/001","Imbat Limited","SALBUTAMOLSULFATE"
"9963","VENTOLIN NEBULES","2.5/2.5 Mg/Ml Nebuliser Solution",1984-07-18,"PA1077/049/005","GlaxoSmithKline (Ireland) Limited","SALBUTAMOLSULFATE"
"9964","VENTOLIN NEBULES","5/2.5 Mg/Ml Nebuliser Solution",1998-04-17,"PA1077/049/009","GlaxoSmithKline (Ireland) Limited","SALBUTAMOLSULFATE"
"9965","VEPACEL","Unknown Suspension for Injection",2012-02-17,"EU/1/12/752/001","Nanotherapeutics UK limited","WHOLEVIRIONNON-ADJUVANTEDINFLUENZAVIRUS(A/VIETNAM/1203/2004(H5N1))"
"9966","VEPESID 100 mg capsule, soft","100 milligram(s) Capsule, soft",1981-09-08,"PA2255/004/002","Bristol-Myers Squibb Pharmaceuticals uc","Etoposide"
"9967","VEPESID 50 mg capsule, soft","50 mg milligram(s) Capsule",1983-10-10,"PA2255/004/001","Bristol-Myers Squibb Pharmaceuticals uc","Etoposide"
"9968","VERAMIL","40 Milligram                                                                                            Film Coated Tablet",1981-01-20,"PA1327/008/001","Orion Corporation","VERAPAMILHYDROCHLORIDE"
"9969","Veramil 120mg Film-coated Tablets","120 milligram(s) Film-coated tablet",1985-09-11,"PA1327/008/003","Orion Corporation","VERAPAMILHYDROCHLORIDE"
"9970","Veramil 80 mg Film-coated Tablets","80 milligram(s) Film-coated tablet",1981-01-20,"PA1327/008/002","Orion Corporation","VERAPAMILHYDROCHLORIDE"
"9971","VERAP","120 Milligram                                                                                            Tablet Prolonged Release",2001-10-05,"PA0711/016/004","Rowex Ltd","VERAPAMILHYDROCHLORIDE"
"9972","VERAP","240 Milligram                                                                                            Tablet Prolonged Release",2001-10-05,"PA0711/016/005","Rowex Ltd","VERAPAMILHYDROCHLORIDE"
"9973","VERASEAL","80mg/ml/500 IU/ML                                                                                                Solution for Sealant",2017-11-10,"EU/1/17/1239/001-002","Instituto Grifols S.A.","HUMANFIBRINOGEN"
"9974","VERASEAL","80mg/ml/500 IU/ML                                                                                                Solution for Sealant",2017-11-10,"EU/1/17/1239/003-004","Instituto Grifols S.A.","HUMANFIBRINOGEN"
"9975","VERKAZIA","1 Mg/Ml Eye Drops Emulsion",2018-07-06,"EU/1/17/1219/001-004","Santen OY","CICLOSPORIN"
"9976","VERMOX","100 Milligram                                                                                            Tablets",1988-04-01,"PA0330/046/002","Johnson & Johnson (Ireland) Limited","MEBENDAZOLE"
"9977","VERMOX","100 MG/5ml                                                                                               Oral Suspension",1978-07-12,"PA0823/057/001","McNeil Healthcare (Ireland) Ltd","MEBENDAZOLE"
"9978","VERMOX","100 Milligram                                                                                            Tablets",2018-01-19,"PPA0465/440/001","PCO Manufacturing","MEBENDAZOLE"
"9979","VERMOX","100/5 MG/5ml                                                                                               Oral Solution",2011-02-11,"PPA1151/145/001","Imbat Limited","MEBENDAZOLE"
"9980","VERMOX","100 Milligram                                                                                            Tablets",2011-02-11,"PPA1151/145/002","Imbat Limited","MEBENDAZOLE"
"9981","VERMOX","100 Milligram                                                                                            Tablets",2011-05-27,"PPA1562/049/001","LTT Pharma Limited","MEBENDAZOLE"
"9982","VERMOX","100 MG/5ml                                                                                               Oral Suspension",2011-05-27,"PPA1562/049/002","LTT Pharma Limited","MEBENDAZOLE"
"9983","Vermox 100mg Tablets","100 milligram(s) Tablet",1998-04-01,"PA0748/042/002","Janssen-Cilag Ltd","Mebendazole"
"9984","Vermox 100mg/5ml Oral Suspension","100 mg/5ml Oral suspension",1998-07-12,"PA0748/042/001","Janssen-Cilag Ltd","Mebendazole"
"9985","Verrugon Ointment","50 percent weight/weight Ointment",1992-04-23,"PA1904/002/001","Optima Consumer Health Limited","Salicylicacid"
"9986","VERSATIS","700 Milligram                                                                                            Medicated Plaster",2010-10-08,"PA2242/007/001","Grunenthal Pharma Ltd","LIDOCAINE"
"9987","VERSATIS","5 Per Cent                                                                                             Medicated Plaster",2012-11-16,"PPA0465/299/001","PCO Manufacturing","LIDOCAINE"
"9988","VERSATIS","5 Per Cent                                                                                             Medicated Plaster",2013-01-11,"PPA1562/097/001","LTT Pharma Limited","LIDOCAINE"
"9989","VERSATIS","5 Per Cent                                                                                             Medicated Plaster",2013-05-10,"PPA1463/079/001","IMED Healthcare Ltd.","LIDOCAINE"
"9990","VERSATIS","5 %w/w                                                                                                 Medicated Plaster",2012-08-17,"PPA1151/186/001","Imbat Limited","LIDOCAINE"
"9991","VERSATIS","5 Per Cent                                                                                             Medicated Plaster",2014-07-04,"PPA1633/037/001","Primecrown 2010 Ltd","LIDOCAINE"
"9992","VERTIGON","8 Milligram                                                                                            Tablets",2014-10-03,"PA1445/023/001","Aurobindo Pharma (Malta) Limited","BETAHISTINEDIHYDROCHLORIDE"
"9993","VERTIGON","16 Milligram                                                                                            Tablets",2014-10-03,"PA1445/023/002","Aurobindo Pharma (Malta) Limited","BETAHISTINEDIHYDROCHLORIDE"
"9994","VESANOID 10 MG SOFT CAPSULES","10 Milligram                                                                                            Capsules, Soft",1996-12-03,"PA1868/001/001","Cheplapharm Arzneimittel GmbH","TRETINOIN"
"9995","VESITIRIM","5 Milligram                                                                                            Film Coated Tablet",2011-05-03,"PPA0465/262/001","PCO Manufacturing","SOLIFENACINSUCCINATE"
"9996","VESITIRIM","10 Milligram                                                                                            Film Coated Tablet",2011-05-03,"PPA0465/262/002","PCO Manufacturing","SOLIFENACINSUCCINATE"
"9997","VESITIRIM","5 Milligram                                                                                            Tablets",2004-08-13,"PA1241/009/001","Astellas Pharma Co. Ltd","SOLIFENACINSUCCINATE"
"9998","VESITIRIM","10 Milligram                                                                                            Tablets",2004-08-13,"PA1241/009/002","Astellas Pharma Co. Ltd","SOLIFENACINSUCCINATE"
"9999","VESITIRIM","1 Mg/Ml Oral Suspension",2015-10-09,"PA1241/009/003","Astellas Pharma Co. Ltd","SOLIFENACINSUCCINATE"
"10000","VESITIRIM","5 Milligram                                                                                            Film Coated Tablet",2011-08-19,"PPA1463/046/001","IMED Healthcare Ltd.","SOLIFENACINSUCCINATE"
"10001","VESITIRIM","10 Milligram                                                                                            Film Coated Tablet",2011-08-19,"PPA1463/046/002","IMED Healthcare Ltd.","SOLIFENACINSUCCINATE"
"10002","VESITIRIM","5 Milligram                                                                                            Film Coated Tablet",2012-08-31,"PPA1562/086/001","LTT Pharma Limited","SOLIFENACINSUCCINATE"
"10003","VESITIRIM","5 Milligram                                                                                            Film Coated Tablet",2010-11-12,"PPA1151/140/001","Imbat Limited","SOLIFENACINSUCCINATE"
"10004","Vesitirim 10 mg Film-coated Tablets","10 milligram(s) Film-coated tablet",2010-11-12,"PPA1151/140/002","Imbat Limited","Solifenacinsuccinate"
"10005","VESOMNI","6 /0.4 Milligram                                                                                            Modified-release Tablets",2014-01-06,"PA1241/016/001","Astellas Pharma Co. Ltd","SOLIFENACINSUCCINATE|TAMSULOSINHYDROCHLORIDE"
"10006","Vesomni 6 mg/0.4 mg modified release tablets","6/0.4 milligram(s) Modified-release tablet",2017-07-14,"PPA1097/023/001","Lexon (UK) Ltd","Solifenacinsuccinate|Tamsulosinhydrochloride"
"10007","VEXARIN XL","75 Milligram                                                                                            Prolonged Release Capsules",2012-09-24,"PA0577/169/001","McDermott Laboratories Ltd t/a Gerard Laboratories","VENLAFAXINEHYDROCHLORIDE"
"10008","VEXARIN XL","150 Milligram                                                                                            Prolonged Release Capsules",2012-09-24,"PA0577/169/002","McDermott Laboratories Ltd t/a Gerard Laboratories","VENLAFAXINEHYDROCHLORIDE"
"10009","VEYANN","0.02/3.0 Milligram                                                                                            Film Coated Tablet",2012-11-16,"PA0749/157/001","Teva Pharma B.V.","DROSPIRENONE|ETHINYLESTRADIOL"
"10010","VEYVONDI","650 international unit(s) Powder and solvent for solution for injection",2018-08-31,"EU/1/18/1298/001","Baxalta Innovations GmbH","VONICOGALFA"
"10011","VEYVONDI","1300 international unit(s) Powder and solvent for solution for injection",2018-08-31,"EU/1/18/1298/002","Baxalta Innovations GmbH","VONICOGALFA"
"10012","Vfend","50 milligram(s) Film-coated tablet",2002-03-19,"EU/1/02/212/001","Pfizer Europe MA EEIG","Voriconazole"
"10013","Vfend","50 milligram(s) Film-coated tablet",NA,"EU/1/02/212/002","Pfizer Europe MA EEIG","Voriconazole"
"10014","Vfend","50 milligram(s) Film-coated tablet",NA,"EU/1/02/212/003","Pfizer Europe MA EEIG","Voriconazole"
"10015","Vfend","50 milligram(s) Film-coated tablet",NA,"EU/1/02/212/004","Pfizer Europe MA EEIG","Voriconazole"
"10016","Vfend","50 milligram(s) Film-coated tablet",NA,"EU/1/02/212/005","Pfizer Europe MA EEIG","Voriconazole"
"10017","Vfend","50 milligram(s) Film-coated tablet",NA,"EU/1/02/212/006","Pfizer Europe MA EEIG","Voriconazole"
"10018","Vfend","50 milligram(s) Film-coated tablet",NA,"EU/1/02/212/007","Pfizer Europe MA EEIG","Voriconazole"
"10019","Vfend","50 milligram(s) Film-coated tablet",NA,"EU/1/02/212/008","Pfizer Europe MA EEIG","Voriconazole"
"10020","Vfend","50 milligram(s) Film-coated tablet",NA,"EU/1/02/212/009","Pfizer Europe MA EEIG","Voriconazole"
"10021","Vfend","50 milligram(s) Film-coated tablet",NA,"EU/1/02/212/010","Pfizer Europe MA EEIG","Voriconazole"
"10022","Vfend","50 milligram(s) Film-coated tablet",NA,"EU/1/02/212/011","Pfizer Europe MA EEIG","Voriconazole"
"10023","Vfend","50 milligram(s) Film-coated tablet",NA,"EU/1/02/212/012","Pfizer Europe MA EEIG","Voriconazole"
"10024","Vfend","200 milligram(s) Film-coated tablet",NA,"EU/1/02/212/013","Pfizer Europe MA EEIG","Voriconazole"
"10025","Vfend","200 milligram(s) Film-coated tablet",NA,"EU/1/02/212/014","Pfizer Europe MA EEIG","Voriconazole"
"10026","Vfend","200 milligram(s) Film-coated tablet",NA,"EU/1/02/212/015","Pfizer Europe MA EEIG","Voriconazole"
"10027","Vfend","200 milligram(s) Film-coated tablet",NA,"EU/1/02/212/016","Pfizer Europe MA EEIG","Voriconazole"
"10028","Vfend","200 milligram(s) Film-coated tablet",NA,"EU/1/02/212/017","Pfizer Europe MA EEIG","Voriconazole"
"10029","Vfend","200 milligram(s) Film-coated tablet",NA,"EU/1/02/212/018","Pfizer Europe MA EEIG","Voriconazole"
"10030","Vfend","200 milligram(s) Film-coated tablet",NA,"EU/1/02/212/019","Pfizer Europe MA EEIG","Voriconazole"
"10031","Vfend","200 milligram(s) Film-coated tablet",NA,"EU/1/02/212/020","Pfizer Europe MA EEIG","Voriconazole"
"10032","Vfend","200 milligram(s) Film-coated tablet",NA,"EU/1/02/212/021","Pfizer Europe MA EEIG","Voriconazole"
"10033","Vfend","200 milligram(s) Film-coated tablet",NA,"EU/1/02/212/022","Pfizer Europe MA EEIG","Voriconazole"
"10034","Vfend","200 milligram(s) Film-coated tablet",NA,"EU/1/02/212/023","Pfizer Europe MA EEIG","Voriconazole"
"10035","Vfend","200 milligram(s) Film-coated tablet",NA,"EU/1/02/212/024","Pfizer Europe MA EEIG","Voriconazole"
"10036","Vfend","200 milligram(s) Powder for solution for infusion",NA,"EU/1/02/212/025","Pfizer Europe MA EEIG","Voriconazole"
"10037","VFEND","40 mg/ml milligram(s)/millilitre Powder for oral suspension",NA,"EU/1/02/212/026","Pfizer Europe MA EEIG","Voriconazole"
"10038","VIACORAM","3.5/2.5 Milligram                                                                                            Tablets",2105-05-22,"PA0568/027/001","Les Laboratoires Servier","PERINDOPRILARGININE|AMLODIPINEBESILATE"
"10039","VIACORAM","7/5 Milligram                                                                                            Tablets",2105-05-22,"PA0568/027/002","Les Laboratoires Servier","PERINDOPRILARGININE|AMLODIPINEBESILATE"
"10040","Viagra","50 milligram(s) Orodispersible tablet",2013-04-17,"EU/1/98/077/020-023","Pfizer Europe MA EEIG","Sildenafilcitrate"
"10041","Viagra","100 milligram(s) Film-coated tablet",1998-09-14,"EU/1/98/077/10-11","Pfizer Europe MA EEIG","Sildenafil"
"10042","Viagra","25 milligram(s) Tablet",1998-09-14,"EU/1/98/077/2-4","Pfizer Europe MA EEIG","Sildenafil"
"10043","Viagra","50 milligram(s) Tablet",1998-09-14,"EU/1/98/077/6-8","Pfizer Europe MA EEIG","Sildenafil"
"10044","VIARTRIL 1500 MG POWDER FOR ORAL SOLUTION","1884.0/150 Milligram                                                                                            Oral Solution",2005-07-08,"PA0868/005/001","Rottapharm Ltd","GLUCOSAMINESULFATEASCRYSTALLINEGLUCOSAMINESULFATE|SODIUMCHLORIDE"
"10045","VIATIM","N/A Suspension for Injection",2003-05-16,"PA2131/014/001","Sanofi Pasteur","VIPOLYSACCHARIDEOFSALMONELLATYPHI|HEPATITAVIRUSANTIGEN"
"10046","Vibramycin Capsules 100 mg","100 milligram(s) Capsule, hard",1977-10-14,"PA0822/193/001","Pfizer Healthcare Ireland","DOXYCYCLINEHYDROCHLORIDE"
"10047","VICKS INHALER","125/50/10 Milligram                                                                                            Nasal Stick",NA,"PA0441/027/001","Procter & Gamble (Health & Beauty Care) Limited","MENTHOL|CAMPHOR|SIBERIANFIROIL"
"10048","VICKS SINEX MICROMIST","0.05 %w/v                                                                                                 Nasal Spray Solution",NA,"PA0441/024/003","Procter & Gamble (Health & Beauty Care) Limited","OXYMETAZOLINEHYDROCHLORIDE"
"10049","VICKS VAPORUB","N/A Inhalation Vapour, Ointment",2000-06-23,"PA0441/002/002","Procter & Gamble (Health & Beauty Care) Limited","LEVOMENTHOL|CAMPHOR|EUCALYPTUSGLOBULUS|TURPENTINEOIL"
"10050","VICTOZA","6 Mg/Ml Solution for Injection",2009-06-30,"EU/1/09/529/1-5","Novo Nordisk A/S","LIRAGLUTIDE"
"10051","VIDAZA","25 Mg/Ml Powder for suspension for injection",2008-12-17,"EU/1/08/488/001","Celgene Europe B.V.","AZACITIDINE"
"10052","VIDENE 10 % W/W ALCOHOLIC TINCTURE","10 %w/w                                                                                                 Cutaneous Solution",2000-06-23,"PA1110/010/003","Ecolab Limited","IODINATEDPOVIDONEPH.EUR."
"10053","VIDENE ANTISEPTIC SOLUTION","10 %w/w                                                                                                 Cutaneous Solution",2000-06-23,"PA1110/010/002","Ecolab Limited","IODINATEDPOVIDONEPH.EUR."
"10054","VIDENE SURGICAL SCRUB","7.5 %w/w                                                                                                 Cutaneous Solution",2000-06-23,"PA1110/010/001","Ecolab Limited","IODINATEDPOVIDONEPH.EUR."
"10055","VIDEX EC","125 Milligram                                                                                            Capsules Gastro-Resistant",2000-09-15,"PA0002/057/016","Bristol-Myers Squibb Pharmaceuticals uc","DIDANOSINE"
"10056","VIDEX EC","200 Milligram                                                                                            Capsules Gastro-Resistant",2000-09-15,"PA0002/057/017","Bristol-Myers Squibb Pharmaceuticals uc","DIDANOSINE"
"10057","VIDEX EC","250 Milligram                                                                                            Capsules Gastro-Resistant",2000-09-15,"PA0002/057/018","Bristol-Myers Squibb Pharmaceuticals uc","DIDANOSINE"
"10058","VIDEX EC","400 Milligram                                                                                            Capsules Gastro-Resistant",2000-09-15,"PA0002/057/019","Bristol-Myers Squibb Pharmaceuticals uc","DIDANOSINE"
"10059","VIDISIC","0.2 %w/w                                                                                                 Eyegel",1993-08-11,"PA0555/006/001","Bausch & Lomb UK Limited","CARBOMER"
"10060","VIDISIC PRESERVATIVE FREE SINGLE DOSE UNIT","0.2 %w/w                                                                                                 Eyegel",2001-12-14,"PA0555/006/002","Bausch & Lomb UK Limited","CARBOMER"
"10061","Viekirax","12.5 *** AWAITING VALUE *** Film-coated tablet",2015-01-15,"EU/1/14/982/001","AbbVie Ltd","Ombitasvir|Paritaprevir|Ritonavir"
"10062","Vihuma","250 international unit(s) Powder and solvent for solution for injection",2017-02-13,"EU/1/16/1168/001","Octapharma AB","Simoctocogalfa"
"10063","VIHUMA","500 International Unit                                                                                   Pdr+Solv for Soln for Inj",2017-02-13,"EU/1/16/1168/002","Octapharma AB","SIMOCTOCOGALFA"
"10064","VIHUMA","1000 International Unit                                                                                   Pdr+Solv for Soln for Inj",2017-02-13,"EU/1/16/1168/003","Octapharma AB","SIMOCTOCOGALFA"
"10065","VIHUMA","2000 International Unit                                                                                   Pdr+Solv for Soln for Inj",2017-02-13,"EU/1/16/1168/004","Octapharma AB","SIMOCTOCOGALFA"
"10066","VILDAGLIPTIN KRKA","50 Milligram                                                                                            Tablets",2018-01-12,"PA1347/076/001","Krka d.d., Novo mesto","VILDAGLIPTIN"
"10067","Vimizim","1 milligram(s)/millilitre Concentrate for solution for infusion",NA,"EU/1/14/914/001","BioMarin International Limited","Rhgalns"
"10068","VIMOVO","500/20 Milligram                                                                                            Modified-release Tablets",2013-12-18,"DPR0465/047/001","PCO Manufacturing","NAPROXEN|ESOMEPRAZOLEMAGNESIUMTRIHYDRATE"
"10069","Vimovo 500 mg/20 mg modified-release tablets","500/20 milligram(s) Modified-release tablet",2013-12-09,"PPA0465/328/001","PCO Manufacturing","Naproxen|Esomeprazole"
"10070","VIMOVO 500 mg/20 mg modified-release tablets","500/20 milligram(s) Modified-release tablet",2010-12-21,"PA0970/060/001","AstraZeneca UK Limited","Esomeprazolemagnesiumtrihydrate|Naproxen"
"10071","VIMOVO 500 mg/20 mg modified-release tablets","500/20 milligram(s) Modified-release tablet",2018-06-29,"PPA1463/122/001","IMED Healthcare Ltd.","Esomeprazole|Naproxen"
"10072","VIMOVO 500 mg/20 mg modified-release tablets","500/20 milligram(s) Modified-release tablet",2018-02-09,"PPA1151/263/001","Imbat Limited","Esomeprazolemagnesiumtrihydrate|Naproxen"
"10073","VIMPAT","10 Mg/Ml Syrup",2012-02-21,"EU/1/08/470/018-019","UCB Pharma S.A.","LACOSAMIDE"
"10074","VIMPAT","50/100/150 Milligram                                                                                            Film Coated Tablet",2008-08-29,"EU/1/08/470/13","UCB Pharma GmbH","LACOSAMIDE"
"10075","VIMPAT 10 MG/ML SOLUTION FOR INFUSION","10 Mg/Ml Solution for Infusion",2008-08-29,"EU/1/08/470/16","UCB Pharma GmbH","LACOSAMIDE"
"10076","VIMPAT 100 MG FILM-COATED TABLETS","100 Milligram                                                                                            Film Coated Tablet",2008-08-29,"EU/1/08/470/4-6","UCB Pharma GmbH","LACOSAMIDE"
"10077","VIMPAT 15 MG/ML SYRUP","15 Mg/Ml Syrup",2008-08-29,"EU/1/08/470/14-15","UCB Pharma GmbH","LACOSAMIDE"
"10078","VIMPAT 150 MG FILM-COATED TABLETS","150 Milligram                                                                                            Film Coated Tablet",2008-08-29,"EU/1/08/470/7-9","UCB Pharma GmbH","LACOSAMIDE"
"10079","VIMPAT 200 MG FILM-COATED TABLETS","200 Milligram                                                                                            Film Coated Tablet",2008-08-29,"EU/1/08/470/10-12","UCB Pharma GmbH","LACOSAMIDE"
"10080","VIMPAT 50 MG FILM-COATED TABLETS","50 Milligram                                                                                            Film Coated Tablet",2008-08-29,"EU/1/08/470/1-3","UCB Pharma GmbH","LACOSAMIDE"
"10081","Vinblastine Sulfate 1mg/ml Solution for Injection or Infusion","1 milligram(s)/millilitre Solution for injection/infusion",1990-10-15,"PA0822/208/001","Pfizer Healthcare Ireland","VINBLASTINESULFATE"
"10082","Vincristine Sulfate 1mg/ml Solution for Injection or Infusion","1 micromole(s) Solution for injection/infusion",1987-05-05,"PA0822/232/001","Pfizer Healthcare Ireland","VINCRISTINESULFATE"
"10083","VIOLITE","100/20 Microgram                                                                                            Film Coated Tablet",2016-06-24,"PA1876/006/001","Consilient Health Limited","LEVONORGESTREL|ETHINYLESTRADIOL"
"10084","Vipdomet","12.5/850 milligram(s) Film-coated tablet",2013-09-19,"EU/1/13/843/001-012","Takeda Global R&D Centre Europe Limited","Alogliptin(asbenzoate)|METFORMINHYDROCHLORIDE"
"10085","VIPDOMET","12.5/1000 Milligram                                                                                            Film Coated Tablet",2013-09-19,"EU/1/13/843/013-024","Takeda Global R&D Centre Europe Limited","ALOGLIPTIN(ASBENZOATE)|METFORMINHYDROCHLORIDE"
"10086","Vipidia","6.25 milligram(s) Film-coated tablet",2013-09-19,"EU/1/13/844/001-009","Takeda Global R&D Centre Europe Limited","Alogliptin(asbenzoate)"
"10087","VIPIDIA","12.5 Milligram                                                                                            Film Coated Tablet",2013-09-19,"EU/1/13/844/010-018","Takeda Global R&D Centre Europe Limited","ALOGLIPTIN(ASBENZOATE)"
"10088","VIPIDIA","25 Milligram                                                                                            Film Coated Tablet",2013-09-19,"EU/1/13/844/019-027","Takeda Global R&D Centre Europe Limited","ALOGLIPTIN(ASBENZOATE)"
"10089","VIRAFERON","International Unit                                                                                   Solution for Injection",2000-03-09,"EU/1/99/128/015","Schering Plough Europe","INTERFERONALFA-2B"
"10090","VIRAFERONPEG","50 mcg microgram(s) Powder and solvent for solution for injection",NA,"EU/1/00/132/001","Merck Sharp & Dohme BV","Peginterferonalfa-2b"
"10091","ViraferonPeg","50 microgram(s) Powder and solvent for solution for injection",NA,"EU/1/00/132/002","Merck Sharp & Dohme BV","Peginterferonalfa-2b"
"10092","ViraferonPeg","50 microgram(s) Powder and solvent for solution for injection",NA,"EU/1/00/132/003","Merck Sharp and Dohme Limited","Peginterferonalfa-2b"
"10093","ViraferonPeg","50 microgram(s) Powder and solvent for solution for injection",NA,"EU/1/00/132/004","Merck Sharp & Dohme BV","Peginterferonalfa-2b"
"10094","Viraferonpeg","50 microgram(s) Powder and solvent for solution for injection",NA,"EU/1/00/132/005","Merck Sharp & Dohme BV","Peginterferonalfa-2b"
"10095","Viraferonpeg","80 microgram(s) Powder and solvent for solution for injection",NA,"EU/1/00/132/006","Merck Sharp & Dohme BV","Peginterferonalfa-2b"
"10096","ViraferonPeg","80 microgram(s) Powder and solvent for solution for injection",NA,"EU/1/00/132/007","Merck Sharp & Dohme BV","Peginterferonalfa-2b"
"10097","ViraferonPeg","80 microgram(s) Powder and solvent for solution for injection",NA,"EU/1/00/132/008","Merck Sharp & Dohme BV","Peginterferonalfa-2b"
"10098","ViraferonPeg","80 microgram(s) Powder and solvent for solution for injection",NA,"EU/1/00/132/009","Merck Sharp & Dohme BV","Peginterferonalfa-2b"
"10099","ViraferonPeg","80 microgram(s) Powder and solvent for suspension for injection",NA,"EU/1/00/132/010","Merck Sharp & Dohme BV","Peginterferonalfa-2b"
"10100","ViraferonPeg","100 microgram(s) Powder and solvent for solution for injection",NA,"EU/1/00/132/011","Merck Sharp & Dohme BV","Peginterferonalfa-2b"
"10101","ViraferonPeg","100 microgram(s) Powder and solvent for solution for injection",NA,"EU/1/00/132/012","Merck Sharp & Dohme BV","Peginterferonalfa-2b"
"10102","ViraferonPeg","100 microgram(s) Powder and solvent for solution for injection",NA,"EU/1/00/132/013","Merck Sharp & Dohme BV","Peginterferonalfa-2b"
"10103","ViraferonPeg","100 microgram(s) Powder and solvent for solution for injection",NA,"EU/1/00/132/014","Merck Sharp & Dohme BV","Peginterferonalfa-2b"
"10104","ViraferonPeg","100 microgram(s) Powder and solvent for solution for injection",NA,"EU/1/00/132/015","Merck Sharp & Dohme BV","Peginterferonalfa-2b"
"10105","ViraferonPeg","120 microgram(s) Powder and solvent for solution for injection",NA,"EU/1/00/132/016","Merck Sharp & Dohme BV","Peginterferonalfa-2b"
"10106","ViraferonPeg","120 microgram(s) Powder and solvent for suspension for injection",NA,"EU/1/00/132/017","Merck Sharp & Dohme BV","Peginterferonalfa-2b"
"10107","ViraferonPeg","120 microgram(s) Powder and solvent for solution for injection",NA,"EU/1/00/132/018","Merck Sharp & Dohme BV","Peginterferonalfa-2b"
"10108","ViraferonPeg","120 microgram(s) Powder and solvent for solution for injection",NA,"EU/1/00/132/019","Merck Sharp & Dohme BV","Peginterferonalfa-2b"
"10109","ViraferonPeg","120 microgram(s) Powder and solvent for suspension for injection",NA,"EU/1/00/132/020","Merck Sharp & Dohme BV","Peginterferonalfa-2b"
"10110","ViraferonPeg","150 microgram(s) Powder and solvent for solution for injection",NA,"EU/1/00/132/021","Merck Sharp & Dohme BV","Peginterferonalfa-2b"
"10111","ViraferonPeg","150 microgram(s) Powder and solvent for solution for injection",NA,"EU/1/00/132/022","Merck Sharp & Dohme BV","Peginterferonalfa-2b"
"10112","ViraferonPeg","150 microgram(s) Powder and solvent for solution for injection",NA,"EU/1/00/132/023","Merck Sharp & Dohme BV","Peginterferonalfa-2b"
"10113","ViraferonPeg","150 microgram(s) Powder and solvent for solution for injection",NA,"EU/1/00/132/024","Merck Sharp & Dohme BV","Peginterferonalfa-2b"
"10114","ViraferonPeg","150 microgram(s) Powder and solvent for suspension for injection",NA,"EU/1/00/132/025","Merck Sharp & Dohme BV","Peginterferonalfa-2b"
"10115","VIRAFERONPEG 0.5 ML 100MCG AMPOULE","Pdr+Solv for Soln for Inj",2002-02-06,"EU/1/00/132/039","Schering Plough Europe","PEGINTERFERONALFA-2B"
"10116","VIRAFERONPEG 0.5 ML 120 MCG AMPOULE","Pdr+Solv for Soln for Inj",2002-02-06,"EU/1/00/132/043","Schering Plough Europe","PEGINTERFERONALFA-2B"
"10117","VIRAFERONPEG 0.5 ML 120 MCG AMPOULE","Pdr+Solv for Soln for Inj",2002-02-06,"EU/1/00/132/044","Schering Plough Europe","PEGINTERFERONALFA-2B"
"10118","VIRAFERONPEG 0.5 ML 120 MCG AMPOULE","Pdr+Solv for Soln for Inj",2002-02-06,"EU/1/00/132/046","Schering Plough Europe","PEGINTERFERONALFA-2B"
"10119","VIRAFERONPEG 0.5ML 100 MCG AMPOULE","Pdr+Solv for Soln for Inj",2002-02-06,"EU/1/00/132/040","Schering Plough Europe","PEGINTERFERONALFA-2B"
"10120","VIRAFERONPEG 0.5ML 100 MCG AMPOULE","Pdr+Solv for Soln for Inj",2002-02-06,"EU/1/00/132/042","Schering Plough Europe","PEGINTERFERONALFA-2B"
"10121","VIRAFERONPEG 0.5ML 120 MCG AMPOULE","Pdr+Solv for Soln for Inj",2002-02-06,"EU/1/00/132/045","Schering Plough Europe","PEGINTERFERONALFA-2B"
"10122","VIRAFERONPEG 2B 150 MCG / 0.5 ML 150 MCG AMPOULE","Pdr+Solv for Soln for Inj",2002-02-06,"EU/1/00/132/047","Schering Plough Europe","PEGINTERFERONALFA-2B"
"10123","VIRAFERONPEG 2B 150 MCG / 0.5 ML 150 MCG AMPOULE","Pdr+Solv for Soln for Inj",2002-02-06,"EU/1/00/132/048","Schering Plough Europe","PEGINTERFERONALFA-2B"
"10124","VIRAFERONPEG 2B 150 MCG / 0.5 ML 150 MCG AMPOULE","Pdr+Solv for Soln for Inj",2002-02-06,"EU/1/00/132/050","Schering Plough Europe","PEGINTERFERONALFA-2B"
"10125","VIRAFERONPEG 2B 150MCG / 0.5 ML 150 MCG AMPOULE","Pdr+Solv for Soln for Inj",2002-02-06,"EU/1/00/132/049","Schering Plough Europe","PEGINTERFERONALFA-2B"
"10126","VIRAFERONPEG 2B 50MCG / 0.5 ML 50 MCG AMPOULE","*** AWAITING VALUE *** Powder and solvent for solution for injection",NA,"EU/1/00/132/031","Merck Sharp & Dohme BV","Peginterferonalfa-2b"
"10127","ViraferonPeg 2b 50mcg / 0.5 ml 50mcg ampoule","*** AWAITING VALUE *** Powder and solvent for solution for injection",NA,"EU/1/00/132/034","Merck Sharp & Dohme BV","Peginterferonalfa-2b"
"10128","ViraferonPeg 2b 50mcg / 0.5ml 50mcg ampoule","*** AWAITING VALUE *** Powder and solvent for solution for injection",NA,"EU/1/00/132/033","Merck Sharp & Dohme BV","Peginterferonalfa-2b"
"10129","ViraferonPeg 2b 50mcg/0.5 ml 50mcg ampoule","*** AWAITING VALUE *** Powder and solvent for solution for injection",NA,"EU/1/00/132/032","Merck Sharp & Dohme BV","Peginterferonalfa-2b"
"10130","VIRAFERONPEG 2B 80 MCG / 0.5 ML 80 MCG AMPOULE","Pdr+Solv for Soln for Inj",2002-02-06,"EU/1/00/132/037","Schering Plough Europe","PEGINTERFERONALFA-2B"
"10131","ViraferonPeg 2b 80mcg / 0.5 ml 80 mcg ampoule","*** AWAITING VALUE *** Powder and solvent for solution for injection",NA,"EU/1/00/132/035","Merck Sharp & Dohme BV","Peginterferonalfa-2b"
"10132","ViraferonPeg 2b 80mcg / 0.5 ml 80 mcg ampoule","*** AWAITING VALUE *** Powder and solvent for solution for injection",NA,"EU/1/00/132/036","Merck Sharp & Dohme BV","Peginterferonalfa-2b"
"10133","VIRAFERONPEG 2B 80MCG / 0.5ML 80 MCG AMPOULE","Pdr+Solv for Soln for Inj",2002-02-06,"EU/1/00/132/038","Schering Plough Europe","PEGINTERFERONALFA-2B"
"10134","VIRAFERONPEG0.5ML 100MCG AMPOULE","Pdr+Solv for Susp for Inj",2002-02-06,"EU/1/00/132/041","Schering Plough Europe","PEGINTERFERONALFA-2B"
"10135","VIRALIEF  50 MG/G CREAM","50 mg/g Cream",1998-11-27,"PA0126/201/001","Clonmel Healthcare Ltd","ACICLOVIR"
"10136","Viralief  50 mg/g Cream","50 milligram(s)/gram Cream",1998-11-27,"PA0593/014/001","Stada Arzneimittel AG","Acyclovir"
"10137","VIRAMUNE","200 Milligram                                                                                            Tablets",1998-02-05,"EU/1/97/055/001","Boehringer Ingelheim International GmbH","NEVIRAPINE"
"10138","VIRAMUNE","50mg/5ml Milligram                                                                                            Oral Suspension",1999-06-18,"EU/1/97/055/002","Boehringer Ingelheim International GmbH","NEVIRAPINEHEMIHYDRATE"
"10139","VIRAMUNE","100 Milligram                                                                                            Tablet Prolonged Release",2011-09-16,"EU/1/97/055/006","Boehringer Ingelheim International GmbH","NEVIRAPINE"
"10140","VIRAMUNE","400 Milligram                                                                                            Tablet Prolonged Release",2011-09-16,"EU/1/97/055/007-009","Boehringer Ingelheim International GmbH","NEVIRAPINE"
"10141","VIREAD","33 mg/g Oral Powder",2012-11-22,"EU/1/01/200/003","Gilead Sciences Ireland UC","TENOFOVIRDISOPROXILFUMARATE"
"10142","VIREAD","123 mg/g Film Coated Tablet",2012-11-22,"EU/1/01/200/004-005","Gilead Sciences Ireland UC","TENOFOVIRDISOPROXILFUMARATE"
"10143","VIREAD","163 mg/g Film Coated Tablet",2012-11-22,"EU/1/01/200/006-007","Gilead Sciences Ireland UC","TENOFOVIRDISOPROXILFUMARATE"
"10144","VIREAD","204 mg/g Film Coated Tablet",2012-11-22,"EU/1/01/200/008-009","Gilead Sciences Ireland UC","TENOFOVIRDISOPROXILFUMARATE"
"10145","VIREAD FILM-COATED","245 mg milligram(s) Tablet",2002-02-05,"EU/1/01/200/001-002","Gilead Sciences International","Tenofovirdisoproxilfumarate"
"10146","VISCOLEX SYRUP","250 MG/5ml                                                                                               Oral Solution",1986-10-15,"PA0281/070/001","Pinewood Laboratories Ltd,","CARBOCISTEINE"
"10147","VISIPAQUE","270 Mg/Ml Solution for Injection",1995-09-19,"PA0735/009/012","GE Healthcare AS","IODIXANOL"
"10148","VISIPAQUE","320 Mg/Ml Solution for Injection",1995-09-19,"PA0735/009/013","GE Healthcare AS","IODIXANOL"
"10149","VISIPAQUE 270 mg I/ml Solution for Injection, glass container","270 milligram(s)/millilitre Solution for injection",1995-09-19,"PA0735/009/003","GE Healthcare AS","Iodixanol"
"10150","VISIPAQUE 320 mg I/ml Solution for Injection, glass container","320 milligram(s)/millilitre Solution for injection",1995-09-19,"PA0735/009/007","GE Healthcare AS","Iodixanol"
"10151","VISTABEL, 4 Allergan Units/0.1ml, Powder for solution for injection","4 Allergan Units Powder for solution for injection",2008-04-25,"PA0148/065/001","Allergan Pharmaceuticals Ireland","Botulinumtoxintypea|Botulinumtoxintypea"
"10152","Vistaprep Powder for Oral Solution","110.44  Powder for oral solution",2016-01-29,"PA2018/002/001","Tillotts Pharma GmbH","Macrogol3000|Sodiumchloride|Potassiumchloride|Sodiumhydrogencarbonate"
"10153","Vistide","375 mg/5ml Concentrate for solution for infusion",NA,"EU/1/97/037/001","Gilead Sciences International","Cidofovir"
"10154","VISUDYNE","15 Milligram                                                                                            Pdr for Soln for Infusion",2000-07-27,"EU/1/00/140/001","Ciba Vision (UK) Ltd","VERTEPORFIN"
"10155","VITAFEN","100 Milligram                                                                                            Film Coated Tablet",2015-04-10,"PA1113/009/001","Phoenix Labs","ACECLOFENAC"
"10156","Vitamin D3 1,000 IU Capsules, soft","1000 international unit(s) Capsule, soft",2017-10-06,"PA1887/008/003","Alissa Healthcare Research Limited","Colecalciferol"
"10157","Vitamin D3 10,000 IU Capsules, soft","10000 international unit(s) Capsule, soft",2017-10-06,"PA1887/008/004","Alissa Healthcare Research Limited","Colecalciferol"
"10158","Vitamin D3 20,000 IU Capsules, soft","20,000 international unit(s) Capsule",2016-10-14,"PA1887/002/001","Alissa Healthcare Research Limited","Colecalciferol|Colecalciferol"
"10159","Vitamin D3 400 IU Capsules, soft","400 international unit(s) Capsule, soft",2017-10-06,"PA1887/008/001","Alissa Healthcare Research Limited","Colecalciferol"
"10160","Vitamin D3 800 IU Capsules, soft","800 international unit(s) Capsule, soft",2017-10-06,"PA1887/008/002","Alissa Healthcare Research Limited","Colecalciferol"
"10161","VITAROS","2 mg/g Cream",2015-10-09,"PA1404/003/001","Recordati Ireland Limited","ALPROSTADIL"
"10162","VITAROS","3 mg/g Cream",2015-10-09,"PA1404/003/002","Recordati Ireland Limited","ALPROSTADIL"
"10163","Vitile MR 30 mg Modified Release Tablets","30 milligram(s) Modified-release tablet",2015-05-22,"PA1380/166/001","Actavis Group PTC ehf","Gliclazide"
"10164","VITLIPID N ADULT","10 Millilitre                                                                                           Concentrate for Susp for Inf",1988-05-16,"PA0566/017/001","Fresenius Kabi Limited","RETINOLPALMITATE|ERGOCALCIFEROL|DL-ALFA-TOCOFEROL|PHYTOMENADIONE"
"10165","VITLIPID N INFANT","10 Millilitre                                                                                           Concentrate for Susp for Inf",1988-05-16,"PA0566/017/002","Fresenius Kabi Limited","RETINOLPALMITATE|ERGOCALCIFEROL|DL-ALFA-TOCOFEROL|PHYTOMENADIONE"
"10166","VIVANZA","10 Milligram                                                                                            Orodispersible Tablet",2013-06-27,"EU/1/03/249/016","Bayer AG","VARDENAFILHYDROCHLORIDETRIHYDRATE(MICRONIZED)"
"10167","VIVANZA FILM-COATED","5 mg milligram(s) Tablet",NA,"EU/1/03/249/1-12","Bayer AG","Vardenafil(ashydrochloridetrihydrate)"
"10168","VIVIDRIN","20 Micromol Eye Drops Solution",1991-03-26,"PA0555/005/002","Bausch & Lomb UK Limited","CROMOGLICATESODIUM"
"10169","VIVIDRIN PRESERVATIVE FREE SDU","2 %w/v                                                                                                 Eye Drops Solution",2000-03-31,"PA0555/005/003","Bausch & Lomb UK Limited","CROMOGLICATESODIUM"
"10170","VIZAMYL","400 mBg/ml                                                                                               Solution for Injection",2014-08-22,"EU/1/14/941/001-002","GE Healthcare Limited","(18F)FLUTEMETAMOL"
"10171","VIZARSIN","25                                                                                                      Orodispersible Tablet",2012-05-15,"EU/1/09/551/013-017","Krka d.d., Novo mesto","SILDENAFIL"
"10172","VIZARSIN","50 Milligram                                                                                            Orodispersible Tablet",2012-05-15,"EU/1/09/551/018-022","Krka d.d., Novo mesto","SILDENAFIL"
"10173","VIZARSIN","100                                                                                                      Orodispersible Tablet",2012-05-15,"EU/1/09/551/023-027","Krka d.d., Novo mesto","SILDENAFIL"
"10174","VIZARSIN","25 Milligram                                                                                            Film Coated Tablet",2009-09-21,"EU/1/09/551/1-4","Krka d.d., Novo mesto","SILDENAFILCITRATE"
"10175","Vizarsin","50 milligram(s) Film-coated tablet",2009-09-21,"EU/1/09/551/5-8","Krka d.d., Novo mesto","Sildenafilcitrate"
"10176","Vizarsin","100 milligram(s) Film-coated tablet",2009-09-21,"EU/1/09/551/9-12","Krka d.d., Novo mesto","Sildenafilcitrate"
"10177","VIZIOBLOK","2.5 Mg/Ml Eye Drops Solution",2016-09-16,"PA1368/017/001","Pharmathen S.A.","TIMOLOLMALEATE"
"10178","VOBOLON","700 Milligram                                                                                            Medicated Plaster",2018-01-19,"PA2242/001/001","Grunenthal Pharma Ltd","LIDOCAINE"
"10179","Vokanamet","50mg/850 milligram(s) Film-coated tablet",NA,"EU/1/14/918/001-003","Janssen-Cilag International NV","Canagliflozin|MICROCRYSTALLINECELLULOSE|Hypromellose2910,15mpa.s|Croscarmellosesodium|Purifiedwater|METFORMINHYDROCHLORIDE"
"10180","VOKANAMET","50mg/1000 Milligram                                                                                            Film Coated Tablet",2014-04-23,"EU/1/14/918/004-006","Janssen-Cilag International NV","CANAGLIFLOZIN|MICROCRYSTALLINECELLULOSE|HYPROMELLOSE2910,15MPA.S|CROSCARMELLOSE|PURIFIEDWATER|METFORMINHYDROCHLORIDE"
"10181","VOKANAMET","150mg/850 Milligram                                                                                            Film Coated Tablet",2014-04-23,"EU/1/14/918/007-009","Janssen-Cilag International NV","CANAGLIFLOZIN|MICROCRYSTALLINECELLULOSE|HYPROMELLOSE2910,15MPA.S|CROSCARMELLOSE|PURIFIEDWATER|METFORMINHYDROCHLORIDE"
"10182","VOKANAMET","150mg/1000 Milligram                                                                                            Film Coated Tablet",2014-04-23,"EU/1/14/918/010-012","Janssen-Cilag International NV","CANAGLIFLOZIN|MICROCRYSTALLINECELLULOSE|HYPROMELLOSE2910,15MPA.S|CROSCARMELLOSE|PURIFIEDWATER|METFORMINHYDROCHLORIDE"
"10183","Volibris","5 milligram(s) Film-coated tablet",2008-04-21,"EU/1/08/451/1-2","Glaxo Group Limited","Ambrisentan"
"10184","Volibris","10 milligram(s) Film-coated tablet",2008-04-21,"EU/1/08/451/3-4","Glaxo Group Limited","Ambrisentan"
"10185","VOLTAROL","50 Milligram                                                                                            Tablets Gastro-Resistant",1979-10-03,"PA0896/034/001","Novartis Ireland Limited","DICLOFENACSODIUM"
"10186","VOLTAROL EMULGEL","1 %w/w                                                                                                 Gel",1989-10-11,"PA0678/140/001","GlaxoSmithKline Consumer Healthcare (Ireland) Limited","DICLOFENACDIETHYLAMMONIUM"
"10187","VOLTAROL EMULGEL","1 %w/w                                                                                                 Gel",2008-05-16,"PPA1151/069/001","Imbat Limited","DICLOFENACSODIUM(ASDICLOFENACDIETHYLAMMONIUM)"
"10188","VOLTAROL EMULGEL EXTRA STRENGTH","2 %w/w                                                                                                 Gel",2014-02-14,"PA0678/140/003","GlaxoSmithKline Consumer Healthcare (Ireland) Limited","DICLOFENACDIETHYLAMINE"
"10189","VOLTAROL EMULGEL P","1 %w/w                                                                                                 Gel",2003-10-17,"PA0678/140/002","GlaxoSmithKline Consumer Healthcare (Ireland) Limited","DICLOFENACDIETHYLAMMONIUM"
"10190","VOLTAROL OPHTHA MULTIDOSE","1 Mg/Ml Eye Drops Solution",2002-05-03,"PA1107/009/002","Laboratoires Thea","DICLOFENACSODIUM"
"10191","VOLTAROL RETARD","100 Milligram                                                                                            Tablet Prolonged Release",1983-07-26,"PA0896/034/002","Novartis Ireland Limited","DICLOFENACSODIUM"
"10192","VOLTAROL RETARD","75 Milligram                                                                                            Tablet Prolonged Release",1991-12-18,"PA0896/034/003","Novartis Ireland Limited","DICLOFENACSODIUM"
"10193","Voltfast Sachets 50 mg Powder for Oral Solution","50 milligram(s) Powder for oral solution",2006-07-14,"PA2308/001/001","Wisdom Pharmaceutical Technology Co Limited","Diclofenacpotassium"
"10194","VONCENTO","250/600 International Unit                                                                                   Pdr+Solv for soln for inf/inj",2013-08-12,"EU/1/13/857/001","CSL Behring GmbH","HUMANCOAGULATIONFACTORVIII|VONWILLEBRANDFACTOR"
"10195","VONCENTO","500/1200 International Unit                                                                                   Pdr+Solv for soln for inf/inj",2013-08-12,"EU/1/13/857/002","CSL Behring GmbH","HUMANCOAGULATIONFACTORVIII|VONWILLEBRANDFACTOR"
"10196","VONCENTO","500/1200 International Unit                                                                                   Pdr+Solv for soln for inf/inj",2013-08-12,"EU/1/13/857/003","CSL Behring GmbH","HUMANCOAGULATIONFACTORVIII|VONWILLEBRANDFACTOR"
"10197","VONCENTO","1000/2400 International Unit                                                                                   Pdr+Solv for soln for inf/inj",2013-08-12,"EU/1/13/857/004","CSL Behring GmbH","HUMANCOAGULATIONFACTORVIII|VONWILLEBRANDFACTOR"
"10198","VONODIOL","100/20 Microgram                                                                                            Film Coated Tablet",2009-08-07,"PA0749/154/001","Teva Pharma B.V.","LEVONORGESTREL|ETHINYLESTRADIOL"
"10199","VORICONAZOLE","200 Milligram                                                                                            Pdr for Soln for Infusion",2015-10-09,"PA2059/020/001","Fresenius Kabi Deutschland GmbH","VORICONAZOLE"
"10200","VORICONAZOLE ACCORD","50 Milligram                                                                                            Film Coated Tablet",NA,"EU/1/13/835/001","Accord Healthcare Limited","VORICONAZOLE"
"10201","VORICONAZOLE ACCORD","200 Milligram                                                                                            Film Coated Tablet",NA,"EU/1/13/835/010","Accord Healthcare Limited","VORICONAZOLE"
"10202","Voriconazole Actavis 200 mg Powder for solution for infusion","200 milligram(s) Powder for solution for infusion",2016-05-26,"PA1380/172/003","Actavis Group PTC ehf","Voriconazole"
"10203","VORICONAZOLE APOTEX","50 Milligram                                                                                            Film Coated Tablet",2015-10-23,"PA1513/006/001","Apotex Europe B.V.","VORICONAZOLE"
"10204","VORICONAZOLE APOTEX","200 Milligram                                                                                            Film Coated Tablet",2015-10-23,"PA1513/006/002","Apotex Europe B.V.","VORICONAZOLE"
"10205","VORICONAZOLE HOSPIRA","200 Milligram                                                                                            Pdr for Soln for Infusion",2015-05-27,"EU/1/15/1004/001-002","Hikma Farmaceutica (Portugal) SA","VORICONAZOLE"
"10206","VORICONAZOLE MYLAN","200 Milligram                                                                                            Film Coated Tablet",2014-07-04,"PA0577/173/001","McDermott Laboratories Ltd t/a Gerard Laboratories","VORICONAZOLE"
"10207","VORICONAZOLE PFIZER","50 Milligram                                                                                            Film Coated Tablet",2013-06-07,"PA0822/174/001","Pfizer Healthcare Ireland","VORICONAZOLE"
"10208","VORICONAZOLE PFIZER","200 Milligram                                                                                            Film Coated Tablet",2013-06-07,"PA0822/174/002","Pfizer Healthcare Ireland","VORICONAZOLE"
"10209","VORICONAZOLE PFIZER","40 Mg/Ml Powder for Oral Suspension",2013-06-07,"PA0822/174/003","Pfizer Healthcare Ireland","VORICONAZOLE"
"10210","VORICONAZOLE PFIZER","200 Milligram                                                                                            Pdr for Soln for Infusion",2013-06-07,"PA0822/174/004","Pfizer Healthcare Ireland","VORICONAZOLE"
"10211","VORICONAZOLE ROWEX","200 Milligram                                                                                            Pdr for Soln for Infusion",2014-02-28,"PA0711/209/003","Rowex Ltd","VORICONAZOLE"
"10212","Voriconazole Rowex 200mg Film-coated Tablets","200 milligram(s) Film-coated tablet",2013-07-04,"PA0711/209/002","Rowex Ltd","Voriconazole"
"10213","Voriconazole Teva 200 mg Film-coated Tablets","200 milligram(s) Film-coated tablet",2013-08-23,"PA0749/181/001","Teva Pharma B.V.","Voriconazole"
"10214","VORICONAZOLE XELLIA","200 Milligram                                                                                            Pdr for Soln for Infusion",2015-08-13,"PA1982/001/001","Xellia Pharmaceuticals ApS","VORICONAZOLE"
"10215","Vosevi","400/100/100 milligram(s) Film-coated tablet",2017-07-26,"EU/1/17/1223/001","Gilead Sciences International","Sofosbuvir|Velpatasvir|Voxilaprevir"
"10216","Votrient","200 milligram(s) Film-coated tablet",2010-06-14,"EU/1/10/628/001-2","Novartis Europharm Limited","Pazopanibhydrochloride"
"10217","VOTRIENT","400 Milligram                                                                                            Film Coated Tablet",2010-06-14,"EU/1/10/628/003-4","Novartis Europharm Limited","PAZOPANIBHYDROCHLORIDE"
"10218","VOTUBIA","2.5 Milligram                                                                                            Tablets",2011-09-02,"EU/1/11/710/001-003","Novartis Europharm Limited","RADNBHT"
"10219","VOTUBIA","5 Milligram                                                                                            Tablets",2011-09-02,"EU/1/11/710/004-005","Novartis Europharm Limited","RADNBHT"
"10220","VOTUBIA","10 Milligram                                                                                            Tablets",2011-09-02,"EU/1/11/710/006-007","Novartis Europharm Limited","RADNBHT"
"10221","Votubia","2 milligram(s) Dispersible tablet",2013-11-15,"EU/1/11/710/009-011","Novartis Europharm Ltd","Radnbht"
"10222","VOTUBIA","3 Milligram                                                                                            Dispersable Tablet",2013-11-15,"EU/1/11/710/012-013","Novartis Europharm Limited","RADNBHT"
"10223","VOTUBIA","5 Milligram                                                                                            Dispersable Tablet",2013-11-15,"EU/1/11/710/014-015","Novartis Europharm Limited","RADNBHT"
"10224","VOTUBIA","1 Milligram                                                                                            Dispersable Tablet",2018-05-31,"EU/1/11/710/016","Novartis Europharm Limited","EVEROLIMUS"
"10225","VPRIV","200 *** AWAITING VALUE *** Powder for solution for injection",2010-08-26,"EU/1/10/646/001","Shire Pharmaceuticals Ireland Limited","Velaglucerasealfa"
"10226","VPRIV","400  Pdr for Soln for Injection",2010-08-26,"EU/1/10/646/002","Shire Pharmaceuticals Ireland Limited","VELAGLUCERASEALFA"
"10227","VYNDAQEL","20 Milligram                                                                                            Capsules, Soft",2011-11-16,"EU/1/11/717/001","Pfizer Europe MA EEIG","TAFAMIDIS"
"10228","Wakix","4.5 milligram(s) Film-coated tablet",2016-03-31,"EU/1/15/1068/001","Bioproject Pharma","Pitolisanthydrochloride"
"10229","WAKIX","18 Milligram                                                                                            Film Coated Tablet",2016-03-31,"EU/1/15/1068/002","Bioproject Pharma","PITOLISANTHYDROCHLORIDE"
"10230","WARFANT","1 Milligram                                                                                            Tablets",1995-10-17,"PA0073/139/001","Mercury Pharmaceuticals (Ireland) Ltd","WARFARINSODIUMCLATHRATE"
"10231","WARFANT","3 Milligram                                                                                            Tablets",1995-10-17,"PA0073/139/002","Mercury Pharmaceuticals (Ireland) Ltd","WARFARINSODIUMCLATHRATE"
"10232","WARFANT","5 Milligram                                                                                            Tablets",1995-10-17,"PA0073/139/003","Mercury Pharmaceuticals (Ireland) Ltd","WARFARINSODIUMCLATHRATE"
"10233","Warfarin Rosemont 1 mg/1 ml Oral Suspension","1 milligram(s)/millilitre Oral suspension",2011-11-18,"PA0312/018/001","Rosemont Pharmaceuticals Ltd","WARFARINSODIUM"
"10234","WARFARIN TEVA","0.5 Milligram                                                                                            Tablets",2007-10-26,"PA2050/001/001","Sun Pharmaceutical Industries Europe B.V.","WARFARINSODIUMCLATHRATE"
"10235","WARFARIN TEVA","1 Milligram                                                                                            Tablets",2007-10-26,"PA2050/001/002","Sun Pharmaceutical Industries Europe B.V.","WARFARINSODIUMCLATHRATE"
"10236","WARFARIN TEVA","2 Milligram                                                                                            Tablets",2007-10-26,"PA2050/001/003","Sun Pharmaceutical Industries Europe B.V.","WARFARINSODIUMCLATHRATE"
"10237","WARFARIN TEVA","2.5 Milligram                                                                                            Tablets",2007-10-26,"PA2050/001/004","Sun Pharmaceutical Industries Europe B.V.","WARFARINSODIUMCLATHRATE"
"10238","WARFARIN TEVA","3 Milligram                                                                                            Tablets",2007-10-26,"PA2050/001/005","Sun Pharmaceutical Industries Europe B.V.","WARFARINSODIUMCLATHRATE"
"10239","WARFARIN TEVA","5 Milligram                                                                                            Tablets",2007-10-26,"PA2050/001/006","Sun Pharmaceutical Industries Europe B.V.","WARFARINSODIUMCLATHRATE"
"10240","WARFARIN TEVA","6 Milligram                                                                                            Tablets",2007-10-26,"PA2050/001/007","Sun Pharmaceutical Industries Europe B.V.","WARFARINSODIUMCLATHRATE"
"10241","WARFARIN TEVA","7.5 Milligram                                                                                            Tablets",2007-10-26,"PA2050/001/008","Sun Pharmaceutical Industries Europe B.V.","WARFARINSODIUMCLATHRATE"
"10242","WARFARIN TEVA","10 Milligram                                                                                            Tablets",2007-10-26,"PA2050/001/009","Sun Pharmaceutical Industries Europe B.V.","WARFARINSODIUMCLATHRATE"
"10243","Wartex Ointment","50 percent weight/weight Ointment",1992-04-23,"PA1904/003/001","Optima Consumer Health Limited","Salicylicacid"
"10244","WARTICON 0.15% W/W CREAM","0.15 %w/w                                                                                                 Cream",1996-09-25,"PA1113/017/001","Phoenix Labs","PODOPHYLLOTOXIN"
"10245","WASP-EZE SPRAY","1/0.5 %w/w                                                                                                 Cutaneous Spray Solution",1996-07-09,"PA0257/071/001","GR Lane Health Products Ltd","MEPYRAMINEMALEATE|BENZOCAINE"
"10246","WATER FOR INJECTIONS","100 %w/v                                                                                                 Solvent for Parenteral Use",2002-05-03,"PA0167/065/004","Baxter Healthcare Limited","WATERFORINJECTIONS"
"10247","WATER FOR INJECTIONS","100 Per Cent                                                                                             Solvent for Parenteral Use",2009-08-07,"PA0566/053/001","Fresenius Kabi Limited","WATERFORINJECTIONS"
"10248","WATER FOR INJECTIONS PH. EUR","500 Millilitre                                                                                           Solvent for Parenteral Use",1993-03-26,"PA0179/009/007","B. Braun Medical Limited","WATERFORINJECTIONS"
"10249","WATER FOR INJECTIONS PH. EUR.","10 Millilitre                                                                                           Solvent for Parenteral Use",1987-04-08,"PA0179/009/003","B. Braun Medical Limited","WATERFORINJECTIONS"
"10250","WATER FOR INJECTIONS PH. EUR.","Unknown Solvent for Parenteral Use",2008-02-01,"PA1122/001/001","Noridem Enterprises Ltd","WATERFORINJECTIONS"
"10251","WAXSOL","0.5 %w/v                                                                                                 Ear Drops Solution",NA,"PA1332/042/001","Meda Health Sales Ireland Limited","DOCUSATESODIUM"
"10252","WECOL","6.9 Grams                                                                                                Powder for Oral Solution",2015-03-13,"PA1944/001/001","Stirling Anglian Pharmaceuticals Ltd","MACROGOL3350|SODIUMCHLORIDE|POTASSIUMCHLORIDE|SODIUMBICARBONATE"
"10253","WECOL PAEDIATRIC","6.9 Grams                                                                                                Powder for Oral Solution",2015-03-13,"PA1944/001/002","Stirling Anglian Pharmaceuticals Ltd","MACROGOL3350|SODIUMCHLORIDE|POTASSIUMCHLORIDE|SODIUMBICARBONATE"
"10254","WELEDA CALENDULA CUTS AND GRAZES SKIN SALVE","Unknown Ointment",2017-07-28,"TR0407/003/001","Weleda (UK) Limited","TINCTUREFROMCALENDULAOFFICINALISL.,HERBA"
"10255","WELEDA HYPERCAL WOUND SALVE","Unknown Infus/Pdr/Oral Soln",2017-07-28,"TR0407/002/001","Weleda (UK) Limited","TINCTUREFROMCALENDULAOFFICINALISL.,HERBA|TINCTUREOFHYPERICUMPERFORATUML.,HERBA"
"10256","WHITFIELD'S ANTIFUNGAL 3% W/W & 6% W/W OINTMENT","3/6 %w/w                                                                                                 Ointment",1991-06-10,"PA0206/024/001","Ovelle Limited","SALICYLICACID|BENZOICACID"
"10257","Wilate, 1000 IU VWF/1000 IU FVIII, powder and solvent for solution for injection","1000/1000 international unit(s) Powder and solvent for solution for injection",2012-03-16,"PA2219/008/002","Octapharma (IP) SPRL","Vonwillebrandfactorhuman|Humanfactorviii"
"10258","Wilate, 500 IU VWF/500 IU FVIII, powder and solvent for solution for injection","500/500 international unit(s) Powder and solvent for solution for injection",2012-03-16,"PA2219/008/001","Octapharma (IP) SPRL","Vonwillebrandfactorhuman|Humanfactorviii"
"10259","WILZIN","25mg and 5 Milligram                                                                                            Capsules Hard",2004-10-29,"EU/1/04/286/1-2","Orphan Europe Sarl","ZINCACETATEDIHYDRATE"
"10260","Xadago","50 milligram(s) Film-coated tablet",2015-02-24,"EU/1/14/984/001-005","Zambon S.p.A.","Safinamidemethanesulfonate"
"10261","XADAGO","100 Milligram                                                                                            Film Coated Tablet",2015-02-24,"EU/1/14/984/006-010","Zambon S.p.A.","SAFINAMIDEMETHANESULFONATE"
"10262","XAGRID","0.5 mg milligram(s) Capsule, hard",2004-11-16,"EU/1/04/295/001","Shire Pharmaceuticals Ireland Limited","ANAGRELIDEHYDROCHLORIDE"
"10263","XALACOM","50mcg/ml + 5 Mg/Ml Eye Drops Solution",2015-04-17,"PPA0465/406/001","PCO Manufacturing","LATANOPROST|TIMOLOLMALEATE"
"10264","XALACOM","50mcg/ml + 5 Mg/Ml Eye Drops Solution",2001-09-07,"PA0822/139/001","Pfizer Healthcare Ireland","LATANOPROST|TIMOLOLMALEATE"
"10265","XALATAN","50 Microgram/ML                                                                                         Eye Drops Solution",2008-10-24,"PPA1151/075/001","Imbat Limited","LATANOPROST"
"10266","XALATAN","50 Microgram/ML                                                                                         Eye Drops Solution",2015-07-24,"PPA1562/160/001","LTT Pharma Limited","LATANOPROST"
"10267","Xalatan 50 micrograms/ml eye drops, solution","0.005 percent weight/volume Eye drops, solution",1997-07-25,"PA0822/140/001","Pfizer Healthcare Ireland","Latanoprost"
"10268","Xalatan 50 micrograms/ml eye drops, solution","0.005 percent weight/volume Eye drops, solution",2011-04-08,"PPA0465/267/001","PCO Manufacturing","Latanoprost"
"10269","Xalkori","200 milligram(s) Capsule, hard",2012-10-23,"EU/1/12/793/001-002","Pfizer Europe MA EEIG","Crizotinib"
"10270","Xalkori","250 milligram(s) Capsule, hard",2012-10-23,"EU/1/12/793/003-004","Pfizer Europe MA EEIG","Crizotinib"
"10271","XALUPRINE","20 Mg/Ml Oral Suspension",2012-03-09,"EU/1/11/727/001","Nova Laboratories Ltd","MERCAPTOPURINE"
"10272","XAMIOL","50 + 0.5 Unknown Gel",2008-09-12,"PA1025/003/001","LEO Pharma A/S","CALCIPOTRIOLHYDRATE|BETAMETHASONEDIPROPIONATE"
"10273","Xanax 1 mg Tablets","1 milligram(s) Tablet",1982-11-01,"PA0822/141/001","Pfizer Healthcare Ireland","Alprazolam"
"10274","Xanax 250 microgram Tablets","250 microgram(s) Tablet",1982-11-01,"PA0822/141/002","Pfizer Healthcare Ireland","Alprazolam"
"10275","Xanax 500 microgram Tablets","500 microgram(s) Tablet",1982-11-01,"PA0822/141/003","Pfizer Healthcare Ireland","Alprazolam"
"10276","Xarelto","15 milligram(s) Film-coated tablet",NA,"EU/1/08/472/011-016","Bayer AG","Rivaroxaban"
"10277","Xarelto","20 milligram(s) Film-coated tablet",2011-12-14,"EU/1/08/472/017-021","Bayer AG","Rivaroxaban"
"10278","Xarelto","2.5 milligram(s) Film-coated tablet",2013-05-22,"EU/1/08/472/025-033","Bayer AG","Rivaroxaban"
"10279","Xarelto","10 milligram(s) Film-coated tablet",2008-09-30,"EU/1/08/472/1-8","Bayer AG","Rivaroxaban"
"10280","Xatger 10mg prolonged release tablets","10 milligram(s) Prolonged-release tablet",2006-10-13,"PA0577/079/002","McDermott Laboratories Ltd t/a Gerard Laboratories","ALFUZOSINHYDROCHLORIDE"
"10281","XATRAL","10 Milligram                                                                                            Tablet Prolonged Release",2005-02-11,"PPA0465/138/002","PCO Manufacturing","ALFUZOSINHYDROCHLORIDE"
"10282","XATRAL","10 Milligram                                                                                            Tablet Prolonged Release",2009-03-06,"PPA1463/017/001","IMED Healthcare Ltd.","ALFUZOSINHYDROCHLORIDE"
"10283","XATRAL","10 Milligram                                                                                            Tablet Prolonged Release",2008-01-18,"PPA1151/042/001","Imbat Limited","ALFUZOSINHYDROCHLORIDE"
"10284","Xatral 10mg Prolonged Release Tablets","10 milligram(s) Prolonged-release tablet",2010-03-12,"PPA1562/020/001","LTT Pharma Limited","ALFUZOSINHYDROCHLORIDE"
"10285","Xatral 10mg Prolonged Release Tablets","10mg milligram(s) Tablet",2000-05-26,"PA0540/162/003","Sanofi-Aventis Ireland Limited T/A SANOFI","ALFUZOSINHYDROCHLORIDE"
"10286","Xatral 2.5mg Film-Coated Tablets","2.5 milligram(s) Film-coated tablet",1991-03-26,"PA0540/162/001","Sanofi-Aventis Ireland Limited T/A SANOFI","ALFUZOSINHYDROCHLORIDE"
"10287","Xatral 2.5mg Film-Coated Tablets","2.5 milligram(s) Film-coated tablet",2014-06-13,"PPA1562/020/002","LTT Pharma Limited","ALFUZOSINHYDROCHLORIDE"
"10288","Xelevia","100 milligram(s) Film-coated tablet",2007-03-23,"EU/1/07/382/13-18","Merck Sharp & Dohme BV","Sitagliptinphosphatemonohydrate"
"10289","Xelevia","25 milligram(s) Film-coated tablet",2007-03-23,"EU/1/07/382/1-6","Merck Sharp & Dohme BV","Sitagliptinphosphatemonohydrate"
"10290","Xelevia","50 milligram(s) Film-coated tablet",2007-03-23,"EU/1/07/382/7-12","Merck Sharp & Dohme BV","Sitagliptinphosphatemonohydrate"
"10291","Xeljanz","5 milligram(s) Film-coated tablet",2017-03-22,"EU/1/17/1178/001-003","Pfizer Limited","Tofacitiniibcitrate"
"10292","XELJANZ","10 milligram(s) Film-coated tablet",NA,"EU/1/17/1178/005-009","Pfizer Limited","Tofacitiniibcitrate"
"10293","XELODA","150 Milligram                                                                                            Film Coated Tablet",2001-02-07,"EU/1/00/163/001","Roche Registration GmbH","CAPECITABINE"
"10294","XELODA","500 Milligram                                                                                            Film Coated Tablet",2001-02-07,"EU/1/00/163/002","Roche Registration GmbH","CAPECITABINE"
"10295","XENETIX","300 Mg/Ml Solution for Injection",1996-10-10,"PA0686/002/002","GUERBET","IOBITRIDOL"
"10296","XENETIX","350 Mg/Ml Solution for Injection",1996-10-10,"PA0686/002/003","GUERBET","IOBITRIDOL"
"10297","XENETIX","300 Mg/Ml Solution for Injection",2010-09-10,"PA0686/002/004","GUERBET","IOBITRIDOL"
"10298","XENETIX","350 Mg/Ml Solution for Injection",2010-09-10,"PA0686/002/005","GUERBET","IOBITRIDOL"
"10299","Xenetix 250mg I/ml Solution for Injection","250 micromole(s) Solution for injection",1996-10-10,"PA0686/002/001","Guerbet","Iobitridol"
"10300","XENICAL","120 Milligram                                                                                            Capsule",1998-07-29,"EU/1/98/071/001","CHEPLAPHARM Arzneimittel GmbH","ORLISTAT"
"10301","XENICAL","120 Milligram                                                                                            Capsule",1998-07-29,"EU/1/98/071/002","CHEPLAPHARM Arzneimittel GmbH","ORLISTAT"
"10302","XENICAL","120 Milligram                                                                                            Capsule",1998-07-29,"EU/1/98/071/003","CHEPLAPHARM Arzneimittel GmbH","ORLISTAT"
"10303","XENICAL","120 Milligram                                                                                            Capsule",1998-07-29,"EU/1/98/071/004","CHEPLAPHARM Arzneimittel GmbH","ORLISTAT"
"10304","XENICAL","120 Milligram                                                                                            Capsule",1998-07-29,"EU/1/98/071/005","CHEPLAPHARM Arzneimittel GmbH","ORLISTAT"
"10305","XENICAL","120 Milligram                                                                                            Capsule",1998-07-29,"EU/1/98/071/006","CHEPLAPHARM Arzneimittel GmbH","ORLISTAT"
"10306","XEOMIN","200 N/A Pdr for Soln for Injection",2016-07-01,"PA1907/001/003","Merz Pharmaceuticals GmbH","CLOSTRIDIUMBOTULINUMNEURO-TOXINTYPEA(150KD),FREEFROMCOMPLEXINGPROTEINS"
"10307","XEOMIN 100 units powder for solution for injection","100 ZZZ LD50 Powder for solution for injection",2014-01-31,"PA1907/001/002","Merz Pharmaceuticals GmbH","Clostridiumbotulinumneuro-toxintypea(150kd),freefromcomplexingproteins"
"10308","XEOMIN 50 units powder for solution for injection","50 ZZZ LD50 Powder for solution for injection",2014-01-31,"PA1907/001/001","Merz Pharmaceuticals GmbH","Clostridiumbotulinumneuro-toxintypea(150kd),freefromcomplexingproteins"
"10309","XEPLION","25 Milligram                                                                                            Suspension for Injection",2011-03-04,"EU/1/11/672/001","Janssen-Cilag International NV","PALIPERIDONEPALMITATE(R092670)"
"10310","XEPLION","50 Milligram                                                                                            Suspension for Injection",2011-03-04,"EU/1/11/672/002","Janssen-Cilag International NV","PALIPERIDONEPALMITATE(R092670)"
"10311","XEPLION","75 Milligram                                                                                            Suspension for Injection",2011-03-04,"EU/1/11/672/003","Janssen-Cilag International NV","PALIPERIDONEPALMITATE(R092670)"
"10312","XEPLION","100 Milligram                                                                                            Suspension for Injection",2011-03-04,"EU/1/11/672/004","Janssen-Cilag International NV","PALIPERIDONEPALMITATE(R092670)"
"10313","XEPLION","150 Milligram                                                                                            Suspension for Injection",2011-03-04,"EU/1/11/672/005-006","Janssen-Cilag International NV","PALIPERIDONEPALMITATE(R092670)"
"10314","Xerava","50 milligram(s) Concentrate and solvent for solution for infusion",2018-09-20,"EU/1/18/1312/001","Tetraphase UK Limited","ERAVACYCLINE"
"10315","XERISTAR","60 Milligram                                                                                            Capsules Gastro-Resistant",0001-01-01,"EU/1/04/297/002-005","Eli Lilly Nederland B.V.","DULOXETINEHYDROCHLORIDE"
"10316","XERISTAR","30 Milligram                                                                                            Capsules Gastro-Resistant",2004-12-17,"EU/1/04/297/1-4","Eli Lilly Nederland B.V.","DULOXETINEHYDROCHLORIDE"
"10317","Xermelo","250 milligram(s) Film-coated tablet",2017-09-18,"EU/1/17/1224/001-002","Ipsen Pharma","Telotristatetiprate"
"10318","XGEVA","120 Milligram                                                                                            Solution for Injection",2011-07-13,"EU/1/11/703/001-002","Amgen Europe B.V.","DENOSUMAB"
"10319","Xiapex","0.9 milligram(s) Powder and solvent for solution for injection",2011-02-28,"EU/1/11/671/001","Swedish Orphan Biovitrum AB","Collagenaseclostridiumhistolyticum"
"10320","Xigduo","5mg/850 milligram(s) Film-coated tablet",NA,"EU/1/13/900/001-006","Bristol-Myers Squibb / AstraZeneca EEIG","Dapagliflozinpropanediolmonohydrate|METFORMINHYDROCHLORIDE"
"10321","Xigduo","5mg/1000 milligram(s) Film-coated tablet",2014-01-16,"EU/1/13/900/007-012","AstraZeneca AB","Dapagliflozinpropanediolmonohydrate|METFORMINHYDROCHLORIDE"
"10322","Xiliarx","50 milligram(s) Tablet",NA,"EU/1/08/486/1-11","Novartis Europharm Limited","Vildagliptin"
"10323","Xofigo","1000 ZZZ K.bequerel Solution for injection",NA,"EU/1/13/873/001","Bayer AG","Radium-223chloride"
"10324","Xolair","75 milligram(s) Powder and solvent for solution for injection",2005-10-25,"EU/1/05/319/001","Novartis Europharm Limited","Omalizumab"
"10325","Xolair","150 milligram(s) Solution for injection",NA,"EU/1/05/319/002","Novartis Europharm Limited","Omalizumab"
"10326","Xolair","75 milligram(s) Solution for injection",NA,"EU/1/05/319/5-7","Novartis Europharm Limited","Omalizumab"
"10327","Xolair","150 milligram(s) Solution for injection",NA,"EU/1/05/319/8-10","Novartis Europharm Limited","Omalizumab"
"10328","XOMOLIX","2.5 Mg/Ml Solution for Injection",2008-02-29,"PA1049/009/001","Kyowa Kirin Ltd","DROPERIDOL"
"10329","XOMOLIX","0.5 Mg/Ml Solution for Injection",2011-09-16,"PA1049/010/001","Kyowa Kirin Ltd","DROPERIDOL"
"10330","XOTERNA BREEZHALER","85/43 Microgram                                                                                            Inhalation Powder, Capsule",2013-09-19,"EU/1/13/863/001-006","Novartis Europharm Limited","INDACATEROLMALEATE|GLYCOPYRRONIUMBROMIDE"
"10331","XTANDI","40 Milligram                                                                                            Capsules, Soft",2013-06-21,"EU/1/13/846/001","Astellas Pharma Europe BV","ENZALUTAMIDE(MDV3100)"
"10332","XTANDI","80 Milligram                                                                                            Film Coated Tablet",2017-09-21,"EU/1/13/846/003","Astellas Pharma Europe B.V.","ENZALUTAMIDE"
"10333","XTANDI","40 Milligram                                                                                            Film Coated Tablet",2017-09-21,"EU/1/13/843/002","Astellas Pharma Europe B.V.","ENZALUTAMIDE"
"10334","XTEX","250mg/5 Millilitre                                                                                           Oral Solution",2017-07-14,"PA0074/071/001","Rowa Pharmaceuticals Limited","CARBOCISTEINE"
"10335","XULTOPHY","100/36 Units/ml                                                                                             Solution for Injection",2014-09-18,"EU/1/14/947/001-004","Novo Nordisk A/S","INSULINDEGLUDEC|LIRAGLUTIDE"
"10336","XYDALBA","500 Unknown Pdr/Conc/Soln for Infus",2015-02-19,"EU/1/14/986/001","Durata Therapeutics International B.V.","DALBAVANCINHCL"
"10337","XYLOCAINE","10 Mg/Dose                                                                                              Oromucosal Spray",1980-04-01,"PA1691/028/001","Aspen Pharma Trading Limited","LIDOCAINE"
"10338","Xylocaine 2% with Adrenaline (Epinephrine) (1:200,000) Solution for Injection","2 (1:200,000 percent volume/volume Solution for injection",1980-04-01,"PA1691/027/001","Aspen Pharma Trading Limited","Adrenalinetartrate|LIDOCAINEHYDROCHLORIDE"
"10339","Xylocaine 2% with Adrenaline (Epinephrine) (1:200,000) Solution for Injection","2 (1:200,000 percent volume/volume Solution for injection",NA,"PA0970/053/003","AstraZeneca UK Limited","LIDOCAINEHYDROCHLORIDE|Adrenalinetartrate"
"10340","XYLOCAINE WITH ADRENALINE (EPINEPHRINE)","2 %w/v                                                                                                 Dental Solution for Injection",1980-04-01,"PA1045/003/001","Dentsply Limited","LIDOCAINEHYDROCHLORIDE|EPINEPHRINEBITARTRATE"
"10341","XYLONASE","0.1 %w/v                                                                                                 Nasal Spray Solution",2012-08-17,"PA0749/150/001","Teva Pharma B.V.","XYLOMETAZOLINEHYDROCHLORIDE"
"10342","XYLONOR","10/0.1 Mg/Dose                                                                                              Oromucosal Spray, Soln",1999-09-17,"PA0196/014/001","Septodont","LIDOCAINE|CETRIMONIUMBROMIDE"
"10343","XYLONOR","50 Mg/Dose                                                                                              Gel",1999-10-01,"PA0196/014/002","Septodont","LIDOCAINE|CETRIMONIUMBROMIDE"
"10344","Xymel 50 mg Capsules","50 milligram(s) Capsule, hard",1999-02-05,"PA0126/099/001","Clonmel Healthcare Ltd","Tramadolhydrochloride"
"10345","XYMEL COMP","37.5/325 Milligram                                                                                            Film Coated Tablet",2013-04-18,"PA0126/244/001","Clonmel Healthcare Ltd","PARACETAMOL|TRAMADOLHYDROCHLORIDE"
"10346","Xyrem 500 mg/ml oral solution","500 milligram(s)/millilitre Oral solution",2005-10-13,"EU/1/05/312/001","UCB Pharma Limited","Sodiumoxybate"
"10347","XYZAL","5 Milligram                                                                                            Film Coated Tablet",2001-10-05,"PA0891/003/001","UCB (Pharma) Ireland Limited","LEVOCETIRIZINEDIHYDROCHLORIDE"
"10348","XYZAL","5 Mg/Ml Oral Drops Solution",2005-12-02,"PA0891/003/002","UCB (Pharma) Ireland Limited","LEVOCETIRIZINEDIHYDROCHLORIDE"
"10349","XYZAL","0.5 Mg/Ml Infus/Pdr/Oral Soln",2006-10-27,"PA0891/003/003","UCB (Pharma) Ireland Limited","LEVOCETIRIZINEDIHYDROCHLORIDE"
"10350","XYZAL","5 Milligram                                                                                            Film Coated Tablet",2005-11-04,"PPA0465/169/001","PCO Manufacturing","LEVOCETIRIZINEDIHYDROCHLORIDE"
"10351","Xyzal 0.5 mg/ml oral solution","0.5 milligram(s)/millilitre ZZZ Infus/Pdr/Oral Soln",2017-10-20,"PPA0465/169/002","PCO Manufacturing","Levocetirizinedihydrochloride"
"10352","Xyzal 0.5 mg/ml Oral Solution","0.5 milligram(s)/millilitre Oral solution",2017-04-28,"PPA1562/187/001","LTT Pharma Limited","Levocetirizinedihydrochloride"
"10353","Xyzal 5 mg film-coated tablets","5 milligram(s) Film-coated tablet",2007-12-19,"PPA1151/052/001","Imbat Limited","Levocetirizinedihydrochloride"
"10354","YALTORMIN SR","500 Milligram                                                                                            Tablet Prolonged Release",2016-04-08,"PA1339/063/001","Wockhardt UK Limited","METFORMINHYDROCHLORIDE"
"10355","YALTORMIN SR","750 Milligram                                                                                            Tablet Prolonged Release",2016-04-08,"PA1339/063/002","Wockhardt UK Limited","METFORMINHYDROCHLORIDE"
"10356","YALTORMIN SR","1000 Milligram                                                                                            Tablet Prolonged Release",2016-04-08,"PA1339/063/003","Wockhardt UK Limited","METFORMINHYDROCHLORIDE"
"10357","Yanimo Respimat 2.5 microgram/2.5 microgram, inhalation solution","2.5/2.5 microgram(s) ZZZ Solution for Inhalation",2015-06-19,"PA0775/010/001","Boehringer Ingelheim International GmbH","Tiotropiumbromidemonohydrate|Olodaterolhydrochloride"
"10358","YARGESA","100 Milligram                                                                                            Capsules Hard",2017-03-22,"EU/1/17/1176/001","Jenson Pharmaceutical Services Ltd","MIGLUSTAT"
"10359","YASMIN","0.03/3 Milligram                                                                                            Film Coated Tablet",2000-10-27,"PA1410/023/001","Bayer Limited","DROSPIRENONE|ETHINYLESTRADIOL"
"10360","YASMIN","0.03/3 Milligram                                                                                            Film Coated Tablet",2015-02-06,"PPA1151/246/001","Imbat Limited","DROSPIRENONE|ETHINYLESTRADIOL"
"10361","Yasminelle 0.02 mg/3 mg film-coated tablets","0.02 / 3 milligram(s) Film-coated tablet",2006-07-24,"PA1410/024/001","Bayer Limited","Drospirenone|Ethinylestradiol(asbetadex-clathrate)"
"10362","Yaz 0.02mg/3mg film-coated tablets","0.020+3.00 milligram(s) Film-coated tablet",2008-10-17,"PA1410/056/001","Bayer Limited","Ethinylestradiol(asbetadex-clathrate)|Drospirenone"
"10363","YELLOX","0.1 Per Cent                                                                                             Eye Drops Solution",2011-05-18,"EU/1/11/692/001","PharmaSwiss Ceska republika s.r.o.","BROMFENACSODIUMSESQUIHYDRATE"
"10364","Yentreve","20 milligram(s) Gastro-resistant capsule",2004-08-11,"EU/1/04/280/001","Eli Lilly Nederland B.V.","Duloxetinehydrochloride"
"10365","YENTREVE","40 Milligram                                                                                            Capsules Gastro-Resistant",2004-08-11,"EU/1/04/280/1-6","Eli Lilly Nederland B.V.","DULOXETINEHYDROCHLORIDE"
"10366","Yervoy","5 milligram(s)/millilitre Concentrate for solution for infusion",NA,"EU/1/11/698/001-002","Bristol-Myers Squibb Pharma EEIG","Ipilimumab"
"10367","YESCARTA","0.4 - 2x108 cells Dispersion for infusion",2018-08-23,"EU/1/18/1299/001","Kite Pharma EU B.V.","AXICABTAGENECILOLEUCEL"
"10368","YONDELIS","0.25 Milligram                                                                                            Pdr/Conc/Soln for Infus",2007-09-17,"EU/1/07/417/1","Pharma Mar S.A.","TRABECTEDIN"
"10369","YONDELIS","1 Milligram                                                                                            Pdr/Conc/Soln for Infus",2007-09-17,"EU/1/07/417/2","Pharma Mar S.A.","TRABECTEDIN"
"10370","YTRACIS","1.850 GBq/ml                                                                                               Infus/Pdr/Oral Soln",2003-03-24,"EU/1/03/250/001","CIS bio International","YTTRIUM(90Y)"
"10371","YTTRIGA","0.1-300 GBq/ml                                                                                               Radio-Pharm Precursor",2006-01-19,"EU/1/05/322/001","Eckert & Ziegler Radiopharm GmbH","YTTRIUM(90Y)"
"10372","ZACIN","0.025 %w/w                                                                                                 Cream",1999-04-16,"PA0827/008/001","Cephalon UK Limited","CAPSAICIN"
"10373","ZADITEN","0.25 Mg/Ml Eye Drops Solution",2000-11-24,"PA1107/010/001","Laboratoires Thea","KETOTIFENFUMARATE"
"10374","ZADITEN 1 MG TABLETS","1 Milligram                                                                                            Tablets",1979-12-19,"PA2206/004/002","Alfasigma S.p.A","KETOTIFENFUMARATE"
"10375","ZADITEN ELIXIR","1 MG/5ml                                                                                               Oral Solution",1979-11-30,"PA2206/004/001","Alfasigma S.p.A","KETOTIFENFUMARATE"
"10376","ZALASTA","5 Milligram                                                                                            Tablets",2007-10-27,"EU/1/07/415/006","Krka d.d., Novo mesto","OLANZAPINE"
"10377","ZALASTA","7.5 Milligram                                                                                            Tablets",2007-10-27,"EU/1/07/415/11-15","Krka d.d., Novo mesto","OLANZAPINE"
"10378","ZALASTA","2.5 Milligram                                                                                            Tablets",2007-10-27,"EU/1/07/415/1-5","Krka d.d., Novo mesto","OLANZAPINE"
"10379","ZALASTA","10 Milligram                                                                                            Tablets",2007-10-27,"EU/1/07/415/16-21","Krka d.d., Novo mesto","OLANZAPINE"
"10380","ZALASTA","15 Milligram                                                                                            Tablets",2007-10-27,"EU/1/07/415/22-26","Krka d.d., Novo mesto","OLANZAPINE"
"10381","ZALASTA","20 Milligram                                                                                            Tablets",2007-10-27,"EU/1/07/415/27-31","Krka d.d., Novo mesto","OLANZAPINE"
"10382","ZALASTA","5 Milligram                                                                                            Orodispersible Tablet",2007-10-27,"EU/1/07/415/32-36","Krka d.d., Novo mesto","OLANZAPINE"
"10383","ZALASTA","7.5 Milligram                                                                                            Orodispersible Tablet",2007-10-27,"EU/1/07/415/37-41","Krka d.d., Novo mesto","OLANZAPINE"
"10384","ZALASTA","10 Milligram                                                                                            Orodispersible Tablet",2007-10-27,"EU/1/07/415/42-46","Krka d.d., Novo mesto","OLANZAPINE"
"10385","ZALASTA","15 Milligram                                                                                            Orodispersible Tablet",2007-10-27,"EU/1/07/415/47-51","Krka d.d., Novo mesto","OLANZAPINE"
"10386","ZALASTA","20 Milligram                                                                                            Orodispersible Tablet",2007-10-27,"EU/1/07/415/52-56","Krka d.d., Novo mesto","OLANZAPINE"
"10387","Zalmoxis","ZZZ 20 Milligram Suspension for Infusion",2016-08-18,"EU/1/16/1121/001","MolMed","Allogeneictcellsmm-tkds"
"10388","ZALTRAP","25 Mg/Ml Concentrate for Soln for Inf",NA,"EU/1/12/814/001-003","Sanofi-Aventis Groupe","AFLIBERCEPT"
"10389","ZALVISO","15 Microgram                                                                                            Tablet Sublingual",2015-09-18,"EU/1/15/1042/001-006","Grunenthal GmbH","SUFENTANILCITRATE"
"10390","Zamadol SR 100 mg Prolonged-Release Capsules","100mg milligram(s) Capsule",1998-12-10,"PA1058/008/002","MEDA Pharmaceuticals Ltd","Tramadolhydrochloride"
"10391","Zamadol SR 150 mg Prolonged-Release Capsules","150mg milligram(s) Capsule",1998-12-10,"PA1058/008/003","MEDA Pharmaceuticals Ltd","Tramadolhydrochloride"
"10392","Zamadol SR 200mg Prolonged-Release Capsules","200mg milligram(s) Capsule",1998-12-10,"PA1058/008/004","MEDA Pharmaceuticals Ltd","Tramadolhydrochloride"
"10393","Zamadol SR 50mg Prolonged-Release Capsules","50mg milligram(s) Capsule",1998-12-10,"PA1058/008/001","MEDA Pharmaceuticals Ltd","Tramadolhydrochloride"
"10394","ZANAFLEX","2 Milligram                                                                                            Tablets",2008-01-25,"PA0749/054/001","Teva Pharma B.V.","TIZANIDINE"
"10395","ZANAFLEX","4 Milligram                                                                                            Tablets",2008-01-25,"PA0749/054/002","Teva Pharma B.V.","TIZANIDINE"
"10396","ZANAFLEX","2 Base Milligrams                                                                                      Tablets",2006-02-10,"PPA0465/168/001","PCO Manufacturing","TIZANIDINEHYDROCHLORIDE"
"10397","ZANAFLEX","4 Base Milligrams                                                                                      Tablets",2006-02-10,"PPA0465/168/002","PCO Manufacturing","TIZANIDINEHYDROCHLORIDE"
"10398","ZANIDIP","10 Milligram                                                                                            Film Coated Tablet",2001-05-17,"PA0812/001/001","Recordati Industria Chimica e Farmaceutica SpA","LERCANIDIPINE"
"10399","ZANIDIP","20 Milligram                                                                                            Film Coated Tablet",2005-08-12,"PA0812/001/002","Recordati Industria Chimica e Farmaceutica SpA","LERCANIDIPINEHYDROCHLORIDE"
"10400","ZANIDIP","10 Milligram                                                                                            Film Coated Tablet",2008-02-29,"PPA1151/057/001","Imbat Limited","LERCANIDIPINE"
"10401","ZANIDIP","20 Milligram                                                                                            Film Coated Tablet",2009-06-25,"PPA1151/057/002","Imbat Limited","LERCANIDIPINEHYDROCHLORIDE"
"10402","ZANTAC","150 Milligram                                                                                            Film Coated Tablet",2006-09-15,"PPA1151/009/001","Imbat Limited","RANITIDINEHYDROCHLORIDE"
"10403","ZANTAC","75 Milligram                                                                                            Film Coated Tablet",2008-03-28,"PPA1151/009/002","Imbat Limited","RANITIDINEHYDROCHLORIDE"
"10404","ZANTAC","300 Milligram                                                                                            Film Coated Tablet",2014-05-02,"PPA1151/009/003","Imbat Limited","RANITIDINE"
"10405","ZANTAC","150 Milligram                                                                                            Film Coated Tablet",2008-07-04,"PPA1463/003/001","IMED Healthcare Ltd.","RANITIDINEHYDROCHLORIDE"
"10406","ZANTAC","150 Milligram                                                                                            Tablets Effervescent",1990-06-27,"PA1077/013/005","GlaxoSmithKline (Ireland) Limited","RANITIDINEHYDROCHLORIDE"
"10407","ZANTAC","150 mg/10ml Syrup",1989-04-26,"PA1077/013/002","GlaxoSmithKline (Ireland) Limited","RANITIDINEHYDROCHLORIDE"
"10408","ZANTAC","75 Milligram                                                                                            Film Coated Tablet",1998-11-13,"PA1186/013/001","Chefaro Ireland DAC","RANITIDINEHYDROCHLORIDE"
"10409","Zantac 150 milligram(s) Film-coated tablet","150 milligram(s) Film-coated tablet",NA,"PA1077/013/003","GlaxoSmithKline (Ireland) Limited","RANITIDINEHYDROCHLORIDE"
"10410","Zantac 300 milligram(s) Film-coated tablet","300 milligram(s) Film-coated tablet",NA,"PA1077/013/004","GlaxoSmithKline (Ireland) Limited","RANITIDINEHYDROCHLORIDE"
"10411","ZANTAC 75 DISSOLVE","75 Milligram                                                                                            Tablets Effervescent",2000-12-20,"PA1186/013/002","Chefaro Ireland DAC","RANITIDINEHYDROCHLORIDE"
"10412","Zantac Solution for Injection or Infusion 25 mg/ml","25 milligram(s)/millilitre Solution for injection/infusion",1983-11-23,"PA1077/013/001","GlaxoSmithKline (Ireland) Limited","Ranitidine"
"10413","Zarontin 250mg/5ml Syrup","250mg/ml micromole(s) Syrup",1979-04-01,"PA1994/005/001","Essential Pharma Ltd","Ethosuximide"
"10414","Zarzio 30 MU (60 MU/ml) Solution for injection or","30 ZZZ MU/ml Solution for injection",NA,"EU/1/08/495/1-4,9-12","Sandoz GmbH","Ep2006(recombinanthumangranulocyte-colonystimulatingfactor)"
"10415","ZARZIO 48 MU (96 MU/ML) SOLUTION FOR INJECTION OR","48 MU/ml                                                                                                Solution for Injection",2009-02-06,"EU/1/08/495/5-8,13-16","Sandoz GmbH","EP2006(RECOMBINANTHUMANGRANULOCYTE-COLONYSTIMULATINGFACTOR)"
"10416","Zavedos 10 mg Hard Capsules","10 milligram(s) Capsule, hard",1995-02-16,"PA0822/142/002","Pfizer Healthcare Ireland","IDARUBICINHYDROCHLORIDE"
"10417","Zavedos 10 mg Powder for Solution for Injection","10 milligram(s) Powder for solution for injection",1990-10-18,"PA0822/142/004","Pfizer Healthcare Ireland","IDARUBICINHYDROCHLORIDE"
"10418","Zavedos 5 mg Hard Capsules","5 milligram(s) Capsule, hard",1995-02-16,"PA0822/142/001","Pfizer Healthcare Ireland","IDARUBICINHYDROCHLORIDE"
"10419","Zavedos 5 mg Powder for Solution for Injection","5 milligram(s) Powder for solution for injection",1990-10-18,"PA0822/142/003","Pfizer Healthcare Ireland","IDARUBICINHYDROCHLORIDE"
"10420","Zavesca","milligram(s) Capsule",NA,"EU/1/02/238/001","Janssen-Cilag International NV","Miglustat"
"10421","Zavicefta","2000/500 milligram(s) Powder for solution for infusion",2016-06-24,"EU/1/16/1109/001","Pfizer Ireland Pharmaceuticals","Avibactamsodium|CEFTAZIDIMEPENTAHYDRATE"
"10422","ZEBINIX","200 Milligram                                                                                            Tablets",2012-08-23,"EU/1/09/514/021-023","BIAL - Portela & Cª, S.A.","ESLICARBAZEPINEACETATE"
"10423","ZEBINIX","50 Mg/Ml Oral Suspension",2016-12-08,"EU/1/09/514/024","BIAL - Portela & Cª, S.A.","ESLICARBAZEPINEACETATE"
"10424","ZEBINIX","800 Milligram                                                                                            Tablets",2009-04-21,"EU/1/09/514/12-20","BIAL - Portela & Cª, S.A.","ESLICARBAZEPINEACETATE"
"10425","ZEBINIX","400 Milligram                                                                                            Tablets",2009-04-21,"EU/1/09/514/1-6","BIAL - Portela & Cª, S.A.","ESLICARBAZEPINEACETATE"
"10426","ZEBINIX","600 Milligram                                                                                            Tablets",2009-04-21,"EU/1/09/514/7-11","BIAL - Portela & Cª, S.A.","ESLICARBAZEPINEACETATE"
"10427","ZEDBAC","500 Milligram                                                                                            Pdr/Conc/Soln for Infus",2012-10-12,"PA1619/004/001","Aspire Pharma Limited","AZITHROMYCINDIHYDRATE"
"10428","ZEFFIX","100 Milligram                                                                                            Tablets",1999-07-29,"EU/1/99/114/001","Glaxo Group Limited","LAMIVUDINE"
"10429","ZEFFIX","100 Milligram                                                                                            Tablets",1999-07-29,"EU/1/99/114/002","Glaxo Group Limited","LAMIVUDINE"
"10430","ZEFFIX","5 Micromol Oral Solution",1999-07-29,"EU/1/99/114/003","Glaxo Group Limited","LAMIVUDINE"
"10431","Zejula","100 milligram(s) Capsule, hard",2017-11-16,"EU/1/17/1235/001","Tesaro UK Limited","Niraparidtosylatemonohydrate"
"10432","ZELBORAF","240 Milligram                                                                                            Film Coated Tablet",2012-02-17,"EU/1/12/751/001","Roche Registration GmbH","30%OFR05185426(VEMURAFENIB)"
"10433","ZEMPLAR","1 Microgram                                                                                            Capsules, Soft",2008-01-25,"PA1824/005/001","AbbVie Limited","PARICALCITOL"
"10434","ZEMPLAR","2 Microgram                                                                                            Capsules, Soft",2008-01-25,"PA1824/005/002","AbbVie Limited","PARICALCITOL"
"10435","ZEMPLAR","5 Microgram/ML                                                                                         Solution for Injection",2005-04-08,"PA1824/005/004","AbbVie Limited","PARICALCITOL"
"10436","ZEMPLAR","5 Microgram/ML                                                                                         Solution for Injection",2014-08-01,"PA1824/005/005","AbbVie Limited","PARICALCITOL"
"10437","Zepatier","50/100 ZZZ mg/mg Film-coated tablet",2016-07-22,"EU/1/16/1119/001","Merck Sharp & Dohme Ltd","Grazoprevir|Elbasvir"
"10438","Zerbaxa","1/0.5 gram(s) Powder for solution for infusion",2015-09-18,"EU/1/15/1032/001","Merck Sharp and Dohme Limited","Ceftolozanesulfate|Tazobactamsodium"
"10439","ZERIT","Milligram                                                                                            Tablet Prolonged Release",2002-11-12,"EU/1/96/09/10-17","Bristol Myers Squibb Pharma EEIG","STAVUDINE"
"10440","ZERIT","15 Milligram                                                                                            Capsule",1996-05-08,"EU/1/96/009/001","Bristol Myers Squibb Pharma EEIG","STAVUDINE"
"10441","ZERIT","15 Milligram                                                                                            Capsule",1996-05-08,"EU/1/96/009/002","Bristol Myers Squibb Pharma EEIG","STAVUDINE"
"10442","ZERIT","20 Milligram                                                                                            Capsule",1996-05-08,"EU/1/96/009/003","Bristol Myers Squibb Pharma EEIG","STAVUDINE"
"10443","ZERIT","20 Milligram                                                                                            Capsule",1996-05-08,"EU/1/96/009/004","Bristol Myers Squibb Pharma EEIG","STAVUDINE"
"10444","ZERIT","30 Milligram                                                                                            Capsule",1996-05-08,"EU/1/96/009/005","Bristol Myers Squibb Pharma EEIG","STAVUDINE"
"10445","ZERIT","30 Milligram                                                                                            Capsule",1996-05-08,"EU/1/96/009/006","Bristol Myers Squibb Pharma EEIG","STAVUDINE"
"10446","ZERIT","40 Milligram                                                                                            Capsule",1996-05-08,"EU/1/96/009/007","Bristol Myers Squibb Pharma EEIG","STAVUDINE"
"10447","ZERIT","40 Milligram                                                                                            Capsule",1996-05-08,"EU/1/96/009/008","Bristol Myers Squibb Pharma EEIG","STAVUDINE"
"10448","ZERIT","1 Mg/Ml Powder for Oral Solution",1996-05-08,"EU/1/96/009/009","Bristol Myers Squibb Pharma EEIG","STAVUDINE"
"10449","ZERLINDA","4mg /100 Millilitre                                                                                           Solution for Infusion",2013-11-04,"PA1380/142/001","Actavis Group PTC ehf","ZOLEDRONICACID"
"10450","ZERSEOS","0.5mg/2.5 Milligram                                                                                            Nebuliser Solution",2017-03-10,"PA1809/022/001","Cipla (EU) Limited","IPRATROPIUMBROMIDEMONOHYDRATE|SALBUTAMOLSULFATE"
"10451","ZESGER","5mg Milligram                                                                                            Tablets",2001-02-08,"PA0577/041/001","McDermott Laboratories Ltd t/a Gerard Laboratories","LISINOPRIL"
"10452","ZESGER","10mg Milligram                                                                                            Tablets",2001-02-08,"PA0577/041/002","McDermott Laboratories Ltd t/a Gerard Laboratories","LISINOPRIL"
"10453","ZESGER","20mg Milligram                                                                                            Tablets",2001-02-08,"PA0577/041/003","McDermott Laboratories Ltd t/a Gerard Laboratories","LISINOPRIL"
"10454","ZESGER PLUS","20/12.5 Milligram                                                                                            Tablets",2005-02-11,"PA0577/055/002","McDermott Laboratories Ltd t/a Gerard Laboratories","LISINOPRIL|HYDROCHLOROTHIAZIDE"
"10455","ZESSLY","100 Milligram                                                                                            Pdr/Conc/Soln for Infus",2018-05-18,"EU/1/18/1280/001-005","Sandoz GmbH","INFLIXIMAB"
"10456","ZESTAN","2.5 Milligram                                                                                            Tablets",2001-07-13,"PA0126/112/001","Clonmel Healthcare Ltd","LISINOPRILDIHYDRATE"
"10457","ZESTAN","5 Milligram                                                                                            Tablets",2001-07-13,"PA0126/112/002","Clonmel Healthcare Ltd","LISINOPRILDIHYDRATE"
"10458","ZESTAN","10 Milligram                                                                                            Tablets",2001-07-13,"PA0126/112/003","Clonmel Healthcare Ltd","LISINOPRILDIHYDRATE"
"10459","ZESTAN","20 Milligram                                                                                            Tablets",2001-07-13,"PA0126/112/004","Clonmel Healthcare Ltd","LISINOPRILDIHYDRATE"
"10460","Zestoretic 10 mg /12.5 mg Tablets","10/12.5 milligram(s) Tablet",1995-03-13,"PA0970/024/001","AstraZeneca UK Limited","Lisinoprildihydrate|Hydrochlorothiazide"
"10461","Zestoretic 20 mg/12.5 mg Tablets","20.0/12.5 milligram(s) Tablet",1992-10-12,"PA0970/024/002","AstraZeneca UK Limited","Lisinopril|Hydrochlorothiazide"
"10462","ZESTRIL","5 Milligram                                                                                            Tablets",1989-05-10,"PA0970/023/002","AstraZeneca UK Limited","LISINOPRIL"
"10463","ZESTRIL","10 Milligram                                                                                            Tablets",1989-05-10,"PA0970/023/003","AstraZeneca UK Limited","LISINOPRIL"
"10464","ZESTRIL","20 Milligram                                                                                            Tablets",1989-05-10,"PA0970/023/004","AstraZeneca UK Limited","LISINOPRIL"
"10465","ZESTRIL","10 Milligram                                                                                            Tablets",2001-07-13,"PPA0465/066/003","PCO Manufacturing","LISINOPRIL"
"10466","ZESTRIL","20 Milligram                                                                                            Tablets",2001-07-13,"PPA0465/066/004","PCO Manufacturing","LISINOPRILDIHYDRATE"
"10467","ZESTRIL","5 Milligram                                                                                            Tablets",2013-10-11,"PPA0465/066/005","PCO Manufacturing","LISINOPRILDIHYDRATE"
"10468","ZEVALIN","1.6 Mg/Ml Solution for Infusion",2004-01-16,"EU/1/03/264/001","Spectrum Pharmaceuticals B.V.","IBRITUMOMABUMTIUXETAN"
"10469","ZIAGEN","300mg Milligram                                                                                            Tablets",1999-07-08,"EU/1/99/112/001","ViiV Healthcare UK Ltd","ABACAVIRSULFATE"
"10470","ZIAGEN","20 Mg/Ml Infus/Pdr/Oral Soln",1999-07-08,"EU/1/99/112/002","ViiV Healthcare UK Ltd","ABACAVIRSULFATE"
"10471","ZIBOR","2,500 IU International Unit                                                                                   Solution for injection in pre-filled pen",2002-05-03,"PA1769/001/001","Frosst Ibérica","BEMIPARINSODIUM"
"10472","ZIBOR","3,500 IU International Unit                                                                                   Solution for injection in pre-filled syringe",2002-05-03,"PA1769/001/002","Frosst Ibérica","BEMIPARINSODIUM"
"10473","ZIBOR","25,000 International Unit                                                                                   Solution for Injection",2007-01-26,"PA1769/001/003","Frosst Ibérica","BEMIPARINSODIUM"
"10474","Zileze 3.75 mg Film-Coated Tablets","3.75 milligram(s) Film-coated tablet",1999-06-25,"PA0743/007/001","Chiesi Limited","Zopiclone"
"10475","Zileze 7.5 mg Film-Coated Tablets","7.5 milligram(s) Film-coated tablet",1999-06-25,"PA0743/007/003","Chiesi Limited","Zopiclone"
"10476","ZIMOCLONE","7.5 Milligram                                                                                            Film Coated Tablet",2000-04-28,"PA0405/044/001","Generics (UK) Limited","ZOPICLONE"
"10477","ZIMOVANE","7.5 Milligram                                                                                            Film Coated Tablet",1987-10-06,"PA1332/007/001","Meda Health Sales Ireland Limited","ZOPICLONE"
"10478","ZIMOVANE","7.5 Milligram                                                                                            Film Coated Tablet",2009-01-23,"PPA1463/011/001","IMED Healthcare Ltd.","ZOPICLONE"
"10479","ZIMOVANE","7.5 Milligram                                                                                            Film Coated Tablet",2006-11-27,"PPA1151/008/001","Imbat Limited","ZOPICLONE"
"10480","ZINACEF","250 Milligram                                                                                            Pdr for Soln for Injection",1978-08-21,"PA1077/014/001","GlaxoSmithKline (Ireland) Limited","CEFUROXIMESODIUM"
"10481","ZINACEF","750 Milligram                                                                                            Pdr for Soln for Injection",1978-08-21,"PA1077/014/002","GlaxoSmithKline (Ireland) Limited","CEFUROXIMESODIUM"
"10482","ZINACEF","1.5 Grams                                                                                                Pdr for Soln Inj/Inf",1978-08-21,"PA1077/014/003","GlaxoSmithKline (Ireland) Limited","CEFUROXIMESODIUM"
"10483","ZINC","15 %w/w                                                                                                 Ointment",1994-11-10,"PA0206/028/001","Ovelle Limited","ZINCOXIDE"
"10484","ZINC & CASTOR OIL OINTMENT","7.5/50 %w/w                                                                                                 Ointment",1992-10-13,"PA0206/027/001","Ovelle Limited","ZINCOXIDE|CASTOROIL"
"10485","ZINDACLIN 1% GEL","1%w/w %w/w                                                                                                 Gel",2002-11-22,"PA1098/001/001","Crawford Healthcare Limited","CLINDAMYCIN"
"10486","ZINERYT","40/12 Mg/Ml Pdr+Solv for Cut Soln",2007-10-19,"PPA0465/206/001","PCO Manufacturing","ERYTHROMYCIN|ZINCACETATE"
"10487","ZINERYT","Unknown Pdr+Solv for Cut Soln",1992-12-17,"PA0046/065/001","Leo Laboratories Limited","ERYTHROMYCIN|ZINCACETATE"
"10488","ZINERYT","40/12 Mg/Ml Pdr+Solv for Cut Soln",2011-05-06,"PPA1151/148/001","Imbat Limited","ERYTHROMYCIN|ZINCACETATE"
"10489","ZINERYT","40 / 12 Mg/Ml Pdr+Solv for Cut Soln",2012-11-05,"PPA1463/067/001","IMED Healthcare Ltd.","ERYTHROMYCIN|ZINCACETATEDIHYDRATE"
"10490","ZINERYT","40/12 Mg/Ml Pdr+Solv for Cut Soln",2016-09-02,"PPA1562/172/001","LTT Pharma Limited","ERYTHROMYCIN|ZINCACETATE"
"10491","ZINFORO","600 Milligram                                                                                            Pdr/Conc/Soln for Infus",2012-08-23,"EU/1/12/785/001","Pfizer Ireland Pharmaceuticals","CEFTAROLINEFOSAMIL"
"10492","ZINNAT","250 MG/5ml                                                                                               Granules for Oral Suspension",1998-12-21,"PA1077/015/001","GlaxoSmithKline (Ireland) Limited","CEFUROXIMEAXETIL"
"10493","ZINNAT","125 Milligram                                                                                            Coated Tablets",1989-08-04,"PA1077/015/002","GlaxoSmithKline (Ireland) Limited","CEFUROXIMEAXETIL"
"10494","ZINNAT","250mg Milligram                                                                                            Coated Tablets",1989-08-04,"PA1077/015/003","GlaxoSmithKline (Ireland) Limited","CEFUROXIMEAXETIL"
"10495","ZINNAT","500mg Milligram                                                                                            Coated Tablets",1989-08-04,"PA1077/015/004","GlaxoSmithKline (Ireland) Limited","CEFUROXIMEAXETIL"
"10496","ZINNAT","125 Milligram                                                                                            Granules for Oral Suspension",1991-01-16,"PA1077/015/005","GlaxoSmithKline (Ireland) Limited","CEFUROXIMEAXETIL"
"10497","ZINNAT","500 Milligram                                                                                            Film Coated Tablet",2015-09-03,"PPA1562/163/001","LTT Pharma Limited","CEFUROXIMEAXETIL"
"10498","ZINPLAVA (Formely known Bezlotoxumab MSD))","25 milligram(s)/millilitre Concentrate for solution for infusion",2017-01-18,"EU/1/16/1156/001","Merck Sharp & Dohme BV","Bezlotoxumab"
"10499","ZIPZOC","%v/v                                                                                                 Impregnated Dressing",1998-07-13,"PA2262/001/001","Evolan Pharma AB","ZINCOXIDE"
"10500","ZIRPINE","10 Milligram                                                                                            Film Coated Tablet",2002-03-08,"PA0281/110/001","Pinewood Laboratories Ltd,","CETIRIZINEHYDROCHLORIDE"
"10501","ZIRTEK","10 Milligram                                                                                            Film Coated Tablet",1988-08-08,"PA0891/008/002","UCB (Pharma) Ireland Limited","CETIRIZINEHYDROCHLORIDE"
"10502","ZIRTEK","1 Mg/Ml Oral Solution",1993-03-26,"PA0891/008/003","UCB (Pharma) Ireland Limited","CETIRIZINEHYDROCHLORIDE"
"10503","ZIRTEK","10 Mg/Ml Oral Drops Solution",2009-08-28,"PA0891/008/004","UCB (Pharma) Ireland Limited","CETIRIZINEDIHYDROCHLORIDE"
"10504","ZIRTEK ALLERGY RELIEF","10 Milligram                                                                                            Film Coated Tablet",2015-03-27,"PA0891/008/005","UCB (Pharma) Ireland Limited","CETIRIZINEDIHYDROCHLORIDE"
"10505","Zirtek Plus Decongestant 5mg/120mg Prolonged Release Tablet","5/120 milligram(s) Prolonged-release tablet",2006-06-30,"PA0891/008/001","UCB (Pharma) Ireland Limited","PSEUDOEPHEDRINEHYDROCHLORIDE|Cetirizinedihydrochloride"
"10506","ZIRTENE","10 Milligram                                                                                            Film Coated Tablet",2006-06-13,"PA0577/084/001","McDermott Laboratories Ltd t/a Gerard Laboratories","CETIRIZINEDIHYDROCHLORIDE"
"10507","ZISMIRT","30 Milligram                                                                                            Film Coated Tablet",2004-09-10,"PA0577/059/001","McDermott Laboratories Ltd t/a Gerard Laboratories","MIRTAZAPINE"
"10508","ZISMIRT OROTAB","15 Milligram                                                                                            Orodispersible Tablet",2008-01-25,"PA0577/059/002","McDermott Laboratories Ltd t/a Gerard Laboratories","MIRTAZAPINE"
"10509","ZISMIRT OROTAB","30 Milligram                                                                                            Orodispersible Tablet",2008-01-25,"PA0577/059/003","McDermott Laboratories Ltd t/a Gerard Laboratories","MIRTAZAPINE"
"10510","ZISMIRT OROTAB","45 Milligram                                                                                            Orodispersible Tablet",2008-01-25,"PA0577/059/004","McDermott Laboratories Ltd t/a Gerard Laboratories","MIRTAZAPINE"
"10511","ZISPIN","15 Milligram                                                                                            Film Coated Tablet",1997-07-25,"PA0964/007/001","NV Organon","MIRTAZAPINE"
"10512","ZISPIN","30 Milligram                                                                                            Film Coated Tablet",1997-07-25,"PA0964/007/002","NV Organon","MIRTAZAPINE"
"10513","ZISPIN SOL TAB","45 Milligram                                                                                            Orodispersible Tablet",2003-02-21,"PA1286/047/003","Merck Sharp & Dohme Ireland (Human Health) Limited","MIRTAZAPINE"
"10514","ZISPIN SOL TAB","15 Milligram                                                                                            Orodispersible Tablet",2003-02-21,"PA1286/047/001","Merck Sharp & Dohme Ireland (Human Health) Limited","MIRTAZAPINE"
"10515","ZISPIN SOLTAB","30 Milligram                                                                                            Orodispersible Tablet",2003-02-21,"PA1286/047/002","Merck Sharp & Dohme Ireland (Human Health) Limited","MIRTAZAPINE"
"10516","ZISPIN SOLTAB","15 Milligram                                                                                            Orodispersible Tablet",2008-12-08,"PPA1151/090/001","Imbat Limited","MIRTAZAPINE"
"10517","ZISPIN SOLTAB","30 Milligram                                                                                            Orodispersible Tablet",2008-12-08,"PPA1151/090/002","Imbat Limited","MIRTAZAPINE"
"10518","ZISPIN SOLTAB","45 Milligram                                                                                            Orodispersible Tablet",2008-12-08,"PPA1151/090/003","Imbat Limited","MIRTAZAPINE"
"10519","ZITHROMAX","250 Milligram                                                                                            Capsules Hard",2013-11-29,"PPA1633/032/001","Primecrown 2010 Ltd","AZITHROMYCINDIHYDRATE"
"10520","Zithromax Capsules 250 mg","250 mg ZZZ Anhyd Milligrams Capsule, hard",1992-02-18,"PA0822/191/001","Pfizer Healthcare Ireland","Azithromycindihydrate"
"10521","Zithromax Powder for Oral Suspension 200mg/5ml","200mg/5ml ZZZ Anhyd mg/5ml Powder for oral suspension",1992-02-18,"PA0822/191/002","Pfizer Healthcare Ireland","Azithromycindihydrate"
"10522","ZOCOR","10 Milligram                                                                                            Film Coated Tablet",1989-11-10,"PA1286/022/002","Merck Sharp & Dohme Ireland (Human Health) Limited","SIMVASTATIN"
"10523","ZOCOR","20 Milligram                                                                                            Film Coated Tablet",1989-11-10,"PA1286/022/003","Merck Sharp & Dohme Ireland (Human Health) Limited","SIMVASTATIN"
"10524","ZOCOR","40 Milligram                                                                                            Film Coated Tablet",1989-11-10,"PA1286/022/004","Merck Sharp & Dohme Ireland (Human Health) Limited","SIMVASTATIN"
"10525","Zoely","2.5/1.5 milligram(s) Film-coated tablet",2011-07-27,"EU/1/11/690/001-002","Teva B.V.","NOMEGESTROLACETATE|Estradiolhemihydrate"
"10526","ZOFENIL 15MG FILM-COATED TABLETS","15mg Milligram                                                                                            Film Coated Tablet",1999-03-04,"PA0865/003/002","Menarini International Operations Luxembourg S.A.","ZOFENOPRILCALCIUM"
"10527","ZOFENIL 30 MG FILM-COATED TABLETS","30mg Milligram                                                                                            Film Coated Tablet",1999-03-04,"PA0865/003/003","Menarini International Operations Luxembourg S.A.","ZOFENOPRILCALCIUM"
"10528","ZOFENIL 60 MG FILM-COATED TABLETS","60mg Milligram                                                                                            Film Coated Tablet",1999-03-04,"PA0865/003/004","Menarini International Operations Luxembourg S.A.","ZOFENOPRILCALCIUM"
"10529","ZOFENIL 7.5 MG FILM-COATED TABLETS","7.5mg Milligram                                                                                            Film Coated Tablet",1999-03-04,"PA0865/003/001","Menarini International Operations Luxembourg S.A.","ZOFENOPRILCALCIUM"
"10530","ZOFENIL PLUS","30/12.5 Milligram                                                                                            Film Coated Tablet",2005-05-13,"PA0865/012/001","Menarini International Operations Luxembourg S.A.","ZOFENOPRILCALCIUM|HYDROCHLOROTHIAZIDE"
"10531","ZOFRAN","4 Milligram                                                                                            Film Coated Tablet",2012-06-22,"PPA1463/062/001","IMED Healthcare Ltd.","ONDANSETRON"
"10532","Zofran 16 mg Suppositories","16 milligram(s) Suppository",1998-05-01,"PA0896/036/004","Novartis Ireland Limited","Ondansetron"
"10533","Zofran 4mg Film-coated Tablets","4 milligram(s) Film-coated tablet",1990-06-27,"PA0896/036/005","Novartis Ireland Limited","Ondansetronhydrochloride"
"10534","ZOFRAN 4MG FILM-COATED TABLETS","4 Base Milligrams                                                                                      Film Coated Tablet",2003-10-17,"PPA0465/113/001","PCO Manufacturing","ONDANSETRONHYDROCHLORIDE"
"10535","Zofran 4mg/2ml Solution for Injection or Infusion","4/2 milligram(s)/millilitre Solution for injection/infusion",1990-06-27,"PA0896/036/001","Novartis Ireland Limited","Ondansetronhydrochloride"
"10536","Zofran 4mg/5ml Syrup","4 mg/5 ml mg/5ml Syrup",1998-04-17,"PA0896/036/003","Novartis Ireland Limited","Ondansetronhydrochloridedihydrate"
"10537","Zofran 8mg Film-coated Tablets","8 milligram(s) Film-coated tablet",1990-06-27,"PA0896/036/006","Novartis Ireland Limited","Ondansetronhydrochloride"
"10538","ZOFRAN 8MG FILM-COATED TABLETS","8 Base Milligrams                                                                                      Film Coated Tablet",2003-10-17,"PPA0465/113/002","PCO Manufacturing","ONDANSETRONHYDROCHLORIDE"
"10539","Zofran 8mg/4ml Solution for Injection or Infusion","8/4 milligram(s)/millilitre Solution for injection/infusion",1990-06-27,"PA0896/036/002","Novartis Ireland Limited","Ondansetronhydrochloride"
"10540","ZOFRAN ZYDIS","8mg Milligram                                                                                            Oral Lyophilisate",1998-07-13,"PA0896/036/008","Novartis Ireland Limited","ONDANSETRON"
"10541","Zofran Zydis 4 mg Oral Lyophilisate","4mg milligram(s) Oral lyophilisate",1998-07-13,"PA0896/036/007","Novartis Ireland Limited","Ondansetron"
"10542","ZOFTACOT","3.35 Mg/Ml Ear Drops Solution",2017-06-23,"PA1107/013/001","Laboratoires Thea","HYDROCORTISONESODIUMPHOSPHATE"
"10543","ZOLADEX","3.6 Base Milligrams                                                                                      Implant",1989-02-02,"PA0970/025/001","AstraZeneca UK Limited","GOSERELINACETATE"
"10544","ZOLADEX","3.6 Milligram                                                                                            Implant",2006-12-21,"PPA0465/188/001","PCO Manufacturing","GOSERELINACETATE"
"10545","ZOLADEX LA","10.8 Milligram                                                                                            Implant",2006-12-21,"PPA0465/188/002","PCO Manufacturing","GOSERELIN"
"10546","ZOLADEX LA","10.8 Base Milligrams                                                                                      Implant",1996-01-03,"PA0970/025/002","AstraZeneca UK Limited","GOSERELINACETATE"
"10547","ZOLADEX LA","10.8 Milligram                                                                                            Implant",2010-01-29,"PPA1151/133/001","Imbat Limited","GOSERELIN"
"10548","ZOLDEM","10 Milligram                                                                                            Film Coated Tablet",2003-06-30,"PA0577/048/001","McDermott Laboratories Ltd t/a Gerard Laboratories","ZOLPIDEMTARTRATE"
"10549","ZOLEDRONIC ACID","4/5 Mg/Ml Concentrate for Soln for Inf",2013-02-22,"PA1122/016/001","Noridem Enterprises Ltd","ZOLEDRONICACIDMONOHYDRATE"
"10550","ZOLEDRONIC ACID","4/5 Mg/Ml Concentrate for Soln for Inf",2013-03-01,"PA1339/032/001","Wockhardt UK Limited","ZOLEDRONICACIDMONOHYDRATE"
"10551","ZOLEDRONIC ACID","4mg/100 Millilitre                                                                                           Solution for Infusion",2013-05-17,"PA1339/032/002","Wockhardt UK Limited","ZOLEDRONICACID"
"10552","ZOLEDRONIC ACID","4/100 Mg/Ml Solution for Infusion",2018-06-22,"PA1390/167/001","Accord Healthcare Limited","ZOLEDRONICACID"
"10553","Zoledronic acid 4 mg/5 ml concentrate for solution for infusion","4/5 milligram(s)/millilitre Concentrate for solution for infusion",2012-10-12,"PA2059/019/001","Fresenius Kabi Deutschland GmbH","Zoledronicacid"
"10554","Zoledronic acid 4mg/5ml concentrate for solution for infusion","4 mg/5ml Concentrate for solution for infusion",2013-07-04,"PA0997/009/001","Intrapharm Laboratories Limited","Zoledronicacidmonohydrate"
"10555","Zoledronic acid 4mg/5ml concentrate for solution for infusion","4 mg/5ml Concentrate for solution for infusion",2013-07-04,"PA0997/009/002","Intrapharm Laboratories Limited","Zoledronicacidmonohydrate"
"10556","ZOLEDRONIC ACID ACCORD","4mg/5 Millilitre                                                                                           Concentrate for Soln for Inf",2014-01-16,"EU/1/13/834/001-003","Accord Healthcare Limited","ZOLEDRONICACIDMONOHYDRATE"
"10557","ZOLEDRONIC ACID ACTAVIS","4/5 Mg/Ml Solution for Infusion",2012-04-20,"EU/1/12/759/001-003","Actavis Group PTC ehf","ZOLEDRONICACIDMONOHYDRATE"
"10558","ZOLEDRONIC ACID FAIR MED","4/5 Mg/Ml Concentrate for Soln for Inf",2013-02-22,"PA1789/004/001","Fair-Med Healthcare GmbH","ZOLEDRONICACIDMONOHYDRATE"
"10559","Zoledronic Acid Hospira","4/5 milligram(s)/millilitre Concentrate for solution for infusion",2012-11-19,"EU/1/12/800/001-002","Pfizer Europe MA EEIG","Zoledronicacidmonohydrate"
"10560","Zoledronic Acid Hospira","4/100 milligram(s)/millilitre Solution for infusion",2012-11-19,"EU/1/12/800/003","Pfizer Europe MA EEIG","Zoledronicacidmonohydrate"
"10561","Zoledronic Acid Hospira","5/100 milligram(s)/millilitre Solution for infusion",2012-11-19,"EU/1/12/800/004","Pfizer Europe MA EEIG","Zoledronicacidmonohydrate"
"10562","ZOLEDRONIC ACID MEDAC","4/5 Mg/Ml Concentrate for Soln for Inf",2012-08-03,"EU/1/12/779/001-003","Medac Gesellschaft fur Klinische Spezialpraparate mbH","ZOLEDRONICACIDMONOHYDRATE"
"10563","ZOLEDRONIC ACID MEDAC","4/100 Mg/Ml Solution for Infusion",2012-08-03,"EU/1/12/779/004-006","Medac Gesellschaft fur Klinische Spezialpraparate mbH","ZOLEDRONICACIDMONOHYDRATE"
"10564","Zoledronic acid Mylan","4/5 milligram(s)/millilitre Concentrate for solution for infusion",NA,"EU/1/12/786/001-003","Mylan S.A.S.","Zoledronicacidmonohydrate"
"10565","ZOLEDRONIC ACID MYLAN","4mg/100 Millilitre                                                                                           Solution for Infusion",2014-07-04,"PA0405/064/001","Generics (UK) Limited","ZOLEDRONICACIDMONOHYDRATE"
"10566","Zoledronic acid Sandoz 4mg/5ml Concentrate for Solution for Infusion","4/5 milligram(s)/millilitre Concentrate for solution for infusion",2012-08-03,"PA0711/203/001","Rowex Ltd","Zoledronicacidmonohydrate"
"10567","ZOLEDRONIC ACID TEVA","4/100 Mg/Ml Solution for Infusion",2014-12-02,"EU/1/12/771/007-009","Teva B.V.","ZOLEDRONICACIDTEVA"
"10568","ZOLEDRONIC ACID TEVA PHARMA","4 mg/5 Millilitre                                                                                           Solution for Infusion",NA,"EU/1/12/771/001-006","Teva B.V.","ZOLEDRONICACID"
"10569","ZOLEPANT","20 Milligram                                                                                            Tablets Gastro-Resistant",2007-11-09,"PA0281/140/001","Pinewood Laboratories Ltd,","PANTOPRAZOLESODIUMSESQUIHYDRATE"
"10570","ZOLEPANT","40 Milligram                                                                                            Tablets Gastro-Resistant",2007-11-09,"PA0281/140/002","Pinewood Laboratories Ltd,","PANTOPRAZOLESODIUMSESQUIHYDRATE"
"10571","Zolmitriptan Actavis 2.5 mg Orodispersible Tablets","2.5 milligram(s) Orodispersible tablet",2009-08-14,"PA1380/035/003","Actavis Group PTC ehf","Zolmitriptan"
"10572","ZOLNOD","10 Milligram                                                                                            Film Coated Tablet",2002-03-08,"PA0711/039/001","Rowex Ltd","ZOLPIDEMTARTRATE"
"10573","ZOLPIDEM TARTRATE","5 Milligram                                                                                            Film Coated Tablet",2017-05-19,"PA0343/005/001","Key Pharmaceuticals Ltd","ZOLPIDEMTARTRATE"
"10574","ZOLPIDEM TARTRATE","10 Milligram                                                                                            Film Coated Tablet",2017-05-19,"PA0343/005/002","Key Pharmaceuticals Ltd","ZOLPIDEMTARTRATE"
"10575","ZOLPIDEM TARTRATE TEVA","5 Milligram                                                                                            Film Coated Tablet",2010-02-26,"PA0749/095/001","Teva Pharma B.V.","ZOLPIDEMTARTRATE"
"10576","ZOLPIDEM TARTRATE TEVA","10 Milligram                                                                                            Film Coated Tablet",2010-02-26,"PA0749/095/002","Teva Pharma B.V.","ZOLPIDEMTARTRATE"
"10577","ZOMACTON","4 Milligram                                                                                            Pdr+Solv for Soln for Inj",1995-05-18,"PA1009/008/002","Ferring Ireland Ltd","SOMATROPIN"
"10578","ZOMACTON","10 Mg/Ml Pdr+Solv for Soln for Inj",2008-12-19,"PA1009/008/003","Ferring Ireland Ltd","SOMATROPIN"
"10579","Zomarist","50/850 milligram(s) Film-coated tablet",NA,"EU/1/08/483/1-6","Novartis Europharm Limited",""
"10580","ZOMARIST","50/1000 Milligram                                                                                            Film Coated Tablet",2008-12-01,"EU/1/08/483/7-18","Novartis Europharm Limited",""
"10581","ZOMEL","30 Milligram                                                                                            Capsules Gastro-Resistant",2005-08-26,"PA0126/147/002","Clonmel Healthcare Ltd","LANSOPRAZOLE"
"10582","Zomel 15 mg gastro-resistant capsule, hard","15 milligram(s) Gastro-resistant capsule",2005-08-26,"PA0126/147/001","Clonmel Healthcare Ltd","Lansoprazole"
"10583","ZOMESTINE","5 Milligram                                                                                            Tablet Prolonged Release",2012-10-12,"PA1390/040/001","Accord Healthcare Limited","OXYCODONEHYDROCHLORIDE"
"10584","ZOMESTINE","10 Milligram                                                                                            Tablet Prolonged Release",2012-10-12,"PA1390/040/002","Accord Healthcare Limited","OXYCODONEHYDROCHLORIDE"
"10585","ZOMESTINE","20 Milligram                                                                                            Tablet Prolonged Release",2012-10-12,"PA1390/040/003","Accord Healthcare Limited","OXYCODONEHYDROCHLORIDE"
"10586","ZOMESTINE","40 Milligram                                                                                            Tablet Prolonged Release",2012-10-12,"PA1390/040/004","Accord Healthcare Limited","OXYCODONEHYDROCHLORIDE"
"10587","ZOMESTINE","80 Milligram                                                                                            Tablet Prolonged Release",2012-10-12,"PA1390/040/005","Accord Healthcare Limited","OXYCODONEHYDROCHLORIDE"
"10588","ZOMETA","4 Milligram                                                                                            Pdr+Solv for soln for Inf",2001-03-20,"EU/1/01/176/001","Novartis Europharm Limited","ZOLEDRONICACID"
"10589","ZOMETA","4 Milligram                                                                                            Pdr+Solv for Soln for Inj",2001-03-20,"EU/1/01/176/002","Novartis Europharm Limited","ZOLEDRONICACID"
"10590","ZOMETA","4 Milligram                                                                                            Pdr+Solv for Soln for Inj",2001-03-20,"EU/1/01/176/003","Novartis Europharm Limited","ZOLEDRONICACID"
"10591","ZOMETA","%v/v                                                                                                 Concentrate for Soln for Inf",2003-03-24,"EU/1/01/176/004","Novartis Europharm Limited","ZOLEDRONICACID"
"10592","ZOMETA","4/100 Mg/Ml Solution for Infusion",2011-08-24,"EU/1/01/176/007-009","Novartis Europharm Limited","ZOLEDRONICACIDMONOHYDRATE"
"10593","Zomig 2.5 mg Tablets","2.5 milligram(s) Film-coated tablet",1998-02-20,"PA2242/004/001","Grunenthal Pharma Ltd","Zolmitriptan"
"10594","ZOMIG 2.5 MG TABLETS.","2.5 Milligram                                                                                            Film Coated Tablet",2003-05-02,"PPA0465/099/001","PCO Manufacturing","ZOLMITRIPTAN"
"10595","Zomig Rapimelt 2.5 mg Orodispersible Tablets","2.5 milligram(s) Orodispersible tablet",2005-11-23,"PPA0465/099/002","PCO Manufacturing","Zolmitriptan"
"10596","Zomig Rapimelt 2.5 mg orodispersible Tablets","2.5 milligram(s) Orodispersible tablet",1999-10-01,"PA2242/004/002","Grunenthal Pharma Ltd","Zolmitriptan"
"10597","Zonegran","50 milligram(s) Capsule, hard",NA,"EU/1/04/307/003","Eisai GmbH","Zonisamide"
"10598","Zonegran","100 milligram(s) Capsule, hard",NA,"EU/1/04/307/004","Eisai GmbH","Zonisamide"
"10599","Zonegran","25 milligram(s) Orodispersible tablet",2010-07-27,"EU/1/04/307/014-015","Eisai GmbH","Zonisamide"
"10600","Zonegran","50 milligram(s) Orodispersible tablet",2010-07-27,"EU/1/04/307/016-017","Eisai GmbH","Zonisamide"
"10601","Zonegran","100 milligram(s) Orodispersible tablet",2010-07-27,"EU/1/04/307/018-019","Eisai GmbH","Zonisamide"
"10602","Zonegran","300 milligram(s) Orodispersible tablet",2010-07-27,"EU/1/04/307/020-021","Eisai GmbH","Zonisamide"
"10603","ZONEGRAN","25 milligram(s) Capsule, hard",2005-03-10,"EU/1/04/307/1-4","Eisai GmbH","Zonisamide"
"10604","ZONISAMIDE ACTAVIS","25 Milligram                                                                                            Capsules Hard",2016-04-15,"PA1380/190/001","Actavis Group PTC ehf","ZONISAMIDE"
"10605","ZONISAMIDE ACTAVIS","50 Milligram                                                                                            Capsules Hard",2016-04-15,"PA1380/190/002","Actavis Group PTC ehf","ZONISAMIDE"
"10606","ZONISAMIDE ACTAVIS","100 Milligram                                                                                            Capsules Hard",2016-04-15,"PA1380/190/003","Actavis Group PTC ehf","ZONISAMIDE"
"10607","ZONISAMIDE MYLAN","25 Milligram                                                                                            Capsules Hard",2016-03-31,"EU/1/16/1093/001-004","Mylan S.A.S.","ZONISAMIDE"
"10608","ZONISAMIDE MYLAN","50 Milligram                                                                                            Capsules Hard",2016-03-31,"EU/1/16/1093/005-008","Mylan S.A.S.","ZONISAMIDE"
"10609","ZONISAMIDE MYLAN","100 Milligram                                                                                            Capsules Hard",2016-03-31,"EU/1/16/1093/009-013","Mylan S.A.S.","ZONISAMIDE"
"10610","ZONISELLE","25 Milligram                                                                                            Capsules Hard",2016-04-15,"PA0688/035/001","Chanelle Medical","ZONISAMIDE"
"10611","ZONISELLE","50 Milligram                                                                                            Capsules Hard",2016-04-15,"PA0688/035/002","Chanelle Medical","ZONISAMIDE"
"10612","ZONISELLE","100 Milligram                                                                                            Capsules Hard",2016-04-15,"PA0688/035/003","Chanelle Medical","ZONISAMIDE"
"10613","Zopitan 3.75 mg Film-Coated Tablet","3.75 milligram(s) Film-coated tablet",1999-06-25,"PA0126/104/001","Clonmel Healthcare Ltd","Zopiclone"
"10614","Zopitan 7.5 mg Film-Coated Tablet","7.5 milligram(s) Film-coated tablet",1999-06-25,"PA0126/104/002","Clonmel Healthcare Ltd","Zopiclone"
"10615","ZORCLONE","7.5 Milligram                                                                                            Film Coated Tablet",1999-06-25,"PA0840/001/002","Synthon BV","ZOPICLONE"
"10616","ZOREEDA 25/125MCG HFA INHALER","25/125 Microgram                                                                                            Pressurised Inhalation Suspension",2017-03-10,"PA1963/009/001","Cipla Europe NV","FLUTICASONEPROPIONATE|SALMETEROLXINAFOATE"
"10617","ZOREEDA 25/250MCG HFA INHALER","25/250 Microgram                                                                                            Pressurised Inhalation Suspension",2017-03-10,"PA1963/009/002","Cipla Europe NV","FLUTICASONEPROPIONATE|SALMETEROLXINAFOATE"
"10618","ZOSTAVAX",">19400 PFU                                                                                                  Powder and solvent for suspension for injection in a pre-filled syringe",2015-12-18,"EU/1/06/341/003","Sanofi Pasteur MSD","VARICELLA-ZOSTERVIRUS,OKA/MERCKSTRAIN(LIVEATTENUATED)"
"10619","ZOSTAVAX","%v/v                                                                                                 Pdr+Solv for Susp for Inj",2006-05-19,"EU/1/06/341/01-13","Sanofi Pasteur MSD","VARICELLAVIRUSVACCINELIVE(OKA/MERCK)"
"10620","ZOTON FASTAB","15 Milligram                                                                                            Orodispersible Tablet",2005-02-18,"PPA0465/058/003","PCO Manufacturing","LANSOPRAZOLE"
"10621","ZOTON FASTAB","30 Milligram                                                                                            Orodispersible Tablet",2005-02-18,"PPA0465/058/004","PCO Manufacturing","LANSOPRAZOLE"
"10622","ZOTON FASTAB","15 Milligram                                                                                            Orodispersible Tablet",2001-11-16,"PA0822/101/002","Pfizer Healthcare Ireland","LANSOPRAZOLE"
"10623","ZOTON FASTAB","30 Milligram                                                                                            Orodispersible Tablet",2001-11-16,"PA0822/101/003","Pfizer Healthcare Ireland","LANSOPRAZOLE"
"10624","ZOTON FASTAB","30 Milligram                                                                                            Orodispersible Tablet",2006-09-15,"PPA1151/003/003","Imbat Limited","LANSOPRAZOLE"
"10625","ZOTON FASTAB","15 Milligram                                                                                            Orodispersible Tablet",2006-11-27,"PPA1151/003/005","Imbat Limited","LANSOPRAZOLE"
"10626","ZOTON FASTAB","15 Milligram                                                                                            Orodispersible Tablet",2008-03-28,"PPA1463/001/001","IMED Healthcare Ltd.","LANSOPRAZOLE"
"10627","ZOTON FASTAB","30 Milligram                                                                                            Orodispersible Tablet",2008-03-28,"PPA1463/001/002","IMED Healthcare Ltd.","LANSOPRAZOLE"
"10628","ZOTON FASTAB","15 Milligram                                                                                            Orodispersible Tablet",2010-06-04,"PPA1633/010/001","Primecrown 2010 Ltd","LANSOPRAZOLE"
"10629","ZOTON FASTAB","30 Milligram                                                                                            Orodispersible Tablet",2010-06-04,"PPA1633/010/002","Primecrown 2010 Ltd","LANSOPRAZOLE"
"10630","ZOVIRAX","200 Milligram                                                                                            Dispersable Tablet",2016-11-11,"PPA1562/183/001","LTT Pharma Limited","ACICLOVIR"
"10631","ZOVIRAX","800 Milligram                                                                                            Dispersable Tablet",2016-11-11,"PPA1562/183/002","LTT Pharma Limited","ACICLOVIR"
"10632","ZOVIRAX","200 MG/5ml                                                                                               Oral Suspension",2016-11-11,"PPA1562/183/003","LTT Pharma Limited","ACICLOVIR"
"10633","ZOVIRAX","200 Milligram                                                                                            Dispersable Tablet",2013-10-25,"PPA1463/086/001","IMED Healthcare Ltd.","ACICLOVIR"
"10634","ZOVIRAX","5 %w/w                                                                                                 Cream",2007-04-20,"PPA1151/028/001","Imbat Limited","ACICLOVIR"
"10635","ZOVIRAX","200 MG/5ml                                                                                               Oral Suspension",1986-03-24,"PA1077/084/005","GlaxoSmithKline (Ireland) Limited","ACICLOVIR"
"10636","ZOVIRAX","200 Milligram                                                                                            Dispersable Tablet",1996-12-03,"PA1077/084/007","GlaxoSmithKline (Ireland) Limited","ACICLOVIR"
"10637","ZOVIRAX","800 Milligram                                                                                            Dispersable Tablet",1994-09-09,"PA1077/084/009","GlaxoSmithKline (Ireland) Limited","ACICLOVIR"
"10638","ZOVIRAX","5 %w/w                                                                                                 Cream",1984-05-02,"PA1077/084/001","GlaxoSmithKline (Ireland) Limited","ACICLOVIR"
"10639","ZOVIRAX","30 mg/g Eye Ointment",1981-08-26,"PA1077/084/002","GlaxoSmithKline (Ireland) Limited","ACICLOVIR"
"10640","ZOVIRAX","5 %w/w                                                                                                 Cream",2001-12-14,"PPA0465/038/004","PCO Manufacturing","ACICLOVIR"
"10641","ZOVIRAX","200 Milligram                                                                                            Dispersable Tablet",2007-03-16,"PPA0465/038/005","PCO Manufacturing","ACICLOVIR"
"10642","ZOVIRAX","800 Milligram                                                                                            Dispersable Tablet",2017-03-31,"PPA0465/038/007","PCO Manufacturing","ACICLOVIR"
"10643","ZOVIRAX","200 MG/5ml                                                                                               Oral Suspension",2017-05-19,"PPA0465/038/008","PCO Manufacturing","ACICLOVIR"
"10644","ZOVIRAX","30 mg/g Eye Ointment",2014-02-21,"PPA0465/333/001","PCO Manufacturing","ACICLOVIR"
"10645","Zovirax 200mg Dispersible Tablets","200 milligram(s) Dispersible tablet",2013-12-20,"PPA1151/028/002","Imbat Limited","ACICLOVIR"
"10646","Zovirax 800 mg Dispersible Tablets","800 milligram(s) Dispersible tablet",2013-12-20,"PPA1151/028/003","Imbat Limited","ACICLOVIR"
"10647","ZOVIRAX COLD SORE","5.0 %w/w                                                                                                 Cream",1993-07-16,"PA0678/090/002","GlaxoSmithKline Consumer Healthcare (Ireland) Limited","ACICLOVIR"
"10648","ZOVIRAX DOUBLE STRENGTH","400 MG/5ml                                                                                               Oral Suspension",1991-02-27,"PA1077/084/006","GlaxoSmithKline (Ireland) Limited","ACICLOVIR"
"10649","ZOVIRAX DUO","50/10 Milligram                                                                                            Cream",2017-04-13,"PA0678/143/001","GlaxoSmithKline Consumer Healthcare (Ireland) Limited","ACICLOVIRPH.EUR.|HYDROCORTISONEPH.EUR."
"10650","ZOVIRAX IV","250 Milligram                                                                                            Pdr for Soln for Infusion",1983-05-03,"PA1077/084/003","GlaxoSmithKline (Ireland) Limited","ACICLOVIRSODIUM"
"10651","ZUBSOLV","0.7/0.18 Milligram                                                                                            Tablet Sublingual",2017-11-10,"EU/1/17/1233/001","Mundipharma Corporation Limited","BUPRENORPHINEHYDROCHLORIDE|NALOXONEHYDROCHLORIDEDIHYDRATE"
"10652","ZUBSOLV","1.4/0.36 Milligram                                                                                            Tablet Sublingual",2017-11-10,"EU/1/17/1233/002","Mundipharma Corporation Limited","BUPRENORPHINEHYDROCHLORIDE|NALOXONEHYDROCHLORIDEDIHYDRATE"
"10653","ZUBSOLV","2.9/0.71 Milligram                                                                                            Tablet Sublingual",2017-11-10,"EU/1/17/1233/003","Mundipharma Corporation Limited","BUPRENORPHINEHYDROCHLORIDE|NALOXONEHYDROCHLORIDEDIHYDRATE"
"10654","ZUBSOLV","5.7/1.4 Milligram                                                                                            Tablet Sublingual",2017-11-10,"EU/1/17/1233/004","Mundipharma Corporation Limited","BUPRENORPHINEHYDROCHLORIDE|NALOXONEHYDROCHLORIDEDIHYDRATE"
"10655","ZUBSOLV","8.6/2.1 Milligram                                                                                            Tablet Sublingual",2017-11-10,"EU/1/17/1233/005","Mundipharma Corporation Limited","BUPRENORPHINEHYDROCHLORIDE|NALOXONEHYDROCHLORIDEDIHYDRATE"
"10656","ZUBSOLV","11.4/2.9 Milligram                                                                                            Tablet Sublingual",2017-11-10,"EU/1/17/1233/006","Mundipharma Corporation Limited","BUPRENORPHINEHYDROCHLORIDE|NALOXONEHYDROCHLORIDEDIHYDRATE"
"10657","ZURAMPIC","200 Milligram                                                                                            Film Coated Tablet",2016-02-18,"EU/1/15/1080/001-005","Grunenthal GmbH","LESINURAD"
"10658","ZUTECTRA","500 International Unit                                                                                   Solution for Injection",2009-11-30,"EU/1/09/600/001","Biotest Pharma GmbH","HUMANPLASMAPROTEIN&gt;96%IMMUNOGLOBULINS|HBSANTIBODIES"
"10659","ZYBAN","150 Milligram                                                                                            Tablet Prolonged Release",2000-06-23,"PA1077/017/001","GlaxoSmithKline (Ireland) Limited","BUPROPIONHYDROCHLORIDE"
"10660","Zyban 150 mg prolonged release tablets","150 milligram(s) Prolonged-release tablet",2017-09-15,"PPA0465/089/002","PCO Manufacturing","Bupropionhydrochloride"
"10661","ZYCLARA","3.75 %w/w                                                                                                 Cream",2012-08-23,"EU/1/12/783/001-003","Meda AB","IMIQUIMOD"
"10662","ZYDELIG","100 Milligram                                                                                            Film Coated Tablet",2014-09-18,"EU/1/14/938/001","Gilead Sciences Ireland UC","IDELALISIB"
"10663","ZYDELIG","150 Milligram                                                                                            Film Coated Tablet",2014-09-18,"EU/1/14/938/002","Gilead Sciences Ireland UC","IDELALISIB"
"10664","ZYDOL","100mg/2ml Mg/Ml Solution for Injection",1993-04-16,"PA2242/005/002","Grunenthal Pharma Ltd","TRAMADOLHYDROCHLORIDE"
"10665","ZYDOL","50 Milligram                                                                                            Capsules Hard",2007-07-27,"PPA1151/031/001","Imbat Limited","TRAMADOLHYDROCHLORIDE"
"10666","ZYDOL 50 mg Hard Capsules","50 milligram(s) Capsule, hard",1993-04-16,"PA2242/005/001","Grunenthal Pharma Ltd","Tramadolhydrochloride"
"10667","ZYDOL SR 100 mg prolonged-release tablets","100 milligram(s) Prolonged-release tablet",1997-02-21,"PA2242/005/003","Grunenthal Pharma Ltd","Tramadolhydrochloride"
"10668","ZYDOL SR 150 mg prolonged-release tablets","150 milligram(s) Prolonged-release tablet",1997-02-21,"PA2242/005/004","Grunenthal Pharma Ltd","Tramadolhydrochloride"
"10669","ZYDOL SR 200 mg prolonged-release tablets","200 milligram(s) Prolonged-release tablet",1997-02-21,"PA2242/005/005","Grunenthal Pharma Ltd","Tramadolhydrochloride"
"10670","ZYDOL SR 50mg prolonged-release tablets","50 milligram(s) Prolonged-release tablet",2007-07-27,"PA2242/005/006","Grunenthal Pharma Ltd","Tramadolhydrochloride"
"10671","ZYKADIA","150 Milligram                                                                                            Capsules Hard",2015-05-06,"EU/1/15/999/001","Novartis Europharm Ltd","CERITINIB"
"10672","ZYLLT","75 Milligram                                                                                            Film Coated Tablet",2009-09-28,"EU/1/09/553/001-10","Krka d.d., Novo mesto","CLOPIDOGRELHYDROGENSULPHATE"
"10673","ZYLORIC","300 Milligram                                                                                            Tablets",1989-02-01,"PPA0465/017/002","PCO Manufacturing","ALLOPURINOL"
"10674","Zyloric 100 mg Tablets","100 milligram(s) Tablet",NA,"PA1691/002/001","Aspen Pharma Trading Limited","Allopurinol"
"10675","Zyloric 300 mg Tablets","300 milligram(s) Tablet",NA,"PA1691/002/002","Aspen Pharma Trading Limited","Allopurinol"
"10676","ZYNOR ALLERGY","10 Milligram                                                                                            Film Coated Tablet",2013-06-21,"PA0749/175/002","Teva Pharma B.V.","CETIRIZINEDIHYDROCHLORIDE"
"10677","ZYPADHERA","210 Milligram                                                                                            Pdr+Solv for Susp for Inj",2008-11-19,"EU/1/08/479/001","Eli Lilly Nederland B.V.","OLANZAPINEPAMOATEMONOHYDRATE"
"10678","ZYPADHERA","300 Milligram                                                                                            Pdr+Solv for Susp for Inj",2008-11-19,"EU/1/08/479/002","Eli Lilly Nederland B.V.","OLANZAPINEPAMOATEMONOHYDRATE"
"10679","ZYPADHERA","405 Milligram                                                                                            Pdr+Solv for Susp for Inj",2008-11-19,"EU/1/08/479/003","Eli Lilly Nederland B.V.","OLANZAPINEPAMOATEMONOHYDRATE"
"10680","Zyprexa","2.5 milligram(s) Coated tablet",1996-09-27,"EU/1/96/022/002","Eli Lilly Nederland B.V.","Olanzapine"
"10681","ZYPREXA","5 Milligram                                                                                            Coated Tablets",1996-09-27,"EU/1/96/022/004","Eli Lilly Nederland B.V.","OLANZAPINE"
"10682","ZYPREXA","7.5 Milligram                                                                                            Coated Tablets",1996-09-27,"EU/1/96/022/006","Eli Lilly Nederland B.V.","OLANZAPINE"
"10683","ZYPREXA","10 Milligram                                                                                            Coated Tablets",1996-09-27,"EU/1/96/022/009","Eli Lilly Nederland B.V.","OLANZAPINE"
"10684","ZYPREXA","15 Milligram                                                                                            Coated Tablets",2000-12-27,"EU/1/96/022/012","Eli Lilly Nederland B.V.","OLANZAPINE"
"10685","ZYPREXA","20 Milligram                                                                                            Coated Tablets",2000-12-27,"EU/1/96/022/014","Eli Lilly Nederland B.V.","OLANZAPINE"
"10686","ZYPREXA","10 Milligram                                                                                            Pdr for Soln for Injection",2001-07-02,"EU/1/96/022/016","Eli Lilly Nederland B.V.","OLANZAPINE"
"10687","ZYPREXA VELOTAB","5 Milligram                                                                                            Orodispersible Tablet",2000-02-03,"EU/1/99/125/001","Eli Lilly Nederland B.V.","OLANZAPINE"
"10688","ZYPREXA VELOTAB","10 Milligram                                                                                            Orodispersible Tablet",2000-02-03,"EU/1/99/125/002","Eli Lilly Nederland B.V.","OLANZAPINE"
"10689","ZYPREXA VELOTAB","15 Milligram                                                                                            Orodispersible Tablet",2000-02-03,"EU/1/99/125/003","Eli Lilly Nederland B.V.","OLANZAPINE"
"10690","ZYPREXA VELOTAB","20 Milligram                                                                                            Orodispersible Tablet",2000-02-03,"EU/1/99/125/004","Eli Lilly Nederland B.V.","OLANZAPINE"
"10691","ZYTIGA","250 Milligram                                                                                            Tablets",2011-09-05,"EU/1/11/714/001","Janssen-Cilag International NV","ABIRATERONEACETATE"
"10692","ZYTIGA","500 Milligram                                                                                            Film Coated Tablet",2016-11-09,"EU/1/11/714/002-003","Janssen-Cilag International NV","ABIRATERONEACETATE"
"10693","ZYVOX 100 MG/5 ML GRANULES FOR ORAL SUSPENSION","100/5 Mg/Ml Granules for Oral Suspension",2001-07-27,"PA0822/143/001","Pfizer Healthcare Ireland","LINEZOLID"
"10694","ZYVOX 2 MG/ML SOLUTION FOR INFUSION","2 Mg/Ml Solution for Infusion",2001-07-27,"PA0822/143/002","Pfizer Healthcare Ireland","LINEZOLID"
"10695","ZYVOX 600 MG FILM-COATED TABLETS","600 Milligram                                                                                            Film Coated Tablet",2001-07-27,"PA0822/143/004","Pfizer Healthcare Ireland","LINEZOLID"
